data_2lcj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lcj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.534 ' HD3' HD12 ' A' ' 76' ' ' LEU . 57.8 Cg_endo -67.21 161.77 41.47 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.561 1.507 . . . . 0.0 109.212 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.512 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.56 -26.21 64.28 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 119.212 -1.471 . . . . 0.0 110.712 175.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.74 -26.17 44.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.468 0.707 . . . . 0.0 112.264 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 20' ' ' THR . 31.8 m -64.77 123.99 20.8 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.352 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.673 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 45.6 mtm-85 -81.42 128.23 33.64 Favored 'General case' 0 C--O 1.184 -2.364 0 C-N-CA 123.195 0.598 . . . . 0.0 109.878 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 19' ' ' ILE . 13.6 tt -112.48 130.34 66.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 122.193 -0.317 . . . . 0.0 110.332 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -85.13 123.77 31.03 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.52 0.676 . . . . 0.0 109.784 177.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.485 ' N ' HD13 ' A' ' 9' ' ' LEU . 24.8 m -136.41 -179.42 2.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.62 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.492 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 33.0 tt0 -130.16 119.58 23.21 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.567 HG12 HG13 ' A' ' 47' ' ' ILE . 11.8 mt -120.45 122.66 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.527 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.786 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 55.34 38.33 30.17 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.807 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.21 22.19 78.51 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.131 -0.94 . . . . 0.0 113.223 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.71 119.92 21.6 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-O 121.11 0.481 . . . . 0.0 109.941 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 57.2 Cg_endo -72.8 126.14 11.1 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 122.486 2.124 . . . . 0.0 111.52 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -129.48 140.59 51.23 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.457 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.515 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 26.6 ttpt -110.42 101.5 10.2 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 8' ' ' ILE . 10.9 pt -139.75 136.86 39.51 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.25 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.711 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 4.5 p -40.02 148.95 0.07 Allowed 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.015 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 51.1 mt -60.15 -25.06 65.22 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.874 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.711 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 7.4 ptm180 -78.08 -28.03 48.69 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.509 ' HA ' ' OE2' ' A' ' 26' ' ' GLU . 60.8 mt-10 -85.29 -48.67 8.85 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.278 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.441 ' HG ' HG23 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -50.94 -51.37 52.94 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.561 0.696 . . . . 0.0 109.887 175.066 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.412 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -45.42 -34.17 2.97 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.322 -1.308 . . . . 0.0 113.598 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.509 ' OE2' ' HA ' ' A' ' 23' ' ' GLU . 30.3 mt-10 -69.68 -18.47 63.56 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.71 1.86 18.65 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.568 0.699 . . . . 0.0 109.836 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.565 ' CZ ' HG23 ' A' ' 47' ' ' ILE . 99.2 m-85 -118.96 160.86 21.2 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.765 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -143.95 -172.15 3.69 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.942 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.453 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.4 t70 63.36 82.36 0.18 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.574 0.702 . . . . 0.0 110.329 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -99.22 129.36 45.45 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.388 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.478 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.4 ptt180 -118.28 152.8 35.05 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.172 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.435 ' HD1' ' O ' ' A' ' 37' ' ' VAL . 3.4 t80 -104.6 123.88 48.35 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.477 ' HG2' ' ND2' ' A' ' 35' ' ' ASN . 36.9 tt0 -167.0 146.73 5.43 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.302 -174.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.477 ' ND2' ' HG2' ' A' ' 34' ' ' GLU . 0.9 OUTLIER 62.5 18.61 10.56 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 123.421 0.451 . . . . 0.0 110.547 177.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.6 mtt 71.12 15.93 6.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.013 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.435 ' O ' ' HD1' ' A' ' 33' ' ' TYR . 27.1 m -130.47 -173.34 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.83 140.26 50.25 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.219 0.533 . . . . 0.0 109.968 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.478 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.3 t -127.72 123.67 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.456 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.008 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.443 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 13.2 ttm180 -111.22 126.96 55.42 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.38 147.3 52.38 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.386 -175.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 8.2 tmtm? 84.24 109.87 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.484 0 O-C-N 124.426 1.079 . . . . 0.0 110.637 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.57 149.43 23.93 Favored 'Trans proline' 0 N--CA 1.435 -1.917 0 C-N-CA 122.252 1.968 . . . . 0.0 111.25 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.488 ' HE2' ' O ' ' A' ' 26' ' ' GLU . 1.5 mtmt -85.66 -2.75 58.5 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.204 0.526 . . . . 0.0 111.118 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -144.32 -165.82 2.22 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.0 tp10 -87.18 103.39 15.37 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 175.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.567 HG13 HG12 ' A' ' 12' ' ' ILE . 1.4 mp -119.09 121.42 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.889 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 37.7 mmtt -118.43 169.51 9.7 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.077 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.501 HG11 ' CB ' ' A' ' 169' ' ' ALA . 14.6 p -128.17 133.92 66.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.326 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.524 ' CD1' HD11 ' A' ' 9' ' ' LEU . 31.5 m-85 -83.71 123.15 29.54 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.915 176.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.9 t -127.66 174.61 8.94 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.501 HG12 HD13 ' A' ' 176' ' ' ILE . 1.2 mm -125.27 141.94 43.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.583 0.706 . . . . 0.0 111.501 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.661 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 32.8 t70 -90.87 115.25 27.77 Favored 'General case' 0 C--O 1.194 -1.842 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.569 ' H ' HD11 ' A' ' 54' ' ' LEU . 4.8 mp -67.16 -33.56 75.67 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 121.848 0.832 . . . . 0.0 111.665 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.661 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -73.72 -30.92 63.11 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.773 -174.05 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.401 ' CB ' ' HD2' ' A' ' 58' ' ' LYS . 64.7 p -113.22 -22.01 10.69 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.179 -177.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 53' ' ' ASP . . . 81.18 18.07 70.26 Favored Glycine 0 N--CA 1.431 -1.633 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.492 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.498 ' C ' HD13 ' A' ' 52' ' ' ILE . 26.2 mttp -98.12 157.46 16.13 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.82 112.01 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.255 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.2 m -110.74 165.46 6.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.651 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.9 tp -120.69 140.28 51.84 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.1 t -143.49 171.59 13.94 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.013 0.435 . . . . 0.0 111.22 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.69 160.93 19.43 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.262 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.477 HD12 ' N ' ' A' ' 64' ' ' ILE . 3.0 mp -97.47 143.05 13.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.141 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.404 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 79.2 mm-40 -91.13 -38.76 12.54 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 176.93 175.48 0.37 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.788 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.3 t -105.69 130.2 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.049 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 61.2 mt -89.89 106.6 17.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.689 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.428 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 88.0 tttt -121.37 110.42 16.07 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.798 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 163' ' ' PHE . . . -130.48 139.01 34.33 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.762 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD2' HG11 ' A' ' 37' ' ' VAL . 7.4 Cg_endo -53.14 124.42 15.56 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.877 2.385 . . . . 0.0 112.108 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.56 96.69 0.18 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.686 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.5 m -105.18 -58.25 1.92 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.994 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -79.66 175.42 10.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.147 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -101.22 171.46 7.59 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.534 HD12 ' HD3' ' A' ' 3' ' ' PRO . 10.6 mt -126.72 141.92 51.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.718 0.771 . . . . 0.0 111.775 -173.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 88' ' ' GLU . 13.9 mt -84.4 143.88 10.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 10.7 ttt85 -116.57 138.02 51.73 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-O 121.213 0.53 . . . . 0.0 109.814 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.61 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.7 m-85 -116.12 122.47 45.2 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.546 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 152' ' ' LYS . 36.0 tt0 -109.77 124.49 51.36 Favored 'General case' 0 CA--C 1.47 -2.104 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.576 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -88.24 160.78 17.54 Favored 'General case' 0 C--N 1.271 -2.818 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.813 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.534 ' HG2' HD13 ' A' ' 149' ' ' LEU . 1.7 pt-20 -60.72 -19.28 58.5 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.592 0.711 . . . . 0.0 110.529 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -91.48 -12.14 35.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.93 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.07 14.38 49.04 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.994 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.543 ' O ' HD23 ' A' ' 81' ' ' LEU . 4.2 mtt180 -84.29 138.25 33.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 27.0 p -141.63 137.84 32.12 Favored 'General case' 0 C--N 1.287 -2.122 0 C-N-CA 118.969 -1.092 . . . . 0.0 112.845 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.451 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 5.0 p90 -136.0 154.64 51.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.507 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 25.2 mt-10 -125.32 151.84 45.49 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.549 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -143.42 157.93 44.06 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.399 178.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.489 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -69.8 15.27 0.08 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.677 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.6 -36.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 125.448 1.499 . . . . 0.0 112.213 178.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.523 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 26.7 t70 -78.41 -18.07 55.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.333 0.587 . . . . 0.0 109.639 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -77.83 125.75 85.14 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.298 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 37.7 Cg_endo -66.12 142.55 68.1 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.133 2.556 . . . . 0.0 112.622 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 20.7 t -111.97 145.47 18.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.6 tp -101.72 108.9 20.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.837 0.351 . . . . 0.0 110.793 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.553 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.2 p -112.22 150.09 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.367 0.603 . . . . 0.0 111.067 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.456 ' CD2' HD13 ' A' ' 148' ' ' LEU . 58.9 t80 -105.62 93.62 4.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.18 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 6.9 pt-20 -139.44 158.81 43.5 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 86.6 m-20 64.57 22.14 12.59 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.212 0.53 . . . . 0.0 110.154 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.25 14.72 64.48 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.031 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -137.21 171.65 14.17 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 117.365 0.583 . . . . 0.0 110.042 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -100.83 122.75 43.96 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.475 HG13 HG12 ' A' ' 97' ' ' VAL . 24.6 pt -121.04 146.98 25.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.836 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 mp0 -104.17 112.09 24.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.278 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.419 ' CE ' HG11 ' A' ' 97' ' ' VAL . 11.5 ptpt -124.2 139.44 53.92 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.576 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.63 ' O ' HG22 ' A' ' 111' ' ' VAL . 14.3 mmt180 -60.55 158.84 11.52 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.677 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -60.38 -40.79 92.13 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.864 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.43 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.7 p90 -73.47 -1.13 17.17 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.868 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -111.13 -13.79 13.97 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.693 0.759 . . . . 0.0 109.772 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 107' ' ' ARG . 93.6 t -79.2 149.0 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.709 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 21.6 mtmt -123.36 165.81 16.38 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.192 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.81 139.68 55.26 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.91 4.5 72.2 Favored Glycine 0 C--N 1.307 -1.032 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.874 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.709 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -75.33 167.93 20.96 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.42 ' HG2' ' HG3' ' A' ' 150' ' ' GLU . 25.2 mttp -119.61 165.1 14.89 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 121.404 0.621 . . . . 0.0 110.511 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.451 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -133.55 159.93 42.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.423 HD21 ' N ' ' A' ' 119' ' ' VAL . 0.9 OUTLIER -88.64 131.79 34.83 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.687 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -119.21 132.58 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.193 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB3' HD21 ' A' ' 180' ' ' ASN . 48.4 t . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 121.626 0.727 . . . . 0.0 109.926 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.456 HD13 ' CD2' ' A' ' 98' ' ' TYR . 14.4 mt . . . . . 0 N--CA 1.417 -2.088 0 CA-C-O 121.199 0.523 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.576 ' HB3' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -113.21 137.86 50.84 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.027 -172.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.42 ' HG3' ' HG2' ' A' ' 116' ' ' LYS . 15.1 mt-10 -92.19 146.68 23.52 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.3 1.047 . . . . 0.0 112.7 175.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.473 HD13 ' CD1' ' A' ' 79' ' ' PHE . 75.2 mt -78.73 111.99 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.534 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.546 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.533 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 48.9 mmtt -71.63 -40.36 69.8 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.54 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -149.51 133.55 17.15 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 76.2 mt -116.92 144.64 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.609 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.448 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 19.0 ptpt -152.78 164.09 38.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.155 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.484 ' CZ ' HD13 ' A' ' 77' ' ' ILE . 15.3 m-85 -101.59 116.55 33.0 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.417 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.16 173.9 11.07 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.958 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -106.24 152.83 22.99 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 120.928 0.394 . . . . 0.0 111.486 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.28 128.38 36.47 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.224 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -65.85 -47.36 75.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.101 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.08 170.95 9.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.822 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -90.29 0.74 57.1 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 121.582 0.706 . . . . 0.0 109.933 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 96.2 m-85 -141.03 148.29 40.02 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.256 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.447 HG13 ' HA ' ' A' ' 3' ' ' PRO . 4.0 m -118.03 155.49 19.91 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.696 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 74.3 m-85 -133.43 173.58 11.33 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.68 0.276 . . . . 0.0 110.926 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.503 ' HB2' ' CD1' ' A' ' 68' ' ' ILE . 67.0 m -158.38 -23.37 0.08 Allowed 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.415 ' HG ' HD13 ' A' ' 24' ' ' LEU . 1.9 tm? 67.17 107.03 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.592 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -88.63 116.48 26.91 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.513 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.501 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -132.27 -167.25 1.86 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.995 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--N 1.328 -0.345 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -179.091 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.511 HG13 HG23 ' A' ' 177' ' ' ILE . 2.8 p -148.78 162.67 5.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.44 0.638 . . . . 0.0 111.225 -176.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.541 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 90.6 mt -108.34 116.91 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.605 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.511 HG23 HG13 ' A' ' 175' ' ' VAL . 37.7 pt -125.24 172.91 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.678 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 7' ' ' ARG . 8.2 t-20 47.9 -130.65 1.61 Allowed 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.055 0.942 . . . . 0.0 109.732 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -88.28 55.37 3.4 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.742 0.782 . . . . 0.0 109.487 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.687 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.6 m-20 67.38 47.76 1.23 Allowed 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.856 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 81.4 mt -87.94 118.18 33.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 118' ' ' LEU . 48.7 t -90.51 135.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.189 -175.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--N 1.307 -1.274 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.102 178.31 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.44 ' CE1' HD11 ' A' ' 177' ' ' ILE . 62.4 m-85 . . . . . 0 C--O 1.221 -0.405 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.526 ' HD3' HD11 ' A' ' 76' ' ' LEU . 18.7 Cg_endo -58.51 -29.69 89.51 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.886 2.391 . . . . 0.0 112.569 -175.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.481 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 124.28 -37.48 2.64 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.06 -4.62 21.95 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.449 0.642 . . . . 0.0 111.523 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.6 m -67.95 127.73 33.91 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.963 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 33.5 mmt180 -80.02 131.44 35.79 Favored 'General case' 0 C--O 1.181 -2.53 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 19' ' ' ILE . 8.1 tt -119.22 130.93 73.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.649 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.482 HD13 ' N ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -87.0 123.44 32.1 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 121.602 0.715 . . . . 0.0 110.187 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.482 ' N ' HD13 ' A' ' 9' ' ' LEU . 31.5 m -135.59 -178.9 2.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.489 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -129.23 121.42 27.58 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.531 HG12 HG13 ' A' ' 47' ' ' ILE . 21.2 mt -119.32 121.47 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.864 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.54 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 54.58 38.49 29.96 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.97 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.35 18.45 79.86 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.061 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.2 t -124.28 121.84 26.06 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.1 121.43 6.9 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 C-N-CA 122.383 2.055 . . . . 0.0 111.05 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -125.41 141.71 51.91 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.702 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 38.8 ttpt -109.93 100.82 9.72 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.9 pt -121.98 -173.71 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.183 -2.447 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.697 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 21.1 p -92.25 172.29 8.51 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.282 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 15.0 mt -72.98 -22.25 60.72 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.77 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.697 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.2 ptm180 -85.28 -24.63 27.64 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.602 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 71.1 mt-10 -83.71 -42.67 16.35 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.917 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.458 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 16.9 tp -55.98 -43.91 78.03 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.996 0.903 . . . . 0.0 108.917 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -51.41 -33.95 32.62 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.463 -1.699 . . . . 0.0 112.613 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 27.3 mt-10 -73.65 -17.07 61.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.69 2.71 21.64 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.393 0.616 . . . . 0.0 109.791 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.467 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.6 m-85 -117.08 161.61 19.14 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.364 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -139.06 -173.45 3.58 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.231 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.499 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER 60.6 86.07 0.1 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.35 0.595 . . . . 0.0 110.919 177.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -107.23 131.19 54.46 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.115 0.959 . . . . 0.0 112.368 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.428 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 15.3 ptt-85 -116.32 153.58 31.72 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.731 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -101.01 130.77 47.05 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -166.55 143.22 4.84 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.405 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 60.66 21.11 11.04 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 123.715 0.634 . . . . 0.0 110.928 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 36.7 mtm 71.59 20.06 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.417 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.406 HG13 ' HD2' ' A' ' 71' ' ' PRO . 5.1 m -134.9 -174.72 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -115.03 138.75 50.5 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-O 121.124 0.488 . . . . 0.0 110.534 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.428 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.2 t -128.52 124.83 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.33 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 18.5 ttm180 -114.04 127.45 55.94 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.499 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -130.66 144.41 51.41 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -173.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 43.5 tptt 82.16 111.77 0.03 OUTLIER Pre-proline 0 CA--C 1.518 -0.273 0 O-C-N 124.361 1.038 . . . . 0.0 111.232 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 62.0 Cg_endo -78.14 153.9 28.64 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.405 2.07 . . . . 0.0 112.282 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -85.81 -1.91 57.71 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.162 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -147.58 -165.9 2.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 32.7 tt0 -86.43 101.51 13.21 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.531 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -116.33 116.01 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.194 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 26.1 mmtp -117.55 164.8 14.37 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.648 175.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.46 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.9 p -119.42 132.1 70.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.536 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -84.62 118.59 24.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.17 0.509 . . . . 0.0 110.04 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.4 p -124.43 176.97 6.15 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.938 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.511 HD12 ' C ' ' A' ' 58' ' ' LYS . 1.2 mm -130.3 138.2 54.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.588 0.709 . . . . 0.0 110.813 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.433 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 25.2 t70 -84.61 120.02 25.89 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.128 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.418 HD22 ' ND2' ' A' ' 174' ' ' ASN . 11.3 mt -67.33 -29.91 69.6 Favored 'General case' 0 CA--C 1.475 -1.933 0 CA-C-O 122.036 0.922 . . . . 0.0 112.048 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.433 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -81.81 -30.24 32.31 Favored 'General case' 0 C--N 1.263 -3.188 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.523 -171.548 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.7 p -114.54 -25.28 8.41 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.264 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.71 14.04 74.03 Favored Glycine 0 N--CA 1.427 -1.904 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.162 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.511 ' C ' HD12 ' A' ' 52' ' ' ILE . 41.5 mtpt -89.83 152.55 21.22 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -91.42 108.48 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.923 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.3 m -110.21 163.27 7.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.096 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.94 141.95 49.18 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.438 HG22 ' HB3' ' A' ' 170' ' ' LYS . 13.5 t -149.89 171.27 17.05 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.131 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.13 160.6 21.83 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 121.617 0.722 . . . . 0.0 111.197 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 64' ' ' ILE . 2.2 mp -96.0 145.52 8.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.174 -178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -91.01 -37.97 13.12 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 p30 174.18 175.33 0.16 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.803 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.12 138.19 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.171 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 35.7 mt -101.44 109.74 26.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.045 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -120.88 112.4 18.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.87 137.37 30.63 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.295 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.406 ' HD2' HG13 ' A' ' 37' ' ' VAL . 71.2 Cg_exo -48.17 131.7 22.39 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.454 2.769 . . . . 0.0 113.275 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.11 93.18 9.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.227 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 p -89.7 -24.9 21.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.04 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -110.97 -169.99 1.56 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.801 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.548 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 28.0 m170 -115.28 171.21 7.84 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.526 HD11 ' HD3' ' A' ' 3' ' ' PRO . 5.9 mt -121.32 148.27 44.56 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.966 0.888 . . . . 0.0 112.762 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.5 HD13 ' CZ ' ' A' ' 156' ' ' TYR . 27.7 mt -85.55 143.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.576 172.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 12.5 ttt85 -116.5 137.99 51.74 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-O 121.126 0.489 . . . . 0.0 110.157 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 86' ' ' SER . 58.5 m-85 -114.36 122.32 46.31 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.622 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 152' ' ' LYS . 23.1 tt0 -112.51 123.02 49.36 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.566 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.3 mm? -86.2 160.39 19.21 Favored 'General case' 0 N--CA 1.403 -2.775 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.218 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.569 ' HG2' ' CD1' ' A' ' 149' ' ' LEU . 1.4 pt-20 -64.74 -13.27 54.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.848 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -97.54 -8.52 28.92 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.538 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.56 10.58 57.88 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.082 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.564 ' O ' HD21 ' A' ' 81' ' ' LEU . 4.7 mtt180 -81.59 136.85 35.56 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 48.4 p -140.6 143.12 35.08 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.685 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -138.17 145.61 41.73 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.573 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 49.0 mt-10 -117.19 146.29 43.32 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.352 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.3 p -142.78 153.86 43.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.733 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.498 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.88 10.28 0.93 Allowed 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.653 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 1.9 m 63.66 161.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 123.475 0.71 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 107' ' ' ARG . 33.9 t70 73.28 -30.61 0.21 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.124 0.488 . . . . 0.0 110.918 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.516 ' H ' ' C ' ' A' ' 91' ' ' VAL . 97.6 m-70 -68.28 132.87 91.47 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.249 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.75 115.76 4.37 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.361 2.707 . . . . 0.0 114.901 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 18.3 t -94.74 149.19 4.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 103' ' ' PHE . 1.1 tm? -103.08 118.58 37.11 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.0 0.428 . . . . 0.0 111.937 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.602 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.3 p -118.45 147.87 21.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.93 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.523 ' CD2' HD11 ' A' ' 148' ' ' LEU . 88.4 t80 -103.86 98.62 8.44 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.775 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 10.3 pt-20 -147.64 158.56 44.06 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.3 m-20 65.04 22.6 12.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.239 0.542 . . . . 0.0 109.866 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.66 12.14 55.69 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.66 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -132.13 172.84 11.89 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.552 0.691 . . . . 0.0 109.791 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.46 ' HB3' HD11 ' A' ' 96' ' ' LEU . 20.3 m-85 -103.1 121.2 42.12 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.464 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.505 HG13 HG13 ' A' ' 97' ' ' VAL . 24.4 pt -122.05 148.77 25.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.522 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 26.9 mt-10 -104.94 118.43 36.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.81 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -119.93 132.6 55.57 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.583 ' O ' HG23 ' A' ' 111' ' ' VAL . 65.3 mtt180 -60.03 158.3 11.27 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.653 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -56.59 -45.66 81.25 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.87 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.423 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.5 p90 -75.32 9.98 1.83 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.411 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -119.35 -20.57 7.83 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.201 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 107' ' ' ARG . 92.5 t -73.55 146.58 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.714 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 70.6 mmtt -119.75 170.77 8.92 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.719 -177.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.58 141.77 53.7 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.646 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.95 4.43 84.61 Favored Glycine 0 N--CA 1.425 -2.046 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.829 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.714 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -76.26 165.43 24.88 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.42 ' HE3' ' HG3' ' A' ' 150' ' ' GLU . 31.3 mttp -117.91 164.82 14.48 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.54 0.686 . . . . 0.0 110.819 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.0 159.75 42.9 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 119' ' ' VAL . 0.9 OUTLIER -88.76 133.66 34.17 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.001 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.3 OUTLIER -116.61 138.13 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.024 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 180' ' ' ASN . 4.8 p . . . . . 0 C--N 1.284 -2.254 0 CA-C-O 121.44 0.638 . . . . 0.0 110.412 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.523 HD11 ' CD2' ' A' ' 98' ' ' TYR . 13.8 mt . . . . . 0 N--CA 1.424 -1.755 0 CA-C-O 121.404 0.621 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.569 ' CD1' ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -111.08 137.06 49.2 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.913 -1.039 . . . . 0.0 113.516 -171.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.42 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 23.3 mt-10 -91.18 146.34 23.92 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.91 176.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 66.6 mt -81.02 107.79 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.921 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.553 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 27.7 mmtt -64.68 -42.84 95.07 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.368 175.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -148.29 132.5 17.4 Favored 'General case' 0 CA--C 1.473 -1.995 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.592 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 84.2 mt -117.24 125.1 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.01 172.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -128.89 163.86 24.35 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.006 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.5 ' CZ ' HD13 ' A' ' 77' ' ' ILE . 12.5 m-85 -101.0 110.96 23.05 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -116.02 176.38 2.45 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.768 -178.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.53 ' HA ' ' HB3' ' A' ' 75' ' ' HIS . 31.5 mtm180 -82.66 -142.83 0.06 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-O 121.787 0.803 . . . . 0.0 112.192 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -133.24 128.01 34.96 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -83.82 21.3 1.3 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -173.2 -178.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -104.78 8.42 34.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.374 0.607 . . . . 0.0 109.734 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -143.24 155.87 44.61 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.412 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' ' 3' ' ' PRO . 7.0 m -129.82 160.92 40.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.432 176.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 67.9 m-85 -132.55 170.46 15.14 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.471 -176.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.506 ' HB2' HD12 ' A' ' 68' ' ' ILE . 1.4 m -155.76 -28.2 0.1 Allowed 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.458 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 1.3 tm? 71.32 107.04 0.06 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.742 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -86.27 115.09 23.59 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.64 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.46 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -135.29 -166.16 1.8 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.438 ' HB3' HG22 ' A' ' 62' ' ' THR . 23.9 tptm . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.418 ' ND2' HD22 ' A' ' 54' ' ' LEU . 27.0 t-20 . . . . . 0 CA--C 1.508 -0.639 0 CA-C-O 120.622 0.248 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.454 HG23 HG23 ' A' ' 177' ' ' ILE . 29.8 m -139.49 178.59 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.808 0 CA-C-O 122.47 1.128 . . . . 0.0 112.501 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.486 HD13 HG12 ' A' ' 52' ' ' ILE . 87.6 mt -117.59 114.27 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 CA-C-N 112.532 -2.122 . . . . 0.0 108.48 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 35.9 pt -120.76 168.04 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.746 0 CA-C-O 120.963 0.411 . . . . 0.0 112.076 -174.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.449 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 2.1 t-20 48.69 -133.23 1.46 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.966 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.444 ' H ' ' CG ' ' A' ' 178' ' ' ASN . 0.8 OUTLIER -80.81 56.27 2.65 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 121.314 0.578 . . . . 0.0 109.932 174.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.662 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 12.8 m120 66.89 42.39 2.52 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.892 1.277 . . . . 0.0 114.256 175.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 92.8 mt -86.85 119.08 34.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 70.0 t -92.47 129.28 43.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.814 -176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.31 -1.143 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.844 178.874 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 . . . . . 0 CA--C 1.51 -0.563 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.436 ' HD3' HD13 ' A' ' 76' ' ' LEU . 53.5 Cg_endo -65.81 158.16 55.22 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 N-CA-C 108.639 -1.331 . . . . 0.0 108.639 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.31 -22.83 56.86 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 119.077 -1.535 . . . . 0.0 111.887 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -71.31 -1.75 13.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.9 m -71.82 128.57 36.19 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.6 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 13.9 mtm-85 -85.58 131.0 34.44 Favored 'General case' 0 C--O 1.18 -2.576 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 19' ' ' ILE . 8.4 tt -120.22 131.14 73.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.419 HD21 ' HB2' ' A' ' 18' ' ' LYS . 2.0 tm? -89.46 123.23 33.39 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-O 121.491 0.662 . . . . 0.0 110.077 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.0 m -133.14 -174.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.29 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 31.5 tt0 -133.19 123.69 26.07 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.572 HG12 HG13 ' A' ' 47' ' ' ILE . 23.1 mt -121.23 121.69 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.748 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.811 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 52.95 39.09 28.69 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.458 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.74 17.27 80.05 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.749 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.94 115.39 22.13 Favored Pre-proline 0 N--CA 1.438 -1.064 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 13.1 Cg_exo -64.4 124.02 12.69 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.277 1.985 . . . . 0.0 111.262 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -122.37 134.97 54.62 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HB2' HD21 ' A' ' 9' ' ' LEU . 40.2 ttmt -106.59 101.25 10.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 8' ' ' ILE . 3.1 pt -123.54 -173.58 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.744 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.777 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 20.4 p -97.11 168.65 10.32 Favored 'General case' 0 C--N 1.281 -2.378 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.725 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 66.1 mt -64.83 -29.7 70.67 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.777 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.5 ptm180 -77.04 -26.37 53.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.543 ' OE1' HG21 ' A' ' 20' ' ' THR . 62.7 mt-10 -84.66 -42.55 15.22 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.957 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.462 HD21 HD22 ' A' ' 167' ' ' LEU . 18.2 tp -57.5 -44.12 84.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-O 121.952 0.882 . . . . 0.0 110.145 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.648 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.5 m-30 -60.41 -23.86 64.7 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 113.747 -1.569 . . . . 0.0 113.188 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -79.88 -12.87 59.72 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.95 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.4 mm? -79.22 3.78 16.86 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.409 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.7 m-85 -118.49 164.72 14.86 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.226 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.538 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 38.0 mt-10 -136.4 -173.48 3.42 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.952 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.41 81.63 0.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.39 0.614 . . . . 0.0 111.55 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -98.65 120.4 39.02 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.783 0.801 . . . . 0.0 110.621 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -106.28 149.73 26.62 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 114.009 -1.451 . . . . 0.0 109.976 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.491 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 19.2 t80 -106.56 130.35 54.34 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.474 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -167.53 141.42 3.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.849 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 56.48 23.58 7.66 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 123.452 0.47 . . . . 0.0 111.865 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.491 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 43.8 mtm 72.07 17.57 5.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.88 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.469 HG12 ' HD2' ' A' ' 71' ' ' PRO . 4.8 m -127.32 -175.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -126.77 147.64 49.98 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.307 0.575 . . . . 0.0 110.603 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -131.47 124.0 53.75 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.007 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.564 ' HB3' HG23 ' A' ' 67' ' ' VAL . 38.1 ttm180 -115.41 126.23 54.12 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.612 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -133.43 146.76 51.48 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.463 -174.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 88.9 mttt 86.46 111.75 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.673 0 C-N-CA 125.183 1.393 . . . . 0.0 111.75 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.72 147.73 19.7 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.527 2.151 . . . . 0.0 111.191 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.538 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 29.3 mtmt -81.75 -6.64 59.23 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -145.91 -164.98 2.08 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.1 tp10 -85.75 99.83 11.61 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.572 HG13 HG12 ' A' ' 12' ' ' ILE . 1.7 mp -115.97 117.37 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.952 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.53 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 25.0 mmtt -116.37 167.14 11.3 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.393 174.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.498 HG11 ' CB ' ' A' ' 169' ' ' ALA . 13.0 p -121.45 130.23 74.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.133 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -85.14 120.61 26.83 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.2 m -133.79 173.24 11.75 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.017 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.461 HD11 ' C ' ' A' ' 58' ' ' LYS . 2.4 mm -115.61 142.57 28.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.223 0.535 . . . . 0.0 110.151 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.411 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 38.8 t0 -80.75 130.85 35.31 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.601 HD11 ' N ' ' A' ' 54' ' ' LEU . 4.1 mp -77.9 -25.63 48.58 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.973 0.892 . . . . 0.0 110.811 -172.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.34 -32.6 16.42 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.93 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 53' ' ' ASP . 57.8 p -111.84 -20.21 12.13 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.522 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.66 12.18 84.65 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.742 177.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.461 ' C ' HD11 ' A' ' 52' ' ' ILE . 3.6 mtpm? -89.86 160.58 16.4 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.953 0.406 . . . . 0.0 112.069 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.45 110.18 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 CA-C-O 121.89 0.852 . . . . 0.0 110.009 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.5 m -111.13 163.8 7.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.6 tp -123.74 141.97 51.52 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.42 ' OG1' ' HB2' ' A' ' 170' ' ' LYS . 14.3 t -151.05 172.21 16.09 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.91 0.386 . . . . 0.0 111.57 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.05 160.58 25.77 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.715 0.769 . . . . 0.0 110.993 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.471 ' N ' HD13 ' A' ' 64' ' ' ILE . 2.1 mp -100.7 136.82 30.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.908 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 5.2 mm-40 -82.93 -38.28 23.03 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 p30 177.56 -179.2 0.23 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.303 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.578 ' HB ' ' CE1' ' A' ' 25' ' ' TYR . 2.9 m -116.82 145.26 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-O 121.124 0.488 . . . . 0.0 110.067 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.491 HD12 ' HB2' ' A' ' 166' ' ' SER . 56.8 mt -99.28 107.67 21.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.076 -173.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.437 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 76.8 tttt -116.08 107.42 14.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.6 137.65 30.89 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.141 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.469 ' HD2' HG12 ' A' ' 37' ' ' VAL . 77.5 Cg_exo -47.52 136.23 20.65 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 123.205 2.603 . . . . 0.0 112.688 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.66 102.7 0.47 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 m -60.44 -55.83 28.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.071 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.45 -138.7 0.11 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.301 -176.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -97.38 171.12 8.6 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.603 ' CD2' ' HA ' ' A' ' 90' ' ' THR . 11.0 mt -124.19 140.54 52.86 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.928 0.87 . . . . 0.0 111.513 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 88' ' ' GLU . 40.0 mt -87.98 142.11 13.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.872 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 12.9 ttt180 -119.45 138.47 53.1 Favored 'General case' 0 N--CA 1.406 -2.651 0 CA-C-O 121.234 0.54 . . . . 0.0 109.655 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 86' ' ' SER . 58.1 m-85 -114.68 125.99 54.37 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.442 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 152' ' ' LYS . 36.8 tt0 -109.73 123.99 50.47 Favored 'General case' 0 CA--C 1.473 -2.013 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 85' ' ' ARG . 1.5 mm? -89.34 162.5 15.78 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.994 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.584 ' HG2' HD13 ' A' ' 149' ' ' LEU . 3.1 pt-20 -63.88 -18.29 64.03 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.889 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -93.37 -7.29 45.14 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.531 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.57 13.22 57.3 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.045 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.546 ' O ' HD22 ' A' ' 81' ' ' LEU . 2.0 mtt180 -82.07 139.07 34.66 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 20.6 p -141.27 140.0 33.8 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 118.889 -1.125 . . . . 0.0 112.449 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -136.67 141.34 43.15 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.657 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 1.7 mp0 -109.61 148.1 31.89 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.779 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.714 ' HB ' ' NE2' ' A' ' 93' ' ' HIS . 3.5 p -137.02 149.14 47.28 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.139 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.603 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -73.44 7.62 2.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.625 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 1.5 m 59.81 169.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 122.911 0.484 . . . . 0.0 110.98 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.581 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 33.4 t70 73.11 -41.26 0.5 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.063 0.459 . . . . 0.0 111.35 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.714 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 8.6 p80 -75.69 148.59 82.64 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.58 142.19 28.98 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.126 2.551 . . . . 0.0 114.534 -178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 23.6 t -111.99 154.3 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.514 1.526 . . . . 0.0 107.274 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.3 tp -106.49 113.45 26.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.841 0.746 . . . . 0.0 112.424 -176.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.505 HG11 HG13 ' A' ' 104' ' ' ILE . 2.4 p -113.39 153.64 14.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 111.808 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -108.48 95.61 5.78 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.989 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 6.6 pt-20 -143.76 159.19 42.95 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER 66.84 22.74 10.17 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.228 0.537 . . . . 0.0 109.644 -179.03 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.61 12.86 57.66 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.771 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -134.21 172.41 12.9 Favored 'General case' 0 N--CA 1.403 -2.815 0 CA-C-O 121.201 0.524 . . . . 0.0 109.807 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -100.68 121.69 42.06 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.505 HG13 HG11 ' A' ' 97' ' ' VAL . 25.9 pt -121.13 157.52 24.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.622 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 21.3 mt-10 -114.18 110.02 19.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.959 0.409 . . . . 0.0 111.666 -176.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -113.97 140.01 48.77 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 92' ' ' ASP . 6.5 mpt_? -60.8 154.79 21.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.625 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -56.63 -45.86 81.28 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.827 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.507 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 2.6 p90 -71.99 3.03 4.75 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.342 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -115.26 -16.34 11.52 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.358 0.599 . . . . 0.0 110.131 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 107' ' ' ARG . 70.0 t -74.51 145.09 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 31.6 mmtp -119.74 172.6 7.57 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.401 0.619 . . . . 0.0 111.689 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -70.9 138.31 50.04 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.393 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.51 5.59 74.99 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.924 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.545 ' HB3' HD13 ' A' ' 151' ' ' ILE . 8.1 t70 -71.27 170.17 13.64 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.646 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 48.2 mttp -127.85 155.72 43.68 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.758 0.79 . . . . 0.0 112.733 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.51 157.52 41.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.584 172.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.576 ' HA ' HD11 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -95.15 134.14 38.2 Favored 'General case' 0 CA--C 1.479 -1.784 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.634 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.6 OUTLIER -107.33 124.45 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.828 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.742 175.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.398 -3.044 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 176.958 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.646 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.7 mm? . . . . . 0 CA--C 1.483 -1.614 0 CA-C-O 121.065 0.459 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.584 HD13 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -114.26 134.68 54.76 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.996 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 8.5 mt-10 -86.82 142.79 27.83 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.155 177.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.545 HD13 ' HB3' ' A' ' 115' ' ' ASP . 80.6 mt -80.46 103.15 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.329 174.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.468 ' HG3' ' CA ' ' A' ' 82' ' ' GLU . 29.9 mtmt -61.1 -44.37 97.46 Favored 'General case' 0 C--N 1.274 -2.715 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.226 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -150.45 136.53 18.54 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 77.7 mt -113.92 145.37 19.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.885 174.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -150.44 160.14 43.97 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.214 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.441 ' CZ ' HD13 ' A' ' 77' ' ' ILE . 21.7 m-85 -100.27 113.17 25.66 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.02 134.73 65.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.358 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.418 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 32.2 ttp180 -66.25 151.71 46.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' A' ' 158' ' ' ARG . . . -67.29 127.77 33.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.898 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -79.84 -24.89 41.01 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.191 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -110.36 -178.35 3.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.17 -7.82 18.8 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.035 0.445 . . . . 0.0 110.01 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -134.24 160.26 38.4 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.24 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.03 155.2 41.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 19.6 m-85 -132.88 169.07 17.29 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.741 -172.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.491 ' HB2' HD12 ' A' ' 68' ' ' ILE . 19.3 m -155.55 -28.13 0.1 Allowed 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.534 ' CD1' HG13 ' A' ' 67' ' ' VAL . 15.4 tp 73.29 116.95 0.05 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.417 1.087 . . . . 0.0 111.618 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -91.8 109.33 20.66 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.46 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.498 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -129.6 -165.02 1.47 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.372 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.42 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 46.4 mmtt . . . . . 0 CA--C 1.489 -1.392 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.218 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 CA--C 1.522 -0.125 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.511 HG12 HG21 ' A' ' 177' ' ' ILE . 1.3 p -166.32 166.67 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.456 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 97.2 mt -117.14 113.04 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.81 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.511 HG21 HG12 ' A' ' 175' ' ' VAL . 40.3 pt -123.19 171.37 12.25 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.521 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.237 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 180' ' ' ASN . 8.0 t-20 50.49 -129.46 2.2 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.431 1.092 . . . . 0.0 110.128 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.69 43.95 0.95 Allowed 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.439 0.637 . . . . 0.0 110.22 175.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.4 m-20 72.89 47.75 0.2 Allowed 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 114.081 -1.418 . . . . 0.0 112.92 176.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 81.3 mt -88.82 115.09 28.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.065 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.524 HG11 ' O ' ' A' ' 118' ' ' LEU . 2.6 m -76.33 156.21 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--N 1.286 -2.156 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.786 -179.275 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.462 ' HD3' HD13 ' A' ' 76' ' ' LEU . 51.8 Cg_endo -66.15 156.51 64.39 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 N-CA-C 108.532 -1.372 . . . . 0.0 108.532 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.09 -22.56 49.69 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.531 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.45 -19.78 66.08 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.203 0.525 . . . . 0.0 112.186 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.9 m -59.61 128.09 35.25 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.771 -176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 65.5 mmt-85 -81.34 133.34 35.41 Favored 'General case' 0 C--O 1.194 -1.856 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.515 HD12 HG22 ' A' ' 175' ' ' VAL . 8.1 tt -121.66 131.88 72.08 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.728 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.511 HD13 ' N ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -89.01 124.21 34.06 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.511 0.672 . . . . 0.0 109.987 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.511 ' N ' HD13 ' A' ' 9' ' ' LEU . 28.9 m -135.11 -176.38 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.378 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -134.04 124.62 26.53 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.047 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 21.0 mt -120.55 119.46 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.026 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 52.62 44.45 30.08 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.744 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.2 75.5 Favored Glycine 0 C--N 1.307 -1.057 0 CA-C-N 114.704 -1.135 . . . . 0.0 114.256 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.9 t -124.76 119.94 25.71 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-O 121.137 0.494 . . . . 0.0 109.769 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 56.8 Cg_endo -73.71 124.03 8.96 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.326 2.018 . . . . 0.0 111.74 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -123.26 146.27 48.0 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.47 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -114.51 100.23 8.14 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.258 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 8' ' ' ILE . 2.9 pt -123.05 -174.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.929 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.663 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 10.9 p -92.99 172.21 8.46 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.234 -0.987 . . . . 0.0 109.088 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 70.4 mt -66.83 -30.49 70.68 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.256 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.663 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 5.7 ptm180 -80.11 -25.01 40.13 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.556 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 78.8 mt-10 -83.58 -39.6 20.15 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.1 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.443 HD21 ' HG ' ' A' ' 167' ' ' LEU . 13.9 tp -57.52 -44.49 85.11 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -49.79 -35.62 23.25 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.414 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 26.8 mt-10 -72.95 -17.84 61.44 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.58 0.06 31.53 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.594 0.712 . . . . 0.0 109.589 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.55 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 95.2 m-85 -113.67 161.3 17.63 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.297 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -133.89 -174.71 3.61 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.803 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.445 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 14.8 t0 60.28 87.56 0.09 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.549 0.69 . . . . 0.0 111.444 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 26.2 tt0 -104.02 128.97 51.62 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.253 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.644 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 1.7 ptm180 -109.8 150.06 28.92 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.611 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -116.9 122.97 45.86 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.42 0.629 . . . . 0.0 110.166 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -167.34 154.38 8.55 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.243 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.4 m120 61.63 16.98 8.2 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 123.685 0.615 . . . . 0.0 110.707 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.9 mtm 69.77 19.58 7.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.06 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.459 HG13 ' HD2' ' A' ' 71' ' ' PRO . 12.4 m -128.54 -179.67 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.461 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 97.1 m-85 -120.26 142.18 49.28 Favored 'General case' 0 CA--C 1.478 -1.803 0 CA-C-O 121.44 0.638 . . . . 0.0 109.993 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.644 ' CG1' ' HG2' ' A' ' 32' ' ' ARG . 1.1 m -135.19 127.7 47.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.336 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.581 ' O ' HG22 ' A' ' 67' ' ' VAL . 16.1 ttm180 -119.68 127.55 52.99 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -133.45 145.09 49.93 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.963 -174.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 12.8 tmtt? 86.73 112.22 0.03 OUTLIER Pre-proline 0 CA--C 1.516 -0.336 0 O-C-N 124.649 1.218 . . . . 0.0 109.963 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 73.2 Cg_endo -80.48 151.48 19.9 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 122.211 1.941 . . . . 0.0 112.269 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -86.17 -0.09 54.88 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.194 0.521 . . . . 0.0 110.976 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -150.68 -165.83 2.38 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 33.0 tt0 -83.92 101.41 11.67 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.55 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.4 mp -115.74 117.67 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.227 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -117.72 165.85 13.14 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.266 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.554 HG11 ' CB ' ' A' ' 169' ' ' ALA . 9.9 p -120.45 133.57 66.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.234 -177.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -85.87 125.27 33.18 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.096 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.9 m -136.86 142.36 42.81 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.179 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 mm -92.26 140.03 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.936 0 CA-C-O 121.479 0.657 . . . . 0.0 110.725 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.426 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 10.7 t0 -83.79 114.04 21.34 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.611 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -75.39 -4.78 41.4 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.685 0.755 . . . . 0.0 111.811 -169.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -102.42 -34.02 9.32 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.114 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' ' 53' ' ' ASP . 81.0 p -111.29 -19.78 12.52 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.634 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.88 12.71 80.87 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.836 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -92.24 156.52 17.24 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.178 0.513 . . . . 0.0 112.284 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.92 106.02 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.006 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.589 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 m -109.46 162.55 7.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.77 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.3 tp -122.32 140.87 52.15 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.014 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.5 t -147.52 172.61 13.7 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.782 0.325 . . . . 0.0 111.338 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.16 162.61 25.66 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.839 0.828 . . . . 0.0 111.397 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.471 ' N ' HD13 ' A' ' 64' ' ' ILE . 2.5 mp -99.07 145.71 9.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.812 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.445 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 31.4 mm-40 -91.27 -38.59 12.57 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 175.62 177.37 0.2 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.672 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 40' ' ' ARG . 5.5 t -106.58 129.43 60.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.894 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 55.3 mt -91.49 111.75 24.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.814 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 83.2 tttt -127.56 112.25 14.69 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.12 135.08 25.92 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.148 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.459 ' HD2' HG13 ' A' ' 37' ' ' VAL . 80.7 Cg_exo -44.71 130.05 9.54 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.671 2.914 . . . . 0.0 113.535 177.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.41 116.44 28.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.147 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -123.0 -65.83 1.07 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.367 0.876 . . . . 0.0 113.367 -176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -57.58 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -177.14 172.44 1.93 Allowed 'General case' 0 CA--C 1.461 -2.474 0 CA-C-O 120.992 0.425 . . . . 0.0 111.46 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.525 HD21 ' HA ' ' A' ' 90' ' ' THR . 10.7 mt -131.65 141.75 49.68 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.735 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.56 HD12 ' CZ ' ' A' ' 156' ' ' TYR . 22.7 mt -87.69 142.37 13.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 11.3 ttt85 -115.28 137.31 52.17 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.177 0.513 . . . . 0.0 109.884 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.629 ' O ' ' HA ' ' A' ' 86' ' ' SER . 64.1 m-85 -114.87 121.19 42.45 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.861 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 152' ' ' LYS . 35.3 tt0 -109.08 120.77 43.53 Favored 'General case' 0 CA--C 1.47 -2.133 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.589 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -85.9 159.96 19.53 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.172 -177.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.504 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -59.71 -19.16 48.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.325 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -92.37 -8.26 45.44 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.091 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.44 15.74 49.29 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.523 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.514 ' O ' HD23 ' A' ' 81' ' ' LEU . 3.9 mtt180 -83.83 138.57 33.15 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 35.6 p -141.85 139.91 32.78 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 118.485 -1.286 . . . . 0.0 112.296 175.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -135.23 146.93 49.1 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.948 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 21.5 mt-10 -119.22 147.68 43.97 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.348 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -138.76 154.01 48.49 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.595 -179.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.525 ' HA ' HD21 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.98 11.58 0.67 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.362 0.601 . . . . 0.0 112.057 -177.325 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.678 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 1.2 m 68.24 -26.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.021 1.328 . . . . 0.0 113.422 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 90' ' ' THR . 5.0 p-10 -83.34 -1.17 52.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.983 0.42 . . . . 0.0 110.658 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -110.63 137.06 20.64 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.477 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 24.0 Cg_exo -65.48 134.18 37.51 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.236 2.624 . . . . 0.0 113.424 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.576 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.2 t -103.58 150.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 tp -107.75 113.76 27.24 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.819 0.342 . . . . 0.0 111.878 -176.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.605 HG22 ' OD1' ' A' ' 115' ' ' ASP . 2.3 p -113.21 151.6 15.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.26 0.552 . . . . 0.0 111.592 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.455 ' CD2' HD11 ' A' ' 148' ' ' LEU . 61.4 t80 -105.13 93.54 4.75 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.294 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 8.5 pt-20 -141.76 158.41 43.85 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 32.0 m-80 63.5 23.22 13.56 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.147 0.499 . . . . 0.0 109.993 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.23 12.02 54.01 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.0 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -133.29 172.31 12.86 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 121.279 0.561 . . . . 0.0 109.914 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -101.76 120.63 40.67 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.486 HG13 HG13 ' A' ' 97' ' ' VAL . 23.1 pt -116.38 152.53 18.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.875 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -109.37 112.57 24.77 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.792 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 12.6 ptpt -130.15 133.95 46.98 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.593 ' O ' HG23 ' A' ' 111' ' ' VAL . 60.5 mtm180 -67.42 163.18 21.43 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.678 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -56.6 -45.45 81.42 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.976 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.522 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.9 p90 -71.86 2.81 4.92 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.515 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.499 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 12.9 tp10 -117.15 -16.05 10.44 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.397 0.618 . . . . 0.0 110.044 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 107' ' ' ARG . 89.4 t -73.97 148.88 8.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.689 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 23.0 mmtp -119.17 169.8 9.63 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.337 0.589 . . . . 0.0 110.537 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -76.21 144.42 40.45 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.551 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.38 4.59 80.44 Favored Glycine 0 C--N 1.308 -1.011 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.15 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.689 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -76.91 167.33 22.0 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.1 mttp -121.87 166.67 14.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.288 0.566 . . . . 0.0 110.558 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.22 160.57 41.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.98 135.14 34.43 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.1 OUTLIER -100.49 149.98 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.716 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.431 ' HB2' ' CG1' ' A' ' 176' ' ' ILE . 43.5 t . . . . . 0 C--N 1.308 -1.234 0 CA-C-O 120.825 0.345 . . . . 0.0 110.797 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.455 HD11 ' CD2' ' A' ' 98' ' ' TYR . 14.5 mt . . . . . 0 N--CA 1.429 -1.501 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.589 ' HB3' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -114.97 138.89 50.32 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -171.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -89.79 146.43 24.47 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 124.672 1.189 . . . . 0.0 113.018 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.499 HD11 ' CD1' ' A' ' 79' ' ' PHE . 64.3 mt -80.15 107.57 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.266 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 80' ' ' GLU . 62.2 mmtt -68.89 -38.98 80.0 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.889 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -150.63 131.86 14.5 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.592 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 74.8 mt -116.98 130.21 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.385 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.444 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 19.3 ptpt -136.46 166.76 22.75 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.516 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.56 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 20.7 m-85 -100.63 115.36 30.01 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.946 173.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.1 133.19 68.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.103 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 21.5 ttm-85 -70.87 155.22 41.06 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.068 0.461 . . . . 0.0 111.072 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.21 113.71 7.66 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.063 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -71.17 -18.68 62.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.567 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -98.9 166.57 11.23 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.953 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -94.28 -6.44 44.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.029 0.443 . . . . 0.0 109.929 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -144.0 150.41 38.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.781 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 4.3 m -119.29 155.8 21.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 50.0 m-85 -130.86 173.59 10.81 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 110.199 -0.296 . . . . 0.0 110.199 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.467 ' HB2' HD12 ' A' ' 68' ' ' ILE . 68.5 m -159.23 -24.49 0.07 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.443 ' HG ' HD21 ' A' ' 24' ' ' LEU . 1.5 tm? 68.68 112.46 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.769 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -90.82 113.26 25.37 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.112 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.554 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -133.94 -173.32 3.22 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.915 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.156 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.6 t30 . . . . . 0 N--CA 1.444 -0.774 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.515 HG22 HD12 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -159.95 158.43 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 120.827 0.346 . . . . 0.0 110.785 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.582 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 2.5 mp -93.08 115.34 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.867 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 45.1 pt -121.48 171.51 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-O 120.985 0.422 . . . . 0.0 111.586 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.433 ' OD1' ' HG3' ' A' ' 179' ' ' GLU . 5.4 t-20 46.71 -127.19 1.54 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 124.16 0.984 . . . . 0.0 110.777 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.468 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 29.3 mt-10 -91.5 55.63 2.82 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.745 0.784 . . . . 0.0 109.466 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.724 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.4 m120 70.2 44.56 0.75 Allowed 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 113.74 -1.573 . . . . 0.0 113.6 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 85.1 mt -92.39 117.65 36.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.0 m -93.45 160.73 2.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.576 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 9.7 t . . . . . 0 C--N 1.306 -1.309 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.132 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.469 ' CE1' HD11 ' A' ' 177' ' ' ILE . 93.3 m-85 . . . . . 0 N--CA 1.446 -0.641 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.475 ' HD3' HD11 ' A' ' 76' ' ' LEU . 18.2 Cg_endo -59.02 -26.92 83.49 Favored 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 122.592 2.195 . . . . 0.0 112.481 -175.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 6' ' ' THR . . . 120.19 -38.65 2.69 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -69.08 -1.34 7.42 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.802 -0.699 . . . . 0.0 111.514 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 28.9 m -69.69 128.25 35.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.564 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.1 mtm-85 -83.77 132.6 34.82 Favored 'General case' 0 C--O 1.186 -2.259 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.515 HD13 HG21 ' A' ' 175' ' ' VAL . 10.7 tt -122.74 131.38 73.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-O 121.017 0.437 . . . . 0.0 110.623 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 10' ' ' VAL . 1.6 tm? -90.77 123.47 34.37 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-O 121.504 0.669 . . . . 0.0 109.447 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 18.8 m -133.83 -175.46 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.5 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 32.1 tt0 -129.29 120.8 26.28 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 14.5 mt -122.44 122.7 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.868 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.864 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 56.14 35.98 26.62 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.859 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.1 17.29 78.62 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.215 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.35 114.55 25.65 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 7.6 Cg_exo -64.86 125.17 14.28 Favored 'Trans proline' 0 N--CA 1.44 -1.656 0 C-N-CA 122.129 1.886 . . . . 0.0 111.356 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -122.14 140.39 52.61 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.436 ' HD3' ' NH2' ' A' ' 7' ' ' ARG . 39.0 ttmt -108.52 100.28 9.57 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.449 ' O ' ' N ' ' A' ' 8' ' ' ILE . 3.6 pt -124.4 -171.93 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.179 -2.63 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.767 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.686 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 21.3 p -94.91 170.98 9.04 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.776 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 10.6 mt -73.96 -20.64 60.3 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.006 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.686 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 13.2 ptm180 -84.58 -25.28 28.76 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 27' ' ' LEU . 52.4 mm-40 -84.64 -44.17 13.71 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.394 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.548 ' CD2' HD23 ' A' ' 167' ' ' LEU . 16.4 tp -57.19 -44.0 83.21 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.927 0.87 . . . . 0.0 110.004 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.432 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -56.09 -24.25 39.03 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.849 -179.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -84.41 -12.15 54.95 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.876 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -80.32 5.6 14.33 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.601 0.715 . . . . 0.0 109.466 177.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.56 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 95.9 m-85 -119.43 167.13 12.23 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.075 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.516 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 9.4 mt-10 -140.34 -173.56 3.71 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.473 174.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 6.0 t0 62.5 83.42 0.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.237 0.542 . . . . 0.0 110.8 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.406 ' CD ' ' HZ1' ' A' ' 69' ' ' LYS . 30.8 tt0 -107.63 129.44 55.0 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.849 0.833 . . . . 0.0 111.257 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -124.1 156.48 36.53 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.892 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -107.46 125.52 51.36 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -164.67 148.22 8.97 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.56 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.7 m120 62.2 19.22 10.78 Favored 'General case' 0 CA--C 1.496 -1.106 0 O-C-N 123.557 0.536 . . . . 0.0 110.302 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.2 mtt 72.17 17.71 4.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.468 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 m -132.77 -178.48 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -115.05 140.72 48.83 Favored 'General case' 0 CA--C 1.478 -1.796 0 CA-C-O 121.257 0.551 . . . . 0.0 110.188 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 t -127.63 123.91 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.3 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.199 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.481 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 38.9 ttm180 -116.96 126.78 53.45 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -132.22 147.08 52.4 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.681 -0.808 . . . . 0.0 113.155 -176.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 54.4 mttp 82.29 111.61 0.03 OUTLIER Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.482 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 66.4 Cg_endo -77.28 151.95 30.27 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 122.688 2.259 . . . . 0.0 111.59 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.516 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 31.1 mtmt -83.28 -3.62 57.63 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.563 0.697 . . . . 0.0 110.427 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -144.48 -164.62 1.95 Allowed 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 32.1 tt0 -88.6 100.07 12.81 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.562 HG13 HG12 ' A' ' 12' ' ' ILE . 1.3 mp -113.83 121.59 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.878 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 74.9 mmtt -123.89 165.73 16.88 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.847 174.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.1 m -113.42 126.66 70.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 120.961 0.41 . . . . 0.0 112.03 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.63 123.44 29.8 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.645 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 p -132.22 173.38 11.31 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.874 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.44 HD12 ' O ' ' A' ' 58' ' ' LYS . 2.1 mm -121.25 140.64 44.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.274 0.559 . . . . 0.0 110.129 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.548 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 23.4 t70 -81.73 120.86 25.66 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.744 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.417 ' N ' HD21 ' A' ' 54' ' ' LEU . 4.7 mt -66.46 -25.34 66.68 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.494 -172.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.548 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -92.95 -24.08 18.51 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.856 -1.066 . . . . 0.0 112.416 -172.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.5 p -119.77 -26.43 5.67 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.607 -175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.16 14.37 69.27 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.44 ' O ' HD12 ' A' ' 52' ' ' ILE . 2.6 mptt -84.16 153.61 23.58 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 122.839 0.455 . . . . 0.0 111.738 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.91 105.5 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 CA-C-O 122.004 0.907 . . . . 0.0 109.724 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.3 m -110.16 163.75 6.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.079 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.7 tp -123.71 139.88 53.55 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 t -144.07 172.4 12.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.738 0.304 . . . . 0.0 110.849 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -86.15 161.99 18.59 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.727 0.775 . . . . 0.0 110.924 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 64' ' ' ILE . 3.3 mp -97.81 141.75 15.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.003 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.45 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 18.2 mm-40 -85.15 -39.58 17.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.423 ' O ' HD13 ' A' ' 167' ' ' LEU . 2.7 p30 173.9 175.11 0.15 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.593 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.481 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 21.7 t -104.41 142.33 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.826 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -112.87 123.5 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.701 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.39 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HZ1' ' CD ' ' A' ' 31' ' ' GLU . 39.6 ttpt -129.85 114.5 15.98 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.733 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.98 139.62 35.55 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.813 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -52.84 123.92 14.21 Favored 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 123.043 2.495 . . . . 0.0 112.61 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.4 106.38 11.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.091 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.1 m -125.23 -26.72 3.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.638 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -78.78 -137.44 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.387 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -155.14 171.33 19.98 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.514 ' CD2' ' HA ' ' A' ' 90' ' ' THR . 11.2 mt -132.83 140.63 48.05 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.937 -175.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.512 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 51.4 mt -88.96 145.87 6.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 19.8 ttt180 -121.28 138.94 54.01 Favored 'General case' 0 N--CA 1.404 -2.768 0 CA-C-O 121.256 0.551 . . . . 0.0 109.87 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.589 ' O ' ' HA ' ' A' ' 86' ' ' SER . 49.3 m-85 -116.35 126.26 53.25 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.119 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.2 tt0 -106.27 132.63 52.09 Favored 'General case' 0 CA--C 1.48 -1.724 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.543 HD13 ' HB3' ' A' ' 149' ' ' LEU . 2.2 mm? -99.05 156.86 16.72 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.205 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.57 ' HA ' ' HG3' ' A' ' 152' ' ' LYS . 1.8 pt-20 -58.62 -18.33 29.45 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.509 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.46 -8.31 48.11 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.746 0.784 . . . . 0.0 109.42 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.27 17.65 49.39 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.564 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.515 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -89.91 139.36 30.67 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 65.5 p -139.79 144.48 37.4 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.467 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -137.1 146.9 45.64 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.105 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.44 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 65.1 mt-10 -119.39 147.42 44.38 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.478 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.9 OUTLIER -142.76 157.84 44.24 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.677 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.539 ' C ' ' H ' ' A' ' 92' ' ' ASP . 0.9 OUTLIER -72.6 9.72 1.01 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 122.942 0.497 . . . . 0.0 111.921 -176.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.722 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.8 OUTLIER 68.03 -25.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.625 1.17 . . . . 0.0 112.494 177.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 90' ' ' THR . 0.2 OUTLIER -74.45 -12.88 60.61 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 124.344 1.058 . . . . 0.0 111.551 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -110.79 147.21 36.01 Favored Pre-proline 0 C--N 1.309 -1.176 0 C-N-CA 120.381 -0.527 . . . . 0.0 112.245 -175.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 3.1 Cg_exo -74.48 132.04 15.68 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.246 2.63 . . . . 0.0 114.047 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.5 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.6 t -97.21 144.88 9.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 tp -102.05 107.81 19.04 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.658 0.265 . . . . 0.0 110.918 -175.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.633 HG22 ' OD1' ' A' ' 115' ' ' ASP . 2.2 p -111.17 151.37 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-O 121.378 0.609 . . . . 0.0 111.93 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -106.95 93.74 4.72 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.917 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.3 pt-20 -140.62 158.47 43.93 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 31.9 m-80 64.76 22.93 12.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.065 0.46 . . . . 0.0 110.289 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.76 15.42 64.42 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.53 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -137.12 172.43 13.01 Favored 'General case' 0 N--CA 1.398 -3.044 0 CA-C-O 121.422 0.63 . . . . 0.0 110.269 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -103.63 120.77 41.56 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.505 HG13 HG11 ' A' ' 97' ' ' VAL . 25.2 pt -121.48 155.84 25.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.518 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -104.35 116.25 31.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.975 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.4 ' HE3' ' CD1' ' A' ' 104' ' ' ILE . 85.7 mttt -125.4 129.48 49.96 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 111' ' ' VAL . 91.2 mtt180 -62.8 161.71 12.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.722 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -58.17 -42.43 85.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.537 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.484 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.1 p90 -73.91 3.48 6.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.077 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 110' ' ' GLU . 6.9 tp10 -114.82 -16.41 11.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.533 0.682 . . . . 0.0 110.22 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 107' ' ' ARG . 92.8 t -77.05 148.68 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.726 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 15.9 mtmt -121.55 162.95 19.68 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 120.827 0.346 . . . . 0.0 111.258 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.96 139.11 57.68 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.62 4.45 70.21 Favored Glycine 0 C--N 1.305 -1.179 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.779 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.726 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -75.14 168.71 19.46 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.573 ' HZ2' ' N ' ' A' ' 150' ' ' GLU . 22.2 mttm -123.84 164.28 19.54 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.577 0.703 . . . . 0.0 111.937 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.88 159.05 41.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.424 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.31 141.04 28.99 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 2.5 m -115.75 158.54 16.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.671 173.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.533 ' HB3' HD21 ' A' ' 180' ' ' ASN . 32.6 t . . . . . 0 C--N 1.305 -1.329 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.68 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.3 mt . . . . . 0 CA--C 1.482 -1.664 0 CA-C-O 121.093 0.473 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 150' ' ' GLU . 0.0 OUTLIER -117.13 137.5 52.26 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -173.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.595 ' N ' HD12 ' A' ' 149' ' ' LEU . 14.5 mt-10 -90.58 147.43 23.34 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.752 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.498 HD11 ' CD1' ' A' ' 79' ' ' PHE . 79.1 mt -79.66 108.45 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.63 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.911 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.57 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 0.9 OUTLIER -64.69 -43.07 94.69 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.751 177.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -152.64 136.9 16.58 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.9 mt -115.7 143.13 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 113.623 -1.626 . . . . 0.0 110.589 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.442 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.0 ptpt -144.86 157.79 44.03 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.288 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.512 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 6.7 m-85 -100.54 118.05 35.94 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.412 HG11 ' HD3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -127.04 173.82 11.91 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.708 -178.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -105.92 157.49 17.45 Favored 'General case' 0 C--N 1.289 -2.051 0 O-C-N 121.911 -0.493 . . . . 0.0 111.627 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.95 118.63 8.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.567 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -63.09 -41.53 99.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.066 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -105.12 -174.12 2.46 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.669 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -99.04 0.41 43.7 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 120.851 0.357 . . . . 0.0 111.461 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -142.42 140.47 31.99 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.867 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 m -107.51 154.46 8.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.94 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.406 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 68.1 m-85 -134.39 166.55 22.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.036 -175.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.73 -22.15 0.06 Allowed 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.548 HD23 ' CD2' ' A' ' 24' ' ' LEU . 20.9 tp 68.46 111.42 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.266 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -82.32 113.38 20.07 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.282 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.45 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -133.34 -160.1 1.02 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.9 mptt . . . . . 0 C--N 1.317 -0.843 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.43 179.715 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 121.815 0.816 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.515 HG21 HD13 ' A' ' 8' ' ' ILE . 2.1 p -142.34 165.33 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 CA-C-O 121.397 0.618 . . . . 0.0 111.289 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.497 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 97.2 mt -92.83 113.13 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.113 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 29.6 pt -120.13 167.67 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.293 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' A' ' 180' ' ' ASN . 6.6 t-20 49.77 -132.38 1.75 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.095 0.958 . . . . 0.0 109.987 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.84 44.62 0.84 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.774 0.797 . . . . 0.0 110.52 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.4 m-20 73.05 47.55 0.19 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 125.61 1.564 . . . . 0.0 113.342 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.7 mt -87.35 113.69 25.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.525 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.67 124.13 39.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.658 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.5 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 8.9 t . . . . . 0 C--N 1.299 -1.625 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.793 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HD3' HD11 ' A' ' 76' ' ' LEU . 72.3 Cg_endo -72.96 162.94 39.72 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 N-CA-C 108.319 -1.454 . . . . 0.0 108.319 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.559 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -63.45 -25.36 68.55 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.055 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.88 -11.77 14.54 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.8 m -73.26 132.32 43.0 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.878 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 72.9 mmt-85 -84.21 135.78 34.22 Favored 'General case' 0 C--O 1.188 -2.163 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.417 ' N ' ' O ' ' A' ' 19' ' ' ILE . 9.6 tt -120.71 130.23 74.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.495 HD13 ' N ' ' A' ' 10' ' ' VAL . 1.3 tm? -89.83 124.32 34.57 Favored 'General case' 0 N--CA 1.412 -2.368 0 CA-C-O 121.545 0.688 . . . . 0.0 110.125 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 30.7 m -135.09 -175.72 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.57 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.431 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 33.0 tt0 -131.63 121.18 23.92 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.543 HG12 HG13 ' A' ' 47' ' ' ILE . 20.2 mt -120.05 121.89 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.949 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.62 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.461 ' OD2' ' HD3' ' A' ' 45' ' ' ARG . 68.1 m-20 55.04 38.41 30.48 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.948 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.86 18.46 78.94 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.841 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.53 120.03 23.17 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.95 121.95 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.623 2.215 . . . . 0.0 111.64 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -124.94 142.34 51.53 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.821 -176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -114.48 101.81 9.48 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.643 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 8' ' ' ILE . 2.4 pt -125.12 -172.5 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.161 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.048 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.705 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 6.8 p -91.68 173.07 8.07 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.333 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.6 mm? -64.12 -35.84 82.08 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.296 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.705 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 8.2 ptm180 -76.95 -26.64 54.24 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.564 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 52.3 mt-10 -80.59 -39.34 27.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.951 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.474 HD23 HD22 ' A' ' 167' ' ' LEU . 18.3 tp -61.35 -41.85 97.73 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.069 0.938 . . . . 0.0 109.139 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.66 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 6.6 m-30 -57.28 -28.98 63.48 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.588 -1.642 . . . . 0.0 113.164 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.618 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 54.1 mt-10 -73.16 -17.49 61.37 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.248 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.0 mm? -78.92 2.54 19.83 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.484 0.659 . . . . 0.0 109.57 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 97.9 m-85 -116.33 163.01 16.65 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.535 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -141.48 -173.12 3.68 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.588 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 1.7 t70 63.23 84.85 0.14 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.326 0.584 . . . . 0.0 110.842 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -100.4 126.93 46.83 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.741 0.782 . . . . 0.0 110.998 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -115.66 150.52 36.61 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.808 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -102.25 129.72 48.74 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.404 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -167.44 148.72 5.58 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.029 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 57.89 19.63 5.95 Favored 'General case' 0 CA--C 1.496 -1.109 0 O-C-N 123.798 0.686 . . . . 0.0 111.726 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.6 mtt 71.02 18.84 5.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.393 0.615 . . . . 0.0 110.274 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 4.5 m -129.01 -173.14 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.459 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 64.7 m-85 -118.5 142.57 47.46 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.186 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 t -129.02 123.73 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.893 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.399 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.602 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 35.4 ttm180 -116.92 126.86 53.6 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.552 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -136.16 144.38 44.98 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.974 -174.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.552 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 14.2 ttmt 88.55 108.83 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.41 0 O-C-N 124.916 1.385 . . . . 0.0 110.568 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 93.0 Cg_endo -79.81 153.83 22.95 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 122.442 2.095 . . . . 0.0 111.843 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -87.78 -1.25 57.84 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.471 0.653 . . . . 0.0 111.108 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.461 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 50.3 mtt180 -143.42 -166.15 2.25 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.6 tp10 -89.28 101.78 14.45 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 172.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.543 HG13 HG12 ' A' ' 12' ' ' ILE . 1.3 mp -114.56 118.16 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.017 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.519 ' HZ1' ' CG ' ' A' ' 63' ' ' ASP . 35.6 mmtt -115.39 169.04 9.45 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.911 175.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.489 HG12 ' CB ' ' A' ' 169' ' ' ALA . 9.3 p -123.85 130.83 73.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.076 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.24 129.4 35.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.031 0.443 . . . . 0.0 110.967 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.7 t -140.94 176.72 8.58 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.699 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.432 HD13 ' C ' ' A' ' 58' ' ' LYS . 2.0 mm -120.75 145.07 27.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.249 0.547 . . . . 0.0 110.561 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.743 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.2 t70 -88.62 123.34 32.99 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.819 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.592 HD21 ' H ' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -75.16 -17.86 60.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.106 0.479 . . . . 0.0 112.195 -172.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.743 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -94.55 -28.24 15.52 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.702 -175.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.446 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 60.3 p -114.85 -21.73 9.99 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.331 -176.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.77 17.64 74.73 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.138 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.446 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 18.5 mtpp -94.56 157.72 15.86 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 p -91.52 110.43 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.47 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 m -110.12 158.19 10.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.202 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.4 tp -122.65 140.27 53.03 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.0 t -147.04 172.05 14.33 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.611 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.519 ' CG ' ' HZ1' ' A' ' 48' ' ' LYS . 2.2 m-20 -83.78 161.58 20.92 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.763 0.792 . . . . 0.0 111.783 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 64' ' ' ILE . 2.1 mp -95.8 142.4 13.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.665 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.543 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 19.5 mt-10 -93.02 -34.88 13.54 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -179.55 -177.33 0.42 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.823 0.821 . . . . 0.0 111.716 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 6.9 t -115.24 128.3 72.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.696 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.477 HD12 ' HB2' ' A' ' 166' ' ' SER . 33.1 mt -97.09 104.73 16.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.548 -175.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.539 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 59.1 tttp -117.25 108.11 15.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.09 136.05 28.22 Favored Pre-proline 0 C--N 1.308 -1.218 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.438 ' HD2' HG13 ' A' ' 37' ' ' VAL . 72.5 Cg_exo -48.28 139.55 21.68 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.677 2.918 . . . . 0.0 113.689 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -85.83 96.32 9.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.158 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -89.11 -31.58 17.94 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.354 -175.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.0 -97.95 0.4 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.42 ' HB2' ' O ' ' A' ' 157' ' ' VAL . 0.4 OUTLIER 178.74 173.48 0.71 Allowed 'General case' 0 CA--C 1.471 -2.088 0 C-N-CA 123.936 0.895 . . . . 0.0 108.832 -175.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.537 HD22 ' HA ' ' A' ' 90' ' ' THR . 5.7 mt -123.96 140.6 52.82 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 118.748 -1.181 . . . . 0.0 112.898 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 109' ' ' PHE . 9.3 mt -84.77 145.94 7.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 172.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 19.9 ttt85 -116.94 138.38 51.58 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-O 121.227 0.537 . . . . 0.0 110.173 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.52 ' CD1' HD13 ' A' ' 151' ' ' ILE . 61.3 m-85 -116.13 122.86 46.33 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.28 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.0 tt0 -110.9 126.4 54.66 Favored 'General case' 0 CA--C 1.468 -2.202 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.564 HD21 ' O ' ' A' ' 85' ' ' ARG . 1.8 mm? -89.88 162.49 15.43 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.464 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.579 ' HG2' ' CD1' ' A' ' 149' ' ' LEU . 3.2 pt-20 -63.15 -15.65 57.52 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.786 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -91.92 -10.29 40.07 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.533 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.06 4.33 66.97 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.749 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.564 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -83.57 143.38 30.19 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 23.0 p -141.76 157.92 44.44 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.748 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -148.34 154.07 39.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.894 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 16.3 mt-10 -125.0 148.87 48.25 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.727 -176.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.47 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -143.0 156.82 44.92 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.532 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.537 ' HA ' HD22 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -67.17 13.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.691 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 1.4 m 67.27 -41.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 125.362 1.465 . . . . 0.0 113.814 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.17 -28.61 34.94 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.304 0.573 . . . . 0.0 109.956 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 29.8 m80 -73.49 144.37 83.66 Favored Pre-proline 0 C--N 1.314 -0.969 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.735 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 5.7 Cg_exo -74.46 144.05 31.85 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.546 2.831 . . . . 0.0 114.704 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.01 146.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 124.841 1.256 . . . . 0.0 107.634 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.4 tp -102.36 113.08 26.1 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.179 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.69 HG23 ' OD1' ' A' ' 115' ' ' ASP . 2.0 p -116.8 150.23 18.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.33 0.586 . . . . 0.0 111.817 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.411 ' CD2' HD12 ' A' ' 148' ' ' LEU . 72.4 t80 -103.17 95.93 6.45 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.877 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.1 pt-20 -138.57 156.66 47.29 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 94.2 m-20 63.15 22.87 13.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.058 0.456 . . . . 0.0 110.319 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.79 13.01 63.07 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.925 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -132.36 171.71 13.39 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 117.434 0.617 . . . . 0.0 109.8 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -104.91 122.39 45.7 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.454 HG13 HG13 ' A' ' 97' ' ' VAL . 22.9 pt -121.61 156.57 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.312 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -111.69 106.98 15.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.808 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.506 ' HZ2' ' HE3' ' A' ' 112' ' ' LYS . 15.7 ptpt -122.81 141.23 52.06 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.725 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.557 ' O ' HG21 ' A' ' 111' ' ' VAL . 66.3 mtm180 -60.96 155.2 20.51 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.691 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -59.34 -40.32 85.99 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.312 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.514 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.2 p90 -75.21 -0.71 20.33 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.797 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -106.3 -19.65 13.63 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.703 0.763 . . . . 0.0 109.311 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.557 HG21 ' O ' ' A' ' 107' ' ' ARG . 86.5 t -71.67 149.11 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.506 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.686 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -122.17 166.83 13.97 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.842 -178.417 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.17 141.95 52.55 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.43 4.96 79.86 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.518 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.69 ' OD1' HG23 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -75.48 173.46 10.94 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -127.04 163.3 24.05 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 121.719 0.771 . . . . 0.0 112.198 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.3 158.26 42.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 114.639 -1.164 . . . . 0.0 107.887 168.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.446 ' HB3' ' HB ' ' A' ' 182' ' ' VAL . 1.1 tt -88.98 133.29 34.37 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -115.93 130.18 71.06 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.1 t . . . . . 0 C--N 1.307 -1.261 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.058 -178.881 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.411 HD12 ' CD2' ' A' ' 98' ' ' TYR . 7.1 mt . . . . . 0 N--CA 1.428 -1.526 0 CA-C-O 121.375 0.607 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.579 ' CD1' ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -116.85 137.9 51.89 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.063 -173.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -88.72 145.58 25.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 124.652 1.181 . . . . 0.0 112.639 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.52 HD13 ' CD1' ' A' ' 79' ' ' PHE . 70.0 mt -80.08 104.26 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.766 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 6.6 mmpt? -68.18 -38.96 82.61 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.876 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -149.59 135.63 18.86 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 82.5 mt -114.77 144.26 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.476 174.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.455 ' CD ' ' HD3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -148.1 158.43 44.06 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.922 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.411 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 15.2 m-85 -99.15 111.76 24.07 Favored 'General case' 0 N--CA 1.407 -2.583 0 CA-C-O 121.802 0.811 . . . . 0.0 109.762 174.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -116.56 175.64 2.91 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.903 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.29 179.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.421 ' HB3' ' H ' ' A' ' 159' ' ' ALA . 78.1 mtt180 -79.56 -146.55 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.381 -0.528 . . . . 0.0 112.169 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.421 ' H ' ' HB3' ' A' ' 158' ' ' ARG . . . -104.08 -13.61 16.21 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.673 -176.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.67 8.11 2.2 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.956 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -175.21 -173.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -104.0 -7.72 20.12 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.35 158.28 44.42 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.269 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.88 157.16 41.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.091 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.66 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 11.3 m-85 -131.29 170.55 14.46 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.714 -172.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.477 ' HB2' HD12 ' A' ' 68' ' ' ILE . 68.3 m -159.88 -22.01 0.06 Allowed 'General case' 0 C--N 1.359 0.994 0 CA-C-O 120.622 0.249 . . . . 0.0 110.377 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.474 HD22 HD23 ' A' ' 24' ' ' LEU . 14.4 tp 64.52 110.87 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.164 0.915 . . . . 0.0 112.081 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.453 HD21 ' HB2' ' A' ' 65' ' ' GLU . 4.4 t30 -84.63 108.26 17.27 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.543 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -112.65 -161.0 0.74 Allowed 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 49.1 tptt . . . . . 0 C--N 1.314 -0.963 0 CA-C-O 120.854 0.359 . . . . 0.0 110.67 -177.122 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 CA--C 1.51 -0.596 0 CA-C-O 120.962 0.411 . . . . 0.0 111.994 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.462 HG13 HG21 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -165.81 158.47 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.686 176.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.583 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 88.9 mt -108.9 116.52 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.779 0 CA-C-O 121.007 0.432 . . . . 0.0 110.321 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.462 HG21 HG13 ' A' ' 175' ' ' VAL . 43.2 pt -122.04 169.44 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.729 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.466 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 6.6 t-20 48.8 -133.05 1.51 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.333 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -83.94 53.97 2.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.459 0.647 . . . . 0.0 110.008 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.678 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.0 m120 70.55 45.32 0.61 Allowed 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.357 -1.292 . . . . 0.0 113.909 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 98.3 mt -86.04 112.38 22.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 118' ' ' LEU . 98.6 t -86.93 117.5 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.299 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.411 -2.39 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.939 179.825 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.529 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 7.0 m-85 . . . . . 0 CA--C 1.517 -0.306 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.475 ' HD3' HD11 ' A' ' 76' ' ' LEU . 73.0 Cg_endo -72.51 161.93 42.8 Favored 'Trans proline' 0 N--CA 1.438 -1.77 0 N-CA-C 108.41 -1.419 . . . . 0.0 108.41 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.503 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.01 -26.49 63.37 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 118.682 -1.723 . . . . 0.0 110.875 175.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 160' ' ' ASN . 6.9 m-20 -59.79 -13.81 12.01 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.7 m -74.4 129.03 37.0 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.351 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 10.9 mtm-85 -84.88 129.45 34.81 Favored 'General case' 0 C--O 1.195 -1.766 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.611 ' CD1' HG22 ' A' ' 175' ' ' VAL . 10.5 tt -115.04 129.87 70.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' ' 18' ' ' LYS . 2.6 tm? -94.96 123.94 38.72 Favored 'General case' 0 N--CA 1.399 -3.009 0 CA-C-O 121.786 0.803 . . . . 0.0 110.474 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.666 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 31.0 m -132.23 -172.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.849 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 30.9 tt0 -131.52 123.54 28.22 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 28.3 mt -120.68 122.49 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.893 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.632 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.74 41.81 31.65 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.033 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.58 18.92 72.43 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.774 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.55 118.73 18.07 Favored Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 52.6 Cg_exo -53.44 148.21 34.72 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 C-N-CA 122.053 1.835 . . . . 0.0 111.104 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -148.83 129.18 13.81 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HB2' HD22 ' A' ' 9' ' ' LEU . 40.3 ttmt -117.62 102.93 9.56 Favored 'General case' 0 CA--C 1.48 -1.741 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.883 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 24' ' ' LEU . 2.4 pt -125.23 -173.9 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.253 177.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.668 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 10.4 p -92.28 172.08 8.65 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.392 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.529 ' CD1' ' HB2' ' A' ' 2' ' ' PHE . 81.8 mt -66.17 -28.47 68.8 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.414 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.668 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 4.3 ptm180 -82.1 -24.56 35.09 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.505 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 51.9 mt-10 -84.16 -39.99 18.73 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.861 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.521 HD21 ' HG ' ' A' ' 167' ' ' LEU . 17.5 tp -61.12 -41.08 96.04 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.546 0.689 . . . . 0.0 109.826 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -51.14 -32.76 24.01 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.978 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.4 mt-10 -74.48 -15.8 60.87 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.248 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.92 2.17 27.8 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.589 0.709 . . . . 0.0 109.56 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.9 m-85 -118.37 164.54 15.09 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.832 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.515 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 12.6 mm-40 -141.16 -172.97 3.61 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.028 175.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t0 63.18 81.33 0.21 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.57 0.7 . . . . 0.0 110.392 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -99.19 122.44 42.39 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.791 0.805 . . . . 0.0 111.044 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -113.14 150.45 32.19 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.923 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -101.79 131.14 48.26 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -166.6 145.76 5.59 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.763 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.98 21.84 9.72 Favored 'General case' 0 CA--C 1.488 -1.41 0 O-C-N 123.85 0.718 . . . . 0.0 111.51 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 43.8 mtm 72.36 18.97 4.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.691 0.619 . . . . 0.0 110.569 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 10.5 m -134.7 -175.16 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.417 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 90.7 m-85 -112.85 139.98 48.02 Favored 'General case' 0 CA--C 1.478 -1.798 0 CA-C-O 121.243 0.544 . . . . 0.0 110.535 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -128.39 124.06 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.85 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.533 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 13.6 ttm180 -118.04 128.26 54.6 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.54 145.69 51.34 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.843 -173.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 5.2 tppp? 81.84 111.81 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.643 1.214 . . . . 0.0 111.235 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HB2' HD11 ' A' ' 47' ' ' ILE . 66.1 Cg_endo -78.91 154.0 25.82 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 122.079 1.853 . . . . 0.0 111.951 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 36.3 mtmt -85.38 -4.34 59.13 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.868 -178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -149.17 -165.22 2.22 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 33.9 tt0 -86.82 101.65 13.55 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.562 HG13 HG12 ' A' ' 12' ' ' ILE . 1.6 mp -114.85 113.02 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.998 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.666 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 72.6 mmtt -116.95 169.39 9.44 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.694 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.527 HG13 ' CB ' ' A' ' 169' ' ' ALA . 10.8 p -120.88 124.93 73.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.551 0.691 . . . . 0.0 111.959 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.788 ' CZ ' HG23 ' A' ' 59' ' ' VAL . 5.5 t80 -76.47 123.31 25.83 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.952 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.5 t -140.13 168.25 20.25 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.932 0.396 . . . . 0.0 110.815 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.13 145.14 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.164 0.507 . . . . 0.0 110.681 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -91.99 117.93 30.29 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.568 HD12 ' H ' ' A' ' 54' ' ' LEU . 4.2 mp -69.42 -31.47 69.83 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.786 0.803 . . . . 0.0 111.763 -172.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.35 -30.35 42.6 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.986 -174.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.4 p -111.08 -25.61 9.67 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.023 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.67 13.33 75.88 Favored Glycine 0 N--CA 1.421 -2.321 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.855 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -92.91 170.18 9.88 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 120.899 0.38 . . . . 0.0 111.24 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.788 HG23 ' CZ ' ' A' ' 50' ' ' TYR . 7.6 p -103.14 118.61 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.671 0 CA-C-O 121.873 0.844 . . . . 0.0 110.529 177.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -111.51 153.78 13.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.424 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 49' ' ' VAL . 11.7 tp -122.36 132.86 54.59 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.422 HG21 ' HB2' ' A' ' 170' ' ' LYS . 10.8 t -140.09 173.28 11.67 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.462 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -86.64 161.38 18.51 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.793 0.806 . . . . 0.0 111.558 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.449 HD11 ' N ' ' A' ' 64' ' ' ILE . 2.1 mp -91.81 141.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.688 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.569 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 7.9 mm-40 -83.46 -39.65 20.27 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 p30 178.12 174.79 0.56 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.812 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 25.9 t -104.76 137.35 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.319 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.455 HG21 HD13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -113.99 126.51 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.335 -178.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.479 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 52.6 tttp -135.38 115.81 13.61 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.889 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.39 142.56 45.86 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.697 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -51.72 136.32 50.19 Favored 'Trans proline' 0 C--N 1.327 -0.58 0 C-N-CA 123.284 2.656 . . . . 0.0 112.185 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.84 97.95 1.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.4 p -88.54 -67.12 0.85 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.073 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -92.64 -161.75 0.86 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.391 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -107.84 173.63 6.24 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.486 HD22 ' HA ' ' A' ' 90' ' ' THR . 10.5 mt -124.47 138.6 54.33 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.541 0.686 . . . . 0.0 111.214 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.493 HD13 ' C ' ' A' ' 108' ' ' ALA . 13.4 mt -85.0 145.01 8.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 31.9 ttt85 -121.24 137.14 54.82 Favored 'General case' 0 N--CA 1.406 -2.664 0 CA-C-O 121.282 0.563 . . . . 0.0 109.597 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' ' 86' ' ' SER . 59.2 m-85 -116.6 127.85 54.86 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.127 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.8 tt0 -113.05 126.16 55.17 Favored 'General case' 0 CA--C 1.471 -2.093 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.983 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.597 HD13 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -90.15 152.4 21.13 Favored 'General case' 0 N--CA 1.399 -2.98 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.63 ' HA ' ' HG3' ' A' ' 152' ' ' LYS . 5.3 pt-20 -55.3 -22.27 18.15 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.592 ' OD1' ' HG3' ' A' ' 85' ' ' ARG . 32.6 p-10 -102.5 1.37 34.98 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.529 0.681 . . . . 0.0 110.968 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.87 19.91 20.52 Favored Glycine 0 C--N 1.304 -1.223 0 CA-C-N 114.767 -1.106 . . . . 0.0 115.837 171.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.592 ' HG3' ' OD1' ' A' ' 83' ' ' ASP . 8.4 mtt180 -88.51 136.29 33.06 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 57.2 p -138.44 137.24 37.03 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.86 173.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -134.63 155.22 50.86 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.362 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 38.3 mt-10 -131.3 151.31 51.63 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.257 0.551 . . . . 0.0 112.008 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.7 OUTLIER -146.6 161.1 41.23 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.693 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.486 ' HA ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -70.35 16.82 0.07 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.657 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.66 -28.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 125.235 1.414 . . . . 0.0 112.715 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 26.8 t70 -87.98 -8.07 56.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.433 0.635 . . . . 0.0 110.219 176.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -82.15 125.97 75.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.579 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -62.92 138.02 65.91 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.921 2.414 . . . . 0.0 112.568 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 17.3 t -114.7 146.17 19.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.3 tp -98.83 106.38 18.63 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.418 HG12 HG13 ' A' ' 104' ' ' ILE . 2.4 p -108.18 148.46 12.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.342 0.591 . . . . 0.0 111.4 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.486 ' CD2' HD13 ' A' ' 148' ' ' LEU . 49.8 t80 -100.99 94.15 5.86 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.813 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.453 ' CD ' HD11 ' A' ' 104' ' ' ILE . 11.5 pt-20 -144.96 158.23 43.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.2 m-20 64.02 22.16 12.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.015 0.436 . . . . 0.0 110.173 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.13 13.36 61.99 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.689 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -136.67 172.61 12.76 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 121.452 0.644 . . . . 0.0 110.425 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -104.72 121.61 43.97 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.686 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.453 HD11 ' CD ' ' A' ' 99' ' ' GLU . 16.7 pt -126.74 151.46 33.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.792 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.3 mp0 -106.28 111.24 23.75 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.092 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HD2' HG11 ' A' ' 97' ' ' VAL . 11.6 ptpt -125.76 143.43 51.05 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.277 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.629 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 79.7 mtt85 -61.57 163.28 7.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.657 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -61.41 -41.17 96.71 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.803 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.441 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.1 p90 -75.17 -0.92 20.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.717 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -106.73 -19.32 13.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.69 0.757 . . . . 0.0 109.172 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 107' ' ' ARG . 52.9 t -76.25 150.41 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -124.47 168.03 13.62 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.408 -177.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -68.24 138.45 55.57 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.25 5.13 67.84 Favored Glycine 0 C--N 1.3 -1.418 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.825 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.587 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 3.7 t70 -75.72 165.77 24.55 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.41 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 29.1 mttp -124.63 160.97 27.26 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.311 0.576 . . . . 0.0 111.116 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.35 160.26 42.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.271 173.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.7 136.24 37.51 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.2 m -109.11 161.15 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 80.6 p . . . . . 0 C--N 1.308 -1.211 0 CA-C-O 121.281 0.562 . . . . 0.0 110.547 179.393 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.486 HD13 ' CD2' ' A' ' 98' ' ' TYR . 9.7 mt . . . . . 0 N--CA 1.415 -2.209 0 CA-C-O 121.356 0.598 . . . . 0.0 109.738 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.597 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -113.9 137.58 51.48 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.423 -172.14 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.41 ' HG3' ' CG ' ' A' ' 116' ' ' LYS . 10.2 mt-10 -90.8 145.28 24.91 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.574 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.572 HD11 ' CD1' ' A' ' 79' ' ' PHE . 82.2 mt -76.96 102.72 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.371 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.63 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 35.5 mmtm -69.33 -35.74 76.23 Favored 'General case' 0 C--N 1.264 -3.125 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.369 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -151.59 128.79 11.18 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 66.7 mt -112.56 144.76 19.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.795 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.432 ' HD3' HG12 ' A' ' 157' ' ' VAL . 5.7 ptpp? -146.41 156.45 43.32 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.123 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -99.42 115.26 28.84 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.432 HG12 ' HD3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -128.87 173.75 13.24 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.568 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.878 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -106.35 166.1 10.78 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.37 132.35 46.24 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.935 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.431 ' HB2' ' OD1' ' A' ' 5' ' ' ASP . 24.3 m-80 -87.95 34.58 0.73 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.276 0.56 . . . . 0.0 110.018 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -161.74 178.86 8.6 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.03 -1.36 23.99 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.399 0.619 . . . . 0.0 110.243 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -139.13 153.38 47.96 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.478 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.8 m -119.01 157.12 20.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 58.5 m-85 -132.84 175.04 9.7 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.553 -176.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.2 m -154.54 -29.55 0.11 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.884 173.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.521 ' HG ' HD21 ' A' ' 24' ' ' LEU . 2.5 mm? 61.93 90.97 0.07 Allowed 'General case' 0 C--N 1.345 0.371 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 65' ' ' GLU . 47.8 m-20 -81.75 104.5 12.18 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.608 0.718 . . . . 0.0 111.974 -175.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.569 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -94.67 -155.41 0.46 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.285 172.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.422 ' HB2' HG21 ' A' ' 62' ' ' THR . 32.7 mmtm . . . . . 0 C--N 1.321 -0.634 0 CA-C-O 121.223 0.535 . . . . 0.0 112.083 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 N--CA 1.448 -0.572 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.611 HG22 ' CD1' ' A' ' 8' ' ' ILE . 1.7 p -158.66 171.07 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -176.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.495 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 71.8 mt -116.42 122.4 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.923 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.475 HG22 HG13 ' A' ' 175' ' ' VAL . 43.1 pt -126.68 167.39 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 121.597 0.713 . . . . 0.0 112.637 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 180' ' ' ASN . 38.9 t30 52.48 -129.63 2.31 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.255 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.412 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 3.2 mp0 -78.89 42.99 0.48 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.017 0.437 . . . . 0.0 110.491 176.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.553 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.3 m-20 71.02 48.37 0.38 Allowed 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 124.508 1.123 . . . . 0.0 112.308 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 85.0 mt -88.75 112.17 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.447 HG12 HG12 ' A' ' 176' ' ' ILE . 2.6 m -79.47 135.51 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 CA-C-O 121.969 0.89 . . . . 0.0 111.208 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--N 1.289 -2.059 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.508 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.515 ' HD3' HD11 ' A' ' 76' ' ' LEU . 74.0 Cg_endo -71.56 164.82 34.44 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.035 1.823 . . . . 0.0 109.356 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.17 -29.85 63.29 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 119.276 -1.44 . . . . 0.0 111.334 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.611 ' HA ' ' NH1' ' A' ' 22' ' ' ARG . 35.7 t70 -61.37 -16.44 46.37 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.1 m -68.73 125.42 26.52 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.072 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.669 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 78.5 mtm-85 -84.01 134.88 34.62 Favored 'General case' 0 C--O 1.182 -2.46 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.451 HD13 ' CD2' ' A' ' 24' ' ' LEU . 9.5 tt -120.47 130.1 74.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.417 HD11 ' N ' ' A' ' 10' ' ' VAL . 0.6 OUTLIER -88.67 122.77 32.46 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-O 121.52 0.676 . . . . 0.0 109.656 178.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.4 m -135.52 -179.36 3.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.071 -176.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.447 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 33.0 tt0 -129.52 121.77 27.88 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.944 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 19.1 mt -121.79 121.8 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.097 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.92 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 56.43 37.48 28.86 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.473 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.38 15.92 77.23 Favored Glycine 0 C--N 1.305 -1.162 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.638 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.27 121.23 27.04 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 56.6 Cg_endo -72.44 122.69 8.51 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 C-N-CA 122.334 2.023 . . . . 0.0 111.416 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -120.45 138.13 53.96 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.916 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -107.98 101.08 10.37 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 8' ' ' ILE . 3.3 pt -127.03 -172.86 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.364 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 21.5 p -97.96 172.24 7.76 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.771 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 66.2 mt -68.15 -27.38 66.38 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.016 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.611 ' NH1' ' HA ' ' A' ' 5' ' ' ASP . 1.0 OUTLIER -78.53 -26.66 45.8 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.48 ' OE1' HG22 ' A' ' 20' ' ' THR . 85.3 mt-10 -85.73 -42.05 14.58 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.238 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.52 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 20.1 tp -58.8 -42.92 90.21 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.866 0.841 . . . . 0.0 109.319 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.406 ' HB2' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -52.41 -31.0 32.12 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.734 -1.575 . . . . 0.0 112.687 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.11 -19.32 61.81 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.757 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.1 mm? -78.29 1.92 20.15 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.483 0.659 . . . . 0.0 109.601 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.466 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 97.9 m-85 -119.15 156.52 29.65 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.035 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 17.4 mt-10 -157.65 131.51 8.05 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.092 175.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 47.6 t0 127.83 85.93 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.794 2.037 . . . . 0.0 107.394 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -99.23 125.28 44.8 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.113 0.959 . . . . 0.0 111.696 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -117.53 150.67 38.57 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.131 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -102.46 131.67 48.99 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -166.55 148.35 6.46 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.499 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 58.26 23.11 9.99 Favored 'General case' 0 CA--C 1.491 -1.296 0 O-C-N 123.81 0.694 . . . . 0.0 111.067 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 44.8 mtm 73.69 15.83 3.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.233 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.8 m -130.4 -170.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.92 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -112.5 138.1 49.75 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 t -130.08 123.54 56.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.08 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 29' ' ' GLU . 17.0 ttm180 -110.02 134.0 52.6 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -116.77 179.31 4.05 Favored 'General case' 0 C--N 1.267 -2.99 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.28 106.37 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 125.079 1.487 . . . . 0.0 114.505 170.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.39 140.01 18.98 Favored 'Trans proline' 0 N--CA 1.426 -2.482 0 C-N-CA 121.552 1.501 . . . . 0.0 110.619 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -83.71 -0.48 50.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.447 0.641 . . . . 0.0 111.735 -175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -147.34 -171.0 3.69 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 19.3 tt0 -79.83 105.34 11.05 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.549 HG13 HG12 ' A' ' 12' ' ' ILE . 1.4 mp -116.28 112.37 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.361 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.46 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 45.7 mmtm -113.56 166.5 11.46 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.739 173.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.465 HG11 ' CB ' ' A' ' 169' ' ' ALA . 12.1 p -121.48 131.29 73.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.447 ' CE2' ' HB2' ' A' ' 11' ' ' GLN . 19.2 m-85 -82.95 121.24 26.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.872 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 m -135.42 170.17 16.35 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.668 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.468 HD11 ' O ' ' A' ' 58' ' ' LYS . 2.4 mm -113.26 142.9 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.433 0.635 . . . . 0.0 110.831 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.64 80.26 3.08 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.577 ' H ' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -36.33 -40.66 0.24 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.399 1.88 . . . . 0.0 114.039 -175.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 2.1 pt-20 -63.33 -37.78 88.61 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.323 -176.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.508 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.4 p -107.34 -22.51 12.56 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.914 -176.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.55 20.46 68.84 Favored Glycine 0 N--CA 1.421 -2.366 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.015 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.508 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 40.8 mtpt -94.07 158.94 15.38 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.57 109.73 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.783 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.67 155.74 11.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-O 121.066 0.46 . . . . 0.0 111.387 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.8 tp -123.01 135.11 54.33 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.2 t -143.1 170.75 15.13 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.324 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -76.73 161.14 28.74 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.202 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 47' ' ' ILE . 1.9 mp -97.43 145.75 8.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.321 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.439 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 14.9 mm-40 -79.7 -53.3 6.95 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -175.48 -171.73 0.51 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.673 1.233 . . . . 0.0 107.918 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.41 ' HA ' HD22 ' A' ' 167' ' ' LEU . 14.3 t -107.31 149.99 10.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 120.889 0.376 . . . . 0.0 110.428 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 166' ' ' SER . 56.4 mt -111.95 118.96 58.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.198 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 19.2 tttm -134.75 112.62 10.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.933 0.397 . . . . 0.0 109.95 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.52 143.63 50.02 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.029 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.32 130.07 37.9 Favored 'Trans proline' 0 C--N 1.328 -0.502 0 C-N-CA 123.208 2.605 . . . . 0.0 112.446 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.98 85.53 6.24 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.611 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.8 p -96.55 -43.12 7.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.665 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.06 174.59 8.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.606 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -102.16 171.78 7.29 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.515 HD11 ' HD3' ' A' ' 3' ' ' PRO . 12.1 mt -126.02 143.05 51.25 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.753 0.787 . . . . 0.0 110.973 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.515 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 7.6 mt -83.82 141.4 14.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 15.9 ttt-85 -116.56 136.38 53.03 Favored 'General case' 0 N--CA 1.407 -2.575 0 CA-C-O 121.191 0.52 . . . . 0.0 109.748 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 86' ' ' SER . 55.0 m-85 -114.66 120.83 41.46 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.256 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 37.4 tt0 -108.07 126.62 52.96 Favored 'General case' 0 CA--C 1.467 -2.222 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.567 HD13 ' HB3' ' A' ' 149' ' ' LEU . 1.6 mm? -88.16 157.53 18.79 Favored 'General case' 0 C--N 1.27 -2.855 0 O-C-N 123.584 0.553 . . . . 0.0 110.97 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.573 ' HG2' HD13 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -59.32 -18.5 38.61 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.1 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -91.92 -10.2 40.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.847 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.42 9.64 57.65 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.965 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.536 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -84.17 141.57 30.96 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -142.09 140.52 32.55 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.823 176.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -135.48 157.47 46.82 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.497 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 31.3 mt-10 -129.1 153.19 47.89 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.154 0.502 . . . . 0.0 112.026 -176.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.499 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -145.88 158.43 43.86 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.384 177.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.497 ' HA ' HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -72.37 18.99 0.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.693 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.71 -41.91 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 C-N-CA 125.367 1.467 . . . . 0.0 114.151 175.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -82.21 2.88 29.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 111.144 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 36.8 m-70 -104.59 136.13 19.22 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.728 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 35.6 Cg_exo -62.3 142.41 91.13 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.543 2.829 . . . . 0.0 114.824 -177.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.506 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.8 t -117.97 147.28 21.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.604 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.6 tp -103.82 111.43 23.94 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.497 HG13 ' CG1' ' A' ' 104' ' ' ILE . 2.0 p -113.79 140.9 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-O 121.592 0.71 . . . . 0.0 111.667 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.603 ' CD2' HD13 ' A' ' 148' ' ' LEU . 81.6 t80 -91.37 92.37 8.55 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.533 ' HG3' HD21 ' A' ' 100' ' ' ASN . 1.0 OUTLIER -142.2 148.86 38.88 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.474 -175.009 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.533 HD21 ' HG3' ' A' ' 99' ' ' GLU . 28.6 m-80 69.18 22.55 6.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 110.027 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.14 14.51 63.88 Favored Glycine 0 CA--C 1.5 -0.905 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.91 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -140.05 173.32 11.64 Favored 'General case' 0 N--CA 1.41 -2.46 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -97.01 120.37 37.23 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.497 ' CG1' HG13 ' A' ' 97' ' ' VAL . 12.3 pt -116.91 143.13 27.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.006 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -107.49 110.44 22.38 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.13 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.423 ' HG3' HG21 ' A' ' 111' ' ' VAL . 11.5 ptpt -127.24 138.86 53.19 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.608 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.641 ' O ' HG23 ' A' ' 111' ' ' VAL . 56.6 mtm180 -64.62 164.14 12.46 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 119.347 -0.359 . . . . 0.0 110.147 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.693 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -61.57 -43.21 99.28 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.514 -175.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -75.05 2.74 9.86 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.524 0.678 . . . . 0.0 110.332 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -114.01 -15.39 12.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.553 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 107' ' ' ARG . 93.2 t -81.87 149.27 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.682 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 18.1 mtmt -124.06 163.47 21.38 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.091 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -64.12 142.89 58.25 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.66 4.2 85.54 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.887 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.682 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -74.98 167.9 21.02 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.465 ' HG3' ' HG3' ' A' ' 150' ' ' GLU . 3.8 ttmt -123.97 166.43 15.72 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.185 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.55 161.43 36.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -90.5 129.89 36.61 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -112.87 125.28 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.909 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.303 -1.425 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.542 -178.931 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.603 HD13 ' CD2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.423 -1.797 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.573 HD13 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -122.73 139.28 54.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.644 -170.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.465 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 19.1 mt-10 -91.19 150.52 21.33 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 122.337 1.065 . . . . 0.0 112.741 177.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.449 HG21 ' CG1' ' A' ' 154' ' ' ILE . 61.1 mt -77.79 121.69 31.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 113.246 -1.797 . . . . 0.0 111.002 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.568 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 49.4 mmtt -80.99 -39.19 26.33 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.482 175.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -148.73 130.2 14.82 Favored 'General case' 0 CA--C 1.473 -2.01 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.6 mt -117.62 126.26 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.445 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.297 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.82 166.89 22.24 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.153 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.515 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 23.8 m-85 -101.58 119.82 39.36 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.57 137.21 49.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.683 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -71.1 154.1 42.02 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.258 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.22 134.64 57.18 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.259 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -82.84 37.55 0.54 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.604 0.716 . . . . 0.0 110.163 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -175.16 179.26 1.58 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -107.34 4.32 26.3 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.858 0.361 . . . . 0.0 111.607 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -141.54 149.48 40.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.458 HG13 ' HA ' ' A' ' 3' ' ' PRO . 3.0 m -118.78 155.41 20.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.536 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.504 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 56.5 m-85 -133.16 174.17 10.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.111 -176.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.503 ' HB2' HD12 ' A' ' 68' ' ' ILE . 49.1 m -159.06 -27.42 0.07 Allowed 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.52 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 1.3 tm? 68.91 107.14 0.05 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.066 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -85.25 116.16 23.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.666 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.465 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -135.36 -163.03 1.33 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.045 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.411 ' HA ' ' CE ' ' A' ' 170' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 66.4 t30 . . . . . 0 CA--C 1.511 -0.558 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.446 HG11 HG22 ' A' ' 177' ' ' ILE . 2.8 p -152.96 163.92 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.433 0.635 . . . . 0.0 111.673 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.605 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 93.8 mt -116.71 115.78 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.444 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.446 HG22 HG11 ' A' ' 175' ' ' VAL . 39.5 pt -123.78 173.48 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.415 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 7.9 t-20 49.19 -122.36 1.71 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.35 1.06 . . . . 0.0 109.81 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -96.21 56.59 1.64 Allowed 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.47 0.652 . . . . 0.0 109.658 175.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.666 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 25.7 m-80 69.51 43.56 1.0 Allowed 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 114.216 -1.357 . . . . 0.0 113.751 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.5 mt -85.49 116.55 28.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.55 129.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.357 -174.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.506 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 14.7 t . . . . . 0 C--N 1.309 -1.176 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.448 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.416 ' HA ' HG13 ' A' ' 164' ' ' VAL . 23.0 Cg_endo -61.25 -32.66 90.45 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 122.852 2.368 . . . . 0.0 112.781 -174.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.516 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 127.04 -39.27 1.99 Allowed Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.38 -16.92 25.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.648 0.779 . . . . 0.0 111.058 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -64.4 126.69 28.63 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.593 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 19.1 mmt85 -82.79 134.41 35.12 Favored 'General case' 0 C--O 1.186 -2.25 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 175' ' ' VAL . 9.9 tt -121.66 131.4 73.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.432 HD11 ' N ' ' A' ' 10' ' ' VAL . 2.1 tm? -87.66 123.71 32.79 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.611 0.72 . . . . 0.0 109.847 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 31.5 m -133.06 -177.26 2.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.02 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -130.3 121.32 25.85 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.537 HG12 HG13 ' A' ' 47' ' ' ILE . 22.3 mt -118.36 121.32 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.523 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.707 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.84 38.12 29.73 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.691 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.02 20.29 79.47 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.769 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.04 118.32 22.09 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-O 120.683 0.277 . . . . 0.0 110.41 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 7.0 Cg_exo -66.78 121.54 8.77 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 122.068 1.845 . . . . 0.0 111.065 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -123.63 137.4 54.74 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.693 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -108.54 101.37 10.53 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.424 ' O ' ' N ' ' A' ' 8' ' ' ILE . 2.9 pt -123.53 -171.9 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.18 -2.555 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.624 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.772 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 6.6 p -94.44 171.82 8.58 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.088 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 12.3 mt -72.38 -24.5 61.27 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 120.683 0.277 . . . . 0.0 110.909 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.772 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 8.1 ptm180 -82.18 -24.35 35.02 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.558 ' HG2' ' HG1' ' A' ' 20' ' ' THR . 67.8 mm-40 -82.96 -44.59 15.13 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.043 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.418 ' HA ' HD11 ' A' ' 19' ' ' ILE . 20.5 tp -54.74 -45.57 74.14 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.88 0.848 . . . . 0.0 109.407 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.433 ' HB2' HG12 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -52.2 -31.16 30.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.554 -1.657 . . . . 0.0 112.754 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 26.8 mt-10 -78.81 -15.35 58.5 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -77.97 5.92 8.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.76 0.79 . . . . 0.0 109.39 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.491 ' CZ ' HG23 ' A' ' 47' ' ' ILE . 97.7 m-85 -121.01 162.46 19.89 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.857 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.559 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 21.1 mm-40 -142.06 -172.86 3.67 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.296 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.45 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.7 t70 63.1 80.04 0.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.376 0.607 . . . . 0.0 110.469 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.35 128.09 43.87 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.841 0.829 . . . . 0.0 110.672 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.421 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.0 ptt180 -121.78 154.42 37.0 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.402 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -102.84 126.33 49.93 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -162.5 140.96 8.78 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.622 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 58.65 24.14 11.78 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 123.671 0.607 . . . . 0.0 110.624 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.6 mtp 72.74 13.44 5.16 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.348 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 12.9 m -127.31 -177.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -112.42 139.68 47.79 Favored 'General case' 0 CA--C 1.471 -2.081 0 CA-C-O 121.303 0.573 . . . . 0.0 109.855 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.421 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.8 t -128.94 122.55 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 0 CA-C-N 115.14 -0.937 . . . . 0.0 108.77 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.424 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 16.1 ttm180 -112.24 126.17 54.94 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.45 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -129.95 145.51 51.63 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.177 -173.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 3.6 tppp? 81.78 111.94 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.48 0 O-C-N 124.54 1.15 . . . . 0.0 110.902 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.72 152.44 25.61 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 122.15 1.9 . . . . 0.0 111.622 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.559 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 32.4 mtmt -81.53 -5.43 57.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.422 0.629 . . . . 0.0 111.214 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -146.19 -165.39 2.2 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 39.9 tt0 -86.04 102.0 13.43 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.537 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -116.91 120.92 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.167 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 22.5 mmtt -120.02 164.7 15.73 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.181 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.412 HG13 ' CB ' ' A' ' 169' ' ' ALA . 12.9 p -118.67 130.92 72.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.274 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -90.73 118.92 30.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.6 0.714 . . . . 0.0 111.461 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.9 m -134.24 146.68 50.31 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.819 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.458 HG12 HD11 ' A' ' 176' ' ' ILE . 2.8 mm -90.26 141.03 14.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.334 0.588 . . . . 0.0 110.345 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.475 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 13.5 t70 -80.57 121.14 25.43 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.588 HD21 ' H ' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -78.16 -8.52 58.39 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.237 0.541 . . . . 0.0 111.876 -169.287 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.475 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.5 pt-20 -103.27 -31.56 10.02 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.35 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.484 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 68.2 p -111.84 -18.11 12.78 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.78 -175.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.46 21.34 79.63 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.345 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 38.2 mtpt -98.14 162.24 13.31 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 120.865 0.364 . . . . 0.0 111.464 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.46 110.45 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-O 121.767 0.794 . . . . 0.0 109.509 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 m -110.05 156.88 10.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.051 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.5 tp -123.1 136.87 54.98 Favored 'General case' 0 N--CA 1.411 -2.387 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.415 ' OG1' ' HB2' ' A' ' 170' ' ' LYS . 10.3 t -142.66 171.21 14.37 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.939 0.399 . . . . 0.0 111.316 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.436 ' O ' ' HB1' ' A' ' 169' ' ' ALA . 0.9 OUTLIER -80.26 161.04 25.34 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.395 178.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.474 HD11 ' N ' ' A' ' 64' ' ' ILE . 2.3 mp -101.15 136.72 31.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.222 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -83.59 -41.22 18.11 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -179.49 178.01 0.7 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.405 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 25' ' ' TYR . 13.3 t -105.86 132.76 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.795 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 60.3 mt -91.28 108.45 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.095 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.497 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.7 tttt -124.56 107.93 11.55 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 163' ' ' PHE . . . -131.52 144.53 53.75 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.312 -175.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.452 ' HD2' HG11 ' A' ' 37' ' ' VAL . 9.8 Cg_endo -53.97 131.67 45.74 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.389 2.726 . . . . 0.0 112.29 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -78.15 -108.95 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.728 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 86.2 m 77.02 -21.45 0.33 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.945 0.498 . . . . 0.0 111.878 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.79 -139.77 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.446 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -150.68 165.79 32.36 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.688 ' CD1' ' HA ' ' A' ' 159' ' ' ALA . 30.5 mt -135.98 136.54 40.44 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.117 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.557 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 15.6 mt -89.61 146.24 6.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 172.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 28.8 ttt85 -121.08 137.87 54.45 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 121.153 0.501 . . . . 0.0 109.999 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.495 ' CD1' HD12 ' A' ' 151' ' ' ILE . 50.7 m-85 -117.57 127.31 53.84 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.2 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 32.4 tt0 -112.88 130.3 56.15 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.554 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 1.7 mm? -94.27 162.04 14.01 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.04 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.565 ' HG2' ' CD1' ' A' ' 149' ' ' LEU . 4.3 pt-20 -58.27 -22.42 52.47 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.875 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.725 ' OD1' ' HG ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -86.69 -10.8 52.92 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.575 0.702 . . . . 0.0 109.498 -178.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.78 14.4 58.11 Favored Glycine 0 C--N 1.297 -1.602 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.191 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.554 ' HG3' ' HB2' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -89.64 142.48 27.64 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.308 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 35.3 p -139.95 154.33 47.17 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.888 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 79' ' ' PHE . 9.3 p90 -142.86 151.34 40.97 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.723 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 96.9 mt-10 -125.8 146.12 49.93 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.56 -177.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.478 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -142.31 159.46 42.19 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.406 -179.065 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.555 ' HA ' HD22 ' A' ' 76' ' ' LEU . 1.7 m -73.62 19.22 0.11 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.3 0.571 . . . . 0.0 112.478 -177.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.689 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.88 -34.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 124.78 1.232 . . . . 0.0 113.249 175.152 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.517 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 23.3 t70 -78.62 -24.59 45.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.129 0.49 . . . . 0.0 110.017 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -77.8 119.97 79.49 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.277 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 35.1 Cg_exo -62.2 139.83 80.13 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.522 2.815 . . . . 0.0 114.014 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.5 t -100.28 147.42 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.736 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.5 tp -98.02 106.16 18.42 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.168 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.51 HG13 HG12 ' A' ' 104' ' ' ILE . 2.4 p -112.55 149.37 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.678 0.751 . . . . 0.0 112.258 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -104.05 92.81 4.54 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.781 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.566 ' OE2' ' HE3' ' A' ' 106' ' ' LYS . 6.1 pt-20 -138.85 159.94 40.9 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 89.9 m-20 63.14 22.37 13.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.332 0.587 . . . . 0.0 109.7 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.29 16.68 62.91 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.298 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -136.4 171.99 13.67 Favored 'General case' 0 N--CA 1.399 -2.979 0 CA-C-N 117.605 0.702 . . . . 0.0 109.916 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -98.36 121.25 40.07 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.51 HG12 HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -126.98 148.75 31.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.132 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 3.3 mp0 -108.11 116.45 31.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.515 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.566 ' HE3' ' OE2' ' A' ' 99' ' ' GLU . 51.0 mttm -124.62 134.72 52.82 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.328 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 75.3 mtm180 -56.66 154.78 8.39 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.689 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -59.87 -41.74 92.18 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.935 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.522 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.4 p90 -73.51 2.11 8.53 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.92 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -114.14 -19.26 11.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.863 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 107' ' ' ARG . 53.1 t -76.97 152.3 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.576 ' HE2' ' H ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -123.94 167.08 14.61 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -71.15 143.53 50.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.99 4.96 74.19 Favored Glycine 0 C--N 1.304 -1.199 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.569 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.575 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 15.2 t70 -72.03 178.81 3.56 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.617 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 71.4 mttt -135.45 154.52 51.41 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.62 0.724 . . . . 0.0 112.037 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.05 155.64 41.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.895 173.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.486 ' HA ' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -97.12 135.91 38.41 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.8 OUTLIER -104.93 125.96 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.747 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.819 176.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.295 -1.77 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 175.647 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.617 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.9 mm? . . . . . 0 CA--C 1.475 -1.907 0 CA-C-O 121.03 0.443 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.725 ' HG ' ' OD1' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -119.28 135.95 54.46 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.006 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.713 ' N ' HD13 ' A' ' 149' ' ' LEU . 25.8 mt-10 -83.19 141.51 31.87 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.96 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.532 HD13 ' HB3' ' A' ' 115' ' ' ASP . 73.0 mt -80.17 104.87 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.995 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.586 174.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.54 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 14.1 mmtm -70.64 -37.13 73.74 Favored 'General case' 0 C--N 1.266 -3.06 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.159 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -148.92 129.25 13.77 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 75.7 mt -113.11 144.82 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.529 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HD2' ' HD3' ' A' ' 78' ' ' ARG . 5.2 ptpp? -145.99 156.14 43.29 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.815 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.557 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 5.1 m-85 -98.94 117.82 34.31 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.2 175.65 7.97 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.094 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.521 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 23.3 mtt-85 -100.6 164.46 11.88 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.625 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.688 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.87 -30.16 63.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.511 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.6 t30 66.37 -38.76 0.31 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.358 1.063 . . . . 0.0 113.279 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 159' ' ' ALA . 8.3 t70 -98.04 -174.36 2.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.37 -13.09 16.8 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 120.71 0.291 . . . . 0.0 110.905 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 84.2 m-85 -139.29 155.95 47.37 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.18 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 3' ' ' PRO . 3.4 m -128.28 160.09 38.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.505 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.625 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 81.4 m-85 -132.76 169.75 16.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.555 0.217 . . . . 0.0 110.736 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.496 ' HB2' HD11 ' A' ' 68' ' ' ILE . 20.3 m -156.78 -27.99 0.09 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.447 HD12 ' CG1' ' A' ' 64' ' ' ILE . 1.3 tm? 73.05 112.22 0.06 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.996 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -91.94 116.67 29.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.605 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 63' ' ' ASP . . . -134.16 -164.1 1.46 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.677 176.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.415 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 26.1 mmmt . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.489 HG11 HG23 ' A' ' 177' ' ' ILE . 0.5 OUTLIER -173.83 166.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.309 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.484 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 85.7 mt -109.53 112.95 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.639 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.489 HG23 HG11 ' A' ' 175' ' ' VAL . 44.9 pt -120.51 171.59 8.8 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.683 0 CA-C-O 121.375 0.607 . . . . 0.0 112.482 -175.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.548 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 44.8 t30 48.68 -128.12 1.97 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.002 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.474 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 19.7 mm-40 -85.61 48.71 1.63 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.334 0.587 . . . . 0.0 109.592 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.5 m-20 70.29 44.79 0.7 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.128 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 82.1 mt -86.27 113.08 23.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 m -80.34 135.6 25.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.758 0.789 . . . . 0.0 111.271 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.293 -1.849 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.581 176.868 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.44 ' HD3' HD11 ' A' ' 76' ' ' LEU . 61.6 Cg_endo -70.43 157.01 60.37 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 N-CA-C 108.413 -1.418 . . . . 0.0 108.413 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.59 -21.46 35.32 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 119.735 -1.221 . . . . 0.0 112.397 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -74.27 -1.26 19.87 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.4 m -74.39 130.93 40.58 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.928 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 8.7 mmt180 -81.86 126.2 31.6 Favored 'General case' 0 C--O 1.197 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.487 HD13 HG21 ' A' ' 175' ' ' VAL . 9.5 tt -117.67 129.75 73.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.039 0.447 . . . . 0.0 109.877 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.488 HD11 ' N ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -89.72 124.17 34.38 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-O 121.531 0.681 . . . . 0.0 109.917 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.488 ' N ' HD11 ' A' ' 9' ' ' LEU . 19.3 m -137.64 -177.87 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.342 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.47 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 30.9 tt0 -126.08 118.84 26.13 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 20.7 mt -119.19 121.7 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.727 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.28 39.5 30.91 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.933 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.27 19.58 78.77 Favored Glycine 0 N--CA 1.439 -1.116 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.849 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.96 122.76 24.45 Favored Pre-proline 0 N--CA 1.434 -1.264 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.54 120.22 6.78 Favored 'Trans proline' 0 N--CA 1.432 -2.126 0 C-N-CA 121.931 1.754 . . . . 0.0 110.675 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -122.98 142.06 51.25 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.622 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.447 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 39.1 ttmt -112.29 100.89 9.16 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 24' ' ' LEU . 3.1 pt -119.44 -178.41 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.912 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.106 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.783 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.8 p -93.28 174.52 7.17 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.142 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 94.5 mt -66.94 -31.39 71.93 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 120.726 0.298 . . . . 0.0 110.551 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.783 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 9.5 ptm180 -78.5 -22.5 47.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.48 ' HB2' ' H ' ' A' ' 20' ' ' THR . 38.8 mm-40 -84.56 -45.79 12.23 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.527 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.538 HD22 ' HG ' ' A' ' 167' ' ' LEU . 13.4 tp -58.91 -42.66 90.19 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.787 0.804 . . . . 0.0 109.51 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.402 ' HB2' HG13 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -53.98 -30.37 46.8 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.637 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.73 -17.89 59.76 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.464 HD22 ' O ' ' A' ' 23' ' ' GLU . 1.5 mm? -80.56 1.51 29.3 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.577 0.703 . . . . 0.0 109.663 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.462 ' CZ ' HG23 ' A' ' 47' ' ' ILE . 97.7 m-85 -119.01 161.65 19.87 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.107 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -144.72 -171.42 3.61 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.033 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.499 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.2 t70 65.71 76.75 0.31 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.539 0.685 . . . . 0.0 109.584 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -100.93 131.54 46.76 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.103 0.954 . . . . 0.0 111.752 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.453 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 17.6 ptt-85 -121.53 153.87 37.4 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.048 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -104.04 123.18 46.77 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -160.76 148.76 16.02 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.06 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 59.57 22.62 11.26 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 123.571 0.544 . . . . 0.0 110.76 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 41.7 mtm 72.96 16.79 4.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.943 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.6 m -133.33 -169.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.937 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.515 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 71.6 m-85 -110.84 137.72 48.14 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.8 t -132.49 124.86 52.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.5 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.438 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 22.9 ttm180 -117.23 127.73 54.38 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.499 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -131.91 147.51 52.47 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.696 -175.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 23.0 tptm 81.8 111.79 0.03 OUTLIER Pre-proline 0 C--O 1.236 0.389 0 O-C-N 124.197 0.935 . . . . 0.0 111.056 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.32 152.28 26.89 Favored 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.299 1.999 . . . . 0.0 112.043 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -87.03 -0.71 57.07 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.134 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -148.67 -164.79 2.11 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 4.1 tp10 -85.58 98.27 10.55 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.531 HG13 HG12 ' A' ' 12' ' ' ILE . 1.8 mp -117.15 114.94 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.083 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.506 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 34.0 mmtp -120.38 163.7 17.47 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.72 175.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.47 HG12 ' CB ' ' A' ' 169' ' ' ALA . 11.7 p -120.49 133.44 67.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.647 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.47 ' CE1' ' HB2' ' A' ' 11' ' ' GLN . 42.7 m-85 -82.92 124.39 30.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.925 176.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.4 ' HB3' ' OD1' ' A' ' 174' ' ' ASN . 56.4 m -121.58 175.54 6.16 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.439 HG12 HD11 ' A' ' 176' ' ' ILE . 2.8 mm -127.95 138.51 54.5 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-O 121.491 0.662 . . . . 0.0 110.625 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.728 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.3 t70 -86.59 110.55 19.9 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.432 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.608 HD21 ' H ' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -68.33 -13.16 62.07 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.897 0.879 . . . . 0.0 112.595 -171.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.728 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -98.28 -25.31 14.9 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.868 -175.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.537 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.3 p -117.24 -26.56 6.72 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.519 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.15 22.59 44.31 Favored Glycine 0 N--CA 1.426 -1.983 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.055 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.537 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 37.1 mtpt -97.6 155.42 16.98 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.9 p -96.95 109.26 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.919 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 m -109.63 162.4 7.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.707 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp -118.57 142.99 47.08 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -149.81 173.06 14.17 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.067 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -84.46 161.74 20.18 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.614 0.721 . . . . 0.0 110.716 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.477 ' N ' HD13 ' A' ' 64' ' ' ILE . 2.5 mp -97.76 144.58 10.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.889 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.509 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.8 mm-40 -88.78 -42.47 11.9 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 p30 178.2 175.81 0.51 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.12 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 14.6 t -108.14 132.22 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.917 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' A' ' 166' ' ' SER . 17.4 mt -98.52 114.78 37.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.511 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 85.8 tttt -126.13 111.92 15.21 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.8 143.34 48.98 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.358 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -52.43 124.04 14.15 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.323 2.682 . . . . 0.0 112.597 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.75 81.9 8.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.367 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.2 m -91.57 -36.37 13.73 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.64 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -85.95 177.98 7.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.447 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -103.96 171.33 7.41 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.555 ' CD2' ' HA ' ' A' ' 90' ' ' THR . 11.1 mt -122.84 140.2 53.2 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.8 0.809 . . . . 0.0 111.24 -174.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.469 HG23 HG23 ' A' ' 154' ' ' ILE . 14.3 mt -86.4 140.17 16.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 31.1 ttt180 -118.23 138.53 52.28 Favored 'General case' 0 N--CA 1.4 -2.972 0 CA-C-O 121.25 0.547 . . . . 0.0 109.741 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.62 ' O ' ' HA ' ' A' ' 86' ' ' SER . 59.4 m-85 -114.67 123.55 49.57 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.344 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 152' ' ' LYS . 40.6 tt0 -109.93 121.25 44.82 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -88.4 160.74 17.43 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.64 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.567 ' HG2' HD13 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -60.57 -22.57 63.82 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.285 -179.376 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -85.17 -11.2 55.57 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.523 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.85 17.41 44.44 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.823 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.566 ' O ' HD21 ' A' ' 81' ' ' LEU . 2.0 mtt180 -83.99 132.27 34.76 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 50.3 p -138.59 137.86 37.38 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 118.608 -1.237 . . . . 0.0 112.033 176.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.405 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 3.8 p90 -133.31 148.78 51.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.348 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 24.5 mt-10 -119.81 151.24 39.14 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.718 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.505 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.7 OUTLIER -144.11 154.99 43.76 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.728 178.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.555 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 2.8 m -75.21 18.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.831 0.824 . . . . 0.0 111.455 -177.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.674 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 71.35 -30.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 125.434 1.493 . . . . 0.0 113.004 175.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 90' ' ' THR . 7.6 p-10 -83.64 -5.94 59.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.155 0.502 . . . . 0.0 109.999 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -87.24 128.84 53.87 Favored Pre-proline 0 CA--C 1.512 -0.484 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.821 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 64.2 Cg_endo -72.52 141.02 34.03 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.808 2.339 . . . . 0.0 112.469 177.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 10.7 t -118.01 152.29 20.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 124.183 0.993 . . . . 0.0 109.585 -176.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -101.22 114.35 28.24 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.558 HG11 HG13 ' A' ' 104' ' ' ILE . 2.2 p -114.12 146.91 18.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.411 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -102.94 91.51 4.16 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.246 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 8.2 pt-20 -141.36 158.84 43.35 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 30.7 m-80 64.74 22.19 12.52 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.211 0.529 . . . . 0.0 109.625 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.39 16.68 60.88 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.849 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -138.27 172.22 13.22 Favored 'General case' 0 N--CA 1.407 -2.617 0 CA-C-O 121.355 0.598 . . . . 0.0 110.244 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -97.35 121.0 38.75 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.896 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.558 HG13 HG11 ' A' ' 97' ' ' VAL . 30.9 pt -121.77 153.3 25.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.068 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 28.5 mt-10 -115.92 116.76 28.52 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.907 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.558 ' HZ1' ' HB3' ' A' ' 106' ' ' LYS . 1.1 ptpm? -137.5 145.49 43.07 Favored 'General case' 0 C--O 1.202 -1.41 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.563 ' O ' HG22 ' A' ' 111' ' ' VAL . 77.3 mtt180 -65.27 162.78 16.67 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.674 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -61.69 -40.72 95.98 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.267 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -75.57 1.47 14.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.61 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -111.22 -19.15 12.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.52 0.676 . . . . 0.0 109.493 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 107' ' ' ARG . 85.2 t -72.43 150.17 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -123.66 163.44 21.06 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.571 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -68.92 143.08 54.56 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.68 5.19 74.99 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.325 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 16.8 t70 -71.4 168.36 17.62 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.572 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 48.4 mttp -127.27 152.49 47.35 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 121.452 0.644 . . . . 0.0 110.789 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.405 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -125.29 153.53 32.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.288 175.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.498 ' HA ' ' CD1' ' A' ' 148' ' ' LEU . 0.5 OUTLIER -89.4 134.89 33.88 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.779 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.7 OUTLIER -100.68 145.0 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.978 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 172.093 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 C--N 1.31 -1.136 0 CA-C-O 121.475 0.655 . . . . 0.0 109.945 179.68 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.572 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.8 mm? . . . . . 0 CA--C 1.484 -1.566 0 CA-C-O 121.081 0.467 . . . . 0.0 109.76 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.576 ' HB3' HD11 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -116.76 137.97 51.81 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.508 -176.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 17.6 mt-10 -89.03 146.38 24.89 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.284 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 115' ' ' ASP . 81.4 mt -78.58 107.46 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.777 0 CA-C-N 113.407 -1.724 . . . . 0.0 108.969 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 80' ' ' GLU . 8.0 mmpt? -70.23 -39.4 75.12 Favored 'General case' 0 C--N 1.268 -2.977 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.566 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -149.29 133.52 17.35 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 74.3 mt -115.61 127.68 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 CA-C-N 113.668 -1.605 . . . . 0.0 110.927 175.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.448 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 1.6 ptpp? -132.49 163.35 29.01 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.97 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.452 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.0 m-85 -100.98 115.33 30.21 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.405 HG11 ' HD3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -127.38 137.47 57.65 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.585 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.798 -178.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -71.44 160.83 32.05 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.36 -176.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.66 126.86 31.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.043 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -65.43 -37.94 88.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.288 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -106.96 174.84 5.71 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.294 -177.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.56 2.29 51.21 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.396 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -141.95 153.13 44.11 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.199 0.523 . . . . 0.0 110.456 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.14 157.43 31.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.712 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 76.4 m-85 -132.8 165.17 25.19 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.777 0.322 . . . . 0.0 110.51 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.506 ' HB2' HD13 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -146.38 -24.93 0.43 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.882 174.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.538 ' HG ' HD22 ' A' ' 24' ' ' LEU . 3.6 mm? 62.68 101.09 0.03 OUTLIER 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.892 0.745 . . . . 0.0 110.645 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.436 ' HB2' HD11 ' A' ' 68' ' ' ILE . 58.6 t30 -83.47 121.17 26.84 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.703 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.509 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -131.28 -157.7 0.84 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? . . . . . 0 C--N 1.319 -0.722 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.712 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.67 ' HA ' ' O ' ' A' ' 183' ' ' THR . 3.7 t-20 . . . . . 0 N--CA 1.439 -1.01 0 CA-C-O 120.824 0.345 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.487 HG21 HD13 ' A' ' 8' ' ' ILE . 5.4 p -149.03 164.13 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-O 121.494 0.664 . . . . 0.0 110.767 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.596 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 2.4 mp -93.88 115.7 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.489 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 36.7 pt -118.49 166.41 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-O 120.87 0.367 . . . . 0.0 110.729 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 30.4 t30 47.91 -131.99 1.46 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.187 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -81.52 53.34 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.338 0.589 . . . . 0.0 110.061 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.779 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 12.6 m120 65.05 46.9 2.65 Favored 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 125.272 1.429 . . . . 0.0 113.194 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 88.9 mt -91.21 115.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.04 148.55 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-O 122.039 0.923 . . . . 0.0 112.528 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.67 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 2.0 t . . . . . 0 C--N 1.294 -1.837 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.362 175.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 N--CA 1.444 -0.745 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.526 ' HD3' HD12 ' A' ' 76' ' ' LEU . 57.3 Cg_endo -67.24 158.48 56.74 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 N-CA-C 108.512 -1.38 . . . . 0.0 108.512 177.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.12 -27.42 51.83 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 119.477 -1.344 . . . . 0.0 112.035 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -67.17 -13.23 61.76 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.6 m -61.44 125.7 24.71 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.422 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 37.6 mmt-85 -79.73 125.26 29.43 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.525 HD12 HG21 ' A' ' 175' ' ' VAL . 10.4 tt -116.33 129.42 72.79 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 CA-C-O 120.84 0.352 . . . . 0.0 110.245 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -89.34 122.99 33.1 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.63 0.729 . . . . 0.0 110.17 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.453 ' N ' HD12 ' A' ' 9' ' ' LEU . 28.2 m -133.03 -179.16 3.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.694 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -130.97 121.35 24.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.425 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.573 HG12 HG13 ' A' ' 47' ' ' ILE . 15.1 mt -119.96 120.98 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.928 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.598 -177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 54.21 37.22 26.8 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.198 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.01 18.12 80.22 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.829 -1.078 . . . . 0.0 113.529 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -123.58 119.31 27.16 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 43.5 Cg_endo -73.0 121.74 7.54 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.438 2.092 . . . . 0.0 111.291 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -125.75 140.49 52.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.829 -177.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -110.39 102.36 11.0 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.653 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 8' ' ' ILE . 2.8 pt -125.43 -171.68 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.642 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.695 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.9 p -96.26 174.39 6.91 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.096 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 62.1 mt -69.87 -31.07 68.7 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.124 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.695 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 3.9 ptm180 -77.34 -25.86 51.51 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.539 ' OE1' HG21 ' A' ' 20' ' ' THR . 84.9 mt-10 -84.73 -40.34 17.41 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.652 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.468 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 18.8 tp -59.35 -45.74 90.56 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.746 0.784 . . . . 0.0 109.842 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -49.07 -32.55 9.83 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.759 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.9 mt-10 -74.63 -17.26 60.72 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.204 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.54 5.12 13.77 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.501 0.667 . . . . 0.0 109.884 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 97.0 m-85 -118.28 164.61 14.94 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.519 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -145.8 -172.85 4.0 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.659 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 18.9 t0 64.88 75.14 0.38 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.602 0.715 . . . . 0.0 109.358 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -102.69 134.28 46.33 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.416 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.439 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.4 ptt180 -127.54 154.54 45.04 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.792 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -105.51 129.9 53.69 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -166.78 153.84 9.05 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.556 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.26 21.24 9.41 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 123.49 0.494 . . . . 0.0 110.804 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 45.3 mtm 70.86 16.79 6.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.411 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 6.1 m -131.82 -168.29 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.444 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.439 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 79.4 m-85 -116.61 140.06 49.81 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.439 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.3 t -130.32 123.5 55.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.411 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 19.6 ttm180 -118.62 127.03 53.21 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -131.15 143.33 50.54 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.185 -174.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 40.0 ttmt 79.58 116.42 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 124.158 0.983 . . . . 0.0 111.383 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 68.6 Cg_endo -79.47 160.31 25.58 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 C-N-CA 122.494 2.129 . . . . 0.0 112.57 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -88.19 -3.19 58.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.534 0.683 . . . . 0.0 110.351 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -142.11 -165.28 1.98 Allowed 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 10.1 tp10 -89.21 100.87 13.56 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 171.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.573 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -114.29 117.46 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.175 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HZ1' ' CD ' ' A' ' 46' ' ' GLU . 17.7 mmtm -115.86 166.17 12.27 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.976 174.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.441 HG21 ' CB ' ' A' ' 169' ' ' ALA . 3.3 m -117.58 130.38 72.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.258 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.496 ' HB3' HD11 ' A' ' 176' ' ' ILE . 3.2 m-85 -79.35 121.86 25.66 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 172.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.0 t -133.59 177.03 8.02 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.513 HD11 ' O ' ' A' ' 58' ' ' LYS . 2.1 mm -131.21 142.18 44.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.332 0.587 . . . . 0.0 110.65 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.564 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.1 t70 -81.43 118.33 22.61 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.585 ' H ' HD23 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -72.52 -12.74 61.2 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -170.277 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.564 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -103.4 -26.9 12.72 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.179 -176.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.0 p -116.77 -20.54 9.45 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.849 -0.741 . . . . 0.0 111.872 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.95 11.84 82.03 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.015 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.513 ' O ' HD11 ' A' ' 52' ' ' ILE . 3.3 mptp? -75.97 145.83 40.04 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 122.693 0.397 . . . . 0.0 111.366 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -90.15 106.72 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 121.993 0.901 . . . . 0.0 109.324 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 m -110.16 155.8 11.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.159 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.421 HD13 ' O ' ' A' ' 49' ' ' VAL . 10.2 tp -122.11 134.25 54.76 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.403 HG23 ' HB2' ' A' ' 170' ' ' LYS . 14.7 t -144.91 172.39 13.1 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.817 -176.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -84.28 162.3 20.16 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.787 0.804 . . . . 0.0 111.515 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.445 HD11 ' N ' ' A' ' 64' ' ' ILE . 2.8 mp -95.95 144.96 9.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.692 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.521 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 29.7 mm-40 -89.65 -39.91 12.91 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 p30 176.88 174.92 0.39 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.959 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.419 ' HA ' HD21 ' A' ' 167' ' ' LEU . 14.7 t -105.04 129.26 58.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.257 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 51.2 mt -91.76 104.96 16.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.474 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.528 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.2 tttt -121.3 109.17 14.6 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.5 139.58 35.18 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.215 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.448 ' HD2' HG12 ' A' ' 37' ' ' VAL . 97.0 Cg_exo -44.76 124.3 5.5 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 123.471 2.781 . . . . 0.0 112.736 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.59 78.4 9.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.711 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.4 p -84.86 -53.03 5.59 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.931 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.6 171.37 14.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.218 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -102.68 171.55 7.36 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.526 HD12 ' HD3' ' A' ' 3' ' ' PRO . 11.2 mt -127.43 143.29 51.23 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.651 0.739 . . . . 0.0 111.673 -173.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.512 HD12 ' CZ ' ' A' ' 156' ' ' TYR . 23.6 mt -86.62 143.02 12.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 173.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 34.5 ttt85 -118.03 138.72 52.03 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.178 0.514 . . . . 0.0 109.999 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.609 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.1 m-85 -116.71 123.3 46.88 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.888 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 152' ' ' LYS . 32.5 tt0 -109.87 125.53 52.88 Favored 'General case' 0 CA--C 1.471 -2.058 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.13 160.02 17.96 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.325 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.637 ' HG2' ' CD1' ' A' ' 149' ' ' LEU . 3.0 pt-20 -61.6 -15.99 44.17 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.113 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -98.06 -6.04 32.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.791 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.3 12.44 56.13 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.164 -0.926 . . . . 0.0 113.759 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.526 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.5 mtt180 -82.97 141.79 31.85 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.8 p -144.22 141.26 29.76 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.972 -1.091 . . . . 0.0 113.497 175.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -138.49 155.99 47.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.613 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 87.0 mt-10 -129.97 153.98 47.83 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.17 0.51 . . . . 0.0 112.265 -177.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.9 OUTLIER -148.51 161.23 42.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.658 178.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.502 ' HA ' HD21 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -70.83 10.45 0.52 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.702 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 72.69 -27.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 124.838 1.255 . . . . 0.0 112.205 177.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.532 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 0.8 OUTLIER -78.75 -10.84 59.91 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.243 0.544 . . . . 0.0 109.807 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -97.14 140.92 22.34 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.367 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 89.3 Cg_endo -79.49 137.87 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.249 2.633 . . . . 0.0 113.699 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.5 t -105.09 147.2 11.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.0 tp -105.39 110.38 22.71 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.716 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.465 HG11 ' CE ' ' A' ' 106' ' ' LYS . 2.5 p -110.87 153.56 12.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.496 0.665 . . . . 0.0 111.531 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -104.21 93.74 4.99 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.258 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.0 pt-20 -143.26 158.48 43.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.3 m-20 64.15 21.85 12.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.17 13.77 60.53 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.803 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -135.2 172.37 13.11 Favored 'General case' 0 N--CA 1.401 -2.885 0 CA-C-O 121.165 0.507 . . . . 0.0 109.93 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -100.94 121.27 41.46 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.447 HG13 ' CG1' ' A' ' 97' ' ' VAL . 25.1 pt -119.27 141.67 38.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.197 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -97.09 114.49 26.15 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.14 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.465 ' CE ' HG11 ' A' ' 97' ' ' VAL . 13.9 ptpt -128.59 135.36 49.24 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.958 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.608 ' O ' HG22 ' A' ' 111' ' ' VAL . 11.5 mmt180 -62.0 159.22 14.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.702 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -57.92 -43.03 85.99 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.222 -176.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.489 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.7 p90 -73.01 -0.21 13.17 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.177 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -110.63 -15.3 13.89 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.606 0.717 . . . . 0.0 109.848 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 107' ' ' ARG . 89.5 t -77.84 149.43 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.715 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 13.8 mtmt -123.24 164.88 17.89 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.994 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -66.98 141.36 57.62 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.66 77.93 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.895 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.715 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -75.04 168.55 19.76 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.4 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.616 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 72.2 mttt -124.18 161.57 25.44 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.339 0.59 . . . . 0.0 112.076 -177.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.11 156.37 39.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.417 172.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.509 ' HG ' HD13 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -95.86 138.29 33.71 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 123.228 0.33 . . . . 0.0 110.571 -178.282 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.763 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.0 m -100.65 145.1 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.299 -1.628 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.122 -176.339 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.616 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 4.1 mm? . . . . . 0 CA--C 1.475 -1.905 0 CA-C-O 121.112 0.482 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.637 ' CD1' ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -111.96 133.29 54.23 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.164 -177.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 20.2 mt-10 -86.02 143.61 28.02 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.111 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.492 HD12 ' CD1' ' A' ' 79' ' ' PHE . 69.5 mt -81.48 102.65 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.077 174.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.539 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 50.9 mmtt -66.1 -38.63 88.71 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.252 177.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -147.87 129.22 14.79 Favored 'General case' 0 CA--C 1.476 -1.882 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 72.1 mt -112.81 143.48 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.324 174.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.43 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.7 ptpt -149.13 161.31 42.24 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.355 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.512 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 17.7 m-85 -101.8 115.01 29.59 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.54 174.61 10.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.237 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.06 159.02 16.03 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.436 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.44 129.75 40.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.354 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -64.15 -42.12 96.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.972 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -101.02 175.89 5.45 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.041 0.448 . . . . 0.0 111.156 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.63 3.68 51.86 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.02 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -141.38 151.16 43.26 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.786 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.43 HG11 ' HA ' ' A' ' 3' ' ' PRO . 2.6 m -121.28 157.27 24.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 72.2 m-85 -132.98 172.11 13.06 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.89 0.376 . . . . 0.0 110.388 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.497 ' HB2' HD11 ' A' ' 68' ' ' ILE . 51.9 m -156.18 -22.17 0.1 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.468 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER 63.36 104.35 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.236 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -85.22 115.68 23.13 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.302 -176.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.521 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -125.63 -149.54 0.42 Allowed 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.403 ' HB2' HG23 ' A' ' 62' ' ' THR . 0.4 OUTLIER . . . . . 0 C--N 1.313 -0.978 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.088 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 CA--C 1.506 -0.748 0 CA-C-O 121.097 0.475 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.525 HG21 HD12 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -144.86 164.07 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 121.354 0.597 . . . . 0.0 111.444 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.613 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.3 mt -95.55 120.78 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.456 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 39.1 pt -125.01 166.93 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.51 -176.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 52.81 -134.97 1.59 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.921 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.19 51.58 2.23 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.602 0.715 . . . . 0.0 109.572 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.763 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 15.0 m120 71.92 53.23 0.2 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.525 177.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 97.2 mt -93.78 116.17 34.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.5 m -82.86 159.06 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.538 0.685 . . . . 0.0 111.861 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.307 -1.27 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.785 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.474 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 34.8 m-85 . . . . . 0 N--CA 1.434 -1.233 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HD3' HD11 ' A' ' 76' ' ' LEU . 19.1 Cg_endo -59.4 -35.34 96.65 Favored 'Trans proline' 0 N--CA 1.48 0.688 0 C-N-CA 123.129 2.553 . . . . 0.0 112.21 -177.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.732 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 132.76 -35.78 2.27 Favored Glycine 0 N--CA 1.413 -2.857 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -177.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.07 -17.03 61.83 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.395 0.617 . . . . 0.0 111.11 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 69.0 m -61.15 125.19 22.84 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.584 177.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.5 mmt180 -86.09 132.95 33.92 Favored 'General case' 0 C--O 1.183 -2.43 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.492 ' HB ' ' CD2' ' A' ' 21' ' ' LEU . 9.5 tt -118.92 131.74 70.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 C-N-CA 122.556 0.342 . . . . 0.0 110.159 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.532 HD11 ' CD2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -84.59 124.86 31.9 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.29 0.567 . . . . 0.0 109.588 178.214 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 30.5 m -136.67 -179.47 2.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.778 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.541 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 30.9 tt0 -131.99 121.57 24.14 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.139 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.586 HG12 HG13 ' A' ' 47' ' ' ILE . 14.7 mt -121.07 119.81 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.962 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 53.53 41.87 32.02 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.898 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.12 17.88 76.07 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.589 -1.187 . . . . 0.0 113.442 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -123.6 116.15 28.06 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 34.7 Cg_endo -73.25 126.24 10.91 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 122.38 2.053 . . . . 0.0 111.402 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -127.47 142.27 51.45 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.554 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -106.16 101.07 10.58 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 8' ' ' ILE . 3.3 pt -122.83 -175.55 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.179 -2.637 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.012 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.852 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.3 p -90.62 174.65 7.39 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.52 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.5 mm? -71.68 -23.75 61.71 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.984 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.852 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 15.7 ptt180 -85.59 -23.82 27.43 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.596 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 49.8 mt-10 -83.71 -42.12 16.94 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.977 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.504 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 14.3 tp -56.18 -43.59 78.57 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.769 0.795 . . . . 0.0 109.099 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -52.46 -35.5 52.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.512 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 6.4 mm-40 -69.22 -21.71 63.92 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -79.51 4.16 16.54 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.57 0.7 . . . . 0.0 110.139 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 93.3 m-85 -117.16 160.17 21.46 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.049 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -139.84 -176.61 4.64 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t0 64.02 85.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.178 0.513 . . . . 0.0 111.082 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -101.39 131.37 47.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.936 0.874 . . . . 0.0 111.051 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -122.6 152.55 40.33 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.942 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.425 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 35.9 t80 -99.46 129.93 45.68 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -167.15 147.11 5.41 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.609 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 59.41 20.43 8.76 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 123.702 0.626 . . . . 0.0 111.027 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.425 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 39.1 mtp 72.37 17.8 4.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.488 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 13.7 m -133.28 -172.27 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -114.76 142.52 46.4 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-O 121.47 0.652 . . . . 0.0 110.158 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 t -128.71 122.02 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.095 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.457 ' HD3' ' O ' ' A' ' 28' ' ' PHE . 17.5 ttm180 -111.77 126.66 55.31 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.46 141.78 48.96 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -173.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.538 ' HB2' ' HZ2' ' A' ' 42' ' ' LYS . 3.2 ttmp? 83.95 113.09 0.03 OUTLIER Pre-proline 0 CA--C 1.503 -0.833 0 O-C-N 124.812 1.32 . . . . 0.0 111.378 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 74.3 Cg_endo -77.07 155.28 33.52 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 C-N-CA 122.447 2.098 . . . . 0.0 111.807 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -87.01 -2.28 58.51 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.371 0.605 . . . . 0.0 110.678 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -147.6 -168.05 2.96 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 40.9 tt0 -85.26 101.41 12.5 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.586 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -115.58 118.2 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.995 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.541 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 67.3 mmtt -114.39 169.64 8.89 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.335 174.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.442 HG13 ' CB ' ' A' ' 169' ' ' ALA . 10.1 p -124.99 131.09 73.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.795 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.532 ' CD2' HD11 ' A' ' 9' ' ' LEU . 14.2 m-85 -86.16 120.46 27.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.106 0.479 . . . . 0.0 110.306 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.8 t -130.22 176.2 8.3 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.472 HG12 HD11 ' A' ' 176' ' ' ILE . 3.3 mm -116.83 142.25 31.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.536 0.684 . . . . 0.0 111.027 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.663 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 14.9 t70 -77.7 120.32 22.47 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.527 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.58 HD21 ' H ' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -75.54 -8.41 56.68 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.764 -170.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.663 ' HG3' ' OD1' ' A' ' 53' ' ' ASP . 2.6 pt-20 -108.18 -25.77 10.92 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.045 -0.662 . . . . 0.0 112.079 -177.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.514 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 70.4 p -117.84 -25.23 6.86 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.772 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.47 12.72 66.71 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.254 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.514 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 40.7 mtpt -87.97 162.97 16.56 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.437 HG21 ' OG ' ' A' ' 120' ' ' SER . 33.5 t -86.67 113.25 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.216 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -110.77 151.78 12.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.088 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.2 tp -122.86 140.26 53.15 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.7 t -148.91 170.54 18.06 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.814 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.83 161.16 26.97 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.522 0.677 . . . . 0.0 110.524 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 64' ' ' ILE . 2.2 mp -96.28 148.14 5.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.84 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.462 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.9 mm-40 -93.09 -42.68 9.27 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 p30 179.59 178.97 0.51 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.72 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 t -107.55 134.21 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.009 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.654 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 42.9 mt -91.69 99.73 10.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.701 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.44 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 84.8 tttt -113.49 107.34 15.69 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.06 136.18 28.64 Favored Pre-proline 0 C--N 1.306 -1.297 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.502 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -48.66 129.4 20.3 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.167 2.578 . . . . 0.0 112.013 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.24 86.94 3.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.07 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.2 m -98.79 -33.16 11.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.436 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.92 167.15 12.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.076 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -100.15 172.84 6.93 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.532 ' CD2' ' HA ' ' A' ' 90' ' ' THR . 14.9 mt -125.89 145.56 50.21 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.911 0.862 . . . . 0.0 111.907 -174.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.495 HD13 ' C ' ' A' ' 108' ' ' ALA . 13.6 mt -91.91 144.13 9.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.444 172.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 13.0 ttt85 -115.92 137.93 51.65 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.562 ' CD1' HD12 ' A' ' 151' ' ' ILE . 65.7 m-85 -115.85 124.48 50.77 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.548 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.2 tt0 -113.1 125.06 53.96 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.603 HD22 ' O ' ' A' ' 85' ' ' ARG . 1.5 mm? -90.08 162.2 15.44 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.356 -177.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.576 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.7 pt-20 -62.78 -15.63 54.45 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.256 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.73 -12.68 28.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.716 0.77 . . . . 0.0 109.729 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.42 10.1 57.26 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.347 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.603 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -85.12 141.34 30.29 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 44.3 p -140.84 151.86 44.68 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.919 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -145.83 153.72 41.21 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.244 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 23.6 mt-10 -124.22 149.66 46.16 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.323 -178.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -144.0 159.6 42.31 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.439 178.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.532 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -68.37 11.33 0.17 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.716 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.6 OUTLIER 69.65 -38.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 124.843 1.257 . . . . 0.0 112.059 178.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 90' ' ' THR . 16.3 t70 -69.48 -37.55 77.3 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.422 0.629 . . . . 0.0 109.41 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 37.0 m80 -72.45 131.18 84.96 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.584 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 30.9 Cg_exo -63.65 142.49 83.92 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 123.975 3.117 . . . . 0.0 114.762 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.32 147.85 14.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.412 ' CD1' ' HG2' ' A' ' 105' ' ' GLU . 10.1 tp -100.49 109.92 22.07 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.816 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.673 HG22 ' OD1' ' A' ' 115' ' ' ASP . 2.6 p -112.24 150.33 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 121.404 0.621 . . . . 0.0 112.046 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -103.04 92.0 4.36 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.472 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 9.1 pt-20 -139.34 158.4 44.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 90.2 m-20 63.25 22.98 13.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.125 0.488 . . . . 0.0 110.07 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.68 14.7 60.9 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.809 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -135.98 171.71 14.07 Favored 'General case' 0 N--CA 1.4 -2.956 0 CA-C-O 121.217 0.532 . . . . 0.0 110.047 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.615 ' CE1' HD13 ' A' ' 118' ' ' LEU . 32.6 m-85 -103.91 121.74 43.74 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.701 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.408 HG13 HG12 ' A' ' 97' ' ' VAL . 23.6 pt -124.44 152.64 30.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.476 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.412 ' HG2' ' CD1' ' A' ' 96' ' ' LEU . 31.8 mt-10 -104.87 110.86 23.4 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.591 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.598 ' HZ1' ' HB3' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -124.3 139.53 53.83 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.134 176.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 5.3 mtp180 -60.79 156.1 17.89 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -176.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.716 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -59.77 -41.06 90.22 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.973 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.422 ' CE1' ' HD3' ' A' ' 107' ' ' ARG . 3.0 p90 -74.13 5.76 4.09 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.435 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -115.31 -18.55 11.04 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.471 0.653 . . . . 0.0 109.712 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 107' ' ' ARG . 79.5 t -71.55 150.33 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.005 0.922 . . . . 0.0 108.899 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.744 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.8 OUTLIER -114.17 165.01 13.1 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 120.814 0.34 . . . . 0.0 110.467 -177.113 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -74.24 142.88 45.31 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.05 5.63 83.02 Favored Glycine 0 C--N 1.3 -1.462 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.488 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.744 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -75.3 175.19 8.6 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.593 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 49.8 mttp -130.36 162.59 28.75 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.75 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.74 158.72 42.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.378 173.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.615 HD13 ' CE1' ' A' ' 103' ' ' PHE . 2.4 mt -88.81 140.04 29.85 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.786 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -101.46 149.2 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.455 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.53 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 47.4 t . . . . . 0 C--N 1.308 -1.231 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.446 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.593 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.8 mm? . . . . . 0 CA--C 1.477 -1.859 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.576 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -101.91 132.01 47.96 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 8.6 mt-10 -85.17 140.31 31.02 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.521 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.562 HD12 ' CD1' ' A' ' 79' ' ' PHE . 62.2 mt -78.97 102.26 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.827 0 CA-C-N 113.635 -1.62 . . . . 0.0 109.326 174.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 6.3 mmpt? -65.64 -37.96 88.02 Favored 'General case' 0 C--N 1.268 -2.948 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.936 178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -149.1 131.28 15.46 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 70.3 mt -115.7 144.76 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.528 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -150.54 161.2 43.02 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.055 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.442 ' HH ' HD11 ' A' ' 77' ' ' ILE . 42.9 m-85 -99.56 113.06 25.23 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-O 121.379 0.609 . . . . 0.0 109.602 174.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.56 132.89 70.7 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.439 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -71.47 154.27 41.63 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.75 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.54 123.53 20.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.062 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -85.9 42.57 0.98 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.097 0.475 . . . . 0.0 110.883 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -163.15 -179.34 6.6 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -107.04 -8.73 16.44 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.214 0.531 . . . . 0.0 109.783 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.58 162.13 35.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.247 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 3' ' ' PRO . 3.5 m -132.73 162.45 39.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.838 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.654 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 62.8 m-85 -138.95 166.01 25.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.94 -175.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.68 -22.75 0.14 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.504 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER 70.95 110.62 0.06 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.784 176.112 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -90.1 115.59 27.47 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.649 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.462 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.81 -162.76 1.2 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 120.669 0.271 . . . . 0.0 110.708 179.541 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.529 HD22 HG12 ' A' ' 182' ' ' VAL . 27.1 t-20 . . . . . 0 C--O 1.234 0.264 0 CA-C-O 120.705 0.288 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.53 148.19 12.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.484 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.472 HD11 HG12 ' A' ' 52' ' ' ILE . 47.3 mt -92.2 116.25 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.988 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 25.1 pt -123.27 164.72 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.535 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 23.6 t30 46.34 -134.13 0.95 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 124.532 1.133 . . . . 0.0 110.958 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.52 55.87 2.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.494 0.664 . . . . 0.0 110.38 176.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.786 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 15.7 m120 63.38 49.14 3.29 Favored 'General case' 0 C--O 1.209 -1.078 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.806 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.454 ' HB ' HG13 ' A' ' 177' ' ' ILE . 96.0 mt -86.78 111.68 21.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.529 HG12 HD22 ' A' ' 174' ' ' ASN . 74.1 t -84.81 117.84 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.889 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.413 -2.295 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.6 179.99 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.451 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 23.3 m-85 . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.501 ' HD3' HD11 ' A' ' 76' ' ' LEU . 21.0 Cg_endo -58.54 -32.28 96.21 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.146 2.564 . . . . 0.0 113.155 -175.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.34 -36.25 2.74 Favored Glycine 0 N--CA 1.426 -1.968 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.71 -15.25 63.55 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.38 0.61 . . . . 0.0 110.571 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 71.9 m -60.08 128.19 35.57 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.055 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.672 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 82.0 mtm-85 -86.51 137.81 32.23 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.521 HD11 HG21 ' A' ' 175' ' ' VAL . 10.0 tt -123.6 132.82 70.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.261 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.489 HD11 ' N ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -87.38 124.61 33.57 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-O 121.464 0.65 . . . . 0.0 109.853 178.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.489 ' N ' HD11 ' A' ' 9' ' ' LEU . 25.1 m -136.26 -179.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.549 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.453 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 32.2 tt0 -129.78 119.61 23.69 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.569 HG12 HG13 ' A' ' 47' ' ' ILE . 15.9 mt -119.53 121.47 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.9 -177.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.8 37.45 28.52 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.518 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.8 17.43 80.09 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.664 -1.153 . . . . 0.0 114.195 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.9 t -122.79 120.67 27.62 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.23 119.92 6.03 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 122.064 1.842 . . . . 0.0 110.475 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -123.97 143.08 50.62 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.498 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -113.35 100.75 8.79 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.413 ' O ' ' N ' ' A' ' 8' ' ' ILE . 3.0 pt -122.1 -172.34 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.618 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.729 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 19.2 p -95.4 169.75 9.84 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.941 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 15.1 mt -71.07 -22.63 62.09 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.099 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.729 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.5 ptm180 -83.73 -25.34 30.66 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.547 ' OE1' HG21 ' A' ' 20' ' ' THR . 67.6 mt-10 -84.69 -43.14 14.62 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.239 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.463 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 20.1 tp -56.24 -43.31 78.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.906 0.86 . . . . 0.0 109.085 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -51.92 -32.56 33.4 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.367 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 29.6 mt-10 -74.94 -16.98 60.62 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.302 -177.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.6 mm? -77.44 0.4 22.76 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 121.322 0.582 . . . . 0.0 109.455 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.482 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 98.1 m-85 -117.64 161.25 19.95 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.404 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.583 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 23.6 mt-10 -136.21 -172.28 3.09 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.117 175.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.459 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 12.3 t0 61.83 75.9 0.39 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.434 0.635 . . . . 0.0 110.558 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -100.3 131.72 46.08 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.404 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -131.41 145.42 51.8 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.517 -177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -88.04 128.01 35.4 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.546 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -167.09 147.78 5.64 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.396 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 60.11 22.96 12.21 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 123.341 0.401 . . . . 0.0 110.683 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 38.3 mtm 71.98 16.14 5.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.612 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.2 m -134.74 -174.31 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -113.48 140.81 47.8 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -127.17 122.48 60.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.658 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.457 ' HD3' ' O ' ' A' ' 28' ' ' PHE . 17.6 ttm180 -113.21 126.61 55.61 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.459 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -133.63 146.94 51.37 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.387 -174.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? 83.16 110.37 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.422 0 O-C-N 124.444 1.09 . . . . 0.0 110.364 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 73.4 Cg_endo -79.12 152.14 24.08 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.45 2.1 . . . . 0.0 112.344 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.583 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 34.7 mtmt -81.92 -4.15 55.92 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.015 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -147.66 -165.62 2.3 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.14 103.86 16.15 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.569 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -116.59 118.61 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.621 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 47.3 mmtt -115.65 168.04 10.38 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.169 173.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.438 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.3 p -123.41 130.39 74.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.298 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -83.57 123.67 30.0 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 p -134.76 172.8 12.45 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.488 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.475 HG12 HD12 ' A' ' 176' ' ' ILE . 3.1 mm -119.23 142.41 34.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.176 0.513 . . . . 0.0 110.054 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.672 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 25.5 t70 -76.0 122.59 24.42 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.606 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.569 HD21 ' H ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -75.71 -9.81 58.91 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.643 -170.424 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.672 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.8 pt-20 -106.59 -26.94 11.15 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.867 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.411 ' HB ' ' HD3' ' A' ' 58' ' ' LYS . 69.0 p -118.1 -25.39 6.69 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.783 -176.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.49 10.88 69.81 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.002 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 2.2 mptp? -78.51 154.2 30.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.022 0.439 . . . . 0.0 111.771 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 p -91.0 104.87 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 121.833 0.825 . . . . 0.0 110.565 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.5 m -110.97 157.7 11.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.243 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.6 tp -116.45 137.82 51.86 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.6 t -143.93 172.47 12.81 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.281 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.29 161.55 19.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.63 0.728 . . . . 0.0 111.356 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.9 mp -100.23 140.75 18.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.519 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.478 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 27.5 mm-40 -92.26 -34.54 14.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.263 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 p30 175.89 176.75 0.23 Allowed 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.175 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 13.6 t -106.89 129.77 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.798 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 36.4 mt -91.13 111.79 24.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.805 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.453 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.1 tttt -127.65 110.29 12.53 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 163' ' ' PHE . . . -129.04 142.08 43.95 Favored Pre-proline 0 C--N 1.309 -1.161 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.442 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -53.87 124.14 15.16 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.115 2.544 . . . . 0.0 111.671 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.0 89.38 7.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.774 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.3 m -103.96 -29.27 11.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.194 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -85.58 166.98 15.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.724 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.491 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 28.7 m170 -98.01 171.69 8.1 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.705 ' CD1' ' HA ' ' A' ' 159' ' ' ALA . 37.0 mt -126.71 140.12 52.64 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.569 0.699 . . . . 0.0 111.643 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.48 HD13 ' C ' ' A' ' 108' ' ' ALA . 44.8 mt -87.73 142.55 12.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 172.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 21.3 ttt180 -122.45 137.26 54.93 Favored 'General case' 0 N--CA 1.398 -3.067 0 CA-C-O 121.308 0.575 . . . . 0.0 109.902 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 86' ' ' SER . 55.0 m-85 -113.47 121.98 45.9 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.774 -177.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 152' ' ' LYS . 44.1 tt0 -108.4 127.42 53.88 Favored 'General case' 0 CA--C 1.474 -1.956 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -89.82 159.09 17.18 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-O 121.21 0.529 . . . . 0.0 111.936 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.629 ' HA ' ' CG ' ' A' ' 152' ' ' LYS . 0.6 OUTLIER -60.15 -16.98 37.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.754 -178.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.632 ' OD1' ' HG3' ' A' ' 85' ' ' ARG . 38.3 p-10 -109.29 0.72 19.7 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.436 0.636 . . . . 0.0 111.065 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.49 19.47 25.2 Favored Glycine 0 C--N 1.309 -0.963 0 N-CA-C 116.511 1.364 . . . . 0.0 116.511 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.632 ' HG3' ' OD1' ' A' ' 83' ' ' ASP . 11.5 mtt180 -86.89 143.28 27.49 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 90.1 p -140.93 138.09 33.59 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 118.728 -1.189 . . . . 0.0 112.155 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.418 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 6.5 p90 -133.37 138.69 46.42 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.962 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.499 ' OE2' ' HG3' ' A' ' 78' ' ' ARG . 43.4 mp0 -115.02 147.94 39.49 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.769 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.1 p -140.79 155.72 46.33 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.945 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.597 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -76.33 12.14 1.32 Allowed 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 122.79 0.436 . . . . 0.0 112.04 -177.116 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.586 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 1.8 m 61.29 170.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 19.4 t70 72.17 -34.92 0.31 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.069 0.461 . . . . 0.0 110.814 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 91' ' ' VAL . 47.6 m-70 -76.31 128.21 83.08 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.309 175.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 18.2 Cg_exo -67.47 127.52 16.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.284 2.656 . . . . 0.0 114.322 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.5 t -96.75 151.3 4.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.2 tp -102.15 106.41 17.25 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.817 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.574 HG23 ' OD1' ' A' ' 115' ' ' ASP . 1.9 p -110.35 148.99 13.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.315 0.579 . . . . 0.0 111.338 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.507 ' CD2' HD12 ' A' ' 148' ' ' LEU . 61.8 t80 -104.47 92.55 4.36 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.111 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.535 ' OE1' ' HE3' ' A' ' 106' ' ' LYS . 8.3 pt-20 -136.06 158.37 44.56 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 82.4 m-20 62.78 22.6 13.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 110.347 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.44 15.19 58.88 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.238 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -132.94 171.95 13.26 Favored 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 117.71 0.755 . . . . 0.0 109.446 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -102.51 120.12 39.99 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.506 HD13 ' CG ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -125.03 144.66 34.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.302 -178.522 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.4 OUTLIER -101.81 111.83 24.22 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.032 -178.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.535 ' HE3' ' OE1' ' A' ' 99' ' ' GLU . 50.4 mttm -120.86 134.6 55.29 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.595 ' H ' ' HD2' ' A' ' 107' ' ' ARG . 5.4 mpt_? -59.77 158.44 10.37 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.586 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -55.16 -45.94 75.72 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.54 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.419 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 2.3 p90 -75.28 11.27 1.24 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.647 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.508 ' OE1' ' HA ' ' A' ' 106' ' ' LYS . 39.1 tt0 -124.14 -15.09 6.89 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.454 0.645 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.55 HG21 ' O ' ' A' ' 107' ' ' ARG . 73.7 t -75.01 150.68 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.726 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -118.42 161.2 20.37 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.445 -176.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -70.57 147.19 49.54 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.403 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.86 4.1 87.45 Favored Glycine 0 C--N 1.305 -1.164 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.16 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.726 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -72.63 163.92 27.3 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 148' ' ' LEU . 33.8 mttt -117.28 162.82 17.27 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.28 0.562 . . . . 0.0 110.503 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.418 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -130.24 157.68 42.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.213 172.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.62 136.29 33.16 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -102.39 152.05 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.686 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.309 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 C--N 1.307 -1.244 0 CA-C-O 120.826 0.346 . . . . 0.0 111.025 -179.561 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.507 HD12 ' CD2' ' A' ' 98' ' ' TYR . 9.9 mt . . . . . 0 N--CA 1.427 -1.607 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.572 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -114.79 138.68 50.46 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -172.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -90.4 145.09 25.21 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.013 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 79.4 mt -79.3 117.22 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-N 113.507 -1.679 . . . . 0.0 110.99 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.629 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 30.3 mmtt -76.06 -37.98 57.62 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.589 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -152.7 134.63 14.77 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 77.0 mt -117.59 125.89 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.279 174.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.423 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.9 ptpt -128.18 159.25 35.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.457 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.423 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 19.0 m-85 -100.36 117.83 35.37 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -127.74 174.08 11.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.376 -178.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.442 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 37.3 ttt180 -95.33 155.25 16.82 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 122.106 -0.371 . . . . 0.0 110.829 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.705 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.4 -25.3 49.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.657 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 68.05 -39.73 0.4 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.45 -173.25 2.6 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.85 -10.89 19.47 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 120.645 0.259 . . . . 0.0 111.171 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 96.5 m-85 -141.86 155.08 45.55 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.94 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 3' ' ' PRO . 3.6 m -126.77 159.86 35.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.935 177.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.633 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 69.9 m-85 -136.22 172.05 13.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.632 0.254 . . . . 0.0 110.478 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.28 -23.2 0.06 Allowed 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.463 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 1.3 tm? 68.23 107.97 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.97 176.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -87.28 118.21 26.55 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.54 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.478 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.41 -153.9 0.6 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.0 tptm . . . . . 0 C--N 1.315 -0.922 0 CA-C-O 120.88 0.372 . . . . 0.0 111.187 -179.236 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 8' ' ' ILE . 4.2 p -129.5 167.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-O 121.568 0.699 . . . . 0.0 112.723 -173.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.509 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 75.7 mt -93.5 113.57 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.716 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 43.8 pt -120.39 172.92 6.78 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.688 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 5.0 t-20 47.84 -123.07 1.55 Allowed 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 124.487 1.115 . . . . 0.0 110.725 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -92.71 48.46 1.37 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.693 0.758 . . . . 0.0 109.862 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.66 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.7 m-20 73.86 46.44 0.19 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.465 1.506 . . . . 0.0 112.82 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.7 mt -88.96 117.2 31.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 56.6 t -84.38 152.09 3.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.693 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 C--N 1.303 -1.442 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.908 -178.179 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.531 ' HD3' HD11 ' A' ' 76' ' ' LEU . 56.4 Cg_endo -68.1 162.65 39.17 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 121.557 1.505 . . . . 0.0 108.9 176.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.75 -24.43 66.41 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 118.857 -1.64 . . . . 0.0 110.146 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.66 -13.69 34.97 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.031 0.932 . . . . 0.0 112.935 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 61.3 m -72.24 131.64 43.0 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.885 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.636 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 12.6 mtm180 -86.34 133.03 33.83 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.6 HD11 ' CG2' ' A' ' 175' ' ' VAL . 2.2 tp -117.13 133.37 64.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-O 121.131 0.491 . . . . 0.0 110.884 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.459 HD11 ' N ' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -92.51 124.25 36.41 Favored 'General case' 0 N--CA 1.4 -2.965 0 CA-C-O 121.788 0.804 . . . . 0.0 110.956 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.459 ' N ' HD11 ' A' ' 9' ' ' LEU . 19.7 m -134.26 -179.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.898 -177.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -125.8 117.14 22.76 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 26.9 mt -118.89 120.56 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 CA-C-O 121.137 0.494 . . . . 0.0 110.015 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 54.11 38.51 29.21 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.92 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.71 20.48 79.69 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.746 -1.115 . . . . 0.0 113.677 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.1 t -131.01 123.04 19.64 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 70.6 Cg_endo -73.85 120.87 6.61 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 122.546 2.164 . . . . 0.0 112.25 -177.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 17' ' ' GLN . 12.4 mt-30 -120.56 138.71 53.73 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.636 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HZ2' ' CD ' ' A' ' 179' ' ' GLU . 37.9 ttmt -108.9 100.78 9.95 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.595 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 8' ' ' ILE . 2.9 pt -124.19 -172.91 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.144 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.743 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 11.3 p -95.44 171.12 8.9 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.622 178.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 92.4 mt -66.56 -31.31 71.94 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.219 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.743 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 6.3 ptm180 -79.43 -24.84 42.21 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.549 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 68.8 mt-10 -83.87 -41.62 17.26 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.389 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.556 ' CD2' HD13 ' A' ' 167' ' ' LEU . 46.8 tp -59.3 -41.52 89.17 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.894 0.854 . . . . 0.0 109.34 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.427 ' HB2' HG13 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -53.49 -31.74 47.21 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.979 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 32.4 mt-10 -77.24 -14.9 59.68 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.733 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -82.59 0.54 42.42 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.643 0.735 . . . . 0.0 109.14 177.05 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.484 ' CZ ' HG23 ' A' ' 47' ' ' ILE . 72.4 m-85 -114.11 162.61 16.27 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.686 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.404 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 6.5 tp10 -142.15 -178.73 5.86 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.437 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.524 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER 65.1 79.89 0.24 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.641 0.777 . . . . 0.0 110.448 -179.187 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -101.13 131.43 47.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 122.078 0.942 . . . . 0.0 110.922 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -122.71 153.61 39.2 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.269 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -101.14 125.18 47.74 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -166.7 145.49 5.39 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.444 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 61.04 19.85 10.32 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.864 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.2 mtt 71.67 16.79 5.68 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.505 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 16.2 m -131.89 -170.77 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -119.3 142.67 47.89 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.92 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.38 123.41 57.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.154 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.461 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 15.0 ttm180 -113.54 127.01 55.93 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.665 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.42 135.33 46.01 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.959 -175.498 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 36.0 mtpt 91.99 118.2 0.02 OUTLIER Pre-proline 0 CA--C 1.502 -0.887 0 C-N-CA 125.375 1.47 . . . . 0.0 112.147 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 87.3 Cg_endo -78.42 156.19 28.73 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.782 2.321 . . . . 0.0 111.045 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.402 ' HD3' ' HB2' ' A' ' 29' ' ' GLU . 38.8 mtmt -94.02 -1.6 54.26 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.439 0.637 . . . . 0.0 110.565 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -146.3 -165.67 2.28 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.624 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 4.9 tp10 -85.28 99.24 11.0 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 174.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.503 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 1.5 mp -116.08 115.8 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.01 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.59 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 30.6 mmtp -123.28 163.94 19.73 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.98 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.412 HG13 ' CG1' ' A' ' 64' ' ' ILE . 6.9 m -111.06 128.78 67.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.068 0.461 . . . . 0.0 111.846 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -83.8 124.11 30.59 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.428 ' HA ' HG13 ' A' ' 176' ' ' ILE . 20.0 m -134.17 172.16 13.24 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.419 HD11 ' C ' ' A' ' 58' ' ' LYS . 2.9 mm -119.49 143.06 32.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.116 0.484 . . . . 0.0 110.071 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 41.9 t0 -84.23 119.77 25.43 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.568 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.603 HD21 ' H ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -72.71 -11.37 60.59 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.124 -171.579 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.42 ' HG3' HG21 ' A' ' 56' ' ' THR . 5.5 pt-20 -102.48 -27.88 12.52 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.82 -176.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.42 HG21 ' HG3' ' A' ' 55' ' ' GLU . 76.1 p -115.48 -23.96 8.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.634 -175.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.41 14.45 76.31 Favored Glycine 0 N--CA 1.429 -1.784 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.149 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.419 ' C ' HD11 ' A' ' 52' ' ' ILE . 5.1 mtpm? -89.75 153.3 20.8 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 p -89.69 107.61 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-O 121.967 0.889 . . . . 0.0 110.042 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 m -110.09 159.37 9.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.201 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.9 tp -121.91 140.69 52.12 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.0 t -147.03 172.31 13.93 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.212 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.31 161.87 19.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.551 0.691 . . . . 0.0 110.824 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.539 ' N ' HD13 ' A' ' 64' ' ' ILE . 3.0 mp -105.32 134.26 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.699 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.48 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 10.9 mm-40 -79.8 -40.21 29.13 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.036 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 p30 179.49 178.03 0.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.175 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 25' ' ' TYR . 20.1 t -105.45 130.0 57.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.633 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.675 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 50.7 mt -90.67 105.2 16.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.538 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 84.9 tttt -118.52 109.82 16.65 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.3 134.57 25.89 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.219 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -47.22 124.35 8.94 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.447 2.765 . . . . 0.0 112.916 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.36 110.4 2.24 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.073 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -68.33 0.93 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -68.23 -117.4 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -159.34 172.68 17.53 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -172.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 90' ' ' THR . 4.5 mt -136.5 140.22 42.86 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.532 0.682 . . . . 0.0 111.283 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.543 HD12 ' CZ ' ' A' ' 156' ' ' TYR . 9.0 mt -86.5 142.55 12.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 171.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 31.8 ttt85 -118.97 138.38 52.85 Favored 'General case' 0 N--CA 1.404 -2.763 0 CA-C-O 121.207 0.527 . . . . 0.0 109.755 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.616 ' O ' ' HA ' ' A' ' 86' ' ' SER . 53.5 m-85 -115.97 125.17 52.16 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.893 -177.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 152' ' ' LYS . 34.5 tt0 -108.18 125.22 51.37 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.554 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -91.25 160.06 15.72 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.889 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.642 ' HG2' ' CD1' ' A' ' 149' ' ' LEU . 5.5 pt-20 -62.54 -19.59 63.79 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.209 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -87.33 -11.31 49.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.762 0.792 . . . . 0.0 109.23 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.52 16.81 47.95 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.036 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.527 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -87.46 142.91 27.51 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 23.6 p -142.38 136.28 29.43 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.456 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -129.97 155.99 45.18 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.165 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.434 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 40.2 mt-10 -129.86 148.01 51.69 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.308 0.575 . . . . 0.0 112.135 -175.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -141.0 154.51 46.05 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.358 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.533 ' HA ' HD23 ' A' ' 76' ' ' LEU . 1.1 p -69.84 15.92 0.07 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.661 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.06 -39.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 125.349 1.46 . . . . 0.0 113.854 175.009 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -90.79 12.68 18.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.414 0.625 . . . . 0.0 110.766 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 39.6 m80 -115.45 141.62 27.53 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.361 177.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 23.6 Cg_exo -64.9 142.78 77.05 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.43 2.753 . . . . 0.0 115.201 -176.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.519 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 19.1 t -119.52 150.13 22.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.381 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.5 tp -104.26 107.57 18.55 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.86 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.529 HG11 HG13 ' A' ' 104' ' ' ILE . 1.6 p -107.11 143.96 16.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.383 0.611 . . . . 0.0 111.684 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.591 ' CD2' HD13 ' A' ' 148' ' ' LEU . 44.5 t80 -99.17 90.95 4.76 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.687 176.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 11.9 pt-20 -138.17 157.51 46.16 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.499 176.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.546 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER 68.81 21.86 7.51 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.93 13.84 60.09 Favored Glycine 0 CA--C 1.508 -0.35 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.669 -177.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -135.61 172.5 12.92 Favored 'General case' 0 N--CA 1.404 -2.748 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -104.77 119.81 39.88 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.529 HG13 HG11 ' A' ' 97' ' ' VAL . 21.4 pt -119.22 144.2 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 120.129 -0.629 . . . . 0.0 112.187 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -101.82 114.87 29.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.551 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.565 ' HB3' ' HZ2' ' A' ' 106' ' ' LYS . 0.7 OUTLIER -136.01 146.56 47.29 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.387 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.572 ' O ' HG21 ' A' ' 111' ' ' VAL . 74.4 mtm180 -63.73 160.23 17.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.661 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -61.54 -41.55 97.51 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.788 -175.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.476 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.3 p90 -72.47 0.5 10.12 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.068 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -112.64 -16.68 12.77 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.479 0.657 . . . . 0.0 109.974 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.572 HG21 ' O ' ' A' ' 107' ' ' ARG . 94.7 t -71.08 150.7 9.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.786 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 1.9 mtmp? -115.08 159.73 20.5 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.178 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -73.97 145.86 44.32 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.08 4.22 86.96 Favored Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.159 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.786 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -76.68 167.32 22.05 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.16 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.454 ' H ' HG23 ' A' ' 97' ' ' VAL . 35.6 mttt -120.03 166.84 12.84 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.498 0.666 . . . . 0.0 111.756 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.35 162.28 35.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.655 171.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.61 141.02 29.09 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.745 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 1.8 m -114.68 149.57 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 173.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.9 t . . . . . 0 C--N 1.308 -1.22 0 CA-C-O 121.281 0.562 . . . . 0.0 110.548 178.487 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.591 HD13 ' CD2' ' A' ' 98' ' ' TYR . 11.9 mt . . . . . 0 CA--C 1.479 -1.751 0 CA-C-O 121.288 0.566 . . . . 0.0 109.68 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.642 ' CD1' ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -108.37 133.86 51.98 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.644 -172.012 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -88.46 143.75 26.79 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.919 175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.481 HD13 ' CD1' ' A' ' 79' ' ' PHE . 68.2 mt -77.5 110.06 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.607 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.006 175.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 80' ' ' GLU . 7.2 mmpt? -72.44 -39.75 67.59 Favored 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.487 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -150.16 133.8 16.67 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.8 mt -113.83 143.08 24.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.054 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.504 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.0 ptpt -144.6 158.03 43.95 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -178.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.543 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 7.2 m-85 -100.9 114.54 28.5 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.563 174.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.43 173.78 11.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.319 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.445 ' HG2' ' H ' ' A' ' 159' ' ' ALA . 49.8 ttt180 -112.21 167.6 10.28 Favored 'General case' 0 N--CA 1.415 -2.193 0 O-C-N 121.329 -0.857 . . . . 0.0 110.693 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.454 ' HA ' HD12 ' A' ' 76' ' ' LEU . . . -67.57 114.94 6.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.433 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -72.5 -32.77 66.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.665 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -81.92 -176.21 6.0 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.305 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -101.29 -15.68 17.2 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -138.17 153.77 49.18 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.489 HG11 ' HA ' ' A' ' 3' ' ' PRO . 3.1 m -118.46 155.95 20.41 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.675 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 78.1 m-85 -135.52 161.3 35.88 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.91 -175.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.639 ' C ' HD21 ' A' ' 167' ' ' LEU . 74.0 m -158.1 13.64 0.2 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.553 176.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.639 HD21 ' C ' ' A' ' 166' ' ' SER . 2.5 pt? 29.39 109.51 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 125.368 1.467 . . . . 0.0 113.923 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -82.03 114.34 20.52 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.147 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.48 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -133.56 -142.43 0.2 Allowed 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 42.8 tptt . . . . . 0 C--N 1.31 -1.151 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.821 178.118 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.7 t30 . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.6 ' CG2' HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -165.1 171.7 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.657 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 97.0 mt -111.99 118.12 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.615 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 44.3 pt -120.78 171.91 8.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.294 0 CA-C-O 121.01 0.433 . . . . 0.0 111.186 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 48.83 -129.79 1.9 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.313 1.045 . . . . 0.0 110.504 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.481 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 24.7 mm-40 -89.73 52.01 2.22 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.558 0.694 . . . . 0.0 109.959 176.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.745 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 13.5 m120 74.05 44.41 0.26 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.685 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 86.5 mt -87.0 113.04 23.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 73.4 t -88.24 130.38 37.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.958 -176.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 12.0 t . . . . . 0 C--N 1.311 -1.07 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.594 176.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.43 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 2.7 m-85 . . . . . 0 C--O 1.234 0.243 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.495 ' HD3' HD13 ' A' ' 76' ' ' LEU . 73.0 Cg_endo -72.14 164.48 35.51 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 N-CA-C 108.408 -1.42 . . . . 0.0 108.408 175.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.76 -26.59 65.26 Favored Glycine 0 C--N 1.301 -1.415 0 C-N-CA 118.993 -1.575 . . . . 0.0 111.44 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.54 -9.32 48.55 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.6 m -71.33 129.69 39.49 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.381 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 26.2 mtm180 -85.77 132.08 34.2 Favored 'General case' 0 C--O 1.187 -2.187 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 175' ' ' VAL . 8.9 tt -119.91 130.1 74.62 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-O 120.863 0.363 . . . . 0.0 110.139 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -88.44 122.13 31.59 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-O 121.527 0.679 . . . . 0.0 109.576 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 28.0 m -132.58 -173.3 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.346 -178.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.464 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 31.4 tt0 -134.4 121.4 21.09 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.586 HG12 HG13 ' A' ' 47' ' ' ILE . 17.0 mt -120.87 123.47 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.922 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.11 37.47 27.09 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.202 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.12 76.92 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.657 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -130.79 119.81 18.28 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 13.5 Cg_exo -64.87 120.93 8.29 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.733 1.622 . . . . 0.0 110.663 178.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -118.62 135.58 54.36 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -106.56 100.78 10.28 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.436 ' O ' ' N ' ' A' ' 8' ' ' ILE . 3.3 pt -125.46 -172.68 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.146 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.243 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.713 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 29.6 p -96.46 170.1 9.46 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.793 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 84.6 mt -67.23 -28.22 67.88 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.797 178.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.713 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 11.2 ptm180 -79.51 -26.54 41.53 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.549 ' OE1' HG23 ' A' ' 20' ' ' THR . 43.9 mt-10 -84.28 -42.34 15.93 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.797 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.588 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 17.5 tp -57.96 -44.01 86.76 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.779 0.8 . . . . 0.0 109.206 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.434 ' HB2' HG12 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -51.42 -34.17 33.72 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.749 -1.568 . . . . 0.0 112.631 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 31.3 mt-10 -76.6 -14.39 60.0 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 23' ' ' GLU . 1.4 mm? -79.97 4.74 15.94 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.572 0.701 . . . . 0.0 109.317 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 96.9 m-85 -118.24 162.11 18.79 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.922 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -142.12 -173.38 3.81 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.512 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.8 OUTLIER 61.91 84.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.45 0.643 . . . . 0.0 110.434 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -103.0 127.25 50.31 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.782 0.801 . . . . 0.0 111.161 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.401 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 14.3 ptt180 -121.04 154.39 36.14 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.237 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -100.3 130.26 46.39 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -164.29 142.04 6.89 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.27 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 59.07 23.12 11.27 Favored 'General case' 0 CA--C 1.493 -1.225 0 O-C-N 123.599 0.562 . . . . 0.0 111.18 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.8 mtp 71.81 17.98 5.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.618 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.521 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 14.6 m -132.56 -173.61 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -114.46 141.4 47.73 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-O 121.253 0.549 . . . . 0.0 109.822 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.401 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.4 t -129.23 123.46 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.059 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.439 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 19.3 ttm180 -114.13 126.6 55.26 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -130.67 144.28 51.32 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.683 -174.686 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 37.5 ttmt 83.97 114.58 0.03 OUTLIER Pre-proline 0 CA--C 1.509 -0.627 0 O-C-N 124.639 1.212 . . . . 0.0 111.279 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 81.7 Cg_endo -80.24 151.62 20.61 Favored 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 122.19 1.926 . . . . 0.0 111.515 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -84.04 -5.91 59.32 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.32 0.581 . . . . 0.0 110.751 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -145.5 -166.09 2.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 8.1 tp10 -85.69 101.07 12.44 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.586 HG13 HG12 ' A' ' 12' ' ' ILE . 1.8 mp -117.36 116.92 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.598 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 57.0 mmtt -115.12 169.08 9.38 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.336 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.455 HG13 ' CB ' ' A' ' 169' ' ' ALA . 13.0 p -127.01 130.77 71.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.45 ' HB3' HD12 ' A' ' 176' ' ' ILE . 5.2 m-85 -88.0 124.2 33.49 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.586 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.8 m -133.73 168.56 18.48 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.641 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.49 HG12 HD13 ' A' ' 176' ' ' ILE . 2.2 mm -116.0 145.91 21.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.32 0.581 . . . . 0.0 111.061 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.677 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 17.5 t70 -84.56 114.13 21.75 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.593 HD21 ' H ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -73.47 -9.2 58.44 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.355 0.662 . . . . 0.0 112.629 -170.049 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.677 ' HG3' ' OD1' ' A' ' 53' ' ' ASP . 3.1 pt-20 -102.12 -28.01 12.58 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.841 -176.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.566 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 61.0 p -118.2 -25.23 6.68 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.67 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.28 16.54 55.4 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.691 -0.686 . . . . 0.0 113.543 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.566 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 38.2 mttt -86.93 151.46 23.28 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.98 0.419 . . . . 0.0 112.092 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.02 107.97 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.581 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.7 m -109.5 157.1 10.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.316 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.9 tp -120.87 142.88 49.26 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 170' ' ' LYS . 9.9 t -148.52 170.77 17.33 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.602 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.79 160.71 22.2 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.365 0.603 . . . . 0.0 109.824 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.2 mp -94.71 143.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.032 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 58.0 mm-40 -89.05 -39.87 13.36 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 178.58 177.26 0.46 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.693 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' A' ' 25' ' ' TYR . 9.9 t -107.48 130.42 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.377 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 38.1 mt -90.51 106.85 17.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.587 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.521 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.5 tttt -121.54 108.73 13.96 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.74 141.87 43.36 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.275 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.442 ' HD2' HG13 ' A' ' 37' ' ' VAL . 9.5 Cg_endo -55.48 130.25 39.5 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 123.379 2.719 . . . . 0.0 112.74 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.5 99.66 9.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.397 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.2 m -106.04 -48.74 3.53 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.43 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.452 ' OD2' HG22 ' A' ' 90' ' ' THR . 12.0 p-10 -87.7 -173.28 4.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.25 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -111.76 172.96 6.59 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 121.163 0.506 . . . . 0.0 111.126 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' A' ' 90' ' ' THR . 9.9 mt -120.2 146.63 45.84 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.031 -175.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.479 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 12.0 mt -89.8 145.47 7.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 30.5 ttt-85 -120.75 136.76 54.79 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.568 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.0 m-85 -114.73 122.33 46.09 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.486 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.1 tt0 -110.04 123.81 50.35 Favored 'General case' 0 CA--C 1.465 -2.312 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.581 HD21 ' O ' ' A' ' 85' ' ' ARG . 1.5 mm? -86.84 162.05 17.99 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.448 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.574 ' HG2' ' CD1' ' A' ' 149' ' ' LEU . 1.5 pt-20 -63.26 -15.64 57.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.312 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -93.03 -9.73 38.71 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.029 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.22 8.68 62.73 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.452 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.581 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -88.83 143.35 26.95 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 176.064 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 55.8 p -138.57 154.89 48.74 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.823 178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -145.69 148.95 33.59 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.883 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 44.1 mt-10 -124.89 148.15 48.44 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.729 -175.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.516 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -144.71 159.03 43.5 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.636 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.514 ' HA ' HD21 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -71.04 18.72 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.055 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.693 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.6 OUTLIER 70.87 -32.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 125.006 1.322 . . . . 0.0 112.429 177.273 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 90' ' ' THR . 12.8 t70 -78.35 -26.87 46.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.149 0.499 . . . . 0.0 109.737 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -69.26 123.75 88.97 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.05 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 33.5 Cg_exo -63.78 142.08 81.33 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.278 2.652 . . . . 0.0 113.126 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.46 146.33 18.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 124.22 1.008 . . . . 0.0 108.332 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.9 tp -105.38 109.7 21.78 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.837 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.457 HG12 HG13 ' A' ' 104' ' ' ILE . 2.1 p -110.72 151.1 12.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.371 0.605 . . . . 0.0 111.214 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -102.66 93.36 5.07 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.984 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.506 ' OE2' HD13 ' A' ' 104' ' ' ILE . 11.4 pt-20 -145.88 157.04 43.92 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 39.1 m-80 66.52 23.52 10.44 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.144 0.497 . . . . 0.0 109.844 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.42 11.89 57.36 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.207 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -136.84 172.23 13.33 Favored 'General case' 0 N--CA 1.402 -2.827 0 CA-C-O 121.462 0.649 . . . . 0.0 110.507 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -98.45 121.41 40.35 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.373 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.506 HD13 ' OE2' ' A' ' 99' ' ' GLU . 22.8 pt -118.72 145.9 24.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.126 -0.63 . . . . 0.0 112.146 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -103.65 109.14 20.72 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.793 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -124.98 135.6 52.95 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.844 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.61 ' O ' HG21 ' A' ' 111' ' ' VAL . 96.1 mtt180 -62.31 163.42 8.47 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.693 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -62.05 -42.13 98.86 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.165 -176.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.436 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.7 p90 -74.14 2.64 8.52 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.814 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -110.87 -19.41 12.82 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.487 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.61 HG21 ' O ' ' A' ' 107' ' ' ARG . 98.5 t -77.55 147.02 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 8.3 mptt -118.46 166.76 12.28 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.005 0.431 . . . . 0.0 111.543 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -70.11 142.9 52.54 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.07 4.21 81.93 Favored Glycine 0 C--N 1.304 -1.245 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.235 -175.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.487 ' HB3' HD12 ' A' ' 151' ' ' ILE . 11.3 t70 -76.93 170.47 16.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.585 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 42.4 mttp -122.78 165.97 15.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.442 0.639 . . . . 0.0 111.648 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.97 156.57 39.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.862 171.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.463 ' HG ' HD12 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -91.57 136.61 33.0 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.732 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.4 m -107.09 154.34 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.206 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.933 173.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.428 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 32.2 t . . . . . 0 C--N 1.306 -1.283 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.809 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.585 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.9 mm? . . . . . 0 N--CA 1.428 -1.553 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.574 ' CD1' ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -109.26 134.89 51.2 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -173.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.518 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 19.9 mt-10 -87.3 142.79 27.63 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.057 176.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.487 HD12 ' HB3' ' A' ' 115' ' ' ASP . 71.1 mt -78.79 109.22 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.246 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.62 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.559 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 36.4 mmtt -68.25 -40.36 81.96 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.918 176.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -151.27 131.33 13.44 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.2 mt -112.83 140.98 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.189 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.371 174.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.4 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.2 ptpt -148.44 159.64 43.84 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.312 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.479 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 18.7 m-85 -99.27 116.75 32.18 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.31 134.69 60.74 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.007 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -67.44 154.19 41.94 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.518 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.0 133.99 56.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.784 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -84.32 37.9 0.64 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.089 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 162' ' ' ASP . 12.6 t70 -176.54 -174.4 0.58 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.29 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.489 ' H ' ' CG ' ' A' ' 161' ' ' ASP . 6.0 m-20 -95.64 -10.43 29.44 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.876 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.21 160.73 38.18 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.265 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.442 HG13 ' HA ' ' A' ' 3' ' ' PRO . 2.7 m -127.55 158.01 39.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.573 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.572 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 77.3 m-85 -135.77 167.22 21.57 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.142 0.496 . . . . 0.0 111.08 -175.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.464 ' HB3' HD11 ' A' ' 68' ' ' ILE . 44.6 t -152.47 -16.39 0.17 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.115 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.588 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 4.5 mm? 59.41 105.02 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.648 0.737 . . . . 0.0 111.655 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -83.81 118.68 24.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.556 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.455 ' CB ' HG13 ' A' ' 49' ' ' VAL . . . -135.32 -162.1 1.22 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.41 ' HB3' HG23 ' A' ' 62' ' ' THR . 72.1 tttt . . . . . 0 C--N 1.319 -0.738 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 183' ' ' THR . 43.9 t30 . . . . . 0 CA--C 1.516 -0.334 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.483 HG21 HD13 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -153.95 162.15 2.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.485 -177.286 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.531 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 87.3 mt -101.22 117.07 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.31 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.43 HG23 HG13 ' A' ' 175' ' ' VAL . 34.1 pt -122.76 162.67 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 CA-C-O 121.386 0.612 . . . . 0.0 111.676 -176.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.404 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 22.0 t30 48.34 -133.2 1.4 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 124.697 1.199 . . . . 0.0 110.862 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.26 52.24 1.3 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.496 0.665 . . . . 0.0 110.654 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.732 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.0 m120 66.97 48.34 1.28 Allowed 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 125.154 1.382 . . . . 0.0 113.365 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.1 mt -90.05 114.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.4 m -86.77 159.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-O 121.458 0.647 . . . . 0.0 110.922 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 4.0 t . . . . . 0 C--N 1.289 -2.057 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.93 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 177' ' ' ILE . 49.1 m-85 . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.447 ' HA ' HG12 ' A' ' 164' ' ' VAL . 22.4 Cg_endo -61.16 -31.68 90.41 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.77 2.313 . . . . 0.0 112.279 -177.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.483 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 129.22 -39.3 1.87 Allowed Glycine 0 N--CA 1.421 -2.366 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.58 -11.86 55.15 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.374 0.607 . . . . 0.0 111.485 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.4 m -63.8 129.84 41.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.564 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 29.6 mtm180 -88.27 137.07 32.65 Favored 'General case' 0 C--O 1.189 -2.091 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.545 HD11 HG23 ' A' ' 175' ' ' VAL . 11.9 tt -122.5 130.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 C-N-CA 122.649 0.379 . . . . 0.0 110.106 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.52 122.5 32.05 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 121.526 0.679 . . . . 0.0 109.467 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.518 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 26.1 m -133.34 179.63 4.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.477 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -126.23 120.42 29.97 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-O 121.35 0.595 . . . . 0.0 109.495 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.592 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 28.5 mt -120.22 122.24 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.463 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.643 -177.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 55.15 37.77 29.41 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 114.22 -1.354 . . . . 0.0 110.044 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.83 17.22 78.23 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.776 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.2 t -127.3 123.32 23.26 Favored Pre-proline 0 C--N 1.312 -1.022 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 21.3 Cg_endo -67.69 126.56 14.9 Favored 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 122.017 1.811 . . . . 0.0 111.104 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -125.97 138.07 53.73 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -106.76 101.32 10.77 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 24' ' ' LEU . 3.7 pt -123.32 -178.14 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.936 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.588 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.7 p -92.23 168.78 11.1 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.803 -177.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.4 mm? -66.19 -25.12 66.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.825 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.588 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 1.1 ptm180 -85.38 -24.38 27.57 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.52 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 35.2 mt-10 -85.51 -39.65 17.21 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.63 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.556 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 22.0 tp -58.84 -41.57 87.22 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.764 0.792 . . . . 0.0 109.602 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.431 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -55.54 -29.38 58.86 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.308 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.62 -17.56 59.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.649 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -78.85 4.04 15.15 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.575 0.702 . . . . 0.0 109.414 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.505 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 95.6 m-85 -117.89 162.2 18.5 Favored 'General case' 0 N--CA 1.412 -2.36 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.861 -177.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.413 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 4.4 mm-40 -139.44 -173.81 3.71 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.375 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.5 t0 60.08 80.96 0.19 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.465 0.65 . . . . 0.0 110.863 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -102.56 130.79 49.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.904 0.859 . . . . 0.0 110.824 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.417 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.1 ptt180 -119.88 153.89 35.19 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.768 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -101.47 123.86 46.2 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -161.94 143.96 11.3 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.94 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 59.35 22.2 10.58 Favored 'General case' 0 CA--C 1.493 -1.236 0 O-C-N 123.78 0.675 . . . . 0.0 111.224 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.7 mtt 73.04 17.07 4.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.525 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 12.5 m -134.12 -171.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -119.3 143.21 47.48 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-O 121.164 0.507 . . . . 0.0 110.183 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.417 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.1 t -129.98 123.99 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.966 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.115 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.505 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 13.7 ttm180 -113.43 128.1 56.34 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.564 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.41 141.39 48.85 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.085 -174.083 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.564 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 24.3 ttmm 85.26 115.5 0.03 OUTLIER Pre-proline 0 CA--C 1.512 -0.513 0 C-N-CA 124.24 1.016 . . . . 0.0 111.928 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 72.3 Cg_endo -79.46 152.26 23.17 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.347 2.032 . . . . 0.0 111.838 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 31.0 mtmt -84.33 -6.09 59.35 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.821 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -148.35 -164.85 2.12 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.592 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 6.2 tp10 -86.73 101.17 13.05 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.469 176.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.546 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -116.21 118.23 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.518 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 29.3 mmtp -123.0 166.31 15.31 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.606 173.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 61' ' ' LEU . 6.3 m -115.36 129.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -84.8 121.91 28.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.827 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.1 m -132.88 171.32 14.08 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.846 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.425 HG12 HD12 ' A' ' 176' ' ' ILE . 2.9 mm -113.41 143.18 23.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.168 0.509 . . . . 0.0 110.008 177.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.616 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 21.2 t70 -77.55 124.22 27.63 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.342 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.597 HD21 ' H ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -75.97 -10.51 59.48 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.608 -171.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.616 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 3.8 pt-20 -107.87 -23.33 12.09 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.895 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.525 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 67.7 p -120.99 -23.78 5.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.999 -176.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.54 17.57 65.94 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.393 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.525 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 18.0 mttp -92.43 159.36 15.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 t -85.79 107.89 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.465 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.26 157.78 12.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.153 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.1 tp -122.24 137.98 54.65 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.5 t -143.79 171.51 14.12 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.08 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.14 161.64 20.54 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.809 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.512 ' N ' HD13 ' A' ' 64' ' ' ILE . 2.9 mp -100.79 141.11 18.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.504 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.555 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 49.7 mt-10 -89.7 -35.85 15.54 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 p30 176.5 174.85 0.35 Allowed 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.006 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 20.5 t -105.54 134.3 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.191 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.297 177.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 166' ' ' SER . 0.1 OUTLIER -101.8 124.04 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.379 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.089 179.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.446 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 86.7 tttt -135.34 108.47 7.7 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.224 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.43 137.17 30.22 Favored Pre-proline 0 C--N 1.31 -1.148 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.44 -175.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -47.43 124.04 8.78 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.394 2.729 . . . . 0.0 112.79 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.37 108.09 7.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.865 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -110.95 -59.52 1.95 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -77.21 -98.94 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.84 172.74 4.73 Favored 'General case' 0 CA--C 1.474 -1.981 0 CA-C-O 121.101 0.477 . . . . 0.0 112.011 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.513 HD22 ' HA ' ' A' ' 90' ' ' THR . 7.3 mt -132.45 141.14 48.7 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.135 -178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.511 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 10.6 mt -87.67 144.86 8.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 19.3 ttt-85 -121.69 136.03 54.95 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-O 121.283 0.564 . . . . 0.0 109.731 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 86' ' ' SER . 48.7 m-85 -114.34 130.32 56.67 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.865 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 152' ' ' LYS . 18.9 tt0 -109.86 129.21 55.67 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.569 HD13 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -94.31 155.64 16.91 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.56 ' HA ' ' HG3' ' A' ' 152' ' ' LYS . 1.1 pt-20 -64.62 -14.34 57.56 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.212 0.53 . . . . 0.0 111.529 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.69 -8.24 52.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.51 -0.768 . . . . 0.0 108.989 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.92 19.11 44.53 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.403 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.512 ' O ' HD22 ' A' ' 81' ' ' LEU . 4.8 mtt-85 -89.2 139.1 30.82 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 9.0 p -139.29 144.87 38.53 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.849 175.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -140.76 147.17 38.7 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.094 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 35.9 mt-10 -117.88 147.75 42.8 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.965 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.1 p -145.8 159.44 43.19 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.302 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.513 ' HA ' HD22 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.55 20.48 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -176.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.671 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.47 -37.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 125.397 1.479 . . . . 0.0 113.532 176.421 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.22 -2.2 58.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.143 0.497 . . . . 0.0 110.633 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -81.31 121.49 80.29 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.686 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 21.3 Cg_endo -63.32 139.04 69.4 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.659 2.239 . . . . 0.0 113.336 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.1 t -113.89 145.82 19.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.5 tp -101.35 107.69 19.1 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 121.059 -0.257 . . . . 0.0 110.336 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.458 ' HB ' ' OD2' ' A' ' 115' ' ' ASP . 2.6 p -107.76 147.5 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 121.63 0.728 . . . . 0.0 111.666 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -103.8 91.18 3.89 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.558 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.501 ' OE2' ' HE3' ' A' ' 106' ' ' LYS . 10.4 pt-20 -141.24 158.83 43.37 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.856 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.2 m-20 65.62 23.13 11.69 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.09 15.45 58.5 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.811 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.408 ' HG3' HG21 ' A' ' 104' ' ' ILE . 9.7 ptm180 -136.33 171.96 13.71 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-O 121.206 0.527 . . . . 0.0 110.145 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -102.55 120.9 41.33 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.49 ' CD1' ' HE2' ' A' ' 106' ' ' LYS . 9.2 pt -125.8 147.94 30.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.316 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.41 119.0 37.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.448 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HE3' ' OE2' ' A' ' 99' ' ' GLU . 64.6 mttm -129.35 133.2 47.3 Favored 'General case' 0 C--O 1.205 -1.275 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.495 ' O ' HG23 ' A' ' 111' ' ' VAL . 86.4 mtt180 -63.42 163.04 11.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.671 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -60.57 -41.44 94.64 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.013 -175.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.439 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 2.8 p90 -74.18 4.61 5.4 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.961 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -118.17 -16.23 9.76 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.695 0.76 . . . . 0.0 110.265 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 107' ' ' ARG . 78.4 t -76.97 149.12 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -119.88 165.63 14.37 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.436 -176.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.8 141.09 53.39 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.286 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.75 5.0 71.99 Favored Glycine 0 C--N 1.307 -1.083 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.527 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 6.8 t70 -72.65 177.54 4.68 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.432 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 23.0 mttp -134.29 160.46 37.84 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.405 0.621 . . . . 0.0 111.013 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.26 158.4 43.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.066 172.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.71 130.86 37.43 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.732 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -102.61 148.73 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 175.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.474 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 33.1 t . . . . . 0 C--N 1.304 -1.384 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.683 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.423 -1.788 0 CA-C-O 121.636 0.732 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.569 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -113.02 136.92 52.16 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.581 -173.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 11.6 mt-10 -91.25 148.08 22.59 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.828 -1.078 . . . . 0.0 113.12 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.563 HD12 ' CD1' ' A' ' 79' ' ' PHE . 86.8 mt -78.97 109.63 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.897 176.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.56 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 1.5 mmmp? -68.12 -42.87 79.59 Favored 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.01 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -150.03 135.3 18.06 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 82.6 mt -118.92 129.29 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.639 -1.618 . . . . 0.0 111.058 174.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.406 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 1.8 ptpp? -133.17 163.0 30.24 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.648 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.511 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 13.5 m-85 -100.82 119.25 38.39 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.04 174.62 11.99 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.97 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.856 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -109.91 166.4 10.96 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.305 -0.958 . . . . 0.0 112.282 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.66 137.1 58.13 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.914 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -101.48 31.05 3.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.974 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -170.99 -178.82 2.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -95.28 -13.26 25.0 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.072 0.463 . . . . 0.0 110.247 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.26 166.09 23.6 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.289 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.1 m -130.91 157.4 43.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.51 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 77.3 m-85 -138.46 159.97 40.73 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.734 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.42 ' H ' HG12 ' A' ' 68' ' ' ILE . 7.8 t -148.34 -18.33 0.33 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.448 174.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.556 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 4.1 mm? 60.29 95.22 0.03 OUTLIER 'General case' 0 C--N 1.347 0.486 0 O-C-N 123.75 0.657 . . . . 0.0 111.04 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 65' ' ' GLU . 41.6 m-20 -82.44 102.61 11.42 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.127 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.555 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -97.5 -149.32 0.33 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.227 172.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.8 tptp . . . . . 0 N--CA 1.443 -0.814 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.603 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 183' ' ' THR . 0.5 OUTLIER . . . . . 0 CA--C 1.5 -0.98 0 CA-C-O 120.998 0.428 . . . . 0.0 110.435 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.545 HG23 HD11 ' A' ' 8' ' ' ILE . 2.5 p -150.13 167.03 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.044 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.563 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 90.5 mt -96.85 115.3 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.823 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 31.7 pt -118.47 166.51 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 121.307 0.575 . . . . 0.0 111.281 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 37.6 t30 46.16 -126.57 1.39 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 124.774 1.23 . . . . 0.0 111.028 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -91.07 59.31 3.99 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.603 0.716 . . . . 0.0 109.355 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.732 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.3 m120 66.08 44.65 2.58 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 113.851 -1.522 . . . . 0.0 114.18 176.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 91.3 mt -91.68 113.74 27.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.4 m -91.5 153.6 3.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.905 0.859 . . . . 0.0 112.394 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 1.4 t . . . . . 0 C--N 1.303 -1.424 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.261 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 . . . . . 0 CA--C 1.52 -0.18 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.496 ' HD3' HD13 ' A' ' 76' ' ' LEU . 67.8 Cg_endo -70.4 161.57 45.55 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 N-CA-C 108.68 -1.315 . . . . 0.0 108.68 177.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.437 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -61.64 -23.67 63.24 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 119.316 -1.421 . . . . 0.0 111.692 177.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.57 -21.23 60.03 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.28 0.562 . . . . 0.0 112.185 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.9 m -62.97 126.33 26.96 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.969 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 177' ' ' ILE . 35.4 mmt180 -80.3 130.83 35.46 Favored 'General case' 0 C--O 1.184 -2.368 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.496 HD12 HG21 ' A' ' 175' ' ' VAL . 7.7 tt -120.3 130.1 74.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 10' ' ' VAL . 1.1 tm? -87.34 124.42 33.35 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-O 121.458 0.647 . . . . 0.0 110.317 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.491 ' N ' HD12 ' A' ' 9' ' ' LEU . 30.3 m -135.89 -178.5 2.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.189 -178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.458 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 33.8 tt0 -130.79 122.64 27.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.56 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 20.4 mt -121.03 120.85 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.568 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.659 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 52.46 40.61 29.97 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.303 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.27 18.3 79.21 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.8 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.3 t -122.5 120.16 28.06 Favored Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 59.6 Cg_endo -74.8 125.23 9.29 Favored 'Trans proline' 0 N--CA 1.427 -2.393 0 C-N-CA 122.207 1.938 . . . . 0.0 110.926 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -128.37 142.34 51.15 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.935 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -108.56 99.85 9.18 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 8' ' ' ILE . 3.0 pt -121.31 -172.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.822 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 20.0 p -98.95 174.11 6.52 Favored 'General case' 0 C--N 1.28 -2.441 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.127 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 65.5 mt -68.54 -28.63 67.15 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.717 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.822 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 11.6 ptm180 -76.85 -26.92 54.84 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.554 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 49.4 mt-10 -85.28 -36.22 21.01 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.191 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.467 HD21 HD22 ' A' ' 167' ' ' LEU . 15.5 tp -66.11 -44.24 84.89 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.129 0.49 . . . . 0.0 111.234 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.57 ' HB2' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -58.6 -26.51 63.74 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.401 -175.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.422 ' OE1' ' HA ' ' A' ' 23' ' ' GLU . 24.9 mt-10 -68.09 -19.02 64.82 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.665 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.37 0.33 42.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.447 0.642 . . . . 0.0 110.091 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.516 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 96.1 m-85 -117.15 163.34 16.43 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.005 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -145.76 -171.91 3.79 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.997 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 t0 63.53 75.43 0.39 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.845 0.831 . . . . 0.0 110.139 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.36 128.91 44.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.474 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.456 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.3 ptt180 -120.51 153.37 36.77 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.323 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -103.74 128.77 51.09 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -166.52 143.4 4.92 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.035 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 60.84 21.03 11.2 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 123.662 0.601 . . . . 0.0 110.783 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 33.5 mtt 71.28 19.62 5.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.648 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.443 HG11 ' HD2' ' A' ' 71' ' ' PRO . 17.2 m -133.26 -175.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -117.45 142.09 47.56 Favored 'General case' 0 CA--C 1.477 -1.836 0 CA-C-O 121.267 0.556 . . . . 0.0 110.497 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.456 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.3 t -130.01 124.3 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.861 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -114.75 126.32 54.71 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.35 145.17 51.06 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.398 -174.488 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 51.5 tptt 80.33 114.86 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.504 0 O-C-N 124.574 1.171 . . . . 0.0 110.697 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 58.0 Cg_endo -77.42 158.56 32.8 Favored 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 121.947 1.765 . . . . 0.0 111.735 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -90.57 -3.44 57.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.422 0.629 . . . . 0.0 110.461 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -148.72 -165.68 2.34 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.637 ' OE1' ' HE3' ' A' ' 48' ' ' LYS . 7.1 tp10 -84.01 96.7 8.95 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.516 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 1.8 mp -116.78 115.63 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.031 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.637 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 34.6 mmtp -118.79 166.13 13.17 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.314 173.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.488 HG13 ' CB ' ' A' ' 169' ' ' ALA . 10.2 p -122.92 134.3 66.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.662 -175.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' A' ' 11' ' ' GLN . 20.2 m-85 -88.18 123.54 32.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.494 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.9 m -136.56 147.56 47.08 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.217 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.501 HD13 ' C ' ' A' ' 58' ' ' LYS . 2.2 mm -93.21 143.54 11.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.222 0.534 . . . . 0.0 110.343 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.451 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 28.3 t70 -87.3 123.47 32.32 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.427 ' N ' HD23 ' A' ' 54' ' ' LEU . 6.4 mt -70.44 -28.82 65.33 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-O 122.109 0.957 . . . . 0.0 111.844 -172.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.451 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -83.51 -30.7 26.94 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.507 -172.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.415 ' CB ' ' HD2' ' A' ' 58' ' ' LYS . 62.7 p -114.87 -22.29 9.7 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.654 -175.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.39 20.73 71.4 Favored Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.524 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.501 ' C ' HD13 ' A' ' 52' ' ' ILE . 27.6 mttm -99.98 153.84 18.87 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.85 106.58 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 CA-C-O 121.769 0.795 . . . . 0.0 110.126 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.72 167.06 5.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.887 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.9 tp -119.72 141.76 49.13 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.9 t -146.98 171.8 14.7 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.853 0.359 . . . . 0.0 111.329 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.531 ' OD2' ' HE2' ' A' ' 48' ' ' LYS . 7.0 m-20 -82.2 161.06 22.88 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.556 0.693 . . . . 0.0 110.552 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.7 mp -99.21 140.92 17.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.244 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -88.18 -35.26 17.48 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 173.79 174.15 0.15 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.579 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' A' ' 25' ' ' TYR . 13.8 t -104.92 132.93 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.192 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 49.7 mt -92.21 113.49 27.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.478 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.424 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 86.6 tttt -127.57 109.34 11.61 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.78 141.62 42.63 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.77 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.443 ' HD2' HG11 ' A' ' 37' ' ' VAL . 8.1 Cg_endo -52.62 129.59 32.95 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.384 2.723 . . . . 0.0 112.41 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.95 73.63 9.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.351 0.596 . . . . 0.0 110.622 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.2 p -71.7 -38.59 70.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.913 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.52 -172.31 2.73 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.323 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.616 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 19.2 m170 -111.98 172.32 6.97 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.561 ' CD2' ' HA ' ' A' ' 90' ' ' THR . 7.1 mt -122.48 146.87 46.99 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.541 0.686 . . . . 0.0 112.007 -175.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.537 HD13 ' C ' ' A' ' 108' ' ' ALA . 20.5 mt -87.82 145.52 7.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.543 ' HB3' ' CG ' ' A' ' 155' ' ' LYS . 41.8 ttt85 -122.07 140.88 51.98 Favored 'General case' 0 N--CA 1.404 -2.752 0 CA-C-O 121.301 0.572 . . . . 0.0 109.945 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 86' ' ' SER . 57.5 m-85 -114.71 125.49 53.79 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.586 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.7 tt0 -109.4 123.52 49.48 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.71 159.65 17.7 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.502 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.602 ' HG2' ' CD1' ' A' ' 149' ' ' LEU . 3.9 pt-20 -63.61 -15.25 57.66 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.456 0.646 . . . . 0.0 111.116 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.06 -10.24 36.82 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.487 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.02 12.77 54.85 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.839 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.525 ' O ' HD22 ' A' ' 81' ' ' LEU . 1.6 mtt180 -83.84 139.3 32.74 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 15.7 p -143.01 136.99 28.97 Favored 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.523 176.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -133.06 151.56 52.03 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.559 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 99.3 mt-10 -123.54 152.2 42.06 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.328 0.585 . . . . 0.0 112.097 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.54 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -142.21 155.33 45.27 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.238 178.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.561 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -72.01 16.85 0.11 Allowed 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 121.621 0.725 . . . . 0.0 111.56 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.688 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.9 OUTLIER 71.05 -29.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 125.64 1.576 . . . . 0.0 113.06 176.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 90' ' ' THR . 19.1 m-20 -82.61 -5.1 58.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.972 0.415 . . . . 0.0 110.493 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -94.86 125.66 50.13 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.57 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 37.9 Cg_exo -63.1 142.28 86.62 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.968 2.445 . . . . 0.0 112.937 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.2 t -112.17 146.19 17.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.41 ' CD1' ' HG3' ' A' ' 105' ' ' GLU . 18.2 tp -101.75 111.46 23.72 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.975 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.568 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.3 p -113.7 150.85 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.345 0.593 . . . . 0.0 111.595 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -102.36 96.02 6.67 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.41 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 11.9 pt-20 -145.56 155.02 42.8 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 83.1 m-20 63.74 23.09 13.35 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.205 0.526 . . . . 0.0 110.332 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.12 12.49 60.52 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.872 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -131.2 170.83 14.04 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-O 121.478 0.656 . . . . 0.0 110.043 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -105.95 121.96 45.16 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.442 HG13 HG12 ' A' ' 97' ' ' VAL . 19.1 pt -122.36 146.77 27.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.007 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 26.7 mp0 -105.01 107.78 18.95 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.988 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 12.0 ptpt -118.38 135.2 54.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.422 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.628 ' O ' HG23 ' A' ' 111' ' ' VAL . 80.3 mtt180 -61.59 160.6 11.08 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.688 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -58.84 -43.41 90.73 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.212 -177.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.409 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.7 p90 -75.43 7.44 3.58 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.885 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -118.32 -17.95 9.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.443 0.639 . . . . 0.0 110.037 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 107' ' ' ARG . 89.4 t -73.15 149.18 8.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.198 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.697 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 69.7 mmtt -115.74 168.19 10.26 Favored 'General case' 0 CA--C 1.486 -1.503 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.382 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -77.71 142.05 38.98 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.11 4.2 74.97 Favored Glycine 0 C--N 1.305 -1.144 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -174.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.697 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -74.69 173.43 10.5 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -129.66 167.28 18.22 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.58 0.705 . . . . 0.0 111.604 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.81 159.82 39.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.738 170.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.8 135.54 37.4 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.603 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.9 OUTLIER -106.35 160.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 C--N 1.303 -1.424 0 CA-C-O 121.024 0.44 . . . . 0.0 111.163 -178.109 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 N--CA 1.421 -1.906 0 CA-C-O 121.348 0.594 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.602 ' CD1' ' HG2' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -107.51 133.68 51.64 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -172.161 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 15.0 mt-10 -88.04 145.65 25.87 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.628 175.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.497 HD13 ' CD1' ' A' ' 79' ' ' PHE . 67.6 mt -79.8 105.55 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.773 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.199 173.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 7.1 mmpt? -70.7 -37.43 73.57 Favored 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 114.645 -1.162 . . . . 0.0 110.682 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -149.96 133.42 16.56 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 71.3 mt -112.74 140.05 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.977 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.543 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.9 ptpt -139.82 152.91 46.9 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.171 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.513 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.2 m-85 -97.75 104.6 16.64 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-O 121.806 0.812 . . . . 0.0 108.825 173.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.616 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -108.02 175.77 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.266 -3.034 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.701 -178.378 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.5 ptt85 -80.74 -145.69 0.05 Allowed 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 121.79 0.805 . . . . 0.0 111.443 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -131.4 99.82 4.96 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -46.39 -49.91 17.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.085 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -102.3 170.68 7.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.041 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -88.6 -4.1 58.65 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.096 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -139.81 155.57 47.2 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.622 176.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.81 156.53 30.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 65.4 m-85 -133.55 171.51 14.0 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.487 ' HB2' HD13 ' A' ' 68' ' ' ILE . 70.7 m -160.17 -25.0 0.06 Allowed 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.467 HD22 HD21 ' A' ' 24' ' ' LEU . 9.1 tp 68.17 111.79 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.215 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -87.3 115.77 24.94 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.912 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.488 ' CB ' HG13 ' A' ' 49' ' ' VAL . . . -136.85 -166.72 1.95 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 45.0 mmtt . . . . . 0 CA--C 1.504 -0.789 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.61 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.536 ' HA ' ' O ' ' A' ' 183' ' ' THR . 30.5 t30 . . . . . 0 CA--C 1.51 -0.574 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.496 HG21 HD12 ' A' ' 8' ' ' ILE . 1.4 p -154.23 160.72 2.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.12 0.486 . . . . 0.0 111.307 -177.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.478 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 97.9 mt -96.55 115.64 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.213 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 47.3 pt -123.5 174.49 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.225 -175.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.464 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 2.9 t-20 47.07 -129.39 1.53 Allowed 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.062 0.945 . . . . 0.0 110.673 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.24 48.95 1.65 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.513 0.673 . . . . 0.0 109.847 176.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.603 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 3.7 m-20 68.79 47.19 0.84 Allowed 'General case' 0 CA--C 1.495 -1.145 0 C-N-CA 125.445 1.498 . . . . 0.0 113.171 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 82.5 mt -91.04 115.88 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.589 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.9 m -80.36 158.84 4.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.418 0.627 . . . . 0.0 110.558 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 5.1 t . . . . . 0 C--N 1.294 -1.805 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.488 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 88' ' ' GLU . 20.6 m-85 . . . . . 0 C--O 1.223 -0.335 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.518 ' HD3' HD13 ' A' ' 76' ' ' LEU . 27.8 Cg_endo -62.74 -34.72 72.34 Favored 'Trans proline' 0 N--CA 1.479 0.637 0 C-N-CA 123.2 2.6 . . . . 0.0 112.321 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.503 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 130.36 -39.79 1.76 Allowed Glycine 0 N--CA 1.423 -2.212 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.49 -9.3 8.13 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 121.468 0.651 . . . . 0.0 111.556 176.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.8 m -69.27 129.07 38.77 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.915 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 16.4 mtm180 -84.07 138.22 33.17 Favored 'General case' 0 C--O 1.184 -2.388 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.5 ' HB ' ' CD2' ' A' ' 21' ' ' LEU . 10.0 tt -123.02 131.55 73.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-O 120.83 0.347 . . . . 0.0 110.217 177.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 18' ' ' LYS . 2.2 tm? -90.49 123.81 34.48 Favored 'General case' 0 N--CA 1.405 -2.707 0 CA-C-O 121.619 0.723 . . . . 0.0 110.657 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.5 m -133.08 -174.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.144 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -134.7 123.2 23.32 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.584 HG12 HG13 ' A' ' 47' ' ' ILE . 20.4 mt -122.63 123.28 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 CA-C-O 121.422 0.63 . . . . 0.0 110.358 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.9 36.67 27.74 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.972 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.4 21.14 79.54 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.627 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.4 t -127.54 114.82 21.13 Favored Pre-proline 0 N--CA 1.432 -1.342 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 17.3 Cg_exo -63.32 123.76 12.68 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 122.579 2.186 . . . . 0.0 111.31 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -126.98 136.41 52.22 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.56 ' HZ1' ' HA ' ' A' ' 179' ' ' GLU . 38.0 ttmt -108.55 102.15 11.25 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.627 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 8' ' ' ILE . 2.6 pt -124.18 -171.7 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.132 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.954 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.707 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 17.8 p -95.48 169.78 9.81 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.249 -0.981 . . . . 0.0 110.673 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.5 ' CD2' ' HB ' ' A' ' 8' ' ' ILE . 4.4 mm? -67.74 -23.6 65.27 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.674 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.707 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 3.1 ptm180 -85.9 -24.32 26.67 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.631 ' OE1' HG23 ' A' ' 20' ' ' THR . 49.2 mt-10 -84.84 -42.08 15.43 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.972 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.443 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 30.7 tp -57.44 -42.55 82.64 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 122.042 0.925 . . . . 0.0 109.897 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.738 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.9 m-30 -53.86 -30.73 46.88 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.393 -1.73 . . . . 0.0 113.084 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -74.39 -15.73 60.91 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.347 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.77 6.38 13.12 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.534 0.683 . . . . 0.0 109.775 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.489 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 98.1 m-85 -118.47 165.66 13.63 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.309 -178.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.473 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 3.4 mm-40 -143.97 -173.68 4.06 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.34 175.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 4.1 t70 64.26 86.74 0.12 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.583 0.706 . . . . 0.0 110.359 -179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -104.07 122.25 44.9 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.558 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -111.27 150.31 29.82 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.962 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.413 ' CZ ' ' HA ' ' A' ' 36' ' ' MET . 24.2 t80 -107.44 131.78 53.91 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.421 ' O ' HG22 ' A' ' 37' ' ' VAL . 7.5 tp10 -166.24 141.42 4.59 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.515 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 59.97 22.12 11.2 Favored 'General case' 0 CA--C 1.494 -1.182 0 O-C-N 123.573 0.545 . . . . 0.0 111.367 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.413 ' HA ' ' CZ ' ' A' ' 33' ' ' TYR . 41.7 mtm 72.75 19.52 3.93 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.998 0.811 . . . . 0.0 110.875 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.521 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 6.0 m -131.27 -179.55 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.471 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 88.7 m-85 -116.81 145.22 43.68 Favored 'General case' 0 CA--C 1.482 -1.644 0 CA-C-O 121.387 0.613 . . . . 0.0 110.438 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.8 t -130.23 123.53 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.747 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.581 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 39.5 ttm180 -116.8 126.32 52.9 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -134.62 144.89 48.14 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.595 -175.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' A' ' 43' ' ' PRO . 12.6 tmtt? 86.93 109.61 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.409 0 O-C-N 124.899 1.375 . . . . 0.0 109.989 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 61.5 Cg_endo -78.18 151.97 27.15 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 122.149 1.899 . . . . 0.0 111.615 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.473 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 36.7 mtmt -83.0 -7.4 59.67 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.191 0.519 . . . . 0.0 111.12 -177.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -144.92 -165.41 2.15 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 8.7 tp10 -85.98 101.66 13.1 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.584 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -115.03 117.41 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.966 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.508 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 32.4 mmtt -116.91 168.47 10.2 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 173.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.465 HG12 ' CB ' ' A' ' 169' ' ' ALA . 9.5 p -125.51 128.81 72.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.04 132.16 34.36 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.966 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.41 ' HA ' HG13 ' A' ' 176' ' ' ILE . 21.5 t -139.12 177.15 8.11 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 58' ' ' LYS . 2.7 mm -116.34 141.72 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.342 0.591 . . . . 0.0 110.844 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.743 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 24.7 t70 -80.11 116.31 20.16 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.152 178.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.571 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.2 mm? -73.57 -13.63 61.06 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.177 0.513 . . . . 0.0 112.191 -171.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.743 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -96.85 -26.25 15.16 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.849 -175.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.4 ' CB ' ' HD3' ' A' ' 58' ' ' LYS . 71.4 p -120.69 -25.68 5.44 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.887 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.48 9.18 65.12 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.421 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.463 ' O ' HD12 ' A' ' 52' ' ' ILE . 3.3 mptp? -81.88 159.66 23.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.157 0.583 . . . . 0.0 111.623 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.53 113.95 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 CA-C-O 121.943 0.878 . . . . 0.0 109.904 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -111.1 160.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.972 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.76 142.64 49.37 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.457 HG21 ' CG1' ' A' ' 49' ' ' VAL . 8.8 t -145.17 172.56 12.93 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.439 -177.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.42 161.02 14.82 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.611 0.719 . . . . 0.0 110.867 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.516 ' N ' HD13 ' A' ' 64' ' ' ILE . 2.6 mp -94.59 142.61 13.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.488 -177.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.544 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.6 mm-40 -85.14 -46.28 11.26 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.421 ' O ' HD22 ' A' ' 167' ' ' LEU . 4.2 p-10 -179.84 -168.01 0.1 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.313 178.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 37.5 t -114.07 128.6 70.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.867 -175.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.492 HD11 ' HB2' ' A' ' 166' ' ' SER . 19.9 mt -92.6 102.12 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.1 -176.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.521 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 48.3 tttp -120.95 110.08 15.86 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.615 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.53 141.3 40.73 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.093 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.418 ' HD2' HG12 ' A' ' 37' ' ' VAL . 5.9 Cg_endo -50.43 140.23 35.61 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.469 2.779 . . . . 0.0 112.86 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.26 94.15 2.45 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.16 0.505 . . . . 0.0 110.29 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.9 p -89.01 -70.96 0.62 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.13 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.47 -175.06 5.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.26 0.553 . . . . 0.0 111.775 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.415 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 34.5 m170 -101.48 172.45 6.97 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.082 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.518 HD13 ' HD3' ' A' ' 3' ' ' PRO . 11.1 mt -125.04 142.12 51.69 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.66 0.743 . . . . 0.0 111.807 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.556 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 9.9 mt -87.16 144.6 8.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 8.3 ttt180 -119.46 137.54 53.71 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.128 0.49 . . . . 0.0 109.686 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 86' ' ' SER . 52.4 m-85 -115.35 126.71 54.76 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.603 -178.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 57.6 tt0 -111.66 125.24 53.75 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.558 HD13 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -90.49 158.44 17.03 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.605 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.546 ' HG2' HD12 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -60.4 -18.12 48.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.271 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -90.76 -12.47 36.41 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.794 0.807 . . . . 0.0 109.556 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.41 16.69 39.22 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.88 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.546 ' O ' HD21 ' A' ' 81' ' ' LEU . 2.9 mtt180 -86.13 137.11 32.91 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.3 p -139.81 136.66 34.27 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.046 -1.062 . . . . 0.0 112.565 176.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -132.77 150.75 52.12 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.261 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 73.1 mt-10 -126.95 149.14 49.98 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.478 -176.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.479 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.9 OUTLIER -146.66 161.35 40.75 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.925 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.517 ' HA ' HD22 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -70.89 15.16 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.451 0.7 . . . . 0.0 112.66 -176.481 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.7 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 72.03 -34.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 125.253 1.421 . . . . 0.0 112.93 177.325 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.453 ' OD1' ' HB ' ' A' ' 90' ' ' THR . 6.1 p-10 -84.42 -5.52 59.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.13 0.491 . . . . 0.0 110.238 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 57.7 t-80 -84.45 126.49 69.05 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.799 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 23.0 Cg_exo -65.9 124.14 12.28 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.842 2.362 . . . . 0.0 112.942 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.85 147.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.645 177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.5 tp -101.26 107.38 18.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.984 0.421 . . . . 0.0 111.102 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.592 HG21 ' OD1' ' A' ' 115' ' ' ASP . 1.6 p -113.29 147.78 16.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.549 0.69 . . . . 0.0 111.87 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -105.2 93.12 4.51 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.046 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.536 ' CD ' ' HZ2' ' A' ' 106' ' ' LYS . 8.1 pt-20 -137.68 159.52 41.75 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.0 m-20 63.27 21.43 12.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.327 0.584 . . . . 0.0 109.753 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.45 16.23 62.63 Favored Glycine 0 N--CA 1.436 -1.367 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.326 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -135.93 172.91 12.33 Favored 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 117.859 0.829 . . . . 0.0 109.844 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -100.55 120.45 40.04 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.523 HD13 ' CG ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -123.16 148.12 27.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.209 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -104.99 110.52 22.96 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.414 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.536 ' HZ2' ' CD ' ' A' ' 99' ' ' GLU . 77.7 mttt -117.76 134.74 54.6 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.576 ' O ' HG22 ' A' ' 111' ' ' VAL . 4.4 mpt_? -60.73 164.13 4.96 Favored 'General case' 0 C--O 1.215 -0.725 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.7 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -62.04 -41.32 97.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 118.955 -1.098 . . . . 0.0 109.539 -178.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.445 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.1 p90 -73.32 -2.63 22.83 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.691 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.464 ' HB3' ' N ' ' A' ' 107' ' ' ARG . 49.3 tp10 -109.68 -15.28 14.19 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.565 0.697 . . . . 0.0 109.988 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 107' ' ' ARG . 79.3 t -82.46 148.76 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.684 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 30.7 mttt -125.65 165.63 18.21 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.035 0.445 . . . . 0.0 111.129 -176.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.83 141.19 58.86 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.928 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.3 4.1 77.85 Favored Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.988 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.684 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -77.55 168.3 20.21 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.407 ' HE3' ' HG3' ' A' ' 150' ' ' GLU . 32.0 mttp -121.41 167.98 12.19 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 121.363 0.601 . . . . 0.0 111.149 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.58 159.96 39.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.993 170.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.48 133.11 35.78 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.734 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.7 OUTLIER -102.04 157.7 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.497 ' HB3' HD21 ' A' ' 180' ' ' ASN . 43.9 t . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 120.893 0.378 . . . . 0.0 110.953 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.415 -2.18 0 CA-C-O 121.227 0.537 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.558 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -111.15 135.83 51.1 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.822 -172.836 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.407 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 23.9 mt-10 -90.52 147.41 23.39 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.448 1.118 . . . . 0.0 112.557 175.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.435 HG21 ' CG1' ' A' ' 154' ' ' ILE . 74.9 mt -79.01 110.03 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.648 0 CA-C-N 113.355 -1.748 . . . . 0.0 110.607 176.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 80' ' ' GLU . 29.7 mtmt -63.48 -46.69 85.02 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.748 175.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -150.6 135.69 17.68 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 76.5 mt -118.92 130.72 73.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.981 176.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.509 ' HD3' HG12 ' A' ' 157' ' ' VAL . 3.3 ptpp? -134.23 163.51 29.46 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.57 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.556 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.8 m-85 -101.34 120.36 40.14 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.844 175.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.509 HG12 ' HD3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -131.56 174.45 13.12 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.603 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.983 -177.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -104.65 163.85 12.19 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.345 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.06 126.31 29.41 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.859 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -71.11 -40.55 71.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.372 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.19 176.33 6.27 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -95.59 -2.29 48.64 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.405 0.621 . . . . 0.0 110.12 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -136.84 154.91 50.39 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.45 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.32 151.46 20.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.738 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 9.8 m-85 -134.67 164.42 27.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.19 -170.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.492 ' HB2' HD11 ' A' ' 68' ' ' ILE . 74.5 m -158.55 -18.03 0.07 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.275 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.489 HD21 ' CE1' ' A' ' 25' ' ' TYR . 2.1 tm? 60.04 106.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.917 0.865 . . . . 0.0 111.462 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.407 HD22 ' CG ' ' A' ' 66' ' ' ASP . 2.2 p-10 -90.33 125.26 35.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.856 0.836 . . . . 0.0 112.291 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.544 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -140.98 -130.06 0.1 Allowed 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.132 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.436 ' CB ' HG23 ' A' ' 62' ' ' THR . 81.0 tttt . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 CA--C 1.519 -0.218 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.478 HG22 HD13 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -152.88 165.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-O 121.401 0.619 . . . . 0.0 112.322 -175.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.579 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.8 mt -105.74 117.43 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.059 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.459 HG22 HG12 ' A' ' 175' ' ' VAL . 44.7 pt -122.84 172.58 9.93 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.811 -176.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 7.4 t-20 48.99 -131.48 1.76 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.683 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.56 ' HA ' ' HZ1' ' A' ' 18' ' ' LYS . 14.1 mm-40 -90.67 57.82 3.71 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.155 0.979 . . . . 0.0 109.502 176.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.734 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 6.2 m-20 68.03 48.83 0.93 Allowed 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.071 -1.877 . . . . 0.0 113.686 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.1 mt -90.03 113.91 26.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.932 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.67 126.61 40.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.156 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.308 -1.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.115 177.164 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.498 ' CE1' HD13 ' A' ' 177' ' ' ILE . 2.8 m-85 . . . . . 0 N--CA 1.443 -0.785 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.508 ' HD3' HD13 ' A' ' 76' ' ' LEU . 18.3 Cg_endo -59.48 -77.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.299 1.999 . . . . 0.0 109.997 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.415 ' H ' ' HG2' ' A' ' 3' ' ' PRO . . . 179.73 -28.6 0.05 OUTLIER Glycine 0 N--CA 1.414 -2.78 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 176.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -67.18 -7.53 24.35 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.283 0.563 . . . . 0.0 111.584 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 23.9 m -67.7 130.22 42.32 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 19.3 mtm180 -84.55 133.88 34.43 Favored 'General case' 0 C--O 1.183 -2.442 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.561 HD11 HG21 ' A' ' 175' ' ' VAL . 10.1 tt -121.45 130.55 74.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 C-N-CA 122.736 0.415 . . . . 0.0 110.098 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.438 HD11 ' N ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -87.08 123.94 32.7 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 121.424 0.63 . . . . 0.0 109.597 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.438 ' N ' HD11 ' A' ' 9' ' ' LEU . 28.2 m -135.41 -179.31 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.595 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.413 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 29.2 tt0 -129.95 122.32 28.31 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.883 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 18.2 mt -121.83 122.68 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.009 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.553 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.0 t0 55.66 37.39 28.81 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.764 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.39 16.08 78.89 Favored Glycine 0 C--N 1.309 -0.945 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.71 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.5 t -121.8 119.51 28.98 Favored Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 36.2 Cg_endo -71.29 128.0 14.09 Favored 'Trans proline' 0 N--CA 1.431 -2.172 0 C-N-CA 122.111 1.874 . . . . 0.0 110.324 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -129.91 141.55 50.78 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -109.11 100.76 9.88 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -122.16 -173.16 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.181 -2.51 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.105 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.717 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 9.7 p -96.1 170.64 9.13 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.66 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.3 mm? -67.59 -27.11 66.64 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.445 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.717 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 6.6 ptm180 -84.06 -22.77 31.12 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HG2' ' HG1' ' A' ' 20' ' ' THR . 10.2 mm-40 -85.32 -42.27 14.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.819 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 19' ' ' ILE . 27.5 tp -58.26 -44.21 88.28 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.967 0.889 . . . . 0.0 109.884 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.683 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.4 m-30 -55.35 -29.37 58.24 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 113.553 -1.658 . . . . 0.0 113.486 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 10.7 mm-40 -79.06 -11.75 60.0 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.02 -175.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.29 6.7 11.23 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.349 0.595 . . . . 0.0 109.528 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 97.6 m-85 -118.68 164.96 14.57 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.885 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.555 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 30.2 mt-10 -137.53 -172.86 3.33 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.575 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 2.5 t70 61.75 83.66 0.15 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.479 0.657 . . . . 0.0 111.082 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -99.0 122.42 42.24 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.536 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -113.59 150.57 32.88 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.342 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.489 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 28.1 t80 -106.87 129.62 54.68 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.316 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 7.6 tp10 -167.46 142.27 3.83 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.696 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.435 ' ND2' ' HG3' ' A' ' 34' ' ' GLU . 51.9 m-80 58.29 23.17 10.12 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 123.478 0.486 . . . . 0.0 111.457 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.489 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 43.8 mtm 72.24 18.66 4.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.814 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.469 HG13 ' HD2' ' A' ' 71' ' ' PRO . 4.3 m -129.37 179.92 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.406 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 81.1 m-85 -118.36 142.02 47.95 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.31 0.576 . . . . 0.0 110.278 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.36 123.77 60.66 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.928 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.585 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 40.9 ttm180 -115.06 126.55 54.83 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -134.2 146.73 50.42 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.98 -174.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 54.5 tptt 83.2 112.62 0.03 OUTLIER Pre-proline 0 C--N 1.318 -0.799 0 O-C-N 124.902 1.376 . . . . 0.0 110.868 -177.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 59.4 Cg_endo -78.79 152.26 25.22 Favored 'Trans proline' 0 N--CA 1.426 -2.482 0 C-N-CA 121.877 1.718 . . . . 0.0 111.4 177.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.555 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 36.2 mtmt -80.87 -6.23 58.36 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.796 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -147.09 -165.77 2.33 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 5.2 tp10 -86.21 100.07 11.99 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.524 HG13 HG12 ' A' ' 12' ' ' ILE . 1.3 mp -115.47 117.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.428 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 34.8 mmtp -119.91 166.66 13.02 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.689 174.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.406 HG12 ' CB ' ' A' ' 169' ' ' ALA . 13.7 p -120.42 127.07 75.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.111 0.481 . . . . 0.0 112.186 -174.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' A' ' 11' ' ' GLN . 6.5 m-85 -80.56 123.14 27.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.65 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.0 p -133.27 176.92 8.09 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.271 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.469 HG12 HD11 ' A' ' 176' ' ' ILE . 2.4 mm -122.96 140.26 47.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.248 0.547 . . . . 0.0 110.024 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -78.17 119.34 21.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.58 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -72.01 -14.0 61.77 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.106 0.479 . . . . 0.0 111.902 -171.591 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -99.41 -28.35 13.31 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.914 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.494 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.4 p -117.2 -26.24 6.84 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.728 -175.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.82 12.7 68.31 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.332 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.494 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 17.1 mtpp -85.97 158.01 19.99 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.64 109.33 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.368 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.3 m -112.58 157.93 13.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.085 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 tp -122.29 135.77 54.79 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -137.83 172.88 12.28 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.669 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.08 161.03 16.0 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.224 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.492 HD11 ' N ' ' A' ' 64' ' ' ILE . 2.9 mp -96.34 144.62 10.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.304 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.464 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 48.5 mm-40 -91.07 -41.5 11.02 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -179.96 178.63 0.59 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.896 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 9.4 t -109.9 129.23 65.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.699 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.5 mt -97.19 102.3 13.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.826 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 45.5 tttp -116.87 107.73 14.97 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.84 137.24 30.47 Favored Pre-proline 0 C--N 1.31 -1.141 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.154 -176.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.469 ' HD2' HG13 ' A' ' 37' ' ' VAL . 80.9 Cg_exo -47.89 124.14 9.53 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 123.424 2.749 . . . . 0.0 113.116 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.46 80.01 8.74 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.948 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.6 m -86.91 -24.68 24.74 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.336 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -101.91 -179.7 4.08 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.042 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.441 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 59.5 m170 -111.37 172.31 6.96 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.426 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.587 ' CD1' ' HA ' ' A' ' 159' ' ' ALA . 22.4 mt -123.78 146.71 48.13 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.856 0.836 . . . . 0.0 111.972 -173.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.47 HD13 ' C ' ' A' ' 108' ' ' ALA . 19.9 mt -88.77 143.05 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.195 173.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 37.2 ttt-85 -120.76 138.96 53.73 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-O 121.331 0.586 . . . . 0.0 109.426 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 86' ' ' SER . 54.0 m-85 -116.05 126.44 53.78 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.038 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 152' ' ' LYS . 31.3 tt0 -109.2 122.68 47.83 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.561 HD13 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.02 154.07 20.78 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.643 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.616 ' HA ' ' HG3' ' A' ' 152' ' ' LYS . 5.2 pt-20 -57.21 -22.43 40.72 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.038 0.535 . . . . 0.0 111.943 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.28 -11.09 55.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.005 0.907 . . . . 0.0 109.111 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.28 14.93 46.29 Favored Glycine 0 N--CA 1.434 -1.451 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.918 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.518 ' O ' HD22 ' A' ' 81' ' ' LEU . 1.5 mtt180 -85.63 139.21 31.59 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 30.5 p -140.02 143.51 36.46 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.11 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -139.49 155.11 47.76 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.373 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 23.7 mt-10 -128.45 151.91 48.84 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.928 -176.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.419 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -148.33 160.54 42.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.867 178.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.575 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -71.55 13.81 0.23 Allowed 'General case' 0 C--N 1.353 0.738 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -175.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.692 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.8 OUTLIER 68.14 -39.32 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 124.681 1.192 . . . . 0.0 113.691 176.11 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -79.68 2.47 22.52 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.803 0.335 . . . . 0.0 111.317 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 50.4 m170 -115.13 143.47 30.29 Favored Pre-proline 0 C--N 1.313 -1.016 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.885 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 15.4 Cg_exo -69.05 140.14 44.53 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.561 2.841 . . . . 0.0 115.25 -175.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 20.6 t -112.15 149.55 14.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 125.285 1.434 . . . . 0.0 107.211 175.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.8 tp -107.59 111.66 24.02 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.485 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.689 HG21 ' OD1' ' A' ' 115' ' ' ASP . 1.8 p -111.47 150.18 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.424 0.63 . . . . 0.0 112.167 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.631 ' CD2' HD12 ' A' ' 148' ' ' LEU . 71.7 t80 -103.31 93.37 4.94 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.256 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.8 pt-20 -135.94 154.94 50.96 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 38.7 m-80 62.26 22.98 13.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.086 0.469 . . . . 0.0 110.394 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.84 13.96 62.31 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.058 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -130.51 171.34 13.12 Favored 'General case' 0 N--CA 1.399 -2.987 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -104.35 121.13 42.73 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.512 HG13 HG13 ' A' ' 97' ' ' VAL . 28.7 pt -121.61 142.42 37.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.995 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.3 OUTLIER -106.16 111.55 24.21 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.008 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.435 ' HG3' HG21 ' A' ' 111' ' ' VAL . 12.6 ptpt -125.24 144.54 50.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.915 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.598 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 64.9 mtt180 -64.85 160.67 19.87 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.692 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -59.95 -41.54 92.08 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.413 -176.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.453 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.8 p90 -74.29 1.73 10.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.824 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -112.9 -13.91 13.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.827 0.822 . . . . 0.0 109.701 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 107' ' ' ARG . 98.9 t -76.79 150.0 6.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.689 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -123.89 166.16 16.14 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 120.606 0.241 . . . . 0.0 110.824 -177.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.61 141.94 51.7 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.17 4.7 77.5 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.638 -175.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.689 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 1.7 t0 -78.5 166.56 22.45 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.412 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 35.1 mttp -120.01 168.68 10.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.79 0.805 . . . . 0.0 111.459 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.62 160.35 37.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 169.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 182' ' ' VAL . 1.1 tt -90.31 122.18 32.98 Favored 'General case' 0 N--CA 1.395 -3.189 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.226 177.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.688 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.0 OUTLIER -104.82 128.76 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 173.642 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.8 t . . . . . 0 C--N 1.304 -1.39 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.544 -177.209 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.631 HD12 ' CD2' ' A' ' 98' ' ' TYR . 13.8 mt . . . . . 0 N--CA 1.428 -1.553 0 CA-C-O 121.709 0.766 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.604 ' CD1' ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -111.36 135.97 51.15 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.07 -172.696 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.412 ' HG3' ' CG ' ' A' ' 116' ' ' LYS . 11.3 mt-10 -91.56 147.33 23.09 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.497 175.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.543 HD11 ' CD1' ' A' ' 79' ' ' PHE . 75.4 mt -78.29 106.93 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.594 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.844 176.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.616 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 34.4 mmtm -70.27 -39.58 74.87 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.856 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -150.94 132.46 14.74 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 71.8 mt -111.76 143.98 20.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.791 176.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.4 ptpt -146.77 159.83 43.01 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.398 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -100.26 114.9 28.71 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.441 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.3 OUTLIER -126.98 175.5 8.84 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.751 -179.073 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.412 ' C ' ' H ' ' A' ' 160' ' ' ASN . 35.8 ttt180 -99.64 154.33 18.36 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.81 -0.556 . . . . 0.0 111.443 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.56 3.11 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 158' ' ' ARG . 13.2 t-20 66.78 -54.41 0.44 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.81 -175.1 2.7 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -99.67 9.57 42.88 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.181 0.515 . . . . 0.0 110.021 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -141.19 155.37 46.07 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.989 176.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.4 m -124.85 154.15 32.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.683 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 8.3 m-85 -131.73 163.04 29.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.1 -172.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -159.09 -16.11 0.07 Allowed 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.829 176.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.415 HD21 ' CE1' ' A' ' 25' ' ' TYR . 2.8 tm? 62.64 112.12 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.333 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -87.3 114.57 24.03 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.738 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -126.14 -156.16 0.72 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm . . . . . 0 C--N 1.31 -1.114 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.055 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 CA--C 1.514 -0.405 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 8' ' ' ILE . 5.2 p -149.02 166.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 121.557 0.694 . . . . 0.0 111.906 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.557 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 81.0 mt -97.57 114.08 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.136 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.498 HD13 ' CE1' ' A' ' 2' ' ' PHE . 45.0 pt -118.89 174.85 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-O 120.978 0.418 . . . . 0.0 111.649 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 44.66 -123.18 0.95 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.13 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -99.57 64.92 1.33 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.822 0.82 . . . . 0.0 108.928 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.688 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 7.8 m120 68.65 38.92 2.14 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 113.537 -1.665 . . . . 0.0 114.339 176.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 99.1 mt -88.31 113.52 25.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 118' ' ' LEU . 2.5 m -83.68 158.2 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--N 1.29 -1.996 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.997 -176.8 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.49 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 30.9 m-85 . . . . . 0 N--CA 1.437 -1.082 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.463 ' HD3' HD13 ' A' ' 76' ' ' LEU . 14.9 Cg_endo -56.42 -27.46 68.17 Favored 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 123.418 2.746 . . . . 0.0 112.771 -177.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.463 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 125.21 -39.38 2.09 Favored Glycine 0 N--CA 1.417 -2.626 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.6 -11.14 60.6 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.697 0.76 . . . . 0.0 111.176 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 55.2 m -60.72 131.12 49.68 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.687 177.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.0 mmt180 -86.26 132.38 34.0 Favored 'General case' 0 C--O 1.185 -2.3 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.532 ' HB ' ' CD2' ' A' ' 21' ' ' LEU . 11.6 tt -119.64 130.57 73.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 CA-C-O 120.862 0.363 . . . . 0.0 110.111 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.467 HD11 ' N ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -88.46 125.35 34.7 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-O 121.452 0.644 . . . . 0.0 109.959 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.6 m -135.15 177.8 6.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.504 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -126.89 119.67 27.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.23 0.538 . . . . 0.0 109.875 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.553 HG12 HG13 ' A' ' 47' ' ' ILE . 12.5 mt -118.43 120.18 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.701 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.788 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 54.69 37.93 29.14 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.15 -1.387 . . . . 0.0 109.824 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 18.26 79.52 Favored Glycine 0 C--N 1.3 -1.47 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.609 -177.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.04 119.22 26.62 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 48.0 Cg_endo -73.31 122.05 7.67 Favored 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 122.534 2.156 . . . . 0.0 111.468 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -124.41 141.74 51.84 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.711 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -107.94 101.28 10.56 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.025 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 8' ' ' ILE . 3.0 pt -123.63 -175.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.681 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.735 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 9.6 p -90.28 173.54 8.08 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.727 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.2 mm? -69.24 -26.91 65.02 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.395 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.735 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.7 ptm180 -84.8 -24.91 28.5 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.572 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 39.2 mt-10 -82.98 -39.4 21.39 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.977 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.453 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 16.2 tp -57.82 -42.18 83.76 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.089 0.947 . . . . 0.0 108.7 176.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -53.71 -31.23 47.29 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.216 -1.811 . . . . 0.0 112.594 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.9 mt-10 -76.0 -17.82 59.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -78.89 2.29 20.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.732 0.777 . . . . 0.0 109.429 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.463 ' C ' ' HD3' ' A' ' 40' ' ' ARG . 96.0 m-85 -117.91 162.24 18.46 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.602 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.7 -173.84 3.99 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.175 176.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 t70 63.47 81.36 0.21 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.248 0.547 . . . . 0.0 110.159 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -106.42 134.18 49.96 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 122.088 0.946 . . . . 0.0 111.465 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.402 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.2 ptt180 -122.54 154.44 37.9 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.557 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -105.57 124.94 50.38 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -160.89 137.66 8.77 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.476 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 61.7 23.12 13.5 Favored 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 123.579 0.55 . . . . 0.0 110.918 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.1 mtt 75.6 13.82 2.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.064 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.458 HG11 ' HD2' ' A' ' 71' ' ' PRO . 5.1 m -129.64 -179.71 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -115.55 140.46 49.14 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.127 0.489 . . . . 0.0 109.823 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.402 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.2 t -129.49 123.29 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.093 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.463 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 16.7 ttm180 -112.71 126.75 55.74 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -131.65 146.08 52.0 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.654 -174.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 27.5 tptp 80.68 113.08 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.438 0 O-C-N 124.531 1.145 . . . . 0.0 111.396 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 56.9 Cg_endo -78.02 155.94 30.15 Favored 'Trans proline' 0 N--CA 1.435 -1.918 0 C-N-CA 122.208 1.939 . . . . 0.0 111.974 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -86.97 -3.46 59.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.349 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -147.3 -164.8 2.09 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 6.0 tp10 -84.5 98.25 10.01 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.553 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -117.34 116.02 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.835 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -116.43 167.52 10.97 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.356 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -116.05 121.53 67.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 121.714 0.769 . . . . 0.0 112.097 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.526 ' CD2' HD11 ' A' ' 176' ' ' ILE . 65.8 t80 -76.1 110.27 10.44 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.643 177.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -134.22 176.52 8.52 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.738 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.438 HG12 HD12 ' A' ' 176' ' ' ILE . 4.3 mm -121.18 144.17 31.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.267 0.556 . . . . 0.0 110.922 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.626 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 19.4 t70 -81.52 120.98 25.73 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.298 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.565 ' H ' HD23 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -74.91 -12.24 60.31 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -170.488 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.626 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.7 pt-20 -104.33 -27.12 12.17 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.2 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.522 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 72.2 p -115.18 -24.95 8.26 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.578 -176.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.69 70.53 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.045 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.522 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 40.2 mttt -85.47 163.74 18.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.5 HG12 ' CE1' ' A' ' 50' ' ' TYR . 90.4 t -88.62 111.43 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.162 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.9 146.71 14.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.299 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.1 tp -120.12 138.59 53.48 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 t -150.54 171.35 17.22 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 120.753 0.311 . . . . 0.0 110.868 -177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.45 161.12 25.06 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.574 0.702 . . . . 0.0 111.169 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.467 ' N ' HD13 ' A' ' 64' ' ' ILE . 2.2 mp -101.06 135.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.887 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.503 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 17.3 mt-10 -81.1 -39.62 25.37 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 p30 179.65 175.49 0.74 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.458 -175.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.0 t -105.8 131.71 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.867 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 57.6 mt -91.53 105.8 16.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.267 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.1 tttt -119.87 108.16 14.02 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.25 138.62 33.25 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.343 -175.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.458 ' HD2' HG11 ' A' ' 37' ' ' VAL . 75.1 Cg_exo -48.54 134.09 26.51 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 123.274 2.649 . . . . 0.0 112.608 177.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.73 95.6 3.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.391 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.7 p -92.76 -54.33 3.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.322 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.71 -179.92 6.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.918 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -100.9 170.71 8.12 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 90' ' ' THR . 17.1 mt -115.23 131.35 56.96 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.504 0.669 . . . . 0.0 112.062 -175.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.577 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 19.5 mt -82.82 141.84 14.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 24.5 ttt-85 -117.11 136.93 52.63 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-O 121.17 0.509 . . . . 0.0 109.769 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 86' ' ' SER . 56.1 m-85 -116.01 127.53 54.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.7 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 152' ' ' LYS . 43.7 tt0 -111.97 128.27 56.12 Favored 'General case' 0 CA--C 1.472 -2.051 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.569 HD13 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -91.09 157.65 17.11 Favored 'General case' 0 C--N 1.269 -2.915 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.576 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.552 ' HG2' ' CD1' ' A' ' 149' ' ' LEU . 2.3 pt-20 -63.88 -14.5 53.87 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.569 0.7 . . . . 0.0 111.07 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -92.81 -9.45 40.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.264 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.14 14.59 54.14 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.217 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.519 ' O ' HD23 ' A' ' 81' ' ' LEU . 3.0 mtt180 -86.34 141.8 28.95 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 26.1 p -141.69 146.52 36.19 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.488 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -141.58 150.21 41.76 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.635 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 29.3 mt-10 -121.85 145.83 47.69 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.351 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.6 p -144.12 157.22 44.44 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.731 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.684 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 0.4 OUTLIER -75.46 9.26 2.26 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -175.583 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.716 ' O ' ' HB3' ' A' ' 107' ' ' ARG . 1.6 t 76.17 -42.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 O-C-N 123.503 0.502 . . . . 0.0 111.274 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 90' ' ' THR . 2.0 t70 -63.37 -20.53 65.6 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 123.764 0.826 . . . . 0.0 110.888 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -103.31 129.56 25.27 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.786 -176.416 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 25.3 Cg_exo -65.18 142.82 75.38 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.623 2.882 . . . . 0.0 114.486 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 17.4 t -105.34 146.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.169 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.43 ' CD1' ' HG3' ' A' ' 105' ' ' GLU . 32.4 tp -98.47 106.99 19.35 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.526 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.537 HG13 HG13 ' A' ' 104' ' ' ILE . 1.7 p -108.74 145.8 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 121.475 0.655 . . . . 0.0 111.55 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.533 ' CD2' HD13 ' A' ' 148' ' ' LEU . 86.3 t80 -104.0 91.74 4.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.209 178.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.509 ' CG ' HD13 ' A' ' 104' ' ' ILE . 9.1 pt-20 -138.87 155.94 47.7 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 32.4 m-80 65.98 22.61 11.24 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.355 0.597 . . . . 0.0 110.02 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.72 13.96 64.38 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.931 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -136.23 171.28 14.7 Favored 'General case' 0 N--CA 1.401 -2.925 0 CA-C-O 121.258 0.551 . . . . 0.0 110.24 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -101.92 121.28 41.82 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.084 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.537 HG13 HG13 ' A' ' 97' ' ' VAL . 16.1 pt -127.61 145.11 35.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.926 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 8.4 mp0 -106.46 115.13 29.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.079 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.446 ' HG3' HG23 ' A' ' 111' ' ' VAL . 12.7 ptpt -128.31 141.71 51.35 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.894 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.716 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 99.8 mtt180 -61.47 165.73 4.58 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 119.404 -0.331 . . . . 0.0 110.635 -176.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.648 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -62.67 -40.27 96.55 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.47 -173.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -72.71 -7.53 50.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.868 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -102.75 -17.01 15.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.716 0.769 . . . . 0.0 109.175 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 107' ' ' ARG . 69.4 t -77.42 150.41 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.487 ' HE3' ' H ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -124.27 163.69 21.12 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.106 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.82 142.95 56.0 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.57 4.54 76.31 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.584 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.515 ' HB3' HD13 ' A' ' 151' ' ' ILE . 18.4 t70 -71.95 164.4 26.16 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' A' ' 148' ' ' LEU . 24.2 mttt -122.55 154.67 37.6 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-O 121.568 0.699 . . . . 0.0 110.753 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.25 159.65 34.75 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.93 129.58 35.59 Favored 'General case' 0 N--CA 1.399 -3.014 0 C-N-CA 119.394 -0.923 . . . . 0.0 108.679 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.737 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -113.42 132.89 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.153 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.34 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 C--N 1.308 -1.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.956 -179.088 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.533 HD13 ' CD2' ' A' ' 98' ' ' TYR . 12.4 mt . . . . . 0 N--CA 1.421 -1.898 0 CA-C-O 121.215 0.531 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.569 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -113.68 136.74 52.51 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.946 -173.312 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.403 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 28.4 mt-10 -90.22 147.2 23.7 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.126 176.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 115' ' ' ASP . 81.3 mt -79.46 112.64 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.012 175.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.579 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 4.9 mmpt? -76.89 -39.81 49.63 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.642 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -148.26 131.55 16.52 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -175.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 86.7 mt -114.26 148.32 17.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.754 174.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -154.33 162.03 41.41 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.708 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.577 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 15.8 m-85 -101.72 116.9 33.75 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.39 133.16 64.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.371 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.43 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 60.3 ttt180 -68.85 161.24 29.02 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.167 0.508 . . . . 0.0 111.726 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.43 ' N ' ' HG2' ' A' ' 158' ' ' ARG . . . -70.4 120.08 15.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.77 -32.76 73.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.833 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -110.9 -173.9 2.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.484 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -100.51 0.03 38.76 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 120.858 0.361 . . . . 0.0 111.413 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -138.98 159.42 42.19 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.443 HG13 ' HA ' ' A' ' 3' ' ' PRO . 6.3 m -132.39 161.41 41.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.921 177.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.639 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 76.2 m-85 -134.56 173.0 12.14 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.461 ' HB2' HD12 ' A' ' 68' ' ' ILE . 69.8 m -158.76 -24.68 0.08 Allowed 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.453 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 1.4 tm? 68.5 111.01 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.253 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -92.65 115.71 28.35 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.99 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.503 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.38 -146.57 0.33 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 23.4 tptm . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.761 0.315 . . . . 0.0 110.309 -179.681 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.0 t30 . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.508 HG23 HD12 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -141.21 167.15 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.34 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.577 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.0 mt -105.7 117.53 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.73 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.456 HD11 ' CE1' ' A' ' 2' ' ' PHE . 44.7 pt -122.27 170.09 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.448 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 48.59 -132.94 1.48 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 124.036 0.934 . . . . 0.0 110.318 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.95 53.87 2.56 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.35 0.595 . . . . 0.0 110.233 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.737 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.7 m120 69.88 44.4 0.83 Allowed 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.887 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 91.7 mt -87.38 116.83 30.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.426 HG23 HG12 ' A' ' 176' ' ' ILE . 59.1 t -94.05 130.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.478 -175.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.516 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 15.1 t . . . . . 0 C--N 1.31 -1.132 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.532 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.674 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 84.6 m . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.068 0.461 . . . . 0.0 111.559 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -126.46 162.06 48.82 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.534 ' HD3' HD12 ' A' ' 76' ' ' LEU . 57.8 Cg_endo -67.21 161.77 41.47 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.561 1.507 . . . . 0.0 109.212 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.512 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.56 -26.21 64.28 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 119.212 -1.471 . . . . 0.0 110.712 175.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.74 -26.17 44.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.468 0.707 . . . . 0.0 112.264 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 20' ' ' THR . 31.8 m -64.77 123.99 20.8 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.352 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.673 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 45.6 mtm-85 -81.42 128.23 33.64 Favored 'General case' 0 C--O 1.184 -2.364 0 C-N-CA 123.195 0.598 . . . . 0.0 109.878 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 19' ' ' ILE . 13.6 tt -112.48 130.34 66.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 122.193 -0.317 . . . . 0.0 110.332 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -85.13 123.77 31.03 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.52 0.676 . . . . 0.0 109.784 177.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.485 ' N ' HD13 ' A' ' 9' ' ' LEU . 24.8 m -136.41 -179.42 2.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.62 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.492 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 33.0 tt0 -130.16 119.58 23.21 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.567 HG12 HG13 ' A' ' 47' ' ' ILE . 11.8 mt -120.45 122.66 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.527 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.786 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 55.34 38.33 30.17 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.807 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.21 22.19 78.51 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.131 -0.94 . . . . 0.0 113.223 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.71 119.92 21.6 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-O 121.11 0.481 . . . . 0.0 109.941 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.503 ' HB2' HD21 ' A' ' 124' ' ' LEU . 57.2 Cg_endo -72.8 126.14 11.1 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 122.486 2.124 . . . . 0.0 111.52 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -129.48 140.59 51.23 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.457 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.515 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 26.6 ttpt -110.42 101.5 10.2 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 8' ' ' ILE . 10.9 pt -139.75 136.86 39.51 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.25 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.711 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 4.5 p -40.02 148.95 0.07 Allowed 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.015 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 51.1 mt -60.15 -25.06 65.22 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.874 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.711 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 7.4 ptm180 -78.08 -28.03 48.69 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.509 ' HA ' ' OE2' ' A' ' 26' ' ' GLU . 60.8 mt-10 -85.29 -48.67 8.85 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.278 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.441 ' HG ' HG23 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -50.94 -51.37 52.94 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.561 0.696 . . . . 0.0 109.887 175.066 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.412 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -45.42 -34.17 2.97 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.322 -1.308 . . . . 0.0 113.598 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.509 ' OE2' ' HA ' ' A' ' 23' ' ' GLU . 30.3 mt-10 -69.68 -18.47 63.56 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.71 1.86 18.65 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.568 0.699 . . . . 0.0 109.836 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.565 ' CZ ' HG23 ' A' ' 47' ' ' ILE . 99.2 m-85 -118.96 160.86 21.2 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.765 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -143.95 -172.15 3.69 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.942 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.453 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.4 t70 63.36 82.36 0.18 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.574 0.702 . . . . 0.0 110.329 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -99.22 129.36 45.45 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.388 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.478 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.4 ptt180 -118.28 152.8 35.05 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.172 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.435 ' HD1' ' O ' ' A' ' 37' ' ' VAL . 3.4 t80 -104.6 123.88 48.35 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.477 ' HG2' ' ND2' ' A' ' 35' ' ' ASN . 36.9 tt0 -167.0 146.73 5.43 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.302 -174.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.477 ' ND2' ' HG2' ' A' ' 34' ' ' GLU . 0.9 OUTLIER 62.5 18.61 10.56 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 123.421 0.451 . . . . 0.0 110.547 177.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.6 mtt 71.12 15.93 6.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.013 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.435 ' O ' ' HD1' ' A' ' 33' ' ' TYR . 27.1 m -130.47 -173.34 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.83 140.26 50.25 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.219 0.533 . . . . 0.0 109.968 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.478 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.3 t -127.72 123.67 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.456 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.008 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.443 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 13.2 ttm180 -111.22 126.96 55.42 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.38 147.3 52.38 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.386 -175.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 8.2 tmtm? 84.24 109.87 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.484 0 O-C-N 124.426 1.079 . . . . 0.0 110.637 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.57 149.43 23.93 Favored 'Trans proline' 0 N--CA 1.435 -1.917 0 C-N-CA 122.252 1.968 . . . . 0.0 111.25 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.488 ' HE2' ' O ' ' A' ' 26' ' ' GLU . 1.5 mtmt -85.66 -2.75 58.5 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.204 0.526 . . . . 0.0 111.118 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -144.32 -165.82 2.22 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.0 tp10 -87.18 103.39 15.37 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 175.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.567 HG13 HG12 ' A' ' 12' ' ' ILE . 1.4 mp -119.09 121.42 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.889 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 37.7 mmtt -118.43 169.51 9.7 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.077 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.501 HG11 ' CB ' ' A' ' 169' ' ' ALA . 14.6 p -128.17 133.92 66.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.326 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.524 ' CD1' HD11 ' A' ' 9' ' ' LEU . 31.5 m-85 -83.71 123.15 29.54 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.915 176.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.9 t -127.66 174.61 8.94 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.501 HG12 HD13 ' A' ' 176' ' ' ILE . 1.2 mm -125.27 141.94 43.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.583 0.706 . . . . 0.0 111.501 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.661 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 32.8 t70 -90.87 115.25 27.77 Favored 'General case' 0 C--O 1.194 -1.842 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.569 ' H ' HD11 ' A' ' 54' ' ' LEU . 4.8 mp -67.16 -33.56 75.67 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 121.848 0.832 . . . . 0.0 111.665 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.661 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -73.72 -30.92 63.11 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.773 -174.05 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.401 ' CB ' ' HD2' ' A' ' 58' ' ' LYS . 64.7 p -113.22 -22.01 10.69 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.179 -177.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 53' ' ' ASP . . . 81.18 18.07 70.26 Favored Glycine 0 N--CA 1.431 -1.633 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.492 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.498 ' C ' HD13 ' A' ' 52' ' ' ILE . 26.2 mttp -98.12 157.46 16.13 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.82 112.01 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.255 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.2 m -110.74 165.46 6.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.651 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.9 tp -120.69 140.28 51.84 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.1 t -143.49 171.59 13.94 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.013 0.435 . . . . 0.0 111.22 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.69 160.93 19.43 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.262 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.477 HD12 ' N ' ' A' ' 64' ' ' ILE . 3.0 mp -97.47 143.05 13.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.141 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.404 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 79.2 mm-40 -91.13 -38.76 12.54 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 176.93 175.48 0.37 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.788 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.3 t -105.69 130.2 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.049 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 61.2 mt -89.89 106.6 17.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.689 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.428 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 88.0 tttt -121.37 110.42 16.07 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.798 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 163' ' ' PHE . . . -130.48 139.01 34.33 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.762 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD2' HG11 ' A' ' 37' ' ' VAL . 7.4 Cg_endo -53.14 124.42 15.56 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.877 2.385 . . . . 0.0 112.108 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.56 96.69 0.18 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.686 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.5 m -105.18 -58.25 1.92 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.994 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -79.66 175.42 10.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.147 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -101.22 171.46 7.59 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.534 HD12 ' HD3' ' A' ' 3' ' ' PRO . 10.6 mt -126.72 141.92 51.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.718 0.771 . . . . 0.0 111.775 -173.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 88' ' ' GLU . 13.9 mt -84.4 143.88 10.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 10.7 ttt85 -116.57 138.02 51.73 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-O 121.213 0.53 . . . . 0.0 109.814 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.61 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.7 m-85 -116.12 122.47 45.2 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.546 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 152' ' ' LYS . 36.0 tt0 -109.77 124.49 51.36 Favored 'General case' 0 CA--C 1.47 -2.104 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.576 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -88.24 160.78 17.54 Favored 'General case' 0 C--N 1.271 -2.818 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.813 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.534 ' HG2' HD13 ' A' ' 149' ' ' LEU . 1.7 pt-20 -60.72 -19.28 58.5 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.592 0.711 . . . . 0.0 110.529 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -91.48 -12.14 35.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.93 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.07 14.38 49.04 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.994 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.543 ' O ' HD23 ' A' ' 81' ' ' LEU . 4.2 mtt180 -84.29 138.25 33.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 27.0 p -141.63 137.84 32.12 Favored 'General case' 0 C--N 1.287 -2.122 0 C-N-CA 118.969 -1.092 . . . . 0.0 112.845 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.451 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 5.0 p90 -136.0 154.64 51.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.507 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 25.2 mt-10 -125.32 151.84 45.49 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.549 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -143.42 157.93 44.06 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.399 178.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.489 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -69.8 15.27 0.08 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.677 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.6 -36.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 125.448 1.499 . . . . 0.0 112.213 178.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.523 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 26.7 t70 -78.41 -18.07 55.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.333 0.587 . . . . 0.0 109.639 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -77.83 125.75 85.14 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.298 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.486 ' CG ' ' HA ' ' A' ' 185' ' ' GLN . 37.7 Cg_endo -66.12 142.55 68.1 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.133 2.556 . . . . 0.0 112.622 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 20.7 t -111.97 145.47 18.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.6 tp -101.72 108.9 20.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.837 0.351 . . . . 0.0 110.793 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.553 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.2 p -112.22 150.09 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.367 0.603 . . . . 0.0 111.067 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.456 ' CD2' HD13 ' A' ' 148' ' ' LEU . 58.9 t80 -105.62 93.62 4.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.18 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 6.9 pt-20 -139.44 158.81 43.5 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 86.6 m-20 64.57 22.14 12.59 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.212 0.53 . . . . 0.0 110.154 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.25 14.72 64.48 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.031 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -137.21 171.65 14.17 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 117.365 0.583 . . . . 0.0 110.042 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -100.83 122.75 43.96 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.475 HG13 HG12 ' A' ' 97' ' ' VAL . 24.6 pt -121.04 146.98 25.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.836 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 mp0 -104.17 112.09 24.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.278 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.419 ' CE ' HG11 ' A' ' 97' ' ' VAL . 11.5 ptpt -124.2 139.44 53.92 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.576 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.63 ' O ' HG22 ' A' ' 111' ' ' VAL . 14.3 mmt180 -60.55 158.84 11.52 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.677 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -60.38 -40.79 92.13 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.864 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.43 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.7 p90 -73.47 -1.13 17.17 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.868 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -111.13 -13.79 13.97 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.693 0.759 . . . . 0.0 109.772 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 107' ' ' ARG . 93.6 t -79.2 149.0 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.709 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 21.6 mtmt -123.36 165.81 16.38 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.192 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.81 139.68 55.26 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.91 4.5 72.2 Favored Glycine 0 C--N 1.307 -1.032 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.874 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.709 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -75.33 167.93 20.96 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.42 ' HG2' ' HG3' ' A' ' 150' ' ' GLU . 25.2 mttp -119.61 165.1 14.89 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 121.404 0.621 . . . . 0.0 110.511 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.451 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -133.55 159.93 42.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.423 HD21 ' N ' ' A' ' 119' ' ' VAL . 0.9 OUTLIER -88.64 131.79 34.83 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.687 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -119.21 132.58 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.193 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.423 ' HB3' HD21 ' A' ' 180' ' ' ASN . 48.4 t -64.34 -19.37 65.41 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.626 0.727 . . . . 0.0 109.926 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 145' ' ' HIS . 10.1 mm-40 46.13 13.57 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.703 -1.589 . . . . 0.0 114.151 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.7 tt -100.4 109.93 22.11 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.055 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -92.18 177.59 6.11 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.24 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -108.24 13.83 25.44 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.316 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.0 t 70.81 -66.37 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.46 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.07 98.29 0.76 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.956 0.408 . . . . 0.0 110.958 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -105.2 25.04 11.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.925 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.4 m -57.22 144.32 35.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.164 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.9 m -71.47 134.52 46.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.827 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.9 t 70.09 173.91 0.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.895 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.7 p -92.21 67.9 5.03 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.33 0.586 . . . . 0.0 110.87 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -84.45 -45.1 13.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.061 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -106.34 173.29 6.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.467 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.481 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . 27.3 t-20 -170.24 -59.18 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 134' ' ' ASN . 77.3 Cg_endo -75.06 62.62 5.95 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.615 2.21 . . . . 0.0 112.589 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -143.83 116.02 8.44 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.363 0.601 . . . . 0.0 110.318 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -134.39 27.51 3.75 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 122.556 1.17 . . . . 0.0 108.054 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -85.65 -155.05 0.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.049 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 60.54 38.36 18.98 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.757 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.6 tp 72.68 -65.46 0.35 Allowed 'General case' 0 C--N 1.343 0.286 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.126 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.94 30.21 8.08 Favored Glycine 0 C--N 1.302 -1.319 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.174 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -127.91 116.34 20.64 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-O 120.765 0.317 . . . . 0.0 110.572 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -95.76 -163.38 0.09 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.929 2.42 . . . . 0.0 111.675 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -178.8 118.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.158 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -169.68 128.38 0.95 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.181 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -137.45 87.25 2.25 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.483 ' O ' HD21 ' A' ' 148' ' ' LEU . 9.1 pt20 -163.57 141.06 7.4 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.827 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.483 HD21 ' O ' ' A' ' 147' ' ' GLN . 14.4 mt -111.81 154.69 24.72 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-O 121.199 0.523 . . . . 0.0 110.211 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.576 ' HB3' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -113.21 137.86 50.84 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.027 -172.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.42 ' HG3' ' HG2' ' A' ' 116' ' ' LYS . 15.1 mt-10 -92.19 146.68 23.52 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.3 1.047 . . . . 0.0 112.7 175.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.473 HD13 ' CD1' ' A' ' 79' ' ' PHE . 75.2 mt -78.73 111.99 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.534 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.546 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.533 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 48.9 mmtt -71.63 -40.36 69.8 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.54 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -149.51 133.55 17.15 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 76.2 mt -116.92 144.64 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.609 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.448 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 19.0 ptpt -152.78 164.09 38.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.155 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.484 ' CZ ' HD13 ' A' ' 77' ' ' ILE . 15.3 m-85 -101.59 116.55 33.0 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.417 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.16 173.9 11.07 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.958 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -106.24 152.83 22.99 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 120.928 0.394 . . . . 0.0 111.486 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.28 128.38 36.47 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.224 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -65.85 -47.36 75.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.101 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.08 170.95 9.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.822 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -90.29 0.74 57.1 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 121.582 0.706 . . . . 0.0 109.933 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 96.2 m-85 -141.03 148.29 40.02 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.256 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.447 HG13 ' HA ' ' A' ' 3' ' ' PRO . 4.0 m -118.03 155.49 19.91 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.696 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 74.3 m-85 -133.43 173.58 11.33 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.68 0.276 . . . . 0.0 110.926 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.674 ' OG ' ' HA ' ' A' ' 1' ' ' CYS . 67.0 m -158.38 -23.37 0.08 Allowed 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.415 ' HG ' HD13 ' A' ' 24' ' ' LEU . 1.9 tm? 67.17 107.03 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.592 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -88.63 116.48 26.91 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.513 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.501 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -132.27 -167.25 1.86 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.995 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -62.89 144.91 56.24 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm 84.55 -25.81 0.12 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.225 1.01 . . . . 0.0 110.308 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 65.52 140.95 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.382 1.073 . . . . 0.0 113.175 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.656 ' O ' ' HA ' ' A' ' 184' ' ' HIS . 16.2 m170 42.36 53.67 4.48 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.67 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.445 ' HB2' ' HD1' ' A' ' 184' ' ' HIS . 56.2 t-20 -150.34 106.27 3.43 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.511 HG13 HG23 ' A' ' 177' ' ' ILE . 2.8 p -148.78 162.67 5.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.44 0.638 . . . . 0.0 111.225 -176.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.541 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 90.6 mt -108.34 116.91 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.605 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.511 HG23 HG13 ' A' ' 175' ' ' VAL . 37.7 pt -125.24 172.91 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.678 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 7' ' ' ARG . 8.2 t-20 47.9 -130.65 1.61 Allowed 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.055 0.942 . . . . 0.0 109.732 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -88.28 55.37 3.4 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.742 0.782 . . . . 0.0 109.487 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.687 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.6 m-20 67.38 47.76 1.23 Allowed 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.856 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 81.4 mt -87.94 118.18 33.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 118' ' ' LEU . 48.7 t -90.51 135.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.189 -175.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 3.5 t -145.33 148.01 32.94 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.102 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.656 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 79.9 t60 -155.89 149.54 25.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.774 0.321 . . . . 0.0 110.2 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.486 ' HA ' ' CG ' ' A' ' 94' ' ' PRO . 52.6 tt0 . . . . . 0 C--O 1.261 1.7 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.015 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 89' ' ' THR . 57.1 m . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.958 0.408 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.44 ' CE1' HD11 ' A' ' 177' ' ' ILE . 62.4 m-85 -129.76 150.21 75.16 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.526 ' HD3' HD11 ' A' ' 76' ' ' LEU . 18.7 Cg_endo -58.51 -29.69 89.51 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.886 2.391 . . . . 0.0 112.569 -175.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.481 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 124.28 -37.48 2.64 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.06 -4.62 21.95 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.449 0.642 . . . . 0.0 111.523 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.6 m -67.95 127.73 33.91 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.963 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 33.5 mmt180 -80.02 131.44 35.79 Favored 'General case' 0 C--O 1.181 -2.53 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 19' ' ' ILE . 8.1 tt -119.22 130.93 73.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.649 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.571 HD22 ' CD1' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -87.0 123.44 32.1 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 121.602 0.715 . . . . 0.0 110.187 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.482 ' N ' HD13 ' A' ' 9' ' ' LEU . 31.5 m -135.59 -178.9 2.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.489 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -129.23 121.42 27.58 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.531 HG12 HG13 ' A' ' 47' ' ' ILE . 21.2 mt -119.32 121.47 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.864 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.54 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 54.58 38.49 29.96 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.97 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.35 18.45 79.86 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.061 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.2 t -124.28 121.84 26.06 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.1 121.43 6.9 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 C-N-CA 122.383 2.055 . . . . 0.0 111.05 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -125.41 141.71 51.91 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.702 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 38.8 ttpt -109.93 100.82 9.72 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.9 pt -121.98 -173.71 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.183 -2.447 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.697 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 21.1 p -92.25 172.29 8.51 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.282 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 15.0 mt -72.98 -22.25 60.72 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.77 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.697 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.2 ptm180 -85.28 -24.63 27.64 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.602 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 71.1 mt-10 -83.71 -42.67 16.35 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.917 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.458 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 16.9 tp -55.98 -43.91 78.03 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.996 0.903 . . . . 0.0 108.917 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -51.41 -33.95 32.62 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.463 -1.699 . . . . 0.0 112.613 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 27.3 mt-10 -73.65 -17.07 61.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.69 2.71 21.64 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.393 0.616 . . . . 0.0 109.791 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.467 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.6 m-85 -117.08 161.61 19.14 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.364 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -139.06 -173.45 3.58 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.231 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.499 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER 60.6 86.07 0.1 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.35 0.595 . . . . 0.0 110.919 177.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -107.23 131.19 54.46 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.115 0.959 . . . . 0.0 112.368 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.428 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 15.3 ptt-85 -116.32 153.58 31.72 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.731 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -101.01 130.77 47.05 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -166.55 143.22 4.84 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.405 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 60.66 21.11 11.04 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 123.715 0.634 . . . . 0.0 110.928 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 36.7 mtm 71.59 20.06 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.417 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG13 ' HD2' ' A' ' 71' ' ' PRO . 5.1 m -134.9 -174.72 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -115.03 138.75 50.5 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-O 121.124 0.488 . . . . 0.0 110.534 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.428 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.2 t -128.52 124.83 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.33 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 18.5 ttm180 -114.04 127.45 55.94 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.499 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -130.66 144.41 51.41 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -173.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 43.5 tptt 82.16 111.77 0.03 OUTLIER Pre-proline 0 CA--C 1.518 -0.273 0 O-C-N 124.361 1.038 . . . . 0.0 111.232 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 62.0 Cg_endo -78.14 153.9 28.64 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.405 2.07 . . . . 0.0 112.282 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -85.81 -1.91 57.71 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.162 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -147.58 -165.9 2.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 32.7 tt0 -86.43 101.51 13.21 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.531 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -116.33 116.01 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.194 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.471 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 26.1 mmtp -117.55 164.8 14.37 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.648 175.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.46 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.9 p -119.42 132.1 70.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.536 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -84.62 118.59 24.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.17 0.509 . . . . 0.0 110.04 176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.4 p -124.43 176.97 6.15 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.938 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.511 HD12 ' C ' ' A' ' 58' ' ' LYS . 1.2 mm -130.3 138.2 54.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.588 0.709 . . . . 0.0 110.813 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.433 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 25.2 t70 -84.61 120.02 25.89 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.128 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.418 HD22 ' ND2' ' A' ' 174' ' ' ASN . 11.3 mt -67.33 -29.91 69.6 Favored 'General case' 0 CA--C 1.475 -1.933 0 CA-C-O 122.036 0.922 . . . . 0.0 112.048 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.433 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -81.81 -30.24 32.31 Favored 'General case' 0 C--N 1.263 -3.188 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.523 -171.548 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.7 p -114.54 -25.28 8.41 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.264 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.71 14.04 74.03 Favored Glycine 0 N--CA 1.427 -1.904 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.162 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.511 ' C ' HD12 ' A' ' 52' ' ' ILE . 41.5 mtpt -89.83 152.55 21.22 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -91.42 108.48 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.923 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.3 m -110.21 163.27 7.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.096 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.94 141.95 49.18 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.438 HG22 ' HB3' ' A' ' 170' ' ' LYS . 13.5 t -149.89 171.27 17.05 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.131 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.13 160.6 21.83 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 121.617 0.722 . . . . 0.0 111.197 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 64' ' ' ILE . 2.2 mp -96.0 145.52 8.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.174 -178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -91.01 -37.97 13.12 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 p30 174.18 175.33 0.16 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.803 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.12 138.19 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.171 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 35.7 mt -101.44 109.74 26.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.045 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -120.88 112.4 18.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.87 137.37 30.63 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.295 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.406 ' HD2' HG13 ' A' ' 37' ' ' VAL . 71.2 Cg_exo -48.17 131.7 22.39 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.454 2.769 . . . . 0.0 113.275 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.11 93.18 9.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.227 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 p -89.7 -24.9 21.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.04 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -110.97 -169.99 1.56 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.801 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.548 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 28.0 m170 -115.28 171.21 7.84 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.526 HD11 ' HD3' ' A' ' 3' ' ' PRO . 5.9 mt -121.32 148.27 44.56 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.966 0.888 . . . . 0.0 112.762 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.5 HD13 ' CZ ' ' A' ' 156' ' ' TYR . 27.7 mt -85.55 143.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.576 172.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 12.5 ttt85 -116.5 137.99 51.74 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-O 121.126 0.489 . . . . 0.0 110.157 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 86' ' ' SER . 58.5 m-85 -114.36 122.32 46.31 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.622 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 152' ' ' LYS . 23.1 tt0 -112.51 123.02 49.36 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.566 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.3 mm? -86.2 160.39 19.21 Favored 'General case' 0 N--CA 1.403 -2.775 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.218 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.569 ' HG2' ' CD1' ' A' ' 149' ' ' LEU . 1.4 pt-20 -64.74 -13.27 54.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.848 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -97.54 -8.52 28.92 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.538 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.56 10.58 57.88 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.082 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.564 ' O ' HD21 ' A' ' 81' ' ' LEU . 4.7 mtt180 -81.59 136.85 35.56 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 48.4 p -140.6 143.12 35.08 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.685 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -138.17 145.61 41.73 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.573 178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 49.0 mt-10 -117.19 146.29 43.32 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.352 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 5.3 p -142.78 153.86 43.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.733 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.498 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.88 10.28 0.93 Allowed 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.653 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 1.9 m 63.66 161.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 123.475 0.71 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 107' ' ' ARG . 33.9 t70 73.28 -30.61 0.21 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.124 0.488 . . . . 0.0 110.918 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.516 ' H ' ' C ' ' A' ' 91' ' ' VAL . 97.6 m-70 -68.28 132.87 91.47 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.249 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.75 115.76 4.37 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.361 2.707 . . . . 0.0 114.901 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 18.3 t -94.74 149.19 4.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 103' ' ' PHE . 1.1 tm? -103.08 118.58 37.11 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.0 0.428 . . . . 0.0 111.937 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.602 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.3 p -118.45 147.87 21.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.93 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.523 ' CD2' HD11 ' A' ' 148' ' ' LEU . 88.4 t80 -103.86 98.62 8.44 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.775 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 10.3 pt-20 -147.64 158.56 44.06 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.3 m-20 65.04 22.6 12.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.239 0.542 . . . . 0.0 109.866 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.66 12.14 55.69 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.66 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -132.13 172.84 11.89 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.552 0.691 . . . . 0.0 109.791 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.46 ' HB3' HD11 ' A' ' 96' ' ' LEU . 20.3 m-85 -103.1 121.2 42.12 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.464 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.505 HG13 HG13 ' A' ' 97' ' ' VAL . 24.4 pt -122.05 148.77 25.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.522 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 26.9 mt-10 -104.94 118.43 36.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.81 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -119.93 132.6 55.57 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.583 ' O ' HG23 ' A' ' 111' ' ' VAL . 65.3 mtt180 -60.03 158.3 11.27 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.653 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -56.59 -45.66 81.25 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.87 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.423 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.5 p90 -75.32 9.98 1.83 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.411 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -119.35 -20.57 7.83 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.201 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 107' ' ' ARG . 92.5 t -73.55 146.58 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.714 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 70.6 mmtt -119.75 170.77 8.92 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.719 -177.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.58 141.77 53.7 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.646 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.95 4.43 84.61 Favored Glycine 0 N--CA 1.425 -2.046 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.829 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.714 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -76.26 165.43 24.88 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.42 ' HE3' ' HG3' ' A' ' 150' ' ' GLU . 31.3 mttp -117.91 164.82 14.48 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.54 0.686 . . . . 0.0 110.819 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.0 159.75 42.9 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 119' ' ' VAL . 0.9 OUTLIER -88.76 133.66 34.17 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.001 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.3 OUTLIER -116.61 138.13 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.024 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 180' ' ' ASN . 4.8 p -72.39 -14.1 61.63 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-O 121.44 0.638 . . . . 0.0 110.412 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.573 ' HB3' ' HB3' ' A' ' 145' ' ' HIS . 24.7 mm-40 45.79 12.2 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.611 -1.631 . . . . 0.0 115.072 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 36.0 tp -83.95 137.98 33.37 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.269 0.557 . . . . 0.0 111.905 -178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -99.16 146.89 25.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.719 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.571 ' CD1' HD22 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -149.0 -48.31 0.15 Allowed 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 121.474 0.654 . . . . 0.0 110.248 -177.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 p -149.78 157.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.621 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 82.94 129.18 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.412 1.085 . . . . 0.0 111.276 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -142.08 -53.17 0.42 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.803 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.4 p -92.85 -160.09 0.72 Allowed 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.2 m -61.17 -29.24 69.68 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.9 m 61.93 -172.66 0.15 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.332 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 88.8 p -148.57 -168.55 3.12 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.892 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -88.64 5.93 40.72 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.867 0.365 . . . . 0.0 110.473 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -66.51 133.32 50.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.22 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -92.28 -52.74 0.27 Allowed Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.71 159.39 38.83 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.966 2.444 . . . . 0.0 112.847 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.621 ' HZ3' ' HB2' ' A' ' 136' ' ' LYS . 8.2 mtmp? 71.19 50.27 0.3 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.388 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -62.74 125.46 24.03 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.557 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -99.63 145.28 27.76 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.182 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -156.84 150.78 24.82 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 58.8 tp -56.43 -53.91 51.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.16 0.505 . . . . 0.0 110.57 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 144.08 -41.24 1.13 Allowed Glycine 0 C--N 1.302 -1.313 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.6 p -137.28 118.28 10.8 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.316 -0.442 . . . . 0.0 109.842 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.89 155.28 58.04 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.003 1.802 . . . . 0.0 111.586 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -162.73 90.16 0.69 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.906 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 16.7 m80 -154.8 118.29 4.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.254 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -138.47 96.53 3.18 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.531 ' O ' HD21 ' A' ' 148' ' ' LEU . 26.3 pt20 -164.3 147.85 9.43 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.162 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.531 HD21 ' O ' ' A' ' 147' ' ' GLN . 13.8 mt -111.17 146.73 36.36 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-O 121.404 0.621 . . . . 0.0 110.128 173.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.569 ' CD1' ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -111.08 137.06 49.2 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.913 -1.039 . . . . 0.0 113.516 -171.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.42 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 23.3 mt-10 -91.18 146.34 23.92 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.91 176.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 66.6 mt -81.02 107.79 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.921 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.553 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 27.7 mmtt -64.68 -42.84 95.07 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.368 175.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -148.29 132.5 17.4 Favored 'General case' 0 CA--C 1.473 -1.995 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.592 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 84.2 mt -117.24 125.1 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.01 172.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -128.89 163.86 24.35 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.006 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.5 ' CZ ' HD13 ' A' ' 77' ' ' ILE . 12.5 m-85 -101.0 110.96 23.05 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -116.02 176.38 2.45 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.768 -178.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.53 ' HA ' ' HB3' ' A' ' 75' ' ' HIS . 31.5 mtm180 -82.66 -142.83 0.06 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-O 121.787 0.803 . . . . 0.0 112.192 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -133.24 128.01 34.96 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -83.82 21.3 1.3 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -173.2 -178.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -104.78 8.42 34.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.374 0.607 . . . . 0.0 109.734 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -143.24 155.87 44.61 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.412 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' ' 3' ' ' PRO . 7.0 m -129.82 160.92 40.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.432 176.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 67.9 m-85 -132.55 170.46 15.14 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.471 -176.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.506 ' HB2' HD12 ' A' ' 68' ' ' ILE . 1.4 m -155.76 -28.2 0.1 Allowed 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.458 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 1.3 tm? 71.32 107.04 0.06 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.742 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -86.27 115.09 23.59 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.64 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.46 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -135.29 -166.16 1.8 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.438 ' HB3' HG22 ' A' ' 62' ' ' THR . 23.9 tptm -63.19 142.4 58.4 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? 77.93 -13.54 0.94 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.578 0.751 . . . . 0.0 110.47 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.424 ' H ' ' C ' ' A' ' 170' ' ' LYS . 33.5 p90 51.19 128.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.095 1.758 . . . . 0.0 115.532 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 185' ' ' GLN . 43.9 m170 64.29 5.11 2.39 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.192 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.418 ' ND2' HD22 ' A' ' 54' ' ' LEU . 27.0 t-20 -98.03 99.79 11.08 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.443 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.454 HG23 HG23 ' A' ' 177' ' ' ILE . 29.8 m -139.49 178.59 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.808 0 CA-C-O 122.47 1.128 . . . . 0.0 112.501 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.486 HD13 HG12 ' A' ' 52' ' ' ILE . 87.6 mt -117.59 114.27 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 CA-C-N 112.532 -2.122 . . . . 0.0 108.48 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 35.9 pt -120.76 168.04 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.746 0 CA-C-O 120.963 0.411 . . . . 0.0 112.076 -174.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.449 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 2.1 t-20 48.69 -133.23 1.46 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.966 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.444 ' H ' ' CG ' ' A' ' 178' ' ' ASN . 0.8 OUTLIER -80.81 56.27 2.65 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 121.314 0.578 . . . . 0.0 109.932 174.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.662 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 12.8 m120 66.89 42.39 2.52 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.892 1.277 . . . . 0.0 114.256 175.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 92.8 mt -86.85 119.08 34.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 70.0 t -92.47 129.28 43.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.814 -176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.8 t -150.52 164.07 36.87 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.844 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -112.07 50.12 0.87 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.109 0.481 . . . . 0.0 110.971 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 173' ' ' HIS . 3.7 pp0? . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.58 -1.2 . . . . 0.0 111.569 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.503 0.668 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -136.9 152.27 73.8 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.436 ' HD3' HD13 ' A' ' 76' ' ' LEU . 53.5 Cg_endo -65.81 158.16 55.22 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 N-CA-C 108.639 -1.331 . . . . 0.0 108.639 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.31 -22.83 56.86 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 119.077 -1.535 . . . . 0.0 111.887 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -71.31 -1.75 13.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.9 m -71.82 128.57 36.19 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.6 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 13.9 mtm-85 -85.58 131.0 34.44 Favored 'General case' 0 C--O 1.18 -2.576 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 19' ' ' ILE . 8.4 tt -120.22 131.14 73.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.419 HD21 ' HB2' ' A' ' 18' ' ' LYS . 2.0 tm? -89.46 123.23 33.39 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-O 121.491 0.662 . . . . 0.0 110.077 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.0 m -133.14 -174.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.29 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 31.5 tt0 -133.19 123.69 26.07 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.572 HG12 HG13 ' A' ' 47' ' ' ILE . 23.1 mt -121.23 121.69 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.748 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.811 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 52.95 39.09 28.69 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.458 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.74 17.27 80.05 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.749 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.94 115.39 22.13 Favored Pre-proline 0 N--CA 1.438 -1.064 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 13.1 Cg_exo -64.4 124.02 12.69 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.277 1.985 . . . . 0.0 111.262 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -122.37 134.97 54.62 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.419 ' HB2' HD21 ' A' ' 9' ' ' LEU . 40.2 ttmt -106.59 101.25 10.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 8' ' ' ILE . 3.1 pt -123.54 -173.58 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.744 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.777 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 20.4 p -97.11 168.65 10.32 Favored 'General case' 0 C--N 1.281 -2.378 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.725 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 66.1 mt -64.83 -29.7 70.67 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.777 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.5 ptm180 -77.04 -26.37 53.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.543 ' OE1' HG21 ' A' ' 20' ' ' THR . 62.7 mt-10 -84.66 -42.55 15.22 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.957 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.462 HD21 HD22 ' A' ' 167' ' ' LEU . 18.2 tp -57.5 -44.12 84.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-O 121.952 0.882 . . . . 0.0 110.145 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.648 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.5 m-30 -60.41 -23.86 64.7 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 113.747 -1.569 . . . . 0.0 113.188 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -79.88 -12.87 59.72 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.95 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.4 mm? -79.22 3.78 16.86 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.409 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.7 m-85 -118.49 164.72 14.86 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.226 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.538 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 38.0 mt-10 -136.4 -173.48 3.42 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.952 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.41 81.63 0.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.39 0.614 . . . . 0.0 111.55 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -98.65 120.4 39.02 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.783 0.801 . . . . 0.0 110.621 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -106.28 149.73 26.62 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 114.009 -1.451 . . . . 0.0 109.976 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.491 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 19.2 t80 -106.56 130.35 54.34 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.474 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -167.53 141.42 3.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.849 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 56.48 23.58 7.66 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 123.452 0.47 . . . . 0.0 111.865 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.491 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 43.8 mtm 72.07 17.57 5.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.88 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.469 HG12 ' HD2' ' A' ' 71' ' ' PRO . 4.8 m -127.32 -175.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -126.77 147.64 49.98 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.307 0.575 . . . . 0.0 110.603 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -131.47 124.0 53.75 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.007 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.564 ' HB3' HG23 ' A' ' 67' ' ' VAL . 38.1 ttm180 -115.41 126.23 54.12 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.612 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -133.43 146.76 51.48 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.463 -174.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 88.9 mttt 86.46 111.75 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.673 0 C-N-CA 125.183 1.393 . . . . 0.0 111.75 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.72 147.73 19.7 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.527 2.151 . . . . 0.0 111.191 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.538 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 29.3 mtmt -81.75 -6.64 59.23 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -145.91 -164.98 2.08 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.1 tp10 -85.75 99.83 11.61 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.572 HG13 HG12 ' A' ' 12' ' ' ILE . 1.7 mp -115.97 117.37 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.952 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.53 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 25.0 mmtt -116.37 167.14 11.3 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.393 174.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.498 HG11 ' CB ' ' A' ' 169' ' ' ALA . 13.0 p -121.45 130.23 74.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.133 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -85.14 120.61 26.83 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.2 m -133.79 173.24 11.75 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.017 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.461 HD11 ' C ' ' A' ' 58' ' ' LYS . 2.4 mm -115.61 142.57 28.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.223 0.535 . . . . 0.0 110.151 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.411 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 38.8 t0 -80.75 130.85 35.31 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.601 HD11 ' N ' ' A' ' 54' ' ' LEU . 4.1 mp -77.9 -25.63 48.58 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.973 0.892 . . . . 0.0 110.811 -172.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.34 -32.6 16.42 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.93 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 53' ' ' ASP . 57.8 p -111.84 -20.21 12.13 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.522 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.66 12.18 84.65 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.742 177.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.461 ' C ' HD11 ' A' ' 52' ' ' ILE . 3.6 mtpm? -89.86 160.58 16.4 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.953 0.406 . . . . 0.0 112.069 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.45 110.18 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 CA-C-O 121.89 0.852 . . . . 0.0 110.009 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.5 m -111.13 163.8 7.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.6 tp -123.74 141.97 51.52 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.42 ' OG1' ' HB2' ' A' ' 170' ' ' LYS . 14.3 t -151.05 172.21 16.09 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.91 0.386 . . . . 0.0 111.57 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.05 160.58 25.77 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.715 0.769 . . . . 0.0 110.993 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.471 ' N ' HD13 ' A' ' 64' ' ' ILE . 2.1 mp -100.7 136.82 30.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.908 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 5.2 mm-40 -82.93 -38.28 23.03 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 p30 177.56 -179.2 0.23 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.303 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.578 ' HB ' ' CE1' ' A' ' 25' ' ' TYR . 2.9 m -116.82 145.26 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-O 121.124 0.488 . . . . 0.0 110.067 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.491 HD12 ' HB2' ' A' ' 166' ' ' SER . 56.8 mt -99.28 107.67 21.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.076 -173.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.437 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 76.8 tttt -116.08 107.42 14.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.6 137.65 30.89 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.141 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.469 ' HD2' HG12 ' A' ' 37' ' ' VAL . 77.5 Cg_exo -47.52 136.23 20.65 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 123.205 2.603 . . . . 0.0 112.688 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.66 102.7 0.47 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 m -60.44 -55.83 28.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.071 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.45 -138.7 0.11 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.301 -176.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -97.38 171.12 8.6 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.603 ' CD2' ' HA ' ' A' ' 90' ' ' THR . 11.0 mt -124.19 140.54 52.86 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.928 0.87 . . . . 0.0 111.513 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 88' ' ' GLU . 40.0 mt -87.98 142.11 13.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.872 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 12.9 ttt180 -119.45 138.47 53.1 Favored 'General case' 0 N--CA 1.406 -2.651 0 CA-C-O 121.234 0.54 . . . . 0.0 109.655 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 86' ' ' SER . 58.1 m-85 -114.68 125.99 54.37 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.442 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 152' ' ' LYS . 36.8 tt0 -109.73 123.99 50.47 Favored 'General case' 0 CA--C 1.473 -2.013 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 85' ' ' ARG . 1.5 mm? -89.34 162.5 15.78 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.994 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.584 ' HG2' HD13 ' A' ' 149' ' ' LEU . 3.1 pt-20 -63.88 -18.29 64.03 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.889 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -93.37 -7.29 45.14 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.531 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.57 13.22 57.3 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.045 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.546 ' O ' HD22 ' A' ' 81' ' ' LEU . 2.0 mtt180 -82.07 139.07 34.66 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 20.6 p -141.27 140.0 33.8 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 118.889 -1.125 . . . . 0.0 112.449 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -136.67 141.34 43.15 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.657 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 1.7 mp0 -109.61 148.1 31.89 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.779 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.714 ' HB ' ' NE2' ' A' ' 93' ' ' HIS . 3.5 p -137.02 149.14 47.28 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.139 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.603 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -73.44 7.62 2.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.625 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 1.5 m 59.81 169.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 122.911 0.484 . . . . 0.0 110.98 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.581 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 33.4 t70 73.11 -41.26 0.5 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.063 0.459 . . . . 0.0 111.35 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.714 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 8.6 p80 -75.69 148.59 82.64 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.58 142.19 28.98 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.126 2.551 . . . . 0.0 114.534 -178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 23.6 t -111.99 154.3 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.514 1.526 . . . . 0.0 107.274 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.437 HD22 ' CD2' ' A' ' 184' ' ' HIS . 18.3 tp -106.49 113.45 26.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.841 0.746 . . . . 0.0 112.424 -176.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.505 HG11 HG13 ' A' ' 104' ' ' ILE . 2.4 p -113.39 153.64 14.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 111.808 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -108.48 95.61 5.78 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.989 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 6.6 pt-20 -143.76 159.19 42.95 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER 66.84 22.74 10.17 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.228 0.537 . . . . 0.0 109.644 -179.03 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.61 12.86 57.66 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.771 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -134.21 172.41 12.9 Favored 'General case' 0 N--CA 1.403 -2.815 0 CA-C-O 121.201 0.524 . . . . 0.0 109.807 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -100.68 121.69 42.06 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.505 HG13 HG11 ' A' ' 97' ' ' VAL . 25.9 pt -121.13 157.52 24.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.622 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 21.3 mt-10 -114.18 110.02 19.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.959 0.409 . . . . 0.0 111.666 -176.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -113.97 140.01 48.77 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 92' ' ' ASP . 6.5 mpt_? -60.8 154.79 21.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.625 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -56.63 -45.86 81.28 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.827 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.507 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 2.6 p90 -71.99 3.03 4.75 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.342 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -115.26 -16.34 11.52 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.358 0.599 . . . . 0.0 110.131 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 107' ' ' ARG . 70.0 t -74.51 145.09 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 31.6 mmtp -119.74 172.6 7.57 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.401 0.619 . . . . 0.0 111.689 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -70.9 138.31 50.04 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.393 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.51 5.59 74.99 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.924 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.545 ' HB3' HD13 ' A' ' 151' ' ' ILE . 8.1 t70 -71.27 170.17 13.64 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.646 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 48.2 mttp -127.85 155.72 43.68 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.758 0.79 . . . . 0.0 112.733 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.51 157.52 41.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.584 172.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.576 ' HA ' HD11 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -95.15 134.14 38.2 Favored 'General case' 0 CA--C 1.479 -1.784 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.634 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.6 OUTLIER -107.33 124.45 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.828 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.742 175.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.476 ' C ' ' H ' ' A' ' 122' ' ' LEU . 4.7 m -80.98 73.92 8.0 Favored 'General case' 0 N--CA 1.398 -3.044 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -62.72 39.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -174.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' A' ' 120' ' ' SER . 34.2 tp -82.01 123.87 29.29 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -106.71 168.2 9.34 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.833 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.93 30.29 4.02 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.957 0.884 . . . . 0.0 109.317 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.1 p -51.23 144.73 2.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 113.482 -1.69 . . . . 0.0 113.014 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -163.9 156.95 18.12 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -98.88 20.93 12.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.403 ' C ' ' HG ' ' A' ' 129' ' ' SER . 27.7 m -81.1 -78.54 0.18 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.77 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.403 ' HG ' ' C ' ' A' ' 128' ' ' SER . 79.5 p 52.48 21.58 1.82 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.575 0.75 . . . . 0.0 112.136 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.3 p -73.82 -65.06 0.88 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.8 -177.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.3 m -148.36 168.12 23.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.233 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -78.63 96.83 5.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.071 0.463 . . . . 0.0 109.997 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.58 ' O ' ' HD3' ' A' ' 135' ' ' PRO . 39.0 t70 -149.58 170.78 17.86 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.204 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -112.8 82.68 5.23 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-O 120.738 0.304 . . . . 0.0 110.919 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.58 ' HD3' ' O ' ' A' ' 133' ' ' ASP . 8.6 Cg_endo -90.93 150.05 3.91 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 123.111 2.541 . . . . 0.0 110.843 177.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -151.88 108.75 3.51 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.274 0.559 . . . . 0.0 109.89 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -123.83 -68.34 0.87 Allowed 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.969 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -134.44 -108.0 0.22 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.142 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 66.52 110.48 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.734 0.646 . . . . 0.0 111.269 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.8 tp -68.8 -64.96 0.77 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 92.92 30.95 8.94 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.11 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 2.5 p -61.81 117.39 28.12 Favored Pre-proline 0 N--CA 1.444 -0.729 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 142' ' ' SER . 15.7 Cg_endo -86.04 -73.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.336 2.024 . . . . 0.0 113.917 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 71.4 74.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -122.29 121.87 37.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.013 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -159.84 87.85 0.82 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.44 -0.8 . . . . 0.0 108.976 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -164.2 140.22 6.26 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.05 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.646 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.7 mm? -112.13 140.22 47.0 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.061 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.584 HD13 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -114.26 134.68 54.76 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.996 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 8.5 mt-10 -86.82 142.79 27.83 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.155 177.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.545 HD13 ' HB3' ' A' ' 115' ' ' ASP . 80.6 mt -80.46 103.15 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.329 174.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.468 ' HG3' ' CA ' ' A' ' 82' ' ' GLU . 29.9 mtmt -61.1 -44.37 97.46 Favored 'General case' 0 C--N 1.274 -2.715 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.226 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -150.45 136.53 18.54 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 77.7 mt -113.92 145.37 19.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.885 174.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -150.44 160.14 43.97 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.214 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.441 ' CZ ' HD13 ' A' ' 77' ' ' ILE . 21.7 m-85 -100.27 113.17 25.66 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.02 134.73 65.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.358 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.418 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 32.2 ttp180 -66.25 151.71 46.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' A' ' 158' ' ' ARG . . . -67.29 127.77 33.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.898 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -79.84 -24.89 41.01 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.191 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -110.36 -178.35 3.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.17 -7.82 18.8 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.035 0.445 . . . . 0.0 110.01 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -134.24 160.26 38.4 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.24 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.03 155.2 41.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 19.6 m-85 -132.88 169.07 17.29 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.741 -172.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.491 ' HB2' HD12 ' A' ' 68' ' ' ILE . 19.3 m -155.55 -28.13 0.1 Allowed 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.534 ' CD1' HG13 ' A' ' 67' ' ' VAL . 15.4 tp 73.29 116.95 0.05 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.417 1.087 . . . . 0.0 111.618 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -91.8 109.33 20.66 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.46 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.498 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -129.6 -165.02 1.47 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.372 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.42 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 46.4 mmtt -68.69 143.74 54.64 Favored 'General case' 0 CA--C 1.489 -1.392 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.218 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt 50.33 47.43 23.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.287 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 173' ' ' HIS . 11.8 p90 -50.41 169.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.373 -177.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.58 ' O ' ' HA ' ' A' ' 184' ' ' HIS . 22.0 m-70 83.34 17.0 0.27 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.986 0.914 . . . . 0.0 109.777 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -148.87 138.93 22.2 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.511 HG12 HG21 ' A' ' 177' ' ' ILE . 1.3 p -166.32 166.67 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.456 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 97.2 mt -117.14 113.04 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.81 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.511 HG21 HG12 ' A' ' 175' ' ' VAL . 40.3 pt -123.19 171.37 12.25 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.521 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.237 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.415 ' C ' ' H ' ' A' ' 180' ' ' ASN . 8.0 t-20 50.49 -129.46 2.2 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.431 1.092 . . . . 0.0 110.128 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.69 43.95 0.95 Allowed 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.439 0.637 . . . . 0.0 110.22 175.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.4 m-20 72.89 47.75 0.2 Allowed 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 114.081 -1.418 . . . . 0.0 112.92 176.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 81.3 mt -88.82 115.09 28.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.065 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.524 HG11 ' O ' ' A' ' 118' ' ' LEU . 2.6 m -76.33 156.21 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.2 t -171.46 169.78 6.05 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.786 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.58 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 14.1 m170 -114.2 -174.16 2.42 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.1 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 117.913 -1.041 . . . . 0.0 111.875 -179.288 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 89' ' ' THR . 71.3 m . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.824 0.345 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -129.08 160.52 63.3 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.462 ' HD3' HD13 ' A' ' 76' ' ' LEU . 51.8 Cg_endo -66.15 156.51 64.39 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 N-CA-C 108.532 -1.372 . . . . 0.0 108.532 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.09 -22.56 49.69 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.531 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.45 -19.78 66.08 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.203 0.525 . . . . 0.0 112.186 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 91.9 m -59.61 128.09 35.25 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.771 -176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 65.5 mmt-85 -81.34 133.34 35.41 Favored 'General case' 0 C--O 1.194 -1.856 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.515 HD12 HG22 ' A' ' 175' ' ' VAL . 8.1 tt -121.66 131.88 72.08 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.728 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.511 HD13 ' N ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -89.01 124.21 34.06 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.511 0.672 . . . . 0.0 109.987 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.511 ' N ' HD13 ' A' ' 9' ' ' LEU . 28.9 m -135.11 -176.38 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.378 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -134.04 124.62 26.53 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.047 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 21.0 mt -120.55 119.46 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.026 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 52.62 44.45 30.08 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.744 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.2 75.5 Favored Glycine 0 C--N 1.307 -1.057 0 CA-C-N 114.704 -1.135 . . . . 0.0 114.256 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.46 HG12 ' CB ' ' A' ' 134' ' ' ASN . 34.9 t -124.76 119.94 25.71 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-O 121.137 0.494 . . . . 0.0 109.769 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.491 ' HB2' HD12 ' A' ' 124' ' ' LEU . 56.8 Cg_endo -73.71 124.03 8.96 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.326 2.018 . . . . 0.0 111.74 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -123.26 146.27 48.0 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.47 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -114.51 100.23 8.14 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.258 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 8' ' ' ILE . 2.9 pt -123.05 -174.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.929 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.663 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 10.9 p -92.99 172.21 8.46 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.234 -0.987 . . . . 0.0 109.088 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 70.4 mt -66.83 -30.49 70.68 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.256 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.663 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 5.7 ptm180 -80.11 -25.01 40.13 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.556 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 78.8 mt-10 -83.58 -39.6 20.15 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.1 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.443 HD21 ' HG ' ' A' ' 167' ' ' LEU . 13.9 tp -57.52 -44.49 85.11 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -49.79 -35.62 23.25 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.414 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 26.8 mt-10 -72.95 -17.84 61.44 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.58 0.06 31.53 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.594 0.712 . . . . 0.0 109.589 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.55 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 95.2 m-85 -113.67 161.3 17.63 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.297 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -133.89 -174.71 3.61 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.803 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.445 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 14.8 t0 60.28 87.56 0.09 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.549 0.69 . . . . 0.0 111.444 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 26.2 tt0 -104.02 128.97 51.62 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.253 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.644 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 1.7 ptm180 -109.8 150.06 28.92 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.611 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -116.9 122.97 45.86 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.42 0.629 . . . . 0.0 110.166 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -167.34 154.38 8.55 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.243 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.4 m120 61.63 16.98 8.2 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 123.685 0.615 . . . . 0.0 110.707 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.9 mtm 69.77 19.58 7.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.06 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.459 HG13 ' HD2' ' A' ' 71' ' ' PRO . 12.4 m -128.54 -179.67 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.461 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 97.1 m-85 -120.26 142.18 49.28 Favored 'General case' 0 CA--C 1.478 -1.803 0 CA-C-O 121.44 0.638 . . . . 0.0 109.993 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.644 ' CG1' ' HG2' ' A' ' 32' ' ' ARG . 1.1 m -135.19 127.7 47.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.336 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.581 ' O ' HG22 ' A' ' 67' ' ' VAL . 16.1 ttm180 -119.68 127.55 52.99 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -133.45 145.09 49.93 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.963 -174.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 12.8 tmtt? 86.73 112.22 0.03 OUTLIER Pre-proline 0 CA--C 1.516 -0.336 0 O-C-N 124.649 1.218 . . . . 0.0 109.963 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 73.2 Cg_endo -80.48 151.48 19.9 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 122.211 1.941 . . . . 0.0 112.269 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -86.17 -0.09 54.88 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.194 0.521 . . . . 0.0 110.976 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -150.68 -165.83 2.38 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 33.0 tt0 -83.92 101.41 11.67 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.55 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.4 mp -115.74 117.67 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.227 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -117.72 165.85 13.14 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.266 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.554 HG11 ' CB ' ' A' ' 169' ' ' ALA . 9.9 p -120.45 133.57 66.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.234 -177.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -85.87 125.27 33.18 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.096 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.9 m -136.86 142.36 42.81 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.179 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 mm -92.26 140.03 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.936 0 CA-C-O 121.479 0.657 . . . . 0.0 110.725 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.426 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 10.7 t0 -83.79 114.04 21.34 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.611 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -75.39 -4.78 41.4 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.685 0.755 . . . . 0.0 111.811 -169.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -102.42 -34.02 9.32 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.114 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.426 ' OG1' ' HB3' ' A' ' 53' ' ' ASP . 81.0 p -111.29 -19.78 12.52 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.634 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.88 12.71 80.87 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.836 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -92.24 156.52 17.24 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.178 0.513 . . . . 0.0 112.284 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.92 106.02 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.006 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.589 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 m -109.46 162.55 7.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.77 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.3 tp -122.32 140.87 52.15 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.014 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.5 t -147.52 172.61 13.7 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.782 0.325 . . . . 0.0 111.338 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.16 162.61 25.66 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.839 0.828 . . . . 0.0 111.397 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.471 ' N ' HD13 ' A' ' 64' ' ' ILE . 2.5 mp -99.07 145.71 9.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.812 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.445 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 31.4 mm-40 -91.27 -38.59 12.57 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 175.62 177.37 0.2 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.672 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 40' ' ' ARG . 5.5 t -106.58 129.43 60.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.894 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 55.3 mt -91.49 111.75 24.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.814 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 83.2 tttt -127.56 112.25 14.69 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.12 135.08 25.92 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.148 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.459 ' HD2' HG13 ' A' ' 37' ' ' VAL . 80.7 Cg_exo -44.71 130.05 9.54 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.671 2.914 . . . . 0.0 113.535 177.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.41 116.44 28.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.147 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -123.0 -65.83 1.07 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.367 0.876 . . . . 0.0 113.367 -176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -57.58 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -177.14 172.44 1.93 Allowed 'General case' 0 CA--C 1.461 -2.474 0 CA-C-O 120.992 0.425 . . . . 0.0 111.46 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.525 HD21 ' HA ' ' A' ' 90' ' ' THR . 10.7 mt -131.65 141.75 49.68 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.735 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.56 HD12 ' CZ ' ' A' ' 156' ' ' TYR . 22.7 mt -87.69 142.37 13.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 11.3 ttt85 -115.28 137.31 52.17 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.177 0.513 . . . . 0.0 109.884 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.629 ' O ' ' HA ' ' A' ' 86' ' ' SER . 64.1 m-85 -114.87 121.19 42.45 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.861 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 152' ' ' LYS . 35.3 tt0 -109.08 120.77 43.53 Favored 'General case' 0 CA--C 1.47 -2.133 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.589 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -85.9 159.96 19.53 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.172 -177.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.504 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -59.71 -19.16 48.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.325 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -92.37 -8.26 45.44 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.091 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.44 15.74 49.29 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.523 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.514 ' O ' HD23 ' A' ' 81' ' ' LEU . 3.9 mtt180 -83.83 138.57 33.15 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 35.6 p -141.85 139.91 32.78 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 118.485 -1.286 . . . . 0.0 112.296 175.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -135.23 146.93 49.1 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.948 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 21.5 mt-10 -119.22 147.68 43.97 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.348 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.8 OUTLIER -138.76 154.01 48.49 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.595 -179.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.525 ' HA ' HD21 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.98 11.58 0.67 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.362 0.601 . . . . 0.0 112.057 -177.325 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.678 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 1.2 m 68.24 -26.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.021 1.328 . . . . 0.0 113.422 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 90' ' ' THR . 5.0 p-10 -83.34 -1.17 52.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.983 0.42 . . . . 0.0 110.658 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -110.63 137.06 20.64 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.477 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 24.0 Cg_exo -65.48 134.18 37.51 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.236 2.624 . . . . 0.0 113.424 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.576 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.2 t -103.58 150.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.547 ' HB2' ' N ' ' A' ' 184' ' ' HIS . 6.2 tp -107.75 113.76 27.24 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.819 0.342 . . . . 0.0 111.878 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.605 HG22 ' OD1' ' A' ' 115' ' ' ASP . 2.3 p -113.21 151.6 15.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.26 0.552 . . . . 0.0 111.592 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.455 ' CD2' HD11 ' A' ' 148' ' ' LEU . 61.4 t80 -105.13 93.54 4.75 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.294 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 8.5 pt-20 -141.76 158.41 43.85 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 32.0 m-80 63.5 23.22 13.56 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.147 0.499 . . . . 0.0 109.993 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.23 12.02 54.01 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.0 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -133.29 172.31 12.86 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 121.279 0.561 . . . . 0.0 109.914 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -101.76 120.63 40.67 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.486 HG13 HG13 ' A' ' 97' ' ' VAL . 23.1 pt -116.38 152.53 18.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.875 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.474 ' OE2' ' HG2' ' A' ' 185' ' ' GLN . 7.7 mt-10 -109.37 112.57 24.77 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.792 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 12.6 ptpt -130.15 133.95 46.98 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.593 ' O ' HG23 ' A' ' 111' ' ' VAL . 60.5 mtm180 -67.42 163.18 21.43 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.678 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -56.6 -45.45 81.42 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.976 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.522 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.9 p90 -71.86 2.81 4.92 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.515 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.499 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 12.9 tp10 -117.15 -16.05 10.44 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.397 0.618 . . . . 0.0 110.044 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 107' ' ' ARG . 89.4 t -73.97 148.88 8.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.689 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 23.0 mmtp -119.17 169.8 9.63 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.337 0.589 . . . . 0.0 110.537 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -76.21 144.42 40.45 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.551 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.38 4.59 80.44 Favored Glycine 0 C--N 1.308 -1.011 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.15 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.689 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -76.91 167.33 22.0 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.1 mttp -121.87 166.67 14.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.288 0.566 . . . . 0.0 110.558 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.22 160.57 41.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.98 135.14 34.43 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.1 OUTLIER -100.49 149.98 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.716 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.431 ' HB2' ' CG1' ' A' ' 176' ' ' ILE . 43.5 t -66.06 -5.45 9.8 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 120.825 0.345 . . . . 0.0 110.797 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.617 ' HB3' ' CG ' ' A' ' 145' ' ' HIS . 39.8 mt-10 40.78 69.58 0.32 Allowed 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 124.753 1.283 . . . . 0.0 111.491 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.486 ' CD1' ' HG3' ' A' ' 143' ' ' PRO . 49.8 tp -174.47 123.79 0.29 Allowed 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.4 ' C ' ' H ' ' A' ' 125' ' ' VAL . 8.6 pt-20 -127.35 104.51 7.97 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.491 HD12 ' HB2' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -54.51 -8.82 0.25 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 114.242 -1.344 . . . . 0.0 112.148 174.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.4 ' H ' ' C ' ' A' ' 123' ' ' GLU . 24.2 t 74.04 75.08 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 122.147 0.975 . . . . 0.0 110.349 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -147.23 131.56 17.53 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.156 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -119.9 -72.77 0.67 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.093 0.473 . . . . 0.0 109.863 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.3 m -125.48 112.71 16.56 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.4 m -62.01 99.13 0.12 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.201 0.524 . . . . 0.0 111.816 -177.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.8 p -92.08 -28.14 17.33 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.347 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.8 p -113.05 140.05 48.17 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.68 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -77.93 -23.09 48.7 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -82.01 153.72 26.05 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.644 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.46 ' CB ' HG12 ' A' ' 15' ' ' VAL . 45.7 m-80 -125.66 78.98 68.38 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-O 121.156 0.503 . . . . 0.0 110.525 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -97.51 37.58 0.11 Allowed 'Trans proline' 0 N--CA 1.439 -1.704 0 C-N-CA 123.272 2.648 . . . . 0.0 112.095 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -163.04 133.97 4.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -158.42 97.29 1.47 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.602 ' CD ' ' H ' ' A' ' 139' ' ' ASN . 0.7 OUTLIER 62.27 177.73 0.13 Allowed 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.805 -177.238 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.602 ' H ' ' CD ' ' A' ' 138' ' ' GLU . 4.5 p30 -122.72 -23.89 5.0 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.969 -0.457 . . . . 0.0 111.606 -177.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.2 tp -130.34 -37.29 1.43 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.726 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.23 -31.59 5.03 Favored Glycine 0 C--N 1.303 -1.257 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.632 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.3 p -98.41 117.36 64.84 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-O 120.612 0.244 . . . . 0.0 110.367 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.486 ' HG3' ' CD1' ' A' ' 122' ' ' LEU . 83.9 Cg_endo -82.49 173.92 10.2 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.646 2.231 . . . . 0.0 112.91 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.03 115.7 28.0 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.781 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.617 ' CG ' ' HB3' ' A' ' 121' ' ' GLU . 29.9 p80 -161.1 149.21 15.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.309 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 145' ' ' HIS . 19.0 t70 174.54 45.55 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.423 ' O ' HD22 ' A' ' 148' ' ' LEU . 6.8 pt20 -163.92 140.56 6.74 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.455 HD11 ' CD2' ' A' ' 98' ' ' TYR . 14.5 mt -112.29 153.37 27.28 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.589 ' HB3' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -114.97 138.89 50.32 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -171.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -89.79 146.43 24.47 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 124.672 1.189 . . . . 0.0 113.018 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.499 HD11 ' CD1' ' A' ' 79' ' ' PHE . 64.3 mt -80.15 107.57 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.266 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 80' ' ' GLU . 62.2 mmtt -68.89 -38.98 80.0 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.889 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -150.63 131.86 14.5 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.592 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 74.8 mt -116.98 130.21 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.385 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.444 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 19.3 ptpt -136.46 166.76 22.75 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.516 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.56 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 20.7 m-85 -100.63 115.36 30.01 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.946 173.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.1 133.19 68.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.103 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 21.5 ttm-85 -70.87 155.22 41.06 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.068 0.461 . . . . 0.0 111.072 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.21 113.71 7.66 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.063 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -71.17 -18.68 62.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.567 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -98.9 166.57 11.23 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.953 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -94.28 -6.44 44.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.029 0.443 . . . . 0.0 109.929 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -144.0 150.41 38.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.781 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 4.3 m -119.29 155.8 21.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 50.0 m-85 -130.86 173.59 10.81 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 110.199 -0.296 . . . . 0.0 110.199 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.484 ' OG ' ' HA ' ' A' ' 1' ' ' CYS . 68.5 m -159.23 -24.49 0.07 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.443 ' HG ' HD21 ' A' ' 24' ' ' LEU . 1.5 tm? 68.68 112.46 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.769 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -90.82 113.26 25.37 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.112 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.554 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -133.94 -173.32 3.22 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.915 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -65.39 128.62 36.61 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 73.5 tttt 61.24 46.13 8.2 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.428 ' O ' ' HB2' ' A' ' 173' ' ' HIS . 49.0 p90 -57.04 179.03 0.05 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.928 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.48 ' O ' ' HB3' ' A' ' 184' ' ' HIS . 57.4 m170 70.56 18.94 6.36 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.46 -175.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -150.04 115.19 5.4 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.896 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.515 HG22 HD12 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -159.95 158.43 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 120.827 0.346 . . . . 0.0 110.785 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.582 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 2.5 mp -93.08 115.34 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.867 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 45.1 pt -121.48 171.51 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-O 120.985 0.422 . . . . 0.0 111.586 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.433 ' OD1' ' HG3' ' A' ' 179' ' ' GLU . 5.4 t-20 46.71 -127.19 1.54 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 124.16 0.984 . . . . 0.0 110.777 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.468 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 29.3 mt-10 -91.5 55.63 2.82 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.745 0.784 . . . . 0.0 109.466 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.724 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.4 m120 70.2 44.56 0.75 Allowed 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 113.74 -1.573 . . . . 0.0 113.6 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 85.1 mt -92.39 117.65 36.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.0 m -93.45 160.73 2.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.576 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 9.7 t -159.33 152.37 22.07 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.132 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.651 ' CG ' ' H ' ' A' ' 185' ' ' GLN . 1.2 t60 42.56 -148.79 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.031 0.932 . . . . 0.0 111.975 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.651 ' H ' ' CG ' ' A' ' 184' ' ' HIS . 26.5 pt20 . . . . . 0 C--O 1.263 1.808 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.99 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 89' ' ' THR . 23.0 p . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.994 0.426 . . . . 0.0 111.568 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.469 ' CE1' HD11 ' A' ' 177' ' ' ILE . 93.3 m-85 -124.29 150.45 63.97 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.475 ' HD3' HD11 ' A' ' 76' ' ' LEU . 18.2 Cg_endo -59.02 -26.92 83.49 Favored 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 122.592 2.195 . . . . 0.0 112.481 -175.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 6' ' ' THR . . . 120.19 -38.65 2.69 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -69.08 -1.34 7.42 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.802 -0.699 . . . . 0.0 111.514 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 28.9 m -69.69 128.25 35.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.564 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.1 mtm-85 -83.77 132.6 34.82 Favored 'General case' 0 C--O 1.186 -2.259 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.515 HD13 HG21 ' A' ' 175' ' ' VAL . 10.7 tt -122.74 131.38 73.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-O 121.017 0.437 . . . . 0.0 110.623 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 10' ' ' VAL . 1.6 tm? -90.77 123.47 34.37 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-O 121.504 0.669 . . . . 0.0 109.447 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 18.8 m -133.83 -175.46 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.5 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 32.1 tt0 -129.29 120.8 26.28 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.597 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 14.5 mt -122.44 122.7 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.868 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.864 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 56.14 35.98 26.62 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.859 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.1 17.29 78.62 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.215 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.35 114.55 25.65 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 7.6 Cg_exo -64.86 125.17 14.28 Favored 'Trans proline' 0 N--CA 1.44 -1.656 0 C-N-CA 122.129 1.886 . . . . 0.0 111.356 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.501 ' HG2' ' ND2' ' A' ' 134' ' ' ASN . 66.2 mt-30 -122.14 140.39 52.61 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.436 ' HD3' ' NH2' ' A' ' 7' ' ' ARG . 39.0 ttmt -108.52 100.28 9.57 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.449 ' O ' ' N ' ' A' ' 8' ' ' ILE . 3.6 pt -124.4 -171.93 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.179 -2.63 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.767 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.686 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 21.3 p -94.91 170.98 9.04 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.776 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 10.6 mt -73.96 -20.64 60.3 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.006 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.686 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 13.2 ptm180 -84.58 -25.28 28.76 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 27' ' ' LEU . 52.4 mm-40 -84.64 -44.17 13.71 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.394 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.548 ' CD2' HD23 ' A' ' 167' ' ' LEU . 16.4 tp -57.19 -44.0 83.21 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.927 0.87 . . . . 0.0 110.004 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.432 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -56.09 -24.25 39.03 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.849 -179.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -84.41 -12.15 54.95 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.876 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -80.32 5.6 14.33 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.601 0.715 . . . . 0.0 109.466 177.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.56 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 95.9 m-85 -119.43 167.13 12.23 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.075 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.516 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 9.4 mt-10 -140.34 -173.56 3.71 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.473 174.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 6.0 t0 62.5 83.42 0.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.237 0.542 . . . . 0.0 110.8 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.406 ' CD ' ' HZ1' ' A' ' 69' ' ' LYS . 30.8 tt0 -107.63 129.44 55.0 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.849 0.833 . . . . 0.0 111.257 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -124.1 156.48 36.53 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.892 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -107.46 125.52 51.36 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -164.67 148.22 8.97 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.56 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.7 m120 62.2 19.22 10.78 Favored 'General case' 0 CA--C 1.496 -1.106 0 O-C-N 123.557 0.536 . . . . 0.0 110.302 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.2 mtt 72.17 17.71 4.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.468 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 m -132.77 -178.48 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -115.05 140.72 48.83 Favored 'General case' 0 CA--C 1.478 -1.796 0 CA-C-O 121.257 0.551 . . . . 0.0 110.188 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 t -127.63 123.91 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.3 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.199 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.481 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 38.9 ttm180 -116.96 126.78 53.45 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -132.22 147.08 52.4 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.681 -0.808 . . . . 0.0 113.155 -176.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 54.4 mttp 82.29 111.61 0.03 OUTLIER Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.482 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 66.4 Cg_endo -77.28 151.95 30.27 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 122.688 2.259 . . . . 0.0 111.59 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.516 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 31.1 mtmt -83.28 -3.62 57.63 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.563 0.697 . . . . 0.0 110.427 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -144.48 -164.62 1.95 Allowed 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 32.1 tt0 -88.6 100.07 12.81 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.562 HG13 HG12 ' A' ' 12' ' ' ILE . 1.3 mp -113.83 121.59 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.878 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.478 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 74.9 mmtt -123.89 165.73 16.88 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.847 174.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.1 m -113.42 126.66 70.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 120.961 0.41 . . . . 0.0 112.03 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.63 123.44 29.8 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.645 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 p -132.22 173.38 11.31 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.874 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.44 HD12 ' O ' ' A' ' 58' ' ' LYS . 2.1 mm -121.25 140.64 44.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.274 0.559 . . . . 0.0 110.129 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.548 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 23.4 t70 -81.73 120.86 25.66 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.744 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.417 ' N ' HD21 ' A' ' 54' ' ' LEU . 4.7 mt -66.46 -25.34 66.68 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.494 -172.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.548 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -92.95 -24.08 18.51 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.856 -1.066 . . . . 0.0 112.416 -172.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.5 p -119.77 -26.43 5.67 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.607 -175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.16 14.37 69.27 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.44 ' O ' HD12 ' A' ' 52' ' ' ILE . 2.6 mptt -84.16 153.61 23.58 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 122.839 0.455 . . . . 0.0 111.738 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.91 105.5 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 CA-C-O 122.004 0.907 . . . . 0.0 109.724 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.3 m -110.16 163.75 6.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.079 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.7 tp -123.71 139.88 53.55 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 t -144.07 172.4 12.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.738 0.304 . . . . 0.0 110.849 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -86.15 161.99 18.59 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.727 0.775 . . . . 0.0 110.924 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 64' ' ' ILE . 3.3 mp -97.81 141.75 15.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.003 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.45 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 18.2 mm-40 -85.15 -39.58 17.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.423 ' O ' HD13 ' A' ' 167' ' ' LEU . 2.7 p30 173.9 175.11 0.15 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.593 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.481 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 21.7 t -104.41 142.33 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.826 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -112.87 123.5 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.701 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.39 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HZ1' ' CD ' ' A' ' 31' ' ' GLU . 39.6 ttpt -129.85 114.5 15.98 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.733 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.98 139.62 35.55 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.813 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -52.84 123.92 14.21 Favored 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 123.043 2.495 . . . . 0.0 112.61 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.4 106.38 11.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.091 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.1 m -125.23 -26.72 3.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.638 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -78.78 -137.44 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.387 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -155.14 171.33 19.98 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.514 ' CD2' ' HA ' ' A' ' 90' ' ' THR . 11.2 mt -132.83 140.63 48.05 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.937 -175.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.512 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 51.4 mt -88.96 145.87 6.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 19.8 ttt180 -121.28 138.94 54.01 Favored 'General case' 0 N--CA 1.404 -2.768 0 CA-C-O 121.256 0.551 . . . . 0.0 109.87 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.589 ' O ' ' HA ' ' A' ' 86' ' ' SER . 49.3 m-85 -116.35 126.26 53.25 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.119 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.2 tt0 -106.27 132.63 52.09 Favored 'General case' 0 CA--C 1.48 -1.724 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.543 HD13 ' HB3' ' A' ' 149' ' ' LEU . 2.2 mm? -99.05 156.86 16.72 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.205 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.57 ' HA ' ' HG3' ' A' ' 152' ' ' LYS . 1.8 pt-20 -58.62 -18.33 29.45 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.509 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.46 -8.31 48.11 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.746 0.784 . . . . 0.0 109.42 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.27 17.65 49.39 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.564 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.515 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -89.91 139.36 30.67 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 65.5 p -139.79 144.48 37.4 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.467 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -137.1 146.9 45.64 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.105 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.44 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 65.1 mt-10 -119.39 147.42 44.38 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.478 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.9 OUTLIER -142.76 157.84 44.24 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.677 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.539 ' C ' ' H ' ' A' ' 92' ' ' ASP . 0.9 OUTLIER -72.6 9.72 1.01 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 122.942 0.497 . . . . 0.0 111.921 -176.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.722 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.8 OUTLIER 68.03 -25.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.625 1.17 . . . . 0.0 112.494 177.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 90' ' ' THR . 0.2 OUTLIER -74.45 -12.88 60.61 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 124.344 1.058 . . . . 0.0 111.551 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -110.79 147.21 36.01 Favored Pre-proline 0 C--N 1.309 -1.176 0 C-N-CA 120.381 -0.527 . . . . 0.0 112.245 -175.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 3.1 Cg_exo -74.48 132.04 15.68 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.246 2.63 . . . . 0.0 114.047 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.5 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.6 t -97.21 144.88 9.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 184' ' ' HIS . 7.0 tp -102.05 107.81 19.04 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.658 0.265 . . . . 0.0 110.918 -175.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.633 HG22 ' OD1' ' A' ' 115' ' ' ASP . 2.2 p -111.17 151.37 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-O 121.378 0.609 . . . . 0.0 111.93 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -106.95 93.74 4.72 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.917 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.3 pt-20 -140.62 158.47 43.93 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 31.9 m-80 64.76 22.93 12.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.065 0.46 . . . . 0.0 110.289 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.76 15.42 64.42 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.53 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -137.12 172.43 13.01 Favored 'General case' 0 N--CA 1.398 -3.044 0 CA-C-O 121.422 0.63 . . . . 0.0 110.269 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -103.63 120.77 41.56 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.505 HG13 HG11 ' A' ' 97' ' ' VAL . 25.2 pt -121.48 155.84 25.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.518 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -104.35 116.25 31.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.975 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.4 ' HE3' ' CD1' ' A' ' 104' ' ' ILE . 85.7 mttt -125.4 129.48 49.96 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 111' ' ' VAL . 91.2 mtt180 -62.8 161.71 12.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.722 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -58.17 -42.43 85.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.537 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.484 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.1 p90 -73.91 3.48 6.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.077 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 110' ' ' GLU . 6.9 tp10 -114.82 -16.41 11.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.533 0.682 . . . . 0.0 110.22 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 107' ' ' ARG . 92.8 t -77.05 148.68 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.726 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 15.9 mtmt -121.55 162.95 19.68 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 120.827 0.346 . . . . 0.0 111.258 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.96 139.11 57.68 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.62 4.45 70.21 Favored Glycine 0 C--N 1.305 -1.179 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.779 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.726 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -75.14 168.71 19.46 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.573 ' HZ2' ' N ' ' A' ' 150' ' ' GLU . 22.2 mttm -123.84 164.28 19.54 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.577 0.703 . . . . 0.0 111.937 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.88 159.05 41.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.424 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.31 141.04 28.99 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 2.5 m -115.75 158.54 16.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.671 173.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.533 ' HB3' HD21 ' A' ' 180' ' ' ASN . 32.6 t -79.5 31.69 0.23 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.68 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 119' ' ' VAL . 43.5 mt-10 73.08 -48.11 0.68 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.512 1.125 . . . . 0.0 112.278 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.508 ' CD2' ' H ' ' A' ' 123' ' ' GLU . 0.5 OUTLIER -169.45 -158.94 0.2 Allowed 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -175.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.508 ' H ' ' CD2' ' A' ' 122' ' ' LEU . 44.3 mt-10 -107.42 -155.07 0.54 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.505 -175.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 16' ' ' PRO . 0.4 OUTLIER -94.86 34.73 1.32 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.006 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.421 ' O ' ' HA2' ' A' ' 141' ' ' GLY . 7.2 p -35.4 110.24 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 113.698 -1.592 . . . . 0.0 114.968 -176.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -147.95 178.08 8.81 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.541 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -89.27 169.42 11.45 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.291 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 m 67.02 36.92 3.99 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.663 0.744 . . . . 0.0 109.715 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.0 p -77.09 171.4 14.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.389 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.2 t 69.73 8.38 6.7 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.153 0.581 . . . . 0.0 111.627 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.4 m -70.82 136.68 48.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.801 0.334 . . . . 0.0 110.814 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -79.59 -22.96 43.06 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -87.56 175.61 7.84 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.349 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.501 ' ND2' ' HG2' ' A' ' 17' ' ' GLN . 22.9 t-20 -125.83 81.04 66.25 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 119.996 -0.682 . . . . 0.0 112.155 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -102.09 -175.29 0.11 Allowed 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 123.386 2.724 . . . . 0.0 111.42 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.8 tttm 173.61 139.03 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -157.95 -39.03 0.07 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.932 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -82.55 -167.57 1.66 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -112.08 -167.01 1.13 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.266 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.466 ' HG ' ' H ' ' A' ' 141' ' ' GLY . 17.4 tp 80.5 -135.54 0.01 OUTLIER 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.598 1.159 . . . . 0.0 110.541 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.466 ' H ' ' HG ' ' A' ' 140' ' ' LEU . . . 91.35 17.77 48.6 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.29 -176.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.0 m -85.96 119.02 71.51 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.71 -0.245 . . . . 0.0 110.828 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.457 ' HB3' ' CB ' ' A' ' 122' ' ' LEU . 16.7 Cg_exo -68.26 -67.7 0.03 OUTLIER 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.512 2.141 . . . . 0.0 111.713 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 54.32 72.31 0.46 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.534 0.733 . . . . 0.0 111.973 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.483 ' ND1' HD13 ' A' ' 122' ' ' LEU . 7.2 m80 -157.32 89.25 1.04 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.95 0.405 . . . . 0.0 111.624 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.02 103.75 5.33 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.456 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.535 ' C ' HD23 ' A' ' 148' ' ' LEU . 6.8 pt20 -163.97 125.01 2.24 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.567 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.535 HD23 ' C ' ' A' ' 147' ' ' GLN . 8.3 mt -111.38 153.45 26.02 Favored 'General case' 0 CA--C 1.482 -1.664 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.998 176.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 150' ' ' GLU . 0.0 OUTLIER -117.13 137.5 52.26 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -173.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.595 ' N ' HD12 ' A' ' 149' ' ' LEU . 14.5 mt-10 -90.58 147.43 23.34 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.752 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.498 HD11 ' CD1' ' A' ' 79' ' ' PHE . 79.1 mt -79.66 108.45 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.63 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.911 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.57 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 0.9 OUTLIER -64.69 -43.07 94.69 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.751 177.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -152.64 136.9 16.58 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.9 mt -115.7 143.13 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 113.623 -1.626 . . . . 0.0 110.589 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.442 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.0 ptpt -144.86 157.79 44.03 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.288 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.512 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 6.7 m-85 -100.54 118.05 35.94 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.412 HG11 ' HD3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -127.04 173.82 11.91 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.708 -178.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -105.92 157.49 17.45 Favored 'General case' 0 C--N 1.289 -2.051 0 O-C-N 121.911 -0.493 . . . . 0.0 111.627 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.95 118.63 8.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.567 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -63.09 -41.53 99.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.066 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -105.12 -174.12 2.46 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.669 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -99.04 0.41 43.7 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 120.851 0.357 . . . . 0.0 111.461 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -142.42 140.47 31.99 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.867 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 m -107.51 154.46 8.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.94 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.406 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 68.1 m-85 -134.39 166.55 22.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.036 -175.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.73 -22.15 0.06 Allowed 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.548 HD23 ' CD2' ' A' ' 24' ' ' LEU . 20.9 tp 68.46 111.42 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.266 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -82.32 113.38 20.07 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.282 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.45 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -133.34 -160.1 1.02 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -64.18 116.32 5.86 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.43 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 53.1 tptt 77.4 59.22 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 O-C-N 124.212 0.945 . . . . 0.0 111.416 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 66.61 -121.65 0.28 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.938 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -124.97 38.28 4.23 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.71 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . 25.2 p-10 -75.1 99.2 3.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.815 0.816 . . . . 0.0 109.335 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.515 HG21 HD13 ' A' ' 8' ' ' ILE . 2.1 p -142.34 165.33 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 CA-C-O 121.397 0.618 . . . . 0.0 111.289 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.497 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 97.2 mt -92.83 113.13 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.113 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 29.6 pt -120.13 167.67 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.293 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' A' ' 180' ' ' ASN . 6.6 t-20 49.77 -132.38 1.75 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.095 0.958 . . . . 0.0 109.987 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.84 44.62 0.84 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.774 0.797 . . . . 0.0 110.52 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.4 m-20 73.05 47.55 0.19 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 125.61 1.564 . . . . 0.0 113.342 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.7 mt -87.35 113.69 25.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.525 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.67 124.13 39.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.658 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.5 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 8.9 t -137.65 167.49 21.57 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.793 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.494 ' O ' HD23 ' A' ' 96' ' ' LEU . 38.4 m80 72.32 140.52 0.06 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.766 0.826 . . . . 0.0 112.996 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 . . . . . 0 C--O 1.258 1.52 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.573 177.504 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.566 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 77.6 m . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.841 0.353 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -114.32 164.72 15.51 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HD3' HD11 ' A' ' 76' ' ' LEU . 72.3 Cg_endo -72.96 162.94 39.72 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 N-CA-C 108.319 -1.454 . . . . 0.0 108.319 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.559 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -63.45 -25.36 68.55 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.055 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.88 -11.77 14.54 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.8 m -73.26 132.32 43.0 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.878 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 72.9 mmt-85 -84.21 135.78 34.22 Favored 'General case' 0 C--O 1.188 -2.163 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.417 ' N ' ' O ' ' A' ' 19' ' ' ILE . 9.6 tt -120.71 130.23 74.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.495 HD13 ' N ' ' A' ' 10' ' ' VAL . 1.3 tm? -89.83 124.32 34.57 Favored 'General case' 0 N--CA 1.412 -2.368 0 CA-C-O 121.545 0.688 . . . . 0.0 110.125 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 30.7 m -135.09 -175.72 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.57 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.431 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 33.0 tt0 -131.63 121.18 23.92 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.543 HG12 HG13 ' A' ' 47' ' ' ILE . 20.2 mt -120.05 121.89 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.949 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.62 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.461 ' OD2' ' HD3' ' A' ' 45' ' ' ARG . 68.1 m-20 55.04 38.41 30.48 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.948 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.86 18.46 78.94 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.841 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.53 120.03 23.17 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HB2' HD11 ' A' ' 124' ' ' LEU . 42.7 Cg_endo -70.95 121.95 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.623 2.215 . . . . 0.0 111.64 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -124.94 142.34 51.53 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.821 -176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -114.48 101.81 9.48 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.643 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 8' ' ' ILE . 2.4 pt -125.12 -172.5 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.161 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.048 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.705 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 6.8 p -91.68 173.07 8.07 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.333 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.6 mm? -64.12 -35.84 82.08 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.296 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.705 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 8.2 ptm180 -76.95 -26.64 54.24 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.564 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 52.3 mt-10 -80.59 -39.34 27.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.951 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.474 HD23 HD22 ' A' ' 167' ' ' LEU . 18.3 tp -61.35 -41.85 97.73 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.069 0.938 . . . . 0.0 109.139 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.66 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 6.6 m-30 -57.28 -28.98 63.48 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.588 -1.642 . . . . 0.0 113.164 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.618 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 54.1 mt-10 -73.16 -17.49 61.37 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.248 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.0 mm? -78.92 2.54 19.83 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.484 0.659 . . . . 0.0 109.57 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 97.9 m-85 -116.33 163.01 16.65 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.535 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -141.48 -173.12 3.68 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.588 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 1.7 t70 63.23 84.85 0.14 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.326 0.584 . . . . 0.0 110.842 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -100.4 126.93 46.83 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.741 0.782 . . . . 0.0 110.998 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -115.66 150.52 36.61 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.808 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -102.25 129.72 48.74 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.404 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -167.44 148.72 5.58 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.029 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 57.89 19.63 5.95 Favored 'General case' 0 CA--C 1.496 -1.109 0 O-C-N 123.798 0.686 . . . . 0.0 111.726 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.6 mtt 71.02 18.84 5.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.393 0.615 . . . . 0.0 110.274 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 4.5 m -129.01 -173.14 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.459 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 64.7 m-85 -118.5 142.57 47.46 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.186 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 t -129.02 123.73 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.893 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.399 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.602 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 35.4 ttm180 -116.92 126.86 53.6 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.552 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -136.16 144.38 44.98 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.974 -174.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.552 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 14.2 ttmt 88.55 108.83 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.41 0 O-C-N 124.916 1.385 . . . . 0.0 110.568 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 93.0 Cg_endo -79.81 153.83 22.95 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 122.442 2.095 . . . . 0.0 111.843 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -87.78 -1.25 57.84 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.471 0.653 . . . . 0.0 111.108 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.461 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 50.3 mtt180 -143.42 -166.15 2.25 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.6 tp10 -89.28 101.78 14.45 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 172.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.543 HG13 HG12 ' A' ' 12' ' ' ILE . 1.3 mp -114.56 118.16 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.017 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.519 ' HZ1' ' CG ' ' A' ' 63' ' ' ASP . 35.6 mmtt -115.39 169.04 9.45 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.911 175.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.489 HG12 ' CB ' ' A' ' 169' ' ' ALA . 9.3 p -123.85 130.83 73.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.076 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.24 129.4 35.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.031 0.443 . . . . 0.0 110.967 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.7 t -140.94 176.72 8.58 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.699 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.432 HD13 ' C ' ' A' ' 58' ' ' LYS . 2.0 mm -120.75 145.07 27.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.249 0.547 . . . . 0.0 110.561 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.743 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.2 t70 -88.62 123.34 32.99 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.819 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.592 HD21 ' H ' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -75.16 -17.86 60.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.106 0.479 . . . . 0.0 112.195 -172.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.743 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -94.55 -28.24 15.52 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.702 -175.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.446 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 60.3 p -114.85 -21.73 9.99 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.331 -176.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.77 17.64 74.73 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.138 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.446 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 18.5 mtpp -94.56 157.72 15.86 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.423 HG12 HD13 ' A' ' 122' ' ' LEU . 6.1 p -91.52 110.43 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.47 178.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 m -110.12 158.19 10.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.202 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.4 tp -122.65 140.27 53.03 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.0 t -147.04 172.05 14.33 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.611 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.519 ' CG ' ' HZ1' ' A' ' 48' ' ' LYS . 2.2 m-20 -83.78 161.58 20.92 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.763 0.792 . . . . 0.0 111.783 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 64' ' ' ILE . 2.1 mp -95.8 142.4 13.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.665 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.543 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 19.5 mt-10 -93.02 -34.88 13.54 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -179.55 -177.33 0.42 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.823 0.821 . . . . 0.0 111.716 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 6.9 t -115.24 128.3 72.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.696 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.477 HD12 ' HB2' ' A' ' 166' ' ' SER . 33.1 mt -97.09 104.73 16.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.548 -175.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.539 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 59.1 tttp -117.25 108.11 15.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.09 136.05 28.22 Favored Pre-proline 0 C--N 1.308 -1.218 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.438 ' HD2' HG13 ' A' ' 37' ' ' VAL . 72.5 Cg_exo -48.28 139.55 21.68 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.677 2.918 . . . . 0.0 113.689 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -85.83 96.32 9.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.158 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -89.11 -31.58 17.94 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.354 -175.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.0 -97.95 0.4 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.42 ' HB2' ' O ' ' A' ' 157' ' ' VAL . 0.4 OUTLIER 178.74 173.48 0.71 Allowed 'General case' 0 CA--C 1.471 -2.088 0 C-N-CA 123.936 0.895 . . . . 0.0 108.832 -175.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.537 HD22 ' HA ' ' A' ' 90' ' ' THR . 5.7 mt -123.96 140.6 52.82 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 118.748 -1.181 . . . . 0.0 112.898 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 109' ' ' PHE . 9.3 mt -84.77 145.94 7.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 172.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 19.9 ttt85 -116.94 138.38 51.58 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-O 121.227 0.537 . . . . 0.0 110.173 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.52 ' CD1' HD13 ' A' ' 151' ' ' ILE . 61.3 m-85 -116.13 122.86 46.33 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.28 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.0 tt0 -110.9 126.4 54.66 Favored 'General case' 0 CA--C 1.468 -2.202 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.564 HD21 ' O ' ' A' ' 85' ' ' ARG . 1.8 mm? -89.88 162.49 15.43 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.464 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.579 ' HG2' ' CD1' ' A' ' 149' ' ' LEU . 3.2 pt-20 -63.15 -15.65 57.52 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.786 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -91.92 -10.29 40.07 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.533 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.06 4.33 66.97 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.749 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.564 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -83.57 143.38 30.19 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 23.0 p -141.76 157.92 44.44 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.748 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -148.34 154.07 39.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.894 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 16.3 mt-10 -125.0 148.87 48.25 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.727 -176.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.47 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -143.0 156.82 44.92 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.532 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.537 ' HA ' HD22 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -67.17 13.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.691 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 1.4 m 67.27 -41.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 125.362 1.465 . . . . 0.0 113.814 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.17 -28.61 34.94 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.304 0.573 . . . . 0.0 109.956 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 29.8 m80 -73.49 144.37 83.66 Favored Pre-proline 0 C--N 1.314 -0.969 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.735 175.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.681 ' O ' ' HB3' ' A' ' 184' ' ' HIS . 5.7 Cg_exo -74.46 144.05 31.85 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.546 2.831 . . . . 0.0 114.704 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.01 146.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 124.841 1.256 . . . . 0.0 107.634 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.4 tp -102.36 113.08 26.1 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.179 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.69 HG23 ' OD1' ' A' ' 115' ' ' ASP . 2.0 p -116.8 150.23 18.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.33 0.586 . . . . 0.0 111.817 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.411 ' CD2' HD12 ' A' ' 148' ' ' LEU . 72.4 t80 -103.17 95.93 6.45 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.877 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.1 pt-20 -138.57 156.66 47.29 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 94.2 m-20 63.15 22.87 13.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.058 0.456 . . . . 0.0 110.319 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.79 13.01 63.07 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.925 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -132.36 171.71 13.39 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 117.434 0.617 . . . . 0.0 109.8 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -104.91 122.39 45.7 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.454 HG13 HG13 ' A' ' 97' ' ' VAL . 22.9 pt -121.61 156.57 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.312 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -111.69 106.98 15.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.808 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.506 ' HZ2' ' HE3' ' A' ' 112' ' ' LYS . 15.7 ptpt -122.81 141.23 52.06 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.725 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.557 ' O ' HG21 ' A' ' 111' ' ' VAL . 66.3 mtm180 -60.96 155.2 20.51 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.691 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -59.34 -40.32 85.99 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.312 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.514 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.2 p90 -75.21 -0.71 20.33 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.797 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -106.3 -19.65 13.63 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.703 0.763 . . . . 0.0 109.311 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.557 HG21 ' O ' ' A' ' 107' ' ' ARG . 86.5 t -71.67 149.11 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.506 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.686 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -122.17 166.83 13.97 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.842 -178.417 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.17 141.95 52.55 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.43 4.96 79.86 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.518 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.69 ' OD1' HG23 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -75.48 173.46 10.94 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -127.04 163.3 24.05 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 121.719 0.771 . . . . 0.0 112.198 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.3 158.26 42.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 114.639 -1.164 . . . . 0.0 107.887 168.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.446 ' HB3' ' HB ' ' A' ' 182' ' ' VAL . 1.1 tt -88.98 133.29 34.37 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -115.93 130.18 71.06 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.1 t -63.74 -19.16 64.74 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.058 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 145' ' ' HIS . 34.2 mm-40 45.2 15.15 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.777 -1.556 . . . . 0.0 114.468 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.423 HD13 HG12 ' A' ' 59' ' ' VAL . 0.8 OUTLIER -83.33 121.91 27.75 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.917 -178.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.41 ' OE2' ' HB3' ' A' ' 143' ' ' PRO . 1.2 pm0 -89.41 156.56 18.6 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.488 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.453 HD11 ' HB2' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -143.5 -66.14 0.37 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.592 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.7 p 178.41 140.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.559 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -106.09 -36.14 7.02 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.148 0.499 . . . . 0.0 110.745 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -89.83 87.28 6.9 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.128 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.5 m -145.63 -91.51 0.1 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.906 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.4 p 42.55 35.79 0.71 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.48 0.712 . . . . 0.0 112.786 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 33.8 m -111.27 152.05 27.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.553 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.0 t -108.35 -4.08 17.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.001 0.429 . . . . 0.0 110.327 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -101.6 -68.27 0.83 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.908 0.385 . . . . 0.0 110.757 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -83.54 98.58 9.64 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.494 0.664 . . . . 0.0 111.001 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.449 ' H ' ' CD ' ' A' ' 135' ' ' PRO . 18.6 m120 -124.91 -49.98 0.04 OUTLIER Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.449 ' CD ' ' H ' ' A' ' 134' ' ' ASN . 10.0 Cg_exo -71.83 81.29 1.37 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.71 2.274 . . . . 0.0 113.607 -175.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -156.57 110.62 2.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.515 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -168.69 95.4 0.36 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.271 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 139' ' ' ASN . 39.1 tt0 -136.66 150.72 48.65 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 28.5 t-20 87.36 5.49 0.3 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 31.6 tp 57.24 -102.84 0.16 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.068 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.89 48.77 2.22 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.7 t -44.79 123.37 4.83 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 124.122 0.969 . . . . 0.0 112.578 -176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.41 ' HB3' ' OE2' ' A' ' 123' ' ' GLU . 26.7 Cg_exo -64.74 175.33 3.71 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 123.161 2.574 . . . . 0.0 110.929 176.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 178.47 121.89 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.706 0.288 . . . . 0.0 111.652 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.575 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 179.96 153.33 0.5 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.872 177.437 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -156.41 98.1 1.81 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.151 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.527 ' C ' HD21 ' A' ' 148' ' ' LEU . 23.8 pt20 -164.76 143.24 6.72 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.346 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.527 HD21 ' C ' ' A' ' 147' ' ' GLN . 7.1 mt -109.28 155.46 21.11 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.375 0.607 . . . . 0.0 110.989 176.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.579 ' CD1' ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -116.85 137.9 51.89 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.063 -173.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -88.72 145.58 25.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 124.652 1.181 . . . . 0.0 112.639 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.52 HD13 ' CD1' ' A' ' 79' ' ' PHE . 70.0 mt -80.08 104.26 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.766 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 6.6 mmpt? -68.18 -38.96 82.61 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.876 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -149.59 135.63 18.86 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 82.5 mt -114.77 144.26 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.476 174.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.455 ' CD ' ' HD3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -148.1 158.43 44.06 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.922 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.411 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 15.2 m-85 -99.15 111.76 24.07 Favored 'General case' 0 N--CA 1.407 -2.583 0 CA-C-O 121.802 0.811 . . . . 0.0 109.762 174.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -116.56 175.64 2.91 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.903 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.29 179.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.421 ' HB3' ' H ' ' A' ' 159' ' ' ALA . 78.1 mtt180 -79.56 -146.55 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.381 -0.528 . . . . 0.0 112.169 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.421 ' H ' ' HB3' ' A' ' 158' ' ' ARG . . . -104.08 -13.61 16.21 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.673 -176.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.67 8.11 2.2 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.956 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -175.21 -173.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -104.0 -7.72 20.12 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.35 158.28 44.42 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.269 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.88 157.16 41.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.091 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.66 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 11.3 m-85 -131.29 170.55 14.46 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.714 -172.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.566 ' OG ' ' HA ' ' A' ' 1' ' ' CYS . 68.3 m -159.88 -22.01 0.06 Allowed 'General case' 0 C--N 1.359 0.994 0 CA-C-O 120.622 0.249 . . . . 0.0 110.377 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.474 HD22 HD23 ' A' ' 24' ' ' LEU . 14.4 tp 64.52 110.87 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.164 0.915 . . . . 0.0 112.081 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.453 HD21 ' HB2' ' A' ' 65' ' ' GLU . 4.4 t30 -84.63 108.26 17.27 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.543 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -112.65 -161.0 0.74 Allowed 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.654 ' O ' ' HG2' ' A' ' 171' ' ' LYS . 49.1 tptt -60.79 109.16 0.98 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.854 0.359 . . . . 0.0 110.67 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 170' ' ' LYS . 48.8 pttt 66.39 9.44 6.46 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.312 1.445 . . . . 0.0 111.934 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' A' ' 173' ' ' HIS . 43.7 p90 38.39 -140.96 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.71 0.804 . . . . 0.0 111.251 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.579 ' O ' ' HA ' ' A' ' 184' ' ' HIS . 12.6 t60 80.28 -45.37 0.28 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 171.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -129.41 153.59 47.77 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.962 0.411 . . . . 0.0 111.994 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.462 HG13 HG21 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -165.81 158.47 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.686 176.406 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.583 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 88.9 mt -108.9 116.52 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.779 0 CA-C-O 121.007 0.432 . . . . 0.0 110.321 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.462 HG21 HG13 ' A' ' 175' ' ' VAL . 43.2 pt -122.04 169.44 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.729 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.466 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 6.6 t-20 48.8 -133.05 1.51 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.333 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -83.94 53.97 2.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.459 0.647 . . . . 0.0 110.008 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.678 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.0 m120 70.55 45.32 0.61 Allowed 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.357 -1.292 . . . . 0.0 113.909 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 98.3 mt -86.04 112.38 22.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 118' ' ' LEU . 98.6 t -86.93 117.5 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.299 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.8 t -146.74 -176.22 5.11 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.939 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.681 ' HB3' ' O ' ' A' ' 94' ' ' PRO . 62.6 t-80 -92.73 137.87 31.99 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 . . . . . 0 C--O 1.263 1.791 0 CA-C-O 117.464 -1.255 . . . . 0.0 110.884 178.123 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.616 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 56.6 m . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 121.095 0.474 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.529 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 7.0 m-85 -136.0 163.32 51.16 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.475 ' HD3' HD11 ' A' ' 76' ' ' LEU . 73.0 Cg_endo -72.51 161.93 42.8 Favored 'Trans proline' 0 N--CA 1.438 -1.77 0 N-CA-C 108.41 -1.419 . . . . 0.0 108.41 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.503 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.01 -26.49 63.37 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 118.682 -1.723 . . . . 0.0 110.875 175.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 160' ' ' ASN . 6.9 m-20 -59.79 -13.81 12.01 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.7 m -74.4 129.03 37.0 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.351 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 10.9 mtm-85 -84.88 129.45 34.81 Favored 'General case' 0 C--O 1.195 -1.766 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.611 ' CD1' HG22 ' A' ' 175' ' ' VAL . 10.5 tt -115.04 129.87 70.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' ' 18' ' ' LYS . 2.6 tm? -94.96 123.94 38.72 Favored 'General case' 0 N--CA 1.399 -3.009 0 CA-C-O 121.786 0.803 . . . . 0.0 110.474 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.666 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 31.0 m -132.23 -172.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.849 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 30.9 tt0 -131.52 123.54 28.22 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 28.3 mt -120.68 122.49 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.893 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.632 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.74 41.81 31.65 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.033 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.58 18.92 72.43 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.774 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.55 118.73 18.07 Favored Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.525 ' HB2' HD11 ' A' ' 124' ' ' LEU . 52.6 Cg_exo -53.44 148.21 34.72 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 C-N-CA 122.053 1.835 . . . . 0.0 111.104 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -148.83 129.18 13.81 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HB2' HD22 ' A' ' 9' ' ' LEU . 40.3 ttmt -117.62 102.93 9.56 Favored 'General case' 0 CA--C 1.48 -1.741 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.883 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 24' ' ' LEU . 2.4 pt -125.23 -173.9 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.253 177.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.668 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 10.4 p -92.28 172.08 8.65 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.392 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.529 ' CD1' ' HB2' ' A' ' 2' ' ' PHE . 81.8 mt -66.17 -28.47 68.8 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.414 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.668 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 4.3 ptm180 -82.1 -24.56 35.09 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.505 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 51.9 mt-10 -84.16 -39.99 18.73 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.861 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.521 HD21 ' HG ' ' A' ' 167' ' ' LEU . 17.5 tp -61.12 -41.08 96.04 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.546 0.689 . . . . 0.0 109.826 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -51.14 -32.76 24.01 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.978 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.4 mt-10 -74.48 -15.8 60.87 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.248 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.92 2.17 27.8 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.589 0.709 . . . . 0.0 109.56 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.9 m-85 -118.37 164.54 15.09 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.832 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.515 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 12.6 mm-40 -141.16 -172.97 3.61 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.028 175.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t0 63.18 81.33 0.21 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.57 0.7 . . . . 0.0 110.392 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -99.19 122.44 42.39 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.791 0.805 . . . . 0.0 111.044 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -113.14 150.45 32.19 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.923 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -101.79 131.14 48.26 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -166.6 145.76 5.59 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.763 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.98 21.84 9.72 Favored 'General case' 0 CA--C 1.488 -1.41 0 O-C-N 123.85 0.718 . . . . 0.0 111.51 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 43.8 mtm 72.36 18.97 4.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.691 0.619 . . . . 0.0 110.569 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 10.5 m -134.7 -175.16 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.417 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 90.7 m-85 -112.85 139.98 48.02 Favored 'General case' 0 CA--C 1.478 -1.798 0 CA-C-O 121.243 0.544 . . . . 0.0 110.535 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -128.39 124.06 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.85 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.533 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 13.6 ttm180 -118.04 128.26 54.6 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.54 145.69 51.34 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.843 -173.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 5.2 tppp? 81.84 111.81 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.643 1.214 . . . . 0.0 111.235 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HB2' HD11 ' A' ' 47' ' ' ILE . 66.1 Cg_endo -78.91 154.0 25.82 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 122.079 1.853 . . . . 0.0 111.951 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 36.3 mtmt -85.38 -4.34 59.13 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.868 -178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -149.17 -165.22 2.22 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 33.9 tt0 -86.82 101.65 13.55 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.562 HG13 HG12 ' A' ' 12' ' ' ILE . 1.6 mp -114.85 113.02 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.998 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.666 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 72.6 mmtt -116.95 169.39 9.44 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.694 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.527 HG13 ' CB ' ' A' ' 169' ' ' ALA . 10.8 p -120.88 124.93 73.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.551 0.691 . . . . 0.0 111.959 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.788 ' CZ ' HG23 ' A' ' 59' ' ' VAL . 5.5 t80 -76.47 123.31 25.83 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.952 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.5 t -140.13 168.25 20.25 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.932 0.396 . . . . 0.0 110.815 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.13 145.14 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.164 0.507 . . . . 0.0 110.681 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -91.99 117.93 30.29 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.568 HD12 ' H ' ' A' ' 54' ' ' LEU . 4.2 mp -69.42 -31.47 69.83 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.786 0.803 . . . . 0.0 111.763 -172.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.35 -30.35 42.6 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.986 -174.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.4 p -111.08 -25.61 9.67 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.023 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.67 13.33 75.88 Favored Glycine 0 N--CA 1.421 -2.321 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.855 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -92.91 170.18 9.88 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 120.899 0.38 . . . . 0.0 111.24 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.788 HG23 ' CZ ' ' A' ' 50' ' ' TYR . 7.6 p -103.14 118.61 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.671 0 CA-C-O 121.873 0.844 . . . . 0.0 110.529 177.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -111.51 153.78 13.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.424 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 49' ' ' VAL . 11.7 tp -122.36 132.86 54.59 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.422 HG21 ' HB2' ' A' ' 170' ' ' LYS . 10.8 t -140.09 173.28 11.67 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.462 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -86.64 161.38 18.51 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.793 0.806 . . . . 0.0 111.558 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.449 HD11 ' N ' ' A' ' 64' ' ' ILE . 2.1 mp -91.81 141.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.688 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.569 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 7.9 mm-40 -83.46 -39.65 20.27 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 p30 178.12 174.79 0.56 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.812 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 25.9 t -104.76 137.35 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.319 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.455 HG21 HD13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -113.99 126.51 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.335 -178.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 52.6 tttp -135.38 115.81 13.61 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.889 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.39 142.56 45.86 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.697 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -51.72 136.32 50.19 Favored 'Trans proline' 0 C--N 1.327 -0.58 0 C-N-CA 123.284 2.656 . . . . 0.0 112.185 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.84 97.95 1.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.4 p -88.54 -67.12 0.85 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.073 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -92.64 -161.75 0.86 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.391 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -107.84 173.63 6.24 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.486 HD22 ' HA ' ' A' ' 90' ' ' THR . 10.5 mt -124.47 138.6 54.33 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.541 0.686 . . . . 0.0 111.214 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.493 HD13 ' C ' ' A' ' 108' ' ' ALA . 13.4 mt -85.0 145.01 8.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 31.9 ttt85 -121.24 137.14 54.82 Favored 'General case' 0 N--CA 1.406 -2.664 0 CA-C-O 121.282 0.563 . . . . 0.0 109.597 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.638 ' O ' ' HA ' ' A' ' 86' ' ' SER . 59.2 m-85 -116.6 127.85 54.86 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.127 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.8 tt0 -113.05 126.16 55.17 Favored 'General case' 0 CA--C 1.471 -2.093 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.983 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.597 HD13 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -90.15 152.4 21.13 Favored 'General case' 0 N--CA 1.399 -2.98 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.63 ' HA ' ' HG3' ' A' ' 152' ' ' LYS . 5.3 pt-20 -55.3 -22.27 18.15 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.592 ' OD1' ' HG3' ' A' ' 85' ' ' ARG . 32.6 p-10 -102.5 1.37 34.98 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.529 0.681 . . . . 0.0 110.968 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.87 19.91 20.52 Favored Glycine 0 C--N 1.304 -1.223 0 CA-C-N 114.767 -1.106 . . . . 0.0 115.837 171.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.592 ' HG3' ' OD1' ' A' ' 83' ' ' ASP . 8.4 mtt180 -88.51 136.29 33.06 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 57.2 p -138.44 137.24 37.03 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.86 173.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -134.63 155.22 50.86 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.362 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 38.3 mt-10 -131.3 151.31 51.63 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.257 0.551 . . . . 0.0 112.008 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.7 OUTLIER -146.6 161.1 41.23 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.693 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.486 ' HA ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -70.35 16.82 0.07 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.657 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.66 -28.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 125.235 1.414 . . . . 0.0 112.715 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.461 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 26.8 t70 -87.98 -8.07 56.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.433 0.635 . . . . 0.0 110.219 176.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -82.15 125.97 75.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.579 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -62.92 138.02 65.91 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.921 2.414 . . . . 0.0 112.568 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 17.3 t -114.7 146.17 19.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.3 tp -98.83 106.38 18.63 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.418 HG12 HG13 ' A' ' 104' ' ' ILE . 2.4 p -108.18 148.46 12.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.342 0.591 . . . . 0.0 111.4 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.486 ' CD2' HD13 ' A' ' 148' ' ' LEU . 49.8 t80 -100.99 94.15 5.86 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.813 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.453 ' CD ' HD11 ' A' ' 104' ' ' ILE . 11.5 pt-20 -144.96 158.23 43.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.2 m-20 64.02 22.16 12.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.015 0.436 . . . . 0.0 110.173 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.13 13.36 61.99 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.689 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -136.67 172.61 12.76 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 121.452 0.644 . . . . 0.0 110.425 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -104.72 121.61 43.97 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.686 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.453 HD11 ' CD ' ' A' ' 99' ' ' GLU . 16.7 pt -126.74 151.46 33.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.792 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.3 mp0 -106.28 111.24 23.75 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.092 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HD2' HG11 ' A' ' 97' ' ' VAL . 11.6 ptpt -125.76 143.43 51.05 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.277 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.629 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 79.7 mtt85 -61.57 163.28 7.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.657 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -61.41 -41.17 96.71 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.803 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.441 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.1 p90 -75.17 -0.92 20.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.717 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -106.73 -19.32 13.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.69 0.757 . . . . 0.0 109.172 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 107' ' ' ARG . 52.9 t -76.25 150.41 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -124.47 168.03 13.62 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.408 -177.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -68.24 138.45 55.57 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.25 5.13 67.84 Favored Glycine 0 C--N 1.3 -1.418 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.825 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.587 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 3.7 t70 -75.72 165.77 24.55 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.41 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 29.1 mttp -124.63 160.97 27.26 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.311 0.576 . . . . 0.0 111.116 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.35 160.26 42.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.271 173.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.7 136.24 37.51 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.2 m -109.11 161.15 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 121' ' ' GLU . 80.6 p -80.87 27.68 0.37 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.281 0.562 . . . . 0.0 110.547 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 119' ' ' VAL . 41.1 mt-10 72.92 -43.36 0.56 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.742 1.217 . . . . 0.0 113.156 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.573 ' HG ' ' H ' ' A' ' 123' ' ' GLU . 12.4 tp 179.11 -169.24 0.1 Allowed 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -170.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.573 ' H ' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER 172.65 -150.7 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 O-C-N 123.567 0.542 . . . . 0.0 111.544 178.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.651 ' O ' ' HG ' ' A' ' 124' ' ' LEU . 1.8 pt? -66.18 49.36 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.427 1.891 . . . . 0.0 111.584 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.0 t -17.14 117.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 125.968 1.707 . . . . 0.0 113.062 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -111.0 169.48 8.74 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.929 -173.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -102.53 -52.85 3.01 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.8 p -169.15 80.57 0.13 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.0 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.1 t 69.34 -164.73 0.18 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.187 -174.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.0 m -99.8 155.09 17.83 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.931 0.396 . . . . 0.0 111.06 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.0 t -95.98 -16.61 21.58 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.069 0.462 . . . . 0.0 110.098 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 135' ' ' PRO . 52.7 mt-30 -123.91 -177.73 3.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.124 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -61.9 -43.27 99.19 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.639 0.733 . . . . 0.0 112.089 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.459 ' H ' ' CD ' ' A' ' 135' ' ' PRO . 49.9 t30 -163.95 -45.1 0.0 OUTLIER Pre-proline 0 C--N 1.281 -2.412 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.211 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 27.5 Cg_exo -63.99 144.81 88.8 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.047 1.832 . . . . 0.0 109.383 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -173.43 -40.15 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.83 -175.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -172.44 134.45 0.67 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.449 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -101.22 -82.89 0.46 Allowed 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 41.61 -97.21 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.255 1.022 . . . . 0.0 112.611 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 38.4 tp -163.82 144.32 8.58 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.406 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.87 56.15 0.54 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 120.159 -1.019 . . . . 0.0 112.524 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.6 p -83.9 117.64 69.23 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.442 ' O ' ' HB2' ' A' ' 144' ' ' GLU . 9.6 Cg_endo -86.96 170.27 7.31 Favored 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.394 2.062 . . . . 0.0 112.111 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 143' ' ' PRO . 34.8 tt0 171.8 113.06 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.836 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 178.47 98.75 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.275 0.36 . . . . 0.0 110.186 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.16 93.22 7.02 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.748 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.43 ' C ' HD23 ' A' ' 148' ' ' LEU . 6.8 pt20 -164.5 119.95 1.48 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.25 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.486 HD13 ' CD2' ' A' ' 98' ' ' TYR . 9.7 mt -102.11 148.82 24.93 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 121.356 0.598 . . . . 0.0 109.738 175.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.597 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -113.9 137.58 51.48 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.423 -172.14 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.41 ' HG3' ' CG ' ' A' ' 116' ' ' LYS . 10.2 mt-10 -90.8 145.28 24.91 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.574 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.572 HD11 ' CD1' ' A' ' 79' ' ' PHE . 82.2 mt -76.96 102.72 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.371 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.63 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 35.5 mmtm -69.33 -35.74 76.23 Favored 'General case' 0 C--N 1.264 -3.125 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.369 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -151.59 128.79 11.18 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 66.7 mt -112.56 144.76 19.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.795 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.432 ' HD3' HG12 ' A' ' 157' ' ' VAL . 5.7 ptpp? -146.41 156.45 43.32 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.123 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -99.42 115.26 28.84 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.432 HG12 ' HD3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -128.87 173.75 13.24 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.568 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.878 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -106.35 166.1 10.78 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.37 132.35 46.24 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.935 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.431 ' HB2' ' OD1' ' A' ' 5' ' ' ASP . 24.3 m-80 -87.95 34.58 0.73 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.276 0.56 . . . . 0.0 110.018 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -161.74 178.86 8.6 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.03 -1.36 23.99 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.399 0.619 . . . . 0.0 110.243 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -139.13 153.38 47.96 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.478 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.8 m -119.01 157.12 20.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 58.5 m-85 -132.84 175.04 9.7 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.553 -176.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.616 ' OG ' ' HA ' ' A' ' 1' ' ' CYS . 49.2 m -154.54 -29.55 0.11 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.884 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.521 ' HG ' HD21 ' A' ' 24' ' ' LEU . 2.5 mm? 61.93 90.97 0.07 Allowed 'General case' 0 C--N 1.345 0.371 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 65' ' ' GLU . 47.8 m-20 -81.75 104.5 12.18 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.608 0.718 . . . . 0.0 111.974 -175.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.569 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -94.67 -155.41 0.46 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.285 172.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.422 ' HB2' HG21 ' A' ' 62' ' ' THR . 32.7 mmtm -61.66 133.77 55.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.223 0.535 . . . . 0.0 112.083 -177.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 74.8 tttt 78.84 -11.92 1.15 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.401 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 69.01 144.0 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.919 0.888 . . . . 0.0 112.078 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 49.16 32.37 4.12 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.949 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -117.59 104.01 10.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.416 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.611 HG22 ' CD1' ' A' ' 8' ' ' ILE . 1.7 p -158.66 171.07 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -176.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.495 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 71.8 mt -116.42 122.4 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.923 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.475 HG22 HG13 ' A' ' 175' ' ' VAL . 43.1 pt -126.68 167.39 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 121.597 0.713 . . . . 0.0 112.637 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 180' ' ' ASN . 38.9 t30 52.48 -129.63 2.31 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.255 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.412 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 3.2 mp0 -78.89 42.99 0.48 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.017 0.437 . . . . 0.0 110.491 176.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.553 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.3 m-20 71.02 48.37 0.38 Allowed 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 124.508 1.123 . . . . 0.0 112.308 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 85.0 mt -88.75 112.17 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.447 HG12 HG12 ' A' ' 176' ' ' ILE . 2.6 m -79.47 135.51 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 CA-C-O 121.969 0.89 . . . . 0.0 111.208 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.6 t -139.69 119.51 13.36 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -144.35 150.71 38.22 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -172.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 . . . . . 0 C--O 1.266 1.94 0 CA-C-O 117.26 -1.352 . . . . 0.0 109.706 176.677 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.701 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 33.7 t . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.922 0.391 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -121.91 166.0 18.33 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.515 ' HD3' HD11 ' A' ' 76' ' ' LEU . 74.0 Cg_endo -71.56 164.82 34.44 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.035 1.823 . . . . 0.0 109.356 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.17 -29.85 63.29 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 119.276 -1.44 . . . . 0.0 111.334 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.611 ' HA ' ' NH1' ' A' ' 22' ' ' ARG . 35.7 t70 -61.37 -16.44 46.37 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.1 m -68.73 125.42 26.52 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.072 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.669 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 78.5 mtm-85 -84.01 134.88 34.62 Favored 'General case' 0 C--O 1.182 -2.46 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.451 HD13 ' CD2' ' A' ' 24' ' ' LEU . 9.5 tt -120.47 130.1 74.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.475 HD21 HD13 ' A' ' 124' ' ' LEU . 0.6 OUTLIER -88.67 122.77 32.46 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-O 121.52 0.676 . . . . 0.0 109.656 178.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.4 m -135.52 -179.36 3.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.071 -176.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.447 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 33.0 tt0 -129.52 121.77 27.88 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.944 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 19.1 mt -121.79 121.8 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.097 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.92 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 56.43 37.48 28.86 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.473 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.38 15.92 77.23 Favored Glycine 0 C--N 1.305 -1.162 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.638 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.27 121.23 27.04 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.518 ' HB2' HD23 ' A' ' 124' ' ' LEU . 56.6 Cg_endo -72.44 122.69 8.51 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 C-N-CA 122.334 2.023 . . . . 0.0 111.416 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -120.45 138.13 53.96 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.916 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -107.98 101.08 10.37 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 8' ' ' ILE . 3.3 pt -127.03 -172.86 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.364 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 21.5 p -97.96 172.24 7.76 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.771 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 66.2 mt -68.15 -27.38 66.38 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.016 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.611 ' NH1' ' HA ' ' A' ' 5' ' ' ASP . 1.0 OUTLIER -78.53 -26.66 45.8 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.48 ' OE1' HG22 ' A' ' 20' ' ' THR . 85.3 mt-10 -85.73 -42.05 14.58 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.238 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.52 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 20.1 tp -58.8 -42.92 90.21 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.866 0.841 . . . . 0.0 109.319 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.406 ' HB2' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -52.41 -31.0 32.12 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.734 -1.575 . . . . 0.0 112.687 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.11 -19.32 61.81 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.757 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.1 mm? -78.29 1.92 20.15 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.483 0.659 . . . . 0.0 109.601 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.466 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 97.9 m-85 -119.15 156.52 29.65 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.035 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 17.4 mt-10 -157.65 131.51 8.05 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.092 175.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 47.6 t0 127.83 85.93 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.794 2.037 . . . . 0.0 107.394 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -99.23 125.28 44.8 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.113 0.959 . . . . 0.0 111.696 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -117.53 150.67 38.57 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.131 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -102.46 131.67 48.99 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -166.55 148.35 6.46 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.499 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 58.26 23.11 9.99 Favored 'General case' 0 CA--C 1.491 -1.296 0 O-C-N 123.81 0.694 . . . . 0.0 111.067 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 44.8 mtm 73.69 15.83 3.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.233 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.8 m -130.4 -170.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.92 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -112.5 138.1 49.75 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 t -130.08 123.54 56.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.08 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HD3' ' HA ' ' A' ' 29' ' ' GLU . 17.0 ttm180 -110.02 134.0 52.6 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -116.77 179.31 4.05 Favored 'General case' 0 C--N 1.267 -2.99 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.28 106.37 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 125.079 1.487 . . . . 0.0 114.505 170.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.39 140.01 18.98 Favored 'Trans proline' 0 N--CA 1.426 -2.482 0 C-N-CA 121.552 1.501 . . . . 0.0 110.619 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -83.71 -0.48 50.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.447 0.641 . . . . 0.0 111.735 -175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -147.34 -171.0 3.69 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 19.3 tt0 -79.83 105.34 11.05 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.549 HG13 HG12 ' A' ' 12' ' ' ILE . 1.4 mp -116.28 112.37 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.361 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.46 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 45.7 mmtm -113.56 166.5 11.46 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.739 173.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.465 HG11 ' CB ' ' A' ' 169' ' ' ALA . 12.1 p -121.48 131.29 73.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.447 ' CE2' ' HB2' ' A' ' 11' ' ' GLN . 19.2 m-85 -82.95 121.24 26.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.872 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 m -135.42 170.17 16.35 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.668 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.468 HD11 ' O ' ' A' ' 58' ' ' LYS . 2.4 mm -113.26 142.9 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.433 0.635 . . . . 0.0 110.831 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.64 80.26 3.08 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.577 ' H ' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -36.33 -40.66 0.24 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.399 1.88 . . . . 0.0 114.039 -175.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 2.1 pt-20 -63.33 -37.78 88.61 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.323 -176.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.508 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.4 p -107.34 -22.51 12.56 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.914 -176.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.55 20.46 68.84 Favored Glycine 0 N--CA 1.421 -2.366 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.015 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.508 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 40.8 mtpt -94.07 158.94 15.38 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.57 109.73 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.783 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.67 155.74 11.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-O 121.066 0.46 . . . . 0.0 111.387 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.8 tp -123.01 135.11 54.33 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.2 t -143.1 170.75 15.13 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.324 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -76.73 161.14 28.74 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.202 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 47' ' ' ILE . 1.9 mp -97.43 145.75 8.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.321 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.439 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 14.9 mm-40 -79.7 -53.3 6.95 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -175.48 -171.73 0.51 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.673 1.233 . . . . 0.0 107.918 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.41 ' HA ' HD22 ' A' ' 167' ' ' LEU . 14.3 t -107.31 149.99 10.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 120.889 0.376 . . . . 0.0 110.428 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 166' ' ' SER . 56.4 mt -111.95 118.96 58.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.198 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 19.2 tttm -134.75 112.62 10.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.933 0.397 . . . . 0.0 109.95 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.52 143.63 50.02 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.029 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -54.32 130.07 37.9 Favored 'Trans proline' 0 C--N 1.328 -0.502 0 C-N-CA 123.208 2.605 . . . . 0.0 112.446 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.98 85.53 6.24 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.611 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.8 p -96.55 -43.12 7.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.665 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.06 174.59 8.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.606 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -102.16 171.78 7.29 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.515 HD11 ' HD3' ' A' ' 3' ' ' PRO . 12.1 mt -126.02 143.05 51.25 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.753 0.787 . . . . 0.0 110.973 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.515 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 7.6 mt -83.82 141.4 14.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 15.9 ttt-85 -116.56 136.38 53.03 Favored 'General case' 0 N--CA 1.407 -2.575 0 CA-C-O 121.191 0.52 . . . . 0.0 109.748 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 86' ' ' SER . 55.0 m-85 -114.66 120.83 41.46 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.256 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 37.4 tt0 -108.07 126.62 52.96 Favored 'General case' 0 CA--C 1.467 -2.222 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.567 HD13 ' HB3' ' A' ' 149' ' ' LEU . 1.6 mm? -88.16 157.53 18.79 Favored 'General case' 0 C--N 1.27 -2.855 0 O-C-N 123.584 0.553 . . . . 0.0 110.97 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.573 ' HG2' HD13 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -59.32 -18.5 38.61 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.1 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -91.92 -10.2 40.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.847 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.42 9.64 57.65 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.965 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.536 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -84.17 141.57 30.96 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -142.09 140.52 32.55 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.823 176.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -135.48 157.47 46.82 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.497 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 31.3 mt-10 -129.1 153.19 47.89 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.154 0.502 . . . . 0.0 112.026 -176.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.8 OUTLIER -145.88 158.43 43.86 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.384 177.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.497 ' HA ' HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -72.37 18.99 0.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.693 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.71 -41.91 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 C-N-CA 125.367 1.467 . . . . 0.0 114.151 175.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -82.21 2.88 29.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 111.144 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.442 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 36.8 m-70 -104.59 136.13 19.22 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.728 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 35.6 Cg_exo -62.3 142.41 91.13 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.543 2.829 . . . . 0.0 114.824 -177.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.506 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.8 t -117.97 147.28 21.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.604 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.6 tp -103.82 111.43 23.94 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.497 HG13 ' CG1' ' A' ' 104' ' ' ILE . 2.0 p -113.79 140.9 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-O 121.592 0.71 . . . . 0.0 111.667 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.603 ' CD2' HD13 ' A' ' 148' ' ' LEU . 81.6 t80 -91.37 92.37 8.55 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.533 ' HG3' HD21 ' A' ' 100' ' ' ASN . 1.0 OUTLIER -142.2 148.86 38.88 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.474 -175.009 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.533 HD21 ' HG3' ' A' ' 99' ' ' GLU . 28.6 m-80 69.18 22.55 6.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 110.027 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.14 14.51 63.88 Favored Glycine 0 CA--C 1.5 -0.905 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.91 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -140.05 173.32 11.64 Favored 'General case' 0 N--CA 1.41 -2.46 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -97.01 120.37 37.23 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.497 ' CG1' HG13 ' A' ' 97' ' ' VAL . 12.3 pt -116.91 143.13 27.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.006 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -107.49 110.44 22.38 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.13 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.423 ' HG3' HG21 ' A' ' 111' ' ' VAL . 11.5 ptpt -127.24 138.86 53.19 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.608 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.641 ' O ' HG23 ' A' ' 111' ' ' VAL . 56.6 mtm180 -64.62 164.14 12.46 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 119.347 -0.359 . . . . 0.0 110.147 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.693 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -61.57 -43.21 99.28 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.514 -175.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -75.05 2.74 9.86 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.524 0.678 . . . . 0.0 110.332 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -114.01 -15.39 12.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.553 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 107' ' ' ARG . 93.2 t -81.87 149.27 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.682 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 18.1 mtmt -124.06 163.47 21.38 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.091 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -64.12 142.89 58.25 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.66 4.2 85.54 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.887 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.682 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -74.98 167.9 21.02 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.465 ' HG3' ' HG3' ' A' ' 150' ' ' GLU . 3.8 ttmt -123.97 166.43 15.72 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.185 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.55 161.43 36.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -90.5 129.89 36.61 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.666 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -112.87 125.28 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.909 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.3 t -65.76 -16.18 63.54 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.542 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 121' ' ' GLU . 1.9 tp10 44.49 26.28 0.17 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 113.402 -1.726 . . . . 0.0 112.769 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 55.5 tp -87.17 111.6 21.13 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.026 0.441 . . . . 0.0 110.757 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -106.5 164.57 11.94 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -121.13 18.9 11.6 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 122.709 1.242 . . . . 0.0 108.434 -174.479 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.2 p -68.28 137.94 23.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 112.48 -2.146 . . . . 0.0 112.323 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 139' ' ' ASN . 17.5 mt-10 -109.53 -11.77 14.76 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.622 177.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 70.44 30.72 3.17 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.581 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.5 p -98.56 -62.13 1.28 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.616 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 55.6 m -157.19 -175.81 5.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.485 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.2 m -67.66 148.41 51.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.757 0.313 . . . . 0.0 110.6 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.6 p -77.99 76.76 4.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.173 0.511 . . . . 0.0 110.672 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -118.82 -8.87 10.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.425 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -106.45 -139.51 0.37 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.04 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.661 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 3.6 t-20 -164.15 -44.32 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.161 -175.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 134' ' ' ASN . 10.9 Cg_endo -55.37 -146.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.691 2.927 . . . . 0.0 113.436 174.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.459 ' H ' ' HB2' ' A' ' 135' ' ' PRO . 84.2 mttt 67.99 -79.57 0.04 OUTLIER 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.258 0.623 . . . . 0.0 110.203 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.8 t30 54.36 42.94 31.15 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.683 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -95.02 -50.3 5.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.987 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.433 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . 4.0 p-10 42.59 -168.51 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.226 1.01 . . . . 0.0 113.372 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 140' ' ' LEU . 2.0 pt? -117.83 160.33 21.56 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.837 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.66 -59.87 6.73 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.285 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.4 m -122.15 118.31 29.12 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-O 120.735 0.303 . . . . 0.0 110.936 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -85.81 -165.59 0.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.765 2.31 . . . . 0.0 111.175 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -117.34 129.96 56.21 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.404 ' HB2' ' H ' ' A' ' 146' ' ' ASP . 15.7 p80 -163.39 -165.03 1.0 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -176.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.404 ' H ' ' HB2' ' A' ' 145' ' ' HIS . 1.0 OUTLIER 74.51 52.7 0.09 Allowed 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 124.109 0.964 . . . . 0.0 111.753 -178.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.546 ' O ' HG21 ' A' ' 119' ' ' VAL . 19.2 pt20 -151.8 142.65 22.95 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.229 -1.351 . . . . 0.0 107.794 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.603 HD13 ' CD2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -125.45 160.27 29.86 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.573 HD13 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -122.73 139.28 54.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.644 -170.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.465 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 19.1 mt-10 -91.19 150.52 21.33 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 122.337 1.065 . . . . 0.0 112.741 177.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.449 HG21 ' CG1' ' A' ' 154' ' ' ILE . 61.1 mt -77.79 121.69 31.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 113.246 -1.797 . . . . 0.0 111.002 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.568 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 49.4 mmtt -80.99 -39.19 26.33 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.482 175.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -148.73 130.2 14.82 Favored 'General case' 0 CA--C 1.473 -2.01 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.6 mt -117.62 126.26 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.445 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.297 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.82 166.89 22.24 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.153 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.515 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 23.8 m-85 -101.58 119.82 39.36 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -135.57 137.21 49.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.683 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -71.1 154.1 42.02 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.258 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.22 134.64 57.18 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.259 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -82.84 37.55 0.54 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.604 0.716 . . . . 0.0 110.163 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -175.16 179.26 1.58 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -107.34 4.32 26.3 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.858 0.361 . . . . 0.0 111.607 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -141.54 149.48 40.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.458 HG13 ' HA ' ' A' ' 3' ' ' PRO . 3.0 m -118.78 155.41 20.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.536 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.504 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 56.5 m-85 -133.16 174.17 10.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.111 -176.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.701 ' OG ' ' HA ' ' A' ' 1' ' ' CYS . 49.1 m -159.06 -27.42 0.07 Allowed 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.52 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 1.3 tm? 68.91 107.14 0.05 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.066 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -85.25 116.16 23.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.666 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.465 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -135.36 -163.03 1.33 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.045 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.411 ' HA ' ' CE ' ' A' ' 170' ' ' LYS . 0.3 OUTLIER -63.67 127.15 30.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 70.12 103.81 0.06 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.884 0.74 . . . . 0.0 109.078 -174.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -56.94 132.67 53.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.226 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 50.6 m80 67.01 12.07 8.76 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.641 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -91.37 99.65 12.58 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.446 HG11 HG22 ' A' ' 177' ' ' ILE . 2.8 p -152.96 163.92 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.433 0.635 . . . . 0.0 111.673 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.605 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 93.8 mt -116.71 115.78 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.444 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.446 HG22 HG11 ' A' ' 175' ' ' VAL . 39.5 pt -123.78 173.48 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.415 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 7.9 t-20 49.19 -122.36 1.71 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.35 1.06 . . . . 0.0 109.81 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -96.21 56.59 1.64 Allowed 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.47 0.652 . . . . 0.0 109.658 175.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.666 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 25.7 m-80 69.51 43.56 1.0 Allowed 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 114.216 -1.357 . . . . 0.0 113.751 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.5 mt -85.49 116.55 28.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.55 129.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.357 -174.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.506 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 14.7 t -139.26 164.54 29.55 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.448 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -160.59 154.17 22.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.588 0.232 . . . . 0.0 110.614 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 C--O 1.27 2.179 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.587 178.083 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.579 ' HA ' ' OG1' ' A' ' 90' ' ' THR . 69.2 m . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.882 0.373 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -140.39 145.1 39.61 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.416 ' HA ' HG13 ' A' ' 164' ' ' VAL . 23.0 Cg_endo -61.25 -32.66 90.45 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 122.852 2.368 . . . . 0.0 112.781 -174.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.516 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 127.04 -39.27 1.99 Allowed Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.38 -16.92 25.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.648 0.779 . . . . 0.0 111.058 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -64.4 126.69 28.63 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.593 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 19.1 mmt85 -82.79 134.41 35.12 Favored 'General case' 0 C--O 1.186 -2.25 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 175' ' ' VAL . 9.9 tt -121.66 131.4 73.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.432 HD11 ' N ' ' A' ' 10' ' ' VAL . 2.1 tm? -87.66 123.71 32.79 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.611 0.72 . . . . 0.0 109.847 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 31.5 m -133.06 -177.26 2.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.02 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -130.3 121.32 25.85 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.537 HG12 HG13 ' A' ' 47' ' ' ILE . 22.3 mt -118.36 121.32 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.523 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.707 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.84 38.12 29.73 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.691 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.02 20.29 79.47 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.769 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.04 118.32 22.09 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-O 120.683 0.277 . . . . 0.0 110.41 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 7.0 Cg_exo -66.78 121.54 8.77 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 122.068 1.845 . . . . 0.0 111.065 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -123.63 137.4 54.74 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.693 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -108.54 101.37 10.53 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.424 ' O ' ' N ' ' A' ' 8' ' ' ILE . 2.9 pt -123.53 -171.9 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.18 -2.555 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.624 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.772 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 6.6 p -94.44 171.82 8.58 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.088 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 12.3 mt -72.38 -24.5 61.27 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 120.683 0.277 . . . . 0.0 110.909 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.772 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 8.1 ptm180 -82.18 -24.35 35.02 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.558 ' HG2' ' HG1' ' A' ' 20' ' ' THR . 67.8 mm-40 -82.96 -44.59 15.13 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.043 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.418 ' HA ' HD11 ' A' ' 19' ' ' ILE . 20.5 tp -54.74 -45.57 74.14 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.88 0.848 . . . . 0.0 109.407 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.433 ' HB2' HG12 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -52.2 -31.16 30.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.554 -1.657 . . . . 0.0 112.754 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 26.8 mt-10 -78.81 -15.35 58.5 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -77.97 5.92 8.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.76 0.79 . . . . 0.0 109.39 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.491 ' CZ ' HG23 ' A' ' 47' ' ' ILE . 97.7 m-85 -121.01 162.46 19.89 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.857 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.559 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 21.1 mm-40 -142.06 -172.86 3.67 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.296 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.45 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.7 t70 63.1 80.04 0.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.376 0.607 . . . . 0.0 110.469 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.35 128.09 43.87 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.841 0.829 . . . . 0.0 110.672 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.421 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.0 ptt180 -121.78 154.42 37.0 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.402 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -102.84 126.33 49.93 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -162.5 140.96 8.78 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.622 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 58.65 24.14 11.78 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 123.671 0.607 . . . . 0.0 110.624 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.6 mtp 72.74 13.44 5.16 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.348 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 12.9 m -127.31 -177.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -112.42 139.68 47.79 Favored 'General case' 0 CA--C 1.471 -2.081 0 CA-C-O 121.303 0.573 . . . . 0.0 109.855 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.421 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.8 t -128.94 122.55 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 0 CA-C-N 115.14 -0.937 . . . . 0.0 108.77 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.424 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 16.1 ttm180 -112.24 126.17 54.94 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.45 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -129.95 145.51 51.63 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.177 -173.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 3.6 tppp? 81.78 111.94 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.48 0 O-C-N 124.54 1.15 . . . . 0.0 110.902 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -78.72 152.44 25.61 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 122.15 1.9 . . . . 0.0 111.622 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.559 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 32.4 mtmt -81.53 -5.43 57.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.422 0.629 . . . . 0.0 111.214 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -146.19 -165.39 2.2 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 39.9 tt0 -86.04 102.0 13.43 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.537 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -116.91 120.92 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.167 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 22.5 mmtt -120.02 164.7 15.73 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.181 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.412 HG13 ' CB ' ' A' ' 169' ' ' ALA . 12.9 p -118.67 130.92 72.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.274 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -90.73 118.92 30.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.6 0.714 . . . . 0.0 111.461 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.9 m -134.24 146.68 50.31 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.819 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.458 HG12 HD11 ' A' ' 176' ' ' ILE . 2.8 mm -90.26 141.03 14.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.334 0.588 . . . . 0.0 110.345 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.475 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 13.5 t70 -80.57 121.14 25.43 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.588 HD21 ' H ' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -78.16 -8.52 58.39 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.237 0.541 . . . . 0.0 111.876 -169.287 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.475 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.5 pt-20 -103.27 -31.56 10.02 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.35 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.484 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 68.2 p -111.84 -18.11 12.78 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.78 -175.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.46 21.34 79.63 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.345 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.484 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 38.2 mtpt -98.14 162.24 13.31 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 120.865 0.364 . . . . 0.0 111.464 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.46 110.45 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-O 121.767 0.794 . . . . 0.0 109.509 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 m -110.05 156.88 10.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.051 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.5 tp -123.1 136.87 54.98 Favored 'General case' 0 N--CA 1.411 -2.387 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.415 ' OG1' ' HB2' ' A' ' 170' ' ' LYS . 10.3 t -142.66 171.21 14.37 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.939 0.399 . . . . 0.0 111.316 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.436 ' O ' ' HB1' ' A' ' 169' ' ' ALA . 0.9 OUTLIER -80.26 161.04 25.34 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.395 178.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.474 HD11 ' N ' ' A' ' 64' ' ' ILE . 2.3 mp -101.15 136.72 31.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.222 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -83.59 -41.22 18.11 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -179.49 178.01 0.7 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.405 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 25' ' ' TYR . 13.3 t -105.86 132.76 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.795 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.625 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 60.3 mt -91.28 108.45 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.095 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.497 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.7 tttt -124.56 107.93 11.55 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 163' ' ' PHE . . . -131.52 144.53 53.75 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.312 -175.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.452 ' HD2' HG11 ' A' ' 37' ' ' VAL . 9.8 Cg_endo -53.97 131.67 45.74 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.389 2.726 . . . . 0.0 112.29 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -78.15 -108.95 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.728 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 86.2 m 77.02 -21.45 0.33 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.945 0.498 . . . . 0.0 111.878 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.79 -139.77 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.446 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -150.68 165.79 32.36 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.688 ' CD1' ' HA ' ' A' ' 159' ' ' ALA . 30.5 mt -135.98 136.54 40.44 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.117 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.557 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 15.6 mt -89.61 146.24 6.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 172.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 28.8 ttt85 -121.08 137.87 54.45 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 121.153 0.501 . . . . 0.0 109.999 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.495 ' CD1' HD12 ' A' ' 151' ' ' ILE . 50.7 m-85 -117.57 127.31 53.84 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.2 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 32.4 tt0 -112.88 130.3 56.15 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.554 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 1.7 mm? -94.27 162.04 14.01 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.04 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.565 ' HG2' ' CD1' ' A' ' 149' ' ' LEU . 4.3 pt-20 -58.27 -22.42 52.47 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.875 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.725 ' OD1' ' HG ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -86.69 -10.8 52.92 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.575 0.702 . . . . 0.0 109.498 -178.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.78 14.4 58.11 Favored Glycine 0 C--N 1.297 -1.602 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.191 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.554 ' HG3' ' HB2' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -89.64 142.48 27.64 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.308 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 35.3 p -139.95 154.33 47.17 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.888 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 79' ' ' PHE . 9.3 p90 -142.86 151.34 40.97 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.723 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 96.9 mt-10 -125.8 146.12 49.93 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.56 -177.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.478 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -142.31 159.46 42.19 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.406 -179.065 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.579 ' OG1' ' HA ' ' A' ' 1' ' ' CYS . 1.7 m -73.62 19.22 0.11 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.3 0.571 . . . . 0.0 112.478 -177.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.689 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.88 -34.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 124.78 1.232 . . . . 0.0 113.249 175.152 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.517 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 23.3 t70 -78.62 -24.59 45.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.129 0.49 . . . . 0.0 110.017 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -77.8 119.97 79.49 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.277 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 35.1 Cg_exo -62.2 139.83 80.13 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.522 2.815 . . . . 0.0 114.014 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.5 t -100.28 147.42 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.736 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.5 tp -98.02 106.16 18.42 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.168 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.51 HG13 HG12 ' A' ' 104' ' ' ILE . 2.4 p -112.55 149.37 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.678 0.751 . . . . 0.0 112.258 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -104.05 92.81 4.54 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.781 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.566 ' OE2' ' HE3' ' A' ' 106' ' ' LYS . 6.1 pt-20 -138.85 159.94 40.9 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 89.9 m-20 63.14 22.37 13.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.332 0.587 . . . . 0.0 109.7 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.29 16.68 62.91 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.298 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -136.4 171.99 13.67 Favored 'General case' 0 N--CA 1.399 -2.979 0 CA-C-N 117.605 0.702 . . . . 0.0 109.916 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -98.36 121.25 40.07 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.51 HG12 HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -126.98 148.75 31.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.132 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 3.3 mp0 -108.11 116.45 31.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.515 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.566 ' HE3' ' OE2' ' A' ' 99' ' ' GLU . 51.0 mttm -124.62 134.72 52.82 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.328 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 75.3 mtm180 -56.66 154.78 8.39 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.689 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -59.87 -41.74 92.18 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.935 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.522 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.4 p90 -73.51 2.11 8.53 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.92 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -114.14 -19.26 11.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.863 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 107' ' ' ARG . 53.1 t -76.97 152.3 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.576 ' HE2' ' H ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -123.94 167.08 14.61 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -71.15 143.53 50.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.99 4.96 74.19 Favored Glycine 0 C--N 1.304 -1.199 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.569 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.575 ' O ' ' HA ' ' A' ' 150' ' ' GLU . 15.2 t70 -72.03 178.81 3.56 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.617 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 71.4 mttt -135.45 154.52 51.41 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.62 0.724 . . . . 0.0 112.037 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.05 155.64 41.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.895 173.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.486 ' HA ' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -97.12 135.91 38.41 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.8 OUTLIER -104.93 125.96 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.747 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.819 176.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.8 t -85.14 43.65 1.02 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' A' ' 119' ' ' VAL . 22.6 tt0 -67.55 38.73 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.168 1.387 . . . . 0.0 113.025 -172.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 143' ' ' PRO . 0.7 OUTLIER -121.06 -171.49 2.21 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 68.05 -84.65 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.833 1.653 . . . . 0.0 114.535 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.569 ' H ' HD23 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -64.61 -62.82 1.35 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -173.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.513 ' H ' ' HG ' ' A' ' 124' ' ' LEU . 43.4 t 77.12 116.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 O-C-N 123.778 0.674 . . . . 0.0 109.878 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 60.82 -101.59 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.295 -174.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 32.92 80.87 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.732 1.213 . . . . 0.0 113.135 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.9 p -93.31 154.68 17.85 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.815 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.4 p -74.34 88.39 2.04 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.391 0.615 . . . . 0.0 110.97 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.6 p -171.37 -150.62 0.07 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.1 m -67.9 86.43 0.23 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.24 0.543 . . . . 0.0 109.989 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -152.92 143.17 22.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.085 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -68.74 131.7 45.61 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.179 0.514 . . . . 0.0 111.261 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.409 ' HB2' ' HD3' ' A' ' 135' ' ' PRO . 5.4 m120 -74.6 -51.86 3.95 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.707 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 134' ' ' ASN . 32.0 Cg_exo -59.84 105.7 0.29 Allowed 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.152 2.568 . . . . 0.0 114.041 -176.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -113.93 102.4 10.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.708 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -153.29 -35.21 0.11 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.708 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.52 33.45 0.42 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -151.53 164.48 36.72 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.703 0.287 . . . . 0.0 110.919 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 140' ' ' LEU . 2.4 pt? -76.29 153.81 35.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.386 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -127.8 19.82 5.8 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.788 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.6 p -70.38 118.07 60.79 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-O 120.868 0.366 . . . . 0.0 110.208 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.505 ' HB3' ' HB2' ' A' ' 122' ' ' LEU . 59.2 Cg_endo -82.17 153.76 16.57 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.389 2.06 . . . . 0.0 114.769 -175.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -144.69 20.84 1.66 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.617 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 39.1 m170 -115.54 96.05 5.45 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.055 0.455 . . . . 0.0 111.171 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -132.5 88.35 2.52 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -147.73 154.11 40.12 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.361 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.617 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.9 mm? -108.49 141.47 40.32 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.042 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.725 ' HG ' ' OD1' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -119.28 135.95 54.46 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.006 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.713 ' N ' HD13 ' A' ' 149' ' ' LEU . 25.8 mt-10 -83.19 141.51 31.87 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.96 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.532 HD13 ' HB3' ' A' ' 115' ' ' ASP . 73.0 mt -80.17 104.87 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.995 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.586 174.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.54 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 14.1 mmtm -70.64 -37.13 73.74 Favored 'General case' 0 C--N 1.266 -3.06 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.159 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -148.92 129.25 13.77 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 75.7 mt -113.11 144.82 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.529 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.41 ' HD2' ' HD3' ' A' ' 78' ' ' ARG . 5.2 ptpp? -145.99 156.14 43.29 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.815 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.557 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 5.1 m-85 -98.94 117.82 34.31 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.2 175.65 7.97 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.094 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.521 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 23.3 mtt-85 -100.6 164.46 11.88 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.625 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.688 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.87 -30.16 63.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.511 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.6 t30 66.37 -38.76 0.31 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.358 1.063 . . . . 0.0 113.279 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 159' ' ' ALA . 8.3 t70 -98.04 -174.36 2.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.37 -13.09 16.8 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 120.71 0.291 . . . . 0.0 110.905 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 84.2 m-85 -139.29 155.95 47.37 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.18 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.416 HG13 ' HA ' ' A' ' 3' ' ' PRO . 3.4 m -128.28 160.09 38.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.505 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.625 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 81.4 m-85 -132.76 169.75 16.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.555 0.217 . . . . 0.0 110.736 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.496 ' HB2' HD11 ' A' ' 68' ' ' ILE . 20.3 m -156.78 -27.99 0.09 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.447 HD12 ' CG1' ' A' ' 64' ' ' ILE . 1.3 tm? 73.05 112.22 0.06 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.996 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -91.94 116.67 29.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.605 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.436 ' HB1' ' O ' ' A' ' 63' ' ' ASP . . . -134.16 -164.1 1.46 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.677 176.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.415 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 26.1 mmmt -73.31 133.23 43.82 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt 51.97 47.28 25.09 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -175.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -59.73 -158.94 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 O-C-N 124.565 1.166 . . . . 0.0 113.978 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 185' ' ' GLN . 20.5 p80 56.0 27.07 10.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.087 0.955 . . . . 0.0 111.727 -176.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -150.23 143.61 25.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.489 HG11 HG23 ' A' ' 177' ' ' ILE . 0.5 OUTLIER -173.83 166.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.309 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.484 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 85.7 mt -109.53 112.95 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.639 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.489 HG23 HG11 ' A' ' 175' ' ' VAL . 44.9 pt -120.51 171.59 8.8 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.683 0 CA-C-O 121.375 0.607 . . . . 0.0 112.482 -175.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.548 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 44.8 t30 48.68 -128.12 1.97 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.002 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.474 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 19.7 mm-40 -85.61 48.71 1.63 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.334 0.587 . . . . 0.0 109.592 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.5 m-20 70.29 44.79 0.7 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.128 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 82.1 mt -86.27 113.08 23.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 m -80.34 135.6 25.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.758 0.789 . . . . 0.0 111.271 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.2 t -135.3 152.88 51.91 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.581 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -156.86 130.71 8.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.936 0.398 . . . . 0.0 111.534 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' A' ' 173' ' ' HIS . 0.6 OUTLIER . . . . . 0 C--O 1.26 1.612 0 CA-C-O 116.61 -1.662 . . . . 0.0 108.413 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.876 ' SG ' ' HB2' ' A' ' 93' ' ' HIS . 4.3 p . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 121.538 0.685 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -133.94 167.65 21.79 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.44 ' HD3' HD11 ' A' ' 76' ' ' LEU . 61.6 Cg_endo -70.43 157.01 60.37 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 N-CA-C 108.413 -1.418 . . . . 0.0 108.413 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.59 -21.46 35.32 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 119.735 -1.221 . . . . 0.0 112.397 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -74.27 -1.26 19.87 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.4 m -74.39 130.93 40.58 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.928 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 8.7 mmt180 -81.86 126.2 31.6 Favored 'General case' 0 C--O 1.197 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.487 HD13 HG21 ' A' ' 175' ' ' VAL . 9.5 tt -117.67 129.75 73.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.039 0.447 . . . . 0.0 109.877 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.488 HD11 ' N ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -89.72 124.17 34.38 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-O 121.531 0.681 . . . . 0.0 109.917 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.488 ' N ' HD11 ' A' ' 9' ' ' LEU . 19.3 m -137.64 -177.87 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.342 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.47 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 30.9 tt0 -126.08 118.84 26.13 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 20.7 mt -119.19 121.7 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.727 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.28 39.5 30.91 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.933 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.27 19.58 78.77 Favored Glycine 0 N--CA 1.439 -1.116 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.849 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.96 122.76 24.45 Favored Pre-proline 0 N--CA 1.434 -1.264 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.54 120.22 6.78 Favored 'Trans proline' 0 N--CA 1.432 -2.126 0 C-N-CA 121.931 1.754 . . . . 0.0 110.675 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.576 ' NE2' HD21 ' A' ' 134' ' ' ASN . 18.5 mm100 -122.98 142.06 51.25 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.622 -176.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.447 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 39.1 ttmt -112.29 100.89 9.16 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 24' ' ' LEU . 3.1 pt -119.44 -178.41 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.912 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.106 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.783 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.8 p -93.28 174.52 7.17 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.142 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 94.5 mt -66.94 -31.39 71.93 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 120.726 0.298 . . . . 0.0 110.551 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.783 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 9.5 ptm180 -78.5 -22.5 47.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.48 ' HB2' ' H ' ' A' ' 20' ' ' THR . 38.8 mm-40 -84.56 -45.79 12.23 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.527 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.538 HD22 ' HG ' ' A' ' 167' ' ' LEU . 13.4 tp -58.91 -42.66 90.19 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.787 0.804 . . . . 0.0 109.51 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.402 ' HB2' HG13 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -53.98 -30.37 46.8 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.637 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.73 -17.89 59.76 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.464 HD22 ' O ' ' A' ' 23' ' ' GLU . 1.5 mm? -80.56 1.51 29.3 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.577 0.703 . . . . 0.0 109.663 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.462 ' CZ ' HG23 ' A' ' 47' ' ' ILE . 97.7 m-85 -119.01 161.65 19.87 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.107 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -144.72 -171.42 3.61 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.033 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.499 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.2 t70 65.71 76.75 0.31 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.539 0.685 . . . . 0.0 109.584 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -100.93 131.54 46.76 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.103 0.954 . . . . 0.0 111.752 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.453 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 17.6 ptt-85 -121.53 153.87 37.4 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.048 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -104.04 123.18 46.77 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -160.76 148.76 16.02 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.06 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 59.57 22.62 11.26 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 123.571 0.544 . . . . 0.0 110.76 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 41.7 mtm 72.96 16.79 4.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.943 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.6 m -133.33 -169.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.937 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.515 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 71.6 m-85 -110.84 137.72 48.14 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.8 t -132.49 124.86 52.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.5 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.438 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 22.9 ttm180 -117.23 127.73 54.38 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.499 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -131.91 147.51 52.47 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.696 -175.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 23.0 tptm 81.8 111.79 0.03 OUTLIER Pre-proline 0 C--O 1.236 0.389 0 O-C-N 124.197 0.935 . . . . 0.0 111.056 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.32 152.28 26.89 Favored 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.299 1.999 . . . . 0.0 112.043 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -87.03 -0.71 57.07 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.134 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -148.67 -164.79 2.11 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 4.1 tp10 -85.58 98.27 10.55 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.531 HG13 HG12 ' A' ' 12' ' ' ILE . 1.8 mp -117.15 114.94 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.083 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.506 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 34.0 mmtp -120.38 163.7 17.47 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.72 175.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.47 HG12 ' CB ' ' A' ' 169' ' ' ALA . 11.7 p -120.49 133.44 67.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.647 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.47 ' CE1' ' HB2' ' A' ' 11' ' ' GLN . 42.7 m-85 -82.92 124.39 30.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.925 176.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.4 ' HB3' ' OD1' ' A' ' 174' ' ' ASN . 56.4 m -121.58 175.54 6.16 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.439 HG12 HD11 ' A' ' 176' ' ' ILE . 2.8 mm -127.95 138.51 54.5 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-O 121.491 0.662 . . . . 0.0 110.625 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.728 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.3 t70 -86.59 110.55 19.9 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.432 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.608 HD21 ' H ' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -68.33 -13.16 62.07 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.897 0.879 . . . . 0.0 112.595 -171.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.728 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -98.28 -25.31 14.9 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.868 -175.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.537 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.3 p -117.24 -26.56 6.72 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.519 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.15 22.59 44.31 Favored Glycine 0 N--CA 1.426 -1.983 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.055 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.537 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 37.1 mtpt -97.6 155.42 16.98 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.9 p -96.95 109.26 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.919 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 m -109.63 162.4 7.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.707 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.4 tp -118.57 142.99 47.08 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -149.81 173.06 14.17 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.067 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -84.46 161.74 20.18 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.614 0.721 . . . . 0.0 110.716 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.477 ' N ' HD13 ' A' ' 64' ' ' ILE . 2.5 mp -97.76 144.58 10.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.889 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.509 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.8 mm-40 -88.78 -42.47 11.9 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 p30 178.2 175.81 0.51 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.12 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 14.6 t -108.14 132.22 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.917 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.506 HD13 ' HB2' ' A' ' 166' ' ' SER . 17.4 mt -98.52 114.78 37.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.511 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 85.8 tttt -126.13 111.92 15.21 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.8 143.34 48.98 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.358 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -52.43 124.04 14.15 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.323 2.682 . . . . 0.0 112.597 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.75 81.9 8.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.367 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.2 m -91.57 -36.37 13.73 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.64 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -85.95 177.98 7.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.447 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -103.96 171.33 7.41 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.555 ' CD2' ' HA ' ' A' ' 90' ' ' THR . 11.1 mt -122.84 140.2 53.2 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.8 0.809 . . . . 0.0 111.24 -174.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.469 HG23 HG23 ' A' ' 154' ' ' ILE . 14.3 mt -86.4 140.17 16.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 31.1 ttt180 -118.23 138.53 52.28 Favored 'General case' 0 N--CA 1.4 -2.972 0 CA-C-O 121.25 0.547 . . . . 0.0 109.741 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.62 ' O ' ' HA ' ' A' ' 86' ' ' SER . 59.4 m-85 -114.67 123.55 49.57 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.344 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 152' ' ' LYS . 40.6 tt0 -109.93 121.25 44.82 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.576 HD11 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -88.4 160.74 17.43 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.64 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.567 ' HG2' HD13 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -60.57 -22.57 63.82 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.285 -179.376 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -85.17 -11.2 55.57 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.523 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.85 17.41 44.44 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.823 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.566 ' O ' HD21 ' A' ' 81' ' ' LEU . 2.0 mtt180 -83.99 132.27 34.76 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 50.3 p -138.59 137.86 37.38 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 118.608 -1.237 . . . . 0.0 112.033 176.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.405 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 3.8 p90 -133.31 148.78 51.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.348 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 24.5 mt-10 -119.81 151.24 39.14 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.718 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.505 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.7 OUTLIER -144.11 154.99 43.76 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.728 178.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.555 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 2.8 m -75.21 18.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.831 0.824 . . . . 0.0 111.455 -177.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.674 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 71.35 -30.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 125.434 1.493 . . . . 0.0 113.004 175.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 90' ' ' THR . 7.6 p-10 -83.64 -5.94 59.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.155 0.502 . . . . 0.0 109.999 177.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.876 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 48.4 t-80 -87.24 128.84 53.87 Favored Pre-proline 0 CA--C 1.512 -0.484 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.821 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.677 ' HB2' ' O ' ' A' ' 185' ' ' GLN . 64.2 Cg_endo -72.52 141.02 34.03 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.808 2.339 . . . . 0.0 112.469 177.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 10.7 t -118.01 152.29 20.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 124.183 0.993 . . . . 0.0 109.585 -176.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -101.22 114.35 28.24 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.558 HG11 HG13 ' A' ' 104' ' ' ILE . 2.2 p -114.12 146.91 18.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.411 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -102.94 91.51 4.16 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.246 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 8.2 pt-20 -141.36 158.84 43.35 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 30.7 m-80 64.74 22.19 12.52 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.211 0.529 . . . . 0.0 109.625 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.39 16.68 60.88 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.849 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -138.27 172.22 13.22 Favored 'General case' 0 N--CA 1.407 -2.617 0 CA-C-O 121.355 0.598 . . . . 0.0 110.244 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -97.35 121.0 38.75 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.896 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.558 HG13 HG11 ' A' ' 97' ' ' VAL . 30.9 pt -121.77 153.3 25.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.068 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.563 ' HB3' ' O ' ' A' ' 185' ' ' GLN . 28.5 mt-10 -115.92 116.76 28.52 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.907 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.558 ' HZ1' ' HB3' ' A' ' 106' ' ' LYS . 1.1 ptpm? -137.5 145.49 43.07 Favored 'General case' 0 C--O 1.202 -1.41 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.563 ' O ' HG22 ' A' ' 111' ' ' VAL . 77.3 mtt180 -65.27 162.78 16.67 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.674 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -61.69 -40.72 95.98 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.267 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -75.57 1.47 14.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.61 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -111.22 -19.15 12.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.52 0.676 . . . . 0.0 109.493 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 107' ' ' ARG . 85.2 t -72.43 150.17 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -123.66 163.44 21.06 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.571 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -68.92 143.08 54.56 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.68 5.19 74.99 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.325 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 16.8 t70 -71.4 168.36 17.62 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.572 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 48.4 mttp -127.27 152.49 47.35 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 121.452 0.644 . . . . 0.0 110.789 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.405 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -125.29 153.53 32.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.288 175.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.498 ' HA ' ' CD1' ' A' ' 148' ' ' LEU . 0.5 OUTLIER -89.4 134.89 33.88 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.779 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.7 OUTLIER -100.68 145.0 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.978 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 172.093 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.534 ' C ' ' H ' ' A' ' 122' ' ' LEU . 40.2 t -64.47 -11.36 32.81 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.475 0.655 . . . . 0.0 109.945 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.66 ' OE2' ' HA ' ' A' ' 146' ' ' ASP . 30.5 mt-10 59.03 -3.4 0.09 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.951 -1.477 . . . . 0.0 112.923 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 120' ' ' SER . 45.3 tp -110.81 116.57 31.49 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.257 0.551 . . . . 0.0 111.931 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -95.09 178.99 5.36 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.973 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.467 ' O ' ' HB ' ' A' ' 125' ' ' VAL . 0.0 OUTLIER -121.08 21.74 11.19 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.082 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 124' ' ' LEU . 92.5 t 85.46 -44.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.933 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 131' ' ' SER . 36.6 tt0 16.32 85.7 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 O-C-N 125.081 1.488 . . . . 0.0 113.705 175.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -93.65 83.15 4.41 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.194 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.7 m 69.26 -62.24 0.41 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.59 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.4 p -130.84 -29.92 1.86 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.9 0.381 . . . . 0.0 111.507 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.5 p -84.41 104.67 14.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.776 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 126' ' ' GLU . 15.7 m -80.15 -78.94 0.15 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.251 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.527 ' O ' ' HD2' ' A' ' 135' ' ' PRO . 60.9 mm-40 -146.26 -110.15 0.09 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.89 -14.66 57.8 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.576 HD21 ' NE2' ' A' ' 17' ' ' GLN . 59.3 t30 -73.06 -47.81 7.96 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.378 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 132' ' ' GLN . 11.6 Cg_exo -72.68 -72.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.547 2.165 . . . . 0.0 111.968 176.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 176.57 -57.08 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.041 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -72.59 126.28 29.49 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.362 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -106.92 -54.23 2.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.161 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.7 p30 41.56 -164.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.548 1.139 . . . . 0.0 113.183 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.2 tp -130.72 139.38 50.28 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 121.878 -0.514 . . . . 0.0 110.746 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -139.97 76.86 0.32 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.8 t -49.56 121.25 11.67 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 123.681 0.283 . . . . 0.0 110.463 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.28 -88.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.015 2.477 . . . . 0.0 113.686 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 65.55 34.58 7.75 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.568 0.699 . . . . 0.0 110.454 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.531 ' HB3' ' O ' ' A' ' 121' ' ' GLU . 5.0 t-160 -96.9 121.43 38.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.744 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.66 ' HA ' ' OE2' ' A' ' 121' ' ' GLU . 15.5 t70 -145.79 89.4 1.9 Allowed 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -165.71 142.7 5.48 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.572 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.8 mm? -104.65 144.61 31.48 Favored 'General case' 0 CA--C 1.484 -1.566 0 CA-C-O 121.081 0.467 . . . . 0.0 109.76 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.576 ' HB3' HD11 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -116.76 137.97 51.81 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.508 -176.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 17.6 mt-10 -89.03 146.38 24.89 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.284 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 115' ' ' ASP . 81.4 mt -78.58 107.46 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.777 0 CA-C-N 113.407 -1.724 . . . . 0.0 108.969 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 80' ' ' GLU . 8.0 mmpt? -70.23 -39.4 75.12 Favored 'General case' 0 C--N 1.268 -2.977 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.566 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -149.29 133.52 17.35 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 74.3 mt -115.61 127.68 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 CA-C-N 113.668 -1.605 . . . . 0.0 110.927 175.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.448 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 1.6 ptpp? -132.49 163.35 29.01 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.97 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.452 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.0 m-85 -100.98 115.33 30.21 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.405 HG11 ' HD3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -127.38 137.47 57.65 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.585 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.798 -178.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -71.44 160.83 32.05 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.36 -176.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.66 126.86 31.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.043 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -65.43 -37.94 88.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.288 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -106.96 174.84 5.71 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.294 -177.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.56 2.29 51.21 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.396 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -141.95 153.13 44.11 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.199 0.523 . . . . 0.0 110.456 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.14 157.43 31.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.712 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 76.4 m-85 -132.8 165.17 25.19 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.777 0.322 . . . . 0.0 110.51 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.506 ' HB2' HD13 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -146.38 -24.93 0.43 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.882 174.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.538 ' HG ' HD22 ' A' ' 24' ' ' LEU . 3.6 mm? 62.68 101.09 0.03 OUTLIER 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.892 0.745 . . . . 0.0 110.645 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.436 ' HB2' HD11 ' A' ' 68' ' ' ILE . 58.6 t30 -83.47 121.17 26.84 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.703 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.509 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -131.28 -157.7 0.84 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -61.93 131.15 48.76 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 81.65 -92.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.525 1.13 . . . . 0.0 110.402 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -144.29 -156.54 0.7 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -77.24 49.07 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 109.755 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.67 ' HA ' ' O ' ' A' ' 183' ' ' THR . 3.7 t-20 -90.15 99.37 12.4 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.216 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.487 HG21 HD13 ' A' ' 8' ' ' ILE . 5.4 p -149.03 164.13 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-O 121.494 0.664 . . . . 0.0 110.767 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.596 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 2.4 mp -93.88 115.7 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.489 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 36.7 pt -118.49 166.41 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-O 120.87 0.367 . . . . 0.0 110.729 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 30.4 t30 47.91 -131.99 1.46 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.187 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -81.52 53.34 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.338 0.589 . . . . 0.0 110.061 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.779 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 12.6 m120 65.05 46.9 2.65 Favored 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 125.272 1.429 . . . . 0.0 113.194 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 88.9 mt -91.21 115.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.04 148.55 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-O 122.039 0.923 . . . . 0.0 112.528 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.67 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 2.0 t -150.11 152.12 34.24 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.362 175.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -136.25 -74.97 0.43 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.2 0.524 . . . . 0.0 110.969 -177.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.677 ' O ' ' HB2' ' A' ' 94' ' ' PRO . 24.2 tt0 . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 116.84 -1.552 . . . . 0.0 108.222 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.526 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 71.4 m . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 121.225 0.536 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -107.29 161.98 21.25 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.526 ' HD3' HD12 ' A' ' 76' ' ' LEU . 57.3 Cg_endo -67.24 158.48 56.74 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 N-CA-C 108.512 -1.38 . . . . 0.0 108.512 177.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.12 -27.42 51.83 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 119.477 -1.344 . . . . 0.0 112.035 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -67.17 -13.23 61.76 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 93.6 m -61.44 125.7 24.71 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.422 -177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 37.6 mmt-85 -79.73 125.26 29.43 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.525 HD12 HG21 ' A' ' 175' ' ' VAL . 10.4 tt -116.33 129.42 72.79 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 CA-C-O 120.84 0.352 . . . . 0.0 110.245 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -89.34 122.99 33.1 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.63 0.729 . . . . 0.0 110.17 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.453 ' N ' HD12 ' A' ' 9' ' ' LEU . 28.2 m -133.03 -179.16 3.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.694 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -130.97 121.35 24.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.425 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.573 HG12 HG13 ' A' ' 47' ' ' ILE . 15.1 mt -119.96 120.98 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.928 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.598 -177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 54.21 37.22 26.8 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.198 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.01 18.12 80.22 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.829 -1.078 . . . . 0.0 113.529 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -123.58 119.31 27.16 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HB2' HD13 ' A' ' 124' ' ' LEU . 43.5 Cg_endo -73.0 121.74 7.54 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.438 2.092 . . . . 0.0 111.291 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.445 ' NE2' HD22 ' A' ' 134' ' ' ASN . 70.4 mt-30 -125.75 140.49 52.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.829 -177.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -110.39 102.36 11.0 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.653 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' A' ' 8' ' ' ILE . 2.8 pt -125.43 -171.68 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.642 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.695 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.9 p -96.26 174.39 6.91 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.096 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 62.1 mt -69.87 -31.07 68.7 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.124 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.695 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 3.9 ptm180 -77.34 -25.86 51.51 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.539 ' OE1' HG21 ' A' ' 20' ' ' THR . 84.9 mt-10 -84.73 -40.34 17.41 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.652 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.468 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 18.8 tp -59.35 -45.74 90.56 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.746 0.784 . . . . 0.0 109.842 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -49.07 -32.55 9.83 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.759 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.9 mt-10 -74.63 -17.26 60.72 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.204 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.54 5.12 13.77 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.501 0.667 . . . . 0.0 109.884 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 97.0 m-85 -118.28 164.61 14.94 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.519 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -145.8 -172.85 4.0 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.659 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 18.9 t0 64.88 75.14 0.38 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.602 0.715 . . . . 0.0 109.358 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -102.69 134.28 46.33 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.416 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.439 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.4 ptt180 -127.54 154.54 45.04 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.792 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -105.51 129.9 53.69 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -166.78 153.84 9.05 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.556 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.26 21.24 9.41 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 123.49 0.494 . . . . 0.0 110.804 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 45.3 mtm 70.86 16.79 6.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.411 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 6.1 m -131.82 -168.29 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.444 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.439 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 79.4 m-85 -116.61 140.06 49.81 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.439 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.3 t -130.32 123.5 55.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.411 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 19.6 ttm180 -118.62 127.03 53.21 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.53 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -131.15 143.33 50.54 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.185 -174.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 40.0 ttmt 79.58 116.42 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 124.158 0.983 . . . . 0.0 111.383 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 68.6 Cg_endo -79.47 160.31 25.58 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 C-N-CA 122.494 2.129 . . . . 0.0 112.57 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -88.19 -3.19 58.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.534 0.683 . . . . 0.0 110.351 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -142.11 -165.28 1.98 Allowed 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 10.1 tp10 -89.21 100.87 13.56 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 171.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.573 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -114.29 117.46 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.175 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HZ1' ' CD ' ' A' ' 46' ' ' GLU . 17.7 mmtm -115.86 166.17 12.27 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.976 174.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.441 HG21 ' CB ' ' A' ' 169' ' ' ALA . 3.3 m -117.58 130.38 72.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.258 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.496 ' HB3' HD11 ' A' ' 176' ' ' ILE . 3.2 m-85 -79.35 121.86 25.66 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 172.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.0 t -133.59 177.03 8.02 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.513 HD11 ' O ' ' A' ' 58' ' ' LYS . 2.1 mm -131.21 142.18 44.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.332 0.587 . . . . 0.0 110.65 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.564 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.1 t70 -81.43 118.33 22.61 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.585 ' H ' HD23 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -72.52 -12.74 61.2 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -170.277 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.564 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -103.4 -26.9 12.72 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.179 -176.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.0 p -116.77 -20.54 9.45 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.849 -0.741 . . . . 0.0 111.872 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.95 11.84 82.03 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.015 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.513 ' O ' HD11 ' A' ' 52' ' ' ILE . 3.3 mptp? -75.97 145.83 40.04 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 122.693 0.397 . . . . 0.0 111.366 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -90.15 106.72 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 121.993 0.901 . . . . 0.0 109.324 177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 m -110.16 155.8 11.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.159 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.421 HD13 ' O ' ' A' ' 49' ' ' VAL . 10.2 tp -122.11 134.25 54.76 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.403 HG23 ' HB2' ' A' ' 170' ' ' LYS . 14.7 t -144.91 172.39 13.1 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.817 -176.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -84.28 162.3 20.16 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.787 0.804 . . . . 0.0 111.515 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.445 HD11 ' N ' ' A' ' 64' ' ' ILE . 2.8 mp -95.95 144.96 9.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.692 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.521 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 29.7 mm-40 -89.65 -39.91 12.91 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 p30 176.88 174.92 0.39 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.959 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.419 ' HA ' HD21 ' A' ' 167' ' ' LEU . 14.7 t -105.04 129.26 58.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.257 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 51.2 mt -91.76 104.96 16.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.474 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.528 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.2 tttt -121.3 109.17 14.6 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.5 139.58 35.18 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.215 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.448 ' HD2' HG12 ' A' ' 37' ' ' VAL . 97.0 Cg_exo -44.76 124.3 5.5 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 123.471 2.781 . . . . 0.0 112.736 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.59 78.4 9.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.711 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.4 p -84.86 -53.03 5.59 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.931 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.6 171.37 14.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.218 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -102.68 171.55 7.36 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.526 HD12 ' HD3' ' A' ' 3' ' ' PRO . 11.2 mt -127.43 143.29 51.23 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.651 0.739 . . . . 0.0 111.673 -173.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.512 HD12 ' CZ ' ' A' ' 156' ' ' TYR . 23.6 mt -86.62 143.02 12.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 173.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 34.5 ttt85 -118.03 138.72 52.03 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.178 0.514 . . . . 0.0 109.999 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.609 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.1 m-85 -116.71 123.3 46.88 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.888 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 152' ' ' LYS . 32.5 tt0 -109.87 125.53 52.88 Favored 'General case' 0 CA--C 1.471 -2.058 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.13 160.02 17.96 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.325 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.637 ' HG2' ' CD1' ' A' ' 149' ' ' LEU . 3.0 pt-20 -61.6 -15.99 44.17 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.113 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -98.06 -6.04 32.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.791 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.3 12.44 56.13 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.164 -0.926 . . . . 0.0 113.759 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.526 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.5 mtt180 -82.97 141.79 31.85 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.8 p -144.22 141.26 29.76 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.972 -1.091 . . . . 0.0 113.497 175.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -138.49 155.99 47.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.613 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 87.0 mt-10 -129.97 153.98 47.83 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.17 0.51 . . . . 0.0 112.265 -177.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.9 OUTLIER -148.51 161.23 42.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.658 178.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.502 ' HA ' HD21 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -70.83 10.45 0.52 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.702 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 72.69 -27.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 124.838 1.255 . . . . 0.0 112.205 177.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.532 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 0.8 OUTLIER -78.75 -10.84 59.91 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.243 0.544 . . . . 0.0 109.807 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -97.14 140.92 22.34 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.367 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 89.3 Cg_endo -79.49 137.87 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.249 2.633 . . . . 0.0 113.699 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.5 t -105.09 147.2 11.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.0 tp -105.39 110.38 22.71 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.716 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.465 HG11 ' CE ' ' A' ' 106' ' ' LYS . 2.5 p -110.87 153.56 12.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.496 0.665 . . . . 0.0 111.531 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -104.21 93.74 4.99 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.258 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.0 pt-20 -143.26 158.48 43.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.3 m-20 64.15 21.85 12.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.17 13.77 60.53 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.803 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -135.2 172.37 13.11 Favored 'General case' 0 N--CA 1.401 -2.885 0 CA-C-O 121.165 0.507 . . . . 0.0 109.93 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -100.94 121.27 41.46 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.447 HG13 ' CG1' ' A' ' 97' ' ' VAL . 25.1 pt -119.27 141.67 38.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.197 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -97.09 114.49 26.15 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.14 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.465 ' CE ' HG11 ' A' ' 97' ' ' VAL . 13.9 ptpt -128.59 135.36 49.24 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.958 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.608 ' O ' HG22 ' A' ' 111' ' ' VAL . 11.5 mmt180 -62.0 159.22 14.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.702 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -57.92 -43.03 85.99 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.222 -176.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.489 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.7 p90 -73.01 -0.21 13.17 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.177 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -110.63 -15.3 13.89 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.606 0.717 . . . . 0.0 109.848 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 107' ' ' ARG . 89.5 t -77.84 149.43 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.715 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 13.8 mtmt -123.24 164.88 17.89 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.994 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -66.98 141.36 57.62 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.66 77.93 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.895 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.715 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -75.04 168.55 19.76 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.4 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.616 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 72.2 mttt -124.18 161.57 25.44 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.339 0.59 . . . . 0.0 112.076 -177.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.11 156.37 39.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.417 172.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.509 ' HG ' HD13 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -95.86 138.29 33.71 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 123.228 0.33 . . . . 0.0 110.571 -178.282 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.763 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.0 m -100.65 145.1 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.7 m -69.28 25.25 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.122 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.593 ' HA ' ' HB2' ' A' ' 145' ' ' HIS . 21.6 mt-10 59.39 15.13 4.17 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 124.021 0.928 . . . . 0.0 112.274 -177.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.53 ' CD2' ' HA ' ' A' ' 125' ' ' VAL . 0.4 OUTLIER 63.54 -174.3 0.16 Allowed 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.349 175.249 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.427 ' HB3' ' H ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -174.98 -96.06 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.203 -179.06 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 124' ' ' LEU . 2.3 pt? -55.03 -45.26 75.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.636 0.374 . . . . 0.0 110.956 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.53 ' HA ' ' CD2' ' A' ' 122' ' ' LEU . 91.9 t 113.2 -93.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.388 1.875 . . . . 0.0 111.203 173.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.428 ' HG2' HG12 ' A' ' 125' ' ' VAL . 12.9 pt-20 -154.16 -178.16 6.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 118.411 0.55 . . . . 0.0 111.165 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -142.6 145.03 33.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.413 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.4 p -142.43 142.38 32.35 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 121.23 -0.188 . . . . 0.0 111.095 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.4 m 66.6 177.26 0.23 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.793 0.683 . . . . 0.0 111.695 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.4 m -75.55 94.75 3.21 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 t -79.78 125.23 29.41 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.274 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -88.22 -17.84 29.94 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -88.23 128.48 35.46 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.887 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.445 HD22 ' NE2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -83.29 -47.54 0.79 Allowed Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.993 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -79.03 -163.29 0.21 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.832 2.355 . . . . 0.0 112.329 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -178.48 117.83 0.08 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.646 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -162.07 -102.38 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.855 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 54.6 -96.89 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.222 0.609 . . . . 0.0 111.265 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -82.71 166.18 19.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.975 0.417 . . . . 0.0 110.656 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.5 tp -70.11 132.96 46.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.914 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -122.22 62.34 0.54 Allowed Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.182 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 10.4 t -64.44 118.53 48.2 Favored Pre-proline 0 N--CA 1.446 -0.645 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.451 ' CB ' ' HB3' ' A' ' 122' ' ' LEU . 6.3 Cg_exo -78.1 160.71 29.86 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.645 2.23 . . . . 0.0 112.516 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -90.54 105.52 17.87 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.593 ' HB2' ' HA ' ' A' ' 121' ' ' GLU . 13.2 p80 -131.64 -162.31 1.21 Allowed 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 44.93 69.69 0.41 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.128 0.971 . . . . 0.0 112.238 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -162.34 151.29 15.25 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.728 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.616 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 4.1 mm? -108.45 137.79 45.83 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-O 121.112 0.482 . . . . 0.0 110.309 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.637 ' CD1' ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -111.96 133.29 54.23 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.164 -177.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 20.2 mt-10 -86.02 143.61 28.02 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.111 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.492 HD12 ' CD1' ' A' ' 79' ' ' PHE . 69.5 mt -81.48 102.65 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.077 174.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.539 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 50.9 mmtt -66.1 -38.63 88.71 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.252 177.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -147.87 129.22 14.79 Favored 'General case' 0 CA--C 1.476 -1.882 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 72.1 mt -112.81 143.48 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.324 174.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.43 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.7 ptpt -149.13 161.31 42.24 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.355 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.512 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 17.7 m-85 -101.8 115.01 29.59 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.54 174.61 10.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.237 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.06 159.02 16.03 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.436 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.44 129.75 40.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.354 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -64.15 -42.12 96.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.972 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -101.02 175.89 5.45 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.041 0.448 . . . . 0.0 111.156 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.63 3.68 51.86 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.02 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -141.38 151.16 43.26 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.786 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.43 HG11 ' HA ' ' A' ' 3' ' ' PRO . 2.6 m -121.28 157.27 24.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.584 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 72.2 m-85 -132.98 172.11 13.06 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.89 0.376 . . . . 0.0 110.388 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 1' ' ' CYS . 51.9 m -156.18 -22.17 0.1 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.468 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER 63.36 104.35 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.236 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -85.22 115.68 23.13 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.302 -176.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.521 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -125.63 -149.54 0.42 Allowed 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.403 ' HB2' HG23 ' A' ' 62' ' ' THR . 0.4 OUTLIER -61.0 141.09 57.62 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.088 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.44 ' HB2' ' OD1' ' A' ' 174' ' ' ASN . 63.0 mttp 70.36 -117.62 0.1 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.397 -173.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -150.05 116.87 5.88 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 38.19 30.4 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 125.469 1.508 . . . . 0.0 114.975 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.459 ' HB3' ' CD2' ' A' ' 184' ' ' HIS . 1.7 p-10 -95.29 104.66 16.56 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.097 0.475 . . . . 0.0 110.229 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.525 HG21 HD12 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -144.86 164.07 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 121.354 0.597 . . . . 0.0 111.444 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.613 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.3 mt -95.55 120.78 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.456 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 39.1 pt -125.01 166.93 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.51 -176.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 52.81 -134.97 1.59 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.921 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.19 51.58 2.23 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.602 0.715 . . . . 0.0 109.572 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.763 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 15.0 m120 71.92 53.23 0.2 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.525 177.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 97.2 mt -93.78 116.17 34.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.5 m -82.86 159.06 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.538 0.685 . . . . 0.0 111.861 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.9 t -168.79 144.76 3.51 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.785 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.459 ' CD2' ' HB3' ' A' ' 174' ' ' ASN . 36.5 t-80 -178.32 145.15 0.33 Allowed 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--O 1.256 1.401 0 CA-C-O 117.618 -1.182 . . . . 0.0 110.742 177.844 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 93.5 m . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.368 0.604 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.474 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 34.8 m-85 -114.61 157.87 41.72 Favored Pre-proline 0 N--CA 1.434 -1.233 0 CA-C-N 114.843 -1.072 . . . . 0.0 108.485 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.53 ' HD3' HD11 ' A' ' 76' ' ' LEU . 19.1 Cg_endo -59.4 -35.34 96.65 Favored 'Trans proline' 0 N--CA 1.48 0.688 0 C-N-CA 123.129 2.553 . . . . 0.0 112.21 -177.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.732 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 132.76 -35.78 2.27 Favored Glycine 0 N--CA 1.413 -2.857 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -177.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.07 -17.03 61.83 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.395 0.617 . . . . 0.0 111.11 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 69.0 m -61.15 125.19 22.84 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.584 177.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.5 mmt180 -86.09 132.95 33.92 Favored 'General case' 0 C--O 1.183 -2.43 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.492 ' HB ' ' CD2' ' A' ' 21' ' ' LEU . 9.5 tt -118.92 131.74 70.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 C-N-CA 122.556 0.342 . . . . 0.0 110.159 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.553 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -84.59 124.86 31.9 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.29 0.567 . . . . 0.0 109.588 178.214 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 30.5 m -136.67 -179.47 2.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.778 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.541 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 30.9 tt0 -131.99 121.57 24.14 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.139 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.586 HG12 HG13 ' A' ' 47' ' ' ILE . 14.7 mt -121.07 119.81 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.962 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 53.53 41.87 32.02 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.898 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.12 17.88 76.07 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.589 -1.187 . . . . 0.0 113.442 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -123.6 116.15 28.06 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 34.7 Cg_endo -73.25 126.24 10.91 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 122.38 2.053 . . . . 0.0 111.402 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -127.47 142.27 51.45 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.554 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -106.16 101.07 10.58 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 8' ' ' ILE . 3.3 pt -122.83 -175.55 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.179 -2.637 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.012 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.852 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.3 p -90.62 174.65 7.39 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.52 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.5 mm? -71.68 -23.75 61.71 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.984 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.852 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 15.7 ptt180 -85.59 -23.82 27.43 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.596 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 49.8 mt-10 -83.71 -42.12 16.94 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.977 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.504 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 14.3 tp -56.18 -43.59 78.57 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.769 0.795 . . . . 0.0 109.099 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -52.46 -35.5 52.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.512 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 6.4 mm-40 -69.22 -21.71 63.92 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -79.51 4.16 16.54 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.57 0.7 . . . . 0.0 110.139 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 93.3 m-85 -117.16 160.17 21.46 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.049 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -139.84 -176.61 4.64 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t0 64.02 85.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.178 0.513 . . . . 0.0 111.082 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -101.39 131.37 47.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.936 0.874 . . . . 0.0 111.051 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -122.6 152.55 40.33 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.942 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.425 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 35.9 t80 -99.46 129.93 45.68 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -167.15 147.11 5.41 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.609 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 59.41 20.43 8.76 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 123.702 0.626 . . . . 0.0 111.027 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.425 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 39.1 mtp 72.37 17.8 4.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.488 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 13.7 m -133.28 -172.27 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -114.76 142.52 46.4 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-O 121.47 0.652 . . . . 0.0 110.158 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 t -128.71 122.02 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.095 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.457 ' HD3' ' O ' ' A' ' 28' ' ' PHE . 17.5 ttm180 -111.77 126.66 55.31 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.46 141.78 48.96 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -173.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.538 ' HB2' ' HZ2' ' A' ' 42' ' ' LYS . 3.2 ttmp? 83.95 113.09 0.03 OUTLIER Pre-proline 0 CA--C 1.503 -0.833 0 O-C-N 124.812 1.32 . . . . 0.0 111.378 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 74.3 Cg_endo -77.07 155.28 33.52 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 C-N-CA 122.447 2.098 . . . . 0.0 111.807 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -87.01 -2.28 58.51 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.371 0.605 . . . . 0.0 110.678 -178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -147.6 -168.05 2.96 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 40.9 tt0 -85.26 101.41 12.5 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.586 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -115.58 118.2 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.995 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.541 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 67.3 mmtt -114.39 169.64 8.89 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.335 174.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.442 HG13 ' CB ' ' A' ' 169' ' ' ALA . 10.1 p -124.99 131.09 73.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.795 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.532 ' CD2' HD11 ' A' ' 9' ' ' LEU . 14.2 m-85 -86.16 120.46 27.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.106 0.479 . . . . 0.0 110.306 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.8 t -130.22 176.2 8.3 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.472 HG12 HD11 ' A' ' 176' ' ' ILE . 3.3 mm -116.83 142.25 31.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.536 0.684 . . . . 0.0 111.027 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.663 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 14.9 t70 -77.7 120.32 22.47 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.527 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.58 HD21 ' H ' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -75.54 -8.41 56.68 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.764 -170.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.663 ' HG3' ' OD1' ' A' ' 53' ' ' ASP . 2.6 pt-20 -108.18 -25.77 10.92 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.045 -0.662 . . . . 0.0 112.079 -177.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.514 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 70.4 p -117.84 -25.23 6.86 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.772 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.47 12.72 66.71 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.254 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.514 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 40.7 mtpt -87.97 162.97 16.56 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.437 HG21 ' OG ' ' A' ' 120' ' ' SER . 33.5 t -86.67 113.25 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.216 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -110.77 151.78 12.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.088 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.2 tp -122.86 140.26 53.15 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.7 t -148.91 170.54 18.06 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.814 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.83 161.16 26.97 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.522 0.677 . . . . 0.0 110.524 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 64' ' ' ILE . 2.2 mp -96.28 148.14 5.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.84 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.462 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.9 mm-40 -93.09 -42.68 9.27 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 p30 179.59 178.97 0.51 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.72 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 t -107.55 134.21 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.009 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.654 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 42.9 mt -91.69 99.73 10.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.701 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.44 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 84.8 tttt -113.49 107.34 15.69 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.06 136.18 28.64 Favored Pre-proline 0 C--N 1.306 -1.297 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.502 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -48.66 129.4 20.3 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.167 2.578 . . . . 0.0 112.013 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.24 86.94 3.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.07 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.2 m -98.79 -33.16 11.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.436 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.92 167.15 12.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.076 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -100.15 172.84 6.93 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.532 ' CD2' ' HA ' ' A' ' 90' ' ' THR . 14.9 mt -125.89 145.56 50.21 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.911 0.862 . . . . 0.0 111.907 -174.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.495 HD13 ' C ' ' A' ' 108' ' ' ALA . 13.6 mt -91.91 144.13 9.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.444 172.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 13.0 ttt85 -115.92 137.93 51.65 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.562 ' CD1' HD12 ' A' ' 151' ' ' ILE . 65.7 m-85 -115.85 124.48 50.77 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.548 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.2 tt0 -113.1 125.06 53.96 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.603 HD22 ' O ' ' A' ' 85' ' ' ARG . 1.5 mm? -90.08 162.2 15.44 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.356 -177.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.576 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.7 pt-20 -62.78 -15.63 54.45 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.256 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.73 -12.68 28.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.716 0.77 . . . . 0.0 109.729 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.42 10.1 57.26 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.347 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.603 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -85.12 141.34 30.29 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 44.3 p -140.84 151.86 44.68 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.919 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -145.83 153.72 41.21 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.244 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 23.6 mt-10 -124.22 149.66 46.16 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.323 -178.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -144.0 159.6 42.31 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.439 178.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.532 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -68.37 11.33 0.17 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.716 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.6 OUTLIER 69.65 -38.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 124.843 1.257 . . . . 0.0 112.059 178.787 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 90' ' ' THR . 16.3 t70 -69.48 -37.55 77.3 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.422 0.629 . . . . 0.0 109.41 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 37.0 m80 -72.45 131.18 84.96 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.584 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 30.9 Cg_exo -63.65 142.49 83.92 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 123.975 3.117 . . . . 0.0 114.762 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.32 147.85 14.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.473 HD21 ' O ' ' A' ' 184' ' ' HIS . 10.1 tp -100.49 109.92 22.07 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.816 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.673 HG22 ' OD1' ' A' ' 115' ' ' ASP . 2.6 p -112.24 150.33 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 121.404 0.621 . . . . 0.0 112.046 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -103.04 92.0 4.36 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.472 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 9.1 pt-20 -139.34 158.4 44.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 90.2 m-20 63.25 22.98 13.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.125 0.488 . . . . 0.0 110.07 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.68 14.7 60.9 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.809 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -135.98 171.71 14.07 Favored 'General case' 0 N--CA 1.4 -2.956 0 CA-C-O 121.217 0.532 . . . . 0.0 110.047 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.615 ' CE1' HD13 ' A' ' 118' ' ' LEU . 32.6 m-85 -103.91 121.74 43.74 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.701 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.408 HG13 HG12 ' A' ' 97' ' ' VAL . 23.6 pt -124.44 152.64 30.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.476 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.412 ' HG2' ' CD1' ' A' ' 96' ' ' LEU . 31.8 mt-10 -104.87 110.86 23.4 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.591 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.598 ' HZ1' ' HB3' ' A' ' 106' ' ' LYS . 0.6 OUTLIER -124.3 139.53 53.83 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.134 176.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 5.3 mtp180 -60.79 156.1 17.89 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -176.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.716 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -59.77 -41.06 90.22 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.973 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.422 ' CE1' ' HD3' ' A' ' 107' ' ' ARG . 3.0 p90 -74.13 5.76 4.09 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.435 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -115.31 -18.55 11.04 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.471 0.653 . . . . 0.0 109.712 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 107' ' ' ARG . 79.5 t -71.55 150.33 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.005 0.922 . . . . 0.0 108.899 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.744 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.8 OUTLIER -114.17 165.01 13.1 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 120.814 0.34 . . . . 0.0 110.467 -177.113 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -74.24 142.88 45.31 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.05 5.63 83.02 Favored Glycine 0 C--N 1.3 -1.462 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.488 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.744 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -75.3 175.19 8.6 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.593 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 49.8 mttp -130.36 162.59 28.75 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.75 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.74 158.72 42.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.378 173.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.615 HD13 ' CE1' ' A' ' 103' ' ' PHE . 2.4 mt -88.81 140.04 29.85 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.786 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -101.46 149.2 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.455 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.53 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 47.4 t -69.54 13.85 0.12 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.446 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.574 ' H ' ' C ' ' A' ' 119' ' ' VAL . 7.6 mm-40 63.8 -36.91 0.17 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.349 1.059 . . . . 0.0 113.769 -177.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.46 ' H ' ' C ' ' A' ' 120' ' ' SER . 31.7 tp -167.84 133.11 1.89 Allowed 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.976 -0.453 . . . . 0.0 110.5 -173.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.572 ' HB3' HD22 ' A' ' 180' ' ' ASN . 8.2 pt-20 -89.1 -124.05 0.06 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.097 176.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.553 ' CD2' HD21 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -82.65 20.91 1.05 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.042 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.4 t 62.06 14.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.652 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 68.74 171.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.711 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 55.75 92.81 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.216 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.0 t -61.46 -45.01 96.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.473 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.2 t -176.2 178.11 1.45 Allowed 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.3 p -97.17 -4.97 38.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.362 0.601 . . . . 0.0 109.712 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.8 p -153.03 -177.52 6.34 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.491 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 66.7 91.58 0.08 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.266 0.555 . . . . 0.0 109.883 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -69.19 92.25 0.55 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.839 0.828 . . . . 0.0 111.63 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.423 ' N ' ' CD ' ' A' ' 135' ' ' PRO . 65.1 t30 -96.16 -45.11 0.26 Allowed Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.322 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 134' ' ' ASN . 12.2 Cg_exo -72.11 -169.61 0.47 Allowed 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.631 2.221 . . . . 0.0 112.099 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -99.34 -11.37 21.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -159.0 151.25 21.28 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.427 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -88.76 84.14 6.69 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -144.73 -174.2 4.27 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.356 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 140' ' ' LEU . 2.6 pt? -142.58 156.11 45.06 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.232 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -135.36 70.25 0.51 Allowed Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.4 m -43.93 118.88 3.09 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.464 1.106 . . . . 0.0 113.439 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.81 171.19 11.37 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.137 2.558 . . . . 0.0 110.893 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.432 ' HB3' ' NE2' ' A' ' 147' ' ' GLN . 30.7 mt-10 -120.51 -70.31 0.79 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.282 -0.261 . . . . 0.0 111.296 -175.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 79.33 162.06 0.19 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 176.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.1 t70 66.03 41.48 3.63 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.855 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.432 ' NE2' ' HB3' ' A' ' 144' ' ' GLU . 7.7 pt20 -163.85 130.14 3.14 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.101 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.593 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.8 mm? -100.01 133.44 44.39 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.576 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -101.91 132.01 47.96 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 8.6 mt-10 -85.17 140.31 31.02 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.521 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.562 HD12 ' CD1' ' A' ' 79' ' ' PHE . 62.2 mt -78.97 102.26 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.827 0 CA-C-N 113.635 -1.62 . . . . 0.0 109.326 174.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 6.3 mmpt? -65.64 -37.96 88.02 Favored 'General case' 0 C--N 1.268 -2.948 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.936 178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -149.1 131.28 15.46 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 70.3 mt -115.7 144.76 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.528 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -150.54 161.2 43.02 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.055 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.442 ' HH ' HD11 ' A' ' 77' ' ' ILE . 42.9 m-85 -99.56 113.06 25.23 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-O 121.379 0.609 . . . . 0.0 109.602 174.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.56 132.89 70.7 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.439 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -71.47 154.27 41.63 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.75 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.54 123.53 20.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.062 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -85.9 42.57 0.98 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.097 0.475 . . . . 0.0 110.883 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -163.15 -179.34 6.6 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -107.04 -8.73 16.44 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.214 0.531 . . . . 0.0 109.783 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.58 162.13 35.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.247 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 3' ' ' PRO . 3.5 m -132.73 162.45 39.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.838 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.654 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 62.8 m-85 -138.95 166.01 25.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.94 -175.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.68 -22.75 0.14 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.504 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER 70.95 110.62 0.06 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.784 176.112 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -90.1 115.59 27.47 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.649 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.462 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.81 -162.76 1.2 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.47 ' C ' ' H ' ' A' ' 172' ' ' TYR . 20.3 ttmt -63.27 119.55 9.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.669 0.271 . . . . 0.0 110.708 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 52.7 tttm 75.86 -25.93 0.2 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.258 1.023 . . . . 0.0 111.06 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.47 ' H ' ' C ' ' A' ' 170' ' ' LYS . 45.5 p90 45.3 -162.01 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.899 1.279 . . . . 0.0 113.164 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 76.61 -53.27 0.59 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.804 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.529 HD22 HG12 ' A' ' 182' ' ' VAL . 27.1 t-20 -99.4 133.42 43.73 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.705 0.288 . . . . 0.0 111.146 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.53 148.19 12.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.484 178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.472 HD11 HG12 ' A' ' 52' ' ' ILE . 47.3 mt -92.2 116.25 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.988 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 25.1 pt -123.27 164.72 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.535 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 23.6 t30 46.34 -134.13 0.95 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 124.532 1.133 . . . . 0.0 110.958 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.52 55.87 2.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.494 0.664 . . . . 0.0 110.38 176.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.786 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 15.7 m120 63.38 49.14 3.29 Favored 'General case' 0 C--O 1.209 -1.078 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.806 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.454 ' HB ' HG13 ' A' ' 177' ' ' ILE . 96.0 mt -86.78 111.68 21.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.529 HG12 HD22 ' A' ' 174' ' ' ASN . 74.1 t -84.81 117.84 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.889 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.7 p -118.57 146.28 44.72 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.6 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.473 ' O ' HD21 ' A' ' 96' ' ' LEU . 50.4 m80 63.07 166.19 0.12 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.498 0.666 . . . . 0.0 111.351 -177.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 . . . . . 0 C--O 1.268 2.057 0 CA-C-O 116.95 -1.5 . . . . 0.0 108.837 174.286 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 89' ' ' THR . 81.9 m . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.894 0.378 . . . . 0.0 111.051 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.451 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 23.3 m-85 -130.99 155.93 80.85 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.501 ' HD3' HD11 ' A' ' 76' ' ' LEU . 21.0 Cg_endo -58.54 -32.28 96.21 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.146 2.564 . . . . 0.0 113.155 -175.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.34 -36.25 2.74 Favored Glycine 0 N--CA 1.426 -1.968 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -176.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.71 -15.25 63.55 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.38 0.61 . . . . 0.0 110.571 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 71.9 m -60.08 128.19 35.57 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.055 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.672 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 82.0 mtm-85 -86.51 137.81 32.23 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.521 HD11 HG21 ' A' ' 175' ' ' VAL . 10.0 tt -123.6 132.82 70.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.261 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.553 HD22 ' CD1' ' A' ' 124' ' ' LEU . 0.4 OUTLIER -87.38 124.61 33.57 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-O 121.464 0.65 . . . . 0.0 109.853 178.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.489 ' N ' HD11 ' A' ' 9' ' ' LEU . 25.1 m -136.26 -179.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.549 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.453 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 32.2 tt0 -129.78 119.61 23.69 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.569 HG12 HG13 ' A' ' 47' ' ' ILE . 15.9 mt -119.53 121.47 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.9 -177.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.8 37.45 28.52 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.518 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.8 17.43 80.09 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.664 -1.153 . . . . 0.0 114.195 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.9 t -122.79 120.67 27.62 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.478 ' HB2' HD12 ' A' ' 124' ' ' LEU . 58.9 Cg_endo -74.23 119.92 6.03 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 122.064 1.842 . . . . 0.0 110.475 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -123.97 143.08 50.62 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.498 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -113.35 100.75 8.79 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.413 ' O ' ' N ' ' A' ' 8' ' ' ILE . 3.0 pt -122.1 -172.34 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.618 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.729 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 19.2 p -95.4 169.75 9.84 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.941 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.472 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 15.1 mt -71.07 -22.63 62.09 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.099 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.729 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.5 ptm180 -83.73 -25.34 30.66 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.547 ' OE1' HG21 ' A' ' 20' ' ' THR . 67.6 mt-10 -84.69 -43.14 14.62 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.239 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.463 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 20.1 tp -56.24 -43.31 78.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.906 0.86 . . . . 0.0 109.085 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -51.92 -32.56 33.4 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.367 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 29.6 mt-10 -74.94 -16.98 60.62 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.302 -177.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.6 mm? -77.44 0.4 22.76 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 121.322 0.582 . . . . 0.0 109.455 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.482 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 98.1 m-85 -117.64 161.25 19.95 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.404 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.583 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 23.6 mt-10 -136.21 -172.28 3.09 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.117 175.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.459 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 12.3 t0 61.83 75.9 0.39 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.434 0.635 . . . . 0.0 110.558 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -100.3 131.72 46.08 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.404 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -131.41 145.42 51.8 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.517 -177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -88.04 128.01 35.4 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.546 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -167.09 147.78 5.64 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.396 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 60.11 22.96 12.21 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 123.341 0.401 . . . . 0.0 110.683 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 38.3 mtm 71.98 16.14 5.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.612 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.2 m -134.74 -174.31 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -113.48 140.81 47.8 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 t -127.17 122.48 60.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.658 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.457 ' HD3' ' O ' ' A' ' 28' ' ' PHE . 17.6 ttm180 -113.21 126.61 55.61 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.459 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -133.63 146.94 51.37 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.387 -174.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? 83.16 110.37 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.422 0 O-C-N 124.444 1.09 . . . . 0.0 110.364 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 73.4 Cg_endo -79.12 152.14 24.08 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.45 2.1 . . . . 0.0 112.344 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.583 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 34.7 mtmt -81.92 -4.15 55.92 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.015 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -147.66 -165.62 2.3 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.14 103.86 16.15 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.569 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -116.59 118.61 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.621 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 47.3 mmtt -115.65 168.04 10.38 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.169 173.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.438 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.3 p -123.41 130.39 74.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.298 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -83.57 123.67 30.0 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 p -134.76 172.8 12.45 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.488 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.475 HG12 HD12 ' A' ' 176' ' ' ILE . 3.1 mm -119.23 142.41 34.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.176 0.513 . . . . 0.0 110.054 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.672 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 25.5 t70 -76.0 122.59 24.42 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.606 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.569 HD21 ' H ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -75.71 -9.81 58.91 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.643 -170.424 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.672 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.8 pt-20 -106.59 -26.94 11.15 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.867 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.411 ' HB ' ' HD3' ' A' ' 58' ' ' LYS . 69.0 p -118.1 -25.39 6.69 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.783 -176.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.49 10.88 69.81 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.002 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 2.2 mptp? -78.51 154.2 30.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.022 0.439 . . . . 0.0 111.771 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.412 HG11 HD22 ' A' ' 122' ' ' LEU . 2.8 p -91.0 104.87 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 121.833 0.825 . . . . 0.0 110.565 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.5 m -110.97 157.7 11.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.243 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.6 tp -116.45 137.82 51.86 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.6 t -143.93 172.47 12.81 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.281 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.29 161.55 19.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.63 0.728 . . . . 0.0 111.356 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.9 mp -100.23 140.75 18.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.519 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.478 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 27.5 mm-40 -92.26 -34.54 14.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.263 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 p30 175.89 176.75 0.23 Allowed 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.175 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 13.6 t -106.89 129.77 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.798 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 36.4 mt -91.13 111.79 24.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.805 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.453 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.1 tttt -127.65 110.29 12.53 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 163' ' ' PHE . . . -129.04 142.08 43.95 Favored Pre-proline 0 C--N 1.309 -1.161 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.442 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -53.87 124.14 15.16 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.115 2.544 . . . . 0.0 111.671 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.0 89.38 7.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.774 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.3 m -103.96 -29.27 11.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.194 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -85.58 166.98 15.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.724 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.491 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 28.7 m170 -98.01 171.69 8.1 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.705 ' CD1' ' HA ' ' A' ' 159' ' ' ALA . 37.0 mt -126.71 140.12 52.64 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.569 0.699 . . . . 0.0 111.643 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.48 HD13 ' C ' ' A' ' 108' ' ' ALA . 44.8 mt -87.73 142.55 12.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 172.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 21.3 ttt180 -122.45 137.26 54.93 Favored 'General case' 0 N--CA 1.398 -3.067 0 CA-C-O 121.308 0.575 . . . . 0.0 109.902 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 86' ' ' SER . 55.0 m-85 -113.47 121.98 45.9 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.774 -177.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 152' ' ' LYS . 44.1 tt0 -108.4 127.42 53.88 Favored 'General case' 0 CA--C 1.474 -1.956 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -89.82 159.09 17.18 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-O 121.21 0.529 . . . . 0.0 111.936 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.629 ' HA ' ' CG ' ' A' ' 152' ' ' LYS . 0.6 OUTLIER -60.15 -16.98 37.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.754 -178.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.632 ' OD1' ' HG3' ' A' ' 85' ' ' ARG . 38.3 p-10 -109.29 0.72 19.7 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.436 0.636 . . . . 0.0 111.065 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.49 19.47 25.2 Favored Glycine 0 C--N 1.309 -0.963 0 N-CA-C 116.511 1.364 . . . . 0.0 116.511 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.632 ' HG3' ' OD1' ' A' ' 83' ' ' ASP . 11.5 mtt180 -86.89 143.28 27.49 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 90.1 p -140.93 138.09 33.59 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 118.728 -1.189 . . . . 0.0 112.155 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.418 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 6.5 p90 -133.37 138.69 46.42 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.962 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.499 ' OE2' ' HG3' ' A' ' 78' ' ' ARG . 43.4 mp0 -115.02 147.94 39.49 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.769 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 1.1 p -140.79 155.72 46.33 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.945 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.597 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -76.33 12.14 1.32 Allowed 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 122.79 0.436 . . . . 0.0 112.04 -177.116 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.586 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 1.8 m 61.29 170.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 19.4 t70 72.17 -34.92 0.31 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.069 0.461 . . . . 0.0 110.814 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.489 ' H ' ' C ' ' A' ' 91' ' ' VAL . 47.6 m-70 -76.31 128.21 83.08 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.309 175.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 18.2 Cg_exo -67.47 127.52 16.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.284 2.656 . . . . 0.0 114.322 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.5 t -96.75 151.3 4.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 184' ' ' HIS . 7.2 tp -102.15 106.41 17.25 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.817 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.574 HG23 ' OD1' ' A' ' 115' ' ' ASP . 1.9 p -110.35 148.99 13.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.315 0.579 . . . . 0.0 111.338 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.507 ' CD2' HD12 ' A' ' 148' ' ' LEU . 61.8 t80 -104.47 92.55 4.36 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.111 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.535 ' OE1' ' HE3' ' A' ' 106' ' ' LYS . 8.3 pt-20 -136.06 158.37 44.56 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 82.4 m-20 62.78 22.6 13.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 110.347 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.44 15.19 58.88 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.238 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -132.94 171.95 13.26 Favored 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 117.71 0.755 . . . . 0.0 109.446 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -102.51 120.12 39.99 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.506 HD13 ' CG ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -125.03 144.66 34.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.302 -178.522 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.4 OUTLIER -101.81 111.83 24.22 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.032 -178.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.535 ' HE3' ' OE1' ' A' ' 99' ' ' GLU . 50.4 mttm -120.86 134.6 55.29 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.595 ' H ' ' HD2' ' A' ' 107' ' ' ARG . 5.4 mpt_? -59.77 158.44 10.37 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.586 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -55.16 -45.94 75.72 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.54 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.419 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 2.3 p90 -75.28 11.27 1.24 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.647 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.508 ' OE1' ' HA ' ' A' ' 106' ' ' LYS . 39.1 tt0 -124.14 -15.09 6.89 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.454 0.645 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.55 HG21 ' O ' ' A' ' 107' ' ' ARG . 73.7 t -75.01 150.68 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.726 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -118.42 161.2 20.37 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.445 -176.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -70.57 147.19 49.54 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.403 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.86 4.1 87.45 Favored Glycine 0 C--N 1.305 -1.164 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.16 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.726 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -72.63 163.92 27.3 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 148' ' ' LEU . 33.8 mttt -117.28 162.82 17.27 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.28 0.562 . . . . 0.0 110.503 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.418 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -130.24 157.68 42.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.213 172.318 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.62 136.29 33.16 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -102.39 152.05 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.686 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.309 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.7 t -66.57 -4.27 8.21 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.826 0.346 . . . . 0.0 111.025 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.476 ' HA ' ' HB3' ' A' ' 145' ' ' HIS . 59.0 mt-10 39.76 69.68 0.28 Allowed 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.917 -177.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.412 HD22 HG11 ' A' ' 59' ' ' VAL . 50.9 tp -160.52 137.8 9.29 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.206 -177.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -108.62 148.14 30.8 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.342 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.553 ' CD1' HD22 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -144.14 -86.92 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.346 0.593 . . . . 0.0 110.481 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.0 p -171.8 138.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.251 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -105.32 -39.2 6.24 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.989 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 69.03 -70.9 0.13 Allowed 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.96 0.788 . . . . 0.0 109.955 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.1 m 54.33 23.52 4.43 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.404 0.681 . . . . 0.0 112.218 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.5 t -141.71 -62.23 0.46 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.807 0.337 . . . . 0.0 110.964 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.4 t -107.18 133.0 52.41 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 120.923 0.392 . . . . 0.0 110.803 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.7 t -104.73 -3.45 23.61 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.46 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -95.38 -18.45 20.73 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.694 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.72 109.27 20.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.204 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -122.2 89.26 48.8 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.921 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.71 96.98 0.86 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.882 2.388 . . . . 0.0 111.693 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -68.64 -18.77 64.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.363 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.71 129.69 34.97 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.029 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -54.46 136.91 43.72 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.375 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -139.95 138.25 35.41 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.176 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 tp 60.82 95.51 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 123.972 0.795 . . . . 0.0 110.81 -175.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.56 25.67 26.77 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.566 -1.302 . . . . 0.0 111.232 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.0 m -129.71 118.75 18.89 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.38 -161.59 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.545 2.164 . . . . 0.0 111.63 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -165.28 -39.61 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.588 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.476 ' HB3' ' HA ' ' A' ' 121' ' ' GLU . 0.4 OUTLIER -63.02 126.6 27.86 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -151.46 30.82 0.6 Allowed 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.804 0.812 . . . . 0.0 109.134 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -140.5 141.44 35.35 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.143 -172.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.507 HD12 ' CD2' ' A' ' 98' ' ' TYR . 9.9 mt -101.81 149.93 23.67 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.572 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -114.79 138.68 50.46 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -172.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -90.4 145.09 25.21 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.013 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 79.4 mt -79.3 117.22 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-N 113.507 -1.679 . . . . 0.0 110.99 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.629 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 30.3 mmtt -76.06 -37.98 57.62 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.589 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -152.7 134.63 14.77 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 77.0 mt -117.59 125.89 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.279 174.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.423 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.9 ptpt -128.18 159.25 35.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.457 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.423 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 19.0 m-85 -100.36 117.83 35.37 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -127.74 174.08 11.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.376 -178.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.442 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 37.3 ttt180 -95.33 155.25 16.82 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 122.106 -0.371 . . . . 0.0 110.829 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.705 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.4 -25.3 49.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.657 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 68.05 -39.73 0.4 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.45 -173.25 2.6 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.85 -10.89 19.47 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 120.645 0.259 . . . . 0.0 111.171 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 96.5 m-85 -141.86 155.08 45.55 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.94 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 3' ' ' PRO . 3.6 m -126.77 159.86 35.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.935 177.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.633 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 69.9 m-85 -136.22 172.05 13.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.632 0.254 . . . . 0.0 110.478 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.28 -23.2 0.06 Allowed 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.463 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 1.3 tm? 68.23 107.97 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.97 176.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -87.28 118.21 26.55 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.54 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.478 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.41 -153.9 0.6 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -61.96 132.34 52.64 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.88 0.372 . . . . 0.0 111.187 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.507 ' HG3' ' CD2' ' A' ' 172' ' ' TYR . 21.1 tptm 77.16 -77.95 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.192 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.507 ' CD2' ' HG3' ' A' ' 171' ' ' LYS . 75.3 m-85 -146.03 -174.08 4.33 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -88.18 34.28 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.12 0.486 . . . . 0.0 110.61 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.442 ' OD1' ' HB2' ' A' ' 172' ' ' TYR . 2.2 p-10 -78.32 99.48 6.34 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 8' ' ' ILE . 4.2 p -129.5 167.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-O 121.568 0.699 . . . . 0.0 112.723 -173.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.509 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 75.7 mt -93.5 113.57 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.716 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 43.8 pt -120.39 172.92 6.78 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.688 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 5.0 t-20 47.84 -123.07 1.55 Allowed 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 124.487 1.115 . . . . 0.0 110.725 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -92.71 48.46 1.37 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.693 0.758 . . . . 0.0 109.862 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.66 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.7 m-20 73.86 46.44 0.19 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.465 1.506 . . . . 0.0 112.82 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.7 mt -88.96 117.2 31.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 56.6 t -84.38 152.09 3.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.693 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 6.4 t -158.67 152.87 23.92 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.908 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.412 ' C ' HD12 ' A' ' 96' ' ' LEU . 71.2 m80 67.72 154.44 0.1 Allowed 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.731 0.644 . . . . 0.0 112.264 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.451 ' C ' ' HG ' ' A' ' 54' ' ' LEU . 57.2 tt0 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.965 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.752 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 62.0 m . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.869 0.366 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -133.07 158.0 76.92 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.531 ' HD3' HD11 ' A' ' 76' ' ' LEU . 56.4 Cg_endo -68.1 162.65 39.17 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 121.557 1.505 . . . . 0.0 108.9 176.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.75 -24.43 66.41 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 118.857 -1.64 . . . . 0.0 110.146 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.66 -13.69 34.97 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.031 0.932 . . . . 0.0 112.935 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 61.3 m -72.24 131.64 43.0 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.885 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.636 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 12.6 mtm180 -86.34 133.03 33.83 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.6 HD11 ' CG2' ' A' ' 175' ' ' VAL . 2.2 tp -117.13 133.37 64.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-O 121.131 0.491 . . . . 0.0 110.884 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.67 HD23 ' CD1' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -92.51 124.25 36.41 Favored 'General case' 0 N--CA 1.4 -2.965 0 CA-C-O 121.788 0.804 . . . . 0.0 110.956 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.459 ' N ' HD11 ' A' ' 9' ' ' LEU . 19.7 m -134.26 -179.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.898 -177.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -125.8 117.14 22.76 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 26.9 mt -118.89 120.56 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 CA-C-O 121.137 0.494 . . . . 0.0 110.015 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 54.11 38.51 29.21 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.92 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.71 20.48 79.69 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.746 -1.115 . . . . 0.0 113.677 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.1 t -131.01 123.04 19.64 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.465 ' CB ' HD23 ' A' ' 124' ' ' LEU . 70.6 Cg_endo -73.85 120.87 6.61 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 122.546 2.164 . . . . 0.0 112.25 -177.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.564 ' HG2' ' ND2' ' A' ' 134' ' ' ASN . 12.4 mt-30 -120.56 138.71 53.73 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.636 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HZ2' ' CD ' ' A' ' 179' ' ' GLU . 37.9 ttmt -108.9 100.78 9.95 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.595 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.5 ' CG2' ' HB3' ' A' ' 130' ' ' SER . 2.9 pt -124.19 -172.91 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.144 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.743 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 11.3 p -95.44 171.12 8.9 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.622 178.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.594 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 92.4 mt -66.56 -31.31 71.94 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.219 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.743 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 6.3 ptm180 -79.43 -24.84 42.21 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.549 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 68.8 mt-10 -83.87 -41.62 17.26 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.389 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.556 ' CD2' HD13 ' A' ' 167' ' ' LEU . 46.8 tp -59.3 -41.52 89.17 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.894 0.854 . . . . 0.0 109.34 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.427 ' HB2' HG13 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -53.49 -31.74 47.21 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.979 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 32.4 mt-10 -77.24 -14.9 59.68 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.733 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -82.59 0.54 42.42 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.643 0.735 . . . . 0.0 109.14 177.05 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.484 ' CZ ' HG23 ' A' ' 47' ' ' ILE . 72.4 m-85 -114.11 162.61 16.27 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.686 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.404 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 6.5 tp10 -142.15 -178.73 5.86 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.437 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.524 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER 65.1 79.89 0.24 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.641 0.777 . . . . 0.0 110.448 -179.187 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -101.13 131.43 47.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 122.078 0.942 . . . . 0.0 110.922 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -122.71 153.61 39.2 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.269 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -101.14 125.18 47.74 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -166.7 145.49 5.39 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.444 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 61.04 19.85 10.32 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.864 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.2 mtt 71.67 16.79 5.68 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.505 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 16.2 m -131.89 -170.77 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -119.3 142.67 47.89 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.92 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 t -129.38 123.41 57.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.154 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.461 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 15.0 ttm180 -113.54 127.01 55.93 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.665 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.42 135.33 46.01 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.959 -175.498 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 36.0 mtpt 91.99 118.2 0.02 OUTLIER Pre-proline 0 CA--C 1.502 -0.887 0 C-N-CA 125.375 1.47 . . . . 0.0 112.147 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 87.3 Cg_endo -78.42 156.19 28.73 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.782 2.321 . . . . 0.0 111.045 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.402 ' HD3' ' HB2' ' A' ' 29' ' ' GLU . 38.8 mtmt -94.02 -1.6 54.26 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.439 0.637 . . . . 0.0 110.565 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -146.3 -165.67 2.28 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.624 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 4.9 tp10 -85.28 99.24 11.0 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 174.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.503 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 1.5 mp -116.08 115.8 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.01 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.59 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 30.6 mmtp -123.28 163.94 19.73 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.98 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.412 HG13 ' CG1' ' A' ' 64' ' ' ILE . 6.9 m -111.06 128.78 67.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.068 0.461 . . . . 0.0 111.846 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -83.8 124.11 30.59 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.428 ' HA ' HG13 ' A' ' 176' ' ' ILE . 20.0 m -134.17 172.16 13.24 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.419 HD11 ' C ' ' A' ' 58' ' ' LYS . 2.9 mm -119.49 143.06 32.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.116 0.484 . . . . 0.0 110.071 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 41.9 t0 -84.23 119.77 25.43 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.568 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.603 HD21 ' H ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -72.71 -11.37 60.59 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.124 -171.579 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.42 ' HG3' HG21 ' A' ' 56' ' ' THR . 5.5 pt-20 -102.48 -27.88 12.52 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.82 -176.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.42 HG21 ' HG3' ' A' ' 55' ' ' GLU . 76.1 p -115.48 -23.96 8.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.634 -175.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.41 14.45 76.31 Favored Glycine 0 N--CA 1.429 -1.784 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.149 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.419 ' C ' HD11 ' A' ' 52' ' ' ILE . 5.1 mtpm? -89.75 153.3 20.8 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.6 p -89.69 107.61 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-O 121.967 0.889 . . . . 0.0 110.042 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 m -110.09 159.37 9.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.201 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 12.9 tp -121.91 140.69 52.12 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.0 t -147.03 172.31 13.93 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.212 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.31 161.87 19.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.551 0.691 . . . . 0.0 110.824 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.539 ' N ' HD13 ' A' ' 64' ' ' ILE . 3.0 mp -105.32 134.26 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.699 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.48 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 10.9 mm-40 -79.8 -40.21 29.13 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.036 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 p30 179.49 178.03 0.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.175 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 25' ' ' TYR . 20.1 t -105.45 130.0 57.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.633 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.675 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 50.7 mt -90.67 105.2 16.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.538 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 84.9 tttt -118.52 109.82 16.65 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.3 134.57 25.89 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.219 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -47.22 124.35 8.94 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.447 2.765 . . . . 0.0 112.916 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.36 110.4 2.24 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.073 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -68.33 0.93 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -68.23 -117.4 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -159.34 172.68 17.53 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -172.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.533 HD23 ' HA ' ' A' ' 90' ' ' THR . 4.5 mt -136.5 140.22 42.86 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.532 0.682 . . . . 0.0 111.283 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.543 HD12 ' CZ ' ' A' ' 156' ' ' TYR . 9.0 mt -86.5 142.55 12.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 171.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 31.8 ttt85 -118.97 138.38 52.85 Favored 'General case' 0 N--CA 1.404 -2.763 0 CA-C-O 121.207 0.527 . . . . 0.0 109.755 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.616 ' O ' ' HA ' ' A' ' 86' ' ' SER . 53.5 m-85 -115.97 125.17 52.16 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.893 -177.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 152' ' ' LYS . 34.5 tt0 -108.18 125.22 51.37 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.554 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -91.25 160.06 15.72 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.889 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.642 ' HG2' ' CD1' ' A' ' 149' ' ' LEU . 5.5 pt-20 -62.54 -19.59 63.79 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.209 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -87.33 -11.31 49.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.762 0.792 . . . . 0.0 109.23 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.52 16.81 47.95 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.036 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.527 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -87.46 142.91 27.51 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.762 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 23.6 p -142.38 136.28 29.43 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.456 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -129.97 155.99 45.18 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.165 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.434 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 40.2 mt-10 -129.86 148.01 51.69 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.308 0.575 . . . . 0.0 112.135 -175.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.526 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.7 OUTLIER -141.0 154.51 46.05 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.358 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.533 ' HA ' HD23 ' A' ' 76' ' ' LEU . 1.1 p -69.84 15.92 0.07 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.661 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.06 -39.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 125.349 1.46 . . . . 0.0 113.854 175.009 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -90.79 12.68 18.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.414 0.625 . . . . 0.0 110.766 -178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 39.6 m80 -115.45 141.62 27.53 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.361 177.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 23.6 Cg_exo -64.9 142.78 77.05 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.43 2.753 . . . . 0.0 115.201 -176.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.519 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 19.1 t -119.52 150.13 22.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.381 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.5 tp -104.26 107.57 18.55 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.86 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.529 HG11 HG13 ' A' ' 104' ' ' ILE . 1.6 p -107.11 143.96 16.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.383 0.611 . . . . 0.0 111.684 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.591 ' CD2' HD13 ' A' ' 148' ' ' LEU . 44.5 t80 -99.17 90.95 4.76 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.687 176.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 11.9 pt-20 -138.17 157.51 46.16 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.499 176.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.546 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER 68.81 21.86 7.51 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.93 13.84 60.09 Favored Glycine 0 CA--C 1.508 -0.35 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.669 -177.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -135.61 172.5 12.92 Favored 'General case' 0 N--CA 1.404 -2.748 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -104.77 119.81 39.88 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.529 HG13 HG11 ' A' ' 97' ' ' VAL . 21.4 pt -119.22 144.2 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 120.129 -0.629 . . . . 0.0 112.187 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -101.82 114.87 29.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.551 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.565 ' HB3' ' HZ2' ' A' ' 106' ' ' LYS . 0.7 OUTLIER -136.01 146.56 47.29 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.387 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.572 ' O ' HG21 ' A' ' 111' ' ' VAL . 74.4 mtm180 -63.73 160.23 17.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.661 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -61.54 -41.55 97.51 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.788 -175.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.476 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.3 p90 -72.47 0.5 10.12 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.068 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -112.64 -16.68 12.77 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.479 0.657 . . . . 0.0 109.974 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.572 HG21 ' O ' ' A' ' 107' ' ' ARG . 94.7 t -71.08 150.7 9.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.786 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 1.9 mtmp? -115.08 159.73 20.5 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.178 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -73.97 145.86 44.32 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.08 4.22 86.96 Favored Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.159 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.786 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -76.68 167.32 22.05 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.16 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.454 ' H ' HG23 ' A' ' 97' ' ' VAL . 35.6 mttt -120.03 166.84 12.84 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.498 0.666 . . . . 0.0 111.756 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.35 162.28 35.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.655 171.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.61 141.02 29.09 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.745 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 1.8 m -114.68 149.57 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 173.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 122' ' ' LEU . 44.9 t -69.53 -1.37 8.5 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.281 0.562 . . . . 0.0 110.548 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.671 ' OE1' ' HA ' ' A' ' 146' ' ' ASP . 27.6 mt-10 56.74 1.04 0.08 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 124.613 1.165 . . . . 0.0 113.274 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.44 ' H ' ' C ' ' A' ' 120' ' ' SER . 45.7 tp -111.59 120.49 42.27 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 120.867 0.365 . . . . 0.0 110.604 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.576 ' C ' ' HG ' ' A' ' 124' ' ' LEU . 7.4 pt-20 -93.63 -17.92 22.75 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -174.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.67 ' CD1' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER 52.96 3.96 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 124.258 1.023 . . . . 0.0 112.289 -177.529 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.565 ' H ' ' C ' ' A' ' 123' ' ' GLU . 80.0 t 77.55 -47.68 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.71 1.204 . . . . 0.0 112.319 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.409 ' OE2' ' HA ' ' A' ' 17' ' ' GLN . 34.9 tt0 -54.41 110.82 0.67 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.636 0.731 . . . . 0.0 112.602 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -126.6 6.84 6.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.42 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.8 t -78.89 -177.95 5.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.855 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.3 p -70.7 -18.52 62.81 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.938 0.399 . . . . 0.0 110.287 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.503 ' HA ' HE22 ' A' ' 132' ' ' GLN . 4.5 t 66.78 23.18 10.15 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.918 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.1 t -80.4 -1.83 43.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.958 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.503 HE22 ' HA ' ' A' ' 130' ' ' SER . 5.1 pm0 -95.02 169.31 10.21 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.63 ' O ' ' HD3' ' A' ' 135' ' ' PRO . 7.3 p-10 -81.25 147.96 29.7 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.564 ' ND2' ' HG2' ' A' ' 17' ' ' GLN . 7.3 m-20 -112.11 88.89 10.97 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.306 0.575 . . . . 0.0 111.201 -176.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 133' ' ' ASP . 7.8 Cg_exo -74.7 -40.48 1.01 Allowed 'Trans proline' 0 C--N 1.326 -0.65 0 C-N-CA 123.521 2.814 . . . . 0.0 112.572 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.443 ' C ' ' H ' ' A' ' 138' ' ' GLU . 68.4 mttm -150.69 -53.49 0.14 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.995 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.5 t30 75.63 -13.43 0.87 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.771 0.828 . . . . 0.0 110.382 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 136' ' ' LYS . 2.4 mp0 63.59 -176.03 0.16 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.975 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -102.57 143.31 32.43 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.526 HD21 ' H ' ' A' ' 140' ' ' LEU . 2.4 pt? -74.15 -40.75 62.38 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.033 0.444 . . . . 0.0 111.863 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 108.86 -76.36 0.22 Allowed Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 26.6 t -137.74 117.79 10.25 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-O 120.686 0.279 . . . . 0.0 110.493 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -67.03 -51.86 0.73 Allowed 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 122.774 2.316 . . . . 0.0 112.113 177.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 76.64 -92.87 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.204 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.93 -91.33 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.828 0 O-C-N 123.7 0.625 . . . . 0.0 112.493 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.671 ' HA ' ' OE1' ' A' ' 121' ' ' GLU . 36.9 t70 49.98 56.59 7.65 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.347 0.659 . . . . 0.0 112.772 176.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -166.27 142.67 4.94 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.638 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.591 HD13 ' CD2' ' A' ' 98' ' ' TYR . 11.9 mt -101.37 148.04 25.62 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-O 121.288 0.566 . . . . 0.0 109.68 175.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.642 ' CD1' ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -108.37 133.86 51.98 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.644 -172.012 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -88.46 143.75 26.79 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.919 175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.481 HD13 ' CD1' ' A' ' 79' ' ' PHE . 68.2 mt -77.5 110.06 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.607 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.006 175.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 80' ' ' GLU . 7.2 mmpt? -72.44 -39.75 67.59 Favored 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.487 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -150.16 133.8 16.67 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.8 mt -113.83 143.08 24.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.054 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.504 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.0 ptpt -144.6 158.03 43.95 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -178.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.543 ' CZ ' HD12 ' A' ' 77' ' ' ILE . 7.2 m-85 -100.9 114.54 28.5 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.563 174.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.43 173.78 11.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.319 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.445 ' HG2' ' H ' ' A' ' 159' ' ' ALA . 49.8 ttt180 -112.21 167.6 10.28 Favored 'General case' 0 N--CA 1.415 -2.193 0 O-C-N 121.329 -0.857 . . . . 0.0 110.693 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.454 ' HA ' HD12 ' A' ' 76' ' ' LEU . . . -67.57 114.94 6.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.433 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -72.5 -32.77 66.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.665 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -81.92 -176.21 6.0 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.305 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -101.29 -15.68 17.2 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -138.17 153.77 49.18 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.489 HG11 ' HA ' ' A' ' 3' ' ' PRO . 3.1 m -118.46 155.95 20.41 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.675 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 78.1 m-85 -135.52 161.3 35.88 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.91 -175.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.752 ' OG ' ' HA ' ' A' ' 1' ' ' CYS . 74.0 m -158.1 13.64 0.2 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.553 176.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.639 HD21 ' C ' ' A' ' 166' ' ' SER . 2.5 pt? 29.39 109.51 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 125.368 1.467 . . . . 0.0 113.923 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -82.03 114.34 20.52 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.147 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.48 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -133.56 -142.43 0.2 Allowed 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -67.03 115.52 6.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.821 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt 70.07 166.95 0.29 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.742 0.817 . . . . 0.0 112.544 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -77.93 121.88 24.76 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.118 -175.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 49.99 27.62 2.53 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 114.581 -1.191 . . . . 0.0 113.266 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.13 99.57 11.6 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.6 ' CG2' HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -165.1 171.7 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.657 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 97.0 mt -111.99 118.12 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.615 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 44.3 pt -120.78 171.91 8.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.294 0 CA-C-O 121.01 0.433 . . . . 0.0 111.186 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 48.83 -129.79 1.9 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.313 1.045 . . . . 0.0 110.504 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.481 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 24.7 mm-40 -89.73 52.01 2.22 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.558 0.694 . . . . 0.0 109.959 176.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.745 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 13.5 m120 74.05 44.41 0.26 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.685 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 86.5 mt -87.0 113.04 23.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 73.4 t -88.24 130.38 37.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.958 -176.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.519 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 12.0 t -139.14 166.16 25.25 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.594 176.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -157.66 145.53 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.656 0.265 . . . . 0.0 110.65 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 C--O 1.256 1.405 0 CA-C-O 117.783 -1.103 . . . . 0.0 110.185 177.391 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 89' ' ' THR . 63.7 m . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.997 0.427 . . . . 0.0 111.42 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.43 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 2.7 m-85 -133.0 167.01 25.1 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.495 ' HD3' HD13 ' A' ' 76' ' ' LEU . 73.0 Cg_endo -72.14 164.48 35.51 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 N-CA-C 108.408 -1.42 . . . . 0.0 108.408 175.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.76 -26.59 65.26 Favored Glycine 0 C--N 1.301 -1.415 0 C-N-CA 118.993 -1.575 . . . . 0.0 111.44 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.54 -9.32 48.55 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.6 m -71.33 129.69 39.49 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.381 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 26.2 mtm180 -85.77 132.08 34.2 Favored 'General case' 0 C--O 1.187 -2.187 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 175' ' ' VAL . 8.9 tt -119.91 130.1 74.62 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-O 120.863 0.363 . . . . 0.0 110.139 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -88.44 122.13 31.59 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-O 121.527 0.679 . . . . 0.0 109.576 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 28.0 m -132.58 -173.3 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.346 -178.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.464 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 31.4 tt0 -134.4 121.4 21.09 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.586 HG12 HG13 ' A' ' 47' ' ' ILE . 17.0 mt -120.87 123.47 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.922 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.11 37.47 27.09 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.202 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.12 76.92 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.657 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -130.79 119.81 18.28 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 13.5 Cg_exo -64.87 120.93 8.29 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.733 1.622 . . . . 0.0 110.663 178.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -118.62 135.58 54.36 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -106.56 100.78 10.28 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.436 ' O ' ' N ' ' A' ' 8' ' ' ILE . 3.3 pt -125.46 -172.68 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.146 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.243 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.713 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 29.6 p -96.46 170.1 9.46 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.793 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 84.6 mt -67.23 -28.22 67.88 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.797 178.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.713 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 11.2 ptm180 -79.51 -26.54 41.53 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.549 ' OE1' HG23 ' A' ' 20' ' ' THR . 43.9 mt-10 -84.28 -42.34 15.93 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.797 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.588 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 17.5 tp -57.96 -44.01 86.76 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.779 0.8 . . . . 0.0 109.206 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.434 ' HB2' HG12 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -51.42 -34.17 33.72 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.749 -1.568 . . . . 0.0 112.631 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 31.3 mt-10 -76.6 -14.39 60.0 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 23' ' ' GLU . 1.4 mm? -79.97 4.74 15.94 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.572 0.701 . . . . 0.0 109.317 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 96.9 m-85 -118.24 162.11 18.79 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.922 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -142.12 -173.38 3.81 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.512 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.8 OUTLIER 61.91 84.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.45 0.643 . . . . 0.0 110.434 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -103.0 127.25 50.31 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.782 0.801 . . . . 0.0 111.161 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.401 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 14.3 ptt180 -121.04 154.39 36.14 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.237 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -100.3 130.26 46.39 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -164.29 142.04 6.89 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.27 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 59.07 23.12 11.27 Favored 'General case' 0 CA--C 1.493 -1.225 0 O-C-N 123.599 0.562 . . . . 0.0 111.18 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.8 mtp 71.81 17.98 5.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.618 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.521 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 14.6 m -132.56 -173.61 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -114.46 141.4 47.73 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-O 121.253 0.549 . . . . 0.0 109.822 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.401 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.4 t -129.23 123.46 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.059 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.439 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 19.3 ttm180 -114.13 126.6 55.26 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -130.67 144.28 51.32 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.683 -174.686 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 37.5 ttmt 83.97 114.58 0.03 OUTLIER Pre-proline 0 CA--C 1.509 -0.627 0 O-C-N 124.639 1.212 . . . . 0.0 111.279 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 81.7 Cg_endo -80.24 151.62 20.61 Favored 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 122.19 1.926 . . . . 0.0 111.515 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -84.04 -5.91 59.32 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.32 0.581 . . . . 0.0 110.751 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -145.5 -166.09 2.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 8.1 tp10 -85.69 101.07 12.44 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.586 HG13 HG12 ' A' ' 12' ' ' ILE . 1.8 mp -117.36 116.92 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.598 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 57.0 mmtt -115.12 169.08 9.38 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.336 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.455 HG13 ' CB ' ' A' ' 169' ' ' ALA . 13.0 p -127.01 130.77 71.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.45 ' HB3' HD12 ' A' ' 176' ' ' ILE . 5.2 m-85 -88.0 124.2 33.49 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.586 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.8 m -133.73 168.56 18.48 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.641 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.49 HG12 HD13 ' A' ' 176' ' ' ILE . 2.2 mm -116.0 145.91 21.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.32 0.581 . . . . 0.0 111.061 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.677 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 17.5 t70 -84.56 114.13 21.75 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.593 HD21 ' H ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -73.47 -9.2 58.44 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.355 0.662 . . . . 0.0 112.629 -170.049 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.677 ' HG3' ' OD1' ' A' ' 53' ' ' ASP . 3.1 pt-20 -102.12 -28.01 12.58 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.841 -176.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.566 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 61.0 p -118.2 -25.23 6.68 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.67 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.28 16.54 55.4 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.691 -0.686 . . . . 0.0 113.543 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.566 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 38.2 mttt -86.93 151.46 23.28 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.98 0.419 . . . . 0.0 112.092 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.02 107.97 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.581 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.7 m -109.5 157.1 10.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.316 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.9 tp -120.87 142.88 49.26 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 170' ' ' LYS . 9.9 t -148.52 170.77 17.33 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.602 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.79 160.71 22.2 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.365 0.603 . . . . 0.0 109.824 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.2 mp -94.71 143.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.032 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.422 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 58.0 mm-40 -89.05 -39.87 13.36 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 178.58 177.26 0.46 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.693 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' A' ' 25' ' ' TYR . 9.9 t -107.48 130.42 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.377 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 38.1 mt -90.51 106.85 17.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.587 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.521 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.5 tttt -121.54 108.73 13.96 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.74 141.87 43.36 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.275 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.442 ' HD2' HG13 ' A' ' 37' ' ' VAL . 9.5 Cg_endo -55.48 130.25 39.5 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 123.379 2.719 . . . . 0.0 112.74 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.5 99.66 9.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.397 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.2 m -106.04 -48.74 3.53 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.43 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.452 ' OD2' HG22 ' A' ' 90' ' ' THR . 12.0 p-10 -87.7 -173.28 4.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.25 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -111.76 172.96 6.59 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 121.163 0.506 . . . . 0.0 111.126 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' A' ' 90' ' ' THR . 9.9 mt -120.2 146.63 45.84 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.031 -175.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.479 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 12.0 mt -89.8 145.47 7.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 30.5 ttt-85 -120.75 136.76 54.79 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.568 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.0 m-85 -114.73 122.33 46.09 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.486 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.1 tt0 -110.04 123.81 50.35 Favored 'General case' 0 CA--C 1.465 -2.312 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.581 HD21 ' O ' ' A' ' 85' ' ' ARG . 1.5 mm? -86.84 162.05 17.99 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.448 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.574 ' HG2' ' CD1' ' A' ' 149' ' ' LEU . 1.5 pt-20 -63.26 -15.64 57.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.312 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -93.03 -9.73 38.71 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.029 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.22 8.68 62.73 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.452 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.581 ' O ' HD21 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -88.83 143.35 26.95 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 176.064 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 55.8 p -138.57 154.89 48.74 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.823 178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -145.69 148.95 33.59 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.883 176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 44.1 mt-10 -124.89 148.15 48.44 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.729 -175.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.516 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -144.71 159.03 43.5 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.636 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.514 ' HA ' HD21 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -71.04 18.72 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.055 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.693 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.6 OUTLIER 70.87 -32.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 125.006 1.322 . . . . 0.0 112.429 177.273 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 90' ' ' THR . 12.8 t70 -78.35 -26.87 46.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.149 0.499 . . . . 0.0 109.737 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -69.26 123.75 88.97 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.05 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 33.5 Cg_exo -63.78 142.08 81.33 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.278 2.652 . . . . 0.0 113.126 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.46 146.33 18.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 124.22 1.008 . . . . 0.0 108.332 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.9 tp -105.38 109.7 21.78 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.837 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.457 HG12 HG13 ' A' ' 104' ' ' ILE . 2.1 p -110.72 151.1 12.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.371 0.605 . . . . 0.0 111.214 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -102.66 93.36 5.07 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.984 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.506 ' OE2' HD13 ' A' ' 104' ' ' ILE . 11.4 pt-20 -145.88 157.04 43.92 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 39.1 m-80 66.52 23.52 10.44 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.144 0.497 . . . . 0.0 109.844 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.42 11.89 57.36 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.207 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -136.84 172.23 13.33 Favored 'General case' 0 N--CA 1.402 -2.827 0 CA-C-O 121.462 0.649 . . . . 0.0 110.507 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -98.45 121.41 40.35 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.373 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.506 HD13 ' OE2' ' A' ' 99' ' ' GLU . 22.8 pt -118.72 145.9 24.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.126 -0.63 . . . . 0.0 112.146 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -103.65 109.14 20.72 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.793 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -124.98 135.6 52.95 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.844 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.61 ' O ' HG21 ' A' ' 111' ' ' VAL . 96.1 mtt180 -62.31 163.42 8.47 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.693 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -62.05 -42.13 98.86 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.165 -176.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.436 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.7 p90 -74.14 2.64 8.52 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.814 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -110.87 -19.41 12.82 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.487 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.61 HG21 ' O ' ' A' ' 107' ' ' ARG . 98.5 t -77.55 147.02 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.476 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 8.3 mptt -118.46 166.76 12.28 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.005 0.431 . . . . 0.0 111.543 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -70.11 142.9 52.54 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.07 4.21 81.93 Favored Glycine 0 C--N 1.304 -1.245 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.235 -175.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.487 ' HB3' HD12 ' A' ' 151' ' ' ILE . 11.3 t70 -76.93 170.47 16.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.585 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 42.4 mttp -122.78 165.97 15.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.442 0.639 . . . . 0.0 111.648 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.97 156.57 39.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.862 171.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.463 ' HG ' HD12 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -91.57 136.61 33.0 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.732 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.4 m -107.09 154.34 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.206 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.933 173.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.428 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 32.2 t -76.2 30.0 0.12 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.809 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.565 ' H ' ' C ' ' A' ' 119' ' ' VAL . 36.5 mt-10 73.4 -49.07 0.69 Allowed 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 124.728 1.211 . . . . 0.0 111.86 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.454 ' CB ' ' HB3' ' A' ' 143' ' ' PRO . 0.7 OUTLIER -173.63 -169.51 0.51 Allowed 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -175.771 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -113.71 -134.44 0.35 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.037 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.472 HD22 ' HB2' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -98.28 16.44 21.46 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.642 0.734 . . . . 0.0 110.439 -176.514 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.449 ' O ' HD23 ' A' ' 122' ' ' LEU . 4.0 p -168.16 154.42 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.459 -177.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -59.33 -59.46 5.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.295 0.372 . . . . 0.0 111.929 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -165.01 79.51 0.34 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.923 0.392 . . . . 0.0 110.372 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.1 m 67.63 -67.23 0.19 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.27 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.2 m 50.5 -99.13 0.07 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.215 1.006 . . . . 0.0 112.477 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.506 ' HB2' ' OE1' ' A' ' 132' ' ' GLN . 1.2 m -68.33 -39.58 81.88 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.611 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.2 m 64.05 94.8 0.05 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.369 0.667 . . . . 0.0 111.878 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.506 ' OE1' ' HB2' ' A' ' 130' ' ' SER . 18.6 mp0 -125.64 172.86 9.41 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.041 0.448 . . . . 0.0 111.291 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.12 -21.43 16.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.913 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.469 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . 25.8 t-20 -178.32 -49.25 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.445 -177.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 134' ' ' ASN . 27.2 Cg_exo -61.92 97.03 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.743 2.295 . . . . 0.0 113.427 -175.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -167.86 -41.46 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 m120 66.11 -172.27 0.19 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.921 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.78 164.76 16.5 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -174.03 -46.65 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.72 0.771 . . . . 0.0 109.797 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.533 HD22 ' H ' ' A' ' 140' ' ' LEU . 2.0 pt? -70.07 -37.77 75.56 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.544 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.59 -72.87 0.25 Allowed Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.8 m -136.0 163.84 47.44 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.454 ' HB3' ' CB ' ' A' ' 122' ' ' LEU . 19.1 Cg_exo -66.01 -169.76 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.661 2.24 . . . . 0.0 112.154 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 145' ' ' HIS . 10.0 tp10 -165.6 92.66 0.54 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.803 -0.181 . . . . 0.0 110.831 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 1.3 t60 172.4 91.2 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -77.06 117.49 18.68 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.123 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.515 ' NE2' HH22 ' A' ' 85' ' ' ARG . 8.2 pt20 -164.39 138.96 5.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.399 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.585 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.9 mm? -115.55 132.19 56.7 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.574 ' CD1' ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -109.26 134.89 51.2 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -173.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.518 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 19.9 mt-10 -87.3 142.79 27.63 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.057 176.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.487 HD12 ' HB3' ' A' ' 115' ' ' ASP . 71.1 mt -78.79 109.22 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.246 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.62 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.559 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 36.4 mmtt -68.25 -40.36 81.96 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.918 176.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -151.27 131.33 13.44 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.2 mt -112.83 140.98 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.189 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.371 174.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.4 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.2 ptpt -148.44 159.64 43.84 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.312 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.479 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 18.7 m-85 -99.27 116.75 32.18 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.31 134.69 60.74 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.007 -178.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -67.44 154.19 41.94 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.518 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.0 133.99 56.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.784 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -84.32 37.9 0.64 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.089 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 162' ' ' ASP . 12.6 t70 -176.54 -174.4 0.58 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.29 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.489 ' H ' ' CG ' ' A' ' 161' ' ' ASP . 6.0 m-20 -95.64 -10.43 29.44 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.876 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.21 160.73 38.18 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.265 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.442 HG13 ' HA ' ' A' ' 3' ' ' PRO . 2.7 m -127.55 158.01 39.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.573 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.572 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 77.3 m-85 -135.77 167.22 21.57 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.142 0.496 . . . . 0.0 111.08 -175.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.464 ' HB3' HD11 ' A' ' 68' ' ' ILE . 44.6 t -152.47 -16.39 0.17 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.115 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.588 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 4.5 mm? 59.41 105.02 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.648 0.737 . . . . 0.0 111.655 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.511 ' OD1' ' HB3' ' A' ' 172' ' ' TYR . 58.2 t30 -83.81 118.68 24.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.556 -176.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.455 ' CB ' HG13 ' A' ' 49' ' ' VAL . . . -135.32 -162.1 1.22 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.41 ' HB3' HG23 ' A' ' 62' ' ' THR . 72.1 tttt -62.89 130.03 43.01 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt 57.49 78.75 0.22 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.549 0.69 . . . . 0.0 109.997 -171.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.511 ' HB3' ' OD1' ' A' ' 168' ' ' ASN . 2.8 p90 -56.71 150.42 15.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.913 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.476 ' O ' ' HA ' ' A' ' 184' ' ' HIS . 33.0 m170 67.15 28.25 8.26 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.345 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 183' ' ' THR . 43.9 t30 -137.34 102.94 4.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.285 177.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.483 HG21 HD13 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -153.95 162.15 2.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.485 -177.286 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.531 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 87.3 mt -101.22 117.07 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.31 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.43 HG23 HG13 ' A' ' 175' ' ' VAL . 34.1 pt -122.76 162.67 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 CA-C-O 121.386 0.612 . . . . 0.0 111.676 -176.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.404 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 22.0 t30 48.34 -133.2 1.4 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 124.697 1.199 . . . . 0.0 110.862 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.26 52.24 1.3 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.496 0.665 . . . . 0.0 110.654 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.732 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.0 m120 66.97 48.34 1.28 Allowed 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 125.154 1.382 . . . . 0.0 113.365 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.1 mt -90.05 114.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.4 m -86.77 159.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-O 121.458 0.647 . . . . 0.0 110.922 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 4.0 t -158.33 149.49 20.86 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.93 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.476 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 50.4 t-80 -152.56 146.25 25.07 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.26 1.639 0 CA-C-O 117.516 -1.23 . . . . 0.0 109.626 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 89' ' ' THR . 56.7 m . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.955 0.407 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 177' ' ' ILE . 49.1 m-85 -129.36 155.22 80.4 Favored Pre-proline 0 N--CA 1.446 -0.636 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.447 ' HA ' HG12 ' A' ' 164' ' ' VAL . 22.4 Cg_endo -61.16 -31.68 90.41 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.77 2.313 . . . . 0.0 112.279 -177.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.483 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 129.22 -39.3 1.87 Allowed Glycine 0 N--CA 1.421 -2.366 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.58 -11.86 55.15 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.374 0.607 . . . . 0.0 111.485 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.4 m -63.8 129.84 41.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.564 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 29.6 mtm180 -88.27 137.07 32.65 Favored 'General case' 0 C--O 1.189 -2.091 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.545 HD11 HG23 ' A' ' 175' ' ' VAL . 11.9 tt -122.5 130.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 C-N-CA 122.649 0.379 . . . . 0.0 110.106 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.579 HD22 ' CD2' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -88.52 122.5 32.05 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 121.526 0.679 . . . . 0.0 109.467 179.393 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.518 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 26.1 m -133.34 179.63 4.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.477 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -126.23 120.42 29.97 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-O 121.35 0.595 . . . . 0.0 109.495 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.592 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 28.5 mt -120.22 122.24 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.463 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.643 -177.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 55.15 37.77 29.41 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 114.22 -1.354 . . . . 0.0 110.044 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.83 17.22 78.23 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.776 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 134' ' ' ASN . 20.2 t -127.3 123.32 23.26 Favored Pre-proline 0 C--N 1.312 -1.022 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 21.3 Cg_endo -67.69 126.56 14.9 Favored 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 122.017 1.811 . . . . 0.0 111.104 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -125.97 138.07 53.73 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -106.76 101.32 10.77 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 24' ' ' LEU . 3.7 pt -123.32 -178.14 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.936 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.588 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.7 p -92.23 168.78 11.1 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.803 -177.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.4 mm? -66.19 -25.12 66.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.825 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.588 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 1.1 ptm180 -85.38 -24.38 27.57 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.52 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 35.2 mt-10 -85.51 -39.65 17.21 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.63 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.556 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 22.0 tp -58.84 -41.57 87.22 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.764 0.792 . . . . 0.0 109.602 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.431 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -55.54 -29.38 58.86 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.308 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.62 -17.56 59.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.649 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -78.85 4.04 15.15 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.575 0.702 . . . . 0.0 109.414 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.505 ' HB3' ' HG2' ' A' ' 40' ' ' ARG . 95.6 m-85 -117.89 162.2 18.5 Favored 'General case' 0 N--CA 1.412 -2.36 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.861 -177.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.413 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 4.4 mm-40 -139.44 -173.81 3.71 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.375 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.5 t0 60.08 80.96 0.19 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.465 0.65 . . . . 0.0 110.863 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -102.56 130.79 49.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.904 0.859 . . . . 0.0 110.824 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.417 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.1 ptt180 -119.88 153.89 35.19 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.768 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -101.47 123.86 46.2 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -161.94 143.96 11.3 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.94 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 59.35 22.2 10.58 Favored 'General case' 0 CA--C 1.493 -1.236 0 O-C-N 123.78 0.675 . . . . 0.0 111.224 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.7 mtt 73.04 17.07 4.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.525 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 12.5 m -134.12 -171.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -119.3 143.21 47.48 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-O 121.164 0.507 . . . . 0.0 110.183 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.417 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.1 t -129.98 123.99 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.966 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.115 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.505 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 13.7 ttm180 -113.43 128.1 56.34 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.564 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.41 141.39 48.85 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.085 -174.083 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.564 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 24.3 ttmm 85.26 115.5 0.03 OUTLIER Pre-proline 0 CA--C 1.512 -0.513 0 C-N-CA 124.24 1.016 . . . . 0.0 111.928 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 72.3 Cg_endo -79.46 152.26 23.17 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.347 2.032 . . . . 0.0 111.838 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 31.0 mtmt -84.33 -6.09 59.35 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.821 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -148.35 -164.85 2.12 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.592 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 6.2 tp10 -86.73 101.17 13.05 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.469 176.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.546 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -116.21 118.23 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.518 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 29.3 mmtp -123.0 166.31 15.31 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.606 173.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 61' ' ' LEU . 6.3 m -115.36 129.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -84.8 121.91 28.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.827 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.1 m -132.88 171.32 14.08 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.846 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.425 HG12 HD12 ' A' ' 176' ' ' ILE . 2.9 mm -113.41 143.18 23.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.168 0.509 . . . . 0.0 110.008 177.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.616 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 21.2 t70 -77.55 124.22 27.63 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.342 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.597 HD21 ' H ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -75.97 -10.51 59.48 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.608 -171.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.616 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 3.8 pt-20 -107.87 -23.33 12.09 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.895 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.525 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 67.7 p -120.99 -23.78 5.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.999 -176.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.54 17.57 65.94 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.393 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.525 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 18.0 mttp -92.43 159.36 15.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 t -85.79 107.89 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.465 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.26 157.78 12.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.153 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.1 tp -122.24 137.98 54.65 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.5 t -143.79 171.51 14.12 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.08 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.14 161.64 20.54 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.809 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.512 ' N ' HD13 ' A' ' 64' ' ' ILE . 2.9 mp -100.79 141.11 18.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.504 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.555 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 49.7 mt-10 -89.7 -35.85 15.54 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 p30 176.5 174.85 0.35 Allowed 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.006 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 20.5 t -105.54 134.3 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.191 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.297 177.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.42 HG12 ' H ' ' A' ' 166' ' ' SER . 0.1 OUTLIER -101.8 124.04 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.379 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.089 179.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.446 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 86.7 tttt -135.34 108.47 7.7 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.224 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.43 137.17 30.22 Favored Pre-proline 0 C--N 1.31 -1.148 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.44 -175.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -47.43 124.04 8.78 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.394 2.729 . . . . 0.0 112.79 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.37 108.09 7.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.865 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -110.95 -59.52 1.95 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -77.21 -98.94 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.84 172.74 4.73 Favored 'General case' 0 CA--C 1.474 -1.981 0 CA-C-O 121.101 0.477 . . . . 0.0 112.011 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.513 HD22 ' HA ' ' A' ' 90' ' ' THR . 7.3 mt -132.45 141.14 48.7 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.135 -178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.511 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 10.6 mt -87.67 144.86 8.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 19.3 ttt-85 -121.69 136.03 54.95 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-O 121.283 0.564 . . . . 0.0 109.731 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 86' ' ' SER . 48.7 m-85 -114.34 130.32 56.67 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.865 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 152' ' ' LYS . 18.9 tt0 -109.86 129.21 55.67 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.569 HD13 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -94.31 155.64 16.91 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.56 ' HA ' ' HG3' ' A' ' 152' ' ' LYS . 1.1 pt-20 -64.62 -14.34 57.56 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.212 0.53 . . . . 0.0 111.529 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.69 -8.24 52.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.51 -0.768 . . . . 0.0 108.989 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.92 19.11 44.53 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.403 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.512 ' O ' HD22 ' A' ' 81' ' ' LEU . 4.8 mtt-85 -89.2 139.1 30.82 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 9.0 p -139.29 144.87 38.53 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.849 175.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -140.76 147.17 38.7 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.094 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 35.9 mt-10 -117.88 147.75 42.8 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.965 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.503 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.1 p -145.8 159.44 43.19 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.302 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.513 ' HA ' HD22 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.55 20.48 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -176.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.671 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.47 -37.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 125.397 1.479 . . . . 0.0 113.532 176.421 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.22 -2.2 58.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.143 0.497 . . . . 0.0 110.633 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -81.31 121.49 80.29 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.686 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.478 ' HG2' ' NE2' ' A' ' 173' ' ' HIS . 21.3 Cg_endo -63.32 139.04 69.4 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.659 2.239 . . . . 0.0 113.336 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.1 t -113.89 145.82 19.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.5 tp -101.35 107.69 19.1 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 121.059 -0.257 . . . . 0.0 110.336 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.458 ' HB ' ' OD2' ' A' ' 115' ' ' ASP . 2.6 p -107.76 147.5 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 121.63 0.728 . . . . 0.0 111.666 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -103.8 91.18 3.89 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.558 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.501 ' OE2' ' HE3' ' A' ' 106' ' ' LYS . 10.4 pt-20 -141.24 158.83 43.37 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.856 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.2 m-20 65.62 23.13 11.69 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.09 15.45 58.5 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.811 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.408 ' HG3' HG21 ' A' ' 104' ' ' ILE . 9.7 ptm180 -136.33 171.96 13.71 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-O 121.206 0.527 . . . . 0.0 110.145 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -102.55 120.9 41.33 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.49 ' CD1' ' HE2' ' A' ' 106' ' ' LYS . 9.2 pt -125.8 147.94 30.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.316 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.41 119.0 37.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.448 -177.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HE3' ' OE2' ' A' ' 99' ' ' GLU . 64.6 mttm -129.35 133.2 47.3 Favored 'General case' 0 C--O 1.205 -1.275 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.495 ' O ' HG23 ' A' ' 111' ' ' VAL . 86.4 mtt180 -63.42 163.04 11.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.671 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -60.57 -41.44 94.64 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.013 -175.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.439 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 2.8 p90 -74.18 4.61 5.4 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.961 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -118.17 -16.23 9.76 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.695 0.76 . . . . 0.0 110.265 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 107' ' ' ARG . 78.4 t -76.97 149.12 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -119.88 165.63 14.37 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.436 -176.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.8 141.09 53.39 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.286 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.75 5.0 71.99 Favored Glycine 0 C--N 1.307 -1.083 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.527 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 6.8 t70 -72.65 177.54 4.68 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.432 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 23.0 mttp -134.29 160.46 37.84 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.405 0.621 . . . . 0.0 111.013 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.26 158.4 43.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.066 172.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.71 130.86 37.43 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.732 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -102.61 148.73 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 175.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.474 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 33.1 t -75.54 34.45 0.12 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.683 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.511 ' H ' ' C ' ' A' ' 119' ' ' VAL . 90.1 mt-10 73.74 -57.27 0.63 Allowed 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.42 1.088 . . . . 0.0 111.027 -177.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.459 ' CD1' ' H ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -174.82 -160.59 0.09 Allowed 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -172.657 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.459 ' H ' ' CD1' ' A' ' 122' ' ' LEU . 9.4 pt-20 -152.67 176.48 11.7 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.838 0.351 . . . . 0.0 111.749 -174.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.593 ' O ' HG13 ' A' ' 125' ' ' VAL . 2.4 pt? -49.22 -29.15 5.28 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.856 172.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 124' ' ' LEU 0.287 10.9 p 68.41 115.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.764 0 C-N-CA 126.623 1.969 . . . . 0.0 114.857 172.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -171.44 138.52 1.18 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 113.811 -1.54 . . . . 0.0 108.264 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -84.75 11.94 8.18 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.5 m -75.22 142.02 43.48 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.952 0.406 . . . . 0.0 110.948 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.453 ' HA ' HH11 ' A' ' 7' ' ' ARG . 22.7 m -79.45 -40.27 30.28 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.281 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.4 m -126.86 -30.04 2.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.684 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.1 t 70.57 118.88 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.439 0.695 . . . . 0.0 111.236 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -96.15 -28.0 14.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.373 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -87.64 107.03 18.42 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.075 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.613 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.2 OUTLIER -65.82 -53.15 37.24 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.491 -179.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 134' ' ' ASN . 15.3 Cg_endo -56.48 145.74 78.26 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.728 2.286 . . . . 0.0 111.744 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.594 ' HG2' ' H ' ' A' ' 137' ' ' ASN . 39.0 tttp -151.56 -150.64 0.35 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.377 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.594 ' H ' ' HG2' ' A' ' 136' ' ' LYS . 20.4 t-20 63.51 52.68 2.26 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.27 -29.32 26.53 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.625 -178.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -151.68 17.85 0.7 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.2 tp 70.63 147.85 0.07 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.879 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -123.2 66.33 0.5 Allowed Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.645 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.2 m -74.34 120.4 81.24 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.443 ' HA ' ' HB3' ' A' ' 122' ' ' LEU . 55.1 Cg_endo -76.86 -99.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.456 2.104 . . . . 0.0 112.705 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 62.36 92.93 0.05 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.18 0.514 . . . . 0.0 112.063 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.96 91.47 0.55 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -90.93 86.98 6.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.131 0.491 . . . . 0.0 112.23 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.415 ' C ' HD21 ' A' ' 148' ' ' LEU . 7.8 pt20 -164.34 138.59 5.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.615 176.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.415 HD21 ' C ' ' A' ' 147' ' ' GLN . 14.2 mt -108.78 156.05 20.07 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 121.636 0.732 . . . . 0.0 111.825 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.569 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -113.02 136.92 52.16 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.581 -173.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 11.6 mt-10 -91.25 148.08 22.59 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.828 -1.078 . . . . 0.0 113.12 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.563 HD12 ' CD1' ' A' ' 79' ' ' PHE . 86.8 mt -78.97 109.63 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.897 176.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.56 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 1.5 mmmp? -68.12 -42.87 79.59 Favored 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.01 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -150.03 135.3 18.06 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 82.6 mt -118.92 129.29 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.639 -1.618 . . . . 0.0 111.058 174.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.406 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 1.8 ptpp? -133.17 163.0 30.24 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.648 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.511 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 13.5 m-85 -100.82 119.25 38.39 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.04 174.62 11.99 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.97 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.856 -178.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -109.91 166.4 10.96 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.305 -0.958 . . . . 0.0 112.282 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.66 137.1 58.13 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.914 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -101.48 31.05 3.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.974 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -170.99 -178.82 2.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -95.28 -13.26 25.0 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.072 0.463 . . . . 0.0 110.247 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.26 166.09 23.6 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.289 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.447 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.1 m -130.91 157.4 43.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.51 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 77.3 m-85 -138.46 159.97 40.73 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.734 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.42 ' H ' HG12 ' A' ' 68' ' ' ILE . 7.8 t -148.34 -18.33 0.33 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.448 174.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.556 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 4.1 mm? 60.29 95.22 0.03 OUTLIER 'General case' 0 C--N 1.347 0.486 0 O-C-N 123.75 0.657 . . . . 0.0 111.04 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.416 ' O ' ' HB2' ' A' ' 65' ' ' GLU . 41.6 m-20 -82.44 102.61 11.42 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.127 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.555 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -97.5 -149.32 0.33 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.227 172.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 171' ' ' LYS . 18.8 tptp -62.01 135.2 57.44 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 170' ' ' LYS . 51.5 mttp 71.01 -133.45 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.75 0.656 . . . . 0.0 109.446 -175.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -140.49 122.56 15.67 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.478 ' NE2' ' HG2' ' A' ' 94' ' ' PRO . 9.9 p-80 36.46 32.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.551 1.54 . . . . 0.0 115.121 177.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 183' ' ' THR . 0.5 OUTLIER -95.01 99.76 11.72 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.998 0.428 . . . . 0.0 110.435 177.727 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.545 HG23 HD11 ' A' ' 8' ' ' ILE . 2.5 p -150.13 167.03 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.044 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.563 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 90.5 mt -96.85 115.3 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.823 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 31.7 pt -118.47 166.51 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 121.307 0.575 . . . . 0.0 111.281 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 37.6 t30 46.16 -126.57 1.39 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 124.774 1.23 . . . . 0.0 111.028 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -91.07 59.31 3.99 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.603 0.716 . . . . 0.0 109.355 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.732 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.3 m120 66.08 44.65 2.58 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 113.851 -1.522 . . . . 0.0 114.18 176.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 91.3 mt -91.68 113.74 27.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.4 m -91.5 153.6 3.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.905 0.859 . . . . 0.0 112.394 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 1.4 t -151.15 156.85 41.82 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.261 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -163.58 155.68 17.53 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 . . . . . 0 C--O 1.269 2.131 0 CA-C-O 117.647 -1.168 . . . . 0.0 110.648 177.083 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.502 ' N ' ' HB2' ' A' ' 93' ' ' HIS . 64.0 m . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.655 0.264 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -133.95 159.36 72.71 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.496 ' HD3' HD13 ' A' ' 76' ' ' LEU . 67.8 Cg_endo -70.4 161.57 45.55 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 N-CA-C 108.68 -1.315 . . . . 0.0 108.68 177.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.437 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -61.64 -23.67 63.24 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 119.316 -1.421 . . . . 0.0 111.692 177.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.57 -21.23 60.03 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.28 0.562 . . . . 0.0 112.185 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.9 m -62.97 126.33 26.96 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.969 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 177' ' ' ILE . 35.4 mmt180 -80.3 130.83 35.46 Favored 'General case' 0 C--O 1.184 -2.368 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.496 HD12 HG21 ' A' ' 175' ' ' VAL . 7.7 tt -120.3 130.1 74.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 10' ' ' VAL . 1.1 tm? -87.34 124.42 33.35 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-O 121.458 0.647 . . . . 0.0 110.317 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.491 ' N ' HD12 ' A' ' 9' ' ' LEU . 30.3 m -135.89 -178.5 2.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.189 -178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.458 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 33.8 tt0 -130.79 122.64 27.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.56 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.588 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 20.4 mt -121.03 120.85 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.568 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.659 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 52.46 40.61 29.97 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.303 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.27 18.3 79.21 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.8 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.3 t -122.5 120.16 28.06 Favored Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.543 ' HB2' HD21 ' A' ' 124' ' ' LEU . 59.6 Cg_endo -74.8 125.23 9.29 Favored 'Trans proline' 0 N--CA 1.427 -2.393 0 C-N-CA 122.207 1.938 . . . . 0.0 110.926 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -128.37 142.34 51.15 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.935 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -108.56 99.85 9.18 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.411 ' O ' ' N ' ' A' ' 8' ' ' ILE . 3.0 pt -121.31 -172.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.822 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 20.0 p -98.95 174.11 6.52 Favored 'General case' 0 C--N 1.28 -2.441 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.127 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 65.5 mt -68.54 -28.63 67.15 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.717 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.822 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 11.6 ptm180 -76.85 -26.92 54.84 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.554 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 49.4 mt-10 -85.28 -36.22 21.01 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.191 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.467 HD21 HD22 ' A' ' 167' ' ' LEU . 15.5 tp -66.11 -44.24 84.89 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.129 0.49 . . . . 0.0 111.234 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.57 ' HB2' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -58.6 -26.51 63.74 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.401 -175.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.422 ' OE1' ' HA ' ' A' ' 23' ' ' GLU . 24.9 mt-10 -68.09 -19.02 64.82 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.665 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.37 0.33 42.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.447 0.642 . . . . 0.0 110.091 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.516 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 96.1 m-85 -117.15 163.34 16.43 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.005 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -145.76 -171.91 3.79 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.997 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 t0 63.53 75.43 0.39 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.845 0.831 . . . . 0.0 110.139 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.36 128.91 44.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.474 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.456 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.3 ptt180 -120.51 153.37 36.77 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.323 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -103.74 128.77 51.09 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -166.52 143.4 4.92 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.035 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 60.84 21.03 11.2 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 123.662 0.601 . . . . 0.0 110.783 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 33.5 mtt 71.28 19.62 5.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.648 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.443 HG11 ' HD2' ' A' ' 71' ' ' PRO . 17.2 m -133.26 -175.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -117.45 142.09 47.56 Favored 'General case' 0 CA--C 1.477 -1.836 0 CA-C-O 121.267 0.556 . . . . 0.0 110.497 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.456 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.3 t -130.01 124.3 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.861 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -114.75 126.32 54.71 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.35 145.17 51.06 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.398 -174.488 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 51.5 tptt 80.33 114.86 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.504 0 O-C-N 124.574 1.171 . . . . 0.0 110.697 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 58.0 Cg_endo -77.42 158.56 32.8 Favored 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 121.947 1.765 . . . . 0.0 111.735 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -90.57 -3.44 57.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.422 0.629 . . . . 0.0 110.461 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -148.72 -165.68 2.34 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.637 ' OE1' ' HE3' ' A' ' 48' ' ' LYS . 7.1 tp10 -84.01 96.7 8.95 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.516 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 1.8 mp -116.78 115.63 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.031 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.637 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 34.6 mmtp -118.79 166.13 13.17 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.314 173.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.488 HG13 ' CB ' ' A' ' 169' ' ' ALA . 10.2 p -122.92 134.3 66.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.662 -175.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' A' ' 11' ' ' GLN . 20.2 m-85 -88.18 123.54 32.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.494 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.9 m -136.56 147.56 47.08 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.217 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.501 HD13 ' C ' ' A' ' 58' ' ' LYS . 2.2 mm -93.21 143.54 11.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.222 0.534 . . . . 0.0 110.343 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.451 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 28.3 t70 -87.3 123.47 32.32 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.427 ' N ' HD23 ' A' ' 54' ' ' LEU . 6.4 mt -70.44 -28.82 65.33 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-O 122.109 0.957 . . . . 0.0 111.844 -172.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.451 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -83.51 -30.7 26.94 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.507 -172.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.415 ' CB ' ' HD2' ' A' ' 58' ' ' LYS . 62.7 p -114.87 -22.29 9.7 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.654 -175.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.39 20.73 71.4 Favored Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.524 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.501 ' C ' HD13 ' A' ' 52' ' ' ILE . 27.6 mttm -99.98 153.84 18.87 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.85 106.58 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 CA-C-O 121.769 0.795 . . . . 0.0 110.126 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.72 167.06 5.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.887 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.9 tp -119.72 141.76 49.13 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.9 t -146.98 171.8 14.7 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.853 0.359 . . . . 0.0 111.329 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.531 ' OD2' ' HE2' ' A' ' 48' ' ' LYS . 7.0 m-20 -82.2 161.06 22.88 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.556 0.693 . . . . 0.0 110.552 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.7 mp -99.21 140.92 17.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.244 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -88.18 -35.26 17.48 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 173.79 174.15 0.15 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.579 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.57 HG12 ' HB2' ' A' ' 25' ' ' TYR . 13.8 t -104.92 132.93 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.192 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 49.7 mt -92.21 113.49 27.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.478 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.424 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 86.6 tttt -127.57 109.34 11.61 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.78 141.62 42.63 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.77 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.443 ' HD2' HG11 ' A' ' 37' ' ' VAL . 8.1 Cg_endo -52.62 129.59 32.95 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.384 2.723 . . . . 0.0 112.41 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.95 73.63 9.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.351 0.596 . . . . 0.0 110.622 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.2 p -71.7 -38.59 70.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.913 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.52 -172.31 2.73 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.323 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.616 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 19.2 m170 -111.98 172.32 6.97 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.561 ' CD2' ' HA ' ' A' ' 90' ' ' THR . 7.1 mt -122.48 146.87 46.99 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.541 0.686 . . . . 0.0 112.007 -175.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.537 HD13 ' C ' ' A' ' 108' ' ' ALA . 20.5 mt -87.82 145.52 7.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.543 ' HB3' ' CG ' ' A' ' 155' ' ' LYS . 41.8 ttt85 -122.07 140.88 51.98 Favored 'General case' 0 N--CA 1.404 -2.752 0 CA-C-O 121.301 0.572 . . . . 0.0 109.945 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 86' ' ' SER . 57.5 m-85 -114.71 125.49 53.79 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.586 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.7 tt0 -109.4 123.52 49.48 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.71 159.65 17.7 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.502 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.602 ' HG2' ' CD1' ' A' ' 149' ' ' LEU . 3.9 pt-20 -63.61 -15.25 57.66 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.456 0.646 . . . . 0.0 111.116 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.06 -10.24 36.82 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.487 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.02 12.77 54.85 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.839 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.525 ' O ' HD22 ' A' ' 81' ' ' LEU . 1.6 mtt180 -83.84 139.3 32.74 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 15.7 p -143.01 136.99 28.97 Favored 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.523 176.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -133.06 151.56 52.03 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.559 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.481 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 99.3 mt-10 -123.54 152.2 42.06 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.328 0.585 . . . . 0.0 112.097 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.54 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -142.21 155.33 45.27 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.238 178.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.561 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -72.01 16.85 0.11 Allowed 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 121.621 0.725 . . . . 0.0 111.56 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.688 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.9 OUTLIER 71.05 -29.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 125.64 1.576 . . . . 0.0 113.06 176.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 90' ' ' THR . 19.1 m-20 -82.61 -5.1 58.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.972 0.415 . . . . 0.0 110.493 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.502 ' HB2' ' N ' ' A' ' 1' ' ' CYS . 60.6 t-80 -94.86 125.66 50.13 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.57 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 37.9 Cg_exo -63.1 142.28 86.62 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.968 2.445 . . . . 0.0 112.937 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.2 t -112.17 146.19 17.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.41 ' CD1' ' HG3' ' A' ' 105' ' ' GLU . 18.2 tp -101.75 111.46 23.72 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.975 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.568 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.3 p -113.7 150.85 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.345 0.593 . . . . 0.0 111.595 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -102.36 96.02 6.67 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.41 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 11.9 pt-20 -145.56 155.02 42.8 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 83.1 m-20 63.74 23.09 13.35 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.205 0.526 . . . . 0.0 110.332 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.12 12.49 60.52 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.872 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -131.2 170.83 14.04 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-O 121.478 0.656 . . . . 0.0 110.043 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -105.95 121.96 45.16 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.442 HG13 HG12 ' A' ' 97' ' ' VAL . 19.1 pt -122.36 146.77 27.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.007 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 26.7 mp0 -105.01 107.78 18.95 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.988 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 12.0 ptpt -118.38 135.2 54.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.422 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.628 ' O ' HG23 ' A' ' 111' ' ' VAL . 80.3 mtt180 -61.59 160.6 11.08 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.688 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -58.84 -43.41 90.73 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.212 -177.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.409 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.7 p90 -75.43 7.44 3.58 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.885 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -118.32 -17.95 9.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.443 0.639 . . . . 0.0 110.037 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 107' ' ' ARG . 89.4 t -73.15 149.18 8.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.198 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.697 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 69.7 mmtt -115.74 168.19 10.26 Favored 'General case' 0 CA--C 1.486 -1.503 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.382 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -77.71 142.05 38.98 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.11 4.2 74.97 Favored Glycine 0 C--N 1.305 -1.144 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -174.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.697 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -74.69 173.43 10.5 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -129.66 167.28 18.22 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.58 0.705 . . . . 0.0 111.604 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.81 159.82 39.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.738 170.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.8 135.54 37.4 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.603 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.9 OUTLIER -106.35 160.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 122' ' ' LEU . 84.3 p -74.61 -1.04 19.83 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.024 0.44 . . . . 0.0 111.163 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.525 ' OE1' HG21 ' A' ' 119' ' ' VAL . 4.4 mm-40 63.56 -16.09 0.07 Allowed 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 124.842 1.257 . . . . 0.0 113.035 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.531 ' H ' ' C ' ' A' ' 120' ' ' SER . 43.2 tp -135.57 126.5 27.66 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -172.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.408 ' HG2' ' ND2' ' A' ' 180' ' ' ASN . 24.4 mt-10 -102.37 -151.6 0.43 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.946 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.543 HD21 ' HB2' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -116.27 3.27 13.39 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.529 0.68 . . . . 0.0 109.593 -174.44 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.9 p -176.85 161.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.725 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.46 160.13 19.93 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -60.17 147.58 39.27 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.3 t 64.58 -154.37 0.29 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.739 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.9 m 74.31 -50.12 0.68 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.469 0.708 . . . . 0.0 112.437 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.402 ' OG ' ' HB2' ' A' ' 133' ' ' ASP . 22.9 t -135.89 136.37 40.47 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 120.987 0.423 . . . . 0.0 111.037 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.3 m -104.54 -16.91 14.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.213 0.53 . . . . 0.0 110.063 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -169.76 124.23 0.78 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.322 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.533 ' OD1' ' HD2' ' A' ' 135' ' ' PRO . 1.2 t70 -155.73 -171.52 3.79 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.563 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . 23.9 t-20 -160.92 -49.6 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.487 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 134' ' ' ASN . 7.8 Cg_exo -77.73 -137.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.602 2.201 . . . . 0.0 110.634 173.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.4 tttp 74.35 109.05 0.07 Allowed 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.871 0.843 . . . . 0.0 110.0 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -153.41 37.85 0.48 Allowed 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.036 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.47 24.36 7.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.681 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -162.75 159.93 24.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.468 ' H ' HD23 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -78.97 -60.17 2.48 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.701 0.286 . . . . 0.0 111.454 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.456 ' H ' ' HG ' ' A' ' 140' ' ' LEU . . . 52.35 48.03 55.04 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.334 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 36.4 t -100.99 117.46 62.4 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.731 0.3 . . . . 0.0 111.381 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 142' ' ' SER . 4.4 Cg_exo -83.08 171.94 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.936 2.424 . . . . 0.0 110.677 174.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.21 -65.15 0.91 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 177.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.441 ' CE1' ' HG3' ' A' ' 147' ' ' GLN . 3.4 t-80 55.32 115.64 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.378 1.071 . . . . 0.0 113.796 176.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.452 ' HA ' ' OE2' ' A' ' 121' ' ' GLU . 8.9 p-10 -136.49 68.22 1.44 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.758 0.789 . . . . 0.0 110.649 174.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.441 ' HG3' ' CE1' ' A' ' 145' ' ' HIS . 14.4 pt20 -165.38 142.06 5.59 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.371 -177.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.9 mt -99.28 150.98 21.56 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-O 121.348 0.594 . . . . 0.0 109.721 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.602 ' CD1' ' HG2' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -107.51 133.68 51.64 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -172.161 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 15.0 mt-10 -88.04 145.65 25.87 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.628 175.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.497 HD13 ' CD1' ' A' ' 79' ' ' PHE . 67.6 mt -79.8 105.55 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.773 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.199 173.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 7.1 mmpt? -70.7 -37.43 73.57 Favored 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 114.645 -1.162 . . . . 0.0 110.682 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -149.96 133.42 16.56 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 71.3 mt -112.74 140.05 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.977 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.543 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.9 ptpt -139.82 152.91 46.9 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.171 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.513 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.2 m-85 -97.75 104.6 16.64 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-O 121.806 0.812 . . . . 0.0 108.825 173.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.616 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -108.02 175.77 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.266 -3.034 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.701 -178.378 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 19.5 ptt85 -80.74 -145.69 0.05 Allowed 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 121.79 0.805 . . . . 0.0 111.443 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -131.4 99.82 4.96 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -46.39 -49.91 17.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.085 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -102.3 170.68 7.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.041 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -88.6 -4.1 58.65 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.096 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -139.81 155.57 47.2 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.622 176.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.81 156.53 30.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 65.4 m-85 -133.55 171.51 14.0 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.487 ' HB2' HD13 ' A' ' 68' ' ' ILE . 70.7 m -160.17 -25.0 0.06 Allowed 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.467 HD22 HD21 ' A' ' 24' ' ' LEU . 9.1 tp 68.17 111.79 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.215 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.404 ' OD1' ' HD1' ' A' ' 172' ' ' TYR . 66.0 t30 -87.3 115.77 24.94 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.912 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.488 ' CB ' HG13 ' A' ' 49' ' ' VAL . . . -136.85 -166.72 1.95 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 172' ' ' TYR . 45.0 mmtt -63.25 146.15 54.03 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 170' ' ' LYS . 67.4 mttm 80.19 -24.34 0.21 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.878 -174.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.444 ' H ' ' C ' ' A' ' 170' ' ' LYS . 42.7 m-85 64.03 132.5 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.878 1.271 . . . . 0.0 113.253 176.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.43 ' O ' ' HA ' ' A' ' 184' ' ' HIS . 34.8 m80 52.78 31.63 10.85 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.153 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.536 ' HA ' ' O ' ' A' ' 183' ' ' THR . 30.5 t30 -132.2 110.33 10.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.496 HG21 HD12 ' A' ' 8' ' ' ILE . 1.4 p -154.23 160.72 2.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.12 0.486 . . . . 0.0 111.307 -177.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.478 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 97.9 mt -96.55 115.64 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.213 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 47.3 pt -123.5 174.49 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.225 -175.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.464 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 2.9 t-20 47.07 -129.39 1.53 Allowed 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.062 0.945 . . . . 0.0 110.673 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.24 48.95 1.65 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.513 0.673 . . . . 0.0 109.847 176.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.603 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 3.7 m-20 68.79 47.19 0.84 Allowed 'General case' 0 CA--C 1.495 -1.145 0 C-N-CA 125.445 1.498 . . . . 0.0 113.171 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 82.5 mt -91.04 115.88 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.589 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.9 m -80.36 158.84 4.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.418 0.627 . . . . 0.0 110.558 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 5.1 t -161.31 153.48 19.89 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.488 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.43 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 25.6 t-80 -152.26 148.96 28.17 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 . . . . . 0 C--O 1.256 1.41 0 CA-C-O 118.549 -0.739 . . . . 0.0 111.08 178.085 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.682 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 4.5 t . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 88' ' ' GLU . 20.6 m-85 -112.64 154.89 44.58 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -175.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.518 ' HD3' HD13 ' A' ' 76' ' ' LEU . 27.8 Cg_endo -62.74 -34.72 72.34 Favored 'Trans proline' 0 N--CA 1.479 0.637 0 C-N-CA 123.2 2.6 . . . . 0.0 112.321 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.503 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 130.36 -39.79 1.76 Allowed Glycine 0 N--CA 1.423 -2.212 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.49 -9.3 8.13 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 121.468 0.651 . . . . 0.0 111.556 176.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.8 m -69.27 129.07 38.77 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.915 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 16.4 mtm180 -84.07 138.22 33.17 Favored 'General case' 0 C--O 1.184 -2.388 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.5 ' HB ' ' CD2' ' A' ' 21' ' ' LEU . 10.0 tt -123.02 131.55 73.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-O 120.83 0.347 . . . . 0.0 110.217 177.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.504 HD23 ' HB2' ' A' ' 18' ' ' LYS . 2.2 tm? -90.49 123.81 34.48 Favored 'General case' 0 N--CA 1.405 -2.707 0 CA-C-O 121.619 0.723 . . . . 0.0 110.657 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.508 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.5 m -133.08 -174.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.144 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -134.7 123.2 23.32 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.584 HG12 HG13 ' A' ' 47' ' ' ILE . 20.4 mt -122.63 123.28 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 CA-C-O 121.422 0.63 . . . . 0.0 110.358 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.9 36.67 27.74 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.972 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.4 21.14 79.54 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.627 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.4 t -127.54 114.82 21.13 Favored Pre-proline 0 N--CA 1.432 -1.342 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.626 ' HB2' ' HG ' ' A' ' 124' ' ' LEU . 17.3 Cg_exo -63.32 123.76 12.68 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 122.579 2.186 . . . . 0.0 111.31 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -126.98 136.41 52.22 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.56 ' HZ1' ' HA ' ' A' ' 179' ' ' GLU . 38.0 ttmt -108.55 102.15 11.25 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.627 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 8' ' ' ILE . 2.6 pt -124.18 -171.7 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.132 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.954 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.707 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 17.8 p -95.48 169.78 9.81 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.249 -0.981 . . . . 0.0 110.673 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.5 ' CD2' ' HB ' ' A' ' 8' ' ' ILE . 4.4 mm? -67.74 -23.6 65.27 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.674 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.707 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 3.1 ptm180 -85.9 -24.32 26.67 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.631 ' OE1' HG23 ' A' ' 20' ' ' THR . 49.2 mt-10 -84.84 -42.08 15.43 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.972 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.443 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 30.7 tp -57.44 -42.55 82.64 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 122.042 0.925 . . . . 0.0 109.897 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.738 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.9 m-30 -53.86 -30.73 46.88 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.393 -1.73 . . . . 0.0 113.084 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -74.39 -15.73 60.91 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.347 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.77 6.38 13.12 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.534 0.683 . . . . 0.0 109.775 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.489 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 98.1 m-85 -118.47 165.66 13.63 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.309 -178.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.473 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 3.4 mm-40 -143.97 -173.68 4.06 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.34 175.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 4.1 t70 64.26 86.74 0.12 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.583 0.706 . . . . 0.0 110.359 -179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -104.07 122.25 44.9 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.558 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -111.27 150.31 29.82 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.962 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.413 ' CZ ' ' HA ' ' A' ' 36' ' ' MET . 24.2 t80 -107.44 131.78 53.91 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.421 ' O ' HG22 ' A' ' 37' ' ' VAL . 7.5 tp10 -166.24 141.42 4.59 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.515 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 59.97 22.12 11.2 Favored 'General case' 0 CA--C 1.494 -1.182 0 O-C-N 123.573 0.545 . . . . 0.0 111.367 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.413 ' HA ' ' CZ ' ' A' ' 33' ' ' TYR . 41.7 mtm 72.75 19.52 3.93 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.998 0.811 . . . . 0.0 110.875 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.521 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 6.0 m -131.27 -179.55 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.471 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 88.7 m-85 -116.81 145.22 43.68 Favored 'General case' 0 CA--C 1.482 -1.644 0 CA-C-O 121.387 0.613 . . . . 0.0 110.438 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.8 t -130.23 123.53 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.747 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.581 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 39.5 ttm180 -116.8 126.32 52.9 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -134.62 144.89 48.14 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.595 -175.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' A' ' 43' ' ' PRO . 12.6 tmtt? 86.93 109.61 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.409 0 O-C-N 124.899 1.375 . . . . 0.0 109.989 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 61.5 Cg_endo -78.18 151.97 27.15 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 122.149 1.899 . . . . 0.0 111.615 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.473 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 36.7 mtmt -83.0 -7.4 59.67 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.191 0.519 . . . . 0.0 111.12 -177.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -144.92 -165.41 2.15 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 8.7 tp10 -85.98 101.66 13.1 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.584 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -115.03 117.41 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.966 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.508 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 32.4 mmtt -116.91 168.47 10.2 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 173.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.465 HG12 ' CB ' ' A' ' 169' ' ' ALA . 9.5 p -125.51 128.81 72.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.04 132.16 34.36 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.966 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.41 ' HA ' HG13 ' A' ' 176' ' ' ILE . 21.5 t -139.12 177.15 8.11 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 58' ' ' LYS . 2.7 mm -116.34 141.72 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.342 0.591 . . . . 0.0 110.844 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.743 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 24.7 t70 -80.11 116.31 20.16 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.152 178.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.571 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.2 mm? -73.57 -13.63 61.06 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.177 0.513 . . . . 0.0 112.191 -171.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.743 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -96.85 -26.25 15.16 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.849 -175.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.4 ' CB ' ' HD3' ' A' ' 58' ' ' LYS . 71.4 p -120.69 -25.68 5.44 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.887 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.48 9.18 65.12 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.421 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.463 ' O ' HD12 ' A' ' 52' ' ' ILE . 3.3 mptp? -81.88 159.66 23.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.157 0.583 . . . . 0.0 111.623 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -92.53 113.95 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 CA-C-O 121.943 0.878 . . . . 0.0 109.904 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -111.1 160.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.972 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.76 142.64 49.37 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.457 HG21 ' CG1' ' A' ' 49' ' ' VAL . 8.8 t -145.17 172.56 12.93 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.439 -177.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.42 161.02 14.82 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.611 0.719 . . . . 0.0 110.867 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.516 ' N ' HD13 ' A' ' 64' ' ' ILE . 2.6 mp -94.59 142.61 13.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.488 -177.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.544 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.6 mm-40 -85.14 -46.28 11.26 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.421 ' O ' HD22 ' A' ' 167' ' ' LEU . 4.2 p-10 -179.84 -168.01 0.1 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.313 178.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 37.5 t -114.07 128.6 70.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.867 -175.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.492 HD11 ' HB2' ' A' ' 166' ' ' SER . 19.9 mt -92.6 102.12 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.1 -176.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.521 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 48.3 tttp -120.95 110.08 15.86 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.615 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.53 141.3 40.73 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.093 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.418 ' HD2' HG12 ' A' ' 37' ' ' VAL . 5.9 Cg_endo -50.43 140.23 35.61 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.469 2.779 . . . . 0.0 112.86 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.26 94.15 2.45 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.16 0.505 . . . . 0.0 110.29 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.9 p -89.01 -70.96 0.62 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.13 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.47 -175.06 5.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.26 0.553 . . . . 0.0 111.775 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.415 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 34.5 m170 -101.48 172.45 6.97 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.082 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.518 HD13 ' HD3' ' A' ' 3' ' ' PRO . 11.1 mt -125.04 142.12 51.69 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.66 0.743 . . . . 0.0 111.807 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.556 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 9.9 mt -87.16 144.6 8.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 8.3 ttt180 -119.46 137.54 53.71 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.128 0.49 . . . . 0.0 109.686 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 86' ' ' SER . 52.4 m-85 -115.35 126.71 54.76 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.603 -178.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 57.6 tt0 -111.66 125.24 53.75 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.558 HD13 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -90.49 158.44 17.03 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.605 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.546 ' HG2' HD12 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -60.4 -18.12 48.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.271 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -90.76 -12.47 36.41 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.794 0.807 . . . . 0.0 109.556 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.41 16.69 39.22 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.88 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.546 ' O ' HD21 ' A' ' 81' ' ' LEU . 2.9 mtt180 -86.13 137.11 32.91 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.3 p -139.81 136.66 34.27 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.046 -1.062 . . . . 0.0 112.565 176.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -132.77 150.75 52.12 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.261 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 73.1 mt-10 -126.95 149.14 49.98 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.478 -176.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.9 OUTLIER -146.66 161.35 40.75 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.925 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.517 ' HA ' HD22 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -70.89 15.16 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.451 0.7 . . . . 0.0 112.66 -176.481 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.7 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 72.03 -34.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 125.253 1.421 . . . . 0.0 112.93 177.325 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.453 ' OD1' ' HB ' ' A' ' 90' ' ' THR . 6.1 p-10 -84.42 -5.52 59.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.13 0.491 . . . . 0.0 110.238 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 57.7 t-80 -84.45 126.49 69.05 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.799 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 23.0 Cg_exo -65.9 124.14 12.28 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.842 2.362 . . . . 0.0 112.942 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.85 147.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.645 177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.496 ' HB2' ' N ' ' A' ' 184' ' ' HIS . 9.5 tp -101.26 107.38 18.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.984 0.421 . . . . 0.0 111.102 -177.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.592 HG21 ' OD1' ' A' ' 115' ' ' ASP . 1.6 p -113.29 147.78 16.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.549 0.69 . . . . 0.0 111.87 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -105.2 93.12 4.51 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.046 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.536 ' CD ' ' HZ2' ' A' ' 106' ' ' LYS . 8.1 pt-20 -137.68 159.52 41.75 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.0 m-20 63.27 21.43 12.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.327 0.584 . . . . 0.0 109.753 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.45 16.23 62.63 Favored Glycine 0 N--CA 1.436 -1.367 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.326 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -135.93 172.91 12.33 Favored 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 117.859 0.829 . . . . 0.0 109.844 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -100.55 120.45 40.04 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.523 HD13 ' CG ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -123.16 148.12 27.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.209 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -104.99 110.52 22.96 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.414 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.536 ' HZ2' ' CD ' ' A' ' 99' ' ' GLU . 77.7 mttt -117.76 134.74 54.6 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.576 ' O ' HG22 ' A' ' 111' ' ' VAL . 4.4 mpt_? -60.73 164.13 4.96 Favored 'General case' 0 C--O 1.215 -0.725 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.7 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -62.04 -41.32 97.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 118.955 -1.098 . . . . 0.0 109.539 -178.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.445 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.1 p90 -73.32 -2.63 22.83 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.691 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.464 ' HB3' ' N ' ' A' ' 107' ' ' ARG . 49.3 tp10 -109.68 -15.28 14.19 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.565 0.697 . . . . 0.0 109.988 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 107' ' ' ARG . 79.3 t -82.46 148.76 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.684 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 30.7 mttt -125.65 165.63 18.21 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.035 0.445 . . . . 0.0 111.129 -176.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.83 141.19 58.86 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.928 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.3 4.1 77.85 Favored Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.988 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.684 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -77.55 168.3 20.21 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.407 ' HE3' ' HG3' ' A' ' 150' ' ' GLU . 32.0 mttp -121.41 167.98 12.19 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 121.363 0.601 . . . . 0.0 111.149 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.58 159.96 39.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.993 170.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.48 133.11 35.78 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.734 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.7 OUTLIER -102.04 157.7 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.513 ' C ' ' H ' ' A' ' 122' ' ' LEU . 43.9 t -72.55 7.88 1.67 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.893 0.378 . . . . 0.0 110.953 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 145' ' ' HIS . 26.4 mt-10 65.68 -27.97 0.11 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.525 1.13 . . . . 0.0 113.861 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 120' ' ' SER . 34.1 tp -126.92 126.65 43.6 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -172.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.474 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 51.9 mm-40 -94.15 115.87 28.21 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.959 175.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.626 ' HG ' ' HB2' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -55.4 -29.37 58.41 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 121.621 0.724 . . . . 0.0 112.013 178.017 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.52 ' H ' HD13 ' A' ' 124' ' ' LEU . 22.8 t -39.51 148.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 CA-C-N 113.114 -1.857 . . . . 0.0 110.845 172.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -115.28 135.55 54.04 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 122.162 -0.337 . . . . 0.0 110.87 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -55.53 -62.94 1.35 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.171 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.9 t -94.01 61.99 3.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.409 0.623 . . . . 0.0 109.785 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.9 p -84.43 102.95 13.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.199 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.0 p -94.21 152.95 18.33 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.231 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.8 m 62.55 84.22 0.14 Allowed 'General case' 0 C--O 1.237 0.418 0 O-C-N 123.85 0.719 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -66.82 129.8 41.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.21 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.504 ' CG ' ' H ' ' A' ' 134' ' ' ASN . 12.4 t70 -147.37 -155.47 0.63 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.037 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.504 ' H ' ' CG ' ' A' ' 133' ' ' ASP . 43.8 t30 -65.9 -49.88 56.06 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 134' ' ' ASN . 2.8 Cg_endo -82.56 -12.09 10.24 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.886 2.39 . . . . 0.0 113.907 -175.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -145.8 105.25 3.95 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.65 -46.02 1.45 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.418 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.8 mp0 -79.13 125.86 29.98 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.503 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -82.47 171.8 13.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 45.7 tp 68.36 -79.81 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.498 0.498 . . . . 0.0 110.88 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 53.27 56.93 16.93 Favored Glycine 0 C--N 1.318 -0.417 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.895 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.1 m -65.76 117.69 44.16 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-O 120.615 0.245 . . . . 0.0 110.611 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.1 -60.63 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.374 2.716 . . . . 0.0 112.879 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 61.29 80.0 0.23 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.459 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.602 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 1.6 p80 -104.72 174.03 6.05 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.304 -176.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.4 t70 67.6 23.99 8.67 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.026 0.917 . . . . 0.0 109.946 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.602 ' HG2' ' O ' ' A' ' 145' ' ' HIS . 7.8 pt20 -156.91 137.6 13.23 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.362 -177.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.408 HD21 ' O ' ' A' ' 147' ' ' GLN . 18.5 mt -111.49 159.83 17.71 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-O 121.227 0.537 . . . . 0.0 110.257 177.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.558 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -111.15 135.83 51.1 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.822 -172.836 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.407 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 23.9 mt-10 -90.52 147.41 23.39 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.448 1.118 . . . . 0.0 112.557 175.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.435 HG21 ' CG1' ' A' ' 154' ' ' ILE . 74.9 mt -79.01 110.03 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.648 0 CA-C-N 113.355 -1.748 . . . . 0.0 110.607 176.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 80' ' ' GLU . 29.7 mtmt -63.48 -46.69 85.02 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.748 175.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -150.6 135.69 17.68 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 76.5 mt -118.92 130.72 73.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.981 176.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.509 ' HD3' HG12 ' A' ' 157' ' ' VAL . 3.3 ptpp? -134.23 163.51 29.46 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.57 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.556 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.8 m-85 -101.34 120.36 40.14 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.844 175.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.509 HG12 ' HD3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -131.56 174.45 13.12 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.603 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.983 -177.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -104.65 163.85 12.19 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.345 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.06 126.31 29.41 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.859 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -71.11 -40.55 71.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.372 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.19 176.33 6.27 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -95.59 -2.29 48.64 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.405 0.621 . . . . 0.0 110.12 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -136.84 154.91 50.39 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.45 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.427 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 0.9 OUTLIER -118.32 151.46 20.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.647 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.738 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 9.8 m-85 -134.67 164.42 27.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.19 -170.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.682 ' OG ' ' HA ' ' A' ' 1' ' ' CYS . 74.5 m -158.55 -18.03 0.07 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.275 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.489 HD21 ' CE1' ' A' ' 25' ' ' TYR . 2.1 tm? 60.04 106.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.917 0.865 . . . . 0.0 111.462 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.407 HD22 ' CG ' ' A' ' 66' ' ' ASP . 2.2 p-10 -90.33 125.26 35.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.856 0.836 . . . . 0.0 112.291 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.544 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -140.98 -130.06 0.1 Allowed 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.132 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.462 ' C ' ' H ' ' A' ' 172' ' ' TYR . 81.0 tttt -61.53 128.48 36.52 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt 62.28 -12.03 0.07 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.462 ' H ' ' C ' ' A' ' 170' ' ' LYS . 22.4 m-85 68.29 133.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.954 0.902 . . . . 0.0 111.152 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 33.2 m170 66.63 -4.35 0.76 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -89.54 100.09 12.96 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.478 HG22 HD13 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -152.88 165.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-O 121.401 0.619 . . . . 0.0 112.322 -175.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.579 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.8 mt -105.74 117.43 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.059 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.459 HG22 HG12 ' A' ' 175' ' ' VAL . 44.7 pt -122.84 172.58 9.93 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.811 -176.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 7.4 t-20 48.99 -131.48 1.76 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.683 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.56 ' HA ' ' HZ1' ' A' ' 18' ' ' LYS . 14.1 mm-40 -90.67 57.82 3.71 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.155 0.979 . . . . 0.0 109.502 176.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.734 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 6.2 m-20 68.03 48.83 0.93 Allowed 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.071 -1.877 . . . . 0.0 113.686 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.1 mt -90.03 113.91 26.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.932 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.67 126.61 40.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.156 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.8 t -126.49 150.42 48.74 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.115 177.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.496 ' N ' ' HB2' ' A' ' 96' ' ' LEU . 59.5 t60 60.96 140.35 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -176.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 . . . . . 0 C--O 1.257 1.477 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.895 178.176 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.567 ' N ' ' HD1' ' A' ' 93' ' ' HIS . 72.2 m . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.203 0.525 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.498 ' CE1' HD13 ' A' ' 177' ' ' ILE . 2.8 m-85 -86.18 160.34 51.99 Favored Pre-proline 0 C--N 1.304 -1.385 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.19 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.508 ' HD3' HD13 ' A' ' 76' ' ' LEU . 18.3 Cg_endo -59.48 -77.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.299 1.999 . . . . 0.0 109.997 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.415 ' H ' ' HG2' ' A' ' 3' ' ' PRO . . . 179.73 -28.6 0.05 OUTLIER Glycine 0 N--CA 1.414 -2.78 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 176.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -67.18 -7.53 24.35 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.283 0.563 . . . . 0.0 111.584 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 23.9 m -67.7 130.22 42.32 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 19.3 mtm180 -84.55 133.88 34.43 Favored 'General case' 0 C--O 1.183 -2.442 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.561 HD11 HG21 ' A' ' 175' ' ' VAL . 10.1 tt -121.45 130.55 74.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 C-N-CA 122.736 0.415 . . . . 0.0 110.098 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.489 HD22 ' CD2' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -87.08 123.94 32.7 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 121.424 0.63 . . . . 0.0 109.597 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.438 ' N ' HD11 ' A' ' 9' ' ' LEU . 28.2 m -135.41 -179.31 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.595 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.413 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 29.2 tt0 -129.95 122.32 28.31 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.883 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 18.2 mt -121.83 122.68 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.009 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.553 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.0 t0 55.66 37.39 28.81 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.764 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.39 16.08 78.89 Favored Glycine 0 C--N 1.309 -0.945 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.71 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.5 t -121.8 119.51 28.98 Favored Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.477 ' O ' HD13 ' A' ' 124' ' ' LEU . 36.2 Cg_endo -71.29 128.0 14.09 Favored 'Trans proline' 0 N--CA 1.431 -2.172 0 C-N-CA 122.111 1.874 . . . . 0.0 110.324 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -129.91 141.55 50.78 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -109.11 100.76 9.88 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -122.16 -173.16 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.181 -2.51 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.105 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.717 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 9.7 p -96.1 170.64 9.13 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.66 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.3 mm? -67.59 -27.11 66.64 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.445 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.717 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 6.6 ptm180 -84.06 -22.77 31.12 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.416 ' HG2' ' HG1' ' A' ' 20' ' ' THR . 10.2 mm-40 -85.32 -42.27 14.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.819 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 19' ' ' ILE . 27.5 tp -58.26 -44.21 88.28 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.967 0.889 . . . . 0.0 109.884 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.683 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.4 m-30 -55.35 -29.37 58.24 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 113.553 -1.658 . . . . 0.0 113.486 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 10.7 mm-40 -79.06 -11.75 60.0 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.02 -175.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.29 6.7 11.23 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.349 0.595 . . . . 0.0 109.528 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 97.6 m-85 -118.68 164.96 14.57 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.885 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.555 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 30.2 mt-10 -137.53 -172.86 3.33 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.575 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 2.5 t70 61.75 83.66 0.15 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.479 0.657 . . . . 0.0 111.082 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -99.0 122.42 42.24 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.536 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -113.59 150.57 32.88 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.342 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.489 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 28.1 t80 -106.87 129.62 54.68 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.316 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 7.6 tp10 -167.46 142.27 3.83 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.696 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.435 ' ND2' ' HG3' ' A' ' 34' ' ' GLU . 51.9 m-80 58.29 23.17 10.12 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 123.478 0.486 . . . . 0.0 111.457 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.489 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 43.8 mtm 72.24 18.66 4.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.814 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.469 HG13 ' HD2' ' A' ' 71' ' ' PRO . 4.3 m -129.37 179.92 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.406 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 81.1 m-85 -118.36 142.02 47.95 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.31 0.576 . . . . 0.0 110.278 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.36 123.77 60.66 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.928 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.585 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 40.9 ttm180 -115.06 126.55 54.83 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -134.2 146.73 50.42 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.98 -174.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 54.5 tptt 83.2 112.62 0.03 OUTLIER Pre-proline 0 C--N 1.318 -0.799 0 O-C-N 124.902 1.376 . . . . 0.0 110.868 -177.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 59.4 Cg_endo -78.79 152.26 25.22 Favored 'Trans proline' 0 N--CA 1.426 -2.482 0 C-N-CA 121.877 1.718 . . . . 0.0 111.4 177.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.555 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 36.2 mtmt -80.87 -6.23 58.36 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.796 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -147.09 -165.77 2.33 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 5.2 tp10 -86.21 100.07 11.99 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.524 HG13 HG12 ' A' ' 12' ' ' ILE . 1.3 mp -115.47 117.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.428 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 34.8 mmtp -119.91 166.66 13.02 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.689 174.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.406 HG12 ' CB ' ' A' ' 169' ' ' ALA . 13.7 p -120.42 127.07 75.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.111 0.481 . . . . 0.0 112.186 -174.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.413 ' CE1' ' HB2' ' A' ' 11' ' ' GLN . 6.5 m-85 -80.56 123.14 27.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.65 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.0 p -133.27 176.92 8.09 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.271 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.469 HG12 HD11 ' A' ' 176' ' ' ILE . 2.4 mm -122.96 140.26 47.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.248 0.547 . . . . 0.0 110.024 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -78.17 119.34 21.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.58 ' H ' HD23 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -72.01 -14.0 61.77 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.106 0.479 . . . . 0.0 111.902 -171.591 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -99.41 -28.35 13.31 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.914 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.494 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.4 p -117.2 -26.24 6.84 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.728 -175.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.82 12.7 68.31 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.332 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.494 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 17.1 mtpp -85.97 158.01 19.99 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.64 109.33 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.368 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.3 m -112.58 157.93 13.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.085 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 tp -122.29 135.77 54.79 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -137.83 172.88 12.28 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.669 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.08 161.03 16.0 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.224 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.492 HD11 ' N ' ' A' ' 64' ' ' ILE . 2.9 mp -96.34 144.62 10.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.304 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.464 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 48.5 mm-40 -91.07 -41.5 11.02 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -179.96 178.63 0.59 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.896 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 9.4 t -109.9 129.23 65.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.699 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.5 mt -97.19 102.3 13.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.826 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 45.5 tttp -116.87 107.73 14.97 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.84 137.24 30.47 Favored Pre-proline 0 C--N 1.31 -1.141 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.154 -176.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.469 ' HD2' HG13 ' A' ' 37' ' ' VAL . 80.9 Cg_exo -47.89 124.14 9.53 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 123.424 2.749 . . . . 0.0 113.116 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.46 80.01 8.74 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.948 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.6 m -86.91 -24.68 24.74 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.336 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -101.91 -179.7 4.08 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.042 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.441 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 59.5 m170 -111.37 172.31 6.96 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.426 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.587 ' CD1' ' HA ' ' A' ' 159' ' ' ALA . 22.4 mt -123.78 146.71 48.13 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.856 0.836 . . . . 0.0 111.972 -173.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.47 HD13 ' C ' ' A' ' 108' ' ' ALA . 19.9 mt -88.77 143.05 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.195 173.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 37.2 ttt-85 -120.76 138.96 53.73 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-O 121.331 0.586 . . . . 0.0 109.426 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 86' ' ' SER . 54.0 m-85 -116.05 126.44 53.78 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.038 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 152' ' ' LYS . 31.3 tt0 -109.2 122.68 47.83 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.561 HD13 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.02 154.07 20.78 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.643 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.616 ' HA ' ' HG3' ' A' ' 152' ' ' LYS . 5.2 pt-20 -57.21 -22.43 40.72 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.038 0.535 . . . . 0.0 111.943 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.28 -11.09 55.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.005 0.907 . . . . 0.0 109.111 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.28 14.93 46.29 Favored Glycine 0 N--CA 1.434 -1.451 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.918 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.518 ' O ' HD22 ' A' ' 81' ' ' LEU . 1.5 mtt180 -85.63 139.21 31.59 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 30.5 p -140.02 143.51 36.46 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.11 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -139.49 155.11 47.76 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.373 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 23.7 mt-10 -128.45 151.91 48.84 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.928 -176.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 1.0 OUTLIER -148.33 160.54 42.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.867 178.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.575 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -71.55 13.81 0.23 Allowed 'General case' 0 C--N 1.353 0.738 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -175.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.692 ' HA ' ' CB ' ' A' ' 108' ' ' ALA . 0.8 OUTLIER 68.14 -39.32 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 124.681 1.192 . . . . 0.0 113.691 176.11 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -79.68 2.47 22.52 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.803 0.335 . . . . 0.0 111.317 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.567 ' HD1' ' N ' ' A' ' 1' ' ' CYS . 50.4 m170 -115.13 143.47 30.29 Favored Pre-proline 0 C--N 1.313 -1.016 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.885 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 15.4 Cg_exo -69.05 140.14 44.53 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.561 2.841 . . . . 0.0 115.25 -175.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 20.6 t -112.15 149.55 14.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 125.285 1.434 . . . . 0.0 107.211 175.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.8 tp -107.59 111.66 24.02 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.485 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.689 HG21 ' OD1' ' A' ' 115' ' ' ASP . 1.8 p -111.47 150.18 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.424 0.63 . . . . 0.0 112.167 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.631 ' CD2' HD12 ' A' ' 148' ' ' LEU . 71.7 t80 -103.31 93.37 4.94 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.256 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.8 pt-20 -135.94 154.94 50.96 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 38.7 m-80 62.26 22.98 13.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.086 0.469 . . . . 0.0 110.394 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.84 13.96 62.31 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.058 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -130.51 171.34 13.12 Favored 'General case' 0 N--CA 1.399 -2.987 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -104.35 121.13 42.73 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.512 HG13 HG13 ' A' ' 97' ' ' VAL . 28.7 pt -121.61 142.42 37.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.995 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.3 OUTLIER -106.16 111.55 24.21 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.008 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.435 ' HG3' HG21 ' A' ' 111' ' ' VAL . 12.6 ptpt -125.24 144.54 50.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.915 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.598 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 64.9 mtt180 -64.85 160.67 19.87 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.692 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -59.95 -41.54 92.08 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.413 -176.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.453 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.8 p90 -74.29 1.73 10.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.824 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -112.9 -13.91 13.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.827 0.822 . . . . 0.0 109.701 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 107' ' ' ARG . 98.9 t -76.79 150.0 6.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.689 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -123.89 166.16 16.14 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 120.606 0.241 . . . . 0.0 110.824 -177.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.61 141.94 51.7 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.17 4.7 77.5 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.638 -175.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.689 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 1.7 t0 -78.5 166.56 22.45 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.412 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 35.1 mttp -120.01 168.68 10.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.79 0.805 . . . . 0.0 111.459 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.62 160.35 37.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 169.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 182' ' ' VAL . 1.1 tt -90.31 122.18 32.98 Favored 'General case' 0 N--CA 1.395 -3.189 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.226 177.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.688 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.0 OUTLIER -104.82 128.76 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 173.642 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 122' ' ' LEU . 37.8 t -61.43 -22.54 65.12 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.544 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.593 ' HB3' ' HB3' ' A' ' 145' ' ' HIS . 6.2 mm-40 46.9 13.26 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 125.578 1.551 . . . . 0.0 113.963 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.417 ' H ' ' C ' ' A' ' 120' ' ' SER . 9.7 tt -113.15 127.07 56.08 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -114.44 -168.88 1.43 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.312 0.577 . . . . 0.0 112.324 -175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.489 ' CD2' HD22 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -113.85 17.71 17.83 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.8 t 73.34 80.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.374 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 127' ' ' GLN . 41.7 tt0 -150.81 165.95 31.99 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.319 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.413 ' N ' ' HG2' ' A' ' 126' ' ' GLU . 83.8 mm-40 -87.23 168.23 13.4 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.594 0.235 . . . . 0.0 110.471 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 p -66.34 -43.52 85.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.842 0.353 . . . . 0.0 111.708 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.8 t -96.99 115.4 27.37 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 55.5 p -147.89 157.82 43.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.812 0.339 . . . . 0.0 111.168 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.6 p -107.46 -53.1 2.67 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -166.09 151.52 8.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.523 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -141.33 175.45 9.64 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.689 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 12.1 t-20 -179.98 -48.87 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 123.456 0.473 . . . . 0.0 111.466 -177.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 134' ' ' ASN . 2.4 Cg_endo -46.02 151.91 1.35 Allowed 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.909 3.073 . . . . 0.0 113.148 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -122.28 179.47 4.55 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.019 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 67.7 91.48 0.09 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.88 0.737 . . . . 0.0 112.086 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -135.39 -78.79 0.44 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.896 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -157.53 -179.73 8.45 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.6 tp -76.13 147.25 38.68 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.93 54.07 0.56 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.345 -0.931 . . . . 0.0 111.429 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.5 p -63.88 118.54 46.44 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.724 0.297 . . . . 0.0 110.69 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -79.1 158.21 26.77 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.156 1.904 . . . . 0.0 112.725 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -167.2 19.55 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.886 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.593 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 8.7 m170 -85.8 124.76 32.66 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -137.38 98.54 3.74 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.373 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.456 ' C ' HD21 ' A' ' 148' ' ' LEU . 8.2 pt20 -164.69 139.24 5.32 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.464 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.631 HD12 ' CD2' ' A' ' 98' ' ' TYR . 13.8 mt -108.73 148.36 30.6 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.709 0.766 . . . . 0.0 111.485 178.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.604 ' CD1' ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -111.36 135.97 51.15 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.07 -172.696 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.412 ' HG3' ' CG ' ' A' ' 116' ' ' LYS . 11.3 mt-10 -91.56 147.33 23.09 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.497 175.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.543 HD11 ' CD1' ' A' ' 79' ' ' PHE . 75.4 mt -78.29 106.93 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.594 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.844 176.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.616 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 34.4 mmtm -70.27 -39.58 74.87 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.856 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -150.94 132.46 14.74 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 71.8 mt -111.76 143.98 20.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.791 176.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.4 ptpt -146.77 159.83 43.01 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.398 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -100.26 114.9 28.71 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.441 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.3 OUTLIER -126.98 175.5 8.84 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.751 -179.073 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.412 ' C ' ' H ' ' A' ' 160' ' ' ASN . 35.8 ttt180 -99.64 154.33 18.36 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.81 -0.556 . . . . 0.0 111.443 -178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.56 3.11 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 158' ' ' ARG . 13.2 t-20 66.78 -54.41 0.44 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.81 -175.1 2.7 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -99.67 9.57 42.88 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.181 0.515 . . . . 0.0 110.021 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -141.19 155.37 46.07 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.989 176.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.4 m -124.85 154.15 32.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.683 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 8.3 m-85 -131.73 163.04 29.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.1 -172.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -159.09 -16.11 0.07 Allowed 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.829 176.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.415 HD21 ' CE1' ' A' ' 25' ' ' TYR . 2.8 tm? 62.64 112.12 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.333 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -87.3 114.57 24.03 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.738 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -126.14 -156.16 0.72 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -63.11 138.9 58.7 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 92.0 mttt 69.64 -73.88 0.09 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.769 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -140.12 -158.07 0.82 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -97.96 29.38 3.47 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -63.38 109.8 1.72 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.178 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 8' ' ' ILE . 5.2 p -149.02 166.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 121.557 0.694 . . . . 0.0 111.906 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.557 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 81.0 mt -97.57 114.08 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.136 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.498 HD13 ' CE1' ' A' ' 2' ' ' PHE . 45.0 pt -118.89 174.85 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-O 120.978 0.418 . . . . 0.0 111.649 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 44.66 -123.18 0.95 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.13 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -99.57 64.92 1.33 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.822 0.82 . . . . 0.0 108.928 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.688 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 7.8 m120 68.65 38.92 2.14 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 113.537 -1.665 . . . . 0.0 114.339 176.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 99.1 mt -88.31 113.52 25.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 118' ' ' LEU . 2.5 m -83.68 158.2 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.4 t -162.5 158.4 23.58 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.997 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -69.39 -26.28 64.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.273 0.559 . . . . 0.0 109.874 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? . . . . . 0 C--O 1.257 1.464 0 CA-C-O 116.493 -1.717 . . . . 0.0 109.655 179.586 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.697 ' O ' ' HA ' ' A' ' 89' ' ' THR . 63.2 m . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.927 0.394 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.49 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 30.9 m-85 -114.71 145.81 34.7 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.463 ' HD3' HD13 ' A' ' 76' ' ' LEU . 14.9 Cg_endo -56.42 -27.46 68.17 Favored 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 123.418 2.746 . . . . 0.0 112.771 -177.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.463 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 125.21 -39.38 2.09 Favored Glycine 0 N--CA 1.417 -2.626 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.6 -11.14 60.6 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.697 0.76 . . . . 0.0 111.176 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 55.2 m -60.72 131.12 49.68 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.687 177.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.0 mmt180 -86.26 132.38 34.0 Favored 'General case' 0 C--O 1.185 -2.3 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.532 ' HB ' ' CD2' ' A' ' 21' ' ' LEU . 11.6 tt -119.64 130.57 73.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 CA-C-O 120.862 0.363 . . . . 0.0 110.111 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.489 HD22 ' CD1' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -88.46 125.35 34.7 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-O 121.452 0.644 . . . . 0.0 109.959 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.6 m -135.15 177.8 6.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.504 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -126.89 119.67 27.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.23 0.538 . . . . 0.0 109.875 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.553 HG12 HG13 ' A' ' 47' ' ' ILE . 12.5 mt -118.43 120.18 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.701 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.788 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 54.69 37.93 29.14 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.15 -1.387 . . . . 0.0 109.824 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 18.26 79.52 Favored Glycine 0 C--N 1.3 -1.47 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.609 -177.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.04 119.22 26.62 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 48.0 Cg_endo -73.31 122.05 7.67 Favored 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 122.534 2.156 . . . . 0.0 111.468 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -124.41 141.74 51.84 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.711 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 127' ' ' GLN . 40.4 ttmt -107.94 101.28 10.56 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.025 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 8' ' ' ILE . 3.0 pt -123.63 -175.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.681 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.735 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 9.6 p -90.28 173.54 8.08 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.727 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.2 mm? -69.24 -26.91 65.02 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.395 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.735 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.7 ptm180 -84.8 -24.91 28.5 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.572 ' HG3' ' HG1' ' A' ' 20' ' ' THR . 39.2 mt-10 -82.98 -39.4 21.39 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.977 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.453 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 16.2 tp -57.82 -42.18 83.76 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.089 0.947 . . . . 0.0 108.7 176.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -53.71 -31.23 47.29 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.216 -1.811 . . . . 0.0 112.594 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.9 mt-10 -76.0 -17.82 59.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -78.89 2.29 20.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.732 0.777 . . . . 0.0 109.429 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.463 ' C ' ' HD3' ' A' ' 40' ' ' ARG . 96.0 m-85 -117.91 162.24 18.46 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.602 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.7 -173.84 3.99 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.175 176.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 t70 63.47 81.36 0.21 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.248 0.547 . . . . 0.0 110.159 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -106.42 134.18 49.96 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 122.088 0.946 . . . . 0.0 111.465 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.402 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.2 ptt180 -122.54 154.44 37.9 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.557 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -105.57 124.94 50.38 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -160.89 137.66 8.77 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.476 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 61.7 23.12 13.5 Favored 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 123.579 0.55 . . . . 0.0 110.918 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.1 mtt 75.6 13.82 2.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.064 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.458 HG11 ' HD2' ' A' ' 71' ' ' PRO . 5.1 m -129.64 -179.71 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -115.55 140.46 49.14 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.127 0.489 . . . . 0.0 109.823 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.402 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.2 t -129.49 123.29 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.093 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.463 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 16.7 ttm180 -112.71 126.75 55.74 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -131.65 146.08 52.0 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.654 -174.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 27.5 tptp 80.68 113.08 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.438 0 O-C-N 124.531 1.145 . . . . 0.0 111.396 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 56.9 Cg_endo -78.02 155.94 30.15 Favored 'Trans proline' 0 N--CA 1.435 -1.918 0 C-N-CA 122.208 1.939 . . . . 0.0 111.974 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -86.97 -3.46 59.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.349 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -147.3 -164.8 2.09 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 6.0 tp10 -84.5 98.25 10.01 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.553 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -117.34 116.02 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.835 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -116.43 167.52 10.97 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.356 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -116.05 121.53 67.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 121.714 0.769 . . . . 0.0 112.097 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.526 ' CD2' HD11 ' A' ' 176' ' ' ILE . 65.8 t80 -76.1 110.27 10.44 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.643 177.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -134.22 176.52 8.52 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.738 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.438 HG12 HD12 ' A' ' 176' ' ' ILE . 4.3 mm -121.18 144.17 31.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.267 0.556 . . . . 0.0 110.922 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.626 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 19.4 t70 -81.52 120.98 25.73 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.298 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.565 ' H ' HD23 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -74.91 -12.24 60.31 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -170.488 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.626 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.7 pt-20 -104.33 -27.12 12.17 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.2 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.522 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 72.2 p -115.18 -24.95 8.26 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.578 -176.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.69 70.53 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.045 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.522 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 40.2 mttt -85.47 163.74 18.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.5 HG12 ' CE1' ' A' ' 50' ' ' TYR . 90.4 t -88.62 111.43 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.162 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.9 146.71 14.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.299 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.1 tp -120.12 138.59 53.48 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.2 t -150.54 171.35 17.22 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 120.753 0.311 . . . . 0.0 110.868 -177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.45 161.12 25.06 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.574 0.702 . . . . 0.0 111.169 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.467 ' N ' HD13 ' A' ' 64' ' ' ILE . 2.2 mp -101.06 135.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.887 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.503 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 17.3 mt-10 -81.1 -39.62 25.37 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 p30 179.65 175.49 0.74 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.458 -175.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.0 t -105.8 131.71 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.867 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.639 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 57.6 mt -91.53 105.8 16.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.267 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.43 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.1 tttt -119.87 108.16 14.02 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.25 138.62 33.25 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.343 -175.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.458 ' HD2' HG11 ' A' ' 37' ' ' VAL . 75.1 Cg_exo -48.54 134.09 26.51 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 123.274 2.649 . . . . 0.0 112.608 177.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.73 95.6 3.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.391 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.7 p -92.76 -54.33 3.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.322 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.71 -179.92 6.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.918 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -100.9 170.71 8.12 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 90' ' ' THR . 17.1 mt -115.23 131.35 56.96 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.504 0.669 . . . . 0.0 112.062 -175.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.577 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 19.5 mt -82.82 141.84 14.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 24.5 ttt-85 -117.11 136.93 52.63 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-O 121.17 0.509 . . . . 0.0 109.769 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 86' ' ' SER . 56.1 m-85 -116.01 127.53 54.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.7 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 152' ' ' LYS . 43.7 tt0 -111.97 128.27 56.12 Favored 'General case' 0 CA--C 1.472 -2.051 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.569 HD13 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -91.09 157.65 17.11 Favored 'General case' 0 C--N 1.269 -2.915 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.576 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.552 ' HG2' ' CD1' ' A' ' 149' ' ' LEU . 2.3 pt-20 -63.88 -14.5 53.87 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.569 0.7 . . . . 0.0 111.07 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -92.81 -9.45 40.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.264 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.14 14.59 54.14 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.217 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.519 ' O ' HD23 ' A' ' 81' ' ' LEU . 3.0 mtt180 -86.34 141.8 28.95 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 26.1 p -141.69 146.52 36.19 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.488 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -141.58 150.21 41.76 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.635 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 29.3 mt-10 -121.85 145.83 47.69 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.351 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.697 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 1.6 p -144.12 157.22 44.44 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.731 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.684 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 0.4 OUTLIER -75.46 9.26 2.26 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -175.583 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.716 ' O ' ' HB3' ' A' ' 107' ' ' ARG . 1.6 t 76.17 -42.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 O-C-N 123.503 0.502 . . . . 0.0 111.274 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 90' ' ' THR . 2.0 t70 -63.37 -20.53 65.6 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 123.764 0.826 . . . . 0.0 110.888 177.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -103.31 129.56 25.27 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.786 -176.416 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 25.3 Cg_exo -65.18 142.82 75.38 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.623 2.882 . . . . 0.0 114.486 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 17.4 t -105.34 146.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.169 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.43 ' CD1' ' HG3' ' A' ' 105' ' ' GLU . 32.4 tp -98.47 106.99 19.35 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.526 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.537 HG13 HG13 ' A' ' 104' ' ' ILE . 1.7 p -108.74 145.8 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 121.475 0.655 . . . . 0.0 111.55 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.533 ' CD2' HD13 ' A' ' 148' ' ' LEU . 86.3 t80 -104.0 91.74 4.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.209 178.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.509 ' CG ' HD13 ' A' ' 104' ' ' ILE . 9.1 pt-20 -138.87 155.94 47.7 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 32.4 m-80 65.98 22.61 11.24 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.355 0.597 . . . . 0.0 110.02 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.72 13.96 64.38 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.931 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -136.23 171.28 14.7 Favored 'General case' 0 N--CA 1.401 -2.925 0 CA-C-O 121.258 0.551 . . . . 0.0 110.24 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -101.92 121.28 41.82 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.084 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.537 HG13 HG13 ' A' ' 97' ' ' VAL . 16.1 pt -127.61 145.11 35.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.926 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 8.4 mp0 -106.46 115.13 29.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.079 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.446 ' HG3' HG23 ' A' ' 111' ' ' VAL . 12.7 ptpt -128.31 141.71 51.35 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.894 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.716 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 99.8 mtt180 -61.47 165.73 4.58 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 119.404 -0.331 . . . . 0.0 110.635 -176.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.648 ' CB ' ' HA ' ' A' ' 91' ' ' VAL . . . -62.67 -40.27 96.55 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.47 -173.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -72.71 -7.53 50.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.868 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -102.75 -17.01 15.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.716 0.769 . . . . 0.0 109.175 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 107' ' ' ARG . 69.4 t -77.42 150.41 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.487 ' HE3' ' H ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -124.27 163.69 21.12 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.106 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.82 142.95 56.0 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.57 4.54 76.31 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.584 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.515 ' HB3' HD13 ' A' ' 151' ' ' ILE . 18.4 t70 -71.95 164.4 26.16 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.469 ' HE2' ' O ' ' A' ' 148' ' ' LEU . 24.2 mttt -122.55 154.67 37.6 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-O 121.568 0.699 . . . . 0.0 110.753 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.25 159.65 34.75 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.93 129.58 35.59 Favored 'General case' 0 N--CA 1.399 -3.014 0 C-N-CA 119.394 -0.923 . . . . 0.0 108.679 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.737 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -113.42 132.89 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.153 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.34 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 122' ' ' LEU . 32.7 t -63.29 -17.54 62.62 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.956 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 145' ' ' HIS . 36.1 mm-40 47.48 8.77 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 125.599 1.56 . . . . 0.0 115.064 -178.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 120' ' ' SER . 29.3 tp -91.35 127.03 36.63 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 120.839 0.352 . . . . 0.0 110.983 -177.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 143' ' ' PRO . 40.6 mt-10 -88.6 160.23 17.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.663 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.489 ' CD1' HD22 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -144.99 -58.85 0.35 Allowed 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.538 0.685 . . . . 0.0 110.134 -178.292 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.54 HG21 ' H ' ' A' ' 126' ' ' GLU . 7.7 p -162.44 -177.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.496 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.54 ' H ' HG21 ' A' ' 125' ' ' VAL . 9.6 tp10 -81.93 -98.38 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.827 -177.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 21.8 tm0? 179.76 -38.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -178.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.3 p -59.78 -81.79 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.934 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.8 t 56.16 83.97 0.09 Allowed 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.502 0.501 . . . . 0.0 109.761 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.0 m -47.27 -45.41 23.93 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.584 -177.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t -112.06 129.52 56.18 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -82.81 91.32 7.04 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -128.17 -3.84 5.63 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.305 0.574 . . . . 0.0 111.098 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.475 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 17.2 m120 46.6 60.33 14.81 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.907 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.475 ' HD3' ' N ' ' A' ' 134' ' ' ASN . 25.5 Cg_exo -62.89 -74.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.81 2.34 . . . . 0.0 113.12 -179.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt 63.08 -89.39 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.509 -177.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 66.0 t30 53.33 39.72 30.23 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.412 0.625 . . . . 0.0 111.532 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -146.78 131.08 17.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.132 0.492 . . . . 0.0 111.526 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -133.49 174.24 10.63 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.582 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.575 ' C ' ' H ' ' A' ' 142' ' ' SER . 32.9 tp 72.88 -42.22 0.53 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.046 0.938 . . . . 0.0 112.988 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.47 41.51 0.18 Allowed Glycine 0 CA--C 1.506 -0.476 0 O-C-N 123.537 0.523 . . . . 0.0 113.157 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.575 ' H ' ' C ' ' A' ' 140' ' ' LEU . 44.0 t -82.83 118.74 72.76 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 123' ' ' GLU . 7.9 Cg_exo -71.95 165.44 32.56 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.313 2.009 . . . . 0.0 111.385 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -112.15 -68.15 0.95 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.067 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 10.1 m-70 66.95 166.97 0.23 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 178.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 179.43 85.5 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.853 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.464 ' C ' HD23 ' A' ' 148' ' ' LEU . 26.4 pt20 -164.99 138.08 4.64 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.165 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.533 HD13 ' CD2' ' A' ' 98' ' ' TYR . 12.4 mt -109.61 152.75 25.14 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-O 121.215 0.531 . . . . 0.0 110.242 176.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.569 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -113.68 136.74 52.51 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.946 -173.312 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.403 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 28.4 mt-10 -90.22 147.2 23.7 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.126 176.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 115' ' ' ASP . 81.3 mt -79.46 112.64 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.012 175.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.579 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 4.9 mmpt? -76.89 -39.81 49.63 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.642 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -148.26 131.55 16.52 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -175.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 86.7 mt -114.26 148.32 17.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.754 174.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -154.33 162.03 41.41 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.708 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.577 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 15.8 m-85 -101.72 116.9 33.75 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.39 133.16 64.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.371 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.43 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 60.3 ttt180 -68.85 161.24 29.02 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.167 0.508 . . . . 0.0 111.726 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.43 ' N ' ' HG2' ' A' ' 158' ' ' ARG . . . -70.4 120.08 15.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.77 -32.76 73.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.833 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -110.9 -173.9 2.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.484 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -100.51 0.03 38.76 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 120.858 0.361 . . . . 0.0 111.413 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -138.98 159.42 42.19 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.443 HG13 ' HA ' ' A' ' 3' ' ' PRO . 6.3 m -132.39 161.41 41.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.921 177.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.639 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 76.2 m-85 -134.56 173.0 12.14 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.461 ' HB2' HD12 ' A' ' 68' ' ' ILE . 69.8 m -158.76 -24.68 0.08 Allowed 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.453 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 1.4 tm? 68.5 111.01 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.253 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -92.65 115.71 28.35 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.99 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.503 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.38 -146.57 0.33 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 171' ' ' LYS . 23.4 tptm -61.49 134.4 56.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.761 0.315 . . . . 0.0 110.309 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 170' ' ' LYS . 92.4 mttt 72.16 -84.09 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.519 -175.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -151.85 -165.58 2.27 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.902 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -74.49 45.29 0.23 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.878 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -83.85 104.05 13.62 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.508 HG23 HD12 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -141.21 167.15 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.34 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.577 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.0 mt -105.7 117.53 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.73 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.456 HD11 ' CE1' ' A' ' 2' ' ' PHE . 44.7 pt -122.27 170.09 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.448 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 48.59 -132.94 1.48 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 124.036 0.934 . . . . 0.0 110.318 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.95 53.87 2.56 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.35 0.595 . . . . 0.0 110.233 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.737 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.7 m120 69.88 44.4 0.83 Allowed 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.887 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 91.7 mt -87.38 116.83 30.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.426 HG23 HG12 ' A' ' 176' ' ' ILE . 59.1 t -94.05 130.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.478 -175.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.516 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 15.1 t -135.55 159.99 39.89 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.532 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -152.27 145.84 24.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 . . . . . 0 C--O 1.26 1.616 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.762 179.5 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.591 ' HD3' HD13 ' A' ' 76' ' ' LEU . 57.8 Cg_endo -67.21 161.77 41.47 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.561 1.507 . . . . 0.0 109.212 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.521 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.56 -26.21 64.28 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 119.212 -1.471 . . . . 0.0 110.712 175.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.74 -26.17 44.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.468 0.707 . . . . 0.0 112.264 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 20' ' ' THR . 31.8 m -64.77 123.99 20.8 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.352 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.767 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 45.6 mtm-85 -81.42 128.23 33.64 Favored 'General case' 0 C--O 1.184 -2.364 0 C-N-CA 123.195 0.598 . . . . 0.0 109.878 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 19' ' ' ILE . 13.6 tt -112.48 130.34 66.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 122.193 -0.317 . . . . 0.0 110.332 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.55 HD12 ' CD1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -85.13 123.77 31.03 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.52 0.676 . . . . 0.0 109.784 177.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 24.8 m -136.41 -179.42 2.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.62 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 31.3 tt0 -130.16 119.58 23.21 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.63 HG12 HG13 ' A' ' 47' ' ' ILE . 11.8 mt -120.45 122.66 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.527 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.786 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 55.34 38.33 30.17 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.807 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.21 22.19 78.51 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.131 -0.94 . . . . 0.0 113.223 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.71 119.92 21.6 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-O 121.11 0.481 . . . . 0.0 109.941 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 57.2 Cg_endo -72.8 126.14 11.1 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 122.486 2.124 . . . . 0.0 111.52 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -129.48 140.59 51.23 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.457 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 26.6 ttpt -110.42 101.5 10.2 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.616 ' O ' HG22 ' A' ' 8' ' ' ILE . 10.9 pt -139.75 136.86 39.51 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.25 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.767 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 4.5 p -40.02 148.95 0.07 Allowed 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.015 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 51.1 mt -60.15 -25.06 65.22 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.874 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.733 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 7.4 ptm180 -78.08 -28.03 48.69 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.529 ' HA ' ' OE2' ' A' ' 26' ' ' GLU . 60.8 mt-10 -85.29 -48.67 8.85 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.278 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.534 HD11 ' HG ' ' A' ' 167' ' ' LEU . 0.5 OUTLIER -50.94 -51.37 52.94 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.561 0.696 . . . . 0.0 109.887 175.066 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.43 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -45.42 -34.17 2.97 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.322 -1.308 . . . . 0.0 113.598 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.529 ' OE2' ' HA ' ' A' ' 23' ' ' GLU . 30.3 mt-10 -69.68 -18.47 63.56 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.71 1.86 18.65 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.568 0.699 . . . . 0.0 109.836 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 99.2 m-85 -118.96 160.86 21.2 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.765 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -143.95 -172.15 3.69 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.942 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.483 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.4 t70 63.36 82.36 0.18 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.574 0.702 . . . . 0.0 110.329 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -99.22 129.36 45.45 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.388 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.53 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.4 ptt180 -118.28 152.8 35.05 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.172 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 37' ' ' VAL . 3.4 t80 -104.6 123.88 48.35 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -167.0 146.73 5.43 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.302 -174.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 62.5 18.61 10.56 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 123.421 0.451 . . . . 0.0 110.547 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.6 mtt 71.12 15.93 6.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.013 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 27.1 m -130.47 -173.34 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.83 140.26 50.25 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.219 0.533 . . . . 0.0 109.968 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.53 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.3 t -127.72 123.67 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.456 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.008 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.449 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 13.2 ttm180 -111.22 126.96 55.42 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.51 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.38 147.3 52.38 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.386 -175.164 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 8.2 tmtm? 84.24 109.87 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.484 0 O-C-N 124.426 1.079 . . . . 0.0 110.637 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HB2' HD13 ' A' ' 47' ' ' ILE . 72.0 Cg_endo -78.57 149.43 23.93 Favored 'Trans proline' 0 N--CA 1.435 -1.917 0 C-N-CA 122.252 1.968 . . . . 0.0 111.25 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.508 ' HE2' ' O ' ' A' ' 26' ' ' GLU . 1.5 mtmt -85.66 -2.75 58.5 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.204 0.526 . . . . 0.0 111.118 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -144.32 -165.82 2.22 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.0 tp10 -87.18 103.39 15.37 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 175.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.63 HG13 HG12 ' A' ' 12' ' ' ILE . 1.4 mp -119.09 121.42 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.889 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 37.7 mmtt -118.43 169.51 9.7 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.077 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.505 HG11 ' CB ' ' A' ' 169' ' ' ALA . 14.6 p -128.17 133.92 66.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.326 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.55 ' CD1' HD12 ' A' ' 9' ' ' LEU . 31.5 m-85 -83.71 123.15 29.54 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.915 176.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.9 t -127.66 174.61 8.94 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.612 HG12 HD11 ' A' ' 176' ' ' ILE . 1.2 mm -125.27 141.94 43.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.583 0.706 . . . . 0.0 111.501 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.679 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 32.8 t70 -90.87 115.25 27.77 Favored 'General case' 0 C--O 1.194 -1.842 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.691 HD12 ' H ' ' A' ' 54' ' ' LEU . 4.8 mp -67.16 -33.56 75.67 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 121.848 0.832 . . . . 0.0 111.665 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.679 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -73.72 -30.92 63.11 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.773 -174.05 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.7 p -113.22 -22.01 10.69 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.179 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.18 18.07 70.26 Favored Glycine 0 N--CA 1.431 -1.633 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.492 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.504 ' C ' HD13 ' A' ' 52' ' ' ILE . 26.2 mttp -98.12 157.46 16.13 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.82 112.01 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.255 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.2 m -110.74 165.46 6.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.651 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.9 tp -120.69 140.28 51.84 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.1 t -143.49 171.59 13.94 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.013 0.435 . . . . 0.0 111.22 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.69 160.93 19.43 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.262 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.559 HD12 ' N ' ' A' ' 64' ' ' ILE . 3.0 mp -97.47 143.05 13.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.141 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.444 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 79.2 mm-40 -91.13 -38.76 12.54 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 176.93 175.48 0.37 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.788 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 17.3 t -105.69 130.2 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.049 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 61.2 mt -89.89 106.6 17.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.689 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.44 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 88.0 tttt -121.37 110.42 16.07 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.798 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 163' ' ' PHE . . . -130.48 139.01 34.33 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.762 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.432 ' HD2' HG12 ' A' ' 37' ' ' VAL . 7.4 Cg_endo -53.14 124.42 15.56 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.877 2.385 . . . . 0.0 112.108 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.56 96.69 0.18 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.686 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.5 m -105.18 -58.25 1.92 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.994 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -79.66 175.42 10.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.147 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -101.22 171.46 7.59 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' A' ' 90' ' ' THR . 10.6 mt -126.72 141.92 51.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.718 0.771 . . . . 0.0 111.775 -173.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 88' ' ' GLU . 13.9 mt -84.4 143.88 10.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 10.7 ttt85 -116.57 138.02 51.73 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-O 121.213 0.53 . . . . 0.0 109.814 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.614 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.7 m-85 -116.12 122.47 45.2 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.546 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 152' ' ' LYS . 36.0 tt0 -109.77 124.49 51.36 Favored 'General case' 0 CA--C 1.47 -2.104 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.734 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -88.24 160.78 17.54 Favored 'General case' 0 C--N 1.271 -2.818 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.813 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.806 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.7 pt-20 -60.72 -19.28 58.5 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.592 0.711 . . . . 0.0 110.529 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -91.48 -12.14 35.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.93 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.07 14.38 49.04 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.994 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.572 ' O ' HD23 ' A' ' 81' ' ' LEU . 4.2 mtt180 -84.29 138.25 33.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 27.0 p -141.63 137.84 32.12 Favored 'General case' 0 C--N 1.287 -2.122 0 C-N-CA 118.969 -1.092 . . . . 0.0 112.845 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.456 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 5.0 p90 -136.0 154.64 51.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.507 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 25.2 mt-10 -125.32 151.84 45.49 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.549 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -143.42 157.93 44.06 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.399 178.315 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.677 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -69.8 15.27 0.08 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.313 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.005 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.6 -36.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 125.448 1.499 . . . . 0.0 112.213 178.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.547 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 26.7 t70 -78.41 -18.07 55.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.333 0.587 . . . . 0.0 109.639 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -77.83 125.75 85.14 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.298 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 37.7 Cg_endo -66.12 142.55 68.1 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.133 2.556 . . . . 0.0 112.622 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 20.7 t -111.97 145.47 18.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.6 tp -101.72 108.9 20.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.837 0.351 . . . . 0.0 110.793 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.605 HG13 HG13 ' A' ' 104' ' ' ILE . 2.2 p -112.22 150.09 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.367 0.603 . . . . 0.0 111.067 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.456 ' CD2' HD12 ' A' ' 148' ' ' LEU . 58.9 t80 -105.62 93.62 4.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.18 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 6.9 pt-20 -139.44 158.81 43.5 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 86.6 m-20 64.57 22.14 12.59 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.212 0.53 . . . . 0.0 110.154 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.25 14.72 64.48 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.031 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -137.21 171.65 14.17 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 117.365 0.583 . . . . 0.0 110.042 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -100.83 122.75 43.96 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.605 HG13 HG13 ' A' ' 97' ' ' VAL . 24.6 pt -121.04 146.98 25.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.836 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 mp0 -104.17 112.09 24.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.278 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 11.5 ptpt -124.2 139.44 53.92 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.576 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.64 ' O ' HG23 ' A' ' 111' ' ' VAL . 14.3 mmt180 -60.55 158.84 11.52 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.005 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -60.38 -40.79 92.13 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.864 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.418 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.7 p90 -73.47 -1.13 17.17 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.868 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -111.13 -13.79 13.97 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.693 0.759 . . . . 0.0 109.772 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 107' ' ' ARG . 93.6 t -79.2 149.0 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.698 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 21.6 mtmt -123.36 165.81 16.38 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.192 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.81 139.68 55.26 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.91 4.5 72.2 Favored Glycine 0 C--N 1.307 -1.032 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.874 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.698 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -75.33 167.93 20.96 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.46 ' HG2' ' HG3' ' A' ' 150' ' ' GLU . 25.2 mttp -119.61 165.1 14.89 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 121.404 0.621 . . . . 0.0 110.511 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.456 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -133.55 159.93 42.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.58 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 182' ' ' VAL . 0.9 OUTLIER -88.64 131.79 34.83 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -119.21 132.58 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.193 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB3' HD22 ' A' ' 180' ' ' ASN . 48.4 t . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 121.626 0.727 . . . . 0.0 109.926 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.456 HD12 ' CD2' ' A' ' 98' ' ' TYR . 14.4 mt . . . . . 0 N--CA 1.417 -2.088 0 CA-C-O 121.199 0.523 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.806 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -113.21 137.86 50.84 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.027 -172.067 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.46 ' HG3' ' HG2' ' A' ' 116' ' ' LYS . 15.1 mt-10 -92.19 146.68 23.52 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.3 1.047 . . . . 0.0 112.7 175.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.44 HD13 ' CD1' ' A' ' 79' ' ' PHE . 75.2 mt -78.73 111.99 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.534 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.546 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.558 ' HE2' ' HB2' ' A' ' 82' ' ' GLU . 48.9 mmtt -71.63 -40.36 69.8 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.54 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -149.51 133.55 17.15 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 76.2 mt -116.92 144.64 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.609 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.479 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 19.0 ptpt -152.78 164.09 38.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.155 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.478 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 15.3 m-85 -101.59 116.55 33.0 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.417 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.16 173.9 11.07 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.958 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -106.24 152.83 22.99 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 120.928 0.394 . . . . 0.0 111.486 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.28 128.38 36.47 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.224 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -65.85 -47.36 75.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.101 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.08 170.95 9.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.822 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -90.29 0.74 57.1 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 121.582 0.706 . . . . 0.0 109.933 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 96.2 m-85 -141.03 148.29 40.02 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.256 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 3' ' ' PRO . 4.0 m -118.03 155.49 19.91 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.699 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 74.3 m-85 -133.43 173.58 11.33 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.68 0.276 . . . . 0.0 110.926 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.698 ' HB2' HD12 ' A' ' 68' ' ' ILE . 67.0 m -158.38 -23.37 0.08 Allowed 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.534 ' HG ' HD11 ' A' ' 24' ' ' LEU . 1.9 tm? 67.17 107.03 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.592 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -88.63 116.48 26.91 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.513 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.505 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -132.27 -167.25 1.86 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.995 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--N 1.328 -0.345 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -179.091 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.644 HG13 HG23 ' A' ' 177' ' ' ILE . 2.8 p -148.78 162.67 5.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.44 0.638 . . . . 0.0 111.225 -176.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.612 HD11 HG12 ' A' ' 52' ' ' ILE . 90.6 mt -108.34 116.91 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.605 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.644 HG23 HG13 ' A' ' 175' ' ' VAL . 37.7 pt -125.24 172.91 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.678 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 7' ' ' ARG . 8.2 t-20 47.9 -130.65 1.61 Allowed 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.055 0.942 . . . . 0.0 109.732 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -88.28 55.37 3.4 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.742 0.782 . . . . 0.0 109.487 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.6 m-20 67.38 47.76 1.23 Allowed 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.856 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 81.4 mt -87.94 118.18 33.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 118' ' ' LEU . 48.7 t -90.51 135.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.189 -175.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--N 1.307 -1.274 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.102 178.31 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.451 ' CE1' HD13 ' A' ' 177' ' ' ILE . 62.4 m-85 . . . . . 0 C--O 1.221 -0.405 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.541 ' HD3' HD13 ' A' ' 76' ' ' LEU . 18.7 Cg_endo -58.51 -29.69 89.51 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.886 2.391 . . . . 0.0 112.569 -175.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 124.28 -37.48 2.64 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.06 -4.62 21.95 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.449 0.642 . . . . 0.0 111.523 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.6 m -67.95 127.73 33.91 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.963 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.579 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 33.5 mmt180 -80.02 131.44 35.79 Favored 'General case' 0 C--O 1.181 -2.53 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 19' ' ' ILE . 8.1 tt -119.22 130.93 73.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.649 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.472 ' CD2' ' HB2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -87.0 123.44 32.1 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 121.602 0.715 . . . . 0.0 110.187 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 31.5 m -135.59 -178.9 2.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.489 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 30.8 tt0 -129.23 121.42 27.58 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.581 HG12 HG13 ' A' ' 47' ' ' ILE . 21.2 mt -119.32 121.47 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.864 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.54 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 54.58 38.49 29.96 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.97 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.35 18.45 79.86 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.061 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.2 t -124.28 121.84 26.06 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 59.7 Cg_endo -74.1 121.43 6.9 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 C-N-CA 122.383 2.055 . . . . 0.0 111.05 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -125.41 141.71 51.91 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.702 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 38.8 ttpt -109.93 100.82 9.72 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.9 pt -121.98 -173.71 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.183 -2.447 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.721 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 21.1 p -92.25 172.29 8.51 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.282 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 15.0 mt -72.98 -22.25 60.72 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.77 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.721 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.2 ptm180 -85.28 -24.63 27.64 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.529 ' OE1' HG23 ' A' ' 20' ' ' THR . 71.1 mt-10 -83.71 -42.67 16.35 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.917 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.467 HD21 ' HG ' ' A' ' 167' ' ' LEU . 16.9 tp -55.98 -43.91 78.03 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.996 0.903 . . . . 0.0 108.917 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.621 ' HD1' HG11 ' A' ' 67' ' ' VAL . 11.8 t80 -51.41 -33.95 32.62 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.463 -1.699 . . . . 0.0 112.613 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 27.3 mt-10 -73.65 -17.07 61.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.69 2.71 21.64 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.393 0.616 . . . . 0.0 109.791 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.526 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.6 m-85 -117.08 161.61 19.14 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.364 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -139.06 -173.45 3.58 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.231 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.557 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER 60.6 86.07 0.1 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.35 0.595 . . . . 0.0 110.919 177.542 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -107.23 131.19 54.46 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.115 0.959 . . . . 0.0 112.368 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.483 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 15.3 ptt-85 -116.32 153.58 31.72 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.731 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -101.01 130.77 47.05 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -166.55 143.22 4.84 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.405 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 60.66 21.11 11.04 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 123.715 0.634 . . . . 0.0 110.928 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 36.7 mtm 71.59 20.06 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.417 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.457 HG12 ' HD2' ' A' ' 71' ' ' PRO . 5.1 m -134.9 -174.72 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -115.03 138.75 50.5 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-O 121.124 0.488 . . . . 0.0 110.534 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.483 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.2 t -128.52 124.83 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.33 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.444 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 18.5 ttm180 -114.04 127.45 55.94 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.557 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -130.66 144.41 51.41 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -173.789 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 43.5 tptt 82.16 111.77 0.03 OUTLIER Pre-proline 0 CA--C 1.518 -0.273 0 O-C-N 124.361 1.038 . . . . 0.0 111.232 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.605 ' HB2' HD13 ' A' ' 47' ' ' ILE . 62.0 Cg_endo -78.14 153.9 28.64 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.405 2.07 . . . . 0.0 112.282 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -85.81 -1.91 57.71 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.162 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -147.58 -165.9 2.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 32.7 tt0 -86.43 101.51 13.21 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.605 HD13 ' HB2' ' A' ' 43' ' ' PRO . 1.5 mp -116.33 116.01 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.194 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.48 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 26.1 mmtp -117.55 164.8 14.37 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.648 175.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.9 p -119.42 132.1 70.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.536 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.404 ' CD2' HD12 ' A' ' 9' ' ' LEU . 11.2 m-85 -84.62 118.59 24.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.17 0.509 . . . . 0.0 110.04 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.4 p -124.43 176.97 6.15 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.938 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.536 HG12 HD11 ' A' ' 176' ' ' ILE . 1.2 mm -130.3 138.2 54.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.588 0.709 . . . . 0.0 110.813 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.423 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 25.2 t70 -84.61 120.02 25.89 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.128 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.404 HD21 ' ND2' ' A' ' 174' ' ' ASN . 11.3 mt -67.33 -29.91 69.6 Favored 'General case' 0 CA--C 1.475 -1.933 0 CA-C-O 122.036 0.922 . . . . 0.0 112.048 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.423 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -81.81 -30.24 32.31 Favored 'General case' 0 C--N 1.263 -3.188 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.523 -171.548 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.7 p -114.54 -25.28 8.41 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.264 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.71 14.04 74.03 Favored Glycine 0 N--CA 1.427 -1.904 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.162 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.517 ' C ' HD13 ' A' ' 52' ' ' ILE . 41.5 mtpt -89.83 152.55 21.22 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -91.42 108.48 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.923 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.3 m -110.21 163.27 7.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.096 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.94 141.95 49.18 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.519 HG21 ' HB3' ' A' ' 170' ' ' LYS . 13.5 t -149.89 171.27 17.05 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.131 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.13 160.6 21.83 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 121.617 0.722 . . . . 0.0 111.197 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.2 mp -96.0 145.52 8.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.174 -178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.428 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 16.0 mm-40 -91.01 -37.97 13.12 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 p30 174.18 175.33 0.16 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.803 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.621 HG11 ' HD1' ' A' ' 25' ' ' TYR . 4.1 t -107.12 138.19 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.171 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.629 HD12 ' HB2' ' A' ' 166' ' ' SER . 35.7 mt -101.44 109.74 26.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.045 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.402 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 8.2 ttpm? -120.88 112.4 18.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.87 137.37 30.63 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.295 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.457 ' HD2' HG12 ' A' ' 37' ' ' VAL . 71.2 Cg_exo -48.17 131.7 22.39 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.454 2.769 . . . . 0.0 113.275 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.11 93.18 9.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.227 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 p -89.7 -24.9 21.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.04 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -110.97 -169.99 1.56 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.801 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.575 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 28.0 m170 -115.28 171.21 7.84 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.728 HD23 ' HA ' ' A' ' 90' ' ' THR . 5.9 mt -121.32 148.27 44.56 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.966 0.888 . . . . 0.0 112.762 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.485 HD12 ' C ' ' A' ' 108' ' ' ALA . 27.7 mt -85.55 143.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.576 172.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 12.5 ttt85 -116.5 137.99 51.74 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-O 121.126 0.489 . . . . 0.0 110.157 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 86' ' ' SER . 58.5 m-85 -114.36 122.32 46.31 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.622 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 152' ' ' LYS . 23.1 tt0 -112.51 123.02 49.36 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.75 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.3 mm? -86.2 160.39 19.21 Favored 'General case' 0 N--CA 1.403 -2.775 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.218 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.743 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.4 pt-20 -64.74 -13.27 54.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.848 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -97.54 -8.52 28.92 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.538 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.56 10.58 57.88 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.082 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.587 ' O ' HD23 ' A' ' 81' ' ' LEU . 4.7 mtt180 -81.59 136.85 35.56 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 48.4 p -140.6 143.12 35.08 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.685 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.437 ' CD1' HD13 ' A' ' 181' ' ' ILE . 7.7 p90 -138.17 145.61 41.73 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.573 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 49.0 mt-10 -117.19 146.29 43.32 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.352 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.3 p -142.78 153.86 43.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.733 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.728 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.88 10.28 0.93 Allowed 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.06 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.9 m 63.66 161.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 123.475 0.71 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 107' ' ' ARG . 33.9 t70 73.28 -30.61 0.21 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.124 0.488 . . . . 0.0 110.918 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.469 ' H ' ' C ' ' A' ' 91' ' ' VAL . 97.6 m-70 -68.28 132.87 91.47 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.249 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.75 115.76 4.37 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.361 2.707 . . . . 0.0 114.901 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 18.3 t -94.74 149.19 4.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 103' ' ' PHE . 1.1 tm? -103.08 118.58 37.11 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.0 0.428 . . . . 0.0 111.937 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.704 HG13 HG13 ' A' ' 104' ' ' ILE . 2.3 p -118.45 147.87 21.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.93 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.523 ' CD2' HD12 ' A' ' 148' ' ' LEU . 88.4 t80 -103.86 98.62 8.44 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.775 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 10.3 pt-20 -147.64 158.56 44.06 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.3 m-20 65.04 22.6 12.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.239 0.542 . . . . 0.0 109.866 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.66 12.14 55.69 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.66 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -132.13 172.84 11.89 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.552 0.691 . . . . 0.0 109.791 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.562 ' HB3' HD11 ' A' ' 96' ' ' LEU . 20.3 m-85 -103.1 121.2 42.12 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.464 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.704 HG13 HG13 ' A' ' 97' ' ' VAL . 24.4 pt -122.05 148.77 25.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.522 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 26.9 mt-10 -104.94 118.43 36.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.81 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.471 ' HB2' HG22 ' A' ' 111' ' ' VAL . 90.1 mttt -119.93 132.6 55.57 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.581 ' O ' HG23 ' A' ' 111' ' ' VAL . 65.3 mtt180 -60.03 158.3 11.27 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.06 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -56.59 -45.66 81.25 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.87 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -75.32 9.98 1.83 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.411 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -119.35 -20.57 7.83 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.201 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 107' ' ' ARG . 92.5 t -73.55 146.58 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.71 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 70.6 mmtt -119.75 170.77 8.92 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.719 -177.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.58 141.77 53.7 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.646 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.95 4.43 84.61 Favored Glycine 0 N--CA 1.425 -2.046 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.829 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.71 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -76.26 165.43 24.88 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.434 ' HE3' ' HG3' ' A' ' 150' ' ' GLU . 31.3 mttp -117.91 164.82 14.48 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.54 0.686 . . . . 0.0 110.819 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.0 159.75 42.9 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.76 133.66 34.17 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.3 OUTLIER -116.61 138.13 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.024 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.26 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 180' ' ' ASN . 4.8 p . . . . . 0 C--N 1.284 -2.254 0 CA-C-O 121.44 0.638 . . . . 0.0 110.412 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.523 HD12 ' CD2' ' A' ' 98' ' ' TYR . 13.8 mt . . . . . 0 N--CA 1.424 -1.755 0 CA-C-O 121.404 0.621 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.75 ' HB3' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -111.08 137.06 49.2 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.913 -1.039 . . . . 0.0 113.516 -171.628 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.434 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 23.3 mt-10 -91.18 146.34 23.92 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.91 176.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.429 HG21 ' CG1' ' A' ' 154' ' ' ILE . 66.6 mt -81.02 107.79 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.921 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.545 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 27.7 mmtt -64.68 -42.84 95.07 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.368 175.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -148.29 132.5 17.4 Favored 'General case' 0 CA--C 1.473 -1.995 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 84.2 mt -117.24 125.1 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.01 172.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.42 ' CD ' ' HD3' ' A' ' 78' ' ' ARG . 19.5 ptpt -128.89 163.86 24.35 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.006 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.467 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 12.5 m-85 -101.0 110.96 23.05 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.575 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -116.02 176.38 2.45 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.768 -178.369 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.531 ' HA ' ' HB3' ' A' ' 75' ' ' HIS . 31.5 mtm180 -82.66 -142.83 0.06 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-O 121.787 0.803 . . . . 0.0 112.192 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.43 ' H ' ' HB3' ' A' ' 158' ' ' ARG . . . -133.24 128.01 34.96 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -83.82 21.3 1.3 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -173.2 -178.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -104.78 8.42 34.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.374 0.607 . . . . 0.0 109.734 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -143.24 155.87 44.61 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.412 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 3' ' ' PRO . 7.0 m -129.82 160.92 40.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.432 176.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 67.9 m-85 -132.55 170.46 15.14 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.471 -176.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.629 ' HB2' HD12 ' A' ' 68' ' ' ILE . 1.4 m -155.76 -28.2 0.1 Allowed 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' A' ' 67' ' ' VAL . 1.3 tm? 71.32 107.04 0.06 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.742 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -86.27 115.09 23.59 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.64 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.456 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -135.29 -166.16 1.8 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.519 ' HB3' HG21 ' A' ' 62' ' ' THR . 23.9 tptm . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.404 ' ND2' HD21 ' A' ' 54' ' ' LEU . 27.0 t-20 . . . . . 0 CA--C 1.508 -0.639 0 CA-C-O 120.622 0.248 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.569 HG23 HG23 ' A' ' 177' ' ' ILE . 29.8 m -139.49 178.59 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.808 0 CA-C-O 122.47 1.128 . . . . 0.0 112.501 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.536 HD11 HG12 ' A' ' 52' ' ' ILE . 87.6 mt -117.59 114.27 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 CA-C-N 112.532 -2.122 . . . . 0.0 108.48 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.569 HG23 HG23 ' A' ' 175' ' ' VAL . 35.9 pt -120.76 168.04 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.746 0 CA-C-O 120.963 0.411 . . . . 0.0 112.076 -174.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.457 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 2.1 t-20 48.69 -133.23 1.46 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.966 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.415 ' H ' ' CG ' ' A' ' 178' ' ' ASN . 0.8 OUTLIER -80.81 56.27 2.65 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 121.314 0.578 . . . . 0.0 109.932 174.698 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.669 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 12.8 m120 66.89 42.39 2.52 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.892 1.277 . . . . 0.0 114.256 175.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.437 HD13 ' CD1' ' A' ' 87' ' ' PHE . 92.8 mt -86.85 119.08 34.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 70.0 t -92.47 129.28 43.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.814 -176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.31 -1.143 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.844 178.874 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 . . . . . 0 CA--C 1.51 -0.563 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.427 ' HD3' HD13 ' A' ' 76' ' ' LEU . 53.5 Cg_endo -65.81 158.16 55.22 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 N-CA-C 108.639 -1.331 . . . . 0.0 108.639 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' A' ' 165' ' ' PHE . . . -59.31 -22.83 56.86 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 119.077 -1.535 . . . . 0.0 111.887 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -71.31 -1.75 13.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.561 ' HB ' HD12 ' A' ' 21' ' ' LEU . 94.9 m -71.82 128.57 36.19 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.639 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 13.9 mtm-85 -85.58 131.0 34.44 Favored 'General case' 0 C--O 1.18 -2.576 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.414 ' CD1' HG21 ' A' ' 175' ' ' VAL . 8.4 tt -120.22 131.14 73.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' A' ' 18' ' ' LYS . 2.0 tm? -89.46 123.23 33.39 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-O 121.491 0.662 . . . . 0.0 110.077 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.0 m -133.14 -174.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.29 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 31.5 tt0 -133.19 123.69 26.07 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.629 HG12 HG13 ' A' ' 47' ' ' ILE . 23.1 mt -121.23 121.69 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.748 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.811 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 52.95 39.09 28.69 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.458 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.74 17.27 80.05 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.749 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.94 115.39 22.13 Favored Pre-proline 0 N--CA 1.438 -1.064 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 13.1 Cg_exo -64.4 124.02 12.69 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.277 1.985 . . . . 0.0 111.262 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -122.37 134.97 54.62 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.456 ' HB2' HD23 ' A' ' 9' ' ' LEU . 40.2 ttmt -106.59 101.25 10.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.1 pt -123.54 -173.58 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.744 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.791 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 20.4 p -97.11 168.65 10.32 Favored 'General case' 0 C--N 1.281 -2.378 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.725 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 66.1 mt -64.83 -29.7 70.67 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.791 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.5 ptm180 -77.04 -26.37 53.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.514 ' OE1' HG23 ' A' ' 20' ' ' THR . 62.7 mt-10 -84.66 -42.55 15.22 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.957 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.706 HD21 HD22 ' A' ' 167' ' ' LEU . 18.2 tp -57.5 -44.12 84.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-O 121.952 0.882 . . . . 0.0 110.145 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.654 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.5 m-30 -60.41 -23.86 64.7 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 113.747 -1.569 . . . . 0.0 113.188 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -79.88 -12.87 59.72 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.95 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.4 mm? -79.22 3.78 16.86 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.521 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.7 m-85 -118.49 164.72 14.86 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.226 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.573 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 38.0 mt-10 -136.4 -173.48 3.42 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.952 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.41 81.63 0.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.39 0.614 . . . . 0.0 111.55 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -98.65 120.4 39.02 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.783 0.801 . . . . 0.0 110.621 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -106.28 149.73 26.62 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 114.009 -1.451 . . . . 0.0 109.976 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.504 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 19.2 t80 -106.56 130.35 54.34 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.474 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 37' ' ' VAL . 6.8 tp10 -167.53 141.42 3.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.849 -176.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.4 m120 56.48 23.58 7.66 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 123.452 0.47 . . . . 0.0 111.865 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.504 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 43.8 mtm 72.07 17.57 5.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.88 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.516 HG12 ' HD2' ' A' ' 71' ' ' PRO . 4.8 m -127.32 -175.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -126.77 147.64 49.98 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.307 0.575 . . . . 0.0 110.603 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -131.47 124.0 53.75 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.007 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.801 ' HB3' HG22 ' A' ' 67' ' ' VAL . 38.1 ttm180 -115.41 126.23 54.12 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -133.43 146.76 51.48 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.463 -174.562 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 88.9 mttt 86.46 111.75 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.673 0 C-N-CA 125.183 1.393 . . . . 0.0 111.75 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.527 ' HB2' HD13 ' A' ' 47' ' ' ILE . 83.5 Cg_endo -79.72 147.73 19.7 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.527 2.151 . . . . 0.0 111.191 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.573 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 29.3 mtmt -81.75 -6.64 59.23 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -145.91 -164.98 2.08 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.1 tp10 -85.75 99.83 11.61 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.629 HG13 HG12 ' A' ' 12' ' ' ILE . 1.7 mp -115.97 117.37 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.952 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.538 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 25.0 mmtt -116.37 167.14 11.3 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.393 174.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.492 HG11 ' CB ' ' A' ' 169' ' ' ALA . 13.0 p -121.45 130.23 74.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.133 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -85.14 120.61 26.83 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.2 m -133.79 173.24 11.75 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.017 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.485 HG12 HD11 ' A' ' 176' ' ' ILE . 2.4 mm -115.61 142.57 28.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.223 0.535 . . . . 0.0 110.151 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.416 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 38.8 t0 -80.75 130.85 35.31 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.591 HD12 ' N ' ' A' ' 54' ' ' LEU . 4.1 mp -77.9 -25.63 48.58 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.973 0.892 . . . . 0.0 110.811 -172.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.34 -32.6 16.42 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.93 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' HB3' ' A' ' 53' ' ' ASP . 57.8 p -111.84 -20.21 12.13 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.522 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.66 12.18 84.65 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.742 177.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.455 ' C ' HD13 ' A' ' 52' ' ' ILE . 3.6 mtpm? -89.86 160.58 16.4 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.953 0.406 . . . . 0.0 112.069 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.45 110.18 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 CA-C-O 121.89 0.852 . . . . 0.0 110.009 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.5 m -111.13 163.8 7.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 49' ' ' VAL . 13.6 tp -123.74 141.97 51.52 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.42 ' OG1' ' HB2' ' A' ' 170' ' ' LYS . 14.3 t -151.05 172.21 16.09 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.91 0.386 . . . . 0.0 111.57 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.05 160.58 25.77 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.715 0.769 . . . . 0.0 110.993 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.567 HD13 HG22 ' A' ' 47' ' ' ILE . 2.1 mp -100.7 136.82 30.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.908 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 5.2 mm-40 -82.93 -38.28 23.03 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 p30 177.56 -179.2 0.23 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.303 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.801 HG22 ' HB3' ' A' ' 40' ' ' ARG . 2.9 m -116.82 145.26 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-O 121.124 0.488 . . . . 0.0 110.067 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' A' ' 166' ' ' SER . 56.8 mt -99.28 107.67 21.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.076 -173.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.455 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 76.8 tttt -116.08 107.42 14.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.6 137.65 30.89 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.141 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.516 ' HD2' HG12 ' A' ' 37' ' ' VAL . 77.5 Cg_exo -47.52 136.23 20.65 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 123.205 2.603 . . . . 0.0 112.688 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.66 102.7 0.47 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 m -60.44 -55.83 28.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.071 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.45 -138.7 0.11 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.301 -176.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -97.38 171.12 8.6 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.719 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.0 mt -124.19 140.54 52.86 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.928 0.87 . . . . 0.0 111.513 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 88' ' ' GLU . 40.0 mt -87.98 142.11 13.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.872 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 12.9 ttt180 -119.45 138.47 53.1 Favored 'General case' 0 N--CA 1.406 -2.651 0 CA-C-O 121.234 0.54 . . . . 0.0 109.655 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.606 ' O ' ' HA ' ' A' ' 86' ' ' SER . 58.1 m-85 -114.68 125.99 54.37 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.442 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 152' ' ' LYS . 36.8 tt0 -109.73 123.99 50.47 Favored 'General case' 0 CA--C 1.473 -2.013 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.753 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -89.34 162.5 15.78 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.994 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.901 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.1 pt-20 -63.88 -18.29 64.03 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.889 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -93.37 -7.29 45.14 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.531 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.57 13.22 57.3 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.045 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.571 ' O ' HD23 ' A' ' 81' ' ' LEU . 2.0 mtt180 -82.07 139.07 34.66 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 20.6 p -141.27 140.0 33.8 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 118.889 -1.125 . . . . 0.0 112.449 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -136.67 141.34 43.15 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.657 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 1.7 mp0 -109.61 148.1 31.89 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.779 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.73 ' HB ' ' NE2' ' A' ' 93' ' ' HIS . 3.5 p -137.02 149.14 47.28 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.139 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.719 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -73.44 7.62 2.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.075 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.5 m 59.81 169.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 122.911 0.484 . . . . 0.0 110.98 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.604 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 33.4 t70 73.11 -41.26 0.5 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.063 0.459 . . . . 0.0 111.35 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.73 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 8.6 p80 -75.69 148.59 82.64 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 7.0 Cg_exo -74.58 142.19 28.98 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.126 2.551 . . . . 0.0 114.534 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 23.6 t -111.99 154.3 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.514 1.526 . . . . 0.0 107.274 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.3 tp -106.49 113.45 26.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.841 0.746 . . . . 0.0 112.424 -176.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.647 HG13 HG13 ' A' ' 104' ' ' ILE . 2.4 p -113.39 153.64 14.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 111.808 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -108.48 95.61 5.78 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.989 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 6.6 pt-20 -143.76 159.19 42.95 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 4.0 m-20 66.84 22.74 10.17 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.228 0.537 . . . . 0.0 109.644 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.61 12.86 57.66 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.771 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -134.21 172.41 12.9 Favored 'General case' 0 N--CA 1.403 -2.815 0 CA-C-O 121.201 0.524 . . . . 0.0 109.807 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -100.68 121.69 42.06 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.647 HG13 HG13 ' A' ' 97' ' ' VAL . 25.9 pt -121.13 157.52 24.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.622 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 21.3 mt-10 -114.18 110.02 19.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.959 0.409 . . . . 0.0 111.666 -176.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.419 ' HE3' ' CD1' ' A' ' 104' ' ' ILE . 88.1 mttt -113.97 140.01 48.77 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 92' ' ' ASP . 6.5 mpt_? -60.8 154.79 21.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.075 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -56.63 -45.86 81.28 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.827 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.482 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 2.6 p90 -71.99 3.03 4.75 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.342 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -115.26 -16.34 11.52 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.358 0.599 . . . . 0.0 110.131 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 107' ' ' ARG . 70.0 t -74.51 145.09 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 31.6 mmtp -119.74 172.6 7.57 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.401 0.619 . . . . 0.0 111.689 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -70.9 138.31 50.04 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.393 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.51 5.59 74.99 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.924 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.842 ' HB3' HD12 ' A' ' 151' ' ' ILE . 8.1 t70 -71.27 170.17 13.64 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.739 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 48.2 mttp -127.85 155.72 43.68 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.758 0.79 . . . . 0.0 112.733 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.51 157.52 41.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.584 172.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.611 ' HA ' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -95.15 134.14 38.2 Favored 'General case' 0 CA--C 1.479 -1.784 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.6 OUTLIER -107.33 124.45 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.828 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.742 175.177 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.398 -3.044 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 176.958 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.739 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.7 mm? . . . . . 0 CA--C 1.483 -1.614 0 CA-C-O 121.065 0.459 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.901 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -114.26 134.68 54.76 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.996 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 8.5 mt-10 -86.82 142.79 27.83 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.155 177.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.842 HD12 ' HB3' ' A' ' 115' ' ' ASP . 80.6 mt -80.46 103.15 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.329 174.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.485 ' HG3' ' CA ' ' A' ' 82' ' ' GLU . 29.9 mtmt -61.1 -44.37 97.46 Favored 'General case' 0 C--N 1.274 -2.715 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.226 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -150.45 136.53 18.54 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 77.7 mt -113.92 145.37 19.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.885 174.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -150.44 160.14 43.97 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.214 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -100.27 113.17 25.66 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.02 134.73 65.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.358 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.427 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 32.2 ttp180 -66.25 151.71 46.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' A' ' 158' ' ' ARG . . . -67.29 127.77 33.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.898 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -79.84 -24.89 41.01 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.191 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -110.36 -178.35 3.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.17 -7.82 18.8 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.035 0.445 . . . . 0.0 110.01 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -134.24 160.26 38.4 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.24 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.03 155.2 41.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.654 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 19.6 m-85 -132.88 169.07 17.29 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.741 -172.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.602 ' HB2' HD12 ' A' ' 68' ' ' ILE . 19.3 m -155.55 -28.13 0.1 Allowed 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.706 HD22 HD21 ' A' ' 24' ' ' LEU . 15.4 tp 73.29 116.95 0.05 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.417 1.087 . . . . 0.0 111.618 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -91.8 109.33 20.66 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.46 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.492 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -129.6 -165.02 1.47 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.372 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.42 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 46.4 mmtt . . . . . 0 CA--C 1.489 -1.392 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.218 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 CA--C 1.522 -0.125 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.619 HG13 HG23 ' A' ' 177' ' ' ILE . 1.3 p -166.32 166.67 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.485 HD11 HG12 ' A' ' 52' ' ' ILE . 97.2 mt -117.14 113.04 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.81 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.619 HG23 HG13 ' A' ' 175' ' ' VAL . 40.3 pt -123.19 171.37 12.25 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.521 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.237 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 7' ' ' ARG . 8.0 t-20 50.49 -129.46 2.2 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.431 1.092 . . . . 0.0 110.128 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.69 43.95 0.95 Allowed 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.439 0.637 . . . . 0.0 110.22 175.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.604 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.4 m-20 72.89 47.75 0.2 Allowed 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 114.081 -1.418 . . . . 0.0 112.92 176.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 81.3 mt -88.82 115.09 28.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.065 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 118' ' ' LEU . 2.6 m -76.33 156.21 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--N 1.286 -2.156 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.786 -179.275 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 76' ' ' LEU . 51.8 Cg_endo -66.15 156.51 64.39 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 N-CA-C 108.532 -1.372 . . . . 0.0 108.532 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.09 -22.56 49.69 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.531 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.45 -19.78 66.08 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.203 0.525 . . . . 0.0 112.186 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.441 ' HB ' HD12 ' A' ' 21' ' ' LEU . 91.9 m -59.61 128.09 35.25 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.771 -176.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 65.5 mmt-85 -81.34 133.34 35.41 Favored 'General case' 0 C--O 1.194 -1.856 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.78 HD11 HG21 ' A' ' 175' ' ' VAL . 8.1 tt -121.66 131.88 72.08 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.728 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -89.01 124.21 34.06 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.511 0.672 . . . . 0.0 109.987 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.9 m -135.11 -176.38 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.378 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -134.04 124.62 26.53 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.047 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.59 HG12 HG13 ' A' ' 47' ' ' ILE . 21.0 mt -120.55 119.46 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.026 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 52.62 44.45 30.08 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.744 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.2 75.5 Favored Glycine 0 C--N 1.307 -1.057 0 CA-C-N 114.704 -1.135 . . . . 0.0 114.256 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.9 t -124.76 119.94 25.71 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-O 121.137 0.494 . . . . 0.0 109.769 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 56.8 Cg_endo -73.71 124.03 8.96 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.326 2.018 . . . . 0.0 111.74 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -123.26 146.27 48.0 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.47 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -114.51 100.23 8.14 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.258 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.9 pt -123.05 -174.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.929 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.671 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 10.9 p -92.99 172.21 8.46 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.234 -0.987 . . . . 0.0 109.088 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 70.4 mt -66.83 -30.49 70.68 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.256 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.671 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 5.7 ptm180 -80.11 -25.01 40.13 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.544 ' OE1' HG23 ' A' ' 20' ' ' THR . 78.8 mt-10 -83.58 -39.6 20.15 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.1 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.52 HD21 ' HG ' ' A' ' 167' ' ' LEU . 13.9 tp -57.52 -44.49 85.11 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.46 ' HD1' HG11 ' A' ' 67' ' ' VAL . 18.8 t80 -49.79 -35.62 23.25 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.414 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 26.8 mt-10 -72.95 -17.84 61.44 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.58 0.06 31.53 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.594 0.712 . . . . 0.0 109.589 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.601 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 95.2 m-85 -113.67 161.3 17.63 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.297 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -133.89 -174.71 3.61 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.803 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 14.8 t0 60.28 87.56 0.09 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.549 0.69 . . . . 0.0 111.444 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 26.2 tt0 -104.02 128.97 51.62 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.253 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.642 ' HG2' HG13 ' A' ' 39' ' ' VAL . 1.7 ptm180 -109.8 150.06 28.92 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.611 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -116.9 122.97 45.86 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.42 0.629 . . . . 0.0 110.166 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -167.34 154.38 8.55 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.243 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 61.63 16.98 8.2 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 123.685 0.615 . . . . 0.0 110.707 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.9 mtm 69.77 19.58 7.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.06 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.489 HG12 ' HD2' ' A' ' 71' ' ' PRO . 12.4 m -128.54 -179.67 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.489 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 97.1 m-85 -120.26 142.18 49.28 Favored 'General case' 0 CA--C 1.478 -1.803 0 CA-C-O 121.44 0.638 . . . . 0.0 109.993 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.642 HG13 ' HG2' ' A' ' 32' ' ' ARG . 1.1 m -135.19 127.7 47.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.336 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.587 ' O ' HG23 ' A' ' 67' ' ' VAL . 16.1 ttm180 -119.68 127.55 52.99 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -133.45 145.09 49.93 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.963 -174.706 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 12.8 tmtt? 86.73 112.22 0.03 OUTLIER Pre-proline 0 CA--C 1.516 -0.336 0 O-C-N 124.649 1.218 . . . . 0.0 109.963 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.55 ' HB2' HD13 ' A' ' 47' ' ' ILE . 73.2 Cg_endo -80.48 151.48 19.9 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 122.211 1.941 . . . . 0.0 112.269 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -86.17 -0.09 54.88 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.194 0.521 . . . . 0.0 110.976 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -150.68 -165.83 2.38 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 33.0 tt0 -83.92 101.41 11.67 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.601 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.4 mp -115.74 117.67 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.227 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -117.72 165.85 13.14 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.266 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.556 HG11 ' CB ' ' A' ' 169' ' ' ALA . 9.9 p -120.45 133.57 66.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.234 -177.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.414 ' CD2' HD12 ' A' ' 9' ' ' LEU . 6.6 m-85 -85.87 125.27 33.18 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.096 175.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.9 m -136.86 142.36 42.81 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.179 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.439 HG12 HD11 ' A' ' 176' ' ' ILE . 2.9 mm -92.26 140.03 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.936 0 CA-C-O 121.479 0.657 . . . . 0.0 110.725 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.43 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 10.7 t0 -83.79 114.04 21.34 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.74 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -75.39 -4.78 41.4 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.685 0.755 . . . . 0.0 111.811 -169.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -102.42 -34.02 9.32 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.114 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 53' ' ' ASP . 81.0 p -111.29 -19.78 12.52 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.634 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.88 12.71 80.87 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.836 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -92.24 156.52 17.24 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.178 0.513 . . . . 0.0 112.284 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.92 106.02 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.006 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.589 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 m -109.46 162.55 7.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.77 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 49' ' ' VAL . 12.3 tp -122.32 140.87 52.15 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.014 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.5 t -147.52 172.61 13.7 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.782 0.325 . . . . 0.0 111.338 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.16 162.61 25.66 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.839 0.828 . . . . 0.0 111.397 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.549 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.5 mp -99.07 145.71 9.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.812 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.48 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 31.4 mm-40 -91.27 -38.59 12.57 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 175.62 177.37 0.2 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.672 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 40' ' ' ARG . 5.5 t -106.58 129.43 60.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.894 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' A' ' 166' ' ' SER . 55.3 mt -91.49 111.75 24.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.814 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 83.2 tttt -127.56 112.25 14.69 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.12 135.08 25.92 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.148 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.489 ' HD2' HG12 ' A' ' 37' ' ' VAL . 80.7 Cg_exo -44.71 130.05 9.54 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.671 2.914 . . . . 0.0 113.535 177.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.41 116.44 28.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.147 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -123.0 -65.83 1.07 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.367 0.876 . . . . 0.0 113.367 -176.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -57.58 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -177.14 172.44 1.93 Allowed 'General case' 0 CA--C 1.461 -2.474 0 CA-C-O 120.992 0.425 . . . . 0.0 111.46 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.794 HD23 ' HA ' ' A' ' 90' ' ' THR . 10.7 mt -131.65 141.75 49.68 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.735 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.536 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 22.7 mt -87.69 142.37 13.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 11.3 ttt85 -115.28 137.31 52.17 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.177 0.513 . . . . 0.0 109.884 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 86' ' ' SER . 64.1 m-85 -114.87 121.19 42.45 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.861 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 152' ' ' LYS . 35.3 tt0 -109.08 120.77 43.53 Favored 'General case' 0 CA--C 1.47 -2.133 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -85.9 159.96 19.53 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.172 -177.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.778 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -59.71 -19.16 48.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.325 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -92.37 -8.26 45.44 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.091 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.44 15.74 49.29 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.523 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.545 ' O ' HD23 ' A' ' 81' ' ' LEU . 3.9 mtt180 -83.83 138.57 33.15 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 35.6 p -141.85 139.91 32.78 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 118.485 -1.286 . . . . 0.0 112.296 175.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -135.23 146.93 49.1 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.948 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 21.5 mt-10 -119.22 147.68 43.97 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.348 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.428 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -138.76 154.01 48.49 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.595 -179.203 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.794 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.98 11.58 0.67 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.362 0.601 . . . . 0.0 112.057 -177.325 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.116 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.2 m 68.24 -26.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.021 1.328 . . . . 0.0 113.422 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 90' ' ' THR . 5.0 p-10 -83.34 -1.17 52.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.983 0.42 . . . . 0.0 110.658 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 20.9 m80 -110.63 137.06 20.64 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.477 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 24.0 Cg_exo -65.48 134.18 37.51 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.236 2.624 . . . . 0.0 113.424 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.578 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.2 t -103.58 150.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 tp -107.75 113.76 27.24 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.819 0.342 . . . . 0.0 111.878 -176.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.604 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.3 p -113.21 151.6 15.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.26 0.552 . . . . 0.0 111.592 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.465 ' CD2' HD12 ' A' ' 148' ' ' LEU . 61.4 t80 -105.13 93.54 4.75 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.294 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 8.5 pt-20 -141.76 158.41 43.85 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 11.2 m120 63.5 23.22 13.56 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.147 0.499 . . . . 0.0 109.993 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.23 12.02 54.01 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.0 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -133.29 172.31 12.86 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 121.279 0.561 . . . . 0.0 109.914 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -101.76 120.63 40.67 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.567 HG13 HG13 ' A' ' 97' ' ' VAL . 23.1 pt -116.38 152.53 18.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.875 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -109.37 112.57 24.77 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.792 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.502 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 12.6 ptpt -130.15 133.95 46.98 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.598 ' O ' HG23 ' A' ' 111' ' ' VAL . 60.5 mtm180 -67.42 163.18 21.43 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.116 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -56.6 -45.45 81.42 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.976 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.505 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.9 p90 -71.86 2.81 4.92 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.515 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.501 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 12.9 tp10 -117.15 -16.05 10.44 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.397 0.618 . . . . 0.0 110.044 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 107' ' ' ARG . 89.4 t -73.97 148.88 8.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.674 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 23.0 mmtp -119.17 169.8 9.63 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.337 0.589 . . . . 0.0 110.537 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -76.21 144.42 40.45 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.551 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.38 4.59 80.44 Favored Glycine 0 C--N 1.308 -1.011 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.15 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.674 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -76.91 167.33 22.0 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.468 ' H ' HG23 ' A' ' 97' ' ' VAL . 28.1 mttp -121.87 166.67 14.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.288 0.566 . . . . 0.0 110.558 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.22 160.57 41.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.98 135.14 34.43 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.1 OUTLIER -100.49 149.98 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.716 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.489 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.454 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 43.5 t . . . . . 0 C--N 1.308 -1.234 0 CA-C-O 120.825 0.345 . . . . 0.0 110.797 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.465 HD12 ' CD2' ' A' ' 98' ' ' TYR . 14.5 mt . . . . . 0 N--CA 1.429 -1.501 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.778 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -114.97 138.89 50.32 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -171.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.464 ' H ' HD13 ' A' ' 149' ' ' LEU . 25.1 mt-10 -89.79 146.43 24.47 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 124.672 1.189 . . . . 0.0 113.018 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' A' ' 79' ' ' PHE . 64.3 mt -80.15 107.57 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.266 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 80' ' ' GLU . 62.2 mmtt -68.89 -38.98 80.0 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.889 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -150.63 131.86 14.5 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 74.8 mt -116.98 130.21 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.385 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.481 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 19.3 ptpt -136.46 166.76 22.75 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.516 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.536 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 20.7 m-85 -100.63 115.36 30.01 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.946 173.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.1 133.19 68.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.103 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 21.5 ttm-85 -70.87 155.22 41.06 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.068 0.461 . . . . 0.0 111.072 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.21 113.71 7.66 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.063 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -71.17 -18.68 62.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.567 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -98.9 166.57 11.23 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.953 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -94.28 -6.44 44.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.029 0.443 . . . . 0.0 109.929 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -144.0 150.41 38.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.781 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 4.3 m -119.29 155.8 21.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.551 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 50.0 m-85 -130.86 173.59 10.81 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 110.199 -0.296 . . . . 0.0 110.199 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.581 ' HB2' HD12 ' A' ' 68' ' ' ILE . 68.5 m -159.23 -24.49 0.07 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.52 ' HG ' HD21 ' A' ' 24' ' ' LEU . 1.5 tm? 68.68 112.46 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.769 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -90.82 113.26 25.37 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.112 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.556 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -133.94 -173.32 3.22 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.915 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.156 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.6 t30 . . . . . 0 N--CA 1.444 -0.774 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.78 HG21 HD11 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -159.95 158.43 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 120.827 0.346 . . . . 0.0 110.785 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.699 HG23 ' HA ' ' A' ' 180' ' ' ASN . 2.5 mp -93.08 115.34 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.867 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.489 HG23 HG13 ' A' ' 175' ' ' VAL . 45.1 pt -121.48 171.51 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-O 120.985 0.422 . . . . 0.0 111.586 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.439 ' HB3' HD12 ' A' ' 181' ' ' ILE . 5.4 t-20 46.71 -127.19 1.54 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 124.16 0.984 . . . . 0.0 110.777 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.498 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 29.3 mt-10 -91.5 55.63 2.82 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.745 0.784 . . . . 0.0 109.466 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.736 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 21.7 m-80 70.2 44.56 0.75 Allowed 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 113.74 -1.573 . . . . 0.0 113.6 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 178' ' ' ASN . 85.1 mt -92.39 117.65 36.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.0 m -93.45 160.73 2.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.578 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 9.7 t . . . . . 0 C--N 1.306 -1.309 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.132 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.48 ' CE1' HD13 ' A' ' 177' ' ' ILE . 93.3 m-85 . . . . . 0 N--CA 1.446 -0.641 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.47 ' HA ' HG12 ' A' ' 164' ' ' VAL . 18.2 Cg_endo -59.02 -26.92 83.49 Favored 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 122.592 2.195 . . . . 0.0 112.481 -175.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.19 -38.65 2.69 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -69.08 -1.34 7.42 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.802 -0.699 . . . . 0.0 111.514 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 28.9 m -69.69 128.25 35.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.1 mtm-85 -83.77 132.6 34.82 Favored 'General case' 0 C--O 1.186 -2.259 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.722 HD11 HG21 ' A' ' 175' ' ' VAL . 10.7 tt -122.74 131.38 73.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-O 121.017 0.437 . . . . 0.0 110.623 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.422 HD23 ' HB2' ' A' ' 18' ' ' LYS . 1.6 tm? -90.77 123.47 34.37 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-O 121.504 0.669 . . . . 0.0 109.447 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 18.8 m -133.83 -175.46 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.5 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 32.1 tt0 -129.29 120.8 26.28 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.627 HG12 HG13 ' A' ' 47' ' ' ILE . 14.5 mt -122.44 122.7 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.868 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.864 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 56.14 35.98 26.62 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.859 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.1 17.29 78.62 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.215 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.35 114.55 25.65 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.604 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 7.6 Cg_exo -64.86 125.17 14.28 Favored 'Trans proline' 0 N--CA 1.44 -1.656 0 C-N-CA 122.129 1.886 . . . . 0.0 111.356 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -122.14 140.39 52.61 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.452 ' HD3' ' NH2' ' A' ' 7' ' ' ARG . 39.0 ttmt -108.52 100.28 9.57 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.6 pt -124.4 -171.93 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.179 -2.63 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.767 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.713 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 21.3 p -94.91 170.98 9.04 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.776 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 10.6 mt -73.96 -20.64 60.3 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.006 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.713 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 13.2 ptm180 -84.58 -25.28 28.76 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.449 ' O ' HD23 ' A' ' 27' ' ' LEU . 52.4 mm-40 -84.64 -44.17 13.71 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.394 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.569 ' CD2' HD22 ' A' ' 167' ' ' LEU . 16.4 tp -57.19 -44.0 83.21 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.927 0.87 . . . . 0.0 110.004 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.44 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -56.09 -24.25 39.03 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.849 -179.144 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -84.41 -12.15 54.95 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.876 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -80.32 5.6 14.33 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.601 0.715 . . . . 0.0 109.466 177.383 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.619 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 95.9 m-85 -119.43 167.13 12.23 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.075 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.565 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 9.4 mt-10 -140.34 -173.56 3.71 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.473 174.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 6.0 t0 62.5 83.42 0.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.237 0.542 . . . . 0.0 110.8 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -107.63 129.44 55.0 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.849 0.833 . . . . 0.0 111.257 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.7 ptm180 -124.1 156.48 36.53 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.892 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -107.46 125.52 51.36 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -164.67 148.22 8.97 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.56 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 62.2 19.22 10.78 Favored 'General case' 0 CA--C 1.496 -1.106 0 O-C-N 123.557 0.536 . . . . 0.0 110.302 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.2 mtt 72.17 17.71 4.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.468 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 m -132.77 -178.48 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -115.05 140.72 48.83 Favored 'General case' 0 CA--C 1.478 -1.796 0 CA-C-O 121.257 0.551 . . . . 0.0 110.188 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.404 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.8 t -127.63 123.91 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.3 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.199 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.525 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 38.9 ttm180 -116.96 126.78 53.45 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -132.22 147.08 52.4 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.681 -0.808 . . . . 0.0 113.155 -176.225 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 54.4 mttp 82.29 111.61 0.03 OUTLIER Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.482 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.542 ' HB2' HD13 ' A' ' 47' ' ' ILE . 66.4 Cg_endo -77.28 151.95 30.27 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 122.688 2.259 . . . . 0.0 111.59 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 31.1 mtmt -83.28 -3.62 57.63 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.563 0.697 . . . . 0.0 110.427 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 45' ' ' ARG . 47.1 mtt180 -144.48 -164.62 1.95 Allowed 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 32.1 tt0 -88.6 100.07 12.81 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.627 HG13 HG12 ' A' ' 12' ' ' ILE . 1.3 mp -113.83 121.59 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.878 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.485 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 74.9 mmtt -123.89 165.73 16.88 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.847 174.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.452 HG13 ' CG1' ' A' ' 64' ' ' ILE . 6.1 m -113.42 126.66 70.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 120.961 0.41 . . . . 0.0 112.03 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.63 123.44 29.8 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.645 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 p -132.22 173.38 11.31 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.874 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.473 HG12 HD11 ' A' ' 176' ' ' ILE . 2.1 mm -121.25 140.64 44.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.274 0.559 . . . . 0.0 110.129 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.556 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 23.4 t70 -81.73 120.86 25.66 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.744 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.7 mt -66.46 -25.34 66.68 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.494 -172.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.556 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -92.95 -24.08 18.51 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.856 -1.066 . . . . 0.0 112.416 -172.699 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.5 p -119.77 -26.43 5.67 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.607 -175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.16 14.37 69.27 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.433 ' C ' HD13 ' A' ' 52' ' ' ILE . 2.6 mptt -84.16 153.61 23.58 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 122.839 0.455 . . . . 0.0 111.738 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.91 105.5 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 CA-C-O 122.004 0.907 . . . . 0.0 109.724 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.3 m -110.16 163.75 6.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.079 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 48' ' ' LYS . 13.7 tp -123.71 139.88 53.55 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 t -144.07 172.4 12.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.738 0.304 . . . . 0.0 110.849 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -86.15 161.99 18.59 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.727 0.775 . . . . 0.0 110.924 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.562 HD12 ' N ' ' A' ' 64' ' ' ILE . 3.3 mp -97.81 141.75 15.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.003 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.473 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 18.2 mm-40 -85.15 -39.58 17.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 p30 173.9 175.11 0.15 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.593 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.752 ' HA ' HD12 ' A' ' 167' ' ' LEU . 21.7 t -104.41 142.33 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.826 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 166' ' ' SER . 0.8 OUTLIER -112.87 123.5 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.701 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.39 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -129.85 114.5 15.98 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.733 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.98 139.62 35.55 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.813 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -52.84 123.92 14.21 Favored 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 123.043 2.495 . . . . 0.0 112.61 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.4 106.38 11.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.091 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.1 m -125.23 -26.72 3.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.638 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -78.78 -137.44 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.387 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -155.14 171.33 19.98 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.2 mt -132.83 140.63 48.05 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.937 -175.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 108' ' ' ALA . 51.4 mt -88.96 145.87 6.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.495 ' HB3' ' HG3' ' A' ' 155' ' ' LYS . 19.8 ttt180 -121.28 138.94 54.01 Favored 'General case' 0 N--CA 1.404 -2.768 0 CA-C-O 121.256 0.551 . . . . 0.0 109.87 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 86' ' ' SER . 49.3 m-85 -116.35 126.26 53.25 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.119 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.2 tt0 -106.27 132.63 52.09 Favored 'General case' 0 CA--C 1.48 -1.724 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.886 HD12 ' HB3' ' A' ' 149' ' ' LEU . 2.2 mm? -99.05 156.86 16.72 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.205 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.914 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.8 pt-20 -58.62 -18.33 29.45 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.509 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.46 -8.31 48.11 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.746 0.784 . . . . 0.0 109.42 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.27 17.65 49.39 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.564 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.537 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -89.91 139.36 30.67 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.443 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 65.5 p -139.79 144.48 37.4 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.467 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -137.1 146.9 45.64 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.105 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 65.1 mt-10 -119.39 147.42 44.38 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.478 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -142.76 157.84 44.24 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.677 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.752 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -72.6 9.72 1.01 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 122.942 0.497 . . . . 0.0 111.921 -176.881 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.078 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.8 OUTLIER 68.03 -25.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.625 1.17 . . . . 0.0 112.494 177.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 90' ' ' THR . 0.2 OUTLIER -74.45 -12.88 60.61 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 124.344 1.058 . . . . 0.0 111.551 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -110.79 147.21 36.01 Favored Pre-proline 0 C--N 1.309 -1.176 0 C-N-CA 120.381 -0.527 . . . . 0.0 112.245 -175.441 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 3.1 Cg_exo -74.48 132.04 15.68 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.246 2.63 . . . . 0.0 114.047 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.506 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.6 t -97.21 144.88 9.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 tp -102.05 107.81 19.04 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.658 0.265 . . . . 0.0 110.918 -175.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.621 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.2 p -111.17 151.37 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-O 121.378 0.609 . . . . 0.0 111.93 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.4 ' CD2' HD12 ' A' ' 148' ' ' LEU . 67.0 t80 -106.95 93.74 4.72 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.917 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.3 pt-20 -140.62 158.47 43.93 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 31.9 m-80 64.76 22.93 12.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.065 0.46 . . . . 0.0 110.289 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.76 15.42 64.42 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.53 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -137.12 172.43 13.01 Favored 'General case' 0 N--CA 1.398 -3.044 0 CA-C-O 121.422 0.63 . . . . 0.0 110.269 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -103.63 120.77 41.56 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.605 HG13 HG13 ' A' ' 97' ' ' VAL . 25.2 pt -121.48 155.84 25.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.518 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -104.35 116.25 31.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.975 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.424 ' HE3' ' CD1' ' A' ' 104' ' ' ILE . 85.7 mttt -125.4 129.48 49.96 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.546 ' O ' HG23 ' A' ' 111' ' ' VAL . 91.2 mtt180 -62.8 161.71 12.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.078 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -58.17 -42.43 85.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.537 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.471 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.1 p90 -73.91 3.48 6.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.077 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -114.82 -16.41 11.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.533 0.682 . . . . 0.0 110.22 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 107' ' ' ARG . 92.8 t -77.05 148.68 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.71 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 15.9 mtmt -121.55 162.95 19.68 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 120.827 0.346 . . . . 0.0 111.258 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.96 139.11 57.68 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.62 4.45 70.21 Favored Glycine 0 C--N 1.305 -1.179 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.779 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.71 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -75.14 168.71 19.46 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.586 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 22.2 mttm -123.84 164.28 19.54 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.577 0.703 . . . . 0.0 111.937 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.88 159.05 41.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.424 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -92.31 141.04 28.99 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.064 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 2.5 m -115.75 158.54 16.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.671 173.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.574 ' HB3' HD22 ' A' ' 180' ' ' ASN . 32.6 t . . . . . 0 C--N 1.305 -1.329 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.68 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 118' ' ' LEU . 8.3 mt . . . . . 0 CA--C 1.482 -1.664 0 CA-C-O 121.093 0.473 . . . . 0.0 109.998 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.914 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -117.13 137.5 52.26 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -173.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.586 ' HG3' ' CG ' ' A' ' 116' ' ' LYS . 14.5 mt-10 -90.58 147.43 23.34 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.752 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.474 HD13 ' CD1' ' A' ' 79' ' ' PHE . 79.1 mt -79.66 108.45 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.63 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.911 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.626 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 0.9 OUTLIER -64.69 -43.07 94.69 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.751 177.209 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -152.64 136.9 16.58 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.9 mt -115.7 143.13 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 113.623 -1.626 . . . . 0.0 110.589 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.495 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.0 ptpt -144.86 157.79 44.03 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.288 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.479 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 6.7 m-85 -100.54 118.05 35.94 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.456 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -127.04 173.82 11.91 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.708 -178.173 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -105.92 157.49 17.45 Favored 'General case' 0 C--N 1.289 -2.051 0 O-C-N 121.911 -0.493 . . . . 0.0 111.627 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.95 118.63 8.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.567 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -63.09 -41.53 99.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.066 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -105.12 -174.12 2.46 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.669 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -99.04 0.41 43.7 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 120.851 0.357 . . . . 0.0 111.461 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -142.42 140.47 31.99 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.867 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.4 m -107.51 154.46 8.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.94 177.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 68.1 m-85 -134.39 166.55 22.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.036 -175.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.447 ' HB2' HD11 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -160.73 -22.15 0.06 Allowed 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 67' ' ' VAL . 20.9 tp 68.46 111.42 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.266 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -82.32 113.38 20.07 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.282 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.473 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -133.34 -160.1 1.02 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.9 mptt . . . . . 0 C--N 1.317 -0.843 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.43 179.715 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.587 HD21 ' N ' ' A' ' 174' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 121.815 0.816 . . . . 0.0 109.335 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.722 HG21 HD11 ' A' ' 8' ' ' ILE . 2.1 p -142.34 165.33 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 CA-C-O 121.397 0.618 . . . . 0.0 111.289 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.517 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 97.2 mt -92.83 113.13 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.113 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.48 HD13 ' CE1' ' A' ' 2' ' ' PHE . 29.6 pt -120.13 167.67 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.293 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.403 ' C ' ' H ' ' A' ' 180' ' ' ASN . 6.6 t-20 49.77 -132.38 1.75 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.095 0.958 . . . . 0.0 109.987 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.84 44.62 0.84 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.774 0.797 . . . . 0.0 110.52 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.4 m-20 73.05 47.55 0.19 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 125.61 1.564 . . . . 0.0 113.342 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.7 mt -87.35 113.69 25.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.525 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.67 124.13 39.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.658 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.506 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 8.9 t . . . . . 0 C--N 1.299 -1.625 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.793 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.549 ' HD3' HD13 ' A' ' 76' ' ' LEU . 72.3 Cg_endo -72.96 162.94 39.72 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 N-CA-C 108.319 -1.454 . . . . 0.0 108.319 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.564 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -63.45 -25.36 68.55 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.055 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.88 -11.77 14.54 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.8 m -73.26 132.32 43.0 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.878 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 72.9 mmt-85 -84.21 135.78 34.22 Favored 'General case' 0 C--O 1.188 -2.163 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.445 HD11 HG21 ' A' ' 175' ' ' VAL . 9.6 tt -120.71 130.23 74.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 10' ' ' VAL . 1.3 tm? -89.83 124.32 34.57 Favored 'General case' 0 N--CA 1.412 -2.368 0 CA-C-O 121.545 0.688 . . . . 0.0 110.125 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.522 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 30.7 m -135.09 -175.72 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.57 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 33.0 tt0 -131.63 121.18 23.92 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.6 HG12 HG13 ' A' ' 47' ' ' ILE . 20.2 mt -120.05 121.89 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.949 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.62 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' A' ' 45' ' ' ARG . 68.1 m-20 55.04 38.41 30.48 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.948 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.86 18.46 78.94 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.841 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.53 120.03 23.17 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 42.7 Cg_endo -70.95 121.95 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.623 2.215 . . . . 0.0 111.64 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -124.94 142.34 51.53 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.821 -176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -114.48 101.81 9.48 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.643 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.4 pt -125.12 -172.5 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.161 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.048 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.722 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 6.8 p -91.68 173.07 8.07 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.333 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.6 mm? -64.12 -35.84 82.08 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.296 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.722 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 8.2 ptm180 -76.95 -26.64 54.24 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.543 ' OE1' HG23 ' A' ' 20' ' ' THR . 52.3 mt-10 -80.59 -39.34 27.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.951 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.799 HD21 HD22 ' A' ' 167' ' ' LEU . 18.3 tp -61.35 -41.85 97.73 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.069 0.938 . . . . 0.0 109.139 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.664 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 6.6 m-30 -57.28 -28.98 63.48 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.588 -1.642 . . . . 0.0 113.164 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.645 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 54.1 mt-10 -73.16 -17.49 61.37 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.248 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.0 mm? -78.92 2.54 19.83 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.484 0.659 . . . . 0.0 109.57 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.503 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.9 m-85 -116.33 163.01 16.65 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.535 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -141.48 -173.12 3.68 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.588 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 1.7 t70 63.23 84.85 0.14 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.326 0.584 . . . . 0.0 110.842 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -100.4 126.93 46.83 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.741 0.782 . . . . 0.0 110.998 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -115.66 150.52 36.61 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.808 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -102.25 129.72 48.74 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.404 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -167.44 148.72 5.58 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.029 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 57.89 19.63 5.95 Favored 'General case' 0 CA--C 1.496 -1.109 0 O-C-N 123.798 0.686 . . . . 0.0 111.726 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.6 mtt 71.02 18.84 5.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.393 0.615 . . . . 0.0 110.274 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 4.5 m -129.01 -173.14 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.484 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 64.7 m-85 -118.5 142.57 47.46 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.186 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 t -129.02 123.73 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.893 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.399 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.652 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 35.4 ttm180 -116.92 126.86 53.6 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -136.16 144.38 44.98 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.974 -174.325 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 14.2 ttmt 88.55 108.83 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.41 0 O-C-N 124.916 1.385 . . . . 0.0 110.568 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.593 ' HB2' HD13 ' A' ' 47' ' ' ILE . 93.0 Cg_endo -79.81 153.83 22.95 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 122.442 2.095 . . . . 0.0 111.843 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -87.78 -1.25 57.84 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.471 0.653 . . . . 0.0 111.108 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 50.3 mtt180 -143.42 -166.15 2.25 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.6 tp10 -89.28 101.78 14.45 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 172.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.6 HG13 HG12 ' A' ' 12' ' ' ILE . 1.3 mp -114.56 118.16 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.017 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.522 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 35.6 mmtt -115.39 169.04 9.45 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.911 175.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.495 HG11 ' CB ' ' A' ' 169' ' ' ALA . 9.3 p -123.85 130.83 73.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.076 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.24 129.4 35.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.031 0.443 . . . . 0.0 110.967 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.7 t -140.94 176.72 8.58 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.699 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.425 HD13 ' C ' ' A' ' 58' ' ' LYS . 2.0 mm -120.75 145.07 27.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.249 0.547 . . . . 0.0 110.561 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.761 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.2 t70 -88.62 123.34 32.99 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.819 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.72 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -75.16 -17.86 60.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.106 0.479 . . . . 0.0 112.195 -172.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.761 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -94.55 -28.24 15.52 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.702 -175.198 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.44 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 60.3 p -114.85 -21.73 9.99 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.331 -176.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.77 17.64 74.73 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.138 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.44 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 18.5 mtpp -94.56 157.72 15.86 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 p -91.52 110.43 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.47 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 m -110.12 158.19 10.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.202 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 49' ' ' VAL . 12.4 tp -122.65 140.27 53.03 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.0 t -147.04 172.05 14.33 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.611 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.78 161.58 20.92 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.763 0.792 . . . . 0.0 111.783 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.55 HD13 HG22 ' A' ' 47' ' ' ILE . 2.1 mp -95.8 142.4 13.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.665 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.543 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 19.5 mt-10 -93.02 -34.88 13.54 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -179.55 -177.33 0.42 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.823 0.821 . . . . 0.0 111.716 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 6.9 t -115.24 128.3 72.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.696 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.575 HD12 ' HB2' ' A' ' 166' ' ' SER . 33.1 mt -97.09 104.73 16.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.548 -175.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.563 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 59.1 tttp -117.25 108.11 15.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.09 136.05 28.22 Favored Pre-proline 0 C--N 1.308 -1.218 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HD2' HG12 ' A' ' 37' ' ' VAL . 72.5 Cg_exo -48.28 139.55 21.68 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.677 2.918 . . . . 0.0 113.689 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -85.83 96.32 9.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.158 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -89.11 -31.58 17.94 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.354 -175.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.0 -97.95 0.4 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 157' ' ' VAL . 0.4 OUTLIER 178.74 173.48 0.71 Allowed 'General case' 0 CA--C 1.471 -2.088 0 C-N-CA 123.936 0.895 . . . . 0.0 108.832 -175.651 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.681 HD23 ' HA ' ' A' ' 90' ' ' THR . 5.7 mt -123.96 140.6 52.82 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 118.748 -1.181 . . . . 0.0 112.898 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.5 HD12 ' C ' ' A' ' 108' ' ' ALA . 9.3 mt -84.77 145.94 7.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 172.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 19.9 ttt85 -116.94 138.38 51.58 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-O 121.227 0.537 . . . . 0.0 110.173 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.499 ' CD1' HD13 ' A' ' 151' ' ' ILE . 61.3 m-85 -116.13 122.86 46.33 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.28 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.0 tt0 -110.9 126.4 54.66 Favored 'General case' 0 CA--C 1.468 -2.202 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -89.88 162.49 15.43 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.464 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.859 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.2 pt-20 -63.15 -15.65 57.52 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.786 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -91.92 -10.29 40.07 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.533 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.06 4.33 66.97 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.749 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.585 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -83.57 143.38 30.19 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.62 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 23.0 p -141.76 157.92 44.44 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.748 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -148.34 154.07 39.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.894 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 16.3 mt-10 -125.0 148.87 48.25 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.727 -176.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -143.0 156.82 44.92 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.532 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.681 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -67.17 13.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.078 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.051 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.4 m 67.27 -41.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 125.362 1.465 . . . . 0.0 113.814 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.17 -28.61 34.94 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.304 0.573 . . . . 0.0 109.956 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -73.49 144.37 83.66 Favored Pre-proline 0 C--N 1.314 -0.969 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.735 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 5.7 Cg_exo -74.46 144.05 31.85 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.546 2.831 . . . . 0.0 114.704 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.01 146.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 124.841 1.256 . . . . 0.0 107.634 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 183' ' ' THR . 12.4 tp -102.36 113.08 26.1 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.179 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.696 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.0 p -116.8 150.23 18.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.33 0.586 . . . . 0.0 111.817 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.427 ' CD2' HD12 ' A' ' 148' ' ' LEU . 72.4 t80 -103.17 95.93 6.45 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.877 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -138.57 156.66 47.29 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 63.15 22.87 13.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.058 0.456 . . . . 0.0 110.319 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.79 13.01 63.07 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.925 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.411 ' HG3' HG23 ' A' ' 104' ' ' ILE . 7.7 ptp180 -132.36 171.71 13.39 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 117.434 0.617 . . . . 0.0 109.8 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.423 ' CE1' HD12 ' A' ' 118' ' ' LEU . 59.5 m-85 -104.91 122.39 45.7 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.54 HG13 HG13 ' A' ' 97' ' ' VAL . 22.9 pt -121.61 156.57 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.312 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -111.69 106.98 15.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.808 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.467 ' HG3' HG22 ' A' ' 111' ' ' VAL . 15.7 ptpt -122.81 141.23 52.06 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.725 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.564 ' O ' HG23 ' A' ' 111' ' ' VAL . 66.3 mtm180 -60.96 155.2 20.51 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.051 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -59.34 -40.32 85.99 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.312 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.494 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.2 p90 -75.21 -0.71 20.33 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.797 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -106.3 -19.65 13.63 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.703 0.763 . . . . 0.0 109.311 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 107' ' ' ARG . 86.5 t -71.67 149.11 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.506 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.692 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -122.17 166.83 13.97 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.842 -178.417 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.17 141.95 52.55 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.43 4.96 79.86 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.518 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.696 ' OD1' HG21 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -75.48 173.46 10.94 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -127.04 163.3 24.05 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 121.719 0.771 . . . . 0.0 112.198 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.3 158.26 42.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 114.639 -1.164 . . . . 0.0 107.887 168.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.509 ' HB3' ' HB ' ' A' ' 182' ' ' VAL . 1.1 tt -88.98 133.29 34.37 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.687 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -115.93 130.18 71.06 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.545 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.1 t . . . . . 0 C--N 1.307 -1.261 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.058 -178.881 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 118' ' ' LEU . 7.1 mt . . . . . 0 N--CA 1.428 -1.526 0 CA-C-O 121.375 0.607 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.859 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -116.85 137.9 51.89 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.063 -173.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.417 ' H ' HD13 ' A' ' 149' ' ' LEU . 14.2 mt-10 -88.72 145.58 25.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 124.652 1.181 . . . . 0.0 112.639 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.502 HD12 ' HB3' ' A' ' 115' ' ' ASP . 70.0 mt -80.08 104.26 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.766 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 6.6 mmpt? -68.18 -38.96 82.61 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.876 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -149.59 135.63 18.86 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 82.5 mt -114.77 144.26 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.476 174.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.507 ' CD ' ' HD3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -148.1 158.43 44.06 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.922 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.423 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 15.2 m-85 -99.15 111.76 24.07 Favored 'General case' 0 N--CA 1.407 -2.583 0 CA-C-O 121.802 0.811 . . . . 0.0 109.762 174.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -116.56 175.64 2.91 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.903 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.29 179.508 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.439 ' HB3' ' H ' ' A' ' 159' ' ' ALA . 78.1 mtt180 -79.56 -146.55 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.381 -0.528 . . . . 0.0 112.169 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.439 ' H ' ' HB3' ' A' ' 158' ' ' ARG . . . -104.08 -13.61 16.21 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.673 -176.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.67 8.11 2.2 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.956 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -175.21 -173.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -104.0 -7.72 20.12 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.35 158.28 44.42 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.269 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.456 HG11 HD21 ' A' ' 76' ' ' LEU . 2.9 m -128.88 157.16 41.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.091 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.664 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 11.3 m-85 -131.29 170.55 14.46 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.714 -172.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.575 ' HB2' HD12 ' A' ' 68' ' ' ILE . 68.3 m -159.88 -22.01 0.06 Allowed 'General case' 0 C--N 1.359 0.994 0 CA-C-O 120.622 0.249 . . . . 0.0 110.377 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.799 HD22 HD21 ' A' ' 24' ' ' LEU . 14.4 tp 64.52 110.87 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.164 0.915 . . . . 0.0 112.081 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -84.63 108.26 17.27 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.543 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -112.65 -161.0 0.74 Allowed 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 49.1 tptt . . . . . 0 C--N 1.314 -0.963 0 CA-C-O 120.854 0.359 . . . . 0.0 110.67 -177.122 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.4 HD21 HD22 ' A' ' 96' ' ' LEU . 6.6 m120 . . . . . 0 CA--C 1.51 -0.596 0 CA-C-O 120.962 0.411 . . . . 0.0 111.994 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.553 HG13 HG23 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -165.81 158.47 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.686 176.406 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.584 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 88.9 mt -108.9 116.52 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.779 0 CA-C-O 121.007 0.432 . . . . 0.0 110.321 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.553 HG23 HG13 ' A' ' 175' ' ' VAL . 43.2 pt -122.04 169.44 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.729 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 6.6 t-20 48.8 -133.05 1.51 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.333 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.424 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 16.1 mm-40 -83.94 53.97 2.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.459 0.647 . . . . 0.0 110.008 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.687 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.0 m120 70.55 45.32 0.61 Allowed 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.357 -1.292 . . . . 0.0 113.909 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 98.3 mt -86.04 112.38 22.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 118' ' ' LEU . 98.6 t -86.93 117.5 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.299 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . 8.8 t . . . . . 0 N--CA 1.411 -2.39 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.939 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.536 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 7.0 m-85 . . . . . 0 CA--C 1.517 -0.306 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.478 ' HD3' HD13 ' A' ' 76' ' ' LEU . 73.0 Cg_endo -72.51 161.93 42.8 Favored 'Trans proline' 0 N--CA 1.438 -1.77 0 N-CA-C 108.41 -1.419 . . . . 0.0 108.41 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.01 -26.49 63.37 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 118.682 -1.723 . . . . 0.0 110.875 175.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.43 ' OD1' ' HB2' ' A' ' 160' ' ' ASN . 6.9 m-20 -59.79 -13.81 12.01 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.7 m -74.4 129.03 37.0 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.351 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 10.9 mtm-85 -84.88 129.45 34.81 Favored 'General case' 0 C--O 1.195 -1.766 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.757 HD11 HG21 ' A' ' 175' ' ' VAL . 10.5 tt -115.04 129.87 70.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.604 HD23 ' HB2' ' A' ' 18' ' ' LYS . 2.6 tm? -94.96 123.94 38.72 Favored 'General case' 0 N--CA 1.399 -3.009 0 CA-C-O 121.786 0.803 . . . . 0.0 110.474 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.671 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 31.0 m -132.23 -172.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.849 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 30.9 tt0 -131.52 123.54 28.22 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 28.3 mt -120.68 122.49 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.893 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.632 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.408 ' HA ' ' HB3' ' A' ' 46' ' ' GLU . 0.7 OUTLIER 54.74 41.81 31.65 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.033 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.58 18.92 72.43 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.774 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.55 118.73 18.07 Favored Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 52.6 Cg_exo -53.44 148.21 34.72 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 C-N-CA 122.053 1.835 . . . . 0.0 111.104 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -148.83 129.18 13.81 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.604 ' HB2' HD23 ' A' ' 9' ' ' LEU . 40.3 ttmt -117.62 102.93 9.56 Favored 'General case' 0 CA--C 1.48 -1.741 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.883 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.4 pt -125.23 -173.9 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.253 177.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.676 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 10.4 p -92.28 172.08 8.65 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.392 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 81.8 mt -66.17 -28.47 68.8 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.414 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.676 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 4.3 ptm180 -82.1 -24.56 35.09 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.466 ' OE1' HG23 ' A' ' 20' ' ' THR . 51.9 mt-10 -84.16 -39.99 18.73 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.861 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.661 HD23 ' HG ' ' A' ' 167' ' ' LEU . 17.5 tp -61.12 -41.08 96.04 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.546 0.689 . . . . 0.0 109.826 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.511 ' HD1' HG11 ' A' ' 67' ' ' VAL . 1.4 t80 -51.14 -32.76 24.01 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.978 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.4 mt-10 -74.48 -15.8 60.87 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.248 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.92 2.17 27.8 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.589 0.709 . . . . 0.0 109.56 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.613 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.9 m-85 -118.37 164.54 15.09 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.832 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.569 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 12.6 mm-40 -141.16 -172.97 3.61 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.028 175.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t0 63.18 81.33 0.21 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.57 0.7 . . . . 0.0 110.392 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -99.19 122.44 42.39 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.791 0.805 . . . . 0.0 111.044 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -113.14 150.45 32.19 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.923 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -101.79 131.14 48.26 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -166.6 145.76 5.59 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.763 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.98 21.84 9.72 Favored 'General case' 0 CA--C 1.488 -1.41 0 O-C-N 123.85 0.718 . . . . 0.0 111.51 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 43.8 mtm 72.36 18.97 4.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.691 0.619 . . . . 0.0 110.569 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 10.5 m -134.7 -175.16 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.441 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 90.7 m-85 -112.85 139.98 48.02 Favored 'General case' 0 CA--C 1.478 -1.798 0 CA-C-O 121.243 0.544 . . . . 0.0 110.535 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -128.39 124.06 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.85 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.582 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 13.6 ttm180 -118.04 128.26 54.6 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.54 145.69 51.34 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.843 -173.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 5.2 tppp? 81.84 111.81 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.643 1.214 . . . . 0.0 111.235 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.568 ' HB2' HD13 ' A' ' 47' ' ' ILE . 66.1 Cg_endo -78.91 154.0 25.82 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 122.079 1.853 . . . . 0.0 111.951 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.569 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 36.3 mtmt -85.38 -4.34 59.13 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.868 -178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -149.17 -165.22 2.22 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 33.9 tt0 -86.82 101.65 13.55 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.613 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.6 mp -114.85 113.02 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.998 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.671 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 72.6 mmtt -116.95 169.39 9.44 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.694 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.537 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.8 p -120.88 124.93 73.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.551 0.691 . . . . 0.0 111.959 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.788 ' CZ ' HG21 ' A' ' 59' ' ' VAL . 5.5 t80 -76.47 123.31 25.83 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.952 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.5 t -140.13 168.25 20.25 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.932 0.396 . . . . 0.0 110.815 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.13 145.14 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.164 0.507 . . . . 0.0 110.681 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -91.99 117.93 30.29 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.634 HD12 ' H ' ' A' ' 54' ' ' LEU . 4.2 mp -69.42 -31.47 69.83 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.786 0.803 . . . . 0.0 111.763 -172.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.35 -30.35 42.6 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.986 -174.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.4 p -111.08 -25.61 9.67 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.023 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.67 13.33 75.88 Favored Glycine 0 N--CA 1.421 -2.321 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.855 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -92.91 170.18 9.88 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 120.899 0.38 . . . . 0.0 111.24 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.788 HG21 ' CZ ' ' A' ' 50' ' ' TYR . 7.6 p -103.14 118.61 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.671 0 CA-C-O 121.873 0.844 . . . . 0.0 110.529 177.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -111.51 153.78 13.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.424 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 49' ' ' VAL . 11.7 tp -122.36 132.86 54.59 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.597 HG21 ' HB2' ' A' ' 170' ' ' LYS . 10.8 t -140.09 173.28 11.67 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.462 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -86.64 161.38 18.51 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.793 0.806 . . . . 0.0 111.558 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.55 HD13 HG22 ' A' ' 47' ' ' ILE . 2.1 mp -91.81 141.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.688 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.6 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 7.9 mm-40 -83.46 -39.65 20.27 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 p30 178.12 174.79 0.56 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.812 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.582 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 25.9 t -104.76 137.35 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.319 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.57 HD13 ' HB2' ' A' ' 166' ' ' SER . 0.0 OUTLIER -113.99 126.51 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.335 -178.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.497 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 52.6 tttp -135.38 115.81 13.61 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.889 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.39 142.56 45.86 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.697 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.431 ' HD2' HG12 ' A' ' 37' ' ' VAL . 7.2 Cg_endo -51.72 136.32 50.19 Favored 'Trans proline' 0 C--N 1.327 -0.58 0 C-N-CA 123.284 2.656 . . . . 0.0 112.185 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.84 97.95 1.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.4 p -88.54 -67.12 0.85 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.073 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -92.64 -161.75 0.86 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.391 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 18.7 m80 -107.84 173.63 6.24 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' A' ' 90' ' ' THR . 10.5 mt -124.47 138.6 54.33 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.541 0.686 . . . . 0.0 111.214 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.498 HD12 ' C ' ' A' ' 108' ' ' ALA . 13.4 mt -85.0 145.01 8.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 31.9 ttt85 -121.24 137.14 54.82 Favored 'General case' 0 N--CA 1.406 -2.664 0 CA-C-O 121.282 0.563 . . . . 0.0 109.597 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.662 ' O ' ' HA ' ' A' ' 86' ' ' SER . 59.2 m-85 -116.6 127.85 54.86 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.127 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.8 tt0 -113.05 126.16 55.17 Favored 'General case' 0 CA--C 1.471 -2.093 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.983 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.788 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -90.15 152.4 21.13 Favored 'General case' 0 N--CA 1.399 -2.98 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.981 ' HG2' HD11 ' A' ' 149' ' ' LEU . 5.3 pt-20 -55.3 -22.27 18.15 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.606 ' OD1' ' HG3' ' A' ' 85' ' ' ARG . 32.6 p-10 -102.5 1.37 34.98 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.529 0.681 . . . . 0.0 110.968 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.87 19.91 20.52 Favored Glycine 0 C--N 1.304 -1.223 0 CA-C-N 114.767 -1.106 . . . . 0.0 115.837 171.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.606 ' HG3' ' OD1' ' A' ' 83' ' ' ASP . 8.4 mtt180 -88.51 136.29 33.06 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 57.2 p -138.44 137.24 37.03 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.86 173.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -134.63 155.22 50.86 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.362 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 38.3 mt-10 -131.3 151.31 51.63 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.257 0.551 . . . . 0.0 112.008 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.496 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.7 OUTLIER -146.6 161.1 41.23 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.693 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.689 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -70.35 16.82 0.07 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.01 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.66 -28.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 125.235 1.414 . . . . 0.0 112.715 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 26.8 t70 -87.98 -8.07 56.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.433 0.635 . . . . 0.0 110.219 176.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 62.6 t-80 -82.15 125.97 75.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.579 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 34.3 Cg_exo -62.92 138.02 65.91 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.921 2.414 . . . . 0.0 112.568 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 17.3 t -114.7 146.17 19.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.3 tp -98.83 106.38 18.63 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 116' ' ' LYS . 2.4 p -108.18 148.46 12.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.342 0.591 . . . . 0.0 111.4 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.505 ' CD2' HD12 ' A' ' 148' ' ' LEU . 49.8 t80 -100.99 94.15 5.86 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.813 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.505 ' CG ' HD11 ' A' ' 104' ' ' ILE . 11.5 pt-20 -144.96 158.23 43.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.2 m-20 64.02 22.16 12.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.015 0.436 . . . . 0.0 110.173 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.13 13.36 61.99 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.689 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -136.67 172.61 12.76 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 121.452 0.644 . . . . 0.0 110.425 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -104.72 121.61 43.97 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.686 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.505 HD11 ' CG ' ' A' ' 99' ' ' GLU . 16.7 pt -126.74 151.46 33.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.792 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.3 mp0 -106.28 111.24 23.75 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.092 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HG3' HG22 ' A' ' 111' ' ' VAL . 11.6 ptpt -125.76 143.43 51.05 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.277 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.643 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 79.7 mtt85 -61.57 163.28 7.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.01 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -61.41 -41.17 96.71 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.803 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 1.1 p90 -75.17 -0.92 20.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.717 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -106.73 -19.32 13.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.69 0.757 . . . . 0.0 109.172 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 107' ' ' ARG . 52.9 t -76.25 150.41 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.616 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -124.47 168.03 13.62 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.408 -177.522 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -68.24 138.45 55.57 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.25 5.13 67.84 Favored Glycine 0 C--N 1.3 -1.418 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.825 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.735 ' HB3' HD12 ' A' ' 151' ' ' ILE . 3.7 t70 -75.72 165.77 24.55 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.448 ' H ' HG23 ' A' ' 97' ' ' VAL . 29.1 mttp -124.63 160.97 27.26 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.311 0.576 . . . . 0.0 111.116 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.35 160.26 42.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.271 173.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.7 136.24 37.51 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.2 m -109.11 161.15 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 80.6 p . . . . . 0 C--N 1.308 -1.211 0 CA-C-O 121.281 0.562 . . . . 0.0 110.547 179.393 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.505 HD12 ' CD2' ' A' ' 98' ' ' TYR . 9.7 mt . . . . . 0 N--CA 1.415 -2.209 0 CA-C-O 121.356 0.598 . . . . 0.0 109.738 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.981 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -113.9 137.58 51.48 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.423 -172.14 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.473 ' H ' HD13 ' A' ' 149' ' ' LEU . 10.2 mt-10 -90.8 145.28 24.91 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.574 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.735 HD12 ' HB3' ' A' ' 115' ' ' ASP . 82.2 mt -76.96 102.72 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.371 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.67 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 35.5 mmtm -69.33 -35.74 76.23 Favored 'General case' 0 C--N 1.264 -3.125 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.369 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -151.59 128.79 11.18 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 66.7 mt -112.56 144.76 19.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.795 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.476 ' HD3' HG13 ' A' ' 157' ' ' VAL . 5.7 ptpp? -146.41 156.45 43.32 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.123 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -99.42 115.26 28.84 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.476 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -128.87 173.75 13.24 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.568 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.878 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -106.35 166.1 10.78 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.37 132.35 46.24 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.935 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.43 ' HB2' ' OD1' ' A' ' 5' ' ' ASP . 24.3 m-80 -87.95 34.58 0.73 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.276 0.56 . . . . 0.0 110.018 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -161.74 178.86 8.6 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.03 -1.36 23.99 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.399 0.619 . . . . 0.0 110.243 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -139.13 153.38 47.96 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.478 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.8 m -119.01 157.12 20.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 58.5 m-85 -132.84 175.04 9.7 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.553 -176.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.57 ' HB2' HD13 ' A' ' 68' ' ' ILE . 49.2 m -154.54 -29.55 0.11 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.884 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.661 ' HG ' HD23 ' A' ' 24' ' ' LEU . 2.5 mm? 61.93 90.97 0.07 Allowed 'General case' 0 C--N 1.345 0.371 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 65' ' ' GLU . 47.8 m-20 -81.75 104.5 12.18 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.608 0.718 . . . . 0.0 111.974 -175.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.6 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -94.67 -155.41 0.46 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.285 172.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.597 ' HB2' HG21 ' A' ' 62' ' ' THR . 32.7 mmtm . . . . . 0 C--N 1.321 -0.634 0 CA-C-O 121.223 0.535 . . . . 0.0 112.083 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 N--CA 1.448 -0.572 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.757 HG21 HD11 ' A' ' 8' ' ' ILE . 1.7 p -158.66 171.07 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -176.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.596 ' H ' HG22 ' A' ' 175' ' ' VAL . 71.8 mt -116.42 122.4 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.923 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.547 HG23 HG13 ' A' ' 175' ' ' VAL . 43.1 pt -126.68 167.39 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 121.597 0.713 . . . . 0.0 112.637 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 52.48 -129.63 2.31 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.255 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.436 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 3.2 mp0 -78.89 42.99 0.48 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.017 0.437 . . . . 0.0 110.491 176.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.3 m-20 71.02 48.37 0.38 Allowed 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 124.508 1.123 . . . . 0.0 112.308 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 85.0 mt -88.75 112.17 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 176' ' ' ILE . 2.6 m -79.47 135.51 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 CA-C-O 121.969 0.89 . . . . 0.0 111.208 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--N 1.289 -2.059 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.508 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.424 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 1.7 m-85 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.546 ' HD3' HD13 ' A' ' 76' ' ' LEU . 74.0 Cg_endo -71.56 164.82 34.44 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.035 1.823 . . . . 0.0 109.356 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.17 -29.85 63.29 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 119.276 -1.44 . . . . 0.0 111.334 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.618 ' HA ' ' NH1' ' A' ' 22' ' ' ARG . 35.7 t70 -61.37 -16.44 46.37 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.1 m -68.73 125.42 26.52 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.072 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.715 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 78.5 mtm-85 -84.01 134.88 34.62 Favored 'General case' 0 C--O 1.182 -2.46 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.453 ' CD1' HG21 ' A' ' 175' ' ' VAL . 9.5 tt -120.47 130.1 74.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.67 122.77 32.46 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-O 121.52 0.676 . . . . 0.0 109.656 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.4 m -135.52 -179.36 3.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.071 -176.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 30.8 tt0 -129.52 121.77 27.88 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.944 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 19.1 mt -121.79 121.8 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.097 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.92 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 56.43 37.48 28.86 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.473 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.38 15.92 77.23 Favored Glycine 0 C--N 1.305 -1.162 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.638 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.27 121.23 27.04 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 56.6 Cg_endo -72.44 122.69 8.51 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 C-N-CA 122.334 2.023 . . . . 0.0 111.416 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -120.45 138.13 53.96 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.916 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -107.98 101.08 10.37 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.3 pt -127.03 -172.86 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.364 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.715 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 21.5 p -97.96 172.24 7.76 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.771 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.574 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 66.2 mt -68.15 -27.38 66.38 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.016 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.618 ' NH1' ' HA ' ' A' ' 5' ' ' ASP . 1.0 OUTLIER -78.53 -26.66 45.8 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.45 ' OE1' HG23 ' A' ' 20' ' ' THR . 85.3 mt-10 -85.73 -42.05 14.58 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.238 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.524 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 20.1 tp -58.8 -42.92 90.21 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.866 0.841 . . . . 0.0 109.319 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.405 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -52.41 -31.0 32.12 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.734 -1.575 . . . . 0.0 112.687 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.11 -19.32 61.81 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.757 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.1 mm? -78.29 1.92 20.15 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.483 0.659 . . . . 0.0 109.601 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.555 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.9 m-85 -119.15 156.52 29.65 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.035 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 17.4 mt-10 -157.65 131.51 8.05 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.092 175.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 47.6 t0 127.83 85.93 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.794 2.037 . . . . 0.0 107.394 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -99.23 125.28 44.8 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.113 0.959 . . . . 0.0 111.696 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -117.53 150.67 38.57 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.131 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -102.46 131.67 48.99 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -166.55 148.35 6.46 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.499 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 58.26 23.11 9.99 Favored 'General case' 0 CA--C 1.491 -1.296 0 O-C-N 123.81 0.694 . . . . 0.0 111.067 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 44.8 mtm 73.69 15.83 3.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.233 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.8 m -130.4 -170.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.92 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -112.5 138.1 49.75 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 t -130.08 123.54 56.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.08 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 29' ' ' GLU . 17.0 ttm180 -110.02 134.0 52.6 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -116.77 179.31 4.05 Favored 'General case' 0 C--N 1.267 -2.99 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.28 106.37 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 125.079 1.487 . . . . 0.0 114.505 170.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.488 ' HB2' HD13 ' A' ' 47' ' ' ILE . 55.5 Cg_endo -77.39 140.01 18.98 Favored 'Trans proline' 0 N--CA 1.426 -2.482 0 C-N-CA 121.552 1.501 . . . . 0.0 110.619 174.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -83.71 -0.48 50.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.447 0.641 . . . . 0.0 111.735 -175.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -147.34 -171.0 3.69 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 19.3 tt0 -79.83 105.34 11.05 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.61 HG13 HG12 ' A' ' 12' ' ' ILE . 1.4 mp -116.28 112.37 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.361 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 45.7 mmtm -113.56 166.5 11.46 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.739 173.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 169' ' ' ALA . 12.1 p -121.48 131.29 73.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 11' ' ' GLN . 19.2 m-85 -82.95 121.24 26.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.872 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 m -135.42 170.17 16.35 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.668 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.478 HD13 ' O ' ' A' ' 58' ' ' LYS . 2.4 mm -113.26 142.9 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.433 0.635 . . . . 0.0 110.831 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.64 80.26 3.08 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.687 HD12 ' H ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -36.33 -40.66 0.24 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.399 1.88 . . . . 0.0 114.039 -175.776 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 55' ' ' GLU . 2.1 pt-20 -63.33 -37.78 88.61 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.323 -176.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.487 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.4 p -107.34 -22.51 12.56 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.914 -176.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.55 20.46 68.84 Favored Glycine 0 N--CA 1.421 -2.366 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.015 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 40.8 mtpt -94.07 158.94 15.38 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.57 109.73 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.783 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.67 155.74 11.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-O 121.066 0.46 . . . . 0.0 111.387 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.8 tp -123.01 135.11 54.33 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.426 HG21 ' HB3' ' A' ' 170' ' ' LYS . 11.2 t -143.1 170.75 15.13 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.324 -176.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -76.73 161.14 28.74 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.202 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.507 HD13 HG22 ' A' ' 47' ' ' ILE . 1.9 mp -97.43 145.75 8.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.321 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.484 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 14.9 mm-40 -79.7 -53.3 6.95 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -175.48 -171.73 0.51 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.673 1.233 . . . . 0.0 107.918 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.567 ' HA ' HD22 ' A' ' 167' ' ' LEU . 14.3 t -107.31 149.99 10.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 120.889 0.376 . . . . 0.0 110.428 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.695 HD12 ' HB2' ' A' ' 166' ' ' SER . 56.4 mt -111.95 118.96 58.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.198 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.466 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 19.2 tttm -134.75 112.62 10.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.933 0.397 . . . . 0.0 109.95 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.52 143.63 50.02 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.029 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.442 ' HD2' HG12 ' A' ' 37' ' ' VAL . 9.7 Cg_endo -54.32 130.07 37.9 Favored 'Trans proline' 0 C--N 1.328 -0.502 0 C-N-CA 123.208 2.605 . . . . 0.0 112.446 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.98 85.53 6.24 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.611 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.8 p -96.55 -43.12 7.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.665 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.06 174.59 8.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.606 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -102.16 171.78 7.29 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' A' ' 90' ' ' THR . 12.1 mt -126.02 143.05 51.25 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.753 0.787 . . . . 0.0 110.973 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.52 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 7.6 mt -83.82 141.4 14.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 15.9 ttt-85 -116.56 136.38 53.03 Favored 'General case' 0 N--CA 1.407 -2.575 0 CA-C-O 121.191 0.52 . . . . 0.0 109.748 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 86' ' ' SER . 55.0 m-85 -114.66 120.83 41.46 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.256 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 37.4 tt0 -108.07 126.62 52.96 Favored 'General case' 0 CA--C 1.467 -2.222 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.671 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.6 mm? -88.16 157.53 18.79 Favored 'General case' 0 C--N 1.27 -2.855 0 O-C-N 123.584 0.553 . . . . 0.0 110.97 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.872 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -59.32 -18.5 38.61 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.1 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -91.92 -10.2 40.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.847 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.42 9.64 57.65 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.965 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.558 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -84.17 141.57 30.96 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.731 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -142.09 140.52 32.55 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.823 176.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -135.48 157.47 46.82 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.497 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 31.3 mt-10 -129.1 153.19 47.89 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.154 0.502 . . . . 0.0 112.026 -176.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.464 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -145.88 158.43 43.86 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.384 177.642 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.686 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -72.37 18.99 0.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.611 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.009 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.71 -41.91 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 C-N-CA 125.367 1.467 . . . . 0.0 114.151 175.363 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -82.21 2.88 29.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 111.144 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.482 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 36.8 m-70 -104.59 136.13 19.22 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.728 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 35.6 Cg_exo -62.3 142.41 91.13 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.543 2.829 . . . . 0.0 114.824 -177.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.503 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.8 t -117.97 147.28 21.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.604 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.6 tp -103.82 111.43 23.94 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.703 HG13 HG13 ' A' ' 104' ' ' ILE . 2.0 p -113.79 140.9 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-O 121.592 0.71 . . . . 0.0 111.667 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.648 ' CD2' HD11 ' A' ' 148' ' ' LEU . 81.6 t80 -91.37 92.37 8.55 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -142.2 148.86 38.88 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.474 -175.009 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 9.0 m120 69.18 22.55 6.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 110.027 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.14 14.51 63.88 Favored Glycine 0 CA--C 1.5 -0.905 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.91 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -140.05 173.32 11.64 Favored 'General case' 0 N--CA 1.41 -2.46 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -97.01 120.37 37.23 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.703 HG13 HG13 ' A' ' 97' ' ' VAL . 12.3 pt -116.91 143.13 27.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.006 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -107.49 110.44 22.38 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.13 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 11.5 ptpt -127.24 138.86 53.19 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.608 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.655 ' O ' HG23 ' A' ' 111' ' ' VAL . 56.6 mtm180 -64.62 164.14 12.46 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 119.347 -0.359 . . . . 0.0 110.147 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.009 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -61.57 -43.21 99.28 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.514 -175.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.412 ' HB3' ' CG2' ' A' ' 91' ' ' VAL . 2.0 p90 -75.05 2.74 9.86 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.524 0.678 . . . . 0.0 110.332 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -114.01 -15.39 12.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.553 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 107' ' ' ARG . 93.2 t -81.87 149.27 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.657 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 18.1 mtmt -124.06 163.47 21.38 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.091 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -64.12 142.89 58.25 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.66 4.2 85.54 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.887 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.657 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -74.98 167.9 21.02 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.481 ' HG3' ' HG3' ' A' ' 150' ' ' GLU . 3.8 ttmt -123.97 166.43 15.72 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.185 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.55 161.43 36.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -90.5 129.89 36.61 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -112.87 125.28 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.909 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.471 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.303 -1.425 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.542 -178.931 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.648 HD11 ' CD2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.423 -1.797 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.872 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -122.73 139.28 54.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.644 -170.848 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.481 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 19.1 mt-10 -91.19 150.52 21.33 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 122.337 1.065 . . . . 0.0 112.741 177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.487 HG21 ' CG1' ' A' ' 154' ' ' ILE . 61.1 mt -77.79 121.69 31.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 113.246 -1.797 . . . . 0.0 111.002 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.612 ' HE2' ' HB2' ' A' ' 82' ' ' GLU . 49.4 mmtt -80.99 -39.19 26.33 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.482 175.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -148.73 130.2 14.82 Favored 'General case' 0 CA--C 1.473 -2.01 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.6 mt -117.62 126.26 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.445 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.297 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HD3' HG13 ' A' ' 157' ' ' VAL . 0.4 OUTLIER -135.82 166.89 22.24 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.153 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.52 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 23.8 m-85 -101.58 119.82 39.36 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.42 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.4 OUTLIER -135.57 137.21 49.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.683 -178.425 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -71.1 154.1 42.02 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.258 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.22 134.64 57.18 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.259 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -82.84 37.55 0.54 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.604 0.716 . . . . 0.0 110.163 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -175.16 179.26 1.58 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -107.34 4.32 26.3 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.858 0.361 . . . . 0.0 111.607 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -141.54 149.48 40.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.0 m -118.78 155.41 20.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.536 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 56.5 m-85 -133.16 174.17 10.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.111 -176.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.695 ' HB2' HD12 ' A' ' 68' ' ' ILE . 49.1 m -159.06 -27.42 0.07 Allowed 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.567 HD22 ' HA ' ' A' ' 67' ' ' VAL . 1.3 tm? 68.91 107.14 0.05 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.066 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -85.25 116.16 23.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.666 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.484 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -135.36 -163.03 1.33 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.045 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.426 ' HB3' HG21 ' A' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 66.4 t30 . . . . . 0 CA--C 1.511 -0.558 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.568 HG13 HG23 ' A' ' 177' ' ' ILE . 2.8 p -152.96 163.92 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.433 0.635 . . . . 0.0 111.673 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.606 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 93.8 mt -116.71 115.78 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.444 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.568 HG23 HG13 ' A' ' 175' ' ' VAL . 39.5 pt -123.78 173.48 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 7' ' ' ARG . 7.9 t-20 49.19 -122.36 1.71 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.35 1.06 . . . . 0.0 109.81 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.404 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 34.8 mm-40 -96.21 56.59 1.64 Allowed 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.47 0.652 . . . . 0.0 109.658 175.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 25.7 m-80 69.51 43.56 1.0 Allowed 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 114.216 -1.357 . . . . 0.0 113.751 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.5 mt -85.49 116.55 28.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.55 129.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.357 -174.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 14.7 t . . . . . 0 C--N 1.309 -1.176 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.448 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.494 ' HA ' HG12 ' A' ' 164' ' ' VAL . 23.0 Cg_endo -61.25 -32.66 90.45 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 122.852 2.368 . . . . 0.0 112.781 -174.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 127.04 -39.27 1.99 Allowed Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.38 -16.92 25.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.648 0.779 . . . . 0.0 111.058 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -64.4 126.69 28.63 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.593 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.633 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 19.1 mmt85 -82.79 134.41 35.12 Favored 'General case' 0 C--O 1.186 -2.25 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.606 HD11 HG21 ' A' ' 175' ' ' VAL . 9.9 tt -121.66 131.4 73.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.426 HD23 ' HB2' ' A' ' 18' ' ' LYS . 2.1 tm? -87.66 123.71 32.79 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.611 0.72 . . . . 0.0 109.847 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 31.5 m -133.06 -177.26 2.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.02 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -130.3 121.32 25.85 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.596 HG12 HG13 ' A' ' 47' ' ' ILE . 22.3 mt -118.36 121.32 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.523 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.707 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.84 38.12 29.73 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.691 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.02 20.29 79.47 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.769 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.04 118.32 22.09 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-O 120.683 0.277 . . . . 0.0 110.41 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 7.0 Cg_exo -66.78 121.54 8.77 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 122.068 1.845 . . . . 0.0 111.065 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -123.63 137.4 54.74 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.693 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HB2' HD23 ' A' ' 9' ' ' LEU . 36.9 ttpt -108.54 101.37 10.53 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.9 pt -123.53 -171.9 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.18 -2.555 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.624 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.798 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 6.6 p -94.44 171.82 8.58 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.088 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 12.3 mt -72.38 -24.5 61.27 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 120.683 0.277 . . . . 0.0 110.909 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.798 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 8.1 ptm180 -82.18 -24.35 35.02 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.542 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 67.8 mm-40 -82.96 -44.59 15.13 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.043 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.504 HD21 ' HG ' ' A' ' 167' ' ' LEU . 20.5 tp -54.74 -45.57 74.14 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.88 0.848 . . . . 0.0 109.407 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.425 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -52.2 -31.16 30.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.554 -1.657 . . . . 0.0 112.754 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 26.8 mt-10 -78.81 -15.35 58.5 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 23' ' ' GLU . 1.8 mm? -77.97 5.92 8.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.76 0.79 . . . . 0.0 109.39 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.7 m-85 -121.01 162.46 19.89 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.857 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.613 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 21.1 mm-40 -142.06 -172.86 3.67 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.296 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.506 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.7 t70 63.1 80.04 0.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.376 0.607 . . . . 0.0 110.469 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.35 128.09 43.87 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.841 0.829 . . . . 0.0 110.672 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.471 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.0 ptt180 -121.78 154.42 37.0 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.402 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -102.84 126.33 49.93 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -162.5 140.96 8.78 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.622 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 58.65 24.14 11.78 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 123.671 0.607 . . . . 0.0 110.624 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.6 mtp 72.74 13.44 5.16 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.348 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.516 HG12 ' HD2' ' A' ' 71' ' ' PRO . 12.9 m -127.31 -177.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -112.42 139.68 47.79 Favored 'General case' 0 CA--C 1.471 -2.081 0 CA-C-O 121.303 0.573 . . . . 0.0 109.855 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.471 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.8 t -128.94 122.55 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 0 CA-C-N 115.14 -0.937 . . . . 0.0 108.77 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.421 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 16.1 ttm180 -112.24 126.17 54.94 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.506 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -129.95 145.51 51.63 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.177 -173.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 3.6 tppp? 81.78 111.94 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.48 0 O-C-N 124.54 1.15 . . . . 0.0 110.902 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.548 ' HB2' HD13 ' A' ' 47' ' ' ILE . 59.3 Cg_endo -78.72 152.44 25.61 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 122.15 1.9 . . . . 0.0 111.622 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.613 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 32.4 mtmt -81.53 -5.43 57.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.422 0.629 . . . . 0.0 111.214 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -146.19 -165.39 2.2 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 39.9 tt0 -86.04 102.0 13.43 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.596 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -116.91 120.92 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.167 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 22.5 mmtt -120.02 164.7 15.73 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.181 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.454 ' O ' HD12 ' A' ' 61' ' ' LEU . 12.9 p -118.67 130.92 72.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.274 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -90.73 118.92 30.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.6 0.714 . . . . 0.0 111.461 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.9 m -134.24 146.68 50.31 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.819 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.527 HG12 HD11 ' A' ' 176' ' ' ILE . 2.8 mm -90.26 141.03 14.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.334 0.588 . . . . 0.0 110.345 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.51 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 13.5 t70 -80.57 121.14 25.43 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.707 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -78.16 -8.52 58.39 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.237 0.541 . . . . 0.0 111.876 -169.287 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.51 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.5 pt-20 -103.27 -31.56 10.02 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.35 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.485 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 68.2 p -111.84 -18.11 12.78 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.78 -175.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.46 21.34 79.63 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.345 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.485 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 38.2 mtpt -98.14 162.24 13.31 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 120.865 0.364 . . . . 0.0 111.464 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.46 110.45 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-O 121.767 0.794 . . . . 0.0 109.509 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 m -110.05 156.88 10.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.051 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 49' ' ' VAL . 13.5 tp -123.1 136.87 54.98 Favored 'General case' 0 N--CA 1.411 -2.387 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 170' ' ' LYS . 10.3 t -142.66 171.21 14.37 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.939 0.399 . . . . 0.0 111.316 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.418 ' O ' ' HB1' ' A' ' 169' ' ' ALA . 0.9 OUTLIER -80.26 161.04 25.34 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.395 178.63 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.3 mp -101.15 136.72 31.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.222 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.404 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 46.6 mm-40 -83.59 -41.22 18.11 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -179.49 178.01 0.7 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.405 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.502 ' HA ' HD22 ' A' ' 167' ' ' LEU . 13.3 t -105.86 132.76 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.795 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 166' ' ' SER . 60.3 mt -91.28 108.45 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.095 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.512 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.7 tttt -124.56 107.93 11.55 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.52 144.53 53.75 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.312 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.516 ' HD2' HG12 ' A' ' 37' ' ' VAL . 9.8 Cg_endo -53.97 131.67 45.74 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.389 2.726 . . . . 0.0 112.29 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.451 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -78.15 -108.95 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.728 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 86.2 m 77.02 -21.45 0.33 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.945 0.498 . . . . 0.0 111.878 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.469 ' HB2' ' H ' ' A' ' 75' ' ' HIS . 0.8 OUTLIER -79.79 -139.77 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.446 179.114 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.469 ' H ' ' HB2' ' A' ' 74' ' ' ASP . 74.3 m-70 -150.68 165.79 32.36 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.828 HD23 ' HA ' ' A' ' 90' ' ' THR . 30.5 mt -135.98 136.54 40.44 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.117 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.539 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 15.6 mt -89.61 146.24 6.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 172.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 28.8 ttt85 -121.08 137.87 54.45 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 121.153 0.501 . . . . 0.0 109.999 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.602 ' CD1' HD13 ' A' ' 151' ' ' ILE . 50.7 m-85 -117.57 127.31 53.84 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.2 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 32.4 tt0 -112.88 130.3 56.15 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.859 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -94.27 162.04 14.01 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.04 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 1.058 ' HG2' HD11 ' A' ' 149' ' ' LEU . 4.3 pt-20 -58.27 -22.42 52.47 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.875 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.715 ' OD1' ' HG ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -86.69 -10.8 52.92 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.575 0.702 . . . . 0.0 109.498 -178.618 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.78 14.4 58.11 Favored Glycine 0 C--N 1.297 -1.602 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.191 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.639 ' HG3' ' HB2' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -89.64 142.48 27.64 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.308 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 35.3 p -139.95 154.33 47.17 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.888 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 79' ' ' PHE . 9.3 p90 -142.86 151.34 40.97 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.723 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 96.9 mt-10 -125.8 146.12 49.93 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.56 -177.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -142.31 159.46 42.19 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.406 -179.065 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.828 ' HA ' HD23 ' A' ' 76' ' ' LEU . 1.7 m -73.62 19.22 0.11 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.3 0.571 . . . . 0.0 112.478 -177.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.017 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.88 -34.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 124.78 1.232 . . . . 0.0 113.249 175.152 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 23.3 t70 -78.62 -24.59 45.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.129 0.49 . . . . 0.0 110.017 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -77.8 119.97 79.49 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.277 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 35.1 Cg_exo -62.2 139.83 80.13 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.522 2.815 . . . . 0.0 114.014 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.5 t -100.28 147.42 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.736 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.5 tp -98.02 106.16 18.42 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.168 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.626 HG13 HG12 ' A' ' 104' ' ' ILE . 2.4 p -112.55 149.37 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.678 0.751 . . . . 0.0 112.258 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -104.05 92.81 4.54 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.781 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.579 ' OE2' ' HE3' ' A' ' 106' ' ' LYS . 6.1 pt-20 -138.85 159.94 40.9 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 89.9 m-20 63.14 22.37 13.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.332 0.587 . . . . 0.0 109.7 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.29 16.68 62.91 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.298 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 102' ' ' ARG . 11.1 ptp180 -136.4 171.99 13.67 Favored 'General case' 0 N--CA 1.399 -2.979 0 CA-C-N 117.605 0.702 . . . . 0.0 109.916 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -98.36 121.25 40.07 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.626 HG12 HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -126.98 148.75 31.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.132 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 3.3 mp0 -108.11 116.45 31.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.515 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.585 ' HE2' HG13 ' A' ' 104' ' ' ILE . 51.0 mttm -124.62 134.72 52.82 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.328 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 75.3 mtm180 -56.66 154.78 8.39 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.017 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -59.87 -41.74 92.18 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.935 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 3.4 p90 -73.51 2.11 8.53 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.92 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -114.14 -19.26 11.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.863 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 107' ' ' ARG . 53.1 t -76.97 152.3 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.723 ' HE2' ' H ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -123.94 167.08 14.61 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -71.15 143.53 50.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.99 4.96 74.19 Favored Glycine 0 C--N 1.304 -1.199 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.569 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.968 ' HB3' HD12 ' A' ' 151' ' ' ILE . 15.2 t70 -72.03 178.81 3.56 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.69 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 71.4 mttt -135.45 154.52 51.41 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.62 0.724 . . . . 0.0 112.037 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.05 155.64 41.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.895 173.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.533 ' HA ' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -97.12 135.91 38.41 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.8 OUTLIER -104.93 125.96 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.747 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.819 176.378 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.295 -1.77 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 175.647 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.69 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.9 mm? . . . . . 0 CA--C 1.475 -1.907 0 CA-C-O 121.03 0.443 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.058 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -119.28 135.95 54.46 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.006 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 25.8 mt-10 -83.19 141.51 31.87 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.96 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.968 HD12 ' HB3' ' A' ' 115' ' ' ASP . 73.0 mt -80.17 104.87 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.995 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.586 174.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.558 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 14.1 mmtm -70.64 -37.13 73.74 Favored 'General case' 0 C--N 1.266 -3.06 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.159 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -148.92 129.25 13.77 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 75.7 mt -113.11 144.82 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.529 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.471 ' HD2' ' HD3' ' A' ' 78' ' ' ARG . 5.2 ptpp? -145.99 156.14 43.29 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.815 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.539 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 5.1 m-85 -98.94 117.82 34.31 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -126.2 175.65 7.97 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.094 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.521 -178.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 23.3 mtt-85 -100.6 164.46 11.88 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.625 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.703 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.87 -30.16 63.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.511 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.6 t30 66.37 -38.76 0.31 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.358 1.063 . . . . 0.0 113.279 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -98.04 -174.36 2.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.37 -13.09 16.8 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 120.71 0.291 . . . . 0.0 110.905 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -139.29 155.95 47.37 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.18 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.4 m -128.28 160.09 38.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.505 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.623 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 81.4 m-85 -132.76 169.75 16.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.555 0.217 . . . . 0.0 110.736 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.654 ' HB2' HD12 ' A' ' 68' ' ' ILE . 20.3 m -156.78 -27.99 0.09 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.504 ' HG ' HD21 ' A' ' 24' ' ' LEU . 1.3 tm? 73.05 112.22 0.06 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.996 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -91.94 116.67 29.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.605 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 63' ' ' ASP . . . -134.16 -164.1 1.46 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.677 176.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.407 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 26.1 mmmt . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.606 HG21 HD11 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -173.83 166.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.309 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.527 HD11 HG12 ' A' ' 52' ' ' ILE . 85.7 mt -109.53 112.95 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.639 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.603 HG23 HG13 ' A' ' 175' ' ' VAL . 44.9 pt -120.51 171.59 8.8 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.683 0 CA-C-O 121.375 0.607 . . . . 0.0 112.482 -175.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.573 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 44.8 t30 48.68 -128.12 1.97 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.002 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.506 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 19.7 mm-40 -85.61 48.71 1.63 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.334 0.587 . . . . 0.0 109.592 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.5 m-20 70.29 44.79 0.7 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.128 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 82.1 mt -86.27 113.08 23.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.407 HG11 HG13 ' A' ' 52' ' ' ILE . 3.0 m -80.34 135.6 25.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.758 0.789 . . . . 0.0 111.271 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.293 -1.849 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.581 176.868 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.401 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 1.5 m-85 . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.454 ' HD3' HD13 ' A' ' 76' ' ' LEU . 61.6 Cg_endo -70.43 157.01 60.37 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 N-CA-C 108.413 -1.418 . . . . 0.0 108.413 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.59 -21.46 35.32 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 119.735 -1.221 . . . . 0.0 112.397 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -74.27 -1.26 19.87 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.4 m -74.39 130.93 40.58 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.928 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 8.7 mmt180 -81.86 126.2 31.6 Favored 'General case' 0 C--O 1.197 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.485 HD11 HG21 ' A' ' 175' ' ' VAL . 9.5 tt -117.67 129.75 73.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.039 0.447 . . . . 0.0 109.877 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.463 ' CD2' ' HB2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -89.72 124.17 34.38 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-O 121.531 0.681 . . . . 0.0 109.917 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 19.3 m -137.64 -177.87 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.342 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.479 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 30.2 tt0 -126.08 118.84 26.13 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.582 HG12 HG13 ' A' ' 47' ' ' ILE . 20.7 mt -119.19 121.7 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.727 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.28 39.5 30.91 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.933 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.27 19.58 78.77 Favored Glycine 0 N--CA 1.439 -1.116 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.849 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.96 122.76 24.45 Favored Pre-proline 0 N--CA 1.434 -1.264 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 44.1 Cg_endo -71.54 120.22 6.78 Favored 'Trans proline' 0 N--CA 1.432 -2.126 0 C-N-CA 121.931 1.754 . . . . 0.0 110.675 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -122.98 142.06 51.25 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.622 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.463 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 39.1 ttmt -112.29 100.89 9.16 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.1 pt -119.44 -178.41 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.912 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.106 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.801 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.8 p -93.28 174.52 7.17 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.142 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 94.5 mt -66.94 -31.39 71.93 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 120.726 0.298 . . . . 0.0 110.551 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.801 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 9.5 ptm180 -78.5 -22.5 47.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB2' ' H ' ' A' ' 20' ' ' THR . 38.8 mm-40 -84.56 -45.79 12.23 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.527 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.737 HD23 ' HG ' ' A' ' 167' ' ' LEU . 13.4 tp -58.91 -42.66 90.19 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.787 0.804 . . . . 0.0 109.51 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.429 ' HD1' HG11 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -53.98 -30.37 46.8 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.637 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.73 -17.89 59.76 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 23' ' ' GLU . 1.5 mm? -80.56 1.51 29.3 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.577 0.703 . . . . 0.0 109.663 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.7 m-85 -119.01 161.65 19.87 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.107 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -144.72 -171.42 3.61 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.033 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.539 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.2 t70 65.71 76.75 0.31 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.539 0.685 . . . . 0.0 109.584 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -100.93 131.54 46.76 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.103 0.954 . . . . 0.0 111.752 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.511 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 17.6 ptt-85 -121.53 153.87 37.4 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.048 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -104.04 123.18 46.77 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -160.76 148.76 16.02 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.06 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 59.57 22.62 11.26 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 123.571 0.544 . . . . 0.0 110.76 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 41.7 mtm 72.96 16.79 4.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.943 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.6 m -133.33 -169.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.937 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.558 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 71.6 m-85 -110.84 137.72 48.14 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.511 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.8 t -132.49 124.86 52.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.5 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.471 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 22.9 ttm180 -117.23 127.73 54.38 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -131.91 147.51 52.47 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.696 -175.156 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 23.0 tptm 81.8 111.79 0.03 OUTLIER Pre-proline 0 C--O 1.236 0.389 0 O-C-N 124.197 0.935 . . . . 0.0 111.056 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.578 ' HB2' HD13 ' A' ' 47' ' ' ILE . 63.3 Cg_endo -78.32 152.28 26.89 Favored 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.299 1.999 . . . . 0.0 112.043 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -87.03 -0.71 57.07 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.134 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 45' ' ' ARG . 49.2 mtt180 -148.67 -164.79 2.11 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 4.1 tp10 -85.58 98.27 10.55 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.582 HG13 HG12 ' A' ' 12' ' ' ILE . 1.8 mp -117.15 114.94 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.083 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 34.0 mmtp -120.38 163.7 17.47 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.72 175.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.486 HG11 ' CB ' ' A' ' 169' ' ' ALA . 11.7 p -120.49 133.44 67.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.647 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.479 ' CE1' ' HB2' ' A' ' 11' ' ' GLN . 42.7 m-85 -82.92 124.39 30.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.925 176.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.403 ' HB3' ' OD1' ' A' ' 174' ' ' ASN . 56.4 m -121.58 175.54 6.16 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.522 HG12 HD11 ' A' ' 176' ' ' ILE . 2.8 mm -127.95 138.51 54.5 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-O 121.491 0.662 . . . . 0.0 110.625 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.749 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.3 t70 -86.59 110.55 19.9 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.432 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.792 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -68.33 -13.16 62.07 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.897 0.879 . . . . 0.0 112.595 -171.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.749 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -98.28 -25.31 14.9 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.868 -175.5 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.538 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.3 p -117.24 -26.56 6.72 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.519 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.15 22.59 44.31 Favored Glycine 0 N--CA 1.426 -1.983 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.055 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.538 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 37.1 mtpt -97.6 155.42 16.98 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.41 ' HA ' HD13 ' A' ' 52' ' ' ILE . 3.9 p -96.95 109.26 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.919 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 m -109.63 162.4 7.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.707 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.4 tp -118.57 142.99 47.08 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -149.81 173.06 14.17 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.067 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -84.46 161.74 20.18 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.614 0.721 . . . . 0.0 110.716 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.5 mp -97.76 144.58 10.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.889 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.559 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.8 mm-40 -88.78 -42.47 11.9 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 p30 178.2 175.81 0.51 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.12 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 14.6 t -108.14 132.22 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.917 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 166' ' ' SER . 17.4 mt -98.52 114.78 37.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.511 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 85.8 tttt -126.13 111.92 15.21 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.8 143.34 48.98 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.358 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.429 ' HD2' HG12 ' A' ' 37' ' ' VAL . 7.0 Cg_endo -52.43 124.04 14.15 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.323 2.682 . . . . 0.0 112.597 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.75 81.9 8.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.367 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.2 m -91.57 -36.37 13.73 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.64 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -85.95 177.98 7.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.447 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -103.96 171.33 7.41 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.1 mt -122.84 140.2 53.2 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.8 0.809 . . . . 0.0 111.24 -174.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.507 HG23 HG23 ' A' ' 154' ' ' ILE . 14.3 mt -86.4 140.17 16.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 31.1 ttt180 -118.23 138.53 52.28 Favored 'General case' 0 N--CA 1.4 -2.972 0 CA-C-O 121.25 0.547 . . . . 0.0 109.741 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 86' ' ' SER . 59.4 m-85 -114.67 123.55 49.57 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.344 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 152' ' ' LYS . 40.6 tt0 -109.93 121.25 44.82 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.679 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -88.4 160.74 17.43 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.64 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.781 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -60.57 -22.57 63.82 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.285 -179.376 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -85.17 -11.2 55.57 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.523 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.85 17.41 44.44 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.823 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.596 ' O ' HD23 ' A' ' 81' ' ' LEU . 2.0 mtt180 -83.99 132.27 34.76 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 50.3 p -138.59 137.86 37.38 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 118.608 -1.237 . . . . 0.0 112.033 176.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.408 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 3.8 p90 -133.31 148.78 51.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.348 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 24.5 mt-10 -119.81 151.24 39.14 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.718 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.474 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.7 OUTLIER -144.11 154.99 43.76 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.728 178.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.706 ' HA ' HD23 ' A' ' 76' ' ' LEU . 2.8 m -75.21 18.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.831 0.824 . . . . 0.0 111.455 -177.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.049 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 71.35 -30.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 125.434 1.493 . . . . 0.0 113.004 175.578 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.64 -5.94 59.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.155 0.502 . . . . 0.0 109.999 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -87.24 128.84 53.87 Favored Pre-proline 0 CA--C 1.512 -0.484 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.821 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 64.2 Cg_endo -72.52 141.02 34.03 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.808 2.339 . . . . 0.0 112.469 177.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 10.7 t -118.01 152.29 20.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 124.183 0.993 . . . . 0.0 109.585 -176.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 103' ' ' PHE . 1.6 tm? -101.22 114.35 28.24 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.643 HG13 HG13 ' A' ' 104' ' ' ILE . 2.2 p -114.12 146.91 18.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.411 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -102.94 91.51 4.16 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.246 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 8.2 pt-20 -141.36 158.84 43.35 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 10.5 m120 64.74 22.19 12.52 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.211 0.529 . . . . 0.0 109.625 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.39 16.68 60.88 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.849 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -138.27 172.22 13.22 Favored 'General case' 0 N--CA 1.407 -2.617 0 CA-C-O 121.355 0.598 . . . . 0.0 110.244 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.44 ' HB3' HD11 ' A' ' 96' ' ' LEU . 44.2 m-85 -97.35 121.0 38.75 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.896 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.643 HG13 HG13 ' A' ' 97' ' ' VAL . 30.9 pt -121.77 153.3 25.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.068 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 28.5 mt-10 -115.92 116.76 28.52 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.907 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.562 ' HG3' HG22 ' A' ' 111' ' ' VAL . 1.1 ptpm? -137.5 145.49 43.07 Favored 'General case' 0 C--O 1.202 -1.41 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.592 ' O ' HG23 ' A' ' 111' ' ' VAL . 77.3 mtt180 -65.27 162.78 16.67 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.049 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -61.69 -40.72 95.98 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.267 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.412 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 2.3 p90 -75.57 1.47 14.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.61 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -111.22 -19.15 12.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.52 0.676 . . . . 0.0 109.493 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 107' ' ' ARG . 85.2 t -72.43 150.17 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -123.66 163.44 21.06 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.571 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -68.92 143.08 54.56 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.68 5.19 74.99 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.325 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.998 ' HB3' HD12 ' A' ' 151' ' ' ILE . 16.8 t70 -71.4 168.36 17.62 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.655 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 48.4 mttp -127.27 152.49 47.35 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 121.452 0.644 . . . . 0.0 110.789 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.408 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -125.29 153.53 32.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.288 175.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.522 ' HA ' ' CD1' ' A' ' 148' ' ' LEU . 0.5 OUTLIER -89.4 134.89 33.88 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.795 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.7 OUTLIER -100.68 145.0 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.978 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 172.093 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 C--N 1.31 -1.136 0 CA-C-O 121.475 0.655 . . . . 0.0 109.945 179.68 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.655 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.8 mm? . . . . . 0 CA--C 1.484 -1.566 0 CA-C-O 121.081 0.467 . . . . 0.0 109.76 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.781 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -116.76 137.97 51.81 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.508 -176.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.53 ' H ' HD13 ' A' ' 149' ' ' LEU . 17.6 mt-10 -89.03 146.38 24.89 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.284 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.998 HD12 ' HB3' ' A' ' 115' ' ' ASP . 81.4 mt -78.58 107.46 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.777 0 CA-C-N 113.407 -1.724 . . . . 0.0 108.969 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 80' ' ' GLU . 8.0 mmpt? -70.23 -39.4 75.12 Favored 'General case' 0 C--N 1.268 -2.977 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.566 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -149.29 133.52 17.35 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 74.3 mt -115.61 127.68 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 CA-C-N 113.668 -1.605 . . . . 0.0 110.927 175.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.5 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 1.6 ptpp? -132.49 163.35 29.01 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.97 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.452 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.0 m-85 -100.98 115.33 30.21 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.434 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -127.38 137.47 57.65 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.585 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.798 -178.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 158' ' ' ARG . 11.0 ptt180 -71.44 160.83 32.05 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.36 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.66 126.86 31.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.043 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -65.43 -37.94 88.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.288 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -106.96 174.84 5.71 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.294 -177.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.56 2.29 51.21 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.396 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -141.95 153.13 44.11 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.199 0.523 . . . . 0.0 110.456 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.14 157.43 31.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.712 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 76.4 m-85 -132.8 165.17 25.19 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.777 0.322 . . . . 0.0 110.51 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.657 ' HB2' HD12 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -146.38 -24.93 0.43 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.882 174.596 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.737 ' HG ' HD23 ' A' ' 24' ' ' LEU . 3.6 mm? 62.68 101.09 0.03 OUTLIER 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.892 0.745 . . . . 0.0 110.645 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.475 ' HB2' HD11 ' A' ' 68' ' ' ILE . 58.6 t30 -83.47 121.17 26.84 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.703 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.559 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -131.28 -157.7 0.84 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? . . . . . 0 C--N 1.319 -0.722 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.712 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' A' ' 183' ' ' THR . 3.7 t-20 . . . . . 0 N--CA 1.439 -1.01 0 CA-C-O 120.824 0.345 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.496 HG13 HG23 ' A' ' 177' ' ' ILE . 5.4 p -149.03 164.13 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-O 121.494 0.664 . . . . 0.0 110.767 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.703 HG23 ' HA ' ' A' ' 180' ' ' ASN . 2.4 mp -93.88 115.7 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.489 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.496 HG23 HG13 ' A' ' 175' ' ' VAL . 36.7 pt -118.49 166.41 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-O 120.87 0.367 . . . . 0.0 110.729 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.41 ' HB3' HD12 ' A' ' 181' ' ' ILE . 30.4 t30 47.91 -131.99 1.46 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.187 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -81.52 53.34 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.338 0.589 . . . . 0.0 110.061 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.795 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 13.0 m-80 65.05 46.9 2.65 Favored 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 125.272 1.429 . . . . 0.0 113.194 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' A' ' 178' ' ' ASN . 88.9 mt -91.21 115.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.04 148.55 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-O 122.039 0.923 . . . . 0.0 112.528 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 2.0 t . . . . . 0 C--N 1.294 -1.837 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.362 175.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 N--CA 1.444 -0.745 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.611 ' HD3' HD13 ' A' ' 76' ' ' LEU . 57.3 Cg_endo -67.24 158.48 56.74 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 N-CA-C 108.512 -1.38 . . . . 0.0 108.512 177.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.12 -27.42 51.83 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 119.477 -1.344 . . . . 0.0 112.035 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -67.17 -13.23 61.76 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.445 ' HB ' HD12 ' A' ' 21' ' ' LEU . 93.6 m -61.44 125.7 24.71 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.422 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 37.6 mmt-85 -79.73 125.26 29.43 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.811 HD11 HG21 ' A' ' 175' ' ' VAL . 10.4 tt -116.33 129.42 72.79 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 CA-C-O 120.84 0.352 . . . . 0.0 110.245 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 9' ' ' LEU . 1.0 OUTLIER -89.34 122.99 33.1 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.63 0.729 . . . . 0.0 110.17 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.2 m -133.03 -179.16 3.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.694 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.409 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 30.9 tt0 -130.97 121.35 24.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.425 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.65 HG12 HG13 ' A' ' 47' ' ' ILE . 15.1 mt -119.96 120.98 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.928 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.598 -177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 54.21 37.22 26.8 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.198 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.01 18.12 80.22 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.829 -1.078 . . . . 0.0 113.529 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -123.58 119.31 27.16 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 43.5 Cg_endo -73.0 121.74 7.54 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.438 2.092 . . . . 0.0 111.291 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -125.75 140.49 52.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.829 -177.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -110.39 102.36 11.0 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.653 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.8 pt -125.43 -171.68 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.642 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.705 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.9 p -96.26 174.39 6.91 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.096 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 62.1 mt -69.87 -31.07 68.7 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.124 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.705 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 3.9 ptm180 -77.34 -25.86 51.51 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.522 ' OE1' HG23 ' A' ' 20' ' ' THR . 84.9 mt-10 -84.73 -40.34 17.41 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.652 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.483 HD21 ' HG ' ' A' ' 167' ' ' LEU . 18.8 tp -59.35 -45.74 90.56 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.746 0.784 . . . . 0.0 109.842 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.512 ' HD1' HG11 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -49.07 -32.55 9.83 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.759 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.9 mt-10 -74.63 -17.26 60.72 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.204 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.54 5.12 13.77 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.501 0.667 . . . . 0.0 109.884 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.526 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.0 m-85 -118.28 164.61 14.94 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.519 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.409 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 5.1 mm-40 -145.8 -172.85 4.0 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.659 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.568 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 18.9 t0 64.88 75.14 0.38 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.602 0.715 . . . . 0.0 109.358 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -102.69 134.28 46.33 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.416 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.492 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.4 ptt180 -127.54 154.54 45.04 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.792 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -105.51 129.9 53.69 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -166.78 153.84 9.05 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.556 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 59.26 21.24 9.41 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 123.49 0.494 . . . . 0.0 110.804 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 45.3 mtm 70.86 16.79 6.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.411 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 6.1 m -131.82 -168.29 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.444 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 79.4 m-85 -116.61 140.06 49.81 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.492 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.3 t -130.32 123.5 55.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.422 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 19.6 ttm180 -118.62 127.03 53.21 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.568 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -131.15 143.33 50.54 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.185 -174.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 40.0 ttmt 79.58 116.42 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 124.158 0.983 . . . . 0.0 111.383 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.598 ' HB2' HD13 ' A' ' 47' ' ' ILE . 68.6 Cg_endo -79.47 160.31 25.58 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 C-N-CA 122.494 2.129 . . . . 0.0 112.57 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.409 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 34.2 mtmt -88.19 -3.19 58.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.534 0.683 . . . . 0.0 110.351 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.469 ' HB2' HD12 ' A' ' 47' ' ' ILE . 64.8 mtt180 -142.11 -165.28 1.98 Allowed 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 10.1 tp10 -89.21 100.87 13.56 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 171.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.65 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -114.29 117.46 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.175 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 17.7 mmtm -115.86 166.17 12.27 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.976 174.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.566 HG13 HD11 ' A' ' 64' ' ' ILE . 3.3 m -117.58 130.38 72.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.258 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.57 ' HB3' HD12 ' A' ' 176' ' ' ILE . 3.2 m-85 -79.35 121.86 25.66 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 172.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.0 t -133.59 177.03 8.02 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 58' ' ' LYS . 2.1 mm -131.21 142.18 44.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.332 0.587 . . . . 0.0 110.65 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.583 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.1 t70 -81.43 118.33 22.61 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.729 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -72.52 -12.74 61.2 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -170.277 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.583 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -103.4 -26.9 12.72 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.179 -176.097 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.0 p -116.77 -20.54 9.45 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.849 -0.741 . . . . 0.0 111.872 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.95 11.84 82.03 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.015 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.477 ' O ' HD13 ' A' ' 52' ' ' ILE . 3.3 mptp? -75.97 145.83 40.04 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 122.693 0.397 . . . . 0.0 111.366 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.451 ' HA ' HD13 ' A' ' 52' ' ' ILE . 4.7 p -90.15 106.72 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 121.993 0.901 . . . . 0.0 109.324 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 m -110.16 155.8 11.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.159 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 49' ' ' VAL . 10.2 tp -122.11 134.25 54.76 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.595 HG21 ' HB2' ' A' ' 170' ' ' LYS . 14.7 t -144.91 172.39 13.1 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.817 -176.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -84.28 162.3 20.16 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.787 0.804 . . . . 0.0 111.515 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 49' ' ' VAL . 2.8 mp -95.95 144.96 9.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.692 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.537 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 29.7 mm-40 -89.65 -39.91 12.91 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 p30 176.88 174.92 0.39 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.959 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.526 ' HA ' HD22 ' A' ' 167' ' ' LEU . 14.7 t -105.04 129.26 58.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.257 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.71 HD12 ' HB2' ' A' ' 166' ' ' SER . 51.2 mt -91.76 104.96 16.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.474 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.549 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.2 tttt -121.3 109.17 14.6 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.5 139.58 35.18 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.215 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.507 ' HD2' HG12 ' A' ' 37' ' ' VAL . 97.0 Cg_exo -44.76 124.3 5.5 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 123.471 2.781 . . . . 0.0 112.736 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.59 78.4 9.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.711 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.4 p -84.86 -53.03 5.59 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.931 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.6 171.37 14.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.218 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -102.68 171.55 7.36 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.681 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.2 mt -127.43 143.29 51.23 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.651 0.739 . . . . 0.0 111.673 -173.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.499 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 23.6 mt -86.62 143.02 12.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 173.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 34.5 ttt85 -118.03 138.72 52.03 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.178 0.514 . . . . 0.0 109.999 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.1 m-85 -116.71 123.3 46.88 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.888 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 152' ' ' LYS . 32.5 tt0 -109.87 125.53 52.88 Favored 'General case' 0 CA--C 1.471 -2.058 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.756 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.13 160.02 17.96 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.325 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.806 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.0 pt-20 -61.6 -15.99 44.17 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.113 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -98.06 -6.04 32.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.791 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.3 12.44 56.13 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.164 -0.926 . . . . 0.0 113.759 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.544 ' O ' HD23 ' A' ' 81' ' ' LEU . 3.5 mtt180 -82.97 141.79 31.85 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.8 p -144.22 141.26 29.76 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.972 -1.091 . . . . 0.0 113.497 175.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -138.49 155.99 47.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.613 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 87.0 mt-10 -129.97 153.98 47.83 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.17 0.51 . . . . 0.0 112.265 -177.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.9 OUTLIER -148.51 161.23 42.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.658 178.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.681 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -70.83 10.45 0.52 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.42 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.044 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 72.69 -27.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 124.838 1.255 . . . . 0.0 112.205 177.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.554 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 0.8 OUTLIER -78.75 -10.84 59.91 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.243 0.544 . . . . 0.0 109.807 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -97.14 140.92 22.34 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.367 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 89.3 Cg_endo -79.49 137.87 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.249 2.633 . . . . 0.0 113.699 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.5 t -105.09 147.2 11.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.0 tp -105.39 110.38 22.71 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.716 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.513 HG13 HG13 ' A' ' 104' ' ' ILE . 2.5 p -110.87 153.56 12.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.496 0.665 . . . . 0.0 111.531 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -104.21 93.74 4.99 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.258 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.0 pt-20 -143.26 158.48 43.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.3 m-20 64.15 21.85 12.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.17 13.77 60.53 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.803 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -135.2 172.37 13.11 Favored 'General case' 0 N--CA 1.401 -2.885 0 CA-C-O 121.165 0.507 . . . . 0.0 109.93 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -100.94 121.27 41.46 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.513 HG13 HG13 ' A' ' 97' ' ' VAL . 25.1 pt -119.27 141.67 38.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.197 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -97.09 114.49 26.15 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.14 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.492 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 13.9 ptpt -128.59 135.36 49.24 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.958 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.618 ' O ' HG23 ' A' ' 111' ' ' VAL . 11.5 mmt180 -62.0 159.22 14.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.044 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -57.92 -43.03 85.99 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.222 -176.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.477 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.7 p90 -73.01 -0.21 13.17 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.177 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -110.63 -15.3 13.89 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.606 0.717 . . . . 0.0 109.848 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 107' ' ' ARG . 89.5 t -77.84 149.43 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.691 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 13.8 mtmt -123.24 164.88 17.89 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.994 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -66.98 141.36 57.62 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.66 77.93 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.895 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.691 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -75.04 168.55 19.76 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.4 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.707 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 72.2 mttt -124.18 161.57 25.44 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.339 0.59 . . . . 0.0 112.076 -177.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.11 156.37 39.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.417 172.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.63 ' HG ' HD11 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -95.86 138.29 33.71 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 123.228 0.33 . . . . 0.0 110.571 -178.282 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.782 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.0 m -100.65 145.1 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.516 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 1.7 m . . . . . 0 C--N 1.299 -1.628 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.122 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.707 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 4.1 mm? . . . . . 0 CA--C 1.475 -1.905 0 CA-C-O 121.112 0.482 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.806 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -111.96 133.29 54.23 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.164 -177.827 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 20.2 mt-10 -86.02 143.61 28.02 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.111 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.48 HD13 ' CD1' ' A' ' 79' ' ' PHE . 69.5 mt -81.48 102.65 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.077 174.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.532 ' HE2' ' HB2' ' A' ' 82' ' ' GLU . 50.9 mmtt -66.1 -38.63 88.71 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.252 177.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -147.87 129.22 14.79 Favored 'General case' 0 CA--C 1.476 -1.882 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 72.1 mt -112.81 143.48 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.324 174.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.463 ' HD2' ' HD3' ' A' ' 78' ' ' ARG . 19.7 ptpt -149.13 161.31 42.24 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.355 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.499 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 17.7 m-85 -101.8 115.01 29.59 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.54 174.61 10.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.237 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.06 159.02 16.03 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.436 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.44 129.75 40.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.354 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -64.15 -42.12 96.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.972 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -101.02 175.89 5.45 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.041 0.448 . . . . 0.0 111.156 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.63 3.68 51.86 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.02 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -141.38 151.16 43.26 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.786 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.6 m -121.28 157.27 24.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 72.2 m-85 -132.98 172.11 13.06 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.89 0.376 . . . . 0.0 110.388 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.71 ' HB2' HD12 ' A' ' 68' ' ' ILE . 51.9 m -156.18 -22.17 0.1 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.526 HD22 ' HA ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER 63.36 104.35 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.236 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -85.22 115.68 23.13 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.302 -176.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.537 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -125.63 -149.54 0.42 Allowed 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.595 ' HB2' HG21 ' A' ' 62' ' ' THR . 0.4 OUTLIER . . . . . 0 C--N 1.313 -0.978 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.088 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 CA--C 1.506 -0.748 0 CA-C-O 121.097 0.475 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.811 HG21 HD11 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -144.86 164.07 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 121.354 0.597 . . . . 0.0 111.444 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.617 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.3 mt -95.55 120.78 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.456 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 39.1 pt -125.01 166.93 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.51 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 52.81 -134.97 1.59 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.921 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.19 51.58 2.23 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.602 0.715 . . . . 0.0 109.572 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.782 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 20.6 m-80 71.92 53.23 0.2 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.525 177.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 97.2 mt -93.78 116.17 34.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.5 m -82.86 159.06 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.538 0.685 . . . . 0.0 111.861 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.307 -1.27 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.785 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.481 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 34.8 m-85 . . . . . 0 N--CA 1.434 -1.233 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.539 ' HD3' HD13 ' A' ' 76' ' ' LEU . 19.1 Cg_endo -59.4 -35.34 96.65 Favored 'Trans proline' 0 N--CA 1.48 0.688 0 C-N-CA 123.129 2.553 . . . . 0.0 112.21 -177.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.719 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 132.76 -35.78 2.27 Favored Glycine 0 N--CA 1.413 -2.857 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -177.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.07 -17.03 61.83 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.395 0.617 . . . . 0.0 111.11 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 69.0 m -61.15 125.19 22.84 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.584 177.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.5 mmt180 -86.09 132.95 33.92 Favored 'General case' 0 C--O 1.183 -2.43 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.496 ' HB ' ' CD2' ' A' ' 21' ' ' LEU . 9.5 tt -118.92 131.74 70.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 C-N-CA 122.556 0.342 . . . . 0.0 110.159 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.543 HD12 ' CD2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -84.59 124.86 31.9 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.29 0.567 . . . . 0.0 109.588 178.214 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 30.5 m -136.67 -179.47 2.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.778 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.585 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 30.1 tt0 -131.99 121.57 24.14 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.139 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.651 HG12 HG13 ' A' ' 47' ' ' ILE . 14.7 mt -121.07 119.81 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.962 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 53.53 41.87 32.02 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.898 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.12 17.88 76.07 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.589 -1.187 . . . . 0.0 113.442 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -123.6 116.15 28.06 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 34.7 Cg_endo -73.25 126.24 10.91 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 122.38 2.053 . . . . 0.0 111.402 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -127.47 142.27 51.45 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.554 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -106.16 101.07 10.58 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.3 pt -122.83 -175.55 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.179 -2.637 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.012 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.867 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.3 p -90.62 174.65 7.39 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.52 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.652 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.5 mm? -71.68 -23.75 61.71 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.984 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.867 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 15.7 ptt180 -85.59 -23.82 27.43 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.444 ' OE1' HG23 ' A' ' 20' ' ' THR . 49.8 mt-10 -83.71 -42.12 16.94 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.977 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.511 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 14.3 tp -56.18 -43.59 78.57 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.769 0.795 . . . . 0.0 109.099 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.496 ' CD1' HG11 ' A' ' 67' ' ' VAL . 7.1 t80 -52.46 -35.5 52.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.512 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 6.4 mm-40 -69.22 -21.71 63.92 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -79.51 4.16 16.54 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.57 0.7 . . . . 0.0 110.139 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.52 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 93.3 m-85 -117.16 160.17 21.46 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.049 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 44' ' ' LYS . 6.7 tt0 -139.84 -176.61 4.64 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t0 64.02 85.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.178 0.513 . . . . 0.0 111.082 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -101.39 131.37 47.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.936 0.874 . . . . 0.0 111.051 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -122.6 152.55 40.33 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.942 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.443 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 35.9 t80 -99.46 129.93 45.68 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -167.15 147.11 5.41 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.609 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 59.41 20.43 8.76 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 123.702 0.626 . . . . 0.0 111.027 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.443 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 39.1 mtp 72.37 17.8 4.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.488 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 13.7 m -133.28 -172.27 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -114.76 142.52 46.4 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-O 121.47 0.652 . . . . 0.0 110.158 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 t -128.71 122.02 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.095 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 28' ' ' PHE . 17.5 ttm180 -111.77 126.66 55.31 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.46 141.78 48.96 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -173.814 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 3.2 ttmp? 83.95 113.09 0.03 OUTLIER Pre-proline 0 CA--C 1.503 -0.833 0 O-C-N 124.812 1.32 . . . . 0.0 111.378 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.603 ' HB2' HD13 ' A' ' 47' ' ' ILE . 74.3 Cg_endo -77.07 155.28 33.52 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 C-N-CA 122.447 2.098 . . . . 0.0 111.807 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 29' ' ' GLU . 37.3 mtmt -87.01 -2.28 58.51 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.371 0.605 . . . . 0.0 110.678 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -147.6 -168.05 2.96 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 40.9 tt0 -85.26 101.41 12.5 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.651 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -115.58 118.2 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.995 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 67.3 mmtt -114.39 169.64 8.89 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.335 174.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.436 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.1 p -124.99 131.09 73.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.795 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.543 ' CD2' HD12 ' A' ' 9' ' ' LEU . 14.2 m-85 -86.16 120.46 27.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.106 0.479 . . . . 0.0 110.306 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.8 t -130.22 176.2 8.3 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.586 HG12 HD11 ' A' ' 176' ' ' ILE . 3.3 mm -116.83 142.25 31.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.536 0.684 . . . . 0.0 111.027 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.688 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 14.9 t70 -77.7 120.32 22.47 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.527 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.726 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -75.54 -8.41 56.68 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.764 -170.443 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.688 ' HG3' ' OD1' ' A' ' 53' ' ' ASP . 2.6 pt-20 -108.18 -25.77 10.92 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.045 -0.662 . . . . 0.0 112.079 -177.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.497 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 70.4 p -117.84 -25.23 6.86 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.772 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.47 12.72 66.71 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.254 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.497 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 40.7 mtpt -87.97 162.97 16.56 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.449 HG22 ' OG ' ' A' ' 120' ' ' SER . 33.5 t -86.67 113.25 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.216 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -110.77 151.78 12.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.088 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 49' ' ' VAL . 10.2 tp -122.86 140.26 53.15 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.7 t -148.91 170.54 18.06 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.814 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.83 161.16 26.97 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.522 0.677 . . . . 0.0 110.524 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.2 mp -96.28 148.14 5.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.84 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.491 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.9 mm-40 -93.09 -42.68 9.27 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 p30 179.59 178.97 0.51 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.72 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.496 HG11 ' CD1' ' A' ' 25' ' ' TYR . 7.6 t -107.55 134.21 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.009 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.654 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 42.9 mt -91.69 99.73 10.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.701 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 84.8 tttt -113.49 107.34 15.69 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.06 136.18 28.64 Favored Pre-proline 0 C--N 1.306 -1.297 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.502 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -48.66 129.4 20.3 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.167 2.578 . . . . 0.0 112.013 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.24 86.94 3.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.07 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.2 m -98.79 -33.16 11.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.436 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.92 167.15 12.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.076 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -100.15 172.84 6.93 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.747 HD23 ' HA ' ' A' ' 90' ' ' THR . 14.9 mt -125.89 145.56 50.21 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.911 0.862 . . . . 0.0 111.907 -174.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.499 HD12 ' C ' ' A' ' 108' ' ' ALA . 13.6 mt -91.91 144.13 9.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.444 172.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 13.0 ttt85 -115.92 137.93 51.65 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.541 ' CD1' HD13 ' A' ' 151' ' ' ILE . 65.7 m-85 -115.85 124.48 50.77 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.548 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.2 tt0 -113.1 125.06 53.96 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.755 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -90.08 162.2 15.44 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.356 -177.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.899 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.7 pt-20 -62.78 -15.63 54.45 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.256 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.73 -12.68 28.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.716 0.77 . . . . 0.0 109.729 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.42 10.1 57.26 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.347 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.624 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -85.12 141.34 30.29 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.729 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 44.3 p -140.84 151.86 44.68 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.919 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -145.83 153.72 41.21 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.244 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 23.6 mt-10 -124.22 149.66 46.16 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.323 -178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -144.0 159.6 42.31 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.439 178.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.747 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -68.37 11.33 0.17 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.67 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.988 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.6 OUTLIER 69.65 -38.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 124.843 1.257 . . . . 0.0 112.059 178.787 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 90' ' ' THR . 16.3 t70 -69.48 -37.55 77.3 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.422 0.629 . . . . 0.0 109.41 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.478 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 37.0 m80 -72.45 131.18 84.96 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.584 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 30.9 Cg_exo -63.65 142.49 83.92 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 123.975 3.117 . . . . 0.0 114.762 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.32 147.85 14.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.437 ' CD1' ' HG2' ' A' ' 105' ' ' GLU . 10.1 tp -100.49 109.92 22.07 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.816 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.642 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.6 p -112.24 150.33 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 121.404 0.621 . . . . 0.0 112.046 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -103.04 92.0 4.36 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.472 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.441 ' CD ' HD11 ' A' ' 104' ' ' ILE . 9.1 pt-20 -139.34 158.4 44.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 90.2 m-20 63.25 22.98 13.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.125 0.488 . . . . 0.0 110.07 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.68 14.7 60.9 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.809 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -135.98 171.71 14.07 Favored 'General case' 0 N--CA 1.4 -2.956 0 CA-C-O 121.217 0.532 . . . . 0.0 110.047 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.603 ' CE1' HD11 ' A' ' 118' ' ' LEU . 32.6 m-85 -103.91 121.74 43.74 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.701 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.441 HD11 ' CD ' ' A' ' 99' ' ' GLU . 23.6 pt -124.44 152.64 30.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.476 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.437 ' HG2' ' CD1' ' A' ' 96' ' ' LEU . 31.8 mt-10 -104.87 110.86 23.4 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.591 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HG3' HG22 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -124.3 139.53 53.83 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.134 176.905 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 5.3 mtp180 -60.79 156.1 17.89 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -176.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.988 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -59.77 -41.06 90.22 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.973 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.483 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 3.0 p90 -74.13 5.76 4.09 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.435 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -115.31 -18.55 11.04 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.471 0.653 . . . . 0.0 109.712 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 107' ' ' ARG . 79.5 t -71.55 150.33 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.005 0.922 . . . . 0.0 108.899 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.748 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.8 OUTLIER -114.17 165.01 13.1 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 120.814 0.34 . . . . 0.0 110.467 -177.113 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -74.24 142.88 45.31 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.409 ' O ' ' HG2' ' A' ' 150' ' ' GLU . . . 86.05 5.63 83.02 Favored Glycine 0 C--N 1.3 -1.462 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.488 -174.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.748 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -75.3 175.19 8.6 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.677 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 49.8 mttp -130.36 162.59 28.75 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.75 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.74 158.72 42.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.378 173.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.603 HD11 ' CE1' ' A' ' 103' ' ' PHE . 2.4 mt -88.81 140.04 29.85 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.79 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -101.46 149.2 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.455 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.191 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.645 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 47.4 t . . . . . 0 C--N 1.308 -1.231 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.446 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.677 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.8 mm? . . . . . 0 CA--C 1.477 -1.859 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.899 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -101.91 132.01 47.96 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 8.6 mt-10 -85.17 140.31 31.02 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.521 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.541 HD13 ' CD1' ' A' ' 79' ' ' PHE . 62.2 mt -78.97 102.26 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.827 0 CA-C-N 113.635 -1.62 . . . . 0.0 109.326 174.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.452 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 6.3 mmpt? -65.64 -37.96 88.02 Favored 'General case' 0 C--N 1.268 -2.948 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.936 178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -149.1 131.28 15.46 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 70.3 mt -115.7 144.76 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.528 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.414 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 18.9 ptpt -150.54 161.2 43.02 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.055 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -99.56 113.06 25.23 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-O 121.379 0.609 . . . . 0.0 109.602 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.56 132.89 70.7 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.439 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -71.47 154.27 41.63 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.75 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.54 123.53 20.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.062 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -85.9 42.57 0.98 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.097 0.475 . . . . 0.0 110.883 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -163.15 -179.34 6.6 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -107.04 -8.73 16.44 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.214 0.531 . . . . 0.0 109.783 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.58 162.13 35.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.247 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.5 m -132.73 162.45 39.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.838 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.654 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 62.8 m-85 -138.95 166.01 25.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.94 -175.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.68 -22.75 0.14 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.511 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER 70.95 110.62 0.06 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.784 176.112 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -90.1 115.59 27.47 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.649 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.491 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.81 -162.76 1.2 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 170' ' ' LYS . 20.3 ttmt . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 120.669 0.271 . . . . 0.0 110.708 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.613 HD21 HG13 ' A' ' 182' ' ' VAL . 27.1 t-20 . . . . . 0 C--O 1.234 0.264 0 CA-C-O 120.705 0.288 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.439 HG21 HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -155.53 148.19 12.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.484 178.725 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 52' ' ' ILE . 47.3 mt -92.2 116.25 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.988 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 25.1 pt -123.27 164.72 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.535 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 23.6 t30 46.34 -134.13 0.95 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 124.532 1.133 . . . . 0.0 110.958 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.52 55.87 2.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.494 0.664 . . . . 0.0 110.38 176.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.79 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 27.8 m-80 63.38 49.14 3.29 Favored 'General case' 0 C--O 1.209 -1.078 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.806 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.471 ' HB ' HG13 ' A' ' 177' ' ' ILE . 96.0 mt -86.78 111.68 21.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.613 HG13 HD21 ' A' ' 174' ' ' ASN . 74.1 t -84.81 117.84 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.889 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.413 -2.295 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.6 179.99 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.464 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 23.3 m-85 . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.566 ' HA ' HG12 ' A' ' 164' ' ' VAL . 21.0 Cg_endo -58.54 -32.28 96.21 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.146 2.564 . . . . 0.0 113.155 -175.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 126.34 -36.25 2.74 Favored Glycine 0 N--CA 1.426 -1.968 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.71 -15.25 63.55 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.38 0.61 . . . . 0.0 110.571 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 71.9 m -60.08 128.19 35.57 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.055 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.705 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 82.0 mtm-85 -86.51 137.81 32.23 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.758 HD11 HG21 ' A' ' 175' ' ' VAL . 10.0 tt -123.6 132.82 70.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.261 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.435 HD13 ' N ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -87.38 124.61 33.57 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-O 121.464 0.65 . . . . 0.0 109.853 178.514 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.435 ' N ' HD13 ' A' ' 9' ' ' LEU . 25.1 m -136.26 -179.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.549 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 32.2 tt0 -129.78 119.61 23.69 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.628 HG12 HG13 ' A' ' 47' ' ' ILE . 15.9 mt -119.53 121.47 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.9 -177.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.8 37.45 28.52 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.518 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.8 17.43 80.09 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.664 -1.153 . . . . 0.0 114.195 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.9 t -122.79 120.67 27.62 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 58.9 Cg_endo -74.23 119.92 6.03 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 122.064 1.842 . . . . 0.0 110.475 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -123.97 143.08 50.62 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.498 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -113.35 100.75 8.79 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -122.1 -172.34 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.618 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.749 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 19.2 p -95.4 169.75 9.84 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.941 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 15.1 mt -71.07 -22.63 62.09 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.099 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.749 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.5 ptm180 -83.73 -25.34 30.66 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.511 ' OE1' HG23 ' A' ' 20' ' ' THR . 67.6 mt-10 -84.69 -43.14 14.62 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.239 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.478 HD21 ' HG ' ' A' ' 167' ' ' LEU . 20.1 tp -56.24 -43.31 78.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.906 0.86 . . . . 0.0 109.085 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.434 ' HD1' HG11 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -51.92 -32.56 33.4 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.367 179.111 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 29.6 mt-10 -74.94 -16.98 60.62 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.302 -177.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.6 mm? -77.44 0.4 22.76 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 121.322 0.582 . . . . 0.0 109.455 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.526 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 98.1 m-85 -117.64 161.25 19.95 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.404 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.646 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 23.6 mt-10 -136.21 -172.28 3.09 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.117 175.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.487 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 12.3 t0 61.83 75.9 0.39 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.434 0.635 . . . . 0.0 110.558 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 25.1 tt0 -100.3 131.72 46.08 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.404 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 11.8 ptt180 -131.41 145.42 51.8 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.517 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -88.04 128.01 35.4 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.546 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -167.09 147.78 5.64 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.396 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 60.11 22.96 12.21 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 123.341 0.401 . . . . 0.0 110.683 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 38.3 mtm 71.98 16.14 5.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.612 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.2 m -134.74 -174.31 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -113.48 140.81 47.8 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.409 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.4 t -127.17 122.48 60.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.658 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 28' ' ' PHE . 17.6 ttm180 -113.21 126.61 55.61 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.487 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -133.63 146.94 51.37 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.387 -174.868 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? 83.16 110.37 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.422 0 O-C-N 124.444 1.09 . . . . 0.0 110.364 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.598 ' HB2' HD13 ' A' ' 47' ' ' ILE . 73.4 Cg_endo -79.12 152.14 24.08 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.45 2.1 . . . . 0.0 112.344 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.646 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 34.7 mtmt -81.92 -4.15 55.92 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.015 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -147.66 -165.62 2.3 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.14 103.86 16.15 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.628 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -116.59 118.61 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.621 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 47.3 mmtt -115.65 168.04 10.38 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.169 173.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.442 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.3 p -123.41 130.39 74.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.298 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.405 ' CE2' ' HB2' ' A' ' 11' ' ' GLN . 5.1 m-85 -83.57 123.67 30.0 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 p -134.76 172.8 12.45 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.488 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.521 HG12 HD11 ' A' ' 176' ' ' ILE . 3.1 mm -119.23 142.41 34.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.176 0.513 . . . . 0.0 110.054 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.699 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 25.5 t70 -76.0 122.59 24.42 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.606 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.726 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -75.71 -9.81 58.91 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.643 -170.424 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.699 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.8 pt-20 -106.59 -26.94 11.15 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.867 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.434 ' HB ' ' HD3' ' A' ' 58' ' ' LYS . 69.0 p -118.1 -25.39 6.69 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.783 -176.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.49 10.88 69.81 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.002 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.451 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 2.2 mptp? -78.51 154.2 30.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.022 0.439 . . . . 0.0 111.771 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.428 ' HA ' HD13 ' A' ' 52' ' ' ILE . 2.8 p -91.0 104.87 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 121.833 0.825 . . . . 0.0 110.565 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.5 m -110.97 157.7 11.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.243 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 49' ' ' VAL . 12.6 tp -116.45 137.82 51.86 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.6 t -143.93 172.47 12.81 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.281 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.29 161.55 19.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.63 0.728 . . . . 0.0 111.356 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.9 mp -100.23 140.75 18.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.519 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.496 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 27.5 mm-40 -92.26 -34.54 14.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.263 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 p30 175.89 176.75 0.23 Allowed 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.175 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.539 ' HA ' HD22 ' A' ' 167' ' ' LEU . 13.6 t -106.89 129.77 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.798 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 36.4 mt -91.13 111.79 24.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.805 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.466 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.1 tttt -127.65 110.29 12.53 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 163' ' ' PHE . . . -129.04 142.08 43.95 Favored Pre-proline 0 C--N 1.309 -1.161 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.442 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -53.87 124.14 15.16 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.115 2.544 . . . . 0.0 111.671 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.0 89.38 7.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.774 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.3 m -103.96 -29.27 11.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.194 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -85.58 166.98 15.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.724 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.496 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 28.7 m170 -98.01 171.69 8.1 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.724 HD23 ' HA ' ' A' ' 90' ' ' THR . 37.0 mt -126.71 140.12 52.64 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.569 0.699 . . . . 0.0 111.643 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.53 HD12 ' C ' ' A' ' 108' ' ' ALA . 44.8 mt -87.73 142.55 12.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 172.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 21.3 ttt180 -122.45 137.26 54.93 Favored 'General case' 0 N--CA 1.398 -3.067 0 CA-C-O 121.308 0.575 . . . . 0.0 109.902 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 86' ' ' SER . 55.0 m-85 -113.47 121.98 45.9 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.774 -177.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 152' ' ' LYS . 44.1 tt0 -108.4 127.42 53.88 Favored 'General case' 0 CA--C 1.474 -1.956 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.733 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -89.82 159.09 17.18 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-O 121.21 0.529 . . . . 0.0 111.936 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.827 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -60.15 -16.98 37.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.754 -178.515 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.642 ' OD1' ' HG3' ' A' ' 85' ' ' ARG . 38.3 p-10 -109.29 0.72 19.7 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.436 0.636 . . . . 0.0 111.065 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.49 19.47 25.2 Favored Glycine 0 C--N 1.309 -0.963 0 N-CA-C 116.511 1.364 . . . . 0.0 116.511 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.642 ' HG3' ' OD1' ' A' ' 83' ' ' ASP . 11.5 mtt180 -86.89 143.28 27.49 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 90.1 p -140.93 138.09 33.59 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 118.728 -1.189 . . . . 0.0 112.155 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.416 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 6.5 p90 -133.37 138.69 46.42 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.962 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.503 ' OE2' ' HG3' ' A' ' 78' ' ' ARG . 43.4 mp0 -115.02 147.94 39.49 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.769 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.1 p -140.79 155.72 46.33 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.945 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.724 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -76.33 12.14 1.32 Allowed 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 122.79 0.436 . . . . 0.0 112.04 -177.116 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.041 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.8 m 61.29 170.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 19.4 t70 72.17 -34.92 0.31 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.069 0.461 . . . . 0.0 110.814 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.444 ' H ' ' C ' ' A' ' 91' ' ' VAL . 47.6 m-70 -76.31 128.21 83.08 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.309 175.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 18.2 Cg_exo -67.47 127.52 16.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.284 2.656 . . . . 0.0 114.322 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.5 t -96.75 151.3 4.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.2 tp -102.15 106.41 17.25 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.817 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.568 HG21 ' OD1' ' A' ' 115' ' ' ASP . 1.9 p -110.35 148.99 13.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.315 0.579 . . . . 0.0 111.338 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.509 ' CD2' HD12 ' A' ' 148' ' ' LEU . 61.8 t80 -104.47 92.55 4.36 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.111 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.554 ' CG ' HD11 ' A' ' 104' ' ' ILE . 8.3 pt-20 -136.06 158.37 44.56 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 82.4 m-20 62.78 22.6 13.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 110.347 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.44 15.19 58.88 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.238 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -132.94 171.95 13.26 Favored 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 117.71 0.755 . . . . 0.0 109.446 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -102.51 120.12 39.99 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.579 HG13 ' HE2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -125.03 144.66 34.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.302 -178.522 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.4 OUTLIER -101.81 111.83 24.22 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.032 -178.246 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.579 ' HE2' HG13 ' A' ' 104' ' ' ILE . 50.4 mttm -120.86 134.6 55.29 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.718 ' H ' ' HD2' ' A' ' 107' ' ' ARG . 5.4 mpt_? -59.77 158.44 10.37 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.041 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -55.16 -45.94 75.72 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.54 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -75.28 11.27 1.24 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.647 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.533 ' OE1' ' HA ' ' A' ' 106' ' ' LYS . 39.1 tt0 -124.14 -15.09 6.89 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.454 0.645 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 107' ' ' ARG . 73.7 t -75.01 150.68 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.703 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -118.42 161.2 20.37 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.445 -176.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -70.57 147.19 49.54 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.403 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.86 4.1 87.45 Favored Glycine 0 C--N 1.305 -1.164 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.16 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.703 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -72.63 163.92 27.3 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD3' ' HB2' ' A' ' 148' ' ' LEU . 33.8 mttt -117.28 162.82 17.27 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.28 0.562 . . . . 0.0 110.503 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.416 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -130.24 157.68 42.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.213 172.318 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.62 136.29 33.16 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -102.39 152.05 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.686 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.309 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 C--N 1.307 -1.244 0 CA-C-O 120.826 0.346 . . . . 0.0 111.025 -179.561 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.509 HD12 ' CD2' ' A' ' 98' ' ' TYR . 9.9 mt . . . . . 0 N--CA 1.427 -1.607 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.827 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -114.79 138.68 50.46 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -172.672 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.503 ' H ' HD13 ' A' ' 149' ' ' LEU . 23.6 mt-10 -90.4 145.09 25.21 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.013 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.426 HG21 ' CG1' ' A' ' 154' ' ' ILE . 79.4 mt -79.3 117.22 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-N 113.507 -1.679 . . . . 0.0 110.99 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.62 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 30.3 mmtt -76.06 -37.98 57.62 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.589 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -152.7 134.63 14.77 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 77.0 mt -117.59 125.89 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.279 174.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.469 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.9 ptpt -128.18 159.25 35.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.457 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -100.36 117.83 35.37 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -127.74 174.08 11.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.376 -178.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.441 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 37.3 ttt180 -95.33 155.25 16.82 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 122.106 -0.371 . . . . 0.0 110.829 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.715 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.4 -25.3 49.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.657 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 68.05 -39.73 0.4 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.45 -173.25 2.6 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.85 -10.89 19.47 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 120.645 0.259 . . . . 0.0 111.171 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 96.5 m-85 -141.86 155.08 45.55 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.94 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.6 m -126.77 159.86 35.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.935 177.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 69.9 m-85 -136.22 172.05 13.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.632 0.254 . . . . 0.0 110.478 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.28 -23.2 0.06 Allowed 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 67' ' ' VAL . 1.3 tm? 68.23 107.97 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.97 176.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -87.28 118.21 26.55 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.54 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.496 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.41 -153.9 0.6 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.0 tptm . . . . . 0 C--N 1.315 -0.922 0 CA-C-O 120.88 0.372 . . . . 0.0 111.187 -179.236 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 8' ' ' ILE . 4.2 p -129.5 167.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-O 121.568 0.699 . . . . 0.0 112.723 -173.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.548 ' H ' HG22 ' A' ' 175' ' ' VAL . 75.7 mt -93.5 113.57 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.716 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.525 HG23 HG13 ' A' ' 175' ' ' VAL . 43.8 pt -120.39 172.92 6.78 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.688 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.417 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 5.0 t-20 47.84 -123.07 1.55 Allowed 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 124.487 1.115 . . . . 0.0 110.725 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -92.71 48.46 1.37 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.693 0.758 . . . . 0.0 109.862 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.676 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.7 m-20 73.86 46.44 0.19 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.465 1.506 . . . . 0.0 112.82 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.7 mt -88.96 117.2 31.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 56.6 t -84.38 152.09 3.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.693 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 C--N 1.303 -1.442 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.908 -178.179 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.559 ' HD3' HD13 ' A' ' 76' ' ' LEU . 56.4 Cg_endo -68.1 162.65 39.17 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 121.557 1.505 . . . . 0.0 108.9 176.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.75 -24.43 66.41 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 118.857 -1.64 . . . . 0.0 110.146 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.66 -13.69 34.97 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.031 0.932 . . . . 0.0 112.935 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 61.3 m -72.24 131.64 43.0 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.885 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.669 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 12.6 mtm180 -86.34 133.03 33.83 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.622 HD11 ' CG2' ' A' ' 175' ' ' VAL . 2.2 tp -117.13 133.37 64.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-O 121.131 0.491 . . . . 0.0 110.884 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 9' ' ' LEU . 0.7 OUTLIER -92.51 124.25 36.41 Favored 'General case' 0 N--CA 1.4 -2.965 0 CA-C-O 121.788 0.804 . . . . 0.0 110.956 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 19.7 m -134.26 -179.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.898 -177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -125.8 117.14 22.76 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.829 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 26.9 mt -118.89 120.56 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 CA-C-O 121.137 0.494 . . . . 0.0 110.015 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 54.11 38.51 29.21 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.92 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.71 20.48 79.69 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.746 -1.115 . . . . 0.0 113.677 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.1 t -131.01 123.04 19.64 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 70.6 Cg_endo -73.85 120.87 6.61 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 122.546 2.164 . . . . 0.0 112.25 -177.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -120.56 138.71 53.73 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.636 -177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -108.9 100.78 9.95 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.595 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.9 pt -124.19 -172.91 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.144 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.755 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 11.3 p -95.44 171.12 8.9 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.622 178.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 92.4 mt -66.56 -31.31 71.94 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.219 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.755 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 6.3 ptm180 -79.43 -24.84 42.21 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.503 ' OE1' HG23 ' A' ' 20' ' ' THR . 68.8 mt-10 -83.87 -41.62 17.26 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.389 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.579 ' CD2' HD13 ' A' ' 167' ' ' LEU . 46.8 tp -59.3 -41.52 89.17 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.894 0.854 . . . . 0.0 109.34 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.42 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -53.49 -31.74 47.21 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.979 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.577 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 32.4 mt-10 -77.24 -14.9 59.68 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.733 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -82.59 0.54 42.42 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.643 0.735 . . . . 0.0 109.14 177.05 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.541 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 72.4 m-85 -114.11 162.61 16.27 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.686 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.413 ' HB2' ' HD3' ' A' ' 44' ' ' LYS . 6.5 tp10 -142.15 -178.73 5.86 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.437 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.558 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER 65.1 79.89 0.24 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.641 0.777 . . . . 0.0 110.448 -179.187 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -101.13 131.43 47.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 122.078 0.942 . . . . 0.0 110.922 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.423 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 18.3 ptt-85 -122.71 153.61 39.2 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.269 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -101.14 125.18 47.74 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -166.7 145.49 5.39 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.444 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 61.04 19.85 10.32 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.864 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.2 mtt 71.67 16.79 5.68 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.505 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 16.2 m -131.89 -170.77 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -119.3 142.67 47.89 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.92 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.423 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.2 t -129.38 123.41 57.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.154 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.477 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 15.0 ttm180 -113.54 127.01 55.93 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.42 135.33 46.01 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.959 -175.498 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 36.0 mtpt 91.99 118.2 0.02 OUTLIER Pre-proline 0 CA--C 1.502 -0.887 0 C-N-CA 125.375 1.47 . . . . 0.0 112.147 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 87.3 Cg_endo -78.42 156.19 28.73 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.782 2.321 . . . . 0.0 111.045 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HD3' ' HB2' ' A' ' 29' ' ' GLU . 38.8 mtmt -94.02 -1.6 54.26 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.439 0.637 . . . . 0.0 110.565 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -146.3 -165.67 2.28 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.624 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 4.9 tp10 -85.28 99.24 11.0 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 174.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.541 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.5 mp -116.08 115.8 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.01 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.608 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 30.6 mmtp -123.28 163.94 19.73 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.98 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.501 HG13 ' CG1' ' A' ' 64' ' ' ILE . 6.9 m -111.06 128.78 67.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.068 0.461 . . . . 0.0 111.846 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -83.8 124.11 30.59 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.441 ' HA ' HG13 ' A' ' 176' ' ' ILE . 20.0 m -134.17 172.16 13.24 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.45 HG12 HD11 ' A' ' 176' ' ' ILE . 2.9 mm -119.49 143.06 32.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.116 0.484 . . . . 0.0 110.071 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 41.9 t0 -84.23 119.77 25.43 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.568 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.789 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -72.71 -11.37 60.59 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.124 -171.579 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' HG23 ' A' ' 56' ' ' THR . 5.5 pt-20 -102.48 -27.88 12.52 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.82 -176.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.469 HG23 ' HG3' ' A' ' 55' ' ' GLU . 76.1 p -115.48 -23.96 8.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.634 -175.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.41 14.45 76.31 Favored Glycine 0 N--CA 1.429 -1.784 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.149 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' C ' HD13 ' A' ' 52' ' ' ILE . 5.1 mtpm? -89.75 153.3 20.8 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.424 ' HA ' HD13 ' A' ' 52' ' ' ILE . 6.6 p -89.69 107.61 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-O 121.967 0.889 . . . . 0.0 110.042 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 m -110.09 159.37 9.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.201 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 49' ' ' VAL . 12.9 tp -121.91 140.69 52.12 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.0 t -147.03 172.31 13.93 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.212 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.31 161.87 19.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.551 0.691 . . . . 0.0 110.824 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 64' ' ' ILE . 3.0 mp -105.32 134.26 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.699 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.5 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 10.9 mm-40 -79.8 -40.21 29.13 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.036 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 p30 179.49 178.03 0.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.175 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.42 HG11 ' HB2' ' A' ' 25' ' ' TYR . 20.1 t -105.45 130.0 57.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.633 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 50.7 mt -90.67 105.2 16.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.555 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 84.9 tttt -118.52 109.82 16.65 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.3 134.57 25.89 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.219 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -47.22 124.35 8.94 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.447 2.765 . . . . 0.0 112.916 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.36 110.4 2.24 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.073 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -68.33 0.93 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -68.23 -117.4 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -159.34 172.68 17.53 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -172.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 90' ' ' THR . 4.5 mt -136.5 140.22 42.86 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.532 0.682 . . . . 0.0 111.283 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.545 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 9.0 mt -86.5 142.55 12.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 171.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.516 ' HB3' ' CG ' ' A' ' 155' ' ' LYS . 31.8 ttt85 -118.97 138.38 52.85 Favored 'General case' 0 N--CA 1.404 -2.763 0 CA-C-O 121.207 0.527 . . . . 0.0 109.755 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' A' ' 86' ' ' SER . 53.5 m-85 -115.97 125.17 52.16 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.893 -177.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 152' ' ' LYS . 34.5 tt0 -108.18 125.22 51.37 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.672 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -91.25 160.06 15.72 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.889 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.91 ' HG2' HD11 ' A' ' 149' ' ' LEU . 5.5 pt-20 -62.54 -19.59 63.79 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.209 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -87.33 -11.31 49.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.762 0.792 . . . . 0.0 109.23 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.52 16.81 47.95 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.036 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.549 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -87.46 142.91 27.51 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.762 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 23.6 p -142.38 136.28 29.43 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.456 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.408 ' CD1' HD13 ' A' ' 181' ' ' ILE . 6.8 p90 -129.97 155.99 45.18 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.165 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 40.2 mt-10 -129.86 148.01 51.69 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.308 0.575 . . . . 0.0 112.135 -175.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -141.0 154.51 46.05 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.358 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.645 ' HA ' HD23 ' A' ' 76' ' ' LEU . 1.1 p -69.84 15.92 0.07 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.021 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.06 -39.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 125.349 1.46 . . . . 0.0 113.854 175.009 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 107' ' ' ARG . 1.1 t70 -90.79 12.68 18.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.414 0.625 . . . . 0.0 110.766 -178.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 39.6 m80 -115.45 141.62 27.53 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.361 177.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 23.6 Cg_exo -64.9 142.78 77.05 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.43 2.753 . . . . 0.0 115.201 -176.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.515 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 19.1 t -119.52 150.13 22.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.381 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.5 tp -104.26 107.57 18.55 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.86 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.631 HG23 ' H ' ' A' ' 116' ' ' LYS . 1.6 p -107.11 143.96 16.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.383 0.611 . . . . 0.0 111.684 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.602 ' CD2' HD12 ' A' ' 148' ' ' LEU . 44.5 t80 -99.17 90.95 4.76 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.687 176.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 11.9 pt-20 -138.17 157.51 46.16 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.499 176.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER 68.81 21.86 7.51 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.93 13.84 60.09 Favored Glycine 0 CA--C 1.508 -0.35 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.669 -177.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.407 ' HE ' ' CB ' ' A' ' 100' ' ' ASN . 29.3 ptt180 -135.61 172.5 12.92 Favored 'General case' 0 N--CA 1.404 -2.748 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -104.77 119.81 39.88 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.59 HG13 HG13 ' A' ' 97' ' ' VAL . 21.4 pt -119.22 144.2 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 120.129 -0.629 . . . . 0.0 112.187 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -101.82 114.87 29.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.551 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.577 ' HG3' HG22 ' A' ' 111' ' ' VAL . 0.7 OUTLIER -136.01 146.56 47.29 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.387 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.582 ' O ' HG23 ' A' ' 111' ' ' VAL . 74.4 mtm180 -63.73 160.23 17.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.021 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -61.54 -41.55 97.51 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.788 -175.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.448 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.3 p90 -72.47 0.5 10.12 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.068 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -112.64 -16.68 12.77 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.479 0.657 . . . . 0.0 109.974 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 107' ' ' ARG . 94.7 t -71.08 150.7 9.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.773 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 1.9 mtmp? -115.08 159.73 20.5 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.178 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -73.97 145.86 44.32 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.08 4.22 86.96 Favored Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.159 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.773 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -76.68 167.32 22.05 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.16 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.631 ' H ' HG23 ' A' ' 97' ' ' VAL . 35.6 mttt -120.03 166.84 12.84 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.498 0.666 . . . . 0.0 111.756 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.35 162.28 35.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.655 171.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.61 141.02 29.09 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 1.8 m -114.68 149.57 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 173.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.495 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 44.9 t . . . . . 0 C--N 1.308 -1.22 0 CA-C-O 121.281 0.562 . . . . 0.0 110.548 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.602 HD12 ' CD2' ' A' ' 98' ' ' TYR . 11.9 mt . . . . . 0 CA--C 1.479 -1.751 0 CA-C-O 121.288 0.566 . . . . 0.0 109.68 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.91 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -108.37 133.86 51.98 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.644 -172.012 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.418 ' N ' HD13 ' A' ' 149' ' ' LEU . 21.5 mt-10 -88.46 143.75 26.79 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.919 175.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.473 HD13 ' CD1' ' A' ' 79' ' ' PHE . 68.2 mt -77.5 110.06 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.607 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.006 175.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 80' ' ' GLU . 7.2 mmpt? -72.44 -39.75 67.59 Favored 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.487 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -150.16 133.8 16.67 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.8 mt -113.83 143.08 24.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.054 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.516 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.0 ptpt -144.6 158.03 43.95 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -178.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.545 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 7.2 m-85 -100.9 114.54 28.5 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.563 174.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.43 173.78 11.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.319 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.435 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 49.8 ttt180 -112.21 167.6 10.28 Favored 'General case' 0 N--CA 1.415 -2.193 0 O-C-N 121.329 -0.857 . . . . 0.0 110.693 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.435 ' N ' ' HG2' ' A' ' 158' ' ' ARG . . . -67.57 114.94 6.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.433 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -72.5 -32.77 66.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.665 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -81.92 -176.21 6.0 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.305 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -101.29 -15.68 17.2 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -138.17 153.77 49.18 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.1 m -118.46 155.95 20.41 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.674 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 78.1 m-85 -135.52 161.3 35.88 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.91 -175.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.644 ' C ' HD23 ' A' ' 167' ' ' LEU . 74.0 m -158.1 13.64 0.2 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.553 176.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.644 HD23 ' C ' ' A' ' 166' ' ' SER . 2.5 pt? 29.39 109.51 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 125.368 1.467 . . . . 0.0 113.923 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -82.03 114.34 20.52 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.147 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.5 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -133.56 -142.43 0.2 Allowed 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 42.8 tptt . . . . . 0 C--N 1.31 -1.151 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.821 178.118 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.7 t30 . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.622 ' CG2' HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -165.1 171.7 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.278 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.666 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 97.0 mt -111.99 118.12 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.615 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.422 HG22 HD12 ' A' ' 8' ' ' ILE . 44.3 pt -120.78 171.91 8.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.294 0 CA-C-O 121.01 0.433 . . . . 0.0 111.186 -177.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 48.83 -129.79 1.9 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.313 1.045 . . . . 0.0 110.504 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -89.73 52.01 2.22 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.558 0.694 . . . . 0.0 109.959 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.754 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 16.4 m-80 74.05 44.41 0.26 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.685 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.408 HD13 ' CD1' ' A' ' 87' ' ' PHE . 86.5 mt -87.0 113.04 23.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 73.4 t -88.24 130.38 37.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.958 -176.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 12.0 t . . . . . 0 C--N 1.311 -1.07 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.594 176.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.433 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 2.7 m-85 . . . . . 0 C--O 1.234 0.243 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.499 ' HD3' HD13 ' A' ' 76' ' ' LEU . 73.0 Cg_endo -72.14 164.48 35.51 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 N-CA-C 108.408 -1.42 . . . . 0.0 108.408 175.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.76 -26.59 65.26 Favored Glycine 0 C--N 1.301 -1.415 0 C-N-CA 118.993 -1.575 . . . . 0.0 111.44 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.54 -9.32 48.55 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.6 m -71.33 129.69 39.49 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.381 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 26.2 mtm180 -85.77 132.08 34.2 Favored 'General case' 0 C--O 1.187 -2.187 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.712 HD11 HG21 ' A' ' 175' ' ' VAL . 8.9 tt -119.91 130.1 74.62 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-O 120.863 0.363 . . . . 0.0 110.139 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -88.44 122.13 31.59 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-O 121.527 0.679 . . . . 0.0 109.576 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 28.0 m -132.58 -173.3 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.346 -178.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 31.0 tt0 -134.4 121.4 21.09 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.637 HG12 HG13 ' A' ' 47' ' ' ILE . 17.0 mt -120.87 123.47 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.922 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.11 37.47 27.09 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.202 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.12 76.92 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.657 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -130.79 119.81 18.28 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 13.5 Cg_exo -64.87 120.93 8.29 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.733 1.622 . . . . 0.0 110.663 178.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -118.62 135.58 54.36 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -106.56 100.78 10.28 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.3 pt -125.46 -172.68 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.146 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.243 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.732 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 29.6 p -96.46 170.1 9.46 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.793 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 84.6 mt -67.23 -28.22 67.88 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.797 178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.732 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 11.2 ptm180 -79.51 -26.54 41.53 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.492 ' OE1' HG23 ' A' ' 20' ' ' THR . 43.9 mt-10 -84.28 -42.34 15.93 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.797 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.727 HD23 ' HG ' ' A' ' 167' ' ' LEU . 17.5 tp -57.96 -44.01 86.76 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.779 0.8 . . . . 0.0 109.206 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.512 ' HD1' HG11 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -51.42 -34.17 33.72 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.749 -1.568 . . . . 0.0 112.631 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.562 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 31.3 mt-10 -76.6 -14.39 60.0 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 23' ' ' GLU . 1.4 mm? -79.97 4.74 15.94 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.572 0.701 . . . . 0.0 109.317 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.527 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.9 m-85 -118.24 162.11 18.79 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.922 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -142.12 -173.38 3.81 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.562 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.8 OUTLIER 61.91 84.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.45 0.643 . . . . 0.0 110.434 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -103.0 127.25 50.31 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.782 0.801 . . . . 0.0 111.161 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.451 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 14.3 ptt180 -121.04 154.39 36.14 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.237 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -100.3 130.26 46.39 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -164.29 142.04 6.89 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.27 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 59.07 23.12 11.27 Favored 'General case' 0 CA--C 1.493 -1.225 0 O-C-N 123.599 0.562 . . . . 0.0 111.18 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.8 mtp 71.81 17.98 5.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.618 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.534 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 14.6 m -132.56 -173.61 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -114.46 141.4 47.73 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-O 121.253 0.549 . . . . 0.0 109.822 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.4 t -129.23 123.46 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.059 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.444 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 19.3 ttm180 -114.13 126.6 55.26 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -130.67 144.28 51.32 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.683 -174.686 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 37.5 ttmt 83.97 114.58 0.03 OUTLIER Pre-proline 0 CA--C 1.509 -0.627 0 O-C-N 124.639 1.212 . . . . 0.0 111.279 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.59 ' HB2' HD13 ' A' ' 47' ' ' ILE . 81.7 Cg_endo -80.24 151.62 20.61 Favored 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 122.19 1.926 . . . . 0.0 111.515 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -84.04 -5.91 59.32 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.32 0.581 . . . . 0.0 110.751 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -145.5 -166.09 2.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 8.1 tp10 -85.69 101.07 12.44 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.637 HG13 HG12 ' A' ' 12' ' ' ILE . 1.8 mp -117.36 116.92 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.607 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 57.0 mmtt -115.12 169.08 9.38 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.336 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 169' ' ' ALA . 13.0 p -127.01 130.77 71.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.463 ' HB3' HD12 ' A' ' 176' ' ' ILE . 5.2 m-85 -88.0 124.2 33.49 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.586 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.8 m -133.73 168.56 18.48 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.641 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.585 HG12 HD11 ' A' ' 176' ' ' ILE . 2.2 mm -116.0 145.91 21.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.32 0.581 . . . . 0.0 111.061 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.7 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 17.5 t70 -84.56 114.13 21.75 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.823 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -73.47 -9.2 58.44 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.355 0.662 . . . . 0.0 112.629 -170.049 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.7 ' HG3' ' OD1' ' A' ' 53' ' ' ASP . 3.1 pt-20 -102.12 -28.01 12.58 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.841 -176.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.553 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 61.0 p -118.2 -25.23 6.68 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.67 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.28 16.54 55.4 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.691 -0.686 . . . . 0.0 113.543 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.553 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 38.2 mttt -86.93 151.46 23.28 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.98 0.419 . . . . 0.0 112.092 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.02 107.97 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.581 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.7 m -109.5 157.1 10.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.316 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.9 tp -120.87 142.88 49.26 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.478 HG21 ' HB3' ' A' ' 170' ' ' LYS . 9.9 t -148.52 170.77 17.33 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.602 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.79 160.71 22.2 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.365 0.603 . . . . 0.0 109.824 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.591 HD13 HG22 ' A' ' 47' ' ' ILE . 2.2 mp -94.71 143.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.032 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.459 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 58.0 mm-40 -89.05 -39.87 13.36 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 178.58 177.26 0.46 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.693 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.512 HG11 ' HD1' ' A' ' 25' ' ' TYR . 9.9 t -107.48 130.42 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.377 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 38.1 mt -90.51 106.85 17.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.587 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.534 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.5 tttt -121.54 108.73 13.96 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.74 141.87 43.36 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.275 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.487 ' HD2' HG12 ' A' ' 37' ' ' VAL . 9.5 Cg_endo -55.48 130.25 39.5 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 123.379 2.719 . . . . 0.0 112.74 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.5 99.66 9.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.397 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.2 m -106.04 -48.74 3.53 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.43 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.505 ' OD2' HG22 ' A' ' 90' ' ' THR . 12.0 p-10 -87.7 -173.28 4.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.25 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -111.76 172.96 6.59 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 121.163 0.506 . . . . 0.0 111.126 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' ' 90' ' ' THR . 9.9 mt -120.2 146.63 45.84 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.031 -175.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.485 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 12.0 mt -89.8 145.47 7.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 30.5 ttt-85 -120.75 136.76 54.79 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.0 m-85 -114.73 122.33 46.09 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.486 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.1 tt0 -110.04 123.81 50.35 Favored 'General case' 0 CA--C 1.465 -2.312 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.722 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -86.84 162.05 17.99 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.448 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.872 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.5 pt-20 -63.26 -15.64 57.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.312 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -93.03 -9.73 38.71 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.029 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.22 8.68 62.73 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.452 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.599 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -88.83 143.35 26.95 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 176.064 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 55.8 p -138.57 154.89 48.74 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.823 178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 79' ' ' PHE . 5.0 p90 -145.69 148.95 33.59 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.883 176.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.492 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 44.1 mt-10 -124.89 148.15 48.44 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.729 -175.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -144.71 159.03 43.5 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.636 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.712 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -71.04 18.72 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.055 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.026 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.6 OUTLIER 70.87 -32.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 125.006 1.322 . . . . 0.0 112.429 177.273 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 90' ' ' THR . 12.8 t70 -78.35 -26.87 46.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.149 0.499 . . . . 0.0 109.737 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -69.26 123.75 88.97 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.05 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 33.5 Cg_exo -63.78 142.08 81.33 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.278 2.652 . . . . 0.0 113.126 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.46 146.33 18.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 124.22 1.008 . . . . 0.0 108.332 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.9 tp -105.38 109.7 21.78 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.837 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.56 HG13 HG13 ' A' ' 104' ' ' ILE . 2.1 p -110.72 151.1 12.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.371 0.605 . . . . 0.0 111.214 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -102.66 93.36 5.07 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.984 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.514 ' OE2' HD11 ' A' ' 104' ' ' ILE . 11.4 pt-20 -145.88 157.04 43.92 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 13.2 m120 66.52 23.52 10.44 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.144 0.497 . . . . 0.0 109.844 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.42 11.89 57.36 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.207 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -136.84 172.23 13.33 Favored 'General case' 0 N--CA 1.402 -2.827 0 CA-C-O 121.462 0.649 . . . . 0.0 110.507 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.406 ' CE1' HD11 ' A' ' 118' ' ' LEU . 28.2 m-85 -98.45 121.41 40.35 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.373 177.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.56 HG13 HG13 ' A' ' 97' ' ' VAL . 22.8 pt -118.72 145.9 24.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.126 -0.63 . . . . 0.0 112.146 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -103.65 109.14 20.72 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.793 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -124.98 135.6 52.95 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.844 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.622 ' O ' HG23 ' A' ' 111' ' ' VAL . 96.1 mtt180 -62.31 163.42 8.47 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.026 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -62.05 -42.13 98.86 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.165 -176.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.496 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 1.7 p90 -74.14 2.64 8.52 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.814 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -110.87 -19.41 12.82 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.487 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 107' ' ' ARG . 98.5 t -77.55 147.02 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 8.3 mptt -118.46 166.76 12.28 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.005 0.431 . . . . 0.0 111.543 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -70.11 142.9 52.54 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.07 4.21 81.93 Favored Glycine 0 C--N 1.304 -1.245 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.235 -175.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.683 ' HB3' HD12 ' A' ' 151' ' ' ILE . 11.3 t70 -76.93 170.47 16.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.684 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 42.4 mttp -122.78 165.97 15.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.442 0.639 . . . . 0.0 111.648 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.97 156.57 39.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.862 171.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.497 ' HG ' HD11 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -91.57 136.61 33.0 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.4 m -107.09 154.34 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.206 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.933 173.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.559 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 32.2 t . . . . . 0 C--N 1.306 -1.283 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.809 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.684 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.9 mm? . . . . . 0 N--CA 1.428 -1.553 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.872 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -109.26 134.89 51.2 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -173.426 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.537 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 19.9 mt-10 -87.3 142.79 27.63 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.057 176.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.683 HD12 ' HB3' ' A' ' 115' ' ' ASP . 71.1 mt -78.79 109.22 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.246 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.62 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.555 ' HE2' ' HB2' ' A' ' 82' ' ' GLU . 36.4 mmtt -68.25 -40.36 81.96 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.918 176.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -151.27 131.33 13.44 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.557 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.2 mt -112.83 140.98 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.189 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.371 174.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.446 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.2 ptpt -148.44 159.64 43.84 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.312 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.485 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 18.7 m-85 -99.27 116.75 32.18 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.425 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -131.31 134.69 60.74 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.007 -178.269 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -67.44 154.19 41.94 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.518 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.0 133.99 56.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.784 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -84.32 37.9 0.64 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.089 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 162' ' ' ASP . 12.6 t70 -176.54 -174.4 0.58 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.29 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.448 ' H ' ' CG ' ' A' ' 161' ' ' ASP . 6.0 m-20 -95.64 -10.43 29.44 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.876 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.21 160.73 38.18 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.265 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.7 m -127.55 158.01 39.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.573 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.567 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 77.3 m-85 -135.77 167.22 21.57 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.142 0.496 . . . . 0.0 111.08 -175.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.562 ' HB3' HD12 ' A' ' 68' ' ' ILE . 44.6 t -152.47 -16.39 0.17 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.115 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.727 ' HG ' HD23 ' A' ' 24' ' ' LEU . 4.5 mm? 59.41 105.02 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.648 0.737 . . . . 0.0 111.655 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -83.81 118.68 24.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.556 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.459 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -135.32 -162.1 1.22 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.478 ' HB3' HG21 ' A' ' 62' ' ' THR . 72.1 tttt . . . . . 0 C--N 1.319 -0.738 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 183' ' ' THR . 43.9 t30 . . . . . 0 CA--C 1.516 -0.334 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.712 HG21 HD11 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -153.95 162.15 2.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.485 -177.286 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.585 HD11 HG12 ' A' ' 52' ' ' ILE . 87.3 mt -101.22 117.07 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.31 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.535 HG23 HG13 ' A' ' 175' ' ' VAL . 34.1 pt -122.76 162.67 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 CA-C-O 121.386 0.612 . . . . 0.0 111.676 -176.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 22.0 t30 48.34 -133.2 1.4 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 124.697 1.199 . . . . 0.0 110.862 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.26 52.24 1.3 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.496 0.665 . . . . 0.0 110.654 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.733 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 17.2 m-80 66.97 48.34 1.28 Allowed 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 125.154 1.382 . . . . 0.0 113.365 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.1 mt -90.05 114.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.4 m -86.77 159.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-O 121.458 0.647 . . . . 0.0 110.922 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 4.0 t . . . . . 0 C--N 1.289 -2.057 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.93 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.414 ' CE1' HD13 ' A' ' 177' ' ' ILE . 49.1 m-85 . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.527 ' HA ' HG12 ' A' ' 164' ' ' VAL . 22.4 Cg_endo -61.16 -31.68 90.41 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.77 2.313 . . . . 0.0 112.279 -177.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.498 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 129.22 -39.3 1.87 Allowed Glycine 0 N--CA 1.421 -2.366 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.58 -11.86 55.15 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.374 0.607 . . . . 0.0 111.485 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 64.4 m -63.8 129.84 41.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 29.6 mtm180 -88.27 137.07 32.65 Favored 'General case' 0 C--O 1.189 -2.091 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 175' ' ' VAL . 11.9 tt -122.5 130.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 C-N-CA 122.649 0.379 . . . . 0.0 110.106 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.52 122.5 32.05 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 121.526 0.679 . . . . 0.0 109.467 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 26.1 m -133.34 179.63 4.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.477 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -126.23 120.42 29.97 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-O 121.35 0.595 . . . . 0.0 109.495 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.603 HG12 HG13 ' A' ' 47' ' ' ILE . 28.5 mt -120.22 122.24 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.463 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.643 -177.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.401 ' HA ' ' HB3' ' A' ' 46' ' ' GLU . 66.9 m-20 55.15 37.77 29.41 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 114.22 -1.354 . . . . 0.0 110.044 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.83 17.22 78.23 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.776 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.2 t -127.3 123.32 23.26 Favored Pre-proline 0 C--N 1.312 -1.022 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 21.3 Cg_endo -67.69 126.56 14.9 Favored 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 122.017 1.811 . . . . 0.0 111.104 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -125.97 138.07 53.73 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -106.76 101.32 10.77 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.7 pt -123.32 -178.14 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.936 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 16.7 p -92.23 168.78 11.1 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.803 -177.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.4 mm? -66.19 -25.12 66.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.825 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.586 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 1.1 ptm180 -85.38 -24.38 27.57 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HB2' ' H ' ' A' ' 20' ' ' THR . 35.2 mt-10 -85.51 -39.65 17.21 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.63 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.758 HD23 ' HG ' ' A' ' 167' ' ' LEU . 22.0 tp -58.84 -41.57 87.22 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.764 0.792 . . . . 0.0 109.602 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.468 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -55.54 -29.38 58.86 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.308 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.62 -17.56 59.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.649 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 23' ' ' GLU . 2.3 mm? -78.85 4.04 15.15 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.575 0.702 . . . . 0.0 109.414 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 95.6 m-85 -117.89 162.2 18.5 Favored 'General case' 0 N--CA 1.412 -2.36 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.861 -177.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 4.4 mm-40 -139.44 -173.81 3.71 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.375 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.445 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 3.5 t0 60.08 80.96 0.19 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.465 0.65 . . . . 0.0 110.863 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -102.56 130.79 49.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.904 0.859 . . . . 0.0 110.824 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.46 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.1 ptt180 -119.88 153.89 35.19 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.768 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -101.47 123.86 46.2 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -161.94 143.96 11.3 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.94 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 59.35 22.2 10.58 Favored 'General case' 0 CA--C 1.493 -1.236 0 O-C-N 123.78 0.675 . . . . 0.0 111.224 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.7 mtt 73.04 17.07 4.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.525 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 12.5 m -134.12 -171.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.413 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . 96.4 m-85 -119.3 143.21 47.48 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-O 121.164 0.507 . . . . 0.0 110.183 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.46 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.1 t -129.98 123.99 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.966 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.115 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.522 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 13.7 ttm180 -113.43 128.1 56.34 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.566 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.41 141.39 48.85 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.085 -174.083 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 24.3 ttmm 85.26 115.5 0.03 OUTLIER Pre-proline 0 CA--C 1.512 -0.513 0 C-N-CA 124.24 1.016 . . . . 0.0 111.928 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.541 ' HB2' HD13 ' A' ' 47' ' ' ILE . 72.3 Cg_endo -79.46 152.26 23.17 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.347 2.032 . . . . 0.0 111.838 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 31.0 mtmt -84.33 -6.09 59.35 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.821 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -148.35 -164.85 2.12 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 6.2 tp10 -86.73 101.17 13.05 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.469 176.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.603 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -116.21 118.23 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.526 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 29.3 mmtp -123.0 166.31 15.31 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.606 173.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.509 ' O ' HD12 ' A' ' 61' ' ' LEU . 6.3 m -115.36 129.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -84.8 121.91 28.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.827 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.1 m -132.88 171.32 14.08 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.846 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.46 HG12 HD11 ' A' ' 176' ' ' ILE . 2.9 mm -113.41 143.18 23.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.168 0.509 . . . . 0.0 110.008 177.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.643 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 21.2 t70 -77.55 124.22 27.63 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.342 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.804 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -75.97 -10.51 59.48 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.608 -171.374 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.643 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 3.8 pt-20 -107.87 -23.33 12.09 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.895 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.529 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 67.7 p -120.99 -23.78 5.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.999 -176.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.54 17.57 65.94 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.393 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.529 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 18.0 mttp -92.43 159.36 15.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 t -85.79 107.89 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.465 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.26 157.78 12.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.153 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.509 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.1 tp -122.24 137.98 54.65 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.5 t -143.79 171.51 14.12 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.08 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.14 161.64 20.54 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.809 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.578 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.9 mp -100.79 141.11 18.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.504 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.587 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 49.7 mt-10 -89.7 -35.85 15.54 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 p30 176.5 174.85 0.35 Allowed 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.006 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 20.5 t -105.54 134.3 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.191 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.297 177.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.525 HD13 ' HB3' ' A' ' 166' ' ' SER . 0.1 OUTLIER -101.8 124.04 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.379 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.089 179.601 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 86.7 tttt -135.34 108.47 7.7 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.224 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.43 137.17 30.22 Favored Pre-proline 0 C--N 1.31 -1.148 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.44 -175.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -47.43 124.04 8.78 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.394 2.729 . . . . 0.0 112.79 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.37 108.09 7.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.865 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -110.95 -59.52 1.95 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -77.21 -98.94 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.84 172.74 4.73 Favored 'General case' 0 CA--C 1.474 -1.981 0 CA-C-O 121.101 0.477 . . . . 0.0 112.011 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.769 HD23 ' HA ' ' A' ' 90' ' ' THR . 7.3 mt -132.45 141.14 48.7 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.135 -178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.513 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 10.6 mt -87.67 144.86 8.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 19.3 ttt-85 -121.69 136.03 54.95 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-O 121.283 0.564 . . . . 0.0 109.731 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 86' ' ' SER . 48.7 m-85 -114.34 130.32 56.67 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.865 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 152' ' ' LYS . 18.9 tt0 -109.86 129.21 55.67 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -94.31 155.64 16.91 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.778 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.1 pt-20 -64.62 -14.34 57.56 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.212 0.53 . . . . 0.0 111.529 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.69 -8.24 52.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.51 -0.768 . . . . 0.0 108.989 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.92 19.11 44.53 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.403 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.54 ' O ' HD23 ' A' ' 81' ' ' LEU . 4.8 mtt-85 -89.2 139.1 30.82 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 9.0 p -139.29 144.87 38.53 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.849 175.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -140.76 147.17 38.7 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.094 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 35.9 mt-10 -117.88 147.75 42.8 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.965 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.1 p -145.8 159.44 43.19 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.302 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.769 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.55 20.48 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -176.048 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.072 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.47 -37.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 125.397 1.479 . . . . 0.0 113.532 176.421 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.22 -2.2 58.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.143 0.497 . . . . 0.0 110.633 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -81.31 121.49 80.29 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.686 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 21.3 Cg_endo -63.32 139.04 69.4 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.659 2.239 . . . . 0.0 113.336 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 18.1 t -113.89 145.82 19.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.5 tp -101.35 107.69 19.1 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 121.059 -0.257 . . . . 0.0 110.336 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.499 HG13 HG13 ' A' ' 104' ' ' ILE . 2.6 p -107.76 147.5 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 121.63 0.728 . . . . 0.0 111.666 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -103.8 91.18 3.89 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.558 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.552 ' CG ' HD11 ' A' ' 104' ' ' ILE . 10.4 pt-20 -141.24 158.83 43.37 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.856 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.2 m-20 65.62 23.13 11.69 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.09 15.45 58.5 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.811 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HG3' HG23 ' A' ' 104' ' ' ILE . 9.7 ptm180 -136.33 171.96 13.71 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-O 121.206 0.527 . . . . 0.0 110.145 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -102.55 120.9 41.33 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.552 HD11 ' CG ' ' A' ' 99' ' ' GLU . 9.2 pt -125.8 147.94 30.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.316 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -100.41 119.0 37.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.448 -177.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.52 ' HE2' ' CD1' ' A' ' 104' ' ' ILE . 64.6 mttm -129.35 133.2 47.3 Favored 'General case' 0 C--O 1.205 -1.275 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.507 ' O ' HG23 ' A' ' 111' ' ' VAL . 86.4 mtt180 -63.42 163.04 11.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.072 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -60.57 -41.44 94.64 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.013 -175.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.487 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 2.8 p90 -74.18 4.61 5.4 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.961 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -118.17 -16.23 9.76 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.695 0.76 . . . . 0.0 110.265 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 107' ' ' ARG . 78.4 t -76.97 149.12 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -119.88 165.63 14.37 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.436 -176.837 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.8 141.09 53.39 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.286 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.75 5.0 71.99 Favored Glycine 0 C--N 1.307 -1.083 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.527 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.936 ' HB3' HD12 ' A' ' 151' ' ' ILE . 6.8 t70 -72.65 177.54 4.68 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.45 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 23.0 mttp -134.29 160.46 37.84 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.405 0.621 . . . . 0.0 111.013 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.26 158.4 43.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.066 172.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.71 130.86 37.43 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.732 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -102.61 148.73 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 175.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.586 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 33.1 t . . . . . 0 C--N 1.304 -1.384 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.683 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.423 -1.788 0 CA-C-O 121.636 0.732 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.778 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -113.02 136.92 52.16 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.581 -173.816 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 11.6 mt-10 -91.25 148.08 22.59 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.828 -1.078 . . . . 0.0 113.12 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.936 HD12 ' HB3' ' A' ' 115' ' ' ASP . 86.8 mt -78.97 109.63 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.897 176.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.594 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 1.5 mmmp? -68.12 -42.87 79.59 Favored 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.01 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -150.03 135.3 18.06 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 82.6 mt -118.92 129.29 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.639 -1.618 . . . . 0.0 111.058 174.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.455 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 1.8 ptpp? -133.17 163.0 30.24 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.648 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.513 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 13.5 m-85 -100.82 119.25 38.39 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.411 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -129.04 174.62 11.99 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.97 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.856 -178.472 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -109.91 166.4 10.96 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.305 -0.958 . . . . 0.0 112.282 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.66 137.1 58.13 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.914 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -101.48 31.05 3.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.974 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -170.99 -178.82 2.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -95.28 -13.26 25.0 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.072 0.463 . . . . 0.0 110.247 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.26 166.09 23.6 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.289 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.1 m -130.91 157.4 43.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 77.3 m-85 -138.46 159.97 40.73 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.734 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.525 ' HB3' HD13 ' A' ' 68' ' ' ILE . 7.8 t -148.34 -18.33 0.33 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.448 174.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.758 ' HG ' HD23 ' A' ' 24' ' ' LEU . 4.1 mm? 60.29 95.22 0.03 OUTLIER 'General case' 0 C--N 1.347 0.486 0 O-C-N 123.75 0.657 . . . . 0.0 111.04 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -82.44 102.61 11.42 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.127 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.587 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -97.5 -149.32 0.33 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.227 172.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.8 tptp . . . . . 0 N--CA 1.443 -0.814 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.603 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 183' ' ' THR . 0.5 OUTLIER . . . . . 0 CA--C 1.5 -0.98 0 CA-C-O 120.998 0.428 . . . . 0.0 110.435 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.696 HG21 HD11 ' A' ' 8' ' ' ILE . 2.5 p -150.13 167.03 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.044 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.566 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 90.5 mt -96.85 115.3 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.823 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.414 HD13 ' CE1' ' A' ' 2' ' ' PHE . 31.7 pt -118.47 166.51 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 121.307 0.575 . . . . 0.0 111.281 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 37.6 t30 46.16 -126.57 1.39 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 124.774 1.23 . . . . 0.0 111.028 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -91.07 59.31 3.99 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.603 0.716 . . . . 0.0 109.355 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.732 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 24.0 m-80 66.08 44.65 2.58 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 113.851 -1.522 . . . . 0.0 114.18 176.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.41 ' O ' HG12 ' A' ' 177' ' ' ILE . 91.3 mt -91.68 113.74 27.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.4 m -91.5 153.6 3.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.905 0.859 . . . . 0.0 112.394 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 1.4 t . . . . . 0 C--N 1.303 -1.424 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.261 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 183' ' ' THR . 12.4 m-85 . . . . . 0 CA--C 1.52 -0.18 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.543 ' HD3' HD13 ' A' ' 76' ' ' LEU . 67.8 Cg_endo -70.4 161.57 45.55 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 N-CA-C 108.68 -1.315 . . . . 0.0 108.68 177.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.437 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -61.64 -23.67 63.24 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 119.316 -1.421 . . . . 0.0 111.692 177.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.57 -21.23 60.03 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.28 0.562 . . . . 0.0 112.185 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.436 ' HB ' HD12 ' A' ' 21' ' ' LEU . 97.9 m -62.97 126.33 26.96 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.969 -177.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 35.4 mmt180 -80.3 130.83 35.46 Favored 'General case' 0 C--O 1.184 -2.368 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.764 HD11 HG21 ' A' ' 175' ' ' VAL . 7.7 tt -120.3 130.1 74.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.572 HD23 ' CE ' ' A' ' 18' ' ' LYS . 1.1 tm? -87.34 124.42 33.35 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-O 121.458 0.647 . . . . 0.0 110.317 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 30.3 m -135.89 -178.5 2.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.189 -178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.467 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 30.7 tt0 -130.79 122.64 27.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.56 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 20.4 mt -121.03 120.85 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.568 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.659 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 52.46 40.61 29.97 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.303 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.27 18.3 79.21 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.8 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.3 t -122.5 120.16 28.06 Favored Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 59.6 Cg_endo -74.8 125.23 9.29 Favored 'Trans proline' 0 N--CA 1.427 -2.393 0 C-N-CA 122.207 1.938 . . . . 0.0 110.926 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -128.37 142.34 51.15 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.935 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.572 ' CE ' HD23 ' A' ' 9' ' ' LEU . 5.1 tppp? -108.56 99.85 9.18 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -121.31 -172.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.847 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 20.0 p -98.95 174.11 6.52 Favored 'General case' 0 C--N 1.28 -2.441 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.127 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 65.5 mt -68.54 -28.63 67.15 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.717 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.847 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 11.6 ptm180 -76.85 -26.92 54.84 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.531 ' OE1' HG23 ' A' ' 20' ' ' THR . 49.4 mt-10 -85.28 -36.22 21.01 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.191 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.777 HD21 HD22 ' A' ' 167' ' ' LEU . 15.5 tp -66.11 -44.24 84.89 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.129 0.49 . . . . 0.0 111.234 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.778 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -58.6 -26.51 63.74 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.401 -175.656 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.442 ' OE1' ' HA ' ' A' ' 23' ' ' GLU . 24.9 mt-10 -68.09 -19.02 64.82 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.665 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.37 0.33 42.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.447 0.642 . . . . 0.0 110.091 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.577 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.1 m-85 -117.15 163.34 16.43 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.005 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -145.76 -171.91 3.79 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.997 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 t0 63.53 75.43 0.39 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.845 0.831 . . . . 0.0 110.139 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.36 128.91 44.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.474 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.505 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.3 ptt180 -120.51 153.37 36.77 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.323 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -103.74 128.77 51.09 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -166.52 143.4 4.92 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.035 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 60.84 21.03 11.2 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 123.662 0.601 . . . . 0.0 110.783 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 33.5 mtt 71.28 19.62 5.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.648 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' HD2' ' A' ' 71' ' ' PRO . 17.2 m -133.26 -175.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -117.45 142.09 47.56 Favored 'General case' 0 CA--C 1.477 -1.836 0 CA-C-O 121.267 0.556 . . . . 0.0 110.497 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.3 t -130.01 124.3 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.861 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.426 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 28.8 ttm180 -114.75 126.32 54.71 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.35 145.17 51.06 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.398 -174.488 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 51.5 tptt 80.33 114.86 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.504 0 O-C-N 124.574 1.171 . . . . 0.0 110.697 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.538 ' HB2' HD13 ' A' ' 47' ' ' ILE . 58.0 Cg_endo -77.42 158.56 32.8 Favored 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 121.947 1.765 . . . . 0.0 111.735 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -90.57 -3.44 57.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.422 0.629 . . . . 0.0 110.461 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -148.72 -165.68 2.34 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.647 ' OE1' ' HE3' ' A' ' 48' ' ' LYS . 7.1 tp10 -84.01 96.7 8.95 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.577 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.8 mp -116.78 115.63 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.031 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.647 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 34.6 mmtp -118.79 166.13 13.17 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.314 173.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.489 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.2 p -122.92 134.3 66.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.662 -175.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 11' ' ' GLN . 20.2 m-85 -88.18 123.54 32.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.494 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.9 m -136.56 147.56 47.08 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.217 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.549 HG12 HD11 ' A' ' 176' ' ' ILE . 2.2 mm -93.21 143.54 11.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.222 0.534 . . . . 0.0 110.343 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.46 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 28.3 t70 -87.3 123.47 32.32 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.4 mt -70.44 -28.82 65.33 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-O 122.109 0.957 . . . . 0.0 111.844 -172.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -83.51 -30.7 26.94 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.507 -172.629 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.7 p -114.87 -22.29 9.7 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.654 -175.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.39 20.73 71.4 Favored Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.524 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.506 ' C ' HD13 ' A' ' 52' ' ' ILE . 27.6 mttm -99.98 153.84 18.87 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.85 106.58 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 CA-C-O 121.769 0.795 . . . . 0.0 110.126 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.72 167.06 5.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.887 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.9 tp -119.72 141.76 49.13 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.9 t -146.98 171.8 14.7 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.853 0.359 . . . . 0.0 111.329 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.534 ' OD2' ' HE2' ' A' ' 48' ' ' LYS . 7.0 m-20 -82.2 161.06 22.88 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.556 0.693 . . . . 0.0 110.552 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.552 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.7 mp -99.21 140.92 17.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.244 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.411 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 6.7 mm-40 -88.18 -35.26 17.48 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 173.79 174.15 0.15 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.579 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 25' ' ' TYR . 13.8 t -104.92 132.93 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.192 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.66 HD12 ' HB2' ' A' ' 166' ' ' SER . 49.7 mt -92.21 113.49 27.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.478 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.438 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 86.6 tttt -127.57 109.34 11.61 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.78 141.62 42.63 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.77 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.474 ' HD2' HG12 ' A' ' 37' ' ' VAL . 8.1 Cg_endo -52.62 129.59 32.95 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.384 2.723 . . . . 0.0 112.41 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.95 73.63 9.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.351 0.596 . . . . 0.0 110.622 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.2 p -71.7 -38.59 70.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.913 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.52 -172.31 2.73 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.323 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.645 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 19.2 m170 -111.98 172.32 6.97 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 90' ' ' THR . 7.1 mt -122.48 146.87 46.99 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.541 0.686 . . . . 0.0 112.007 -175.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.552 HD12 ' C ' ' A' ' 108' ' ' ALA . 20.5 mt -87.82 145.52 7.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.554 ' HB3' ' CG ' ' A' ' 155' ' ' LYS . 41.8 ttt85 -122.07 140.88 51.98 Favored 'General case' 0 N--CA 1.404 -2.752 0 CA-C-O 121.301 0.572 . . . . 0.0 109.945 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 86' ' ' SER . 57.5 m-85 -114.71 125.49 53.79 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.586 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.7 tt0 -109.4 123.52 49.48 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.716 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.71 159.65 17.7 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.502 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.811 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.9 pt-20 -63.61 -15.25 57.66 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.456 0.646 . . . . 0.0 111.116 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.06 -10.24 36.82 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.487 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.02 12.77 54.85 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.839 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.564 ' O ' HD23 ' A' ' 81' ' ' LEU . 1.6 mtt180 -83.84 139.3 32.74 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 15.7 p -143.01 136.99 28.97 Favored 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.523 176.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -133.06 151.56 52.03 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.559 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.474 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 99.3 mt-10 -123.54 152.2 42.06 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.328 0.585 . . . . 0.0 112.097 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.512 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -142.21 155.33 45.27 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.238 178.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.649 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -72.01 16.85 0.11 Allowed 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 121.621 0.725 . . . . 0.0 111.56 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.037 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.9 OUTLIER 71.05 -29.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 125.64 1.576 . . . . 0.0 113.06 176.708 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -82.61 -5.1 58.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.972 0.415 . . . . 0.0 110.493 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -94.86 125.66 50.13 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.57 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 37.9 Cg_exo -63.1 142.28 86.62 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.968 2.445 . . . . 0.0 112.937 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.2 t -112.17 146.19 17.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.432 ' CD1' ' HG3' ' A' ' 105' ' ' GLU . 18.2 tp -101.75 111.46 23.72 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.975 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.57 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.3 p -113.7 150.85 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.345 0.593 . . . . 0.0 111.595 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -102.36 96.02 6.67 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.41 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.451 ' CD ' HD11 ' A' ' 104' ' ' ILE . 11.9 pt-20 -145.56 155.02 42.8 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 83.1 m-20 63.74 23.09 13.35 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.205 0.526 . . . . 0.0 110.332 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.12 12.49 60.52 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.872 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -131.2 170.83 14.04 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-O 121.478 0.656 . . . . 0.0 110.043 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -105.95 121.96 45.16 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.515 HG13 HG13 ' A' ' 97' ' ' VAL . 19.1 pt -122.36 146.77 27.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.007 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 26.7 mp0 -105.01 107.78 18.95 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.988 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 12.0 ptpt -118.38 135.2 54.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.422 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.637 ' O ' HG23 ' A' ' 111' ' ' VAL . 80.3 mtt180 -61.59 160.6 11.08 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.037 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -58.84 -43.41 90.73 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.212 -177.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.409 ' HB3' ' CG2' ' A' ' 91' ' ' VAL . 1.7 p90 -75.43 7.44 3.58 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.885 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -118.32 -17.95 9.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.443 0.639 . . . . 0.0 110.037 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 107' ' ' ARG . 89.4 t -73.15 149.18 8.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.198 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.685 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 69.7 mmtt -115.74 168.19 10.26 Favored 'General case' 0 CA--C 1.486 -1.503 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.382 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -77.71 142.05 38.98 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.11 4.2 74.97 Favored Glycine 0 C--N 1.305 -1.144 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -174.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.685 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -74.69 173.43 10.5 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -129.66 167.28 18.22 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.58 0.705 . . . . 0.0 111.604 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.81 159.82 39.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.738 170.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.8 135.54 37.4 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.9 OUTLIER -106.35 160.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.687 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 C--N 1.303 -1.424 0 CA-C-O 121.024 0.44 . . . . 0.0 111.163 -178.109 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 N--CA 1.421 -1.906 0 CA-C-O 121.348 0.594 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.811 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -107.51 133.68 51.64 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -172.161 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -88.04 145.65 25.87 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.628 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.469 HD13 ' CD1' ' A' ' 79' ' ' PHE . 67.6 mt -79.8 105.55 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.773 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.199 173.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 7.1 mmpt? -70.7 -37.43 73.57 Favored 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 114.645 -1.162 . . . . 0.0 110.682 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -149.96 133.42 16.56 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 71.3 mt -112.74 140.05 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.977 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.554 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.9 ptpt -139.82 152.91 46.9 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.171 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.496 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.2 m-85 -97.75 104.6 16.64 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-O 121.806 0.812 . . . . 0.0 108.825 173.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.645 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -108.02 175.77 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.266 -3.034 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.701 -178.378 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.405 ' HA ' ' CG ' ' A' ' 75' ' ' HIS . 19.5 ptt85 -80.74 -145.69 0.05 Allowed 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 121.79 0.805 . . . . 0.0 111.443 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -131.4 99.82 4.96 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -46.39 -49.91 17.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.085 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -102.3 170.68 7.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.041 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -88.6 -4.1 58.65 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.096 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -139.81 155.57 47.2 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.622 176.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.81 156.53 30.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.614 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 65.4 m-85 -133.55 171.51 14.0 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.66 ' HB2' HD12 ' A' ' 68' ' ' ILE . 70.7 m -160.17 -25.0 0.06 Allowed 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.777 HD22 HD21 ' A' ' 24' ' ' LEU . 9.1 tp 68.17 111.79 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.215 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -87.3 115.77 24.94 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.912 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.489 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -136.85 -166.72 1.95 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 45.0 mmtt . . . . . 0 CA--C 1.504 -0.789 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.61 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 183' ' ' THR . 30.5 t30 . . . . . 0 CA--C 1.51 -0.574 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.764 HG21 HD11 ' A' ' 8' ' ' ILE . 1.4 p -154.23 160.72 2.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.12 0.486 . . . . 0.0 111.307 -177.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.549 HD11 HG12 ' A' ' 52' ' ' ILE . 97.9 mt -96.55 115.64 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.213 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.567 HG23 HG13 ' A' ' 175' ' ' VAL . 47.3 pt -123.5 174.49 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.225 -175.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.479 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 2.9 t-20 47.07 -129.39 1.53 Allowed 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.062 0.945 . . . . 0.0 110.673 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.24 48.95 1.65 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.513 0.673 . . . . 0.0 109.847 176.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 3.7 m-20 68.79 47.19 0.84 Allowed 'General case' 0 CA--C 1.495 -1.145 0 C-N-CA 125.445 1.498 . . . . 0.0 113.171 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.4 HD12 ' HB3' ' A' ' 178' ' ' ASN . 82.5 mt -91.04 115.88 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.589 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.9 m -80.36 158.84 4.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.418 0.627 . . . . 0.0 110.558 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 5.1 t . . . . . 0 C--N 1.294 -1.805 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.488 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.41 ' CE1' HD13 ' A' ' 177' ' ' ILE . 20.6 m-85 . . . . . 0 C--O 1.223 -0.335 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.517 ' HD3' HD13 ' A' ' 76' ' ' LEU . 27.8 Cg_endo -62.74 -34.72 72.34 Favored 'Trans proline' 0 N--CA 1.479 0.637 0 C-N-CA 123.2 2.6 . . . . 0.0 112.321 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.509 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 130.36 -39.79 1.76 Allowed Glycine 0 N--CA 1.423 -2.212 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.49 -9.3 8.13 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 121.468 0.651 . . . . 0.0 111.556 176.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.8 m -69.27 129.07 38.77 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.915 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.601 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 16.4 mtm180 -84.07 138.22 33.17 Favored 'General case' 0 C--O 1.184 -2.388 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.717 HD11 HG21 ' A' ' 175' ' ' VAL . 10.0 tt -123.02 131.55 73.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-O 120.83 0.347 . . . . 0.0 110.217 177.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.53 HD23 ' HB2' ' A' ' 18' ' ' LYS . 2.2 tm? -90.49 123.81 34.48 Favored 'General case' 0 N--CA 1.405 -2.707 0 CA-C-O 121.619 0.723 . . . . 0.0 110.657 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.5 m -133.08 -174.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.144 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 30.7 tt0 -134.7 123.2 23.32 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.623 HG12 HG13 ' A' ' 47' ' ' ILE . 20.4 mt -122.63 123.28 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 CA-C-O 121.422 0.63 . . . . 0.0 110.358 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.9 36.67 27.74 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.972 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.4 21.14 79.54 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.627 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.4 t -127.54 114.82 21.13 Favored Pre-proline 0 N--CA 1.432 -1.342 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 17.3 Cg_exo -63.32 123.76 12.68 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 122.579 2.186 . . . . 0.0 111.31 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -126.98 136.41 52.22 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HB2' HD23 ' A' ' 9' ' ' LEU . 38.0 ttmt -108.55 102.15 11.25 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.627 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.6 pt -124.18 -171.7 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.132 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.954 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.713 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 17.8 p -95.48 169.78 9.81 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.249 -0.981 . . . . 0.0 110.673 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.549 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.4 mm? -67.74 -23.6 65.27 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.674 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.713 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 3.1 ptm180 -85.9 -24.32 26.67 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.609 ' OE1' HG23 ' A' ' 20' ' ' THR . 49.2 mt-10 -84.84 -42.08 15.43 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.972 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 19' ' ' ILE . 30.7 tp -57.44 -42.55 82.64 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 122.042 0.925 . . . . 0.0 109.897 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.742 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.9 m-30 -53.86 -30.73 46.88 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.393 -1.73 . . . . 0.0 113.084 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -74.39 -15.73 60.91 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.347 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.422 ' HB3' HD11 ' A' ' 47' ' ' ILE . 2.5 mm? -80.77 6.38 13.12 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.534 0.683 . . . . 0.0 109.775 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.559 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 98.1 m-85 -118.47 165.66 13.63 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.309 -178.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.516 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 3.4 mm-40 -143.97 -173.68 4.06 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.34 175.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 4.1 t70 64.26 86.74 0.12 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.583 0.706 . . . . 0.0 110.359 -179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -104.07 122.25 44.9 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.558 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -111.27 150.31 29.82 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.962 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.415 ' CZ ' ' HA ' ' A' ' 36' ' ' MET . 24.2 t80 -107.44 131.78 53.91 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' O ' HG22 ' A' ' 37' ' ' VAL . 7.5 tp10 -166.24 141.42 4.59 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.515 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 59.97 22.12 11.2 Favored 'General case' 0 CA--C 1.494 -1.182 0 O-C-N 123.573 0.545 . . . . 0.0 111.367 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 33' ' ' TYR . 41.7 mtm 72.75 19.52 3.93 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.998 0.811 . . . . 0.0 110.875 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.534 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 6.0 m -131.27 -179.55 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.498 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 88.7 m-85 -116.81 145.22 43.68 Favored 'General case' 0 CA--C 1.482 -1.644 0 CA-C-O 121.387 0.613 . . . . 0.0 110.438 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.8 t -130.23 123.53 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.747 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.61 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 39.5 ttm180 -116.8 126.32 52.9 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -134.62 144.89 48.14 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.595 -175.104 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' HD3' ' O ' ' A' ' 43' ' ' PRO . 12.6 tmtt? 86.93 109.61 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.409 0 O-C-N 124.899 1.375 . . . . 0.0 109.989 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.644 ' HB2' HD13 ' A' ' 47' ' ' ILE . 61.5 Cg_endo -78.18 151.97 27.15 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 122.149 1.899 . . . . 0.0 111.615 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.516 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 36.7 mtmt -83.0 -7.4 59.67 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.191 0.519 . . . . 0.0 111.12 -177.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -144.92 -165.41 2.15 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 8.7 tp10 -85.98 101.66 13.1 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.644 HD13 ' HB2' ' A' ' 43' ' ' PRO . 1.5 mp -115.03 117.41 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.966 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.514 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 32.4 mmtt -116.91 168.47 10.2 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 173.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.502 ' CG1' HG23 ' A' ' 62' ' ' THR . 9.5 p -125.51 128.81 72.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.04 132.16 34.36 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.966 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.408 ' HA ' HG13 ' A' ' 176' ' ' ILE . 21.5 t -139.12 177.15 8.11 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 59' ' ' VAL . 2.7 mm -116.34 141.72 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.342 0.591 . . . . 0.0 110.844 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.765 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 24.7 t70 -80.11 116.31 20.16 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.152 178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.745 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.2 mm? -73.57 -13.63 61.06 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.177 0.513 . . . . 0.0 112.191 -171.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.765 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -96.85 -26.25 15.16 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.849 -175.623 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.41 ' CB ' ' HD3' ' A' ' 58' ' ' LYS . 71.4 p -120.69 -25.68 5.44 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.887 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.48 9.18 65.12 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.421 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.42 ' O ' HD13 ' A' ' 52' ' ' ILE . 3.3 mptp? -81.88 159.66 23.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.157 0.583 . . . . 0.0 111.623 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.471 ' HA ' HD13 ' A' ' 52' ' ' ILE . 7.3 p -92.53 113.95 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 CA-C-O 121.943 0.878 . . . . 0.0 109.904 178.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -111.1 160.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.972 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.76 142.64 49.37 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.502 HG23 ' CG1' ' A' ' 49' ' ' VAL . 8.8 t -145.17 172.56 12.93 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.439 -177.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.42 161.02 14.82 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.611 0.719 . . . . 0.0 110.867 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.565 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.6 mp -94.59 142.61 13.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.488 -177.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.591 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.6 mm-40 -85.14 -46.28 11.26 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -179.84 -168.01 0.1 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.313 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.61 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 37.5 t -114.07 128.6 70.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.867 -175.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 166' ' ' SER . 19.9 mt -92.6 102.12 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.1 -176.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.534 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 48.3 tttp -120.95 110.08 15.86 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.615 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.53 141.3 40.73 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.093 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.454 ' HD2' HG12 ' A' ' 37' ' ' VAL . 5.9 Cg_endo -50.43 140.23 35.61 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.469 2.779 . . . . 0.0 112.86 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.26 94.15 2.45 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.16 0.505 . . . . 0.0 110.29 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.9 p -89.01 -70.96 0.62 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.13 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.47 -175.06 5.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.26 0.553 . . . . 0.0 111.775 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 34.5 m170 -101.48 172.45 6.97 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.082 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.1 mt -125.04 142.12 51.69 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.66 0.743 . . . . 0.0 111.807 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.563 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 9.9 mt -87.16 144.6 8.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 8.3 ttt180 -119.46 137.54 53.71 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.128 0.49 . . . . 0.0 109.686 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 86' ' ' SER . 52.4 m-85 -115.35 126.71 54.76 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.603 -178.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 57.6 tt0 -111.66 125.24 53.75 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.73 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -90.49 158.44 17.03 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.605 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.765 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -60.4 -18.12 48.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.271 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -90.76 -12.47 36.41 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.794 0.807 . . . . 0.0 109.556 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.41 16.69 39.22 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.88 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.582 ' O ' HD23 ' A' ' 81' ' ' LEU . 2.9 mtt180 -86.13 137.11 32.91 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.3 p -139.81 136.66 34.27 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.046 -1.062 . . . . 0.0 112.565 176.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -132.77 150.75 52.12 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.261 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.48 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 73.1 mt-10 -126.95 149.14 49.98 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.478 -176.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.457 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.9 OUTLIER -146.66 161.35 40.75 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.925 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.749 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -70.89 15.16 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.451 0.7 . . . . 0.0 112.66 -176.481 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.01 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 72.03 -34.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 125.253 1.421 . . . . 0.0 112.93 177.325 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.469 ' OD1' ' HB ' ' A' ' 90' ' ' THR . 6.1 p-10 -84.42 -5.52 59.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.13 0.491 . . . . 0.0 110.238 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 57.7 t-80 -84.45 126.49 69.05 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.799 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 23.0 Cg_exo -65.9 124.14 12.28 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.842 2.362 . . . . 0.0 112.942 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.8 t -97.85 147.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.645 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.5 tp -101.26 107.38 18.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.984 0.421 . . . . 0.0 111.102 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.601 HG21 ' OD1' ' A' ' 115' ' ' ASP . 1.6 p -113.29 147.78 16.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.549 0.69 . . . . 0.0 111.87 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -105.2 93.12 4.51 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.046 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.635 ' CG ' HD11 ' A' ' 104' ' ' ILE . 8.1 pt-20 -137.68 159.52 41.75 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.0 m-20 63.27 21.43 12.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.327 0.584 . . . . 0.0 109.753 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.45 16.23 62.63 Favored Glycine 0 N--CA 1.436 -1.367 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.326 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -135.93 172.91 12.33 Favored 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 117.859 0.829 . . . . 0.0 109.844 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -100.55 120.45 40.04 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.635 HD11 ' CG ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -123.16 148.12 27.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.209 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 23.7 mt-10 -104.99 110.52 22.96 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.414 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.514 ' HE3' HG11 ' A' ' 97' ' ' VAL . 77.7 mttt -117.76 134.74 54.6 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.594 ' O ' HG23 ' A' ' 111' ' ' VAL . 4.4 mpt_? -60.73 164.13 4.96 Favored 'General case' 0 C--O 1.215 -0.725 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.01 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -62.04 -41.32 97.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 118.955 -1.098 . . . . 0.0 109.539 -178.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.461 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 3.1 p90 -73.32 -2.63 22.83 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.691 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.469 ' HB3' ' N ' ' A' ' 107' ' ' ARG . 49.3 tp10 -109.68 -15.28 14.19 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.565 0.697 . . . . 0.0 109.988 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 107' ' ' ARG . 79.3 t -82.46 148.76 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.648 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 30.7 mttt -125.65 165.63 18.21 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.035 0.445 . . . . 0.0 111.129 -176.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.83 141.19 58.86 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.928 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.3 4.1 77.85 Favored Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.988 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.648 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -77.55 168.3 20.21 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.406 ' HE3' ' HG3' ' A' ' 150' ' ' GLU . 32.0 mttp -121.41 167.98 12.19 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 121.363 0.601 . . . . 0.0 111.149 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.58 159.96 39.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.993 170.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.48 133.11 35.78 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.7 OUTLIER -102.04 157.7 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.86 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.525 ' HB3' HD22 ' A' ' 180' ' ' ASN . 43.9 t . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 120.893 0.378 . . . . 0.0 110.953 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.415 -2.18 0 CA-C-O 121.227 0.537 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.765 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -111.15 135.83 51.1 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.822 -172.836 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.412 ' H ' HD13 ' A' ' 149' ' ' LEU . 23.9 mt-10 -90.52 147.41 23.39 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.448 1.118 . . . . 0.0 112.557 175.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.469 HG21 ' CG1' ' A' ' 154' ' ' ILE . 74.9 mt -79.01 110.03 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.648 0 CA-C-N 113.355 -1.748 . . . . 0.0 110.607 176.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 80' ' ' GLU . 29.7 mtmt -63.48 -46.69 85.02 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.748 175.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -150.6 135.69 17.68 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 76.5 mt -118.92 130.72 73.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.981 176.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.608 ' HD3' HG13 ' A' ' 157' ' ' VAL . 3.3 ptpp? -134.23 163.51 29.46 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.57 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.563 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.8 m-85 -101.34 120.36 40.14 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.844 175.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.608 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -131.56 174.45 13.12 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.603 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.983 -177.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -104.65 163.85 12.19 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.345 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.06 126.31 29.41 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.859 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -71.11 -40.55 71.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.372 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.19 176.33 6.27 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -95.59 -2.29 48.64 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.405 0.621 . . . . 0.0 110.12 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -136.84 154.91 50.39 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.45 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 3' ' ' PRO . 0.9 OUTLIER -118.32 151.46 20.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.647 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.742 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 9.8 m-85 -134.67 164.42 27.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.19 -170.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.605 ' HB2' HD12 ' A' ' 68' ' ' ILE . 74.5 m -158.55 -18.03 0.07 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.275 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.459 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 2.1 tm? 60.04 106.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.917 0.865 . . . . 0.0 111.462 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -90.33 125.26 35.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.856 0.836 . . . . 0.0 112.291 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.591 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -140.98 -130.06 0.1 Allowed 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.132 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.495 ' CB ' HG21 ' A' ' 62' ' ' THR . 81.0 tttt . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 CA--C 1.519 -0.218 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.717 HG21 HD11 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -152.88 165.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-O 121.401 0.619 . . . . 0.0 112.322 -175.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.601 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.8 mt -105.74 117.43 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.059 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.535 HG23 HG13 ' A' ' 175' ' ' VAL . 44.7 pt -122.84 172.58 9.93 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.811 -176.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 7.4 t-20 48.99 -131.48 1.76 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.683 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -90.67 57.82 3.71 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.155 0.979 . . . . 0.0 109.502 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.742 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 6.2 m-20 68.03 48.83 0.93 Allowed 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.071 -1.877 . . . . 0.0 113.686 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.1 mt -90.03 113.91 26.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.932 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.67 126.61 40.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.156 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.308 -1.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.115 177.164 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.512 ' CE1' HD13 ' A' ' 177' ' ' ILE . 2.8 m-85 . . . . . 0 N--CA 1.443 -0.785 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.576 ' HD3' HD13 ' A' ' 76' ' ' LEU . 18.3 Cg_endo -59.48 -77.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.299 1.999 . . . . 0.0 109.997 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.419 ' H ' ' HG2' ' A' ' 3' ' ' PRO . . . 179.73 -28.6 0.05 OUTLIER Glycine 0 N--CA 1.414 -2.78 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 176.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -67.18 -7.53 24.35 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.283 0.563 . . . . 0.0 111.584 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 23.9 m -67.7 130.22 42.32 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 19.3 mtm180 -84.55 133.88 34.43 Favored 'General case' 0 C--O 1.183 -2.442 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.64 HD11 HG21 ' A' ' 175' ' ' VAL . 10.1 tt -121.45 130.55 74.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 C-N-CA 122.736 0.415 . . . . 0.0 110.098 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.425 HD12 ' CD1' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -87.08 123.94 32.7 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 121.424 0.63 . . . . 0.0 109.597 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.2 m -135.41 -179.31 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.595 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 29.0 tt0 -129.95 122.32 28.31 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.883 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.594 HG12 HG13 ' A' ' 47' ' ' ILE . 18.2 mt -121.83 122.68 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.009 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.553 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.0 t0 55.66 37.39 28.81 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.764 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.39 16.08 78.89 Favored Glycine 0 C--N 1.309 -0.945 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.71 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.5 t -121.8 119.51 28.98 Favored Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 36.2 Cg_endo -71.29 128.0 14.09 Favored 'Trans proline' 0 N--CA 1.431 -2.172 0 C-N-CA 122.111 1.874 . . . . 0.0 110.324 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -129.91 141.55 50.78 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -109.11 100.76 9.88 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -122.16 -173.16 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.181 -2.51 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.105 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.731 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 9.7 p -96.1 170.64 9.13 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.66 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.3 mm? -67.59 -27.11 66.64 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.445 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.731 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 6.6 ptm180 -84.06 -22.77 31.12 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.472 ' HB2' ' H ' ' A' ' 20' ' ' THR . 10.2 mm-40 -85.32 -42.27 14.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.819 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.504 ' HA ' HD12 ' A' ' 19' ' ' ILE . 27.5 tp -58.26 -44.21 88.28 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.967 0.889 . . . . 0.0 109.884 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.686 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.4 m-30 -55.35 -29.37 58.24 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 113.553 -1.658 . . . . 0.0 113.486 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 10.7 mm-40 -79.06 -11.75 60.0 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.02 -175.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.29 6.7 11.23 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.349 0.595 . . . . 0.0 109.528 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 97.6 m-85 -118.68 164.96 14.57 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.885 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.595 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 30.2 mt-10 -137.53 -172.86 3.33 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.575 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 2.5 t70 61.75 83.66 0.15 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.479 0.657 . . . . 0.0 111.082 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -99.0 122.42 42.24 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.536 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -113.59 150.57 32.88 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.342 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.505 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 28.1 t80 -106.87 129.62 54.68 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.316 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' O ' HG22 ' A' ' 37' ' ' VAL . 7.6 tp10 -167.46 142.27 3.83 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.696 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.6 m120 58.29 23.17 10.12 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 123.478 0.486 . . . . 0.0 111.457 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.505 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 43.8 mtm 72.24 18.66 4.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.814 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.527 HG12 ' HD2' ' A' ' 71' ' ' PRO . 4.3 m -129.37 179.92 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.433 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 81.1 m-85 -118.36 142.02 47.95 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.31 0.576 . . . . 0.0 110.278 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.36 123.77 60.66 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.928 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.622 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 40.9 ttm180 -115.06 126.55 54.83 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -134.2 146.73 50.42 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.98 -174.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 54.5 tptt 83.2 112.62 0.03 OUTLIER Pre-proline 0 C--N 1.318 -0.799 0 O-C-N 124.902 1.376 . . . . 0.0 110.868 -177.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.602 ' HB2' HD13 ' A' ' 47' ' ' ILE . 59.4 Cg_endo -78.79 152.26 25.22 Favored 'Trans proline' 0 N--CA 1.426 -2.482 0 C-N-CA 121.877 1.718 . . . . 0.0 111.4 177.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.595 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 36.2 mtmt -80.87 -6.23 58.36 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.796 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -147.09 -165.77 2.33 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 5.2 tp10 -86.21 100.07 11.99 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.602 HD13 ' HB2' ' A' ' 43' ' ' PRO . 1.3 mp -115.47 117.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.433 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 34.8 mmtp -119.91 166.66 13.02 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.689 174.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 175' ' ' VAL . 13.7 p -120.42 127.07 75.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.111 0.481 . . . . 0.0 112.186 -174.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CD1' HD12 ' A' ' 9' ' ' LEU . 6.5 m-85 -80.56 123.14 27.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.65 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.0 p -133.27 176.92 8.09 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.271 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.532 HG12 HD11 ' A' ' 176' ' ' ILE . 2.4 mm -122.96 140.26 47.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.248 0.547 . . . . 0.0 110.024 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -78.17 119.34 21.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.787 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -72.01 -14.0 61.77 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.106 0.479 . . . . 0.0 111.902 -171.591 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -99.41 -28.35 13.31 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.914 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.486 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.4 p -117.2 -26.24 6.84 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.728 -175.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.82 12.7 68.31 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.332 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.486 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 17.1 mtpp -85.97 158.01 19.99 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.64 109.33 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.368 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.3 m -112.58 157.93 13.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.085 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 tp -122.29 135.77 54.79 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -137.83 172.88 12.28 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.669 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.08 161.03 16.0 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.224 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.9 mp -96.34 144.62 10.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.304 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.478 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 48.5 mm-40 -91.07 -41.5 11.02 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -179.96 178.63 0.59 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.896 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 9.4 t -109.9 129.23 65.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.699 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.5 mt -97.19 102.3 13.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.826 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 45.5 tttp -116.87 107.73 14.97 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.84 137.24 30.47 Favored Pre-proline 0 C--N 1.31 -1.141 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.154 -176.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.527 ' HD2' HG12 ' A' ' 37' ' ' VAL . 80.9 Cg_exo -47.89 124.14 9.53 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 123.424 2.749 . . . . 0.0 113.116 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.46 80.01 8.74 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.948 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.6 m -86.91 -24.68 24.74 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.336 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -101.91 -179.7 4.08 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.042 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 59.5 m170 -111.37 172.31 6.96 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.426 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.591 ' CD2' ' HA ' ' A' ' 90' ' ' THR . 22.4 mt -123.78 146.71 48.13 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.856 0.836 . . . . 0.0 111.972 -173.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.482 HD12 ' C ' ' A' ' 108' ' ' ALA . 19.9 mt -88.77 143.05 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.195 173.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 37.2 ttt-85 -120.76 138.96 53.73 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-O 121.331 0.586 . . . . 0.0 109.426 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' A' ' 86' ' ' SER . 54.0 m-85 -116.05 126.44 53.78 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.038 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 152' ' ' LYS . 31.3 tt0 -109.2 122.68 47.83 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.751 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.02 154.07 20.78 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.643 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.979 ' HG2' HD11 ' A' ' 149' ' ' LEU . 5.2 pt-20 -57.21 -22.43 40.72 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.038 0.535 . . . . 0.0 111.943 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.28 -11.09 55.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.005 0.907 . . . . 0.0 109.111 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.28 14.93 46.29 Favored Glycine 0 N--CA 1.434 -1.451 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.918 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.554 ' O ' HD23 ' A' ' 81' ' ' LEU . 1.5 mtt180 -85.63 139.21 31.59 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 30.5 p -140.02 143.51 36.46 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.11 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -139.49 155.11 47.76 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.373 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 23.7 mt-10 -128.45 151.91 48.84 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.928 -176.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -148.33 160.54 42.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.867 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.591 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -71.55 13.81 0.23 Allowed 'General case' 0 C--N 1.353 0.738 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -175.798 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.077 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.8 OUTLIER 68.14 -39.32 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 124.681 1.192 . . . . 0.0 113.691 176.11 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -79.68 2.47 22.52 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.803 0.335 . . . . 0.0 111.317 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 50.4 m170 -115.13 143.47 30.29 Favored Pre-proline 0 C--N 1.313 -1.016 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.885 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 15.4 Cg_exo -69.05 140.14 44.53 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.561 2.841 . . . . 0.0 115.25 -175.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 20.6 t -112.15 149.55 14.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 125.285 1.434 . . . . 0.0 107.211 175.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.8 tp -107.59 111.66 24.02 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.485 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.693 HG21 ' OD1' ' A' ' 115' ' ' ASP . 1.8 p -111.47 150.18 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.424 0.63 . . . . 0.0 112.167 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.641 ' CD2' HD12 ' A' ' 148' ' ' LEU . 71.7 t80 -103.31 93.37 4.94 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.256 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -135.94 154.94 50.96 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 62.26 22.98 13.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.086 0.469 . . . . 0.0 110.394 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.84 13.96 62.31 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.058 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -130.51 171.34 13.12 Favored 'General case' 0 N--CA 1.399 -2.987 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -104.35 121.13 42.73 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.644 HG13 HG13 ' A' ' 97' ' ' VAL . 28.7 pt -121.61 142.42 37.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.995 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.3 OUTLIER -106.16 111.55 24.21 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.008 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HG3' HG22 ' A' ' 111' ' ' VAL . 12.6 ptpt -125.24 144.54 50.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.915 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.608 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 64.9 mtt180 -64.85 160.67 19.87 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.077 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -59.95 -41.54 92.08 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.413 -176.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.459 ' HB3' ' CG2' ' A' ' 91' ' ' VAL . 1.8 p90 -74.29 1.73 10.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.824 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -112.9 -13.91 13.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.827 0.822 . . . . 0.0 109.701 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 107' ' ' ARG . 98.9 t -76.79 150.0 6.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.714 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -123.89 166.16 16.14 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 120.606 0.241 . . . . 0.0 110.824 -177.695 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.61 141.94 51.7 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.17 4.7 77.5 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.638 -175.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.714 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 1.7 t0 -78.5 166.56 22.45 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.433 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 35.1 mttp -120.01 168.68 10.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.79 0.805 . . . . 0.0 111.459 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.62 160.35 37.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 169.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 182' ' ' VAL . 1.1 tt -90.31 122.18 32.98 Favored 'General case' 0 N--CA 1.395 -3.189 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.226 177.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.0 OUTLIER -104.82 128.76 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 173.642 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.8 t . . . . . 0 C--N 1.304 -1.39 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.544 -177.209 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.641 HD12 ' CD2' ' A' ' 98' ' ' TYR . 13.8 mt . . . . . 0 N--CA 1.428 -1.553 0 CA-C-O 121.709 0.766 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.979 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -111.36 135.97 51.15 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.07 -172.696 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.433 ' HG3' ' CG ' ' A' ' 116' ' ' LYS . 11.3 mt-10 -91.56 147.33 23.09 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.497 175.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.522 HD12 ' HB3' ' A' ' 115' ' ' ASP . 75.4 mt -78.29 106.93 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.594 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.844 176.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.652 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 34.4 mmtm -70.27 -39.58 74.87 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.856 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -150.94 132.46 14.74 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 71.8 mt -111.76 143.98 20.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.791 176.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.413 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.4 ptpt -146.77 159.83 43.01 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.398 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -100.26 114.9 28.71 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.3 OUTLIER -126.98 175.5 8.84 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.751 -179.073 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -99.64 154.33 18.36 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.81 -0.556 . . . . 0.0 111.443 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.56 3.11 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 66.78 -54.41 0.44 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.81 -175.1 2.7 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -99.67 9.57 42.88 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.181 0.515 . . . . 0.0 110.021 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -141.19 155.37 46.07 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.989 176.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 3' ' ' PRO . 1.4 m -124.85 154.15 32.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.686 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 8.3 m-85 -131.73 163.04 29.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.1 -172.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -159.09 -16.11 0.07 Allowed 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.829 176.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.424 ' HG ' HD21 ' A' ' 24' ' ' LEU . 2.8 tm? 62.64 112.12 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.333 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -87.3 114.57 24.03 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.738 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.478 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -126.14 -156.16 0.72 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 170' ' ' LYS . 35.0 mmtm . . . . . 0 C--N 1.31 -1.114 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 CA--C 1.514 -0.405 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.64 HG21 HD11 ' A' ' 8' ' ' ILE . 5.2 p -149.02 166.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 121.557 0.694 . . . . 0.0 111.906 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.554 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 81.0 mt -97.57 114.08 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.136 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.551 HG23 HG13 ' A' ' 175' ' ' VAL . 45.0 pt -118.89 174.85 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-O 120.978 0.418 . . . . 0.0 111.649 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 7' ' ' ARG . 2.1 t-20 44.66 -123.18 0.95 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.13 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -99.57 64.92 1.33 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.822 0.82 . . . . 0.0 108.928 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.701 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 7.8 m120 68.65 38.92 2.14 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 113.537 -1.665 . . . . 0.0 114.339 176.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.404 ' O ' HG12 ' A' ' 177' ' ' ILE . 99.1 mt -88.31 113.52 25.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 118' ' ' LEU . 2.5 m -83.68 158.2 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--N 1.29 -1.996 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.997 -176.8 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.501 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 30.9 m-85 . . . . . 0 N--CA 1.437 -1.082 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.504 ' HA ' HG12 ' A' ' 164' ' ' VAL . 14.9 Cg_endo -56.42 -27.46 68.17 Favored 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 123.418 2.746 . . . . 0.0 112.771 -177.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 125.21 -39.38 2.09 Favored Glycine 0 N--CA 1.417 -2.626 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.6 -11.14 60.6 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.697 0.76 . . . . 0.0 111.176 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 55.2 m -60.72 131.12 49.68 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.687 177.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.0 mmt180 -86.26 132.38 34.0 Favored 'General case' 0 C--O 1.185 -2.3 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.888 HD11 HG21 ' A' ' 175' ' ' VAL . 11.6 tt -119.64 130.57 73.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 CA-C-O 120.862 0.363 . . . . 0.0 110.111 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.434 HD13 ' N ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -88.46 125.35 34.7 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-O 121.452 0.644 . . . . 0.0 109.959 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.6 m -135.15 177.8 6.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.504 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -126.89 119.67 27.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.23 0.538 . . . . 0.0 109.875 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.61 HG12 HG13 ' A' ' 47' ' ' ILE . 12.5 mt -118.43 120.18 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.701 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.788 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 54.69 37.93 29.14 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.15 -1.387 . . . . 0.0 109.824 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 18.26 79.52 Favored Glycine 0 C--N 1.3 -1.47 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.609 -177.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.04 119.22 26.62 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 48.0 Cg_endo -73.31 122.05 7.67 Favored 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 122.534 2.156 . . . . 0.0 111.468 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -124.41 141.74 51.84 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.711 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -107.94 101.28 10.56 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.025 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.486 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -123.63 -175.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.681 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.752 ' HG1' ' HG2' ' A' ' 22' ' ' ARG . 9.6 p -90.28 173.54 8.08 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.727 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.617 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.2 mm? -69.24 -26.91 65.02 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.395 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.752 ' HG2' ' HG1' ' A' ' 20' ' ' THR . 10.7 ptm180 -84.8 -24.91 28.5 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.435 ' HB2' ' H ' ' A' ' 20' ' ' THR . 39.2 mt-10 -82.98 -39.4 21.39 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.977 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.512 HD23 HD13 ' A' ' 8' ' ' ILE . 16.2 tp -57.82 -42.18 83.76 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.089 0.947 . . . . 0.0 108.7 176.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.4 ' CD1' HG11 ' A' ' 67' ' ' VAL . 7.4 t80 -53.71 -31.23 47.29 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.216 -1.811 . . . . 0.0 112.594 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.9 mt-10 -76.0 -17.82 59.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -78.89 2.29 20.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.732 0.777 . . . . 0.0 109.429 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.476 ' C ' ' HD3' ' A' ' 40' ' ' ARG . 96.0 m-85 -117.91 162.24 18.46 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.602 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.7 -173.84 3.99 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.175 176.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 t70 63.47 81.36 0.21 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.248 0.547 . . . . 0.0 110.159 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -106.42 134.18 49.96 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 122.088 0.946 . . . . 0.0 111.465 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.451 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.2 ptt180 -122.54 154.44 37.9 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.557 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -105.57 124.94 50.38 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -160.89 137.66 8.77 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.476 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 61.7 23.12 13.5 Favored 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 123.579 0.55 . . . . 0.0 110.918 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.1 mtt 75.6 13.82 2.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.064 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.495 HG12 ' HD2' ' A' ' 71' ' ' PRO . 5.1 m -129.64 -179.71 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -115.55 140.46 49.14 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.127 0.489 . . . . 0.0 109.823 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.2 t -129.49 123.29 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.093 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.476 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 16.7 ttm180 -112.71 126.75 55.74 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -131.65 146.08 52.0 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.654 -174.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 27.5 tptp 80.68 113.08 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.438 0 O-C-N 124.531 1.145 . . . . 0.0 111.396 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.556 ' HB2' HD13 ' A' ' 47' ' ' ILE . 56.9 Cg_endo -78.02 155.94 30.15 Favored 'Trans proline' 0 N--CA 1.435 -1.918 0 C-N-CA 122.208 1.939 . . . . 0.0 111.974 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -86.97 -3.46 59.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.349 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -147.3 -164.8 2.09 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 6.0 tp10 -84.5 98.25 10.01 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.61 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -117.34 116.02 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.835 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -116.43 167.52 10.97 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.356 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 61' ' ' LEU . 13.2 p -116.05 121.53 67.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 121.714 0.769 . . . . 0.0 112.097 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.526 ' CE1' HG11 ' A' ' 59' ' ' VAL . 65.8 t80 -76.1 110.27 10.44 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.643 177.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -134.22 176.52 8.52 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.738 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.547 HG12 HD11 ' A' ' 176' ' ' ILE . 4.3 mm -121.18 144.17 31.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.267 0.556 . . . . 0.0 110.922 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.657 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 19.4 t70 -81.52 120.98 25.73 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.298 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.732 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -74.91 -12.24 60.31 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -170.488 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.657 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.7 pt-20 -104.33 -27.12 12.17 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.2 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.522 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 72.2 p -115.18 -24.95 8.26 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.578 -176.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.69 70.53 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.045 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.522 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 40.2 mttt -85.47 163.74 18.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.526 HG11 ' CE1' ' A' ' 50' ' ' TYR . 90.4 t -88.62 111.43 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.162 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.9 146.71 14.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.299 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.1 tp -120.12 138.59 53.48 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.437 HG21 ' HB3' ' A' ' 170' ' ' LYS . 10.2 t -150.54 171.35 17.22 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 120.753 0.311 . . . . 0.0 110.868 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.45 161.12 25.06 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.574 0.702 . . . . 0.0 111.169 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.2 mp -101.06 135.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.887 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.516 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 17.3 mt-10 -81.1 -39.62 25.37 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 p30 179.65 175.49 0.74 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.458 -175.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.48 ' HA ' HD22 ' A' ' 167' ' ' LEU . 6.0 t -105.8 131.71 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.867 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 57.6 mt -91.53 105.8 16.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.267 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.449 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.1 tttt -119.87 108.16 14.02 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.25 138.62 33.25 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.343 -175.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HD2' HG12 ' A' ' 37' ' ' VAL . 75.1 Cg_exo -48.54 134.09 26.51 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 123.274 2.649 . . . . 0.0 112.608 177.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.73 95.6 3.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.391 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.7 p -92.76 -54.33 3.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.322 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.71 -179.92 6.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.918 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -100.9 170.71 8.12 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 90' ' ' THR . 17.1 mt -115.23 131.35 56.96 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.504 0.669 . . . . 0.0 112.062 -175.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.575 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 19.5 mt -82.82 141.84 14.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.603 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 24.5 ttt-85 -117.11 136.93 52.63 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-O 121.17 0.509 . . . . 0.0 109.769 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.582 ' CD1' HD13 ' A' ' 151' ' ' ILE . 56.1 m-85 -116.01 127.53 54.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.7 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 152' ' ' LYS . 43.7 tt0 -111.97 128.27 56.12 Favored 'General case' 0 CA--C 1.472 -2.051 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.754 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -91.09 157.65 17.11 Favored 'General case' 0 C--N 1.269 -2.915 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.576 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.755 ' HG2' HD11 ' A' ' 149' ' ' LEU . 2.3 pt-20 -63.88 -14.5 53.87 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.569 0.7 . . . . 0.0 111.07 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -92.81 -9.45 40.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.264 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.14 14.59 54.14 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.217 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.554 ' O ' HD23 ' A' ' 81' ' ' LEU . 3.0 mtt180 -86.34 141.8 28.95 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 26.1 p -141.69 146.52 36.19 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.488 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -141.58 150.21 41.76 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.635 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 29.3 mt-10 -121.85 145.83 47.69 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.351 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.6 p -144.12 157.22 44.44 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.731 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.696 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -75.46 9.26 2.26 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -175.583 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.035 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.6 t 76.17 -42.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 O-C-N 123.503 0.502 . . . . 0.0 111.274 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.37 -20.53 65.6 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 123.764 0.826 . . . . 0.0 110.888 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.505 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -103.31 129.56 25.27 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.786 -176.416 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.611 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 25.3 Cg_exo -65.18 142.82 75.38 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.623 2.882 . . . . 0.0 114.486 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 17.4 t -105.34 146.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.169 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.452 ' CD1' ' HG3' ' A' ' 105' ' ' GLU . 32.4 tp -98.47 106.99 19.35 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.526 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.596 HG13 HG13 ' A' ' 104' ' ' ILE . 1.7 p -108.74 145.8 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 121.475 0.655 . . . . 0.0 111.55 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.548 ' CD2' HD12 ' A' ' 148' ' ' LEU . 86.3 t80 -104.0 91.74 4.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.209 178.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.523 ' CG ' HD11 ' A' ' 104' ' ' ILE . 9.1 pt-20 -138.87 155.94 47.7 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 11.9 m120 65.98 22.61 11.24 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.355 0.597 . . . . 0.0 110.02 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.72 13.96 64.38 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.931 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -136.23 171.28 14.7 Favored 'General case' 0 N--CA 1.401 -2.925 0 CA-C-O 121.258 0.551 . . . . 0.0 110.24 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -101.92 121.28 41.82 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.084 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.596 HG13 HG13 ' A' ' 97' ' ' VAL . 16.1 pt -127.61 145.11 35.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.926 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 8.4 mp0 -106.46 115.13 29.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.079 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.618 ' HG3' HG22 ' A' ' 111' ' ' VAL . 12.7 ptpt -128.31 141.71 51.35 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.894 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.719 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 99.8 mtt180 -61.47 165.73 4.58 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 119.404 -0.331 . . . . 0.0 110.635 -176.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 1.035 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -62.67 -40.27 96.55 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.47 -173.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.525 ' HB3' HG13 ' A' ' 91' ' ' VAL . 5.8 p90 -72.71 -7.53 50.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.868 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -102.75 -17.01 15.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.716 0.769 . . . . 0.0 109.175 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.618 HG22 ' HG3' ' A' ' 106' ' ' LYS . 69.4 t -77.42 150.41 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.569 ' HE3' ' H ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -124.27 163.69 21.12 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.106 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.82 142.95 56.0 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.57 4.54 76.31 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.584 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.962 ' HB3' HD12 ' A' ' 151' ' ' ILE . 18.4 t70 -71.95 164.4 26.16 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.467 ' HE2' ' O ' ' A' ' 148' ' ' LEU . 24.2 mttt -122.55 154.67 37.6 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-O 121.568 0.699 . . . . 0.0 110.753 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.25 159.65 34.75 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.93 129.58 35.59 Favored 'General case' 0 N--CA 1.399 -3.014 0 C-N-CA 119.394 -0.923 . . . . 0.0 108.679 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -113.42 132.89 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.153 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.34 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 C--N 1.308 -1.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.956 -179.088 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.548 HD12 ' CD2' ' A' ' 98' ' ' TYR . 12.4 mt . . . . . 0 N--CA 1.421 -1.898 0 CA-C-O 121.215 0.531 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.755 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -113.68 136.74 52.51 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.946 -173.312 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.434 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 28.4 mt-10 -90.22 147.2 23.7 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.126 176.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.962 HD12 ' HB3' ' A' ' 115' ' ' ASP . 81.3 mt -79.46 112.64 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.012 175.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 4.9 mmpt? -76.89 -39.81 49.63 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.642 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -148.26 131.55 16.52 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -175.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 86.7 mt -114.26 148.32 17.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.754 174.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -154.33 162.03 41.41 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.708 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.575 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 15.8 m-85 -101.72 116.9 33.75 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.39 133.16 64.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.371 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.436 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 60.3 ttt180 -68.85 161.24 29.02 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.167 0.508 . . . . 0.0 111.726 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.436 ' N ' ' HG2' ' A' ' 158' ' ' ARG . . . -70.4 120.08 15.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.77 -32.76 73.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.833 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -110.9 -173.9 2.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.484 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -100.51 0.03 38.76 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 120.858 0.361 . . . . 0.0 111.413 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -138.98 159.42 42.19 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 3' ' ' PRO . 6.3 m -132.39 161.41 41.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.921 177.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.635 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 76.2 m-85 -134.56 173.0 12.14 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.565 ' HB2' HD12 ' A' ' 68' ' ' ILE . 69.8 m -158.76 -24.68 0.08 Allowed 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.512 ' HG ' HD21 ' A' ' 24' ' ' LEU . 1.4 tm? 68.5 111.01 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.253 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -92.65 115.71 28.35 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.99 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.516 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.38 -146.57 0.33 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.437 ' HB3' HG21 ' A' ' 62' ' ' THR . 23.4 tptm . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.761 0.315 . . . . 0.0 110.309 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.407 ' OD1' HD11 ' A' ' 54' ' ' LEU . 10.0 t30 . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.888 HG21 HD11 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -141.21 167.15 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.34 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.58 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.0 mt -105.7 117.53 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.73 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.518 HG23 HG13 ' A' ' 175' ' ' VAL . 44.7 pt -122.27 170.09 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.448 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 48.59 -132.94 1.48 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 124.036 0.934 . . . . 0.0 110.318 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.95 53.87 2.56 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.35 0.595 . . . . 0.0 110.233 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.754 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 20.5 m-80 69.88 44.4 0.83 Allowed 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.887 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 91.7 mt -87.38 116.83 30.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.475 HG22 HG12 ' A' ' 176' ' ' ILE . 59.1 t -94.05 130.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.478 -175.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.522 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 15.1 t . . . . . 0 C--N 1.31 -1.132 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.532 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.683 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 84.6 m . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.068 0.461 . . . . 0.0 111.559 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -126.46 162.06 48.82 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.591 ' HD3' HD13 ' A' ' 76' ' ' LEU . 57.8 Cg_endo -67.21 161.77 41.47 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.561 1.507 . . . . 0.0 109.212 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.521 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.56 -26.21 64.28 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 119.212 -1.471 . . . . 0.0 110.712 175.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.74 -26.17 44.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.468 0.707 . . . . 0.0 112.264 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 20' ' ' THR . 31.8 m -64.77 123.99 20.8 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.352 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.767 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 45.6 mtm-85 -81.42 128.23 33.64 Favored 'General case' 0 C--O 1.184 -2.364 0 C-N-CA 123.195 0.598 . . . . 0.0 109.878 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 19' ' ' ILE . 13.6 tt -112.48 130.34 66.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 122.193 -0.317 . . . . 0.0 110.332 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.574 HD21 HD21 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -85.13 123.77 31.03 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.52 0.676 . . . . 0.0 109.784 177.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 24.8 m -136.41 -179.42 2.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.62 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 31.3 tt0 -130.16 119.58 23.21 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.63 HG12 HG13 ' A' ' 47' ' ' ILE . 11.8 mt -120.45 122.66 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.527 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.786 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 55.34 38.33 30.17 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.807 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.21 22.19 78.51 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.131 -0.94 . . . . 0.0 113.223 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.71 119.92 21.6 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-O 121.11 0.481 . . . . 0.0 109.941 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.569 ' HG2' ' HB3' ' A' ' 124' ' ' LEU . 57.2 Cg_endo -72.8 126.14 11.1 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 122.486 2.124 . . . . 0.0 111.52 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -129.48 140.59 51.23 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.457 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 26.6 ttpt -110.42 101.5 10.2 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.616 ' O ' HG22 ' A' ' 8' ' ' ILE . 10.9 pt -139.75 136.86 39.51 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.25 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.767 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 4.5 p -40.02 148.95 0.07 Allowed 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.015 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 51.1 mt -60.15 -25.06 65.22 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.874 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.733 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 7.4 ptm180 -78.08 -28.03 48.69 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.529 ' HA ' ' OE2' ' A' ' 26' ' ' GLU . 60.8 mt-10 -85.29 -48.67 8.85 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.278 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.534 HD11 ' HG ' ' A' ' 167' ' ' LEU . 0.5 OUTLIER -50.94 -51.37 52.94 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.561 0.696 . . . . 0.0 109.887 175.066 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.43 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -45.42 -34.17 2.97 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.322 -1.308 . . . . 0.0 113.598 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.529 ' OE2' ' HA ' ' A' ' 23' ' ' GLU . 30.3 mt-10 -69.68 -18.47 63.56 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.71 1.86 18.65 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.568 0.699 . . . . 0.0 109.836 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 99.2 m-85 -118.96 160.86 21.2 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.765 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -143.95 -172.15 3.69 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.942 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.483 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.4 t70 63.36 82.36 0.18 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.574 0.702 . . . . 0.0 110.329 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -99.22 129.36 45.45 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.388 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.53 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.4 ptt180 -118.28 152.8 35.05 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.172 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 37' ' ' VAL . 3.4 t80 -104.6 123.88 48.35 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -167.0 146.73 5.43 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.302 -174.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 62.5 18.61 10.56 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 123.421 0.451 . . . . 0.0 110.547 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.6 mtt 71.12 15.93 6.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.013 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 27.1 m -130.47 -173.34 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.83 140.26 50.25 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.219 0.533 . . . . 0.0 109.968 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.53 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.3 t -127.72 123.67 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.456 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.008 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.449 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 13.2 ttm180 -111.22 126.96 55.42 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.51 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.38 147.3 52.38 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.386 -175.164 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 8.2 tmtm? 84.24 109.87 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.484 0 O-C-N 124.426 1.079 . . . . 0.0 110.637 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HB2' HD13 ' A' ' 47' ' ' ILE . 72.0 Cg_endo -78.57 149.43 23.93 Favored 'Trans proline' 0 N--CA 1.435 -1.917 0 C-N-CA 122.252 1.968 . . . . 0.0 111.25 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.508 ' HE2' ' O ' ' A' ' 26' ' ' GLU . 1.5 mtmt -85.66 -2.75 58.5 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.204 0.526 . . . . 0.0 111.118 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -144.32 -165.82 2.22 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.0 tp10 -87.18 103.39 15.37 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 175.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.63 HG13 HG12 ' A' ' 12' ' ' ILE . 1.4 mp -119.09 121.42 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.889 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 37.7 mmtt -118.43 169.51 9.7 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.077 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.505 HG11 ' CB ' ' A' ' 169' ' ' ALA . 14.6 p -128.17 133.92 66.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.326 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.55 ' CD1' HD12 ' A' ' 9' ' ' LEU . 31.5 m-85 -83.71 123.15 29.54 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.915 176.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.9 t -127.66 174.61 8.94 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.612 HG12 HD11 ' A' ' 176' ' ' ILE . 1.2 mm -125.27 141.94 43.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.583 0.706 . . . . 0.0 111.501 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.679 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 32.8 t70 -90.87 115.25 27.77 Favored 'General case' 0 C--O 1.194 -1.842 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.691 HD12 ' H ' ' A' ' 54' ' ' LEU . 4.8 mp -67.16 -33.56 75.67 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 121.848 0.832 . . . . 0.0 111.665 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.679 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -73.72 -30.92 63.11 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.773 -174.05 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.7 p -113.22 -22.01 10.69 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.179 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.18 18.07 70.26 Favored Glycine 0 N--CA 1.431 -1.633 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.492 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.504 ' C ' HD13 ' A' ' 52' ' ' ILE . 26.2 mttp -98.12 157.46 16.13 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.82 112.01 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.255 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.2 m -110.74 165.46 6.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.651 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.9 tp -120.69 140.28 51.84 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.1 t -143.49 171.59 13.94 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.013 0.435 . . . . 0.0 111.22 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.69 160.93 19.43 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.262 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.559 HD12 ' N ' ' A' ' 64' ' ' ILE . 3.0 mp -97.47 143.05 13.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.141 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.444 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 79.2 mm-40 -91.13 -38.76 12.54 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 176.93 175.48 0.37 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.788 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 17.3 t -105.69 130.2 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.049 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 61.2 mt -89.89 106.6 17.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.689 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.44 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 88.0 tttt -121.37 110.42 16.07 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.798 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 163' ' ' PHE . . . -130.48 139.01 34.33 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.762 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.432 ' HD2' HG12 ' A' ' 37' ' ' VAL . 7.4 Cg_endo -53.14 124.42 15.56 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.877 2.385 . . . . 0.0 112.108 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.56 96.69 0.18 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.686 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.5 m -105.18 -58.25 1.92 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.994 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -79.66 175.42 10.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.147 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -101.22 171.46 7.59 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' A' ' 90' ' ' THR . 10.6 mt -126.72 141.92 51.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.718 0.771 . . . . 0.0 111.775 -173.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 88' ' ' GLU . 13.9 mt -84.4 143.88 10.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 10.7 ttt85 -116.57 138.02 51.73 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-O 121.213 0.53 . . . . 0.0 109.814 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.614 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.7 m-85 -116.12 122.47 45.2 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.546 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 152' ' ' LYS . 36.0 tt0 -109.77 124.49 51.36 Favored 'General case' 0 CA--C 1.47 -2.104 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.734 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -88.24 160.78 17.54 Favored 'General case' 0 C--N 1.271 -2.818 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.813 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.806 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.7 pt-20 -60.72 -19.28 58.5 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.592 0.711 . . . . 0.0 110.529 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -91.48 -12.14 35.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.93 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.07 14.38 49.04 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.994 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.572 ' O ' HD23 ' A' ' 81' ' ' LEU . 4.2 mtt180 -84.29 138.25 33.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 27.0 p -141.63 137.84 32.12 Favored 'General case' 0 C--N 1.287 -2.122 0 C-N-CA 118.969 -1.092 . . . . 0.0 112.845 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.456 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 5.0 p90 -136.0 154.64 51.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.507 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 25.2 mt-10 -125.32 151.84 45.49 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.549 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -143.42 157.93 44.06 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.399 178.315 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.677 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -69.8 15.27 0.08 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.005 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.6 -36.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 125.448 1.499 . . . . 0.0 112.213 178.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.547 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 26.7 t70 -78.41 -18.07 55.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.333 0.587 . . . . 0.0 109.639 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -77.83 125.75 85.14 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.298 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.502 ' CG ' ' HA ' ' A' ' 185' ' ' GLN . 37.7 Cg_endo -66.12 142.55 68.1 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.133 2.556 . . . . 0.0 112.622 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 20.7 t -111.97 145.47 18.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.6 tp -101.72 108.9 20.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.837 0.351 . . . . 0.0 110.793 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.605 HG13 HG13 ' A' ' 104' ' ' ILE . 2.2 p -112.22 150.09 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.367 0.603 . . . . 0.0 111.067 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.456 ' CD2' HD12 ' A' ' 148' ' ' LEU . 58.9 t80 -105.62 93.62 4.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.18 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 6.9 pt-20 -139.44 158.81 43.5 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 86.6 m-20 64.57 22.14 12.59 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.212 0.53 . . . . 0.0 110.154 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.25 14.72 64.48 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.031 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -137.21 171.65 14.17 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 117.365 0.583 . . . . 0.0 110.042 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -100.83 122.75 43.96 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.605 HG13 HG13 ' A' ' 97' ' ' VAL . 24.6 pt -121.04 146.98 25.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.836 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 mp0 -104.17 112.09 24.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.278 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 11.5 ptpt -124.2 139.44 53.92 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.576 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.64 ' O ' HG23 ' A' ' 111' ' ' VAL . 14.3 mmt180 -60.55 158.84 11.52 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.005 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -60.38 -40.79 92.13 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.864 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.418 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.7 p90 -73.47 -1.13 17.17 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.868 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -111.13 -13.79 13.97 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.693 0.759 . . . . 0.0 109.772 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 107' ' ' ARG . 93.6 t -79.2 149.0 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.698 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 21.6 mtmt -123.36 165.81 16.38 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.192 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.81 139.68 55.26 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.91 4.5 72.2 Favored Glycine 0 C--N 1.307 -1.032 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.874 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.698 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -75.33 167.93 20.96 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.46 ' HG2' ' HG3' ' A' ' 150' ' ' GLU . 25.2 mttp -119.61 165.1 14.89 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 121.404 0.621 . . . . 0.0 110.511 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.456 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -133.55 159.93 42.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.58 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 182' ' ' VAL . 0.9 OUTLIER -88.64 131.79 34.83 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -119.21 132.58 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.193 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB3' HD22 ' A' ' 180' ' ' ASN . 48.4 t -64.34 -19.37 65.41 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.626 0.727 . . . . 0.0 109.926 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.703 ' HB3' ' HB3' ' A' ' 145' ' ' HIS . 10.1 mm-40 46.13 13.57 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.703 -1.589 . . . . 0.0 114.151 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.7 tt -100.4 109.93 22.11 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.055 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -92.18 177.59 6.11 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.24 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.574 HD21 HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -108.24 13.83 25.44 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.316 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.0 t 70.81 -66.37 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.46 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.07 98.29 0.76 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.956 0.408 . . . . 0.0 110.958 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -105.2 25.04 11.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.925 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.4 m -57.22 144.32 35.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.164 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.9 m -71.47 134.52 46.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.827 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.9 t 70.09 173.91 0.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.895 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.7 p -92.21 67.9 5.03 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.33 0.586 . . . . 0.0 110.87 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -84.45 -45.1 13.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.061 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -106.34 173.29 6.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.467 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.514 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . 27.3 t-20 -170.24 -59.18 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 134' ' ' ASN . 77.3 Cg_endo -75.06 62.62 5.95 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.615 2.21 . . . . 0.0 112.589 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -143.83 116.02 8.44 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.363 0.601 . . . . 0.0 110.318 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -134.39 27.51 3.75 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 122.556 1.17 . . . . 0.0 108.054 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -85.65 -155.05 0.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.049 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 60.54 38.36 18.98 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.757 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.6 tp 72.68 -65.46 0.35 Allowed 'General case' 0 C--N 1.343 0.286 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.126 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.94 30.21 8.08 Favored Glycine 0 C--N 1.302 -1.319 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.174 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -127.91 116.34 20.64 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-O 120.765 0.317 . . . . 0.0 110.572 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -95.76 -163.38 0.09 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.929 2.42 . . . . 0.0 111.675 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -178.8 118.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.158 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.703 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -169.68 128.38 0.95 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.181 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -137.45 87.25 2.25 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.495 ' O ' HD23 ' A' ' 148' ' ' LEU . 9.1 pt20 -163.57 141.06 7.4 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.827 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 147' ' ' GLN . 14.4 mt -111.81 154.69 24.72 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-O 121.199 0.523 . . . . 0.0 110.211 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.806 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -113.21 137.86 50.84 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.027 -172.067 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.46 ' HG3' ' HG2' ' A' ' 116' ' ' LYS . 15.1 mt-10 -92.19 146.68 23.52 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.3 1.047 . . . . 0.0 112.7 175.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.44 HD13 ' CD1' ' A' ' 79' ' ' PHE . 75.2 mt -78.73 111.99 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.534 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.546 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.558 ' HE2' ' HB2' ' A' ' 82' ' ' GLU . 48.9 mmtt -71.63 -40.36 69.8 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.54 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -149.51 133.55 17.15 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 76.2 mt -116.92 144.64 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.609 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.479 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 19.0 ptpt -152.78 164.09 38.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.155 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.478 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 15.3 m-85 -101.59 116.55 33.0 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.417 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.16 173.9 11.07 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.958 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -106.24 152.83 22.99 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 120.928 0.394 . . . . 0.0 111.486 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.28 128.38 36.47 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.224 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -65.85 -47.36 75.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.101 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.08 170.95 9.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.822 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -90.29 0.74 57.1 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 121.582 0.706 . . . . 0.0 109.933 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 96.2 m-85 -141.03 148.29 40.02 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.256 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 3' ' ' PRO . 4.0 m -118.03 155.49 19.91 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.699 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 74.3 m-85 -133.43 173.58 11.33 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.68 0.276 . . . . 0.0 110.926 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.698 ' HB2' HD12 ' A' ' 68' ' ' ILE . 67.0 m -158.38 -23.37 0.08 Allowed 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.534 ' HG ' HD11 ' A' ' 24' ' ' LEU . 1.9 tm? 67.17 107.03 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.592 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -88.63 116.48 26.91 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.513 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.505 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -132.27 -167.25 1.86 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.995 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -62.89 144.91 56.24 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm 84.55 -25.81 0.12 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.225 1.01 . . . . 0.0 110.308 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 65.52 140.95 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.382 1.073 . . . . 0.0 113.175 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.669 ' O ' ' HA ' ' A' ' 184' ' ' HIS . 16.2 m170 42.36 53.67 4.48 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.67 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -150.34 106.27 3.43 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.644 HG13 HG23 ' A' ' 177' ' ' ILE . 2.8 p -148.78 162.67 5.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.44 0.638 . . . . 0.0 111.225 -176.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.612 HD11 HG12 ' A' ' 52' ' ' ILE . 90.6 mt -108.34 116.91 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.605 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.644 HG23 HG13 ' A' ' 175' ' ' VAL . 37.7 pt -125.24 172.91 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.678 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 7' ' ' ARG . 8.2 t-20 47.9 -130.65 1.61 Allowed 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.055 0.942 . . . . 0.0 109.732 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -88.28 55.37 3.4 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.742 0.782 . . . . 0.0 109.487 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.6 m-20 67.38 47.76 1.23 Allowed 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.856 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 81.4 mt -87.94 118.18 33.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 118' ' ' LEU . 48.7 t -90.51 135.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.189 -175.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 3.5 t -145.33 148.01 32.94 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.102 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.669 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 79.9 t60 -155.89 149.54 25.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.774 0.321 . . . . 0.0 110.2 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.502 ' HA ' ' CG ' ' A' ' 94' ' ' PRO . 52.6 tt0 . . . . . 0 C--O 1.261 1.7 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.015 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 89' ' ' THR . 57.1 m . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.958 0.408 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.451 ' CE1' HD13 ' A' ' 177' ' ' ILE . 62.4 m-85 -129.76 150.21 75.16 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.541 ' HD3' HD13 ' A' ' 76' ' ' LEU . 18.7 Cg_endo -58.51 -29.69 89.51 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.886 2.391 . . . . 0.0 112.569 -175.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 124.28 -37.48 2.64 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.06 -4.62 21.95 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.449 0.642 . . . . 0.0 111.523 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.6 m -67.95 127.73 33.91 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.963 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.579 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 33.5 mmt180 -80.02 131.44 35.79 Favored 'General case' 0 C--O 1.181 -2.53 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 19' ' ' ILE . 8.1 tt -119.22 130.93 73.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.649 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.697 HD21 ' CD1' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -87.0 123.44 32.1 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 121.602 0.715 . . . . 0.0 110.187 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 31.5 m -135.59 -178.9 2.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.489 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 30.8 tt0 -129.23 121.42 27.58 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.581 HG12 HG13 ' A' ' 47' ' ' ILE . 21.2 mt -119.32 121.47 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.864 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.54 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 54.58 38.49 29.96 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.97 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.35 18.45 79.86 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.061 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.2 t -124.28 121.84 26.06 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 59.7 Cg_endo -74.1 121.43 6.9 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 C-N-CA 122.383 2.055 . . . . 0.0 111.05 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -125.41 141.71 51.91 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.702 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 38.8 ttpt -109.93 100.82 9.72 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.9 pt -121.98 -173.71 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.183 -2.447 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.721 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 21.1 p -92.25 172.29 8.51 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.282 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 15.0 mt -72.98 -22.25 60.72 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.77 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.721 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.2 ptm180 -85.28 -24.63 27.64 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.529 ' OE1' HG23 ' A' ' 20' ' ' THR . 71.1 mt-10 -83.71 -42.67 16.35 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.917 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.467 HD21 ' HG ' ' A' ' 167' ' ' LEU . 16.9 tp -55.98 -43.91 78.03 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.996 0.903 . . . . 0.0 108.917 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.621 ' HD1' HG11 ' A' ' 67' ' ' VAL . 11.8 t80 -51.41 -33.95 32.62 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.463 -1.699 . . . . 0.0 112.613 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 27.3 mt-10 -73.65 -17.07 61.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.69 2.71 21.64 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.393 0.616 . . . . 0.0 109.791 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.526 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.6 m-85 -117.08 161.61 19.14 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.364 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -139.06 -173.45 3.58 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.231 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.557 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER 60.6 86.07 0.1 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.35 0.595 . . . . 0.0 110.919 177.542 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -107.23 131.19 54.46 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.115 0.959 . . . . 0.0 112.368 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.483 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 15.3 ptt-85 -116.32 153.58 31.72 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.731 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -101.01 130.77 47.05 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -166.55 143.22 4.84 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.405 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 60.66 21.11 11.04 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 123.715 0.634 . . . . 0.0 110.928 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 36.7 mtm 71.59 20.06 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.417 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.457 HG12 ' HD2' ' A' ' 71' ' ' PRO . 5.1 m -134.9 -174.72 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -115.03 138.75 50.5 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-O 121.124 0.488 . . . . 0.0 110.534 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.483 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.2 t -128.52 124.83 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.33 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.444 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 18.5 ttm180 -114.04 127.45 55.94 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.557 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -130.66 144.41 51.41 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -173.789 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 43.5 tptt 82.16 111.77 0.03 OUTLIER Pre-proline 0 CA--C 1.518 -0.273 0 O-C-N 124.361 1.038 . . . . 0.0 111.232 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.605 ' HB2' HD13 ' A' ' 47' ' ' ILE . 62.0 Cg_endo -78.14 153.9 28.64 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.405 2.07 . . . . 0.0 112.282 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -85.81 -1.91 57.71 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.162 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -147.58 -165.9 2.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 32.7 tt0 -86.43 101.51 13.21 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.605 HD13 ' HB2' ' A' ' 43' ' ' PRO . 1.5 mp -116.33 116.01 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.194 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.48 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 26.1 mmtp -117.55 164.8 14.37 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.648 175.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.9 p -119.42 132.1 70.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.536 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.404 ' CD2' HD12 ' A' ' 9' ' ' LEU . 11.2 m-85 -84.62 118.59 24.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.17 0.509 . . . . 0.0 110.04 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.4 p -124.43 176.97 6.15 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.938 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.536 HG12 HD11 ' A' ' 176' ' ' ILE . 1.2 mm -130.3 138.2 54.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.588 0.709 . . . . 0.0 110.813 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.423 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 25.2 t70 -84.61 120.02 25.89 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.128 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.404 HD21 ' ND2' ' A' ' 174' ' ' ASN . 11.3 mt -67.33 -29.91 69.6 Favored 'General case' 0 CA--C 1.475 -1.933 0 CA-C-O 122.036 0.922 . . . . 0.0 112.048 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.423 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -81.81 -30.24 32.31 Favored 'General case' 0 C--N 1.263 -3.188 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.523 -171.548 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.7 p -114.54 -25.28 8.41 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.264 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.71 14.04 74.03 Favored Glycine 0 N--CA 1.427 -1.904 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.162 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.517 ' C ' HD13 ' A' ' 52' ' ' ILE . 41.5 mtpt -89.83 152.55 21.22 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -91.42 108.48 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.923 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.3 m -110.21 163.27 7.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.096 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.94 141.95 49.18 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.519 HG21 ' HB3' ' A' ' 170' ' ' LYS . 13.5 t -149.89 171.27 17.05 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.131 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.13 160.6 21.83 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 121.617 0.722 . . . . 0.0 111.197 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.2 mp -96.0 145.52 8.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.174 -178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.428 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 16.0 mm-40 -91.01 -37.97 13.12 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 p30 174.18 175.33 0.16 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.803 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.621 HG11 ' HD1' ' A' ' 25' ' ' TYR . 4.1 t -107.12 138.19 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.171 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.629 HD12 ' HB2' ' A' ' 166' ' ' SER . 35.7 mt -101.44 109.74 26.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.045 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.402 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 8.2 ttpm? -120.88 112.4 18.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.87 137.37 30.63 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.295 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.457 ' HD2' HG12 ' A' ' 37' ' ' VAL . 71.2 Cg_exo -48.17 131.7 22.39 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.454 2.769 . . . . 0.0 113.275 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.11 93.18 9.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.227 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 p -89.7 -24.9 21.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.04 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -110.97 -169.99 1.56 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.801 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.575 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 28.0 m170 -115.28 171.21 7.84 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.728 HD23 ' HA ' ' A' ' 90' ' ' THR . 5.9 mt -121.32 148.27 44.56 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.966 0.888 . . . . 0.0 112.762 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.485 HD12 ' C ' ' A' ' 108' ' ' ALA . 27.7 mt -85.55 143.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.576 172.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 12.5 ttt85 -116.5 137.99 51.74 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-O 121.126 0.489 . . . . 0.0 110.157 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 86' ' ' SER . 58.5 m-85 -114.36 122.32 46.31 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.622 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 152' ' ' LYS . 23.1 tt0 -112.51 123.02 49.36 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.75 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.3 mm? -86.2 160.39 19.21 Favored 'General case' 0 N--CA 1.403 -2.775 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.218 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.743 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.4 pt-20 -64.74 -13.27 54.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.848 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -97.54 -8.52 28.92 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.538 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.56 10.58 57.88 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.082 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.587 ' O ' HD23 ' A' ' 81' ' ' LEU . 4.7 mtt180 -81.59 136.85 35.56 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 48.4 p -140.6 143.12 35.08 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.685 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.437 ' CD1' HD13 ' A' ' 181' ' ' ILE . 7.7 p90 -138.17 145.61 41.73 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.573 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 49.0 mt-10 -117.19 146.29 43.32 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.352 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 5.3 p -142.78 153.86 43.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.733 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.728 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.88 10.28 0.93 Allowed 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.06 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.9 m 63.66 161.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 123.475 0.71 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 107' ' ' ARG . 33.9 t70 73.28 -30.61 0.21 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.124 0.488 . . . . 0.0 110.918 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 185' ' ' GLN . 97.6 m-70 -68.28 132.87 91.47 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.249 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.75 115.76 4.37 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.361 2.707 . . . . 0.0 114.901 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 18.3 t -94.74 149.19 4.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 103' ' ' PHE . 1.1 tm? -103.08 118.58 37.11 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.0 0.428 . . . . 0.0 111.937 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.704 HG13 HG13 ' A' ' 104' ' ' ILE . 2.3 p -118.45 147.87 21.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.93 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.523 ' CD2' HD12 ' A' ' 148' ' ' LEU . 88.4 t80 -103.86 98.62 8.44 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.775 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 10.3 pt-20 -147.64 158.56 44.06 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.3 m-20 65.04 22.6 12.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.239 0.542 . . . . 0.0 109.866 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.66 12.14 55.69 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.66 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -132.13 172.84 11.89 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.552 0.691 . . . . 0.0 109.791 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.562 ' HB3' HD11 ' A' ' 96' ' ' LEU . 20.3 m-85 -103.1 121.2 42.12 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.464 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.704 HG13 HG13 ' A' ' 97' ' ' VAL . 24.4 pt -122.05 148.77 25.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.522 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 26.9 mt-10 -104.94 118.43 36.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.81 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.471 ' HB2' HG22 ' A' ' 111' ' ' VAL . 90.1 mttt -119.93 132.6 55.57 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.581 ' O ' HG23 ' A' ' 111' ' ' VAL . 65.3 mtt180 -60.03 158.3 11.27 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.06 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -56.59 -45.66 81.25 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.87 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -75.32 9.98 1.83 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.411 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -119.35 -20.57 7.83 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.201 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 107' ' ' ARG . 92.5 t -73.55 146.58 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.71 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 70.6 mmtt -119.75 170.77 8.92 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.719 -177.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.58 141.77 53.7 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.646 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.95 4.43 84.61 Favored Glycine 0 N--CA 1.425 -2.046 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.829 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.71 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -76.26 165.43 24.88 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.434 ' HE3' ' HG3' ' A' ' 150' ' ' GLU . 31.3 mttp -117.91 164.82 14.48 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.54 0.686 . . . . 0.0 110.819 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.0 159.75 42.9 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.76 133.66 34.17 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.3 OUTLIER -116.61 138.13 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.024 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.26 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 180' ' ' ASN . 4.8 p -72.39 -14.1 61.63 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-O 121.44 0.638 . . . . 0.0 110.412 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 145' ' ' HIS . 24.7 mm-40 45.79 12.2 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.611 -1.631 . . . . 0.0 115.072 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 36.0 tp -83.95 137.98 33.37 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.269 0.557 . . . . 0.0 111.905 -178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -99.16 146.89 25.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.719 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.697 ' CD1' HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -149.0 -48.31 0.15 Allowed 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 121.474 0.654 . . . . 0.0 110.248 -177.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.484 HG12 HD12 ' A' ' 124' ' ' LEU . 2.3 p -149.78 157.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.621 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 82.94 129.18 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.412 1.085 . . . . 0.0 111.276 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -142.08 -53.17 0.42 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.803 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.4 p -92.85 -160.09 0.72 Allowed 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.2 m -61.17 -29.24 69.68 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.9 m 61.93 -172.66 0.15 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.332 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 88.8 p -148.57 -168.55 3.12 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.892 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -88.64 5.93 40.72 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.867 0.365 . . . . 0.0 110.473 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -66.51 133.32 50.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.22 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -92.28 -52.74 0.27 Allowed Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.71 159.39 38.83 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.966 2.444 . . . . 0.0 112.847 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.509 ' NZ ' ' HB2' ' A' ' 136' ' ' LYS . 8.2 mtmp? 71.19 50.27 0.3 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.388 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -62.74 125.46 24.03 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.557 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -99.63 145.28 27.76 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.182 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -156.84 150.78 24.82 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 58.8 tp -56.43 -53.91 51.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.16 0.505 . . . . 0.0 110.57 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 144.08 -41.24 1.13 Allowed Glycine 0 C--N 1.302 -1.313 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 5.6 p -137.28 118.28 10.8 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.316 -0.442 . . . . 0.0 109.842 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 142' ' ' SER . 8.1 Cg_exo -71.89 155.28 58.04 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.003 1.802 . . . . 0.0 111.586 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -162.73 90.16 0.69 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.906 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 16.7 m80 -154.8 118.29 4.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.254 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -138.47 96.53 3.18 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.544 ' O ' HD23 ' A' ' 148' ' ' LEU . 26.3 pt20 -164.3 147.85 9.43 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.162 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 147' ' ' GLN . 13.8 mt -111.17 146.73 36.36 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-O 121.404 0.621 . . . . 0.0 110.128 173.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.75 ' HB3' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -111.08 137.06 49.2 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.913 -1.039 . . . . 0.0 113.516 -171.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.434 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 23.3 mt-10 -91.18 146.34 23.92 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.91 176.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.429 HG21 ' CG1' ' A' ' 154' ' ' ILE . 66.6 mt -81.02 107.79 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.921 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.545 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 27.7 mmtt -64.68 -42.84 95.07 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.368 175.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -148.29 132.5 17.4 Favored 'General case' 0 CA--C 1.473 -1.995 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 84.2 mt -117.24 125.1 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.01 172.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.42 ' CD ' ' HD3' ' A' ' 78' ' ' ARG . 19.5 ptpt -128.89 163.86 24.35 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.006 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.467 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 12.5 m-85 -101.0 110.96 23.05 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.575 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -116.02 176.38 2.45 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.768 -178.369 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.531 ' HA ' ' HB3' ' A' ' 75' ' ' HIS . 31.5 mtm180 -82.66 -142.83 0.06 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-O 121.787 0.803 . . . . 0.0 112.192 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.43 ' H ' ' HB3' ' A' ' 158' ' ' ARG . . . -133.24 128.01 34.96 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -83.82 21.3 1.3 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -173.2 -178.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -104.78 8.42 34.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.374 0.607 . . . . 0.0 109.734 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -143.24 155.87 44.61 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.412 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 3' ' ' PRO . 7.0 m -129.82 160.92 40.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.432 176.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 67.9 m-85 -132.55 170.46 15.14 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.471 -176.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.629 ' HB2' HD12 ' A' ' 68' ' ' ILE . 1.4 m -155.76 -28.2 0.1 Allowed 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' A' ' 67' ' ' VAL . 1.3 tm? 71.32 107.04 0.06 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.742 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -86.27 115.09 23.59 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.64 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.456 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -135.29 -166.16 1.8 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.519 ' HB3' HG21 ' A' ' 62' ' ' THR . 23.9 tptm -63.19 142.4 58.4 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 170' ' ' LYS . 17.5 tppt? 77.93 -13.54 0.94 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.578 0.751 . . . . 0.0 110.47 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.405 ' H ' ' C ' ' A' ' 170' ' ' LYS . 33.5 p90 51.19 128.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.095 1.758 . . . . 0.0 115.532 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.527 ' HB3' ' HA ' ' A' ' 185' ' ' GLN . 43.9 m170 64.29 5.11 2.39 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.192 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.404 ' ND2' HD21 ' A' ' 54' ' ' LEU . 27.0 t-20 -98.03 99.79 11.08 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.443 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.569 HG23 HG23 ' A' ' 177' ' ' ILE . 29.8 m -139.49 178.59 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.808 0 CA-C-O 122.47 1.128 . . . . 0.0 112.501 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.536 HD11 HG12 ' A' ' 52' ' ' ILE . 87.6 mt -117.59 114.27 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 CA-C-N 112.532 -2.122 . . . . 0.0 108.48 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.569 HG23 HG23 ' A' ' 175' ' ' VAL . 35.9 pt -120.76 168.04 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.746 0 CA-C-O 120.963 0.411 . . . . 0.0 112.076 -174.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.457 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 2.1 t-20 48.69 -133.23 1.46 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.966 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.415 ' H ' ' CG ' ' A' ' 178' ' ' ASN . 0.8 OUTLIER -80.81 56.27 2.65 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 121.314 0.578 . . . . 0.0 109.932 174.698 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.669 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 12.8 m120 66.89 42.39 2.52 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.892 1.277 . . . . 0.0 114.256 175.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.437 HD13 ' CD1' ' A' ' 87' ' ' PHE . 92.8 mt -86.85 119.08 34.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 70.0 t -92.47 129.28 43.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.814 -176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.8 t -150.52 164.07 36.87 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.844 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -112.07 50.12 0.87 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.109 0.481 . . . . 0.0 110.971 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.527 ' HA ' ' HB3' ' A' ' 173' ' ' HIS . 3.7 pp0? . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.58 -1.2 . . . . 0.0 111.569 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.407 ' HB2' ' CG ' ' A' ' 93' ' ' HIS . 25.2 p . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.503 0.668 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -136.9 152.27 73.8 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.427 ' HD3' HD13 ' A' ' 76' ' ' LEU . 53.5 Cg_endo -65.81 158.16 55.22 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 N-CA-C 108.639 -1.331 . . . . 0.0 108.639 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' A' ' 165' ' ' PHE . . . -59.31 -22.83 56.86 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 119.077 -1.535 . . . . 0.0 111.887 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -71.31 -1.75 13.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.561 ' HB ' HD12 ' A' ' 21' ' ' LEU . 94.9 m -71.82 128.57 36.19 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.639 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 13.9 mtm-85 -85.58 131.0 34.44 Favored 'General case' 0 C--O 1.18 -2.576 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.414 ' CD1' HG21 ' A' ' 175' ' ' VAL . 8.4 tt -120.22 131.14 73.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' A' ' 18' ' ' LYS . 2.0 tm? -89.46 123.23 33.39 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-O 121.491 0.662 . . . . 0.0 110.077 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.0 m -133.14 -174.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.29 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 31.5 tt0 -133.19 123.69 26.07 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.629 HG12 HG13 ' A' ' 47' ' ' ILE . 23.1 mt -121.23 121.69 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.748 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.811 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 52.95 39.09 28.69 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.458 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.74 17.27 80.05 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.749 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.94 115.39 22.13 Favored Pre-proline 0 N--CA 1.438 -1.064 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 13.1 Cg_exo -64.4 124.02 12.69 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.277 1.985 . . . . 0.0 111.262 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -122.37 134.97 54.62 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.456 ' HB2' HD23 ' A' ' 9' ' ' LEU . 40.2 ttmt -106.59 101.25 10.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.1 pt -123.54 -173.58 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.744 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.791 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 20.4 p -97.11 168.65 10.32 Favored 'General case' 0 C--N 1.281 -2.378 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.725 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 66.1 mt -64.83 -29.7 70.67 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.791 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.5 ptm180 -77.04 -26.37 53.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.514 ' OE1' HG23 ' A' ' 20' ' ' THR . 62.7 mt-10 -84.66 -42.55 15.22 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.957 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.706 HD21 HD22 ' A' ' 167' ' ' LEU . 18.2 tp -57.5 -44.12 84.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-O 121.952 0.882 . . . . 0.0 110.145 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.654 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.5 m-30 -60.41 -23.86 64.7 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 113.747 -1.569 . . . . 0.0 113.188 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -79.88 -12.87 59.72 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.95 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.4 mm? -79.22 3.78 16.86 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.521 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.7 m-85 -118.49 164.72 14.86 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.226 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.573 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 38.0 mt-10 -136.4 -173.48 3.42 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.952 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.41 81.63 0.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.39 0.614 . . . . 0.0 111.55 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -98.65 120.4 39.02 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.783 0.801 . . . . 0.0 110.621 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -106.28 149.73 26.62 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 114.009 -1.451 . . . . 0.0 109.976 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.504 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 19.2 t80 -106.56 130.35 54.34 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.474 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 37' ' ' VAL . 6.8 tp10 -167.53 141.42 3.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.849 -176.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.4 m120 56.48 23.58 7.66 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 123.452 0.47 . . . . 0.0 111.865 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.504 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 43.8 mtm 72.07 17.57 5.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.88 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.516 HG12 ' HD2' ' A' ' 71' ' ' PRO . 4.8 m -127.32 -175.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -126.77 147.64 49.98 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.307 0.575 . . . . 0.0 110.603 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -131.47 124.0 53.75 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.007 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.801 ' HB3' HG22 ' A' ' 67' ' ' VAL . 38.1 ttm180 -115.41 126.23 54.12 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -133.43 146.76 51.48 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.463 -174.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 88.9 mttt 86.46 111.75 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.673 0 C-N-CA 125.183 1.393 . . . . 0.0 111.75 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.527 ' HB2' HD13 ' A' ' 47' ' ' ILE . 83.5 Cg_endo -79.72 147.73 19.7 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.527 2.151 . . . . 0.0 111.191 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.573 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 29.3 mtmt -81.75 -6.64 59.23 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -145.91 -164.98 2.08 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.1 tp10 -85.75 99.83 11.61 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.629 HG13 HG12 ' A' ' 12' ' ' ILE . 1.7 mp -115.97 117.37 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.952 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.538 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 25.0 mmtt -116.37 167.14 11.3 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.393 174.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.492 HG11 ' CB ' ' A' ' 169' ' ' ALA . 13.0 p -121.45 130.23 74.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.133 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -85.14 120.61 26.83 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.2 m -133.79 173.24 11.75 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.017 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.485 HG12 HD11 ' A' ' 176' ' ' ILE . 2.4 mm -115.61 142.57 28.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.223 0.535 . . . . 0.0 110.151 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.416 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 38.8 t0 -80.75 130.85 35.31 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.591 HD12 ' N ' ' A' ' 54' ' ' LEU . 4.1 mp -77.9 -25.63 48.58 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.973 0.892 . . . . 0.0 110.811 -172.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.34 -32.6 16.42 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.93 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' HB3' ' A' ' 53' ' ' ASP . 57.8 p -111.84 -20.21 12.13 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.522 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.66 12.18 84.65 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.742 177.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.455 ' C ' HD13 ' A' ' 52' ' ' ILE . 3.6 mtpm? -89.86 160.58 16.4 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.953 0.406 . . . . 0.0 112.069 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.45 110.18 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 CA-C-O 121.89 0.852 . . . . 0.0 110.009 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.5 m -111.13 163.8 7.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 49' ' ' VAL . 13.6 tp -123.74 141.97 51.52 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.42 ' OG1' ' HB2' ' A' ' 170' ' ' LYS . 14.3 t -151.05 172.21 16.09 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.91 0.386 . . . . 0.0 111.57 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.05 160.58 25.77 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.715 0.769 . . . . 0.0 110.993 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.567 HD13 HG22 ' A' ' 47' ' ' ILE . 2.1 mp -100.7 136.82 30.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.908 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 5.2 mm-40 -82.93 -38.28 23.03 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 p30 177.56 -179.2 0.23 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.303 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.801 HG22 ' HB3' ' A' ' 40' ' ' ARG . 2.9 m -116.82 145.26 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-O 121.124 0.488 . . . . 0.0 110.067 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' A' ' 166' ' ' SER . 56.8 mt -99.28 107.67 21.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.076 -173.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.455 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 76.8 tttt -116.08 107.42 14.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.6 137.65 30.89 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.141 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.516 ' HD2' HG12 ' A' ' 37' ' ' VAL . 77.5 Cg_exo -47.52 136.23 20.65 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 123.205 2.603 . . . . 0.0 112.688 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.66 102.7 0.47 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 m -60.44 -55.83 28.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.071 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.45 -138.7 0.11 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.301 -176.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -97.38 171.12 8.6 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.719 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.0 mt -124.19 140.54 52.86 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.928 0.87 . . . . 0.0 111.513 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 88' ' ' GLU . 40.0 mt -87.98 142.11 13.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.872 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 12.9 ttt180 -119.45 138.47 53.1 Favored 'General case' 0 N--CA 1.406 -2.651 0 CA-C-O 121.234 0.54 . . . . 0.0 109.655 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.606 ' O ' ' HA ' ' A' ' 86' ' ' SER . 58.1 m-85 -114.68 125.99 54.37 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.442 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 152' ' ' LYS . 36.8 tt0 -109.73 123.99 50.47 Favored 'General case' 0 CA--C 1.473 -2.013 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.753 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -89.34 162.5 15.78 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.994 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.901 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.1 pt-20 -63.88 -18.29 64.03 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.889 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -93.37 -7.29 45.14 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.531 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.57 13.22 57.3 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.045 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.571 ' O ' HD23 ' A' ' 81' ' ' LEU . 2.0 mtt180 -82.07 139.07 34.66 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 20.6 p -141.27 140.0 33.8 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 118.889 -1.125 . . . . 0.0 112.449 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -136.67 141.34 43.15 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.657 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 1.7 mp0 -109.61 148.1 31.89 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.779 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.73 ' HB ' ' NE2' ' A' ' 93' ' ' HIS . 3.5 p -137.02 149.14 47.28 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.139 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.719 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -73.44 7.62 2.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.075 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.5 m 59.81 169.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 122.911 0.484 . . . . 0.0 110.98 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.604 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 33.4 t70 73.11 -41.26 0.5 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.063 0.459 . . . . 0.0 111.35 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.73 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 8.6 p80 -75.69 148.59 82.64 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 7.0 Cg_exo -74.58 142.19 28.98 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.126 2.551 . . . . 0.0 114.534 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 23.6 t -111.99 154.3 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.514 1.526 . . . . 0.0 107.274 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.446 HD22 ' CD2' ' A' ' 184' ' ' HIS . 18.3 tp -106.49 113.45 26.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.841 0.746 . . . . 0.0 112.424 -176.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.647 HG13 HG13 ' A' ' 104' ' ' ILE . 2.4 p -113.39 153.64 14.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 111.808 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -108.48 95.61 5.78 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.989 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 6.6 pt-20 -143.76 159.19 42.95 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 4.0 m-20 66.84 22.74 10.17 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.228 0.537 . . . . 0.0 109.644 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.61 12.86 57.66 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.771 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -134.21 172.41 12.9 Favored 'General case' 0 N--CA 1.403 -2.815 0 CA-C-O 121.201 0.524 . . . . 0.0 109.807 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -100.68 121.69 42.06 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.647 HG13 HG13 ' A' ' 97' ' ' VAL . 25.9 pt -121.13 157.52 24.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.622 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 21.3 mt-10 -114.18 110.02 19.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.959 0.409 . . . . 0.0 111.666 -176.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.419 ' HE3' ' CD1' ' A' ' 104' ' ' ILE . 88.1 mttt -113.97 140.01 48.77 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 92' ' ' ASP . 6.5 mpt_? -60.8 154.79 21.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.075 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -56.63 -45.86 81.28 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.827 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.482 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 2.6 p90 -71.99 3.03 4.75 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.342 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -115.26 -16.34 11.52 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.358 0.599 . . . . 0.0 110.131 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 107' ' ' ARG . 70.0 t -74.51 145.09 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 31.6 mmtp -119.74 172.6 7.57 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.401 0.619 . . . . 0.0 111.689 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -70.9 138.31 50.04 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.393 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.51 5.59 74.99 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.924 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.842 ' HB3' HD12 ' A' ' 151' ' ' ILE . 8.1 t70 -71.27 170.17 13.64 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.739 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 48.2 mttp -127.85 155.72 43.68 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.758 0.79 . . . . 0.0 112.733 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.51 157.52 41.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.584 172.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.611 ' HA ' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -95.15 134.14 38.2 Favored 'General case' 0 CA--C 1.479 -1.784 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.6 OUTLIER -107.33 124.45 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.828 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.742 175.177 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 122' ' ' LEU . 4.7 m -80.98 73.92 8.0 Favored 'General case' 0 N--CA 1.398 -3.044 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 145' ' ' HIS . 19.6 tt0 -62.72 39.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -174.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 120' ' ' SER . 34.2 tp -82.01 123.87 29.29 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -106.71 168.2 9.34 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.833 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -132.93 30.29 4.02 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.957 0.884 . . . . 0.0 109.317 -176.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.1 p -51.23 144.73 2.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 113.482 -1.69 . . . . 0.0 113.014 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -163.9 156.95 18.12 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -98.88 20.93 12.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.7 m -81.1 -78.54 0.18 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.77 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 79.5 p 52.48 21.58 1.82 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.575 0.75 . . . . 0.0 112.136 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.3 p -73.82 -65.06 0.88 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.8 -177.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.3 m -148.36 168.12 23.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.233 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -78.63 96.83 5.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.071 0.463 . . . . 0.0 109.997 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.594 ' O ' ' HD3' ' A' ' 135' ' ' PRO . 39.0 t70 -149.58 170.78 17.86 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.204 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -112.8 82.68 5.23 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-O 120.738 0.304 . . . . 0.0 110.919 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 133' ' ' ASP . 8.6 Cg_endo -90.93 150.05 3.91 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 123.111 2.541 . . . . 0.0 110.843 177.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -151.88 108.75 3.51 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.274 0.559 . . . . 0.0 109.89 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -123.83 -68.34 0.87 Allowed 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.969 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -134.44 -108.0 0.22 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.142 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 66.52 110.48 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.734 0.646 . . . . 0.0 111.269 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.8 tp -68.8 -64.96 0.77 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 92.92 30.95 8.94 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.11 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.46 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 2.5 p -61.81 117.39 28.12 Favored Pre-proline 0 N--CA 1.444 -0.729 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 142' ' ' SER . 15.7 Cg_endo -86.04 -73.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.336 2.024 . . . . 0.0 113.917 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 71.4 74.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 121' ' ' GLU . 11.0 p80 -122.29 121.87 37.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.013 -174.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -159.84 87.85 0.82 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.44 -0.8 . . . . 0.0 108.976 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -164.2 140.22 6.26 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.05 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.739 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.7 mm? -112.13 140.22 47.0 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.061 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.901 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -114.26 134.68 54.76 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.996 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 8.5 mt-10 -86.82 142.79 27.83 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.155 177.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.842 HD12 ' HB3' ' A' ' 115' ' ' ASP . 80.6 mt -80.46 103.15 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.329 174.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.485 ' HG3' ' CA ' ' A' ' 82' ' ' GLU . 29.9 mtmt -61.1 -44.37 97.46 Favored 'General case' 0 C--N 1.274 -2.715 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.226 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -150.45 136.53 18.54 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 77.7 mt -113.92 145.37 19.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.885 174.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -150.44 160.14 43.97 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.214 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -100.27 113.17 25.66 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.02 134.73 65.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.358 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.427 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 32.2 ttp180 -66.25 151.71 46.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' A' ' 158' ' ' ARG . . . -67.29 127.77 33.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.898 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -79.84 -24.89 41.01 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.191 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -110.36 -178.35 3.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.17 -7.82 18.8 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.035 0.445 . . . . 0.0 110.01 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -134.24 160.26 38.4 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.24 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.03 155.2 41.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.654 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 19.6 m-85 -132.88 169.07 17.29 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.741 -172.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.602 ' HB2' HD12 ' A' ' 68' ' ' ILE . 19.3 m -155.55 -28.13 0.1 Allowed 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.706 HD22 HD21 ' A' ' 24' ' ' LEU . 15.4 tp 73.29 116.95 0.05 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.417 1.087 . . . . 0.0 111.618 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -91.8 109.33 20.66 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.46 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.492 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -129.6 -165.02 1.47 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.372 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.42 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 46.4 mmtt -68.69 143.74 54.64 Favored 'General case' 0 CA--C 1.489 -1.392 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.218 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt 50.33 47.43 23.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.287 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 173' ' ' HIS . 11.8 p90 -50.41 169.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.373 -177.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.595 ' O ' ' HA ' ' A' ' 184' ' ' HIS . 22.0 m-70 83.34 17.0 0.27 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.986 0.914 . . . . 0.0 109.777 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -148.87 138.93 22.2 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.619 HG13 HG23 ' A' ' 177' ' ' ILE . 1.3 p -166.32 166.67 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.485 HD11 HG12 ' A' ' 52' ' ' ILE . 97.2 mt -117.14 113.04 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.81 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.619 HG23 HG13 ' A' ' 175' ' ' VAL . 40.3 pt -123.19 171.37 12.25 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.521 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.237 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 7' ' ' ARG . 8.0 t-20 50.49 -129.46 2.2 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.431 1.092 . . . . 0.0 110.128 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.69 43.95 0.95 Allowed 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.439 0.637 . . . . 0.0 110.22 175.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.604 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.4 m-20 72.89 47.75 0.2 Allowed 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 114.081 -1.418 . . . . 0.0 112.92 176.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 81.3 mt -88.82 115.09 28.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.065 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 118' ' ' LEU . 2.6 m -76.33 156.21 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.2 t -171.46 169.78 6.05 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.786 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.595 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 14.1 m170 -114.2 -174.16 2.42 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.1 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 117.913 -1.041 . . . . 0.0 111.875 -179.288 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 89' ' ' THR . 71.3 m . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.824 0.345 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -129.08 160.52 63.3 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 76' ' ' LEU . 51.8 Cg_endo -66.15 156.51 64.39 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 N-CA-C 108.532 -1.372 . . . . 0.0 108.532 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.09 -22.56 49.69 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.531 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.45 -19.78 66.08 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.203 0.525 . . . . 0.0 112.186 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.441 ' HB ' HD12 ' A' ' 21' ' ' LEU . 91.9 m -59.61 128.09 35.25 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.771 -176.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 65.5 mmt-85 -81.34 133.34 35.41 Favored 'General case' 0 C--O 1.194 -1.856 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.78 HD11 HG21 ' A' ' 175' ' ' VAL . 8.1 tt -121.66 131.88 72.08 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.728 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.577 HD21 HD21 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -89.01 124.21 34.06 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.511 0.672 . . . . 0.0 109.987 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.9 m -135.11 -176.38 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.378 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -134.04 124.62 26.53 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.047 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.59 HG12 HG13 ' A' ' 47' ' ' ILE . 21.0 mt -120.55 119.46 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.026 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 52.62 44.45 30.08 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.744 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.2 75.5 Favored Glycine 0 C--N 1.307 -1.057 0 CA-C-N 114.704 -1.135 . . . . 0.0 114.256 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.47 HG11 ' CB ' ' A' ' 134' ' ' ASN . 34.9 t -124.76 119.94 25.71 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-O 121.137 0.494 . . . . 0.0 109.769 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HB2' HD13 ' A' ' 124' ' ' LEU . 56.8 Cg_endo -73.71 124.03 8.96 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.326 2.018 . . . . 0.0 111.74 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -123.26 146.27 48.0 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.47 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -114.51 100.23 8.14 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.258 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.9 pt -123.05 -174.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.929 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.671 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 10.9 p -92.99 172.21 8.46 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.234 -0.987 . . . . 0.0 109.088 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 70.4 mt -66.83 -30.49 70.68 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.256 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.671 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 5.7 ptm180 -80.11 -25.01 40.13 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.544 ' OE1' HG23 ' A' ' 20' ' ' THR . 78.8 mt-10 -83.58 -39.6 20.15 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.1 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.52 HD21 ' HG ' ' A' ' 167' ' ' LEU . 13.9 tp -57.52 -44.49 85.11 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.46 ' HD1' HG11 ' A' ' 67' ' ' VAL . 18.8 t80 -49.79 -35.62 23.25 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.414 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 26.8 mt-10 -72.95 -17.84 61.44 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.58 0.06 31.53 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.594 0.712 . . . . 0.0 109.589 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.601 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 95.2 m-85 -113.67 161.3 17.63 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.297 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -133.89 -174.71 3.61 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.803 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 14.8 t0 60.28 87.56 0.09 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.549 0.69 . . . . 0.0 111.444 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 26.2 tt0 -104.02 128.97 51.62 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.253 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.642 ' HG2' HG13 ' A' ' 39' ' ' VAL . 1.7 ptm180 -109.8 150.06 28.92 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.611 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -116.9 122.97 45.86 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.42 0.629 . . . . 0.0 110.166 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -167.34 154.38 8.55 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.243 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 61.63 16.98 8.2 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 123.685 0.615 . . . . 0.0 110.707 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.9 mtm 69.77 19.58 7.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.06 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.489 HG12 ' HD2' ' A' ' 71' ' ' PRO . 12.4 m -128.54 -179.67 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.489 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 97.1 m-85 -120.26 142.18 49.28 Favored 'General case' 0 CA--C 1.478 -1.803 0 CA-C-O 121.44 0.638 . . . . 0.0 109.993 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.642 HG13 ' HG2' ' A' ' 32' ' ' ARG . 1.1 m -135.19 127.7 47.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.336 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.587 ' O ' HG23 ' A' ' 67' ' ' VAL . 16.1 ttm180 -119.68 127.55 52.99 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -133.45 145.09 49.93 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.963 -174.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 12.8 tmtt? 86.73 112.22 0.03 OUTLIER Pre-proline 0 CA--C 1.516 -0.336 0 O-C-N 124.649 1.218 . . . . 0.0 109.963 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.55 ' HB2' HD13 ' A' ' 47' ' ' ILE . 73.2 Cg_endo -80.48 151.48 19.9 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 122.211 1.941 . . . . 0.0 112.269 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -86.17 -0.09 54.88 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.194 0.521 . . . . 0.0 110.976 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -150.68 -165.83 2.38 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 33.0 tt0 -83.92 101.41 11.67 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.601 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.4 mp -115.74 117.67 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.227 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -117.72 165.85 13.14 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.266 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.556 HG11 ' CB ' ' A' ' 169' ' ' ALA . 9.9 p -120.45 133.57 66.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.234 -177.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.414 ' CD2' HD12 ' A' ' 9' ' ' LEU . 6.6 m-85 -85.87 125.27 33.18 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.096 175.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.9 m -136.86 142.36 42.81 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.179 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.439 HG12 HD11 ' A' ' 176' ' ' ILE . 2.9 mm -92.26 140.03 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.936 0 CA-C-O 121.479 0.657 . . . . 0.0 110.725 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.43 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 10.7 t0 -83.79 114.04 21.34 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.74 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -75.39 -4.78 41.4 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.685 0.755 . . . . 0.0 111.811 -169.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -102.42 -34.02 9.32 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.114 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 53' ' ' ASP . 81.0 p -111.29 -19.78 12.52 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.634 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.88 12.71 80.87 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.836 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -92.24 156.52 17.24 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.178 0.513 . . . . 0.0 112.284 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.92 106.02 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.006 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.589 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 m -109.46 162.55 7.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.77 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 49' ' ' VAL . 12.3 tp -122.32 140.87 52.15 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.014 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.5 t -147.52 172.61 13.7 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.782 0.325 . . . . 0.0 111.338 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.16 162.61 25.66 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.839 0.828 . . . . 0.0 111.397 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.549 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.5 mp -99.07 145.71 9.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.812 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.48 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 31.4 mm-40 -91.27 -38.59 12.57 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 175.62 177.37 0.2 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.672 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 40' ' ' ARG . 5.5 t -106.58 129.43 60.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.894 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' A' ' 166' ' ' SER . 55.3 mt -91.49 111.75 24.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.814 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 83.2 tttt -127.56 112.25 14.69 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.12 135.08 25.92 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.148 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.489 ' HD2' HG12 ' A' ' 37' ' ' VAL . 80.7 Cg_exo -44.71 130.05 9.54 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.671 2.914 . . . . 0.0 113.535 177.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.41 116.44 28.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.147 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -123.0 -65.83 1.07 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.367 0.876 . . . . 0.0 113.367 -176.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -57.58 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -177.14 172.44 1.93 Allowed 'General case' 0 CA--C 1.461 -2.474 0 CA-C-O 120.992 0.425 . . . . 0.0 111.46 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.794 HD23 ' HA ' ' A' ' 90' ' ' THR . 10.7 mt -131.65 141.75 49.68 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.735 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.536 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 22.7 mt -87.69 142.37 13.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 11.3 ttt85 -115.28 137.31 52.17 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.177 0.513 . . . . 0.0 109.884 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 86' ' ' SER . 64.1 m-85 -114.87 121.19 42.45 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.861 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 152' ' ' LYS . 35.3 tt0 -109.08 120.77 43.53 Favored 'General case' 0 CA--C 1.47 -2.133 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -85.9 159.96 19.53 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.172 -177.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.778 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -59.71 -19.16 48.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.325 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -92.37 -8.26 45.44 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.091 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.44 15.74 49.29 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.523 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.545 ' O ' HD23 ' A' ' 81' ' ' LEU . 3.9 mtt180 -83.83 138.57 33.15 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 35.6 p -141.85 139.91 32.78 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 118.485 -1.286 . . . . 0.0 112.296 175.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -135.23 146.93 49.1 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.948 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 21.5 mt-10 -119.22 147.68 43.97 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.348 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.8 OUTLIER -138.76 154.01 48.49 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.595 -179.203 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.794 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.98 11.58 0.67 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.362 0.601 . . . . 0.0 112.057 -177.325 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.116 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.2 m 68.24 -26.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.021 1.328 . . . . 0.0 113.422 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 90' ' ' THR . 5.0 p-10 -83.34 -1.17 52.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.983 0.42 . . . . 0.0 110.658 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 20.9 m80 -110.63 137.06 20.64 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.477 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 24.0 Cg_exo -65.48 134.18 37.51 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.236 2.624 . . . . 0.0 113.424 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.578 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.2 t -103.58 150.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.554 ' HB2' ' N ' ' A' ' 184' ' ' HIS . 6.2 tp -107.75 113.76 27.24 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.819 0.342 . . . . 0.0 111.878 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.604 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.3 p -113.21 151.6 15.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.26 0.552 . . . . 0.0 111.592 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.465 ' CD2' HD12 ' A' ' 148' ' ' LEU . 61.4 t80 -105.13 93.54 4.75 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.294 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 8.5 pt-20 -141.76 158.41 43.85 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 11.2 m120 63.5 23.22 13.56 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.147 0.499 . . . . 0.0 109.993 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.23 12.02 54.01 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.0 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -133.29 172.31 12.86 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 121.279 0.561 . . . . 0.0 109.914 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -101.76 120.63 40.67 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.567 HG13 HG13 ' A' ' 97' ' ' VAL . 23.1 pt -116.38 152.53 18.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.875 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.47 ' OE2' ' HG2' ' A' ' 185' ' ' GLN . 7.7 mt-10 -109.37 112.57 24.77 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.792 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.502 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 12.6 ptpt -130.15 133.95 46.98 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.598 ' O ' HG23 ' A' ' 111' ' ' VAL . 60.5 mtm180 -67.42 163.18 21.43 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.116 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -56.6 -45.45 81.42 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.976 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.505 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.9 p90 -71.86 2.81 4.92 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.515 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.501 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 12.9 tp10 -117.15 -16.05 10.44 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.397 0.618 . . . . 0.0 110.044 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 107' ' ' ARG . 89.4 t -73.97 148.88 8.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.674 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 23.0 mmtp -119.17 169.8 9.63 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.337 0.589 . . . . 0.0 110.537 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -76.21 144.42 40.45 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.551 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.38 4.59 80.44 Favored Glycine 0 C--N 1.308 -1.011 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.15 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.674 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -76.91 167.33 22.0 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.468 ' H ' HG23 ' A' ' 97' ' ' VAL . 28.1 mttp -121.87 166.67 14.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.288 0.566 . . . . 0.0 110.558 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.22 160.57 41.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.98 135.14 34.43 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.1 OUTLIER -100.49 149.98 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.716 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.454 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 43.5 t -66.06 -5.45 9.8 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 120.825 0.345 . . . . 0.0 110.797 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.627 ' HB3' ' CG ' ' A' ' 145' ' ' HIS . 39.8 mt-10 40.78 69.58 0.32 Allowed 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 124.753 1.283 . . . . 0.0 111.491 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.492 ' CD1' ' HG3' ' A' ' 143' ' ' PRO . 49.8 tp -174.47 123.79 0.29 Allowed 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.35 104.51 7.97 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.577 HD21 HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -54.51 -8.82 0.25 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 114.242 -1.344 . . . . 0.0 112.148 174.535 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.2 t 74.04 75.08 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 122.147 0.975 . . . . 0.0 110.349 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -147.23 131.56 17.53 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.156 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -119.9 -72.77 0.67 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.093 0.473 . . . . 0.0 109.863 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.3 m -125.48 112.71 16.56 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.4 m -62.01 99.13 0.12 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.201 0.524 . . . . 0.0 111.816 -177.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.8 p -92.08 -28.14 17.33 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.347 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.8 p -113.05 140.05 48.17 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.68 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -77.93 -23.09 48.7 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -82.01 153.72 26.05 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.644 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.47 ' CB ' HG11 ' A' ' 15' ' ' VAL . 24.2 m120 -125.66 78.98 68.38 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-O 121.156 0.503 . . . . 0.0 110.525 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -97.51 37.58 0.11 Allowed 'Trans proline' 0 N--CA 1.439 -1.704 0 C-N-CA 123.272 2.648 . . . . 0.0 112.095 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -163.04 133.97 4.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -158.42 97.29 1.47 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 139' ' ' ASN . 0.7 OUTLIER 62.27 177.73 0.13 Allowed 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.805 -177.238 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.59 ' H ' ' CD ' ' A' ' 138' ' ' GLU . 4.5 p30 -122.72 -23.89 5.0 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.969 -0.457 . . . . 0.0 111.606 -177.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.2 tp -130.34 -37.29 1.43 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.726 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.23 -31.59 5.03 Favored Glycine 0 C--N 1.303 -1.257 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.632 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.3 p -98.41 117.36 64.84 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-O 120.612 0.244 . . . . 0.0 110.367 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.492 ' HG3' ' CD1' ' A' ' 122' ' ' LEU . 83.9 Cg_endo -82.49 173.92 10.2 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.646 2.231 . . . . 0.0 112.91 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.03 115.7 28.0 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.781 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.627 ' CG ' ' HB3' ' A' ' 121' ' ' GLU . 29.9 p80 -161.1 149.21 15.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.309 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 145' ' ' HIS . 19.0 t70 174.54 45.55 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.426 ' O ' HD23 ' A' ' 148' ' ' LEU . 6.8 pt20 -163.92 140.56 6.74 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.465 HD12 ' CD2' ' A' ' 98' ' ' TYR . 14.5 mt -112.29 153.37 27.28 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.778 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -114.97 138.89 50.32 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -171.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.464 ' H ' HD13 ' A' ' 149' ' ' LEU . 25.1 mt-10 -89.79 146.43 24.47 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 124.672 1.189 . . . . 0.0 113.018 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' A' ' 79' ' ' PHE . 64.3 mt -80.15 107.57 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.266 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 80' ' ' GLU . 62.2 mmtt -68.89 -38.98 80.0 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.889 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -150.63 131.86 14.5 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 74.8 mt -116.98 130.21 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.385 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.481 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 19.3 ptpt -136.46 166.76 22.75 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.516 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.536 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 20.7 m-85 -100.63 115.36 30.01 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.946 173.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.1 133.19 68.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.103 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 21.5 ttm-85 -70.87 155.22 41.06 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.068 0.461 . . . . 0.0 111.072 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.21 113.71 7.66 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.063 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -71.17 -18.68 62.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.567 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -98.9 166.57 11.23 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.953 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -94.28 -6.44 44.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.029 0.443 . . . . 0.0 109.929 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -144.0 150.41 38.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.781 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 4.3 m -119.29 155.8 21.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.551 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 50.0 m-85 -130.86 173.59 10.81 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 110.199 -0.296 . . . . 0.0 110.199 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.581 ' HB2' HD12 ' A' ' 68' ' ' ILE . 68.5 m -159.23 -24.49 0.07 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.52 ' HG ' HD21 ' A' ' 24' ' ' LEU . 1.5 tm? 68.68 112.46 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.769 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -90.82 113.26 25.37 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.112 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.556 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -133.94 -173.32 3.22 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.915 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -65.39 128.62 36.61 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 73.5 tttt 61.24 46.13 8.2 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.428 ' O ' ' HB2' ' A' ' 173' ' ' HIS . 49.0 p90 -57.04 179.03 0.05 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.928 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.489 ' O ' ' HB3' ' A' ' 184' ' ' HIS . 57.4 m170 70.56 18.94 6.36 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.46 -175.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -150.04 115.19 5.4 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.896 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.78 HG21 HD11 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -159.95 158.43 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 120.827 0.346 . . . . 0.0 110.785 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.699 HG23 ' HA ' ' A' ' 180' ' ' ASN . 2.5 mp -93.08 115.34 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.867 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.489 HG23 HG13 ' A' ' 175' ' ' VAL . 45.1 pt -121.48 171.51 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-O 120.985 0.422 . . . . 0.0 111.586 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.439 ' HB3' HD12 ' A' ' 181' ' ' ILE . 5.4 t-20 46.71 -127.19 1.54 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 124.16 0.984 . . . . 0.0 110.777 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.498 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 29.3 mt-10 -91.5 55.63 2.82 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.745 0.784 . . . . 0.0 109.466 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.736 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 21.7 m-80 70.2 44.56 0.75 Allowed 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 113.74 -1.573 . . . . 0.0 113.6 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 178' ' ' ASN . 85.1 mt -92.39 117.65 36.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.0 m -93.45 160.73 2.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.578 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 9.7 t -159.33 152.37 22.07 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.132 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.636 ' CG ' ' H ' ' A' ' 185' ' ' GLN . 1.2 t60 42.56 -148.79 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.031 0.932 . . . . 0.0 111.975 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.636 ' H ' ' CG ' ' A' ' 184' ' ' HIS . 26.5 pt20 . . . . . 0 C--O 1.263 1.808 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.99 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 89' ' ' THR . 23.0 p . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.994 0.426 . . . . 0.0 111.568 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.48 ' CE1' HD13 ' A' ' 177' ' ' ILE . 93.3 m-85 -124.29 150.45 63.97 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.47 ' HA ' HG12 ' A' ' 164' ' ' VAL . 18.2 Cg_endo -59.02 -26.92 83.49 Favored 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 122.592 2.195 . . . . 0.0 112.481 -175.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.19 -38.65 2.69 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -69.08 -1.34 7.42 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.802 -0.699 . . . . 0.0 111.514 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 28.9 m -69.69 128.25 35.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.1 mtm-85 -83.77 132.6 34.82 Favored 'General case' 0 C--O 1.186 -2.259 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.722 HD11 HG21 ' A' ' 175' ' ' VAL . 10.7 tt -122.74 131.38 73.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-O 121.017 0.437 . . . . 0.0 110.623 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.427 HD21 ' CD2' ' A' ' 124' ' ' LEU . 1.6 tm? -90.77 123.47 34.37 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-O 121.504 0.669 . . . . 0.0 109.447 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 18.8 m -133.83 -175.46 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.5 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 32.1 tt0 -129.29 120.8 26.28 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.627 HG12 HG13 ' A' ' 47' ' ' ILE . 14.5 mt -122.44 122.7 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.868 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.864 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 56.14 35.98 26.62 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.859 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.1 17.29 78.62 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.215 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.35 114.55 25.65 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.604 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 7.6 Cg_exo -64.86 125.17 14.28 Favored 'Trans proline' 0 N--CA 1.44 -1.656 0 C-N-CA 122.129 1.886 . . . . 0.0 111.356 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.512 ' HG2' ' ND2' ' A' ' 134' ' ' ASN . 66.2 mt-30 -122.14 140.39 52.61 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.452 ' HD3' ' NH2' ' A' ' 7' ' ' ARG . 39.0 ttmt -108.52 100.28 9.57 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.6 pt -124.4 -171.93 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.179 -2.63 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.767 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.713 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 21.3 p -94.91 170.98 9.04 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.776 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 10.6 mt -73.96 -20.64 60.3 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.006 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.713 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 13.2 ptm180 -84.58 -25.28 28.76 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.449 ' O ' HD23 ' A' ' 27' ' ' LEU . 52.4 mm-40 -84.64 -44.17 13.71 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.394 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.569 ' CD2' HD22 ' A' ' 167' ' ' LEU . 16.4 tp -57.19 -44.0 83.21 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.927 0.87 . . . . 0.0 110.004 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.44 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -56.09 -24.25 39.03 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.849 -179.144 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -84.41 -12.15 54.95 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.876 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -80.32 5.6 14.33 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.601 0.715 . . . . 0.0 109.466 177.383 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.619 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 95.9 m-85 -119.43 167.13 12.23 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.075 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.565 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 9.4 mt-10 -140.34 -173.56 3.71 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.473 174.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 6.0 t0 62.5 83.42 0.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.237 0.542 . . . . 0.0 110.8 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -107.63 129.44 55.0 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.849 0.833 . . . . 0.0 111.257 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.7 ptm180 -124.1 156.48 36.53 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.892 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -107.46 125.52 51.36 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -164.67 148.22 8.97 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.56 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 62.2 19.22 10.78 Favored 'General case' 0 CA--C 1.496 -1.106 0 O-C-N 123.557 0.536 . . . . 0.0 110.302 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.2 mtt 72.17 17.71 4.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.468 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 m -132.77 -178.48 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -115.05 140.72 48.83 Favored 'General case' 0 CA--C 1.478 -1.796 0 CA-C-O 121.257 0.551 . . . . 0.0 110.188 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.404 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.8 t -127.63 123.91 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.3 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.199 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.525 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 38.9 ttm180 -116.96 126.78 53.45 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -132.22 147.08 52.4 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.681 -0.808 . . . . 0.0 113.155 -176.225 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 54.4 mttp 82.29 111.61 0.03 OUTLIER Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.482 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.542 ' HB2' HD13 ' A' ' 47' ' ' ILE . 66.4 Cg_endo -77.28 151.95 30.27 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 122.688 2.259 . . . . 0.0 111.59 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 31.1 mtmt -83.28 -3.62 57.63 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.563 0.697 . . . . 0.0 110.427 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 45' ' ' ARG . 47.1 mtt180 -144.48 -164.62 1.95 Allowed 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 32.1 tt0 -88.6 100.07 12.81 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.627 HG13 HG12 ' A' ' 12' ' ' ILE . 1.3 mp -113.83 121.59 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.878 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.485 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 74.9 mmtt -123.89 165.73 16.88 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.847 174.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.452 HG13 ' CG1' ' A' ' 64' ' ' ILE . 6.1 m -113.42 126.66 70.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 120.961 0.41 . . . . 0.0 112.03 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.63 123.44 29.8 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.645 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 p -132.22 173.38 11.31 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.874 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.473 HG12 HD11 ' A' ' 176' ' ' ILE . 2.1 mm -121.25 140.64 44.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.274 0.559 . . . . 0.0 110.129 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.556 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 23.4 t70 -81.73 120.86 25.66 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.744 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.7 mt -66.46 -25.34 66.68 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.494 -172.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.556 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -92.95 -24.08 18.51 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.856 -1.066 . . . . 0.0 112.416 -172.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.5 p -119.77 -26.43 5.67 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.607 -175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.16 14.37 69.27 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.433 ' C ' HD13 ' A' ' 52' ' ' ILE . 2.6 mptt -84.16 153.61 23.58 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 122.839 0.455 . . . . 0.0 111.738 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.91 105.5 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 CA-C-O 122.004 0.907 . . . . 0.0 109.724 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.3 m -110.16 163.75 6.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.079 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 48' ' ' LYS . 13.7 tp -123.71 139.88 53.55 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 t -144.07 172.4 12.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.738 0.304 . . . . 0.0 110.849 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -86.15 161.99 18.59 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.727 0.775 . . . . 0.0 110.924 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.562 HD12 ' N ' ' A' ' 64' ' ' ILE . 3.3 mp -97.81 141.75 15.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.003 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.473 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 18.2 mm-40 -85.15 -39.58 17.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 p30 173.9 175.11 0.15 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.593 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.752 ' HA ' HD12 ' A' ' 167' ' ' LEU . 21.7 t -104.41 142.33 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.826 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 166' ' ' SER . 0.8 OUTLIER -112.87 123.5 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.701 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.39 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -129.85 114.5 15.98 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.733 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.98 139.62 35.55 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.813 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -52.84 123.92 14.21 Favored 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 123.043 2.495 . . . . 0.0 112.61 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.4 106.38 11.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.091 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.1 m -125.23 -26.72 3.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.638 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -78.78 -137.44 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.387 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -155.14 171.33 19.98 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.2 mt -132.83 140.63 48.05 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.937 -175.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 108' ' ' ALA . 51.4 mt -88.96 145.87 6.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.495 ' HB3' ' HG3' ' A' ' 155' ' ' LYS . 19.8 ttt180 -121.28 138.94 54.01 Favored 'General case' 0 N--CA 1.404 -2.768 0 CA-C-O 121.256 0.551 . . . . 0.0 109.87 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 86' ' ' SER . 49.3 m-85 -116.35 126.26 53.25 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.119 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.2 tt0 -106.27 132.63 52.09 Favored 'General case' 0 CA--C 1.48 -1.724 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.886 HD12 ' HB3' ' A' ' 149' ' ' LEU . 2.2 mm? -99.05 156.86 16.72 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.205 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.914 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.8 pt-20 -58.62 -18.33 29.45 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.509 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.46 -8.31 48.11 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.746 0.784 . . . . 0.0 109.42 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.27 17.65 49.39 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.564 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.537 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -89.91 139.36 30.67 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.443 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 65.5 p -139.79 144.48 37.4 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.467 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -137.1 146.9 45.64 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.105 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 65.1 mt-10 -119.39 147.42 44.38 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.478 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.9 OUTLIER -142.76 157.84 44.24 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.677 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.752 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -72.6 9.72 1.01 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 122.942 0.497 . . . . 0.0 111.921 -176.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.078 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.8 OUTLIER 68.03 -25.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.625 1.17 . . . . 0.0 112.494 177.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 90' ' ' THR . 0.2 OUTLIER -74.45 -12.88 60.61 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 124.344 1.058 . . . . 0.0 111.551 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -110.79 147.21 36.01 Favored Pre-proline 0 C--N 1.309 -1.176 0 C-N-CA 120.381 -0.527 . . . . 0.0 112.245 -175.441 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 3.1 Cg_exo -74.48 132.04 15.68 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.246 2.63 . . . . 0.0 114.047 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.506 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.6 t -97.21 144.88 9.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.493 HD22 ' O ' ' A' ' 184' ' ' HIS . 7.0 tp -102.05 107.81 19.04 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.658 0.265 . . . . 0.0 110.918 -175.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.621 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.2 p -111.17 151.37 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-O 121.378 0.609 . . . . 0.0 111.93 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.4 ' CD2' HD12 ' A' ' 148' ' ' LEU . 67.0 t80 -106.95 93.74 4.72 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.917 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.3 pt-20 -140.62 158.47 43.93 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 31.9 m-80 64.76 22.93 12.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.065 0.46 . . . . 0.0 110.289 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.76 15.42 64.42 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.53 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -137.12 172.43 13.01 Favored 'General case' 0 N--CA 1.398 -3.044 0 CA-C-O 121.422 0.63 . . . . 0.0 110.269 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -103.63 120.77 41.56 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.605 HG13 HG13 ' A' ' 97' ' ' VAL . 25.2 pt -121.48 155.84 25.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.518 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -104.35 116.25 31.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.975 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.424 ' HE3' ' CD1' ' A' ' 104' ' ' ILE . 85.7 mttt -125.4 129.48 49.96 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.546 ' O ' HG23 ' A' ' 111' ' ' VAL . 91.2 mtt180 -62.8 161.71 12.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.078 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -58.17 -42.43 85.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.537 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.471 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.1 p90 -73.91 3.48 6.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.077 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -114.82 -16.41 11.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.533 0.682 . . . . 0.0 110.22 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 107' ' ' ARG . 92.8 t -77.05 148.68 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.71 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 15.9 mtmt -121.55 162.95 19.68 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 120.827 0.346 . . . . 0.0 111.258 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.96 139.11 57.68 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.62 4.45 70.21 Favored Glycine 0 C--N 1.305 -1.179 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.779 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.71 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -75.14 168.71 19.46 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.586 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 22.2 mttm -123.84 164.28 19.54 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.577 0.703 . . . . 0.0 111.937 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.88 159.05 41.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.424 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -92.31 141.04 28.99 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.064 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 2.5 m -115.75 158.54 16.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.671 173.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.574 ' HB3' HD22 ' A' ' 180' ' ' ASN . 32.6 t -79.5 31.69 0.23 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.68 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 119' ' ' VAL . 43.5 mt-10 73.08 -48.11 0.68 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.512 1.125 . . . . 0.0 112.278 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.505 ' CD2' ' H ' ' A' ' 123' ' ' GLU . 0.5 OUTLIER -169.45 -158.94 0.2 Allowed 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -175.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.505 ' H ' ' CD2' ' A' ' 122' ' ' LEU . 44.3 mt-10 -107.42 -155.07 0.54 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.505 -175.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 16' ' ' PRO . 0.4 OUTLIER -94.86 34.73 1.32 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.006 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.422 ' O ' ' HA2' ' A' ' 141' ' ' GLY . 7.2 p -35.4 110.24 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 113.698 -1.592 . . . . 0.0 114.968 -176.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -147.95 178.08 8.81 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.541 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -89.27 169.42 11.45 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.291 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 m 67.02 36.92 3.99 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.663 0.744 . . . . 0.0 109.715 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.0 p -77.09 171.4 14.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.389 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.2 t 69.73 8.38 6.7 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.153 0.581 . . . . 0.0 111.627 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.4 m -70.82 136.68 48.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.801 0.334 . . . . 0.0 110.814 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -79.59 -22.96 43.06 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -87.56 175.61 7.84 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.349 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.512 ' ND2' ' HG2' ' A' ' 17' ' ' GLN . 22.9 t-20 -125.83 81.04 66.25 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 119.996 -0.682 . . . . 0.0 112.155 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -102.09 -175.29 0.11 Allowed 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 123.386 2.724 . . . . 0.0 111.42 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.8 tttm 173.61 139.03 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -157.95 -39.03 0.07 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.932 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -82.55 -167.57 1.66 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -112.08 -167.01 1.13 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.266 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.5 ' HG ' ' H ' ' A' ' 141' ' ' GLY . 17.4 tp 80.5 -135.54 0.01 OUTLIER 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.598 1.159 . . . . 0.0 110.541 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.5 ' H ' ' HG ' ' A' ' 140' ' ' LEU . . . 91.35 17.77 48.6 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.29 -176.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.0 m -85.96 119.02 71.51 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.71 -0.245 . . . . 0.0 110.828 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.44 ' HB3' ' CB ' ' A' ' 122' ' ' LEU . 16.7 Cg_exo -68.26 -67.7 0.03 OUTLIER 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.512 2.141 . . . . 0.0 111.713 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 54.32 72.31 0.46 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.534 0.733 . . . . 0.0 111.973 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.489 ' ND1' HD12 ' A' ' 122' ' ' LEU . 7.2 m80 -157.32 89.25 1.04 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.95 0.405 . . . . 0.0 111.624 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.02 103.75 5.33 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.456 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.535 ' C ' HD23 ' A' ' 148' ' ' LEU . 6.8 pt20 -163.97 125.01 2.24 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.567 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.535 HD23 ' C ' ' A' ' 147' ' ' GLN . 8.3 mt -111.38 153.45 26.02 Favored 'General case' 0 CA--C 1.482 -1.664 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.998 176.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.914 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -117.13 137.5 52.26 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -173.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.586 ' HG3' ' CG ' ' A' ' 116' ' ' LYS . 14.5 mt-10 -90.58 147.43 23.34 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.752 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.474 HD13 ' CD1' ' A' ' 79' ' ' PHE . 79.1 mt -79.66 108.45 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.63 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.911 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.626 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 0.9 OUTLIER -64.69 -43.07 94.69 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.751 177.209 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -152.64 136.9 16.58 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.9 mt -115.7 143.13 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 113.623 -1.626 . . . . 0.0 110.589 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.495 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.0 ptpt -144.86 157.79 44.03 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.288 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.479 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 6.7 m-85 -100.54 118.05 35.94 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.456 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -127.04 173.82 11.91 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.708 -178.173 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -105.92 157.49 17.45 Favored 'General case' 0 C--N 1.289 -2.051 0 O-C-N 121.911 -0.493 . . . . 0.0 111.627 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.95 118.63 8.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.567 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -63.09 -41.53 99.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.066 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -105.12 -174.12 2.46 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.669 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -99.04 0.41 43.7 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 120.851 0.357 . . . . 0.0 111.461 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -142.42 140.47 31.99 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.867 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.4 m -107.51 154.46 8.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.94 177.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 68.1 m-85 -134.39 166.55 22.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.036 -175.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.447 ' HB2' HD11 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -160.73 -22.15 0.06 Allowed 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 67' ' ' VAL . 20.9 tp 68.46 111.42 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.266 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -82.32 113.38 20.07 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.282 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.473 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -133.34 -160.1 1.02 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -64.18 116.32 5.86 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.43 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 53.1 tptt 77.4 59.22 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 O-C-N 124.212 0.945 . . . . 0.0 111.416 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 66.61 -121.65 0.28 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.938 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -124.97 38.28 4.23 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.71 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.481 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . 25.2 p-10 -75.1 99.2 3.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.815 0.816 . . . . 0.0 109.335 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.722 HG21 HD11 ' A' ' 8' ' ' ILE . 2.1 p -142.34 165.33 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 CA-C-O 121.397 0.618 . . . . 0.0 111.289 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.517 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 97.2 mt -92.83 113.13 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.113 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.48 HD13 ' CE1' ' A' ' 2' ' ' PHE . 29.6 pt -120.13 167.67 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.293 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.403 ' C ' ' H ' ' A' ' 180' ' ' ASN . 6.6 t-20 49.77 -132.38 1.75 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.095 0.958 . . . . 0.0 109.987 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.84 44.62 0.84 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.774 0.797 . . . . 0.0 110.52 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.4 m-20 73.05 47.55 0.19 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 125.61 1.564 . . . . 0.0 113.342 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.7 mt -87.35 113.69 25.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.525 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.67 124.13 39.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.658 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.506 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 8.9 t -137.65 167.49 21.57 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.793 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.493 ' O ' HD22 ' A' ' 96' ' ' LEU . 38.4 m80 72.32 140.52 0.06 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.766 0.826 . . . . 0.0 112.996 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.422 ' H ' ' CD ' ' A' ' 185' ' ' GLN . 4.4 pm0 . . . . . 0 C--O 1.258 1.52 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.573 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.574 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 77.6 m . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.841 0.353 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -114.32 164.72 15.51 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.549 ' HD3' HD13 ' A' ' 76' ' ' LEU . 72.3 Cg_endo -72.96 162.94 39.72 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 N-CA-C 108.319 -1.454 . . . . 0.0 108.319 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.564 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -63.45 -25.36 68.55 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.055 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.88 -11.77 14.54 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.8 m -73.26 132.32 43.0 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.878 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 72.9 mmt-85 -84.21 135.78 34.22 Favored 'General case' 0 C--O 1.188 -2.163 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.445 HD11 HG21 ' A' ' 175' ' ' VAL . 9.6 tt -120.71 130.23 74.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.74 HD21 HD11 ' A' ' 124' ' ' LEU . 1.3 tm? -89.83 124.32 34.57 Favored 'General case' 0 N--CA 1.412 -2.368 0 CA-C-O 121.545 0.688 . . . . 0.0 110.125 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.522 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 30.7 m -135.09 -175.72 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.57 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 33.0 tt0 -131.63 121.18 23.92 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.6 HG12 HG13 ' A' ' 47' ' ' ILE . 20.2 mt -120.05 121.89 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.949 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.62 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' A' ' 45' ' ' ARG . 68.1 m-20 55.04 38.41 30.48 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.948 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.86 18.46 78.94 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.841 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.53 120.03 23.17 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.49 ' HB2' HD13 ' A' ' 124' ' ' LEU . 42.7 Cg_endo -70.95 121.95 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.623 2.215 . . . . 0.0 111.64 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -124.94 142.34 51.53 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.821 -176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -114.48 101.81 9.48 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.643 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.4 pt -125.12 -172.5 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.161 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.048 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.722 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 6.8 p -91.68 173.07 8.07 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.333 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.6 mm? -64.12 -35.84 82.08 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.296 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.722 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 8.2 ptm180 -76.95 -26.64 54.24 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.543 ' OE1' HG23 ' A' ' 20' ' ' THR . 52.3 mt-10 -80.59 -39.34 27.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.951 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.799 HD21 HD22 ' A' ' 167' ' ' LEU . 18.3 tp -61.35 -41.85 97.73 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.069 0.938 . . . . 0.0 109.139 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.664 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 6.6 m-30 -57.28 -28.98 63.48 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.588 -1.642 . . . . 0.0 113.164 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.645 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 54.1 mt-10 -73.16 -17.49 61.37 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.248 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.0 mm? -78.92 2.54 19.83 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.484 0.659 . . . . 0.0 109.57 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.503 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.9 m-85 -116.33 163.01 16.65 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.535 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -141.48 -173.12 3.68 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.588 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 1.7 t70 63.23 84.85 0.14 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.326 0.584 . . . . 0.0 110.842 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -100.4 126.93 46.83 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.741 0.782 . . . . 0.0 110.998 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -115.66 150.52 36.61 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.808 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -102.25 129.72 48.74 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.404 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -167.44 148.72 5.58 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.029 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 57.89 19.63 5.95 Favored 'General case' 0 CA--C 1.496 -1.109 0 O-C-N 123.798 0.686 . . . . 0.0 111.726 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.6 mtt 71.02 18.84 5.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.393 0.615 . . . . 0.0 110.274 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 4.5 m -129.01 -173.14 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.484 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 64.7 m-85 -118.5 142.57 47.46 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.186 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 t -129.02 123.73 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.893 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.399 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.652 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 35.4 ttm180 -116.92 126.86 53.6 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -136.16 144.38 44.98 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.974 -174.325 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 14.2 ttmt 88.55 108.83 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.41 0 O-C-N 124.916 1.385 . . . . 0.0 110.568 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.593 ' HB2' HD13 ' A' ' 47' ' ' ILE . 93.0 Cg_endo -79.81 153.83 22.95 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 122.442 2.095 . . . . 0.0 111.843 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -87.78 -1.25 57.84 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.471 0.653 . . . . 0.0 111.108 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 50.3 mtt180 -143.42 -166.15 2.25 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.6 tp10 -89.28 101.78 14.45 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 172.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.6 HG13 HG12 ' A' ' 12' ' ' ILE . 1.3 mp -114.56 118.16 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.017 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.522 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 35.6 mmtt -115.39 169.04 9.45 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.911 175.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.495 HG11 ' CB ' ' A' ' 169' ' ' ALA . 9.3 p -123.85 130.83 73.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.076 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.24 129.4 35.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.031 0.443 . . . . 0.0 110.967 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.7 t -140.94 176.72 8.58 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.699 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.425 HD13 ' C ' ' A' ' 58' ' ' LYS . 2.0 mm -120.75 145.07 27.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.249 0.547 . . . . 0.0 110.561 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.761 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.2 t70 -88.62 123.34 32.99 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.819 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.72 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -75.16 -17.86 60.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.106 0.479 . . . . 0.0 112.195 -172.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.761 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -94.55 -28.24 15.52 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.702 -175.198 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.44 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 60.3 p -114.85 -21.73 9.99 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.331 -176.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.77 17.64 74.73 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.138 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.44 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 18.5 mtpp -94.56 157.72 15.86 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.506 HG11 HD13 ' A' ' 122' ' ' LEU . 6.1 p -91.52 110.43 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.47 178.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 m -110.12 158.19 10.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.202 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 49' ' ' VAL . 12.4 tp -122.65 140.27 53.03 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.0 t -147.04 172.05 14.33 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.611 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.78 161.58 20.92 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.763 0.792 . . . . 0.0 111.783 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.55 HD13 HG22 ' A' ' 47' ' ' ILE . 2.1 mp -95.8 142.4 13.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.665 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.543 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 19.5 mt-10 -93.02 -34.88 13.54 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -179.55 -177.33 0.42 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.823 0.821 . . . . 0.0 111.716 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 6.9 t -115.24 128.3 72.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.696 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.575 HD12 ' HB2' ' A' ' 166' ' ' SER . 33.1 mt -97.09 104.73 16.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.548 -175.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.563 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 59.1 tttp -117.25 108.11 15.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.09 136.05 28.22 Favored Pre-proline 0 C--N 1.308 -1.218 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HD2' HG12 ' A' ' 37' ' ' VAL . 72.5 Cg_exo -48.28 139.55 21.68 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.677 2.918 . . . . 0.0 113.689 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -85.83 96.32 9.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.158 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -89.11 -31.58 17.94 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.354 -175.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.0 -97.95 0.4 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 157' ' ' VAL . 0.4 OUTLIER 178.74 173.48 0.71 Allowed 'General case' 0 CA--C 1.471 -2.088 0 C-N-CA 123.936 0.895 . . . . 0.0 108.832 -175.651 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.681 HD23 ' HA ' ' A' ' 90' ' ' THR . 5.7 mt -123.96 140.6 52.82 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 118.748 -1.181 . . . . 0.0 112.898 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.5 HD12 ' C ' ' A' ' 108' ' ' ALA . 9.3 mt -84.77 145.94 7.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 172.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 19.9 ttt85 -116.94 138.38 51.58 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-O 121.227 0.537 . . . . 0.0 110.173 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.499 ' CD1' HD13 ' A' ' 151' ' ' ILE . 61.3 m-85 -116.13 122.86 46.33 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.28 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.0 tt0 -110.9 126.4 54.66 Favored 'General case' 0 CA--C 1.468 -2.202 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -89.88 162.49 15.43 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.464 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.859 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.2 pt-20 -63.15 -15.65 57.52 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.786 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -91.92 -10.29 40.07 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.533 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.06 4.33 66.97 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.749 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.585 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -83.57 143.38 30.19 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.62 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 23.0 p -141.76 157.92 44.44 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.748 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -148.34 154.07 39.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.894 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 16.3 mt-10 -125.0 148.87 48.25 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.727 -176.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -143.0 156.82 44.92 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.532 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.681 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -67.17 13.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.078 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.051 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.4 m 67.27 -41.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 125.362 1.465 . . . . 0.0 113.814 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.17 -28.61 34.94 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.304 0.573 . . . . 0.0 109.956 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -73.49 144.37 83.66 Favored Pre-proline 0 C--N 1.314 -0.969 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.735 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.687 ' O ' ' HB3' ' A' ' 184' ' ' HIS . 5.7 Cg_exo -74.46 144.05 31.85 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.546 2.831 . . . . 0.0 114.704 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.01 146.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 124.841 1.256 . . . . 0.0 107.634 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 183' ' ' THR . 12.4 tp -102.36 113.08 26.1 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.179 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.696 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.0 p -116.8 150.23 18.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.33 0.586 . . . . 0.0 111.817 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.427 ' CD2' HD12 ' A' ' 148' ' ' LEU . 72.4 t80 -103.17 95.93 6.45 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.877 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -138.57 156.66 47.29 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 63.15 22.87 13.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.058 0.456 . . . . 0.0 110.319 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.79 13.01 63.07 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.925 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.411 ' HG3' HG23 ' A' ' 104' ' ' ILE . 7.7 ptp180 -132.36 171.71 13.39 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 117.434 0.617 . . . . 0.0 109.8 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.423 ' CE1' HD12 ' A' ' 118' ' ' LEU . 59.5 m-85 -104.91 122.39 45.7 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.54 HG13 HG13 ' A' ' 97' ' ' VAL . 22.9 pt -121.61 156.57 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.312 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -111.69 106.98 15.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.808 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.467 ' HG3' HG22 ' A' ' 111' ' ' VAL . 15.7 ptpt -122.81 141.23 52.06 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.725 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.564 ' O ' HG23 ' A' ' 111' ' ' VAL . 66.3 mtm180 -60.96 155.2 20.51 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.051 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -59.34 -40.32 85.99 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.312 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.494 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.2 p90 -75.21 -0.71 20.33 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.797 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -106.3 -19.65 13.63 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.703 0.763 . . . . 0.0 109.311 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 107' ' ' ARG . 86.5 t -71.67 149.11 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.506 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.692 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -122.17 166.83 13.97 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.842 -178.417 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.17 141.95 52.55 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.43 4.96 79.86 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.518 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.696 ' OD1' HG21 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -75.48 173.46 10.94 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -127.04 163.3 24.05 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 121.719 0.771 . . . . 0.0 112.198 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.3 158.26 42.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 114.639 -1.164 . . . . 0.0 107.887 168.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.509 ' HB3' ' HB ' ' A' ' 182' ' ' VAL . 1.1 tt -88.98 133.29 34.37 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.687 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -115.93 130.18 71.06 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.1 t -63.74 -19.16 64.74 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.058 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.657 ' HB3' ' HB3' ' A' ' 145' ' ' HIS . 34.2 mm-40 45.2 15.15 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.777 -1.556 . . . . 0.0 114.468 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.506 HD13 HG11 ' A' ' 59' ' ' VAL . 0.8 OUTLIER -83.33 121.91 27.75 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.917 -178.643 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.405 ' OE2' ' HB3' ' A' ' 143' ' ' PRO . 1.2 pm0 -89.41 156.56 18.6 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.488 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.74 HD11 HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -143.5 -66.14 0.37 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.592 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.7 p 178.41 140.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.559 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -106.09 -36.14 7.02 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.148 0.499 . . . . 0.0 110.745 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -89.83 87.28 6.9 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.128 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.5 m -145.63 -91.51 0.1 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.906 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.4 p 42.55 35.79 0.71 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.48 0.712 . . . . 0.0 112.786 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 33.8 m -111.27 152.05 27.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.553 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.0 t -108.35 -4.08 17.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.001 0.429 . . . . 0.0 110.327 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -101.6 -68.27 0.83 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.908 0.385 . . . . 0.0 110.757 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -83.54 98.58 9.64 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.494 0.664 . . . . 0.0 111.001 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.544 ' H ' ' CD ' ' A' ' 135' ' ' PRO . 18.6 m120 -124.91 -49.98 0.04 OUTLIER Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.544 ' CD ' ' H ' ' A' ' 134' ' ' ASN . 10.0 Cg_exo -71.83 81.29 1.37 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.71 2.274 . . . . 0.0 113.607 -175.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -156.57 110.62 2.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.515 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -168.69 95.4 0.36 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.271 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 139' ' ' ASN . 39.1 tt0 -136.66 150.72 48.65 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 28.5 t-20 87.36 5.49 0.3 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 31.6 tp 57.24 -102.84 0.16 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.068 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.89 48.77 2.22 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 34.7 t -44.79 123.37 4.83 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 124.122 0.969 . . . . 0.0 112.578 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 142' ' ' SER . 26.7 Cg_exo -64.74 175.33 3.71 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 123.161 2.574 . . . . 0.0 110.929 176.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 178.47 121.89 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.706 0.288 . . . . 0.0 111.652 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 179.96 153.33 0.5 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.872 177.437 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -156.41 98.1 1.81 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.151 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.541 ' C ' HD23 ' A' ' 148' ' ' LEU . 23.8 pt20 -164.76 143.24 6.72 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.346 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.541 HD23 ' C ' ' A' ' 147' ' ' GLN . 7.1 mt -109.28 155.46 21.11 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.375 0.607 . . . . 0.0 110.989 176.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.859 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -116.85 137.9 51.89 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.063 -173.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.417 ' H ' HD13 ' A' ' 149' ' ' LEU . 14.2 mt-10 -88.72 145.58 25.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 124.652 1.181 . . . . 0.0 112.639 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.502 HD12 ' HB3' ' A' ' 115' ' ' ASP . 70.0 mt -80.08 104.26 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.766 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 6.6 mmpt? -68.18 -38.96 82.61 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.876 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -149.59 135.63 18.86 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 82.5 mt -114.77 144.26 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.476 174.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.507 ' CD ' ' HD3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -148.1 158.43 44.06 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.922 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.423 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 15.2 m-85 -99.15 111.76 24.07 Favored 'General case' 0 N--CA 1.407 -2.583 0 CA-C-O 121.802 0.811 . . . . 0.0 109.762 174.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -116.56 175.64 2.91 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.903 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.29 179.508 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.439 ' HB3' ' H ' ' A' ' 159' ' ' ALA . 78.1 mtt180 -79.56 -146.55 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.381 -0.528 . . . . 0.0 112.169 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.439 ' H ' ' HB3' ' A' ' 158' ' ' ARG . . . -104.08 -13.61 16.21 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.673 -176.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.67 8.11 2.2 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.956 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -175.21 -173.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -104.0 -7.72 20.12 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.35 158.28 44.42 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.269 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.456 HG11 HD21 ' A' ' 76' ' ' LEU . 2.9 m -128.88 157.16 41.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.091 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.664 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 11.3 m-85 -131.29 170.55 14.46 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.714 -172.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.575 ' HB2' HD12 ' A' ' 68' ' ' ILE . 68.3 m -159.88 -22.01 0.06 Allowed 'General case' 0 C--N 1.359 0.994 0 CA-C-O 120.622 0.249 . . . . 0.0 110.377 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.799 HD22 HD21 ' A' ' 24' ' ' LEU . 14.4 tp 64.52 110.87 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.164 0.915 . . . . 0.0 112.081 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -84.63 108.26 17.27 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.543 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -112.65 -161.0 0.74 Allowed 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.665 ' O ' ' HG2' ' A' ' 171' ' ' LYS . 49.1 tptt -60.79 109.16 0.98 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.854 0.359 . . . . 0.0 110.67 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.665 ' HG2' ' O ' ' A' ' 170' ' ' LYS . 48.8 pttt 66.39 9.44 6.46 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.312 1.445 . . . . 0.0 111.934 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.458 ' O ' ' HB3' ' A' ' 173' ' ' HIS . 43.7 p90 38.39 -140.96 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.71 0.804 . . . . 0.0 111.251 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.597 ' O ' ' HA ' ' A' ' 184' ' ' HIS . 34.8 t-80 80.28 -45.37 0.28 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 171.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.4 HD21 HD22 ' A' ' 96' ' ' LEU . 6.6 m120 -129.41 153.59 47.77 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.962 0.411 . . . . 0.0 111.994 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.553 HG13 HG23 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -165.81 158.47 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.686 176.406 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.584 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 88.9 mt -108.9 116.52 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.779 0 CA-C-O 121.007 0.432 . . . . 0.0 110.321 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.553 HG23 HG13 ' A' ' 175' ' ' VAL . 43.2 pt -122.04 169.44 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.729 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 6.6 t-20 48.8 -133.05 1.51 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.333 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.424 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 16.1 mm-40 -83.94 53.97 2.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.459 0.647 . . . . 0.0 110.008 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.687 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.0 m120 70.55 45.32 0.61 Allowed 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.357 -1.292 . . . . 0.0 113.909 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 98.3 mt -86.04 112.38 22.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 118' ' ' LEU . 98.6 t -86.93 117.5 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.299 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . 8.8 t -146.74 -176.22 5.11 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.939 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.687 ' HB3' ' O ' ' A' ' 94' ' ' PRO . 62.6 t-80 -92.73 137.87 31.99 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 . . . . . 0 C--O 1.263 1.791 0 CA-C-O 117.464 -1.255 . . . . 0.0 110.884 178.123 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.624 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 56.6 m . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 121.095 0.474 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.536 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 7.0 m-85 -136.0 163.32 51.16 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.478 ' HD3' HD13 ' A' ' 76' ' ' LEU . 73.0 Cg_endo -72.51 161.93 42.8 Favored 'Trans proline' 0 N--CA 1.438 -1.77 0 N-CA-C 108.41 -1.419 . . . . 0.0 108.41 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.01 -26.49 63.37 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 118.682 -1.723 . . . . 0.0 110.875 175.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.43 ' OD1' ' HB2' ' A' ' 160' ' ' ASN . 6.9 m-20 -59.79 -13.81 12.01 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.7 m -74.4 129.03 37.0 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.351 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 10.9 mtm-85 -84.88 129.45 34.81 Favored 'General case' 0 C--O 1.195 -1.766 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.757 HD11 HG21 ' A' ' 175' ' ' VAL . 10.5 tt -115.04 129.87 70.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.779 HD21 HD21 ' A' ' 124' ' ' LEU . 2.6 tm? -94.96 123.94 38.72 Favored 'General case' 0 N--CA 1.399 -3.009 0 CA-C-O 121.786 0.803 . . . . 0.0 110.474 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.671 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 31.0 m -132.23 -172.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.849 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 30.9 tt0 -131.52 123.54 28.22 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 28.3 mt -120.68 122.49 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.893 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.632 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.408 ' HA ' ' HB3' ' A' ' 46' ' ' GLU . 0.7 OUTLIER 54.74 41.81 31.65 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.033 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.58 18.92 72.43 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.774 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.55 118.73 18.07 Favored Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.53 ' HB2' HD13 ' A' ' 124' ' ' LEU . 52.6 Cg_exo -53.44 148.21 34.72 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 C-N-CA 122.053 1.835 . . . . 0.0 111.104 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -148.83 129.18 13.81 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.604 ' HB2' HD23 ' A' ' 9' ' ' LEU . 40.3 ttmt -117.62 102.93 9.56 Favored 'General case' 0 CA--C 1.48 -1.741 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.883 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.4 pt -125.23 -173.9 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.253 177.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.676 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 10.4 p -92.28 172.08 8.65 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.392 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 81.8 mt -66.17 -28.47 68.8 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.414 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.676 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 4.3 ptm180 -82.1 -24.56 35.09 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.466 ' OE1' HG23 ' A' ' 20' ' ' THR . 51.9 mt-10 -84.16 -39.99 18.73 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.861 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.661 HD23 ' HG ' ' A' ' 167' ' ' LEU . 17.5 tp -61.12 -41.08 96.04 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.546 0.689 . . . . 0.0 109.826 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.511 ' HD1' HG11 ' A' ' 67' ' ' VAL . 1.4 t80 -51.14 -32.76 24.01 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.978 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.4 mt-10 -74.48 -15.8 60.87 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.248 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.92 2.17 27.8 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.589 0.709 . . . . 0.0 109.56 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.613 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.9 m-85 -118.37 164.54 15.09 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.832 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.569 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 12.6 mm-40 -141.16 -172.97 3.61 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.028 175.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t0 63.18 81.33 0.21 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.57 0.7 . . . . 0.0 110.392 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -99.19 122.44 42.39 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.791 0.805 . . . . 0.0 111.044 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -113.14 150.45 32.19 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.923 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -101.79 131.14 48.26 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -166.6 145.76 5.59 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.763 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.98 21.84 9.72 Favored 'General case' 0 CA--C 1.488 -1.41 0 O-C-N 123.85 0.718 . . . . 0.0 111.51 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 43.8 mtm 72.36 18.97 4.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.691 0.619 . . . . 0.0 110.569 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 10.5 m -134.7 -175.16 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.441 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 90.7 m-85 -112.85 139.98 48.02 Favored 'General case' 0 CA--C 1.478 -1.798 0 CA-C-O 121.243 0.544 . . . . 0.0 110.535 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -128.39 124.06 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.85 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.582 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 13.6 ttm180 -118.04 128.26 54.6 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.54 145.69 51.34 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.843 -173.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 5.2 tppp? 81.84 111.81 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.643 1.214 . . . . 0.0 111.235 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.568 ' HB2' HD13 ' A' ' 47' ' ' ILE . 66.1 Cg_endo -78.91 154.0 25.82 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 122.079 1.853 . . . . 0.0 111.951 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.569 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 36.3 mtmt -85.38 -4.34 59.13 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.868 -178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -149.17 -165.22 2.22 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 33.9 tt0 -86.82 101.65 13.55 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.613 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.6 mp -114.85 113.02 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.998 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.671 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 72.6 mmtt -116.95 169.39 9.44 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.694 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.537 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.8 p -120.88 124.93 73.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.551 0.691 . . . . 0.0 111.959 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.788 ' CZ ' HG21 ' A' ' 59' ' ' VAL . 5.5 t80 -76.47 123.31 25.83 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.952 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.5 t -140.13 168.25 20.25 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.932 0.396 . . . . 0.0 110.815 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.13 145.14 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.164 0.507 . . . . 0.0 110.681 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -91.99 117.93 30.29 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.634 HD12 ' H ' ' A' ' 54' ' ' LEU . 4.2 mp -69.42 -31.47 69.83 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.786 0.803 . . . . 0.0 111.763 -172.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.35 -30.35 42.6 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.986 -174.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.4 p -111.08 -25.61 9.67 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.023 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.67 13.33 75.88 Favored Glycine 0 N--CA 1.421 -2.321 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.855 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -92.91 170.18 9.88 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 120.899 0.38 . . . . 0.0 111.24 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.788 HG21 ' CZ ' ' A' ' 50' ' ' TYR . 7.6 p -103.14 118.61 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.671 0 CA-C-O 121.873 0.844 . . . . 0.0 110.529 177.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -111.51 153.78 13.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.424 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 49' ' ' VAL . 11.7 tp -122.36 132.86 54.59 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.597 HG21 ' HB2' ' A' ' 170' ' ' LYS . 10.8 t -140.09 173.28 11.67 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.462 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -86.64 161.38 18.51 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.793 0.806 . . . . 0.0 111.558 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.55 HD13 HG22 ' A' ' 47' ' ' ILE . 2.1 mp -91.81 141.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.688 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.6 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 7.9 mm-40 -83.46 -39.65 20.27 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 p30 178.12 174.79 0.56 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.812 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.582 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 25.9 t -104.76 137.35 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.319 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.57 HD13 ' HB2' ' A' ' 166' ' ' SER . 0.0 OUTLIER -113.99 126.51 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.335 -178.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.497 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 52.6 tttp -135.38 115.81 13.61 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.889 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.39 142.56 45.86 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.697 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.431 ' HD2' HG12 ' A' ' 37' ' ' VAL . 7.2 Cg_endo -51.72 136.32 50.19 Favored 'Trans proline' 0 C--N 1.327 -0.58 0 C-N-CA 123.284 2.656 . . . . 0.0 112.185 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.84 97.95 1.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.4 p -88.54 -67.12 0.85 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.073 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -92.64 -161.75 0.86 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.391 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 18.7 m80 -107.84 173.63 6.24 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' A' ' 90' ' ' THR . 10.5 mt -124.47 138.6 54.33 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.541 0.686 . . . . 0.0 111.214 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.498 HD12 ' C ' ' A' ' 108' ' ' ALA . 13.4 mt -85.0 145.01 8.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 31.9 ttt85 -121.24 137.14 54.82 Favored 'General case' 0 N--CA 1.406 -2.664 0 CA-C-O 121.282 0.563 . . . . 0.0 109.597 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.662 ' O ' ' HA ' ' A' ' 86' ' ' SER . 59.2 m-85 -116.6 127.85 54.86 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.127 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.8 tt0 -113.05 126.16 55.17 Favored 'General case' 0 CA--C 1.471 -2.093 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.983 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.788 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -90.15 152.4 21.13 Favored 'General case' 0 N--CA 1.399 -2.98 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.981 ' HG2' HD11 ' A' ' 149' ' ' LEU . 5.3 pt-20 -55.3 -22.27 18.15 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.606 ' OD1' ' HG3' ' A' ' 85' ' ' ARG . 32.6 p-10 -102.5 1.37 34.98 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.529 0.681 . . . . 0.0 110.968 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.87 19.91 20.52 Favored Glycine 0 C--N 1.304 -1.223 0 CA-C-N 114.767 -1.106 . . . . 0.0 115.837 171.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.606 ' HG3' ' OD1' ' A' ' 83' ' ' ASP . 8.4 mtt180 -88.51 136.29 33.06 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 57.2 p -138.44 137.24 37.03 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.86 173.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -134.63 155.22 50.86 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.362 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 38.3 mt-10 -131.3 151.31 51.63 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.257 0.551 . . . . 0.0 112.008 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.496 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.7 OUTLIER -146.6 161.1 41.23 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.693 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.689 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -70.35 16.82 0.07 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.01 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.66 -28.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 125.235 1.414 . . . . 0.0 112.715 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 26.8 t70 -87.98 -8.07 56.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.433 0.635 . . . . 0.0 110.219 176.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.432 ' CE1' ' HB3' ' A' ' 173' ' ' HIS . 19.3 t60 -82.15 125.97 75.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.579 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 34.3 Cg_exo -62.92 138.02 65.91 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.921 2.414 . . . . 0.0 112.568 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 17.3 t -114.7 146.17 19.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.3 tp -98.83 106.38 18.63 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 116' ' ' LYS . 2.4 p -108.18 148.46 12.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.342 0.591 . . . . 0.0 111.4 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.505 ' CD2' HD12 ' A' ' 148' ' ' LEU . 49.8 t80 -100.99 94.15 5.86 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.813 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.505 ' CG ' HD11 ' A' ' 104' ' ' ILE . 11.5 pt-20 -144.96 158.23 43.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.2 m-20 64.02 22.16 12.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.015 0.436 . . . . 0.0 110.173 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.13 13.36 61.99 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.689 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -136.67 172.61 12.76 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 121.452 0.644 . . . . 0.0 110.425 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -104.72 121.61 43.97 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.686 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.505 HD11 ' CG ' ' A' ' 99' ' ' GLU . 16.7 pt -126.74 151.46 33.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.792 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.3 mp0 -106.28 111.24 23.75 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.092 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HG3' HG22 ' A' ' 111' ' ' VAL . 11.6 ptpt -125.76 143.43 51.05 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.277 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.643 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 79.7 mtt85 -61.57 163.28 7.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.01 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -61.41 -41.17 96.71 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.803 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 1.1 p90 -75.17 -0.92 20.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.717 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -106.73 -19.32 13.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.69 0.757 . . . . 0.0 109.172 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 107' ' ' ARG . 52.9 t -76.25 150.41 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.616 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -124.47 168.03 13.62 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.408 -177.522 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -68.24 138.45 55.57 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.25 5.13 67.84 Favored Glycine 0 C--N 1.3 -1.418 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.825 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.735 ' HB3' HD12 ' A' ' 151' ' ' ILE . 3.7 t70 -75.72 165.77 24.55 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.448 ' H ' HG23 ' A' ' 97' ' ' VAL . 29.1 mttp -124.63 160.97 27.26 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.311 0.576 . . . . 0.0 111.116 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.35 160.26 42.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.271 173.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.7 136.24 37.51 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.2 m -109.11 161.15 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 121' ' ' GLU . 80.6 p -80.87 27.68 0.37 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.281 0.562 . . . . 0.0 110.547 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' A' ' 119' ' ' VAL . 41.1 mt-10 72.92 -43.36 0.56 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.742 1.217 . . . . 0.0 113.156 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.616 ' HG ' ' H ' ' A' ' 123' ' ' GLU . 12.4 tp 179.11 -169.24 0.1 Allowed 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -170.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.616 ' H ' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER 172.65 -150.7 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 O-C-N 123.567 0.542 . . . . 0.0 111.544 178.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.779 HD21 HD21 ' A' ' 9' ' ' LEU . 1.8 pt? -66.18 49.36 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.427 1.891 . . . . 0.0 111.584 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.0 t -17.14 117.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 125.968 1.707 . . . . 0.0 113.062 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -111.0 169.48 8.74 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.929 -173.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -102.53 -52.85 3.01 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.8 p -169.15 80.57 0.13 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.0 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.1 t 69.34 -164.73 0.18 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.187 -174.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.0 m -99.8 155.09 17.83 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.931 0.396 . . . . 0.0 111.06 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.0 t -95.98 -16.61 21.58 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.069 0.462 . . . . 0.0 110.098 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 135' ' ' PRO . 52.7 mt-30 -123.91 -177.73 3.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.124 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -61.9 -43.27 99.19 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.639 0.733 . . . . 0.0 112.089 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.57 ' H ' ' CD ' ' A' ' 135' ' ' PRO . 49.9 t30 -163.95 -45.1 0.0 OUTLIER Pre-proline 0 C--N 1.281 -2.412 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.211 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.57 ' CD ' ' H ' ' A' ' 134' ' ' ASN . 27.5 Cg_exo -63.99 144.81 88.8 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.047 1.832 . . . . 0.0 109.383 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -173.43 -40.15 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.83 -175.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -172.44 134.45 0.67 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.449 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -101.22 -82.89 0.46 Allowed 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 41.61 -97.21 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.255 1.022 . . . . 0.0 112.611 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 38.4 tp -163.82 144.32 8.58 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.406 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.87 56.15 0.54 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 120.159 -1.019 . . . . 0.0 112.524 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.6 p -83.9 117.64 69.23 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 144' ' ' GLU . 9.6 Cg_endo -86.96 170.27 7.31 Favored 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.394 2.062 . . . . 0.0 112.111 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 143' ' ' PRO . 34.8 tt0 171.8 113.06 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.836 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 178.47 98.75 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.275 0.36 . . . . 0.0 110.186 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.16 93.22 7.02 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.748 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.424 ' C ' HD23 ' A' ' 148' ' ' LEU . 6.8 pt20 -164.5 119.95 1.48 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.25 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.505 HD12 ' CD2' ' A' ' 98' ' ' TYR . 9.7 mt -102.11 148.82 24.93 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 121.356 0.598 . . . . 0.0 109.738 175.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.981 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -113.9 137.58 51.48 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.423 -172.14 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.473 ' H ' HD13 ' A' ' 149' ' ' LEU . 10.2 mt-10 -90.8 145.28 24.91 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.574 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.735 HD12 ' HB3' ' A' ' 115' ' ' ASP . 82.2 mt -76.96 102.72 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.371 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.67 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 35.5 mmtm -69.33 -35.74 76.23 Favored 'General case' 0 C--N 1.264 -3.125 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.369 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -151.59 128.79 11.18 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 66.7 mt -112.56 144.76 19.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.795 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.476 ' HD3' HG13 ' A' ' 157' ' ' VAL . 5.7 ptpp? -146.41 156.45 43.32 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.123 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -99.42 115.26 28.84 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.476 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -128.87 173.75 13.24 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.568 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.878 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -106.35 166.1 10.78 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.37 132.35 46.24 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.935 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.43 ' HB2' ' OD1' ' A' ' 5' ' ' ASP . 24.3 m-80 -87.95 34.58 0.73 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.276 0.56 . . . . 0.0 110.018 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -161.74 178.86 8.6 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.03 -1.36 23.99 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.399 0.619 . . . . 0.0 110.243 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -139.13 153.38 47.96 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.478 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.8 m -119.01 157.12 20.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 58.5 m-85 -132.84 175.04 9.7 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.553 -176.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.624 ' OG ' ' HA ' ' A' ' 1' ' ' CYS . 49.2 m -154.54 -29.55 0.11 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.884 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.661 ' HG ' HD23 ' A' ' 24' ' ' LEU . 2.5 mm? 61.93 90.97 0.07 Allowed 'General case' 0 C--N 1.345 0.371 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 65' ' ' GLU . 47.8 m-20 -81.75 104.5 12.18 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.608 0.718 . . . . 0.0 111.974 -175.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.6 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -94.67 -155.41 0.46 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.285 172.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.597 ' HB2' HG21 ' A' ' 62' ' ' THR . 32.7 mmtm -61.66 133.77 55.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.223 0.535 . . . . 0.0 112.083 -177.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 74.8 tttt 78.84 -11.92 1.15 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.401 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 69.01 144.0 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.919 0.888 . . . . 0.0 112.078 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.432 ' HB3' ' CE1' ' A' ' 93' ' ' HIS . 91.3 m-70 49.16 32.37 4.12 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.949 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -117.59 104.01 10.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.416 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.757 HG21 HD11 ' A' ' 8' ' ' ILE . 1.7 p -158.66 171.07 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -176.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.596 ' H ' HG22 ' A' ' 175' ' ' VAL . 71.8 mt -116.42 122.4 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.923 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.547 HG23 HG13 ' A' ' 175' ' ' VAL . 43.1 pt -126.68 167.39 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 121.597 0.713 . . . . 0.0 112.637 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 52.48 -129.63 2.31 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.255 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.436 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 3.2 mp0 -78.89 42.99 0.48 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.017 0.437 . . . . 0.0 110.491 176.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.3 m-20 71.02 48.37 0.38 Allowed 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 124.508 1.123 . . . . 0.0 112.308 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 85.0 mt -88.75 112.17 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 176' ' ' ILE . 2.6 m -79.47 135.51 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 CA-C-O 121.969 0.89 . . . . 0.0 111.208 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.6 t -139.69 119.51 13.36 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -144.35 150.71 38.22 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -172.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 . . . . . 0 C--O 1.266 1.94 0 CA-C-O 117.26 -1.352 . . . . 0.0 109.706 176.677 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.721 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 33.7 t . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.922 0.391 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.424 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 1.7 m-85 -121.91 166.0 18.33 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.546 ' HD3' HD13 ' A' ' 76' ' ' LEU . 74.0 Cg_endo -71.56 164.82 34.44 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.035 1.823 . . . . 0.0 109.356 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.17 -29.85 63.29 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 119.276 -1.44 . . . . 0.0 111.334 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.618 ' HA ' ' NH1' ' A' ' 22' ' ' ARG . 35.7 t70 -61.37 -16.44 46.37 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.1 m -68.73 125.42 26.52 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.072 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.715 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 78.5 mtm-85 -84.01 134.88 34.62 Favored 'General case' 0 C--O 1.182 -2.46 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.453 ' CD1' HG21 ' A' ' 175' ' ' VAL . 9.5 tt -120.47 130.1 74.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.529 HD21 HD11 ' A' ' 124' ' ' LEU . 0.6 OUTLIER -88.67 122.77 32.46 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-O 121.52 0.676 . . . . 0.0 109.656 178.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.4 m -135.52 -179.36 3.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.071 -176.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 30.8 tt0 -129.52 121.77 27.88 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.944 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 19.1 mt -121.79 121.8 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.097 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.92 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 56.43 37.48 28.86 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.473 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.38 15.92 77.23 Favored Glycine 0 C--N 1.305 -1.162 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.638 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.27 121.23 27.04 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.597 ' HB2' HD22 ' A' ' 124' ' ' LEU . 56.6 Cg_endo -72.44 122.69 8.51 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 C-N-CA 122.334 2.023 . . . . 0.0 111.416 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -120.45 138.13 53.96 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.916 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -107.98 101.08 10.37 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.3 pt -127.03 -172.86 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.364 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.715 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 21.5 p -97.96 172.24 7.76 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.771 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.574 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 66.2 mt -68.15 -27.38 66.38 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.016 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.618 ' NH1' ' HA ' ' A' ' 5' ' ' ASP . 1.0 OUTLIER -78.53 -26.66 45.8 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.45 ' OE1' HG23 ' A' ' 20' ' ' THR . 85.3 mt-10 -85.73 -42.05 14.58 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.238 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.524 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 20.1 tp -58.8 -42.92 90.21 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.866 0.841 . . . . 0.0 109.319 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.405 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -52.41 -31.0 32.12 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.734 -1.575 . . . . 0.0 112.687 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.11 -19.32 61.81 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.757 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.1 mm? -78.29 1.92 20.15 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.483 0.659 . . . . 0.0 109.601 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.555 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.9 m-85 -119.15 156.52 29.65 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.035 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 17.4 mt-10 -157.65 131.51 8.05 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.092 175.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 47.6 t0 127.83 85.93 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.794 2.037 . . . . 0.0 107.394 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -99.23 125.28 44.8 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.113 0.959 . . . . 0.0 111.696 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -117.53 150.67 38.57 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.131 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -102.46 131.67 48.99 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -166.55 148.35 6.46 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.499 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 58.26 23.11 9.99 Favored 'General case' 0 CA--C 1.491 -1.296 0 O-C-N 123.81 0.694 . . . . 0.0 111.067 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 44.8 mtm 73.69 15.83 3.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.233 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.8 m -130.4 -170.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.92 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -112.5 138.1 49.75 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 t -130.08 123.54 56.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.08 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 29' ' ' GLU . 17.0 ttm180 -110.02 134.0 52.6 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -116.77 179.31 4.05 Favored 'General case' 0 C--N 1.267 -2.99 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.28 106.37 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 125.079 1.487 . . . . 0.0 114.505 170.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.488 ' HB2' HD13 ' A' ' 47' ' ' ILE . 55.5 Cg_endo -77.39 140.01 18.98 Favored 'Trans proline' 0 N--CA 1.426 -2.482 0 C-N-CA 121.552 1.501 . . . . 0.0 110.619 174.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -83.71 -0.48 50.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.447 0.641 . . . . 0.0 111.735 -175.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -147.34 -171.0 3.69 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 19.3 tt0 -79.83 105.34 11.05 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.61 HG13 HG12 ' A' ' 12' ' ' ILE . 1.4 mp -116.28 112.37 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.361 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 45.7 mmtm -113.56 166.5 11.46 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.739 173.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 169' ' ' ALA . 12.1 p -121.48 131.29 73.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 11' ' ' GLN . 19.2 m-85 -82.95 121.24 26.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.872 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 m -135.42 170.17 16.35 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.668 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.478 HD13 ' O ' ' A' ' 58' ' ' LYS . 2.4 mm -113.26 142.9 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.433 0.635 . . . . 0.0 110.831 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.64 80.26 3.08 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.687 HD12 ' H ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -36.33 -40.66 0.24 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.399 1.88 . . . . 0.0 114.039 -175.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 55' ' ' GLU . 2.1 pt-20 -63.33 -37.78 88.61 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.323 -176.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.487 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.4 p -107.34 -22.51 12.56 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.914 -176.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.55 20.46 68.84 Favored Glycine 0 N--CA 1.421 -2.366 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.015 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 40.8 mtpt -94.07 158.94 15.38 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.57 109.73 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.783 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.67 155.74 11.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-O 121.066 0.46 . . . . 0.0 111.387 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.8 tp -123.01 135.11 54.33 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.426 HG21 ' HB3' ' A' ' 170' ' ' LYS . 11.2 t -143.1 170.75 15.13 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.324 -176.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -76.73 161.14 28.74 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.202 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.507 HD13 HG22 ' A' ' 47' ' ' ILE . 1.9 mp -97.43 145.75 8.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.321 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.484 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 14.9 mm-40 -79.7 -53.3 6.95 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -175.48 -171.73 0.51 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.673 1.233 . . . . 0.0 107.918 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.567 ' HA ' HD22 ' A' ' 167' ' ' LEU . 14.3 t -107.31 149.99 10.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 120.889 0.376 . . . . 0.0 110.428 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.695 HD12 ' HB2' ' A' ' 166' ' ' SER . 56.4 mt -111.95 118.96 58.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.198 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.466 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 19.2 tttm -134.75 112.62 10.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.933 0.397 . . . . 0.0 109.95 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.52 143.63 50.02 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.029 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.442 ' HD2' HG12 ' A' ' 37' ' ' VAL . 9.7 Cg_endo -54.32 130.07 37.9 Favored 'Trans proline' 0 C--N 1.328 -0.502 0 C-N-CA 123.208 2.605 . . . . 0.0 112.446 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.98 85.53 6.24 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.611 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.8 p -96.55 -43.12 7.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.665 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.06 174.59 8.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.606 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -102.16 171.78 7.29 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' A' ' 90' ' ' THR . 12.1 mt -126.02 143.05 51.25 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.753 0.787 . . . . 0.0 110.973 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.52 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 7.6 mt -83.82 141.4 14.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 15.9 ttt-85 -116.56 136.38 53.03 Favored 'General case' 0 N--CA 1.407 -2.575 0 CA-C-O 121.191 0.52 . . . . 0.0 109.748 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 86' ' ' SER . 55.0 m-85 -114.66 120.83 41.46 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.256 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 37.4 tt0 -108.07 126.62 52.96 Favored 'General case' 0 CA--C 1.467 -2.222 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.671 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.6 mm? -88.16 157.53 18.79 Favored 'General case' 0 C--N 1.27 -2.855 0 O-C-N 123.584 0.553 . . . . 0.0 110.97 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.872 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -59.32 -18.5 38.61 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.1 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -91.92 -10.2 40.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.847 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.42 9.64 57.65 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.965 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.558 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -84.17 141.57 30.96 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.731 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -142.09 140.52 32.55 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.823 176.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -135.48 157.47 46.82 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.497 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 31.3 mt-10 -129.1 153.19 47.89 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.154 0.502 . . . . 0.0 112.026 -176.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.8 OUTLIER -145.88 158.43 43.86 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.384 177.642 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.686 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -72.37 18.99 0.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.009 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.71 -41.91 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 C-N-CA 125.367 1.467 . . . . 0.0 114.151 175.363 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -82.21 2.88 29.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 111.144 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.482 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 36.8 m-70 -104.59 136.13 19.22 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.728 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 35.6 Cg_exo -62.3 142.41 91.13 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.543 2.829 . . . . 0.0 114.824 -177.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.503 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.8 t -117.97 147.28 21.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.604 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.6 tp -103.82 111.43 23.94 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.703 HG13 HG13 ' A' ' 104' ' ' ILE . 2.0 p -113.79 140.9 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-O 121.592 0.71 . . . . 0.0 111.667 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.648 ' CD2' HD11 ' A' ' 148' ' ' LEU . 81.6 t80 -91.37 92.37 8.55 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -142.2 148.86 38.88 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.474 -175.009 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 9.0 m120 69.18 22.55 6.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 110.027 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.14 14.51 63.88 Favored Glycine 0 CA--C 1.5 -0.905 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.91 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -140.05 173.32 11.64 Favored 'General case' 0 N--CA 1.41 -2.46 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -97.01 120.37 37.23 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.703 HG13 HG13 ' A' ' 97' ' ' VAL . 12.3 pt -116.91 143.13 27.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.006 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -107.49 110.44 22.38 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.13 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 11.5 ptpt -127.24 138.86 53.19 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.608 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.655 ' O ' HG23 ' A' ' 111' ' ' VAL . 56.6 mtm180 -64.62 164.14 12.46 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 119.347 -0.359 . . . . 0.0 110.147 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.009 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -61.57 -43.21 99.28 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.514 -175.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.412 ' HB3' ' CG2' ' A' ' 91' ' ' VAL . 2.0 p90 -75.05 2.74 9.86 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.524 0.678 . . . . 0.0 110.332 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -114.01 -15.39 12.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.553 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 107' ' ' ARG . 93.2 t -81.87 149.27 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.657 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 18.1 mtmt -124.06 163.47 21.38 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.091 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -64.12 142.89 58.25 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.66 4.2 85.54 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.887 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.657 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -74.98 167.9 21.02 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.481 ' HG3' ' HG3' ' A' ' 150' ' ' GLU . 3.8 ttmt -123.97 166.43 15.72 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.185 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.55 161.43 36.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -90.5 129.89 36.61 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -112.87 125.28 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.909 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.471 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.3 t -65.76 -16.18 63.54 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.542 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 44.49 26.28 0.17 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 113.402 -1.726 . . . . 0.0 112.769 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 55.5 tp -87.17 111.6 21.13 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.026 0.441 . . . . 0.0 110.757 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -106.5 164.57 11.94 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.597 HD22 ' HB2' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -121.13 18.9 11.6 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 122.709 1.242 . . . . 0.0 108.434 -174.479 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.2 p -68.28 137.94 23.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 112.48 -2.146 . . . . 0.0 112.323 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 139' ' ' ASN . 17.5 mt-10 -109.53 -11.77 14.76 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.622 177.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 70.44 30.72 3.17 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.581 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.5 p -98.56 -62.13 1.28 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.616 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 55.6 m -157.19 -175.81 5.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.485 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.2 m -67.66 148.41 51.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.757 0.313 . . . . 0.0 110.6 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.6 p -77.99 76.76 4.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.173 0.511 . . . . 0.0 110.672 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -118.82 -8.87 10.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.425 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -106.45 -139.51 0.37 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.04 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.715 ' H ' ' HD2' ' A' ' 135' ' ' PRO . 60.3 t30 -164.15 -44.32 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.161 -175.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.715 ' HD2' ' H ' ' A' ' 134' ' ' ASN . 10.9 Cg_endo -55.37 -146.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.691 2.927 . . . . 0.0 113.436 174.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 84.2 mttt 67.99 -79.57 0.04 OUTLIER 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.258 0.623 . . . . 0.0 110.203 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.8 t30 54.36 42.94 31.15 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.683 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -95.02 -50.3 5.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.987 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.451 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . 4.0 p-10 42.59 -168.51 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.226 1.01 . . . . 0.0 113.372 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.611 ' H ' HD23 ' A' ' 140' ' ' LEU . 2.0 pt? -117.83 160.33 21.56 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.837 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.66 -59.87 6.73 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.285 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.4 m -122.15 118.31 29.12 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-O 120.735 0.303 . . . . 0.0 110.936 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.414 ' HA ' HD11 ' A' ' 140' ' ' LEU . 54.8 Cg_endo -85.81 -165.59 0.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.765 2.31 . . . . 0.0 111.175 177.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -117.34 129.96 56.21 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -163.39 -165.03 1.0 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 74.51 52.7 0.09 Allowed 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 124.109 0.964 . . . . 0.0 111.753 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.544 ' O ' HG23 ' A' ' 119' ' ' VAL . 3.6 pt20 -151.8 142.65 22.95 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.229 -1.351 . . . . 0.0 107.794 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.648 HD11 ' CD2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -125.45 160.27 29.86 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.872 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -122.73 139.28 54.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.644 -170.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.481 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 19.1 mt-10 -91.19 150.52 21.33 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 122.337 1.065 . . . . 0.0 112.741 177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.487 HG21 ' CG1' ' A' ' 154' ' ' ILE . 61.1 mt -77.79 121.69 31.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 113.246 -1.797 . . . . 0.0 111.002 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.612 ' HE2' ' HB2' ' A' ' 82' ' ' GLU . 49.4 mmtt -80.99 -39.19 26.33 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.482 175.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -148.73 130.2 14.82 Favored 'General case' 0 CA--C 1.473 -2.01 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.6 mt -117.62 126.26 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.445 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.297 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HD3' HG13 ' A' ' 157' ' ' VAL . 0.4 OUTLIER -135.82 166.89 22.24 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.153 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.52 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 23.8 m-85 -101.58 119.82 39.36 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.42 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.4 OUTLIER -135.57 137.21 49.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.683 -178.425 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -71.1 154.1 42.02 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.258 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.22 134.64 57.18 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.259 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -82.84 37.55 0.54 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.604 0.716 . . . . 0.0 110.163 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -175.16 179.26 1.58 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -107.34 4.32 26.3 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.858 0.361 . . . . 0.0 111.607 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -141.54 149.48 40.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.0 m -118.78 155.41 20.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.536 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 56.5 m-85 -133.16 174.17 10.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.111 -176.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.721 ' OG ' ' HA ' ' A' ' 1' ' ' CYS . 49.1 m -159.06 -27.42 0.07 Allowed 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.567 HD22 ' HA ' ' A' ' 67' ' ' VAL . 1.3 tm? 68.91 107.14 0.05 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.066 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -85.25 116.16 23.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.666 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.484 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -135.36 -163.03 1.33 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.045 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.426 ' HB3' HG21 ' A' ' 62' ' ' THR . 0.3 OUTLIER -63.67 127.15 30.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.588 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 70.12 103.81 0.06 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.884 0.74 . . . . 0.0 109.078 -174.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -56.94 132.67 53.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.226 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 50.6 m80 67.01 12.07 8.76 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.641 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -91.37 99.65 12.58 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.568 HG13 HG23 ' A' ' 177' ' ' ILE . 2.8 p -152.96 163.92 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.433 0.635 . . . . 0.0 111.673 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.606 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 93.8 mt -116.71 115.78 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.444 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.568 HG23 HG13 ' A' ' 175' ' ' VAL . 39.5 pt -123.78 173.48 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 7' ' ' ARG . 7.9 t-20 49.19 -122.36 1.71 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.35 1.06 . . . . 0.0 109.81 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.404 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 34.8 mm-40 -96.21 56.59 1.64 Allowed 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.47 0.652 . . . . 0.0 109.658 175.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 25.7 m-80 69.51 43.56 1.0 Allowed 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 114.216 -1.357 . . . . 0.0 113.751 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.5 mt -85.49 116.55 28.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.55 129.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.357 -174.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 14.7 t -139.26 164.54 29.55 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.448 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -160.59 154.17 22.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.588 0.232 . . . . 0.0 110.614 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 C--O 1.27 2.179 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.587 178.083 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.583 ' HA ' ' OG1' ' A' ' 90' ' ' THR . 69.2 m . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.882 0.373 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -140.39 145.1 39.61 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.494 ' HA ' HG12 ' A' ' 164' ' ' VAL . 23.0 Cg_endo -61.25 -32.66 90.45 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 122.852 2.368 . . . . 0.0 112.781 -174.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 127.04 -39.27 1.99 Allowed Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.38 -16.92 25.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.648 0.779 . . . . 0.0 111.058 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -64.4 126.69 28.63 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.593 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.633 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 19.1 mmt85 -82.79 134.41 35.12 Favored 'General case' 0 C--O 1.186 -2.25 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.606 HD11 HG21 ' A' ' 175' ' ' VAL . 9.9 tt -121.66 131.4 73.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.432 HD21 ' CD1' ' A' ' 124' ' ' LEU . 2.1 tm? -87.66 123.71 32.79 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.611 0.72 . . . . 0.0 109.847 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 31.5 m -133.06 -177.26 2.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.02 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -130.3 121.32 25.85 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.596 HG12 HG13 ' A' ' 47' ' ' ILE . 22.3 mt -118.36 121.32 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.523 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.707 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.84 38.12 29.73 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.691 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.02 20.29 79.47 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.769 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 134' ' ' ASN . 58.6 t -127.04 118.32 22.09 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-O 120.683 0.277 . . . . 0.0 110.41 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 7.0 Cg_exo -66.78 121.54 8.77 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 122.068 1.845 . . . . 0.0 111.065 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -123.63 137.4 54.74 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.693 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HB2' HD23 ' A' ' 9' ' ' LEU . 36.9 ttpt -108.54 101.37 10.53 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.9 pt -123.53 -171.9 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.18 -2.555 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.624 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.798 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 6.6 p -94.44 171.82 8.58 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.088 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 12.3 mt -72.38 -24.5 61.27 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 120.683 0.277 . . . . 0.0 110.909 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.798 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 8.1 ptm180 -82.18 -24.35 35.02 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.542 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 67.8 mm-40 -82.96 -44.59 15.13 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.043 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.504 HD21 ' HG ' ' A' ' 167' ' ' LEU . 20.5 tp -54.74 -45.57 74.14 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.88 0.848 . . . . 0.0 109.407 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.425 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -52.2 -31.16 30.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.554 -1.657 . . . . 0.0 112.754 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 26.8 mt-10 -78.81 -15.35 58.5 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 23' ' ' GLU . 1.8 mm? -77.97 5.92 8.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.76 0.79 . . . . 0.0 109.39 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.7 m-85 -121.01 162.46 19.89 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.857 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.613 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 21.1 mm-40 -142.06 -172.86 3.67 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.296 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.506 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.7 t70 63.1 80.04 0.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.376 0.607 . . . . 0.0 110.469 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.35 128.09 43.87 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.841 0.829 . . . . 0.0 110.672 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.471 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.0 ptt180 -121.78 154.42 37.0 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.402 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -102.84 126.33 49.93 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -162.5 140.96 8.78 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.622 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 58.65 24.14 11.78 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 123.671 0.607 . . . . 0.0 110.624 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.6 mtp 72.74 13.44 5.16 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.348 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.516 HG12 ' HD2' ' A' ' 71' ' ' PRO . 12.9 m -127.31 -177.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -112.42 139.68 47.79 Favored 'General case' 0 CA--C 1.471 -2.081 0 CA-C-O 121.303 0.573 . . . . 0.0 109.855 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.471 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.8 t -128.94 122.55 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 0 CA-C-N 115.14 -0.937 . . . . 0.0 108.77 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.421 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 16.1 ttm180 -112.24 126.17 54.94 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.506 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -129.95 145.51 51.63 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.177 -173.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 3.6 tppp? 81.78 111.94 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.48 0 O-C-N 124.54 1.15 . . . . 0.0 110.902 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.548 ' HB2' HD13 ' A' ' 47' ' ' ILE . 59.3 Cg_endo -78.72 152.44 25.61 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 122.15 1.9 . . . . 0.0 111.622 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.613 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 32.4 mtmt -81.53 -5.43 57.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.422 0.629 . . . . 0.0 111.214 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -146.19 -165.39 2.2 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 39.9 tt0 -86.04 102.0 13.43 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.596 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -116.91 120.92 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.167 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 22.5 mmtt -120.02 164.7 15.73 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.181 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.454 ' O ' HD12 ' A' ' 61' ' ' LEU . 12.9 p -118.67 130.92 72.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.274 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -90.73 118.92 30.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.6 0.714 . . . . 0.0 111.461 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.9 m -134.24 146.68 50.31 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.819 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.527 HG12 HD11 ' A' ' 176' ' ' ILE . 2.8 mm -90.26 141.03 14.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.334 0.588 . . . . 0.0 110.345 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.51 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 13.5 t70 -80.57 121.14 25.43 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.707 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -78.16 -8.52 58.39 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.237 0.541 . . . . 0.0 111.876 -169.287 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.51 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.5 pt-20 -103.27 -31.56 10.02 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.35 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.485 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 68.2 p -111.84 -18.11 12.78 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.78 -175.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.46 21.34 79.63 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.345 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.485 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 38.2 mtpt -98.14 162.24 13.31 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 120.865 0.364 . . . . 0.0 111.464 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.46 110.45 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-O 121.767 0.794 . . . . 0.0 109.509 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 m -110.05 156.88 10.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.051 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 49' ' ' VAL . 13.5 tp -123.1 136.87 54.98 Favored 'General case' 0 N--CA 1.411 -2.387 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 170' ' ' LYS . 10.3 t -142.66 171.21 14.37 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.939 0.399 . . . . 0.0 111.316 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.418 ' O ' ' HB1' ' A' ' 169' ' ' ALA . 0.9 OUTLIER -80.26 161.04 25.34 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.395 178.63 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.3 mp -101.15 136.72 31.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.222 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.404 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 46.6 mm-40 -83.59 -41.22 18.11 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -179.49 178.01 0.7 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.405 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.502 ' HA ' HD22 ' A' ' 167' ' ' LEU . 13.3 t -105.86 132.76 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.795 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 166' ' ' SER . 60.3 mt -91.28 108.45 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.095 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.512 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.7 tttt -124.56 107.93 11.55 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.52 144.53 53.75 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.312 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.516 ' HD2' HG12 ' A' ' 37' ' ' VAL . 9.8 Cg_endo -53.97 131.67 45.74 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.389 2.726 . . . . 0.0 112.29 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.451 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -78.15 -108.95 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.728 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 86.2 m 77.02 -21.45 0.33 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.945 0.498 . . . . 0.0 111.878 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.469 ' HB2' ' H ' ' A' ' 75' ' ' HIS . 0.8 OUTLIER -79.79 -139.77 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.446 179.114 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.469 ' H ' ' HB2' ' A' ' 74' ' ' ASP . 74.3 m-70 -150.68 165.79 32.36 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.828 HD23 ' HA ' ' A' ' 90' ' ' THR . 30.5 mt -135.98 136.54 40.44 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.117 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.539 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 15.6 mt -89.61 146.24 6.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 172.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 28.8 ttt85 -121.08 137.87 54.45 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 121.153 0.501 . . . . 0.0 109.999 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.602 ' CD1' HD13 ' A' ' 151' ' ' ILE . 50.7 m-85 -117.57 127.31 53.84 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.2 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 32.4 tt0 -112.88 130.3 56.15 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.859 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -94.27 162.04 14.01 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.04 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 1.058 ' HG2' HD11 ' A' ' 149' ' ' LEU . 4.3 pt-20 -58.27 -22.42 52.47 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.875 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.715 ' OD1' ' HG ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -86.69 -10.8 52.92 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.575 0.702 . . . . 0.0 109.498 -178.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.78 14.4 58.11 Favored Glycine 0 C--N 1.297 -1.602 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.191 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.639 ' HG3' ' HB2' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -89.64 142.48 27.64 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.308 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 35.3 p -139.95 154.33 47.17 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.888 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 79' ' ' PHE . 9.3 p90 -142.86 151.34 40.97 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.723 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 96.9 mt-10 -125.8 146.12 49.93 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.56 -177.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -142.31 159.46 42.19 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.406 -179.065 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.828 ' HA ' HD23 ' A' ' 76' ' ' LEU . 1.7 m -73.62 19.22 0.11 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.3 0.571 . . . . 0.0 112.478 -177.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.017 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.88 -34.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 124.78 1.232 . . . . 0.0 113.249 175.152 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 23.3 t70 -78.62 -24.59 45.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.129 0.49 . . . . 0.0 110.017 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -77.8 119.97 79.49 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.277 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 35.1 Cg_exo -62.2 139.83 80.13 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.522 2.815 . . . . 0.0 114.014 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.5 t -100.28 147.42 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.736 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.5 tp -98.02 106.16 18.42 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.168 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.626 HG13 HG12 ' A' ' 104' ' ' ILE . 2.4 p -112.55 149.37 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.678 0.751 . . . . 0.0 112.258 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -104.05 92.81 4.54 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.781 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.579 ' OE2' ' HE3' ' A' ' 106' ' ' LYS . 6.1 pt-20 -138.85 159.94 40.9 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 89.9 m-20 63.14 22.37 13.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.332 0.587 . . . . 0.0 109.7 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.29 16.68 62.91 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.298 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 102' ' ' ARG . 11.1 ptp180 -136.4 171.99 13.67 Favored 'General case' 0 N--CA 1.399 -2.979 0 CA-C-N 117.605 0.702 . . . . 0.0 109.916 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -98.36 121.25 40.07 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.626 HG12 HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -126.98 148.75 31.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.132 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 3.3 mp0 -108.11 116.45 31.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.515 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.585 ' HE2' HG13 ' A' ' 104' ' ' ILE . 51.0 mttm -124.62 134.72 52.82 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.328 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 75.3 mtm180 -56.66 154.78 8.39 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.017 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -59.87 -41.74 92.18 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.935 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 3.4 p90 -73.51 2.11 8.53 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.92 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -114.14 -19.26 11.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.863 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 107' ' ' ARG . 53.1 t -76.97 152.3 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.723 ' HE2' ' H ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -123.94 167.08 14.61 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -71.15 143.53 50.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.99 4.96 74.19 Favored Glycine 0 C--N 1.304 -1.199 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.569 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.968 ' HB3' HD12 ' A' ' 151' ' ' ILE . 15.2 t70 -72.03 178.81 3.56 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.69 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 71.4 mttt -135.45 154.52 51.41 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.62 0.724 . . . . 0.0 112.037 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.05 155.64 41.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.895 173.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.533 ' HA ' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -97.12 135.91 38.41 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.8 OUTLIER -104.93 125.96 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.747 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.819 176.378 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.8 t -85.14 43.65 1.02 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 119' ' ' VAL . 22.6 tt0 -67.55 38.73 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.168 1.387 . . . . 0.0 113.025 -172.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 143' ' ' PRO . 0.7 OUTLIER -121.06 -171.49 2.21 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 68.05 -84.65 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.833 1.653 . . . . 0.0 114.535 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.685 ' H ' HD23 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -64.61 -62.82 1.35 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -173.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.517 ' H ' ' HG ' ' A' ' 124' ' ' LEU . 43.4 t 77.12 116.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 O-C-N 123.778 0.674 . . . . 0.0 109.878 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 60.82 -101.59 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.295 -174.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 32.92 80.87 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.732 1.213 . . . . 0.0 113.135 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.9 p -93.31 154.68 17.85 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.815 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.4 p -74.34 88.39 2.04 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.391 0.615 . . . . 0.0 110.97 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.6 p -171.37 -150.62 0.07 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.1 m -67.9 86.43 0.23 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.24 0.543 . . . . 0.0 109.989 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -152.92 143.17 22.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.085 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -68.74 131.7 45.61 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.179 0.514 . . . . 0.0 111.261 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.45 ' HB3' HG21 ' A' ' 15' ' ' VAL . 6.9 m-80 -74.6 -51.86 3.95 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.707 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.43 ' HD3' ' HB2' ' A' ' 134' ' ' ASN . 32.0 Cg_exo -59.84 105.7 0.29 Allowed 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.152 2.568 . . . . 0.0 114.041 -176.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -113.93 102.4 10.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.708 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -153.29 -35.21 0.11 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.708 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.52 33.45 0.42 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -151.53 164.48 36.72 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.703 0.287 . . . . 0.0 110.919 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 140' ' ' LEU . 2.4 pt? -76.29 153.81 35.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.386 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -127.8 19.82 5.8 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.788 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.6 p -70.38 118.07 60.79 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-O 120.868 0.366 . . . . 0.0 110.208 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.554 ' HB3' ' HB2' ' A' ' 122' ' ' LEU . 59.2 Cg_endo -82.17 153.76 16.57 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.389 2.06 . . . . 0.0 114.769 -175.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -144.69 20.84 1.66 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.617 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 39.1 m170 -115.54 96.05 5.45 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.055 0.455 . . . . 0.0 111.171 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -132.5 88.35 2.52 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -147.73 154.11 40.12 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.361 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.69 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.9 mm? -108.49 141.47 40.32 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.042 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.058 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -119.28 135.95 54.46 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.006 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 25.8 mt-10 -83.19 141.51 31.87 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.96 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.968 HD12 ' HB3' ' A' ' 115' ' ' ASP . 73.0 mt -80.17 104.87 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.995 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.586 174.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.558 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 14.1 mmtm -70.64 -37.13 73.74 Favored 'General case' 0 C--N 1.266 -3.06 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.159 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -148.92 129.25 13.77 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 75.7 mt -113.11 144.82 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.529 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.471 ' HD2' ' HD3' ' A' ' 78' ' ' ARG . 5.2 ptpp? -145.99 156.14 43.29 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.815 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.539 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 5.1 m-85 -98.94 117.82 34.31 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -126.2 175.65 7.97 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.094 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.521 -178.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 23.3 mtt-85 -100.6 164.46 11.88 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.625 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.703 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.87 -30.16 63.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.511 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.6 t30 66.37 -38.76 0.31 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.358 1.063 . . . . 0.0 113.279 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -98.04 -174.36 2.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.37 -13.09 16.8 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 120.71 0.291 . . . . 0.0 110.905 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -139.29 155.95 47.37 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.18 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.4 m -128.28 160.09 38.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.505 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.623 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 81.4 m-85 -132.76 169.75 16.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.555 0.217 . . . . 0.0 110.736 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.654 ' HB2' HD12 ' A' ' 68' ' ' ILE . 20.3 m -156.78 -27.99 0.09 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.504 ' HG ' HD21 ' A' ' 24' ' ' LEU . 1.3 tm? 73.05 112.22 0.06 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.996 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -91.94 116.67 29.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.605 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 63' ' ' ASP . . . -134.16 -164.1 1.46 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.677 176.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.407 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 26.1 mmmt -73.31 133.23 43.82 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt 51.97 47.28 25.09 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -59.73 -158.94 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 O-C-N 124.565 1.166 . . . . 0.0 113.978 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 185' ' ' GLN . 20.5 p80 56.0 27.07 10.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.087 0.955 . . . . 0.0 111.727 -176.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -150.23 143.61 25.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.606 HG21 HD11 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -173.83 166.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.309 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.527 HD11 HG12 ' A' ' 52' ' ' ILE . 85.7 mt -109.53 112.95 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.639 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.603 HG23 HG13 ' A' ' 175' ' ' VAL . 44.9 pt -120.51 171.59 8.8 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.683 0 CA-C-O 121.375 0.607 . . . . 0.0 112.482 -175.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.573 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 44.8 t30 48.68 -128.12 1.97 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.002 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.506 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 19.7 mm-40 -85.61 48.71 1.63 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.334 0.587 . . . . 0.0 109.592 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.5 m-20 70.29 44.79 0.7 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.128 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 82.1 mt -86.27 113.08 23.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.407 HG11 HG13 ' A' ' 52' ' ' ILE . 3.0 m -80.34 135.6 25.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.758 0.789 . . . . 0.0 111.271 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.2 t -135.3 152.88 51.91 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.581 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -156.86 130.71 8.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.936 0.398 . . . . 0.0 111.534 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.522 ' HB3' ' HB2' ' A' ' 173' ' ' HIS . 0.6 OUTLIER . . . . . 0 C--O 1.26 1.612 0 CA-C-O 116.61 -1.662 . . . . 0.0 108.413 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.882 ' SG ' ' HB2' ' A' ' 93' ' ' HIS . 4.3 p . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 121.538 0.685 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.401 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 1.5 m-85 -133.94 167.65 21.79 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.454 ' HD3' HD13 ' A' ' 76' ' ' LEU . 61.6 Cg_endo -70.43 157.01 60.37 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 N-CA-C 108.413 -1.418 . . . . 0.0 108.413 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.59 -21.46 35.32 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 119.735 -1.221 . . . . 0.0 112.397 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -74.27 -1.26 19.87 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.4 m -74.39 130.93 40.58 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.928 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 8.7 mmt180 -81.86 126.2 31.6 Favored 'General case' 0 C--O 1.197 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.485 HD11 HG21 ' A' ' 175' ' ' VAL . 9.5 tt -117.67 129.75 73.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.039 0.447 . . . . 0.0 109.877 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.543 HD21 HD21 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -89.72 124.17 34.38 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-O 121.531 0.681 . . . . 0.0 109.917 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 19.3 m -137.64 -177.87 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.342 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.479 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 30.2 tt0 -126.08 118.84 26.13 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.582 HG12 HG13 ' A' ' 47' ' ' ILE . 20.7 mt -119.19 121.7 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.727 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.28 39.5 30.91 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.933 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.27 19.58 78.77 Favored Glycine 0 N--CA 1.439 -1.116 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.849 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.96 122.76 24.45 Favored Pre-proline 0 N--CA 1.434 -1.264 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 44.1 Cg_endo -71.54 120.22 6.78 Favored 'Trans proline' 0 N--CA 1.432 -2.126 0 C-N-CA 121.931 1.754 . . . . 0.0 110.675 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -122.98 142.06 51.25 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.622 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.463 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 39.1 ttmt -112.29 100.89 9.16 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.1 pt -119.44 -178.41 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.912 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.106 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.801 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.8 p -93.28 174.52 7.17 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.142 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 94.5 mt -66.94 -31.39 71.93 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 120.726 0.298 . . . . 0.0 110.551 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.801 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 9.5 ptm180 -78.5 -22.5 47.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB2' ' H ' ' A' ' 20' ' ' THR . 38.8 mm-40 -84.56 -45.79 12.23 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.527 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.737 HD23 ' HG ' ' A' ' 167' ' ' LEU . 13.4 tp -58.91 -42.66 90.19 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.787 0.804 . . . . 0.0 109.51 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.429 ' HD1' HG11 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -53.98 -30.37 46.8 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.637 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.73 -17.89 59.76 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 23' ' ' GLU . 1.5 mm? -80.56 1.51 29.3 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.577 0.703 . . . . 0.0 109.663 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.7 m-85 -119.01 161.65 19.87 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.107 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -144.72 -171.42 3.61 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.033 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.539 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.2 t70 65.71 76.75 0.31 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.539 0.685 . . . . 0.0 109.584 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -100.93 131.54 46.76 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.103 0.954 . . . . 0.0 111.752 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.511 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 17.6 ptt-85 -121.53 153.87 37.4 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.048 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -104.04 123.18 46.77 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -160.76 148.76 16.02 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.06 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 59.57 22.62 11.26 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 123.571 0.544 . . . . 0.0 110.76 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 41.7 mtm 72.96 16.79 4.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.943 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.6 m -133.33 -169.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.937 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.558 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 71.6 m-85 -110.84 137.72 48.14 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.511 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.8 t -132.49 124.86 52.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.5 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.471 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 22.9 ttm180 -117.23 127.73 54.38 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -131.91 147.51 52.47 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.696 -175.156 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 23.0 tptm 81.8 111.79 0.03 OUTLIER Pre-proline 0 C--O 1.236 0.389 0 O-C-N 124.197 0.935 . . . . 0.0 111.056 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.578 ' HB2' HD13 ' A' ' 47' ' ' ILE . 63.3 Cg_endo -78.32 152.28 26.89 Favored 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.299 1.999 . . . . 0.0 112.043 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -87.03 -0.71 57.07 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.134 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 45' ' ' ARG . 49.2 mtt180 -148.67 -164.79 2.11 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 4.1 tp10 -85.58 98.27 10.55 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.582 HG13 HG12 ' A' ' 12' ' ' ILE . 1.8 mp -117.15 114.94 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.083 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 34.0 mmtp -120.38 163.7 17.47 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.72 175.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.486 HG11 ' CB ' ' A' ' 169' ' ' ALA . 11.7 p -120.49 133.44 67.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.647 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.479 ' CE1' ' HB2' ' A' ' 11' ' ' GLN . 42.7 m-85 -82.92 124.39 30.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.925 176.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.403 ' HB3' ' OD1' ' A' ' 174' ' ' ASN . 56.4 m -121.58 175.54 6.16 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.522 HG12 HD11 ' A' ' 176' ' ' ILE . 2.8 mm -127.95 138.51 54.5 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-O 121.491 0.662 . . . . 0.0 110.625 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.749 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.3 t70 -86.59 110.55 19.9 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.432 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.792 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -68.33 -13.16 62.07 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.897 0.879 . . . . 0.0 112.595 -171.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.749 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -98.28 -25.31 14.9 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.868 -175.5 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.538 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.3 p -117.24 -26.56 6.72 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.519 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.15 22.59 44.31 Favored Glycine 0 N--CA 1.426 -1.983 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.055 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.538 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 37.1 mtpt -97.6 155.42 16.98 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.41 ' HA ' HD13 ' A' ' 52' ' ' ILE . 3.9 p -96.95 109.26 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.919 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 m -109.63 162.4 7.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.707 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.4 tp -118.57 142.99 47.08 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -149.81 173.06 14.17 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.067 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -84.46 161.74 20.18 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.614 0.721 . . . . 0.0 110.716 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.5 mp -97.76 144.58 10.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.889 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.559 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.8 mm-40 -88.78 -42.47 11.9 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 p30 178.2 175.81 0.51 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.12 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 14.6 t -108.14 132.22 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.917 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 166' ' ' SER . 17.4 mt -98.52 114.78 37.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.511 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 85.8 tttt -126.13 111.92 15.21 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.8 143.34 48.98 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.358 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.429 ' HD2' HG12 ' A' ' 37' ' ' VAL . 7.0 Cg_endo -52.43 124.04 14.15 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.323 2.682 . . . . 0.0 112.597 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.75 81.9 8.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.367 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.2 m -91.57 -36.37 13.73 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.64 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -85.95 177.98 7.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.447 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -103.96 171.33 7.41 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.1 mt -122.84 140.2 53.2 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.8 0.809 . . . . 0.0 111.24 -174.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.507 HG23 HG23 ' A' ' 154' ' ' ILE . 14.3 mt -86.4 140.17 16.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 31.1 ttt180 -118.23 138.53 52.28 Favored 'General case' 0 N--CA 1.4 -2.972 0 CA-C-O 121.25 0.547 . . . . 0.0 109.741 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 86' ' ' SER . 59.4 m-85 -114.67 123.55 49.57 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.344 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 152' ' ' LYS . 40.6 tt0 -109.93 121.25 44.82 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.679 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -88.4 160.74 17.43 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.64 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.781 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -60.57 -22.57 63.82 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.285 -179.376 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -85.17 -11.2 55.57 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.523 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.85 17.41 44.44 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.823 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.596 ' O ' HD23 ' A' ' 81' ' ' LEU . 2.0 mtt180 -83.99 132.27 34.76 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 50.3 p -138.59 137.86 37.38 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 118.608 -1.237 . . . . 0.0 112.033 176.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.408 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 3.8 p90 -133.31 148.78 51.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.348 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 24.5 mt-10 -119.81 151.24 39.14 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.718 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.474 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.7 OUTLIER -144.11 154.99 43.76 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.728 178.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.706 ' HA ' HD23 ' A' ' 76' ' ' LEU . 2.8 m -75.21 18.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.831 0.824 . . . . 0.0 111.455 -177.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.049 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 71.35 -30.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 125.434 1.493 . . . . 0.0 113.004 175.578 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.64 -5.94 59.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.155 0.502 . . . . 0.0 109.999 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.882 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 48.4 t-80 -87.24 128.84 53.87 Favored Pre-proline 0 CA--C 1.512 -0.484 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.821 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.68 ' HB2' ' O ' ' A' ' 185' ' ' GLN . 64.2 Cg_endo -72.52 141.02 34.03 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.808 2.339 . . . . 0.0 112.469 177.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 10.7 t -118.01 152.29 20.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 124.183 0.993 . . . . 0.0 109.585 -176.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 103' ' ' PHE . 1.6 tm? -101.22 114.35 28.24 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.643 HG13 HG13 ' A' ' 104' ' ' ILE . 2.2 p -114.12 146.91 18.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.411 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -102.94 91.51 4.16 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.246 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 8.2 pt-20 -141.36 158.84 43.35 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 10.5 m120 64.74 22.19 12.52 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.211 0.529 . . . . 0.0 109.625 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.39 16.68 60.88 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.849 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -138.27 172.22 13.22 Favored 'General case' 0 N--CA 1.407 -2.617 0 CA-C-O 121.355 0.598 . . . . 0.0 110.244 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.44 ' HB3' HD11 ' A' ' 96' ' ' LEU . 44.2 m-85 -97.35 121.0 38.75 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.896 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.643 HG13 HG13 ' A' ' 97' ' ' VAL . 30.9 pt -121.77 153.3 25.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.068 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.568 ' HB3' ' O ' ' A' ' 185' ' ' GLN . 28.5 mt-10 -115.92 116.76 28.52 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.907 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.562 ' HG3' HG22 ' A' ' 111' ' ' VAL . 1.1 ptpm? -137.5 145.49 43.07 Favored 'General case' 0 C--O 1.202 -1.41 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.592 ' O ' HG23 ' A' ' 111' ' ' VAL . 77.3 mtt180 -65.27 162.78 16.67 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.049 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -61.69 -40.72 95.98 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.267 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.412 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 2.3 p90 -75.57 1.47 14.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.61 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -111.22 -19.15 12.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.52 0.676 . . . . 0.0 109.493 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 107' ' ' ARG . 85.2 t -72.43 150.17 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -123.66 163.44 21.06 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.571 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -68.92 143.08 54.56 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.68 5.19 74.99 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.325 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.998 ' HB3' HD12 ' A' ' 151' ' ' ILE . 16.8 t70 -71.4 168.36 17.62 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.655 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 48.4 mttp -127.27 152.49 47.35 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 121.452 0.644 . . . . 0.0 110.789 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.408 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -125.29 153.53 32.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.288 175.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.522 ' HA ' ' CD1' ' A' ' 148' ' ' LEU . 0.5 OUTLIER -89.4 134.89 33.88 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.795 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.7 OUTLIER -100.68 145.0 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.978 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 172.093 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 122' ' ' LEU . 40.2 t -64.47 -11.36 32.81 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.475 0.655 . . . . 0.0 109.945 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.664 ' OE2' ' HA ' ' A' ' 146' ' ' ASP . 30.5 mt-10 59.03 -3.4 0.09 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.951 -1.477 . . . . 0.0 112.923 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.457 ' H ' ' C ' ' A' ' 120' ' ' SER . 45.3 tp -110.81 116.57 31.49 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.257 0.551 . . . . 0.0 111.931 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -95.09 178.99 5.36 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.973 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.543 HD21 HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -121.08 21.74 11.19 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.082 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 124' ' ' LEU . 92.5 t 85.46 -44.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.933 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 131' ' ' SER . 36.6 tt0 16.32 85.7 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 O-C-N 125.081 1.488 . . . . 0.0 113.705 175.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -93.65 83.15 4.41 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.194 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.7 m 69.26 -62.24 0.41 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.59 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.4 p -130.84 -29.92 1.86 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.9 0.381 . . . . 0.0 111.507 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.5 p -84.41 104.67 14.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.776 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 126' ' ' GLU . 15.7 m -80.15 -78.94 0.15 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.251 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' O ' ' HD2' ' A' ' 135' ' ' PRO . 60.9 mm-40 -146.26 -110.15 0.09 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.89 -14.66 57.8 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.468 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . 1.6 t-20 -73.06 -47.81 7.96 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.378 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.544 ' HD2' ' O ' ' A' ' 132' ' ' GLN . 11.6 Cg_exo -72.68 -72.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.547 2.165 . . . . 0.0 111.968 176.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 176.57 -57.08 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.041 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -72.59 126.28 29.49 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.362 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -106.92 -54.23 2.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.161 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.7 p30 41.56 -164.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.548 1.139 . . . . 0.0 113.183 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.2 tp -130.72 139.38 50.28 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 121.878 -0.514 . . . . 0.0 110.746 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -139.97 76.86 0.32 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.8 t -49.56 121.25 11.67 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 123.681 0.283 . . . . 0.0 110.463 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.28 -88.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.015 2.477 . . . . 0.0 113.686 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 65.55 34.58 7.75 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.568 0.699 . . . . 0.0 110.454 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.547 ' HB3' ' O ' ' A' ' 121' ' ' GLU . 5.0 t-160 -96.9 121.43 38.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.744 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.664 ' HA ' ' OE2' ' A' ' 121' ' ' GLU . 15.5 t70 -145.79 89.4 1.9 Allowed 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -165.71 142.7 5.48 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.655 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.8 mm? -104.65 144.61 31.48 Favored 'General case' 0 CA--C 1.484 -1.566 0 CA-C-O 121.081 0.467 . . . . 0.0 109.76 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.781 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -116.76 137.97 51.81 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.508 -176.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.53 ' H ' HD13 ' A' ' 149' ' ' LEU . 17.6 mt-10 -89.03 146.38 24.89 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.284 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.998 HD12 ' HB3' ' A' ' 115' ' ' ASP . 81.4 mt -78.58 107.46 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.777 0 CA-C-N 113.407 -1.724 . . . . 0.0 108.969 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 80' ' ' GLU . 8.0 mmpt? -70.23 -39.4 75.12 Favored 'General case' 0 C--N 1.268 -2.977 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.566 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -149.29 133.52 17.35 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 74.3 mt -115.61 127.68 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 CA-C-N 113.668 -1.605 . . . . 0.0 110.927 175.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.5 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 1.6 ptpp? -132.49 163.35 29.01 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.97 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.452 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.0 m-85 -100.98 115.33 30.21 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.434 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -127.38 137.47 57.65 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.585 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.798 -178.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 158' ' ' ARG . 11.0 ptt180 -71.44 160.83 32.05 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.36 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.66 126.86 31.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.043 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -65.43 -37.94 88.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.288 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -106.96 174.84 5.71 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.294 -177.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.56 2.29 51.21 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.396 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -141.95 153.13 44.11 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.199 0.523 . . . . 0.0 110.456 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.14 157.43 31.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.712 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 76.4 m-85 -132.8 165.17 25.19 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.777 0.322 . . . . 0.0 110.51 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.657 ' HB2' HD12 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -146.38 -24.93 0.43 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.882 174.596 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.737 ' HG ' HD23 ' A' ' 24' ' ' LEU . 3.6 mm? 62.68 101.09 0.03 OUTLIER 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.892 0.745 . . . . 0.0 110.645 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.475 ' HB2' HD11 ' A' ' 68' ' ' ILE . 58.6 t30 -83.47 121.17 26.84 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.703 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.559 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -131.28 -157.7 0.84 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -61.93 131.15 48.76 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 81.65 -92.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.525 1.13 . . . . 0.0 110.402 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -144.29 -156.54 0.7 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -77.24 49.07 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 109.755 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' A' ' 183' ' ' THR . 3.7 t-20 -90.15 99.37 12.4 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.216 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.496 HG13 HG23 ' A' ' 177' ' ' ILE . 5.4 p -149.03 164.13 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-O 121.494 0.664 . . . . 0.0 110.767 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.703 HG23 ' HA ' ' A' ' 180' ' ' ASN . 2.4 mp -93.88 115.7 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.489 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.496 HG23 HG13 ' A' ' 175' ' ' VAL . 36.7 pt -118.49 166.41 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-O 120.87 0.367 . . . . 0.0 110.729 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.41 ' HB3' HD12 ' A' ' 181' ' ' ILE . 30.4 t30 47.91 -131.99 1.46 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.187 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -81.52 53.34 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.338 0.589 . . . . 0.0 110.061 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.795 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 13.0 m-80 65.05 46.9 2.65 Favored 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 125.272 1.429 . . . . 0.0 113.194 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' A' ' 178' ' ' ASN . 88.9 mt -91.21 115.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.04 148.55 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-O 122.039 0.923 . . . . 0.0 112.528 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 2.0 t -150.11 152.12 34.24 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.362 175.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -136.25 -74.97 0.43 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.2 0.524 . . . . 0.0 110.969 -177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.68 ' O ' ' HB2' ' A' ' 94' ' ' PRO . 24.2 tt0 . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 116.84 -1.552 . . . . 0.0 108.222 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.532 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 71.4 m . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 121.225 0.536 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -107.29 161.98 21.25 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.611 ' HD3' HD13 ' A' ' 76' ' ' LEU . 57.3 Cg_endo -67.24 158.48 56.74 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 N-CA-C 108.512 -1.38 . . . . 0.0 108.512 177.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.12 -27.42 51.83 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 119.477 -1.344 . . . . 0.0 112.035 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -67.17 -13.23 61.76 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.445 ' HB ' HD12 ' A' ' 21' ' ' LEU . 93.6 m -61.44 125.7 24.71 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.422 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 37.6 mmt-85 -79.73 125.26 29.43 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.811 HD11 HG21 ' A' ' 175' ' ' VAL . 10.4 tt -116.33 129.42 72.79 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 CA-C-O 120.84 0.352 . . . . 0.0 110.245 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.583 HD21 HD11 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -89.34 122.99 33.1 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.63 0.729 . . . . 0.0 110.17 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.2 m -133.03 -179.16 3.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.694 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.409 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 30.9 tt0 -130.97 121.35 24.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.425 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.65 HG12 HG13 ' A' ' 47' ' ' ILE . 15.1 mt -119.96 120.98 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.928 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.598 -177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 54.21 37.22 26.8 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.198 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.01 18.12 80.22 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.829 -1.078 . . . . 0.0 113.529 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -123.58 119.31 27.16 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 43.5 Cg_endo -73.0 121.74 7.54 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.438 2.092 . . . . 0.0 111.291 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -125.75 140.49 52.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.829 -177.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -110.39 102.36 11.0 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.653 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.8 pt -125.43 -171.68 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.642 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.705 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.9 p -96.26 174.39 6.91 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.096 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 62.1 mt -69.87 -31.07 68.7 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.124 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.705 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 3.9 ptm180 -77.34 -25.86 51.51 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.522 ' OE1' HG23 ' A' ' 20' ' ' THR . 84.9 mt-10 -84.73 -40.34 17.41 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.652 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.483 HD21 ' HG ' ' A' ' 167' ' ' LEU . 18.8 tp -59.35 -45.74 90.56 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.746 0.784 . . . . 0.0 109.842 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.512 ' HD1' HG11 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -49.07 -32.55 9.83 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.759 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.9 mt-10 -74.63 -17.26 60.72 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.204 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.54 5.12 13.77 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.501 0.667 . . . . 0.0 109.884 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.526 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.0 m-85 -118.28 164.61 14.94 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.519 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.409 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 5.1 mm-40 -145.8 -172.85 4.0 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.659 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.568 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 18.9 t0 64.88 75.14 0.38 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.602 0.715 . . . . 0.0 109.358 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -102.69 134.28 46.33 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.416 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.492 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.4 ptt180 -127.54 154.54 45.04 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.792 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -105.51 129.9 53.69 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -166.78 153.84 9.05 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.556 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 59.26 21.24 9.41 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 123.49 0.494 . . . . 0.0 110.804 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 45.3 mtm 70.86 16.79 6.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.411 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 6.1 m -131.82 -168.29 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.444 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 79.4 m-85 -116.61 140.06 49.81 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.492 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.3 t -130.32 123.5 55.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.422 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 19.6 ttm180 -118.62 127.03 53.21 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.568 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -131.15 143.33 50.54 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.185 -174.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 40.0 ttmt 79.58 116.42 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 124.158 0.983 . . . . 0.0 111.383 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.598 ' HB2' HD13 ' A' ' 47' ' ' ILE . 68.6 Cg_endo -79.47 160.31 25.58 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 C-N-CA 122.494 2.129 . . . . 0.0 112.57 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.409 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 34.2 mtmt -88.19 -3.19 58.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.534 0.683 . . . . 0.0 110.351 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.469 ' HB2' HD12 ' A' ' 47' ' ' ILE . 64.8 mtt180 -142.11 -165.28 1.98 Allowed 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 10.1 tp10 -89.21 100.87 13.56 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 171.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.65 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -114.29 117.46 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.175 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 17.7 mmtm -115.86 166.17 12.27 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.976 174.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.566 HG13 HD11 ' A' ' 64' ' ' ILE . 3.3 m -117.58 130.38 72.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.258 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.57 ' HB3' HD12 ' A' ' 176' ' ' ILE . 3.2 m-85 -79.35 121.86 25.66 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 172.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.0 t -133.59 177.03 8.02 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 58' ' ' LYS . 2.1 mm -131.21 142.18 44.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.332 0.587 . . . . 0.0 110.65 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.583 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.1 t70 -81.43 118.33 22.61 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.729 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -72.52 -12.74 61.2 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -170.277 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.583 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -103.4 -26.9 12.72 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.179 -176.097 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.0 p -116.77 -20.54 9.45 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.849 -0.741 . . . . 0.0 111.872 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.95 11.84 82.03 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.015 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.477 ' O ' HD13 ' A' ' 52' ' ' ILE . 3.3 mptp? -75.97 145.83 40.04 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 122.693 0.397 . . . . 0.0 111.366 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.451 ' HA ' HD13 ' A' ' 52' ' ' ILE . 4.7 p -90.15 106.72 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 121.993 0.901 . . . . 0.0 109.324 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 m -110.16 155.8 11.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.159 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 49' ' ' VAL . 10.2 tp -122.11 134.25 54.76 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.595 HG21 ' HB2' ' A' ' 170' ' ' LYS . 14.7 t -144.91 172.39 13.1 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.817 -176.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -84.28 162.3 20.16 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.787 0.804 . . . . 0.0 111.515 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 49' ' ' VAL . 2.8 mp -95.95 144.96 9.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.692 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.537 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 29.7 mm-40 -89.65 -39.91 12.91 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 p30 176.88 174.92 0.39 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.959 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.526 ' HA ' HD22 ' A' ' 167' ' ' LEU . 14.7 t -105.04 129.26 58.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.257 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.71 HD12 ' HB2' ' A' ' 166' ' ' SER . 51.2 mt -91.76 104.96 16.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.474 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.549 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.2 tttt -121.3 109.17 14.6 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.5 139.58 35.18 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.215 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.507 ' HD2' HG12 ' A' ' 37' ' ' VAL . 97.0 Cg_exo -44.76 124.3 5.5 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 123.471 2.781 . . . . 0.0 112.736 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.59 78.4 9.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.711 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.4 p -84.86 -53.03 5.59 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.931 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.6 171.37 14.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.218 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -102.68 171.55 7.36 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.681 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.2 mt -127.43 143.29 51.23 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.651 0.739 . . . . 0.0 111.673 -173.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.499 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 23.6 mt -86.62 143.02 12.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 173.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 34.5 ttt85 -118.03 138.72 52.03 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.178 0.514 . . . . 0.0 109.999 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.1 m-85 -116.71 123.3 46.88 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.888 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 152' ' ' LYS . 32.5 tt0 -109.87 125.53 52.88 Favored 'General case' 0 CA--C 1.471 -2.058 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.756 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.13 160.02 17.96 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.325 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.806 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.0 pt-20 -61.6 -15.99 44.17 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.113 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -98.06 -6.04 32.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.791 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.3 12.44 56.13 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.164 -0.926 . . . . 0.0 113.759 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.544 ' O ' HD23 ' A' ' 81' ' ' LEU . 3.5 mtt180 -82.97 141.79 31.85 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.8 p -144.22 141.26 29.76 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.972 -1.091 . . . . 0.0 113.497 175.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -138.49 155.99 47.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.613 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 87.0 mt-10 -129.97 153.98 47.83 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.17 0.51 . . . . 0.0 112.265 -177.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.9 OUTLIER -148.51 161.23 42.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.658 178.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.681 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -70.83 10.45 0.52 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.42 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.044 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 72.69 -27.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 124.838 1.255 . . . . 0.0 112.205 177.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.554 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 0.8 OUTLIER -78.75 -10.84 59.91 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.243 0.544 . . . . 0.0 109.807 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -97.14 140.92 22.34 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.367 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 89.3 Cg_endo -79.49 137.87 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.249 2.633 . . . . 0.0 113.699 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.5 t -105.09 147.2 11.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.0 tp -105.39 110.38 22.71 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.716 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.513 HG13 HG13 ' A' ' 104' ' ' ILE . 2.5 p -110.87 153.56 12.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.496 0.665 . . . . 0.0 111.531 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -104.21 93.74 4.99 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.258 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.0 pt-20 -143.26 158.48 43.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.3 m-20 64.15 21.85 12.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.17 13.77 60.53 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.803 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -135.2 172.37 13.11 Favored 'General case' 0 N--CA 1.401 -2.885 0 CA-C-O 121.165 0.507 . . . . 0.0 109.93 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -100.94 121.27 41.46 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.513 HG13 HG13 ' A' ' 97' ' ' VAL . 25.1 pt -119.27 141.67 38.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.197 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -97.09 114.49 26.15 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.14 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.492 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 13.9 ptpt -128.59 135.36 49.24 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.958 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.618 ' O ' HG23 ' A' ' 111' ' ' VAL . 11.5 mmt180 -62.0 159.22 14.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.044 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -57.92 -43.03 85.99 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.222 -176.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.477 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.7 p90 -73.01 -0.21 13.17 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.177 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -110.63 -15.3 13.89 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.606 0.717 . . . . 0.0 109.848 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 107' ' ' ARG . 89.5 t -77.84 149.43 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.691 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 13.8 mtmt -123.24 164.88 17.89 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.994 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -66.98 141.36 57.62 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.66 77.93 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.895 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.691 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -75.04 168.55 19.76 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.4 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.707 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 72.2 mttt -124.18 161.57 25.44 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.339 0.59 . . . . 0.0 112.076 -177.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.11 156.37 39.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.417 172.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.63 ' HG ' HD11 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -95.86 138.29 33.71 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 123.228 0.33 . . . . 0.0 110.571 -178.282 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.782 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.0 m -100.65 145.1 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.516 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 1.7 m -69.28 25.25 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.122 -176.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.639 ' HA ' ' HB2' ' A' ' 145' ' ' HIS . 21.6 mt-10 59.39 15.13 4.17 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 124.021 0.928 . . . . 0.0 112.274 -177.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.511 ' CD2' ' HA ' ' A' ' 125' ' ' VAL . 0.4 OUTLIER 63.54 -174.3 0.16 Allowed 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.349 175.249 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.4 ' HB3' ' H ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -174.98 -96.06 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.203 -179.06 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.583 HD11 HD21 ' A' ' 9' ' ' LEU . 2.3 pt? -55.03 -45.26 75.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.636 0.374 . . . . 0.0 110.956 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.519 HG12 ' HG2' ' A' ' 126' ' ' GLU . 91.9 t 113.2 -93.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.388 1.875 . . . . 0.0 111.203 173.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.519 ' HG2' HG12 ' A' ' 125' ' ' VAL . 12.9 pt-20 -154.16 -178.16 6.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 118.411 0.55 . . . . 0.0 111.165 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -142.6 145.03 33.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.413 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.4 p -142.43 142.38 32.35 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 121.23 -0.188 . . . . 0.0 111.095 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.4 m 66.6 177.26 0.23 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.793 0.683 . . . . 0.0 111.695 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.4 m -75.55 94.75 3.21 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 t -79.78 125.23 29.41 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.274 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -88.22 -17.84 29.94 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -88.23 128.48 35.46 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.887 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -83.29 -47.54 0.79 Allowed Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.993 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -79.03 -163.29 0.21 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.832 2.355 . . . . 0.0 112.329 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -178.48 117.83 0.08 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.646 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -162.07 -102.38 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.855 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 54.6 -96.89 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.222 0.609 . . . . 0.0 111.265 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -82.71 166.18 19.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.975 0.417 . . . . 0.0 110.656 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.5 tp -70.11 132.96 46.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.914 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -122.22 62.34 0.54 Allowed Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.182 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 10.4 t -64.44 118.53 48.2 Favored Pre-proline 0 N--CA 1.446 -0.645 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.464 ' CB ' ' HB3' ' A' ' 122' ' ' LEU . 6.3 Cg_exo -78.1 160.71 29.86 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.645 2.23 . . . . 0.0 112.516 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -90.54 105.52 17.87 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.639 ' HB2' ' HA ' ' A' ' 121' ' ' GLU . 13.2 p80 -131.64 -162.31 1.21 Allowed 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 44.93 69.69 0.41 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.128 0.971 . . . . 0.0 112.238 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -162.34 151.29 15.25 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.728 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.707 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 4.1 mm? -108.45 137.79 45.83 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-O 121.112 0.482 . . . . 0.0 110.309 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.806 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -111.96 133.29 54.23 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.164 -177.827 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 20.2 mt-10 -86.02 143.61 28.02 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.111 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.48 HD13 ' CD1' ' A' ' 79' ' ' PHE . 69.5 mt -81.48 102.65 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.077 174.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.532 ' HE2' ' HB2' ' A' ' 82' ' ' GLU . 50.9 mmtt -66.1 -38.63 88.71 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.252 177.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -147.87 129.22 14.79 Favored 'General case' 0 CA--C 1.476 -1.882 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 72.1 mt -112.81 143.48 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.324 174.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.463 ' HD2' ' HD3' ' A' ' 78' ' ' ARG . 19.7 ptpt -149.13 161.31 42.24 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.355 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.499 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 17.7 m-85 -101.8 115.01 29.59 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.54 174.61 10.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.237 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.06 159.02 16.03 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.436 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.44 129.75 40.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.354 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -64.15 -42.12 96.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.972 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -101.02 175.89 5.45 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.041 0.448 . . . . 0.0 111.156 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.63 3.68 51.86 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.02 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -141.38 151.16 43.26 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.786 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.6 m -121.28 157.27 24.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 72.2 m-85 -132.98 172.11 13.06 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.89 0.376 . . . . 0.0 110.388 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.71 ' HB2' HD12 ' A' ' 68' ' ' ILE . 51.9 m -156.18 -22.17 0.1 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.526 HD22 ' HA ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER 63.36 104.35 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.236 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -85.22 115.68 23.13 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.302 -176.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.537 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -125.63 -149.54 0.42 Allowed 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.595 ' HB2' HG21 ' A' ' 62' ' ' THR . 0.4 OUTLIER -61.0 141.09 57.62 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.088 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.459 ' HB2' ' OD1' ' A' ' 174' ' ' ASN . 63.0 mttp 70.36 -117.62 0.1 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.397 -173.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -150.05 116.87 5.88 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 38.19 30.4 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 125.469 1.508 . . . . 0.0 114.975 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.459 ' OD1' ' HB2' ' A' ' 171' ' ' LYS . 1.7 p-10 -95.29 104.66 16.56 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.097 0.475 . . . . 0.0 110.229 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.811 HG21 HD11 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -144.86 164.07 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 121.354 0.597 . . . . 0.0 111.444 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.617 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.3 mt -95.55 120.78 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.456 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 39.1 pt -125.01 166.93 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.51 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 52.81 -134.97 1.59 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.921 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.19 51.58 2.23 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.602 0.715 . . . . 0.0 109.572 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.782 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 20.6 m-80 71.92 53.23 0.2 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.525 177.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 97.2 mt -93.78 116.17 34.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.5 m -82.86 159.06 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.538 0.685 . . . . 0.0 111.861 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.9 t -168.79 144.76 3.51 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.785 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -178.32 145.15 0.33 Allowed 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--O 1.256 1.401 0 CA-C-O 117.618 -1.182 . . . . 0.0 110.742 177.844 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 93.5 m . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.368 0.604 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.481 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 34.8 m-85 -114.61 157.87 41.72 Favored Pre-proline 0 N--CA 1.434 -1.233 0 CA-C-N 114.843 -1.072 . . . . 0.0 108.485 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.539 ' HD3' HD13 ' A' ' 76' ' ' LEU . 19.1 Cg_endo -59.4 -35.34 96.65 Favored 'Trans proline' 0 N--CA 1.48 0.688 0 C-N-CA 123.129 2.553 . . . . 0.0 112.21 -177.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.719 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 132.76 -35.78 2.27 Favored Glycine 0 N--CA 1.413 -2.857 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -177.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.07 -17.03 61.83 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.395 0.617 . . . . 0.0 111.11 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 69.0 m -61.15 125.19 22.84 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.584 177.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.5 mmt180 -86.09 132.95 33.92 Favored 'General case' 0 C--O 1.183 -2.43 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.496 ' HB ' ' CD2' ' A' ' 21' ' ' LEU . 9.5 tt -118.92 131.74 70.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 C-N-CA 122.556 0.342 . . . . 0.0 110.159 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.548 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -84.59 124.86 31.9 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.29 0.567 . . . . 0.0 109.588 178.214 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 30.5 m -136.67 -179.47 2.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.778 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.585 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 30.1 tt0 -131.99 121.57 24.14 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.139 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.651 HG12 HG13 ' A' ' 47' ' ' ILE . 14.7 mt -121.07 119.81 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.962 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 53.53 41.87 32.02 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.898 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.12 17.88 76.07 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.589 -1.187 . . . . 0.0 113.442 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -123.6 116.15 28.06 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 34.7 Cg_endo -73.25 126.24 10.91 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 122.38 2.053 . . . . 0.0 111.402 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -127.47 142.27 51.45 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.554 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -106.16 101.07 10.58 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.3 pt -122.83 -175.55 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.179 -2.637 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.012 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.867 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.3 p -90.62 174.65 7.39 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.52 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.652 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.5 mm? -71.68 -23.75 61.71 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.984 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.867 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 15.7 ptt180 -85.59 -23.82 27.43 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.444 ' OE1' HG23 ' A' ' 20' ' ' THR . 49.8 mt-10 -83.71 -42.12 16.94 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.977 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.511 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 14.3 tp -56.18 -43.59 78.57 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.769 0.795 . . . . 0.0 109.099 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.496 ' CD1' HG11 ' A' ' 67' ' ' VAL . 7.1 t80 -52.46 -35.5 52.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.512 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 6.4 mm-40 -69.22 -21.71 63.92 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -79.51 4.16 16.54 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.57 0.7 . . . . 0.0 110.139 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.52 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 93.3 m-85 -117.16 160.17 21.46 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.049 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 44' ' ' LYS . 6.7 tt0 -139.84 -176.61 4.64 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t0 64.02 85.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.178 0.513 . . . . 0.0 111.082 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -101.39 131.37 47.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.936 0.874 . . . . 0.0 111.051 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -122.6 152.55 40.33 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.942 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.443 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 35.9 t80 -99.46 129.93 45.68 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -167.15 147.11 5.41 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.609 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 59.41 20.43 8.76 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 123.702 0.626 . . . . 0.0 111.027 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.443 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 39.1 mtp 72.37 17.8 4.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.488 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 13.7 m -133.28 -172.27 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -114.76 142.52 46.4 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-O 121.47 0.652 . . . . 0.0 110.158 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 t -128.71 122.02 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.095 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 28' ' ' PHE . 17.5 ttm180 -111.77 126.66 55.31 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.46 141.78 48.96 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -173.814 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 3.2 ttmp? 83.95 113.09 0.03 OUTLIER Pre-proline 0 CA--C 1.503 -0.833 0 O-C-N 124.812 1.32 . . . . 0.0 111.378 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.603 ' HB2' HD13 ' A' ' 47' ' ' ILE . 74.3 Cg_endo -77.07 155.28 33.52 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 C-N-CA 122.447 2.098 . . . . 0.0 111.807 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 29' ' ' GLU . 37.3 mtmt -87.01 -2.28 58.51 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.371 0.605 . . . . 0.0 110.678 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -147.6 -168.05 2.96 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 40.9 tt0 -85.26 101.41 12.5 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.651 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -115.58 118.2 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.995 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 67.3 mmtt -114.39 169.64 8.89 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.335 174.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.436 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.1 p -124.99 131.09 73.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.795 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.543 ' CD2' HD12 ' A' ' 9' ' ' LEU . 14.2 m-85 -86.16 120.46 27.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.106 0.479 . . . . 0.0 110.306 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.8 t -130.22 176.2 8.3 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.586 HG12 HD11 ' A' ' 176' ' ' ILE . 3.3 mm -116.83 142.25 31.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.536 0.684 . . . . 0.0 111.027 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.688 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 14.9 t70 -77.7 120.32 22.47 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.527 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.726 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -75.54 -8.41 56.68 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.764 -170.443 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.688 ' HG3' ' OD1' ' A' ' 53' ' ' ASP . 2.6 pt-20 -108.18 -25.77 10.92 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.045 -0.662 . . . . 0.0 112.079 -177.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.497 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 70.4 p -117.84 -25.23 6.86 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.772 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.47 12.72 66.71 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.254 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.497 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 40.7 mtpt -87.97 162.97 16.56 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.449 HG22 ' OG ' ' A' ' 120' ' ' SER . 33.5 t -86.67 113.25 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.216 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -110.77 151.78 12.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.088 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 49' ' ' VAL . 10.2 tp -122.86 140.26 53.15 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.7 t -148.91 170.54 18.06 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.814 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.83 161.16 26.97 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.522 0.677 . . . . 0.0 110.524 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.2 mp -96.28 148.14 5.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.84 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.491 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.9 mm-40 -93.09 -42.68 9.27 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 p30 179.59 178.97 0.51 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.72 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.496 HG11 ' CD1' ' A' ' 25' ' ' TYR . 7.6 t -107.55 134.21 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.009 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.654 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 42.9 mt -91.69 99.73 10.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.701 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 84.8 tttt -113.49 107.34 15.69 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.06 136.18 28.64 Favored Pre-proline 0 C--N 1.306 -1.297 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.502 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -48.66 129.4 20.3 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.167 2.578 . . . . 0.0 112.013 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.24 86.94 3.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.07 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.2 m -98.79 -33.16 11.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.436 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.92 167.15 12.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.076 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -100.15 172.84 6.93 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.747 HD23 ' HA ' ' A' ' 90' ' ' THR . 14.9 mt -125.89 145.56 50.21 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.911 0.862 . . . . 0.0 111.907 -174.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.499 HD12 ' C ' ' A' ' 108' ' ' ALA . 13.6 mt -91.91 144.13 9.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.444 172.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 13.0 ttt85 -115.92 137.93 51.65 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.541 ' CD1' HD13 ' A' ' 151' ' ' ILE . 65.7 m-85 -115.85 124.48 50.77 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.548 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.2 tt0 -113.1 125.06 53.96 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.755 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -90.08 162.2 15.44 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.356 -177.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.899 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.7 pt-20 -62.78 -15.63 54.45 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.256 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.73 -12.68 28.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.716 0.77 . . . . 0.0 109.729 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.42 10.1 57.26 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.347 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.624 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -85.12 141.34 30.29 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.729 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 44.3 p -140.84 151.86 44.68 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.919 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -145.83 153.72 41.21 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.244 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 23.6 mt-10 -124.22 149.66 46.16 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.323 -178.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -144.0 159.6 42.31 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.439 178.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.747 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -68.37 11.33 0.17 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.67 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.988 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.6 OUTLIER 69.65 -38.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 124.843 1.257 . . . . 0.0 112.059 178.787 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 90' ' ' THR . 16.3 t70 -69.48 -37.55 77.3 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.422 0.629 . . . . 0.0 109.41 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.478 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 37.0 m80 -72.45 131.18 84.96 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.584 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 30.9 Cg_exo -63.65 142.49 83.92 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 123.975 3.117 . . . . 0.0 114.762 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.32 147.85 14.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.475 HD22 ' O ' ' A' ' 184' ' ' HIS . 10.1 tp -100.49 109.92 22.07 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.816 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.642 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.6 p -112.24 150.33 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 121.404 0.621 . . . . 0.0 112.046 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -103.04 92.0 4.36 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.472 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.441 ' CD ' HD11 ' A' ' 104' ' ' ILE . 9.1 pt-20 -139.34 158.4 44.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 90.2 m-20 63.25 22.98 13.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.125 0.488 . . . . 0.0 110.07 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.68 14.7 60.9 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.809 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -135.98 171.71 14.07 Favored 'General case' 0 N--CA 1.4 -2.956 0 CA-C-O 121.217 0.532 . . . . 0.0 110.047 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.603 ' CE1' HD11 ' A' ' 118' ' ' LEU . 32.6 m-85 -103.91 121.74 43.74 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.701 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.441 HD11 ' CD ' ' A' ' 99' ' ' GLU . 23.6 pt -124.44 152.64 30.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.476 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.437 ' HG2' ' CD1' ' A' ' 96' ' ' LEU . 31.8 mt-10 -104.87 110.86 23.4 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.591 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HG3' HG22 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -124.3 139.53 53.83 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.134 176.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 5.3 mtp180 -60.79 156.1 17.89 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -176.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.988 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -59.77 -41.06 90.22 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.973 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.483 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 3.0 p90 -74.13 5.76 4.09 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.435 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -115.31 -18.55 11.04 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.471 0.653 . . . . 0.0 109.712 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 107' ' ' ARG . 79.5 t -71.55 150.33 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.005 0.922 . . . . 0.0 108.899 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.748 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.8 OUTLIER -114.17 165.01 13.1 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 120.814 0.34 . . . . 0.0 110.467 -177.113 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -74.24 142.88 45.31 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.409 ' O ' ' HG2' ' A' ' 150' ' ' GLU . . . 86.05 5.63 83.02 Favored Glycine 0 C--N 1.3 -1.462 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.488 -174.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.748 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -75.3 175.19 8.6 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.677 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 49.8 mttp -130.36 162.59 28.75 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.75 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.74 158.72 42.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.378 173.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.603 HD11 ' CE1' ' A' ' 103' ' ' PHE . 2.4 mt -88.81 140.04 29.85 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.79 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -101.46 149.2 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.455 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.191 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.645 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 47.4 t -69.54 13.85 0.12 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.446 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 119' ' ' VAL . 7.6 mm-40 63.8 -36.91 0.17 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.349 1.059 . . . . 0.0 113.769 -177.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 125' ' ' VAL . 31.7 tp -167.84 133.11 1.89 Allowed 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.976 -0.453 . . . . 0.0 110.5 -173.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.465 ' HB2' HD23 ' A' ' 124' ' ' LEU . 8.2 pt-20 -89.1 -124.05 0.06 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.097 176.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.608 ' H ' HD23 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -82.65 20.91 1.05 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.042 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.43 ' HA ' HD11 ' A' ' 122' ' ' LEU . 3.4 t 62.06 14.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.652 178.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 68.74 171.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.711 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 55.75 92.81 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.216 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.0 t -61.46 -45.01 96.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.473 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.2 t -176.2 178.11 1.45 Allowed 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.3 p -97.17 -4.97 38.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.362 0.601 . . . . 0.0 109.712 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.8 p -153.03 -177.52 6.34 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.491 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 66.7 91.58 0.08 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.266 0.555 . . . . 0.0 109.883 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -69.19 92.25 0.55 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.839 0.828 . . . . 0.0 111.63 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.423 ' N ' ' CD ' ' A' ' 135' ' ' PRO . 65.1 t30 -96.16 -45.11 0.26 Allowed Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.322 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 134' ' ' ASN . 12.2 Cg_exo -72.11 -169.61 0.47 Allowed 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.631 2.221 . . . . 0.0 112.099 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -99.34 -11.37 21.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -159.0 151.25 21.28 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.427 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -88.76 84.14 6.69 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -144.73 -174.2 4.27 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.356 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.457 ' H ' HD23 ' A' ' 140' ' ' LEU . 2.6 pt? -142.58 156.11 45.06 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.232 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -135.36 70.25 0.51 Allowed Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.4 m -43.93 118.88 3.09 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.464 1.106 . . . . 0.0 113.439 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.81 171.19 11.37 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.137 2.558 . . . . 0.0 110.893 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -120.51 -70.31 0.79 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.282 -0.261 . . . . 0.0 111.296 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 79.33 162.06 0.19 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 176.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.1 t70 66.03 41.48 3.63 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.855 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -163.85 130.14 3.14 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.101 -175.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.677 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.8 mm? -100.01 133.44 44.39 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.899 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -101.91 132.01 47.96 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 8.6 mt-10 -85.17 140.31 31.02 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.521 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.541 HD13 ' CD1' ' A' ' 79' ' ' PHE . 62.2 mt -78.97 102.26 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.827 0 CA-C-N 113.635 -1.62 . . . . 0.0 109.326 174.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.452 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 6.3 mmpt? -65.64 -37.96 88.02 Favored 'General case' 0 C--N 1.268 -2.948 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.936 178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -149.1 131.28 15.46 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 70.3 mt -115.7 144.76 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.528 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.414 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 18.9 ptpt -150.54 161.2 43.02 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.055 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -99.56 113.06 25.23 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-O 121.379 0.609 . . . . 0.0 109.602 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.56 132.89 70.7 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.439 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -71.47 154.27 41.63 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.75 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.54 123.53 20.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.062 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -85.9 42.57 0.98 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.097 0.475 . . . . 0.0 110.883 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -163.15 -179.34 6.6 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -107.04 -8.73 16.44 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.214 0.531 . . . . 0.0 109.783 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.58 162.13 35.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.247 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.5 m -132.73 162.45 39.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.838 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.654 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 62.8 m-85 -138.95 166.01 25.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.94 -175.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.68 -22.75 0.14 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.511 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER 70.95 110.62 0.06 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.784 176.112 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -90.1 115.59 27.47 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.649 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.491 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.81 -162.76 1.2 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 172' ' ' TYR . 20.3 ttmt -63.27 119.55 9.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.669 0.271 . . . . 0.0 110.708 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 52.7 tttm 75.86 -25.93 0.2 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.258 1.023 . . . . 0.0 111.06 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.432 ' H ' ' C ' ' A' ' 170' ' ' LYS . 45.5 p90 45.3 -162.01 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.899 1.279 . . . . 0.0 113.164 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 76.61 -53.27 0.59 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.804 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.613 HD21 HG13 ' A' ' 182' ' ' VAL . 27.1 t-20 -99.4 133.42 43.73 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.705 0.288 . . . . 0.0 111.146 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.439 HG21 HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -155.53 148.19 12.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.484 178.725 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 52' ' ' ILE . 47.3 mt -92.2 116.25 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.988 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 25.1 pt -123.27 164.72 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.535 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 23.6 t30 46.34 -134.13 0.95 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 124.532 1.133 . . . . 0.0 110.958 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.52 55.87 2.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.494 0.664 . . . . 0.0 110.38 176.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.79 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 27.8 m-80 63.38 49.14 3.29 Favored 'General case' 0 C--O 1.209 -1.078 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.806 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.471 ' HB ' HG13 ' A' ' 177' ' ' ILE . 96.0 mt -86.78 111.68 21.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.613 HG13 HD21 ' A' ' 174' ' ' ASN . 74.1 t -84.81 117.84 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.889 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.7 p -118.57 146.28 44.72 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.6 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.475 ' O ' HD22 ' A' ' 96' ' ' LEU . 50.4 m80 63.07 166.19 0.12 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.498 0.666 . . . . 0.0 111.351 -177.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 . . . . . 0 C--O 1.268 2.057 0 CA-C-O 116.95 -1.5 . . . . 0.0 108.837 174.286 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 89' ' ' THR . 81.9 m . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.894 0.378 . . . . 0.0 111.051 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.464 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 23.3 m-85 -130.99 155.93 80.85 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.566 ' HA ' HG12 ' A' ' 164' ' ' VAL . 21.0 Cg_endo -58.54 -32.28 96.21 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.146 2.564 . . . . 0.0 113.155 -175.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 126.34 -36.25 2.74 Favored Glycine 0 N--CA 1.426 -1.968 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.71 -15.25 63.55 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.38 0.61 . . . . 0.0 110.571 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 71.9 m -60.08 128.19 35.57 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.055 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.705 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 82.0 mtm-85 -86.51 137.81 32.23 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.758 HD11 HG21 ' A' ' 175' ' ' VAL . 10.0 tt -123.6 132.82 70.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.261 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.004 HD21 HD11 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -87.38 124.61 33.57 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-O 121.464 0.65 . . . . 0.0 109.853 178.514 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.435 ' N ' HD13 ' A' ' 9' ' ' LEU . 25.1 m -136.26 -179.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.549 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 32.2 tt0 -129.78 119.61 23.69 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.628 HG12 HG13 ' A' ' 47' ' ' ILE . 15.9 mt -119.53 121.47 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.9 -177.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.8 37.45 28.52 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.518 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.8 17.43 80.09 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.664 -1.153 . . . . 0.0 114.195 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.9 t -122.79 120.67 27.62 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.794 ' HB2' HD13 ' A' ' 124' ' ' LEU . 58.9 Cg_endo -74.23 119.92 6.03 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 122.064 1.842 . . . . 0.0 110.475 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -123.97 143.08 50.62 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.498 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -113.35 100.75 8.79 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -122.1 -172.34 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.618 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.749 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 19.2 p -95.4 169.75 9.84 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.941 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 15.1 mt -71.07 -22.63 62.09 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.099 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.749 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.5 ptm180 -83.73 -25.34 30.66 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' OE1' HG23 ' A' ' 20' ' ' THR . 67.6 mt-10 -84.69 -43.14 14.62 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.239 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.478 HD21 ' HG ' ' A' ' 167' ' ' LEU . 20.1 tp -56.24 -43.31 78.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.906 0.86 . . . . 0.0 109.085 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.434 ' HD1' HG11 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -51.92 -32.56 33.4 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.367 179.111 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 29.6 mt-10 -74.94 -16.98 60.62 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.302 -177.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.6 mm? -77.44 0.4 22.76 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 121.322 0.582 . . . . 0.0 109.455 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.526 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 98.1 m-85 -117.64 161.25 19.95 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.404 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.646 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 23.6 mt-10 -136.21 -172.28 3.09 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.117 175.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.487 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 12.3 t0 61.83 75.9 0.39 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.434 0.635 . . . . 0.0 110.558 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 25.1 tt0 -100.3 131.72 46.08 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.404 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 11.8 ptt180 -131.41 145.42 51.8 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.517 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -88.04 128.01 35.4 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.546 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -167.09 147.78 5.64 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.396 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 60.11 22.96 12.21 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 123.341 0.401 . . . . 0.0 110.683 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 38.3 mtm 71.98 16.14 5.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.612 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.2 m -134.74 -174.31 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -113.48 140.81 47.8 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.409 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.4 t -127.17 122.48 60.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.658 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.471 ' HD3' ' O ' ' A' ' 28' ' ' PHE . 17.6 ttm180 -113.21 126.61 55.61 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.487 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -133.63 146.94 51.37 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.387 -174.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? 83.16 110.37 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.422 0 O-C-N 124.444 1.09 . . . . 0.0 110.364 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.598 ' HB2' HD13 ' A' ' 47' ' ' ILE . 73.4 Cg_endo -79.12 152.14 24.08 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.45 2.1 . . . . 0.0 112.344 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.646 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 34.7 mtmt -81.92 -4.15 55.92 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.015 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -147.66 -165.62 2.3 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.14 103.86 16.15 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.628 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -116.59 118.61 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.621 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 47.3 mmtt -115.65 168.04 10.38 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.169 173.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.442 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.3 p -123.41 130.39 74.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.298 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.405 ' CE2' ' HB2' ' A' ' 11' ' ' GLN . 5.1 m-85 -83.57 123.67 30.0 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 p -134.76 172.8 12.45 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.488 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.521 HG12 HD11 ' A' ' 176' ' ' ILE . 3.1 mm -119.23 142.41 34.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.176 0.513 . . . . 0.0 110.054 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.699 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 25.5 t70 -76.0 122.59 24.42 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.606 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.726 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -75.71 -9.81 58.91 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.643 -170.424 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.699 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.8 pt-20 -106.59 -26.94 11.15 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.867 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.434 ' HB ' ' HD3' ' A' ' 58' ' ' LYS . 69.0 p -118.1 -25.39 6.69 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.783 -176.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.49 10.88 69.81 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.002 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.451 ' HD2' ' N ' ' A' ' 58' ' ' LYS . 2.2 mptp? -78.51 154.2 30.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.022 0.439 . . . . 0.0 111.771 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.487 HG11 HD22 ' A' ' 122' ' ' LEU . 2.8 p -91.0 104.87 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 121.833 0.825 . . . . 0.0 110.565 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.5 m -110.97 157.7 11.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.243 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 49' ' ' VAL . 12.6 tp -116.45 137.82 51.86 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.6 t -143.93 172.47 12.81 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.281 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.29 161.55 19.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.63 0.728 . . . . 0.0 111.356 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.9 mp -100.23 140.75 18.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.519 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.496 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 27.5 mm-40 -92.26 -34.54 14.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.263 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 p30 175.89 176.75 0.23 Allowed 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.175 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.539 ' HA ' HD22 ' A' ' 167' ' ' LEU . 13.6 t -106.89 129.77 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.798 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 36.4 mt -91.13 111.79 24.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.805 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.466 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.1 tttt -127.65 110.29 12.53 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 163' ' ' PHE . . . -129.04 142.08 43.95 Favored Pre-proline 0 C--N 1.309 -1.161 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.442 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -53.87 124.14 15.16 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.115 2.544 . . . . 0.0 111.671 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.0 89.38 7.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.774 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.3 m -103.96 -29.27 11.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.194 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -85.58 166.98 15.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.724 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.496 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 28.7 m170 -98.01 171.69 8.1 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.724 HD23 ' HA ' ' A' ' 90' ' ' THR . 37.0 mt -126.71 140.12 52.64 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.569 0.699 . . . . 0.0 111.643 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.53 HD12 ' C ' ' A' ' 108' ' ' ALA . 44.8 mt -87.73 142.55 12.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 172.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 21.3 ttt180 -122.45 137.26 54.93 Favored 'General case' 0 N--CA 1.398 -3.067 0 CA-C-O 121.308 0.575 . . . . 0.0 109.902 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 86' ' ' SER . 55.0 m-85 -113.47 121.98 45.9 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.774 -177.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 152' ' ' LYS . 44.1 tt0 -108.4 127.42 53.88 Favored 'General case' 0 CA--C 1.474 -1.956 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.733 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -89.82 159.09 17.18 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-O 121.21 0.529 . . . . 0.0 111.936 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.827 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -60.15 -16.98 37.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.754 -178.515 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.642 ' OD1' ' HG3' ' A' ' 85' ' ' ARG . 38.3 p-10 -109.29 0.72 19.7 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.436 0.636 . . . . 0.0 111.065 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.49 19.47 25.2 Favored Glycine 0 C--N 1.309 -0.963 0 N-CA-C 116.511 1.364 . . . . 0.0 116.511 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.642 ' HG3' ' OD1' ' A' ' 83' ' ' ASP . 11.5 mtt180 -86.89 143.28 27.49 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 90.1 p -140.93 138.09 33.59 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 118.728 -1.189 . . . . 0.0 112.155 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.416 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 6.5 p90 -133.37 138.69 46.42 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.962 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.503 ' OE2' ' HG3' ' A' ' 78' ' ' ARG . 43.4 mp0 -115.02 147.94 39.49 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.769 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 1.1 p -140.79 155.72 46.33 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.945 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.724 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -76.33 12.14 1.32 Allowed 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 122.79 0.436 . . . . 0.0 112.04 -177.116 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.041 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.8 m 61.29 170.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 19.4 t70 72.17 -34.92 0.31 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.069 0.461 . . . . 0.0 110.814 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.511 ' HB3' ' HE2' ' A' ' 184' ' ' HIS . 47.6 m-70 -76.31 128.21 83.08 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.309 175.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 18.2 Cg_exo -67.47 127.52 16.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.284 2.656 . . . . 0.0 114.322 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.5 t -96.75 151.3 4.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.421 HD13 ' C ' ' A' ' 184' ' ' HIS . 7.2 tp -102.15 106.41 17.25 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.817 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.568 HG21 ' OD1' ' A' ' 115' ' ' ASP . 1.9 p -110.35 148.99 13.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.315 0.579 . . . . 0.0 111.338 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.509 ' CD2' HD12 ' A' ' 148' ' ' LEU . 61.8 t80 -104.47 92.55 4.36 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.111 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.554 ' CG ' HD11 ' A' ' 104' ' ' ILE . 8.3 pt-20 -136.06 158.37 44.56 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 82.4 m-20 62.78 22.6 13.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 110.347 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.44 15.19 58.88 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.238 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -132.94 171.95 13.26 Favored 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 117.71 0.755 . . . . 0.0 109.446 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -102.51 120.12 39.99 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.579 HG13 ' HE2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -125.03 144.66 34.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.302 -178.522 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.4 OUTLIER -101.81 111.83 24.22 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.032 -178.246 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.579 ' HE2' HG13 ' A' ' 104' ' ' ILE . 50.4 mttm -120.86 134.6 55.29 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.718 ' H ' ' HD2' ' A' ' 107' ' ' ARG . 5.4 mpt_? -59.77 158.44 10.37 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.041 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -55.16 -45.94 75.72 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.54 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -75.28 11.27 1.24 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.647 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.533 ' OE1' ' HA ' ' A' ' 106' ' ' LYS . 39.1 tt0 -124.14 -15.09 6.89 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.454 0.645 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 107' ' ' ARG . 73.7 t -75.01 150.68 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.703 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -118.42 161.2 20.37 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.445 -176.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -70.57 147.19 49.54 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.403 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.86 4.1 87.45 Favored Glycine 0 C--N 1.305 -1.164 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.16 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.703 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -72.63 163.92 27.3 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD3' ' HB2' ' A' ' 148' ' ' LEU . 33.8 mttt -117.28 162.82 17.27 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.28 0.562 . . . . 0.0 110.503 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.416 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -130.24 157.68 42.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.213 172.318 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.62 136.29 33.16 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -102.39 152.05 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.686 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.309 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.7 t -66.57 -4.27 8.21 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.826 0.346 . . . . 0.0 111.025 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 145' ' ' HIS . 59.0 mt-10 39.76 69.68 0.28 Allowed 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.917 -177.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.487 HD22 HG11 ' A' ' 59' ' ' VAL . 50.9 tp -160.52 137.8 9.29 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.206 -177.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -108.62 148.14 30.8 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.342 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 1.004 HD11 HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -144.14 -86.92 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.346 0.593 . . . . 0.0 110.481 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.579 ' H ' HD12 ' A' ' 124' ' ' LEU . 3.0 p -171.8 138.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.251 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -105.32 -39.2 6.24 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.989 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 69.03 -70.9 0.13 Allowed 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.96 0.788 . . . . 0.0 109.955 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.1 m 54.33 23.52 4.43 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.404 0.681 . . . . 0.0 112.218 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.5 t -141.71 -62.23 0.46 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.807 0.337 . . . . 0.0 110.964 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.4 t -107.18 133.0 52.41 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 120.923 0.392 . . . . 0.0 110.803 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.7 t -104.73 -3.45 23.61 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.46 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -95.38 -18.45 20.73 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.694 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.72 109.27 20.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.204 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -122.2 89.26 48.8 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.921 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.71 96.98 0.86 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.882 2.388 . . . . 0.0 111.693 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -68.64 -18.77 64.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.363 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.71 129.69 34.97 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.029 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -54.46 136.91 43.72 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.375 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -139.95 138.25 35.41 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.176 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 tp 60.82 95.51 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 123.972 0.795 . . . . 0.0 110.81 -175.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.56 25.67 26.77 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.566 -1.302 . . . . 0.0 111.232 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.0 m -129.71 118.75 18.89 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.38 -161.59 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.545 2.164 . . . . 0.0 111.63 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -165.28 -39.61 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.588 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.492 ' HB3' ' HA ' ' A' ' 121' ' ' GLU . 0.4 OUTLIER -63.02 126.6 27.86 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.616 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -151.46 30.82 0.6 Allowed 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.804 0.812 . . . . 0.0 109.134 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -140.5 141.44 35.35 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.143 -172.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.509 HD12 ' CD2' ' A' ' 98' ' ' TYR . 9.9 mt -101.81 149.93 23.67 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.827 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -114.79 138.68 50.46 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -172.672 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.503 ' H ' HD13 ' A' ' 149' ' ' LEU . 23.6 mt-10 -90.4 145.09 25.21 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.013 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.426 HG21 ' CG1' ' A' ' 154' ' ' ILE . 79.4 mt -79.3 117.22 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-N 113.507 -1.679 . . . . 0.0 110.99 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.62 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 30.3 mmtt -76.06 -37.98 57.62 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.589 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -152.7 134.63 14.77 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 77.0 mt -117.59 125.89 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.279 174.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.469 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.9 ptpt -128.18 159.25 35.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.457 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -100.36 117.83 35.37 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -127.74 174.08 11.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.376 -178.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.441 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 37.3 ttt180 -95.33 155.25 16.82 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 122.106 -0.371 . . . . 0.0 110.829 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.715 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.4 -25.3 49.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.657 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 68.05 -39.73 0.4 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.45 -173.25 2.6 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.85 -10.89 19.47 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 120.645 0.259 . . . . 0.0 111.171 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 96.5 m-85 -141.86 155.08 45.55 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.94 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.6 m -126.77 159.86 35.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.935 177.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 69.9 m-85 -136.22 172.05 13.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.632 0.254 . . . . 0.0 110.478 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.28 -23.2 0.06 Allowed 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 67' ' ' VAL . 1.3 tm? 68.23 107.97 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.97 176.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -87.28 118.21 26.55 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.54 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.496 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.41 -153.9 0.6 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -61.96 132.34 52.64 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.88 0.372 . . . . 0.0 111.187 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.523 ' HG3' ' CD2' ' A' ' 172' ' ' TYR . 21.1 tptm 77.16 -77.95 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.192 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.523 ' CD2' ' HG3' ' A' ' 171' ' ' LYS . 75.3 m-85 -146.03 -174.08 4.33 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -88.18 34.28 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.12 0.486 . . . . 0.0 110.61 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.455 ' OD1' ' HB2' ' A' ' 172' ' ' TYR . 2.2 p-10 -78.32 99.48 6.34 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 8' ' ' ILE . 4.2 p -129.5 167.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-O 121.568 0.699 . . . . 0.0 112.723 -173.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.548 ' H ' HG22 ' A' ' 175' ' ' VAL . 75.7 mt -93.5 113.57 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.716 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.525 HG23 HG13 ' A' ' 175' ' ' VAL . 43.8 pt -120.39 172.92 6.78 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.688 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.417 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 5.0 t-20 47.84 -123.07 1.55 Allowed 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 124.487 1.115 . . . . 0.0 110.725 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -92.71 48.46 1.37 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.693 0.758 . . . . 0.0 109.862 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.676 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.7 m-20 73.86 46.44 0.19 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.465 1.506 . . . . 0.0 112.82 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.7 mt -88.96 117.2 31.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 56.6 t -84.38 152.09 3.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.693 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 6.4 t -158.67 152.87 23.92 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.908 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.511 ' HE2' ' HB3' ' A' ' 93' ' ' HIS . 71.2 m80 67.72 154.44 0.1 Allowed 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.731 0.644 . . . . 0.0 112.264 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.458 ' C ' ' HG ' ' A' ' 54' ' ' LEU . 57.2 tt0 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.965 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.761 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 62.0 m . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.869 0.366 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -133.07 158.0 76.92 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.559 ' HD3' HD13 ' A' ' 76' ' ' LEU . 56.4 Cg_endo -68.1 162.65 39.17 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 121.557 1.505 . . . . 0.0 108.9 176.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.75 -24.43 66.41 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 118.857 -1.64 . . . . 0.0 110.146 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.66 -13.69 34.97 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.031 0.932 . . . . 0.0 112.935 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 61.3 m -72.24 131.64 43.0 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.885 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.669 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 12.6 mtm180 -86.34 133.03 33.83 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.622 HD11 ' CG2' ' A' ' 175' ' ' VAL . 2.2 tp -117.13 133.37 64.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-O 121.131 0.491 . . . . 0.0 110.884 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.654 HD21 ' CD1' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -92.51 124.25 36.41 Favored 'General case' 0 N--CA 1.4 -2.965 0 CA-C-O 121.788 0.804 . . . . 0.0 110.956 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 19.7 m -134.26 -179.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.898 -177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -125.8 117.14 22.76 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 26.9 mt -118.89 120.56 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 CA-C-O 121.137 0.494 . . . . 0.0 110.015 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 54.11 38.51 29.21 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.92 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.71 20.48 79.69 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.746 -1.115 . . . . 0.0 113.677 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.1 t -131.01 123.04 19.64 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 70.6 Cg_endo -73.85 120.87 6.61 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 122.546 2.164 . . . . 0.0 112.25 -177.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.567 ' HG2' ' ND2' ' A' ' 134' ' ' ASN . 12.4 mt-30 -120.56 138.71 53.73 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.636 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -108.9 100.78 9.95 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.595 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.517 ' CG2' ' HB3' ' A' ' 130' ' ' SER . 2.9 pt -124.19 -172.91 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.144 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.755 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 11.3 p -95.44 171.12 8.9 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.622 178.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 92.4 mt -66.56 -31.31 71.94 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.219 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.755 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 6.3 ptm180 -79.43 -24.84 42.21 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.503 ' OE1' HG23 ' A' ' 20' ' ' THR . 68.8 mt-10 -83.87 -41.62 17.26 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.389 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.579 ' CD2' HD13 ' A' ' 167' ' ' LEU . 46.8 tp -59.3 -41.52 89.17 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.894 0.854 . . . . 0.0 109.34 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.42 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -53.49 -31.74 47.21 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.979 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.577 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 32.4 mt-10 -77.24 -14.9 59.68 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.733 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -82.59 0.54 42.42 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.643 0.735 . . . . 0.0 109.14 177.05 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.541 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 72.4 m-85 -114.11 162.61 16.27 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.686 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.413 ' HB2' ' HD3' ' A' ' 44' ' ' LYS . 6.5 tp10 -142.15 -178.73 5.86 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.437 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.558 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER 65.1 79.89 0.24 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.641 0.777 . . . . 0.0 110.448 -179.187 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -101.13 131.43 47.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 122.078 0.942 . . . . 0.0 110.922 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.423 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 18.3 ptt-85 -122.71 153.61 39.2 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.269 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -101.14 125.18 47.74 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -166.7 145.49 5.39 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.444 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 61.04 19.85 10.32 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.864 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.2 mtt 71.67 16.79 5.68 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.505 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 16.2 m -131.89 -170.77 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -119.3 142.67 47.89 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.92 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.423 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.2 t -129.38 123.41 57.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.154 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.477 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 15.0 ttm180 -113.54 127.01 55.93 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.42 135.33 46.01 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.959 -175.498 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 36.0 mtpt 91.99 118.2 0.02 OUTLIER Pre-proline 0 CA--C 1.502 -0.887 0 C-N-CA 125.375 1.47 . . . . 0.0 112.147 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 87.3 Cg_endo -78.42 156.19 28.73 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.782 2.321 . . . . 0.0 111.045 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HD3' ' HB2' ' A' ' 29' ' ' GLU . 38.8 mtmt -94.02 -1.6 54.26 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.439 0.637 . . . . 0.0 110.565 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -146.3 -165.67 2.28 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.624 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 4.9 tp10 -85.28 99.24 11.0 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 174.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.541 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.5 mp -116.08 115.8 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.01 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.608 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 30.6 mmtp -123.28 163.94 19.73 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.98 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.501 HG13 ' CG1' ' A' ' 64' ' ' ILE . 6.9 m -111.06 128.78 67.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.068 0.461 . . . . 0.0 111.846 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -83.8 124.11 30.59 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.441 ' HA ' HG13 ' A' ' 176' ' ' ILE . 20.0 m -134.17 172.16 13.24 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.45 HG12 HD11 ' A' ' 176' ' ' ILE . 2.9 mm -119.49 143.06 32.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.116 0.484 . . . . 0.0 110.071 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 41.9 t0 -84.23 119.77 25.43 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.568 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.789 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -72.71 -11.37 60.59 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.124 -171.579 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' HG23 ' A' ' 56' ' ' THR . 5.5 pt-20 -102.48 -27.88 12.52 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.82 -176.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.469 HG23 ' HG3' ' A' ' 55' ' ' GLU . 76.1 p -115.48 -23.96 8.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.634 -175.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.41 14.45 76.31 Favored Glycine 0 N--CA 1.429 -1.784 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.149 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' C ' HD13 ' A' ' 52' ' ' ILE . 5.1 mtpm? -89.75 153.3 20.8 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.424 ' HA ' HD13 ' A' ' 52' ' ' ILE . 6.6 p -89.69 107.61 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-O 121.967 0.889 . . . . 0.0 110.042 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 m -110.09 159.37 9.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.201 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 49' ' ' VAL . 12.9 tp -121.91 140.69 52.12 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.0 t -147.03 172.31 13.93 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.212 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.31 161.87 19.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.551 0.691 . . . . 0.0 110.824 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 64' ' ' ILE . 3.0 mp -105.32 134.26 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.699 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.5 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 10.9 mm-40 -79.8 -40.21 29.13 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.036 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 p30 179.49 178.03 0.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.175 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.42 HG11 ' HB2' ' A' ' 25' ' ' TYR . 20.1 t -105.45 130.0 57.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.633 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 50.7 mt -90.67 105.2 16.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.555 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 84.9 tttt -118.52 109.82 16.65 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.3 134.57 25.89 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.219 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -47.22 124.35 8.94 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.447 2.765 . . . . 0.0 112.916 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.36 110.4 2.24 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.073 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -68.33 0.93 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -68.23 -117.4 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -159.34 172.68 17.53 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -172.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 90' ' ' THR . 4.5 mt -136.5 140.22 42.86 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.532 0.682 . . . . 0.0 111.283 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.545 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 9.0 mt -86.5 142.55 12.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 171.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.516 ' HB3' ' CG ' ' A' ' 155' ' ' LYS . 31.8 ttt85 -118.97 138.38 52.85 Favored 'General case' 0 N--CA 1.404 -2.763 0 CA-C-O 121.207 0.527 . . . . 0.0 109.755 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' A' ' 86' ' ' SER . 53.5 m-85 -115.97 125.17 52.16 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.893 -177.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 152' ' ' LYS . 34.5 tt0 -108.18 125.22 51.37 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.672 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -91.25 160.06 15.72 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.889 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.91 ' HG2' HD11 ' A' ' 149' ' ' LEU . 5.5 pt-20 -62.54 -19.59 63.79 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.209 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -87.33 -11.31 49.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.762 0.792 . . . . 0.0 109.23 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.52 16.81 47.95 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.036 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.549 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -87.46 142.91 27.51 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.762 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 23.6 p -142.38 136.28 29.43 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.456 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.408 ' CD1' HD13 ' A' ' 181' ' ' ILE . 6.8 p90 -129.97 155.99 45.18 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.165 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 40.2 mt-10 -129.86 148.01 51.69 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.308 0.575 . . . . 0.0 112.135 -175.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.7 OUTLIER -141.0 154.51 46.05 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.358 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.645 ' HA ' HD23 ' A' ' 76' ' ' LEU . 1.1 p -69.84 15.92 0.07 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.021 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.06 -39.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 125.349 1.46 . . . . 0.0 113.854 175.009 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 107' ' ' ARG . 1.1 t70 -90.79 12.68 18.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.414 0.625 . . . . 0.0 110.766 -178.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 39.6 m80 -115.45 141.62 27.53 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.361 177.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 23.6 Cg_exo -64.9 142.78 77.05 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.43 2.753 . . . . 0.0 115.201 -176.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.515 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 19.1 t -119.52 150.13 22.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.381 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.5 tp -104.26 107.57 18.55 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.86 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.631 HG23 ' H ' ' A' ' 116' ' ' LYS . 1.6 p -107.11 143.96 16.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.383 0.611 . . . . 0.0 111.684 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.602 ' CD2' HD12 ' A' ' 148' ' ' LEU . 44.5 t80 -99.17 90.95 4.76 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.687 176.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 11.9 pt-20 -138.17 157.51 46.16 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.499 176.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER 68.81 21.86 7.51 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.93 13.84 60.09 Favored Glycine 0 CA--C 1.508 -0.35 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.669 -177.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.407 ' HE ' ' CB ' ' A' ' 100' ' ' ASN . 29.3 ptt180 -135.61 172.5 12.92 Favored 'General case' 0 N--CA 1.404 -2.748 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -104.77 119.81 39.88 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.59 HG13 HG13 ' A' ' 97' ' ' VAL . 21.4 pt -119.22 144.2 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 120.129 -0.629 . . . . 0.0 112.187 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -101.82 114.87 29.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.551 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.577 ' HG3' HG22 ' A' ' 111' ' ' VAL . 0.7 OUTLIER -136.01 146.56 47.29 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.387 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.582 ' O ' HG23 ' A' ' 111' ' ' VAL . 74.4 mtm180 -63.73 160.23 17.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.021 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -61.54 -41.55 97.51 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.788 -175.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.448 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.3 p90 -72.47 0.5 10.12 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.068 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -112.64 -16.68 12.77 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.479 0.657 . . . . 0.0 109.974 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 107' ' ' ARG . 94.7 t -71.08 150.7 9.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.773 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 1.9 mtmp? -115.08 159.73 20.5 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.178 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -73.97 145.86 44.32 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.08 4.22 86.96 Favored Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.159 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.773 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -76.68 167.32 22.05 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.16 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.631 ' H ' HG23 ' A' ' 97' ' ' VAL . 35.6 mttt -120.03 166.84 12.84 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.498 0.666 . . . . 0.0 111.756 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.35 162.28 35.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.655 171.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.61 141.02 29.09 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 1.8 m -114.68 149.57 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 173.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.495 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 44.9 t -69.53 -1.37 8.5 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.281 0.562 . . . . 0.0 110.548 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.689 ' OE1' ' HA ' ' A' ' 146' ' ' ASP . 27.6 mt-10 56.74 1.04 0.08 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 124.613 1.165 . . . . 0.0 113.274 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.7 tp -111.59 120.49 42.27 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 120.867 0.365 . . . . 0.0 110.604 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.545 ' C ' ' HG ' ' A' ' 124' ' ' LEU . 7.4 pt-20 -93.63 -17.92 22.75 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -174.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.654 ' CD1' HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER 52.96 3.96 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 124.258 1.023 . . . . 0.0 112.289 -177.529 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.502 ' H ' ' C ' ' A' ' 123' ' ' GLU . 80.0 t 77.55 -47.68 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.71 1.204 . . . . 0.0 112.319 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.408 ' OE2' ' HA ' ' A' ' 17' ' ' GLN . 34.9 tt0 -54.41 110.82 0.67 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.636 0.731 . . . . 0.0 112.602 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -126.6 6.84 6.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.42 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.8 t -78.89 -177.95 5.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.855 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.3 p -70.7 -18.52 62.81 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.938 0.399 . . . . 0.0 110.287 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.555 ' HA ' HE22 ' A' ' 132' ' ' GLN . 4.5 t 66.78 23.18 10.15 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.918 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.1 t -80.4 -1.83 43.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.958 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.555 HE22 ' HA ' ' A' ' 130' ' ' SER . 5.1 pm0 -95.02 169.31 10.21 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.644 ' O ' ' HD3' ' A' ' 135' ' ' PRO . 7.3 p-10 -81.25 147.96 29.7 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.567 ' ND2' ' HG2' ' A' ' 17' ' ' GLN . 7.3 m-20 -112.11 88.89 10.97 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.306 0.575 . . . . 0.0 111.201 -176.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.644 ' HD3' ' O ' ' A' ' 133' ' ' ASP . 7.8 Cg_exo -74.7 -40.48 1.01 Allowed 'Trans proline' 0 C--N 1.326 -0.65 0 C-N-CA 123.521 2.814 . . . . 0.0 112.572 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 138' ' ' GLU . 68.4 mttm -150.69 -53.49 0.14 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.995 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.5 t30 75.63 -13.43 0.87 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.771 0.828 . . . . 0.0 110.382 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 136' ' ' LYS . 2.4 mp0 63.59 -176.03 0.16 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.975 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -102.57 143.31 32.43 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.698 ' H ' HD23 ' A' ' 140' ' ' LEU . 2.4 pt? -74.15 -40.75 62.38 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.033 0.444 . . . . 0.0 111.863 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 108.86 -76.36 0.22 Allowed Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 143' ' ' PRO . 26.6 t -137.74 117.79 10.25 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-O 120.686 0.279 . . . . 0.0 110.493 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 142' ' ' SER . 20.4 Cg_endo -67.03 -51.86 0.73 Allowed 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 122.774 2.316 . . . . 0.0 112.113 177.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 143' ' ' PRO . 37.3 tt0 76.64 -92.87 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.204 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.93 -91.33 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.828 0 O-C-N 123.7 0.625 . . . . 0.0 112.493 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.689 ' HA ' ' OE1' ' A' ' 121' ' ' GLU . 36.9 t70 49.98 56.59 7.65 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.347 0.659 . . . . 0.0 112.772 176.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -166.27 142.67 4.94 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.638 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.602 HD12 ' CD2' ' A' ' 98' ' ' TYR . 11.9 mt -101.37 148.04 25.62 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-O 121.288 0.566 . . . . 0.0 109.68 175.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.91 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -108.37 133.86 51.98 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.644 -172.012 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.418 ' N ' HD13 ' A' ' 149' ' ' LEU . 21.5 mt-10 -88.46 143.75 26.79 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.919 175.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.473 HD13 ' CD1' ' A' ' 79' ' ' PHE . 68.2 mt -77.5 110.06 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.607 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.006 175.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 80' ' ' GLU . 7.2 mmpt? -72.44 -39.75 67.59 Favored 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.487 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -150.16 133.8 16.67 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.8 mt -113.83 143.08 24.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.054 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.516 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.0 ptpt -144.6 158.03 43.95 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -178.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.545 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 7.2 m-85 -100.9 114.54 28.5 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.563 174.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.43 173.78 11.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.319 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.435 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 49.8 ttt180 -112.21 167.6 10.28 Favored 'General case' 0 N--CA 1.415 -2.193 0 O-C-N 121.329 -0.857 . . . . 0.0 110.693 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.435 ' N ' ' HG2' ' A' ' 158' ' ' ARG . . . -67.57 114.94 6.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.433 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -72.5 -32.77 66.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.665 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -81.92 -176.21 6.0 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.305 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -101.29 -15.68 17.2 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -138.17 153.77 49.18 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.1 m -118.46 155.95 20.41 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.674 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 78.1 m-85 -135.52 161.3 35.88 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.91 -175.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.761 ' OG ' ' HA ' ' A' ' 1' ' ' CYS . 74.0 m -158.1 13.64 0.2 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.553 176.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.644 HD23 ' C ' ' A' ' 166' ' ' SER . 2.5 pt? 29.39 109.51 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 125.368 1.467 . . . . 0.0 113.923 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -82.03 114.34 20.52 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.147 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.5 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -133.56 -142.43 0.2 Allowed 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -67.03 115.52 6.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.821 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt 70.07 166.95 0.29 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.742 0.817 . . . . 0.0 112.544 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -77.93 121.88 24.76 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.118 -175.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 12.8 m80 49.99 27.62 2.53 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 114.581 -1.191 . . . . 0.0 113.266 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.13 99.57 11.6 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.622 ' CG2' HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -165.1 171.7 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.278 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.666 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 97.0 mt -111.99 118.12 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.615 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.422 HG22 HD12 ' A' ' 8' ' ' ILE . 44.3 pt -120.78 171.91 8.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.294 0 CA-C-O 121.01 0.433 . . . . 0.0 111.186 -177.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 48.83 -129.79 1.9 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.313 1.045 . . . . 0.0 110.504 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -89.73 52.01 2.22 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.558 0.694 . . . . 0.0 109.959 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.754 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 16.4 m-80 74.05 44.41 0.26 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.685 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.408 HD13 ' CD1' ' A' ' 87' ' ' PHE . 86.5 mt -87.0 113.04 23.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 73.4 t -88.24 130.38 37.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.958 -176.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 12.0 t -139.14 166.16 25.25 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.594 176.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -157.66 145.53 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.656 0.265 . . . . 0.0 110.65 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 C--O 1.256 1.405 0 CA-C-O 117.783 -1.103 . . . . 0.0 110.185 177.391 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 89' ' ' THR . 63.7 m . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.997 0.427 . . . . 0.0 111.42 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.433 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 2.7 m-85 -133.0 167.01 25.1 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.499 ' HD3' HD13 ' A' ' 76' ' ' LEU . 73.0 Cg_endo -72.14 164.48 35.51 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 N-CA-C 108.408 -1.42 . . . . 0.0 108.408 175.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.76 -26.59 65.26 Favored Glycine 0 C--N 1.301 -1.415 0 C-N-CA 118.993 -1.575 . . . . 0.0 111.44 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.54 -9.32 48.55 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.6 m -71.33 129.69 39.49 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.381 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 26.2 mtm180 -85.77 132.08 34.2 Favored 'General case' 0 C--O 1.187 -2.187 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.712 HD11 HG21 ' A' ' 175' ' ' VAL . 8.9 tt -119.91 130.1 74.62 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-O 120.863 0.363 . . . . 0.0 110.139 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -88.44 122.13 31.59 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-O 121.527 0.679 . . . . 0.0 109.576 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 28.0 m -132.58 -173.3 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.346 -178.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 31.0 tt0 -134.4 121.4 21.09 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.637 HG12 HG13 ' A' ' 47' ' ' ILE . 17.0 mt -120.87 123.47 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.922 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.11 37.47 27.09 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.202 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.12 76.92 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.657 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -130.79 119.81 18.28 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.569 ' HB2' HD22 ' A' ' 124' ' ' LEU . 13.5 Cg_exo -64.87 120.93 8.29 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.733 1.622 . . . . 0.0 110.663 178.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -118.62 135.58 54.36 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -106.56 100.78 10.28 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.3 pt -125.46 -172.68 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.146 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.243 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.732 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 29.6 p -96.46 170.1 9.46 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.793 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 84.6 mt -67.23 -28.22 67.88 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.797 178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.732 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 11.2 ptm180 -79.51 -26.54 41.53 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.492 ' OE1' HG23 ' A' ' 20' ' ' THR . 43.9 mt-10 -84.28 -42.34 15.93 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.797 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.727 HD23 ' HG ' ' A' ' 167' ' ' LEU . 17.5 tp -57.96 -44.01 86.76 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.779 0.8 . . . . 0.0 109.206 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.512 ' HD1' HG11 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -51.42 -34.17 33.72 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.749 -1.568 . . . . 0.0 112.631 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.562 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 31.3 mt-10 -76.6 -14.39 60.0 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 23' ' ' GLU . 1.4 mm? -79.97 4.74 15.94 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.572 0.701 . . . . 0.0 109.317 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.527 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.9 m-85 -118.24 162.11 18.79 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.922 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -142.12 -173.38 3.81 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.562 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.8 OUTLIER 61.91 84.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.45 0.643 . . . . 0.0 110.434 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -103.0 127.25 50.31 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.782 0.801 . . . . 0.0 111.161 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.451 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 14.3 ptt180 -121.04 154.39 36.14 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.237 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -100.3 130.26 46.39 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -164.29 142.04 6.89 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.27 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 59.07 23.12 11.27 Favored 'General case' 0 CA--C 1.493 -1.225 0 O-C-N 123.599 0.562 . . . . 0.0 111.18 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.8 mtp 71.81 17.98 5.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.618 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.534 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 14.6 m -132.56 -173.61 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -114.46 141.4 47.73 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-O 121.253 0.549 . . . . 0.0 109.822 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.4 t -129.23 123.46 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.059 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.444 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 19.3 ttm180 -114.13 126.6 55.26 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -130.67 144.28 51.32 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.683 -174.686 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 37.5 ttmt 83.97 114.58 0.03 OUTLIER Pre-proline 0 CA--C 1.509 -0.627 0 O-C-N 124.639 1.212 . . . . 0.0 111.279 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.59 ' HB2' HD13 ' A' ' 47' ' ' ILE . 81.7 Cg_endo -80.24 151.62 20.61 Favored 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 122.19 1.926 . . . . 0.0 111.515 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -84.04 -5.91 59.32 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.32 0.581 . . . . 0.0 110.751 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -145.5 -166.09 2.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 8.1 tp10 -85.69 101.07 12.44 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.637 HG13 HG12 ' A' ' 12' ' ' ILE . 1.8 mp -117.36 116.92 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.607 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 57.0 mmtt -115.12 169.08 9.38 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.336 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 169' ' ' ALA . 13.0 p -127.01 130.77 71.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.463 ' HB3' HD12 ' A' ' 176' ' ' ILE . 5.2 m-85 -88.0 124.2 33.49 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.586 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.8 m -133.73 168.56 18.48 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.641 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.585 HG12 HD11 ' A' ' 176' ' ' ILE . 2.2 mm -116.0 145.91 21.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.32 0.581 . . . . 0.0 111.061 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.7 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 17.5 t70 -84.56 114.13 21.75 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.823 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -73.47 -9.2 58.44 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.355 0.662 . . . . 0.0 112.629 -170.049 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.7 ' HG3' ' OD1' ' A' ' 53' ' ' ASP . 3.1 pt-20 -102.12 -28.01 12.58 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.841 -176.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.553 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 61.0 p -118.2 -25.23 6.68 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.67 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.28 16.54 55.4 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.691 -0.686 . . . . 0.0 113.543 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.553 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 38.2 mttt -86.93 151.46 23.28 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.98 0.419 . . . . 0.0 112.092 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.02 107.97 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.581 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.7 m -109.5 157.1 10.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.316 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.9 tp -120.87 142.88 49.26 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.478 HG21 ' HB3' ' A' ' 170' ' ' LYS . 9.9 t -148.52 170.77 17.33 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.602 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.79 160.71 22.2 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.365 0.603 . . . . 0.0 109.824 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.591 HD13 HG22 ' A' ' 47' ' ' ILE . 2.2 mp -94.71 143.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.032 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.459 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 58.0 mm-40 -89.05 -39.87 13.36 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 178.58 177.26 0.46 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.693 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.512 HG11 ' HD1' ' A' ' 25' ' ' TYR . 9.9 t -107.48 130.42 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.377 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 38.1 mt -90.51 106.85 17.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.587 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.534 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.5 tttt -121.54 108.73 13.96 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.74 141.87 43.36 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.275 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.487 ' HD2' HG12 ' A' ' 37' ' ' VAL . 9.5 Cg_endo -55.48 130.25 39.5 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 123.379 2.719 . . . . 0.0 112.74 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.5 99.66 9.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.397 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.2 m -106.04 -48.74 3.53 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.43 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.505 ' OD2' HG22 ' A' ' 90' ' ' THR . 12.0 p-10 -87.7 -173.28 4.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.25 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -111.76 172.96 6.59 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 121.163 0.506 . . . . 0.0 111.126 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' ' 90' ' ' THR . 9.9 mt -120.2 146.63 45.84 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.031 -175.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.485 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 12.0 mt -89.8 145.47 7.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 30.5 ttt-85 -120.75 136.76 54.79 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.0 m-85 -114.73 122.33 46.09 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.486 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.1 tt0 -110.04 123.81 50.35 Favored 'General case' 0 CA--C 1.465 -2.312 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.722 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -86.84 162.05 17.99 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.448 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.872 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.5 pt-20 -63.26 -15.64 57.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.312 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -93.03 -9.73 38.71 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.029 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.22 8.68 62.73 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.452 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.599 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -88.83 143.35 26.95 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 176.064 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 55.8 p -138.57 154.89 48.74 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.823 178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 79' ' ' PHE . 5.0 p90 -145.69 148.95 33.59 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.883 176.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.492 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 44.1 mt-10 -124.89 148.15 48.44 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.729 -175.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -144.71 159.03 43.5 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.636 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.712 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -71.04 18.72 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.055 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.026 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.6 OUTLIER 70.87 -32.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 125.006 1.322 . . . . 0.0 112.429 177.273 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 90' ' ' THR . 12.8 t70 -78.35 -26.87 46.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.149 0.499 . . . . 0.0 109.737 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -69.26 123.75 88.97 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.05 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 33.5 Cg_exo -63.78 142.08 81.33 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.278 2.652 . . . . 0.0 113.126 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.46 146.33 18.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 124.22 1.008 . . . . 0.0 108.332 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.9 tp -105.38 109.7 21.78 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.837 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.56 HG13 HG13 ' A' ' 104' ' ' ILE . 2.1 p -110.72 151.1 12.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.371 0.605 . . . . 0.0 111.214 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -102.66 93.36 5.07 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.984 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.514 ' OE2' HD11 ' A' ' 104' ' ' ILE . 11.4 pt-20 -145.88 157.04 43.92 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 13.2 m120 66.52 23.52 10.44 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.144 0.497 . . . . 0.0 109.844 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.42 11.89 57.36 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.207 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -136.84 172.23 13.33 Favored 'General case' 0 N--CA 1.402 -2.827 0 CA-C-O 121.462 0.649 . . . . 0.0 110.507 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.406 ' CE1' HD11 ' A' ' 118' ' ' LEU . 28.2 m-85 -98.45 121.41 40.35 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.373 177.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.56 HG13 HG13 ' A' ' 97' ' ' VAL . 22.8 pt -118.72 145.9 24.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.126 -0.63 . . . . 0.0 112.146 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -103.65 109.14 20.72 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.793 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -124.98 135.6 52.95 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.844 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.622 ' O ' HG23 ' A' ' 111' ' ' VAL . 96.1 mtt180 -62.31 163.42 8.47 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.026 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -62.05 -42.13 98.86 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.165 -176.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.496 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 1.7 p90 -74.14 2.64 8.52 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.814 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -110.87 -19.41 12.82 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.487 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 107' ' ' ARG . 98.5 t -77.55 147.02 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 8.3 mptt -118.46 166.76 12.28 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.005 0.431 . . . . 0.0 111.543 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -70.11 142.9 52.54 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.07 4.21 81.93 Favored Glycine 0 C--N 1.304 -1.245 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.235 -175.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.683 ' HB3' HD12 ' A' ' 151' ' ' ILE . 11.3 t70 -76.93 170.47 16.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.684 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 42.4 mttp -122.78 165.97 15.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.442 0.639 . . . . 0.0 111.648 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.97 156.57 39.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.862 171.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.497 ' HG ' HD11 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -91.57 136.61 33.0 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.4 m -107.09 154.34 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.206 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.933 173.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.559 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 32.2 t -76.2 30.0 0.12 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.809 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 119' ' ' VAL . 36.5 mt-10 73.4 -49.07 0.69 Allowed 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 124.728 1.211 . . . . 0.0 111.86 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.472 ' CB ' ' HB3' ' A' ' 143' ' ' PRO . 0.7 OUTLIER -173.63 -169.51 0.51 Allowed 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -175.771 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.501 ' HB2' HD23 ' A' ' 124' ' ' LEU . 9.8 pt-20 -113.71 -134.44 0.35 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.037 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -98.28 16.44 21.46 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.642 0.734 . . . . 0.0 110.439 -176.514 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.449 ' O ' HD22 ' A' ' 122' ' ' LEU . 4.0 p -168.16 154.42 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.459 -177.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -59.33 -59.46 5.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.295 0.372 . . . . 0.0 111.929 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -165.01 79.51 0.34 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.923 0.392 . . . . 0.0 110.372 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.1 m 67.63 -67.23 0.19 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.27 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.2 m 50.5 -99.13 0.07 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.215 1.006 . . . . 0.0 112.477 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.527 ' HB2' ' OE1' ' A' ' 132' ' ' GLN . 1.2 m -68.33 -39.58 81.88 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.611 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.2 m 64.05 94.8 0.05 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.369 0.667 . . . . 0.0 111.878 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.527 ' OE1' ' HB2' ' A' ' 130' ' ' SER . 18.6 mp0 -125.64 172.86 9.41 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.041 0.448 . . . . 0.0 111.291 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.12 -21.43 16.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.913 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.464 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . 4.6 t30 -178.32 -49.25 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.445 -177.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 134' ' ' ASN . 27.2 Cg_exo -61.92 97.03 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.743 2.295 . . . . 0.0 113.427 -175.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -167.86 -41.46 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 66.11 -172.27 0.19 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.921 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.78 164.76 16.5 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -174.03 -46.65 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.72 0.771 . . . . 0.0 109.797 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.736 ' H ' HD23 ' A' ' 140' ' ' LEU . 2.0 pt? -70.07 -37.77 75.56 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.544 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.59 -72.87 0.25 Allowed Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.8 m -136.0 163.84 47.44 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.472 ' HB3' ' CB ' ' A' ' 122' ' ' LEU . 19.1 Cg_exo -66.01 -169.76 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.661 2.24 . . . . 0.0 112.154 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 145' ' ' HIS . 10.0 tp10 -165.6 92.66 0.54 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.803 -0.181 . . . . 0.0 110.831 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 6.3 t-80 172.4 91.2 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -77.06 117.49 18.68 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.123 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.414 ' C ' HD22 ' A' ' 148' ' ' LEU . 3.3 pt20 -164.39 138.96 5.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.399 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.684 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.9 mm? -115.55 132.19 56.7 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.872 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -109.26 134.89 51.2 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -173.426 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.537 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 19.9 mt-10 -87.3 142.79 27.63 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.057 176.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.683 HD12 ' HB3' ' A' ' 115' ' ' ASP . 71.1 mt -78.79 109.22 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.246 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.62 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.555 ' HE2' ' HB2' ' A' ' 82' ' ' GLU . 36.4 mmtt -68.25 -40.36 81.96 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.918 176.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -151.27 131.33 13.44 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.557 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.2 mt -112.83 140.98 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.189 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.371 174.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.446 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.2 ptpt -148.44 159.64 43.84 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.312 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.485 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 18.7 m-85 -99.27 116.75 32.18 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.425 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -131.31 134.69 60.74 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.007 -178.269 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -67.44 154.19 41.94 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.518 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.0 133.99 56.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.784 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -84.32 37.9 0.64 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.089 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 162' ' ' ASP . 12.6 t70 -176.54 -174.4 0.58 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.29 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.448 ' H ' ' CG ' ' A' ' 161' ' ' ASP . 6.0 m-20 -95.64 -10.43 29.44 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.876 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.21 160.73 38.18 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.265 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.7 m -127.55 158.01 39.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.573 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.567 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 77.3 m-85 -135.77 167.22 21.57 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.142 0.496 . . . . 0.0 111.08 -175.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.562 ' HB3' HD12 ' A' ' 68' ' ' ILE . 44.6 t -152.47 -16.39 0.17 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.115 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.727 ' HG ' HD23 ' A' ' 24' ' ' LEU . 4.5 mm? 59.41 105.02 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.648 0.737 . . . . 0.0 111.655 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.528 ' OD1' ' HB3' ' A' ' 172' ' ' TYR . 58.2 t30 -83.81 118.68 24.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.556 -176.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.459 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -135.32 -162.1 1.22 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.478 ' HB3' HG21 ' A' ' 62' ' ' THR . 72.1 tttt -62.89 130.03 43.01 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt 57.49 78.75 0.22 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.549 0.69 . . . . 0.0 109.997 -171.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.528 ' HB3' ' OD1' ' A' ' 168' ' ' ASN . 2.8 p90 -56.71 150.42 15.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.913 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 184' ' ' HIS . 33.0 m170 67.15 28.25 8.26 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.345 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 183' ' ' THR . 43.9 t30 -137.34 102.94 4.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.285 177.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.712 HG21 HD11 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -153.95 162.15 2.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.485 -177.286 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.585 HD11 HG12 ' A' ' 52' ' ' ILE . 87.3 mt -101.22 117.07 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.31 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.535 HG23 HG13 ' A' ' 175' ' ' VAL . 34.1 pt -122.76 162.67 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 CA-C-O 121.386 0.612 . . . . 0.0 111.676 -176.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 22.0 t30 48.34 -133.2 1.4 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 124.697 1.199 . . . . 0.0 110.862 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.26 52.24 1.3 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.496 0.665 . . . . 0.0 110.654 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.733 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 17.2 m-80 66.97 48.34 1.28 Allowed 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 125.154 1.382 . . . . 0.0 113.365 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.1 mt -90.05 114.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.4 m -86.77 159.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-O 121.458 0.647 . . . . 0.0 110.922 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 4.0 t -158.33 149.49 20.86 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.93 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 85.7 t60 -152.56 146.25 25.07 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.41 ' HA ' ' HG2' ' A' ' 94' ' ' PRO . 14.3 tm0? . . . . . 0 C--O 1.26 1.639 0 CA-C-O 117.516 -1.23 . . . . 0.0 109.626 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 89' ' ' THR . 56.7 m . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.955 0.407 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.414 ' CE1' HD13 ' A' ' 177' ' ' ILE . 49.1 m-85 -129.36 155.22 80.4 Favored Pre-proline 0 N--CA 1.446 -0.636 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.527 ' HA ' HG12 ' A' ' 164' ' ' VAL . 22.4 Cg_endo -61.16 -31.68 90.41 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.77 2.313 . . . . 0.0 112.279 -177.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.498 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 129.22 -39.3 1.87 Allowed Glycine 0 N--CA 1.421 -2.366 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.58 -11.86 55.15 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.374 0.607 . . . . 0.0 111.485 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 64.4 m -63.8 129.84 41.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 29.6 mtm180 -88.27 137.07 32.65 Favored 'General case' 0 C--O 1.189 -2.091 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 175' ' ' VAL . 11.9 tt -122.5 130.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 C-N-CA 122.649 0.379 . . . . 0.0 110.106 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.602 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -88.52 122.5 32.05 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 121.526 0.679 . . . . 0.0 109.467 179.393 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 26.1 m -133.34 179.63 4.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.477 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -126.23 120.42 29.97 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-O 121.35 0.595 . . . . 0.0 109.495 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.603 HG12 HG13 ' A' ' 47' ' ' ILE . 28.5 mt -120.22 122.24 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.463 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.643 -177.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.401 ' HA ' ' HB3' ' A' ' 46' ' ' GLU . 66.9 m-20 55.15 37.77 29.41 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 114.22 -1.354 . . . . 0.0 110.044 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.83 17.22 78.23 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.776 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.595 HG11 ' O ' ' A' ' 134' ' ' ASN . 20.2 t -127.3 123.32 23.26 Favored Pre-proline 0 C--N 1.312 -1.022 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 21.3 Cg_endo -67.69 126.56 14.9 Favored 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 122.017 1.811 . . . . 0.0 111.104 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -125.97 138.07 53.73 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -106.76 101.32 10.77 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.7 pt -123.32 -178.14 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.936 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 16.7 p -92.23 168.78 11.1 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.803 -177.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.4 mm? -66.19 -25.12 66.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.825 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.586 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 1.1 ptm180 -85.38 -24.38 27.57 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HB2' ' H ' ' A' ' 20' ' ' THR . 35.2 mt-10 -85.51 -39.65 17.21 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.63 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.758 HD23 ' HG ' ' A' ' 167' ' ' LEU . 22.0 tp -58.84 -41.57 87.22 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.764 0.792 . . . . 0.0 109.602 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.468 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -55.54 -29.38 58.86 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.308 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.62 -17.56 59.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.649 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 23' ' ' GLU . 2.3 mm? -78.85 4.04 15.15 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.575 0.702 . . . . 0.0 109.414 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 95.6 m-85 -117.89 162.2 18.5 Favored 'General case' 0 N--CA 1.412 -2.36 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.861 -177.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 4.4 mm-40 -139.44 -173.81 3.71 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.375 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.445 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 3.5 t0 60.08 80.96 0.19 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.465 0.65 . . . . 0.0 110.863 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -102.56 130.79 49.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.904 0.859 . . . . 0.0 110.824 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.46 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.1 ptt180 -119.88 153.89 35.19 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.768 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -101.47 123.86 46.2 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -161.94 143.96 11.3 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.94 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 59.35 22.2 10.58 Favored 'General case' 0 CA--C 1.493 -1.236 0 O-C-N 123.78 0.675 . . . . 0.0 111.224 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.7 mtt 73.04 17.07 4.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.525 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 12.5 m -134.12 -171.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.413 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . 96.4 m-85 -119.3 143.21 47.48 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-O 121.164 0.507 . . . . 0.0 110.183 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.46 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.1 t -129.98 123.99 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.966 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.115 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.522 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 13.7 ttm180 -113.43 128.1 56.34 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.566 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.41 141.39 48.85 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.085 -174.083 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 24.3 ttmm 85.26 115.5 0.03 OUTLIER Pre-proline 0 CA--C 1.512 -0.513 0 C-N-CA 124.24 1.016 . . . . 0.0 111.928 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.541 ' HB2' HD13 ' A' ' 47' ' ' ILE . 72.3 Cg_endo -79.46 152.26 23.17 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.347 2.032 . . . . 0.0 111.838 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 31.0 mtmt -84.33 -6.09 59.35 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.821 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -148.35 -164.85 2.12 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 6.2 tp10 -86.73 101.17 13.05 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.469 176.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.603 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -116.21 118.23 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.526 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 29.3 mmtp -123.0 166.31 15.31 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.606 173.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.509 ' O ' HD12 ' A' ' 61' ' ' LEU . 6.3 m -115.36 129.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -84.8 121.91 28.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.827 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.1 m -132.88 171.32 14.08 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.846 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.46 HG12 HD11 ' A' ' 176' ' ' ILE . 2.9 mm -113.41 143.18 23.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.168 0.509 . . . . 0.0 110.008 177.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.643 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 21.2 t70 -77.55 124.22 27.63 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.342 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.804 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -75.97 -10.51 59.48 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.608 -171.374 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.643 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 3.8 pt-20 -107.87 -23.33 12.09 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.895 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.529 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 67.7 p -120.99 -23.78 5.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.999 -176.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.54 17.57 65.94 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.393 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.529 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 18.0 mttp -92.43 159.36 15.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 t -85.79 107.89 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.465 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.26 157.78 12.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.153 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.509 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.1 tp -122.24 137.98 54.65 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.5 t -143.79 171.51 14.12 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.08 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.14 161.64 20.54 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.809 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.578 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.9 mp -100.79 141.11 18.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.504 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.587 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 49.7 mt-10 -89.7 -35.85 15.54 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 p30 176.5 174.85 0.35 Allowed 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.006 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 20.5 t -105.54 134.3 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.191 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.297 177.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.525 HD13 ' HB3' ' A' ' 166' ' ' SER . 0.1 OUTLIER -101.8 124.04 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.379 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.089 179.601 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 86.7 tttt -135.34 108.47 7.7 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.224 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.43 137.17 30.22 Favored Pre-proline 0 C--N 1.31 -1.148 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.44 -175.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -47.43 124.04 8.78 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.394 2.729 . . . . 0.0 112.79 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.37 108.09 7.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.865 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -110.95 -59.52 1.95 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -77.21 -98.94 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.84 172.74 4.73 Favored 'General case' 0 CA--C 1.474 -1.981 0 CA-C-O 121.101 0.477 . . . . 0.0 112.011 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.769 HD23 ' HA ' ' A' ' 90' ' ' THR . 7.3 mt -132.45 141.14 48.7 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.135 -178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.513 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 10.6 mt -87.67 144.86 8.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 19.3 ttt-85 -121.69 136.03 54.95 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-O 121.283 0.564 . . . . 0.0 109.731 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 86' ' ' SER . 48.7 m-85 -114.34 130.32 56.67 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.865 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 152' ' ' LYS . 18.9 tt0 -109.86 129.21 55.67 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -94.31 155.64 16.91 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.778 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.1 pt-20 -64.62 -14.34 57.56 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.212 0.53 . . . . 0.0 111.529 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.69 -8.24 52.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.51 -0.768 . . . . 0.0 108.989 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.92 19.11 44.53 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.403 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.54 ' O ' HD23 ' A' ' 81' ' ' LEU . 4.8 mtt-85 -89.2 139.1 30.82 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 9.0 p -139.29 144.87 38.53 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.849 175.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -140.76 147.17 38.7 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.094 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 35.9 mt-10 -117.88 147.75 42.8 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.965 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.1 p -145.8 159.44 43.19 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.302 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.769 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.55 20.48 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -176.048 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.072 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.47 -37.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 125.397 1.479 . . . . 0.0 113.532 176.421 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.22 -2.2 58.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.143 0.497 . . . . 0.0 110.633 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -81.31 121.49 80.29 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.686 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HG2' ' NE2' ' A' ' 173' ' ' HIS . 21.3 Cg_endo -63.32 139.04 69.4 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.659 2.239 . . . . 0.0 113.336 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 18.1 t -113.89 145.82 19.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.5 tp -101.35 107.69 19.1 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 121.059 -0.257 . . . . 0.0 110.336 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.499 HG13 HG13 ' A' ' 104' ' ' ILE . 2.6 p -107.76 147.5 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 121.63 0.728 . . . . 0.0 111.666 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -103.8 91.18 3.89 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.558 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.552 ' CG ' HD11 ' A' ' 104' ' ' ILE . 10.4 pt-20 -141.24 158.83 43.37 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.856 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.2 m-20 65.62 23.13 11.69 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.09 15.45 58.5 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.811 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HG3' HG23 ' A' ' 104' ' ' ILE . 9.7 ptm180 -136.33 171.96 13.71 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-O 121.206 0.527 . . . . 0.0 110.145 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -102.55 120.9 41.33 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.552 HD11 ' CG ' ' A' ' 99' ' ' GLU . 9.2 pt -125.8 147.94 30.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.316 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -100.41 119.0 37.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.448 -177.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.52 ' HE2' ' CD1' ' A' ' 104' ' ' ILE . 64.6 mttm -129.35 133.2 47.3 Favored 'General case' 0 C--O 1.205 -1.275 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.507 ' O ' HG23 ' A' ' 111' ' ' VAL . 86.4 mtt180 -63.42 163.04 11.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.072 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -60.57 -41.44 94.64 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.013 -175.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.487 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 2.8 p90 -74.18 4.61 5.4 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.961 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -118.17 -16.23 9.76 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.695 0.76 . . . . 0.0 110.265 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 107' ' ' ARG . 78.4 t -76.97 149.12 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -119.88 165.63 14.37 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.436 -176.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.8 141.09 53.39 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.286 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.75 5.0 71.99 Favored Glycine 0 C--N 1.307 -1.083 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.527 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.936 ' HB3' HD12 ' A' ' 151' ' ' ILE . 6.8 t70 -72.65 177.54 4.68 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.45 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 23.0 mttp -134.29 160.46 37.84 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.405 0.621 . . . . 0.0 111.013 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.26 158.4 43.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.066 172.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.71 130.86 37.43 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.732 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -102.61 148.73 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 175.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.586 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 33.1 t -75.54 34.45 0.12 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.683 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.476 ' H ' ' C ' ' A' ' 119' ' ' VAL . 90.1 mt-10 73.74 -57.27 0.63 Allowed 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.42 1.088 . . . . 0.0 111.027 -177.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -174.82 -160.59 0.09 Allowed 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -172.657 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.523 ' H ' HD12 ' A' ' 122' ' ' LEU . 9.4 pt-20 -152.67 176.48 11.7 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.838 0.351 . . . . 0.0 111.749 -174.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.602 ' CD2' HD21 ' A' ' 9' ' ' LEU . 2.4 pt? -49.22 -29.15 5.28 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.856 172.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 124' ' ' LEU 0.287 10.9 p 68.41 115.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.764 0 C-N-CA 126.623 1.969 . . . . 0.0 114.857 172.474 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -171.44 138.52 1.18 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 113.811 -1.54 . . . . 0.0 108.264 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -84.75 11.94 8.18 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.5 m -75.22 142.02 43.48 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.952 0.406 . . . . 0.0 110.948 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.475 ' HA ' HH11 ' A' ' 7' ' ' ARG . 22.7 m -79.45 -40.27 30.28 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.281 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.4 m -126.86 -30.04 2.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.684 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.1 t 70.57 118.88 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.439 0.695 . . . . 0.0 111.236 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -96.15 -28.0 14.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.373 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -87.64 107.03 18.42 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.075 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.595 ' O ' HG11 ' A' ' 15' ' ' VAL . 30.1 t-20 -65.82 -53.15 37.24 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.491 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 134' ' ' ASN . 15.3 Cg_endo -56.48 145.74 78.26 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.728 2.286 . . . . 0.0 111.744 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.593 ' HG2' ' H ' ' A' ' 137' ' ' ASN . 39.0 tttp -151.56 -150.64 0.35 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.377 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.593 ' H ' ' HG2' ' A' ' 136' ' ' LYS . 20.4 t-20 63.51 52.68 2.26 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -84.27 -29.32 26.53 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.625 -178.215 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -151.68 17.85 0.7 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.2 tp 70.63 147.85 0.07 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.879 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -123.2 66.33 0.5 Allowed Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.645 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.2 m -74.34 120.4 81.24 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.434 ' HA ' ' HB3' ' A' ' 122' ' ' LEU . 55.1 Cg_endo -76.86 -99.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.456 2.104 . . . . 0.0 112.705 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 62.36 92.93 0.05 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.18 0.514 . . . . 0.0 112.063 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.96 91.47 0.55 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -90.93 86.98 6.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.131 0.491 . . . . 0.0 112.23 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.413 ' C ' HD23 ' A' ' 148' ' ' LEU . 7.8 pt20 -164.34 138.59 5.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.615 176.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.413 HD23 ' C ' ' A' ' 147' ' ' GLN . 14.2 mt -108.78 156.05 20.07 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 121.636 0.732 . . . . 0.0 111.825 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.778 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -113.02 136.92 52.16 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.581 -173.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 11.6 mt-10 -91.25 148.08 22.59 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.828 -1.078 . . . . 0.0 113.12 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.936 HD12 ' HB3' ' A' ' 115' ' ' ASP . 86.8 mt -78.97 109.63 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.897 176.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.594 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 1.5 mmmp? -68.12 -42.87 79.59 Favored 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.01 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -150.03 135.3 18.06 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 82.6 mt -118.92 129.29 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.639 -1.618 . . . . 0.0 111.058 174.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.455 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 1.8 ptpp? -133.17 163.0 30.24 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.648 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.513 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 13.5 m-85 -100.82 119.25 38.39 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.411 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -129.04 174.62 11.99 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.97 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.856 -178.472 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -109.91 166.4 10.96 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.305 -0.958 . . . . 0.0 112.282 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.66 137.1 58.13 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.914 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -101.48 31.05 3.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.974 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -170.99 -178.82 2.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -95.28 -13.26 25.0 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.072 0.463 . . . . 0.0 110.247 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.26 166.09 23.6 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.289 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.1 m -130.91 157.4 43.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 77.3 m-85 -138.46 159.97 40.73 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.734 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.525 ' HB3' HD13 ' A' ' 68' ' ' ILE . 7.8 t -148.34 -18.33 0.33 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.448 174.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.758 ' HG ' HD23 ' A' ' 24' ' ' LEU . 4.1 mm? 60.29 95.22 0.03 OUTLIER 'General case' 0 C--N 1.347 0.486 0 O-C-N 123.75 0.657 . . . . 0.0 111.04 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -82.44 102.61 11.42 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.127 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.587 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -97.5 -149.32 0.33 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.227 172.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 171' ' ' LYS . 18.8 tptp -62.01 135.2 57.44 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 170' ' ' LYS . 51.5 mttp 71.01 -133.45 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.75 0.656 . . . . 0.0 109.446 -175.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -140.49 122.56 15.67 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.498 ' NE2' ' HG2' ' A' ' 94' ' ' PRO . 9.9 p-80 36.46 32.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.551 1.54 . . . . 0.0 115.121 177.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 183' ' ' THR . 0.5 OUTLIER -95.01 99.76 11.72 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.998 0.428 . . . . 0.0 110.435 177.727 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.696 HG21 HD11 ' A' ' 8' ' ' ILE . 2.5 p -150.13 167.03 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.044 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.566 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 90.5 mt -96.85 115.3 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.823 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.414 HD13 ' CE1' ' A' ' 2' ' ' PHE . 31.7 pt -118.47 166.51 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 121.307 0.575 . . . . 0.0 111.281 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 37.6 t30 46.16 -126.57 1.39 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 124.774 1.23 . . . . 0.0 111.028 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -91.07 59.31 3.99 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.603 0.716 . . . . 0.0 109.355 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.732 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 24.0 m-80 66.08 44.65 2.58 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 113.851 -1.522 . . . . 0.0 114.18 176.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.41 ' O ' HG12 ' A' ' 177' ' ' ILE . 91.3 mt -91.68 113.74 27.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.4 m -91.5 153.6 3.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.905 0.859 . . . . 0.0 112.394 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 1.4 t -151.15 156.85 41.82 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.261 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -163.58 155.68 17.53 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 . . . . . 0 C--O 1.269 2.131 0 CA-C-O 117.647 -1.168 . . . . 0.0 110.648 177.083 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.513 ' H2 ' ' HB2' ' A' ' 93' ' ' HIS . 64.0 m . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.655 0.264 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 183' ' ' THR . 12.4 m-85 -133.95 159.36 72.71 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.543 ' HD3' HD13 ' A' ' 76' ' ' LEU . 67.8 Cg_endo -70.4 161.57 45.55 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 N-CA-C 108.68 -1.315 . . . . 0.0 108.68 177.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.437 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -61.64 -23.67 63.24 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 119.316 -1.421 . . . . 0.0 111.692 177.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.57 -21.23 60.03 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.28 0.562 . . . . 0.0 112.185 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.436 ' HB ' HD12 ' A' ' 21' ' ' LEU . 97.9 m -62.97 126.33 26.96 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.969 -177.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 35.4 mmt180 -80.3 130.83 35.46 Favored 'General case' 0 C--O 1.184 -2.368 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.764 HD11 HG21 ' A' ' 175' ' ' VAL . 7.7 tt -120.3 130.1 74.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.743 HD21 HD11 ' A' ' 124' ' ' LEU . 1.1 tm? -87.34 124.42 33.35 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-O 121.458 0.647 . . . . 0.0 110.317 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 30.3 m -135.89 -178.5 2.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.189 -178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.467 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 30.7 tt0 -130.79 122.64 27.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.56 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 20.4 mt -121.03 120.85 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.568 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.659 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 52.46 40.61 29.97 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.303 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.27 18.3 79.21 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.8 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.3 t -122.5 120.16 28.06 Favored Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.681 ' HB2' HD22 ' A' ' 124' ' ' LEU . 59.6 Cg_endo -74.8 125.23 9.29 Favored 'Trans proline' 0 N--CA 1.427 -2.393 0 C-N-CA 122.207 1.938 . . . . 0.0 110.926 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -128.37 142.34 51.15 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.935 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.572 ' CE ' HD23 ' A' ' 9' ' ' LEU . 5.1 tppp? -108.56 99.85 9.18 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -121.31 -172.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.847 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 20.0 p -98.95 174.11 6.52 Favored 'General case' 0 C--N 1.28 -2.441 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.127 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 65.5 mt -68.54 -28.63 67.15 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.717 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.847 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 11.6 ptm180 -76.85 -26.92 54.84 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.531 ' OE1' HG23 ' A' ' 20' ' ' THR . 49.4 mt-10 -85.28 -36.22 21.01 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.191 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.777 HD21 HD22 ' A' ' 167' ' ' LEU . 15.5 tp -66.11 -44.24 84.89 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.129 0.49 . . . . 0.0 111.234 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.778 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -58.6 -26.51 63.74 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.401 -175.656 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.442 ' OE1' ' HA ' ' A' ' 23' ' ' GLU . 24.9 mt-10 -68.09 -19.02 64.82 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.665 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.37 0.33 42.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.447 0.642 . . . . 0.0 110.091 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.577 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.1 m-85 -117.15 163.34 16.43 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.005 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -145.76 -171.91 3.79 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.997 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 t0 63.53 75.43 0.39 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.845 0.831 . . . . 0.0 110.139 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.36 128.91 44.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.474 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.505 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.3 ptt180 -120.51 153.37 36.77 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.323 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -103.74 128.77 51.09 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -166.52 143.4 4.92 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.035 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 60.84 21.03 11.2 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 123.662 0.601 . . . . 0.0 110.783 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 33.5 mtt 71.28 19.62 5.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.648 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' HD2' ' A' ' 71' ' ' PRO . 17.2 m -133.26 -175.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -117.45 142.09 47.56 Favored 'General case' 0 CA--C 1.477 -1.836 0 CA-C-O 121.267 0.556 . . . . 0.0 110.497 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.3 t -130.01 124.3 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.861 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.426 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 28.8 ttm180 -114.75 126.32 54.71 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.35 145.17 51.06 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.398 -174.488 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 51.5 tptt 80.33 114.86 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.504 0 O-C-N 124.574 1.171 . . . . 0.0 110.697 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.538 ' HB2' HD13 ' A' ' 47' ' ' ILE . 58.0 Cg_endo -77.42 158.56 32.8 Favored 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 121.947 1.765 . . . . 0.0 111.735 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -90.57 -3.44 57.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.422 0.629 . . . . 0.0 110.461 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -148.72 -165.68 2.34 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.647 ' OE1' ' HE3' ' A' ' 48' ' ' LYS . 7.1 tp10 -84.01 96.7 8.95 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.577 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.8 mp -116.78 115.63 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.031 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.647 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 34.6 mmtp -118.79 166.13 13.17 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.314 173.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.489 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.2 p -122.92 134.3 66.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.662 -175.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 11' ' ' GLN . 20.2 m-85 -88.18 123.54 32.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.494 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.9 m -136.56 147.56 47.08 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.217 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.549 HG12 HD11 ' A' ' 176' ' ' ILE . 2.2 mm -93.21 143.54 11.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.222 0.534 . . . . 0.0 110.343 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.46 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 28.3 t70 -87.3 123.47 32.32 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.4 mt -70.44 -28.82 65.33 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-O 122.109 0.957 . . . . 0.0 111.844 -172.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -83.51 -30.7 26.94 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.507 -172.629 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.7 p -114.87 -22.29 9.7 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.654 -175.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.39 20.73 71.4 Favored Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.524 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.506 ' C ' HD13 ' A' ' 52' ' ' ILE . 27.6 mttm -99.98 153.84 18.87 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.85 106.58 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 CA-C-O 121.769 0.795 . . . . 0.0 110.126 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.72 167.06 5.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.887 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.9 tp -119.72 141.76 49.13 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.9 t -146.98 171.8 14.7 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.853 0.359 . . . . 0.0 111.329 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.534 ' OD2' ' HE2' ' A' ' 48' ' ' LYS . 7.0 m-20 -82.2 161.06 22.88 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.556 0.693 . . . . 0.0 110.552 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.552 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.7 mp -99.21 140.92 17.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.244 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.411 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 6.7 mm-40 -88.18 -35.26 17.48 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 173.79 174.15 0.15 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.579 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 25' ' ' TYR . 13.8 t -104.92 132.93 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.192 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.66 HD12 ' HB2' ' A' ' 166' ' ' SER . 49.7 mt -92.21 113.49 27.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.478 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.438 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 86.6 tttt -127.57 109.34 11.61 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.78 141.62 42.63 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.77 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.474 ' HD2' HG12 ' A' ' 37' ' ' VAL . 8.1 Cg_endo -52.62 129.59 32.95 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.384 2.723 . . . . 0.0 112.41 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.95 73.63 9.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.351 0.596 . . . . 0.0 110.622 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.2 p -71.7 -38.59 70.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.913 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.52 -172.31 2.73 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.323 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.645 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 19.2 m170 -111.98 172.32 6.97 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 90' ' ' THR . 7.1 mt -122.48 146.87 46.99 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.541 0.686 . . . . 0.0 112.007 -175.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.552 HD12 ' C ' ' A' ' 108' ' ' ALA . 20.5 mt -87.82 145.52 7.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.554 ' HB3' ' CG ' ' A' ' 155' ' ' LYS . 41.8 ttt85 -122.07 140.88 51.98 Favored 'General case' 0 N--CA 1.404 -2.752 0 CA-C-O 121.301 0.572 . . . . 0.0 109.945 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 86' ' ' SER . 57.5 m-85 -114.71 125.49 53.79 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.586 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.7 tt0 -109.4 123.52 49.48 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.716 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.71 159.65 17.7 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.502 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.811 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.9 pt-20 -63.61 -15.25 57.66 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.456 0.646 . . . . 0.0 111.116 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.06 -10.24 36.82 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.487 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.02 12.77 54.85 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.839 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.564 ' O ' HD23 ' A' ' 81' ' ' LEU . 1.6 mtt180 -83.84 139.3 32.74 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 15.7 p -143.01 136.99 28.97 Favored 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.523 176.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -133.06 151.56 52.03 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.559 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.474 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 99.3 mt-10 -123.54 152.2 42.06 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.328 0.585 . . . . 0.0 112.097 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.512 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -142.21 155.33 45.27 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.238 178.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.649 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -72.01 16.85 0.11 Allowed 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 121.621 0.725 . . . . 0.0 111.56 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.037 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.9 OUTLIER 71.05 -29.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 125.64 1.576 . . . . 0.0 113.06 176.708 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -82.61 -5.1 58.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.972 0.415 . . . . 0.0 110.493 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.513 ' HB2' ' H2 ' ' A' ' 1' ' ' CYS . 60.6 t-80 -94.86 125.66 50.13 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.57 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 37.9 Cg_exo -63.1 142.28 86.62 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.968 2.445 . . . . 0.0 112.937 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.2 t -112.17 146.19 17.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.432 ' CD1' ' HG3' ' A' ' 105' ' ' GLU . 18.2 tp -101.75 111.46 23.72 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.975 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.57 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.3 p -113.7 150.85 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.345 0.593 . . . . 0.0 111.595 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -102.36 96.02 6.67 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.41 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.451 ' CD ' HD11 ' A' ' 104' ' ' ILE . 11.9 pt-20 -145.56 155.02 42.8 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 83.1 m-20 63.74 23.09 13.35 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.205 0.526 . . . . 0.0 110.332 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.12 12.49 60.52 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.872 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -131.2 170.83 14.04 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-O 121.478 0.656 . . . . 0.0 110.043 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -105.95 121.96 45.16 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.515 HG13 HG13 ' A' ' 97' ' ' VAL . 19.1 pt -122.36 146.77 27.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.007 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 26.7 mp0 -105.01 107.78 18.95 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.988 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 12.0 ptpt -118.38 135.2 54.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.422 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.637 ' O ' HG23 ' A' ' 111' ' ' VAL . 80.3 mtt180 -61.59 160.6 11.08 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.037 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -58.84 -43.41 90.73 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.212 -177.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.409 ' HB3' ' CG2' ' A' ' 91' ' ' VAL . 1.7 p90 -75.43 7.44 3.58 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.885 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -118.32 -17.95 9.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.443 0.639 . . . . 0.0 110.037 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 107' ' ' ARG . 89.4 t -73.15 149.18 8.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.198 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.685 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 69.7 mmtt -115.74 168.19 10.26 Favored 'General case' 0 CA--C 1.486 -1.503 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.382 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -77.71 142.05 38.98 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.11 4.2 74.97 Favored Glycine 0 C--N 1.305 -1.144 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -174.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.685 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -74.69 173.43 10.5 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -129.66 167.28 18.22 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.58 0.705 . . . . 0.0 111.604 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.81 159.82 39.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.738 170.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.8 135.54 37.4 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.9 OUTLIER -106.35 160.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.687 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.459 ' C ' ' H ' ' A' ' 122' ' ' LEU . 84.3 p -74.61 -1.04 19.83 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.024 0.44 . . . . 0.0 111.163 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.536 ' OE1' HG23 ' A' ' 119' ' ' VAL . 4.4 mm-40 63.56 -16.09 0.07 Allowed 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 124.842 1.257 . . . . 0.0 113.035 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.459 ' H ' ' C ' ' A' ' 120' ' ' SER . 43.2 tp -135.57 126.5 27.66 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -172.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.423 ' HG2' ' ND2' ' A' ' 180' ' ' ASN . 24.4 mt-10 -102.37 -151.6 0.43 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.946 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.743 HD11 HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -116.27 3.27 13.39 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.529 0.68 . . . . 0.0 109.593 -174.44 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.9 p -176.85 161.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.725 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.46 160.13 19.93 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -60.17 147.58 39.27 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.3 t 64.58 -154.37 0.29 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.739 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.9 m 74.31 -50.12 0.68 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.469 0.708 . . . . 0.0 112.437 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 133' ' ' ASP . 22.9 t -135.89 136.37 40.47 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 120.987 0.423 . . . . 0.0 111.037 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.3 m -104.54 -16.91 14.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.213 0.53 . . . . 0.0 110.063 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -169.76 124.23 0.78 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.322 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.537 ' OD1' ' HD2' ' A' ' 135' ' ' PRO . 1.2 t70 -155.73 -171.52 3.79 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . 6.2 t30 -160.92 -49.6 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.487 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 134' ' ' ASN . 7.8 Cg_exo -77.73 -137.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.602 2.201 . . . . 0.0 110.634 173.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.4 tttp 74.35 109.05 0.07 Allowed 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.871 0.843 . . . . 0.0 110.0 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -153.41 37.85 0.48 Allowed 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.036 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.47 24.36 7.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.681 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -162.75 159.93 24.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 140' ' ' LEU . 0.2 OUTLIER -78.97 -60.17 2.48 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.701 0.286 . . . . 0.0 111.454 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.462 ' H ' ' HG ' ' A' ' 140' ' ' LEU . . . 52.35 48.03 55.04 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.334 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.458 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 36.4 t -100.99 117.46 62.4 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.731 0.3 . . . . 0.0 111.381 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 142' ' ' SER . 4.4 Cg_exo -83.08 171.94 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.936 2.424 . . . . 0.0 110.677 174.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 145' ' ' HIS . 0.0 OUTLIER -128.21 -65.15 0.91 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 177.554 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.458 ' CE1' ' HG3' ' A' ' 147' ' ' GLN . 3.4 t-80 55.32 115.64 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.378 1.071 . . . . 0.0 113.796 176.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.424 ' HA ' ' OE2' ' A' ' 121' ' ' GLU . 8.9 p-10 -136.49 68.22 1.44 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.758 0.789 . . . . 0.0 110.649 174.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.458 ' HG3' ' CE1' ' A' ' 145' ' ' HIS . 14.4 pt20 -165.38 142.06 5.59 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.371 -177.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.9 mt -99.28 150.98 21.56 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-O 121.348 0.594 . . . . 0.0 109.721 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.811 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -107.51 133.68 51.64 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -172.161 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -88.04 145.65 25.87 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.628 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.469 HD13 ' CD1' ' A' ' 79' ' ' PHE . 67.6 mt -79.8 105.55 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.773 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.199 173.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 7.1 mmpt? -70.7 -37.43 73.57 Favored 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 114.645 -1.162 . . . . 0.0 110.682 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -149.96 133.42 16.56 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 71.3 mt -112.74 140.05 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.977 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.554 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.9 ptpt -139.82 152.91 46.9 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.171 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.496 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.2 m-85 -97.75 104.6 16.64 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-O 121.806 0.812 . . . . 0.0 108.825 173.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.645 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -108.02 175.77 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.266 -3.034 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.701 -178.378 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.405 ' HA ' ' CG ' ' A' ' 75' ' ' HIS . 19.5 ptt85 -80.74 -145.69 0.05 Allowed 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 121.79 0.805 . . . . 0.0 111.443 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -131.4 99.82 4.96 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -46.39 -49.91 17.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.085 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -102.3 170.68 7.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.041 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -88.6 -4.1 58.65 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.096 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -139.81 155.57 47.2 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.622 176.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.81 156.53 30.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.614 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 65.4 m-85 -133.55 171.51 14.0 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.66 ' HB2' HD12 ' A' ' 68' ' ' ILE . 70.7 m -160.17 -25.0 0.06 Allowed 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.777 HD22 HD21 ' A' ' 24' ' ' LEU . 9.1 tp 68.17 111.79 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.215 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.404 ' OD1' ' HD1' ' A' ' 172' ' ' TYR . 66.0 t30 -87.3 115.77 24.94 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.912 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.489 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -136.85 -166.72 1.95 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 172' ' ' TYR . 45.0 mmtt -63.25 146.15 54.03 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 67.4 mttm 80.19 -24.34 0.21 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.878 -174.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.423 ' H ' ' C ' ' A' ' 170' ' ' LYS . 42.7 m-85 64.03 132.5 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.878 1.271 . . . . 0.0 113.253 176.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 184' ' ' HIS . 34.8 m80 52.78 31.63 10.85 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.153 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 183' ' ' THR . 30.5 t30 -132.2 110.33 10.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.764 HG21 HD11 ' A' ' 8' ' ' ILE . 1.4 p -154.23 160.72 2.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.12 0.486 . . . . 0.0 111.307 -177.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.549 HD11 HG12 ' A' ' 52' ' ' ILE . 97.9 mt -96.55 115.64 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.213 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.567 HG23 HG13 ' A' ' 175' ' ' VAL . 47.3 pt -123.5 174.49 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.225 -175.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.479 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 2.9 t-20 47.07 -129.39 1.53 Allowed 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.062 0.945 . . . . 0.0 110.673 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.24 48.95 1.65 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.513 0.673 . . . . 0.0 109.847 176.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 3.7 m-20 68.79 47.19 0.84 Allowed 'General case' 0 CA--C 1.495 -1.145 0 C-N-CA 125.445 1.498 . . . . 0.0 113.171 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.4 HD12 ' HB3' ' A' ' 178' ' ' ASN . 82.5 mt -91.04 115.88 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.589 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.9 m -80.36 158.84 4.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.418 0.627 . . . . 0.0 110.558 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 5.1 t -161.31 153.48 19.89 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.488 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 25.6 t-80 -152.26 148.96 28.17 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 . . . . . 0 C--O 1.256 1.41 0 CA-C-O 118.549 -0.739 . . . . 0.0 111.08 178.085 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.703 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 4.5 t . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.41 ' CE1' HD13 ' A' ' 177' ' ' ILE . 20.6 m-85 -112.64 154.89 44.58 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -175.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.517 ' HD3' HD13 ' A' ' 76' ' ' LEU . 27.8 Cg_endo -62.74 -34.72 72.34 Favored 'Trans proline' 0 N--CA 1.479 0.637 0 C-N-CA 123.2 2.6 . . . . 0.0 112.321 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.509 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 130.36 -39.79 1.76 Allowed Glycine 0 N--CA 1.423 -2.212 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.49 -9.3 8.13 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 121.468 0.651 . . . . 0.0 111.556 176.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.8 m -69.27 129.07 38.77 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.915 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.601 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 16.4 mtm180 -84.07 138.22 33.17 Favored 'General case' 0 C--O 1.184 -2.388 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.717 HD11 HG21 ' A' ' 175' ' ' VAL . 10.0 tt -123.02 131.55 73.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-O 120.83 0.347 . . . . 0.0 110.217 177.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.535 HD21 HD11 ' A' ' 124' ' ' LEU . 2.2 tm? -90.49 123.81 34.48 Favored 'General case' 0 N--CA 1.405 -2.707 0 CA-C-O 121.619 0.723 . . . . 0.0 110.657 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.5 m -133.08 -174.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.144 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 30.7 tt0 -134.7 123.2 23.32 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.623 HG12 HG13 ' A' ' 47' ' ' ILE . 20.4 mt -122.63 123.28 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 CA-C-O 121.422 0.63 . . . . 0.0 110.358 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.9 36.67 27.74 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.972 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.4 21.14 79.54 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.627 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.4 t -127.54 114.82 21.13 Favored Pre-proline 0 N--CA 1.432 -1.342 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.733 ' HB2' ' HG ' ' A' ' 124' ' ' LEU . 17.3 Cg_exo -63.32 123.76 12.68 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 122.579 2.186 . . . . 0.0 111.31 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -126.98 136.41 52.22 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HB2' HD23 ' A' ' 9' ' ' LEU . 38.0 ttmt -108.55 102.15 11.25 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.627 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.6 pt -124.18 -171.7 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.132 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.954 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.713 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 17.8 p -95.48 169.78 9.81 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.249 -0.981 . . . . 0.0 110.673 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.549 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.4 mm? -67.74 -23.6 65.27 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.674 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.713 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 3.1 ptm180 -85.9 -24.32 26.67 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.609 ' OE1' HG23 ' A' ' 20' ' ' THR . 49.2 mt-10 -84.84 -42.08 15.43 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.972 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 19' ' ' ILE . 30.7 tp -57.44 -42.55 82.64 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 122.042 0.925 . . . . 0.0 109.897 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.742 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.9 m-30 -53.86 -30.73 46.88 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.393 -1.73 . . . . 0.0 113.084 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -74.39 -15.73 60.91 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.347 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.422 ' HB3' HD11 ' A' ' 47' ' ' ILE . 2.5 mm? -80.77 6.38 13.12 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.534 0.683 . . . . 0.0 109.775 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.559 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 98.1 m-85 -118.47 165.66 13.63 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.309 -178.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.516 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 3.4 mm-40 -143.97 -173.68 4.06 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.34 175.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 4.1 t70 64.26 86.74 0.12 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.583 0.706 . . . . 0.0 110.359 -179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -104.07 122.25 44.9 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.558 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -111.27 150.31 29.82 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.962 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.415 ' CZ ' ' HA ' ' A' ' 36' ' ' MET . 24.2 t80 -107.44 131.78 53.91 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' O ' HG22 ' A' ' 37' ' ' VAL . 7.5 tp10 -166.24 141.42 4.59 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.515 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 59.97 22.12 11.2 Favored 'General case' 0 CA--C 1.494 -1.182 0 O-C-N 123.573 0.545 . . . . 0.0 111.367 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 33' ' ' TYR . 41.7 mtm 72.75 19.52 3.93 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.998 0.811 . . . . 0.0 110.875 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.534 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 6.0 m -131.27 -179.55 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.498 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 88.7 m-85 -116.81 145.22 43.68 Favored 'General case' 0 CA--C 1.482 -1.644 0 CA-C-O 121.387 0.613 . . . . 0.0 110.438 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.8 t -130.23 123.53 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.747 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.61 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 39.5 ttm180 -116.8 126.32 52.9 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -134.62 144.89 48.14 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.595 -175.104 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' HD3' ' O ' ' A' ' 43' ' ' PRO . 12.6 tmtt? 86.93 109.61 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.409 0 O-C-N 124.899 1.375 . . . . 0.0 109.989 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.644 ' HB2' HD13 ' A' ' 47' ' ' ILE . 61.5 Cg_endo -78.18 151.97 27.15 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 122.149 1.899 . . . . 0.0 111.615 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.516 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 36.7 mtmt -83.0 -7.4 59.67 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.191 0.519 . . . . 0.0 111.12 -177.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -144.92 -165.41 2.15 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 8.7 tp10 -85.98 101.66 13.1 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.644 HD13 ' HB2' ' A' ' 43' ' ' PRO . 1.5 mp -115.03 117.41 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.966 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.514 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 32.4 mmtt -116.91 168.47 10.2 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 173.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.502 ' CG1' HG23 ' A' ' 62' ' ' THR . 9.5 p -125.51 128.81 72.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.04 132.16 34.36 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.966 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.408 ' HA ' HG13 ' A' ' 176' ' ' ILE . 21.5 t -139.12 177.15 8.11 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 59' ' ' VAL . 2.7 mm -116.34 141.72 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.342 0.591 . . . . 0.0 110.844 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.765 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 24.7 t70 -80.11 116.31 20.16 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.152 178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.745 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.2 mm? -73.57 -13.63 61.06 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.177 0.513 . . . . 0.0 112.191 -171.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.765 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -96.85 -26.25 15.16 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.849 -175.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.41 ' CB ' ' HD3' ' A' ' 58' ' ' LYS . 71.4 p -120.69 -25.68 5.44 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.887 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.48 9.18 65.12 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.421 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.42 ' O ' HD13 ' A' ' 52' ' ' ILE . 3.3 mptp? -81.88 159.66 23.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.157 0.583 . . . . 0.0 111.623 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.471 ' HA ' HD13 ' A' ' 52' ' ' ILE . 7.3 p -92.53 113.95 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 CA-C-O 121.943 0.878 . . . . 0.0 109.904 178.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -111.1 160.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.972 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.76 142.64 49.37 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.502 HG23 ' CG1' ' A' ' 49' ' ' VAL . 8.8 t -145.17 172.56 12.93 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.439 -177.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.42 161.02 14.82 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.611 0.719 . . . . 0.0 110.867 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.565 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.6 mp -94.59 142.61 13.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.488 -177.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.591 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.6 mm-40 -85.14 -46.28 11.26 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -179.84 -168.01 0.1 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.313 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.61 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 37.5 t -114.07 128.6 70.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.867 -175.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 166' ' ' SER . 19.9 mt -92.6 102.12 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.1 -176.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.534 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 48.3 tttp -120.95 110.08 15.86 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.615 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.53 141.3 40.73 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.093 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.454 ' HD2' HG12 ' A' ' 37' ' ' VAL . 5.9 Cg_endo -50.43 140.23 35.61 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.469 2.779 . . . . 0.0 112.86 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.26 94.15 2.45 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.16 0.505 . . . . 0.0 110.29 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.9 p -89.01 -70.96 0.62 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.13 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.47 -175.06 5.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.26 0.553 . . . . 0.0 111.775 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 34.5 m170 -101.48 172.45 6.97 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.082 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.1 mt -125.04 142.12 51.69 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.66 0.743 . . . . 0.0 111.807 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.563 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 9.9 mt -87.16 144.6 8.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 8.3 ttt180 -119.46 137.54 53.71 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.128 0.49 . . . . 0.0 109.686 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 86' ' ' SER . 52.4 m-85 -115.35 126.71 54.76 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.603 -178.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 57.6 tt0 -111.66 125.24 53.75 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.73 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -90.49 158.44 17.03 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.605 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.765 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -60.4 -18.12 48.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.271 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -90.76 -12.47 36.41 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.794 0.807 . . . . 0.0 109.556 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.41 16.69 39.22 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.88 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.582 ' O ' HD23 ' A' ' 81' ' ' LEU . 2.9 mtt180 -86.13 137.11 32.91 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.3 p -139.81 136.66 34.27 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.046 -1.062 . . . . 0.0 112.565 176.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -132.77 150.75 52.12 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.261 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.48 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 73.1 mt-10 -126.95 149.14 49.98 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.478 -176.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.9 OUTLIER -146.66 161.35 40.75 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.925 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.749 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -70.89 15.16 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.451 0.7 . . . . 0.0 112.66 -176.481 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.01 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 72.03 -34.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 125.253 1.421 . . . . 0.0 112.93 177.325 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.469 ' OD1' ' HB ' ' A' ' 90' ' ' THR . 6.1 p-10 -84.42 -5.52 59.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.13 0.491 . . . . 0.0 110.238 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 57.7 t-80 -84.45 126.49 69.05 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.799 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 23.0 Cg_exo -65.9 124.14 12.28 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.842 2.362 . . . . 0.0 112.942 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.8 t -97.85 147.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.645 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.506 ' HB2' ' N ' ' A' ' 184' ' ' HIS . 9.5 tp -101.26 107.38 18.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.984 0.421 . . . . 0.0 111.102 -177.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.601 HG21 ' OD1' ' A' ' 115' ' ' ASP . 1.6 p -113.29 147.78 16.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.549 0.69 . . . . 0.0 111.87 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -105.2 93.12 4.51 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.046 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.635 ' CG ' HD11 ' A' ' 104' ' ' ILE . 8.1 pt-20 -137.68 159.52 41.75 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.0 m-20 63.27 21.43 12.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.327 0.584 . . . . 0.0 109.753 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.45 16.23 62.63 Favored Glycine 0 N--CA 1.436 -1.367 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.326 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -135.93 172.91 12.33 Favored 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 117.859 0.829 . . . . 0.0 109.844 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -100.55 120.45 40.04 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.635 HD11 ' CG ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -123.16 148.12 27.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.209 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 23.7 mt-10 -104.99 110.52 22.96 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.414 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.514 ' HE3' HG11 ' A' ' 97' ' ' VAL . 77.7 mttt -117.76 134.74 54.6 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.594 ' O ' HG23 ' A' ' 111' ' ' VAL . 4.4 mpt_? -60.73 164.13 4.96 Favored 'General case' 0 C--O 1.215 -0.725 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.01 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -62.04 -41.32 97.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 118.955 -1.098 . . . . 0.0 109.539 -178.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.461 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 3.1 p90 -73.32 -2.63 22.83 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.691 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.469 ' HB3' ' N ' ' A' ' 107' ' ' ARG . 49.3 tp10 -109.68 -15.28 14.19 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.565 0.697 . . . . 0.0 109.988 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 107' ' ' ARG . 79.3 t -82.46 148.76 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.648 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 30.7 mttt -125.65 165.63 18.21 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.035 0.445 . . . . 0.0 111.129 -176.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.83 141.19 58.86 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.928 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.3 4.1 77.85 Favored Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.988 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.648 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -77.55 168.3 20.21 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.406 ' HE3' ' HG3' ' A' ' 150' ' ' GLU . 32.0 mttp -121.41 167.98 12.19 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 121.363 0.601 . . . . 0.0 111.149 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.58 159.96 39.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.993 170.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.48 133.11 35.78 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.7 OUTLIER -102.04 157.7 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.86 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.525 ' HB3' HD22 ' A' ' 180' ' ' ASN . 43.9 t -72.55 7.88 1.67 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.893 0.378 . . . . 0.0 110.953 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 145' ' ' HIS . 26.4 mt-10 65.68 -27.97 0.11 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.525 1.13 . . . . 0.0 113.861 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 120' ' ' SER . 34.1 tp -126.92 126.65 43.6 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -172.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -94.15 115.87 28.21 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.959 175.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.733 ' HG ' ' HB2' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -55.4 -29.37 58.41 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 121.621 0.724 . . . . 0.0 112.013 178.017 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.519 ' H ' HD13 ' A' ' 124' ' ' LEU . 22.8 t -39.51 148.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 CA-C-N 113.114 -1.857 . . . . 0.0 110.845 172.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -115.28 135.55 54.04 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 122.162 -0.337 . . . . 0.0 110.87 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -55.53 -62.94 1.35 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.171 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.9 t -94.01 61.99 3.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.409 0.623 . . . . 0.0 109.785 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.9 p -84.43 102.95 13.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.199 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.0 p -94.21 152.95 18.33 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.231 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.8 m 62.55 84.22 0.14 Allowed 'General case' 0 C--O 1.237 0.418 0 O-C-N 123.85 0.719 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -66.82 129.8 41.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.21 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 134' ' ' ASN . 12.4 t70 -147.37 -155.47 0.63 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.037 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.468 ' H ' ' CG ' ' A' ' 133' ' ' ASP . 3.1 t-20 -65.9 -49.88 56.06 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 134' ' ' ASN . 2.8 Cg_endo -82.56 -12.09 10.24 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.886 2.39 . . . . 0.0 113.907 -175.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -145.8 105.25 3.95 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.65 -46.02 1.45 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.418 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.8 mp0 -79.13 125.86 29.98 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.503 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -82.47 171.8 13.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 45.7 tp 68.36 -79.81 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.498 0.498 . . . . 0.0 110.88 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 53.27 56.93 16.93 Favored Glycine 0 C--N 1.318 -0.417 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.895 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.1 m -65.76 117.69 44.16 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-O 120.615 0.245 . . . . 0.0 110.611 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.1 -60.63 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.374 2.716 . . . . 0.0 112.879 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 61.29 80.0 0.23 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.459 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.607 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 1.6 p80 -104.72 174.03 6.05 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.304 -176.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.4 t70 67.6 23.99 8.67 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.026 0.917 . . . . 0.0 109.946 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.607 ' HG2' ' O ' ' A' ' 145' ' ' HIS . 7.8 pt20 -156.91 137.6 13.23 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.362 -177.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 147' ' ' GLN . 18.5 mt -111.49 159.83 17.71 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-O 121.227 0.537 . . . . 0.0 110.257 177.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.765 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -111.15 135.83 51.1 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.822 -172.836 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.412 ' H ' HD13 ' A' ' 149' ' ' LEU . 23.9 mt-10 -90.52 147.41 23.39 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.448 1.118 . . . . 0.0 112.557 175.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.469 HG21 ' CG1' ' A' ' 154' ' ' ILE . 74.9 mt -79.01 110.03 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.648 0 CA-C-N 113.355 -1.748 . . . . 0.0 110.607 176.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 80' ' ' GLU . 29.7 mtmt -63.48 -46.69 85.02 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.748 175.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -150.6 135.69 17.68 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 76.5 mt -118.92 130.72 73.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.981 176.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.608 ' HD3' HG13 ' A' ' 157' ' ' VAL . 3.3 ptpp? -134.23 163.51 29.46 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.57 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.563 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.8 m-85 -101.34 120.36 40.14 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.844 175.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.608 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -131.56 174.45 13.12 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.603 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.983 -177.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -104.65 163.85 12.19 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.345 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.06 126.31 29.41 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.859 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -71.11 -40.55 71.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.372 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.19 176.33 6.27 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -95.59 -2.29 48.64 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.405 0.621 . . . . 0.0 110.12 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -136.84 154.91 50.39 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.45 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.443 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 0.9 OUTLIER -118.32 151.46 20.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.647 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.742 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 9.8 m-85 -134.67 164.42 27.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.19 -170.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.703 ' OG ' ' HA ' ' A' ' 1' ' ' CYS . 74.5 m -158.55 -18.03 0.07 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.275 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.459 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 2.1 tm? 60.04 106.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.917 0.865 . . . . 0.0 111.462 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -90.33 125.26 35.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.856 0.836 . . . . 0.0 112.291 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.591 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -140.98 -130.06 0.1 Allowed 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.132 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.495 ' CB ' HG21 ' A' ' 62' ' ' THR . 81.0 tttt -61.53 128.48 36.52 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt 62.28 -12.03 0.07 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.426 ' H ' ' C ' ' A' ' 170' ' ' LYS . 22.4 m-85 68.29 133.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.954 0.902 . . . . 0.0 111.152 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 33.2 m170 66.63 -4.35 0.76 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -89.54 100.09 12.96 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.717 HG21 HD11 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -152.88 165.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-O 121.401 0.619 . . . . 0.0 112.322 -175.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.601 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.8 mt -105.74 117.43 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.059 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.535 HG23 HG13 ' A' ' 175' ' ' VAL . 44.7 pt -122.84 172.58 9.93 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.811 -176.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 7.4 t-20 48.99 -131.48 1.76 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.683 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -90.67 57.82 3.71 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.155 0.979 . . . . 0.0 109.502 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.742 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 6.2 m-20 68.03 48.83 0.93 Allowed 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.071 -1.877 . . . . 0.0 113.686 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.1 mt -90.03 113.91 26.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.932 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.67 126.61 40.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.156 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.8 t -126.49 150.42 48.74 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.115 177.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.506 ' N ' ' HB2' ' A' ' 96' ' ' LEU . 59.5 t60 60.96 140.35 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -176.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 . . . . . 0 C--O 1.257 1.477 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.895 178.176 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 89' ' ' THR . 72.2 m . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.203 0.525 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.512 ' CE1' HD13 ' A' ' 177' ' ' ILE . 2.8 m-85 -86.18 160.34 51.99 Favored Pre-proline 0 C--N 1.304 -1.385 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.19 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.576 ' HD3' HD13 ' A' ' 76' ' ' LEU . 18.3 Cg_endo -59.48 -77.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.299 1.999 . . . . 0.0 109.997 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.419 ' H ' ' HG2' ' A' ' 3' ' ' PRO . . . 179.73 -28.6 0.05 OUTLIER Glycine 0 N--CA 1.414 -2.78 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 176.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -67.18 -7.53 24.35 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.283 0.563 . . . . 0.0 111.584 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 23.9 m -67.7 130.22 42.32 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 19.3 mtm180 -84.55 133.88 34.43 Favored 'General case' 0 C--O 1.183 -2.442 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.64 HD11 HG21 ' A' ' 175' ' ' VAL . 10.1 tt -121.45 130.55 74.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 C-N-CA 122.736 0.415 . . . . 0.0 110.098 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.57 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -87.08 123.94 32.7 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 121.424 0.63 . . . . 0.0 109.597 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.2 m -135.41 -179.31 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.595 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 29.0 tt0 -129.95 122.32 28.31 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.883 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.594 HG12 HG13 ' A' ' 47' ' ' ILE . 18.2 mt -121.83 122.68 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.009 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.553 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.0 t0 55.66 37.39 28.81 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.764 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.39 16.08 78.89 Favored Glycine 0 C--N 1.309 -0.945 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.71 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.5 t -121.8 119.51 28.98 Favored Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.49 ' O ' HD13 ' A' ' 124' ' ' LEU . 36.2 Cg_endo -71.29 128.0 14.09 Favored 'Trans proline' 0 N--CA 1.431 -2.172 0 C-N-CA 122.111 1.874 . . . . 0.0 110.324 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -129.91 141.55 50.78 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -109.11 100.76 9.88 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -122.16 -173.16 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.181 -2.51 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.105 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.731 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 9.7 p -96.1 170.64 9.13 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.66 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.3 mm? -67.59 -27.11 66.64 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.445 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.731 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 6.6 ptm180 -84.06 -22.77 31.12 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' HB2' ' H ' ' A' ' 20' ' ' THR . 10.2 mm-40 -85.32 -42.27 14.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.819 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.504 ' HA ' HD12 ' A' ' 19' ' ' ILE . 27.5 tp -58.26 -44.21 88.28 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.967 0.889 . . . . 0.0 109.884 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.686 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.4 m-30 -55.35 -29.37 58.24 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 113.553 -1.658 . . . . 0.0 113.486 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 10.7 mm-40 -79.06 -11.75 60.0 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.02 -175.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.29 6.7 11.23 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.349 0.595 . . . . 0.0 109.528 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 97.6 m-85 -118.68 164.96 14.57 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.885 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.595 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 30.2 mt-10 -137.53 -172.86 3.33 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.575 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 2.5 t70 61.75 83.66 0.15 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.479 0.657 . . . . 0.0 111.082 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -99.0 122.42 42.24 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.536 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -113.59 150.57 32.88 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.342 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.505 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 28.1 t80 -106.87 129.62 54.68 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.316 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' O ' HG22 ' A' ' 37' ' ' VAL . 7.6 tp10 -167.46 142.27 3.83 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.696 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.6 m120 58.29 23.17 10.12 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 123.478 0.486 . . . . 0.0 111.457 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.505 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 43.8 mtm 72.24 18.66 4.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.814 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.527 HG12 ' HD2' ' A' ' 71' ' ' PRO . 4.3 m -129.37 179.92 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.433 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 81.1 m-85 -118.36 142.02 47.95 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.31 0.576 . . . . 0.0 110.278 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.36 123.77 60.66 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.928 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.622 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 40.9 ttm180 -115.06 126.55 54.83 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -134.2 146.73 50.42 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.98 -174.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 54.5 tptt 83.2 112.62 0.03 OUTLIER Pre-proline 0 C--N 1.318 -0.799 0 O-C-N 124.902 1.376 . . . . 0.0 110.868 -177.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.602 ' HB2' HD13 ' A' ' 47' ' ' ILE . 59.4 Cg_endo -78.79 152.26 25.22 Favored 'Trans proline' 0 N--CA 1.426 -2.482 0 C-N-CA 121.877 1.718 . . . . 0.0 111.4 177.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.595 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 36.2 mtmt -80.87 -6.23 58.36 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.796 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -147.09 -165.77 2.33 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 5.2 tp10 -86.21 100.07 11.99 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.602 HD13 ' HB2' ' A' ' 43' ' ' PRO . 1.3 mp -115.47 117.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.433 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 34.8 mmtp -119.91 166.66 13.02 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.689 174.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 175' ' ' VAL . 13.7 p -120.42 127.07 75.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.111 0.481 . . . . 0.0 112.186 -174.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CD1' HD12 ' A' ' 9' ' ' LEU . 6.5 m-85 -80.56 123.14 27.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.65 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.0 p -133.27 176.92 8.09 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.271 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.532 HG12 HD11 ' A' ' 176' ' ' ILE . 2.4 mm -122.96 140.26 47.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.248 0.547 . . . . 0.0 110.024 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -78.17 119.34 21.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.787 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -72.01 -14.0 61.77 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.106 0.479 . . . . 0.0 111.902 -171.591 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -99.41 -28.35 13.31 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.914 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.486 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.4 p -117.2 -26.24 6.84 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.728 -175.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.82 12.7 68.31 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.332 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.486 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 17.1 mtpp -85.97 158.01 19.99 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.64 109.33 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.368 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.3 m -112.58 157.93 13.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.085 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 tp -122.29 135.77 54.79 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -137.83 172.88 12.28 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.669 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.08 161.03 16.0 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.224 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.9 mp -96.34 144.62 10.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.304 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.478 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 48.5 mm-40 -91.07 -41.5 11.02 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -179.96 178.63 0.59 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.896 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 9.4 t -109.9 129.23 65.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.699 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.5 mt -97.19 102.3 13.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.826 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 45.5 tttp -116.87 107.73 14.97 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.84 137.24 30.47 Favored Pre-proline 0 C--N 1.31 -1.141 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.154 -176.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.527 ' HD2' HG12 ' A' ' 37' ' ' VAL . 80.9 Cg_exo -47.89 124.14 9.53 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 123.424 2.749 . . . . 0.0 113.116 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.46 80.01 8.74 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.948 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.6 m -86.91 -24.68 24.74 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.336 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -101.91 -179.7 4.08 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.042 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 59.5 m170 -111.37 172.31 6.96 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.426 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.591 ' CD2' ' HA ' ' A' ' 90' ' ' THR . 22.4 mt -123.78 146.71 48.13 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.856 0.836 . . . . 0.0 111.972 -173.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.482 HD12 ' C ' ' A' ' 108' ' ' ALA . 19.9 mt -88.77 143.05 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.195 173.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 37.2 ttt-85 -120.76 138.96 53.73 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-O 121.331 0.586 . . . . 0.0 109.426 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' A' ' 86' ' ' SER . 54.0 m-85 -116.05 126.44 53.78 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.038 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 152' ' ' LYS . 31.3 tt0 -109.2 122.68 47.83 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.751 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.02 154.07 20.78 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.643 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.979 ' HG2' HD11 ' A' ' 149' ' ' LEU . 5.2 pt-20 -57.21 -22.43 40.72 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.038 0.535 . . . . 0.0 111.943 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.28 -11.09 55.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.005 0.907 . . . . 0.0 109.111 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.28 14.93 46.29 Favored Glycine 0 N--CA 1.434 -1.451 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.918 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.554 ' O ' HD23 ' A' ' 81' ' ' LEU . 1.5 mtt180 -85.63 139.21 31.59 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 30.5 p -140.02 143.51 36.46 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.11 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -139.49 155.11 47.76 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.373 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 23.7 mt-10 -128.45 151.91 48.84 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.928 -176.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 1.0 OUTLIER -148.33 160.54 42.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.867 178.137 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.591 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -71.55 13.81 0.23 Allowed 'General case' 0 C--N 1.353 0.738 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -175.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.077 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.8 OUTLIER 68.14 -39.32 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 124.681 1.192 . . . . 0.0 113.691 176.11 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -79.68 2.47 22.52 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.803 0.335 . . . . 0.0 111.317 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 50.4 m170 -115.13 143.47 30.29 Favored Pre-proline 0 C--N 1.313 -1.016 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.885 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 15.4 Cg_exo -69.05 140.14 44.53 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.561 2.841 . . . . 0.0 115.25 -175.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 20.6 t -112.15 149.55 14.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 125.285 1.434 . . . . 0.0 107.211 175.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.8 tp -107.59 111.66 24.02 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.485 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.693 HG21 ' OD1' ' A' ' 115' ' ' ASP . 1.8 p -111.47 150.18 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.424 0.63 . . . . 0.0 112.167 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.641 ' CD2' HD12 ' A' ' 148' ' ' LEU . 71.7 t80 -103.31 93.37 4.94 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.256 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -135.94 154.94 50.96 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 62.26 22.98 13.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.086 0.469 . . . . 0.0 110.394 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.84 13.96 62.31 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.058 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -130.51 171.34 13.12 Favored 'General case' 0 N--CA 1.399 -2.987 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -104.35 121.13 42.73 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.644 HG13 HG13 ' A' ' 97' ' ' VAL . 28.7 pt -121.61 142.42 37.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.995 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.3 OUTLIER -106.16 111.55 24.21 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.008 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HG3' HG22 ' A' ' 111' ' ' VAL . 12.6 ptpt -125.24 144.54 50.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.915 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.608 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 64.9 mtt180 -64.85 160.67 19.87 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.077 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -59.95 -41.54 92.08 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.413 -176.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.459 ' HB3' ' CG2' ' A' ' 91' ' ' VAL . 1.8 p90 -74.29 1.73 10.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.824 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -112.9 -13.91 13.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.827 0.822 . . . . 0.0 109.701 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 107' ' ' ARG . 98.9 t -76.79 150.0 6.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.714 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -123.89 166.16 16.14 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 120.606 0.241 . . . . 0.0 110.824 -177.695 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.61 141.94 51.7 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.17 4.7 77.5 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.638 -175.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.714 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 1.7 t0 -78.5 166.56 22.45 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.433 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 35.1 mttp -120.01 168.68 10.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.79 0.805 . . . . 0.0 111.459 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.62 160.35 37.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 169.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 182' ' ' VAL . 1.1 tt -90.31 122.18 32.98 Favored 'General case' 0 N--CA 1.395 -3.189 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.226 177.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.0 OUTLIER -104.82 128.76 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 173.642 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.8 t -61.43 -22.54 65.12 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.544 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 145' ' ' HIS . 6.2 mm-40 46.9 13.26 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 125.578 1.551 . . . . 0.0 113.963 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.7 tt -113.15 127.07 56.08 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -114.44 -168.88 1.43 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.312 0.577 . . . . 0.0 112.324 -175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.57 ' CD2' HD21 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -113.85 17.71 17.83 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.8 t 73.34 80.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.374 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.433 ' HG2' ' N ' ' A' ' 127' ' ' GLN . 41.7 tt0 -150.81 165.95 31.99 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.319 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.433 ' N ' ' HG2' ' A' ' 126' ' ' GLU . 83.8 mm-40 -87.23 168.23 13.4 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.594 0.235 . . . . 0.0 110.471 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 p -66.34 -43.52 85.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.842 0.353 . . . . 0.0 111.708 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.8 t -96.99 115.4 27.37 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 55.5 p -147.89 157.82 43.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.812 0.339 . . . . 0.0 111.168 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.6 p -107.46 -53.1 2.67 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -166.09 151.52 8.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.523 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -141.33 175.45 9.64 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.659 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 4.3 t30 -179.98 -48.87 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 123.456 0.473 . . . . 0.0 111.466 -177.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 134' ' ' ASN . 2.4 Cg_endo -46.02 151.91 1.35 Allowed 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.909 3.073 . . . . 0.0 113.148 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -122.28 179.47 4.55 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.019 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.8 t30 67.7 91.48 0.09 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.88 0.737 . . . . 0.0 112.086 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -135.39 -78.79 0.44 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.896 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -157.53 -179.73 8.45 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.6 tp -76.13 147.25 38.68 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.93 54.07 0.56 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.345 -0.931 . . . . 0.0 111.429 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.5 p -63.88 118.54 46.44 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.724 0.297 . . . . 0.0 110.69 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -79.1 158.21 26.77 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.156 1.904 . . . . 0.0 112.725 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -167.2 19.55 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.886 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.631 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 8.7 m170 -85.8 124.76 32.66 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -137.38 98.54 3.74 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.373 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.454 ' C ' HD23 ' A' ' 148' ' ' LEU . 8.2 pt20 -164.69 139.24 5.32 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.464 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.641 HD12 ' CD2' ' A' ' 98' ' ' TYR . 13.8 mt -108.73 148.36 30.6 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.709 0.766 . . . . 0.0 111.485 178.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.979 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -111.36 135.97 51.15 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.07 -172.696 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.433 ' HG3' ' CG ' ' A' ' 116' ' ' LYS . 11.3 mt-10 -91.56 147.33 23.09 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.497 175.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.522 HD12 ' HB3' ' A' ' 115' ' ' ASP . 75.4 mt -78.29 106.93 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.594 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.844 176.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.652 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 34.4 mmtm -70.27 -39.58 74.87 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.856 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -150.94 132.46 14.74 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 71.8 mt -111.76 143.98 20.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.791 176.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.413 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.4 ptpt -146.77 159.83 43.01 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.398 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -100.26 114.9 28.71 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.3 OUTLIER -126.98 175.5 8.84 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.751 -179.073 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -99.64 154.33 18.36 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.81 -0.556 . . . . 0.0 111.443 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.56 3.11 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 66.78 -54.41 0.44 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.81 -175.1 2.7 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -99.67 9.57 42.88 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.181 0.515 . . . . 0.0 110.021 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -141.19 155.37 46.07 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.989 176.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 3' ' ' PRO . 1.4 m -124.85 154.15 32.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.686 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 8.3 m-85 -131.73 163.04 29.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.1 -172.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -159.09 -16.11 0.07 Allowed 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.829 176.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.424 ' HG ' HD21 ' A' ' 24' ' ' LEU . 2.8 tm? 62.64 112.12 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.333 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -87.3 114.57 24.03 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.738 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.478 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -126.14 -156.16 0.72 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 170' ' ' LYS . 35.0 mmtm -63.11 138.9 58.7 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 92.0 mttt 69.64 -73.88 0.09 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.769 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -140.12 -158.07 0.82 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -97.96 29.38 3.47 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -63.38 109.8 1.72 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.178 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.64 HG21 HD11 ' A' ' 8' ' ' ILE . 5.2 p -149.02 166.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 121.557 0.694 . . . . 0.0 111.906 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.554 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 81.0 mt -97.57 114.08 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.136 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.551 HG23 HG13 ' A' ' 175' ' ' VAL . 45.0 pt -118.89 174.85 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-O 120.978 0.418 . . . . 0.0 111.649 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 7' ' ' ARG . 2.1 t-20 44.66 -123.18 0.95 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.13 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -99.57 64.92 1.33 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.822 0.82 . . . . 0.0 108.928 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.701 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 7.8 m120 68.65 38.92 2.14 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 113.537 -1.665 . . . . 0.0 114.339 176.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.404 ' O ' HG12 ' A' ' 177' ' ' ILE . 99.1 mt -88.31 113.52 25.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 118' ' ' LEU . 2.5 m -83.68 158.2 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.4 t -162.5 158.4 23.58 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.997 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -69.39 -26.28 64.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.273 0.559 . . . . 0.0 109.874 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? . . . . . 0 C--O 1.257 1.464 0 CA-C-O 116.493 -1.717 . . . . 0.0 109.655 179.586 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.703 ' O ' ' HA ' ' A' ' 89' ' ' THR . 63.2 m . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.927 0.394 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.501 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 30.9 m-85 -114.71 145.81 34.7 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.504 ' HA ' HG12 ' A' ' 164' ' ' VAL . 14.9 Cg_endo -56.42 -27.46 68.17 Favored 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 123.418 2.746 . . . . 0.0 112.771 -177.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 125.21 -39.38 2.09 Favored Glycine 0 N--CA 1.417 -2.626 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.6 -11.14 60.6 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.697 0.76 . . . . 0.0 111.176 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 55.2 m -60.72 131.12 49.68 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.687 177.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.0 mmt180 -86.26 132.38 34.0 Favored 'General case' 0 C--O 1.185 -2.3 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.888 HD11 HG21 ' A' ' 175' ' ' VAL . 11.6 tt -119.64 130.57 73.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 CA-C-O 120.862 0.363 . . . . 0.0 110.111 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.82 HD21 HD11 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -88.46 125.35 34.7 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-O 121.452 0.644 . . . . 0.0 109.959 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.6 m -135.15 177.8 6.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.504 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -126.89 119.67 27.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.23 0.538 . . . . 0.0 109.875 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.61 HG12 HG13 ' A' ' 47' ' ' ILE . 12.5 mt -118.43 120.18 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.701 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.788 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 54.69 37.93 29.14 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.15 -1.387 . . . . 0.0 109.824 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 18.26 79.52 Favored Glycine 0 C--N 1.3 -1.47 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.609 -177.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.452 HG11 HD22 ' A' ' 134' ' ' ASN . 38.2 t -124.04 119.22 26.62 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 48.0 Cg_endo -73.31 122.05 7.67 Favored 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 122.534 2.156 . . . . 0.0 111.468 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -124.41 141.74 51.84 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.711 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 127' ' ' GLN . 40.4 ttmt -107.94 101.28 10.56 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.025 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.486 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -123.63 -175.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.681 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.752 ' HG1' ' HG2' ' A' ' 22' ' ' ARG . 9.6 p -90.28 173.54 8.08 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.727 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.617 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.2 mm? -69.24 -26.91 65.02 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.395 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.752 ' HG2' ' HG1' ' A' ' 20' ' ' THR . 10.7 ptm180 -84.8 -24.91 28.5 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' HB2' ' H ' ' A' ' 20' ' ' THR . 39.2 mt-10 -82.98 -39.4 21.39 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.977 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.512 HD23 HD13 ' A' ' 8' ' ' ILE . 16.2 tp -57.82 -42.18 83.76 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.089 0.947 . . . . 0.0 108.7 176.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.4 ' CD1' HG11 ' A' ' 67' ' ' VAL . 7.4 t80 -53.71 -31.23 47.29 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.216 -1.811 . . . . 0.0 112.594 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.9 mt-10 -76.0 -17.82 59.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -78.89 2.29 20.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.732 0.777 . . . . 0.0 109.429 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.476 ' C ' ' HD3' ' A' ' 40' ' ' ARG . 96.0 m-85 -117.91 162.24 18.46 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.602 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.7 -173.84 3.99 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.175 176.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 t70 63.47 81.36 0.21 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.248 0.547 . . . . 0.0 110.159 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -106.42 134.18 49.96 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 122.088 0.946 . . . . 0.0 111.465 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.451 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.2 ptt180 -122.54 154.44 37.9 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.557 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -105.57 124.94 50.38 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -160.89 137.66 8.77 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.476 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 61.7 23.12 13.5 Favored 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 123.579 0.55 . . . . 0.0 110.918 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.1 mtt 75.6 13.82 2.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.064 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.495 HG12 ' HD2' ' A' ' 71' ' ' PRO . 5.1 m -129.64 -179.71 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -115.55 140.46 49.14 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.127 0.489 . . . . 0.0 109.823 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.2 t -129.49 123.29 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.093 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.476 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 16.7 ttm180 -112.71 126.75 55.74 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -131.65 146.08 52.0 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.654 -174.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 27.5 tptp 80.68 113.08 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.438 0 O-C-N 124.531 1.145 . . . . 0.0 111.396 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.556 ' HB2' HD13 ' A' ' 47' ' ' ILE . 56.9 Cg_endo -78.02 155.94 30.15 Favored 'Trans proline' 0 N--CA 1.435 -1.918 0 C-N-CA 122.208 1.939 . . . . 0.0 111.974 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -86.97 -3.46 59.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.349 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -147.3 -164.8 2.09 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 6.0 tp10 -84.5 98.25 10.01 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.61 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -117.34 116.02 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.835 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -116.43 167.52 10.97 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.356 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 61' ' ' LEU . 13.2 p -116.05 121.53 67.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 121.714 0.769 . . . . 0.0 112.097 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.526 ' CE1' HG11 ' A' ' 59' ' ' VAL . 65.8 t80 -76.1 110.27 10.44 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.643 177.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -134.22 176.52 8.52 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.738 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.547 HG12 HD11 ' A' ' 176' ' ' ILE . 4.3 mm -121.18 144.17 31.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.267 0.556 . . . . 0.0 110.922 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.657 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 19.4 t70 -81.52 120.98 25.73 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.298 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.732 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -74.91 -12.24 60.31 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -170.488 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.657 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.7 pt-20 -104.33 -27.12 12.17 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.2 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.522 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 72.2 p -115.18 -24.95 8.26 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.578 -176.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.69 70.53 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.045 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.522 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 40.2 mttt -85.47 163.74 18.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.526 HG11 ' CE1' ' A' ' 50' ' ' TYR . 90.4 t -88.62 111.43 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.162 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.9 146.71 14.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.299 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.1 tp -120.12 138.59 53.48 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.437 HG21 ' HB3' ' A' ' 170' ' ' LYS . 10.2 t -150.54 171.35 17.22 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 120.753 0.311 . . . . 0.0 110.868 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.45 161.12 25.06 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.574 0.702 . . . . 0.0 111.169 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 64' ' ' ILE . 2.2 mp -101.06 135.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.887 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.516 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 17.3 mt-10 -81.1 -39.62 25.37 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 p30 179.65 175.49 0.74 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.458 -175.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.48 ' HA ' HD22 ' A' ' 167' ' ' LEU . 6.0 t -105.8 131.71 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.867 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 57.6 mt -91.53 105.8 16.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.267 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.449 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.1 tttt -119.87 108.16 14.02 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.25 138.62 33.25 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.343 -175.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HD2' HG12 ' A' ' 37' ' ' VAL . 75.1 Cg_exo -48.54 134.09 26.51 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 123.274 2.649 . . . . 0.0 112.608 177.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.73 95.6 3.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.391 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.7 p -92.76 -54.33 3.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.322 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.71 -179.92 6.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.918 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -100.9 170.71 8.12 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 90' ' ' THR . 17.1 mt -115.23 131.35 56.96 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.504 0.669 . . . . 0.0 112.062 -175.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.575 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 19.5 mt -82.82 141.84 14.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.603 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 24.5 ttt-85 -117.11 136.93 52.63 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-O 121.17 0.509 . . . . 0.0 109.769 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.582 ' CD1' HD13 ' A' ' 151' ' ' ILE . 56.1 m-85 -116.01 127.53 54.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.7 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 152' ' ' LYS . 43.7 tt0 -111.97 128.27 56.12 Favored 'General case' 0 CA--C 1.472 -2.051 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.754 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -91.09 157.65 17.11 Favored 'General case' 0 C--N 1.269 -2.915 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.576 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.755 ' HG2' HD11 ' A' ' 149' ' ' LEU . 2.3 pt-20 -63.88 -14.5 53.87 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.569 0.7 . . . . 0.0 111.07 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -92.81 -9.45 40.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.264 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.14 14.59 54.14 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.217 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.554 ' O ' HD23 ' A' ' 81' ' ' LEU . 3.0 mtt180 -86.34 141.8 28.95 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 26.1 p -141.69 146.52 36.19 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.488 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -141.58 150.21 41.76 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.635 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 29.3 mt-10 -121.85 145.83 47.69 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.351 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.703 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 1.6 p -144.12 157.22 44.44 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.731 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.696 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -75.46 9.26 2.26 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -175.583 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.035 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.6 t 76.17 -42.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 O-C-N 123.503 0.502 . . . . 0.0 111.274 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.37 -20.53 65.6 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 123.764 0.826 . . . . 0.0 110.888 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.505 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -103.31 129.56 25.27 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.786 -176.416 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.611 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 25.3 Cg_exo -65.18 142.82 75.38 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.623 2.882 . . . . 0.0 114.486 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 17.4 t -105.34 146.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.169 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.452 ' CD1' ' HG3' ' A' ' 105' ' ' GLU . 32.4 tp -98.47 106.99 19.35 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.526 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.596 HG13 HG13 ' A' ' 104' ' ' ILE . 1.7 p -108.74 145.8 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 121.475 0.655 . . . . 0.0 111.55 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.548 ' CD2' HD12 ' A' ' 148' ' ' LEU . 86.3 t80 -104.0 91.74 4.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.209 178.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.523 ' CG ' HD11 ' A' ' 104' ' ' ILE . 9.1 pt-20 -138.87 155.94 47.7 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 11.9 m120 65.98 22.61 11.24 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.355 0.597 . . . . 0.0 110.02 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.72 13.96 64.38 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.931 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -136.23 171.28 14.7 Favored 'General case' 0 N--CA 1.401 -2.925 0 CA-C-O 121.258 0.551 . . . . 0.0 110.24 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -101.92 121.28 41.82 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.084 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.596 HG13 HG13 ' A' ' 97' ' ' VAL . 16.1 pt -127.61 145.11 35.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.926 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 8.4 mp0 -106.46 115.13 29.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.079 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.618 ' HG3' HG22 ' A' ' 111' ' ' VAL . 12.7 ptpt -128.31 141.71 51.35 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.894 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.719 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 99.8 mtt180 -61.47 165.73 4.58 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 119.404 -0.331 . . . . 0.0 110.635 -176.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 1.035 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -62.67 -40.27 96.55 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.47 -173.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.525 ' HB3' HG13 ' A' ' 91' ' ' VAL . 5.8 p90 -72.71 -7.53 50.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.868 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -102.75 -17.01 15.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.716 0.769 . . . . 0.0 109.175 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.618 HG22 ' HG3' ' A' ' 106' ' ' LYS . 69.4 t -77.42 150.41 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.569 ' HE3' ' H ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -124.27 163.69 21.12 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.106 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.82 142.95 56.0 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.57 4.54 76.31 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.584 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.962 ' HB3' HD12 ' A' ' 151' ' ' ILE . 18.4 t70 -71.95 164.4 26.16 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.467 ' HE2' ' O ' ' A' ' 148' ' ' LEU . 24.2 mttt -122.55 154.67 37.6 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-O 121.568 0.699 . . . . 0.0 110.753 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.25 159.65 34.75 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.93 129.58 35.59 Favored 'General case' 0 N--CA 1.399 -3.014 0 C-N-CA 119.394 -0.923 . . . . 0.0 108.679 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -113.42 132.89 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.153 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.34 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.7 t -63.29 -17.54 62.62 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.956 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 145' ' ' HIS . 36.1 mm-40 47.48 8.77 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 125.599 1.56 . . . . 0.0 115.064 -178.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.402 ' HB3' ' OH ' ' A' ' 50' ' ' TYR . 29.3 tp -91.35 127.03 36.63 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 120.839 0.352 . . . . 0.0 110.983 -177.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.443 ' HB2' ' HG2' ' A' ' 143' ' ' PRO . 40.6 mt-10 -88.6 160.23 17.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.663 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.82 HD11 HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -144.99 -58.85 0.35 Allowed 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.538 0.685 . . . . 0.0 110.134 -178.292 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 126' ' ' GLU . 7.7 p -162.44 -177.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.496 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.653 ' H ' HG22 ' A' ' 125' ' ' VAL . 9.6 tp10 -81.93 -98.38 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.827 -177.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 21.8 tm0? 179.76 -38.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -178.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.3 p -59.78 -81.79 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.934 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.8 t 56.16 83.97 0.09 Allowed 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.502 0.501 . . . . 0.0 109.761 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.0 m -47.27 -45.41 23.93 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.584 -177.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t -112.06 129.52 56.18 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -82.81 91.32 7.04 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -128.17 -3.84 5.63 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.305 0.574 . . . . 0.0 111.098 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.476 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 17.2 m120 46.6 60.33 14.81 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.907 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 134' ' ' ASN . 25.5 Cg_exo -62.89 -74.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.81 2.34 . . . . 0.0 113.12 -179.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt 63.08 -89.39 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.509 -177.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 66.0 t30 53.33 39.72 30.23 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.412 0.625 . . . . 0.0 111.532 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -146.78 131.08 17.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.132 0.492 . . . . 0.0 111.526 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -133.49 174.24 10.63 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.582 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' A' ' 142' ' ' SER . 32.9 tp 72.88 -42.22 0.53 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.046 0.938 . . . . 0.0 112.988 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.47 41.51 0.18 Allowed Glycine 0 CA--C 1.506 -0.476 0 O-C-N 123.537 0.523 . . . . 0.0 113.157 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 140' ' ' LEU . 44.0 t -82.83 118.74 72.76 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.443 ' HG2' ' HB2' ' A' ' 123' ' ' GLU . 7.9 Cg_exo -71.95 165.44 32.56 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.313 2.009 . . . . 0.0 111.385 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -112.15 -68.15 0.95 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.067 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 10.1 m-70 66.95 166.97 0.23 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 178.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 179.43 85.5 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.853 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.463 ' C ' HD23 ' A' ' 148' ' ' LEU . 26.4 pt20 -164.99 138.08 4.64 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.165 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.548 HD12 ' CD2' ' A' ' 98' ' ' TYR . 12.4 mt -109.61 152.75 25.14 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-O 121.215 0.531 . . . . 0.0 110.242 176.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.755 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -113.68 136.74 52.51 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.946 -173.312 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.434 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 28.4 mt-10 -90.22 147.2 23.7 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.126 176.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.962 HD12 ' HB3' ' A' ' 115' ' ' ASP . 81.3 mt -79.46 112.64 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.012 175.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' A' ' 152' ' ' LYS . 4.9 mmpt? -76.89 -39.81 49.63 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.642 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -148.26 131.55 16.52 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -175.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 86.7 mt -114.26 148.32 17.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.754 174.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -154.33 162.03 41.41 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.708 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.575 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 15.8 m-85 -101.72 116.9 33.75 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.39 133.16 64.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.371 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.436 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 60.3 ttt180 -68.85 161.24 29.02 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.167 0.508 . . . . 0.0 111.726 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.436 ' N ' ' HG2' ' A' ' 158' ' ' ARG . . . -70.4 120.08 15.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.77 -32.76 73.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.833 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -110.9 -173.9 2.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.484 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -100.51 0.03 38.76 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 120.858 0.361 . . . . 0.0 111.413 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -138.98 159.42 42.19 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 3' ' ' PRO . 6.3 m -132.39 161.41 41.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.921 177.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.635 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 76.2 m-85 -134.56 173.0 12.14 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.565 ' HB2' HD12 ' A' ' 68' ' ' ILE . 69.8 m -158.76 -24.68 0.08 Allowed 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.512 ' HG ' HD21 ' A' ' 24' ' ' LEU . 1.4 tm? 68.5 111.01 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.253 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -92.65 115.71 28.35 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.99 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.516 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.38 -146.57 0.33 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.437 ' HB3' HG21 ' A' ' 62' ' ' THR . 23.4 tptm -61.49 134.4 56.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.761 0.315 . . . . 0.0 110.309 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 170' ' ' LYS . 92.4 mttt 72.16 -84.09 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.519 -175.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -151.85 -165.58 2.27 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.902 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -74.49 45.29 0.23 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.878 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.407 ' OD1' HD11 ' A' ' 54' ' ' LEU . 10.0 t30 -83.85 104.05 13.62 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.888 HG21 HD11 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -141.21 167.15 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.34 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.58 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.0 mt -105.7 117.53 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.73 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.518 HG23 HG13 ' A' ' 175' ' ' VAL . 44.7 pt -122.27 170.09 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.448 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 48.59 -132.94 1.48 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 124.036 0.934 . . . . 0.0 110.318 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.95 53.87 2.56 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.35 0.595 . . . . 0.0 110.233 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.754 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 20.5 m-80 69.88 44.4 0.83 Allowed 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.887 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 91.7 mt -87.38 116.83 30.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.475 HG22 HG12 ' A' ' 176' ' ' ILE . 59.1 t -94.05 130.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.478 -175.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.522 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 15.1 t -135.55 159.99 39.89 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.532 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -152.27 145.84 24.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 . . . . . 0 C--O 1.26 1.616 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.762 179.5 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.591 ' HD3' HD13 ' A' ' 76' ' ' LEU . 57.8 Cg_endo -67.21 161.77 41.47 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.561 1.507 . . . . 0.0 109.212 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.521 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.56 -26.21 64.28 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 119.212 -1.471 . . . . 0.0 110.712 175.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.74 -26.17 44.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.468 0.707 . . . . 0.0 112.264 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 20' ' ' THR . 31.8 m -64.77 123.99 20.8 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.352 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.767 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 45.6 mtm-85 -81.42 128.23 33.64 Favored 'General case' 0 C--O 1.184 -2.364 0 C-N-CA 123.195 0.598 . . . . 0.0 109.878 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 19' ' ' ILE . 13.6 tt -112.48 130.34 66.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 122.193 -0.317 . . . . 0.0 110.332 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.55 HD12 ' CD1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -85.13 123.77 31.03 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.52 0.676 . . . . 0.0 109.784 177.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 24.8 m -136.41 -179.42 2.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.62 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 33.0 tt0 -130.16 119.58 23.21 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.63 HG12 HG13 ' A' ' 47' ' ' ILE . 11.8 mt -120.45 122.66 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.527 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.786 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 55.34 38.33 30.17 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.807 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.21 22.19 78.51 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.131 -0.94 . . . . 0.0 113.223 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.71 119.92 21.6 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-O 121.11 0.481 . . . . 0.0 109.941 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 57.2 Cg_endo -72.8 126.14 11.1 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 122.486 2.124 . . . . 0.0 111.52 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -129.48 140.59 51.23 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.457 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 26.6 ttpt -110.42 101.5 10.2 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.616 ' O ' HG22 ' A' ' 8' ' ' ILE . 10.9 pt -139.75 136.86 39.51 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.25 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.767 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 4.5 p -40.02 148.95 0.07 Allowed 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.015 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 51.1 mt -60.15 -25.06 65.22 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.874 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.733 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 7.4 ptm180 -78.08 -28.03 48.69 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.529 ' HA ' ' OE2' ' A' ' 26' ' ' GLU . 60.8 mt-10 -85.29 -48.67 8.85 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.278 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.534 HD11 ' HG ' ' A' ' 167' ' ' LEU . 0.5 OUTLIER -50.94 -51.37 52.94 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.561 0.696 . . . . 0.0 109.887 175.066 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.43 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -45.42 -34.17 2.97 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.322 -1.308 . . . . 0.0 113.598 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.529 ' OE2' ' HA ' ' A' ' 23' ' ' GLU . 30.3 mt-10 -69.68 -18.47 63.56 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.71 1.86 18.65 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.568 0.699 . . . . 0.0 109.836 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 99.2 m-85 -118.96 160.86 21.2 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.765 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -143.95 -172.15 3.69 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.942 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.483 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.4 t70 63.36 82.36 0.18 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.574 0.702 . . . . 0.0 110.329 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -99.22 129.36 45.45 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.388 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.53 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.4 ptt180 -118.28 152.8 35.05 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.172 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 37' ' ' VAL . 3.4 t80 -104.6 123.88 48.35 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.494 ' HG2' ' ND2' ' A' ' 35' ' ' ASN . 36.9 tt0 -167.0 146.73 5.43 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.302 -174.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.494 ' ND2' ' HG2' ' A' ' 34' ' ' GLU . 0.9 OUTLIER 62.5 18.61 10.56 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 123.421 0.451 . . . . 0.0 110.547 177.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.6 mtt 71.12 15.93 6.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.013 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 27.1 m -130.47 -173.34 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.83 140.26 50.25 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.219 0.533 . . . . 0.0 109.968 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.53 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.3 t -127.72 123.67 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.456 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.008 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.449 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 13.2 ttm180 -111.22 126.96 55.42 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.51 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.38 147.3 52.38 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.386 -175.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 8.2 tmtm? 84.24 109.87 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.484 0 O-C-N 124.426 1.079 . . . . 0.0 110.637 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HB2' HD13 ' A' ' 47' ' ' ILE . 72.0 Cg_endo -78.57 149.43 23.93 Favored 'Trans proline' 0 N--CA 1.435 -1.917 0 C-N-CA 122.252 1.968 . . . . 0.0 111.25 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.508 ' HE2' ' O ' ' A' ' 26' ' ' GLU . 1.5 mtmt -85.66 -2.75 58.5 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.204 0.526 . . . . 0.0 111.118 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -144.32 -165.82 2.22 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.0 tp10 -87.18 103.39 15.37 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 175.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.63 HG13 HG12 ' A' ' 12' ' ' ILE . 1.4 mp -119.09 121.42 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.889 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 37.7 mmtt -118.43 169.51 9.7 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.077 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.505 HG11 ' CB ' ' A' ' 169' ' ' ALA . 14.6 p -128.17 133.92 66.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.326 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.55 ' CD1' HD12 ' A' ' 9' ' ' LEU . 31.5 m-85 -83.71 123.15 29.54 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.915 176.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.9 t -127.66 174.61 8.94 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.612 HG12 HD11 ' A' ' 176' ' ' ILE . 1.2 mm -125.27 141.94 43.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.583 0.706 . . . . 0.0 111.501 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.679 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 32.8 t70 -90.87 115.25 27.77 Favored 'General case' 0 C--O 1.194 -1.842 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.691 ' H ' HD12 ' A' ' 54' ' ' LEU . 4.8 mp -67.16 -33.56 75.67 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 121.848 0.832 . . . . 0.0 111.665 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.679 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -73.72 -30.92 63.11 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.773 -174.05 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.7 p -113.22 -22.01 10.69 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.179 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.18 18.07 70.26 Favored Glycine 0 N--CA 1.431 -1.633 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.492 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.504 ' C ' HD13 ' A' ' 52' ' ' ILE . 26.2 mttp -98.12 157.46 16.13 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.82 112.01 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.255 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.2 m -110.74 165.46 6.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.651 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.9 tp -120.69 140.28 51.84 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.1 t -143.49 171.59 13.94 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.013 0.435 . . . . 0.0 111.22 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.69 160.93 19.43 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.262 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.559 ' N ' HD12 ' A' ' 64' ' ' ILE . 3.0 mp -97.47 143.05 13.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.141 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.444 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 79.2 mm-40 -91.13 -38.76 12.54 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 176.93 175.48 0.37 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.788 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 17.3 t -105.69 130.2 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.049 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 61.2 mt -89.89 106.6 17.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.689 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.44 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 88.0 tttt -121.37 110.42 16.07 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.798 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 163' ' ' PHE . . . -130.48 139.01 34.33 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.762 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.432 ' HD2' HG12 ' A' ' 37' ' ' VAL . 7.4 Cg_endo -53.14 124.42 15.56 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.877 2.385 . . . . 0.0 112.108 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.56 96.69 0.18 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.686 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.5 m -105.18 -58.25 1.92 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.994 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -79.66 175.42 10.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.147 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -101.22 171.46 7.59 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' A' ' 90' ' ' THR . 10.6 mt -126.72 141.92 51.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.718 0.771 . . . . 0.0 111.775 -173.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 88' ' ' GLU . 13.9 mt -84.4 143.88 10.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 10.7 ttt85 -116.57 138.02 51.73 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-O 121.213 0.53 . . . . 0.0 109.814 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.614 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.7 m-85 -116.12 122.47 45.2 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.546 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 152' ' ' LYS . 36.0 tt0 -109.77 124.49 51.36 Favored 'General case' 0 CA--C 1.47 -2.104 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.734 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -88.24 160.78 17.54 Favored 'General case' 0 C--N 1.271 -2.818 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.813 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.806 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.7 pt-20 -60.72 -19.28 58.5 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.592 0.711 . . . . 0.0 110.529 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -91.48 -12.14 35.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.93 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.07 14.38 49.04 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.994 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.572 ' O ' HD23 ' A' ' 81' ' ' LEU . 4.2 mtt180 -84.29 138.25 33.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 27.0 p -141.63 137.84 32.12 Favored 'General case' 0 C--N 1.287 -2.122 0 C-N-CA 118.969 -1.092 . . . . 0.0 112.845 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.456 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 5.0 p90 -136.0 154.64 51.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.507 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 25.2 mt-10 -125.32 151.84 45.49 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.549 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -143.42 157.93 44.06 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.399 178.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.677 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -69.8 15.27 0.08 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.005 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.6 -36.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 125.448 1.499 . . . . 0.0 112.213 178.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.547 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 26.7 t70 -78.41 -18.07 55.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.333 0.587 . . . . 0.0 109.639 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -77.83 125.75 85.14 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.298 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 37.7 Cg_endo -66.12 142.55 68.1 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.133 2.556 . . . . 0.0 112.622 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 20.7 t -111.97 145.47 18.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.6 tp -101.72 108.9 20.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.837 0.351 . . . . 0.0 110.793 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.605 HG13 HG13 ' A' ' 104' ' ' ILE . 2.2 p -112.22 150.09 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.367 0.603 . . . . 0.0 111.067 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.456 ' CD2' HD12 ' A' ' 148' ' ' LEU . 58.9 t80 -105.62 93.62 4.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.18 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 6.9 pt-20 -139.44 158.81 43.5 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 86.6 m-20 64.57 22.14 12.59 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.212 0.53 . . . . 0.0 110.154 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.25 14.72 64.48 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.031 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -137.21 171.65 14.17 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 117.365 0.583 . . . . 0.0 110.042 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -100.83 122.75 43.96 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.605 HG13 HG13 ' A' ' 97' ' ' VAL . 24.6 pt -121.04 146.98 25.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.836 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 mp0 -104.17 112.09 24.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.278 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 11.5 ptpt -124.2 139.44 53.92 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.576 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.64 ' O ' HG23 ' A' ' 111' ' ' VAL . 14.3 mmt180 -60.55 158.84 11.52 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.005 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -60.38 -40.79 92.13 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.864 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.418 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.7 p90 -73.47 -1.13 17.17 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.868 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -111.13 -13.79 13.97 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.693 0.759 . . . . 0.0 109.772 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 107' ' ' ARG . 93.6 t -79.2 149.0 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.698 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 21.6 mtmt -123.36 165.81 16.38 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.192 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.81 139.68 55.26 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.91 4.5 72.2 Favored Glycine 0 C--N 1.307 -1.032 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.874 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.698 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -75.33 167.93 20.96 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.46 ' HG2' ' HG3' ' A' ' 150' ' ' GLU . 25.2 mttp -119.61 165.1 14.89 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 121.404 0.621 . . . . 0.0 110.511 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.456 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -133.55 159.93 42.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 182' ' ' VAL . 0.9 OUTLIER -88.64 131.79 34.83 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -119.21 132.58 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.193 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB3' HD22 ' A' ' 180' ' ' ASN . 48.4 t . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 121.626 0.727 . . . . 0.0 109.926 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.456 HD12 ' CD2' ' A' ' 98' ' ' TYR . 14.4 mt . . . . . 0 N--CA 1.417 -2.088 0 CA-C-O 121.199 0.523 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.806 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -113.21 137.86 50.84 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.027 -172.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.46 ' HG3' ' HG2' ' A' ' 116' ' ' LYS . 15.1 mt-10 -92.19 146.68 23.52 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.3 1.047 . . . . 0.0 112.7 175.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.44 HD13 ' CD1' ' A' ' 79' ' ' PHE . 75.2 mt -78.73 111.99 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.534 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.546 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.558 ' HE2' ' HB2' ' A' ' 82' ' ' GLU . 48.9 mmtt -71.63 -40.36 69.8 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.54 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -149.51 133.55 17.15 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 76.2 mt -116.92 144.64 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.609 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.479 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 19.0 ptpt -152.78 164.09 38.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.155 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.478 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 15.3 m-85 -101.59 116.55 33.0 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.417 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.16 173.9 11.07 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.958 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -106.24 152.83 22.99 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 120.928 0.394 . . . . 0.0 111.486 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.28 128.38 36.47 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.224 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -65.85 -47.36 75.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.101 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.08 170.95 9.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.822 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -90.29 0.74 57.1 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 121.582 0.706 . . . . 0.0 109.933 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 96.2 m-85 -141.03 148.29 40.02 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.256 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 3' ' ' PRO . 4.0 m -118.03 155.49 19.91 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.699 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 74.3 m-85 -133.43 173.58 11.33 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.68 0.276 . . . . 0.0 110.926 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.698 ' HB2' HD12 ' A' ' 68' ' ' ILE . 67.0 m -158.38 -23.37 0.08 Allowed 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.534 ' HG ' HD11 ' A' ' 24' ' ' LEU . 1.9 tm? 67.17 107.03 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.592 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -88.63 116.48 26.91 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.513 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.505 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -132.27 -167.25 1.86 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.995 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt . . . . . 0 C--N 1.328 -0.345 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -179.091 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.644 HG13 HG23 ' A' ' 177' ' ' ILE . 2.8 p -148.78 162.67 5.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.44 0.638 . . . . 0.0 111.225 -176.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.612 HD11 HG12 ' A' ' 52' ' ' ILE . 90.6 mt -108.34 116.91 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.605 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.644 HG23 HG13 ' A' ' 175' ' ' VAL . 37.7 pt -125.24 172.91 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.678 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 7' ' ' ARG . 8.2 t-20 47.9 -130.65 1.61 Allowed 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.055 0.942 . . . . 0.0 109.732 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -88.28 55.37 3.4 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.742 0.782 . . . . 0.0 109.487 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.6 m-20 67.38 47.76 1.23 Allowed 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.856 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 81.4 mt -87.94 118.18 33.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 118' ' ' LEU . 48.7 t -90.51 135.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.189 -175.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--N 1.307 -1.274 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.102 178.31 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.451 ' CE1' HD13 ' A' ' 177' ' ' ILE . 62.4 m-85 . . . . . 0 C--O 1.221 -0.405 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.541 ' HD3' HD13 ' A' ' 76' ' ' LEU . 18.7 Cg_endo -58.51 -29.69 89.51 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.886 2.391 . . . . 0.0 112.569 -175.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 124.28 -37.48 2.64 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.06 -4.62 21.95 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.449 0.642 . . . . 0.0 111.523 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.6 m -67.95 127.73 33.91 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.963 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.579 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 33.5 mmt180 -80.02 131.44 35.79 Favored 'General case' 0 C--O 1.181 -2.53 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 19' ' ' ILE . 8.1 tt -119.22 130.93 73.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.649 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.472 ' CD2' ' HB2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -87.0 123.44 32.1 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 121.602 0.715 . . . . 0.0 110.187 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 31.5 m -135.59 -178.9 2.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.489 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 34.0 tt0 -129.23 121.42 27.58 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.581 HG12 HG13 ' A' ' 47' ' ' ILE . 21.2 mt -119.32 121.47 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.864 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.54 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 54.58 38.49 29.96 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.97 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.35 18.45 79.86 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.061 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.2 t -124.28 121.84 26.06 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 59.7 Cg_endo -74.1 121.43 6.9 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 C-N-CA 122.383 2.055 . . . . 0.0 111.05 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -125.41 141.71 51.91 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.702 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 38.8 ttpt -109.93 100.82 9.72 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.9 pt -121.98 -173.71 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.183 -2.447 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.721 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 21.1 p -92.25 172.29 8.51 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.282 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 15.0 mt -72.98 -22.25 60.72 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.77 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.721 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.2 ptm180 -85.28 -24.63 27.64 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.529 ' OE1' HG23 ' A' ' 20' ' ' THR . 71.1 mt-10 -83.71 -42.67 16.35 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.917 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.467 HD21 ' HG ' ' A' ' 167' ' ' LEU . 16.9 tp -55.98 -43.91 78.03 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.996 0.903 . . . . 0.0 108.917 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.621 ' HD1' HG11 ' A' ' 67' ' ' VAL . 11.8 t80 -51.41 -33.95 32.62 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.463 -1.699 . . . . 0.0 112.613 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 27.3 mt-10 -73.65 -17.07 61.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.69 2.71 21.64 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.393 0.616 . . . . 0.0 109.791 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.526 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.6 m-85 -117.08 161.61 19.14 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.364 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -139.06 -173.45 3.58 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.231 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.557 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER 60.6 86.07 0.1 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.35 0.595 . . . . 0.0 110.919 177.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -107.23 131.19 54.46 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.115 0.959 . . . . 0.0 112.368 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.483 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 15.3 ptt-85 -116.32 153.58 31.72 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.731 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -101.01 130.77 47.05 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -166.55 143.22 4.84 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.405 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 60.66 21.11 11.04 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 123.715 0.634 . . . . 0.0 110.928 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 36.7 mtm 71.59 20.06 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.417 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.457 HG12 ' HD2' ' A' ' 71' ' ' PRO . 5.1 m -134.9 -174.72 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -115.03 138.75 50.5 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-O 121.124 0.488 . . . . 0.0 110.534 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.483 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.2 t -128.52 124.83 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.33 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.444 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 18.5 ttm180 -114.04 127.45 55.94 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.557 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -130.66 144.41 51.41 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -173.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 43.5 tptt 82.16 111.77 0.03 OUTLIER Pre-proline 0 CA--C 1.518 -0.273 0 O-C-N 124.361 1.038 . . . . 0.0 111.232 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.605 ' HB2' HD13 ' A' ' 47' ' ' ILE . 62.0 Cg_endo -78.14 153.9 28.64 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.405 2.07 . . . . 0.0 112.282 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -85.81 -1.91 57.71 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.162 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -147.58 -165.9 2.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 32.7 tt0 -86.43 101.51 13.21 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.605 HD13 ' HB2' ' A' ' 43' ' ' PRO . 1.5 mp -116.33 116.01 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.194 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.48 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 26.1 mmtp -117.55 164.8 14.37 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.648 175.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.9 p -119.42 132.1 70.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.536 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.404 ' CD2' HD12 ' A' ' 9' ' ' LEU . 11.2 m-85 -84.62 118.59 24.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.17 0.509 . . . . 0.0 110.04 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.4 p -124.43 176.97 6.15 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.938 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.536 HG12 HD11 ' A' ' 176' ' ' ILE . 1.2 mm -130.3 138.2 54.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.588 0.709 . . . . 0.0 110.813 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.423 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 25.2 t70 -84.61 120.02 25.89 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.128 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.404 HD21 ' ND2' ' A' ' 174' ' ' ASN . 11.3 mt -67.33 -29.91 69.6 Favored 'General case' 0 CA--C 1.475 -1.933 0 CA-C-O 122.036 0.922 . . . . 0.0 112.048 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.423 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -81.81 -30.24 32.31 Favored 'General case' 0 C--N 1.263 -3.188 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.523 -171.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.7 p -114.54 -25.28 8.41 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.264 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.71 14.04 74.03 Favored Glycine 0 N--CA 1.427 -1.904 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.162 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.517 ' C ' HD13 ' A' ' 52' ' ' ILE . 41.5 mtpt -89.83 152.55 21.22 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -91.42 108.48 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.923 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.3 m -110.21 163.27 7.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.096 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.94 141.95 49.18 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.519 HG21 ' HB3' ' A' ' 170' ' ' LYS . 13.5 t -149.89 171.27 17.05 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.131 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.13 160.6 21.83 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 121.617 0.722 . . . . 0.0 111.197 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.2 mp -96.0 145.52 8.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.174 -178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.428 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 16.0 mm-40 -91.01 -37.97 13.12 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 p30 174.18 175.33 0.16 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.803 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.621 HG11 ' HD1' ' A' ' 25' ' ' TYR . 4.1 t -107.12 138.19 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.171 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.629 HD12 ' HB2' ' A' ' 166' ' ' SER . 35.7 mt -101.44 109.74 26.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.045 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.402 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 8.2 ttpm? -120.88 112.4 18.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.87 137.37 30.63 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.295 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.457 ' HD2' HG12 ' A' ' 37' ' ' VAL . 71.2 Cg_exo -48.17 131.7 22.39 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.454 2.769 . . . . 0.0 113.275 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.11 93.18 9.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.227 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 p -89.7 -24.9 21.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.04 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -110.97 -169.99 1.56 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.801 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.575 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 28.0 m170 -115.28 171.21 7.84 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.728 HD23 ' HA ' ' A' ' 90' ' ' THR . 5.9 mt -121.32 148.27 44.56 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.966 0.888 . . . . 0.0 112.762 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.485 HD12 ' C ' ' A' ' 108' ' ' ALA . 27.7 mt -85.55 143.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.576 172.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 12.5 ttt85 -116.5 137.99 51.74 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-O 121.126 0.489 . . . . 0.0 110.157 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 86' ' ' SER . 58.5 m-85 -114.36 122.32 46.31 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.622 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 152' ' ' LYS . 23.1 tt0 -112.51 123.02 49.36 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.75 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.3 mm? -86.2 160.39 19.21 Favored 'General case' 0 N--CA 1.403 -2.775 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.218 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.743 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.4 pt-20 -64.74 -13.27 54.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.848 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -97.54 -8.52 28.92 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.538 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.56 10.58 57.88 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.082 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.587 ' O ' HD23 ' A' ' 81' ' ' LEU . 4.7 mtt180 -81.59 136.85 35.56 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 48.4 p -140.6 143.12 35.08 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.685 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.437 ' CD1' HD13 ' A' ' 181' ' ' ILE . 7.7 p90 -138.17 145.61 41.73 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.573 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 49.0 mt-10 -117.19 146.29 43.32 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.352 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.3 p -142.78 153.86 43.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.733 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.728 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.88 10.28 0.93 Allowed 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.06 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.9 m 63.66 161.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 123.475 0.71 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 107' ' ' ARG . 33.9 t70 73.28 -30.61 0.21 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.124 0.488 . . . . 0.0 110.918 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.469 ' H ' ' C ' ' A' ' 91' ' ' VAL . 97.6 m-70 -68.28 132.87 91.47 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.249 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.75 115.76 4.37 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.361 2.707 . . . . 0.0 114.901 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 18.3 t -94.74 149.19 4.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 103' ' ' PHE . 1.1 tm? -103.08 118.58 37.11 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.0 0.428 . . . . 0.0 111.937 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.704 HG13 HG13 ' A' ' 104' ' ' ILE . 2.3 p -118.45 147.87 21.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.93 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.523 ' CD2' HD12 ' A' ' 148' ' ' LEU . 88.4 t80 -103.86 98.62 8.44 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.775 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 10.3 pt-20 -147.64 158.56 44.06 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.3 m-20 65.04 22.6 12.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.239 0.542 . . . . 0.0 109.866 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.66 12.14 55.69 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.66 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -132.13 172.84 11.89 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.552 0.691 . . . . 0.0 109.791 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.562 ' HB3' HD11 ' A' ' 96' ' ' LEU . 20.3 m-85 -103.1 121.2 42.12 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.464 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.704 HG13 HG13 ' A' ' 97' ' ' VAL . 24.4 pt -122.05 148.77 25.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.522 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 26.9 mt-10 -104.94 118.43 36.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.81 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.471 ' HB2' HG22 ' A' ' 111' ' ' VAL . 90.1 mttt -119.93 132.6 55.57 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.581 ' O ' HG23 ' A' ' 111' ' ' VAL . 65.3 mtt180 -60.03 158.3 11.27 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.06 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -56.59 -45.66 81.25 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.87 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -75.32 9.98 1.83 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.411 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -119.35 -20.57 7.83 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.201 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 107' ' ' ARG . 92.5 t -73.55 146.58 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.71 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 70.6 mmtt -119.75 170.77 8.92 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.719 -177.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.58 141.77 53.7 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.646 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.95 4.43 84.61 Favored Glycine 0 N--CA 1.425 -2.046 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.829 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.71 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -76.26 165.43 24.88 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.434 ' HE3' ' HG3' ' A' ' 150' ' ' GLU . 31.3 mttp -117.91 164.82 14.48 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.54 0.686 . . . . 0.0 110.819 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.0 159.75 42.9 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.76 133.66 34.17 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.3 OUTLIER -116.61 138.13 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.024 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 180' ' ' ASN . 4.8 p . . . . . 0 C--N 1.284 -2.254 0 CA-C-O 121.44 0.638 . . . . 0.0 110.412 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.523 HD12 ' CD2' ' A' ' 98' ' ' TYR . 13.8 mt . . . . . 0 N--CA 1.424 -1.755 0 CA-C-O 121.404 0.621 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.75 ' HB3' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -111.08 137.06 49.2 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.913 -1.039 . . . . 0.0 113.516 -171.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.434 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 23.3 mt-10 -91.18 146.34 23.92 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.91 176.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.429 HG21 ' CG1' ' A' ' 154' ' ' ILE . 66.6 mt -81.02 107.79 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.921 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.545 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 27.7 mmtt -64.68 -42.84 95.07 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.368 175.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -148.29 132.5 17.4 Favored 'General case' 0 CA--C 1.473 -1.995 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 84.2 mt -117.24 125.1 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.01 172.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.42 ' CD ' ' HD3' ' A' ' 78' ' ' ARG . 19.5 ptpt -128.89 163.86 24.35 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.006 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.467 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 12.5 m-85 -101.0 110.96 23.05 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.575 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -116.02 176.38 2.45 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.768 -178.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.531 ' HA ' ' HB3' ' A' ' 75' ' ' HIS . 31.5 mtm180 -82.66 -142.83 0.06 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-O 121.787 0.803 . . . . 0.0 112.192 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.43 ' H ' ' HB3' ' A' ' 158' ' ' ARG . . . -133.24 128.01 34.96 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -83.82 21.3 1.3 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -173.2 -178.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -104.78 8.42 34.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.374 0.607 . . . . 0.0 109.734 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -143.24 155.87 44.61 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.412 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 3' ' ' PRO . 7.0 m -129.82 160.92 40.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.432 176.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 67.9 m-85 -132.55 170.46 15.14 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.471 -176.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.629 ' HB2' HD12 ' A' ' 68' ' ' ILE . 1.4 m -155.76 -28.2 0.1 Allowed 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' A' ' 67' ' ' VAL . 1.3 tm? 71.32 107.04 0.06 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.742 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -86.27 115.09 23.59 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.64 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.456 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -135.29 -166.16 1.8 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.519 ' HB3' HG21 ' A' ' 62' ' ' THR . 23.9 tptm . . . . . 0 C--N 1.325 -0.488 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.404 ' ND2' HD21 ' A' ' 54' ' ' LEU . 27.0 t-20 . . . . . 0 CA--C 1.508 -0.639 0 CA-C-O 120.622 0.248 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.569 HG23 HG23 ' A' ' 177' ' ' ILE . 29.8 m -139.49 178.59 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.808 0 CA-C-O 122.47 1.128 . . . . 0.0 112.501 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.536 HD11 HG12 ' A' ' 52' ' ' ILE . 87.6 mt -117.59 114.27 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 CA-C-N 112.532 -2.122 . . . . 0.0 108.48 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.569 HG23 HG23 ' A' ' 175' ' ' VAL . 35.9 pt -120.76 168.04 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.746 0 CA-C-O 120.963 0.411 . . . . 0.0 112.076 -174.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.457 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 2.1 t-20 48.69 -133.23 1.46 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.966 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.415 ' H ' ' CG ' ' A' ' 178' ' ' ASN . 0.8 OUTLIER -80.81 56.27 2.65 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 121.314 0.578 . . . . 0.0 109.932 174.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.669 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 12.8 m120 66.89 42.39 2.52 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.892 1.277 . . . . 0.0 114.256 175.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.437 HD13 ' CD1' ' A' ' 87' ' ' PHE . 92.8 mt -86.85 119.08 34.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 70.0 t -92.47 129.28 43.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.814 -176.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.31 -1.143 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.844 178.874 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 . . . . . 0 CA--C 1.51 -0.563 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.427 ' HD3' HD13 ' A' ' 76' ' ' LEU . 53.5 Cg_endo -65.81 158.16 55.22 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 N-CA-C 108.639 -1.331 . . . . 0.0 108.639 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' A' ' 165' ' ' PHE . . . -59.31 -22.83 56.86 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 119.077 -1.535 . . . . 0.0 111.887 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -71.31 -1.75 13.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.561 ' HB ' HD12 ' A' ' 21' ' ' LEU . 94.9 m -71.82 128.57 36.19 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.639 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 13.9 mtm-85 -85.58 131.0 34.44 Favored 'General case' 0 C--O 1.18 -2.576 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.414 ' CD1' HG21 ' A' ' 175' ' ' VAL . 8.4 tt -120.22 131.14 73.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' A' ' 18' ' ' LYS . 2.0 tm? -89.46 123.23 33.39 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-O 121.491 0.662 . . . . 0.0 110.077 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.0 m -133.14 -174.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.29 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 31.5 tt0 -133.19 123.69 26.07 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.629 HG12 HG13 ' A' ' 47' ' ' ILE . 23.1 mt -121.23 121.69 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.748 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.811 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 52.95 39.09 28.69 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.458 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.74 17.27 80.05 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.749 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.94 115.39 22.13 Favored Pre-proline 0 N--CA 1.438 -1.064 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 13.1 Cg_exo -64.4 124.02 12.69 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.277 1.985 . . . . 0.0 111.262 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -122.37 134.97 54.62 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.456 ' HB2' HD23 ' A' ' 9' ' ' LEU . 40.2 ttmt -106.59 101.25 10.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.1 pt -123.54 -173.58 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.744 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.791 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 20.4 p -97.11 168.65 10.32 Favored 'General case' 0 C--N 1.281 -2.378 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.725 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 66.1 mt -64.83 -29.7 70.67 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.791 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.5 ptm180 -77.04 -26.37 53.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.514 ' OE1' HG23 ' A' ' 20' ' ' THR . 62.7 mt-10 -84.66 -42.55 15.22 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.957 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.706 HD21 HD22 ' A' ' 167' ' ' LEU . 18.2 tp -57.5 -44.12 84.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-O 121.952 0.882 . . . . 0.0 110.145 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.654 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.5 m-30 -60.41 -23.86 64.7 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 113.747 -1.569 . . . . 0.0 113.188 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -79.88 -12.87 59.72 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.95 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.4 mm? -79.22 3.78 16.86 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.521 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.7 m-85 -118.49 164.72 14.86 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.226 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.573 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 38.0 mt-10 -136.4 -173.48 3.42 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.952 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.41 81.63 0.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.39 0.614 . . . . 0.0 111.55 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -98.65 120.4 39.02 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.783 0.801 . . . . 0.0 110.621 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -106.28 149.73 26.62 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 114.009 -1.451 . . . . 0.0 109.976 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.504 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 19.2 t80 -106.56 130.35 54.34 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.474 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 6.8 tp10 -167.53 141.42 3.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.849 -176.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.412 ' ND2' ' HG3' ' A' ' 34' ' ' GLU . 47.6 m-80 56.48 23.58 7.66 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 123.452 0.47 . . . . 0.0 111.865 177.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.504 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 43.8 mtm 72.07 17.57 5.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.88 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.516 HG12 ' HD2' ' A' ' 71' ' ' PRO . 4.8 m -127.32 -175.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -126.77 147.64 49.98 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.307 0.575 . . . . 0.0 110.603 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -131.47 124.0 53.75 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.007 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.801 ' HB3' HG22 ' A' ' 67' ' ' VAL . 38.1 ttm180 -115.41 126.23 54.12 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -133.43 146.76 51.48 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.463 -174.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 88.9 mttt 86.46 111.75 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.673 0 C-N-CA 125.183 1.393 . . . . 0.0 111.75 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.527 ' HB2' HD13 ' A' ' 47' ' ' ILE . 83.5 Cg_endo -79.72 147.73 19.7 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.527 2.151 . . . . 0.0 111.191 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.573 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 29.3 mtmt -81.75 -6.64 59.23 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -145.91 -164.98 2.08 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.1 tp10 -85.75 99.83 11.61 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.629 HG13 HG12 ' A' ' 12' ' ' ILE . 1.7 mp -115.97 117.37 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.952 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.538 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 25.0 mmtt -116.37 167.14 11.3 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.393 174.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.492 HG11 ' CB ' ' A' ' 169' ' ' ALA . 13.0 p -121.45 130.23 74.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.133 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -85.14 120.61 26.83 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.2 m -133.79 173.24 11.75 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.017 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.485 HG12 HD11 ' A' ' 176' ' ' ILE . 2.4 mm -115.61 142.57 28.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.223 0.535 . . . . 0.0 110.151 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.416 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 38.8 t0 -80.75 130.85 35.31 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 54' ' ' LEU . 4.1 mp -77.9 -25.63 48.58 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.973 0.892 . . . . 0.0 110.811 -172.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.34 -32.6 16.42 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.93 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' HB3' ' A' ' 53' ' ' ASP . 57.8 p -111.84 -20.21 12.13 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.522 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.66 12.18 84.65 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.742 177.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.455 ' C ' HD13 ' A' ' 52' ' ' ILE . 3.6 mtpm? -89.86 160.58 16.4 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.953 0.406 . . . . 0.0 112.069 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.45 110.18 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 CA-C-O 121.89 0.852 . . . . 0.0 110.009 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.5 m -111.13 163.8 7.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 49' ' ' VAL . 13.6 tp -123.74 141.97 51.52 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.42 ' OG1' ' HB2' ' A' ' 170' ' ' LYS . 14.3 t -151.05 172.21 16.09 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.91 0.386 . . . . 0.0 111.57 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.05 160.58 25.77 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.715 0.769 . . . . 0.0 110.993 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.567 HD13 HG22 ' A' ' 47' ' ' ILE . 2.1 mp -100.7 136.82 30.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.908 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 5.2 mm-40 -82.93 -38.28 23.03 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 p30 177.56 -179.2 0.23 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.303 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.801 HG22 ' HB3' ' A' ' 40' ' ' ARG . 2.9 m -116.82 145.26 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-O 121.124 0.488 . . . . 0.0 110.067 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' A' ' 166' ' ' SER . 56.8 mt -99.28 107.67 21.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.076 -173.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.455 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 76.8 tttt -116.08 107.42 14.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.6 137.65 30.89 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.141 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.516 ' HD2' HG12 ' A' ' 37' ' ' VAL . 77.5 Cg_exo -47.52 136.23 20.65 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 123.205 2.603 . . . . 0.0 112.688 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.66 102.7 0.47 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 m -60.44 -55.83 28.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.071 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.45 -138.7 0.11 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.301 -176.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -97.38 171.12 8.6 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.719 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.0 mt -124.19 140.54 52.86 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.928 0.87 . . . . 0.0 111.513 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 88' ' ' GLU . 40.0 mt -87.98 142.11 13.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.872 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 12.9 ttt180 -119.45 138.47 53.1 Favored 'General case' 0 N--CA 1.406 -2.651 0 CA-C-O 121.234 0.54 . . . . 0.0 109.655 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.606 ' O ' ' HA ' ' A' ' 86' ' ' SER . 58.1 m-85 -114.68 125.99 54.37 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.442 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 152' ' ' LYS . 36.8 tt0 -109.73 123.99 50.47 Favored 'General case' 0 CA--C 1.473 -2.013 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.753 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -89.34 162.5 15.78 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.994 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.901 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.1 pt-20 -63.88 -18.29 64.03 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.889 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -93.37 -7.29 45.14 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.531 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.57 13.22 57.3 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.045 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.571 ' O ' HD23 ' A' ' 81' ' ' LEU . 2.0 mtt180 -82.07 139.07 34.66 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 20.6 p -141.27 140.0 33.8 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 118.889 -1.125 . . . . 0.0 112.449 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -136.67 141.34 43.15 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.657 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 1.7 mp0 -109.61 148.1 31.89 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.779 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.73 ' HB ' ' NE2' ' A' ' 93' ' ' HIS . 3.5 p -137.02 149.14 47.28 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.139 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.719 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -73.44 7.62 2.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.075 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.5 m 59.81 169.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 122.911 0.484 . . . . 0.0 110.98 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.604 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 33.4 t70 73.11 -41.26 0.5 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.063 0.459 . . . . 0.0 111.35 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.73 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 8.6 p80 -75.69 148.59 82.64 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 7.0 Cg_exo -74.58 142.19 28.98 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.126 2.551 . . . . 0.0 114.534 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 23.6 t -111.99 154.3 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.514 1.526 . . . . 0.0 107.274 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.3 tp -106.49 113.45 26.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.841 0.746 . . . . 0.0 112.424 -176.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.647 HG13 HG13 ' A' ' 104' ' ' ILE . 2.4 p -113.39 153.64 14.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 111.808 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -108.48 95.61 5.78 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.989 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 6.6 pt-20 -143.76 159.19 42.95 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER 66.84 22.74 10.17 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.228 0.537 . . . . 0.0 109.644 -179.03 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.61 12.86 57.66 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.771 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -134.21 172.41 12.9 Favored 'General case' 0 N--CA 1.403 -2.815 0 CA-C-O 121.201 0.524 . . . . 0.0 109.807 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -100.68 121.69 42.06 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.647 HG13 HG13 ' A' ' 97' ' ' VAL . 25.9 pt -121.13 157.52 24.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.622 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 21.3 mt-10 -114.18 110.02 19.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.959 0.409 . . . . 0.0 111.666 -176.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.419 ' HE3' ' CD1' ' A' ' 104' ' ' ILE . 88.1 mttt -113.97 140.01 48.77 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 92' ' ' ASP . 6.5 mpt_? -60.8 154.79 21.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.075 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -56.63 -45.86 81.28 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.827 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.482 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 2.6 p90 -71.99 3.03 4.75 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.342 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -115.26 -16.34 11.52 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.358 0.599 . . . . 0.0 110.131 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 107' ' ' ARG . 70.0 t -74.51 145.09 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 31.6 mmtp -119.74 172.6 7.57 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.401 0.619 . . . . 0.0 111.689 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -70.9 138.31 50.04 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.393 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.51 5.59 74.99 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.924 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.842 ' HB3' HD12 ' A' ' 151' ' ' ILE . 8.1 t70 -71.27 170.17 13.64 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.739 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 48.2 mttp -127.85 155.72 43.68 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.758 0.79 . . . . 0.0 112.733 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.51 157.52 41.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.584 172.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.611 ' HA ' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -95.15 134.14 38.2 Favored 'General case' 0 CA--C 1.479 -1.784 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.6 OUTLIER -107.33 124.45 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.828 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.742 175.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.398 -3.044 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 176.958 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.739 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.7 mm? . . . . . 0 CA--C 1.483 -1.614 0 CA-C-O 121.065 0.459 . . . . 0.0 110.061 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.901 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -114.26 134.68 54.76 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.996 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 8.5 mt-10 -86.82 142.79 27.83 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.155 177.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.842 HD12 ' HB3' ' A' ' 115' ' ' ASP . 80.6 mt -80.46 103.15 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.329 174.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.485 ' HG3' ' CA ' ' A' ' 82' ' ' GLU . 29.9 mtmt -61.1 -44.37 97.46 Favored 'General case' 0 C--N 1.274 -2.715 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.226 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -150.45 136.53 18.54 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 77.7 mt -113.92 145.37 19.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.885 174.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -150.44 160.14 43.97 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.214 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -100.27 113.17 25.66 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.02 134.73 65.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.358 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.427 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 32.2 ttp180 -66.25 151.71 46.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' A' ' 158' ' ' ARG . . . -67.29 127.77 33.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.898 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -79.84 -24.89 41.01 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.191 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -110.36 -178.35 3.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.17 -7.82 18.8 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.035 0.445 . . . . 0.0 110.01 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -134.24 160.26 38.4 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.24 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.03 155.2 41.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.654 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 19.6 m-85 -132.88 169.07 17.29 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.741 -172.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.602 ' HB2' HD12 ' A' ' 68' ' ' ILE . 19.3 m -155.55 -28.13 0.1 Allowed 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.706 HD22 HD21 ' A' ' 24' ' ' LEU . 15.4 tp 73.29 116.95 0.05 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.417 1.087 . . . . 0.0 111.618 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -91.8 109.33 20.66 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.46 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.492 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -129.6 -165.02 1.47 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.372 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.42 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 46.4 mmtt . . . . . 0 CA--C 1.489 -1.392 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.218 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 . . . . . 0 CA--C 1.522 -0.125 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.619 HG13 HG23 ' A' ' 177' ' ' ILE . 1.3 p -166.32 166.67 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.485 HD11 HG12 ' A' ' 52' ' ' ILE . 97.2 mt -117.14 113.04 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.81 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.619 HG23 HG13 ' A' ' 175' ' ' VAL . 40.3 pt -123.19 171.37 12.25 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.521 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.237 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 7' ' ' ARG . 8.0 t-20 50.49 -129.46 2.2 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.431 1.092 . . . . 0.0 110.128 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.69 43.95 0.95 Allowed 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.439 0.637 . . . . 0.0 110.22 175.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.604 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.4 m-20 72.89 47.75 0.2 Allowed 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 114.081 -1.418 . . . . 0.0 112.92 176.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 81.3 mt -88.82 115.09 28.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.065 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 118' ' ' LEU . 2.6 m -76.33 156.21 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--N 1.286 -2.156 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.786 -179.275 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 76' ' ' LEU . 51.8 Cg_endo -66.15 156.51 64.39 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 N-CA-C 108.532 -1.372 . . . . 0.0 108.532 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.09 -22.56 49.69 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.531 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.45 -19.78 66.08 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.203 0.525 . . . . 0.0 112.186 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.441 ' HB ' HD12 ' A' ' 21' ' ' LEU . 91.9 m -59.61 128.09 35.25 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.771 -176.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 65.5 mmt-85 -81.34 133.34 35.41 Favored 'General case' 0 C--O 1.194 -1.856 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.78 HD11 HG21 ' A' ' 175' ' ' VAL . 8.1 tt -121.66 131.88 72.08 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.728 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -89.01 124.21 34.06 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.511 0.672 . . . . 0.0 109.987 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.9 m -135.11 -176.38 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.378 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -134.04 124.62 26.53 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.047 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.59 HG12 HG13 ' A' ' 47' ' ' ILE . 21.0 mt -120.55 119.46 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.026 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 52.62 44.45 30.08 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.744 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.2 75.5 Favored Glycine 0 C--N 1.307 -1.057 0 CA-C-N 114.704 -1.135 . . . . 0.0 114.256 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.9 t -124.76 119.94 25.71 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-O 121.137 0.494 . . . . 0.0 109.769 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 56.8 Cg_endo -73.71 124.03 8.96 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.326 2.018 . . . . 0.0 111.74 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -123.26 146.27 48.0 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.47 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -114.51 100.23 8.14 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.258 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.9 pt -123.05 -174.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.929 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.671 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 10.9 p -92.99 172.21 8.46 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.234 -0.987 . . . . 0.0 109.088 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 70.4 mt -66.83 -30.49 70.68 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.256 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.671 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 5.7 ptm180 -80.11 -25.01 40.13 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.544 ' OE1' HG23 ' A' ' 20' ' ' THR . 78.8 mt-10 -83.58 -39.6 20.15 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.1 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.52 HD21 ' HG ' ' A' ' 167' ' ' LEU . 13.9 tp -57.52 -44.49 85.11 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.46 ' HD1' HG11 ' A' ' 67' ' ' VAL . 18.8 t80 -49.79 -35.62 23.25 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.414 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 26.8 mt-10 -72.95 -17.84 61.44 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.58 0.06 31.53 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.594 0.712 . . . . 0.0 109.589 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.601 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 95.2 m-85 -113.67 161.3 17.63 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.297 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -133.89 -174.71 3.61 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.803 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 14.8 t0 60.28 87.56 0.09 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.549 0.69 . . . . 0.0 111.444 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 26.2 tt0 -104.02 128.97 51.62 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.253 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.642 ' HG2' HG13 ' A' ' 39' ' ' VAL . 1.7 ptm180 -109.8 150.06 28.92 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.611 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -116.9 122.97 45.86 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.42 0.629 . . . . 0.0 110.166 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -167.34 154.38 8.55 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.243 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.4 m120 61.63 16.98 8.2 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 123.685 0.615 . . . . 0.0 110.707 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.9 mtm 69.77 19.58 7.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.06 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.489 HG12 ' HD2' ' A' ' 71' ' ' PRO . 12.4 m -128.54 -179.67 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.489 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 97.1 m-85 -120.26 142.18 49.28 Favored 'General case' 0 CA--C 1.478 -1.803 0 CA-C-O 121.44 0.638 . . . . 0.0 109.993 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.642 HG13 ' HG2' ' A' ' 32' ' ' ARG . 1.1 m -135.19 127.7 47.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.336 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.587 ' O ' HG23 ' A' ' 67' ' ' VAL . 16.1 ttm180 -119.68 127.55 52.99 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -133.45 145.09 49.93 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.963 -174.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 12.8 tmtt? 86.73 112.22 0.03 OUTLIER Pre-proline 0 CA--C 1.516 -0.336 0 O-C-N 124.649 1.218 . . . . 0.0 109.963 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.55 ' HB2' HD13 ' A' ' 47' ' ' ILE . 73.2 Cg_endo -80.48 151.48 19.9 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 122.211 1.941 . . . . 0.0 112.269 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -86.17 -0.09 54.88 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.194 0.521 . . . . 0.0 110.976 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -150.68 -165.83 2.38 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 33.0 tt0 -83.92 101.41 11.67 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.601 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.4 mp -115.74 117.67 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.227 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -117.72 165.85 13.14 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.266 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.556 HG11 ' CB ' ' A' ' 169' ' ' ALA . 9.9 p -120.45 133.57 66.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.234 -177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.414 ' CD2' HD12 ' A' ' 9' ' ' LEU . 6.6 m-85 -85.87 125.27 33.18 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.096 175.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.9 m -136.86 142.36 42.81 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.179 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.439 HG12 HD11 ' A' ' 176' ' ' ILE . 2.9 mm -92.26 140.03 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.936 0 CA-C-O 121.479 0.657 . . . . 0.0 110.725 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.43 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 10.7 t0 -83.79 114.04 21.34 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.74 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -75.39 -4.78 41.4 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.685 0.755 . . . . 0.0 111.811 -169.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -102.42 -34.02 9.32 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.114 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 53' ' ' ASP . 81.0 p -111.29 -19.78 12.52 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.634 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.88 12.71 80.87 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.836 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -92.24 156.52 17.24 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.178 0.513 . . . . 0.0 112.284 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.92 106.02 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.006 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.589 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 m -109.46 162.55 7.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.77 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 49' ' ' VAL . 12.3 tp -122.32 140.87 52.15 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.014 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.5 t -147.52 172.61 13.7 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.782 0.325 . . . . 0.0 111.338 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.16 162.61 25.66 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.839 0.828 . . . . 0.0 111.397 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.549 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.5 mp -99.07 145.71 9.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.812 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.48 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 31.4 mm-40 -91.27 -38.59 12.57 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 175.62 177.37 0.2 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.672 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 40' ' ' ARG . 5.5 t -106.58 129.43 60.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.894 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' A' ' 166' ' ' SER . 55.3 mt -91.49 111.75 24.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.814 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 83.2 tttt -127.56 112.25 14.69 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.12 135.08 25.92 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.148 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.489 ' HD2' HG12 ' A' ' 37' ' ' VAL . 80.7 Cg_exo -44.71 130.05 9.54 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.671 2.914 . . . . 0.0 113.535 177.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.41 116.44 28.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.147 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -123.0 -65.83 1.07 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.367 0.876 . . . . 0.0 113.367 -176.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -57.58 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -177.14 172.44 1.93 Allowed 'General case' 0 CA--C 1.461 -2.474 0 CA-C-O 120.992 0.425 . . . . 0.0 111.46 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.794 HD23 ' HA ' ' A' ' 90' ' ' THR . 10.7 mt -131.65 141.75 49.68 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.735 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.536 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 22.7 mt -87.69 142.37 13.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 11.3 ttt85 -115.28 137.31 52.17 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.177 0.513 . . . . 0.0 109.884 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 86' ' ' SER . 64.1 m-85 -114.87 121.19 42.45 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.861 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 152' ' ' LYS . 35.3 tt0 -109.08 120.77 43.53 Favored 'General case' 0 CA--C 1.47 -2.133 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -85.9 159.96 19.53 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.172 -177.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.778 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -59.71 -19.16 48.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.325 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -92.37 -8.26 45.44 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.091 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.44 15.74 49.29 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.523 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.545 ' O ' HD23 ' A' ' 81' ' ' LEU . 3.9 mtt180 -83.83 138.57 33.15 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 35.6 p -141.85 139.91 32.78 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 118.485 -1.286 . . . . 0.0 112.296 175.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -135.23 146.93 49.1 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.948 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 21.5 mt-10 -119.22 147.68 43.97 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.348 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.428 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -138.76 154.01 48.49 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.595 -179.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.794 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.98 11.58 0.67 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.362 0.601 . . . . 0.0 112.057 -177.325 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.116 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.2 m 68.24 -26.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.021 1.328 . . . . 0.0 113.422 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 90' ' ' THR . 5.0 p-10 -83.34 -1.17 52.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.983 0.42 . . . . 0.0 110.658 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 20.9 m80 -110.63 137.06 20.64 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.477 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 24.0 Cg_exo -65.48 134.18 37.51 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.236 2.624 . . . . 0.0 113.424 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.578 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.2 t -103.58 150.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 tp -107.75 113.76 27.24 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.819 0.342 . . . . 0.0 111.878 -176.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.604 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.3 p -113.21 151.6 15.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.26 0.552 . . . . 0.0 111.592 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.465 ' CD2' HD12 ' A' ' 148' ' ' LEU . 61.4 t80 -105.13 93.54 4.75 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.294 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 8.5 pt-20 -141.76 158.41 43.85 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 32.0 m-80 63.5 23.22 13.56 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.147 0.499 . . . . 0.0 109.993 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.23 12.02 54.01 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.0 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -133.29 172.31 12.86 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 121.279 0.561 . . . . 0.0 109.914 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -101.76 120.63 40.67 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.567 HG13 HG13 ' A' ' 97' ' ' VAL . 23.1 pt -116.38 152.53 18.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.875 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -109.37 112.57 24.77 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.792 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.502 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 12.6 ptpt -130.15 133.95 46.98 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.598 ' O ' HG23 ' A' ' 111' ' ' VAL . 60.5 mtm180 -67.42 163.18 21.43 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.116 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -56.6 -45.45 81.42 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.976 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.505 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.9 p90 -71.86 2.81 4.92 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.515 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.501 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 12.9 tp10 -117.15 -16.05 10.44 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.397 0.618 . . . . 0.0 110.044 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 107' ' ' ARG . 89.4 t -73.97 148.88 8.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.674 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 23.0 mmtp -119.17 169.8 9.63 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.337 0.589 . . . . 0.0 110.537 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -76.21 144.42 40.45 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.551 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.38 4.59 80.44 Favored Glycine 0 C--N 1.308 -1.011 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.15 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.674 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -76.91 167.33 22.0 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.468 ' H ' HG23 ' A' ' 97' ' ' VAL . 28.1 mttp -121.87 166.67 14.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.288 0.566 . . . . 0.0 110.558 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.22 160.57 41.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.98 135.14 34.43 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.1 OUTLIER -100.49 149.98 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.716 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.454 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 43.5 t . . . . . 0 C--N 1.308 -1.234 0 CA-C-O 120.825 0.345 . . . . 0.0 110.797 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.465 HD12 ' CD2' ' A' ' 98' ' ' TYR . 14.5 mt . . . . . 0 N--CA 1.429 -1.501 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.778 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -114.97 138.89 50.32 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -171.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.464 ' H ' HD13 ' A' ' 149' ' ' LEU . 25.1 mt-10 -89.79 146.43 24.47 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 124.672 1.189 . . . . 0.0 113.018 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' A' ' 79' ' ' PHE . 64.3 mt -80.15 107.57 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.266 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 80' ' ' GLU . 62.2 mmtt -68.89 -38.98 80.0 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.889 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -150.63 131.86 14.5 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 74.8 mt -116.98 130.21 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.385 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.481 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 19.3 ptpt -136.46 166.76 22.75 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.516 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.536 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 20.7 m-85 -100.63 115.36 30.01 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.946 173.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.1 133.19 68.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.103 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 21.5 ttm-85 -70.87 155.22 41.06 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.068 0.461 . . . . 0.0 111.072 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.21 113.71 7.66 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.063 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -71.17 -18.68 62.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.567 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -98.9 166.57 11.23 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.953 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -94.28 -6.44 44.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.029 0.443 . . . . 0.0 109.929 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -144.0 150.41 38.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.781 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 4.3 m -119.29 155.8 21.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.551 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 50.0 m-85 -130.86 173.59 10.81 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 110.199 -0.296 . . . . 0.0 110.199 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.581 ' HB2' HD12 ' A' ' 68' ' ' ILE . 68.5 m -159.23 -24.49 0.07 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.52 ' HG ' HD21 ' A' ' 24' ' ' LEU . 1.5 tm? 68.68 112.46 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.769 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -90.82 113.26 25.37 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.112 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.556 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -133.94 -173.32 3.22 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.915 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.156 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.6 t30 . . . . . 0 N--CA 1.444 -0.774 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.78 HG21 HD11 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -159.95 158.43 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 120.827 0.346 . . . . 0.0 110.785 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.699 HG23 ' HA ' ' A' ' 180' ' ' ASN . 2.5 mp -93.08 115.34 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.867 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.489 HG23 HG13 ' A' ' 175' ' ' VAL . 45.1 pt -121.48 171.51 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-O 120.985 0.422 . . . . 0.0 111.586 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.439 ' HB3' HD12 ' A' ' 181' ' ' ILE . 5.4 t-20 46.71 -127.19 1.54 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 124.16 0.984 . . . . 0.0 110.777 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.498 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 29.3 mt-10 -91.5 55.63 2.82 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.745 0.784 . . . . 0.0 109.466 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.736 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.4 m120 70.2 44.56 0.75 Allowed 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 113.74 -1.573 . . . . 0.0 113.6 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 178' ' ' ASN . 85.1 mt -92.39 117.65 36.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.0 m -93.45 160.73 2.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.578 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 9.7 t . . . . . 0 C--N 1.306 -1.309 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.132 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.48 ' CE1' HD13 ' A' ' 177' ' ' ILE . 93.3 m-85 . . . . . 0 N--CA 1.446 -0.641 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.47 ' HA ' HG12 ' A' ' 164' ' ' VAL . 18.2 Cg_endo -59.02 -26.92 83.49 Favored 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 122.592 2.195 . . . . 0.0 112.481 -175.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.19 -38.65 2.69 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -69.08 -1.34 7.42 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.802 -0.699 . . . . 0.0 111.514 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 28.9 m -69.69 128.25 35.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.1 mtm-85 -83.77 132.6 34.82 Favored 'General case' 0 C--O 1.186 -2.259 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.722 HD11 HG21 ' A' ' 175' ' ' VAL . 10.7 tt -122.74 131.38 73.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-O 121.017 0.437 . . . . 0.0 110.623 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.422 HD23 ' HB2' ' A' ' 18' ' ' LYS . 1.6 tm? -90.77 123.47 34.37 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-O 121.504 0.669 . . . . 0.0 109.447 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 18.8 m -133.83 -175.46 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.5 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 32.1 tt0 -129.29 120.8 26.28 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.627 HG12 HG13 ' A' ' 47' ' ' ILE . 14.5 mt -122.44 122.7 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.868 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.864 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 56.14 35.98 26.62 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.859 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.1 17.29 78.62 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.215 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.35 114.55 25.65 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.604 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 7.6 Cg_exo -64.86 125.17 14.28 Favored 'Trans proline' 0 N--CA 1.44 -1.656 0 C-N-CA 122.129 1.886 . . . . 0.0 111.356 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -122.14 140.39 52.61 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.452 ' HD3' ' NH2' ' A' ' 7' ' ' ARG . 39.0 ttmt -108.52 100.28 9.57 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.6 pt -124.4 -171.93 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.179 -2.63 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.767 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.713 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 21.3 p -94.91 170.98 9.04 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.776 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 10.6 mt -73.96 -20.64 60.3 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.006 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.713 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 13.2 ptm180 -84.58 -25.28 28.76 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.449 ' O ' HD23 ' A' ' 27' ' ' LEU . 52.4 mm-40 -84.64 -44.17 13.71 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.394 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.569 ' CD2' HD22 ' A' ' 167' ' ' LEU . 16.4 tp -57.19 -44.0 83.21 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.927 0.87 . . . . 0.0 110.004 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.44 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -56.09 -24.25 39.03 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.849 -179.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -84.41 -12.15 54.95 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.876 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -80.32 5.6 14.33 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.601 0.715 . . . . 0.0 109.466 177.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.619 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 95.9 m-85 -119.43 167.13 12.23 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.075 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.565 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 9.4 mt-10 -140.34 -173.56 3.71 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.473 174.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 6.0 t0 62.5 83.42 0.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.237 0.542 . . . . 0.0 110.8 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -107.63 129.44 55.0 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.849 0.833 . . . . 0.0 111.257 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.7 ptm180 -124.1 156.48 36.53 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.892 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -107.46 125.52 51.36 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -164.67 148.22 8.97 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.56 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.7 m120 62.2 19.22 10.78 Favored 'General case' 0 CA--C 1.496 -1.106 0 O-C-N 123.557 0.536 . . . . 0.0 110.302 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.2 mtt 72.17 17.71 4.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.468 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 m -132.77 -178.48 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -115.05 140.72 48.83 Favored 'General case' 0 CA--C 1.478 -1.796 0 CA-C-O 121.257 0.551 . . . . 0.0 110.188 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.404 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.8 t -127.63 123.91 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.3 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.199 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.525 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 38.9 ttm180 -116.96 126.78 53.45 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -132.22 147.08 52.4 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.681 -0.808 . . . . 0.0 113.155 -176.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 54.4 mttp 82.29 111.61 0.03 OUTLIER Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.482 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.542 ' HB2' HD13 ' A' ' 47' ' ' ILE . 66.4 Cg_endo -77.28 151.95 30.27 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 122.688 2.259 . . . . 0.0 111.59 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 31.1 mtmt -83.28 -3.62 57.63 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.563 0.697 . . . . 0.0 110.427 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 45' ' ' ARG . 47.1 mtt180 -144.48 -164.62 1.95 Allowed 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 32.1 tt0 -88.6 100.07 12.81 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.627 HG13 HG12 ' A' ' 12' ' ' ILE . 1.3 mp -113.83 121.59 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.878 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.485 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 74.9 mmtt -123.89 165.73 16.88 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.847 174.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.452 HG13 ' CG1' ' A' ' 64' ' ' ILE . 6.1 m -113.42 126.66 70.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 120.961 0.41 . . . . 0.0 112.03 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.63 123.44 29.8 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.645 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 p -132.22 173.38 11.31 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.874 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.473 HG12 HD11 ' A' ' 176' ' ' ILE . 2.1 mm -121.25 140.64 44.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.274 0.559 . . . . 0.0 110.129 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.556 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 23.4 t70 -81.73 120.86 25.66 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.744 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.7 mt -66.46 -25.34 66.68 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.494 -172.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.556 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -92.95 -24.08 18.51 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.856 -1.066 . . . . 0.0 112.416 -172.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.5 p -119.77 -26.43 5.67 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.607 -175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.16 14.37 69.27 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.433 ' C ' HD13 ' A' ' 52' ' ' ILE . 2.6 mptt -84.16 153.61 23.58 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 122.839 0.455 . . . . 0.0 111.738 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.91 105.5 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 CA-C-O 122.004 0.907 . . . . 0.0 109.724 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.3 m -110.16 163.75 6.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.079 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 48' ' ' LYS . 13.7 tp -123.71 139.88 53.55 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 t -144.07 172.4 12.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.738 0.304 . . . . 0.0 110.849 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -86.15 161.99 18.59 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.727 0.775 . . . . 0.0 110.924 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.562 ' N ' HD12 ' A' ' 64' ' ' ILE . 3.3 mp -97.81 141.75 15.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.003 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.473 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 18.2 mm-40 -85.15 -39.58 17.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 p30 173.9 175.11 0.15 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.593 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.752 ' HA ' HD12 ' A' ' 167' ' ' LEU . 21.7 t -104.41 142.33 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.826 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 166' ' ' SER . 0.8 OUTLIER -112.87 123.5 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.701 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.39 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -129.85 114.5 15.98 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.733 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.98 139.62 35.55 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.813 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -52.84 123.92 14.21 Favored 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 123.043 2.495 . . . . 0.0 112.61 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.4 106.38 11.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.091 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.1 m -125.23 -26.72 3.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.638 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -78.78 -137.44 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.387 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -155.14 171.33 19.98 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.2 mt -132.83 140.63 48.05 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.937 -175.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 108' ' ' ALA . 51.4 mt -88.96 145.87 6.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.495 ' HB3' ' HG3' ' A' ' 155' ' ' LYS . 19.8 ttt180 -121.28 138.94 54.01 Favored 'General case' 0 N--CA 1.404 -2.768 0 CA-C-O 121.256 0.551 . . . . 0.0 109.87 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 86' ' ' SER . 49.3 m-85 -116.35 126.26 53.25 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.119 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.2 tt0 -106.27 132.63 52.09 Favored 'General case' 0 CA--C 1.48 -1.724 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.886 HD12 ' HB3' ' A' ' 149' ' ' LEU . 2.2 mm? -99.05 156.86 16.72 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.205 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.914 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.8 pt-20 -58.62 -18.33 29.45 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.509 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.46 -8.31 48.11 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.746 0.784 . . . . 0.0 109.42 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.27 17.65 49.39 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.564 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.537 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -89.91 139.36 30.67 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 65.5 p -139.79 144.48 37.4 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.467 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -137.1 146.9 45.64 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.105 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 65.1 mt-10 -119.39 147.42 44.38 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.478 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.9 OUTLIER -142.76 157.84 44.24 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.677 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.752 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -72.6 9.72 1.01 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 122.942 0.497 . . . . 0.0 111.921 -176.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.078 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.8 OUTLIER 68.03 -25.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.625 1.17 . . . . 0.0 112.494 177.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 90' ' ' THR . 0.2 OUTLIER -74.45 -12.88 60.61 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 124.344 1.058 . . . . 0.0 111.551 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -110.79 147.21 36.01 Favored Pre-proline 0 C--N 1.309 -1.176 0 C-N-CA 120.381 -0.527 . . . . 0.0 112.245 -175.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 3.1 Cg_exo -74.48 132.04 15.68 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.246 2.63 . . . . 0.0 114.047 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.506 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.6 t -97.21 144.88 9.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.0 tp -102.05 107.81 19.04 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.658 0.265 . . . . 0.0 110.918 -175.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.621 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.2 p -111.17 151.37 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-O 121.378 0.609 . . . . 0.0 111.93 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.4 ' CD2' HD12 ' A' ' 148' ' ' LEU . 67.0 t80 -106.95 93.74 4.72 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.917 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.3 pt-20 -140.62 158.47 43.93 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 31.9 m-80 64.76 22.93 12.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.065 0.46 . . . . 0.0 110.289 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.76 15.42 64.42 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.53 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -137.12 172.43 13.01 Favored 'General case' 0 N--CA 1.398 -3.044 0 CA-C-O 121.422 0.63 . . . . 0.0 110.269 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -103.63 120.77 41.56 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.605 HG13 HG13 ' A' ' 97' ' ' VAL . 25.2 pt -121.48 155.84 25.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.518 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -104.35 116.25 31.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.975 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.424 ' HE3' ' CD1' ' A' ' 104' ' ' ILE . 85.7 mttt -125.4 129.48 49.96 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.546 ' O ' HG23 ' A' ' 111' ' ' VAL . 91.2 mtt180 -62.8 161.71 12.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.078 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -58.17 -42.43 85.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.537 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.471 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.1 p90 -73.91 3.48 6.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.077 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -114.82 -16.41 11.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.533 0.682 . . . . 0.0 110.22 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 107' ' ' ARG . 92.8 t -77.05 148.68 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.71 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 15.9 mtmt -121.55 162.95 19.68 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 120.827 0.346 . . . . 0.0 111.258 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.96 139.11 57.68 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.62 4.45 70.21 Favored Glycine 0 C--N 1.305 -1.179 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.779 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.71 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -75.14 168.71 19.46 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.586 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 22.2 mttm -123.84 164.28 19.54 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.577 0.703 . . . . 0.0 111.937 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.88 159.05 41.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.424 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -92.31 141.04 28.99 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 2.5 m -115.75 158.54 16.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.671 173.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.574 ' HB3' HD22 ' A' ' 180' ' ' ASN . 32.6 t . . . . . 0 C--N 1.305 -1.329 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.68 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 118' ' ' LEU . 8.3 mt . . . . . 0 CA--C 1.482 -1.664 0 CA-C-O 121.093 0.473 . . . . 0.0 109.998 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.914 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -117.13 137.5 52.26 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -173.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.586 ' HG3' ' CG ' ' A' ' 116' ' ' LYS . 14.5 mt-10 -90.58 147.43 23.34 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.752 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.474 HD13 ' CD1' ' A' ' 79' ' ' PHE . 79.1 mt -79.66 108.45 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.63 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.911 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.626 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 0.9 OUTLIER -64.69 -43.07 94.69 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.751 177.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -152.64 136.9 16.58 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.9 mt -115.7 143.13 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 113.623 -1.626 . . . . 0.0 110.589 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.495 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.0 ptpt -144.86 157.79 44.03 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.288 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.479 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 6.7 m-85 -100.54 118.05 35.94 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.456 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -127.04 173.82 11.91 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.708 -178.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -105.92 157.49 17.45 Favored 'General case' 0 C--N 1.289 -2.051 0 O-C-N 121.911 -0.493 . . . . 0.0 111.627 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.95 118.63 8.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.567 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -63.09 -41.53 99.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.066 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -105.12 -174.12 2.46 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.669 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -99.04 0.41 43.7 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 120.851 0.357 . . . . 0.0 111.461 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -142.42 140.47 31.99 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.867 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.4 m -107.51 154.46 8.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.94 177.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 68.1 m-85 -134.39 166.55 22.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.036 -175.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.447 ' HB2' HD11 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -160.73 -22.15 0.06 Allowed 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 67' ' ' VAL . 20.9 tp 68.46 111.42 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.266 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -82.32 113.38 20.07 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.282 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.473 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -133.34 -160.1 1.02 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.9 mptt . . . . . 0 C--N 1.317 -0.843 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.43 179.715 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 121.815 0.816 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.722 HG21 HD11 ' A' ' 8' ' ' ILE . 2.1 p -142.34 165.33 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 CA-C-O 121.397 0.618 . . . . 0.0 111.289 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.517 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 97.2 mt -92.83 113.13 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.113 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.48 HD13 ' CE1' ' A' ' 2' ' ' PHE . 29.6 pt -120.13 167.67 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.293 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.403 ' C ' ' H ' ' A' ' 180' ' ' ASN . 6.6 t-20 49.77 -132.38 1.75 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.095 0.958 . . . . 0.0 109.987 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.84 44.62 0.84 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.774 0.797 . . . . 0.0 110.52 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.4 m-20 73.05 47.55 0.19 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 125.61 1.564 . . . . 0.0 113.342 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.7 mt -87.35 113.69 25.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.525 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.67 124.13 39.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.658 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.506 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 8.9 t . . . . . 0 C--N 1.299 -1.625 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.793 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.549 ' HD3' HD13 ' A' ' 76' ' ' LEU . 72.3 Cg_endo -72.96 162.94 39.72 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 N-CA-C 108.319 -1.454 . . . . 0.0 108.319 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.564 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -63.45 -25.36 68.55 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.055 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.88 -11.77 14.54 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.8 m -73.26 132.32 43.0 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.878 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 72.9 mmt-85 -84.21 135.78 34.22 Favored 'General case' 0 C--O 1.188 -2.163 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.445 HD11 HG21 ' A' ' 175' ' ' VAL . 9.6 tt -120.71 130.23 74.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 10' ' ' VAL . 1.3 tm? -89.83 124.32 34.57 Favored 'General case' 0 N--CA 1.412 -2.368 0 CA-C-O 121.545 0.688 . . . . 0.0 110.125 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.522 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 30.7 m -135.09 -175.72 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.57 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 33.0 tt0 -131.63 121.18 23.92 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.6 HG12 HG13 ' A' ' 47' ' ' ILE . 20.2 mt -120.05 121.89 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.949 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.62 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' A' ' 45' ' ' ARG . 68.1 m-20 55.04 38.41 30.48 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.948 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.86 18.46 78.94 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.841 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.53 120.03 23.17 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 42.7 Cg_endo -70.95 121.95 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.623 2.215 . . . . 0.0 111.64 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -124.94 142.34 51.53 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.821 -176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -114.48 101.81 9.48 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.643 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.4 pt -125.12 -172.5 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.161 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.048 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.722 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 6.8 p -91.68 173.07 8.07 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.333 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.6 mm? -64.12 -35.84 82.08 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.296 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.722 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 8.2 ptm180 -76.95 -26.64 54.24 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.543 ' OE1' HG23 ' A' ' 20' ' ' THR . 52.3 mt-10 -80.59 -39.34 27.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.951 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.799 HD21 HD22 ' A' ' 167' ' ' LEU . 18.3 tp -61.35 -41.85 97.73 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.069 0.938 . . . . 0.0 109.139 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.664 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 6.6 m-30 -57.28 -28.98 63.48 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.588 -1.642 . . . . 0.0 113.164 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.645 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 54.1 mt-10 -73.16 -17.49 61.37 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.248 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.0 mm? -78.92 2.54 19.83 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.484 0.659 . . . . 0.0 109.57 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.503 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.9 m-85 -116.33 163.01 16.65 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.535 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -141.48 -173.12 3.68 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.588 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 1.7 t70 63.23 84.85 0.14 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.326 0.584 . . . . 0.0 110.842 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -100.4 126.93 46.83 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.741 0.782 . . . . 0.0 110.998 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -115.66 150.52 36.61 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.808 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -102.25 129.72 48.74 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.404 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -167.44 148.72 5.58 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.029 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 57.89 19.63 5.95 Favored 'General case' 0 CA--C 1.496 -1.109 0 O-C-N 123.798 0.686 . . . . 0.0 111.726 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.6 mtt 71.02 18.84 5.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.393 0.615 . . . . 0.0 110.274 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 4.5 m -129.01 -173.14 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.484 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 64.7 m-85 -118.5 142.57 47.46 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.186 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 t -129.02 123.73 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.893 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.399 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.652 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 35.4 ttm180 -116.92 126.86 53.6 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -136.16 144.38 44.98 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.974 -174.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 14.2 ttmt 88.55 108.83 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.41 0 O-C-N 124.916 1.385 . . . . 0.0 110.568 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.593 ' HB2' HD13 ' A' ' 47' ' ' ILE . 93.0 Cg_endo -79.81 153.83 22.95 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 122.442 2.095 . . . . 0.0 111.843 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -87.78 -1.25 57.84 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.471 0.653 . . . . 0.0 111.108 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 50.3 mtt180 -143.42 -166.15 2.25 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.6 tp10 -89.28 101.78 14.45 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 172.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.6 HG13 HG12 ' A' ' 12' ' ' ILE . 1.3 mp -114.56 118.16 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.017 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.522 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 35.6 mmtt -115.39 169.04 9.45 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.911 175.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.495 HG11 ' CB ' ' A' ' 169' ' ' ALA . 9.3 p -123.85 130.83 73.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.076 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.24 129.4 35.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.031 0.443 . . . . 0.0 110.967 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.7 t -140.94 176.72 8.58 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.699 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.425 HD13 ' C ' ' A' ' 58' ' ' LYS . 2.0 mm -120.75 145.07 27.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.249 0.547 . . . . 0.0 110.561 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.761 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.2 t70 -88.62 123.34 32.99 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.819 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.72 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -75.16 -17.86 60.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.106 0.479 . . . . 0.0 112.195 -172.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.761 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -94.55 -28.24 15.52 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.702 -175.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.44 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 60.3 p -114.85 -21.73 9.99 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.331 -176.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.77 17.64 74.73 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.138 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.44 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 18.5 mtpp -94.56 157.72 15.86 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 p -91.52 110.43 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.47 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 m -110.12 158.19 10.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.202 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 49' ' ' VAL . 12.4 tp -122.65 140.27 53.03 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.0 t -147.04 172.05 14.33 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.611 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.78 161.58 20.92 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.763 0.792 . . . . 0.0 111.783 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.55 HD13 HG22 ' A' ' 47' ' ' ILE . 2.1 mp -95.8 142.4 13.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.665 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.543 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 19.5 mt-10 -93.02 -34.88 13.54 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -179.55 -177.33 0.42 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.823 0.821 . . . . 0.0 111.716 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 6.9 t -115.24 128.3 72.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.696 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.575 HD12 ' HB2' ' A' ' 166' ' ' SER . 33.1 mt -97.09 104.73 16.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.548 -175.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.563 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 59.1 tttp -117.25 108.11 15.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.09 136.05 28.22 Favored Pre-proline 0 C--N 1.308 -1.218 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HD2' HG12 ' A' ' 37' ' ' VAL . 72.5 Cg_exo -48.28 139.55 21.68 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.677 2.918 . . . . 0.0 113.689 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -85.83 96.32 9.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.158 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -89.11 -31.58 17.94 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.354 -175.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.0 -97.95 0.4 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 157' ' ' VAL . 0.4 OUTLIER 178.74 173.48 0.71 Allowed 'General case' 0 CA--C 1.471 -2.088 0 C-N-CA 123.936 0.895 . . . . 0.0 108.832 -175.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.681 HD23 ' HA ' ' A' ' 90' ' ' THR . 5.7 mt -123.96 140.6 52.82 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 118.748 -1.181 . . . . 0.0 112.898 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.5 HD12 ' C ' ' A' ' 108' ' ' ALA . 9.3 mt -84.77 145.94 7.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 172.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 19.9 ttt85 -116.94 138.38 51.58 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-O 121.227 0.537 . . . . 0.0 110.173 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.499 ' CD1' HD13 ' A' ' 151' ' ' ILE . 61.3 m-85 -116.13 122.86 46.33 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.28 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.0 tt0 -110.9 126.4 54.66 Favored 'General case' 0 CA--C 1.468 -2.202 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -89.88 162.49 15.43 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.464 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.859 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.2 pt-20 -63.15 -15.65 57.52 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.786 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -91.92 -10.29 40.07 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.533 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.06 4.33 66.97 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.749 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.585 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -83.57 143.38 30.19 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 23.0 p -141.76 157.92 44.44 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.748 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -148.34 154.07 39.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.894 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 16.3 mt-10 -125.0 148.87 48.25 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.727 -176.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -143.0 156.82 44.92 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.532 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.681 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -67.17 13.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.051 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.4 m 67.27 -41.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 125.362 1.465 . . . . 0.0 113.814 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.17 -28.61 34.94 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.304 0.573 . . . . 0.0 109.956 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -73.49 144.37 83.66 Favored Pre-proline 0 C--N 1.314 -0.969 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.735 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 5.7 Cg_exo -74.46 144.05 31.85 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.546 2.831 . . . . 0.0 114.704 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.01 146.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 124.841 1.256 . . . . 0.0 107.634 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 183' ' ' THR . 12.4 tp -102.36 113.08 26.1 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.179 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.696 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.0 p -116.8 150.23 18.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.33 0.586 . . . . 0.0 111.817 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.427 ' CD2' HD12 ' A' ' 148' ' ' LEU . 72.4 t80 -103.17 95.93 6.45 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.877 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -138.57 156.66 47.29 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 63.15 22.87 13.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.058 0.456 . . . . 0.0 110.319 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.79 13.01 63.07 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.925 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.411 ' HG3' HG23 ' A' ' 104' ' ' ILE . 7.7 ptp180 -132.36 171.71 13.39 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 117.434 0.617 . . . . 0.0 109.8 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.423 ' CE1' HD12 ' A' ' 118' ' ' LEU . 59.5 m-85 -104.91 122.39 45.7 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.54 HG13 HG13 ' A' ' 97' ' ' VAL . 22.9 pt -121.61 156.57 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.312 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -111.69 106.98 15.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.808 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.467 ' HG3' HG22 ' A' ' 111' ' ' VAL . 15.7 ptpt -122.81 141.23 52.06 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.725 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.564 ' O ' HG23 ' A' ' 111' ' ' VAL . 66.3 mtm180 -60.96 155.2 20.51 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.051 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -59.34 -40.32 85.99 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.312 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.494 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.2 p90 -75.21 -0.71 20.33 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.797 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -106.3 -19.65 13.63 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.703 0.763 . . . . 0.0 109.311 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 107' ' ' ARG . 86.5 t -71.67 149.11 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.506 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.692 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -122.17 166.83 13.97 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.842 -178.417 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.17 141.95 52.55 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.43 4.96 79.86 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.518 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.696 ' OD1' HG21 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -75.48 173.46 10.94 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -127.04 163.3 24.05 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 121.719 0.771 . . . . 0.0 112.198 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.3 158.26 42.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 114.639 -1.164 . . . . 0.0 107.887 168.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.509 ' HB3' ' HB ' ' A' ' 182' ' ' VAL . 1.1 tt -88.98 133.29 34.37 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.687 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -115.93 130.18 71.06 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.1 t . . . . . 0 C--N 1.307 -1.261 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.058 -178.881 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 118' ' ' LEU . 7.1 mt . . . . . 0 N--CA 1.428 -1.526 0 CA-C-O 121.375 0.607 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.859 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -116.85 137.9 51.89 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.063 -173.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.417 ' H ' HD13 ' A' ' 149' ' ' LEU . 14.2 mt-10 -88.72 145.58 25.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 124.652 1.181 . . . . 0.0 112.639 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.502 HD12 ' HB3' ' A' ' 115' ' ' ASP . 70.0 mt -80.08 104.26 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.766 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 6.6 mmpt? -68.18 -38.96 82.61 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.876 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -149.59 135.63 18.86 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 82.5 mt -114.77 144.26 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.476 174.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.507 ' CD ' ' HD3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -148.1 158.43 44.06 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.922 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.423 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 15.2 m-85 -99.15 111.76 24.07 Favored 'General case' 0 N--CA 1.407 -2.583 0 CA-C-O 121.802 0.811 . . . . 0.0 109.762 174.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -116.56 175.64 2.91 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.903 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.29 179.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.439 ' HB3' ' H ' ' A' ' 159' ' ' ALA . 78.1 mtt180 -79.56 -146.55 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.381 -0.528 . . . . 0.0 112.169 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.439 ' H ' ' HB3' ' A' ' 158' ' ' ARG . . . -104.08 -13.61 16.21 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.673 -176.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.67 8.11 2.2 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.956 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -175.21 -173.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -104.0 -7.72 20.12 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.35 158.28 44.42 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.269 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.456 HG11 HD21 ' A' ' 76' ' ' LEU . 2.9 m -128.88 157.16 41.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.091 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.664 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 11.3 m-85 -131.29 170.55 14.46 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.714 -172.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.575 ' HB2' HD12 ' A' ' 68' ' ' ILE . 68.3 m -159.88 -22.01 0.06 Allowed 'General case' 0 C--N 1.359 0.994 0 CA-C-O 120.622 0.249 . . . . 0.0 110.377 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.799 HD22 HD21 ' A' ' 24' ' ' LEU . 14.4 tp 64.52 110.87 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.164 0.915 . . . . 0.0 112.081 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.526 HD22 ' HB2' ' A' ' 65' ' ' GLU . 4.4 t30 -84.63 108.26 17.27 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.543 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -112.65 -161.0 0.74 Allowed 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 49.1 tptt . . . . . 0 C--N 1.314 -0.963 0 CA-C-O 120.854 0.359 . . . . 0.0 110.67 -177.122 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.4 HD21 HD22 ' A' ' 96' ' ' LEU . 6.6 m120 . . . . . 0 CA--C 1.51 -0.596 0 CA-C-O 120.962 0.411 . . . . 0.0 111.994 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.553 HG13 HG23 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -165.81 158.47 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.686 176.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.584 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 88.9 mt -108.9 116.52 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.779 0 CA-C-O 121.007 0.432 . . . . 0.0 110.321 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.553 HG23 HG13 ' A' ' 175' ' ' VAL . 43.2 pt -122.04 169.44 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.729 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 6.6 t-20 48.8 -133.05 1.51 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.333 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.424 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 16.1 mm-40 -83.94 53.97 2.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.459 0.647 . . . . 0.0 110.008 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.687 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.0 m120 70.55 45.32 0.61 Allowed 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.357 -1.292 . . . . 0.0 113.909 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 98.3 mt -86.04 112.38 22.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 118' ' ' LEU . 98.6 t -86.93 117.5 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.299 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . 8.8 t . . . . . 0 N--CA 1.411 -2.39 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.939 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.536 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 7.0 m-85 . . . . . 0 CA--C 1.517 -0.306 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.478 ' HD3' HD13 ' A' ' 76' ' ' LEU . 73.0 Cg_endo -72.51 161.93 42.8 Favored 'Trans proline' 0 N--CA 1.438 -1.77 0 N-CA-C 108.41 -1.419 . . . . 0.0 108.41 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.01 -26.49 63.37 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 118.682 -1.723 . . . . 0.0 110.875 175.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.43 ' OD1' ' HB2' ' A' ' 160' ' ' ASN . 6.9 m-20 -59.79 -13.81 12.01 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.7 m -74.4 129.03 37.0 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.351 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 10.9 mtm-85 -84.88 129.45 34.81 Favored 'General case' 0 C--O 1.195 -1.766 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.757 HD11 HG21 ' A' ' 175' ' ' VAL . 10.5 tt -115.04 129.87 70.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.604 HD23 ' HB2' ' A' ' 18' ' ' LYS . 2.6 tm? -94.96 123.94 38.72 Favored 'General case' 0 N--CA 1.399 -3.009 0 CA-C-O 121.786 0.803 . . . . 0.0 110.474 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.671 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 31.0 m -132.23 -172.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.849 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 30.9 tt0 -131.52 123.54 28.22 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 28.3 mt -120.68 122.49 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.893 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.632 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.408 ' HA ' ' HB3' ' A' ' 46' ' ' GLU . 0.7 OUTLIER 54.74 41.81 31.65 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.033 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.58 18.92 72.43 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.774 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.55 118.73 18.07 Favored Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 11' ' ' GLN . 52.6 Cg_exo -53.44 148.21 34.72 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 C-N-CA 122.053 1.835 . . . . 0.0 111.104 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -148.83 129.18 13.81 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.604 ' HB2' HD23 ' A' ' 9' ' ' LEU . 40.3 ttmt -117.62 102.93 9.56 Favored 'General case' 0 CA--C 1.48 -1.741 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.883 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.4 pt -125.23 -173.9 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.253 177.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.676 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 10.4 p -92.28 172.08 8.65 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.392 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 81.8 mt -66.17 -28.47 68.8 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.414 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.676 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 4.3 ptm180 -82.1 -24.56 35.09 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.466 ' OE1' HG23 ' A' ' 20' ' ' THR . 51.9 mt-10 -84.16 -39.99 18.73 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.861 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.661 HD23 ' HG ' ' A' ' 167' ' ' LEU . 17.5 tp -61.12 -41.08 96.04 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.546 0.689 . . . . 0.0 109.826 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.511 ' HD1' HG11 ' A' ' 67' ' ' VAL . 1.4 t80 -51.14 -32.76 24.01 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.978 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.4 mt-10 -74.48 -15.8 60.87 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.248 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.92 2.17 27.8 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.589 0.709 . . . . 0.0 109.56 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.613 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.9 m-85 -118.37 164.54 15.09 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.832 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.569 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 12.6 mm-40 -141.16 -172.97 3.61 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.028 175.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t0 63.18 81.33 0.21 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.57 0.7 . . . . 0.0 110.392 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -99.19 122.44 42.39 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.791 0.805 . . . . 0.0 111.044 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -113.14 150.45 32.19 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.923 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -101.79 131.14 48.26 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -166.6 145.76 5.59 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.763 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.98 21.84 9.72 Favored 'General case' 0 CA--C 1.488 -1.41 0 O-C-N 123.85 0.718 . . . . 0.0 111.51 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 43.8 mtm 72.36 18.97 4.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.691 0.619 . . . . 0.0 110.569 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 10.5 m -134.7 -175.16 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.441 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 90.7 m-85 -112.85 139.98 48.02 Favored 'General case' 0 CA--C 1.478 -1.798 0 CA-C-O 121.243 0.544 . . . . 0.0 110.535 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -128.39 124.06 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.85 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.582 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 13.6 ttm180 -118.04 128.26 54.6 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.54 145.69 51.34 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.843 -173.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 5.2 tppp? 81.84 111.81 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.643 1.214 . . . . 0.0 111.235 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.568 ' HB2' HD13 ' A' ' 47' ' ' ILE . 66.1 Cg_endo -78.91 154.0 25.82 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 122.079 1.853 . . . . 0.0 111.951 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.569 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 36.3 mtmt -85.38 -4.34 59.13 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.868 -178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -149.17 -165.22 2.22 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 33.9 tt0 -86.82 101.65 13.55 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.613 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.6 mp -114.85 113.02 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.998 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.671 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 72.6 mmtt -116.95 169.39 9.44 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.694 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.537 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.8 p -120.88 124.93 73.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.551 0.691 . . . . 0.0 111.959 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.788 ' CZ ' HG21 ' A' ' 59' ' ' VAL . 5.5 t80 -76.47 123.31 25.83 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.952 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.5 t -140.13 168.25 20.25 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.932 0.396 . . . . 0.0 110.815 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.13 145.14 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.164 0.507 . . . . 0.0 110.681 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -91.99 117.93 30.29 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.634 ' H ' HD12 ' A' ' 54' ' ' LEU . 4.2 mp -69.42 -31.47 69.83 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.786 0.803 . . . . 0.0 111.763 -172.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.35 -30.35 42.6 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.986 -174.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.4 p -111.08 -25.61 9.67 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.023 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.67 13.33 75.88 Favored Glycine 0 N--CA 1.421 -2.321 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.855 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -92.91 170.18 9.88 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 120.899 0.38 . . . . 0.0 111.24 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.788 HG21 ' CZ ' ' A' ' 50' ' ' TYR . 7.6 p -103.14 118.61 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.671 0 CA-C-O 121.873 0.844 . . . . 0.0 110.529 177.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -111.51 153.78 13.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.424 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 49' ' ' VAL . 11.7 tp -122.36 132.86 54.59 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.597 HG21 ' HB2' ' A' ' 170' ' ' LYS . 10.8 t -140.09 173.28 11.67 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.462 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -86.64 161.38 18.51 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.793 0.806 . . . . 0.0 111.558 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.55 HD13 HG22 ' A' ' 47' ' ' ILE . 2.1 mp -91.81 141.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.688 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.6 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 7.9 mm-40 -83.46 -39.65 20.27 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 p30 178.12 174.79 0.56 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.812 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.582 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 25.9 t -104.76 137.35 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.319 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.57 HD13 ' HB2' ' A' ' 166' ' ' SER . 0.0 OUTLIER -113.99 126.51 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.335 -178.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.497 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 52.6 tttp -135.38 115.81 13.61 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.889 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.39 142.56 45.86 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.697 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.431 ' HD2' HG12 ' A' ' 37' ' ' VAL . 7.2 Cg_endo -51.72 136.32 50.19 Favored 'Trans proline' 0 C--N 1.327 -0.58 0 C-N-CA 123.284 2.656 . . . . 0.0 112.185 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.84 97.95 1.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.4 p -88.54 -67.12 0.85 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.073 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -92.64 -161.75 0.86 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.391 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 18.7 m80 -107.84 173.63 6.24 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' A' ' 90' ' ' THR . 10.5 mt -124.47 138.6 54.33 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.541 0.686 . . . . 0.0 111.214 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.498 HD12 ' C ' ' A' ' 108' ' ' ALA . 13.4 mt -85.0 145.01 8.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 31.9 ttt85 -121.24 137.14 54.82 Favored 'General case' 0 N--CA 1.406 -2.664 0 CA-C-O 121.282 0.563 . . . . 0.0 109.597 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.662 ' O ' ' HA ' ' A' ' 86' ' ' SER . 59.2 m-85 -116.6 127.85 54.86 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.127 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.8 tt0 -113.05 126.16 55.17 Favored 'General case' 0 CA--C 1.471 -2.093 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.983 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.788 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -90.15 152.4 21.13 Favored 'General case' 0 N--CA 1.399 -2.98 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.981 ' HG2' HD11 ' A' ' 149' ' ' LEU . 5.3 pt-20 -55.3 -22.27 18.15 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.606 ' OD1' ' HG3' ' A' ' 85' ' ' ARG . 32.6 p-10 -102.5 1.37 34.98 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.529 0.681 . . . . 0.0 110.968 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.87 19.91 20.52 Favored Glycine 0 C--N 1.304 -1.223 0 CA-C-N 114.767 -1.106 . . . . 0.0 115.837 171.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.606 ' HG3' ' OD1' ' A' ' 83' ' ' ASP . 8.4 mtt180 -88.51 136.29 33.06 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 57.2 p -138.44 137.24 37.03 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.86 173.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -134.63 155.22 50.86 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.362 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 38.3 mt-10 -131.3 151.31 51.63 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.257 0.551 . . . . 0.0 112.008 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.496 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.7 OUTLIER -146.6 161.1 41.23 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.693 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.689 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -70.35 16.82 0.07 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.01 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.66 -28.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 125.235 1.414 . . . . 0.0 112.715 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 26.8 t70 -87.98 -8.07 56.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.433 0.635 . . . . 0.0 110.219 176.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 62.6 t-80 -82.15 125.97 75.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.579 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 34.3 Cg_exo -62.92 138.02 65.91 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.921 2.414 . . . . 0.0 112.568 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 17.3 t -114.7 146.17 19.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.3 tp -98.83 106.38 18.63 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 116' ' ' LYS . 2.4 p -108.18 148.46 12.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.342 0.591 . . . . 0.0 111.4 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.505 ' CD2' HD12 ' A' ' 148' ' ' LEU . 49.8 t80 -100.99 94.15 5.86 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.813 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.505 ' CG ' HD11 ' A' ' 104' ' ' ILE . 11.5 pt-20 -144.96 158.23 43.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.2 m-20 64.02 22.16 12.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.015 0.436 . . . . 0.0 110.173 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.13 13.36 61.99 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.689 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -136.67 172.61 12.76 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 121.452 0.644 . . . . 0.0 110.425 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -104.72 121.61 43.97 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.686 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.505 HD11 ' CG ' ' A' ' 99' ' ' GLU . 16.7 pt -126.74 151.46 33.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.792 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.3 mp0 -106.28 111.24 23.75 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.092 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HG3' HG22 ' A' ' 111' ' ' VAL . 11.6 ptpt -125.76 143.43 51.05 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.277 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.643 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 79.7 mtt85 -61.57 163.28 7.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.01 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -61.41 -41.17 96.71 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.803 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 1.1 p90 -75.17 -0.92 20.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.717 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -106.73 -19.32 13.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.69 0.757 . . . . 0.0 109.172 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 107' ' ' ARG . 52.9 t -76.25 150.41 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.616 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -124.47 168.03 13.62 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.408 -177.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -68.24 138.45 55.57 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.25 5.13 67.84 Favored Glycine 0 C--N 1.3 -1.418 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.825 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.735 ' HB3' HD12 ' A' ' 151' ' ' ILE . 3.7 t70 -75.72 165.77 24.55 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.448 ' H ' HG23 ' A' ' 97' ' ' VAL . 29.1 mttp -124.63 160.97 27.26 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.311 0.576 . . . . 0.0 111.116 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.35 160.26 42.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.271 173.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.7 136.24 37.51 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.2 m -109.11 161.15 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 80.6 p . . . . . 0 C--N 1.308 -1.211 0 CA-C-O 121.281 0.562 . . . . 0.0 110.547 179.393 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.505 HD12 ' CD2' ' A' ' 98' ' ' TYR . 9.7 mt . . . . . 0 N--CA 1.415 -2.209 0 CA-C-O 121.356 0.598 . . . . 0.0 109.738 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.981 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -113.9 137.58 51.48 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.423 -172.14 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.473 ' H ' HD13 ' A' ' 149' ' ' LEU . 10.2 mt-10 -90.8 145.28 24.91 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.574 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.735 HD12 ' HB3' ' A' ' 115' ' ' ASP . 82.2 mt -76.96 102.72 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.371 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.67 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 35.5 mmtm -69.33 -35.74 76.23 Favored 'General case' 0 C--N 1.264 -3.125 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.369 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -151.59 128.79 11.18 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 66.7 mt -112.56 144.76 19.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.795 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.476 ' HD3' HG13 ' A' ' 157' ' ' VAL . 5.7 ptpp? -146.41 156.45 43.32 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.123 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -99.42 115.26 28.84 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.476 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -128.87 173.75 13.24 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.568 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.878 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -106.35 166.1 10.78 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.37 132.35 46.24 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.935 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.43 ' HB2' ' OD1' ' A' ' 5' ' ' ASP . 24.3 m-80 -87.95 34.58 0.73 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.276 0.56 . . . . 0.0 110.018 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -161.74 178.86 8.6 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.03 -1.36 23.99 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.399 0.619 . . . . 0.0 110.243 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -139.13 153.38 47.96 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.478 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.8 m -119.01 157.12 20.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 58.5 m-85 -132.84 175.04 9.7 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.553 -176.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.57 ' HB2' HD13 ' A' ' 68' ' ' ILE . 49.2 m -154.54 -29.55 0.11 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.884 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.661 ' HG ' HD23 ' A' ' 24' ' ' LEU . 2.5 mm? 61.93 90.97 0.07 Allowed 'General case' 0 C--N 1.345 0.371 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 65' ' ' GLU . 47.8 m-20 -81.75 104.5 12.18 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.608 0.718 . . . . 0.0 111.974 -175.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.6 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -94.67 -155.41 0.46 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.285 172.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.597 ' HB2' HG21 ' A' ' 62' ' ' THR . 32.7 mmtm . . . . . 0 C--N 1.321 -0.634 0 CA-C-O 121.223 0.535 . . . . 0.0 112.083 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.9 t30 . . . . . 0 N--CA 1.448 -0.572 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.757 HG21 HD11 ' A' ' 8' ' ' ILE . 1.7 p -158.66 171.07 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -176.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.596 ' H ' HG22 ' A' ' 175' ' ' VAL . 71.8 mt -116.42 122.4 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.923 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.547 HG23 HG13 ' A' ' 175' ' ' VAL . 43.1 pt -126.68 167.39 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 121.597 0.713 . . . . 0.0 112.637 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 38.9 t30 52.48 -129.63 2.31 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.255 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.436 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 3.2 mp0 -78.89 42.99 0.48 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.017 0.437 . . . . 0.0 110.491 176.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.3 m-20 71.02 48.37 0.38 Allowed 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 124.508 1.123 . . . . 0.0 112.308 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 85.0 mt -88.75 112.17 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 176' ' ' ILE . 2.6 m -79.47 135.51 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 CA-C-O 121.969 0.89 . . . . 0.0 111.208 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--N 1.289 -2.059 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.508 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.424 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 1.7 m-85 . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.546 ' HD3' HD13 ' A' ' 76' ' ' LEU . 74.0 Cg_endo -71.56 164.82 34.44 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.035 1.823 . . . . 0.0 109.356 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.17 -29.85 63.29 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 119.276 -1.44 . . . . 0.0 111.334 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.618 ' HA ' ' NH1' ' A' ' 22' ' ' ARG . 35.7 t70 -61.37 -16.44 46.37 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.1 m -68.73 125.42 26.52 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.072 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.715 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 78.5 mtm-85 -84.01 134.88 34.62 Favored 'General case' 0 C--O 1.182 -2.46 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.453 ' CD1' HG21 ' A' ' 175' ' ' VAL . 9.5 tt -120.47 130.1 74.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.67 122.77 32.46 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-O 121.52 0.676 . . . . 0.0 109.656 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.4 m -135.52 -179.36 3.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.071 -176.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 33.0 tt0 -129.52 121.77 27.88 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.944 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 19.1 mt -121.79 121.8 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.097 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.92 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 56.43 37.48 28.86 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.473 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.38 15.92 77.23 Favored Glycine 0 C--N 1.305 -1.162 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.638 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.27 121.23 27.04 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 56.6 Cg_endo -72.44 122.69 8.51 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 C-N-CA 122.334 2.023 . . . . 0.0 111.416 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -120.45 138.13 53.96 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.916 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -107.98 101.08 10.37 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.3 pt -127.03 -172.86 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.364 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.715 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 21.5 p -97.96 172.24 7.76 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.771 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.574 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 66.2 mt -68.15 -27.38 66.38 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.016 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.618 ' NH1' ' HA ' ' A' ' 5' ' ' ASP . 1.0 OUTLIER -78.53 -26.66 45.8 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.45 ' OE1' HG23 ' A' ' 20' ' ' THR . 85.3 mt-10 -85.73 -42.05 14.58 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.238 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.524 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 20.1 tp -58.8 -42.92 90.21 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.866 0.841 . . . . 0.0 109.319 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.405 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -52.41 -31.0 32.12 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.734 -1.575 . . . . 0.0 112.687 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.11 -19.32 61.81 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.757 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.1 mm? -78.29 1.92 20.15 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.483 0.659 . . . . 0.0 109.601 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.555 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.9 m-85 -119.15 156.52 29.65 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.035 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 17.4 mt-10 -157.65 131.51 8.05 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.092 175.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 47.6 t0 127.83 85.93 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.794 2.037 . . . . 0.0 107.394 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -99.23 125.28 44.8 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.113 0.959 . . . . 0.0 111.696 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -117.53 150.67 38.57 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.131 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -102.46 131.67 48.99 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -166.55 148.35 6.46 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.499 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 58.26 23.11 9.99 Favored 'General case' 0 CA--C 1.491 -1.296 0 O-C-N 123.81 0.694 . . . . 0.0 111.067 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 44.8 mtm 73.69 15.83 3.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.233 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.8 m -130.4 -170.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.92 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -112.5 138.1 49.75 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 t -130.08 123.54 56.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.08 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 29' ' ' GLU . 17.0 ttm180 -110.02 134.0 52.6 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -116.77 179.31 4.05 Favored 'General case' 0 C--N 1.267 -2.99 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.28 106.37 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 125.079 1.487 . . . . 0.0 114.505 170.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.488 ' HB2' HD13 ' A' ' 47' ' ' ILE . 55.5 Cg_endo -77.39 140.01 18.98 Favored 'Trans proline' 0 N--CA 1.426 -2.482 0 C-N-CA 121.552 1.501 . . . . 0.0 110.619 174.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -83.71 -0.48 50.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.447 0.641 . . . . 0.0 111.735 -175.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -147.34 -171.0 3.69 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 19.3 tt0 -79.83 105.34 11.05 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.61 HG13 HG12 ' A' ' 12' ' ' ILE . 1.4 mp -116.28 112.37 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.361 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 45.7 mmtm -113.56 166.5 11.46 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.739 173.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 169' ' ' ALA . 12.1 p -121.48 131.29 73.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 11' ' ' GLN . 19.2 m-85 -82.95 121.24 26.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.872 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 m -135.42 170.17 16.35 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.668 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.478 HD13 ' O ' ' A' ' 58' ' ' LYS . 2.4 mm -113.26 142.9 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.433 0.635 . . . . 0.0 110.831 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.64 80.26 3.08 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.687 ' H ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -36.33 -40.66 0.24 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.399 1.88 . . . . 0.0 114.039 -175.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 55' ' ' GLU . 2.1 pt-20 -63.33 -37.78 88.61 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.323 -176.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.487 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.4 p -107.34 -22.51 12.56 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.914 -176.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.55 20.46 68.84 Favored Glycine 0 N--CA 1.421 -2.366 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.015 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 40.8 mtpt -94.07 158.94 15.38 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.57 109.73 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.783 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.67 155.74 11.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-O 121.066 0.46 . . . . 0.0 111.387 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.8 tp -123.01 135.11 54.33 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.426 HG21 ' HB3' ' A' ' 170' ' ' LYS . 11.2 t -143.1 170.75 15.13 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.324 -176.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -76.73 161.14 28.74 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.202 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.507 HD13 HG22 ' A' ' 47' ' ' ILE . 1.9 mp -97.43 145.75 8.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.321 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.484 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 14.9 mm-40 -79.7 -53.3 6.95 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -175.48 -171.73 0.51 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.673 1.233 . . . . 0.0 107.918 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.567 ' HA ' HD22 ' A' ' 167' ' ' LEU . 14.3 t -107.31 149.99 10.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 120.889 0.376 . . . . 0.0 110.428 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.695 HD12 ' HB2' ' A' ' 166' ' ' SER . 56.4 mt -111.95 118.96 58.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.198 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.466 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 19.2 tttm -134.75 112.62 10.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.933 0.397 . . . . 0.0 109.95 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.52 143.63 50.02 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.029 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.442 ' HD2' HG12 ' A' ' 37' ' ' VAL . 9.7 Cg_endo -54.32 130.07 37.9 Favored 'Trans proline' 0 C--N 1.328 -0.502 0 C-N-CA 123.208 2.605 . . . . 0.0 112.446 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.98 85.53 6.24 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.611 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.8 p -96.55 -43.12 7.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.665 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.06 174.59 8.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.606 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -102.16 171.78 7.29 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' A' ' 90' ' ' THR . 12.1 mt -126.02 143.05 51.25 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.753 0.787 . . . . 0.0 110.973 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.52 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 7.6 mt -83.82 141.4 14.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 15.9 ttt-85 -116.56 136.38 53.03 Favored 'General case' 0 N--CA 1.407 -2.575 0 CA-C-O 121.191 0.52 . . . . 0.0 109.748 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 86' ' ' SER . 55.0 m-85 -114.66 120.83 41.46 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.256 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 37.4 tt0 -108.07 126.62 52.96 Favored 'General case' 0 CA--C 1.467 -2.222 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.671 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.6 mm? -88.16 157.53 18.79 Favored 'General case' 0 C--N 1.27 -2.855 0 O-C-N 123.584 0.553 . . . . 0.0 110.97 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.872 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -59.32 -18.5 38.61 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.1 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -91.92 -10.2 40.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.847 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.42 9.64 57.65 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.965 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.558 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -84.17 141.57 30.96 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -142.09 140.52 32.55 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.823 176.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -135.48 157.47 46.82 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.497 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 31.3 mt-10 -129.1 153.19 47.89 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.154 0.502 . . . . 0.0 112.026 -176.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.464 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -145.88 158.43 43.86 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.384 177.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.686 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -72.37 18.99 0.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.009 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.71 -41.91 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 C-N-CA 125.367 1.467 . . . . 0.0 114.151 175.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -82.21 2.88 29.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 111.144 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.482 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 36.8 m-70 -104.59 136.13 19.22 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.728 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 35.6 Cg_exo -62.3 142.41 91.13 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.543 2.829 . . . . 0.0 114.824 -177.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.503 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.8 t -117.97 147.28 21.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.604 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.6 tp -103.82 111.43 23.94 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.703 HG13 HG13 ' A' ' 104' ' ' ILE . 2.0 p -113.79 140.9 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-O 121.592 0.71 . . . . 0.0 111.667 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.648 ' CD2' HD11 ' A' ' 148' ' ' LEU . 81.6 t80 -91.37 92.37 8.55 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.625 ' HG3' HD22 ' A' ' 100' ' ' ASN . 1.0 OUTLIER -142.2 148.86 38.88 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.474 -175.009 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.625 HD22 ' HG3' ' A' ' 99' ' ' GLU . 28.6 m-80 69.18 22.55 6.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 110.027 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.14 14.51 63.88 Favored Glycine 0 CA--C 1.5 -0.905 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.91 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -140.05 173.32 11.64 Favored 'General case' 0 N--CA 1.41 -2.46 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -97.01 120.37 37.23 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.703 HG13 HG13 ' A' ' 97' ' ' VAL . 12.3 pt -116.91 143.13 27.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.006 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -107.49 110.44 22.38 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.13 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 11.5 ptpt -127.24 138.86 53.19 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.608 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.655 ' O ' HG23 ' A' ' 111' ' ' VAL . 56.6 mtm180 -64.62 164.14 12.46 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 119.347 -0.359 . . . . 0.0 110.147 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.009 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -61.57 -43.21 99.28 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.514 -175.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.412 ' HB3' ' CG2' ' A' ' 91' ' ' VAL . 2.0 p90 -75.05 2.74 9.86 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.524 0.678 . . . . 0.0 110.332 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -114.01 -15.39 12.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.553 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 107' ' ' ARG . 93.2 t -81.87 149.27 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.657 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 18.1 mtmt -124.06 163.47 21.38 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.091 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -64.12 142.89 58.25 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.66 4.2 85.54 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.887 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.657 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -74.98 167.9 21.02 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.481 ' HG3' ' HG3' ' A' ' 150' ' ' GLU . 3.8 ttmt -123.97 166.43 15.72 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.185 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.55 161.43 36.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -90.5 129.89 36.61 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -112.87 125.28 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.909 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.303 -1.425 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.542 -178.931 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.648 HD11 ' CD2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.423 -1.797 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.872 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -122.73 139.28 54.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.644 -170.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.481 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 19.1 mt-10 -91.19 150.52 21.33 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 122.337 1.065 . . . . 0.0 112.741 177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.487 HG21 ' CG1' ' A' ' 154' ' ' ILE . 61.1 mt -77.79 121.69 31.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 113.246 -1.797 . . . . 0.0 111.002 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.612 ' HE2' ' HB2' ' A' ' 82' ' ' GLU . 49.4 mmtt -80.99 -39.19 26.33 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.482 175.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -148.73 130.2 14.82 Favored 'General case' 0 CA--C 1.473 -2.01 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.6 mt -117.62 126.26 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.445 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.297 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HD3' HG13 ' A' ' 157' ' ' VAL . 0.4 OUTLIER -135.82 166.89 22.24 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.153 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.52 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 23.8 m-85 -101.58 119.82 39.36 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.42 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.4 OUTLIER -135.57 137.21 49.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.683 -178.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -71.1 154.1 42.02 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.258 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.22 134.64 57.18 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.259 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -82.84 37.55 0.54 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.604 0.716 . . . . 0.0 110.163 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -175.16 179.26 1.58 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -107.34 4.32 26.3 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.858 0.361 . . . . 0.0 111.607 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -141.54 149.48 40.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.0 m -118.78 155.41 20.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.536 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 56.5 m-85 -133.16 174.17 10.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.111 -176.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.695 ' HB2' HD12 ' A' ' 68' ' ' ILE . 49.1 m -159.06 -27.42 0.07 Allowed 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.567 HD22 ' HA ' ' A' ' 67' ' ' VAL . 1.3 tm? 68.91 107.14 0.05 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.066 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -85.25 116.16 23.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.666 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.484 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -135.36 -163.03 1.33 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.045 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.426 ' HB3' HG21 ' A' ' 62' ' ' THR . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 66.4 t30 . . . . . 0 CA--C 1.511 -0.558 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.568 HG13 HG23 ' A' ' 177' ' ' ILE . 2.8 p -152.96 163.92 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.433 0.635 . . . . 0.0 111.673 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.606 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 93.8 mt -116.71 115.78 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.444 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.568 HG23 HG13 ' A' ' 175' ' ' VAL . 39.5 pt -123.78 173.48 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 7' ' ' ARG . 7.9 t-20 49.19 -122.36 1.71 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.35 1.06 . . . . 0.0 109.81 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.404 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 34.8 mm-40 -96.21 56.59 1.64 Allowed 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.47 0.652 . . . . 0.0 109.658 175.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 25.7 m-80 69.51 43.56 1.0 Allowed 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 114.216 -1.357 . . . . 0.0 113.751 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.5 mt -85.49 116.55 28.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.55 129.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.357 -174.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 14.7 t . . . . . 0 C--N 1.309 -1.176 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.448 176.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.494 ' HA ' HG12 ' A' ' 164' ' ' VAL . 23.0 Cg_endo -61.25 -32.66 90.45 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 122.852 2.368 . . . . 0.0 112.781 -174.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 127.04 -39.27 1.99 Allowed Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.38 -16.92 25.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.648 0.779 . . . . 0.0 111.058 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -64.4 126.69 28.63 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.593 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.633 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 19.1 mmt85 -82.79 134.41 35.12 Favored 'General case' 0 C--O 1.186 -2.25 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.606 HD11 HG21 ' A' ' 175' ' ' VAL . 9.9 tt -121.66 131.4 73.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.426 HD23 ' HB2' ' A' ' 18' ' ' LYS . 2.1 tm? -87.66 123.71 32.79 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.611 0.72 . . . . 0.0 109.847 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 31.5 m -133.06 -177.26 2.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.02 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -130.3 121.32 25.85 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.596 HG12 HG13 ' A' ' 47' ' ' ILE . 22.3 mt -118.36 121.32 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.523 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.707 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.84 38.12 29.73 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.691 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.02 20.29 79.47 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.769 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.04 118.32 22.09 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-O 120.683 0.277 . . . . 0.0 110.41 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 7.0 Cg_exo -66.78 121.54 8.77 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 122.068 1.845 . . . . 0.0 111.065 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -123.63 137.4 54.74 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.693 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HB2' HD23 ' A' ' 9' ' ' LEU . 36.9 ttpt -108.54 101.37 10.53 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.9 pt -123.53 -171.9 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.18 -2.555 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.624 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.798 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 6.6 p -94.44 171.82 8.58 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.088 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 12.3 mt -72.38 -24.5 61.27 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 120.683 0.277 . . . . 0.0 110.909 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.798 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 8.1 ptm180 -82.18 -24.35 35.02 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.542 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 67.8 mm-40 -82.96 -44.59 15.13 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.043 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.504 HD21 ' HG ' ' A' ' 167' ' ' LEU . 20.5 tp -54.74 -45.57 74.14 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.88 0.848 . . . . 0.0 109.407 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.425 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -52.2 -31.16 30.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.554 -1.657 . . . . 0.0 112.754 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 26.8 mt-10 -78.81 -15.35 58.5 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 23' ' ' GLU . 1.8 mm? -77.97 5.92 8.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.76 0.79 . . . . 0.0 109.39 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.7 m-85 -121.01 162.46 19.89 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.857 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.613 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 21.1 mm-40 -142.06 -172.86 3.67 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.296 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.506 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.7 t70 63.1 80.04 0.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.376 0.607 . . . . 0.0 110.469 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.35 128.09 43.87 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.841 0.829 . . . . 0.0 110.672 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.471 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.0 ptt180 -121.78 154.42 37.0 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.402 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -102.84 126.33 49.93 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -162.5 140.96 8.78 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.622 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 58.65 24.14 11.78 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 123.671 0.607 . . . . 0.0 110.624 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.6 mtp 72.74 13.44 5.16 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.348 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.516 HG12 ' HD2' ' A' ' 71' ' ' PRO . 12.9 m -127.31 -177.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -112.42 139.68 47.79 Favored 'General case' 0 CA--C 1.471 -2.081 0 CA-C-O 121.303 0.573 . . . . 0.0 109.855 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.471 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.8 t -128.94 122.55 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 0 CA-C-N 115.14 -0.937 . . . . 0.0 108.77 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.421 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 16.1 ttm180 -112.24 126.17 54.94 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.506 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -129.95 145.51 51.63 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.177 -173.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 3.6 tppp? 81.78 111.94 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.48 0 O-C-N 124.54 1.15 . . . . 0.0 110.902 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.548 ' HB2' HD13 ' A' ' 47' ' ' ILE . 59.3 Cg_endo -78.72 152.44 25.61 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 122.15 1.9 . . . . 0.0 111.622 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.613 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 32.4 mtmt -81.53 -5.43 57.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.422 0.629 . . . . 0.0 111.214 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -146.19 -165.39 2.2 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 39.9 tt0 -86.04 102.0 13.43 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.596 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -116.91 120.92 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.167 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 22.5 mmtt -120.02 164.7 15.73 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.181 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.454 ' O ' HD12 ' A' ' 61' ' ' LEU . 12.9 p -118.67 130.92 72.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.274 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -90.73 118.92 30.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.6 0.714 . . . . 0.0 111.461 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.9 m -134.24 146.68 50.31 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.819 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.527 HG12 HD11 ' A' ' 176' ' ' ILE . 2.8 mm -90.26 141.03 14.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.334 0.588 . . . . 0.0 110.345 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.51 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 13.5 t70 -80.57 121.14 25.43 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.707 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -78.16 -8.52 58.39 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.237 0.541 . . . . 0.0 111.876 -169.287 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.51 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.5 pt-20 -103.27 -31.56 10.02 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.35 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.485 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 68.2 p -111.84 -18.11 12.78 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.78 -175.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.46 21.34 79.63 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.345 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.485 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 38.2 mtpt -98.14 162.24 13.31 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 120.865 0.364 . . . . 0.0 111.464 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.46 110.45 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-O 121.767 0.794 . . . . 0.0 109.509 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 m -110.05 156.88 10.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.051 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 49' ' ' VAL . 13.5 tp -123.1 136.87 54.98 Favored 'General case' 0 N--CA 1.411 -2.387 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 170' ' ' LYS . 10.3 t -142.66 171.21 14.37 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.939 0.399 . . . . 0.0 111.316 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.418 ' O ' ' HB1' ' A' ' 169' ' ' ALA . 0.9 OUTLIER -80.26 161.04 25.34 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.395 178.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.537 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.3 mp -101.15 136.72 31.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.222 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.404 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 46.6 mm-40 -83.59 -41.22 18.11 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -179.49 178.01 0.7 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.405 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.502 ' HA ' HD22 ' A' ' 167' ' ' LEU . 13.3 t -105.86 132.76 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.795 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 166' ' ' SER . 60.3 mt -91.28 108.45 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.095 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.512 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.7 tttt -124.56 107.93 11.55 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.52 144.53 53.75 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.312 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.516 ' HD2' HG12 ' A' ' 37' ' ' VAL . 9.8 Cg_endo -53.97 131.67 45.74 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.389 2.726 . . . . 0.0 112.29 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.451 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -78.15 -108.95 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.728 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 86.2 m 77.02 -21.45 0.33 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.945 0.498 . . . . 0.0 111.878 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.469 ' HB2' ' H ' ' A' ' 75' ' ' HIS . 0.8 OUTLIER -79.79 -139.77 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.446 179.114 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.469 ' H ' ' HB2' ' A' ' 74' ' ' ASP . 52.7 m80 -150.68 165.79 32.36 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.828 HD23 ' HA ' ' A' ' 90' ' ' THR . 30.5 mt -135.98 136.54 40.44 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.117 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.539 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 15.6 mt -89.61 146.24 6.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 172.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 28.8 ttt85 -121.08 137.87 54.45 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 121.153 0.501 . . . . 0.0 109.999 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.602 ' CD1' HD13 ' A' ' 151' ' ' ILE . 50.7 m-85 -117.57 127.31 53.84 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.2 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 32.4 tt0 -112.88 130.3 56.15 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.859 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -94.27 162.04 14.01 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.04 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 1.058 ' HG2' HD11 ' A' ' 149' ' ' LEU . 4.3 pt-20 -58.27 -22.42 52.47 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.875 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.715 ' OD1' ' HG ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -86.69 -10.8 52.92 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.575 0.702 . . . . 0.0 109.498 -178.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.78 14.4 58.11 Favored Glycine 0 C--N 1.297 -1.602 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.191 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.639 ' HG3' ' HB2' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -89.64 142.48 27.64 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 35.3 p -139.95 154.33 47.17 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.888 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 79' ' ' PHE . 9.3 p90 -142.86 151.34 40.97 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.723 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 96.9 mt-10 -125.8 146.12 49.93 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.56 -177.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -142.31 159.46 42.19 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.406 -179.065 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.828 ' HA ' HD23 ' A' ' 76' ' ' LEU . 1.7 m -73.62 19.22 0.11 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.3 0.571 . . . . 0.0 112.478 -177.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.017 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.88 -34.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 124.78 1.232 . . . . 0.0 113.249 175.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 23.3 t70 -78.62 -24.59 45.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.129 0.49 . . . . 0.0 110.017 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -77.8 119.97 79.49 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.277 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 35.1 Cg_exo -62.2 139.83 80.13 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.522 2.815 . . . . 0.0 114.014 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.5 t -100.28 147.42 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.736 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.5 tp -98.02 106.16 18.42 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.168 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.626 HG13 HG12 ' A' ' 104' ' ' ILE . 2.4 p -112.55 149.37 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.678 0.751 . . . . 0.0 112.258 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -104.05 92.81 4.54 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.781 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.579 ' OE2' ' HE3' ' A' ' 106' ' ' LYS . 6.1 pt-20 -138.85 159.94 40.9 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 89.9 m-20 63.14 22.37 13.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.332 0.587 . . . . 0.0 109.7 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.29 16.68 62.91 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.298 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 102' ' ' ARG . 11.1 ptp180 -136.4 171.99 13.67 Favored 'General case' 0 N--CA 1.399 -2.979 0 CA-C-N 117.605 0.702 . . . . 0.0 109.916 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -98.36 121.25 40.07 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.626 HG12 HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -126.98 148.75 31.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.132 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 3.3 mp0 -108.11 116.45 31.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.515 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.585 ' HE2' HG13 ' A' ' 104' ' ' ILE . 51.0 mttm -124.62 134.72 52.82 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.328 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 75.3 mtm180 -56.66 154.78 8.39 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.017 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -59.87 -41.74 92.18 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.935 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 3.4 p90 -73.51 2.11 8.53 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.92 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -114.14 -19.26 11.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.863 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 107' ' ' ARG . 53.1 t -76.97 152.3 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.723 ' HE2' ' H ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -123.94 167.08 14.61 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -71.15 143.53 50.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.99 4.96 74.19 Favored Glycine 0 C--N 1.304 -1.199 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.569 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.968 ' HB3' HD12 ' A' ' 151' ' ' ILE . 15.2 t70 -72.03 178.81 3.56 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.69 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 71.4 mttt -135.45 154.52 51.41 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.62 0.724 . . . . 0.0 112.037 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.05 155.64 41.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.895 173.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.533 ' HA ' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -97.12 135.91 38.41 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.8 OUTLIER -104.93 125.96 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.747 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.819 176.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 C--N 1.295 -1.77 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 175.647 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.69 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.9 mm? . . . . . 0 CA--C 1.475 -1.907 0 CA-C-O 121.03 0.443 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.058 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -119.28 135.95 54.46 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.006 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 25.8 mt-10 -83.19 141.51 31.87 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.96 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.968 HD12 ' HB3' ' A' ' 115' ' ' ASP . 73.0 mt -80.17 104.87 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.995 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.586 174.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.558 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 14.1 mmtm -70.64 -37.13 73.74 Favored 'General case' 0 C--N 1.266 -3.06 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.159 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -148.92 129.25 13.77 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 75.7 mt -113.11 144.82 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.529 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.471 ' HD2' ' HD3' ' A' ' 78' ' ' ARG . 5.2 ptpp? -145.99 156.14 43.29 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.815 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.539 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 5.1 m-85 -98.94 117.82 34.31 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -126.2 175.65 7.97 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.094 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.521 -178.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 23.3 mtt-85 -100.6 164.46 11.88 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.625 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.703 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.87 -30.16 63.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.511 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.6 t30 66.37 -38.76 0.31 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.358 1.063 . . . . 0.0 113.279 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -98.04 -174.36 2.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.37 -13.09 16.8 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 120.71 0.291 . . . . 0.0 110.905 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -139.29 155.95 47.37 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.18 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.4 m -128.28 160.09 38.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.505 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.623 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 81.4 m-85 -132.76 169.75 16.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.555 0.217 . . . . 0.0 110.736 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.654 ' HB2' HD12 ' A' ' 68' ' ' ILE . 20.3 m -156.78 -27.99 0.09 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.504 ' HG ' HD21 ' A' ' 24' ' ' LEU . 1.3 tm? 73.05 112.22 0.06 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.996 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -91.94 116.67 29.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.605 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 63' ' ' ASP . . . -134.16 -164.1 1.46 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.677 176.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.407 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 26.1 mmmt . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.606 HG21 HD11 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -173.83 166.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.309 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.527 HD11 HG12 ' A' ' 52' ' ' ILE . 85.7 mt -109.53 112.95 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.639 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.603 HG23 HG13 ' A' ' 175' ' ' VAL . 44.9 pt -120.51 171.59 8.8 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.683 0 CA-C-O 121.375 0.607 . . . . 0.0 112.482 -175.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.573 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 44.8 t30 48.68 -128.12 1.97 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.002 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.506 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 19.7 mm-40 -85.61 48.71 1.63 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.334 0.587 . . . . 0.0 109.592 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.5 m-20 70.29 44.79 0.7 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.128 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 82.1 mt -86.27 113.08 23.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.407 HG11 HG13 ' A' ' 52' ' ' ILE . 3.0 m -80.34 135.6 25.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.758 0.789 . . . . 0.0 111.271 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.293 -1.849 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.581 176.868 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.401 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 1.5 m-85 . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.454 ' HD3' HD13 ' A' ' 76' ' ' LEU . 61.6 Cg_endo -70.43 157.01 60.37 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 N-CA-C 108.413 -1.418 . . . . 0.0 108.413 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.59 -21.46 35.32 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 119.735 -1.221 . . . . 0.0 112.397 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -74.27 -1.26 19.87 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.4 m -74.39 130.93 40.58 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.928 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 8.7 mmt180 -81.86 126.2 31.6 Favored 'General case' 0 C--O 1.197 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.485 HD11 HG21 ' A' ' 175' ' ' VAL . 9.5 tt -117.67 129.75 73.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.039 0.447 . . . . 0.0 109.877 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.463 ' CD2' ' HB2' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -89.72 124.17 34.38 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-O 121.531 0.681 . . . . 0.0 109.917 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 19.3 m -137.64 -177.87 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.342 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.479 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 30.9 tt0 -126.08 118.84 26.13 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.582 HG12 HG13 ' A' ' 47' ' ' ILE . 20.7 mt -119.19 121.7 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.727 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.28 39.5 30.91 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.933 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.27 19.58 78.77 Favored Glycine 0 N--CA 1.439 -1.116 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.849 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.96 122.76 24.45 Favored Pre-proline 0 N--CA 1.434 -1.264 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 44.1 Cg_endo -71.54 120.22 6.78 Favored 'Trans proline' 0 N--CA 1.432 -2.126 0 C-N-CA 121.931 1.754 . . . . 0.0 110.675 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -122.98 142.06 51.25 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.622 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.463 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 39.1 ttmt -112.29 100.89 9.16 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.1 pt -119.44 -178.41 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.912 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.106 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.801 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.8 p -93.28 174.52 7.17 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.142 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 94.5 mt -66.94 -31.39 71.93 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 120.726 0.298 . . . . 0.0 110.551 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.801 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 9.5 ptm180 -78.5 -22.5 47.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB2' ' H ' ' A' ' 20' ' ' THR . 38.8 mm-40 -84.56 -45.79 12.23 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.527 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.737 HD23 ' HG ' ' A' ' 167' ' ' LEU . 13.4 tp -58.91 -42.66 90.19 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.787 0.804 . . . . 0.0 109.51 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.429 ' HD1' HG11 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -53.98 -30.37 46.8 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.637 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.73 -17.89 59.76 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 23' ' ' GLU . 1.5 mm? -80.56 1.51 29.3 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.577 0.703 . . . . 0.0 109.663 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.7 m-85 -119.01 161.65 19.87 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.107 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -144.72 -171.42 3.61 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.033 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.539 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.2 t70 65.71 76.75 0.31 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.539 0.685 . . . . 0.0 109.584 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -100.93 131.54 46.76 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.103 0.954 . . . . 0.0 111.752 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.511 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 17.6 ptt-85 -121.53 153.87 37.4 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.048 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -104.04 123.18 46.77 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -160.76 148.76 16.02 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.06 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 59.57 22.62 11.26 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 123.571 0.544 . . . . 0.0 110.76 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 41.7 mtm 72.96 16.79 4.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.943 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.6 m -133.33 -169.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.937 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.558 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 71.6 m-85 -110.84 137.72 48.14 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.511 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.8 t -132.49 124.86 52.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.5 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.471 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 22.9 ttm180 -117.23 127.73 54.38 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -131.91 147.51 52.47 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.696 -175.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 23.0 tptm 81.8 111.79 0.03 OUTLIER Pre-proline 0 C--O 1.236 0.389 0 O-C-N 124.197 0.935 . . . . 0.0 111.056 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.578 ' HB2' HD13 ' A' ' 47' ' ' ILE . 63.3 Cg_endo -78.32 152.28 26.89 Favored 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.299 1.999 . . . . 0.0 112.043 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -87.03 -0.71 57.07 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.134 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 45' ' ' ARG . 49.2 mtt180 -148.67 -164.79 2.11 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 4.1 tp10 -85.58 98.27 10.55 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.582 HG13 HG12 ' A' ' 12' ' ' ILE . 1.8 mp -117.15 114.94 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.083 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 34.0 mmtp -120.38 163.7 17.47 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.72 175.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.486 HG11 ' CB ' ' A' ' 169' ' ' ALA . 11.7 p -120.49 133.44 67.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.647 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.479 ' CE1' ' HB2' ' A' ' 11' ' ' GLN . 42.7 m-85 -82.92 124.39 30.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.925 176.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.403 ' HB3' ' OD1' ' A' ' 174' ' ' ASN . 56.4 m -121.58 175.54 6.16 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.522 HG12 HD11 ' A' ' 176' ' ' ILE . 2.8 mm -127.95 138.51 54.5 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-O 121.491 0.662 . . . . 0.0 110.625 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.749 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.3 t70 -86.59 110.55 19.9 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.432 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.792 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -68.33 -13.16 62.07 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.897 0.879 . . . . 0.0 112.595 -171.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.749 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -98.28 -25.31 14.9 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.868 -175.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.538 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.3 p -117.24 -26.56 6.72 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.519 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.15 22.59 44.31 Favored Glycine 0 N--CA 1.426 -1.983 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.055 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.538 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 37.1 mtpt -97.6 155.42 16.98 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.41 ' HA ' HD13 ' A' ' 52' ' ' ILE . 3.9 p -96.95 109.26 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.919 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 m -109.63 162.4 7.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.707 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.4 tp -118.57 142.99 47.08 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -149.81 173.06 14.17 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.067 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -84.46 161.74 20.18 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.614 0.721 . . . . 0.0 110.716 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.548 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.5 mp -97.76 144.58 10.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.889 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.559 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.8 mm-40 -88.78 -42.47 11.9 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 p30 178.2 175.81 0.51 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.12 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 14.6 t -108.14 132.22 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.917 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 166' ' ' SER . 17.4 mt -98.52 114.78 37.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.511 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 85.8 tttt -126.13 111.92 15.21 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.8 143.34 48.98 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.358 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.429 ' HD2' HG12 ' A' ' 37' ' ' VAL . 7.0 Cg_endo -52.43 124.04 14.15 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.323 2.682 . . . . 0.0 112.597 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.75 81.9 8.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.367 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.2 m -91.57 -36.37 13.73 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.64 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -85.95 177.98 7.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.447 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -103.96 171.33 7.41 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.1 mt -122.84 140.2 53.2 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.8 0.809 . . . . 0.0 111.24 -174.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.507 HG23 HG23 ' A' ' 154' ' ' ILE . 14.3 mt -86.4 140.17 16.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 31.1 ttt180 -118.23 138.53 52.28 Favored 'General case' 0 N--CA 1.4 -2.972 0 CA-C-O 121.25 0.547 . . . . 0.0 109.741 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 86' ' ' SER . 59.4 m-85 -114.67 123.55 49.57 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.344 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 152' ' ' LYS . 40.6 tt0 -109.93 121.25 44.82 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.679 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -88.4 160.74 17.43 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.64 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.781 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -60.57 -22.57 63.82 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.285 -179.376 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -85.17 -11.2 55.57 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.523 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.85 17.41 44.44 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.823 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.596 ' O ' HD23 ' A' ' 81' ' ' LEU . 2.0 mtt180 -83.99 132.27 34.76 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 50.3 p -138.59 137.86 37.38 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 118.608 -1.237 . . . . 0.0 112.033 176.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.408 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 3.8 p90 -133.31 148.78 51.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.348 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 24.5 mt-10 -119.81 151.24 39.14 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.718 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.474 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.7 OUTLIER -144.11 154.99 43.76 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.728 178.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.706 ' HA ' HD23 ' A' ' 76' ' ' LEU . 2.8 m -75.21 18.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.831 0.824 . . . . 0.0 111.455 -177.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.049 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 71.35 -30.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 125.434 1.493 . . . . 0.0 113.004 175.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.64 -5.94 59.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.155 0.502 . . . . 0.0 109.999 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -87.24 128.84 53.87 Favored Pre-proline 0 CA--C 1.512 -0.484 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.821 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.556 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 64.2 Cg_endo -72.52 141.02 34.03 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.808 2.339 . . . . 0.0 112.469 177.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 10.7 t -118.01 152.29 20.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 124.183 0.993 . . . . 0.0 109.585 -176.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 103' ' ' PHE . 1.6 tm? -101.22 114.35 28.24 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.643 HG13 HG13 ' A' ' 104' ' ' ILE . 2.2 p -114.12 146.91 18.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.411 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -102.94 91.51 4.16 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.246 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 8.2 pt-20 -141.36 158.84 43.35 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 30.7 m-80 64.74 22.19 12.52 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.211 0.529 . . . . 0.0 109.625 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.39 16.68 60.88 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.849 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -138.27 172.22 13.22 Favored 'General case' 0 N--CA 1.407 -2.617 0 CA-C-O 121.355 0.598 . . . . 0.0 110.244 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.44 ' HB3' HD11 ' A' ' 96' ' ' LEU . 44.2 m-85 -97.35 121.0 38.75 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.896 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.643 HG13 HG13 ' A' ' 97' ' ' VAL . 30.9 pt -121.77 153.3 25.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.068 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 28.5 mt-10 -115.92 116.76 28.52 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.907 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.562 ' HG3' HG22 ' A' ' 111' ' ' VAL . 1.1 ptpm? -137.5 145.49 43.07 Favored 'General case' 0 C--O 1.202 -1.41 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.592 ' O ' HG23 ' A' ' 111' ' ' VAL . 77.3 mtt180 -65.27 162.78 16.67 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.049 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -61.69 -40.72 95.98 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.267 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.412 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 2.3 p90 -75.57 1.47 14.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.61 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -111.22 -19.15 12.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.52 0.676 . . . . 0.0 109.493 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 107' ' ' ARG . 85.2 t -72.43 150.17 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -123.66 163.44 21.06 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.571 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -68.92 143.08 54.56 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.68 5.19 74.99 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.325 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.998 ' HB3' HD12 ' A' ' 151' ' ' ILE . 16.8 t70 -71.4 168.36 17.62 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.655 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 48.4 mttp -127.27 152.49 47.35 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 121.452 0.644 . . . . 0.0 110.789 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.408 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -125.29 153.53 32.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.288 175.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.522 ' HA ' ' CD1' ' A' ' 148' ' ' LEU . 0.5 OUTLIER -89.4 134.89 33.88 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.795 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.7 OUTLIER -100.68 145.0 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.978 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 172.093 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 C--N 1.31 -1.136 0 CA-C-O 121.475 0.655 . . . . 0.0 109.945 179.68 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.655 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.8 mm? . . . . . 0 CA--C 1.484 -1.566 0 CA-C-O 121.081 0.467 . . . . 0.0 109.76 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.781 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -116.76 137.97 51.81 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.508 -176.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.53 ' H ' HD13 ' A' ' 149' ' ' LEU . 17.6 mt-10 -89.03 146.38 24.89 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.284 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.998 HD12 ' HB3' ' A' ' 115' ' ' ASP . 81.4 mt -78.58 107.46 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.777 0 CA-C-N 113.407 -1.724 . . . . 0.0 108.969 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 80' ' ' GLU . 8.0 mmpt? -70.23 -39.4 75.12 Favored 'General case' 0 C--N 1.268 -2.977 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.566 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -149.29 133.52 17.35 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 74.3 mt -115.61 127.68 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 CA-C-N 113.668 -1.605 . . . . 0.0 110.927 175.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.5 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 1.6 ptpp? -132.49 163.35 29.01 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.97 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.452 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.0 m-85 -100.98 115.33 30.21 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.434 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -127.38 137.47 57.65 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.585 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.798 -178.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 158' ' ' ARG . 11.0 ptt180 -71.44 160.83 32.05 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.36 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.66 126.86 31.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.043 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -65.43 -37.94 88.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.288 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -106.96 174.84 5.71 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.294 -177.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.56 2.29 51.21 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.396 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -141.95 153.13 44.11 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.199 0.523 . . . . 0.0 110.456 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.14 157.43 31.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.712 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 76.4 m-85 -132.8 165.17 25.19 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.777 0.322 . . . . 0.0 110.51 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.657 ' HB2' HD12 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -146.38 -24.93 0.43 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.882 174.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.737 ' HG ' HD23 ' A' ' 24' ' ' LEU . 3.6 mm? 62.68 101.09 0.03 OUTLIER 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.892 0.745 . . . . 0.0 110.645 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.475 ' HB2' HD11 ' A' ' 68' ' ' ILE . 58.6 t30 -83.47 121.17 26.84 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.703 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.559 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -131.28 -157.7 0.84 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? . . . . . 0 C--N 1.319 -0.722 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.712 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' A' ' 183' ' ' THR . 3.7 t-20 . . . . . 0 N--CA 1.439 -1.01 0 CA-C-O 120.824 0.345 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.496 HG13 HG23 ' A' ' 177' ' ' ILE . 5.4 p -149.03 164.13 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-O 121.494 0.664 . . . . 0.0 110.767 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.703 HG23 ' HA ' ' A' ' 180' ' ' ASN . 2.4 mp -93.88 115.7 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.489 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.496 HG23 HG13 ' A' ' 175' ' ' VAL . 36.7 pt -118.49 166.41 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-O 120.87 0.367 . . . . 0.0 110.729 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.41 ' HB3' HD12 ' A' ' 181' ' ' ILE . 30.4 t30 47.91 -131.99 1.46 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.187 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -81.52 53.34 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.338 0.589 . . . . 0.0 110.061 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.795 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 12.6 m120 65.05 46.9 2.65 Favored 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 125.272 1.429 . . . . 0.0 113.194 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' A' ' 178' ' ' ASN . 88.9 mt -91.21 115.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.04 148.55 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-O 122.039 0.923 . . . . 0.0 112.528 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 2.0 t . . . . . 0 C--N 1.294 -1.837 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.362 175.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 N--CA 1.444 -0.745 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.611 ' HD3' HD13 ' A' ' 76' ' ' LEU . 57.3 Cg_endo -67.24 158.48 56.74 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 N-CA-C 108.512 -1.38 . . . . 0.0 108.512 177.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.12 -27.42 51.83 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 119.477 -1.344 . . . . 0.0 112.035 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -67.17 -13.23 61.76 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.445 ' HB ' HD12 ' A' ' 21' ' ' LEU . 93.6 m -61.44 125.7 24.71 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.422 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 37.6 mmt-85 -79.73 125.26 29.43 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.811 HD11 HG21 ' A' ' 175' ' ' VAL . 10.4 tt -116.33 129.42 72.79 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 CA-C-O 120.84 0.352 . . . . 0.0 110.245 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 9' ' ' LEU . 1.0 OUTLIER -89.34 122.99 33.1 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.63 0.729 . . . . 0.0 110.17 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.2 m -133.03 -179.16 3.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.694 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.409 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 30.9 tt0 -130.97 121.35 24.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.425 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.65 HG12 HG13 ' A' ' 47' ' ' ILE . 15.1 mt -119.96 120.98 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.928 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.598 -177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 54.21 37.22 26.8 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.198 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.01 18.12 80.22 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.829 -1.078 . . . . 0.0 113.529 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -123.58 119.31 27.16 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 43.5 Cg_endo -73.0 121.74 7.54 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.438 2.092 . . . . 0.0 111.291 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -125.75 140.49 52.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.829 -177.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -110.39 102.36 11.0 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.653 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.8 pt -125.43 -171.68 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.642 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.705 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.9 p -96.26 174.39 6.91 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.096 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 62.1 mt -69.87 -31.07 68.7 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.124 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.705 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 3.9 ptm180 -77.34 -25.86 51.51 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.522 ' OE1' HG23 ' A' ' 20' ' ' THR . 84.9 mt-10 -84.73 -40.34 17.41 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.652 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.483 HD21 ' HG ' ' A' ' 167' ' ' LEU . 18.8 tp -59.35 -45.74 90.56 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.746 0.784 . . . . 0.0 109.842 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.512 ' HD1' HG11 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -49.07 -32.55 9.83 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.759 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.9 mt-10 -74.63 -17.26 60.72 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.204 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.54 5.12 13.77 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.501 0.667 . . . . 0.0 109.884 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.526 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.0 m-85 -118.28 164.61 14.94 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.519 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.409 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 5.1 mm-40 -145.8 -172.85 4.0 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.659 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.568 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 18.9 t0 64.88 75.14 0.38 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.602 0.715 . . . . 0.0 109.358 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -102.69 134.28 46.33 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.416 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.492 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.4 ptt180 -127.54 154.54 45.04 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.792 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -105.51 129.9 53.69 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -166.78 153.84 9.05 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.556 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.26 21.24 9.41 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 123.49 0.494 . . . . 0.0 110.804 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 45.3 mtm 70.86 16.79 6.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.411 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 6.1 m -131.82 -168.29 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.444 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 79.4 m-85 -116.61 140.06 49.81 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.492 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.3 t -130.32 123.5 55.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.422 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 19.6 ttm180 -118.62 127.03 53.21 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.568 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -131.15 143.33 50.54 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.185 -174.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 40.0 ttmt 79.58 116.42 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 124.158 0.983 . . . . 0.0 111.383 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.598 ' HB2' HD13 ' A' ' 47' ' ' ILE . 68.6 Cg_endo -79.47 160.31 25.58 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 C-N-CA 122.494 2.129 . . . . 0.0 112.57 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.409 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 34.2 mtmt -88.19 -3.19 58.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.534 0.683 . . . . 0.0 110.351 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.469 ' HB2' HD12 ' A' ' 47' ' ' ILE . 64.8 mtt180 -142.11 -165.28 1.98 Allowed 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 10.1 tp10 -89.21 100.87 13.56 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 171.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.65 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -114.29 117.46 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.175 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 17.7 mmtm -115.86 166.17 12.27 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.976 174.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.566 HG13 HD11 ' A' ' 64' ' ' ILE . 3.3 m -117.58 130.38 72.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.258 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.57 ' HB3' HD12 ' A' ' 176' ' ' ILE . 3.2 m-85 -79.35 121.86 25.66 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 172.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.0 t -133.59 177.03 8.02 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 58' ' ' LYS . 2.1 mm -131.21 142.18 44.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.332 0.587 . . . . 0.0 110.65 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.583 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.1 t70 -81.43 118.33 22.61 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.729 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -72.52 -12.74 61.2 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -170.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.583 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -103.4 -26.9 12.72 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.179 -176.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.0 p -116.77 -20.54 9.45 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.849 -0.741 . . . . 0.0 111.872 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.95 11.84 82.03 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.015 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.477 ' O ' HD13 ' A' ' 52' ' ' ILE . 3.3 mptp? -75.97 145.83 40.04 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 122.693 0.397 . . . . 0.0 111.366 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.451 ' HA ' HD13 ' A' ' 52' ' ' ILE . 4.7 p -90.15 106.72 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 121.993 0.901 . . . . 0.0 109.324 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 m -110.16 155.8 11.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.159 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 49' ' ' VAL . 10.2 tp -122.11 134.25 54.76 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.595 HG21 ' HB2' ' A' ' 170' ' ' LYS . 14.7 t -144.91 172.39 13.1 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.817 -176.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -84.28 162.3 20.16 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.787 0.804 . . . . 0.0 111.515 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 49' ' ' VAL . 2.8 mp -95.95 144.96 9.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.692 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.537 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 29.7 mm-40 -89.65 -39.91 12.91 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 p30 176.88 174.92 0.39 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.959 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.526 ' HA ' HD22 ' A' ' 167' ' ' LEU . 14.7 t -105.04 129.26 58.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.257 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.71 HD12 ' HB2' ' A' ' 166' ' ' SER . 51.2 mt -91.76 104.96 16.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.474 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.549 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.2 tttt -121.3 109.17 14.6 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.5 139.58 35.18 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.215 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.507 ' HD2' HG12 ' A' ' 37' ' ' VAL . 97.0 Cg_exo -44.76 124.3 5.5 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 123.471 2.781 . . . . 0.0 112.736 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.59 78.4 9.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.711 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.4 p -84.86 -53.03 5.59 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.931 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.6 171.37 14.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.218 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -102.68 171.55 7.36 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.681 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.2 mt -127.43 143.29 51.23 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.651 0.739 . . . . 0.0 111.673 -173.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.499 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 23.6 mt -86.62 143.02 12.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 173.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 34.5 ttt85 -118.03 138.72 52.03 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.178 0.514 . . . . 0.0 109.999 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.1 m-85 -116.71 123.3 46.88 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.888 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 152' ' ' LYS . 32.5 tt0 -109.87 125.53 52.88 Favored 'General case' 0 CA--C 1.471 -2.058 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.756 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.13 160.02 17.96 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.325 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.806 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.0 pt-20 -61.6 -15.99 44.17 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.113 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -98.06 -6.04 32.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.791 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.3 12.44 56.13 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.164 -0.926 . . . . 0.0 113.759 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.544 ' O ' HD23 ' A' ' 81' ' ' LEU . 3.5 mtt180 -82.97 141.79 31.85 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.8 p -144.22 141.26 29.76 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.972 -1.091 . . . . 0.0 113.497 175.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -138.49 155.99 47.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.613 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 87.0 mt-10 -129.97 153.98 47.83 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.17 0.51 . . . . 0.0 112.265 -177.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.9 OUTLIER -148.51 161.23 42.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.658 178.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.681 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -70.83 10.45 0.52 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.044 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 72.69 -27.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 124.838 1.255 . . . . 0.0 112.205 177.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.554 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 0.8 OUTLIER -78.75 -10.84 59.91 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.243 0.544 . . . . 0.0 109.807 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -97.14 140.92 22.34 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.367 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 89.3 Cg_endo -79.49 137.87 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.249 2.633 . . . . 0.0 113.699 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.5 t -105.09 147.2 11.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.0 tp -105.39 110.38 22.71 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.716 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.513 HG13 HG13 ' A' ' 104' ' ' ILE . 2.5 p -110.87 153.56 12.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.496 0.665 . . . . 0.0 111.531 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -104.21 93.74 4.99 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.258 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.0 pt-20 -143.26 158.48 43.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.3 m-20 64.15 21.85 12.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.17 13.77 60.53 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.803 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -135.2 172.37 13.11 Favored 'General case' 0 N--CA 1.401 -2.885 0 CA-C-O 121.165 0.507 . . . . 0.0 109.93 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -100.94 121.27 41.46 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.513 HG13 HG13 ' A' ' 97' ' ' VAL . 25.1 pt -119.27 141.67 38.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.197 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -97.09 114.49 26.15 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.14 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.492 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 13.9 ptpt -128.59 135.36 49.24 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.958 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.618 ' O ' HG23 ' A' ' 111' ' ' VAL . 11.5 mmt180 -62.0 159.22 14.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.044 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -57.92 -43.03 85.99 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.222 -176.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.477 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.7 p90 -73.01 -0.21 13.17 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.177 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -110.63 -15.3 13.89 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.606 0.717 . . . . 0.0 109.848 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 107' ' ' ARG . 89.5 t -77.84 149.43 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.691 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 13.8 mtmt -123.24 164.88 17.89 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.994 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -66.98 141.36 57.62 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.66 77.93 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.895 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.691 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -75.04 168.55 19.76 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.707 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 72.2 mttt -124.18 161.57 25.44 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.339 0.59 . . . . 0.0 112.076 -177.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.11 156.37 39.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.417 172.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.63 ' HG ' HD11 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -95.86 138.29 33.71 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 123.228 0.33 . . . . 0.0 110.571 -178.282 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.782 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.0 m -100.65 145.1 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.516 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 1.7 m . . . . . 0 C--N 1.299 -1.628 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.122 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.707 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 4.1 mm? . . . . . 0 CA--C 1.475 -1.905 0 CA-C-O 121.112 0.482 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.806 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -111.96 133.29 54.23 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.164 -177.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 20.2 mt-10 -86.02 143.61 28.02 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.111 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.48 HD13 ' CD1' ' A' ' 79' ' ' PHE . 69.5 mt -81.48 102.65 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.077 174.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.532 ' HE2' ' HB2' ' A' ' 82' ' ' GLU . 50.9 mmtt -66.1 -38.63 88.71 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.252 177.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -147.87 129.22 14.79 Favored 'General case' 0 CA--C 1.476 -1.882 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 72.1 mt -112.81 143.48 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.324 174.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.463 ' HD2' ' HD3' ' A' ' 78' ' ' ARG . 19.7 ptpt -149.13 161.31 42.24 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.355 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.499 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 17.7 m-85 -101.8 115.01 29.59 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.54 174.61 10.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.237 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.06 159.02 16.03 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.436 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.44 129.75 40.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.354 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -64.15 -42.12 96.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.972 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -101.02 175.89 5.45 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.041 0.448 . . . . 0.0 111.156 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.63 3.68 51.86 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.02 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -141.38 151.16 43.26 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.786 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.6 m -121.28 157.27 24.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 72.2 m-85 -132.98 172.11 13.06 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.89 0.376 . . . . 0.0 110.388 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.71 ' HB2' HD12 ' A' ' 68' ' ' ILE . 51.9 m -156.18 -22.17 0.1 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.526 HD22 ' HA ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER 63.36 104.35 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.236 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -85.22 115.68 23.13 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.302 -176.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.537 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -125.63 -149.54 0.42 Allowed 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.595 ' HB2' HG21 ' A' ' 62' ' ' THR . 0.4 OUTLIER . . . . . 0 C--N 1.313 -0.978 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.088 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 . . . . . 0 CA--C 1.506 -0.748 0 CA-C-O 121.097 0.475 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.811 HG21 HD11 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -144.86 164.07 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 121.354 0.597 . . . . 0.0 111.444 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.617 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.3 mt -95.55 120.78 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.456 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 39.1 pt -125.01 166.93 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.51 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 52.81 -134.97 1.59 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.921 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.19 51.58 2.23 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.602 0.715 . . . . 0.0 109.572 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.782 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 15.0 m120 71.92 53.23 0.2 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.525 177.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 97.2 mt -93.78 116.17 34.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.5 m -82.86 159.06 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.538 0.685 . . . . 0.0 111.861 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.307 -1.27 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.785 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.481 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 34.8 m-85 . . . . . 0 N--CA 1.434 -1.233 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.539 ' HD3' HD13 ' A' ' 76' ' ' LEU . 19.1 Cg_endo -59.4 -35.34 96.65 Favored 'Trans proline' 0 N--CA 1.48 0.688 0 C-N-CA 123.129 2.553 . . . . 0.0 112.21 -177.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.719 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 132.76 -35.78 2.27 Favored Glycine 0 N--CA 1.413 -2.857 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -177.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.07 -17.03 61.83 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.395 0.617 . . . . 0.0 111.11 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 69.0 m -61.15 125.19 22.84 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.584 177.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.5 mmt180 -86.09 132.95 33.92 Favored 'General case' 0 C--O 1.183 -2.43 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.496 ' HB ' ' CD2' ' A' ' 21' ' ' LEU . 9.5 tt -118.92 131.74 70.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 C-N-CA 122.556 0.342 . . . . 0.0 110.159 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.543 HD12 ' CD2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -84.59 124.86 31.9 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.29 0.567 . . . . 0.0 109.588 178.214 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 30.5 m -136.67 -179.47 2.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.778 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.585 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 30.9 tt0 -131.99 121.57 24.14 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.139 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.651 HG12 HG13 ' A' ' 47' ' ' ILE . 14.7 mt -121.07 119.81 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.962 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 53.53 41.87 32.02 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.898 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.12 17.88 76.07 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.589 -1.187 . . . . 0.0 113.442 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -123.6 116.15 28.06 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 34.7 Cg_endo -73.25 126.24 10.91 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 122.38 2.053 . . . . 0.0 111.402 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -127.47 142.27 51.45 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.554 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -106.16 101.07 10.58 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.3 pt -122.83 -175.55 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.179 -2.637 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.012 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.867 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.3 p -90.62 174.65 7.39 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.52 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.652 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.5 mm? -71.68 -23.75 61.71 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.984 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.867 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 15.7 ptt180 -85.59 -23.82 27.43 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.444 ' OE1' HG23 ' A' ' 20' ' ' THR . 49.8 mt-10 -83.71 -42.12 16.94 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.977 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.511 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 14.3 tp -56.18 -43.59 78.57 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.769 0.795 . . . . 0.0 109.099 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.496 ' CD1' HG11 ' A' ' 67' ' ' VAL . 7.1 t80 -52.46 -35.5 52.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.512 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 6.4 mm-40 -69.22 -21.71 63.92 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -79.51 4.16 16.54 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.57 0.7 . . . . 0.0 110.139 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.52 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 93.3 m-85 -117.16 160.17 21.46 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.049 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 44' ' ' LYS . 6.7 tt0 -139.84 -176.61 4.64 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t0 64.02 85.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.178 0.513 . . . . 0.0 111.082 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -101.39 131.37 47.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.936 0.874 . . . . 0.0 111.051 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -122.6 152.55 40.33 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.942 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.443 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 35.9 t80 -99.46 129.93 45.68 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -167.15 147.11 5.41 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.609 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 59.41 20.43 8.76 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 123.702 0.626 . . . . 0.0 111.027 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.443 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 39.1 mtp 72.37 17.8 4.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.488 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 13.7 m -133.28 -172.27 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -114.76 142.52 46.4 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-O 121.47 0.652 . . . . 0.0 110.158 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 t -128.71 122.02 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.095 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 28' ' ' PHE . 17.5 ttm180 -111.77 126.66 55.31 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.46 141.78 48.96 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -173.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 3.2 ttmp? 83.95 113.09 0.03 OUTLIER Pre-proline 0 CA--C 1.503 -0.833 0 O-C-N 124.812 1.32 . . . . 0.0 111.378 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.603 ' HB2' HD13 ' A' ' 47' ' ' ILE . 74.3 Cg_endo -77.07 155.28 33.52 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 C-N-CA 122.447 2.098 . . . . 0.0 111.807 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 29' ' ' GLU . 37.3 mtmt -87.01 -2.28 58.51 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.371 0.605 . . . . 0.0 110.678 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -147.6 -168.05 2.96 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 40.9 tt0 -85.26 101.41 12.5 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.651 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -115.58 118.2 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.995 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 67.3 mmtt -114.39 169.64 8.89 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.335 174.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.436 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.1 p -124.99 131.09 73.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.795 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.543 ' CD2' HD12 ' A' ' 9' ' ' LEU . 14.2 m-85 -86.16 120.46 27.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.106 0.479 . . . . 0.0 110.306 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.8 t -130.22 176.2 8.3 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.586 HG12 HD11 ' A' ' 176' ' ' ILE . 3.3 mm -116.83 142.25 31.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.536 0.684 . . . . 0.0 111.027 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.688 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 14.9 t70 -77.7 120.32 22.47 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.527 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.726 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -75.54 -8.41 56.68 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.764 -170.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.688 ' HG3' ' OD1' ' A' ' 53' ' ' ASP . 2.6 pt-20 -108.18 -25.77 10.92 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.045 -0.662 . . . . 0.0 112.079 -177.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.497 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 70.4 p -117.84 -25.23 6.86 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.772 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.47 12.72 66.71 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.254 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.497 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 40.7 mtpt -87.97 162.97 16.56 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.449 HG22 ' OG ' ' A' ' 120' ' ' SER . 33.5 t -86.67 113.25 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.216 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -110.77 151.78 12.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.088 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 49' ' ' VAL . 10.2 tp -122.86 140.26 53.15 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.7 t -148.91 170.54 18.06 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.814 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.83 161.16 26.97 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.522 0.677 . . . . 0.0 110.524 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.2 mp -96.28 148.14 5.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.84 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.491 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.9 mm-40 -93.09 -42.68 9.27 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 p30 179.59 178.97 0.51 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.72 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.496 HG11 ' CD1' ' A' ' 25' ' ' TYR . 7.6 t -107.55 134.21 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.009 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.654 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 42.9 mt -91.69 99.73 10.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.701 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 84.8 tttt -113.49 107.34 15.69 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.06 136.18 28.64 Favored Pre-proline 0 C--N 1.306 -1.297 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.502 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -48.66 129.4 20.3 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.167 2.578 . . . . 0.0 112.013 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.24 86.94 3.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.07 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.2 m -98.79 -33.16 11.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.436 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.92 167.15 12.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.076 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -100.15 172.84 6.93 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.747 HD23 ' HA ' ' A' ' 90' ' ' THR . 14.9 mt -125.89 145.56 50.21 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.911 0.862 . . . . 0.0 111.907 -174.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.499 HD12 ' C ' ' A' ' 108' ' ' ALA . 13.6 mt -91.91 144.13 9.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.444 172.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 13.0 ttt85 -115.92 137.93 51.65 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.541 ' CD1' HD13 ' A' ' 151' ' ' ILE . 65.7 m-85 -115.85 124.48 50.77 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.548 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.2 tt0 -113.1 125.06 53.96 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.755 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -90.08 162.2 15.44 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.356 -177.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.899 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.7 pt-20 -62.78 -15.63 54.45 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.256 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.73 -12.68 28.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.716 0.77 . . . . 0.0 109.729 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.42 10.1 57.26 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.347 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.624 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -85.12 141.34 30.29 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 44.3 p -140.84 151.86 44.68 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.919 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -145.83 153.72 41.21 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.244 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 23.6 mt-10 -124.22 149.66 46.16 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.323 -178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -144.0 159.6 42.31 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.439 178.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.747 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -68.37 11.33 0.17 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.988 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.6 OUTLIER 69.65 -38.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 124.843 1.257 . . . . 0.0 112.059 178.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 90' ' ' THR . 16.3 t70 -69.48 -37.55 77.3 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.422 0.629 . . . . 0.0 109.41 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.478 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 37.0 m80 -72.45 131.18 84.96 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.584 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 30.9 Cg_exo -63.65 142.49 83.92 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 123.975 3.117 . . . . 0.0 114.762 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.32 147.85 14.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.437 ' CD1' ' HG2' ' A' ' 105' ' ' GLU . 10.1 tp -100.49 109.92 22.07 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.816 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.642 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.6 p -112.24 150.33 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 121.404 0.621 . . . . 0.0 112.046 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -103.04 92.0 4.36 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.472 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.441 ' CD ' HD11 ' A' ' 104' ' ' ILE . 9.1 pt-20 -139.34 158.4 44.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 90.2 m-20 63.25 22.98 13.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.125 0.488 . . . . 0.0 110.07 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.68 14.7 60.9 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.809 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -135.98 171.71 14.07 Favored 'General case' 0 N--CA 1.4 -2.956 0 CA-C-O 121.217 0.532 . . . . 0.0 110.047 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.603 ' CE1' HD11 ' A' ' 118' ' ' LEU . 32.6 m-85 -103.91 121.74 43.74 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.701 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.441 HD11 ' CD ' ' A' ' 99' ' ' GLU . 23.6 pt -124.44 152.64 30.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.476 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.437 ' HG2' ' CD1' ' A' ' 96' ' ' LEU . 31.8 mt-10 -104.87 110.86 23.4 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.591 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HG3' HG22 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -124.3 139.53 53.83 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.134 176.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 5.3 mtp180 -60.79 156.1 17.89 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -176.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.988 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -59.77 -41.06 90.22 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.973 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.483 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 3.0 p90 -74.13 5.76 4.09 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.435 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -115.31 -18.55 11.04 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.471 0.653 . . . . 0.0 109.712 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 107' ' ' ARG . 79.5 t -71.55 150.33 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.005 0.922 . . . . 0.0 108.899 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.748 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.8 OUTLIER -114.17 165.01 13.1 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 120.814 0.34 . . . . 0.0 110.467 -177.113 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -74.24 142.88 45.31 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.409 ' O ' ' HG2' ' A' ' 150' ' ' GLU . . . 86.05 5.63 83.02 Favored Glycine 0 C--N 1.3 -1.462 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.488 -174.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.748 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -75.3 175.19 8.6 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.677 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 49.8 mttp -130.36 162.59 28.75 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.75 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.74 158.72 42.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.378 173.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.603 HD11 ' CE1' ' A' ' 103' ' ' PHE . 2.4 mt -88.81 140.04 29.85 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.79 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -101.46 149.2 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.455 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.645 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 47.4 t . . . . . 0 C--N 1.308 -1.231 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.446 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.677 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.8 mm? . . . . . 0 CA--C 1.477 -1.859 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.899 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -101.91 132.01 47.96 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 8.6 mt-10 -85.17 140.31 31.02 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.521 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.541 HD13 ' CD1' ' A' ' 79' ' ' PHE . 62.2 mt -78.97 102.26 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.827 0 CA-C-N 113.635 -1.62 . . . . 0.0 109.326 174.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.452 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 6.3 mmpt? -65.64 -37.96 88.02 Favored 'General case' 0 C--N 1.268 -2.948 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.936 178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -149.1 131.28 15.46 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 70.3 mt -115.7 144.76 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.528 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.414 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 18.9 ptpt -150.54 161.2 43.02 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.055 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -99.56 113.06 25.23 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-O 121.379 0.609 . . . . 0.0 109.602 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.56 132.89 70.7 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.439 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -71.47 154.27 41.63 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.75 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.54 123.53 20.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.062 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -85.9 42.57 0.98 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.097 0.475 . . . . 0.0 110.883 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -163.15 -179.34 6.6 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -107.04 -8.73 16.44 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.214 0.531 . . . . 0.0 109.783 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.58 162.13 35.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.247 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.5 m -132.73 162.45 39.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.838 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.654 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 62.8 m-85 -138.95 166.01 25.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.94 -175.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.68 -22.75 0.14 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.511 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER 70.95 110.62 0.06 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.784 176.112 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -90.1 115.59 27.47 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.649 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.491 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.81 -162.76 1.2 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 170' ' ' LYS . 20.3 ttmt . . . . . 0 C--N 1.324 -0.535 0 CA-C-O 120.669 0.271 . . . . 0.0 110.708 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.613 HD21 HG13 ' A' ' 182' ' ' VAL . 27.1 t-20 . . . . . 0 C--O 1.234 0.264 0 CA-C-O 120.705 0.288 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.439 HG21 HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -155.53 148.19 12.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.484 178.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 52' ' ' ILE . 47.3 mt -92.2 116.25 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.988 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 25.1 pt -123.27 164.72 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.535 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 23.6 t30 46.34 -134.13 0.95 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 124.532 1.133 . . . . 0.0 110.958 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.52 55.87 2.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.494 0.664 . . . . 0.0 110.38 176.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.79 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 15.7 m120 63.38 49.14 3.29 Favored 'General case' 0 C--O 1.209 -1.078 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.806 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.471 ' HB ' HG13 ' A' ' 177' ' ' ILE . 96.0 mt -86.78 111.68 21.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.613 HG13 HD21 ' A' ' 174' ' ' ASN . 74.1 t -84.81 117.84 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.889 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.413 -2.295 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.6 179.99 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.464 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 23.3 m-85 . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.566 ' HA ' HG12 ' A' ' 164' ' ' VAL . 21.0 Cg_endo -58.54 -32.28 96.21 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.146 2.564 . . . . 0.0 113.155 -175.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 126.34 -36.25 2.74 Favored Glycine 0 N--CA 1.426 -1.968 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.71 -15.25 63.55 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.38 0.61 . . . . 0.0 110.571 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 71.9 m -60.08 128.19 35.57 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.055 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.705 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 82.0 mtm-85 -86.51 137.81 32.23 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.758 HD11 HG21 ' A' ' 175' ' ' VAL . 10.0 tt -123.6 132.82 70.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.261 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.435 HD13 ' N ' ' A' ' 10' ' ' VAL . 0.4 OUTLIER -87.38 124.61 33.57 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-O 121.464 0.65 . . . . 0.0 109.853 178.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.435 ' N ' HD13 ' A' ' 9' ' ' LEU . 25.1 m -136.26 -179.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.549 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 32.2 tt0 -129.78 119.61 23.69 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.628 HG12 HG13 ' A' ' 47' ' ' ILE . 15.9 mt -119.53 121.47 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.9 -177.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.8 37.45 28.52 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.518 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.8 17.43 80.09 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.664 -1.153 . . . . 0.0 114.195 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.9 t -122.79 120.67 27.62 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 58.9 Cg_endo -74.23 119.92 6.03 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 122.064 1.842 . . . . 0.0 110.475 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -123.97 143.08 50.62 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.498 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -113.35 100.75 8.79 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -122.1 -172.34 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.618 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.749 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 19.2 p -95.4 169.75 9.84 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.941 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 15.1 mt -71.07 -22.63 62.09 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.099 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.749 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.5 ptm180 -83.73 -25.34 30.66 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.511 ' OE1' HG23 ' A' ' 20' ' ' THR . 67.6 mt-10 -84.69 -43.14 14.62 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.239 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.478 HD21 ' HG ' ' A' ' 167' ' ' LEU . 20.1 tp -56.24 -43.31 78.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.906 0.86 . . . . 0.0 109.085 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.434 ' HD1' HG11 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -51.92 -32.56 33.4 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.367 179.111 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 29.6 mt-10 -74.94 -16.98 60.62 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.302 -177.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.6 mm? -77.44 0.4 22.76 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 121.322 0.582 . . . . 0.0 109.455 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.526 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 98.1 m-85 -117.64 161.25 19.95 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.404 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.646 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 23.6 mt-10 -136.21 -172.28 3.09 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.117 175.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.487 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 12.3 t0 61.83 75.9 0.39 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.434 0.635 . . . . 0.0 110.558 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 25.1 tt0 -100.3 131.72 46.08 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.404 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 11.8 ptt180 -131.41 145.42 51.8 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.517 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -88.04 128.01 35.4 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.546 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -167.09 147.78 5.64 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.396 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 60.11 22.96 12.21 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 123.341 0.401 . . . . 0.0 110.683 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 38.3 mtm 71.98 16.14 5.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.612 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.2 m -134.74 -174.31 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -113.48 140.81 47.8 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.409 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.4 t -127.17 122.48 60.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.658 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.471 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 17.6 ttm180 -113.21 126.61 55.61 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.487 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -133.63 146.94 51.37 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.387 -174.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? 83.16 110.37 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.422 0 O-C-N 124.444 1.09 . . . . 0.0 110.364 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.598 ' HB2' HD13 ' A' ' 47' ' ' ILE . 73.4 Cg_endo -79.12 152.14 24.08 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.45 2.1 . . . . 0.0 112.344 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.646 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 34.7 mtmt -81.92 -4.15 55.92 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.015 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -147.66 -165.62 2.3 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.14 103.86 16.15 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.628 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -116.59 118.61 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.621 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 47.3 mmtt -115.65 168.04 10.38 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.169 173.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.442 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.3 p -123.41 130.39 74.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.298 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.405 ' CE2' ' HB2' ' A' ' 11' ' ' GLN . 5.1 m-85 -83.57 123.67 30.0 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 p -134.76 172.8 12.45 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.488 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.521 HG12 HD11 ' A' ' 176' ' ' ILE . 3.1 mm -119.23 142.41 34.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.176 0.513 . . . . 0.0 110.054 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.699 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 25.5 t70 -76.0 122.59 24.42 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.606 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.726 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -75.71 -9.81 58.91 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.643 -170.424 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.699 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.8 pt-20 -106.59 -26.94 11.15 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.867 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.434 ' HB ' ' HD3' ' A' ' 58' ' ' LYS . 69.0 p -118.1 -25.39 6.69 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.783 -176.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.49 10.88 69.81 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.002 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.451 ' N ' ' HD2' ' A' ' 58' ' ' LYS . 2.2 mptp? -78.51 154.2 30.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.022 0.439 . . . . 0.0 111.771 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.428 ' HA ' HD13 ' A' ' 52' ' ' ILE . 2.8 p -91.0 104.87 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 121.833 0.825 . . . . 0.0 110.565 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.5 m -110.97 157.7 11.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.243 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 49' ' ' VAL . 12.6 tp -116.45 137.82 51.86 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.6 t -143.93 172.47 12.81 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.281 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.29 161.55 19.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.63 0.728 . . . . 0.0 111.356 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.548 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.9 mp -100.23 140.75 18.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.519 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.496 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 27.5 mm-40 -92.26 -34.54 14.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.263 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 p30 175.89 176.75 0.23 Allowed 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.175 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.539 ' HA ' HD22 ' A' ' 167' ' ' LEU . 13.6 t -106.89 129.77 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.798 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 36.4 mt -91.13 111.79 24.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.805 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.466 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.1 tttt -127.65 110.29 12.53 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 163' ' ' PHE . . . -129.04 142.08 43.95 Favored Pre-proline 0 C--N 1.309 -1.161 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.442 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -53.87 124.14 15.16 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.115 2.544 . . . . 0.0 111.671 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.0 89.38 7.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.774 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.3 m -103.96 -29.27 11.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.194 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -85.58 166.98 15.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.724 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.496 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 28.7 m170 -98.01 171.69 8.1 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.724 HD23 ' HA ' ' A' ' 90' ' ' THR . 37.0 mt -126.71 140.12 52.64 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.569 0.699 . . . . 0.0 111.643 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.53 HD12 ' C ' ' A' ' 108' ' ' ALA . 44.8 mt -87.73 142.55 12.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 172.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 21.3 ttt180 -122.45 137.26 54.93 Favored 'General case' 0 N--CA 1.398 -3.067 0 CA-C-O 121.308 0.575 . . . . 0.0 109.902 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 86' ' ' SER . 55.0 m-85 -113.47 121.98 45.9 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.774 -177.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 152' ' ' LYS . 44.1 tt0 -108.4 127.42 53.88 Favored 'General case' 0 CA--C 1.474 -1.956 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.733 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -89.82 159.09 17.18 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-O 121.21 0.529 . . . . 0.0 111.936 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.827 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -60.15 -16.98 37.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.754 -178.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.642 ' OD1' ' HG3' ' A' ' 85' ' ' ARG . 38.3 p-10 -109.29 0.72 19.7 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.436 0.636 . . . . 0.0 111.065 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.49 19.47 25.2 Favored Glycine 0 C--N 1.309 -0.963 0 N-CA-C 116.511 1.364 . . . . 0.0 116.511 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.642 ' HG3' ' OD1' ' A' ' 83' ' ' ASP . 11.5 mtt180 -86.89 143.28 27.49 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 90.1 p -140.93 138.09 33.59 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 118.728 -1.189 . . . . 0.0 112.155 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.416 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 6.5 p90 -133.37 138.69 46.42 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.962 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.503 ' OE2' ' HG3' ' A' ' 78' ' ' ARG . 43.4 mp0 -115.02 147.94 39.49 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.769 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.1 p -140.79 155.72 46.33 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.945 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.724 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -76.33 12.14 1.32 Allowed 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 122.79 0.436 . . . . 0.0 112.04 -177.116 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.041 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.8 m 61.29 170.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 19.4 t70 72.17 -34.92 0.31 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.069 0.461 . . . . 0.0 110.814 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.444 ' H ' ' C ' ' A' ' 91' ' ' VAL . 47.6 m-70 -76.31 128.21 83.08 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.309 175.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 18.2 Cg_exo -67.47 127.52 16.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.284 2.656 . . . . 0.0 114.322 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.5 t -96.75 151.3 4.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.2 tp -102.15 106.41 17.25 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.817 -176.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.568 HG21 ' OD1' ' A' ' 115' ' ' ASP . 1.9 p -110.35 148.99 13.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.315 0.579 . . . . 0.0 111.338 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.509 ' CD2' HD12 ' A' ' 148' ' ' LEU . 61.8 t80 -104.47 92.55 4.36 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.111 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.554 ' CG ' HD11 ' A' ' 104' ' ' ILE . 8.3 pt-20 -136.06 158.37 44.56 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 82.4 m-20 62.78 22.6 13.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 110.347 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.44 15.19 58.88 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.238 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -132.94 171.95 13.26 Favored 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 117.71 0.755 . . . . 0.0 109.446 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -102.51 120.12 39.99 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.579 HG13 ' HE2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -125.03 144.66 34.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.302 -178.522 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.4 OUTLIER -101.81 111.83 24.22 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.032 -178.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.579 ' HE2' HG13 ' A' ' 104' ' ' ILE . 50.4 mttm -120.86 134.6 55.29 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.718 ' HD2' ' H ' ' A' ' 107' ' ' ARG . 5.4 mpt_? -59.77 158.44 10.37 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.041 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -55.16 -45.94 75.72 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.54 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -75.28 11.27 1.24 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.647 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.533 ' OE1' ' HA ' ' A' ' 106' ' ' LYS . 39.1 tt0 -124.14 -15.09 6.89 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.454 0.645 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 107' ' ' ARG . 73.7 t -75.01 150.68 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.703 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -118.42 161.2 20.37 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.445 -176.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -70.57 147.19 49.54 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.403 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.86 4.1 87.45 Favored Glycine 0 C--N 1.305 -1.164 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.16 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.703 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -72.63 163.92 27.3 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD3' ' HB2' ' A' ' 148' ' ' LEU . 33.8 mttt -117.28 162.82 17.27 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.28 0.562 . . . . 0.0 110.503 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.416 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -130.24 157.68 42.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.213 172.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.62 136.29 33.16 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -102.39 152.05 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.686 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.309 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 C--N 1.307 -1.244 0 CA-C-O 120.826 0.346 . . . . 0.0 111.025 -179.561 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.509 HD12 ' CD2' ' A' ' 98' ' ' TYR . 9.9 mt . . . . . 0 N--CA 1.427 -1.607 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.827 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -114.79 138.68 50.46 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -172.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.503 ' H ' HD13 ' A' ' 149' ' ' LEU . 23.6 mt-10 -90.4 145.09 25.21 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.013 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.426 HG21 ' CG1' ' A' ' 154' ' ' ILE . 79.4 mt -79.3 117.22 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-N 113.507 -1.679 . . . . 0.0 110.99 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.62 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 30.3 mmtt -76.06 -37.98 57.62 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.589 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -152.7 134.63 14.77 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 77.0 mt -117.59 125.89 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.279 174.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.469 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.9 ptpt -128.18 159.25 35.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.457 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -100.36 117.83 35.37 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -127.74 174.08 11.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.376 -178.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.441 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 37.3 ttt180 -95.33 155.25 16.82 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 122.106 -0.371 . . . . 0.0 110.829 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.715 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.4 -25.3 49.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.657 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 68.05 -39.73 0.4 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.45 -173.25 2.6 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.85 -10.89 19.47 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 120.645 0.259 . . . . 0.0 111.171 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 96.5 m-85 -141.86 155.08 45.55 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.94 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.6 m -126.77 159.86 35.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.935 177.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 69.9 m-85 -136.22 172.05 13.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.632 0.254 . . . . 0.0 110.478 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.28 -23.2 0.06 Allowed 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 67' ' ' VAL . 1.3 tm? 68.23 107.97 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.97 176.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -87.28 118.21 26.55 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.54 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.496 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.41 -153.9 0.6 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.0 tptm . . . . . 0 C--N 1.315 -0.922 0 CA-C-O 120.88 0.372 . . . . 0.0 111.187 -179.236 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 8' ' ' ILE . 4.2 p -129.5 167.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-O 121.568 0.699 . . . . 0.0 112.723 -173.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.548 ' H ' HG22 ' A' ' 175' ' ' VAL . 75.7 mt -93.5 113.57 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.716 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.525 HG23 HG13 ' A' ' 175' ' ' VAL . 43.8 pt -120.39 172.92 6.78 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.688 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.417 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 5.0 t-20 47.84 -123.07 1.55 Allowed 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 124.487 1.115 . . . . 0.0 110.725 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -92.71 48.46 1.37 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.693 0.758 . . . . 0.0 109.862 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.676 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.7 m-20 73.86 46.44 0.19 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.465 1.506 . . . . 0.0 112.82 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.7 mt -88.96 117.2 31.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 56.6 t -84.38 152.09 3.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.693 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 C--N 1.303 -1.442 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.908 -178.179 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.559 ' HD3' HD13 ' A' ' 76' ' ' LEU . 56.4 Cg_endo -68.1 162.65 39.17 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 121.557 1.505 . . . . 0.0 108.9 176.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.75 -24.43 66.41 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 118.857 -1.64 . . . . 0.0 110.146 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.66 -13.69 34.97 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.031 0.932 . . . . 0.0 112.935 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 61.3 m -72.24 131.64 43.0 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.885 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.669 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 12.6 mtm180 -86.34 133.03 33.83 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.622 HD11 ' CG2' ' A' ' 175' ' ' VAL . 2.2 tp -117.13 133.37 64.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-O 121.131 0.491 . . . . 0.0 110.884 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 9' ' ' LEU . 0.7 OUTLIER -92.51 124.25 36.41 Favored 'General case' 0 N--CA 1.4 -2.965 0 CA-C-O 121.788 0.804 . . . . 0.0 110.956 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 19.7 m -134.26 -179.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.898 -177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -125.8 117.14 22.76 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 26.9 mt -118.89 120.56 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 CA-C-O 121.137 0.494 . . . . 0.0 110.015 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 54.11 38.51 29.21 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.92 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.71 20.48 79.69 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.746 -1.115 . . . . 0.0 113.677 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.1 t -131.01 123.04 19.64 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 70.6 Cg_endo -73.85 120.87 6.61 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 122.546 2.164 . . . . 0.0 112.25 -177.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.422 HE21 ' HB3' ' A' ' 17' ' ' GLN . 12.4 mt-30 -120.56 138.71 53.73 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.636 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -108.9 100.78 9.95 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.595 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.9 pt -124.19 -172.91 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.144 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.755 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 11.3 p -95.44 171.12 8.9 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.622 178.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 92.4 mt -66.56 -31.31 71.94 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.219 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.755 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 6.3 ptm180 -79.43 -24.84 42.21 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.503 ' OE1' HG23 ' A' ' 20' ' ' THR . 68.8 mt-10 -83.87 -41.62 17.26 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.389 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.579 ' CD2' HD13 ' A' ' 167' ' ' LEU . 46.8 tp -59.3 -41.52 89.17 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.894 0.854 . . . . 0.0 109.34 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.42 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -53.49 -31.74 47.21 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.979 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.577 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 32.4 mt-10 -77.24 -14.9 59.68 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.733 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -82.59 0.54 42.42 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.643 0.735 . . . . 0.0 109.14 177.05 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.541 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 72.4 m-85 -114.11 162.61 16.27 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.686 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.413 ' HB2' ' HD3' ' A' ' 44' ' ' LYS . 6.5 tp10 -142.15 -178.73 5.86 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.437 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.558 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER 65.1 79.89 0.24 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.641 0.777 . . . . 0.0 110.448 -179.187 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -101.13 131.43 47.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 122.078 0.942 . . . . 0.0 110.922 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.423 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 18.3 ptt-85 -122.71 153.61 39.2 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.269 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -101.14 125.18 47.74 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -166.7 145.49 5.39 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.444 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 61.04 19.85 10.32 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.864 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.2 mtt 71.67 16.79 5.68 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.505 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 16.2 m -131.89 -170.77 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -119.3 142.67 47.89 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.92 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.423 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.2 t -129.38 123.41 57.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.154 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.477 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 15.0 ttm180 -113.54 127.01 55.93 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.42 135.33 46.01 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.959 -175.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 36.0 mtpt 91.99 118.2 0.02 OUTLIER Pre-proline 0 CA--C 1.502 -0.887 0 C-N-CA 125.375 1.47 . . . . 0.0 112.147 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 87.3 Cg_endo -78.42 156.19 28.73 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.782 2.321 . . . . 0.0 111.045 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HD3' ' HB2' ' A' ' 29' ' ' GLU . 38.8 mtmt -94.02 -1.6 54.26 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.439 0.637 . . . . 0.0 110.565 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -146.3 -165.67 2.28 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.624 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 4.9 tp10 -85.28 99.24 11.0 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 174.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.541 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.5 mp -116.08 115.8 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.01 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.608 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 30.6 mmtp -123.28 163.94 19.73 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.98 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.501 HG13 ' CG1' ' A' ' 64' ' ' ILE . 6.9 m -111.06 128.78 67.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.068 0.461 . . . . 0.0 111.846 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -83.8 124.11 30.59 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.441 ' HA ' HG13 ' A' ' 176' ' ' ILE . 20.0 m -134.17 172.16 13.24 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.45 HG12 HD11 ' A' ' 176' ' ' ILE . 2.9 mm -119.49 143.06 32.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.116 0.484 . . . . 0.0 110.071 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 41.9 t0 -84.23 119.77 25.43 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.568 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.789 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -72.71 -11.37 60.59 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.124 -171.579 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' HG23 ' A' ' 56' ' ' THR . 5.5 pt-20 -102.48 -27.88 12.52 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.82 -176.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.469 HG23 ' HG3' ' A' ' 55' ' ' GLU . 76.1 p -115.48 -23.96 8.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.634 -175.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.41 14.45 76.31 Favored Glycine 0 N--CA 1.429 -1.784 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.149 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' C ' HD13 ' A' ' 52' ' ' ILE . 5.1 mtpm? -89.75 153.3 20.8 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.424 ' HA ' HD13 ' A' ' 52' ' ' ILE . 6.6 p -89.69 107.61 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-O 121.967 0.889 . . . . 0.0 110.042 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 m -110.09 159.37 9.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.201 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 49' ' ' VAL . 12.9 tp -121.91 140.69 52.12 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.0 t -147.03 172.31 13.93 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.212 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.31 161.87 19.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.551 0.691 . . . . 0.0 110.824 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 64' ' ' ILE . 3.0 mp -105.32 134.26 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.699 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.5 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 10.9 mm-40 -79.8 -40.21 29.13 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.036 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 p30 179.49 178.03 0.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.175 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.42 HG11 ' HB2' ' A' ' 25' ' ' TYR . 20.1 t -105.45 130.0 57.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.633 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 50.7 mt -90.67 105.2 16.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.555 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 84.9 tttt -118.52 109.82 16.65 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.3 134.57 25.89 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.219 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -47.22 124.35 8.94 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.447 2.765 . . . . 0.0 112.916 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.36 110.4 2.24 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.073 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -68.33 0.93 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -68.23 -117.4 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -159.34 172.68 17.53 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -172.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 90' ' ' THR . 4.5 mt -136.5 140.22 42.86 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.532 0.682 . . . . 0.0 111.283 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.545 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 9.0 mt -86.5 142.55 12.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 171.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.516 ' HB3' ' CG ' ' A' ' 155' ' ' LYS . 31.8 ttt85 -118.97 138.38 52.85 Favored 'General case' 0 N--CA 1.404 -2.763 0 CA-C-O 121.207 0.527 . . . . 0.0 109.755 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' A' ' 86' ' ' SER . 53.5 m-85 -115.97 125.17 52.16 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.893 -177.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 152' ' ' LYS . 34.5 tt0 -108.18 125.22 51.37 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.672 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -91.25 160.06 15.72 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.889 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.91 ' HG2' HD11 ' A' ' 149' ' ' LEU . 5.5 pt-20 -62.54 -19.59 63.79 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.209 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -87.33 -11.31 49.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.762 0.792 . . . . 0.0 109.23 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.52 16.81 47.95 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.036 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.549 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -87.46 142.91 27.51 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 23.6 p -142.38 136.28 29.43 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.456 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.408 ' CD1' HD13 ' A' ' 181' ' ' ILE . 6.8 p90 -129.97 155.99 45.18 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.165 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 40.2 mt-10 -129.86 148.01 51.69 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.308 0.575 . . . . 0.0 112.135 -175.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -141.0 154.51 46.05 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.358 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.645 ' HA ' HD23 ' A' ' 76' ' ' LEU . 1.1 p -69.84 15.92 0.07 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.021 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.06 -39.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 125.349 1.46 . . . . 0.0 113.854 175.009 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 107' ' ' ARG . 1.1 t70 -90.79 12.68 18.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.414 0.625 . . . . 0.0 110.766 -178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 39.6 m80 -115.45 141.62 27.53 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.361 177.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 23.6 Cg_exo -64.9 142.78 77.05 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.43 2.753 . . . . 0.0 115.201 -176.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.515 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 19.1 t -119.52 150.13 22.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.381 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.5 tp -104.26 107.57 18.55 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.86 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.631 HG23 ' H ' ' A' ' 116' ' ' LYS . 1.6 p -107.11 143.96 16.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.383 0.611 . . . . 0.0 111.684 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.602 ' CD2' HD12 ' A' ' 148' ' ' LEU . 44.5 t80 -99.17 90.95 4.76 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.687 176.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 11.9 pt-20 -138.17 157.51 46.16 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.499 176.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER 68.81 21.86 7.51 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.93 13.84 60.09 Favored Glycine 0 CA--C 1.508 -0.35 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.669 -177.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.407 ' HE ' ' CB ' ' A' ' 100' ' ' ASN . 29.3 ptt180 -135.61 172.5 12.92 Favored 'General case' 0 N--CA 1.404 -2.748 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -104.77 119.81 39.88 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.59 HG13 HG13 ' A' ' 97' ' ' VAL . 21.4 pt -119.22 144.2 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 120.129 -0.629 . . . . 0.0 112.187 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -101.82 114.87 29.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.551 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.577 ' HG3' HG22 ' A' ' 111' ' ' VAL . 0.7 OUTLIER -136.01 146.56 47.29 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.387 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.582 ' O ' HG23 ' A' ' 111' ' ' VAL . 74.4 mtm180 -63.73 160.23 17.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.021 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -61.54 -41.55 97.51 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.788 -175.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.448 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.3 p90 -72.47 0.5 10.12 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.068 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -112.64 -16.68 12.77 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.479 0.657 . . . . 0.0 109.974 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 107' ' ' ARG . 94.7 t -71.08 150.7 9.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.773 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 1.9 mtmp? -115.08 159.73 20.5 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.178 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -73.97 145.86 44.32 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.08 4.22 86.96 Favored Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.159 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.773 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -76.68 167.32 22.05 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.16 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.631 ' H ' HG23 ' A' ' 97' ' ' VAL . 35.6 mttt -120.03 166.84 12.84 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.498 0.666 . . . . 0.0 111.756 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.35 162.28 35.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.655 171.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.61 141.02 29.09 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 1.8 m -114.68 149.57 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 173.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.495 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 44.9 t . . . . . 0 C--N 1.308 -1.22 0 CA-C-O 121.281 0.562 . . . . 0.0 110.548 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.602 HD12 ' CD2' ' A' ' 98' ' ' TYR . 11.9 mt . . . . . 0 CA--C 1.479 -1.751 0 CA-C-O 121.288 0.566 . . . . 0.0 109.68 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.91 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -108.37 133.86 51.98 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.644 -172.012 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.418 ' N ' HD13 ' A' ' 149' ' ' LEU . 21.5 mt-10 -88.46 143.75 26.79 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.919 175.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.473 HD13 ' CD1' ' A' ' 79' ' ' PHE . 68.2 mt -77.5 110.06 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.607 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.006 175.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 80' ' ' GLU . 7.2 mmpt? -72.44 -39.75 67.59 Favored 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.487 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -150.16 133.8 16.67 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.8 mt -113.83 143.08 24.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.054 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.516 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.0 ptpt -144.6 158.03 43.95 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -178.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.545 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 7.2 m-85 -100.9 114.54 28.5 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.563 174.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.43 173.78 11.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.319 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.435 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 49.8 ttt180 -112.21 167.6 10.28 Favored 'General case' 0 N--CA 1.415 -2.193 0 O-C-N 121.329 -0.857 . . . . 0.0 110.693 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.435 ' N ' ' HG2' ' A' ' 158' ' ' ARG . . . -67.57 114.94 6.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.433 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -72.5 -32.77 66.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.665 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -81.92 -176.21 6.0 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.305 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -101.29 -15.68 17.2 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -138.17 153.77 49.18 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.1 m -118.46 155.95 20.41 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.674 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 78.1 m-85 -135.52 161.3 35.88 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.91 -175.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.644 ' C ' HD23 ' A' ' 167' ' ' LEU . 74.0 m -158.1 13.64 0.2 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.553 176.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.644 HD23 ' C ' ' A' ' 166' ' ' SER . 2.5 pt? 29.39 109.51 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 125.368 1.467 . . . . 0.0 113.923 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -82.03 114.34 20.52 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.147 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.5 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -133.56 -142.43 0.2 Allowed 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 42.8 tptt . . . . . 0 C--N 1.31 -1.151 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.821 178.118 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.7 t30 . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.622 ' CG2' HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -165.1 171.7 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.666 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 97.0 mt -111.99 118.12 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.615 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.422 HG22 HD12 ' A' ' 8' ' ' ILE . 44.3 pt -120.78 171.91 8.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.294 0 CA-C-O 121.01 0.433 . . . . 0.0 111.186 -177.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 48.83 -129.79 1.9 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.313 1.045 . . . . 0.0 110.504 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -89.73 52.01 2.22 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.558 0.694 . . . . 0.0 109.959 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.754 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 13.5 m120 74.05 44.41 0.26 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.685 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.408 HD13 ' CD1' ' A' ' 87' ' ' PHE . 86.5 mt -87.0 113.04 23.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 73.4 t -88.24 130.38 37.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.958 -176.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 12.0 t . . . . . 0 C--N 1.311 -1.07 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.594 176.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.433 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 2.7 m-85 . . . . . 0 C--O 1.234 0.243 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.499 ' HD3' HD13 ' A' ' 76' ' ' LEU . 73.0 Cg_endo -72.14 164.48 35.51 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 N-CA-C 108.408 -1.42 . . . . 0.0 108.408 175.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.76 -26.59 65.26 Favored Glycine 0 C--N 1.301 -1.415 0 C-N-CA 118.993 -1.575 . . . . 0.0 111.44 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.54 -9.32 48.55 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.6 m -71.33 129.69 39.49 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.381 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 26.2 mtm180 -85.77 132.08 34.2 Favored 'General case' 0 C--O 1.187 -2.187 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.712 HD11 HG21 ' A' ' 175' ' ' VAL . 8.9 tt -119.91 130.1 74.62 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-O 120.863 0.363 . . . . 0.0 110.139 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -88.44 122.13 31.59 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-O 121.527 0.679 . . . . 0.0 109.576 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 28.0 m -132.58 -173.3 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.346 -178.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 31.4 tt0 -134.4 121.4 21.09 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.637 HG12 HG13 ' A' ' 47' ' ' ILE . 17.0 mt -120.87 123.47 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.922 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.11 37.47 27.09 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.202 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.12 76.92 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.657 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -130.79 119.81 18.28 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 13.5 Cg_exo -64.87 120.93 8.29 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.733 1.622 . . . . 0.0 110.663 178.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -118.62 135.58 54.36 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -106.56 100.78 10.28 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.3 pt -125.46 -172.68 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.146 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.243 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.732 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 29.6 p -96.46 170.1 9.46 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.793 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 84.6 mt -67.23 -28.22 67.88 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.797 178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.732 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 11.2 ptm180 -79.51 -26.54 41.53 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.492 ' OE1' HG23 ' A' ' 20' ' ' THR . 43.9 mt-10 -84.28 -42.34 15.93 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.797 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.727 HD23 ' HG ' ' A' ' 167' ' ' LEU . 17.5 tp -57.96 -44.01 86.76 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.779 0.8 . . . . 0.0 109.206 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.512 ' HD1' HG11 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -51.42 -34.17 33.72 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.749 -1.568 . . . . 0.0 112.631 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.562 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 31.3 mt-10 -76.6 -14.39 60.0 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 23' ' ' GLU . 1.4 mm? -79.97 4.74 15.94 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.572 0.701 . . . . 0.0 109.317 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.527 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.9 m-85 -118.24 162.11 18.79 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.922 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -142.12 -173.38 3.81 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.562 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.8 OUTLIER 61.91 84.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.45 0.643 . . . . 0.0 110.434 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -103.0 127.25 50.31 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.782 0.801 . . . . 0.0 111.161 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.451 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 14.3 ptt180 -121.04 154.39 36.14 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.237 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -100.3 130.26 46.39 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -164.29 142.04 6.89 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.27 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 59.07 23.12 11.27 Favored 'General case' 0 CA--C 1.493 -1.225 0 O-C-N 123.599 0.562 . . . . 0.0 111.18 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.8 mtp 71.81 17.98 5.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.618 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.534 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 14.6 m -132.56 -173.61 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -114.46 141.4 47.73 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-O 121.253 0.549 . . . . 0.0 109.822 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.4 t -129.23 123.46 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.059 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.444 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 19.3 ttm180 -114.13 126.6 55.26 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -130.67 144.28 51.32 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.683 -174.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 37.5 ttmt 83.97 114.58 0.03 OUTLIER Pre-proline 0 CA--C 1.509 -0.627 0 O-C-N 124.639 1.212 . . . . 0.0 111.279 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.59 ' HB2' HD13 ' A' ' 47' ' ' ILE . 81.7 Cg_endo -80.24 151.62 20.61 Favored 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 122.19 1.926 . . . . 0.0 111.515 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -84.04 -5.91 59.32 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.32 0.581 . . . . 0.0 110.751 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -145.5 -166.09 2.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 8.1 tp10 -85.69 101.07 12.44 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.637 HG13 HG12 ' A' ' 12' ' ' ILE . 1.8 mp -117.36 116.92 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.607 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 57.0 mmtt -115.12 169.08 9.38 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.336 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 169' ' ' ALA . 13.0 p -127.01 130.77 71.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.463 ' HB3' HD12 ' A' ' 176' ' ' ILE . 5.2 m-85 -88.0 124.2 33.49 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.586 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.8 m -133.73 168.56 18.48 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.641 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.585 HG12 HD11 ' A' ' 176' ' ' ILE . 2.2 mm -116.0 145.91 21.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.32 0.581 . . . . 0.0 111.061 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.7 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 17.5 t70 -84.56 114.13 21.75 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.823 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -73.47 -9.2 58.44 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.355 0.662 . . . . 0.0 112.629 -170.049 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.7 ' HG3' ' OD1' ' A' ' 53' ' ' ASP . 3.1 pt-20 -102.12 -28.01 12.58 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.841 -176.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.553 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 61.0 p -118.2 -25.23 6.68 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.67 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.28 16.54 55.4 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.691 -0.686 . . . . 0.0 113.543 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.553 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 38.2 mttt -86.93 151.46 23.28 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.98 0.419 . . . . 0.0 112.092 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.02 107.97 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.581 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.7 m -109.5 157.1 10.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.316 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.9 tp -120.87 142.88 49.26 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.478 HG21 ' HB3' ' A' ' 170' ' ' LYS . 9.9 t -148.52 170.77 17.33 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.602 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.79 160.71 22.2 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.365 0.603 . . . . 0.0 109.824 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.591 HD13 HG22 ' A' ' 47' ' ' ILE . 2.2 mp -94.71 143.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.032 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.459 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 58.0 mm-40 -89.05 -39.87 13.36 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 178.58 177.26 0.46 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.693 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.512 HG11 ' HD1' ' A' ' 25' ' ' TYR . 9.9 t -107.48 130.42 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.377 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 38.1 mt -90.51 106.85 17.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.587 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.534 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.5 tttt -121.54 108.73 13.96 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.74 141.87 43.36 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.275 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.487 ' HD2' HG12 ' A' ' 37' ' ' VAL . 9.5 Cg_endo -55.48 130.25 39.5 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 123.379 2.719 . . . . 0.0 112.74 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.5 99.66 9.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.397 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.2 m -106.04 -48.74 3.53 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.43 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.505 ' OD2' HG22 ' A' ' 90' ' ' THR . 12.0 p-10 -87.7 -173.28 4.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.25 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -111.76 172.96 6.59 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 121.163 0.506 . . . . 0.0 111.126 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' ' 90' ' ' THR . 9.9 mt -120.2 146.63 45.84 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.031 -175.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.485 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 12.0 mt -89.8 145.47 7.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 30.5 ttt-85 -120.75 136.76 54.79 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.0 m-85 -114.73 122.33 46.09 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.486 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.1 tt0 -110.04 123.81 50.35 Favored 'General case' 0 CA--C 1.465 -2.312 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.722 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -86.84 162.05 17.99 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.448 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.872 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.5 pt-20 -63.26 -15.64 57.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.312 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -93.03 -9.73 38.71 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.029 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.22 8.68 62.73 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.452 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.599 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -88.83 143.35 26.95 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 176.064 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 55.8 p -138.57 154.89 48.74 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.823 178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 79' ' ' PHE . 5.0 p90 -145.69 148.95 33.59 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.883 176.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.492 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 44.1 mt-10 -124.89 148.15 48.44 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.729 -175.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -144.71 159.03 43.5 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.636 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.712 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -71.04 18.72 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.055 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.026 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.6 OUTLIER 70.87 -32.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 125.006 1.322 . . . . 0.0 112.429 177.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 90' ' ' THR . 12.8 t70 -78.35 -26.87 46.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.149 0.499 . . . . 0.0 109.737 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -69.26 123.75 88.97 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.05 -178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 33.5 Cg_exo -63.78 142.08 81.33 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.278 2.652 . . . . 0.0 113.126 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.46 146.33 18.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 124.22 1.008 . . . . 0.0 108.332 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.9 tp -105.38 109.7 21.78 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.837 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.56 HG13 HG13 ' A' ' 104' ' ' ILE . 2.1 p -110.72 151.1 12.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.371 0.605 . . . . 0.0 111.214 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -102.66 93.36 5.07 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.984 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.514 ' OE2' HD11 ' A' ' 104' ' ' ILE . 11.4 pt-20 -145.88 157.04 43.92 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.487 HD22 ' HG3' ' A' ' 99' ' ' GLU . 39.1 m-80 66.52 23.52 10.44 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.144 0.497 . . . . 0.0 109.844 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.42 11.89 57.36 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.207 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -136.84 172.23 13.33 Favored 'General case' 0 N--CA 1.402 -2.827 0 CA-C-O 121.462 0.649 . . . . 0.0 110.507 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.406 ' CE1' HD11 ' A' ' 118' ' ' LEU . 28.2 m-85 -98.45 121.41 40.35 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.373 177.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.56 HG13 HG13 ' A' ' 97' ' ' VAL . 22.8 pt -118.72 145.9 24.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.126 -0.63 . . . . 0.0 112.146 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -103.65 109.14 20.72 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.793 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -124.98 135.6 52.95 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.844 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.622 ' O ' HG23 ' A' ' 111' ' ' VAL . 96.1 mtt180 -62.31 163.42 8.47 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.026 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -62.05 -42.13 98.86 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.165 -176.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.496 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 1.7 p90 -74.14 2.64 8.52 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.814 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -110.87 -19.41 12.82 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.487 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 107' ' ' ARG . 98.5 t -77.55 147.02 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 8.3 mptt -118.46 166.76 12.28 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.005 0.431 . . . . 0.0 111.543 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -70.11 142.9 52.54 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.07 4.21 81.93 Favored Glycine 0 C--N 1.304 -1.245 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.235 -175.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.683 ' HB3' HD12 ' A' ' 151' ' ' ILE . 11.3 t70 -76.93 170.47 16.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.684 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 42.4 mttp -122.78 165.97 15.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.442 0.639 . . . . 0.0 111.648 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.97 156.57 39.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.862 171.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.497 ' HG ' HD11 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -91.57 136.61 33.0 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.4 m -107.09 154.34 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.206 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.933 173.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.559 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 32.2 t . . . . . 0 C--N 1.306 -1.283 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.809 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.684 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.9 mm? . . . . . 0 N--CA 1.428 -1.553 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.872 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -109.26 134.89 51.2 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -173.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.537 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 19.9 mt-10 -87.3 142.79 27.63 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.057 176.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.683 HD12 ' HB3' ' A' ' 115' ' ' ASP . 71.1 mt -78.79 109.22 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.246 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.62 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.555 ' HE2' ' HB2' ' A' ' 82' ' ' GLU . 36.4 mmtt -68.25 -40.36 81.96 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.918 176.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -151.27 131.33 13.44 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.557 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.2 mt -112.83 140.98 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.189 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.371 174.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.446 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.2 ptpt -148.44 159.64 43.84 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.312 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.485 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 18.7 m-85 -99.27 116.75 32.18 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.425 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -131.31 134.69 60.74 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.007 -178.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -67.44 154.19 41.94 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.518 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.0 133.99 56.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.784 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -84.32 37.9 0.64 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.089 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 162' ' ' ASP . 12.6 t70 -176.54 -174.4 0.58 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.29 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.448 ' H ' ' CG ' ' A' ' 161' ' ' ASP . 6.0 m-20 -95.64 -10.43 29.44 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.876 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.21 160.73 38.18 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.265 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.7 m -127.55 158.01 39.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.573 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.567 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 77.3 m-85 -135.77 167.22 21.57 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.142 0.496 . . . . 0.0 111.08 -175.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.562 ' HB3' HD12 ' A' ' 68' ' ' ILE . 44.6 t -152.47 -16.39 0.17 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.115 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.727 ' HG ' HD23 ' A' ' 24' ' ' LEU . 4.5 mm? 59.41 105.02 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.648 0.737 . . . . 0.0 111.655 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -83.81 118.68 24.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.556 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.459 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -135.32 -162.1 1.22 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.478 ' HB3' HG21 ' A' ' 62' ' ' THR . 72.1 tttt . . . . . 0 C--N 1.319 -0.738 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 183' ' ' THR . 43.9 t30 . . . . . 0 CA--C 1.516 -0.334 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.712 HG21 HD11 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -153.95 162.15 2.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.485 -177.286 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.585 HD11 HG12 ' A' ' 52' ' ' ILE . 87.3 mt -101.22 117.07 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.31 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.535 HG23 HG13 ' A' ' 175' ' ' VAL . 34.1 pt -122.76 162.67 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 CA-C-O 121.386 0.612 . . . . 0.0 111.676 -176.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 22.0 t30 48.34 -133.2 1.4 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 124.697 1.199 . . . . 0.0 110.862 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.26 52.24 1.3 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.496 0.665 . . . . 0.0 110.654 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.733 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.0 m120 66.97 48.34 1.28 Allowed 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 125.154 1.382 . . . . 0.0 113.365 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.1 mt -90.05 114.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.4 m -86.77 159.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-O 121.458 0.647 . . . . 0.0 110.922 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 4.0 t . . . . . 0 C--N 1.289 -2.057 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.93 -178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.414 ' CE1' HD13 ' A' ' 177' ' ' ILE . 49.1 m-85 . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.527 ' HA ' HG12 ' A' ' 164' ' ' VAL . 22.4 Cg_endo -61.16 -31.68 90.41 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.77 2.313 . . . . 0.0 112.279 -177.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.498 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 129.22 -39.3 1.87 Allowed Glycine 0 N--CA 1.421 -2.366 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.58 -11.86 55.15 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.374 0.607 . . . . 0.0 111.485 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 64.4 m -63.8 129.84 41.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 29.6 mtm180 -88.27 137.07 32.65 Favored 'General case' 0 C--O 1.189 -2.091 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 175' ' ' VAL . 11.9 tt -122.5 130.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 C-N-CA 122.649 0.379 . . . . 0.0 110.106 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.52 122.5 32.05 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 121.526 0.679 . . . . 0.0 109.467 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 26.1 m -133.34 179.63 4.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.477 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -126.23 120.42 29.97 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-O 121.35 0.595 . . . . 0.0 109.495 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.603 HG12 HG13 ' A' ' 47' ' ' ILE . 28.5 mt -120.22 122.24 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.463 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.643 -177.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.401 ' HA ' ' HB3' ' A' ' 46' ' ' GLU . 66.9 m-20 55.15 37.77 29.41 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 114.22 -1.354 . . . . 0.0 110.044 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.83 17.22 78.23 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.776 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.2 t -127.3 123.32 23.26 Favored Pre-proline 0 C--N 1.312 -1.022 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 21.3 Cg_endo -67.69 126.56 14.9 Favored 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 122.017 1.811 . . . . 0.0 111.104 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -125.97 138.07 53.73 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -106.76 101.32 10.77 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.7 pt -123.32 -178.14 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.936 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 16.7 p -92.23 168.78 11.1 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.803 -177.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.4 mm? -66.19 -25.12 66.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.825 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.586 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 1.1 ptm180 -85.38 -24.38 27.57 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HB2' ' H ' ' A' ' 20' ' ' THR . 35.2 mt-10 -85.51 -39.65 17.21 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.63 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.758 HD23 ' HG ' ' A' ' 167' ' ' LEU . 22.0 tp -58.84 -41.57 87.22 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.764 0.792 . . . . 0.0 109.602 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.468 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -55.54 -29.38 58.86 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.308 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.62 -17.56 59.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.649 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 23' ' ' GLU . 2.3 mm? -78.85 4.04 15.15 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.575 0.702 . . . . 0.0 109.414 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 95.6 m-85 -117.89 162.2 18.5 Favored 'General case' 0 N--CA 1.412 -2.36 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.861 -177.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 4.4 mm-40 -139.44 -173.81 3.71 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.375 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.445 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 3.5 t0 60.08 80.96 0.19 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.465 0.65 . . . . 0.0 110.863 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -102.56 130.79 49.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.904 0.859 . . . . 0.0 110.824 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.46 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.1 ptt180 -119.88 153.89 35.19 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.768 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -101.47 123.86 46.2 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -161.94 143.96 11.3 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.94 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 59.35 22.2 10.58 Favored 'General case' 0 CA--C 1.493 -1.236 0 O-C-N 123.78 0.675 . . . . 0.0 111.224 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.7 mtt 73.04 17.07 4.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.525 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 12.5 m -134.12 -171.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.413 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . 96.4 m-85 -119.3 143.21 47.48 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-O 121.164 0.507 . . . . 0.0 110.183 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.46 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.1 t -129.98 123.99 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.966 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.115 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.522 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 13.7 ttm180 -113.43 128.1 56.34 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.566 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.41 141.39 48.85 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.085 -174.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 24.3 ttmm 85.26 115.5 0.03 OUTLIER Pre-proline 0 CA--C 1.512 -0.513 0 C-N-CA 124.24 1.016 . . . . 0.0 111.928 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.541 ' HB2' HD13 ' A' ' 47' ' ' ILE . 72.3 Cg_endo -79.46 152.26 23.17 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.347 2.032 . . . . 0.0 111.838 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 31.0 mtmt -84.33 -6.09 59.35 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.821 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -148.35 -164.85 2.12 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 6.2 tp10 -86.73 101.17 13.05 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.469 176.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.603 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -116.21 118.23 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.526 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 29.3 mmtp -123.0 166.31 15.31 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.606 173.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.509 ' O ' HD12 ' A' ' 61' ' ' LEU . 6.3 m -115.36 129.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -84.8 121.91 28.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.827 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.1 m -132.88 171.32 14.08 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.846 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.46 HG12 HD11 ' A' ' 176' ' ' ILE . 2.9 mm -113.41 143.18 23.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.168 0.509 . . . . 0.0 110.008 177.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.643 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 21.2 t70 -77.55 124.22 27.63 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.342 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.804 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -75.97 -10.51 59.48 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.608 -171.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.643 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 3.8 pt-20 -107.87 -23.33 12.09 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.895 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.529 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 67.7 p -120.99 -23.78 5.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.999 -176.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.54 17.57 65.94 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.393 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.529 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 18.0 mttp -92.43 159.36 15.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 t -85.79 107.89 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.465 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.26 157.78 12.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.153 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.509 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.1 tp -122.24 137.98 54.65 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.5 t -143.79 171.51 14.12 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.08 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.14 161.64 20.54 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.809 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.578 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.9 mp -100.79 141.11 18.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.504 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.587 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 49.7 mt-10 -89.7 -35.85 15.54 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 p30 176.5 174.85 0.35 Allowed 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.006 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 20.5 t -105.54 134.3 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.191 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.297 177.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.525 HD13 ' HB3' ' A' ' 166' ' ' SER . 0.1 OUTLIER -101.8 124.04 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.379 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.089 179.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 86.7 tttt -135.34 108.47 7.7 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.224 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.43 137.17 30.22 Favored Pre-proline 0 C--N 1.31 -1.148 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.44 -175.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -47.43 124.04 8.78 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.394 2.729 . . . . 0.0 112.79 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.37 108.09 7.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.865 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -110.95 -59.52 1.95 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -77.21 -98.94 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.84 172.74 4.73 Favored 'General case' 0 CA--C 1.474 -1.981 0 CA-C-O 121.101 0.477 . . . . 0.0 112.011 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.769 HD23 ' HA ' ' A' ' 90' ' ' THR . 7.3 mt -132.45 141.14 48.7 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.135 -178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.513 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 10.6 mt -87.67 144.86 8.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 19.3 ttt-85 -121.69 136.03 54.95 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-O 121.283 0.564 . . . . 0.0 109.731 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 86' ' ' SER . 48.7 m-85 -114.34 130.32 56.67 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.865 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 152' ' ' LYS . 18.9 tt0 -109.86 129.21 55.67 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -94.31 155.64 16.91 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.778 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.1 pt-20 -64.62 -14.34 57.56 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.212 0.53 . . . . 0.0 111.529 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.69 -8.24 52.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.51 -0.768 . . . . 0.0 108.989 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.92 19.11 44.53 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.403 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.54 ' O ' HD23 ' A' ' 81' ' ' LEU . 4.8 mtt-85 -89.2 139.1 30.82 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 9.0 p -139.29 144.87 38.53 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.849 175.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -140.76 147.17 38.7 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.094 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 35.9 mt-10 -117.88 147.75 42.8 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.965 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.1 p -145.8 159.44 43.19 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.302 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.769 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.55 20.48 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -176.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.072 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.47 -37.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 125.397 1.479 . . . . 0.0 113.532 176.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.22 -2.2 58.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.143 0.497 . . . . 0.0 110.633 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -81.31 121.49 80.29 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.686 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 21.3 Cg_endo -63.32 139.04 69.4 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.659 2.239 . . . . 0.0 113.336 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 18.1 t -113.89 145.82 19.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.5 tp -101.35 107.69 19.1 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 121.059 -0.257 . . . . 0.0 110.336 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.499 HG13 HG13 ' A' ' 104' ' ' ILE . 2.6 p -107.76 147.5 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 121.63 0.728 . . . . 0.0 111.666 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -103.8 91.18 3.89 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.558 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.552 ' CG ' HD11 ' A' ' 104' ' ' ILE . 10.4 pt-20 -141.24 158.83 43.37 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.856 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.2 m-20 65.62 23.13 11.69 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.09 15.45 58.5 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.811 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HG3' HG23 ' A' ' 104' ' ' ILE . 9.7 ptm180 -136.33 171.96 13.71 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-O 121.206 0.527 . . . . 0.0 110.145 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -102.55 120.9 41.33 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.552 HD11 ' CG ' ' A' ' 99' ' ' GLU . 9.2 pt -125.8 147.94 30.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.316 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -100.41 119.0 37.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.448 -177.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.52 ' HE2' ' CD1' ' A' ' 104' ' ' ILE . 64.6 mttm -129.35 133.2 47.3 Favored 'General case' 0 C--O 1.205 -1.275 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.507 ' O ' HG23 ' A' ' 111' ' ' VAL . 86.4 mtt180 -63.42 163.04 11.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.072 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -60.57 -41.44 94.64 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.013 -175.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.487 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 2.8 p90 -74.18 4.61 5.4 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.961 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -118.17 -16.23 9.76 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.695 0.76 . . . . 0.0 110.265 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 107' ' ' ARG . 78.4 t -76.97 149.12 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -119.88 165.63 14.37 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.436 -176.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.8 141.09 53.39 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.286 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.75 5.0 71.99 Favored Glycine 0 C--N 1.307 -1.083 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.527 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.936 ' HB3' HD12 ' A' ' 151' ' ' ILE . 6.8 t70 -72.65 177.54 4.68 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.45 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 23.0 mttp -134.29 160.46 37.84 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.405 0.621 . . . . 0.0 111.013 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.26 158.4 43.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.066 172.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.71 130.86 37.43 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.732 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -102.61 148.73 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 175.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.586 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 33.1 t . . . . . 0 C--N 1.304 -1.384 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.683 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.423 -1.788 0 CA-C-O 121.636 0.732 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.778 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -113.02 136.92 52.16 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.581 -173.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 11.6 mt-10 -91.25 148.08 22.59 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.828 -1.078 . . . . 0.0 113.12 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.936 HD12 ' HB3' ' A' ' 115' ' ' ASP . 86.8 mt -78.97 109.63 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.897 176.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.594 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 1.5 mmmp? -68.12 -42.87 79.59 Favored 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.01 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -150.03 135.3 18.06 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 82.6 mt -118.92 129.29 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.639 -1.618 . . . . 0.0 111.058 174.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.455 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 1.8 ptpp? -133.17 163.0 30.24 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.648 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.513 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 13.5 m-85 -100.82 119.25 38.39 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.411 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -129.04 174.62 11.99 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.97 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.856 -178.472 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -109.91 166.4 10.96 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.305 -0.958 . . . . 0.0 112.282 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.66 137.1 58.13 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.914 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -101.48 31.05 3.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.974 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -170.99 -178.82 2.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -95.28 -13.26 25.0 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.072 0.463 . . . . 0.0 110.247 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.26 166.09 23.6 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.289 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.1 m -130.91 157.4 43.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 77.3 m-85 -138.46 159.97 40.73 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.734 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.525 ' HB3' HD13 ' A' ' 68' ' ' ILE . 7.8 t -148.34 -18.33 0.33 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.448 174.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.758 ' HG ' HD23 ' A' ' 24' ' ' LEU . 4.1 mm? 60.29 95.22 0.03 OUTLIER 'General case' 0 C--N 1.347 0.486 0 O-C-N 123.75 0.657 . . . . 0.0 111.04 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -82.44 102.61 11.42 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.127 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.587 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -97.5 -149.32 0.33 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.227 172.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 18.8 tptp . . . . . 0 N--CA 1.443 -0.814 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.603 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 183' ' ' THR . 0.5 OUTLIER . . . . . 0 CA--C 1.5 -0.98 0 CA-C-O 120.998 0.428 . . . . 0.0 110.435 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.696 HG21 HD11 ' A' ' 8' ' ' ILE . 2.5 p -150.13 167.03 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.044 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.566 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 90.5 mt -96.85 115.3 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.823 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.414 HD13 ' CE1' ' A' ' 2' ' ' PHE . 31.7 pt -118.47 166.51 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 121.307 0.575 . . . . 0.0 111.281 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 37.6 t30 46.16 -126.57 1.39 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 124.774 1.23 . . . . 0.0 111.028 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -91.07 59.31 3.99 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.603 0.716 . . . . 0.0 109.355 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.732 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.3 m120 66.08 44.65 2.58 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 113.851 -1.522 . . . . 0.0 114.18 176.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.41 ' O ' HG12 ' A' ' 177' ' ' ILE . 91.3 mt -91.68 113.74 27.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.4 m -91.5 153.6 3.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.905 0.859 . . . . 0.0 112.394 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 1.4 t . . . . . 0 C--N 1.303 -1.424 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.261 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 183' ' ' THR . 12.4 m-85 . . . . . 0 CA--C 1.52 -0.18 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.543 ' HD3' HD13 ' A' ' 76' ' ' LEU . 67.8 Cg_endo -70.4 161.57 45.55 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 N-CA-C 108.68 -1.315 . . . . 0.0 108.68 177.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.437 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -61.64 -23.67 63.24 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 119.316 -1.421 . . . . 0.0 111.692 177.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.57 -21.23 60.03 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.28 0.562 . . . . 0.0 112.185 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.436 ' HB ' HD12 ' A' ' 21' ' ' LEU . 97.9 m -62.97 126.33 26.96 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.969 -177.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 35.4 mmt180 -80.3 130.83 35.46 Favored 'General case' 0 C--O 1.184 -2.368 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.764 HD11 HG21 ' A' ' 175' ' ' VAL . 7.7 tt -120.3 130.1 74.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.572 HD23 ' CE ' ' A' ' 18' ' ' LYS . 1.1 tm? -87.34 124.42 33.35 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-O 121.458 0.647 . . . . 0.0 110.317 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 30.3 m -135.89 -178.5 2.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.189 -178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.467 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 33.8 tt0 -130.79 122.64 27.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.56 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 20.4 mt -121.03 120.85 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.568 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.659 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 52.46 40.61 29.97 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.303 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.27 18.3 79.21 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.8 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.3 t -122.5 120.16 28.06 Favored Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 59.6 Cg_endo -74.8 125.23 9.29 Favored 'Trans proline' 0 N--CA 1.427 -2.393 0 C-N-CA 122.207 1.938 . . . . 0.0 110.926 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -128.37 142.34 51.15 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.935 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.572 ' CE ' HD23 ' A' ' 9' ' ' LEU . 5.1 tppp? -108.56 99.85 9.18 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -121.31 -172.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.847 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 20.0 p -98.95 174.11 6.52 Favored 'General case' 0 C--N 1.28 -2.441 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.127 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 65.5 mt -68.54 -28.63 67.15 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.717 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.847 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 11.6 ptm180 -76.85 -26.92 54.84 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.531 ' OE1' HG23 ' A' ' 20' ' ' THR . 49.4 mt-10 -85.28 -36.22 21.01 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.191 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.777 HD21 HD22 ' A' ' 167' ' ' LEU . 15.5 tp -66.11 -44.24 84.89 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.129 0.49 . . . . 0.0 111.234 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.778 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -58.6 -26.51 63.74 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.401 -175.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.442 ' OE1' ' HA ' ' A' ' 23' ' ' GLU . 24.9 mt-10 -68.09 -19.02 64.82 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.665 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.37 0.33 42.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.447 0.642 . . . . 0.0 110.091 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.577 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.1 m-85 -117.15 163.34 16.43 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.005 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -145.76 -171.91 3.79 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.997 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 t0 63.53 75.43 0.39 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.845 0.831 . . . . 0.0 110.139 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.36 128.91 44.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.474 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.505 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.3 ptt180 -120.51 153.37 36.77 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.323 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -103.74 128.77 51.09 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -166.52 143.4 4.92 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.035 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 60.84 21.03 11.2 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 123.662 0.601 . . . . 0.0 110.783 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 33.5 mtt 71.28 19.62 5.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.648 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' HD2' ' A' ' 71' ' ' PRO . 17.2 m -133.26 -175.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -117.45 142.09 47.56 Favored 'General case' 0 CA--C 1.477 -1.836 0 CA-C-O 121.267 0.556 . . . . 0.0 110.497 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.3 t -130.01 124.3 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.861 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.426 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 28.8 ttm180 -114.75 126.32 54.71 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.35 145.17 51.06 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.398 -174.488 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 51.5 tptt 80.33 114.86 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.504 0 O-C-N 124.574 1.171 . . . . 0.0 110.697 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.538 ' HB2' HD13 ' A' ' 47' ' ' ILE . 58.0 Cg_endo -77.42 158.56 32.8 Favored 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 121.947 1.765 . . . . 0.0 111.735 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -90.57 -3.44 57.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.422 0.629 . . . . 0.0 110.461 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -148.72 -165.68 2.34 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.647 ' OE1' ' HE3' ' A' ' 48' ' ' LYS . 7.1 tp10 -84.01 96.7 8.95 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.577 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.8 mp -116.78 115.63 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.031 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.647 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 34.6 mmtp -118.79 166.13 13.17 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.314 173.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.489 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.2 p -122.92 134.3 66.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.662 -175.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 11' ' ' GLN . 20.2 m-85 -88.18 123.54 32.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.494 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.9 m -136.56 147.56 47.08 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.217 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.549 HG12 HD11 ' A' ' 176' ' ' ILE . 2.2 mm -93.21 143.54 11.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.222 0.534 . . . . 0.0 110.343 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.46 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 28.3 t70 -87.3 123.47 32.32 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.4 mt -70.44 -28.82 65.33 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-O 122.109 0.957 . . . . 0.0 111.844 -172.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -83.51 -30.7 26.94 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.507 -172.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.7 p -114.87 -22.29 9.7 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.654 -175.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.39 20.73 71.4 Favored Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.524 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.506 ' C ' HD13 ' A' ' 52' ' ' ILE . 27.6 mttm -99.98 153.84 18.87 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.85 106.58 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 CA-C-O 121.769 0.795 . . . . 0.0 110.126 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.72 167.06 5.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.887 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.9 tp -119.72 141.76 49.13 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.9 t -146.98 171.8 14.7 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.853 0.359 . . . . 0.0 111.329 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.534 ' OD2' ' HE2' ' A' ' 48' ' ' LYS . 7.0 m-20 -82.2 161.06 22.88 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.556 0.693 . . . . 0.0 110.552 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.552 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.7 mp -99.21 140.92 17.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.244 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.411 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 6.7 mm-40 -88.18 -35.26 17.48 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 173.79 174.15 0.15 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.579 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 25' ' ' TYR . 13.8 t -104.92 132.93 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.192 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.66 HD12 ' HB2' ' A' ' 166' ' ' SER . 49.7 mt -92.21 113.49 27.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.478 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.438 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 86.6 tttt -127.57 109.34 11.61 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.78 141.62 42.63 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.77 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.474 ' HD2' HG12 ' A' ' 37' ' ' VAL . 8.1 Cg_endo -52.62 129.59 32.95 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.384 2.723 . . . . 0.0 112.41 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.95 73.63 9.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.351 0.596 . . . . 0.0 110.622 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.2 p -71.7 -38.59 70.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.913 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.52 -172.31 2.73 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.323 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.645 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 19.2 m170 -111.98 172.32 6.97 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 90' ' ' THR . 7.1 mt -122.48 146.87 46.99 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.541 0.686 . . . . 0.0 112.007 -175.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.552 HD12 ' C ' ' A' ' 108' ' ' ALA . 20.5 mt -87.82 145.52 7.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.554 ' HB3' ' CG ' ' A' ' 155' ' ' LYS . 41.8 ttt85 -122.07 140.88 51.98 Favored 'General case' 0 N--CA 1.404 -2.752 0 CA-C-O 121.301 0.572 . . . . 0.0 109.945 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 86' ' ' SER . 57.5 m-85 -114.71 125.49 53.79 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.586 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.7 tt0 -109.4 123.52 49.48 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.716 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.71 159.65 17.7 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.502 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.811 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.9 pt-20 -63.61 -15.25 57.66 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.456 0.646 . . . . 0.0 111.116 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.06 -10.24 36.82 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.487 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.02 12.77 54.85 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.839 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.564 ' O ' HD23 ' A' ' 81' ' ' LEU . 1.6 mtt180 -83.84 139.3 32.74 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 15.7 p -143.01 136.99 28.97 Favored 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.523 176.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -133.06 151.56 52.03 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.559 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.474 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 99.3 mt-10 -123.54 152.2 42.06 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.328 0.585 . . . . 0.0 112.097 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.512 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -142.21 155.33 45.27 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.238 178.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.649 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -72.01 16.85 0.11 Allowed 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 121.621 0.725 . . . . 0.0 111.56 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.037 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.9 OUTLIER 71.05 -29.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 125.64 1.576 . . . . 0.0 113.06 176.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -82.61 -5.1 58.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.972 0.415 . . . . 0.0 110.493 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -94.86 125.66 50.13 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.57 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 37.9 Cg_exo -63.1 142.28 86.62 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.968 2.445 . . . . 0.0 112.937 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.2 t -112.17 146.19 17.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.432 ' CD1' ' HG3' ' A' ' 105' ' ' GLU . 18.2 tp -101.75 111.46 23.72 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.975 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.57 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.3 p -113.7 150.85 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.345 0.593 . . . . 0.0 111.595 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -102.36 96.02 6.67 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.41 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.451 ' CD ' HD11 ' A' ' 104' ' ' ILE . 11.9 pt-20 -145.56 155.02 42.8 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 83.1 m-20 63.74 23.09 13.35 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.205 0.526 . . . . 0.0 110.332 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.12 12.49 60.52 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.872 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -131.2 170.83 14.04 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-O 121.478 0.656 . . . . 0.0 110.043 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -105.95 121.96 45.16 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.515 HG13 HG13 ' A' ' 97' ' ' VAL . 19.1 pt -122.36 146.77 27.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.007 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 26.7 mp0 -105.01 107.78 18.95 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.988 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 12.0 ptpt -118.38 135.2 54.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.422 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.637 ' O ' HG23 ' A' ' 111' ' ' VAL . 80.3 mtt180 -61.59 160.6 11.08 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.037 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -58.84 -43.41 90.73 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.212 -177.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.409 ' HB3' ' CG2' ' A' ' 91' ' ' VAL . 1.7 p90 -75.43 7.44 3.58 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.885 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -118.32 -17.95 9.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.443 0.639 . . . . 0.0 110.037 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 107' ' ' ARG . 89.4 t -73.15 149.18 8.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.198 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.685 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 69.7 mmtt -115.74 168.19 10.26 Favored 'General case' 0 CA--C 1.486 -1.503 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.382 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -77.71 142.05 38.98 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.11 4.2 74.97 Favored Glycine 0 C--N 1.305 -1.144 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -174.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.685 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -74.69 173.43 10.5 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -129.66 167.28 18.22 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.58 0.705 . . . . 0.0 111.604 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.81 159.82 39.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.738 170.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.8 135.54 37.4 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.9 OUTLIER -106.35 160.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 C--N 1.303 -1.424 0 CA-C-O 121.024 0.44 . . . . 0.0 111.163 -178.109 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 N--CA 1.421 -1.906 0 CA-C-O 121.348 0.594 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.811 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -107.51 133.68 51.64 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -172.161 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -88.04 145.65 25.87 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.628 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.469 HD13 ' CD1' ' A' ' 79' ' ' PHE . 67.6 mt -79.8 105.55 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.773 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.199 173.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 7.1 mmpt? -70.7 -37.43 73.57 Favored 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 114.645 -1.162 . . . . 0.0 110.682 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -149.96 133.42 16.56 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 71.3 mt -112.74 140.05 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.977 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.554 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.9 ptpt -139.82 152.91 46.9 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.171 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.496 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.2 m-85 -97.75 104.6 16.64 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-O 121.806 0.812 . . . . 0.0 108.825 173.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.645 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -108.02 175.77 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.266 -3.034 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.701 -178.378 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.405 ' HA ' ' CG ' ' A' ' 75' ' ' HIS . 19.5 ptt85 -80.74 -145.69 0.05 Allowed 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 121.79 0.805 . . . . 0.0 111.443 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -131.4 99.82 4.96 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -46.39 -49.91 17.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.085 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -102.3 170.68 7.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.041 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -88.6 -4.1 58.65 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.096 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -139.81 155.57 47.2 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.622 176.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.81 156.53 30.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.614 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 65.4 m-85 -133.55 171.51 14.0 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.66 ' HB2' HD12 ' A' ' 68' ' ' ILE . 70.7 m -160.17 -25.0 0.06 Allowed 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.777 HD22 HD21 ' A' ' 24' ' ' LEU . 9.1 tp 68.17 111.79 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.215 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -87.3 115.77 24.94 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.912 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.489 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -136.85 -166.72 1.95 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 45.0 mmtt . . . . . 0 CA--C 1.504 -0.789 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.61 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 183' ' ' THR . 30.5 t30 . . . . . 0 CA--C 1.51 -0.574 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.764 HG21 HD11 ' A' ' 8' ' ' ILE . 1.4 p -154.23 160.72 2.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.12 0.486 . . . . 0.0 111.307 -177.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.549 HD11 HG12 ' A' ' 52' ' ' ILE . 97.9 mt -96.55 115.64 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.213 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.567 HG23 HG13 ' A' ' 175' ' ' VAL . 47.3 pt -123.5 174.49 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.225 -175.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.479 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 2.9 t-20 47.07 -129.39 1.53 Allowed 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.062 0.945 . . . . 0.0 110.673 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.24 48.95 1.65 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.513 0.673 . . . . 0.0 109.847 176.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 3.7 m-20 68.79 47.19 0.84 Allowed 'General case' 0 CA--C 1.495 -1.145 0 C-N-CA 125.445 1.498 . . . . 0.0 113.171 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.4 HD12 ' HB3' ' A' ' 178' ' ' ASN . 82.5 mt -91.04 115.88 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.589 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.9 m -80.36 158.84 4.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.418 0.627 . . . . 0.0 110.558 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 5.1 t . . . . . 0 C--N 1.294 -1.805 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.488 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.41 ' CE1' HD13 ' A' ' 177' ' ' ILE . 20.6 m-85 . . . . . 0 C--O 1.223 -0.335 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.517 ' HD3' HD13 ' A' ' 76' ' ' LEU . 27.8 Cg_endo -62.74 -34.72 72.34 Favored 'Trans proline' 0 N--CA 1.479 0.637 0 C-N-CA 123.2 2.6 . . . . 0.0 112.321 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.509 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 130.36 -39.79 1.76 Allowed Glycine 0 N--CA 1.423 -2.212 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.49 -9.3 8.13 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 121.468 0.651 . . . . 0.0 111.556 176.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.8 m -69.27 129.07 38.77 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.915 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.601 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 16.4 mtm180 -84.07 138.22 33.17 Favored 'General case' 0 C--O 1.184 -2.388 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.717 HD11 HG21 ' A' ' 175' ' ' VAL . 10.0 tt -123.02 131.55 73.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-O 120.83 0.347 . . . . 0.0 110.217 177.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.53 HD23 ' HB2' ' A' ' 18' ' ' LYS . 2.2 tm? -90.49 123.81 34.48 Favored 'General case' 0 N--CA 1.405 -2.707 0 CA-C-O 121.619 0.723 . . . . 0.0 110.657 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.5 m -133.08 -174.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.144 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 30.3 tt0 -134.7 123.2 23.32 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.623 HG12 HG13 ' A' ' 47' ' ' ILE . 20.4 mt -122.63 123.28 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 CA-C-O 121.422 0.63 . . . . 0.0 110.358 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.9 36.67 27.74 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.972 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.4 21.14 79.54 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.627 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.4 t -127.54 114.82 21.13 Favored Pre-proline 0 N--CA 1.432 -1.342 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 17.3 Cg_exo -63.32 123.76 12.68 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 122.579 2.186 . . . . 0.0 111.31 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.425 HE21 HD12 ' A' ' 12' ' ' ILE . 21.3 mt-30 -126.98 136.41 52.22 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HB2' HD23 ' A' ' 9' ' ' LEU . 38.0 ttmt -108.55 102.15 11.25 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.627 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.6 pt -124.18 -171.7 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.132 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.954 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.713 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 17.8 p -95.48 169.78 9.81 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.249 -0.981 . . . . 0.0 110.673 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.549 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.4 mm? -67.74 -23.6 65.27 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.674 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.713 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 3.1 ptm180 -85.9 -24.32 26.67 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.609 ' OE1' HG23 ' A' ' 20' ' ' THR . 49.2 mt-10 -84.84 -42.08 15.43 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.972 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 19' ' ' ILE . 30.7 tp -57.44 -42.55 82.64 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 122.042 0.925 . . . . 0.0 109.897 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.742 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.9 m-30 -53.86 -30.73 46.88 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.393 -1.73 . . . . 0.0 113.084 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -74.39 -15.73 60.91 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.347 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.422 ' HB3' HD11 ' A' ' 47' ' ' ILE . 2.5 mm? -80.77 6.38 13.12 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.534 0.683 . . . . 0.0 109.775 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.559 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 98.1 m-85 -118.47 165.66 13.63 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.309 -178.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.516 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 3.4 mm-40 -143.97 -173.68 4.06 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.34 175.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 4.1 t70 64.26 86.74 0.12 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.583 0.706 . . . . 0.0 110.359 -179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -104.07 122.25 44.9 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.558 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -111.27 150.31 29.82 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.962 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.415 ' CZ ' ' HA ' ' A' ' 36' ' ' MET . 24.2 t80 -107.44 131.78 53.91 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' O ' HG22 ' A' ' 37' ' ' VAL . 7.5 tp10 -166.24 141.42 4.59 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.515 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 59.97 22.12 11.2 Favored 'General case' 0 CA--C 1.494 -1.182 0 O-C-N 123.573 0.545 . . . . 0.0 111.367 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 33' ' ' TYR . 41.7 mtm 72.75 19.52 3.93 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.998 0.811 . . . . 0.0 110.875 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.534 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 6.0 m -131.27 -179.55 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.498 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 88.7 m-85 -116.81 145.22 43.68 Favored 'General case' 0 CA--C 1.482 -1.644 0 CA-C-O 121.387 0.613 . . . . 0.0 110.438 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.8 t -130.23 123.53 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.747 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.61 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 39.5 ttm180 -116.8 126.32 52.9 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -134.62 144.89 48.14 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.595 -175.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.44 ' HD3' ' O ' ' A' ' 43' ' ' PRO . 12.6 tmtt? 86.93 109.61 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.409 0 O-C-N 124.899 1.375 . . . . 0.0 109.989 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.644 ' HB2' HD13 ' A' ' 47' ' ' ILE . 61.5 Cg_endo -78.18 151.97 27.15 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 122.149 1.899 . . . . 0.0 111.615 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.516 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 36.7 mtmt -83.0 -7.4 59.67 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.191 0.519 . . . . 0.0 111.12 -177.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -144.92 -165.41 2.15 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 8.7 tp10 -85.98 101.66 13.1 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.644 HD13 ' HB2' ' A' ' 43' ' ' PRO . 1.5 mp -115.03 117.41 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.966 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.514 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 32.4 mmtt -116.91 168.47 10.2 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 173.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.502 ' CG1' HG23 ' A' ' 62' ' ' THR . 9.5 p -125.51 128.81 72.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.04 132.16 34.36 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.966 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.408 ' HA ' HG13 ' A' ' 176' ' ' ILE . 21.5 t -139.12 177.15 8.11 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 59' ' ' VAL . 2.7 mm -116.34 141.72 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.342 0.591 . . . . 0.0 110.844 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.765 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 24.7 t70 -80.11 116.31 20.16 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.152 178.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.745 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.2 mm? -73.57 -13.63 61.06 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.177 0.513 . . . . 0.0 112.191 -171.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.765 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -96.85 -26.25 15.16 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.849 -175.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.41 ' CB ' ' HD3' ' A' ' 58' ' ' LYS . 71.4 p -120.69 -25.68 5.44 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.887 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.48 9.18 65.12 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.421 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.42 ' O ' HD13 ' A' ' 52' ' ' ILE . 3.3 mptp? -81.88 159.66 23.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.157 0.583 . . . . 0.0 111.623 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.471 ' HA ' HD13 ' A' ' 52' ' ' ILE . 7.3 p -92.53 113.95 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 CA-C-O 121.943 0.878 . . . . 0.0 109.904 178.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -111.1 160.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.972 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.76 142.64 49.37 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.502 HG23 ' CG1' ' A' ' 49' ' ' VAL . 8.8 t -145.17 172.56 12.93 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.439 -177.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.42 161.02 14.82 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.611 0.719 . . . . 0.0 110.867 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.565 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.6 mp -94.59 142.61 13.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.488 -177.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.591 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.6 mm-40 -85.14 -46.28 11.26 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -179.84 -168.01 0.1 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.313 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.61 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 37.5 t -114.07 128.6 70.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.867 -175.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 166' ' ' SER . 19.9 mt -92.6 102.12 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.1 -176.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.534 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 48.3 tttp -120.95 110.08 15.86 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.615 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.53 141.3 40.73 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.093 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.454 ' HD2' HG12 ' A' ' 37' ' ' VAL . 5.9 Cg_endo -50.43 140.23 35.61 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.469 2.779 . . . . 0.0 112.86 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.26 94.15 2.45 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.16 0.505 . . . . 0.0 110.29 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.9 p -89.01 -70.96 0.62 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.13 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.47 -175.06 5.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.26 0.553 . . . . 0.0 111.775 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 34.5 m170 -101.48 172.45 6.97 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.082 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.1 mt -125.04 142.12 51.69 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.66 0.743 . . . . 0.0 111.807 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.563 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 9.9 mt -87.16 144.6 8.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 8.3 ttt180 -119.46 137.54 53.71 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.128 0.49 . . . . 0.0 109.686 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 86' ' ' SER . 52.4 m-85 -115.35 126.71 54.76 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.603 -178.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 57.6 tt0 -111.66 125.24 53.75 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.73 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -90.49 158.44 17.03 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.605 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.765 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -60.4 -18.12 48.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.271 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -90.76 -12.47 36.41 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.794 0.807 . . . . 0.0 109.556 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.41 16.69 39.22 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.88 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.582 ' O ' HD23 ' A' ' 81' ' ' LEU . 2.9 mtt180 -86.13 137.11 32.91 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.3 p -139.81 136.66 34.27 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.046 -1.062 . . . . 0.0 112.565 176.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -132.77 150.75 52.12 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.261 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.48 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 73.1 mt-10 -126.95 149.14 49.98 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.478 -176.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.457 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.9 OUTLIER -146.66 161.35 40.75 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.925 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.749 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -70.89 15.16 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.451 0.7 . . . . 0.0 112.66 -176.481 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.01 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 72.03 -34.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 125.253 1.421 . . . . 0.0 112.93 177.325 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.469 ' OD1' ' HB ' ' A' ' 90' ' ' THR . 6.1 p-10 -84.42 -5.52 59.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.13 0.491 . . . . 0.0 110.238 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 57.7 t-80 -84.45 126.49 69.05 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.799 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 23.0 Cg_exo -65.9 124.14 12.28 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.842 2.362 . . . . 0.0 112.942 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.8 t -97.85 147.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.645 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.5 tp -101.26 107.38 18.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.984 0.421 . . . . 0.0 111.102 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.601 HG21 ' OD1' ' A' ' 115' ' ' ASP . 1.6 p -113.29 147.78 16.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.549 0.69 . . . . 0.0 111.87 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -105.2 93.12 4.51 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.046 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.635 ' CG ' HD11 ' A' ' 104' ' ' ILE . 8.1 pt-20 -137.68 159.52 41.75 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.0 m-20 63.27 21.43 12.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.327 0.584 . . . . 0.0 109.753 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.45 16.23 62.63 Favored Glycine 0 N--CA 1.436 -1.367 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.326 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -135.93 172.91 12.33 Favored 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 117.859 0.829 . . . . 0.0 109.844 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -100.55 120.45 40.04 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.635 HD11 ' CG ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -123.16 148.12 27.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.209 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 23.7 mt-10 -104.99 110.52 22.96 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.414 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.514 ' HE3' HG11 ' A' ' 97' ' ' VAL . 77.7 mttt -117.76 134.74 54.6 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.594 ' O ' HG23 ' A' ' 111' ' ' VAL . 4.4 mpt_? -60.73 164.13 4.96 Favored 'General case' 0 C--O 1.215 -0.725 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.01 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -62.04 -41.32 97.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 118.955 -1.098 . . . . 0.0 109.539 -178.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.461 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 3.1 p90 -73.32 -2.63 22.83 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.691 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.469 ' HB3' ' N ' ' A' ' 107' ' ' ARG . 49.3 tp10 -109.68 -15.28 14.19 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.565 0.697 . . . . 0.0 109.988 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 107' ' ' ARG . 79.3 t -82.46 148.76 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.648 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 30.7 mttt -125.65 165.63 18.21 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.035 0.445 . . . . 0.0 111.129 -176.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.83 141.19 58.86 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.928 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.3 4.1 77.85 Favored Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.988 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.648 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -77.55 168.3 20.21 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.406 ' HE3' ' HG3' ' A' ' 150' ' ' GLU . 32.0 mttp -121.41 167.98 12.19 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 121.363 0.601 . . . . 0.0 111.149 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.58 159.96 39.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.993 170.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.48 133.11 35.78 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.7 OUTLIER -102.04 157.7 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.525 ' HB3' HD22 ' A' ' 180' ' ' ASN . 43.9 t . . . . . 0 C--N 1.304 -1.393 0 CA-C-O 120.893 0.378 . . . . 0.0 110.953 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.415 -2.18 0 CA-C-O 121.227 0.537 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.765 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -111.15 135.83 51.1 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.822 -172.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.412 ' H ' HD13 ' A' ' 149' ' ' LEU . 23.9 mt-10 -90.52 147.41 23.39 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.448 1.118 . . . . 0.0 112.557 175.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.469 HG21 ' CG1' ' A' ' 154' ' ' ILE . 74.9 mt -79.01 110.03 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.648 0 CA-C-N 113.355 -1.748 . . . . 0.0 110.607 176.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 80' ' ' GLU . 29.7 mtmt -63.48 -46.69 85.02 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.748 175.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -150.6 135.69 17.68 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 76.5 mt -118.92 130.72 73.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.981 176.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.608 ' HD3' HG13 ' A' ' 157' ' ' VAL . 3.3 ptpp? -134.23 163.51 29.46 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.57 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.563 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.8 m-85 -101.34 120.36 40.14 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.844 175.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.608 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -131.56 174.45 13.12 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.603 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.983 -177.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -104.65 163.85 12.19 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.345 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.06 126.31 29.41 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.859 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -71.11 -40.55 71.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.372 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.19 176.33 6.27 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -95.59 -2.29 48.64 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.405 0.621 . . . . 0.0 110.12 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -136.84 154.91 50.39 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.45 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 3' ' ' PRO . 0.9 OUTLIER -118.32 151.46 20.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.647 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.742 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 9.8 m-85 -134.67 164.42 27.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.19 -170.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.605 ' HB2' HD12 ' A' ' 68' ' ' ILE . 74.5 m -158.55 -18.03 0.07 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.275 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.459 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 2.1 tm? 60.04 106.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.917 0.865 . . . . 0.0 111.462 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -90.33 125.26 35.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.856 0.836 . . . . 0.0 112.291 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.591 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -140.98 -130.06 0.1 Allowed 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.132 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.495 ' CB ' HG21 ' A' ' 62' ' ' THR . 81.0 tttt . . . . . 0 C--N 1.307 -1.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 CA--C 1.519 -0.218 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.717 HG21 HD11 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -152.88 165.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-O 121.401 0.619 . . . . 0.0 112.322 -175.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.601 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.8 mt -105.74 117.43 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.059 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.535 HG23 HG13 ' A' ' 175' ' ' VAL . 44.7 pt -122.84 172.58 9.93 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.811 -176.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 7.4 t-20 48.99 -131.48 1.76 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.683 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -90.67 57.82 3.71 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.155 0.979 . . . . 0.0 109.502 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.742 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 6.2 m-20 68.03 48.83 0.93 Allowed 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.071 -1.877 . . . . 0.0 113.686 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.1 mt -90.03 113.91 26.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.932 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.67 126.61 40.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.156 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 C--N 1.308 -1.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.115 177.164 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.512 ' CE1' HD13 ' A' ' 177' ' ' ILE . 2.8 m-85 . . . . . 0 N--CA 1.443 -0.785 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.576 ' HD3' HD13 ' A' ' 76' ' ' LEU . 18.3 Cg_endo -59.48 -77.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.299 1.999 . . . . 0.0 109.997 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.419 ' H ' ' HG2' ' A' ' 3' ' ' PRO . . . 179.73 -28.6 0.05 OUTLIER Glycine 0 N--CA 1.414 -2.78 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 176.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -67.18 -7.53 24.35 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.283 0.563 . . . . 0.0 111.584 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 23.9 m -67.7 130.22 42.32 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 19.3 mtm180 -84.55 133.88 34.43 Favored 'General case' 0 C--O 1.183 -2.442 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.64 HD11 HG21 ' A' ' 175' ' ' VAL . 10.1 tt -121.45 130.55 74.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 C-N-CA 122.736 0.415 . . . . 0.0 110.098 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.425 HD12 ' CD1' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -87.08 123.94 32.7 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 121.424 0.63 . . . . 0.0 109.597 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.2 m -135.41 -179.31 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.595 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 29.2 tt0 -129.95 122.32 28.31 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.883 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.594 HG12 HG13 ' A' ' 47' ' ' ILE . 18.2 mt -121.83 122.68 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.009 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.553 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.0 t0 55.66 37.39 28.81 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.764 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.39 16.08 78.89 Favored Glycine 0 C--N 1.309 -0.945 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.71 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.5 t -121.8 119.51 28.98 Favored Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 36.2 Cg_endo -71.29 128.0 14.09 Favored 'Trans proline' 0 N--CA 1.431 -2.172 0 C-N-CA 122.111 1.874 . . . . 0.0 110.324 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -129.91 141.55 50.78 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -109.11 100.76 9.88 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -122.16 -173.16 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.181 -2.51 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.105 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.731 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 9.7 p -96.1 170.64 9.13 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.66 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.3 mm? -67.59 -27.11 66.64 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.445 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.731 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 6.6 ptm180 -84.06 -22.77 31.12 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.472 ' HB2' ' H ' ' A' ' 20' ' ' THR . 10.2 mm-40 -85.32 -42.27 14.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.819 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.504 ' HA ' HD12 ' A' ' 19' ' ' ILE . 27.5 tp -58.26 -44.21 88.28 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.967 0.889 . . . . 0.0 109.884 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.686 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.4 m-30 -55.35 -29.37 58.24 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 113.553 -1.658 . . . . 0.0 113.486 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 10.7 mm-40 -79.06 -11.75 60.0 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.02 -175.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.29 6.7 11.23 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.349 0.595 . . . . 0.0 109.528 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 97.6 m-85 -118.68 164.96 14.57 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.885 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.595 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 30.2 mt-10 -137.53 -172.86 3.33 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.575 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 2.5 t70 61.75 83.66 0.15 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.479 0.657 . . . . 0.0 111.082 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -99.0 122.42 42.24 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.536 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -113.59 150.57 32.88 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.342 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.505 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 28.1 t80 -106.87 129.62 54.68 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.316 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.456 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 7.6 tp10 -167.46 142.27 3.83 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.696 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.456 ' ND2' ' HG3' ' A' ' 34' ' ' GLU . 51.9 m-80 58.29 23.17 10.12 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 123.478 0.486 . . . . 0.0 111.457 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.505 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 43.8 mtm 72.24 18.66 4.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.814 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.527 HG12 ' HD2' ' A' ' 71' ' ' PRO . 4.3 m -129.37 179.92 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.433 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 81.1 m-85 -118.36 142.02 47.95 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.31 0.576 . . . . 0.0 110.278 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.36 123.77 60.66 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.928 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.622 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 40.9 ttm180 -115.06 126.55 54.83 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -134.2 146.73 50.42 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.98 -174.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 54.5 tptt 83.2 112.62 0.03 OUTLIER Pre-proline 0 C--N 1.318 -0.799 0 O-C-N 124.902 1.376 . . . . 0.0 110.868 -177.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.602 ' HB2' HD13 ' A' ' 47' ' ' ILE . 59.4 Cg_endo -78.79 152.26 25.22 Favored 'Trans proline' 0 N--CA 1.426 -2.482 0 C-N-CA 121.877 1.718 . . . . 0.0 111.4 177.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.595 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 36.2 mtmt -80.87 -6.23 58.36 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.796 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -147.09 -165.77 2.33 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 5.2 tp10 -86.21 100.07 11.99 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.602 HD13 ' HB2' ' A' ' 43' ' ' PRO . 1.3 mp -115.47 117.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.433 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 34.8 mmtp -119.91 166.66 13.02 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.689 174.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 175' ' ' VAL . 13.7 p -120.42 127.07 75.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.111 0.481 . . . . 0.0 112.186 -174.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CD1' HD12 ' A' ' 9' ' ' LEU . 6.5 m-85 -80.56 123.14 27.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.65 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.0 p -133.27 176.92 8.09 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.271 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.532 HG12 HD11 ' A' ' 176' ' ' ILE . 2.4 mm -122.96 140.26 47.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.248 0.547 . . . . 0.0 110.024 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -78.17 119.34 21.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.787 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -72.01 -14.0 61.77 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.106 0.479 . . . . 0.0 111.902 -171.591 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -99.41 -28.35 13.31 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.914 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.486 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.4 p -117.2 -26.24 6.84 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.728 -175.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.82 12.7 68.31 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.332 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.486 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 17.1 mtpp -85.97 158.01 19.99 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.64 109.33 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.368 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.3 m -112.58 157.93 13.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.085 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 tp -122.29 135.77 54.79 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -137.83 172.88 12.28 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.669 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.08 161.03 16.0 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.224 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.554 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.9 mp -96.34 144.62 10.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.304 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.478 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 48.5 mm-40 -91.07 -41.5 11.02 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -179.96 178.63 0.59 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.896 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 9.4 t -109.9 129.23 65.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.699 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.5 mt -97.19 102.3 13.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.826 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 45.5 tttp -116.87 107.73 14.97 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.84 137.24 30.47 Favored Pre-proline 0 C--N 1.31 -1.141 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.154 -176.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.527 ' HD2' HG12 ' A' ' 37' ' ' VAL . 80.9 Cg_exo -47.89 124.14 9.53 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 123.424 2.749 . . . . 0.0 113.116 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.46 80.01 8.74 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.948 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.6 m -86.91 -24.68 24.74 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.336 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -101.91 -179.7 4.08 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.042 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 59.5 m170 -111.37 172.31 6.96 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.426 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.591 ' CD2' ' HA ' ' A' ' 90' ' ' THR . 22.4 mt -123.78 146.71 48.13 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.856 0.836 . . . . 0.0 111.972 -173.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.482 HD12 ' C ' ' A' ' 108' ' ' ALA . 19.9 mt -88.77 143.05 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.195 173.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 37.2 ttt-85 -120.76 138.96 53.73 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-O 121.331 0.586 . . . . 0.0 109.426 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' A' ' 86' ' ' SER . 54.0 m-85 -116.05 126.44 53.78 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.038 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 152' ' ' LYS . 31.3 tt0 -109.2 122.68 47.83 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.751 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.02 154.07 20.78 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.643 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.979 ' HG2' HD11 ' A' ' 149' ' ' LEU . 5.2 pt-20 -57.21 -22.43 40.72 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.038 0.535 . . . . 0.0 111.943 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.28 -11.09 55.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.005 0.907 . . . . 0.0 109.111 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.28 14.93 46.29 Favored Glycine 0 N--CA 1.434 -1.451 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.918 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.554 ' O ' HD23 ' A' ' 81' ' ' LEU . 1.5 mtt180 -85.63 139.21 31.59 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 30.5 p -140.02 143.51 36.46 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.11 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -139.49 155.11 47.76 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.373 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 23.7 mt-10 -128.45 151.91 48.84 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.928 -176.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -148.33 160.54 42.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.867 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.591 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -71.55 13.81 0.23 Allowed 'General case' 0 C--N 1.353 0.738 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -175.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.077 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.8 OUTLIER 68.14 -39.32 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 124.681 1.192 . . . . 0.0 113.691 176.11 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -79.68 2.47 22.52 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.803 0.335 . . . . 0.0 111.317 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 50.4 m170 -115.13 143.47 30.29 Favored Pre-proline 0 C--N 1.313 -1.016 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.885 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 15.4 Cg_exo -69.05 140.14 44.53 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.561 2.841 . . . . 0.0 115.25 -175.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 20.6 t -112.15 149.55 14.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 125.285 1.434 . . . . 0.0 107.211 175.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.8 tp -107.59 111.66 24.02 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.485 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.693 HG21 ' OD1' ' A' ' 115' ' ' ASP . 1.8 p -111.47 150.18 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.424 0.63 . . . . 0.0 112.167 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.641 ' CD2' HD12 ' A' ' 148' ' ' LEU . 71.7 t80 -103.31 93.37 4.94 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.256 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -135.94 154.94 50.96 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 62.26 22.98 13.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.086 0.469 . . . . 0.0 110.394 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.84 13.96 62.31 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.058 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -130.51 171.34 13.12 Favored 'General case' 0 N--CA 1.399 -2.987 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -104.35 121.13 42.73 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.644 HG13 HG13 ' A' ' 97' ' ' VAL . 28.7 pt -121.61 142.42 37.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.995 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.3 OUTLIER -106.16 111.55 24.21 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.008 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HG3' HG22 ' A' ' 111' ' ' VAL . 12.6 ptpt -125.24 144.54 50.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.915 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.608 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 64.9 mtt180 -64.85 160.67 19.87 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.077 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -59.95 -41.54 92.08 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.413 -176.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.459 ' HB3' ' CG2' ' A' ' 91' ' ' VAL . 1.8 p90 -74.29 1.73 10.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.824 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -112.9 -13.91 13.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.827 0.822 . . . . 0.0 109.701 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 107' ' ' ARG . 98.9 t -76.79 150.0 6.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.714 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -123.89 166.16 16.14 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 120.606 0.241 . . . . 0.0 110.824 -177.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.61 141.94 51.7 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.17 4.7 77.5 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.638 -175.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.714 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 1.7 t0 -78.5 166.56 22.45 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.433 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 35.1 mttp -120.01 168.68 10.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.79 0.805 . . . . 0.0 111.459 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.62 160.35 37.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 169.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 182' ' ' VAL . 1.1 tt -90.31 122.18 32.98 Favored 'General case' 0 N--CA 1.395 -3.189 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.226 177.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.0 OUTLIER -104.82 128.76 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 173.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.8 t . . . . . 0 C--N 1.304 -1.39 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.544 -177.209 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.641 HD12 ' CD2' ' A' ' 98' ' ' TYR . 13.8 mt . . . . . 0 N--CA 1.428 -1.553 0 CA-C-O 121.709 0.766 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.979 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -111.36 135.97 51.15 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.07 -172.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.433 ' HG3' ' CG ' ' A' ' 116' ' ' LYS . 11.3 mt-10 -91.56 147.33 23.09 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.497 175.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.522 HD12 ' HB3' ' A' ' 115' ' ' ASP . 75.4 mt -78.29 106.93 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.594 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.844 176.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.652 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 34.4 mmtm -70.27 -39.58 74.87 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.856 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -150.94 132.46 14.74 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 71.8 mt -111.76 143.98 20.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.791 176.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.413 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.4 ptpt -146.77 159.83 43.01 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.398 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -100.26 114.9 28.71 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.3 OUTLIER -126.98 175.5 8.84 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.751 -179.073 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -99.64 154.33 18.36 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.81 -0.556 . . . . 0.0 111.443 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.56 3.11 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 66.78 -54.41 0.44 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.81 -175.1 2.7 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -99.67 9.57 42.88 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.181 0.515 . . . . 0.0 110.021 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -141.19 155.37 46.07 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.989 176.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 3' ' ' PRO . 1.4 m -124.85 154.15 32.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.686 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 8.3 m-85 -131.73 163.04 29.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.1 -172.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -159.09 -16.11 0.07 Allowed 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.829 176.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.424 ' HG ' HD21 ' A' ' 24' ' ' LEU . 2.8 tm? 62.64 112.12 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.333 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -87.3 114.57 24.03 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.738 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.478 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -126.14 -156.16 0.72 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 170' ' ' LYS . 35.0 mmtm . . . . . 0 C--N 1.31 -1.114 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 CA--C 1.514 -0.405 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.64 HG21 HD11 ' A' ' 8' ' ' ILE . 5.2 p -149.02 166.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 121.557 0.694 . . . . 0.0 111.906 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.554 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 81.0 mt -97.57 114.08 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.136 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.551 HG23 HG13 ' A' ' 175' ' ' VAL . 45.0 pt -118.89 174.85 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-O 120.978 0.418 . . . . 0.0 111.649 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 7' ' ' ARG . 2.1 t-20 44.66 -123.18 0.95 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.13 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -99.57 64.92 1.33 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.822 0.82 . . . . 0.0 108.928 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.701 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 7.8 m120 68.65 38.92 2.14 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 113.537 -1.665 . . . . 0.0 114.339 176.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.404 ' O ' HG12 ' A' ' 177' ' ' ILE . 99.1 mt -88.31 113.52 25.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 118' ' ' LEU . 2.5 m -83.68 158.2 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 C--N 1.29 -1.996 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.997 -176.8 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.501 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 30.9 m-85 . . . . . 0 N--CA 1.437 -1.082 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.504 ' HA ' HG12 ' A' ' 164' ' ' VAL . 14.9 Cg_endo -56.42 -27.46 68.17 Favored 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 123.418 2.746 . . . . 0.0 112.771 -177.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 125.21 -39.38 2.09 Favored Glycine 0 N--CA 1.417 -2.626 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.6 -11.14 60.6 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.697 0.76 . . . . 0.0 111.176 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 55.2 m -60.72 131.12 49.68 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.687 177.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.0 mmt180 -86.26 132.38 34.0 Favored 'General case' 0 C--O 1.185 -2.3 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.888 HD11 HG21 ' A' ' 175' ' ' VAL . 11.6 tt -119.64 130.57 73.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 CA-C-O 120.862 0.363 . . . . 0.0 110.111 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.434 HD13 ' N ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -88.46 125.35 34.7 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-O 121.452 0.644 . . . . 0.0 109.959 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.6 m -135.15 177.8 6.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.504 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -126.89 119.67 27.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.23 0.538 . . . . 0.0 109.875 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.61 HG12 HG13 ' A' ' 47' ' ' ILE . 12.5 mt -118.43 120.18 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.701 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.788 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 54.69 37.93 29.14 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.15 -1.387 . . . . 0.0 109.824 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 18.26 79.52 Favored Glycine 0 C--N 1.3 -1.47 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.609 -177.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.2 t -124.04 119.22 26.62 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 48.0 Cg_endo -73.31 122.05 7.67 Favored 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 122.534 2.156 . . . . 0.0 111.468 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -124.41 141.74 51.84 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.711 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -107.94 101.28 10.56 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.025 178.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.486 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -123.63 -175.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.681 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.752 ' HG1' ' HG2' ' A' ' 22' ' ' ARG . 9.6 p -90.28 173.54 8.08 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.727 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.617 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.2 mm? -69.24 -26.91 65.02 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.395 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.752 ' HG2' ' HG1' ' A' ' 20' ' ' THR . 10.7 ptm180 -84.8 -24.91 28.5 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.435 ' HB2' ' H ' ' A' ' 20' ' ' THR . 39.2 mt-10 -82.98 -39.4 21.39 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.977 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.512 HD23 HD13 ' A' ' 8' ' ' ILE . 16.2 tp -57.82 -42.18 83.76 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.089 0.947 . . . . 0.0 108.7 176.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.4 ' CD1' HG11 ' A' ' 67' ' ' VAL . 7.4 t80 -53.71 -31.23 47.29 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.216 -1.811 . . . . 0.0 112.594 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.9 mt-10 -76.0 -17.82 59.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -78.89 2.29 20.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.732 0.777 . . . . 0.0 109.429 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.476 ' C ' ' HD3' ' A' ' 40' ' ' ARG . 96.0 m-85 -117.91 162.24 18.46 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.602 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.7 -173.84 3.99 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.175 176.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 t70 63.47 81.36 0.21 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.248 0.547 . . . . 0.0 110.159 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -106.42 134.18 49.96 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 122.088 0.946 . . . . 0.0 111.465 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.451 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.2 ptt180 -122.54 154.44 37.9 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.557 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -105.57 124.94 50.38 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -160.89 137.66 8.77 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.476 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 61.7 23.12 13.5 Favored 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 123.579 0.55 . . . . 0.0 110.918 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.1 mtt 75.6 13.82 2.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.064 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.495 HG12 ' HD2' ' A' ' 71' ' ' PRO . 5.1 m -129.64 -179.71 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -115.55 140.46 49.14 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.127 0.489 . . . . 0.0 109.823 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.2 t -129.49 123.29 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.093 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.476 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 16.7 ttm180 -112.71 126.75 55.74 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -131.65 146.08 52.0 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.654 -174.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 27.5 tptp 80.68 113.08 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.438 0 O-C-N 124.531 1.145 . . . . 0.0 111.396 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.556 ' HB2' HD13 ' A' ' 47' ' ' ILE . 56.9 Cg_endo -78.02 155.94 30.15 Favored 'Trans proline' 0 N--CA 1.435 -1.918 0 C-N-CA 122.208 1.939 . . . . 0.0 111.974 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -86.97 -3.46 59.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.349 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -147.3 -164.8 2.09 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 6.0 tp10 -84.5 98.25 10.01 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.61 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -117.34 116.02 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.835 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -116.43 167.52 10.97 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.356 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 61' ' ' LEU . 13.2 p -116.05 121.53 67.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 121.714 0.769 . . . . 0.0 112.097 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.526 ' CE1' HG11 ' A' ' 59' ' ' VAL . 65.8 t80 -76.1 110.27 10.44 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.643 177.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -134.22 176.52 8.52 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.738 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.547 HG12 HD11 ' A' ' 176' ' ' ILE . 4.3 mm -121.18 144.17 31.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.267 0.556 . . . . 0.0 110.922 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.657 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 19.4 t70 -81.52 120.98 25.73 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.298 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.732 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -74.91 -12.24 60.31 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -170.488 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.657 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.7 pt-20 -104.33 -27.12 12.17 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.2 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.522 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 72.2 p -115.18 -24.95 8.26 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.578 -176.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.69 70.53 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.045 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.522 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 40.2 mttt -85.47 163.74 18.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.526 HG11 ' CE1' ' A' ' 50' ' ' TYR . 90.4 t -88.62 111.43 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.162 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.9 146.71 14.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.299 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.1 tp -120.12 138.59 53.48 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.437 HG21 ' HB3' ' A' ' 170' ' ' LYS . 10.2 t -150.54 171.35 17.22 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 120.753 0.311 . . . . 0.0 110.868 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.45 161.12 25.06 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.574 0.702 . . . . 0.0 111.169 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.542 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.2 mp -101.06 135.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.887 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.516 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 17.3 mt-10 -81.1 -39.62 25.37 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 p30 179.65 175.49 0.74 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.458 -175.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.48 ' HA ' HD22 ' A' ' 167' ' ' LEU . 6.0 t -105.8 131.71 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.867 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 57.6 mt -91.53 105.8 16.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.267 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.449 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.1 tttt -119.87 108.16 14.02 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.25 138.62 33.25 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.343 -175.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HD2' HG12 ' A' ' 37' ' ' VAL . 75.1 Cg_exo -48.54 134.09 26.51 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 123.274 2.649 . . . . 0.0 112.608 177.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.73 95.6 3.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.391 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.7 p -92.76 -54.33 3.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.322 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.71 -179.92 6.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.918 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -100.9 170.71 8.12 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 90' ' ' THR . 17.1 mt -115.23 131.35 56.96 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.504 0.669 . . . . 0.0 112.062 -175.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.575 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 19.5 mt -82.82 141.84 14.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.603 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 24.5 ttt-85 -117.11 136.93 52.63 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-O 121.17 0.509 . . . . 0.0 109.769 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.582 ' CD1' HD13 ' A' ' 151' ' ' ILE . 56.1 m-85 -116.01 127.53 54.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.7 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 152' ' ' LYS . 43.7 tt0 -111.97 128.27 56.12 Favored 'General case' 0 CA--C 1.472 -2.051 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.754 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -91.09 157.65 17.11 Favored 'General case' 0 C--N 1.269 -2.915 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.576 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.755 ' HG2' HD11 ' A' ' 149' ' ' LEU . 2.3 pt-20 -63.88 -14.5 53.87 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.569 0.7 . . . . 0.0 111.07 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -92.81 -9.45 40.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.264 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.14 14.59 54.14 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.217 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.554 ' O ' HD23 ' A' ' 81' ' ' LEU . 3.0 mtt180 -86.34 141.8 28.95 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 26.1 p -141.69 146.52 36.19 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.488 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -141.58 150.21 41.76 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.635 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 29.3 mt-10 -121.85 145.83 47.69 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.351 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.6 p -144.12 157.22 44.44 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.731 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.696 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -75.46 9.26 2.26 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -175.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.035 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.6 t 76.17 -42.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 O-C-N 123.503 0.502 . . . . 0.0 111.274 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.37 -20.53 65.6 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 123.764 0.826 . . . . 0.0 110.888 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.505 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -103.31 129.56 25.27 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.786 -176.416 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.611 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 25.3 Cg_exo -65.18 142.82 75.38 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.623 2.882 . . . . 0.0 114.486 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 17.4 t -105.34 146.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.169 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.452 ' CD1' ' HG3' ' A' ' 105' ' ' GLU . 32.4 tp -98.47 106.99 19.35 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.526 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.596 HG13 HG13 ' A' ' 104' ' ' ILE . 1.7 p -108.74 145.8 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 121.475 0.655 . . . . 0.0 111.55 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.548 ' CD2' HD12 ' A' ' 148' ' ' LEU . 86.3 t80 -104.0 91.74 4.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.209 178.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.523 ' CG ' HD11 ' A' ' 104' ' ' ILE . 9.1 pt-20 -138.87 155.94 47.7 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 32.4 m-80 65.98 22.61 11.24 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.355 0.597 . . . . 0.0 110.02 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.72 13.96 64.38 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.931 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -136.23 171.28 14.7 Favored 'General case' 0 N--CA 1.401 -2.925 0 CA-C-O 121.258 0.551 . . . . 0.0 110.24 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -101.92 121.28 41.82 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.084 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.596 HG13 HG13 ' A' ' 97' ' ' VAL . 16.1 pt -127.61 145.11 35.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.926 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 8.4 mp0 -106.46 115.13 29.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.079 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.618 ' HG3' HG22 ' A' ' 111' ' ' VAL . 12.7 ptpt -128.31 141.71 51.35 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.894 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.719 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 99.8 mtt180 -61.47 165.73 4.58 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 119.404 -0.331 . . . . 0.0 110.635 -176.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 1.035 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -62.67 -40.27 96.55 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.47 -173.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.525 ' HB3' HG13 ' A' ' 91' ' ' VAL . 5.8 p90 -72.71 -7.53 50.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.868 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -102.75 -17.01 15.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.716 0.769 . . . . 0.0 109.175 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.618 HG22 ' HG3' ' A' ' 106' ' ' LYS . 69.4 t -77.42 150.41 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.569 ' HE3' ' H ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -124.27 163.69 21.12 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.106 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.82 142.95 56.0 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.57 4.54 76.31 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.584 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.962 ' HB3' HD12 ' A' ' 151' ' ' ILE . 18.4 t70 -71.95 164.4 26.16 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.467 ' HE2' ' O ' ' A' ' 148' ' ' LEU . 24.2 mttt -122.55 154.67 37.6 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-O 121.568 0.699 . . . . 0.0 110.753 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.25 159.65 34.75 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.93 129.58 35.59 Favored 'General case' 0 N--CA 1.399 -3.014 0 C-N-CA 119.394 -0.923 . . . . 0.0 108.679 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -113.42 132.89 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.153 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.34 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.7 t . . . . . 0 C--N 1.308 -1.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.956 -179.088 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.548 HD12 ' CD2' ' A' ' 98' ' ' TYR . 12.4 mt . . . . . 0 N--CA 1.421 -1.898 0 CA-C-O 121.215 0.531 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.755 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -113.68 136.74 52.51 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.946 -173.312 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.434 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 28.4 mt-10 -90.22 147.2 23.7 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.126 176.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.962 HD12 ' HB3' ' A' ' 115' ' ' ASP . 81.3 mt -79.46 112.64 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.012 175.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.62 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 4.9 mmpt? -76.89 -39.81 49.63 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.642 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -148.26 131.55 16.52 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -175.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 86.7 mt -114.26 148.32 17.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.754 174.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -154.33 162.03 41.41 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.708 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.575 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 15.8 m-85 -101.72 116.9 33.75 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.39 133.16 64.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.371 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.436 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 60.3 ttt180 -68.85 161.24 29.02 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.167 0.508 . . . . 0.0 111.726 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.436 ' N ' ' HG2' ' A' ' 158' ' ' ARG . . . -70.4 120.08 15.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.77 -32.76 73.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.833 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -110.9 -173.9 2.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.484 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -100.51 0.03 38.76 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 120.858 0.361 . . . . 0.0 111.413 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -138.98 159.42 42.19 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 3' ' ' PRO . 6.3 m -132.39 161.41 41.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.921 177.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.635 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 76.2 m-85 -134.56 173.0 12.14 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.565 ' HB2' HD12 ' A' ' 68' ' ' ILE . 69.8 m -158.76 -24.68 0.08 Allowed 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.512 ' HG ' HD21 ' A' ' 24' ' ' LEU . 1.4 tm? 68.5 111.01 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.253 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -92.65 115.71 28.35 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.99 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.516 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.38 -146.57 0.33 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.437 ' HB3' HG21 ' A' ' 62' ' ' THR . 23.4 tptm . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.761 0.315 . . . . 0.0 110.309 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.407 ' OD1' HD11 ' A' ' 54' ' ' LEU . 10.0 t30 . . . . . 0 CA--C 1.507 -0.705 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.888 HG21 HD11 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -141.21 167.15 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.34 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.58 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.0 mt -105.7 117.53 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.73 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.518 HG23 HG13 ' A' ' 175' ' ' VAL . 44.7 pt -122.27 170.09 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.448 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 48.59 -132.94 1.48 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 124.036 0.934 . . . . 0.0 110.318 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.95 53.87 2.56 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.35 0.595 . . . . 0.0 110.233 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.754 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.7 m120 69.88 44.4 0.83 Allowed 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.887 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 91.7 mt -87.38 116.83 30.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.475 HG22 HG12 ' A' ' 176' ' ' ILE . 59.1 t -94.05 130.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.478 -175.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.522 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 15.1 t . . . . . 0 C--N 1.31 -1.132 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.532 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.683 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 84.6 m . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.068 0.461 . . . . 0.0 111.559 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -126.46 162.06 48.82 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.591 ' HD3' HD13 ' A' ' 76' ' ' LEU . 57.8 Cg_endo -67.21 161.77 41.47 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.561 1.507 . . . . 0.0 109.212 177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.521 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.56 -26.21 64.28 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 119.212 -1.471 . . . . 0.0 110.712 175.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -55.74 -26.17 44.26 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.468 0.707 . . . . 0.0 112.264 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.553 ' O ' ' HA ' ' A' ' 20' ' ' THR . 31.8 m -64.77 123.99 20.8 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.352 -176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.767 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 45.6 mtm-85 -81.42 128.23 33.64 Favored 'General case' 0 C--O 1.184 -2.364 0 C-N-CA 123.195 0.598 . . . . 0.0 109.878 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 19' ' ' ILE . 13.6 tt -112.48 130.34 66.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 122.193 -0.317 . . . . 0.0 110.332 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.574 HD21 HD21 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -85.13 123.77 31.03 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.52 0.676 . . . . 0.0 109.784 177.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 24.8 m -136.41 -179.42 2.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.62 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 33.0 tt0 -130.16 119.58 23.21 Favored 'General case' 0 CA--C 1.498 -1.052 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.63 HG12 HG13 ' A' ' 47' ' ' ILE . 11.8 mt -120.45 122.66 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.527 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.786 -178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 55.34 38.33 30.17 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.807 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.21 22.19 78.51 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.131 -0.94 . . . . 0.0 113.223 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.71 119.92 21.6 Favored Pre-proline 0 N--CA 1.437 -1.112 0 CA-C-O 121.11 0.481 . . . . 0.0 109.941 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.569 ' HG2' ' HB3' ' A' ' 124' ' ' LEU . 57.2 Cg_endo -72.8 126.14 11.1 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 C-N-CA 122.486 2.124 . . . . 0.0 111.52 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -129.48 140.59 51.23 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.457 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 26.6 ttpt -110.42 101.5 10.2 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.616 ' O ' HG22 ' A' ' 8' ' ' ILE . 10.9 pt -139.75 136.86 39.51 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.25 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.767 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 4.5 p -40.02 148.95 0.07 Allowed 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.015 175.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 51.1 mt -60.15 -25.06 65.22 Favored 'General case' 0 N--CA 1.412 -2.34 0 CA-C-N 114.559 -1.201 . . . . 0.0 111.874 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.733 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 7.4 ptm180 -78.08 -28.03 48.69 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.529 ' HA ' ' OE2' ' A' ' 26' ' ' GLU . 60.8 mt-10 -85.29 -48.67 8.85 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.278 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.534 HD11 ' HG ' ' A' ' 167' ' ' LEU . 0.5 OUTLIER -50.94 -51.37 52.94 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.561 0.696 . . . . 0.0 109.887 175.066 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.43 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -45.42 -34.17 2.97 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.322 -1.308 . . . . 0.0 113.598 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.529 ' OE2' ' HA ' ' A' ' 23' ' ' GLU . 30.3 mt-10 -69.68 -18.47 63.56 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -77.71 1.86 18.65 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.568 0.699 . . . . 0.0 109.836 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 99.2 m-85 -118.96 160.86 21.2 Favored 'General case' 0 N--CA 1.409 -2.506 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.765 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -143.95 -172.15 3.69 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.942 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.483 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.4 t70 63.36 82.36 0.18 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.574 0.702 . . . . 0.0 110.329 -177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -99.22 129.36 45.45 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.388 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.53 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.4 ptt180 -118.28 152.8 35.05 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.172 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 37' ' ' VAL . 3.4 t80 -104.6 123.88 48.35 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.494 ' HG2' ' ND2' ' A' ' 35' ' ' ASN . 36.9 tt0 -167.0 146.73 5.43 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.302 -174.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.494 ' ND2' ' HG2' ' A' ' 34' ' ' GLU . 0.9 OUTLIER 62.5 18.61 10.56 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 123.421 0.451 . . . . 0.0 110.547 177.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.6 mtt 71.12 15.93 6.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.013 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 27.1 m -130.47 -173.34 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -118.83 140.26 50.25 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.219 0.533 . . . . 0.0 109.968 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.53 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.3 t -127.72 123.67 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.456 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.008 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.449 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 13.2 ttm180 -111.22 126.96 55.42 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.51 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.38 147.3 52.38 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.386 -175.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 8.2 tmtm? 84.24 109.87 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.484 0 O-C-N 124.426 1.079 . . . . 0.0 110.637 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HB2' HD13 ' A' ' 47' ' ' ILE . 72.0 Cg_endo -78.57 149.43 23.93 Favored 'Trans proline' 0 N--CA 1.435 -1.917 0 C-N-CA 122.252 1.968 . . . . 0.0 111.25 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.508 ' HE2' ' O ' ' A' ' 26' ' ' GLU . 1.5 mtmt -85.66 -2.75 58.5 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.204 0.526 . . . . 0.0 111.118 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -144.32 -165.82 2.22 Favored 'General case' 0 CA--C 1.485 -1.554 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.0 tp10 -87.18 103.39 15.37 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 175.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.63 HG13 HG12 ' A' ' 12' ' ' ILE . 1.4 mp -119.09 121.42 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.889 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 37.7 mmtt -118.43 169.51 9.7 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.077 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.505 HG11 ' CB ' ' A' ' 169' ' ' ALA . 14.6 p -128.17 133.92 66.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.326 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.55 ' CD1' HD12 ' A' ' 9' ' ' LEU . 31.5 m-85 -83.71 123.15 29.54 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.915 176.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.9 t -127.66 174.61 8.94 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.612 HG12 HD11 ' A' ' 176' ' ' ILE . 1.2 mm -125.27 141.94 43.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-O 121.583 0.706 . . . . 0.0 111.501 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.679 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 32.8 t70 -90.87 115.25 27.77 Favored 'General case' 0 C--O 1.194 -1.842 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.691 ' H ' HD12 ' A' ' 54' ' ' LEU . 4.8 mp -67.16 -33.56 75.67 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 121.848 0.832 . . . . 0.0 111.665 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.679 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -73.72 -30.92 63.11 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.773 -174.05 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.7 p -113.22 -22.01 10.69 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.837 -0.745 . . . . 0.0 111.179 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.18 18.07 70.26 Favored Glycine 0 N--CA 1.431 -1.633 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.492 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.504 ' C ' HD13 ' A' ' 52' ' ' ILE . 26.2 mttp -98.12 157.46 16.13 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.82 112.01 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.255 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.2 m -110.74 165.46 6.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.651 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.9 tp -120.69 140.28 51.84 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.1 t -143.49 171.59 13.94 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.013 0.435 . . . . 0.0 111.22 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -85.69 160.93 19.43 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.262 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.559 ' N ' HD12 ' A' ' 64' ' ' ILE . 3.0 mp -97.47 143.05 13.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.141 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.444 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 79.2 mm-40 -91.13 -38.76 12.54 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 176.93 175.48 0.37 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.788 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 17.3 t -105.69 130.2 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.049 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 61.2 mt -89.89 106.6 17.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.689 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.44 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 88.0 tttt -121.37 110.42 16.07 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.798 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 163' ' ' PHE . . . -130.48 139.01 34.33 Favored Pre-proline 0 C--N 1.306 -1.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.762 -177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.432 ' HD2' HG12 ' A' ' 37' ' ' VAL . 7.4 Cg_endo -53.14 124.42 15.56 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.877 2.385 . . . . 0.0 112.108 177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.56 96.69 0.18 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.686 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.5 m -105.18 -58.25 1.92 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.994 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -79.66 175.42 10.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.147 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -101.22 171.46 7.59 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' A' ' 90' ' ' THR . 10.6 mt -126.72 141.92 51.7 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.718 0.771 . . . . 0.0 111.775 -173.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 88' ' ' GLU . 13.9 mt -84.4 143.88 10.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 173.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 10.7 ttt85 -116.57 138.02 51.73 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-O 121.213 0.53 . . . . 0.0 109.814 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.614 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.7 m-85 -116.12 122.47 45.2 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.546 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 152' ' ' LYS . 36.0 tt0 -109.77 124.49 51.36 Favored 'General case' 0 CA--C 1.47 -2.104 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.734 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -88.24 160.78 17.54 Favored 'General case' 0 C--N 1.271 -2.818 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.813 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.806 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.7 pt-20 -60.72 -19.28 58.5 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.592 0.711 . . . . 0.0 110.529 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -91.48 -12.14 35.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.93 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.07 14.38 49.04 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.994 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.572 ' O ' HD23 ' A' ' 81' ' ' LEU . 4.2 mtt180 -84.29 138.25 33.02 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 27.0 p -141.63 137.84 32.12 Favored 'General case' 0 C--N 1.287 -2.122 0 C-N-CA 118.969 -1.092 . . . . 0.0 112.845 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.456 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 5.0 p90 -136.0 154.64 51.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.507 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 25.2 mt-10 -125.32 151.84 45.49 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.549 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -143.42 157.93 44.06 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.399 178.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.677 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -69.8 15.27 0.08 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -178.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.005 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.6 -36.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 125.448 1.499 . . . . 0.0 112.213 178.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.547 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 26.7 t70 -78.41 -18.07 55.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.333 0.587 . . . . 0.0 109.639 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -77.83 125.75 85.14 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.298 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.502 ' CG ' ' HA ' ' A' ' 185' ' ' GLN . 37.7 Cg_endo -66.12 142.55 68.1 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 123.133 2.556 . . . . 0.0 112.622 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 20.7 t -111.97 145.47 18.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.6 tp -101.72 108.9 20.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.837 0.351 . . . . 0.0 110.793 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.605 HG13 HG13 ' A' ' 104' ' ' ILE . 2.2 p -112.22 150.09 14.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.367 0.603 . . . . 0.0 111.067 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.456 ' CD2' HD12 ' A' ' 148' ' ' LEU . 58.9 t80 -105.62 93.62 4.75 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.18 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 6.9 pt-20 -139.44 158.81 43.5 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 86.6 m-20 64.57 22.14 12.59 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.212 0.53 . . . . 0.0 110.154 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.25 14.72 64.48 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.031 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -137.21 171.65 14.17 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 117.365 0.583 . . . . 0.0 110.042 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -100.83 122.75 43.96 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.605 HG13 HG13 ' A' ' 97' ' ' VAL . 24.6 pt -121.04 146.98 25.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.836 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 mp0 -104.17 112.09 24.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.278 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 11.5 ptpt -124.2 139.44 53.92 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.576 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.64 ' O ' HG23 ' A' ' 111' ' ' VAL . 14.3 mmt180 -60.55 158.84 11.52 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.005 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -60.38 -40.79 92.13 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.325 -0.95 . . . . 0.0 109.864 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.418 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.7 p90 -73.47 -1.13 17.17 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.868 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -111.13 -13.79 13.97 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.693 0.759 . . . . 0.0 109.772 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 107' ' ' ARG . 93.6 t -79.2 149.0 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.698 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 21.6 mtmt -123.36 165.81 16.38 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.966 -0.293 . . . . 0.0 111.192 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.81 139.68 55.26 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.91 4.5 72.2 Favored Glycine 0 C--N 1.307 -1.032 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.874 -174.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.698 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -75.33 167.93 20.96 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.46 ' HG2' ' HG3' ' A' ' 150' ' ' GLU . 25.2 mttp -119.61 165.1 14.89 Favored 'General case' 0 CA--C 1.488 -1.42 0 CA-C-O 121.404 0.621 . . . . 0.0 110.511 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.456 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -133.55 159.93 42.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 182' ' ' VAL . 0.9 OUTLIER -88.64 131.79 34.83 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -119.21 132.58 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.193 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.453 ' HB3' HD22 ' A' ' 180' ' ' ASN . 48.4 t -64.34 -19.37 65.41 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.626 0.727 . . . . 0.0 109.926 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.703 ' HB3' ' HB3' ' A' ' 145' ' ' HIS . 10.1 mm-40 46.13 13.57 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.703 -1.589 . . . . 0.0 114.151 -176.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 7.7 tt -100.4 109.93 22.11 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.055 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -92.18 177.59 6.11 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.24 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.574 HD21 HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -108.24 13.83 25.44 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.316 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.0 t 70.81 -66.37 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 113.677 -1.601 . . . . 0.0 111.46 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.07 98.29 0.76 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.956 0.408 . . . . 0.0 110.958 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -105.2 25.04 11.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.925 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.4 m -57.22 144.32 35.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.164 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.9 m -71.47 134.52 46.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.827 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.9 t 70.09 173.91 0.3 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.895 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.7 p -92.21 67.9 5.03 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.33 0.586 . . . . 0.0 110.87 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -84.45 -45.1 13.03 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.061 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -106.34 173.29 6.38 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.467 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.514 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . 27.3 t-20 -170.24 -59.18 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 134' ' ' ASN . 77.3 Cg_endo -75.06 62.62 5.95 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.615 2.21 . . . . 0.0 112.589 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -143.83 116.02 8.44 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 121.363 0.601 . . . . 0.0 110.318 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -134.39 27.51 3.75 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 122.556 1.17 . . . . 0.0 108.054 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -85.65 -155.05 0.22 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.049 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 60.54 38.36 18.98 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.757 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.6 tp 72.68 -65.46 0.35 Allowed 'General case' 0 C--N 1.343 0.286 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.126 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.94 30.21 8.08 Favored Glycine 0 C--N 1.302 -1.319 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.174 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -127.91 116.34 20.64 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-O 120.765 0.317 . . . . 0.0 110.572 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -95.76 -163.38 0.09 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.929 2.42 . . . . 0.0 111.675 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -178.8 118.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.158 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.703 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -169.68 128.38 0.95 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.181 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -137.45 87.25 2.25 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.495 ' O ' HD23 ' A' ' 148' ' ' LEU . 9.1 pt20 -163.57 141.06 7.4 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.827 -178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 147' ' ' GLN . 14.4 mt -111.81 154.69 24.72 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-O 121.199 0.523 . . . . 0.0 110.211 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.806 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -113.21 137.86 50.84 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.027 -172.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.46 ' HG3' ' HG2' ' A' ' 116' ' ' LYS . 15.1 mt-10 -92.19 146.68 23.52 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 122.3 1.047 . . . . 0.0 112.7 175.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.44 HD13 ' CD1' ' A' ' 79' ' ' PHE . 75.2 mt -78.73 111.99 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.534 0 CA-C-N 113.38 -1.736 . . . . 0.0 110.546 177.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.558 ' HE2' ' HB2' ' A' ' 82' ' ' GLU . 48.9 mmtt -71.63 -40.36 69.8 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.54 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -149.51 133.55 17.15 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -175.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 76.2 mt -116.92 144.64 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 CA-C-N 113.824 -1.535 . . . . 0.0 110.609 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.479 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 19.0 ptpt -152.78 164.09 38.46 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.155 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.478 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 15.3 m-85 -101.59 116.55 33.0 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.417 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.16 173.9 11.07 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.958 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -106.24 152.83 22.99 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 120.928 0.394 . . . . 0.0 111.486 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.28 128.38 36.47 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.224 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -65.85 -47.36 75.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.101 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.08 170.95 9.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.822 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -90.29 0.74 57.1 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 121.582 0.706 . . . . 0.0 109.933 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 96.2 m-85 -141.03 148.29 40.02 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.256 176.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 3' ' ' PRO . 4.0 m -118.03 155.49 19.91 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.699 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 74.3 m-85 -133.43 173.58 11.33 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 120.68 0.276 . . . . 0.0 110.926 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.698 ' HB2' HD12 ' A' ' 68' ' ' ILE . 67.0 m -158.38 -23.37 0.08 Allowed 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.534 ' HG ' HD11 ' A' ' 24' ' ' LEU . 1.9 tm? 67.17 107.03 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.592 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -88.63 116.48 26.91 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.513 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.505 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -132.27 -167.25 1.86 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.995 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -62.89 144.91 56.24 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.498 -0.186 . . . . 0.0 110.498 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm 84.55 -25.81 0.12 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.225 1.01 . . . . 0.0 110.308 -177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 65.52 140.95 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.382 1.073 . . . . 0.0 113.175 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.669 ' O ' ' HA ' ' A' ' 184' ' ' HIS . 16.2 m170 42.36 53.67 4.48 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.67 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -150.34 106.27 3.43 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.644 HG13 HG23 ' A' ' 177' ' ' ILE . 2.8 p -148.78 162.67 5.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.44 0.638 . . . . 0.0 111.225 -176.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.612 HD11 HG12 ' A' ' 52' ' ' ILE . 90.6 mt -108.34 116.91 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.207 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.605 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.644 HG23 HG13 ' A' ' 175' ' ' VAL . 37.7 pt -125.24 172.91 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.678 -175.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 7' ' ' ARG . 8.2 t-20 47.9 -130.65 1.61 Allowed 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 124.055 0.942 . . . . 0.0 109.732 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -88.28 55.37 3.4 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.742 0.782 . . . . 0.0 109.487 176.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.6 m-20 67.38 47.76 1.23 Allowed 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.856 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 81.4 mt -87.94 118.18 33.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 118' ' ' LEU . 48.7 t -90.51 135.7 25.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.189 -175.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 3.5 t -145.33 148.01 32.94 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.102 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.669 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 79.9 t60 -155.89 149.54 25.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.774 0.321 . . . . 0.0 110.2 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.502 ' HA ' ' CG ' ' A' ' 94' ' ' PRO . 52.6 tt0 . . . . . 0 C--O 1.261 1.7 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.015 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 89' ' ' THR . 57.1 m . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.958 0.408 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.451 ' CE1' HD13 ' A' ' 177' ' ' ILE . 62.4 m-85 -129.76 150.21 75.16 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.541 ' HD3' HD13 ' A' ' 76' ' ' LEU . 18.7 Cg_endo -58.51 -29.69 89.51 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.886 2.391 . . . . 0.0 112.569 -175.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 124.28 -37.48 2.64 Favored Glycine 0 N--CA 1.424 -2.164 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -177.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -70.06 -4.62 21.95 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.449 0.642 . . . . 0.0 111.523 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.6 m -67.95 127.73 33.91 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.963 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.579 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 33.5 mmt180 -80.02 131.44 35.79 Favored 'General case' 0 C--O 1.181 -2.53 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 19' ' ' ILE . 8.1 tt -119.22 130.93 73.26 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.649 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.697 HD21 ' CD1' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -87.0 123.44 32.1 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 121.602 0.715 . . . . 0.0 110.187 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 31.5 m -135.59 -178.9 2.72 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.489 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 34.0 tt0 -129.23 121.42 27.58 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.581 HG12 HG13 ' A' ' 47' ' ' ILE . 21.2 mt -119.32 121.47 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.864 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.54 -178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 54.58 38.49 29.96 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.97 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.35 18.45 79.86 Favored Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 114.96 -1.018 . . . . 0.0 114.061 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.2 t -124.28 121.84 26.06 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 59.7 Cg_endo -74.1 121.43 6.9 Favored 'Trans proline' 0 N--CA 1.438 -1.746 0 C-N-CA 122.383 2.055 . . . . 0.0 111.05 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -125.41 141.71 51.91 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.702 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 38.8 ttpt -109.93 100.82 9.72 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 2.9 pt -121.98 -173.71 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.183 -2.447 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.721 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 21.1 p -92.25 172.29 8.51 Favored 'General case' 0 C--N 1.287 -2.137 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.282 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 15.0 mt -72.98 -22.25 60.72 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.77 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.721 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.2 ptm180 -85.28 -24.63 27.64 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.529 ' OE1' HG23 ' A' ' 20' ' ' THR . 71.1 mt-10 -83.71 -42.67 16.35 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.917 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.467 HD21 ' HG ' ' A' ' 167' ' ' LEU . 16.9 tp -55.98 -43.91 78.03 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.996 0.903 . . . . 0.0 108.917 177.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.621 ' HD1' HG11 ' A' ' 67' ' ' VAL . 11.8 t80 -51.41 -33.95 32.62 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.463 -1.699 . . . . 0.0 112.613 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 27.3 mt-10 -73.65 -17.07 61.19 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.69 2.71 21.64 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.393 0.616 . . . . 0.0 109.791 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.526 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.6 m-85 -117.08 161.61 19.14 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.364 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -139.06 -173.45 3.58 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.231 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.557 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER 60.6 86.07 0.1 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.35 0.595 . . . . 0.0 110.919 177.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -107.23 131.19 54.46 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 122.115 0.959 . . . . 0.0 112.368 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.483 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 15.3 ptt-85 -116.32 153.58 31.72 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.731 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -101.01 130.77 47.05 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -166.55 143.22 4.84 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.405 -174.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 60.66 21.11 11.04 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 123.715 0.634 . . . . 0.0 110.928 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 36.7 mtm 71.59 20.06 4.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.417 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.457 HG12 ' HD2' ' A' ' 71' ' ' PRO . 5.1 m -134.9 -174.72 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -115.03 138.75 50.5 Favored 'General case' 0 CA--C 1.478 -1.815 0 CA-C-O 121.124 0.488 . . . . 0.0 110.534 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.483 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.2 t -128.52 124.83 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.33 -178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.444 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 18.5 ttm180 -114.04 127.45 55.94 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.557 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -130.66 144.41 51.41 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -173.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 43.5 tptt 82.16 111.77 0.03 OUTLIER Pre-proline 0 CA--C 1.518 -0.273 0 O-C-N 124.361 1.038 . . . . 0.0 111.232 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.605 ' HB2' HD13 ' A' ' 47' ' ' ILE . 62.0 Cg_endo -78.14 153.9 28.64 Favored 'Trans proline' 0 N--CA 1.442 -1.547 0 C-N-CA 122.405 2.07 . . . . 0.0 112.282 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -85.81 -1.91 57.71 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.162 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -147.58 -165.9 2.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 32.7 tt0 -86.43 101.51 13.21 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.605 HD13 ' HB2' ' A' ' 43' ' ' PRO . 1.5 mp -116.33 116.01 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.194 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.48 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 26.1 mmtp -117.55 164.8 14.37 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.648 175.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.9 p -119.42 132.1 70.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.536 -176.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.404 ' CD2' HD12 ' A' ' 9' ' ' LEU . 11.2 m-85 -84.62 118.59 24.46 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.17 0.509 . . . . 0.0 110.04 176.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.4 p -124.43 176.97 6.15 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.938 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.536 HG12 HD11 ' A' ' 176' ' ' ILE . 1.2 mm -130.3 138.2 54.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-O 121.588 0.709 . . . . 0.0 110.813 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.423 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 25.2 t70 -84.61 120.02 25.89 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.748 -1.115 . . . . 0.0 108.128 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.404 HD21 ' ND2' ' A' ' 174' ' ' ASN . 11.3 mt -67.33 -29.91 69.6 Favored 'General case' 0 CA--C 1.475 -1.933 0 CA-C-O 122.036 0.922 . . . . 0.0 112.048 -173.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.423 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -81.81 -30.24 32.31 Favored 'General case' 0 C--N 1.263 -3.188 0 CA-C-N 113.845 -1.525 . . . . 0.0 111.523 -171.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.7 p -114.54 -25.28 8.41 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.264 -175.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.71 14.04 74.03 Favored Glycine 0 N--CA 1.427 -1.904 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.162 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.517 ' C ' HD13 ' A' ' 52' ' ' ILE . 41.5 mtpt -89.83 152.55 21.22 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -177.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -91.42 108.48 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.923 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.3 m -110.21 163.27 7.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.096 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.94 141.95 49.18 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.519 HG21 ' HB3' ' A' ' 170' ' ' LYS . 13.5 t -149.89 171.27 17.05 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.131 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.13 160.6 21.83 Favored 'General case' 0 CA--C 1.503 -0.827 0 CA-C-O 121.617 0.722 . . . . 0.0 111.197 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.2 mp -96.0 145.52 8.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.174 -178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.428 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 16.0 mm-40 -91.01 -37.97 13.12 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 p30 174.18 175.33 0.16 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.803 -176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.621 HG11 ' HD1' ' A' ' 25' ' ' TYR . 4.1 t -107.12 138.19 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.171 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.629 HD12 ' HB2' ' A' ' 166' ' ' SER . 35.7 mt -101.44 109.74 26.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.045 -177.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.402 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 8.2 ttpm? -120.88 112.4 18.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.87 137.37 30.63 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.295 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.457 ' HD2' HG12 ' A' ' 37' ' ' VAL . 71.2 Cg_exo -48.17 131.7 22.39 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.454 2.769 . . . . 0.0 113.275 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.11 93.18 9.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.227 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 p -89.7 -24.9 21.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.04 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -110.97 -169.99 1.56 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.801 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.575 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 28.0 m170 -115.28 171.21 7.84 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.728 HD23 ' HA ' ' A' ' 90' ' ' THR . 5.9 mt -121.32 148.27 44.56 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.966 0.888 . . . . 0.0 112.762 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.485 HD12 ' C ' ' A' ' 108' ' ' ALA . 27.7 mt -85.55 143.57 11.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.576 172.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 12.5 ttt85 -116.5 137.99 51.74 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-O 121.126 0.489 . . . . 0.0 110.157 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 86' ' ' SER . 58.5 m-85 -114.36 122.32 46.31 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.622 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 152' ' ' LYS . 23.1 tt0 -112.51 123.02 49.36 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.75 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.3 mm? -86.2 160.39 19.21 Favored 'General case' 0 N--CA 1.403 -2.775 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.218 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.743 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.4 pt-20 -64.74 -13.27 54.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.848 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -97.54 -8.52 28.92 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.538 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.56 10.58 57.88 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.274 -0.875 . . . . 0.0 113.082 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.587 ' O ' HD23 ' A' ' 81' ' ' LEU . 4.7 mtt180 -81.59 136.85 35.56 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 48.4 p -140.6 143.12 35.08 Favored 'General case' 0 C--N 1.283 -2.285 0 C-N-CA 118.883 -1.127 . . . . 0.0 112.685 177.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.437 ' CD1' HD13 ' A' ' 181' ' ' ILE . 7.7 p90 -138.17 145.61 41.73 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.573 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 49.0 mt-10 -117.19 146.29 43.32 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.352 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 5.3 p -142.78 153.86 43.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.733 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.728 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.88 10.28 0.93 Allowed 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.06 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.9 m 63.66 161.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 123.475 0.71 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.422 ' HA ' ' HB3' ' A' ' 107' ' ' ARG . 33.9 t70 73.28 -30.61 0.21 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.124 0.488 . . . . 0.0 110.918 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 185' ' ' GLN . 97.6 m-70 -68.28 132.87 91.47 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.249 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.75 115.76 4.37 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.361 2.707 . . . . 0.0 114.901 -176.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 18.3 t -94.74 149.19 4.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 103' ' ' PHE . 1.1 tm? -103.08 118.58 37.11 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.0 0.428 . . . . 0.0 111.937 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.704 HG13 HG13 ' A' ' 104' ' ' ILE . 2.3 p -118.45 147.87 21.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.93 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.523 ' CD2' HD12 ' A' ' 148' ' ' LEU . 88.4 t80 -103.86 98.62 8.44 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.775 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 10.3 pt-20 -147.64 158.56 44.06 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.3 m-20 65.04 22.6 12.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.239 0.542 . . . . 0.0 109.866 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.66 12.14 55.69 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.66 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -132.13 172.84 11.89 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.552 0.691 . . . . 0.0 109.791 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.562 ' HB3' HD11 ' A' ' 96' ' ' LEU . 20.3 m-85 -103.1 121.2 42.12 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.464 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.704 HG13 HG13 ' A' ' 97' ' ' VAL . 24.4 pt -122.05 148.77 25.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.522 179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 26.9 mt-10 -104.94 118.43 36.51 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.81 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.471 ' HB2' HG22 ' A' ' 111' ' ' VAL . 90.1 mttt -119.93 132.6 55.57 Favored 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 176.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.581 ' O ' HG23 ' A' ' 111' ' ' VAL . 65.3 mtt180 -60.03 158.3 11.27 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.06 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -56.59 -45.66 81.25 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 118.624 -1.23 . . . . 0.0 109.87 -178.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -75.32 9.98 1.83 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.411 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -119.35 -20.57 7.83 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.201 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 107' ' ' ARG . 92.5 t -73.55 146.58 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.71 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 70.6 mmtt -119.75 170.77 8.92 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.719 -177.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.58 141.77 53.7 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.646 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.95 4.43 84.61 Favored Glycine 0 N--CA 1.425 -2.046 0 C-N-CA 119.954 -1.117 . . . . 0.0 111.829 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.71 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -76.26 165.43 24.88 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.434 ' HE3' ' HG3' ' A' ' 150' ' ' GLU . 31.3 mttp -117.91 164.82 14.48 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.54 0.686 . . . . 0.0 110.819 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.0 159.75 42.9 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.76 133.66 34.17 Favored 'General case' 0 N--CA 1.398 -3.055 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.3 OUTLIER -116.61 138.13 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.024 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 180' ' ' ASN . 4.8 p -72.39 -14.1 61.63 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-O 121.44 0.638 . . . . 0.0 110.412 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 145' ' ' HIS . 24.7 mm-40 45.79 12.2 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.611 -1.631 . . . . 0.0 115.072 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 36.0 tp -83.95 137.98 33.37 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.269 0.557 . . . . 0.0 111.905 -178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -99.16 146.89 25.67 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.719 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.697 ' CD1' HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -149.0 -48.31 0.15 Allowed 'General case' 0 CA--C 1.498 -1.053 0 CA-C-O 121.474 0.654 . . . . 0.0 110.248 -177.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.484 HG12 HD12 ' A' ' 124' ' ' LEU . 2.3 p -149.78 157.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.621 -177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 82.94 129.18 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.412 1.085 . . . . 0.0 111.276 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -142.08 -53.17 0.42 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.803 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 24.4 p -92.85 -160.09 0.72 Allowed 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.2 m -61.17 -29.24 69.68 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.9 m 61.93 -172.66 0.15 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.332 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 88.8 p -148.57 -168.55 3.12 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.892 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -88.64 5.93 40.72 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.867 0.365 . . . . 0.0 110.473 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -66.51 133.32 50.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.22 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -92.28 -52.74 0.27 Allowed Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.71 159.39 38.83 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.966 2.444 . . . . 0.0 112.847 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.509 ' NZ ' ' HB2' ' A' ' 136' ' ' LYS . 8.2 mtmp? 71.19 50.27 0.3 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.388 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -62.74 125.46 24.03 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.557 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -99.63 145.28 27.76 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.182 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -156.84 150.78 24.82 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 58.8 tp -56.43 -53.91 51.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.16 0.505 . . . . 0.0 110.57 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 144.08 -41.24 1.13 Allowed Glycine 0 C--N 1.302 -1.313 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 5.6 p -137.28 118.28 10.8 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 115.316 -0.442 . . . . 0.0 109.842 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 142' ' ' SER . 8.1 Cg_exo -71.89 155.28 58.04 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.003 1.802 . . . . 0.0 111.586 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -162.73 90.16 0.69 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.906 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 16.7 m80 -154.8 118.29 4.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.254 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -138.47 96.53 3.18 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.544 ' O ' HD23 ' A' ' 148' ' ' LEU . 26.3 pt20 -164.3 147.85 9.43 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.162 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 147' ' ' GLN . 13.8 mt -111.17 146.73 36.36 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-O 121.404 0.621 . . . . 0.0 110.128 173.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.75 ' HB3' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -111.08 137.06 49.2 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.913 -1.039 . . . . 0.0 113.516 -171.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.434 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 23.3 mt-10 -91.18 146.34 23.92 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.91 176.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.429 HG21 ' CG1' ' A' ' 154' ' ' ILE . 66.6 mt -81.02 107.79 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.921 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.545 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 27.7 mmtt -64.68 -42.84 95.07 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.368 175.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -148.29 132.5 17.4 Favored 'General case' 0 CA--C 1.473 -1.995 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -173.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 84.2 mt -117.24 125.1 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.077 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.01 172.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.42 ' CD ' ' HD3' ' A' ' 78' ' ' ARG . 19.5 ptpt -128.89 163.86 24.35 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.006 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.467 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 12.5 m-85 -101.0 110.96 23.05 Favored 'General case' 0 N--CA 1.402 -2.85 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 173.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.575 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -116.02 176.38 2.45 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.901 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.768 -178.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.531 ' HA ' ' HB3' ' A' ' 75' ' ' HIS . 31.5 mtm180 -82.66 -142.83 0.06 Allowed 'General case' 0 C--N 1.285 -2.201 0 CA-C-O 121.787 0.803 . . . . 0.0 112.192 -177.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.43 ' H ' ' HB3' ' A' ' 158' ' ' ARG . . . -133.24 128.01 34.96 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -83.82 21.3 1.3 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -173.2 -178.4 1.74 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 -179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -104.78 8.42 34.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.374 0.607 . . . . 0.0 109.734 178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -143.24 155.87 44.61 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.412 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.498 HG12 ' HA ' ' A' ' 3' ' ' PRO . 7.0 m -129.82 160.92 40.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.432 176.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 67.9 m-85 -132.55 170.46 15.14 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.471 -176.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.629 ' HB2' HD12 ' A' ' 68' ' ' ILE . 1.4 m -155.76 -28.2 0.1 Allowed 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' A' ' 67' ' ' VAL . 1.3 tm? 71.32 107.04 0.06 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.742 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -86.27 115.09 23.59 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.64 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.456 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -135.29 -166.16 1.8 Allowed 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.519 ' HB3' HG21 ' A' ' 62' ' ' THR . 23.9 tptm -63.19 142.4 58.4 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 170' ' ' LYS . 17.5 tppt? 77.93 -13.54 0.94 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.578 0.751 . . . . 0.0 110.47 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.405 ' H ' ' C ' ' A' ' 170' ' ' LYS . 33.5 p90 51.19 128.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.095 1.758 . . . . 0.0 115.532 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.527 ' HB3' ' HA ' ' A' ' 185' ' ' GLN . 43.9 m170 64.29 5.11 2.39 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.542 -1.208 . . . . 0.0 113.192 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.404 ' ND2' HD21 ' A' ' 54' ' ' LEU . 27.0 t-20 -98.03 99.79 11.08 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.443 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.569 HG23 HG23 ' A' ' 177' ' ' ILE . 29.8 m -139.49 178.59 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.808 0 CA-C-O 122.47 1.128 . . . . 0.0 112.501 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.536 HD11 HG12 ' A' ' 52' ' ' ILE . 87.6 mt -117.59 114.27 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 CA-C-N 112.532 -2.122 . . . . 0.0 108.48 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.569 HG23 HG23 ' A' ' 175' ' ' VAL . 35.9 pt -120.76 168.04 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.746 0 CA-C-O 120.963 0.411 . . . . 0.0 112.076 -174.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.457 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 2.1 t-20 48.69 -133.23 1.46 Allowed 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.966 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.415 ' H ' ' CG ' ' A' ' 178' ' ' ASN . 0.8 OUTLIER -80.81 56.27 2.65 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-O 121.314 0.578 . . . . 0.0 109.932 174.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.669 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 12.8 m120 66.89 42.39 2.52 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.892 1.277 . . . . 0.0 114.256 175.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.437 HD13 ' CD1' ' A' ' 87' ' ' PHE . 92.8 mt -86.85 119.08 34.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 70.0 t -92.47 129.28 43.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.814 -176.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.8 t -150.52 164.07 36.87 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.844 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -112.07 50.12 0.87 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.109 0.481 . . . . 0.0 110.971 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.527 ' HA ' ' HB3' ' A' ' 173' ' ' HIS . 3.7 pp0? . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.58 -1.2 . . . . 0.0 111.569 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.407 ' HB2' ' CG ' ' A' ' 93' ' ' HIS . 25.2 p . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.503 0.668 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -136.9 152.27 73.8 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.427 ' HD3' HD13 ' A' ' 76' ' ' LEU . 53.5 Cg_endo -65.81 158.16 55.22 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 N-CA-C 108.639 -1.331 . . . . 0.0 108.639 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' A' ' 165' ' ' PHE . . . -59.31 -22.83 56.86 Favored Glycine 0 N--CA 1.434 -1.453 0 C-N-CA 119.077 -1.535 . . . . 0.0 111.887 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -71.31 -1.75 13.91 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.561 ' HB ' HD12 ' A' ' 21' ' ' LEU . 94.9 m -71.82 128.57 36.19 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.639 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 13.9 mtm-85 -85.58 131.0 34.44 Favored 'General case' 0 C--O 1.18 -2.576 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.414 ' CD1' HG21 ' A' ' 175' ' ' VAL . 8.4 tt -120.22 131.14 73.33 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' A' ' 18' ' ' LYS . 2.0 tm? -89.46 123.23 33.39 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-O 121.491 0.662 . . . . 0.0 110.077 179.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.0 m -133.14 -174.79 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.29 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 31.5 tt0 -133.19 123.69 26.07 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 177.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.629 HG12 HG13 ' A' ' 47' ' ' ILE . 23.1 mt -121.23 121.69 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.748 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.811 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 52.95 39.09 28.69 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.458 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.74 17.27 80.05 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.749 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.94 115.39 22.13 Favored Pre-proline 0 N--CA 1.438 -1.064 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 13.1 Cg_exo -64.4 124.02 12.69 Favored 'Trans proline' 0 N--CA 1.441 -1.575 0 C-N-CA 122.277 1.985 . . . . 0.0 111.262 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 78.3 mm-40 -122.37 134.97 54.62 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.456 ' HB2' HD23 ' A' ' 9' ' ' LEU . 40.2 ttmt -106.59 101.25 10.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.1 pt -123.54 -173.58 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.744 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.791 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 20.4 p -97.11 168.65 10.32 Favored 'General case' 0 C--N 1.281 -2.378 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.725 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 66.1 mt -64.83 -29.7 70.67 Favored 'General case' 0 N--CA 1.411 -2.388 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.791 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.5 ptm180 -77.04 -26.37 53.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.514 ' OE1' HG23 ' A' ' 20' ' ' THR . 62.7 mt-10 -84.66 -42.55 15.22 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.957 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.706 HD21 HD22 ' A' ' 167' ' ' LEU . 18.2 tp -57.5 -44.12 84.73 Favored 'General case' 0 CA--C 1.495 -1.168 0 CA-C-O 121.952 0.882 . . . . 0.0 110.145 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.654 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.5 m-30 -60.41 -23.86 64.7 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 113.747 -1.569 . . . . 0.0 113.188 -176.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -79.88 -12.87 59.72 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.95 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.4 mm? -79.22 3.78 16.86 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.521 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.7 m-85 -118.49 164.72 14.86 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.226 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.573 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 38.0 mt-10 -136.4 -173.48 3.42 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.952 175.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.41 81.63 0.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.39 0.614 . . . . 0.0 111.55 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -98.65 120.4 39.02 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.783 0.801 . . . . 0.0 110.621 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -106.28 149.73 26.62 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 114.009 -1.451 . . . . 0.0 109.976 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.504 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 19.2 t80 -106.56 130.35 54.34 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.474 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 6.8 tp10 -167.53 141.42 3.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.849 -176.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.412 ' ND2' ' HG3' ' A' ' 34' ' ' GLU . 47.6 m-80 56.48 23.58 7.66 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 123.452 0.47 . . . . 0.0 111.865 177.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.504 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 43.8 mtm 72.07 17.57 5.08 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.88 177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.516 HG12 ' HD2' ' A' ' 71' ' ' PRO . 4.8 m -127.32 -175.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -126.77 147.64 49.98 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.307 0.575 . . . . 0.0 110.603 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -131.47 124.0 53.75 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.007 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.801 ' HB3' HG22 ' A' ' 67' ' ' VAL . 38.1 ttm180 -115.41 126.23 54.12 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.573 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -133.43 146.76 51.48 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.463 -174.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 88.9 mttt 86.46 111.75 0.03 OUTLIER Pre-proline 0 C--N 1.321 -0.673 0 C-N-CA 125.183 1.393 . . . . 0.0 111.75 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.527 ' HB2' HD13 ' A' ' 47' ' ' ILE . 83.5 Cg_endo -79.72 147.73 19.7 Favored 'Trans proline' 0 N--CA 1.439 -1.698 0 C-N-CA 122.527 2.151 . . . . 0.0 111.191 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.573 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 29.3 mtmt -81.75 -6.64 59.23 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 55.6 mtt-85 -145.91 -164.98 2.08 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.1 tp10 -85.75 99.83 11.61 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.629 HG13 HG12 ' A' ' 12' ' ' ILE . 1.7 mp -115.97 117.37 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.952 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.538 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 25.0 mmtt -116.37 167.14 11.3 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.393 174.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.492 HG11 ' CB ' ' A' ' 169' ' ' ALA . 13.0 p -121.45 130.23 74.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.133 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -85.14 120.61 26.83 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.2 m -133.79 173.24 11.75 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.017 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.485 HG12 HD11 ' A' ' 176' ' ' ILE . 2.4 mm -115.61 142.57 28.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.223 0.535 . . . . 0.0 110.151 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.416 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 38.8 t0 -80.75 130.85 35.31 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 54' ' ' LEU . 4.1 mp -77.9 -25.63 48.58 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-O 121.973 0.892 . . . . 0.0 110.811 -172.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.34 -32.6 16.42 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.087 -1.415 . . . . 0.0 111.93 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' HB3' ' A' ' 53' ' ' ASP . 57.8 p -111.84 -20.21 12.13 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.522 -175.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.66 12.18 84.65 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.742 177.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.455 ' C ' HD13 ' A' ' 52' ' ' ILE . 3.6 mtpm? -89.86 160.58 16.4 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.953 0.406 . . . . 0.0 112.069 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.45 110.18 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 CA-C-O 121.89 0.852 . . . . 0.0 110.009 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.5 m -111.13 163.8 7.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 49' ' ' VAL . 13.6 tp -123.74 141.97 51.52 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.42 ' OG1' ' HB2' ' A' ' 170' ' ' LYS . 14.3 t -151.05 172.21 16.09 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.91 0.386 . . . . 0.0 111.57 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.05 160.58 25.77 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.715 0.769 . . . . 0.0 110.993 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.567 HD13 HG22 ' A' ' 47' ' ' ILE . 2.1 mp -100.7 136.82 30.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.908 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 5.2 mm-40 -82.93 -38.28 23.03 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 p30 177.56 -179.2 0.23 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.303 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.801 HG22 ' HB3' ' A' ' 40' ' ' ARG . 2.9 m -116.82 145.26 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-O 121.124 0.488 . . . . 0.0 110.067 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' A' ' 166' ' ' SER . 56.8 mt -99.28 107.67 21.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.076 -173.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.455 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 76.8 tttt -116.08 107.42 14.91 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.6 137.65 30.89 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.141 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.516 ' HD2' HG12 ' A' ' 37' ' ' VAL . 77.5 Cg_exo -47.52 136.23 20.65 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 123.205 2.603 . . . . 0.0 112.688 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.66 102.7 0.47 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 m -60.44 -55.83 28.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.465 -0.789 . . . . 0.0 113.071 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -143.45 -138.7 0.11 Allowed 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.301 -176.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -97.38 171.12 8.6 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.719 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.0 mt -124.19 140.54 52.86 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.928 0.87 . . . . 0.0 111.513 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 88' ' ' GLU . 40.0 mt -87.98 142.11 13.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.872 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 12.9 ttt180 -119.45 138.47 53.1 Favored 'General case' 0 N--CA 1.406 -2.651 0 CA-C-O 121.234 0.54 . . . . 0.0 109.655 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.606 ' O ' ' HA ' ' A' ' 86' ' ' SER . 58.1 m-85 -114.68 125.99 54.37 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.442 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' N ' ' A' ' 152' ' ' LYS . 36.8 tt0 -109.73 123.99 50.47 Favored 'General case' 0 CA--C 1.473 -2.013 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.753 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -89.34 162.5 15.78 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.994 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.901 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.1 pt-20 -63.88 -18.29 64.03 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.889 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -93.37 -7.29 45.14 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.531 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.57 13.22 57.3 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.045 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.571 ' O ' HD23 ' A' ' 81' ' ' LEU . 2.0 mtt180 -82.07 139.07 34.66 Favored 'General case' 0 CA--C 1.486 -1.481 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 20.6 p -141.27 140.0 33.8 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 118.889 -1.125 . . . . 0.0 112.449 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -136.67 141.34 43.15 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.657 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 1.7 mp0 -109.61 148.1 31.89 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.779 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.73 ' HB ' ' NE2' ' A' ' 93' ' ' HIS . 3.5 p -137.02 149.14 47.28 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.139 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.719 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -73.44 7.62 2.22 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -176.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.075 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.5 m 59.81 169.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.125 0 C-N-CA 122.911 0.484 . . . . 0.0 110.98 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.604 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 33.4 t70 73.11 -41.26 0.5 Allowed 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.063 0.459 . . . . 0.0 111.35 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.73 ' NE2' ' HB ' ' A' ' 89' ' ' THR . 8.6 p80 -75.69 148.59 82.64 Favored Pre-proline 0 C--N 1.31 -1.122 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 7.0 Cg_exo -74.58 142.19 28.98 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.126 2.551 . . . . 0.0 114.534 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 23.6 t -111.99 154.3 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.514 1.526 . . . . 0.0 107.274 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.446 HD22 ' CD2' ' A' ' 184' ' ' HIS . 18.3 tp -106.49 113.45 26.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 118.841 0.746 . . . . 0.0 112.424 -176.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.647 HG13 HG13 ' A' ' 104' ' ' ILE . 2.4 p -113.39 153.64 14.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 111.808 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -108.48 95.61 5.78 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.989 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 6.6 pt-20 -143.76 159.19 42.95 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER 66.84 22.74 10.17 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.228 0.537 . . . . 0.0 109.644 -179.03 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.61 12.86 57.66 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.771 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -134.21 172.41 12.9 Favored 'General case' 0 N--CA 1.403 -2.815 0 CA-C-O 121.201 0.524 . . . . 0.0 109.807 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -100.68 121.69 42.06 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.647 HG13 HG13 ' A' ' 97' ' ' VAL . 25.9 pt -121.13 157.52 24.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 120.358 -0.537 . . . . 0.0 111.622 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 21.3 mt-10 -114.18 110.02 19.32 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.959 0.409 . . . . 0.0 111.666 -176.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.419 ' HE3' ' CD1' ' A' ' 104' ' ' ILE . 88.1 mttt -113.97 140.01 48.77 Favored 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 92' ' ' ASP . 6.5 mpt_? -60.8 154.79 21.0 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.075 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -56.63 -45.86 81.28 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.827 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.482 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 2.6 p90 -71.99 3.03 4.75 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.342 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -115.26 -16.34 11.52 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.358 0.599 . . . . 0.0 110.131 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 107' ' ' ARG . 70.0 t -74.51 145.09 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 31.6 mmtp -119.74 172.6 7.57 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.401 0.619 . . . . 0.0 111.689 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -70.9 138.31 50.04 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.393 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.51 5.59 74.99 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.432 -0.889 . . . . 0.0 111.924 -176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.842 ' HB3' HD12 ' A' ' 151' ' ' ILE . 8.1 t70 -71.27 170.17 13.64 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.739 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 48.2 mttp -127.85 155.72 43.68 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.758 0.79 . . . . 0.0 112.733 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.51 157.52 41.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.584 172.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.611 ' HA ' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -95.15 134.14 38.2 Favored 'General case' 0 CA--C 1.479 -1.784 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.6 OUTLIER -107.33 124.45 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.828 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.742 175.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 122' ' ' LEU . 4.7 m -80.98 73.92 8.0 Favored 'General case' 0 N--CA 1.398 -3.044 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 145' ' ' HIS . 19.6 tt0 -62.72 39.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -174.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.431 ' H ' ' C ' ' A' ' 120' ' ' SER . 34.2 tp -82.01 123.87 29.29 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 172.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -106.71 168.2 9.34 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.833 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -132.93 30.29 4.02 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.957 0.884 . . . . 0.0 109.317 -176.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.1 p -51.23 144.73 2.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 113.482 -1.69 . . . . 0.0 113.014 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -163.9 156.95 18.12 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -98.88 20.93 12.28 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 27.7 m -81.1 -78.54 0.18 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.77 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 79.5 p 52.48 21.58 1.82 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.575 0.75 . . . . 0.0 112.136 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.3 p -73.82 -65.06 0.88 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.8 -177.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 50.3 m -148.36 168.12 23.44 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.233 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -78.63 96.83 5.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.071 0.463 . . . . 0.0 109.997 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.594 ' O ' ' HD3' ' A' ' 135' ' ' PRO . 39.0 t70 -149.58 170.78 17.86 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.204 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -112.8 82.68 5.23 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-O 120.738 0.304 . . . . 0.0 110.919 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 133' ' ' ASP . 8.6 Cg_endo -90.93 150.05 3.91 Favored 'Trans proline' 0 N--CA 1.439 -1.683 0 C-N-CA 123.111 2.541 . . . . 0.0 110.843 177.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -151.88 108.75 3.51 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.274 0.559 . . . . 0.0 109.89 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -123.83 -68.34 0.87 Allowed 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.969 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -134.44 -108.0 0.22 Allowed 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.142 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 66.52 110.48 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.734 0.646 . . . . 0.0 111.269 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 67.8 tp -68.8 -64.96 0.77 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 92.92 30.95 8.94 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.11 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.46 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 2.5 p -61.81 117.39 28.12 Favored Pre-proline 0 N--CA 1.444 -0.729 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 142' ' ' SER . 15.7 Cg_endo -86.04 -73.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.336 2.024 . . . . 0.0 113.917 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 71.4 74.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 121' ' ' GLU . 47.6 p-80 -122.29 121.87 37.77 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.8 -0.637 . . . . 0.0 112.013 -174.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -159.84 87.85 0.82 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.44 -0.8 . . . . 0.0 108.976 177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -164.2 140.22 6.26 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.05 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.739 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.7 mm? -112.13 140.22 47.0 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.061 176.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.901 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -114.26 134.68 54.76 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.996 -178.147 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 8.5 mt-10 -86.82 142.79 27.83 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.155 177.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.842 HD12 ' HB3' ' A' ' 115' ' ' ASP . 80.6 mt -80.46 103.15 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-N 113.43 -1.714 . . . . 0.0 110.329 174.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.485 ' HG3' ' CA ' ' A' ' 82' ' ' GLU . 29.9 mtmt -61.1 -44.37 97.46 Favored 'General case' 0 C--N 1.274 -2.715 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.226 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -150.45 136.53 18.54 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 77.7 mt -113.92 145.37 19.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.885 174.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.8 ptpt -150.44 160.14 43.97 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.214 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -100.27 113.17 25.66 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.02 134.73 65.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.358 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.427 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 32.2 ttp180 -66.25 151.71 46.45 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' A' ' 158' ' ' ARG . . . -67.29 127.77 33.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.898 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -79.84 -24.89 41.01 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.191 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -110.36 -178.35 3.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.51 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.17 -7.82 18.8 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.035 0.445 . . . . 0.0 110.01 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -134.24 160.26 38.4 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.24 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.03 155.2 41.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.654 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 19.6 m-85 -132.88 169.07 17.29 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.741 -172.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.602 ' HB2' HD12 ' A' ' 68' ' ' ILE . 19.3 m -155.55 -28.13 0.1 Allowed 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.706 HD22 HD21 ' A' ' 24' ' ' LEU . 15.4 tp 73.29 116.95 0.05 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.417 1.087 . . . . 0.0 111.618 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -91.8 109.33 20.66 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.46 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.492 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -129.6 -165.02 1.47 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.372 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.42 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 46.4 mmtt -68.69 143.74 54.64 Favored 'General case' 0 CA--C 1.489 -1.392 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.218 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt 50.33 47.43 23.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.287 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 173' ' ' HIS . 11.8 p90 -50.41 169.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 114.805 -1.089 . . . . 0.0 113.373 -177.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.595 ' O ' ' HA ' ' A' ' 184' ' ' HIS . 22.0 m-70 83.34 17.0 0.27 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.986 0.914 . . . . 0.0 109.777 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -148.87 138.93 22.2 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.619 HG13 HG23 ' A' ' 177' ' ' ILE . 1.3 p -166.32 166.67 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.485 HD11 HG12 ' A' ' 52' ' ' ILE . 97.2 mt -117.14 113.04 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.81 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.619 HG23 HG13 ' A' ' 175' ' ' VAL . 40.3 pt -123.19 171.37 12.25 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.521 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.237 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 7' ' ' ARG . 8.0 t-20 50.49 -129.46 2.2 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.431 1.092 . . . . 0.0 110.128 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.69 43.95 0.95 Allowed 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.439 0.637 . . . . 0.0 110.22 175.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.604 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.4 m-20 72.89 47.75 0.2 Allowed 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 114.081 -1.418 . . . . 0.0 112.92 176.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 81.3 mt -88.82 115.09 28.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.065 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 118' ' ' LEU . 2.6 m -76.33 156.21 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.2 t -171.46 169.78 6.05 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.786 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.595 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 14.1 m170 -114.2 -174.16 2.42 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.1 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 117.913 -1.041 . . . . 0.0 111.875 -179.288 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 89' ' ' THR . 71.3 m . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.824 0.345 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -129.08 160.52 63.3 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 76' ' ' LEU . 51.8 Cg_endo -66.15 156.51 64.39 Favored 'Trans proline' 0 N--CA 1.441 -1.613 0 N-CA-C 108.532 -1.372 . . . . 0.0 108.532 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.09 -22.56 49.69 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.728 -1.225 . . . . 0.0 112.531 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -65.45 -19.78 66.08 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.203 0.525 . . . . 0.0 112.186 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.441 ' HB ' HD12 ' A' ' 21' ' ' LEU . 91.9 m -59.61 128.09 35.25 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.771 -176.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 65.5 mmt-85 -81.34 133.34 35.41 Favored 'General case' 0 C--O 1.194 -1.856 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.78 HD11 HG21 ' A' ' 175' ' ' VAL . 8.1 tt -121.66 131.88 72.08 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.728 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.577 HD21 HD21 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -89.01 124.21 34.06 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 121.511 0.672 . . . . 0.0 109.987 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.9 m -135.11 -176.38 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.378 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -134.04 124.62 26.53 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.047 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.59 HG12 HG13 ' A' ' 47' ' ' ILE . 21.0 mt -120.55 119.46 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.026 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 52.62 44.45 30.08 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-N 114.289 -1.323 . . . . 0.0 109.744 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.65 20.2 75.5 Favored Glycine 0 C--N 1.307 -1.057 0 CA-C-N 114.704 -1.135 . . . . 0.0 114.256 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.47 HG11 ' CB ' ' A' ' 134' ' ' ASN . 34.9 t -124.76 119.94 25.71 Favored Pre-proline 0 C--N 1.31 -1.146 0 CA-C-O 121.137 0.494 . . . . 0.0 109.769 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HB2' HD13 ' A' ' 124' ' ' LEU . 56.8 Cg_endo -73.71 124.03 8.96 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.326 2.018 . . . . 0.0 111.74 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -123.26 146.27 48.0 Favored 'General case' 0 CA--C 1.486 -1.513 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.47 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -114.51 100.23 8.14 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.258 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.9 pt -123.05 -174.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.929 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.671 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 10.9 p -92.99 172.21 8.46 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.234 -0.987 . . . . 0.0 109.088 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 70.4 mt -66.83 -30.49 70.68 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.256 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.671 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 5.7 ptm180 -80.11 -25.01 40.13 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.544 ' OE1' HG23 ' A' ' 20' ' ' THR . 78.8 mt-10 -83.58 -39.6 20.15 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.1 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.52 HD21 ' HG ' ' A' ' 167' ' ' LEU . 13.9 tp -57.52 -44.49 85.11 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.46 ' HD1' HG11 ' A' ' 67' ' ' VAL . 18.8 t80 -49.79 -35.62 23.25 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 113.687 -1.597 . . . . 0.0 112.414 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 26.8 mt-10 -72.95 -17.84 61.44 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.58 0.06 31.53 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.594 0.712 . . . . 0.0 109.589 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.601 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 95.2 m-85 -113.67 161.3 17.63 Favored 'General case' 0 N--CA 1.415 -2.201 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.297 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -133.89 -174.71 3.61 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.803 176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 14.8 t0 60.28 87.56 0.09 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.549 0.69 . . . . 0.0 111.444 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 26.2 tt0 -104.02 128.97 51.62 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.253 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.642 ' HG2' HG13 ' A' ' 39' ' ' VAL . 1.7 ptm180 -109.8 150.06 28.92 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.611 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -116.9 122.97 45.86 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.42 0.629 . . . . 0.0 110.166 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -167.34 154.38 8.55 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.243 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.4 m120 61.63 16.98 8.2 Favored 'General case' 0 CA--C 1.494 -1.199 0 O-C-N 123.685 0.615 . . . . 0.0 110.707 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.9 mtm 69.77 19.58 7.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.06 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.489 HG12 ' HD2' ' A' ' 71' ' ' PRO . 12.4 m -128.54 -179.67 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.489 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 97.1 m-85 -120.26 142.18 49.28 Favored 'General case' 0 CA--C 1.478 -1.803 0 CA-C-O 121.44 0.638 . . . . 0.0 109.993 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.642 HG13 ' HG2' ' A' ' 32' ' ' ARG . 1.1 m -135.19 127.7 47.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.713 -1.131 . . . . 0.0 108.336 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.587 ' O ' HG23 ' A' ' 67' ' ' VAL . 16.1 ttm180 -119.68 127.55 52.99 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -133.45 145.09 49.93 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.963 -174.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 12.8 tmtt? 86.73 112.22 0.03 OUTLIER Pre-proline 0 CA--C 1.516 -0.336 0 O-C-N 124.649 1.218 . . . . 0.0 109.963 -178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.55 ' HB2' HD13 ' A' ' 47' ' ' ILE . 73.2 Cg_endo -80.48 151.48 19.9 Favored 'Trans proline' 0 N--CA 1.439 -1.678 0 C-N-CA 122.211 1.941 . . . . 0.0 112.269 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -86.17 -0.09 54.88 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.194 0.521 . . . . 0.0 110.976 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -150.68 -165.83 2.38 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 33.0 tt0 -83.92 101.41 11.67 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.601 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.4 mp -115.74 117.67 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.227 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -117.72 165.85 13.14 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.266 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.556 HG11 ' CB ' ' A' ' 169' ' ' ALA . 9.9 p -120.45 133.57 66.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.234 -177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.414 ' CD2' HD12 ' A' ' 9' ' ' LEU . 6.6 m-85 -85.87 125.27 33.18 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.096 175.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.9 m -136.86 142.36 42.81 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.179 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.439 HG12 HD11 ' A' ' 176' ' ' ILE . 2.9 mm -92.26 140.03 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.936 0 CA-C-O 121.479 0.657 . . . . 0.0 110.725 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.43 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 10.7 t0 -83.79 114.04 21.34 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.74 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -75.39 -4.78 41.4 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.685 0.755 . . . . 0.0 111.811 -169.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -102.42 -34.02 9.32 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.114 -177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 53' ' ' ASP . 81.0 p -111.29 -19.78 12.52 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.634 -175.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.88 12.71 80.87 Favored Glycine 0 N--CA 1.431 -1.688 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.836 177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 48.0 mttt -92.24 156.52 17.24 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.178 0.513 . . . . 0.0 112.284 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.92 106.02 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.006 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.589 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 m -109.46 162.55 7.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.77 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 49' ' ' VAL . 12.3 tp -122.32 140.87 52.15 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.014 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.5 t -147.52 172.61 13.7 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 120.782 0.325 . . . . 0.0 111.338 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.16 162.61 25.66 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.839 0.828 . . . . 0.0 111.397 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.549 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.5 mp -99.07 145.71 9.77 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.812 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.48 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 31.4 mm-40 -91.27 -38.59 12.57 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 p30 175.62 177.37 0.2 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.672 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 40' ' ' ARG . 5.5 t -106.58 129.43 60.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.894 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' A' ' 166' ' ' SER . 55.3 mt -91.49 111.75 24.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.814 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 83.2 tttt -127.56 112.25 14.69 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.12 135.08 25.92 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.148 -175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.489 ' HD2' HG12 ' A' ' 37' ' ' VAL . 80.7 Cg_exo -44.71 130.05 9.54 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.671 2.914 . . . . 0.0 113.535 177.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.41 116.44 28.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.147 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -123.0 -65.83 1.07 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.367 0.876 . . . . 0.0 113.367 -176.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -57.58 -92.32 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -177.14 172.44 1.93 Allowed 'General case' 0 CA--C 1.461 -2.474 0 CA-C-O 120.992 0.425 . . . . 0.0 111.46 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.794 HD23 ' HA ' ' A' ' 90' ' ' THR . 10.7 mt -131.65 141.75 49.68 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.735 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.536 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 22.7 mt -87.69 142.37 13.05 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.585 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 11.3 ttt85 -115.28 137.31 52.17 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.177 0.513 . . . . 0.0 109.884 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 86' ' ' SER . 64.1 m-85 -114.87 121.19 42.45 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 114.698 -1.137 . . . . 0.0 108.861 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' A' ' 152' ' ' LYS . 35.3 tt0 -109.08 120.77 43.53 Favored 'General case' 0 CA--C 1.47 -2.133 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.726 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -85.9 159.96 19.53 Favored 'General case' 0 C--N 1.271 -2.846 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.172 -177.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.778 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -59.71 -19.16 48.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.325 179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -92.37 -8.26 45.44 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.091 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.44 15.74 49.29 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.523 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.545 ' O ' HD23 ' A' ' 81' ' ' LEU . 3.9 mtt180 -83.83 138.57 33.15 Favored 'General case' 0 CA--C 1.483 -1.596 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 35.6 p -141.85 139.91 32.78 Favored 'General case' 0 C--N 1.28 -2.43 0 C-N-CA 118.485 -1.286 . . . . 0.0 112.296 175.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -135.23 146.93 49.1 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.948 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 21.5 mt-10 -119.22 147.68 43.97 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.348 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.8 OUTLIER -138.76 154.01 48.49 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.595 -179.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.794 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.98 11.58 0.67 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.362 0.601 . . . . 0.0 112.057 -177.325 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.116 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.2 m 68.24 -26.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.021 1.328 . . . . 0.0 113.422 175.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.413 ' H ' ' C ' ' A' ' 90' ' ' THR . 5.0 p-10 -83.34 -1.17 52.69 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.983 0.42 . . . . 0.0 110.658 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 20.9 m80 -110.63 137.06 20.64 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.477 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 24.0 Cg_exo -65.48 134.18 37.51 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.236 2.624 . . . . 0.0 113.424 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.578 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.2 t -103.58 150.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 176.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.554 ' HB2' ' N ' ' A' ' 184' ' ' HIS . 6.2 tp -107.75 113.76 27.24 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.819 0.342 . . . . 0.0 111.878 -176.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.604 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.3 p -113.21 151.6 15.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.26 0.552 . . . . 0.0 111.592 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.465 ' CD2' HD12 ' A' ' 148' ' ' LEU . 61.4 t80 -105.13 93.54 4.75 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.294 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 8.5 pt-20 -141.76 158.41 43.85 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 32.0 m-80 63.5 23.22 13.56 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.147 0.499 . . . . 0.0 109.993 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.23 12.02 54.01 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.0 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -133.29 172.31 12.86 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 121.279 0.561 . . . . 0.0 109.914 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -101.76 120.63 40.67 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.567 HG13 HG13 ' A' ' 97' ' ' VAL . 23.1 pt -116.38 152.53 18.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.875 178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.47 ' OE2' ' HG2' ' A' ' 185' ' ' GLN . 7.7 mt-10 -109.37 112.57 24.77 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.792 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.502 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 12.6 ptpt -130.15 133.95 46.98 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.598 ' O ' HG23 ' A' ' 111' ' ' VAL . 60.5 mtm180 -67.42 163.18 21.43 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.116 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -56.6 -45.45 81.42 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.976 -174.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.505 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.9 p90 -71.86 2.81 4.92 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.515 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.501 ' O ' ' HE3' ' A' ' 112' ' ' LYS . 12.9 tp10 -117.15 -16.05 10.44 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.397 0.618 . . . . 0.0 110.044 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 107' ' ' ARG . 89.4 t -73.97 148.88 8.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.674 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 23.0 mmtp -119.17 169.8 9.63 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.337 0.589 . . . . 0.0 110.537 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -76.21 144.42 40.45 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.551 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.38 4.59 80.44 Favored Glycine 0 C--N 1.308 -1.011 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.15 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.674 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -76.91 167.33 22.0 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.468 ' H ' HG23 ' A' ' 97' ' ' VAL . 28.1 mttp -121.87 166.67 14.03 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.288 0.566 . . . . 0.0 110.558 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.22 160.57 41.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 171.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.98 135.14 34.43 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.1 OUTLIER -100.49 149.98 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.716 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.454 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 43.5 t -66.06 -5.45 9.8 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 120.825 0.345 . . . . 0.0 110.797 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.627 ' HB3' ' CG ' ' A' ' 145' ' ' HIS . 39.8 mt-10 40.78 69.58 0.32 Allowed 'General case' 0 N--CA 1.439 -0.984 0 O-C-N 124.753 1.283 . . . . 0.0 111.491 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.492 ' CD1' ' HG3' ' A' ' 143' ' ' PRO . 49.8 tp -174.47 123.79 0.29 Allowed 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.35 104.51 7.97 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.577 HD21 HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -54.51 -8.82 0.25 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 114.242 -1.344 . . . . 0.0 112.148 174.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.2 t 74.04 75.08 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 122.147 0.975 . . . . 0.0 110.349 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -147.23 131.56 17.53 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.135 -1.393 . . . . 0.0 108.156 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -119.9 -72.77 0.67 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.093 0.473 . . . . 0.0 109.863 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 12.3 m -125.48 112.71 16.56 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 16.4 m -62.01 99.13 0.12 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.201 0.524 . . . . 0.0 111.816 -177.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.8 p -92.08 -28.14 17.33 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.347 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.8 p -113.05 140.05 48.17 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.68 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -77.93 -23.09 48.7 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -82.01 153.72 26.05 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.644 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.47 ' CB ' HG11 ' A' ' 15' ' ' VAL . 45.7 m-80 -125.66 78.98 68.38 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-O 121.156 0.503 . . . . 0.0 110.525 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -97.51 37.58 0.11 Allowed 'Trans proline' 0 N--CA 1.439 -1.704 0 C-N-CA 123.272 2.648 . . . . 0.0 112.095 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -163.04 133.97 4.76 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -158.42 97.29 1.47 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 139' ' ' ASN . 0.7 OUTLIER 62.27 177.73 0.13 Allowed 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.805 -177.238 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.59 ' H ' ' CD ' ' A' ' 138' ' ' GLU . 4.5 p30 -122.72 -23.89 5.0 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.969 -0.457 . . . . 0.0 111.606 -177.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.2 tp -130.34 -37.29 1.43 Allowed 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.726 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.23 -31.59 5.03 Favored Glycine 0 C--N 1.303 -1.257 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.632 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.3 p -98.41 117.36 64.84 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-O 120.612 0.244 . . . . 0.0 110.367 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.492 ' HG3' ' CD1' ' A' ' 122' ' ' LEU . 83.9 Cg_endo -82.49 173.92 10.2 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.646 2.231 . . . . 0.0 112.91 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.03 115.7 28.0 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.781 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.627 ' CG ' ' HB3' ' A' ' 121' ' ' GLU . 29.9 p80 -161.1 149.21 15.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.309 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 145' ' ' HIS . 19.0 t70 174.54 45.55 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.426 ' O ' HD23 ' A' ' 148' ' ' LEU . 6.8 pt20 -163.92 140.56 6.74 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.465 HD12 ' CD2' ' A' ' 98' ' ' TYR . 14.5 mt -112.29 153.37 27.28 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 171.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.778 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -114.97 138.89 50.32 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -171.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.464 ' H ' HD13 ' A' ' 149' ' ' LEU . 25.1 mt-10 -89.79 146.43 24.47 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 124.672 1.189 . . . . 0.0 113.018 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' A' ' 79' ' ' PHE . 64.3 mt -80.15 107.57 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 CA-C-N 113.303 -1.771 . . . . 0.0 110.266 175.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 80' ' ' GLU . 62.2 mmtt -68.89 -38.98 80.0 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.889 177.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -150.63 131.86 14.5 Favored 'General case' 0 CA--C 1.483 -1.609 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 74.8 mt -116.98 130.21 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.627 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.385 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.481 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 19.3 ptpt -136.46 166.76 22.75 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.516 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.536 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 20.7 m-85 -100.63 115.36 30.01 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.946 173.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.1 133.19 68.83 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.103 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 21.5 ttm-85 -70.87 155.22 41.06 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.068 0.461 . . . . 0.0 111.072 -177.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.21 113.71 7.66 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.063 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -71.17 -18.68 62.48 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.567 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -98.9 166.57 11.23 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.953 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -94.28 -6.44 44.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.029 0.443 . . . . 0.0 109.929 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -144.0 150.41 38.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.781 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 4.3 m -119.29 155.8 21.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.551 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 50.0 m-85 -130.86 173.59 10.81 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 110.199 -0.296 . . . . 0.0 110.199 -175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.581 ' HB2' HD12 ' A' ' 68' ' ' ILE . 68.5 m -159.23 -24.49 0.07 Allowed 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.52 ' HG ' HD21 ' A' ' 24' ' ' LEU . 1.5 tm? 68.68 112.46 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.769 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -90.82 113.26 25.37 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.112 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.556 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -133.94 -173.32 3.22 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.915 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.9 mtpp -65.39 128.62 36.61 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 73.5 tttt 61.24 46.13 8.2 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.428 ' O ' ' HB2' ' A' ' 173' ' ' HIS . 49.0 p90 -57.04 179.03 0.05 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.252 -1.34 . . . . 0.0 113.928 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.489 ' O ' ' HB3' ' A' ' 184' ' ' HIS . 57.4 m170 70.56 18.94 6.36 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.46 -175.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -150.04 115.19 5.4 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.896 -177.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.78 HG21 HD11 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -159.95 158.43 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 120.827 0.346 . . . . 0.0 110.785 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.699 HG23 ' HA ' ' A' ' 180' ' ' ASN . 2.5 mp -93.08 115.34 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.867 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.489 HG23 HG13 ' A' ' 175' ' ' VAL . 45.1 pt -121.48 171.51 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 CA-C-O 120.985 0.422 . . . . 0.0 111.586 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.439 ' HB3' HD12 ' A' ' 181' ' ' ILE . 5.4 t-20 46.71 -127.19 1.54 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 124.16 0.984 . . . . 0.0 110.777 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.498 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 29.3 mt-10 -91.5 55.63 2.82 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.745 0.784 . . . . 0.0 109.466 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.736 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.4 m120 70.2 44.56 0.75 Allowed 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 113.74 -1.573 . . . . 0.0 113.6 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 178' ' ' ASN . 85.1 mt -92.39 117.65 36.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.0 m -93.45 160.73 2.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.578 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 9.7 t -159.33 152.37 22.07 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.132 -178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.636 ' CG ' ' H ' ' A' ' 185' ' ' GLN . 1.2 t60 42.56 -148.79 0.04 OUTLIER 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 124.031 0.932 . . . . 0.0 111.975 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.636 ' H ' ' CG ' ' A' ' 184' ' ' HIS . 26.5 pt20 . . . . . 0 C--O 1.263 1.808 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.99 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 89' ' ' THR . 23.0 p . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.994 0.426 . . . . 0.0 111.568 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.48 ' CE1' HD13 ' A' ' 177' ' ' ILE . 93.3 m-85 -124.29 150.45 63.97 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.47 ' HA ' HG12 ' A' ' 164' ' ' VAL . 18.2 Cg_endo -59.02 -26.92 83.49 Favored 'Trans proline' 0 N--CA 1.474 0.368 0 C-N-CA 122.592 2.195 . . . . 0.0 112.481 -175.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 120.19 -38.65 2.69 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 108.469 -1.853 . . . . 0.0 108.469 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -69.08 -1.34 7.42 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.802 -0.699 . . . . 0.0 111.514 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 28.9 m -69.69 128.25 35.79 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 2.1 mtm-85 -83.77 132.6 34.82 Favored 'General case' 0 C--O 1.186 -2.259 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.722 HD11 HG21 ' A' ' 175' ' ' VAL . 10.7 tt -122.74 131.38 73.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-O 121.017 0.437 . . . . 0.0 110.623 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.427 HD21 ' CD2' ' A' ' 124' ' ' LEU . 1.6 tm? -90.77 123.47 34.37 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-O 121.504 0.669 . . . . 0.0 109.447 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 18.8 m -133.83 -175.46 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.5 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 32.1 tt0 -129.29 120.8 26.28 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.627 HG12 HG13 ' A' ' 47' ' ' ILE . 14.5 mt -122.44 122.7 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.868 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.864 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 56.14 35.98 26.62 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.515 -1.221 . . . . 0.0 109.859 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.1 17.29 78.62 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.215 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.35 114.55 25.65 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.604 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 7.6 Cg_exo -64.86 125.17 14.28 Favored 'Trans proline' 0 N--CA 1.44 -1.656 0 C-N-CA 122.129 1.886 . . . . 0.0 111.356 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.512 ' HG2' ' ND2' ' A' ' 134' ' ' ASN . 66.2 mt-30 -122.14 140.39 52.61 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.452 ' HD3' ' NH2' ' A' ' 7' ' ' ARG . 39.0 ttmt -108.52 100.28 9.57 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 176.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.6 pt -124.4 -171.93 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.179 -2.63 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.767 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.713 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 21.3 p -94.91 170.98 9.04 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.776 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 10.6 mt -73.96 -20.64 60.3 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.006 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.713 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 13.2 ptm180 -84.58 -25.28 28.76 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.449 ' O ' HD23 ' A' ' 27' ' ' LEU . 52.4 mm-40 -84.64 -44.17 13.71 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.394 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.569 ' CD2' HD22 ' A' ' 167' ' ' LEU . 16.4 tp -57.19 -44.0 83.21 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.927 0.87 . . . . 0.0 110.004 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.44 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -56.09 -24.25 39.03 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.849 -179.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -84.41 -12.15 54.95 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.876 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -80.32 5.6 14.33 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.601 0.715 . . . . 0.0 109.466 177.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.619 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 95.9 m-85 -119.43 167.13 12.23 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.075 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.565 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 9.4 mt-10 -140.34 -173.56 3.71 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.473 174.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 6.0 t0 62.5 83.42 0.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.237 0.542 . . . . 0.0 110.8 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -107.63 129.44 55.0 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-O 121.849 0.833 . . . . 0.0 111.257 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.7 ptm180 -124.1 156.48 36.53 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.892 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -107.46 125.52 51.36 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -164.67 148.22 8.97 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.56 -177.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.7 m120 62.2 19.22 10.78 Favored 'General case' 0 CA--C 1.496 -1.106 0 O-C-N 123.557 0.536 . . . . 0.0 110.302 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.2 mtt 72.17 17.71 4.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.468 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.2 m -132.77 -178.48 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -115.05 140.72 48.83 Favored 'General case' 0 CA--C 1.478 -1.796 0 CA-C-O 121.257 0.551 . . . . 0.0 110.188 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.404 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.8 t -127.63 123.91 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.3 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.199 -177.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.525 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 38.9 ttm180 -116.96 126.78 53.45 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.1 OUTLIER -132.22 147.08 52.4 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.681 -0.808 . . . . 0.0 113.155 -176.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 54.4 mttp 82.29 111.61 0.03 OUTLIER Pre-proline 0 N--CA 1.442 -0.825 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.482 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.542 ' HB2' HD13 ' A' ' 47' ' ' ILE . 66.4 Cg_endo -77.28 151.95 30.27 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 122.688 2.259 . . . . 0.0 111.59 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 31.1 mtmt -83.28 -3.62 57.63 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.563 0.697 . . . . 0.0 110.427 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 45' ' ' ARG . 47.1 mtt180 -144.48 -164.62 1.95 Allowed 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 32.1 tt0 -88.6 100.07 12.81 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.627 HG13 HG12 ' A' ' 12' ' ' ILE . 1.3 mp -113.83 121.59 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.878 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.485 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 74.9 mmtt -123.89 165.73 16.88 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.847 174.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.452 HG13 ' CG1' ' A' ' 64' ' ' ILE . 6.1 m -113.42 126.66 70.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 120.961 0.41 . . . . 0.0 112.03 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -83.63 123.44 29.8 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.645 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 p -132.22 173.38 11.31 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.874 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.473 HG12 HD11 ' A' ' 176' ' ' ILE . 2.1 mm -121.25 140.64 44.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.274 0.559 . . . . 0.0 110.129 178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.556 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 23.4 t70 -81.73 120.86 25.66 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.744 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.7 mt -66.46 -25.34 66.68 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.494 -172.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.556 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -92.95 -24.08 18.51 Favored 'General case' 0 C--N 1.272 -2.801 0 CA-C-N 114.856 -1.066 . . . . 0.0 112.416 -172.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.5 p -119.77 -26.43 5.67 Favored 'General case' 0 C--N 1.284 -2.264 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.607 -175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.16 14.37 69.27 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.433 ' C ' HD13 ' A' ' 52' ' ' ILE . 2.6 mptt -84.16 153.61 23.58 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 122.839 0.455 . . . . 0.0 111.738 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.7 p -93.91 105.5 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 CA-C-O 122.004 0.907 . . . . 0.0 109.724 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.3 m -110.16 163.75 6.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.079 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 48' ' ' LYS . 13.7 tp -123.71 139.88 53.55 Favored 'General case' 0 N--CA 1.416 -2.147 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 t -144.07 172.4 12.94 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 120.738 0.304 . . . . 0.0 110.849 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -86.15 161.99 18.59 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.727 0.775 . . . . 0.0 110.924 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.562 ' N ' HD12 ' A' ' 64' ' ' ILE . 3.3 mp -97.81 141.75 15.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.003 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.473 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 18.2 mm-40 -85.15 -39.58 17.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 p30 173.9 175.11 0.15 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.593 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.752 ' HA ' HD12 ' A' ' 167' ' ' LEU . 21.7 t -104.41 142.33 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.826 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 166' ' ' SER . 0.8 OUTLIER -112.87 123.5 68.59 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.701 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.39 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -129.85 114.5 15.98 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.247 -0.888 . . . . 0.0 108.733 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.98 139.62 35.55 Favored Pre-proline 0 C--N 1.305 -1.33 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.813 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -52.84 123.92 14.21 Favored 'Trans proline' 0 C--N 1.324 -0.74 0 C-N-CA 123.043 2.495 . . . . 0.0 112.61 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.4 106.38 11.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.091 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.1 m -125.23 -26.72 3.6 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.638 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -78.78 -137.44 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.387 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -155.14 171.33 19.98 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.2 mt -132.83 140.63 48.05 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.937 -175.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 108' ' ' ALA . 51.4 mt -88.96 145.87 6.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 172.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.495 ' HB3' ' HG3' ' A' ' 155' ' ' LYS . 19.8 ttt180 -121.28 138.94 54.01 Favored 'General case' 0 N--CA 1.404 -2.768 0 CA-C-O 121.256 0.551 . . . . 0.0 109.87 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 86' ' ' SER . 49.3 m-85 -116.35 126.26 53.25 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.119 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.2 tt0 -106.27 132.63 52.09 Favored 'General case' 0 CA--C 1.48 -1.724 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.886 HD12 ' HB3' ' A' ' 149' ' ' LEU . 2.2 mm? -99.05 156.86 16.72 Favored 'General case' 0 C--N 1.272 -2.797 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.205 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.914 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.8 pt-20 -58.62 -18.33 29.45 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.509 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.46 -8.31 48.11 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.746 0.784 . . . . 0.0 109.42 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.27 17.65 49.39 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.564 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.537 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -89.91 139.36 30.67 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 65.5 p -139.79 144.48 37.4 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.467 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -137.1 146.9 45.64 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.105 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 65.1 mt-10 -119.39 147.42 44.38 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.478 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.9 OUTLIER -142.76 157.84 44.24 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.677 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.752 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -72.6 9.72 1.01 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 122.942 0.497 . . . . 0.0 111.921 -176.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.078 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.8 OUTLIER 68.03 -25.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.625 1.17 . . . . 0.0 112.494 177.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 90' ' ' THR . 0.2 OUTLIER -74.45 -12.88 60.61 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 124.344 1.058 . . . . 0.0 111.551 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.462 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -110.79 147.21 36.01 Favored Pre-proline 0 C--N 1.309 -1.176 0 C-N-CA 120.381 -0.527 . . . . 0.0 112.245 -175.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 3.1 Cg_exo -74.48 132.04 15.68 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 123.246 2.63 . . . . 0.0 114.047 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.506 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.6 t -97.21 144.88 9.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.493 HD22 ' O ' ' A' ' 184' ' ' HIS . 7.0 tp -102.05 107.81 19.04 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.658 0.265 . . . . 0.0 110.918 -175.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.621 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.2 p -111.17 151.37 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-O 121.378 0.609 . . . . 0.0 111.93 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.4 ' CD2' HD12 ' A' ' 148' ' ' LEU . 67.0 t80 -106.95 93.74 4.72 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.917 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.3 pt-20 -140.62 158.47 43.93 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 31.9 m-80 64.76 22.93 12.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.065 0.46 . . . . 0.0 110.289 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.76 15.42 64.42 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.53 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -137.12 172.43 13.01 Favored 'General case' 0 N--CA 1.398 -3.044 0 CA-C-O 121.422 0.63 . . . . 0.0 110.269 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -103.63 120.77 41.56 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.605 HG13 HG13 ' A' ' 97' ' ' VAL . 25.2 pt -121.48 155.84 25.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 120.14 -0.624 . . . . 0.0 112.518 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -104.35 116.25 31.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.975 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.424 ' HE3' ' CD1' ' A' ' 104' ' ' ILE . 85.7 mttt -125.4 129.48 49.96 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.546 ' O ' HG23 ' A' ' 111' ' ' VAL . 91.2 mtt180 -62.8 161.71 12.16 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.078 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -58.17 -42.43 85.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 118.708 -1.197 . . . . 0.0 110.537 -175.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.471 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.1 p90 -73.91 3.48 6.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.077 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -114.82 -16.41 11.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.533 0.682 . . . . 0.0 110.22 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 107' ' ' ARG . 92.8 t -77.05 148.68 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.71 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 15.9 mtmt -121.55 162.95 19.68 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 120.827 0.346 . . . . 0.0 111.258 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -66.96 139.11 57.68 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.62 4.45 70.21 Favored Glycine 0 C--N 1.305 -1.179 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.779 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.71 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -75.14 168.71 19.46 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.238 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.586 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 22.2 mttm -123.84 164.28 19.54 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.577 0.703 . . . . 0.0 111.937 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.88 159.05 41.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.424 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.409 ' HA ' HD22 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -92.31 141.04 28.99 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 2.5 m -115.75 158.54 16.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.671 173.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.574 ' HB3' HD22 ' A' ' 180' ' ' ASN . 32.6 t -79.5 31.69 0.23 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.68 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 119' ' ' VAL . 43.5 mt-10 73.08 -48.11 0.68 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.512 1.125 . . . . 0.0 112.278 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.505 ' CD2' ' H ' ' A' ' 123' ' ' GLU . 0.5 OUTLIER -169.45 -158.94 0.2 Allowed 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -175.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.505 ' H ' ' CD2' ' A' ' 122' ' ' LEU . 44.3 mt-10 -107.42 -155.07 0.54 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.505 -175.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 16' ' ' PRO . 0.4 OUTLIER -94.86 34.73 1.32 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.006 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.422 ' O ' ' HA2' ' A' ' 141' ' ' GLY . 7.2 p -35.4 110.24 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 113.698 -1.592 . . . . 0.0 114.968 -176.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -147.95 178.08 8.81 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.541 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -89.27 169.42 11.45 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.291 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 m 67.02 36.92 3.99 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.663 0.744 . . . . 0.0 109.715 -175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.0 p -77.09 171.4 14.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.389 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.2 t 69.73 8.38 6.7 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.153 0.581 . . . . 0.0 111.627 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.4 m -70.82 136.68 48.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.801 0.334 . . . . 0.0 110.814 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -79.59 -22.96 43.06 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -87.56 175.61 7.84 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.349 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.512 ' ND2' ' HG2' ' A' ' 17' ' ' GLN . 22.9 t-20 -125.83 81.04 66.25 Favored Pre-proline 0 C--N 1.314 -0.975 0 C-N-CA 119.996 -0.682 . . . . 0.0 112.155 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -102.09 -175.29 0.11 Allowed 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 123.386 2.724 . . . . 0.0 111.42 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.8 tttm 173.61 139.03 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -157.95 -39.03 0.07 Allowed 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.388 -0.525 . . . . 0.0 111.932 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -82.55 -167.57 1.66 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -112.08 -167.01 1.13 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.266 -174.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.5 ' HG ' ' H ' ' A' ' 141' ' ' GLY . 17.4 tp 80.5 -135.54 0.01 OUTLIER 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.598 1.159 . . . . 0.0 110.541 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.5 ' H ' ' HG ' ' A' ' 140' ' ' LEU . . . 91.35 17.77 48.6 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.304 -0.95 . . . . 0.0 111.29 -176.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.0 m -85.96 119.02 71.51 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.71 -0.245 . . . . 0.0 110.828 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.44 ' HB3' ' CB ' ' A' ' 122' ' ' LEU . 16.7 Cg_exo -68.26 -67.7 0.03 OUTLIER 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.512 2.141 . . . . 0.0 111.713 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 54.32 72.31 0.46 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.534 0.733 . . . . 0.0 111.973 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.489 ' ND1' HD12 ' A' ' 122' ' ' LEU . 7.2 m80 -157.32 89.25 1.04 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.95 0.405 . . . . 0.0 111.624 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -75.02 103.75 5.33 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.456 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.535 ' C ' HD23 ' A' ' 148' ' ' LEU . 6.8 pt20 -163.97 125.01 2.24 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.567 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.535 HD23 ' C ' ' A' ' 147' ' ' GLN . 8.3 mt -111.38 153.45 26.02 Favored 'General case' 0 CA--C 1.482 -1.664 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.998 176.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.914 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -117.13 137.5 52.26 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -173.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.586 ' HG3' ' CG ' ' A' ' 116' ' ' LYS . 14.5 mt-10 -90.58 147.43 23.34 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.752 175.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.474 HD13 ' CD1' ' A' ' 79' ' ' PHE . 79.1 mt -79.66 108.45 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.63 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.911 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.626 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 0.9 OUTLIER -64.69 -43.07 94.69 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.751 177.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -152.64 136.9 16.58 Favored 'General case' 0 CA--C 1.478 -1.798 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -175.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.9 mt -115.7 143.13 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 113.623 -1.626 . . . . 0.0 110.589 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.495 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.0 ptpt -144.86 157.79 44.03 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.288 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.479 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 6.7 m-85 -100.54 118.05 35.94 Favored 'General case' 0 N--CA 1.412 -2.332 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 174.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.456 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -127.04 173.82 11.91 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.708 -178.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -105.92 157.49 17.45 Favored 'General case' 0 C--N 1.289 -2.051 0 O-C-N 121.911 -0.493 . . . . 0.0 111.627 -177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.95 118.63 8.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.567 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -63.09 -41.53 99.42 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.066 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -105.12 -174.12 2.46 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.669 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -99.04 0.41 43.7 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 120.851 0.357 . . . . 0.0 111.461 -178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -142.42 140.47 31.99 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.867 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.4 m -107.51 154.46 8.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.94 177.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 68.1 m-85 -134.39 166.55 22.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.036 -175.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.447 ' HB2' HD11 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -160.73 -22.15 0.06 Allowed 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 67' ' ' VAL . 20.9 tp 68.46 111.42 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.266 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -82.32 113.38 20.07 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.282 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.473 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -133.34 -160.1 1.02 Allowed 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -64.18 116.32 5.86 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.43 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 53.1 tptt 77.4 59.22 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 O-C-N 124.212 0.945 . . . . 0.0 111.416 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 66.61 -121.65 0.28 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.938 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -124.97 38.28 4.23 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.71 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.481 ' HA ' ' HB2' ' A' ' 184' ' ' HIS . 25.2 p-10 -75.1 99.2 3.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.815 0.816 . . . . 0.0 109.335 177.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.722 HG21 HD11 ' A' ' 8' ' ' ILE . 2.1 p -142.34 165.33 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 CA-C-O 121.397 0.618 . . . . 0.0 111.289 -175.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.517 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 97.2 mt -92.83 113.13 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.954 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.113 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.48 HD13 ' CE1' ' A' ' 2' ' ' PHE . 29.6 pt -120.13 167.67 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.293 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.403 ' C ' ' H ' ' A' ' 180' ' ' ASN . 6.6 t-20 49.77 -132.38 1.75 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.095 0.958 . . . . 0.0 109.987 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.84 44.62 0.84 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.774 0.797 . . . . 0.0 110.52 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.4 m-20 73.05 47.55 0.19 Allowed 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 125.61 1.564 . . . . 0.0 113.342 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.7 mt -87.35 113.69 25.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.525 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.67 124.13 39.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.658 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.506 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 8.9 t -137.65 167.49 21.57 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.793 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.493 ' O ' HD22 ' A' ' 96' ' ' LEU . 38.4 m80 72.32 140.52 0.06 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.766 0.826 . . . . 0.0 112.996 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.422 ' H ' ' CD ' ' A' ' 185' ' ' GLN . 4.4 pm0 . . . . . 0 C--O 1.258 1.52 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.573 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.574 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 77.6 m . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.841 0.353 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -114.32 164.72 15.51 Favored Pre-proline 0 C--N 1.317 -0.825 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.549 ' HD3' HD13 ' A' ' 76' ' ' LEU . 72.3 Cg_endo -72.96 162.94 39.72 Favored 'Trans proline' 0 N--CA 1.429 -2.292 0 N-CA-C 108.319 -1.454 . . . . 0.0 108.319 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.564 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -63.45 -25.36 68.55 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.055 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.88 -11.77 14.54 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.8 m -73.26 132.32 43.0 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.878 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 72.9 mmt-85 -84.21 135.78 34.22 Favored 'General case' 0 C--O 1.188 -2.163 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.445 HD11 HG21 ' A' ' 175' ' ' VAL . 9.6 tt -120.71 130.23 74.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.74 HD21 HD11 ' A' ' 124' ' ' LEU . 1.3 tm? -89.83 124.32 34.57 Favored 'General case' 0 N--CA 1.412 -2.368 0 CA-C-O 121.545 0.688 . . . . 0.0 110.125 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.522 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 30.7 m -135.09 -175.72 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.57 -178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 33.0 tt0 -131.63 121.18 23.92 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.6 HG12 HG13 ' A' ' 47' ' ' ILE . 20.2 mt -120.05 121.89 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.949 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.62 -177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' A' ' 45' ' ' ARG . 68.1 m-20 55.04 38.41 30.48 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.948 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.86 18.46 78.94 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.841 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.53 120.03 23.17 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.49 ' HB2' HD13 ' A' ' 124' ' ' LEU . 42.7 Cg_endo -70.95 121.95 8.35 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.623 2.215 . . . . 0.0 111.64 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -124.94 142.34 51.53 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.821 -176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -114.48 101.81 9.48 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.643 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.478 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.4 pt -125.12 -172.5 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.161 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.048 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.722 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 6.8 p -91.68 173.07 8.07 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.333 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.6 mm? -64.12 -35.84 82.08 Favored 'General case' 0 N--CA 1.421 -1.923 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.296 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.722 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 8.2 ptm180 -76.95 -26.64 54.24 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.543 ' OE1' HG23 ' A' ' 20' ' ' THR . 52.3 mt-10 -80.59 -39.34 27.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.951 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.799 HD21 HD22 ' A' ' 167' ' ' LEU . 18.3 tp -61.35 -41.85 97.73 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.069 0.938 . . . . 0.0 109.139 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.664 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 6.6 m-30 -57.28 -28.98 63.48 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 113.588 -1.642 . . . . 0.0 113.164 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.645 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 54.1 mt-10 -73.16 -17.49 61.37 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.248 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.0 mm? -78.92 2.54 19.83 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 121.484 0.659 . . . . 0.0 109.57 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.503 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.9 m-85 -116.33 163.01 16.65 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.535 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -141.48 -173.12 3.68 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.588 176.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 1.7 t70 63.23 84.85 0.14 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.326 0.584 . . . . 0.0 110.842 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -100.4 126.93 46.83 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.741 0.782 . . . . 0.0 110.998 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -115.66 150.52 36.61 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.808 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -102.25 129.72 48.74 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.404 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -167.44 148.72 5.58 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.029 -177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 57.89 19.63 5.95 Favored 'General case' 0 CA--C 1.496 -1.109 0 O-C-N 123.798 0.686 . . . . 0.0 111.726 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.6 mtt 71.02 18.84 5.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.393 0.615 . . . . 0.0 110.274 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 4.5 m -129.01 -173.14 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.484 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 64.7 m-85 -118.5 142.57 47.46 Favored 'General case' 0 CA--C 1.483 -1.607 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.186 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.1 t -129.02 123.73 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.893 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.399 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.652 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 35.4 ttm180 -116.92 126.86 53.6 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -136.16 144.38 44.98 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.574 -0.451 . . . . 0.0 110.974 -174.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 14.2 ttmt 88.55 108.83 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.41 0 O-C-N 124.916 1.385 . . . . 0.0 110.568 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.593 ' HB2' HD13 ' A' ' 47' ' ' ILE . 93.0 Cg_endo -79.81 153.83 22.95 Favored 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 122.442 2.095 . . . . 0.0 111.843 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -87.78 -1.25 57.84 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.471 0.653 . . . . 0.0 111.108 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' A' ' 13' ' ' ASP . 50.3 mtt180 -143.42 -166.15 2.25 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 9.6 tp10 -89.28 101.78 14.45 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 172.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.6 HG13 HG12 ' A' ' 12' ' ' ILE . 1.3 mp -114.56 118.16 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.017 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.522 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 35.6 mmtt -115.39 169.04 9.45 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.911 175.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.495 HG11 ' CB ' ' A' ' 169' ' ' ALA . 9.3 p -123.85 130.83 73.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.076 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -88.24 129.4 35.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.031 0.443 . . . . 0.0 110.967 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.7 t -140.94 176.72 8.58 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.699 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.425 HD13 ' C ' ' A' ' 58' ' ' LYS . 2.0 mm -120.75 145.07 27.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.249 0.547 . . . . 0.0 110.561 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.761 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.2 t70 -88.62 123.34 32.99 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.819 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.72 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -75.16 -17.86 60.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.106 0.479 . . . . 0.0 112.195 -172.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.761 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -94.55 -28.24 15.52 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.702 -175.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.44 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 60.3 p -114.85 -21.73 9.99 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.331 -176.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.77 17.64 74.73 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.138 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.44 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 18.5 mtpp -94.56 157.72 15.86 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.506 HG11 HD13 ' A' ' 122' ' ' LEU . 6.1 p -91.52 110.43 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.47 178.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.2 m -110.12 158.19 10.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.202 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 49' ' ' VAL . 12.4 tp -122.65 140.27 53.03 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.0 t -147.04 172.05 14.33 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.611 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.78 161.58 20.92 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.763 0.792 . . . . 0.0 111.783 178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.55 HD13 HG22 ' A' ' 47' ' ' ILE . 2.1 mp -95.8 142.4 13.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.665 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.543 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 19.5 mt-10 -93.02 -34.88 13.54 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -179.55 -177.33 0.42 Allowed 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.823 0.821 . . . . 0.0 111.716 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 6.9 t -115.24 128.3 72.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.696 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.575 HD12 ' HB2' ' A' ' 166' ' ' SER . 33.1 mt -97.09 104.73 16.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.548 -175.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.563 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 59.1 tttp -117.25 108.11 15.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.09 136.05 28.22 Favored Pre-proline 0 C--N 1.308 -1.218 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.137 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HD2' HG12 ' A' ' 37' ' ' VAL . 72.5 Cg_exo -48.28 139.55 21.68 Favored 'Trans proline' 0 C--O 1.24 0.612 0 C-N-CA 123.677 2.918 . . . . 0.0 113.689 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -85.83 96.32 9.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.158 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 41.1 p -89.11 -31.58 17.94 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.354 -175.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.0 -97.95 0.4 Allowed 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 157' ' ' VAL . 0.4 OUTLIER 178.74 173.48 0.71 Allowed 'General case' 0 CA--C 1.471 -2.088 0 C-N-CA 123.936 0.895 . . . . 0.0 108.832 -175.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.681 HD23 ' HA ' ' A' ' 90' ' ' THR . 5.7 mt -123.96 140.6 52.82 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 118.748 -1.181 . . . . 0.0 112.898 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.5 HD12 ' C ' ' A' ' 108' ' ' ALA . 9.3 mt -84.77 145.94 7.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 172.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 19.9 ttt85 -116.94 138.38 51.58 Favored 'General case' 0 N--CA 1.408 -2.564 0 CA-C-O 121.227 0.537 . . . . 0.0 110.173 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.499 ' CD1' HD13 ' A' ' 151' ' ' ILE . 61.3 m-85 -116.13 122.86 46.33 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.28 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.0 tt0 -110.9 126.4 54.66 Favored 'General case' 0 CA--C 1.468 -2.202 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -89.88 162.49 15.43 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.464 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.859 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.2 pt-20 -63.15 -15.65 57.52 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.786 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -91.92 -10.29 40.07 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.533 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.06 4.33 66.97 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.749 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.585 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -83.57 143.38 30.19 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 23.0 p -141.76 157.92 44.44 Favored 'General case' 0 C--N 1.285 -2.214 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.748 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -148.34 154.07 39.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.894 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 16.3 mt-10 -125.0 148.87 48.25 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.727 -176.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -143.0 156.82 44.92 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.532 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.681 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -67.17 13.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.051 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.4 m 67.27 -41.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 125.362 1.465 . . . . 0.0 113.814 176.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -81.17 -28.61 34.94 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.304 0.573 . . . . 0.0 109.956 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -73.49 144.37 83.66 Favored Pre-proline 0 C--N 1.314 -0.969 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.735 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.687 ' O ' ' HB3' ' A' ' 184' ' ' HIS . 5.7 Cg_exo -74.46 144.05 31.85 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.546 2.831 . . . . 0.0 114.704 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.9 t -109.01 146.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 124.841 1.256 . . . . 0.0 107.634 175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 183' ' ' THR . 12.4 tp -102.36 113.08 26.1 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.179 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.696 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.0 p -116.8 150.23 18.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.33 0.586 . . . . 0.0 111.817 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.427 ' CD2' HD12 ' A' ' 148' ' ' LEU . 72.4 t80 -103.17 95.93 6.45 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.877 177.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -138.57 156.66 47.29 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 63.15 22.87 13.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.058 0.456 . . . . 0.0 110.319 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.79 13.01 63.07 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.925 -177.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.411 ' HG3' HG23 ' A' ' 104' ' ' ILE . 7.7 ptp180 -132.36 171.71 13.39 Favored 'General case' 0 N--CA 1.404 -2.767 0 CA-C-N 117.434 0.617 . . . . 0.0 109.8 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.423 ' CE1' HD12 ' A' ' 118' ' ' LEU . 59.5 m-85 -104.91 122.39 45.7 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.54 HG13 HG13 ' A' ' 97' ' ' VAL . 22.9 pt -121.61 156.57 25.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.312 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -111.69 106.98 15.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.808 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.467 ' HG3' HG22 ' A' ' 111' ' ' VAL . 15.7 ptpt -122.81 141.23 52.06 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.725 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.564 ' O ' HG23 ' A' ' 111' ' ' VAL . 66.3 mtm180 -60.96 155.2 20.51 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.051 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -59.34 -40.32 85.99 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.312 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.494 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.2 p90 -75.21 -0.71 20.33 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.797 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -106.3 -19.65 13.63 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.703 0.763 . . . . 0.0 109.311 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 107' ' ' ARG . 86.5 t -71.67 149.11 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.506 177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.692 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -122.17 166.83 13.97 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.842 -178.417 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.17 141.95 52.55 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.43 4.96 79.86 Favored Glycine 0 C--N 1.306 -1.086 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.518 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.696 ' OD1' HG21 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -75.48 173.46 10.94 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -127.04 163.3 24.05 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-O 121.719 0.771 . . . . 0.0 112.198 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.3 158.26 42.92 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 CA-C-N 114.639 -1.164 . . . . 0.0 107.887 168.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.509 ' HB3' ' HB ' ' A' ' 182' ' ' VAL . 1.1 tt -88.98 133.29 34.37 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.687 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -115.93 130.18 71.06 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 173.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.1 t -63.74 -19.16 64.74 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.058 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.657 ' HB3' ' HB3' ' A' ' 145' ' ' HIS . 34.2 mm-40 45.2 15.15 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.777 -1.556 . . . . 0.0 114.468 -176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.506 HD13 HG11 ' A' ' 59' ' ' VAL . 0.8 OUTLIER -83.33 121.91 27.75 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.917 -178.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.405 ' OE2' ' HB3' ' A' ' 143' ' ' PRO . 1.2 pm0 -89.41 156.56 18.6 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.488 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.74 HD11 HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -143.5 -66.14 0.37 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.592 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.7 p 178.41 140.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.559 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -106.09 -36.14 7.02 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.148 0.499 . . . . 0.0 110.745 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -89.83 87.28 6.9 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.128 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.5 m -145.63 -91.51 0.1 Allowed 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.906 177.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.4 p 42.55 35.79 0.71 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.48 0.712 . . . . 0.0 112.786 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 33.8 m -111.27 152.05 27.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.553 -178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.0 t -108.35 -4.08 17.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.001 0.429 . . . . 0.0 110.327 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -101.6 -68.27 0.83 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.908 0.385 . . . . 0.0 110.757 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -83.54 98.58 9.64 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.494 0.664 . . . . 0.0 111.001 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.544 ' H ' ' CD ' ' A' ' 135' ' ' PRO . 18.6 m120 -124.91 -49.98 0.04 OUTLIER Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.544 ' CD ' ' H ' ' A' ' 134' ' ' ASN . 10.0 Cg_exo -71.83 81.29 1.37 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.71 2.274 . . . . 0.0 113.607 -175.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -156.57 110.62 2.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.515 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -168.69 95.4 0.36 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.271 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 139' ' ' ASN . 39.1 tt0 -136.66 150.72 48.65 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 28.5 t-20 87.36 5.49 0.3 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 31.6 tp 57.24 -102.84 0.16 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.068 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.89 48.77 2.22 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.415 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 34.7 t -44.79 123.37 4.83 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 124.122 0.969 . . . . 0.0 112.578 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 142' ' ' SER . 26.7 Cg_exo -64.74 175.33 3.71 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 123.161 2.574 . . . . 0.0 110.929 176.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 178.47 121.89 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.706 0.288 . . . . 0.0 111.652 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER 179.96 153.33 0.5 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.872 177.437 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -156.41 98.1 1.81 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.151 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.541 ' C ' HD23 ' A' ' 148' ' ' LEU . 23.8 pt20 -164.76 143.24 6.72 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.346 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.541 HD23 ' C ' ' A' ' 147' ' ' GLN . 7.1 mt -109.28 155.46 21.11 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 121.375 0.607 . . . . 0.0 110.989 176.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.859 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -116.85 137.9 51.89 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.897 -1.047 . . . . 0.0 113.063 -173.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.417 ' H ' HD13 ' A' ' 149' ' ' LEU . 14.2 mt-10 -88.72 145.58 25.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 124.652 1.181 . . . . 0.0 112.639 175.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.502 HD12 ' HB3' ' A' ' 115' ' ' ASP . 70.0 mt -80.08 104.26 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.515 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.766 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 6.6 mmpt? -68.18 -38.96 82.61 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.876 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -149.59 135.63 18.86 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 82.5 mt -114.77 144.26 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.476 174.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.507 ' CD ' ' HD3' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -148.1 158.43 44.06 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.922 -178.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.423 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 15.2 m-85 -99.15 111.76 24.07 Favored 'General case' 0 N--CA 1.407 -2.583 0 CA-C-O 121.802 0.811 . . . . 0.0 109.762 174.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -116.56 175.64 2.91 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.903 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.29 179.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.439 ' HB3' ' H ' ' A' ' 159' ' ' ALA . 78.1 mtt180 -79.56 -146.55 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 120.381 -0.528 . . . . 0.0 112.169 -177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.439 ' H ' ' HB3' ' A' ' 158' ' ' ARG . . . -104.08 -13.61 16.21 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.673 -176.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 61.67 8.11 2.2 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.956 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -175.21 -173.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -104.0 -7.72 20.12 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -139.35 158.28 44.42 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.269 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.456 HG11 HD21 ' A' ' 76' ' ' LEU . 2.9 m -128.88 157.16 41.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.091 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.664 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 11.3 m-85 -131.29 170.55 14.46 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.714 -172.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.575 ' HB2' HD12 ' A' ' 68' ' ' ILE . 68.3 m -159.88 -22.01 0.06 Allowed 'General case' 0 C--N 1.359 0.994 0 CA-C-O 120.622 0.249 . . . . 0.0 110.377 178.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.799 HD22 HD21 ' A' ' 24' ' ' LEU . 14.4 tp 64.52 110.87 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.164 0.915 . . . . 0.0 112.081 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.526 HD22 ' HB2' ' A' ' 65' ' ' GLU . 4.4 t30 -84.63 108.26 17.27 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.543 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -112.65 -161.0 0.74 Allowed 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.665 ' O ' ' HG2' ' A' ' 171' ' ' LYS . 49.1 tptt -60.79 109.16 0.98 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.854 0.359 . . . . 0.0 110.67 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.665 ' HG2' ' O ' ' A' ' 170' ' ' LYS . 48.8 pttt 66.39 9.44 6.46 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.312 1.445 . . . . 0.0 111.934 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.458 ' O ' ' HB3' ' A' ' 173' ' ' HIS . 43.7 p90 38.39 -140.96 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.71 0.804 . . . . 0.0 111.251 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.597 ' O ' ' HA ' ' A' ' 184' ' ' HIS . 12.6 t60 80.28 -45.37 0.28 Allowed 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 171.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.4 HD21 HD22 ' A' ' 96' ' ' LEU . 6.6 m120 -129.41 153.59 47.77 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.962 0.411 . . . . 0.0 111.994 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.553 HG13 HG23 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -165.81 158.47 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.686 176.406 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.584 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 88.9 mt -108.9 116.52 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.779 0 CA-C-O 121.007 0.432 . . . . 0.0 110.321 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.553 HG23 HG13 ' A' ' 175' ' ' VAL . 43.2 pt -122.04 169.44 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.729 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 6.6 t-20 48.8 -133.05 1.51 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.333 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.424 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 16.1 mm-40 -83.94 53.97 2.76 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.459 0.647 . . . . 0.0 110.008 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.687 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.0 m120 70.55 45.32 0.61 Allowed 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.357 -1.292 . . . . 0.0 113.909 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 98.3 mt -86.04 112.38 22.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 118' ' ' LEU . 98.6 t -86.93 117.5 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.299 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . 8.8 t -146.74 -176.22 5.11 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.939 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.687 ' HB3' ' O ' ' A' ' 94' ' ' PRO . 62.6 t-80 -92.73 137.87 31.99 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 . . . . . 0 C--O 1.263 1.791 0 CA-C-O 117.464 -1.255 . . . . 0.0 110.884 178.123 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.624 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 56.6 m . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 121.095 0.474 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.536 ' HB2' ' CD1' ' A' ' 21' ' ' LEU . 7.0 m-85 -136.0 163.32 51.16 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.478 ' HD3' HD13 ' A' ' 76' ' ' LEU . 73.0 Cg_endo -72.51 161.93 42.8 Favored 'Trans proline' 0 N--CA 1.438 -1.77 0 N-CA-C 108.41 -1.419 . . . . 0.0 108.41 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.01 -26.49 63.37 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 118.682 -1.723 . . . . 0.0 110.875 175.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.43 ' OD1' ' HB2' ' A' ' 160' ' ' ASN . 6.9 m-20 -59.79 -13.81 12.01 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.7 m -74.4 129.03 37.0 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.484 -0.487 . . . . 0.0 110.351 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 10.9 mtm-85 -84.88 129.45 34.81 Favored 'General case' 0 C--O 1.195 -1.766 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.757 HD11 HG21 ' A' ' 175' ' ' VAL . 10.5 tt -115.04 129.87 70.51 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.779 HD21 HD21 ' A' ' 124' ' ' LEU . 2.6 tm? -94.96 123.94 38.72 Favored 'General case' 0 N--CA 1.399 -3.009 0 CA-C-O 121.786 0.803 . . . . 0.0 110.474 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.671 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 31.0 m -132.23 -172.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.849 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 30.9 tt0 -131.52 123.54 28.22 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.619 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 28.3 mt -120.68 122.49 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.893 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.632 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.408 ' HA ' ' HB3' ' A' ' 46' ' ' GLU . 0.7 OUTLIER 54.74 41.81 31.65 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.033 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.58 18.92 72.43 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 114.49 -1.232 . . . . 0.0 113.774 -177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -130.55 118.73 18.07 Favored Pre-proline 0 N--CA 1.43 -1.456 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.53 ' HB2' HD13 ' A' ' 124' ' ' LEU . 52.6 Cg_exo -53.44 148.21 34.72 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 C-N-CA 122.053 1.835 . . . . 0.0 111.104 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -148.83 129.18 13.81 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.604 ' HB2' HD23 ' A' ' 9' ' ' LEU . 40.3 ttmt -117.62 102.93 9.56 Favored 'General case' 0 CA--C 1.48 -1.741 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.883 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.4 pt -125.23 -173.9 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.253 177.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.676 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 10.4 p -92.28 172.08 8.65 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.392 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 81.8 mt -66.17 -28.47 68.8 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.414 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.676 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 4.3 ptm180 -82.1 -24.56 35.09 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.466 ' OE1' HG23 ' A' ' 20' ' ' THR . 51.9 mt-10 -84.16 -39.99 18.73 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.861 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.661 HD23 ' HG ' ' A' ' 167' ' ' LEU . 17.5 tp -61.12 -41.08 96.04 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.546 0.689 . . . . 0.0 109.826 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.511 ' HD1' HG11 ' A' ' 67' ' ' VAL . 1.4 t80 -51.14 -32.76 24.01 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.978 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.4 mt-10 -74.48 -15.8 60.87 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.248 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.92 2.17 27.8 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.589 0.709 . . . . 0.0 109.56 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.613 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.9 m-85 -118.37 164.54 15.09 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.832 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.569 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 12.6 mm-40 -141.16 -172.97 3.61 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.028 175.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t0 63.18 81.33 0.21 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.57 0.7 . . . . 0.0 110.392 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -99.19 122.44 42.39 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-O 121.791 0.805 . . . . 0.0 111.044 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -113.14 150.45 32.19 Favored 'General case' 0 N--CA 1.413 -2.298 0 CA-C-N 114.168 -1.378 . . . . 0.0 109.923 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -101.79 131.14 48.26 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -166.6 145.76 5.59 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.763 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.98 21.84 9.72 Favored 'General case' 0 CA--C 1.488 -1.41 0 O-C-N 123.85 0.718 . . . . 0.0 111.51 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 43.8 mtm 72.36 18.97 4.45 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.691 0.619 . . . . 0.0 110.569 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 10.5 m -134.7 -175.16 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.441 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 90.7 m-85 -112.85 139.98 48.02 Favored 'General case' 0 CA--C 1.478 -1.798 0 CA-C-O 121.243 0.544 . . . . 0.0 110.535 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -128.39 124.06 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.85 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.582 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 13.6 ttm180 -118.04 128.26 54.6 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.54 145.69 51.34 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.843 -173.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 5.2 tppp? 81.84 111.81 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.643 1.214 . . . . 0.0 111.235 -178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.568 ' HB2' HD13 ' A' ' 47' ' ' ILE . 66.1 Cg_endo -78.91 154.0 25.82 Favored 'Trans proline' 0 N--CA 1.437 -1.821 0 C-N-CA 122.079 1.853 . . . . 0.0 111.951 177.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.569 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 36.3 mtmt -85.38 -4.34 59.13 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.868 -178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -149.17 -165.22 2.22 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 33.9 tt0 -86.82 101.65 13.55 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.613 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.6 mp -114.85 113.02 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.998 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.671 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 72.6 mmtt -116.95 169.39 9.44 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.694 175.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.537 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.8 p -120.88 124.93 73.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.551 0.691 . . . . 0.0 111.959 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.788 ' CZ ' HG21 ' A' ' 59' ' ' VAL . 5.5 t80 -76.47 123.31 25.83 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.952 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.5 t -140.13 168.25 20.25 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.932 0.396 . . . . 0.0 110.815 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.6 mm -115.13 145.14 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.164 0.507 . . . . 0.0 110.681 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -91.99 117.93 30.29 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.634 ' H ' HD12 ' A' ' 54' ' ' LEU . 4.2 mp -69.42 -31.47 69.83 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.786 0.803 . . . . 0.0 111.763 -172.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.35 -30.35 42.6 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.986 -174.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.4 p -111.08 -25.61 9.67 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.023 -176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.67 13.33 75.88 Favored Glycine 0 N--CA 1.421 -2.321 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.855 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.9 mtpt -92.91 170.18 9.88 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 120.899 0.38 . . . . 0.0 111.24 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.788 HG21 ' CZ ' ' A' ' 50' ' ' TYR . 7.6 p -103.14 118.61 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.671 0 CA-C-O 121.873 0.844 . . . . 0.0 110.529 177.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.8 m -111.51 153.78 13.19 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.424 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 49' ' ' VAL . 11.7 tp -122.36 132.86 54.59 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.597 HG21 ' HB2' ' A' ' 170' ' ' LYS . 10.8 t -140.09 173.28 11.67 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.462 -176.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -86.64 161.38 18.51 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.793 0.806 . . . . 0.0 111.558 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.55 HD13 HG22 ' A' ' 47' ' ' ILE . 2.1 mp -91.81 141.24 14.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.688 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.6 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 7.9 mm-40 -83.46 -39.65 20.27 Favored 'General case' 0 CA--C 1.5 -0.968 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 p30 178.12 174.79 0.56 Allowed 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.812 -177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.582 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 25.9 t -104.76 137.35 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.319 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.57 HD13 ' HB2' ' A' ' 166' ' ' SER . 0.0 OUTLIER -113.99 126.51 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.335 -178.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.497 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 52.6 tttp -135.38 115.81 13.61 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.889 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.39 142.56 45.86 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.697 -176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.431 ' HD2' HG12 ' A' ' 37' ' ' VAL . 7.2 Cg_endo -51.72 136.32 50.19 Favored 'Trans proline' 0 C--N 1.327 -0.58 0 C-N-CA 123.284 2.656 . . . . 0.0 112.185 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.84 97.95 1.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.4 p -88.54 -67.12 0.85 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.073 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -92.64 -161.75 0.86 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.391 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 18.7 m80 -107.84 173.63 6.24 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' A' ' 90' ' ' THR . 10.5 mt -124.47 138.6 54.33 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.541 0.686 . . . . 0.0 111.214 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.498 HD12 ' C ' ' A' ' 108' ' ' ALA . 13.4 mt -85.0 145.01 8.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 31.9 ttt85 -121.24 137.14 54.82 Favored 'General case' 0 N--CA 1.406 -2.664 0 CA-C-O 121.282 0.563 . . . . 0.0 109.597 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.662 ' O ' ' HA ' ' A' ' 86' ' ' SER . 59.2 m-85 -116.6 127.85 54.86 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.127 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.8 tt0 -113.05 126.16 55.17 Favored 'General case' 0 CA--C 1.471 -2.093 0 C-N-CA 120.551 -0.46 . . . . 0.0 109.983 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.788 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -90.15 152.4 21.13 Favored 'General case' 0 N--CA 1.399 -2.98 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.676 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.981 ' HG2' HD11 ' A' ' 149' ' ' LEU . 5.3 pt-20 -55.3 -22.27 18.15 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.606 ' OD1' ' HG3' ' A' ' 85' ' ' ARG . 32.6 p-10 -102.5 1.37 34.98 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.529 0.681 . . . . 0.0 110.968 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 98.87 19.91 20.52 Favored Glycine 0 C--N 1.304 -1.223 0 CA-C-N 114.767 -1.106 . . . . 0.0 115.837 171.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.606 ' HG3' ' OD1' ' A' ' 83' ' ' ASP . 8.4 mtt180 -88.51 136.29 33.06 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 57.2 p -138.44 137.24 37.03 Favored 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 119.034 -1.066 . . . . 0.0 111.86 173.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -134.63 155.22 50.86 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.362 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 38.3 mt-10 -131.3 151.31 51.63 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.257 0.551 . . . . 0.0 112.008 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.496 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.7 OUTLIER -146.6 161.1 41.23 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.693 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.689 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -70.35 16.82 0.07 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.01 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.66 -28.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 125.235 1.414 . . . . 0.0 112.715 177.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 26.8 t70 -87.98 -8.07 56.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.433 0.635 . . . . 0.0 110.219 176.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.504 ' HB2' ' H2 ' ' A' ' 1' ' ' CYS . 62.6 t-80 -82.15 125.97 75.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.579 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 34.3 Cg_exo -62.92 138.02 65.91 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.921 2.414 . . . . 0.0 112.568 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 17.3 t -114.7 146.17 19.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.3 tp -98.83 106.38 18.63 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 116' ' ' LYS . 2.4 p -108.18 148.46 12.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.342 0.591 . . . . 0.0 111.4 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.505 ' CD2' HD12 ' A' ' 148' ' ' LEU . 49.8 t80 -100.99 94.15 5.86 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.813 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.505 ' CG ' HD11 ' A' ' 104' ' ' ILE . 11.5 pt-20 -144.96 158.23 43.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.2 m-20 64.02 22.16 12.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.015 0.436 . . . . 0.0 110.173 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.13 13.36 61.99 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.689 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -136.67 172.61 12.76 Favored 'General case' 0 N--CA 1.4 -2.926 0 CA-C-O 121.452 0.644 . . . . 0.0 110.425 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -104.72 121.61 43.97 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.686 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.505 HD11 ' CG ' ' A' ' 99' ' ' GLU . 16.7 pt -126.74 151.46 33.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.792 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.3 mp0 -106.28 111.24 23.75 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.092 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HG3' HG22 ' A' ' 111' ' ' VAL . 11.6 ptpt -125.76 143.43 51.05 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.277 177.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.643 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 79.7 mtt85 -61.57 163.28 7.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -177.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.01 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -61.41 -41.17 96.71 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.803 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 1.1 p90 -75.17 -0.92 20.93 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.717 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -106.73 -19.32 13.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.69 0.757 . . . . 0.0 109.172 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 107' ' ' ARG . 52.9 t -76.25 150.41 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 176.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.616 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -124.47 168.03 13.62 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.408 -177.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -68.24 138.45 55.57 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.25 5.13 67.84 Favored Glycine 0 C--N 1.3 -1.418 0 C-N-CA 120.194 -1.003 . . . . 0.0 111.825 -174.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.735 ' HB3' HD12 ' A' ' 151' ' ' ILE . 3.7 t70 -75.72 165.77 24.55 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.448 ' H ' HG23 ' A' ' 97' ' ' VAL . 29.1 mttp -124.63 160.97 27.26 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.311 0.576 . . . . 0.0 111.116 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.35 160.26 42.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.271 173.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.7 136.24 37.51 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.565 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.2 m -109.11 161.15 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 121' ' ' GLU . 80.6 p -80.87 27.68 0.37 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.281 0.562 . . . . 0.0 110.547 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' A' ' 119' ' ' VAL . 41.1 mt-10 72.92 -43.36 0.56 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 124.742 1.217 . . . . 0.0 113.156 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.616 ' HG ' ' H ' ' A' ' 123' ' ' GLU . 12.4 tp 179.11 -169.24 0.1 Allowed 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -170.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.616 ' H ' ' HG ' ' A' ' 122' ' ' LEU . 0.6 OUTLIER 172.65 -150.7 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 O-C-N 123.567 0.542 . . . . 0.0 111.544 178.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.779 HD21 HD21 ' A' ' 9' ' ' LEU . 1.8 pt? -66.18 49.36 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.427 1.891 . . . . 0.0 111.584 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.0 t -17.14 117.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 125.968 1.707 . . . . 0.0 113.062 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -111.0 169.48 8.74 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.929 -173.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -102.53 -52.85 3.01 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.8 p -169.15 80.57 0.13 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.172 -1.376 . . . . 0.0 108.0 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.1 t 69.34 -164.73 0.18 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.187 -174.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.0 m -99.8 155.09 17.83 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.931 0.396 . . . . 0.0 111.06 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.0 t -95.98 -16.61 21.58 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.069 0.462 . . . . 0.0 110.098 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 135' ' ' PRO . 52.7 mt-30 -123.91 -177.73 3.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.124 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -61.9 -43.27 99.19 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.639 0.733 . . . . 0.0 112.089 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.57 ' H ' ' CD ' ' A' ' 135' ' ' PRO . 49.9 t30 -163.95 -45.1 0.0 OUTLIER Pre-proline 0 C--N 1.281 -2.412 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.211 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.57 ' CD ' ' H ' ' A' ' 134' ' ' ASN . 27.5 Cg_exo -63.99 144.81 88.8 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.047 1.832 . . . . 0.0 109.383 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -173.43 -40.15 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.83 -175.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -172.44 134.45 0.67 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.449 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -101.22 -82.89 0.46 Allowed 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 41.61 -97.21 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.255 1.022 . . . . 0.0 112.611 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 38.4 tp -163.82 144.32 8.58 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.406 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.87 56.15 0.54 Allowed Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 120.159 -1.019 . . . . 0.0 112.524 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.6 p -83.9 117.64 69.23 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 144' ' ' GLU . 9.6 Cg_endo -86.96 170.27 7.31 Favored 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.394 2.062 . . . . 0.0 112.111 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 143' ' ' PRO . 34.8 tt0 171.8 113.06 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.836 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 178.47 98.75 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.275 0.36 . . . . 0.0 110.186 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.16 93.22 7.02 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.748 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.424 ' C ' HD23 ' A' ' 148' ' ' LEU . 6.8 pt20 -164.5 119.95 1.48 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.25 177.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.505 HD12 ' CD2' ' A' ' 98' ' ' TYR . 9.7 mt -102.11 148.82 24.93 Favored 'General case' 0 N--CA 1.415 -2.209 0 CA-C-O 121.356 0.598 . . . . 0.0 109.738 175.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.981 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -113.9 137.58 51.48 Favored 'General case' 0 C--N 1.279 -2.474 0 CA-C-N 115.043 -0.98 . . . . 0.0 112.423 -172.14 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.473 ' H ' HD13 ' A' ' 149' ' ' LEU . 10.2 mt-10 -90.8 145.28 24.91 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.574 177.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.735 HD12 ' HB3' ' A' ' 115' ' ' ASP . 82.2 mt -76.96 102.72 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.371 176.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.67 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 35.5 mmtm -69.33 -35.74 76.23 Favored 'General case' 0 C--N 1.264 -3.125 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.369 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -151.59 128.79 11.18 Favored 'General case' 0 CA--C 1.483 -1.599 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 66.7 mt -112.56 144.76 19.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.795 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.476 ' HD3' HG13 ' A' ' 157' ' ' VAL . 5.7 ptpp? -146.41 156.45 43.32 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.123 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -99.42 115.26 28.84 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.476 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -128.87 173.75 13.24 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.568 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.878 -177.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 27.1 ptt180 -106.35 166.1 10.78 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.37 132.35 46.24 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.935 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.43 ' HB2' ' OD1' ' A' ' 5' ' ' ASP . 24.3 m-80 -87.95 34.58 0.73 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.276 0.56 . . . . 0.0 110.018 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -161.74 178.86 8.6 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -106.03 -1.36 23.99 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.399 0.619 . . . . 0.0 110.243 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -139.13 153.38 47.96 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.478 175.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.8 m -119.01 157.12 20.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 58.5 m-85 -132.84 175.04 9.7 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.553 -176.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.624 ' OG ' ' HA ' ' A' ' 1' ' ' CYS . 49.2 m -154.54 -29.55 0.11 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.884 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.661 ' HG ' HD23 ' A' ' 24' ' ' LEU . 2.5 mm? 61.93 90.97 0.07 Allowed 'General case' 0 C--N 1.345 0.371 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -177.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 65' ' ' GLU . 47.8 m-20 -81.75 104.5 12.18 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-O 121.608 0.718 . . . . 0.0 111.974 -175.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.6 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -94.67 -155.41 0.46 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.285 172.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.597 ' HB2' HG21 ' A' ' 62' ' ' THR . 32.7 mmtm -61.66 133.77 55.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.223 0.535 . . . . 0.0 112.083 -177.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 74.8 tttt 78.84 -11.92 1.15 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.401 -177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 69.01 144.0 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.919 0.888 . . . . 0.0 112.078 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 49.16 32.37 4.12 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.949 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -117.59 104.01 10.61 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.416 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.757 HG21 HD11 ' A' ' 8' ' ' ILE . 1.7 p -158.66 171.07 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -176.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.596 ' H ' HG22 ' A' ' 175' ' ' VAL . 71.8 mt -116.42 122.4 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.923 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.547 HG23 HG13 ' A' ' 175' ' ' VAL . 43.1 pt -126.68 167.39 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 121.597 0.713 . . . . 0.0 112.637 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 38.9 t30 52.48 -129.63 2.31 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.255 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.436 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 3.2 mp0 -78.89 42.99 0.48 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.017 0.437 . . . . 0.0 110.491 176.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.3 m-20 71.02 48.37 0.38 Allowed 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 124.508 1.123 . . . . 0.0 112.308 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 85.0 mt -88.75 112.17 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.469 HG12 HG12 ' A' ' 176' ' ' ILE . 2.6 m -79.47 135.51 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.694 0 CA-C-O 121.969 0.89 . . . . 0.0 111.208 -178.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.6 t -139.69 119.51 13.36 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -144.35 150.71 38.22 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -172.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 . . . . . 0 C--O 1.266 1.94 0 CA-C-O 117.26 -1.352 . . . . 0.0 109.706 176.677 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.721 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 33.7 t . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.922 0.391 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.424 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 1.7 m-85 -121.91 166.0 18.33 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.546 ' HD3' HD13 ' A' ' 76' ' ' LEU . 74.0 Cg_endo -71.56 164.82 34.44 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 122.035 1.823 . . . . 0.0 109.356 175.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.17 -29.85 63.29 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 119.276 -1.44 . . . . 0.0 111.334 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.618 ' HA ' ' NH1' ' A' ' 22' ' ' ARG . 35.7 t70 -61.37 -16.44 46.37 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.1 m -68.73 125.42 26.52 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.072 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.715 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 78.5 mtm-85 -84.01 134.88 34.62 Favored 'General case' 0 C--O 1.182 -2.46 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.453 ' CD1' HG21 ' A' ' 175' ' ' VAL . 9.5 tt -120.47 130.1 74.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.529 HD21 HD11 ' A' ' 124' ' ' LEU . 0.6 OUTLIER -88.67 122.77 32.46 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-O 121.52 0.676 . . . . 0.0 109.656 178.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.4 m -135.52 -179.36 3.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.071 -176.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 33.0 tt0 -129.52 121.77 27.88 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.944 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.631 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 19.1 mt -121.79 121.8 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.097 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.92 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 56.43 37.48 28.86 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.473 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.38 15.92 77.23 Favored Glycine 0 C--N 1.305 -1.162 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.638 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -123.27 121.23 27.04 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.597 ' HB2' HD22 ' A' ' 124' ' ' LEU . 56.6 Cg_endo -72.44 122.69 8.51 Favored 'Trans proline' 0 N--CA 1.431 -2.163 0 C-N-CA 122.334 2.023 . . . . 0.0 111.416 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -120.45 138.13 53.96 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.466 -0.788 . . . . 0.0 108.916 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -107.98 101.08 10.37 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.3 pt -127.03 -172.86 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.364 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.715 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 21.5 p -97.96 172.24 7.76 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.771 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.574 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 66.2 mt -68.15 -27.38 66.38 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.016 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.618 ' NH1' ' HA ' ' A' ' 5' ' ' ASP . 1.0 OUTLIER -78.53 -26.66 45.8 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.45 ' OE1' HG23 ' A' ' 20' ' ' THR . 85.3 mt-10 -85.73 -42.05 14.58 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.238 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.524 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 20.1 tp -58.8 -42.92 90.21 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.866 0.841 . . . . 0.0 109.319 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.405 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -52.41 -31.0 32.12 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 113.734 -1.575 . . . . 0.0 112.687 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.11 -19.32 61.81 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.757 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.1 mm? -78.29 1.92 20.15 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-O 121.483 0.659 . . . . 0.0 109.601 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.555 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.9 m-85 -119.15 156.52 29.65 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.035 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 17.4 mt-10 -157.65 131.51 8.05 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.092 175.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 47.6 t0 127.83 85.93 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.794 2.037 . . . . 0.0 107.394 -175.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -99.23 125.28 44.8 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.113 0.959 . . . . 0.0 111.696 -175.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -117.53 150.67 38.57 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.131 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -102.46 131.67 48.99 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -166.55 148.35 6.46 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.499 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 58.26 23.11 9.99 Favored 'General case' 0 CA--C 1.491 -1.296 0 O-C-N 123.81 0.694 . . . . 0.0 111.067 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 44.8 mtm 73.69 15.83 3.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.233 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.8 m -130.4 -170.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.92 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -112.5 138.1 49.75 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.4 t -130.08 123.54 56.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.08 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 29' ' ' GLU . 17.0 ttm180 -110.02 134.0 52.6 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -116.77 179.31 4.05 Favored 'General case' 0 C--N 1.267 -2.99 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.28 106.37 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 125.079 1.487 . . . . 0.0 114.505 170.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.488 ' HB2' HD13 ' A' ' 47' ' ' ILE . 55.5 Cg_endo -77.39 140.01 18.98 Favored 'Trans proline' 0 N--CA 1.426 -2.482 0 C-N-CA 121.552 1.501 . . . . 0.0 110.619 174.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -83.71 -0.48 50.99 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.447 0.641 . . . . 0.0 111.735 -175.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -147.34 -171.0 3.69 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 19.3 tt0 -79.83 105.34 11.05 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.61 HG13 HG12 ' A' ' 12' ' ' ILE . 1.4 mp -116.28 112.37 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.361 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 45.7 mmtm -113.56 166.5 11.46 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.739 173.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 169' ' ' ALA . 12.1 p -121.48 131.29 73.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.455 ' CE2' ' HB2' ' A' ' 11' ' ' GLN . 19.2 m-85 -82.95 121.24 26.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.872 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 m -135.42 170.17 16.35 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.668 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.478 HD13 ' O ' ' A' ' 58' ' ' LYS . 2.4 mm -113.26 142.9 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.433 0.635 . . . . 0.0 110.831 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -96.64 80.26 3.08 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.687 ' H ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -36.33 -40.66 0.24 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.399 1.88 . . . . 0.0 114.039 -175.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 55' ' ' GLU . 2.1 pt-20 -63.33 -37.78 88.61 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.323 -176.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.487 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.4 p -107.34 -22.51 12.56 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.914 -176.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.55 20.46 68.84 Favored Glycine 0 N--CA 1.421 -2.366 0 CA-C-N 114.678 -1.147 . . . . 0.0 112.015 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 40.8 mtpt -94.07 158.94 15.38 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.2 t -91.57 109.73 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.783 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.67 155.74 11.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-O 121.066 0.46 . . . . 0.0 111.387 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.8 tp -123.01 135.11 54.33 Favored 'General case' 0 N--CA 1.413 -2.305 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.426 HG21 ' HB3' ' A' ' 170' ' ' LYS . 11.2 t -143.1 170.75 15.13 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.324 -176.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -76.73 161.14 28.74 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.202 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.507 HD13 HG22 ' A' ' 47' ' ' ILE . 1.9 mp -97.43 145.75 8.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.321 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.484 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 14.9 mm-40 -79.7 -53.3 6.95 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -175.48 -171.73 0.51 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.673 1.233 . . . . 0.0 107.918 -176.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.567 ' HA ' HD22 ' A' ' 167' ' ' LEU . 14.3 t -107.31 149.99 10.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 120.889 0.376 . . . . 0.0 110.428 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.695 HD12 ' HB2' ' A' ' 166' ' ' SER . 56.4 mt -111.95 118.96 58.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.198 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.466 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 19.2 tttm -134.75 112.62 10.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.933 0.397 . . . . 0.0 109.95 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.52 143.63 50.02 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.029 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.442 ' HD2' HG12 ' A' ' 37' ' ' VAL . 9.7 Cg_endo -54.32 130.07 37.9 Favored 'Trans proline' 0 C--N 1.328 -0.502 0 C-N-CA 123.208 2.605 . . . . 0.0 112.446 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.98 85.53 6.24 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.611 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 37.8 p -96.55 -43.12 7.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.665 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.06 174.59 8.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.606 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -102.16 171.78 7.29 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' A' ' 90' ' ' THR . 12.1 mt -126.02 143.05 51.25 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.753 0.787 . . . . 0.0 110.973 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.52 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 7.6 mt -83.82 141.4 14.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 15.9 ttt-85 -116.56 136.38 53.03 Favored 'General case' 0 N--CA 1.407 -2.575 0 CA-C-O 121.191 0.52 . . . . 0.0 109.748 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.579 ' O ' ' HA ' ' A' ' 86' ' ' SER . 55.0 m-85 -114.66 120.83 41.46 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.256 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 37.4 tt0 -108.07 126.62 52.96 Favored 'General case' 0 CA--C 1.467 -2.222 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.671 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.6 mm? -88.16 157.53 18.79 Favored 'General case' 0 C--N 1.27 -2.855 0 O-C-N 123.584 0.553 . . . . 0.0 110.97 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.872 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -59.32 -18.5 38.61 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.1 178.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -91.92 -10.2 40.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.847 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.42 9.64 57.65 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.965 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.558 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -84.17 141.57 30.96 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 0.0 OUTLIER -142.09 140.52 32.55 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.091 -1.044 . . . . 0.0 112.823 176.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -135.48 157.47 46.82 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.497 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 31.3 mt-10 -129.1 153.19 47.89 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 121.154 0.502 . . . . 0.0 112.026 -176.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.8 OUTLIER -145.88 158.43 43.86 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.384 177.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.686 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -72.37 18.99 0.08 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -177.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.009 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.71 -41.91 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 C-N-CA 125.367 1.467 . . . . 0.0 114.151 175.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -82.21 2.88 29.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.957 0.408 . . . . 0.0 111.144 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.482 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 36.8 m-70 -104.59 136.13 19.22 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.728 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 35.6 Cg_exo -62.3 142.41 91.13 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.543 2.829 . . . . 0.0 114.824 -177.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.503 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 21.8 t -117.97 147.28 21.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.604 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.6 tp -103.82 111.43 23.94 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.703 HG13 HG13 ' A' ' 104' ' ' ILE . 2.0 p -113.79 140.9 31.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-O 121.592 0.71 . . . . 0.0 111.667 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.648 ' CD2' HD11 ' A' ' 148' ' ' LEU . 81.6 t80 -91.37 92.37 8.55 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.625 ' HG3' HD22 ' A' ' 100' ' ' ASN . 1.0 OUTLIER -142.2 148.86 38.88 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.304 -1.316 . . . . 0.0 108.474 -175.009 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.625 HD22 ' HG3' ' A' ' 99' ' ' GLU . 28.6 m-80 69.18 22.55 6.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.021 0.439 . . . . 0.0 110.027 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.14 14.51 63.88 Favored Glycine 0 CA--C 1.5 -0.905 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.91 -177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -140.05 173.32 11.64 Favored 'General case' 0 N--CA 1.41 -2.46 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -97.01 120.37 37.23 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.703 HG13 HG13 ' A' ' 97' ' ' VAL . 12.3 pt -116.91 143.13 27.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.006 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -107.49 110.44 22.38 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.13 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 11.5 ptpt -127.24 138.86 53.19 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.608 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.655 ' O ' HG23 ' A' ' 111' ' ' VAL . 56.6 mtm180 -64.62 164.14 12.46 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 119.347 -0.359 . . . . 0.0 110.147 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.009 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -61.57 -43.21 99.28 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.514 -175.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.412 ' HB3' ' CG2' ' A' ' 91' ' ' VAL . 2.0 p90 -75.05 2.74 9.86 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.524 0.678 . . . . 0.0 110.332 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -114.01 -15.39 12.31 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.553 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 107' ' ' ARG . 93.2 t -81.87 149.27 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.657 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 18.1 mtmt -124.06 163.47 21.38 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.091 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -64.12 142.89 58.25 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.66 4.2 85.54 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.887 -175.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.657 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -74.98 167.9 21.02 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.481 ' HG3' ' HG3' ' A' ' 150' ' ' GLU . 3.8 ttmt -123.97 166.43 15.72 Favored 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.185 -177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.55 161.43 36.74 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.308 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -90.5 129.89 36.61 Favored 'General case' 0 N--CA 1.401 -2.881 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -112.87 125.28 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.909 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.3 t -65.76 -16.18 63.54 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.542 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 44.49 26.28 0.17 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 113.402 -1.726 . . . . 0.0 112.769 -177.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 55.5 tp -87.17 111.6 21.13 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.026 0.441 . . . . 0.0 110.757 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -106.5 164.57 11.94 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.597 HD22 ' HB2' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -121.13 18.9 11.6 Favored 'General case' 0 CA--C 1.494 -1.186 0 CA-C-O 122.709 1.242 . . . . 0.0 108.434 -174.479 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.2 p -68.28 137.94 23.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 112.48 -2.146 . . . . 0.0 112.323 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 139' ' ' ASN . 17.5 mt-10 -109.53 -11.77 14.76 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.622 177.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 70.44 30.72 3.17 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.581 -175.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.5 p -98.56 -62.13 1.28 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.616 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 55.6 m -157.19 -175.81 5.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.485 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.2 m -67.66 148.41 51.39 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.757 0.313 . . . . 0.0 110.6 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.6 p -77.99 76.76 4.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.173 0.511 . . . . 0.0 110.672 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -118.82 -8.87 10.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.425 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -106.45 -139.51 0.37 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.04 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.715 ' H ' ' HD2' ' A' ' 135' ' ' PRO . 3.6 t-20 -164.15 -44.32 0.0 OUTLIER Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.161 -175.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.715 ' HD2' ' H ' ' A' ' 134' ' ' ASN . 10.9 Cg_endo -55.37 -146.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 123.691 2.927 . . . . 0.0 113.436 174.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 84.2 mttt 67.99 -79.57 0.04 OUTLIER 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.258 0.623 . . . . 0.0 110.203 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.8 t30 54.36 42.94 31.15 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.683 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -95.02 -50.3 5.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.987 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.451 ' HA ' ' HG2' ' A' ' 126' ' ' GLU . 4.0 p-10 42.59 -168.51 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.226 1.01 . . . . 0.0 113.372 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.611 HD23 ' H ' ' A' ' 140' ' ' LEU . 2.0 pt? -117.83 160.33 21.56 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.837 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.66 -59.87 6.73 Favored Glycine 0 N--CA 1.438 -1.219 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.285 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.4 m -122.15 118.31 29.12 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-O 120.735 0.303 . . . . 0.0 110.936 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.414 ' HA ' HD11 ' A' ' 140' ' ' LEU . 54.8 Cg_endo -85.81 -165.59 0.28 Allowed 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.765 2.31 . . . . 0.0 111.175 177.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -117.34 129.96 56.21 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -163.39 -165.03 1.0 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 74.51 52.7 0.09 Allowed 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 124.109 0.964 . . . . 0.0 111.753 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.544 ' O ' HG23 ' A' ' 119' ' ' VAL . 19.2 pt20 -151.8 142.65 22.95 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.229 -1.351 . . . . 0.0 107.794 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.648 HD11 ' CD2' ' A' ' 98' ' ' TYR . 0.1 OUTLIER -125.45 160.27 29.86 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.872 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -122.73 139.28 54.15 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.644 -170.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.481 ' HG3' ' HG3' ' A' ' 116' ' ' LYS . 19.1 mt-10 -91.19 150.52 21.33 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 122.337 1.065 . . . . 0.0 112.741 177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.487 HG21 ' CG1' ' A' ' 154' ' ' ILE . 61.1 mt -77.79 121.69 31.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-N 113.246 -1.797 . . . . 0.0 111.002 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.612 ' HE2' ' HB2' ' A' ' 82' ' ' GLU . 49.4 mmtt -80.99 -39.19 26.33 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.482 175.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -148.73 130.2 14.82 Favored 'General case' 0 CA--C 1.473 -2.01 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.6 mt -117.62 126.26 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.445 0 CA-C-N 113.876 -1.511 . . . . 0.0 110.297 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.42 ' HD3' HG13 ' A' ' 157' ' ' VAL . 0.4 OUTLIER -135.82 166.89 22.24 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.153 -179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.52 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 23.8 m-85 -101.58 119.82 39.36 Favored 'General case' 0 N--CA 1.409 -2.51 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 174.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.42 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.4 OUTLIER -135.57 137.21 49.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.683 -178.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -71.1 154.1 42.02 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.258 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.22 134.64 57.18 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.259 -177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -82.84 37.55 0.54 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.604 0.716 . . . . 0.0 110.163 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -175.16 179.26 1.58 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -107.34 4.32 26.3 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.858 0.361 . . . . 0.0 111.607 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -141.54 149.48 40.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.0 m -118.78 155.41 20.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.536 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 56.5 m-85 -133.16 174.17 10.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.111 -176.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.721 ' OG ' ' HA ' ' A' ' 1' ' ' CYS . 49.1 m -159.06 -27.42 0.07 Allowed 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.567 HD22 ' HA ' ' A' ' 67' ' ' VAL . 1.3 tm? 68.91 107.14 0.05 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.066 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -85.25 116.16 23.44 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.666 -176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.484 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -135.36 -163.03 1.33 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.045 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.426 ' HB3' HG21 ' A' ' 62' ' ' THR . 0.3 OUTLIER -63.67 127.15 30.09 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 89.8 mttt 70.12 103.81 0.06 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.884 0.74 . . . . 0.0 109.078 -174.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -56.94 132.67 53.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.226 -174.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 50.6 m80 67.01 12.07 8.76 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.641 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -91.37 99.65 12.58 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.568 HG13 HG23 ' A' ' 177' ' ' ILE . 2.8 p -152.96 163.92 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.433 0.635 . . . . 0.0 111.673 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.606 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 93.8 mt -116.71 115.78 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.444 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.568 HG23 HG13 ' A' ' 175' ' ' VAL . 39.5 pt -123.78 173.48 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 7' ' ' ARG . 7.9 t-20 49.19 -122.36 1.71 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 124.35 1.06 . . . . 0.0 109.81 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.404 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 34.8 mm-40 -96.21 56.59 1.64 Allowed 'General case' 0 N--CA 1.433 -1.287 0 CA-C-O 121.47 0.652 . . . . 0.0 109.658 175.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.675 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 25.7 m-80 69.51 43.56 1.0 Allowed 'General case' 0 CA--C 1.505 -0.756 0 CA-C-N 114.216 -1.357 . . . . 0.0 113.751 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.5 mt -85.49 116.55 28.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.9 t -92.55 129.4 43.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.357 -174.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 14.7 t -139.26 164.54 29.55 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.448 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -160.59 154.17 22.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.588 0.232 . . . . 0.0 110.614 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 C--O 1.27 2.179 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.587 178.083 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.583 ' HA ' ' OG1' ' A' ' 90' ' ' THR . 69.2 m . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.882 0.373 . . . . 0.0 110.97 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -140.39 145.1 39.61 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.494 ' HA ' HG12 ' A' ' 164' ' ' VAL . 23.0 Cg_endo -61.25 -32.66 90.45 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 122.852 2.368 . . . . 0.0 112.781 -174.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 127.04 -39.27 1.99 Allowed Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -59.38 -16.92 25.89 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.648 0.779 . . . . 0.0 111.058 175.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 98.9 m -64.4 126.69 28.63 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.593 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.633 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 19.1 mmt85 -82.79 134.41 35.12 Favored 'General case' 0 C--O 1.186 -2.25 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.606 HD11 HG21 ' A' ' 175' ' ' VAL . 9.9 tt -121.66 131.4 73.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.432 HD21 ' CD1' ' A' ' 124' ' ' LEU . 2.1 tm? -87.66 123.71 32.79 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.611 0.72 . . . . 0.0 109.847 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 31.5 m -133.06 -177.26 2.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.02 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -130.3 121.32 25.85 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.596 HG12 HG13 ' A' ' 47' ' ' ILE . 22.3 mt -118.36 121.32 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.523 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.707 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.84 38.12 29.73 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.691 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.02 20.29 79.47 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.769 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 134' ' ' ASN . 58.6 t -127.04 118.32 22.09 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-O 120.683 0.277 . . . . 0.0 110.41 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 7.0 Cg_exo -66.78 121.54 8.77 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 122.068 1.845 . . . . 0.0 111.065 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -123.63 137.4 54.74 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.693 -178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HB2' HD23 ' A' ' 9' ' ' LEU . 36.9 ttpt -108.54 101.37 10.53 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.9 pt -123.53 -171.9 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.18 -2.555 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.624 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.798 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 6.6 p -94.44 171.82 8.58 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.088 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 12.3 mt -72.38 -24.5 61.27 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 120.683 0.277 . . . . 0.0 110.909 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.798 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 8.1 ptm180 -82.18 -24.35 35.02 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.542 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 67.8 mm-40 -82.96 -44.59 15.13 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.043 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.504 HD21 ' HG ' ' A' ' 167' ' ' LEU . 20.5 tp -54.74 -45.57 74.14 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 121.88 0.848 . . . . 0.0 109.407 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.425 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -52.2 -31.16 30.53 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.554 -1.657 . . . . 0.0 112.754 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.572 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 26.8 mt-10 -78.81 -15.35 58.5 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 112.341 0.496 . . . . 0.0 112.341 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 23' ' ' GLU . 1.8 mm? -77.97 5.92 8.82 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.76 0.79 . . . . 0.0 109.39 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.7 m-85 -121.01 162.46 19.89 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.857 -178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.613 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 21.1 mm-40 -142.06 -172.86 3.67 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.296 176.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.506 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.7 t70 63.1 80.04 0.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.376 0.607 . . . . 0.0 110.469 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.35 128.09 43.87 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.841 0.829 . . . . 0.0 110.672 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.471 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.0 ptt180 -121.78 154.42 37.0 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.402 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -102.84 126.33 49.93 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -162.5 140.96 8.78 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.622 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 58.65 24.14 11.78 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 123.671 0.607 . . . . 0.0 110.624 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.6 mtp 72.74 13.44 5.16 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.348 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.516 HG12 ' HD2' ' A' ' 71' ' ' PRO . 12.9 m -127.31 -177.11 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -112.42 139.68 47.79 Favored 'General case' 0 CA--C 1.471 -2.081 0 CA-C-O 121.303 0.573 . . . . 0.0 109.855 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.471 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.8 t -128.94 122.55 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.603 0 CA-C-N 115.14 -0.937 . . . . 0.0 108.77 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.421 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 16.1 ttm180 -112.24 126.17 54.94 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.506 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -129.95 145.51 51.63 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.177 -173.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 3.6 tppp? 81.78 111.94 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.48 0 O-C-N 124.54 1.15 . . . . 0.0 110.902 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.548 ' HB2' HD13 ' A' ' 47' ' ' ILE . 59.3 Cg_endo -78.72 152.44 25.61 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 122.15 1.9 . . . . 0.0 111.622 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.613 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 32.4 mtmt -81.53 -5.43 57.97 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.422 0.629 . . . . 0.0 111.214 -177.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -146.19 -165.39 2.2 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 39.9 tt0 -86.04 102.0 13.43 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.596 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -116.91 120.92 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.167 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 22.5 mmtt -120.02 164.7 15.73 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.181 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.454 ' O ' HD12 ' A' ' 61' ' ' LEU . 12.9 p -118.67 130.92 72.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.274 -177.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -90.73 118.92 30.54 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 121.6 0.714 . . . . 0.0 111.461 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.9 m -134.24 146.68 50.31 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.819 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.527 HG12 HD11 ' A' ' 176' ' ' ILE . 2.8 mm -90.26 141.03 14.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.334 0.588 . . . . 0.0 110.345 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.51 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 13.5 t70 -80.57 121.14 25.43 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.707 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -78.16 -8.52 58.39 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.237 0.541 . . . . 0.0 111.876 -169.287 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.51 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.5 pt-20 -103.27 -31.56 10.02 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.35 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.485 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 68.2 p -111.84 -18.11 12.78 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.78 -175.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.46 21.34 79.63 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.345 179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.485 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 38.2 mtpt -98.14 162.24 13.31 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 120.865 0.364 . . . . 0.0 111.464 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.46 110.45 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 CA-C-O 121.767 0.794 . . . . 0.0 109.509 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.5 m -110.05 156.88 10.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.051 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.454 HD12 ' O ' ' A' ' 49' ' ' VAL . 13.5 tp -123.1 136.87 54.98 Favored 'General case' 0 N--CA 1.411 -2.387 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 170' ' ' LYS . 10.3 t -142.66 171.21 14.37 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.939 0.399 . . . . 0.0 111.316 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.418 ' O ' ' HB1' ' A' ' 169' ' ' ALA . 0.9 OUTLIER -80.26 161.04 25.34 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.395 178.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.537 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.3 mp -101.15 136.72 31.5 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.222 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.404 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 46.6 mm-40 -83.59 -41.22 18.11 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -179.49 178.01 0.7 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.405 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.502 ' HA ' HD22 ' A' ' 167' ' ' LEU . 13.3 t -105.86 132.76 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.795 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 166' ' ' SER . 60.3 mt -91.28 108.45 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.095 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.512 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.7 tttt -124.56 107.93 11.55 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.52 144.53 53.75 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.312 -175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.516 ' HD2' HG12 ' A' ' 37' ' ' VAL . 9.8 Cg_endo -53.97 131.67 45.74 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 123.389 2.726 . . . . 0.0 112.29 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.451 ' O ' ' HB ' ' A' ' 73' ' ' THR . . . -78.15 -108.95 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.728 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' ' 72' ' ' ALA . 86.2 m 77.02 -21.45 0.33 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 122.945 0.498 . . . . 0.0 111.878 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.469 ' HB2' ' H ' ' A' ' 75' ' ' HIS . 0.8 OUTLIER -79.79 -139.77 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.446 179.114 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.469 ' H ' ' HB2' ' A' ' 74' ' ' ASP . 52.7 m80 -150.68 165.79 32.36 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.828 HD23 ' HA ' ' A' ' 90' ' ' THR . 30.5 mt -135.98 136.54 40.44 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.117 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.539 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 15.6 mt -89.61 146.24 6.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 172.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 28.8 ttt85 -121.08 137.87 54.45 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 121.153 0.501 . . . . 0.0 109.999 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.602 ' CD1' HD13 ' A' ' 151' ' ' ILE . 50.7 m-85 -117.57 127.31 53.84 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.2 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 32.4 tt0 -112.88 130.3 56.15 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.859 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -94.27 162.04 14.01 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.04 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 1.058 ' HG2' HD11 ' A' ' 149' ' ' LEU . 4.3 pt-20 -58.27 -22.42 52.47 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.875 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.715 ' OD1' ' HG ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -86.69 -10.8 52.92 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.575 0.702 . . . . 0.0 109.498 -178.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.78 14.4 58.11 Favored Glycine 0 C--N 1.297 -1.602 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.191 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.639 ' HG3' ' HB2' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -89.64 142.48 27.64 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 175.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 35.3 p -139.95 154.33 47.17 Favored 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.888 178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 79' ' ' PHE . 9.3 p90 -142.86 151.34 40.97 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.723 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 96.9 mt-10 -125.8 146.12 49.93 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.56 -177.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.455 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -142.31 159.46 42.19 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.406 -179.065 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.828 ' HA ' HD23 ' A' ' 76' ' ' LEU . 1.7 m -73.62 19.22 0.11 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.3 0.571 . . . . 0.0 112.478 -177.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.017 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.88 -34.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 C-N-CA 124.78 1.232 . . . . 0.0 113.249 175.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 23.3 t70 -78.62 -24.59 45.24 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.129 0.49 . . . . 0.0 110.017 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -77.8 119.97 79.49 Favored Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.277 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 35.1 Cg_exo -62.2 139.83 80.13 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.522 2.815 . . . . 0.0 114.014 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.5 t -100.28 147.42 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.736 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 21.5 tp -98.02 106.16 18.42 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.168 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.626 HG13 HG12 ' A' ' 104' ' ' ILE . 2.4 p -112.55 149.37 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.678 0.751 . . . . 0.0 112.258 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -104.05 92.81 4.54 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.781 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.579 ' OE2' ' HE3' ' A' ' 106' ' ' LYS . 6.1 pt-20 -138.85 159.94 40.9 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 89.9 m-20 63.14 22.37 13.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.332 0.587 . . . . 0.0 109.7 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.29 16.68 62.91 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.298 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 102' ' ' ARG . 11.1 ptp180 -136.4 171.99 13.67 Favored 'General case' 0 N--CA 1.399 -2.979 0 CA-C-N 117.605 0.702 . . . . 0.0 109.916 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -98.36 121.25 40.07 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.626 HG12 HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -126.98 148.75 31.78 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.132 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 3.3 mp0 -108.11 116.45 31.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.515 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.585 ' HE2' HG13 ' A' ' 104' ' ' ILE . 51.0 mttm -124.62 134.72 52.82 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.328 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 75.3 mtm180 -56.66 154.78 8.39 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.017 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -59.87 -41.74 92.18 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.935 -176.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 3.4 p90 -73.51 2.11 8.53 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.92 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -114.14 -19.26 11.42 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.863 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 107' ' ' ARG . 53.1 t -76.97 152.3 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.723 ' HE2' ' H ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -123.94 167.08 14.61 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -71.15 143.53 50.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.99 4.96 74.19 Favored Glycine 0 C--N 1.304 -1.199 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.569 -175.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.968 ' HB3' HD12 ' A' ' 151' ' ' ILE . 15.2 t70 -72.03 178.81 3.56 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.69 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 71.4 mttt -135.45 154.52 51.41 Favored 'General case' 0 CA--C 1.495 -1.139 0 CA-C-O 121.62 0.724 . . . . 0.0 112.037 -178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.05 155.64 41.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.895 173.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.533 ' HA ' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -97.12 135.91 38.41 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.8 OUTLIER -104.93 125.96 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.747 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.819 176.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.8 t -85.14 43.65 1.02 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 119' ' ' VAL . 22.6 tt0 -67.55 38.73 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.168 1.387 . . . . 0.0 113.025 -172.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 143' ' ' PRO . 0.7 OUTLIER -121.06 -171.49 2.21 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 68.05 -84.65 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.833 1.653 . . . . 0.0 114.535 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.685 ' H ' HD23 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -64.61 -62.82 1.35 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -173.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.517 ' H ' ' HG ' ' A' ' 124' ' ' LEU . 43.4 t 77.12 116.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 O-C-N 123.778 0.674 . . . . 0.0 109.878 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 60.82 -101.59 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.295 -174.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 32.92 80.87 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.732 1.213 . . . . 0.0 113.135 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 13.9 p -93.31 154.68 17.85 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.815 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.4 p -74.34 88.39 2.04 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.391 0.615 . . . . 0.0 110.97 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.6 p -171.37 -150.62 0.07 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.1 m -67.9 86.43 0.23 Allowed 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.24 0.543 . . . . 0.0 109.989 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -152.92 143.17 22.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.085 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -68.74 131.7 45.61 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.179 0.514 . . . . 0.0 111.261 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.45 ' HB3' HG21 ' A' ' 15' ' ' VAL . 5.4 m120 -74.6 -51.86 3.95 Favored Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.707 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.43 ' HD3' ' HB2' ' A' ' 134' ' ' ASN . 32.0 Cg_exo -59.84 105.7 0.29 Allowed 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.152 2.568 . . . . 0.0 114.041 -176.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -113.93 102.4 10.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.708 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -153.29 -35.21 0.11 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.708 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.52 33.45 0.42 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -151.53 164.48 36.72 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.703 0.287 . . . . 0.0 110.919 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.498 HD23 ' H ' ' A' ' 140' ' ' LEU . 2.4 pt? -76.29 153.81 35.63 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.386 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -127.8 19.82 5.8 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.788 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.6 p -70.38 118.07 60.79 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-O 120.868 0.366 . . . . 0.0 110.208 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.554 ' HB3' ' HB2' ' A' ' 122' ' ' LEU . 59.2 Cg_endo -82.17 153.76 16.57 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 C-N-CA 122.389 2.06 . . . . 0.0 114.769 -175.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -144.69 20.84 1.66 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.617 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 39.1 m170 -115.54 96.05 5.45 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.055 0.455 . . . . 0.0 111.171 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -132.5 88.35 2.52 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -147.73 154.11 40.12 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.361 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.69 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.9 mm? -108.49 141.47 40.32 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.042 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.058 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -119.28 135.95 54.46 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.006 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 25.8 mt-10 -83.19 141.51 31.87 Favored 'General case' 0 CA--C 1.479 -1.771 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.96 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.968 HD12 ' HB3' ' A' ' 115' ' ' ASP . 73.0 mt -80.17 104.87 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.995 0 CA-C-N 113.515 -1.675 . . . . 0.0 109.586 174.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.558 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 14.1 mmtm -70.64 -37.13 73.74 Favored 'General case' 0 C--N 1.266 -3.06 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.159 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -148.92 129.25 13.77 Favored 'General case' 0 CA--C 1.475 -1.916 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 75.7 mt -113.11 144.82 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.962 0 CA-C-N 113.41 -1.723 . . . . 0.0 110.529 174.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.471 ' HD2' ' HD3' ' A' ' 78' ' ' ARG . 5.2 ptpp? -145.99 156.14 43.29 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.815 178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.539 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 5.1 m-85 -98.94 117.82 34.31 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -126.2 175.65 7.97 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.094 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.521 -178.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 23.3 mtt-85 -100.6 164.46 11.88 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.625 -178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.703 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.87 -30.16 63.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.511 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.6 t30 66.37 -38.76 0.31 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.358 1.063 . . . . 0.0 113.279 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -98.04 -174.36 2.84 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.37 -13.09 16.8 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 120.71 0.291 . . . . 0.0 110.905 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -139.29 155.95 47.37 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.18 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.494 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.4 m -128.28 160.09 38.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.505 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.623 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 81.4 m-85 -132.76 169.75 16.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.555 0.217 . . . . 0.0 110.736 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.654 ' HB2' HD12 ' A' ' 68' ' ' ILE . 20.3 m -156.78 -27.99 0.09 Allowed 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.504 ' HG ' HD21 ' A' ' 24' ' ' LEU . 1.3 tm? 73.05 112.22 0.06 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 114.713 -1.131 . . . . 0.0 110.996 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -91.94 116.67 29.11 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.605 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 63' ' ' ASP . . . -134.16 -164.1 1.46 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.677 176.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.407 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 26.1 mmmt -73.31 133.23 43.82 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 37.5 mtmt 51.97 47.28 25.09 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -59.73 -158.94 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 O-C-N 124.565 1.166 . . . . 0.0 113.978 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 185' ' ' GLN . 20.5 p80 56.0 27.07 10.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.087 0.955 . . . . 0.0 111.727 -176.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -150.23 143.61 25.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.606 HG21 HD11 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -173.83 166.21 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.309 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.527 HD11 HG12 ' A' ' 52' ' ' ILE . 85.7 mt -109.53 112.95 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.639 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.603 HG23 HG13 ' A' ' 175' ' ' VAL . 44.9 pt -120.51 171.59 8.8 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.683 0 CA-C-O 121.375 0.607 . . . . 0.0 112.482 -175.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.573 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 44.8 t30 48.68 -128.12 1.97 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.002 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.506 ' HB2' ' HD3' ' A' ' 85' ' ' ARG . 19.7 mm-40 -85.61 48.71 1.63 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.334 0.587 . . . . 0.0 109.592 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.5 m-20 70.29 44.79 0.7 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.254 -1.339 . . . . 0.0 113.128 177.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 82.1 mt -86.27 113.08 23.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.407 HG11 HG13 ' A' ' 52' ' ' ILE . 3.0 m -80.34 135.6 25.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.758 0.789 . . . . 0.0 111.271 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.2 t -135.3 152.88 51.91 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.581 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -156.86 130.71 8.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.936 0.398 . . . . 0.0 111.534 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.522 ' HB3' ' HB2' ' A' ' 173' ' ' HIS . 0.6 OUTLIER . . . . . 0 C--O 1.26 1.612 0 CA-C-O 116.61 -1.662 . . . . 0.0 108.413 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.882 ' SG ' ' HB2' ' A' ' 93' ' ' HIS . 4.3 p . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 121.538 0.685 . . . . 0.0 111.467 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.401 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 1.5 m-85 -133.94 167.65 21.79 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.454 ' HD3' HD13 ' A' ' 76' ' ' LEU . 61.6 Cg_endo -70.43 157.01 60.37 Favored 'Trans proline' 0 N--CA 1.438 -1.787 0 N-CA-C 108.413 -1.418 . . . . 0.0 108.413 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.59 -21.46 35.32 Favored Glycine 0 C--N 1.31 -0.867 0 C-N-CA 119.735 -1.221 . . . . 0.0 112.397 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -74.27 -1.26 19.87 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.4 m -74.39 130.93 40.58 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.928 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 8.7 mmt180 -81.86 126.2 31.6 Favored 'General case' 0 C--O 1.197 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.485 HD11 HG21 ' A' ' 175' ' ' VAL . 9.5 tt -117.67 129.75 73.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-O 121.039 0.447 . . . . 0.0 109.877 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.543 HD21 HD21 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -89.72 124.17 34.38 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-O 121.531 0.681 . . . . 0.0 109.917 -179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 19.3 m -137.64 -177.87 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.342 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.479 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 30.9 tt0 -126.08 118.84 26.13 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.582 HG12 HG13 ' A' ' 47' ' ' ILE . 20.7 mt -119.19 121.7 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.885 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.727 -178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.28 39.5 30.91 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.933 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.27 19.58 78.77 Favored Glycine 0 N--CA 1.439 -1.116 0 CA-C-N 114.732 -1.122 . . . . 0.0 113.849 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.96 122.76 24.45 Favored Pre-proline 0 N--CA 1.434 -1.264 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 44.1 Cg_endo -71.54 120.22 6.78 Favored 'Trans proline' 0 N--CA 1.432 -2.126 0 C-N-CA 121.931 1.754 . . . . 0.0 110.675 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.623 ' NE2' HD22 ' A' ' 134' ' ' ASN . 18.5 mm100 -122.98 142.06 51.25 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.622 -176.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.463 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 39.1 ttmt -112.29 100.89 9.16 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 175.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.1 pt -119.44 -178.41 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.912 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.106 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.801 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.8 p -93.28 174.52 7.17 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.142 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 94.5 mt -66.94 -31.39 71.93 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-O 120.726 0.298 . . . . 0.0 110.551 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.801 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 9.5 ptm180 -78.5 -22.5 47.31 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB2' ' H ' ' A' ' 20' ' ' THR . 38.8 mm-40 -84.56 -45.79 12.23 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.527 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.737 HD23 ' HG ' ' A' ' 167' ' ' LEU . 13.4 tp -58.91 -42.66 90.19 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.787 0.804 . . . . 0.0 109.51 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.429 ' HD1' HG11 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -53.98 -30.37 46.8 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.637 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.73 -17.89 59.76 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 23' ' ' GLU . 1.5 mm? -80.56 1.51 29.3 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.577 0.703 . . . . 0.0 109.663 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.7 m-85 -119.01 161.65 19.87 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.107 -178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -144.72 -171.42 3.61 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.033 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.539 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 1.2 t70 65.71 76.75 0.31 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.539 0.685 . . . . 0.0 109.584 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -100.93 131.54 46.76 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 122.103 0.954 . . . . 0.0 111.752 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.511 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 17.6 ptt-85 -121.53 153.87 37.4 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 113.596 -1.638 . . . . 0.0 110.048 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -104.04 123.18 46.77 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -160.76 148.76 16.02 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.06 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 59.57 22.62 11.26 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 123.571 0.544 . . . . 0.0 110.76 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 41.7 mtm 72.96 16.79 4.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.943 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.6 m -133.33 -169.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.937 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.558 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 71.6 m-85 -110.84 137.72 48.14 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.511 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.8 t -132.49 124.86 52.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.5 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.471 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 22.9 ttm180 -117.23 127.73 54.38 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.539 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -131.91 147.51 52.47 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.696 -175.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 23.0 tptm 81.8 111.79 0.03 OUTLIER Pre-proline 0 C--O 1.236 0.389 0 O-C-N 124.197 0.935 . . . . 0.0 111.056 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.578 ' HB2' HD13 ' A' ' 47' ' ' ILE . 63.3 Cg_endo -78.32 152.28 26.89 Favored 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 122.299 1.999 . . . . 0.0 112.043 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 mtmt -87.03 -0.71 57.07 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.134 -177.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 45' ' ' ARG . 49.2 mtt180 -148.67 -164.79 2.11 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.58 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 4.1 tp10 -85.58 98.27 10.55 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.582 HG13 HG12 ' A' ' 12' ' ' ILE . 1.8 mp -117.15 114.94 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.083 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 34.0 mmtp -120.38 163.7 17.47 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.72 175.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.486 HG11 ' CB ' ' A' ' 169' ' ' ALA . 11.7 p -120.49 133.44 67.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.647 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.479 ' CE1' ' HB2' ' A' ' 11' ' ' GLN . 42.7 m-85 -82.92 124.39 30.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.925 176.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.403 ' HB3' ' OD1' ' A' ' 174' ' ' ASN . 56.4 m -121.58 175.54 6.16 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 177.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.522 HG12 HD11 ' A' ' 176' ' ' ILE . 2.8 mm -127.95 138.51 54.5 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-O 121.491 0.662 . . . . 0.0 110.625 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.749 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.3 t70 -86.59 110.55 19.9 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.432 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.792 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -68.33 -13.16 62.07 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 123.897 0.879 . . . . 0.0 112.595 -171.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.749 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.4 OUTLIER -98.28 -25.31 14.9 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.868 -175.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.538 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.3 p -117.24 -26.56 6.72 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.519 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.15 22.59 44.31 Favored Glycine 0 N--CA 1.426 -1.983 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.055 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.538 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 37.1 mtpt -97.6 155.42 16.98 Favored 'General case' 0 CA--C 1.504 -0.827 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.41 ' HA ' HD13 ' A' ' 52' ' ' ILE . 3.9 p -96.95 109.26 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.901 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.919 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 m -109.63 162.4 7.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.707 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.439 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.4 tp -118.57 142.99 47.08 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 t -149.81 173.06 14.17 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.067 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -84.46 161.74 20.18 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.614 0.721 . . . . 0.0 110.716 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.548 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.5 mp -97.76 144.58 10.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.889 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.559 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.8 mm-40 -88.78 -42.47 11.9 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.5 p30 178.2 175.81 0.51 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.12 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 14.6 t -108.14 132.22 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.917 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 166' ' ' SER . 17.4 mt -98.52 114.78 37.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.511 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 85.8 tttt -126.13 111.92 15.21 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.8 143.34 48.98 Favored Pre-proline 0 C--N 1.314 -0.951 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.358 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.429 ' HD2' HG12 ' A' ' 37' ' ' VAL . 7.0 Cg_endo -52.43 124.04 14.15 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.323 2.682 . . . . 0.0 112.597 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.75 81.9 8.31 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.367 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.2 m -91.57 -36.37 13.73 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.64 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -85.95 177.98 7.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.447 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -103.96 171.33 7.41 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.1 mt -122.84 140.2 53.2 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.8 0.809 . . . . 0.0 111.24 -174.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.507 HG23 HG23 ' A' ' 154' ' ' ILE . 14.3 mt -86.4 140.17 16.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 31.1 ttt180 -118.23 138.53 52.28 Favored 'General case' 0 N--CA 1.4 -2.972 0 CA-C-O 121.25 0.547 . . . . 0.0 109.741 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.636 ' O ' ' HA ' ' A' ' 86' ' ' SER . 59.4 m-85 -114.67 123.55 49.57 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.344 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 152' ' ' LYS . 40.6 tt0 -109.93 121.25 44.82 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.679 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -88.4 160.74 17.43 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.64 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.781 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -60.57 -22.57 63.82 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.285 -179.376 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -85.17 -11.2 55.57 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.523 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.85 17.41 44.44 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.823 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.596 ' O ' HD23 ' A' ' 81' ' ' LEU . 2.0 mtt180 -83.99 132.27 34.76 Favored 'General case' 0 CA--C 1.487 -1.478 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 50.3 p -138.59 137.86 37.38 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 118.608 -1.237 . . . . 0.0 112.033 176.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.408 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 3.8 p90 -133.31 148.78 51.92 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.348 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 24.5 mt-10 -119.81 151.24 39.14 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.718 -177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.474 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.7 OUTLIER -144.11 154.99 43.76 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.728 178.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.706 ' HA ' HD23 ' A' ' 76' ' ' LEU . 2.8 m -75.21 18.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.831 0.824 . . . . 0.0 111.455 -177.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.049 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 71.35 -30.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 125.434 1.493 . . . . 0.0 113.004 175.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.64 -5.94 59.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.155 0.502 . . . . 0.0 109.999 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.882 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 48.4 t-80 -87.24 128.84 53.87 Favored Pre-proline 0 CA--C 1.512 -0.484 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.821 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.68 ' HB2' ' O ' ' A' ' 185' ' ' GLN . 64.2 Cg_endo -72.52 141.02 34.03 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.808 2.339 . . . . 0.0 112.469 177.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 10.7 t -118.01 152.29 20.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 124.183 0.993 . . . . 0.0 109.585 -176.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 103' ' ' PHE . 1.6 tm? -101.22 114.35 28.24 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.643 HG13 HG13 ' A' ' 104' ' ' ILE . 2.2 p -114.12 146.91 18.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.411 177.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -102.94 91.51 4.16 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.246 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 8.2 pt-20 -141.36 158.84 43.35 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 30.7 m-80 64.74 22.19 12.52 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.211 0.529 . . . . 0.0 109.625 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.39 16.68 60.88 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.849 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -138.27 172.22 13.22 Favored 'General case' 0 N--CA 1.407 -2.617 0 CA-C-O 121.355 0.598 . . . . 0.0 110.244 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.44 ' HB3' HD11 ' A' ' 96' ' ' LEU . 44.2 m-85 -97.35 121.0 38.75 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.896 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.643 HG13 HG13 ' A' ' 97' ' ' VAL . 30.9 pt -121.77 153.3 25.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.068 175.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.568 ' HB3' ' O ' ' A' ' 185' ' ' GLN . 28.5 mt-10 -115.92 116.76 28.52 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.907 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.562 ' HG3' HG22 ' A' ' 111' ' ' VAL . 1.1 ptpm? -137.5 145.49 43.07 Favored 'General case' 0 C--O 1.202 -1.41 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.592 ' O ' HG23 ' A' ' 111' ' ' VAL . 77.3 mtt180 -65.27 162.78 16.67 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.049 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -61.69 -40.72 95.98 Favored 'General case' 0 CA--C 1.502 -0.867 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.267 -176.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.412 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 2.3 p90 -75.57 1.47 14.24 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.61 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -111.22 -19.15 12.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.52 0.676 . . . . 0.0 109.493 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 107' ' ' ARG . 85.2 t -72.43 150.17 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -123.66 163.44 21.06 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.571 -178.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -68.92 143.08 54.56 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.68 5.19 74.99 Favored Glycine 0 C--N 1.305 -1.153 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.325 -175.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.998 ' HB3' HD12 ' A' ' 151' ' ' ILE . 16.8 t70 -71.4 168.36 17.62 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.655 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 48.4 mttp -127.27 152.49 47.35 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 121.452 0.644 . . . . 0.0 110.789 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.408 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -125.29 153.53 32.82 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.288 175.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.522 ' HA ' ' CD1' ' A' ' 148' ' ' LEU . 0.5 OUTLIER -89.4 134.89 33.88 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.795 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.7 OUTLIER -100.68 145.0 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.978 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 172.093 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 122' ' ' LEU . 40.2 t -64.47 -11.36 32.81 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.475 0.655 . . . . 0.0 109.945 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.664 ' OE2' ' HA ' ' A' ' 146' ' ' ASP . 30.5 mt-10 59.03 -3.4 0.09 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 113.951 -1.477 . . . . 0.0 112.923 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.457 ' H ' ' C ' ' A' ' 120' ' ' SER . 45.3 tp -110.81 116.57 31.49 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.257 0.551 . . . . 0.0 111.931 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -95.09 178.99 5.36 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.973 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.543 HD21 HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -121.08 21.74 11.19 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.082 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 124' ' ' LEU . 92.5 t 85.46 -44.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.933 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 131' ' ' SER . 36.6 tt0 16.32 85.7 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 O-C-N 125.081 1.488 . . . . 0.0 113.705 175.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -93.65 83.15 4.41 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.194 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.7 m 69.26 -62.24 0.41 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.59 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.4 p -130.84 -29.92 1.86 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.9 0.381 . . . . 0.0 111.507 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.5 p -84.41 104.67 14.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.776 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 126' ' ' GLU . 15.7 m -80.15 -78.94 0.15 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.251 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.544 ' O ' ' HD2' ' A' ' 135' ' ' PRO . 60.9 mm-40 -146.26 -110.15 0.09 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -80.89 -14.66 57.8 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.623 HD22 ' NE2' ' A' ' 17' ' ' GLN . 59.3 t30 -73.06 -47.81 7.96 Favored Pre-proline 0 C--N 1.299 -1.627 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.378 -178.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.544 ' HD2' ' O ' ' A' ' 132' ' ' GLN . 11.6 Cg_exo -72.68 -72.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.547 2.165 . . . . 0.0 111.968 176.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 176.57 -57.08 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.041 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -72.59 126.28 29.49 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.362 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -106.92 -54.23 2.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.161 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.7 p30 41.56 -164.49 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.548 1.139 . . . . 0.0 113.183 -177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 14.2 tp -130.72 139.38 50.28 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 121.878 -0.514 . . . . 0.0 110.746 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -139.97 76.86 0.32 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 110.936 -0.865 . . . . 0.0 110.936 177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.8 t -49.56 121.25 11.67 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 123.681 0.283 . . . . 0.0 110.463 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -63.28 -88.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.015 2.477 . . . . 0.0 113.686 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 65.55 34.58 7.75 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.568 0.699 . . . . 0.0 110.454 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.547 ' HB3' ' O ' ' A' ' 121' ' ' GLU . 5.0 t-160 -96.9 121.43 38.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.744 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.664 ' HA ' ' OE2' ' A' ' 121' ' ' GLU . 15.5 t70 -145.79 89.4 1.9 Allowed 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -165.71 142.7 5.48 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.655 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.8 mm? -104.65 144.61 31.48 Favored 'General case' 0 CA--C 1.484 -1.566 0 CA-C-O 121.081 0.467 . . . . 0.0 109.76 175.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.781 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -116.76 137.97 51.81 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.508 -176.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.53 ' H ' HD13 ' A' ' 149' ' ' LEU . 17.6 mt-10 -89.03 146.38 24.89 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.284 177.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.998 HD12 ' HB3' ' A' ' 115' ' ' ASP . 81.4 mt -78.58 107.46 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.777 0 CA-C-N 113.407 -1.724 . . . . 0.0 108.969 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 80' ' ' GLU . 8.0 mmpt? -70.23 -39.4 75.12 Favored 'General case' 0 C--N 1.268 -2.977 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.566 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -149.29 133.52 17.35 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 74.3 mt -115.61 127.68 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.937 0 CA-C-N 113.668 -1.605 . . . . 0.0 110.927 175.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.5 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 1.6 ptpp? -132.49 163.35 29.01 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.97 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.452 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.0 m-85 -100.98 115.33 30.21 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.434 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -127.38 137.47 57.65 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.585 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.798 -178.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 158' ' ' ARG . 11.0 ptt180 -71.44 160.83 32.05 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.36 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.66 126.86 31.02 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.043 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -65.43 -37.94 88.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.288 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -106.96 174.84 5.71 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.294 -177.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -87.56 2.29 51.21 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.396 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -141.95 153.13 44.11 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.199 0.523 . . . . 0.0 110.456 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.2 m -124.14 157.43 31.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.712 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 76.4 m-85 -132.8 165.17 25.19 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.777 0.322 . . . . 0.0 110.51 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.657 ' HB2' HD12 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -146.38 -24.93 0.43 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.882 174.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.737 ' HG ' HD23 ' A' ' 24' ' ' LEU . 3.6 mm? 62.68 101.09 0.03 OUTLIER 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.892 0.745 . . . . 0.0 110.645 -178.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.475 ' HB2' HD11 ' A' ' 68' ' ' ILE . 58.6 t30 -83.47 121.17 26.84 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.703 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.559 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -131.28 -157.7 0.84 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -61.93 131.15 48.76 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 81.65 -92.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.525 1.13 . . . . 0.0 110.402 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -144.29 -156.54 0.7 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -77.24 49.07 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 109.755 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.681 ' HA ' ' O ' ' A' ' 183' ' ' THR . 3.7 t-20 -90.15 99.37 12.4 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.216 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.496 HG13 HG23 ' A' ' 177' ' ' ILE . 5.4 p -149.03 164.13 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 CA-C-O 121.494 0.664 . . . . 0.0 110.767 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.703 HG23 ' HA ' ' A' ' 180' ' ' ASN . 2.4 mp -93.88 115.7 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.163 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.489 178.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.496 HG23 HG13 ' A' ' 175' ' ' VAL . 36.7 pt -118.49 166.41 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 CA-C-O 120.87 0.367 . . . . 0.0 110.729 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.41 ' HB3' HD12 ' A' ' 181' ' ' ILE . 30.4 t30 47.91 -131.99 1.46 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.187 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -81.52 53.34 2.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.338 0.589 . . . . 0.0 110.061 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.795 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 12.6 m120 65.05 46.9 2.65 Favored 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 125.272 1.429 . . . . 0.0 113.194 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' A' ' 178' ' ' ASN . 88.9 mt -91.21 115.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.04 148.55 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-O 122.039 0.923 . . . . 0.0 112.528 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 2.0 t -150.11 152.12 34.24 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.362 175.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -136.25 -74.97 0.43 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.2 0.524 . . . . 0.0 110.969 -177.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.68 ' O ' ' HB2' ' A' ' 94' ' ' PRO . 24.2 tt0 . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 116.84 -1.552 . . . . 0.0 108.222 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.532 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 71.4 m . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 121.225 0.536 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -107.29 161.98 21.25 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.611 ' HD3' HD13 ' A' ' 76' ' ' LEU . 57.3 Cg_endo -67.24 158.48 56.74 Favored 'Trans proline' 0 N--CA 1.438 -1.738 0 N-CA-C 108.512 -1.38 . . . . 0.0 108.512 177.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.12 -27.42 51.83 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 119.477 -1.344 . . . . 0.0 112.035 177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -67.17 -13.23 61.76 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.445 ' HB ' HD12 ' A' ' 21' ' ' LEU . 93.6 m -61.44 125.7 24.71 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.422 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 37.6 mmt-85 -79.73 125.26 29.43 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.811 HD11 HG21 ' A' ' 175' ' ' VAL . 10.4 tt -116.33 129.42 72.79 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 CA-C-O 120.84 0.352 . . . . 0.0 110.245 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.583 HD21 HD11 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -89.34 122.99 33.1 Favored 'General case' 0 N--CA 1.406 -2.673 0 CA-C-O 121.63 0.729 . . . . 0.0 110.17 179.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.2 m -133.03 -179.16 3.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.694 -177.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.409 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 30.9 tt0 -130.97 121.35 24.95 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.425 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.65 HG12 HG13 ' A' ' 47' ' ' ILE . 15.1 mt -119.96 120.98 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.928 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.598 -177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 54.21 37.22 26.8 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.198 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.01 18.12 80.22 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.829 -1.078 . . . . 0.0 113.529 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -123.58 119.31 27.16 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 43.5 Cg_endo -73.0 121.74 7.54 Favored 'Trans proline' 0 N--CA 1.44 -1.635 0 C-N-CA 122.438 2.092 . . . . 0.0 111.291 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.476 ' NE2' HD21 ' A' ' 134' ' ' ASN . 70.4 mt-30 -125.75 140.49 52.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.829 -177.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -110.39 102.36 11.0 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.653 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.8 pt -125.43 -171.68 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.642 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.705 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.9 p -96.26 174.39 6.91 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.49 -0.884 . . . . 0.0 109.096 178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 62.1 mt -69.87 -31.07 68.7 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.124 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.705 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 3.9 ptm180 -77.34 -25.86 51.51 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.522 ' OE1' HG23 ' A' ' 20' ' ' THR . 84.9 mt-10 -84.73 -40.34 17.41 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.652 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.483 HD21 ' HG ' ' A' ' 167' ' ' LEU . 18.8 tp -59.35 -45.74 90.56 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.746 0.784 . . . . 0.0 109.842 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.512 ' HD1' HG11 ' A' ' 67' ' ' VAL . 1.0 OUTLIER -49.07 -32.55 9.83 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.759 179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.9 mt-10 -74.63 -17.26 60.72 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.204 -176.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.54 5.12 13.77 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.501 0.667 . . . . 0.0 109.884 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.526 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 97.0 m-85 -118.28 164.61 14.94 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.519 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.409 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 5.1 mm-40 -145.8 -172.85 4.0 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.659 176.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.568 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 18.9 t0 64.88 75.14 0.38 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.602 0.715 . . . . 0.0 109.358 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -102.69 134.28 46.33 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.416 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.492 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.4 ptt180 -127.54 154.54 45.04 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.991 -1.459 . . . . 0.0 109.792 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -105.51 129.9 53.69 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -166.78 153.84 9.05 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.556 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.26 21.24 9.41 Favored 'General case' 0 CA--C 1.497 -1.064 0 O-C-N 123.49 0.494 . . . . 0.0 110.804 177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 45.3 mtm 70.86 16.79 6.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.411 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 6.1 m -131.82 -168.29 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.444 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 79.4 m-85 -116.61 140.06 49.81 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.492 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.3 t -130.32 123.5 55.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.422 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 19.6 ttm180 -118.62 127.03 53.21 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.568 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -131.15 143.33 50.54 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.185 -174.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 40.0 ttmt 79.58 116.42 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.527 0 C-N-CA 124.158 0.983 . . . . 0.0 111.383 -178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.598 ' HB2' HD13 ' A' ' 47' ' ' ILE . 68.6 Cg_endo -79.47 160.31 25.58 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 C-N-CA 122.494 2.129 . . . . 0.0 112.57 179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.409 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 34.2 mtmt -88.19 -3.19 58.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.534 0.683 . . . . 0.0 110.351 -178.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.469 ' HB2' HD12 ' A' ' 47' ' ' ILE . 64.8 mtt180 -142.11 -165.28 1.98 Allowed 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 10.1 tp10 -89.21 100.87 13.56 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 171.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.65 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -114.29 117.46 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.175 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 17.7 mmtm -115.86 166.17 12.27 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.976 174.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.566 HG13 HD11 ' A' ' 64' ' ' ILE . 3.3 m -117.58 130.38 72.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.258 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.57 ' HB3' HD12 ' A' ' 176' ' ' ILE . 3.2 m-85 -79.35 121.86 25.66 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 172.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.0 t -133.59 177.03 8.02 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 58' ' ' LYS . 2.1 mm -131.21 142.18 44.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.332 0.587 . . . . 0.0 110.65 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.583 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 20.1 t70 -81.43 118.33 22.61 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.729 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -72.52 -12.74 61.2 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -170.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.583 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -103.4 -26.9 12.72 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 120.106 -0.638 . . . . 0.0 112.179 -176.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.0 p -116.77 -20.54 9.45 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.849 -0.741 . . . . 0.0 111.872 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.95 11.84 82.03 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.015 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.477 ' O ' HD13 ' A' ' 52' ' ' ILE . 3.3 mptp? -75.97 145.83 40.04 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 122.693 0.397 . . . . 0.0 111.366 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.451 ' HA ' HD13 ' A' ' 52' ' ' ILE . 4.7 p -90.15 106.72 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-O 121.993 0.901 . . . . 0.0 109.324 177.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 m -110.16 155.8 11.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.159 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 49' ' ' VAL . 10.2 tp -122.11 134.25 54.76 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.595 HG21 ' HB2' ' A' ' 170' ' ' LYS . 14.7 t -144.91 172.39 13.1 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.817 -176.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -84.28 162.3 20.16 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.787 0.804 . . . . 0.0 111.515 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 49' ' ' VAL . 2.8 mp -95.95 144.96 9.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.692 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.537 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 29.7 mm-40 -89.65 -39.91 12.91 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 p30 176.88 174.92 0.39 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.959 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.526 ' HA ' HD22 ' A' ' 167' ' ' LEU . 14.7 t -105.04 129.26 58.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.257 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.71 HD12 ' HB2' ' A' ' 166' ' ' SER . 51.2 mt -91.76 104.96 16.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.474 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.549 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.2 tttt -121.3 109.17 14.6 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.5 139.58 35.18 Favored Pre-proline 0 C--N 1.309 -1.185 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.215 -176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.507 ' HD2' HG12 ' A' ' 37' ' ' VAL . 97.0 Cg_exo -44.76 124.3 5.5 Favored 'Trans proline' 0 C--O 1.239 0.531 0 C-N-CA 123.471 2.781 . . . . 0.0 112.736 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.59 78.4 9.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.711 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.4 p -84.86 -53.03 5.59 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.931 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.6 171.37 14.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.218 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -102.68 171.55 7.36 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.681 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.2 mt -127.43 143.29 51.23 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.651 0.739 . . . . 0.0 111.673 -173.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.499 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 23.6 mt -86.62 143.02 12.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 173.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 34.5 ttt85 -118.03 138.72 52.03 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.178 0.514 . . . . 0.0 109.999 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.1 m-85 -116.71 123.3 46.88 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.888 -177.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.45 ' O ' ' N ' ' A' ' 152' ' ' LYS . 32.5 tt0 -109.87 125.53 52.88 Favored 'General case' 0 CA--C 1.471 -2.058 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.756 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.13 160.02 17.96 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.325 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.806 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.0 pt-20 -61.6 -15.99 44.17 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.113 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -98.06 -6.04 32.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.791 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.3 12.44 56.13 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.164 -0.926 . . . . 0.0 113.759 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.544 ' O ' HD23 ' A' ' 81' ' ' LEU . 3.5 mtt180 -82.97 141.79 31.85 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.8 p -144.22 141.26 29.76 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.972 -1.091 . . . . 0.0 113.497 175.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -138.49 155.99 47.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.613 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 87.0 mt-10 -129.97 153.98 47.83 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.17 0.51 . . . . 0.0 112.265 -177.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.9 OUTLIER -148.51 161.23 42.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.658 178.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.681 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -70.83 10.45 0.52 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -177.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.044 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 72.69 -27.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 124.838 1.255 . . . . 0.0 112.205 177.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.554 ' O ' ' HD2' ' A' ' 107' ' ' ARG . 0.8 OUTLIER -78.75 -10.84 59.91 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.243 0.544 . . . . 0.0 109.807 178.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -97.14 140.92 22.34 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.367 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 89.3 Cg_endo -79.49 137.87 13.37 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.249 2.633 . . . . 0.0 113.699 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.5 t -105.09 147.2 11.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.0 tp -105.39 110.38 22.71 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.716 -178.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.513 HG13 HG13 ' A' ' 104' ' ' ILE . 2.5 p -110.87 153.56 12.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.496 0.665 . . . . 0.0 111.531 -179.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -104.21 93.74 4.99 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.258 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 7.0 pt-20 -143.26 158.48 43.59 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.3 m-20 64.15 21.85 12.69 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.17 13.77 60.53 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.803 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -135.2 172.37 13.11 Favored 'General case' 0 N--CA 1.401 -2.885 0 CA-C-O 121.165 0.507 . . . . 0.0 109.93 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -100.94 121.27 41.46 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.513 HG13 HG13 ' A' ' 97' ' ' VAL . 25.1 pt -119.27 141.67 38.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.197 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -97.09 114.49 26.15 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.14 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.492 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 13.9 ptpt -128.59 135.36 49.24 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.958 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.618 ' O ' HG23 ' A' ' 111' ' ' VAL . 11.5 mmt180 -62.0 159.22 14.7 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -177.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.044 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -57.92 -43.03 85.99 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.222 -176.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.477 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 3.7 p90 -73.01 -0.21 13.17 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.177 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -110.63 -15.3 13.89 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.606 0.717 . . . . 0.0 109.848 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 107' ' ' ARG . 89.5 t -77.84 149.43 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.691 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 13.8 mtmt -123.24 164.88 17.89 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.994 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -66.98 141.36 57.62 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.66 77.93 Favored Glycine 0 C--N 1.304 -1.237 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.895 -175.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.691 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -75.04 168.55 19.76 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.707 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 72.2 mttt -124.18 161.57 25.44 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.339 0.59 . . . . 0.0 112.076 -177.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.11 156.37 39.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.417 172.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.63 ' HG ' HD11 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -95.86 138.29 33.71 Favored 'General case' 0 N--CA 1.436 -1.172 0 O-C-N 123.228 0.33 . . . . 0.0 110.571 -178.282 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.782 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.0 m -100.65 145.1 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.516 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 1.7 m -69.28 25.25 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.812 -1.085 . . . . 0.0 113.122 -176.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.639 ' HA ' ' HB2' ' A' ' 145' ' ' HIS . 21.6 mt-10 59.39 15.13 4.17 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 124.021 0.928 . . . . 0.0 112.274 -177.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.511 ' CD2' ' HA ' ' A' ' 125' ' ' VAL . 0.4 OUTLIER 63.54 -174.3 0.16 Allowed 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 114.368 -1.287 . . . . 0.0 113.349 175.249 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.4 ' HB3' ' H ' ' A' ' 124' ' ' LEU . 0.6 OUTLIER -174.98 -96.06 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.203 -179.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.583 HD11 HD21 ' A' ' 9' ' ' LEU . 2.3 pt? -55.03 -45.26 75.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.636 0.374 . . . . 0.0 110.956 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.519 HG12 ' HG2' ' A' ' 126' ' ' GLU . 91.9 t 113.2 -93.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.388 1.875 . . . . 0.0 111.203 173.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.519 ' HG2' HG12 ' A' ' 125' ' ' VAL . 12.9 pt-20 -154.16 -178.16 6.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 118.411 0.55 . . . . 0.0 111.165 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -142.6 145.03 33.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.413 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.4 p -142.43 142.38 32.35 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 121.23 -0.188 . . . . 0.0 111.095 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 30.4 m 66.6 177.26 0.23 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.793 0.683 . . . . 0.0 111.695 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.4 m -75.55 94.75 3.21 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 t -79.78 125.23 29.41 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.274 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -88.22 -17.84 29.94 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -88.23 128.48 35.46 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.887 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.476 HD21 ' NE2' ' A' ' 17' ' ' GLN . 0.2 OUTLIER -83.29 -47.54 0.79 Allowed Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.993 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -79.03 -163.29 0.21 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.832 2.355 . . . . 0.0 112.329 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -178.48 117.83 0.08 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.646 -177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -162.07 -102.38 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.855 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 54.6 -96.89 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.222 0.609 . . . . 0.0 111.265 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -82.71 166.18 19.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.975 0.417 . . . . 0.0 110.656 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.5 tp -70.11 132.96 46.64 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.914 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -122.22 62.34 0.54 Allowed Glycine 0 N--CA 1.427 -1.914 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.182 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 10.4 t -64.44 118.53 48.2 Favored Pre-proline 0 N--CA 1.446 -0.645 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.464 ' CB ' ' HB3' ' A' ' 122' ' ' LEU . 6.3 Cg_exo -78.1 160.71 29.86 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.645 2.23 . . . . 0.0 112.516 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -90.54 105.52 17.87 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.639 ' HB2' ' HA ' ' A' ' 121' ' ' GLU . 13.2 p80 -131.64 -162.31 1.21 Allowed 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -169.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 44.93 69.69 0.41 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.128 0.971 . . . . 0.0 112.238 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -162.34 151.29 15.25 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.728 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.707 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 4.1 mm? -108.45 137.79 45.83 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-O 121.112 0.482 . . . . 0.0 110.309 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.806 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -111.96 133.29 54.23 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.164 -177.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 81' ' ' LEU . 20.2 mt-10 -86.02 143.61 28.02 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 115.059 -0.973 . . . . 0.0 113.111 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.48 HD13 ' CD1' ' A' ' 79' ' ' PHE . 69.5 mt -81.48 102.65 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.077 174.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.532 ' HE2' ' HB2' ' A' ' 82' ' ' GLU . 50.9 mmtt -66.1 -38.63 88.71 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.252 177.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -147.87 129.22 14.79 Favored 'General case' 0 CA--C 1.476 -1.882 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 72.1 mt -112.81 143.48 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.324 174.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.463 ' HD2' ' HD3' ' A' ' 78' ' ' ARG . 19.7 ptpt -149.13 161.31 42.24 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.355 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.499 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 17.7 m-85 -101.8 115.01 29.59 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 173.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.54 174.61 10.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.237 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.06 159.02 16.03 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.436 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.44 129.75 40.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.354 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -64.15 -42.12 96.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.972 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -101.02 175.89 5.45 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-O 121.041 0.448 . . . . 0.0 111.156 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -89.63 3.68 51.86 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.02 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -141.38 151.16 43.26 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.786 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.6 m -121.28 157.27 24.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 72.2 m-85 -132.98 172.11 13.06 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.89 0.376 . . . . 0.0 110.388 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.71 ' HB2' HD12 ' A' ' 68' ' ' ILE . 51.9 m -156.18 -22.17 0.1 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 176.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.526 HD22 ' HA ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER 63.36 104.35 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.761 -1.108 . . . . 0.0 110.236 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -85.22 115.68 23.13 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.302 -176.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.537 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -125.63 -149.54 0.42 Allowed 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.595 ' HB2' HG21 ' A' ' 62' ' ' THR . 0.4 OUTLIER -61.0 141.09 57.62 Favored 'General case' 0 C--N 1.313 -0.978 0 C-N-CA 120.454 -0.498 . . . . 0.0 111.088 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.459 ' HB2' ' OD1' ' A' ' 174' ' ' ASN . 63.0 mttp 70.36 -117.62 0.1 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.397 -173.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -150.05 116.87 5.88 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.1 0.408 . . . . 0.0 112.1 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 38.19 30.4 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 125.469 1.508 . . . . 0.0 114.975 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.461 ' HB3' ' CD2' ' A' ' 184' ' ' HIS . 1.7 p-10 -95.29 104.66 16.56 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.097 0.475 . . . . 0.0 110.229 177.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.811 HG21 HD11 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -144.86 164.07 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 121.354 0.597 . . . . 0.0 111.444 -178.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.617 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.3 mt -95.55 120.78 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.456 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 39.1 pt -125.01 166.93 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.51 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 52.81 -134.97 1.59 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.921 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -88.19 51.58 2.23 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.602 0.715 . . . . 0.0 109.572 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.782 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 15.0 m120 71.92 53.23 0.2 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.525 177.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 97.2 mt -93.78 116.17 34.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.891 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.5 m -82.86 159.06 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-O 121.538 0.685 . . . . 0.0 111.861 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.9 t -168.79 144.76 3.51 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.785 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.461 ' CD2' ' HB3' ' A' ' 174' ' ' ASN . 36.5 t-80 -178.32 145.15 0.33 Allowed 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 C--O 1.256 1.401 0 CA-C-O 117.618 -1.182 . . . . 0.0 110.742 177.844 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 93.5 m . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.368 0.604 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.481 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 34.8 m-85 -114.61 157.87 41.72 Favored Pre-proline 0 N--CA 1.434 -1.233 0 CA-C-N 114.843 -1.072 . . . . 0.0 108.485 -176.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.539 ' HD3' HD13 ' A' ' 76' ' ' LEU . 19.1 Cg_endo -59.4 -35.34 96.65 Favored 'Trans proline' 0 N--CA 1.48 0.688 0 C-N-CA 123.129 2.553 . . . . 0.0 112.21 -177.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.719 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 132.76 -35.78 2.27 Favored Glycine 0 N--CA 1.413 -2.857 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -177.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.07 -17.03 61.83 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.395 0.617 . . . . 0.0 111.11 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.481 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 69.0 m -61.15 125.19 22.84 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.584 177.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.5 mmt180 -86.09 132.95 33.92 Favored 'General case' 0 C--O 1.183 -2.43 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.496 ' HB ' ' CD2' ' A' ' 21' ' ' LEU . 9.5 tt -118.92 131.74 70.83 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 C-N-CA 122.556 0.342 . . . . 0.0 110.159 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.548 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -84.59 124.86 31.9 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.29 0.567 . . . . 0.0 109.588 178.214 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 30.5 m -136.67 -179.47 2.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.778 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.585 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 30.9 tt0 -131.99 121.57 24.14 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.139 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.651 HG12 HG13 ' A' ' 47' ' ' ILE . 14.7 mt -121.07 119.81 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.652 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.962 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 53.53 41.87 32.02 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.898 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.12 17.88 76.07 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.589 -1.187 . . . . 0.0 113.442 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -123.6 116.15 28.06 Favored Pre-proline 0 C--N 1.311 -1.094 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 34.7 Cg_endo -73.25 126.24 10.91 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 122.38 2.053 . . . . 0.0 111.402 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -127.47 142.27 51.45 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.554 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -106.16 101.07 10.58 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.46 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.3 pt -122.83 -175.55 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.179 -2.637 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.012 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.867 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 16.3 p -90.62 174.65 7.39 Favored 'General case' 0 C--N 1.291 -1.948 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.52 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.652 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.5 mm? -71.68 -23.75 61.71 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.984 175.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.867 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 15.7 ptt180 -85.59 -23.82 27.43 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.444 ' OE1' HG23 ' A' ' 20' ' ' THR . 49.8 mt-10 -83.71 -42.12 16.94 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.977 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.511 ' CD2' ' HG ' ' A' ' 167' ' ' LEU . 14.3 tp -56.18 -43.59 78.57 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 121.769 0.795 . . . . 0.0 109.099 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.496 ' CD1' HG11 ' A' ' 67' ' ' VAL . 7.1 t80 -52.46 -35.5 52.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.512 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 6.4 mm-40 -69.22 -21.71 63.92 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -79.51 4.16 16.54 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 121.57 0.7 . . . . 0.0 110.139 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.52 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 93.3 m-85 -117.16 160.17 21.46 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.049 -177.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 44' ' ' LYS . 6.7 tt0 -139.84 -176.61 4.64 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 t0 64.02 85.29 0.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.178 0.513 . . . . 0.0 111.082 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -101.39 131.37 47.51 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.936 0.874 . . . . 0.0 111.051 -179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -122.6 152.55 40.33 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.942 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.443 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 35.9 t80 -99.46 129.93 45.68 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -167.15 147.11 5.41 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.609 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 59.41 20.43 8.76 Favored 'General case' 0 CA--C 1.496 -1.099 0 O-C-N 123.702 0.626 . . . . 0.0 111.027 177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.443 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 39.1 mtp 72.37 17.8 4.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.488 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 13.7 m -133.28 -172.27 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -114.76 142.52 46.4 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-O 121.47 0.652 . . . . 0.0 110.158 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.5 t -128.71 122.02 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.446 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.095 -176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 28' ' ' PHE . 17.5 ttm180 -111.77 126.66 55.31 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.46 141.78 48.96 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -173.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 3.2 ttmp? 83.95 113.09 0.03 OUTLIER Pre-proline 0 CA--C 1.503 -0.833 0 O-C-N 124.812 1.32 . . . . 0.0 111.378 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.603 ' HB2' HD13 ' A' ' 47' ' ' ILE . 74.3 Cg_endo -77.07 155.28 33.52 Favored 'Trans proline' 0 N--CA 1.432 -2.102 0 C-N-CA 122.447 2.098 . . . . 0.0 111.807 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.41 ' HG2' ' HB2' ' A' ' 29' ' ' GLU . 37.3 mtmt -87.01 -2.28 58.51 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.371 0.605 . . . . 0.0 110.678 -178.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -147.6 -168.05 2.96 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 40.9 tt0 -85.26 101.41 12.5 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.651 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -115.58 118.2 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.995 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 67.3 mmtt -114.39 169.64 8.89 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.335 174.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.436 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.1 p -124.99 131.09 73.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.795 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.543 ' CD2' HD12 ' A' ' 9' ' ' LEU . 14.2 m-85 -86.16 120.46 27.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.106 0.479 . . . . 0.0 110.306 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.8 t -130.22 176.2 8.3 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.586 HG12 HD11 ' A' ' 176' ' ' ILE . 3.3 mm -116.83 142.25 31.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.536 0.684 . . . . 0.0 111.027 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.688 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 14.9 t70 -77.7 120.32 22.47 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.527 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.726 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -75.54 -8.41 56.68 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.764 -170.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.688 ' HG3' ' OD1' ' A' ' 53' ' ' ASP . 2.6 pt-20 -108.18 -25.77 10.92 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 120.045 -0.662 . . . . 0.0 112.079 -177.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.497 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 70.4 p -117.84 -25.23 6.86 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.772 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.47 12.72 66.71 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.254 178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.497 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 40.7 mtpt -87.97 162.97 16.56 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.449 HG22 ' OG ' ' A' ' 120' ' ' SER . 33.5 t -86.67 113.25 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.216 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -110.77 151.78 12.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.088 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 49' ' ' VAL . 10.2 tp -122.86 140.26 53.15 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.7 t -148.91 170.54 18.06 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.814 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.83 161.16 26.97 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.522 0.677 . . . . 0.0 110.524 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.2 mp -96.28 148.14 5.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.84 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.491 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.9 mm-40 -93.09 -42.68 9.27 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 p30 179.59 178.97 0.51 Allowed 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.72 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.496 HG11 ' CD1' ' A' ' 25' ' ' TYR . 7.6 t -107.55 134.21 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.009 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.654 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 42.9 mt -91.69 99.73 10.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.701 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.458 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 84.8 tttt -113.49 107.34 15.69 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.06 136.18 28.64 Favored Pre-proline 0 C--N 1.306 -1.297 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.502 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -48.66 129.4 20.3 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 123.167 2.578 . . . . 0.0 112.013 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.24 86.94 3.67 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.07 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.2 m -98.79 -33.16 11.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.436 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.92 167.15 12.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.076 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -100.15 172.84 6.93 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.747 HD23 ' HA ' ' A' ' 90' ' ' THR . 14.9 mt -125.89 145.56 50.21 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.911 0.862 . . . . 0.0 111.907 -174.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.499 HD12 ' C ' ' A' ' 108' ' ' ALA . 13.6 mt -91.91 144.13 9.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.444 172.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 13.0 ttt85 -115.92 137.93 51.65 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.541 ' CD1' HD13 ' A' ' 151' ' ' ILE . 65.7 m-85 -115.85 124.48 50.77 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.548 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.43 ' O ' ' N ' ' A' ' 152' ' ' LYS . 19.2 tt0 -113.1 125.06 53.96 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.755 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -90.08 162.2 15.44 Favored 'General case' 0 C--N 1.274 -2.684 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.356 -177.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.899 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.7 pt-20 -62.78 -15.63 54.45 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.256 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -93.73 -12.68 28.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.716 0.77 . . . . 0.0 109.729 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.42 10.1 57.26 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.347 -179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.624 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -85.12 141.34 30.29 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 175.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 44.3 p -140.84 151.86 44.68 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.919 178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -145.83 153.72 41.21 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.244 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 23.6 mt-10 -124.22 149.66 46.16 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.323 -178.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -144.0 159.6 42.31 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.439 178.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.747 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -68.37 11.33 0.17 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -176.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.988 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.6 OUTLIER 69.65 -38.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 C-N-CA 124.843 1.257 . . . . 0.0 112.059 178.787 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 90' ' ' THR . 16.3 t70 -69.48 -37.55 77.3 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.422 0.629 . . . . 0.0 109.41 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.478 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 37.0 m80 -72.45 131.18 84.96 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.584 -178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 30.9 Cg_exo -63.65 142.49 83.92 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 123.975 3.117 . . . . 0.0 114.762 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.32 147.85 14.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 175.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.475 HD22 ' O ' ' A' ' 184' ' ' HIS . 10.1 tp -100.49 109.92 22.07 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.213 -0.195 . . . . 0.0 110.816 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.642 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.6 p -112.24 150.33 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 121.404 0.621 . . . . 0.0 112.046 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -103.04 92.0 4.36 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.472 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.441 ' CD ' HD11 ' A' ' 104' ' ' ILE . 9.1 pt-20 -139.34 158.4 44.21 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 90.2 m-20 63.25 22.98 13.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.125 0.488 . . . . 0.0 110.07 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.68 14.7 60.9 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.809 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -135.98 171.71 14.07 Favored 'General case' 0 N--CA 1.4 -2.956 0 CA-C-O 121.217 0.532 . . . . 0.0 110.047 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.603 ' CE1' HD11 ' A' ' 118' ' ' LEU . 32.6 m-85 -103.91 121.74 43.74 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.323 -0.853 . . . . 0.0 108.701 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.441 HD11 ' CD ' ' A' ' 99' ' ' GLU . 23.6 pt -124.44 152.64 30.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 120.107 -0.637 . . . . 0.0 112.476 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.437 ' HG2' ' CD1' ' A' ' 96' ' ' LEU . 31.8 mt-10 -104.87 110.86 23.4 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.591 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HG3' HG22 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -124.3 139.53 53.83 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.134 176.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 5.3 mtp180 -60.79 156.1 17.89 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -176.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.988 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -59.77 -41.06 90.22 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.973 -175.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.483 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 3.0 p90 -74.13 5.76 4.09 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.435 177.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -115.31 -18.55 11.04 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.471 0.653 . . . . 0.0 109.712 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 107' ' ' ARG . 79.5 t -71.55 150.33 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 124.005 0.922 . . . . 0.0 108.899 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.748 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.8 OUTLIER -114.17 165.01 13.1 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 120.814 0.34 . . . . 0.0 110.467 -177.113 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -74.24 142.88 45.31 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.409 ' O ' ' HG2' ' A' ' 150' ' ' GLU . . . 86.05 5.63 83.02 Favored Glycine 0 C--N 1.3 -1.462 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.488 -174.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.748 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -75.3 175.19 8.6 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.677 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 49.8 mttp -130.36 162.59 28.75 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.75 -178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.74 158.72 42.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.378 173.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.603 HD11 ' CE1' ' A' ' 103' ' ' PHE . 2.4 mt -88.81 140.04 29.85 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.79 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -101.46 149.2 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.455 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.645 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 47.4 t -69.54 13.85 0.12 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.446 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 119' ' ' VAL . 7.6 mm-40 63.8 -36.91 0.17 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.349 1.059 . . . . 0.0 113.769 -177.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 125' ' ' VAL . 31.7 tp -167.84 133.11 1.89 Allowed 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 121.976 -0.453 . . . . 0.0 110.5 -173.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.59 ' HB3' HD21 ' A' ' 180' ' ' ASN . 8.2 pt-20 -89.1 -124.05 0.06 Allowed 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.097 176.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.608 ' H ' HD23 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -82.65 20.91 1.05 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.042 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.43 ' HA ' HD11 ' A' ' 122' ' ' LEU . 3.4 t 62.06 14.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.652 178.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 68.74 171.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.711 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 55.75 92.81 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.216 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.0 t -61.46 -45.01 96.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.473 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.2 t -176.2 178.11 1.45 Allowed 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.3 p -97.17 -4.97 38.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.362 0.601 . . . . 0.0 109.712 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.8 p -153.03 -177.52 6.34 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.491 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 66.7 91.58 0.08 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.266 0.555 . . . . 0.0 109.883 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -69.19 92.25 0.55 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.839 0.828 . . . . 0.0 111.63 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.423 ' N ' ' CD ' ' A' ' 135' ' ' PRO . 65.1 t30 -96.16 -45.11 0.26 Allowed Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 115.194 -0.912 . . . . 0.0 112.322 178.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 134' ' ' ASN . 12.2 Cg_exo -72.11 -169.61 0.47 Allowed 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.631 2.221 . . . . 0.0 112.099 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -99.34 -11.37 21.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.927 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -159.0 151.25 21.28 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.427 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -88.76 84.14 6.69 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -144.73 -174.2 4.27 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.356 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.457 HD23 ' H ' ' A' ' 140' ' ' LEU . 2.6 pt? -142.58 156.11 45.06 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.232 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -135.36 70.25 0.51 Allowed Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.4 m -43.93 118.88 3.09 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 124.464 1.106 . . . . 0.0 113.439 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.81 171.19 11.37 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.137 2.558 . . . . 0.0 110.893 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.454 ' HB3' ' NE2' ' A' ' 147' ' ' GLN . 30.7 mt-10 -120.51 -70.31 0.79 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.282 -0.261 . . . . 0.0 111.296 -175.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 79.33 162.06 0.19 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 176.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.1 t70 66.03 41.48 3.63 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.855 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.454 ' NE2' ' HB3' ' A' ' 144' ' ' GLU . 7.7 pt20 -163.85 130.14 3.14 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.101 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.677 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.8 mm? -100.01 133.44 44.39 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 174.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.899 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -101.91 132.01 47.96 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -172.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 8.6 mt-10 -85.17 140.31 31.02 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.521 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.541 HD13 ' CD1' ' A' ' 79' ' ' PHE . 62.2 mt -78.97 102.26 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.827 0 CA-C-N 113.635 -1.62 . . . . 0.0 109.326 174.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.452 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 6.3 mmpt? -65.64 -37.96 88.02 Favored 'General case' 0 C--N 1.268 -2.948 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.936 178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -149.1 131.28 15.46 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 70.3 mt -115.7 144.76 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.875 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.528 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.414 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 18.9 ptpt -150.54 161.2 43.02 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.055 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -99.56 113.06 25.23 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-O 121.379 0.609 . . . . 0.0 109.602 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.56 132.89 70.7 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.439 -177.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -71.47 154.27 41.63 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.75 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.54 123.53 20.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.062 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -85.9 42.57 0.98 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.097 0.475 . . . . 0.0 110.883 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -163.15 -179.34 6.6 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -107.04 -8.73 16.44 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.214 0.531 . . . . 0.0 109.783 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -139.58 162.13 35.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.247 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.5 m -132.73 162.45 39.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.838 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.654 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 62.8 m-85 -138.95 166.01 25.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.94 -175.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.68 -22.75 0.14 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.511 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 0.8 OUTLIER 70.95 110.62 0.06 Allowed 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.784 176.112 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -90.1 115.59 27.47 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.649 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.491 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.81 -162.76 1.2 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 172' ' ' TYR . 20.3 ttmt -63.27 119.55 9.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.669 0.271 . . . . 0.0 110.708 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 52.7 tttm 75.86 -25.93 0.2 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.258 1.023 . . . . 0.0 111.06 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.432 ' H ' ' C ' ' A' ' 170' ' ' LYS . 45.5 p90 45.3 -162.01 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.899 1.279 . . . . 0.0 113.164 177.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 76.61 -53.27 0.59 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.804 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.613 HD21 HG13 ' A' ' 182' ' ' VAL . 27.1 t-20 -99.4 133.42 43.73 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.705 0.288 . . . . 0.0 111.146 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.439 HG21 HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -155.53 148.19 12.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.484 178.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 52' ' ' ILE . 47.3 mt -92.2 116.25 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.988 -178.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 25.1 pt -123.27 164.72 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.535 -176.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 23.6 t30 46.34 -134.13 0.95 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 124.532 1.133 . . . . 0.0 110.958 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.52 55.87 2.43 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.494 0.664 . . . . 0.0 110.38 176.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.79 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 15.7 m120 63.38 49.14 3.29 Favored 'General case' 0 C--O 1.209 -1.078 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.806 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.471 ' HB ' HG13 ' A' ' 177' ' ' ILE . 96.0 mt -86.78 111.68 21.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.613 HG13 HD21 ' A' ' 174' ' ' ASN . 74.1 t -84.81 117.84 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.889 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 22.7 p -118.57 146.28 44.72 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.6 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.475 ' O ' HD22 ' A' ' 96' ' ' LEU . 50.4 m80 63.07 166.19 0.12 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.498 0.666 . . . . 0.0 111.351 -177.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 . . . . . 0 C--O 1.268 2.057 0 CA-C-O 116.95 -1.5 . . . . 0.0 108.837 174.286 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 89' ' ' THR . 81.9 m . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.894 0.378 . . . . 0.0 111.051 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.464 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 23.3 m-85 -130.99 155.93 80.85 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.566 ' HA ' HG12 ' A' ' 164' ' ' VAL . 21.0 Cg_endo -58.54 -32.28 96.21 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.146 2.564 . . . . 0.0 113.155 -175.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 126.34 -36.25 2.74 Favored Glycine 0 N--CA 1.426 -1.968 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.71 -15.25 63.55 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.38 0.61 . . . . 0.0 110.571 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 71.9 m -60.08 128.19 35.57 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.055 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.705 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 82.0 mtm-85 -86.51 137.81 32.23 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.758 HD11 HG21 ' A' ' 175' ' ' VAL . 10.0 tt -123.6 132.82 70.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 CA-C-O 120.846 0.355 . . . . 0.0 110.261 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.004 HD21 HD11 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -87.38 124.61 33.57 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-O 121.464 0.65 . . . . 0.0 109.853 178.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.435 ' N ' HD13 ' A' ' 9' ' ' LEU . 25.1 m -136.26 -179.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.549 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 32.2 tt0 -129.78 119.61 23.69 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.628 HG12 HG13 ' A' ' 47' ' ' ILE . 15.9 mt -119.53 121.47 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.9 -177.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.8 37.45 28.52 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.063 -1.426 . . . . 0.0 109.518 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.8 17.43 80.09 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.664 -1.153 . . . . 0.0 114.195 -177.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.9 t -122.79 120.67 27.62 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.794 ' HB2' HD13 ' A' ' 124' ' ' LEU . 58.9 Cg_endo -74.23 119.92 6.03 Favored 'Trans proline' 0 N--CA 1.432 -2.122 0 C-N-CA 122.064 1.842 . . . . 0.0 110.475 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -123.97 143.08 50.62 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.498 -174.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -113.35 100.75 8.79 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -122.1 -172.34 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.618 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.749 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 19.2 p -95.4 169.75 9.84 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.941 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 15.1 mt -71.07 -22.63 62.09 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.099 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.749 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 10.5 ptm180 -83.73 -25.34 30.66 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' OE1' HG23 ' A' ' 20' ' ' THR . 67.6 mt-10 -84.69 -43.14 14.62 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.239 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.478 HD21 ' HG ' ' A' ' 167' ' ' LEU . 20.1 tp -56.24 -43.31 78.53 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.906 0.86 . . . . 0.0 109.085 177.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.434 ' HD1' HG11 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -51.92 -32.56 33.4 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.653 -1.612 . . . . 0.0 112.367 179.111 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 29.6 mt-10 -74.94 -16.98 60.62 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.302 -177.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 2.6 mm? -77.44 0.4 22.76 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 121.322 0.582 . . . . 0.0 109.455 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.526 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 98.1 m-85 -117.64 161.25 19.95 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.404 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.646 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 23.6 mt-10 -136.21 -172.28 3.09 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.117 175.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.487 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 12.3 t0 61.83 75.9 0.39 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.434 0.635 . . . . 0.0 110.558 178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 25.1 tt0 -100.3 131.72 46.08 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.404 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 11.8 ptt180 -131.41 145.42 51.8 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.517 -177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -88.04 128.01 35.4 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.546 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -167.09 147.78 5.64 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.396 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 60.11 22.96 12.21 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 123.341 0.401 . . . . 0.0 110.683 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 38.3 mtm 71.98 16.14 5.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.612 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 17.2 m -134.74 -174.31 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -113.48 140.81 47.8 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.409 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.4 t -127.17 122.48 60.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 115.22 -0.9 . . . . 0.0 108.658 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.471 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 17.6 ttm180 -113.21 126.61 55.61 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.487 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -133.63 146.94 51.37 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.387 -174.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? 83.16 110.37 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.422 0 O-C-N 124.444 1.09 . . . . 0.0 110.364 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.598 ' HB2' HD13 ' A' ' 47' ' ' ILE . 73.4 Cg_endo -79.12 152.14 24.08 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 122.45 2.1 . . . . 0.0 112.344 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.646 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 34.7 mtmt -81.92 -4.15 55.92 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.015 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -147.66 -165.62 2.3 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.14 103.86 16.15 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.628 HG13 HG12 ' A' ' 12' ' ' ILE . 1.2 mp -116.59 118.61 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.127 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.621 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 11' ' ' GLN . 47.3 mmtt -115.65 168.04 10.38 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.169 173.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.442 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.3 p -123.41 130.39 74.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.298 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.405 ' CE2' ' HB2' ' A' ' 11' ' ' GLN . 5.1 m-85 -83.57 123.67 30.0 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.4 p -134.76 172.8 12.45 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.488 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.521 HG12 HD11 ' A' ' 176' ' ' ILE . 3.1 mm -119.23 142.41 34.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.176 0.513 . . . . 0.0 110.054 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.699 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 25.5 t70 -76.0 122.59 24.42 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.606 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.726 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -75.71 -9.81 58.91 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.643 -170.424 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.699 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.8 pt-20 -106.59 -26.94 11.15 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.867 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.434 ' HB ' ' HD3' ' A' ' 58' ' ' LYS . 69.0 p -118.1 -25.39 6.69 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.783 -176.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.49 10.88 69.81 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.002 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.451 ' N ' ' HD2' ' A' ' 58' ' ' LYS . 2.2 mptp? -78.51 154.2 30.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.022 0.439 . . . . 0.0 111.771 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.487 HG11 HD22 ' A' ' 122' ' ' LEU . 2.8 p -91.0 104.87 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 121.833 0.825 . . . . 0.0 110.565 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.5 m -110.97 157.7 11.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.243 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 49' ' ' VAL . 12.6 tp -116.45 137.82 51.86 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.6 t -143.93 172.47 12.81 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.281 -177.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -85.29 161.55 19.48 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.63 0.728 . . . . 0.0 111.356 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.548 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.9 mp -100.23 140.75 18.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.519 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.496 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 27.5 mm-40 -92.26 -34.54 14.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.263 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.9 p30 175.89 176.75 0.23 Allowed 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.175 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.539 ' HA ' HD22 ' A' ' 167' ' ' LEU . 13.6 t -106.89 129.77 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.798 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 36.4 mt -91.13 111.79 24.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.805 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.466 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.1 tttt -127.65 110.29 12.53 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 163' ' ' PHE . . . -129.04 142.08 43.95 Favored Pre-proline 0 C--N 1.309 -1.161 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.442 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -53.87 124.14 15.16 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 123.115 2.544 . . . . 0.0 111.671 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.0 89.38 7.24 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.774 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.3 m -103.96 -29.27 11.05 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.194 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -85.58 166.98 15.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.724 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.496 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 28.7 m170 -98.01 171.69 8.1 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.724 HD23 ' HA ' ' A' ' 90' ' ' THR . 37.0 mt -126.71 140.12 52.64 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.569 0.699 . . . . 0.0 111.643 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.53 HD12 ' C ' ' A' ' 108' ' ' ALA . 44.8 mt -87.73 142.55 12.79 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 172.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 21.3 ttt180 -122.45 137.26 54.93 Favored 'General case' 0 N--CA 1.398 -3.067 0 CA-C-O 121.308 0.575 . . . . 0.0 109.902 -178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 86' ' ' SER . 55.0 m-85 -113.47 121.98 45.9 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.774 -177.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 152' ' ' LYS . 44.1 tt0 -108.4 127.42 53.88 Favored 'General case' 0 CA--C 1.474 -1.956 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.733 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -89.82 159.09 17.18 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-O 121.21 0.529 . . . . 0.0 111.936 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.827 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -60.15 -16.98 37.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.754 -178.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.642 ' OD1' ' HG3' ' A' ' 85' ' ' ARG . 38.3 p-10 -109.29 0.72 19.7 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.436 0.636 . . . . 0.0 111.065 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.49 19.47 25.2 Favored Glycine 0 C--N 1.309 -0.963 0 N-CA-C 116.511 1.364 . . . . 0.0 116.511 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.642 ' HG3' ' OD1' ' A' ' 83' ' ' ASP . 11.5 mtt180 -86.89 143.28 27.49 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 174.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 90.1 p -140.93 138.09 33.59 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 118.728 -1.189 . . . . 0.0 112.155 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.416 ' CZ ' HG11 ' A' ' 117' ' ' VAL . 6.5 p90 -133.37 138.69 46.42 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.962 177.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.503 ' OE2' ' HG3' ' A' ' 78' ' ' ARG . 43.4 mp0 -115.02 147.94 39.49 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.769 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 1.1 p -140.79 155.72 46.33 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.945 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.724 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -76.33 12.14 1.32 Allowed 'General case' 0 CA--C 1.507 -0.689 0 C-N-CA 122.79 0.436 . . . . 0.0 112.04 -177.116 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.041 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.8 m 61.29 170.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 19.4 t70 72.17 -34.92 0.31 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.069 0.461 . . . . 0.0 110.814 -176.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.511 ' HB3' ' HE2' ' A' ' 184' ' ' HIS . 47.6 m-70 -76.31 128.21 83.08 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.309 175.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 18.2 Cg_exo -67.47 127.52 16.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.284 2.656 . . . . 0.0 114.322 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.5 t -96.75 151.3 4.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.421 HD13 ' C ' ' A' ' 184' ' ' HIS . 7.2 tp -102.15 106.41 17.25 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.817 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.568 HG21 ' OD1' ' A' ' 115' ' ' ASP . 1.9 p -110.35 148.99 13.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.315 0.579 . . . . 0.0 111.338 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.509 ' CD2' HD12 ' A' ' 148' ' ' LEU . 61.8 t80 -104.47 92.55 4.36 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.111 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.554 ' CG ' HD11 ' A' ' 104' ' ' ILE . 8.3 pt-20 -136.06 158.37 44.56 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 82.4 m-20 62.78 22.6 13.48 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 110.347 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.44 15.19 58.88 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.238 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -132.94 171.95 13.26 Favored 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 117.71 0.755 . . . . 0.0 109.446 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -102.51 120.12 39.99 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.579 HG13 ' HE2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -125.03 144.66 34.25 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.302 -178.522 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.4 OUTLIER -101.81 111.83 24.22 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.032 -178.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.579 ' HE2' HG13 ' A' ' 104' ' ' ILE . 50.4 mttm -120.86 134.6 55.29 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.718 ' HD2' ' H ' ' A' ' 107' ' ' ARG . 5.4 mpt_? -59.77 158.44 10.37 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.041 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -55.16 -45.94 75.72 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.54 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -75.28 11.27 1.24 Allowed 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.647 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.533 ' OE1' ' HA ' ' A' ' 106' ' ' LYS . 39.1 tt0 -124.14 -15.09 6.89 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.454 0.645 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 107' ' ' ARG . 73.7 t -75.01 150.68 6.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.703 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -118.42 161.2 20.37 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.445 -176.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -70.57 147.19 49.54 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.403 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.86 4.1 87.45 Favored Glycine 0 C--N 1.305 -1.164 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.16 -175.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.703 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -72.63 163.92 27.3 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.439 ' HD3' ' HB2' ' A' ' 148' ' ' LEU . 33.8 mttt -117.28 162.82 17.27 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.28 0.562 . . . . 0.0 110.503 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.416 HG11 ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -130.24 157.68 42.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.213 172.318 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.62 136.29 33.16 Favored 'General case' 0 N--CA 1.409 -2.482 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -102.39 152.05 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.686 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.309 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.7 t -66.57 -4.27 8.21 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.826 0.346 . . . . 0.0 111.025 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.492 ' HA ' ' HB3' ' A' ' 145' ' ' HIS . 59.0 mt-10 39.76 69.68 0.28 Allowed 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.917 -177.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.487 HD22 HG11 ' A' ' 59' ' ' VAL . 50.9 tp -160.52 137.8 9.29 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.206 -177.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -108.62 148.14 30.8 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.342 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 1.004 HD11 HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -144.14 -86.92 0.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.346 0.593 . . . . 0.0 110.481 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.579 ' H ' HD12 ' A' ' 124' ' ' LEU . 3.0 p -171.8 138.48 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.251 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -105.32 -39.2 6.24 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.989 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 69.03 -70.9 0.13 Allowed 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.96 0.788 . . . . 0.0 109.955 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.1 m 54.33 23.52 4.43 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.404 0.681 . . . . 0.0 112.218 177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.5 t -141.71 -62.23 0.46 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.807 0.337 . . . . 0.0 110.964 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.4 t -107.18 133.0 52.41 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 120.923 0.392 . . . . 0.0 110.803 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.7 t -104.73 -3.45 23.61 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.46 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -95.38 -18.45 20.73 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.694 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.72 109.27 20.26 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.204 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -122.2 89.26 48.8 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.921 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.71 96.98 0.86 Allowed 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.882 2.388 . . . . 0.0 111.693 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -68.64 -18.77 64.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.363 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -78.71 129.69 34.97 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.029 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -54.46 136.91 43.72 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.375 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -139.95 138.25 35.41 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.176 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 tp 60.82 95.51 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 123.972 0.795 . . . . 0.0 110.81 -175.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.56 25.67 26.77 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.566 -1.302 . . . . 0.0 111.232 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.0 m -129.71 118.75 18.89 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.38 -161.59 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.545 2.164 . . . . 0.0 111.63 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -165.28 -39.61 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.588 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.492 ' HB3' ' HA ' ' A' ' 121' ' ' GLU . 0.4 OUTLIER -63.02 126.6 27.86 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -151.46 30.82 0.6 Allowed 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.804 0.812 . . . . 0.0 109.134 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -140.5 141.44 35.35 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.143 -172.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.509 HD12 ' CD2' ' A' ' 98' ' ' TYR . 9.9 mt -101.81 149.93 23.67 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 175.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.827 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -114.79 138.68 50.46 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -172.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.503 ' H ' HD13 ' A' ' 149' ' ' LEU . 23.6 mt-10 -90.4 145.09 25.21 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.013 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.426 HG21 ' CG1' ' A' ' 154' ' ' ILE . 79.4 mt -79.3 117.22 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.106 0 CA-C-N 113.507 -1.679 . . . . 0.0 110.99 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.62 ' CG ' ' HA ' ' A' ' 82' ' ' GLU . 30.3 mmtt -76.06 -37.98 57.62 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.589 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -152.7 134.63 14.77 Favored 'General case' 0 CA--C 1.48 -1.746 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -175.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 77.0 mt -117.59 125.89 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.271 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.279 174.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.469 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.9 ptpt -128.18 159.25 35.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.457 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -100.36 117.83 35.37 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.496 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -127.74 174.08 11.94 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.376 -178.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.441 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 37.3 ttt180 -95.33 155.25 16.82 Favored 'General case' 0 C--N 1.287 -2.113 0 O-C-N 122.106 -0.371 . . . . 0.0 110.829 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.715 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.4 -25.3 49.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.657 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 68.05 -39.73 0.4 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.45 -173.25 2.6 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -101.85 -10.89 19.47 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 120.645 0.259 . . . . 0.0 111.171 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 96.5 m-85 -141.86 155.08 45.55 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.94 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.6 m -126.77 159.86 35.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 115.493 -0.776 . . . . 0.0 108.935 177.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.628 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 69.9 m-85 -136.22 172.05 13.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.632 0.254 . . . . 0.0 110.478 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.28 -23.2 0.06 Allowed 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.539 HD22 ' HA ' ' A' ' 67' ' ' VAL . 1.3 tm? 68.23 107.97 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.97 176.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -87.28 118.21 26.55 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.54 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.496 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.41 -153.9 0.6 Allowed 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -61.96 132.34 52.64 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.88 0.372 . . . . 0.0 111.187 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.523 ' HG3' ' CD2' ' A' ' 172' ' ' TYR . 21.1 tptm 77.16 -77.95 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.192 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.523 ' CD2' ' HG3' ' A' ' 171' ' ' LYS . 75.3 m-85 -146.03 -174.08 4.33 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -88.18 34.28 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.12 0.486 . . . . 0.0 110.61 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.455 ' OD1' ' HB2' ' A' ' 172' ' ' TYR . 2.2 p-10 -78.32 99.48 6.34 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 8' ' ' ILE . 4.2 p -129.5 167.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-O 121.568 0.699 . . . . 0.0 112.723 -173.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.548 ' H ' HG22 ' A' ' 175' ' ' VAL . 75.7 mt -93.5 113.57 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 CA-C-N 114.235 -1.348 . . . . 0.0 109.716 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.525 HG23 HG13 ' A' ' 175' ' ' VAL . 43.8 pt -120.39 172.92 6.78 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.688 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -174.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.417 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 5.0 t-20 47.84 -123.07 1.55 Allowed 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 124.487 1.115 . . . . 0.0 110.725 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -92.71 48.46 1.37 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.693 0.758 . . . . 0.0 109.862 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.676 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 2.7 m-20 73.86 46.44 0.19 Allowed 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.465 1.506 . . . . 0.0 112.82 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.7 mt -88.96 117.2 31.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 56.6 t -84.38 152.09 3.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 115.173 -0.922 . . . . 0.0 109.693 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 6.4 t -158.67 152.87 23.92 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.908 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.511 ' HE2' ' HB3' ' A' ' 93' ' ' HIS . 71.2 m80 67.72 154.44 0.1 Allowed 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.731 0.644 . . . . 0.0 112.264 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.458 ' C ' ' HG ' ' A' ' 54' ' ' LEU . 57.2 tt0 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.965 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.761 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 62.0 m . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.869 0.366 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -133.07 158.0 76.92 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.559 ' HD3' HD13 ' A' ' 76' ' ' LEU . 56.4 Cg_endo -68.1 162.65 39.17 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 121.557 1.505 . . . . 0.0 108.9 176.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.75 -24.43 66.41 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 118.857 -1.64 . . . . 0.0 110.146 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -62.66 -13.69 34.97 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.031 0.932 . . . . 0.0 112.935 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 61.3 m -72.24 131.64 43.0 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.638 -0.425 . . . . 0.0 109.885 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.669 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 12.6 mtm180 -86.34 133.03 33.83 Favored 'General case' 0 N--CA 1.415 -2.215 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.622 HD11 ' CG2' ' A' ' 175' ' ' VAL . 2.2 tp -117.13 133.37 64.09 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-O 121.131 0.491 . . . . 0.0 110.884 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.654 HD21 ' CD1' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -92.51 124.25 36.41 Favored 'General case' 0 N--CA 1.4 -2.965 0 CA-C-O 121.788 0.804 . . . . 0.0 110.956 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 19.7 m -134.26 -179.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.898 -177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -125.8 117.14 22.76 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 26.9 mt -118.89 120.56 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.809 0 CA-C-O 121.137 0.494 . . . . 0.0 110.015 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 54.11 38.51 29.21 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.92 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.71 20.48 79.69 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.746 -1.115 . . . . 0.0 113.677 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.1 t -131.01 123.04 19.64 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 70.6 Cg_endo -73.85 120.87 6.61 Favored 'Trans proline' 0 N--CA 1.433 -2.048 0 C-N-CA 122.546 2.164 . . . . 0.0 112.25 -177.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.567 ' HG2' ' ND2' ' A' ' 134' ' ' ASN . 12.4 mt-30 -120.56 138.71 53.73 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.636 -177.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -108.9 100.78 9.95 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.595 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.517 ' CG2' ' HB3' ' A' ' 130' ' ' SER . 2.9 pt -124.19 -172.91 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.144 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.755 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 11.3 p -95.44 171.12 8.9 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.158 -1.017 . . . . 0.0 109.622 178.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 92.4 mt -66.56 -31.31 71.94 Favored 'General case' 0 N--CA 1.415 -2.215 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.219 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.755 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 6.3 ptm180 -79.43 -24.84 42.21 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.503 ' OE1' HG23 ' A' ' 20' ' ' THR . 68.8 mt-10 -83.87 -41.62 17.26 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.389 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.579 ' CD2' HD13 ' A' ' 167' ' ' LEU . 46.8 tp -59.3 -41.52 89.17 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-O 121.894 0.854 . . . . 0.0 109.34 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.42 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.6 OUTLIER -53.49 -31.74 47.21 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.673 -1.603 . . . . 0.0 111.979 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.577 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 32.4 mt-10 -77.24 -14.9 59.68 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.733 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 24' ' ' LEU . 1.0 OUTLIER -82.59 0.54 42.42 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.643 0.735 . . . . 0.0 109.14 177.05 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.541 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 72.4 m-85 -114.11 162.61 16.27 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.686 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.413 ' HB2' ' HD3' ' A' ' 44' ' ' LYS . 6.5 tp10 -142.15 -178.73 5.86 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.437 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.558 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER 65.1 79.89 0.24 Allowed 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.641 0.777 . . . . 0.0 110.448 -179.187 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -101.13 131.43 47.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 122.078 0.942 . . . . 0.0 110.922 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.423 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 18.3 ptt-85 -122.71 153.61 39.2 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.269 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -101.14 125.18 47.74 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -166.7 145.49 5.39 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.444 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 61.04 19.85 10.32 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.864 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 32.2 mtt 71.67 16.79 5.68 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.505 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 16.2 m -131.89 -170.77 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -119.3 142.67 47.89 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.92 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.423 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.2 t -129.38 123.41 57.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.154 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.477 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 15.0 ttm180 -113.54 127.01 55.93 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.42 135.33 46.01 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.959 -175.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 41' ' ' LYS . 36.0 mtpt 91.99 118.2 0.02 OUTLIER Pre-proline 0 CA--C 1.502 -0.887 0 C-N-CA 125.375 1.47 . . . . 0.0 112.147 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 87.3 Cg_endo -78.42 156.19 28.73 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.782 2.321 . . . . 0.0 111.045 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HD3' ' HB2' ' A' ' 29' ' ' GLU . 38.8 mtmt -94.02 -1.6 54.26 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.439 0.637 . . . . 0.0 110.565 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -146.3 -165.67 2.28 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.624 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 4.9 tp10 -85.28 99.24 11.0 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 174.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.541 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.5 mp -116.08 115.8 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.01 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.608 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 30.6 mmtp -123.28 163.94 19.73 Favored 'General case' 0 C--N 1.289 -2.06 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.98 174.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.501 HG13 ' CG1' ' A' ' 64' ' ' ILE . 6.9 m -111.06 128.78 67.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.068 0.461 . . . . 0.0 111.846 -178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -83.8 124.11 30.59 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.441 ' HA ' HG13 ' A' ' 176' ' ' ILE . 20.0 m -134.17 172.16 13.24 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.317 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.45 HG12 HD11 ' A' ' 176' ' ' ILE . 2.9 mm -119.49 143.06 32.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-O 121.116 0.484 . . . . 0.0 110.071 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 41.9 t0 -84.23 119.77 25.43 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.568 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.789 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -72.71 -11.37 60.59 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.124 -171.579 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' HG23 ' A' ' 56' ' ' THR . 5.5 pt-20 -102.48 -27.88 12.52 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.82 -176.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.469 HG23 ' HG3' ' A' ' 55' ' ' GLU . 76.1 p -115.48 -23.96 8.58 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.634 -175.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.41 14.45 76.31 Favored Glycine 0 N--CA 1.429 -1.784 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.149 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' C ' HD13 ' A' ' 52' ' ' ILE . 5.1 mtpm? -89.75 153.3 20.8 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.424 ' HA ' HD13 ' A' ' 52' ' ' ILE . 6.6 p -89.69 107.61 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.667 0 CA-C-O 121.967 0.889 . . . . 0.0 110.042 178.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 m -110.09 159.37 9.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.201 -178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 49' ' ' VAL . 12.9 tp -121.91 140.69 52.12 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.0 t -147.03 172.31 13.93 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.212 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.31 161.87 19.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.551 0.691 . . . . 0.0 110.824 -177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 64' ' ' ILE . 3.0 mp -105.32 134.26 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.699 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.5 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 10.9 mm-40 -79.8 -40.21 29.13 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.036 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 p30 179.49 178.03 0.55 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.175 -175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.42 HG11 ' HB2' ' A' ' 25' ' ' TYR . 20.1 t -105.45 130.0 57.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.633 179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 50.7 mt -90.67 105.2 16.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.555 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 84.9 tttt -118.52 109.82 16.65 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.3 134.57 25.89 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.219 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -47.22 124.35 8.94 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.447 2.765 . . . . 0.0 112.916 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.36 110.4 2.24 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.073 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.85 -68.33 0.93 Allowed 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -176.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -68.23 -117.4 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -159.34 172.68 17.53 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -172.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.645 HD23 ' HA ' ' A' ' 90' ' ' THR . 4.5 mt -136.5 140.22 42.86 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.532 0.682 . . . . 0.0 111.283 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.545 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 9.0 mt -86.5 142.55 12.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 171.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.516 ' HB3' ' CG ' ' A' ' 155' ' ' LYS . 31.8 ttt85 -118.97 138.38 52.85 Favored 'General case' 0 N--CA 1.404 -2.763 0 CA-C-O 121.207 0.527 . . . . 0.0 109.755 -178.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' A' ' 86' ' ' SER . 53.5 m-85 -115.97 125.17 52.16 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.893 -177.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 152' ' ' LYS . 34.5 tt0 -108.18 125.22 51.37 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.672 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -91.25 160.06 15.72 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.889 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.91 ' HG2' HD11 ' A' ' 149' ' ' LEU . 5.5 pt-20 -62.54 -19.59 63.79 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.209 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -87.33 -11.31 49.81 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.762 0.792 . . . . 0.0 109.23 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.52 16.81 47.95 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.036 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.549 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -87.46 142.91 27.51 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.762 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 23.6 p -142.38 136.28 29.43 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.456 175.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.408 ' CD1' HD13 ' A' ' 181' ' ' ILE . 6.8 p90 -129.97 155.99 45.18 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.165 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 40.2 mt-10 -129.86 148.01 51.69 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.308 0.575 . . . . 0.0 112.135 -175.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.7 OUTLIER -141.0 154.51 46.05 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.358 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.645 ' HA ' HD23 ' A' ' 76' ' ' LEU . 1.1 p -69.84 15.92 0.07 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -176.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.021 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 70.06 -39.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 C-N-CA 125.349 1.46 . . . . 0.0 113.854 175.009 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 107' ' ' ARG . 1.1 t70 -90.79 12.68 18.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.414 0.625 . . . . 0.0 110.766 -178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 39.6 m80 -115.45 141.62 27.53 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.361 177.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 23.6 Cg_exo -64.9 142.78 77.05 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.43 2.753 . . . . 0.0 115.201 -176.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.515 ' HA ' ' OG1' ' A' ' 183' ' ' THR . 19.1 t -119.52 150.13 22.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 113.782 -1.554 . . . . 0.0 107.381 176.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 18.5 tp -104.26 107.57 18.55 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.86 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.631 HG23 ' H ' ' A' ' 116' ' ' LYS . 1.6 p -107.11 143.96 16.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.383 0.611 . . . . 0.0 111.684 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.602 ' CD2' HD12 ' A' ' 148' ' ' LEU . 44.5 t80 -99.17 90.95 4.76 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.687 176.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 100' ' ' ASN . 11.9 pt-20 -138.17 157.51 46.16 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.499 176.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER 68.81 21.86 7.51 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -178.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.93 13.84 60.09 Favored Glycine 0 CA--C 1.508 -0.35 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.669 -177.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.407 ' HE ' ' CB ' ' A' ' 100' ' ' ASN . 29.3 ptt180 -135.61 172.5 12.92 Favored 'General case' 0 N--CA 1.404 -2.748 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -104.77 119.81 39.88 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.59 HG13 HG13 ' A' ' 97' ' ' VAL . 21.4 pt -119.22 144.2 28.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 120.129 -0.629 . . . . 0.0 112.187 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -101.82 114.87 29.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.551 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.577 ' HG3' HG22 ' A' ' 111' ' ' VAL . 0.7 OUTLIER -136.01 146.56 47.29 Favored 'General case' 0 C--O 1.208 -1.111 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.387 179.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.582 ' O ' HG23 ' A' ' 111' ' ' VAL . 74.4 mtm180 -63.73 160.23 17.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.021 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -61.54 -41.55 97.51 Favored 'General case' 0 CA--C 1.497 -1.087 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.788 -175.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.448 ' HA ' ' CD1' ' A' ' 77' ' ' ILE . 1.3 p90 -72.47 0.5 10.12 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.068 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -112.64 -16.68 12.77 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.479 0.657 . . . . 0.0 109.974 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 107' ' ' ARG . 94.7 t -71.08 150.7 9.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.773 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 1.9 mtmp? -115.08 159.73 20.5 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.178 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -73.97 145.86 44.32 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.08 4.22 86.96 Favored Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.159 -174.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.773 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -76.68 167.32 22.05 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.16 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.631 ' H ' HG23 ' A' ' 97' ' ' VAL . 35.6 mttt -120.03 166.84 12.84 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.498 0.666 . . . . 0.0 111.756 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.35 162.28 35.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.655 171.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.61 141.02 29.09 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 1.8 m -114.68 149.57 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 173.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.495 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 44.9 t -69.53 -1.37 8.5 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.281 0.562 . . . . 0.0 110.548 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.689 ' OE1' ' HA ' ' A' ' 146' ' ' ASP . 27.6 mt-10 56.74 1.04 0.08 Allowed 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 124.613 1.165 . . . . 0.0 113.274 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 45.7 tp -111.59 120.49 42.27 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 120.867 0.365 . . . . 0.0 110.604 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.545 ' C ' ' HG ' ' A' ' 124' ' ' LEU . 7.4 pt-20 -93.63 -17.92 22.75 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -174.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.654 ' CD1' HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER 52.96 3.96 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 124.258 1.023 . . . . 0.0 112.289 -177.529 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.502 ' H ' ' C ' ' A' ' 123' ' ' GLU . 80.0 t 77.55 -47.68 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.71 1.204 . . . . 0.0 112.319 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.408 ' OE2' ' HA ' ' A' ' 17' ' ' GLN . 34.9 tt0 -54.41 110.82 0.67 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.636 0.731 . . . . 0.0 112.602 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -126.6 6.84 6.85 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.42 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.8 t -78.89 -177.95 5.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.855 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.3 p -70.7 -18.52 62.81 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.938 0.399 . . . . 0.0 110.287 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.555 ' HA ' HE22 ' A' ' 132' ' ' GLN . 4.5 t 66.78 23.18 10.15 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.918 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 25.1 t -80.4 -1.83 43.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.958 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.555 HE22 ' HA ' ' A' ' 130' ' ' SER . 5.1 pm0 -95.02 169.31 10.21 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.644 ' O ' ' HD3' ' A' ' 135' ' ' PRO . 7.3 p-10 -81.25 147.96 29.7 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.567 ' ND2' ' HG2' ' A' ' 17' ' ' GLN . 7.3 m-20 -112.11 88.89 10.97 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.306 0.575 . . . . 0.0 111.201 -176.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.644 ' HD3' ' O ' ' A' ' 133' ' ' ASP . 7.8 Cg_exo -74.7 -40.48 1.01 Allowed 'Trans proline' 0 C--N 1.326 -0.65 0 C-N-CA 123.521 2.814 . . . . 0.0 112.572 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 138' ' ' GLU . 68.4 mttm -150.69 -53.49 0.14 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.995 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.5 t30 75.63 -13.43 0.87 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.771 0.828 . . . . 0.0 110.382 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 136' ' ' LYS . 2.4 mp0 63.59 -176.03 0.16 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.975 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -102.57 143.31 32.43 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.698 HD23 ' H ' ' A' ' 140' ' ' LEU . 2.4 pt? -74.15 -40.75 62.38 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.033 0.444 . . . . 0.0 111.863 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 108.86 -76.36 0.22 Allowed Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 143' ' ' PRO . 26.6 t -137.74 117.79 10.25 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-O 120.686 0.279 . . . . 0.0 110.493 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 142' ' ' SER . 20.4 Cg_endo -67.03 -51.86 0.73 Allowed 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 122.774 2.316 . . . . 0.0 112.113 177.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 143' ' ' PRO . 37.3 tt0 76.64 -92.87 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.204 -178.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 49.93 -91.33 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.828 0 O-C-N 123.7 0.625 . . . . 0.0 112.493 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.689 ' HA ' ' OE1' ' A' ' 121' ' ' GLU . 36.9 t70 49.98 56.59 7.65 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.347 0.659 . . . . 0.0 112.772 176.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -166.27 142.67 4.94 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.638 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.602 HD12 ' CD2' ' A' ' 98' ' ' TYR . 11.9 mt -101.37 148.04 25.62 Favored 'General case' 0 CA--C 1.479 -1.751 0 CA-C-O 121.288 0.566 . . . . 0.0 109.68 175.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.91 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -108.37 133.86 51.98 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.914 -1.039 . . . . 0.0 113.644 -172.012 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.418 ' N ' HD13 ' A' ' 149' ' ' LEU . 21.5 mt-10 -88.46 143.75 26.79 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.709 -1.132 . . . . 0.0 112.919 175.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.473 HD13 ' CD1' ' A' ' 79' ' ' PHE . 68.2 mt -77.5 110.06 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.607 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.006 175.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 80' ' ' GLU . 7.2 mmpt? -72.44 -39.75 67.59 Favored 'General case' 0 C--N 1.268 -2.94 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.487 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -150.16 133.8 16.67 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.8 mt -113.83 143.08 24.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.054 175.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.516 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.0 ptpt -144.6 158.03 43.95 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.605 -178.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.545 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 7.2 m-85 -100.9 114.54 28.5 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.563 174.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -126.43 173.78 11.5 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.319 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.435 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 49.8 ttt180 -112.21 167.6 10.28 Favored 'General case' 0 N--CA 1.415 -2.193 0 O-C-N 121.329 -0.857 . . . . 0.0 110.693 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.435 ' N ' ' HG2' ' A' ' 158' ' ' ARG . . . -67.57 114.94 6.63 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.433 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -72.5 -32.77 66.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.665 -177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -81.92 -176.21 6.0 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.305 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -101.29 -15.68 17.2 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -138.17 153.77 49.18 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 3' ' ' PRO . 3.1 m -118.46 155.95 20.41 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.674 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 78.1 m-85 -135.52 161.3 35.88 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.91 -175.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.761 ' OG ' ' HA ' ' A' ' 1' ' ' CYS . 74.0 m -158.1 13.64 0.2 Allowed 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.553 176.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.644 HD23 ' C ' ' A' ' 166' ' ' SER . 2.5 pt? 29.39 109.51 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 125.368 1.467 . . . . 0.0 113.923 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -82.03 114.34 20.52 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.147 -177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.5 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -133.56 -142.43 0.2 Allowed 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -67.03 115.52 6.84 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.662 -0.244 . . . . 0.0 110.821 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt 70.07 166.95 0.29 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.742 0.817 . . . . 0.0 112.544 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -77.93 121.88 24.76 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.118 -175.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 49.99 27.62 2.53 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 114.581 -1.191 . . . . 0.0 113.266 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -86.13 99.57 11.6 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.622 ' CG2' HD11 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -165.1 171.7 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.666 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 97.0 mt -111.99 118.12 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-N 114.744 -1.117 . . . . 0.0 110.615 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.422 HG22 HD12 ' A' ' 8' ' ' ILE . 44.3 pt -120.78 171.91 8.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.294 0 CA-C-O 121.01 0.433 . . . . 0.0 111.186 -177.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 48.83 -129.79 1.9 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.313 1.045 . . . . 0.0 110.504 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -89.73 52.01 2.22 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.558 0.694 . . . . 0.0 109.959 176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.754 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 13.5 m120 74.05 44.41 0.26 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.685 176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.408 HD13 ' CD1' ' A' ' 87' ' ' PHE . 86.5 mt -87.0 113.04 23.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 73.4 t -88.24 130.38 37.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.958 -176.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 12.0 t -139.14 166.16 25.25 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.594 176.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -157.66 145.53 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.656 0.265 . . . . 0.0 110.65 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 C--O 1.256 1.405 0 CA-C-O 117.783 -1.103 . . . . 0.0 110.185 177.391 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.522 ' H2 ' ' HB2' ' A' ' 93' ' ' HIS . 63.7 m . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.997 0.427 . . . . 0.0 111.42 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.433 ' HB3' ' HD2' ' A' ' 3' ' ' PRO . 2.7 m-85 -133.0 167.01 25.1 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.499 ' HD3' HD13 ' A' ' 76' ' ' LEU . 73.0 Cg_endo -72.14 164.48 35.51 Favored 'Trans proline' 0 N--CA 1.437 -1.806 0 N-CA-C 108.408 -1.42 . . . . 0.0 108.408 175.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -60.76 -26.59 65.26 Favored Glycine 0 C--N 1.301 -1.415 0 C-N-CA 118.993 -1.575 . . . . 0.0 111.44 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.54 -9.32 48.55 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.6 m -71.33 129.69 39.49 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.381 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.642 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 26.2 mtm180 -85.77 132.08 34.2 Favored 'General case' 0 C--O 1.187 -2.187 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.712 HD11 HG21 ' A' ' 175' ' ' VAL . 8.9 tt -119.91 130.1 74.62 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-O 120.863 0.363 . . . . 0.0 110.139 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -88.44 122.13 31.59 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-O 121.527 0.679 . . . . 0.0 109.576 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.607 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 28.0 m -132.58 -173.3 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.346 -178.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 31.4 tt0 -134.4 121.4 21.09 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.637 HG12 HG13 ' A' ' 47' ' ' ILE . 17.0 mt -120.87 123.47 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.922 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.11 37.47 27.09 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.202 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.12 76.92 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.657 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.1 t -130.79 119.81 18.28 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.569 ' HB2' HD22 ' A' ' 124' ' ' LEU . 13.5 Cg_exo -64.87 120.93 8.29 Favored 'Trans proline' 0 N--CA 1.437 -1.809 0 C-N-CA 121.733 1.622 . . . . 0.0 110.663 178.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -118.62 135.58 54.36 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -106.56 100.78 10.28 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.443 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.3 pt -125.46 -172.68 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.146 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.243 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.732 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 29.6 p -96.46 170.1 9.46 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.793 179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 84.6 mt -67.23 -28.22 67.88 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.797 178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.732 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 11.2 ptm180 -79.51 -26.54 41.53 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.492 ' OE1' HG23 ' A' ' 20' ' ' THR . 43.9 mt-10 -84.28 -42.34 15.93 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.797 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.727 HD23 ' HG ' ' A' ' 167' ' ' LEU . 17.5 tp -57.96 -44.01 86.76 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 121.779 0.8 . . . . 0.0 109.206 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.512 ' HD1' HG11 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -51.42 -34.17 33.72 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.749 -1.568 . . . . 0.0 112.631 179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.562 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 31.3 mt-10 -76.6 -14.39 60.0 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -175.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 23' ' ' GLU . 1.4 mm? -79.97 4.74 15.94 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.572 0.701 . . . . 0.0 109.317 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.527 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.9 m-85 -118.24 162.11 18.79 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.922 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -142.12 -173.38 3.81 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.562 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 0.8 OUTLIER 61.91 84.93 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.45 0.643 . . . . 0.0 110.434 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -103.0 127.25 50.31 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.782 0.801 . . . . 0.0 111.161 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.451 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 14.3 ptt180 -121.04 154.39 36.14 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.237 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -100.3 130.26 46.39 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -164.29 142.04 6.89 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.27 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 59.07 23.12 11.27 Favored 'General case' 0 CA--C 1.493 -1.225 0 O-C-N 123.599 0.562 . . . . 0.0 111.18 177.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 40.8 mtp 71.81 17.98 5.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.618 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.534 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 14.6 m -132.56 -173.61 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -114.46 141.4 47.73 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-O 121.253 0.549 . . . . 0.0 109.822 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 3.4 t -129.23 123.46 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.059 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.444 ' HG2' ' HB3' ' A' ' 28' ' ' PHE . 19.3 ttm180 -114.13 126.6 55.26 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -130.67 144.28 51.32 Favored 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.683 -174.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 37.5 ttmt 83.97 114.58 0.03 OUTLIER Pre-proline 0 CA--C 1.509 -0.627 0 O-C-N 124.639 1.212 . . . . 0.0 111.279 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.59 ' HB2' HD13 ' A' ' 47' ' ' ILE . 81.7 Cg_endo -80.24 151.62 20.61 Favored 'Trans proline' 0 N--CA 1.432 -2.111 0 C-N-CA 122.19 1.926 . . . . 0.0 111.515 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -84.04 -5.91 59.32 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.32 0.581 . . . . 0.0 110.751 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -145.5 -166.09 2.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 8.1 tp10 -85.69 101.07 12.44 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.637 HG13 HG12 ' A' ' 12' ' ' ILE . 1.8 mp -117.36 116.92 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.607 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 57.0 mmtt -115.12 169.08 9.38 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.336 174.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.456 HG11 ' CB ' ' A' ' 169' ' ' ALA . 13.0 p -127.01 130.77 71.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.314 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.463 ' HB3' HD12 ' A' ' 176' ' ' ILE . 5.2 m-85 -88.0 124.2 33.49 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.586 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.8 m -133.73 168.56 18.48 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.641 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.585 HG12 HD11 ' A' ' 176' ' ' ILE . 2.2 mm -116.0 145.91 21.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.32 0.581 . . . . 0.0 111.061 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.7 ' OD1' ' HG3' ' A' ' 55' ' ' GLU . 17.5 t70 -84.56 114.13 21.75 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 176.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.823 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -73.47 -9.2 58.44 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.355 0.662 . . . . 0.0 112.629 -170.049 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.7 ' HG3' ' OD1' ' A' ' 53' ' ' ASP . 3.1 pt-20 -102.12 -28.01 12.58 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.841 -176.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.553 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 61.0 p -118.2 -25.23 6.68 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.67 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.28 16.54 55.4 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.691 -0.686 . . . . 0.0 113.543 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.553 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 38.2 mttt -86.93 151.46 23.28 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.98 0.419 . . . . 0.0 112.092 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.02 107.97 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.581 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.7 m -109.5 157.1 10.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.316 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.9 tp -120.87 142.88 49.26 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.478 HG21 ' HB3' ' A' ' 170' ' ' LYS . 9.9 t -148.52 170.77 17.33 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.602 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -82.79 160.71 22.2 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.365 0.603 . . . . 0.0 109.824 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.591 HD13 HG22 ' A' ' 47' ' ' ILE . 2.2 mp -94.71 143.85 10.94 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.032 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.459 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 58.0 mm-40 -89.05 -39.87 13.36 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 178.58 177.26 0.46 Allowed 'General case' 0 CA--C 1.51 -0.58 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.693 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.512 HG11 ' HD1' ' A' ' 25' ' ' TYR . 9.9 t -107.48 130.42 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.377 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 38.1 mt -90.51 106.85 17.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.587 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.534 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.5 tttt -121.54 108.73 13.96 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.74 141.87 43.36 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.275 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.487 ' HD2' HG12 ' A' ' 37' ' ' VAL . 9.5 Cg_endo -55.48 130.25 39.5 Favored 'Trans proline' 0 C--O 1.242 0.676 0 C-N-CA 123.379 2.719 . . . . 0.0 112.74 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.5 99.66 9.61 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.397 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.2 m -106.04 -48.74 3.53 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.43 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.505 ' OD2' HG22 ' A' ' 90' ' ' THR . 12.0 p-10 -87.7 -173.28 4.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.25 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -111.76 172.96 6.59 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 121.163 0.506 . . . . 0.0 111.126 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' ' 90' ' ' THR . 9.9 mt -120.2 146.63 45.84 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.031 -175.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.485 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 12.0 mt -89.8 145.47 7.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 172.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 30.5 ttt-85 -120.75 136.76 54.79 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 86' ' ' SER . 60.0 m-85 -114.73 122.33 46.09 Favored 'General case' 0 C--N 1.281 -2.406 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.486 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.1 tt0 -110.04 123.81 50.35 Favored 'General case' 0 CA--C 1.465 -2.312 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.722 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.5 mm? -86.84 162.05 17.99 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.448 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.872 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.5 pt-20 -63.26 -15.64 57.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.312 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -93.03 -9.73 38.71 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.029 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.22 8.68 62.73 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.12 -0.945 . . . . 0.0 113.452 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.599 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -88.83 143.35 26.95 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 176.064 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 55.8 p -138.57 154.89 48.74 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.823 178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 79' ' ' PHE . 5.0 p90 -145.69 148.95 33.59 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.883 176.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.492 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 44.1 mt-10 -124.89 148.15 48.44 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.729 -175.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -144.71 159.03 43.5 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.636 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.712 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -71.04 18.72 0.06 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.055 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.026 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.6 OUTLIER 70.87 -32.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 125.006 1.322 . . . . 0.0 112.429 177.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 90' ' ' THR . 12.8 t70 -78.35 -26.87 46.89 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.149 0.499 . . . . 0.0 109.737 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.522 ' HB2' ' H2 ' ' A' ' 1' ' ' CYS . 61.0 t-80 -69.26 123.75 88.97 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.05 -178.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 33.5 Cg_exo -63.78 142.08 81.33 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.278 2.652 . . . . 0.0 113.126 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.46 146.33 18.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 C-N-CA 124.22 1.008 . . . . 0.0 108.332 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 15.9 tp -105.38 109.7 21.78 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.837 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.56 HG13 HG13 ' A' ' 104' ' ' ILE . 2.1 p -110.72 151.1 12.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.371 0.605 . . . . 0.0 111.214 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -102.66 93.36 5.07 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.984 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.514 ' OE2' HD11 ' A' ' 104' ' ' ILE . 11.4 pt-20 -145.88 157.04 43.92 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.487 HD22 ' HG3' ' A' ' 99' ' ' GLU . 39.1 m-80 66.52 23.52 10.44 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.144 0.497 . . . . 0.0 109.844 -177.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.42 11.89 57.36 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.207 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -136.84 172.23 13.33 Favored 'General case' 0 N--CA 1.402 -2.827 0 CA-C-O 121.462 0.649 . . . . 0.0 110.507 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.406 ' CE1' HD11 ' A' ' 118' ' ' LEU . 28.2 m-85 -98.45 121.41 40.35 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.373 177.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.56 HG13 HG13 ' A' ' 97' ' ' VAL . 22.8 pt -118.72 145.9 24.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.126 -0.63 . . . . 0.0 112.146 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -103.65 109.14 20.72 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.793 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -124.98 135.6 52.95 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.844 179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.622 ' O ' HG23 ' A' ' 111' ' ' VAL . 96.1 mtt180 -62.31 163.42 8.47 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.026 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -62.05 -42.13 98.86 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.165 -176.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.496 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 1.7 p90 -74.14 2.64 8.52 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.814 178.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -110.87 -19.41 12.82 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.487 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 107' ' ' ARG . 98.5 t -77.55 147.02 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 8.3 mptt -118.46 166.76 12.28 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.005 0.431 . . . . 0.0 111.543 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -70.11 142.9 52.54 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.07 4.21 81.93 Favored Glycine 0 C--N 1.304 -1.245 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.235 -175.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.683 ' HB3' HD12 ' A' ' 151' ' ' ILE . 11.3 t70 -76.93 170.47 16.45 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.684 ' HD3' ' HB3' ' A' ' 148' ' ' LEU . 42.4 mttp -122.78 165.97 15.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.442 0.639 . . . . 0.0 111.648 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.97 156.57 39.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.862 171.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.497 ' HG ' HD11 ' A' ' 148' ' ' LEU . 0.8 OUTLIER -91.57 136.61 33.0 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 3.4 m -107.09 154.34 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.206 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.933 173.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.559 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 32.2 t -76.2 30.0 0.12 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.809 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 119' ' ' VAL . 36.5 mt-10 73.4 -49.07 0.69 Allowed 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 124.728 1.211 . . . . 0.0 111.86 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.472 ' CB ' ' HB3' ' A' ' 143' ' ' PRO . 0.7 OUTLIER -173.63 -169.51 0.51 Allowed 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -175.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.501 ' HB2' HD23 ' A' ' 124' ' ' LEU . 9.8 pt-20 -113.71 -134.44 0.35 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.037 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 124' ' ' LEU . 0.5 OUTLIER -98.28 16.44 21.46 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.642 0.734 . . . . 0.0 110.439 -176.514 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.449 ' O ' HD22 ' A' ' 122' ' ' LEU . 4.0 p -168.16 154.42 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.375 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.459 -177.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -59.33 -59.46 5.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.295 0.372 . . . . 0.0 111.929 -179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -165.01 79.51 0.34 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.923 0.392 . . . . 0.0 110.372 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.1 m 67.63 -67.23 0.19 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.27 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.2 m 50.5 -99.13 0.07 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.215 1.006 . . . . 0.0 112.477 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.527 ' HB2' ' OE1' ' A' ' 132' ' ' GLN . 1.2 m -68.33 -39.58 81.88 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.611 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.2 m 64.05 94.8 0.05 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.369 0.667 . . . . 0.0 111.878 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.527 ' OE1' ' HB2' ' A' ' 130' ' ' SER . 18.6 mp0 -125.64 172.86 9.41 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.041 0.448 . . . . 0.0 111.291 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -99.12 -21.43 16.17 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.913 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.464 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . 25.8 t-20 -178.32 -49.25 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.486 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.445 -177.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 134' ' ' ASN . 27.2 Cg_exo -61.92 97.03 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.743 2.295 . . . . 0.0 113.427 -175.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -167.86 -41.46 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 m120 66.11 -172.27 0.19 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.921 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.78 164.76 16.5 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -174.03 -46.65 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 121.72 0.771 . . . . 0.0 109.797 -177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.736 HD23 ' H ' ' A' ' 140' ' ' LEU . 2.0 pt? -70.07 -37.77 75.56 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.544 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 104.59 -72.87 0.25 Allowed Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.8 m -136.0 163.84 47.44 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.472 ' HB3' ' CB ' ' A' ' 122' ' ' LEU . 19.1 Cg_exo -66.01 -169.76 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.661 2.24 . . . . 0.0 112.154 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 145' ' ' HIS . 10.0 tp10 -165.6 92.66 0.54 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.803 -0.181 . . . . 0.0 110.831 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 144' ' ' GLU . 1.3 t60 172.4 91.2 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -77.06 117.49 18.68 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.123 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.53 ' NE2' HH22 ' A' ' 85' ' ' ARG . 8.2 pt20 -164.39 138.96 5.55 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.399 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.684 ' HB3' ' HD3' ' A' ' 116' ' ' LYS . 3.9 mm? -115.55 132.19 56.7 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.872 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -109.26 134.89 51.2 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -173.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.537 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 19.9 mt-10 -87.3 142.79 27.63 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.057 176.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.683 HD12 ' HB3' ' A' ' 115' ' ' ASP . 71.1 mt -78.79 109.22 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.246 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.62 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.555 ' HE2' ' HB2' ' A' ' 82' ' ' GLU . 36.4 mmtt -68.25 -40.36 81.96 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.918 176.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -151.27 131.33 13.44 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.557 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 73.2 mt -112.83 140.98 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.189 0 CA-C-N 113.472 -1.695 . . . . 0.0 110.371 174.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.446 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 18.2 ptpt -148.44 159.64 43.84 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.312 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.485 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 18.7 m-85 -99.27 116.75 32.18 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.425 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.3 OUTLIER -131.31 134.69 60.74 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.007 -178.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -67.44 154.19 41.94 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.518 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.0 133.99 56.65 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.784 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -84.32 37.9 0.64 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.089 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 162' ' ' ASP . 12.6 t70 -176.54 -174.4 0.58 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.29 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.448 ' H ' ' CG ' ' A' ' 161' ' ' ASP . 6.0 m-20 -95.64 -10.43 29.44 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.876 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.21 160.73 38.18 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.265 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.7 m -127.55 158.01 39.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.573 176.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.567 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 77.3 m-85 -135.77 167.22 21.57 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.142 0.496 . . . . 0.0 111.08 -175.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.562 ' HB3' HD12 ' A' ' 68' ' ' ILE . 44.6 t -152.47 -16.39 0.17 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.115 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.727 ' HG ' HD23 ' A' ' 24' ' ' LEU . 4.5 mm? 59.41 105.02 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.648 0.737 . . . . 0.0 111.655 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.528 ' OD1' ' HB3' ' A' ' 172' ' ' TYR . 58.2 t30 -83.81 118.68 24.09 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.556 -176.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.459 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -135.32 -162.1 1.22 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.478 ' HB3' HG21 ' A' ' 62' ' ' THR . 72.1 tttt -62.89 130.03 43.01 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt 57.49 78.75 0.22 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.549 0.69 . . . . 0.0 109.997 -171.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.528 ' HB3' ' OD1' ' A' ' 168' ' ' ASN . 2.8 p90 -56.71 150.42 15.96 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.913 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 184' ' ' HIS . 33.0 m170 67.15 28.25 8.26 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.345 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 183' ' ' THR . 43.9 t30 -137.34 102.94 4.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.285 177.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.712 HG21 HD11 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -153.95 162.15 2.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.485 -177.286 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.585 HD11 HG12 ' A' ' 52' ' ' ILE . 87.3 mt -101.22 117.07 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.31 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.535 HG23 HG13 ' A' ' 175' ' ' VAL . 34.1 pt -122.76 162.67 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 CA-C-O 121.386 0.612 . . . . 0.0 111.676 -176.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 22.0 t30 48.34 -133.2 1.4 Allowed 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 124.697 1.199 . . . . 0.0 110.862 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.26 52.24 1.3 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.496 0.665 . . . . 0.0 110.654 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.733 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.0 m120 66.97 48.34 1.28 Allowed 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 125.154 1.382 . . . . 0.0 113.365 176.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.1 mt -90.05 114.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.4 m -86.77 159.11 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-O 121.458 0.647 . . . . 0.0 110.922 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 4.0 t -158.33 149.49 20.86 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.93 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 50.4 t-80 -152.56 146.25 25.07 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -177.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.41 ' HA ' ' HG2' ' A' ' 94' ' ' PRO . 0.7 OUTLIER . . . . . 0 C--O 1.26 1.639 0 CA-C-O 117.516 -1.23 . . . . 0.0 109.626 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 89' ' ' THR . 56.7 m . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.955 0.407 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.414 ' CE1' HD13 ' A' ' 177' ' ' ILE . 49.1 m-85 -129.36 155.22 80.4 Favored Pre-proline 0 N--CA 1.446 -0.636 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.527 ' HA ' HG12 ' A' ' 164' ' ' VAL . 22.4 Cg_endo -61.16 -31.68 90.41 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.77 2.313 . . . . 0.0 112.279 -177.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.498 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 129.22 -39.3 1.87 Allowed Glycine 0 N--CA 1.421 -2.366 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.58 -11.86 55.15 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.374 0.607 . . . . 0.0 111.485 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 64.4 m -63.8 129.84 41.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 29.6 mtm180 -88.27 137.07 32.65 Favored 'General case' 0 C--O 1.189 -2.091 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 175' ' ' VAL . 11.9 tt -122.5 130.47 74.49 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 C-N-CA 122.649 0.379 . . . . 0.0 110.106 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.602 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -88.52 122.5 32.05 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 121.526 0.679 . . . . 0.0 109.467 179.393 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 26.1 m -133.34 179.63 4.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.477 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -126.23 120.42 29.97 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-O 121.35 0.595 . . . . 0.0 109.495 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.603 HG12 HG13 ' A' ' 47' ' ' ILE . 28.5 mt -120.22 122.24 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.463 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.643 -177.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.401 ' HA ' ' HB3' ' A' ' 46' ' ' GLU . 66.9 m-20 55.15 37.77 29.41 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 114.22 -1.354 . . . . 0.0 110.044 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.83 17.22 78.23 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.776 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.595 HG11 ' O ' ' A' ' 134' ' ' ASN . 20.2 t -127.3 123.32 23.26 Favored Pre-proline 0 C--N 1.312 -1.022 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 21.3 Cg_endo -67.69 126.56 14.9 Favored 'Trans proline' 0 N--CA 1.436 -1.868 0 C-N-CA 122.017 1.811 . . . . 0.0 111.104 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -125.97 138.07 53.73 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -106.76 101.32 10.77 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.7 pt -123.32 -178.14 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.936 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 16.7 p -92.23 168.78 11.1 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.803 -177.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.4 mm? -66.19 -25.12 66.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.825 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.586 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 1.1 ptm180 -85.38 -24.38 27.57 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HB2' ' H ' ' A' ' 20' ' ' THR . 35.2 mt-10 -85.51 -39.65 17.21 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.63 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.758 HD23 ' HG ' ' A' ' 167' ' ' LEU . 22.0 tp -58.84 -41.57 87.22 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 121.764 0.792 . . . . 0.0 109.602 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.468 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -55.54 -29.38 58.86 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 113.947 -1.479 . . . . 0.0 112.308 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.62 -17.56 59.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.649 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.412 HD23 ' O ' ' A' ' 23' ' ' GLU . 2.3 mm? -78.85 4.04 15.15 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.575 0.702 . . . . 0.0 109.414 179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 95.6 m-85 -117.89 162.2 18.5 Favored 'General case' 0 N--CA 1.412 -2.36 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.861 -177.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 4.4 mm-40 -139.44 -173.81 3.71 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.375 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.445 ' HB3' ' HD3' ' A' ' 41' ' ' LYS . 3.5 t0 60.08 80.96 0.19 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.465 0.65 . . . . 0.0 110.863 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -102.56 130.79 49.52 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 121.904 0.859 . . . . 0.0 110.824 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.46 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.1 ptt180 -119.88 153.89 35.19 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.768 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -101.47 123.86 46.2 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -161.94 143.96 11.3 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.94 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 59.35 22.2 10.58 Favored 'General case' 0 CA--C 1.493 -1.236 0 O-C-N 123.78 0.675 . . . . 0.0 111.224 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.7 mtt 73.04 17.07 4.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.525 177.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 12.5 m -134.12 -171.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 176.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.413 ' HB2' ' HD3' ' A' ' 69' ' ' LYS . 96.4 m-85 -119.3 143.21 47.48 Favored 'General case' 0 CA--C 1.481 -1.693 0 CA-C-O 121.164 0.507 . . . . 0.0 110.183 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.46 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.1 t -129.98 123.99 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.966 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.115 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.522 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 13.7 ttm180 -113.43 128.1 56.34 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.566 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.41 141.39 48.85 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.085 -174.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 24.3 ttmm 85.26 115.5 0.03 OUTLIER Pre-proline 0 CA--C 1.512 -0.513 0 C-N-CA 124.24 1.016 . . . . 0.0 111.928 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.541 ' HB2' HD13 ' A' ' 47' ' ' ILE . 72.3 Cg_endo -79.46 152.26 23.17 Favored 'Trans proline' 0 N--CA 1.436 -1.89 0 C-N-CA 122.347 2.032 . . . . 0.0 111.838 177.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 31.0 mtmt -84.33 -6.09 59.35 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.821 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -148.35 -164.85 2.12 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 6.2 tp10 -86.73 101.17 13.05 Favored 'General case' 0 C--N 1.287 -2.136 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.469 176.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.603 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -116.21 118.23 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.526 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 29.3 mmtp -123.0 166.31 15.31 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.606 173.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.509 ' O ' HD12 ' A' ' 61' ' ' LEU . 6.3 m -115.36 129.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -84.8 121.91 28.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.827 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.1 m -132.88 171.32 14.08 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.846 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.46 HG12 HD11 ' A' ' 176' ' ' ILE . 2.9 mm -113.41 143.18 23.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-O 121.168 0.509 . . . . 0.0 110.008 177.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.643 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 21.2 t70 -77.55 124.22 27.63 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.342 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.804 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -75.97 -10.51 59.48 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.608 -171.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.643 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 3.8 pt-20 -107.87 -23.33 12.09 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 120.141 -0.623 . . . . 0.0 111.895 -177.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.529 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 67.7 p -120.99 -23.78 5.76 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.999 -176.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.54 17.57 65.94 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.393 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.529 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 18.0 mttp -92.43 159.36 15.59 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 t -85.79 107.89 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.465 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.26 157.78 12.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.153 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.509 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.1 tp -122.24 137.98 54.65 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.5 t -143.79 171.51 14.12 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.591 -0.444 . . . . 0.0 111.08 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -84.14 161.64 20.54 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.809 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.578 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.9 mp -100.79 141.11 18.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.504 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.587 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 49.7 mt-10 -89.7 -35.85 15.54 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 p30 176.5 174.85 0.35 Allowed 'General case' 0 CA--C 1.499 -0.984 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.006 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 20.5 t -105.54 134.3 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.191 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.297 177.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.525 HD13 ' HB3' ' A' ' 166' ' ' SER . 0.1 OUTLIER -101.8 124.04 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.379 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.089 179.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 86.7 tttt -135.34 108.47 7.7 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.224 -176.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.43 137.17 30.22 Favored Pre-proline 0 C--N 1.31 -1.148 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.44 -175.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -47.43 124.04 8.78 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.394 2.729 . . . . 0.0 112.79 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.37 108.09 7.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.865 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -110.95 -59.52 1.95 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -77.21 -98.94 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -171.84 172.74 4.73 Favored 'General case' 0 CA--C 1.474 -1.981 0 CA-C-O 121.101 0.477 . . . . 0.0 112.011 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.769 HD23 ' HA ' ' A' ' 90' ' ' THR . 7.3 mt -132.45 141.14 48.7 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.135 -178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.513 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 10.6 mt -87.67 144.86 8.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 19.3 ttt-85 -121.69 136.03 54.95 Favored 'General case' 0 N--CA 1.408 -2.535 0 CA-C-O 121.283 0.564 . . . . 0.0 109.731 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 86' ' ' SER . 48.7 m-85 -114.34 130.32 56.67 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.865 -176.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 152' ' ' LYS . 18.9 tt0 -109.86 129.21 55.67 Favored 'General case' 0 CA--C 1.477 -1.857 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.7 mm? -94.31 155.64 16.91 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.778 ' HG2' HD11 ' A' ' 149' ' ' LEU . 1.1 pt-20 -64.62 -14.34 57.56 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.212 0.53 . . . . 0.0 111.529 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.69 -8.24 52.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.51 -0.768 . . . . 0.0 108.989 177.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.92 19.11 44.53 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.403 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.54 ' O ' HD23 ' A' ' 81' ' ' LEU . 4.8 mtt-85 -89.2 139.1 30.82 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 9.0 p -139.29 144.87 38.53 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.849 175.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -140.76 147.17 38.7 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.094 178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 35.9 mt-10 -117.88 147.75 42.8 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.965 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 91' ' ' VAL . 1.1 p -145.8 159.44 43.19 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.302 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.769 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -72.55 20.48 0.07 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -176.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.072 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 69.47 -37.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 C-N-CA 125.397 1.479 . . . . 0.0 113.532 176.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -87.22 -2.2 58.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.143 0.497 . . . . 0.0 110.633 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -81.31 121.49 80.29 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.686 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HG2' ' NE2' ' A' ' 173' ' ' HIS . 21.3 Cg_endo -63.32 139.04 69.4 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 122.659 2.239 . . . . 0.0 113.336 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 18.1 t -113.89 145.82 19.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.5 tp -101.35 107.69 19.1 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 121.059 -0.257 . . . . 0.0 110.336 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.499 HG13 HG13 ' A' ' 104' ' ' ILE . 2.6 p -107.76 147.5 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 CA-C-O 121.63 0.728 . . . . 0.0 111.666 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -103.8 91.18 3.89 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.558 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.552 ' CG ' HD11 ' A' ' 104' ' ' ILE . 10.4 pt-20 -141.24 158.83 43.37 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.856 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.2 m-20 65.62 23.13 11.69 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.09 15.45 58.5 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.811 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HG3' HG23 ' A' ' 104' ' ' ILE . 9.7 ptm180 -136.33 171.96 13.71 Favored 'General case' 0 N--CA 1.408 -2.537 0 CA-C-O 121.206 0.527 . . . . 0.0 110.145 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -102.55 120.9 41.33 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.552 HD11 ' CG ' ' A' ' 99' ' ' GLU . 9.2 pt -125.8 147.94 30.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.316 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -100.41 119.0 37.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.448 -177.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.52 ' HE2' ' CD1' ' A' ' 104' ' ' ILE . 64.6 mttm -129.35 133.2 47.3 Favored 'General case' 0 C--O 1.205 -1.275 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.507 ' O ' HG23 ' A' ' 111' ' ' VAL . 86.4 mtt180 -63.42 163.04 11.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.072 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -60.57 -41.44 94.64 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.013 -175.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.487 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 2.8 p90 -74.18 4.61 5.4 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.961 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -118.17 -16.23 9.76 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.695 0.76 . . . . 0.0 110.265 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 107' ' ' ARG . 78.4 t -76.97 149.12 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -119.88 165.63 14.37 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.436 -176.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.8 141.09 53.39 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.286 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.75 5.0 71.99 Favored Glycine 0 C--N 1.307 -1.083 0 C-N-CA 120.222 -0.99 . . . . 0.0 111.527 -175.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.936 ' HB3' HD12 ' A' ' 151' ' ' ILE . 6.8 t70 -72.65 177.54 4.68 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.45 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 23.0 mttp -134.29 160.46 37.84 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.405 0.621 . . . . 0.0 111.013 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.26 158.4 43.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.066 172.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.71 130.86 37.43 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.732 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.4 OUTLIER -102.61 148.73 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 175.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.586 ' H ' ' HB3' ' A' ' 180' ' ' ASN . 33.1 t -75.54 34.45 0.12 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.683 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.476 ' H ' ' C ' ' A' ' 119' ' ' VAL . 90.1 mt-10 73.74 -57.27 0.63 Allowed 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 124.42 1.088 . . . . 0.0 111.027 -177.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -174.82 -160.59 0.09 Allowed 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 -172.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.523 ' H ' HD12 ' A' ' 122' ' ' LEU . 9.4 pt-20 -152.67 176.48 11.7 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 120.838 0.351 . . . . 0.0 111.749 -174.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.602 ' CD2' HD21 ' A' ' 9' ' ' LEU . 2.4 pt? -49.22 -29.15 5.28 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.856 172.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 124' ' ' LEU 0.287 10.9 p 68.41 115.31 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.764 0 C-N-CA 126.623 1.969 . . . . 0.0 114.857 172.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -171.44 138.52 1.18 Allowed 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 113.811 -1.54 . . . . 0.0 108.264 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -84.75 11.94 8.18 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -177.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 19.5 m -75.22 142.02 43.48 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.952 0.406 . . . . 0.0 110.948 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.475 ' HA ' HH11 ' A' ' 7' ' ' ARG . 22.7 m -79.45 -40.27 30.28 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.281 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.4 m -126.86 -30.04 2.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.684 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.1 t 70.57 118.88 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.439 0.695 . . . . 0.0 111.236 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -96.15 -28.0 14.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.373 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -87.64 107.03 18.42 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.075 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.595 ' O ' HG11 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -65.82 -53.15 37.24 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.491 -179.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 134' ' ' ASN . 15.3 Cg_endo -56.48 145.74 78.26 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.728 2.286 . . . . 0.0 111.744 178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.593 ' HG2' ' H ' ' A' ' 137' ' ' ASN . 39.0 tttp -151.56 -150.64 0.35 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.377 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.593 ' H ' ' HG2' ' A' ' 136' ' ' LYS . 20.4 t-20 63.51 52.68 2.26 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -84.27 -29.32 26.53 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.625 -178.215 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -151.68 17.85 0.7 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.2 tp 70.63 147.85 0.07 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.879 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -123.2 66.33 0.5 Allowed Glycine 0 N--CA 1.434 -1.473 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.645 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.2 m -74.34 120.4 81.24 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.434 ' HA ' ' HB3' ' A' ' 122' ' ' LEU . 55.1 Cg_endo -76.86 -99.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.456 2.104 . . . . 0.0 112.705 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 62.36 92.93 0.05 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.18 0.514 . . . . 0.0 112.063 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.96 91.47 0.55 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -90.93 86.98 6.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.131 0.491 . . . . 0.0 112.23 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.413 ' C ' HD23 ' A' ' 148' ' ' LEU . 7.8 pt20 -164.34 138.59 5.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.615 176.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.413 HD23 ' C ' ' A' ' 147' ' ' GLN . 14.2 mt -108.78 156.05 20.07 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 121.636 0.732 . . . . 0.0 111.825 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.778 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -113.02 136.92 52.16 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.581 -173.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 115' ' ' ASP . 11.6 mt-10 -91.25 148.08 22.59 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.828 -1.078 . . . . 0.0 113.12 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.936 HD12 ' HB3' ' A' ' 115' ' ' ASP . 86.8 mt -78.97 109.63 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 CA-C-N 113.541 -1.663 . . . . 0.0 110.897 176.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.594 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 1.5 mmmp? -68.12 -42.87 79.59 Favored 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.161 -1.381 . . . . 0.0 111.01 177.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -150.03 135.3 18.06 Favored 'General case' 0 CA--C 1.478 -1.807 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 82.6 mt -118.92 129.29 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.639 -1.618 . . . . 0.0 111.058 174.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.455 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 1.8 ptpp? -133.17 163.0 30.24 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.648 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.513 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 13.5 m-85 -100.82 119.25 38.39 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.411 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -129.04 174.62 11.99 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.97 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.856 -178.472 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -109.91 166.4 10.96 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.305 -0.958 . . . . 0.0 112.282 -177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.66 137.1 58.13 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.425 -1.262 . . . . 0.0 111.914 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -101.48 31.05 3.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.974 -177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -170.99 -178.82 2.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -95.28 -13.26 25.0 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-O 121.072 0.463 . . . . 0.0 110.247 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -134.26 166.09 23.6 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.289 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 3' ' ' PRO . 2.1 m -130.91 157.4 43.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 77.3 m-85 -138.46 159.97 40.73 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 121.159 -0.216 . . . . 0.0 110.734 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.525 ' HB3' HD13 ' A' ' 68' ' ' ILE . 7.8 t -148.34 -18.33 0.33 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.448 174.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.758 ' HG ' HD23 ' A' ' 24' ' ' LEU . 4.1 mm? 60.29 95.22 0.03 OUTLIER 'General case' 0 C--N 1.347 0.486 0 O-C-N 123.75 0.657 . . . . 0.0 111.04 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -82.44 102.61 11.42 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.127 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.587 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -97.5 -149.32 0.33 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.227 172.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.414 ' O ' ' HB2' ' A' ' 171' ' ' LYS . 18.8 tptp -62.01 135.2 57.44 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 170' ' ' LYS . 51.5 mttp 71.01 -133.45 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.75 0.656 . . . . 0.0 109.446 -175.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -140.49 122.56 15.67 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.498 ' NE2' ' HG2' ' A' ' 94' ' ' PRO . 9.9 p-80 36.46 32.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 125.551 1.54 . . . . 0.0 115.121 177.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 183' ' ' THR . 0.5 OUTLIER -95.01 99.76 11.72 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.998 0.428 . . . . 0.0 110.435 177.727 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.696 HG21 HD11 ' A' ' 8' ' ' ILE . 2.5 p -150.13 167.03 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.044 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.566 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 90.5 mt -96.85 115.3 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.823 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.414 HD13 ' CE1' ' A' ' 2' ' ' PHE . 31.7 pt -118.47 166.51 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-O 121.307 0.575 . . . . 0.0 111.281 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.413 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 37.6 t30 46.16 -126.57 1.39 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 124.774 1.23 . . . . 0.0 111.028 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -91.07 59.31 3.99 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.603 0.716 . . . . 0.0 109.355 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.732 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.3 m120 66.08 44.65 2.58 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 113.851 -1.522 . . . . 0.0 114.18 176.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.41 ' O ' HG12 ' A' ' 177' ' ' ILE . 91.3 mt -91.68 113.74 27.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.4 m -91.5 153.6 3.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.905 0.859 . . . . 0.0 112.394 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 1.4 t -151.15 156.85 41.82 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.261 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -163.58 155.68 17.53 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 . . . . . 0 C--O 1.269 2.131 0 CA-C-O 117.647 -1.168 . . . . 0.0 110.648 177.083 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.513 ' H2 ' ' HB2' ' A' ' 93' ' ' HIS . 64.0 m . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.655 0.264 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 183' ' ' THR . 12.4 m-85 -133.95 159.36 72.71 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.543 ' HD3' HD13 ' A' ' 76' ' ' LEU . 67.8 Cg_endo -70.4 161.57 45.55 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 N-CA-C 108.68 -1.315 . . . . 0.0 108.68 177.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.437 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . -61.64 -23.67 63.24 Favored Glycine 0 C--N 1.304 -1.226 0 C-N-CA 119.316 -1.421 . . . . 0.0 111.692 177.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -59.57 -21.23 60.03 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.28 0.562 . . . . 0.0 112.185 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.436 ' HB ' HD12 ' A' ' 21' ' ' LEU . 97.9 m -62.97 126.33 26.96 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.969 -177.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 35.4 mmt180 -80.3 130.83 35.46 Favored 'General case' 0 C--O 1.184 -2.368 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.764 HD11 HG21 ' A' ' 175' ' ' VAL . 7.7 tt -120.3 130.1 74.77 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.743 HD21 HD11 ' A' ' 124' ' ' LEU . 1.1 tm? -87.34 124.42 33.35 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-O 121.458 0.647 . . . . 0.0 110.317 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 30.3 m -135.89 -178.5 2.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.189 -178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.467 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 33.8 tt0 -130.79 122.64 27.54 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.56 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 46' ' ' GLU . 20.4 mt -121.03 120.85 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.568 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.659 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 52.46 40.61 29.97 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.303 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.27 18.3 79.21 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.8 -178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.3 t -122.5 120.16 28.06 Favored Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.681 ' HB2' HD22 ' A' ' 124' ' ' LEU . 59.6 Cg_endo -74.8 125.23 9.29 Favored 'Trans proline' 0 N--CA 1.427 -2.393 0 C-N-CA 122.207 1.938 . . . . 0.0 110.926 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -128.37 142.34 51.15 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.935 -178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.572 ' CE ' HD23 ' A' ' 9' ' ' LEU . 5.1 tppp? -108.56 99.85 9.18 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -121.31 -172.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.847 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 20.0 p -98.95 174.11 6.52 Favored 'General case' 0 C--N 1.28 -2.441 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.127 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 65.5 mt -68.54 -28.63 67.15 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.717 177.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.847 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 11.6 ptm180 -76.85 -26.92 54.84 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.531 ' OE1' HG23 ' A' ' 20' ' ' THR . 49.4 mt-10 -85.28 -36.22 21.01 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.191 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.777 HD21 HD22 ' A' ' 167' ' ' LEU . 15.5 tp -66.11 -44.24 84.89 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.129 0.49 . . . . 0.0 111.234 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.778 ' HB2' HG11 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -58.6 -26.51 63.74 Favored 'General case' 0 CA--C 1.49 -1.336 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.401 -175.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.442 ' OE1' ' HA ' ' A' ' 23' ' ' GLU . 24.9 mt-10 -68.09 -19.02 64.82 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.665 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -82.37 0.33 42.38 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.447 0.642 . . . . 0.0 110.091 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.577 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 96.1 m-85 -117.15 163.34 16.43 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.005 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -145.76 -171.91 3.79 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.997 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.9 t0 63.53 75.43 0.39 Allowed 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.845 0.831 . . . . 0.0 110.139 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -97.36 128.91 44.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.474 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.505 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 10.3 ptt180 -120.51 153.37 36.77 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.323 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -103.74 128.77 51.09 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -166.52 143.4 4.92 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.035 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 60.84 21.03 11.2 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 123.662 0.601 . . . . 0.0 110.783 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 33.5 mtt 71.28 19.62 5.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.648 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' HD2' ' A' ' 71' ' ' PRO . 17.2 m -133.26 -175.43 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -117.45 142.09 47.56 Favored 'General case' 0 CA--C 1.477 -1.836 0 CA-C-O 121.267 0.556 . . . . 0.0 110.497 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.3 t -130.01 124.3 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.253 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.861 -178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.426 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 28.8 ttm180 -114.75 126.32 54.71 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -132.35 145.17 51.06 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.398 -174.488 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 51.5 tptt 80.33 114.86 0.03 OUTLIER Pre-proline 0 N--CA 1.449 -0.504 0 O-C-N 124.574 1.171 . . . . 0.0 110.697 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.538 ' HB2' HD13 ' A' ' 47' ' ' ILE . 58.0 Cg_endo -77.42 158.56 32.8 Favored 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 121.947 1.765 . . . . 0.0 111.735 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -90.57 -3.44 57.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.422 0.629 . . . . 0.0 110.461 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.1 mtt180 -148.72 -165.68 2.34 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.647 ' OE1' ' HE3' ' A' ' 48' ' ' LYS . 7.1 tp10 -84.01 96.7 8.95 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.577 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 1.8 mp -116.78 115.63 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.031 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.647 ' HE3' ' OE1' ' A' ' 46' ' ' GLU . 34.6 mmtp -118.79 166.13 13.17 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.314 173.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.489 HG11 ' CB ' ' A' ' 169' ' ' ALA . 10.2 p -122.92 134.3 66.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.662 -175.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 11' ' ' GLN . 20.2 m-85 -88.18 123.54 32.92 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.494 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.9 m -136.56 147.56 47.08 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.217 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.549 HG12 HD11 ' A' ' 176' ' ' ILE . 2.2 mm -93.21 143.54 11.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.222 0.534 . . . . 0.0 110.343 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.46 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 28.3 t70 -87.3 123.47 32.32 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.4 mt -70.44 -28.82 65.33 Favored 'General case' 0 CA--C 1.481 -1.707 0 CA-C-O 122.109 0.957 . . . . 0.0 111.844 -172.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -83.51 -30.7 26.94 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.507 -172.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.7 p -114.87 -22.29 9.7 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.654 -175.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.39 20.73 71.4 Favored Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.524 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.506 ' C ' HD13 ' A' ' 52' ' ' ILE . 27.6 mttm -99.98 153.84 18.87 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.0 p -91.85 106.58 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 CA-C-O 121.769 0.795 . . . . 0.0 110.126 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.72 167.06 5.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.887 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.9 tp -119.72 141.76 49.13 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 179.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.9 t -146.98 171.8 14.7 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.853 0.359 . . . . 0.0 111.329 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.534 ' OD2' ' HE2' ' A' ' 48' ' ' LYS . 7.0 m-20 -82.2 161.06 22.88 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 121.556 0.693 . . . . 0.0 110.552 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.552 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.7 mp -99.21 140.92 17.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.244 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.411 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 6.7 mm-40 -88.18 -35.26 17.48 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 173.79 174.15 0.15 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.579 -177.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 25' ' ' TYR . 13.8 t -104.92 132.93 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.192 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.66 HD12 ' HB2' ' A' ' 166' ' ' SER . 49.7 mt -92.21 113.49 27.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.478 -178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.438 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 86.6 tttt -127.57 109.34 11.61 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.78 141.62 42.63 Favored Pre-proline 0 C--N 1.31 -1.121 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.77 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.474 ' HD2' HG12 ' A' ' 37' ' ' VAL . 8.1 Cg_endo -52.62 129.59 32.95 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 123.384 2.723 . . . . 0.0 112.41 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -87.95 73.63 9.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.351 0.596 . . . . 0.0 110.622 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.2 p -71.7 -38.59 70.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.913 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.52 -172.31 2.73 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.323 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.645 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 19.2 m170 -111.98 172.32 6.97 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 90' ' ' THR . 7.1 mt -122.48 146.87 46.99 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.541 0.686 . . . . 0.0 112.007 -175.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.552 HD12 ' C ' ' A' ' 108' ' ' ALA . 20.5 mt -87.82 145.52 7.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.554 ' HB3' ' CG ' ' A' ' 155' ' ' LYS . 41.8 ttt85 -122.07 140.88 51.98 Favored 'General case' 0 N--CA 1.404 -2.752 0 CA-C-O 121.301 0.572 . . . . 0.0 109.945 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.612 ' O ' ' HA ' ' A' ' 86' ' ' SER . 57.5 m-85 -114.71 125.49 53.79 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.586 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 152' ' ' LYS . 33.7 tt0 -109.4 123.52 49.48 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.716 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.71 159.65 17.7 Favored 'General case' 0 C--N 1.268 -2.959 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.502 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.811 ' HG2' HD11 ' A' ' 149' ' ' LEU . 3.9 pt-20 -63.61 -15.25 57.66 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.456 0.646 . . . . 0.0 111.116 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.06 -10.24 36.82 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.487 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.02 12.77 54.85 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.839 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.564 ' O ' HD23 ' A' ' 81' ' ' LEU . 1.6 mtt180 -83.84 139.3 32.74 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 15.7 p -143.01 136.99 28.97 Favored 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.523 176.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -133.06 151.56 52.03 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.559 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.474 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 99.3 mt-10 -123.54 152.2 42.06 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.328 0.585 . . . . 0.0 112.097 -177.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.512 ' C ' ' H ' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -142.21 155.33 45.27 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.238 178.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.649 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -72.01 16.85 0.11 Allowed 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 121.621 0.725 . . . . 0.0 111.56 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.037 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.9 OUTLIER 71.05 -29.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 125.64 1.576 . . . . 0.0 113.06 176.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -82.61 -5.1 58.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.972 0.415 . . . . 0.0 110.493 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.513 ' HB2' ' H2 ' ' A' ' 1' ' ' CYS . 60.6 t-80 -94.86 125.66 50.13 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.57 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 37.9 Cg_exo -63.1 142.28 86.62 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.968 2.445 . . . . 0.0 112.937 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.2 t -112.17 146.19 17.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.432 ' CD1' ' HG3' ' A' ' 105' ' ' GLU . 18.2 tp -101.75 111.46 23.72 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.975 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.57 HG21 ' OD1' ' A' ' 115' ' ' ASP . 2.3 p -113.7 150.85 15.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.345 0.593 . . . . 0.0 111.595 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -102.36 96.02 6.67 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.41 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.451 ' CD ' HD11 ' A' ' 104' ' ' ILE . 11.9 pt-20 -145.56 155.02 42.8 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 83.1 m-20 63.74 23.09 13.35 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.205 0.526 . . . . 0.0 110.332 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.12 12.49 60.52 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.872 -177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -131.2 170.83 14.04 Favored 'General case' 0 N--CA 1.4 -2.941 0 CA-C-O 121.478 0.656 . . . . 0.0 110.043 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -105.95 121.96 45.16 Favored 'General case' 0 C--N 1.277 -2.559 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.515 HG13 HG13 ' A' ' 97' ' ' VAL . 19.1 pt -122.36 146.77 27.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 120.011 -0.675 . . . . 0.0 112.007 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 26.7 mp0 -105.01 107.78 18.95 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.988 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' A' ' 111' ' ' VAL . 12.0 ptpt -118.38 135.2 54.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.422 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.637 ' O ' HG23 ' A' ' 111' ' ' VAL . 80.3 mtt180 -61.59 160.6 11.08 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.037 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -58.84 -43.41 90.73 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.212 -177.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.409 ' HB3' ' CG2' ' A' ' 91' ' ' VAL . 1.7 p90 -75.43 7.44 3.58 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.885 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -118.32 -17.95 9.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.443 0.639 . . . . 0.0 110.037 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 107' ' ' ARG . 89.4 t -73.15 149.18 8.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.198 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.685 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 69.7 mmtt -115.74 168.19 10.26 Favored 'General case' 0 CA--C 1.486 -1.503 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.382 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -77.71 142.05 38.98 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.11 4.2 74.97 Favored Glycine 0 C--N 1.305 -1.144 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -174.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.685 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -74.69 173.43 10.5 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -129.66 167.28 18.22 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.58 0.705 . . . . 0.0 111.604 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.81 159.82 39.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.738 170.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.8 135.54 37.4 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.9 OUTLIER -106.35 160.72 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 173.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.459 ' C ' ' H ' ' A' ' 122' ' ' LEU . 84.3 p -74.61 -1.04 19.83 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.024 0.44 . . . . 0.0 111.163 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.536 ' OE1' HG23 ' A' ' 119' ' ' VAL . 4.4 mm-40 63.56 -16.09 0.07 Allowed 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 124.842 1.257 . . . . 0.0 113.035 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.459 ' H ' ' C ' ' A' ' 120' ' ' SER . 43.2 tp -135.57 126.5 27.66 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -172.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.423 ' HG2' ' ND2' ' A' ' 180' ' ' ASN . 24.4 mt-10 -102.37 -151.6 0.43 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.946 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.743 HD11 HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -116.27 3.27 13.39 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 121.529 0.68 . . . . 0.0 109.593 -174.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.9 p -176.85 161.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-N 114.615 -1.175 . . . . 0.0 109.725 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.46 160.13 19.93 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -60.17 147.58 39.27 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.3 t 64.58 -154.37 0.29 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.739 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.9 m 74.31 -50.12 0.68 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.469 0.708 . . . . 0.0 112.437 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 133' ' ' ASP . 22.9 t -135.89 136.37 40.47 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 120.987 0.423 . . . . 0.0 111.037 -178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.3 m -104.54 -16.91 14.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.213 0.53 . . . . 0.0 110.063 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -169.76 124.23 0.78 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.322 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.537 ' OD1' ' HD2' ' A' ' 135' ' ' PRO . 1.2 t70 -155.73 -171.52 3.79 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.575 ' HB3' ' HD3' ' A' ' 135' ' ' PRO . 23.9 t-20 -160.92 -49.6 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.487 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 134' ' ' ASN . 7.8 Cg_exo -77.73 -137.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.602 2.201 . . . . 0.0 110.634 173.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.4 tttp 74.35 109.05 0.07 Allowed 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.871 0.843 . . . . 0.0 110.0 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -153.41 37.85 0.48 Allowed 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.036 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.47 24.36 7.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.3 -0.863 . . . . 0.0 111.681 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -162.75 159.93 24.77 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.568 HD23 ' H ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -78.97 -60.17 2.48 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.701 0.286 . . . . 0.0 111.454 -179.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.462 ' H ' ' HG ' ' A' ' 140' ' ' LEU . . . 52.35 48.03 55.04 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.334 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.458 ' HA ' ' HD3' ' A' ' 143' ' ' PRO . 36.4 t -100.99 117.46 62.4 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.731 0.3 . . . . 0.0 111.381 -177.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 142' ' ' SER . 4.4 Cg_exo -83.08 171.94 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.936 2.424 . . . . 0.0 110.677 174.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 145' ' ' HIS . 0.0 OUTLIER -128.21 -65.15 0.91 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 177.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.458 ' CE1' ' HG3' ' A' ' 147' ' ' GLN . 3.4 t-80 55.32 115.64 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.378 1.071 . . . . 0.0 113.796 176.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.424 ' HA ' ' OE2' ' A' ' 121' ' ' GLU . 8.9 p-10 -136.49 68.22 1.44 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.758 0.789 . . . . 0.0 110.649 174.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.458 ' HG3' ' CE1' ' A' ' 145' ' ' HIS . 14.4 pt20 -165.38 142.06 5.59 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.371 -177.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 7.9 mt -99.28 150.98 21.56 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-O 121.348 0.594 . . . . 0.0 109.721 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.811 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -107.51 133.68 51.64 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -172.161 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -88.04 145.65 25.87 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.628 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.469 HD13 ' CD1' ' A' ' 79' ' ' PHE . 67.6 mt -79.8 105.55 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.773 0 CA-C-N 113.647 -1.615 . . . . 0.0 109.199 173.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 7.1 mmpt? -70.7 -37.43 73.57 Favored 'General case' 0 C--N 1.266 -3.023 0 CA-C-N 114.645 -1.162 . . . . 0.0 110.682 178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -149.96 133.42 16.56 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 71.3 mt -112.74 140.05 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.977 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.554 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.9 ptpt -139.82 152.91 46.9 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.171 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.496 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.2 m-85 -97.75 104.6 16.64 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-O 121.806 0.812 . . . . 0.0 108.825 173.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.645 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -108.02 175.77 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.266 -3.034 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.701 -178.378 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.405 ' HA ' ' CG ' ' A' ' 75' ' ' HIS . 19.5 ptt85 -80.74 -145.69 0.05 Allowed 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 121.79 0.805 . . . . 0.0 111.443 -178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -131.4 99.82 4.96 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -46.39 -49.91 17.31 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.085 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -102.3 170.68 7.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.041 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -88.6 -4.1 58.65 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.096 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -139.81 155.57 47.2 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.622 176.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.81 156.53 30.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.614 ' HB2' ' HB3' ' A' ' 21' ' ' LEU . 65.4 m-85 -133.55 171.51 14.0 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.66 ' HB2' HD12 ' A' ' 68' ' ' ILE . 70.7 m -160.17 -25.0 0.06 Allowed 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.777 HD22 HD21 ' A' ' 24' ' ' LEU . 9.1 tp 68.17 111.79 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.215 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.404 ' OD1' ' HD1' ' A' ' 172' ' ' TYR . 66.0 t30 -87.3 115.77 24.94 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.912 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.489 ' CB ' HG11 ' A' ' 49' ' ' VAL . . . -136.85 -166.72 1.95 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 172' ' ' TYR . 45.0 mmtt -63.25 146.15 54.03 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 67.4 mttm 80.19 -24.34 0.21 Allowed 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.878 -174.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.423 ' H ' ' C ' ' A' ' 170' ' ' LYS . 42.7 m-85 64.03 132.5 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.878 1.271 . . . . 0.0 113.253 176.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 184' ' ' HIS . 34.8 m80 52.78 31.63 10.85 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.153 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 183' ' ' THR . 30.5 t30 -132.2 110.33 10.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.764 HG21 HD11 ' A' ' 8' ' ' ILE . 1.4 p -154.23 160.72 2.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 121.12 0.486 . . . . 0.0 111.307 -177.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.549 HD11 HG12 ' A' ' 52' ' ' ILE . 97.9 mt -96.55 115.64 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.213 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.567 HG23 HG13 ' A' ' 175' ' ' VAL . 47.3 pt -123.5 174.49 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.225 -175.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.479 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 2.9 t-20 47.07 -129.39 1.53 Allowed 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 124.062 0.945 . . . . 0.0 110.673 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.24 48.95 1.65 Allowed 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 121.513 0.673 . . . . 0.0 109.847 176.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.623 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 3.7 m-20 68.79 47.19 0.84 Allowed 'General case' 0 CA--C 1.495 -1.145 0 C-N-CA 125.445 1.498 . . . . 0.0 113.171 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.4 HD12 ' HB3' ' A' ' 178' ' ' ASN . 82.5 mt -91.04 115.88 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.589 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.9 m -80.36 158.84 4.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.418 0.627 . . . . 0.0 110.558 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 174' ' ' ASN . 5.1 t -161.31 153.48 19.89 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.488 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 25.6 t-80 -152.26 148.96 28.17 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 . . . . . 0 C--O 1.256 1.41 0 CA-C-O 118.549 -0.739 . . . . 0.0 111.08 178.085 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.703 ' HA ' ' OG ' ' A' ' 166' ' ' SER . 4.5 t . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.41 ' CE1' HD13 ' A' ' 177' ' ' ILE . 20.6 m-85 -112.64 154.89 44.58 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -175.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.517 ' HD3' HD13 ' A' ' 76' ' ' LEU . 27.8 Cg_endo -62.74 -34.72 72.34 Favored 'Trans proline' 0 N--CA 1.479 0.637 0 C-N-CA 123.2 2.6 . . . . 0.0 112.321 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.509 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 130.36 -39.79 1.76 Allowed Glycine 0 N--CA 1.423 -2.212 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -175.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.49 -9.3 8.13 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 121.468 0.651 . . . . 0.0 111.556 176.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.8 m -69.27 129.07 38.77 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.915 176.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.601 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 16.4 mtm180 -84.07 138.22 33.17 Favored 'General case' 0 C--O 1.184 -2.388 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.717 HD11 HG21 ' A' ' 175' ' ' VAL . 10.0 tt -123.02 131.55 73.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-O 120.83 0.347 . . . . 0.0 110.217 177.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.535 HD21 HD11 ' A' ' 124' ' ' LEU . 2.2 tm? -90.49 123.81 34.48 Favored 'General case' 0 N--CA 1.405 -2.707 0 CA-C-O 121.619 0.723 . . . . 0.0 110.657 178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 48' ' ' LYS . 27.5 m -133.08 -174.56 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.144 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . 30.3 tt0 -134.7 123.2 23.32 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.623 HG12 HG13 ' A' ' 47' ' ' ILE . 20.4 mt -122.63 123.28 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.863 0 CA-C-O 121.422 0.63 . . . . 0.0 110.358 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.9 36.67 27.74 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.972 -178.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.4 21.14 79.54 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.627 -176.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.4 t -127.54 114.82 21.13 Favored Pre-proline 0 N--CA 1.432 -1.342 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.733 ' HB2' ' HG ' ' A' ' 124' ' ' LEU . 17.3 Cg_exo -63.32 123.76 12.68 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 122.579 2.186 . . . . 0.0 111.31 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.425 HE21 HD12 ' A' ' 12' ' ' ILE . 21.3 mt-30 -126.98 136.41 52.22 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HB2' HD23 ' A' ' 9' ' ' LEU . 38.0 ttmt -108.55 102.15 11.25 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.627 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 24' ' ' LEU . 2.6 pt -124.18 -171.7 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.188 -2.132 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.954 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.713 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 17.8 p -95.48 169.78 9.81 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.249 -0.981 . . . . 0.0 110.673 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.549 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.4 mm? -67.74 -23.6 65.27 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.674 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.713 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 3.1 ptm180 -85.9 -24.32 26.67 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.609 ' OE1' HG23 ' A' ' 20' ' ' THR . 49.2 mt-10 -84.84 -42.08 15.43 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.972 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 19' ' ' ILE . 30.7 tp -57.44 -42.55 82.64 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 122.042 0.925 . . . . 0.0 109.897 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.742 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.9 m-30 -53.86 -30.73 46.88 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 113.393 -1.73 . . . . 0.0 113.084 -178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -74.39 -15.73 60.91 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.347 -176.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.422 ' HB3' HD11 ' A' ' 47' ' ' ILE . 2.5 mm? -80.77 6.38 13.12 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.534 0.683 . . . . 0.0 109.775 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.559 ' CZ ' HG21 ' A' ' 47' ' ' ILE . 98.1 m-85 -118.47 165.66 13.63 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.309 -178.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.516 ' HG2' ' HD3' ' A' ' 44' ' ' LYS . 3.4 mm-40 -143.97 -173.68 4.06 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.34 175.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 4.1 t70 64.26 86.74 0.12 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.583 0.706 . . . . 0.0 110.359 -179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -104.07 122.25 44.9 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.558 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -111.27 150.31 29.82 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.356 -1.293 . . . . 0.0 109.962 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.415 ' CZ ' ' HA ' ' A' ' 36' ' ' MET . 24.2 t80 -107.44 131.78 53.91 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' O ' HG22 ' A' ' 37' ' ' VAL . 7.5 tp10 -166.24 141.42 4.59 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.515 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 59.97 22.12 11.2 Favored 'General case' 0 CA--C 1.494 -1.182 0 O-C-N 123.573 0.545 . . . . 0.0 111.367 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 33' ' ' TYR . 41.7 mtm 72.75 19.52 3.93 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.998 0.811 . . . . 0.0 110.875 178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.534 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 6.0 m -131.27 -179.55 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.498 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 88.7 m-85 -116.81 145.22 43.68 Favored 'General case' 0 CA--C 1.482 -1.644 0 CA-C-O 121.387 0.613 . . . . 0.0 110.438 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.8 t -130.23 123.53 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.747 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.61 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 39.5 ttm180 -116.8 126.32 52.9 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -134.62 144.89 48.14 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.595 -175.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.44 ' HD3' ' O ' ' A' ' 43' ' ' PRO . 12.6 tmtt? 86.93 109.61 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.409 0 O-C-N 124.899 1.375 . . . . 0.0 109.989 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.644 ' HB2' HD13 ' A' ' 47' ' ' ILE . 61.5 Cg_endo -78.18 151.97 27.15 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 122.149 1.899 . . . . 0.0 111.615 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.516 ' HD3' ' HG2' ' A' ' 29' ' ' GLU . 36.7 mtmt -83.0 -7.4 59.67 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.191 0.519 . . . . 0.0 111.12 -177.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -144.92 -165.41 2.15 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 8.7 tp10 -85.98 101.66 13.1 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.644 HD13 ' HB2' ' A' ' 43' ' ' PRO . 1.5 mp -115.03 117.41 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.966 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.514 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 32.4 mmtt -116.91 168.47 10.2 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 173.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.502 ' CG1' HG23 ' A' ' 62' ' ' THR . 9.5 p -125.51 128.81 72.75 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -85.04 132.16 34.36 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.966 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.408 ' HA ' HG13 ' A' ' 176' ' ' ILE . 21.5 t -139.12 177.15 8.11 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 59' ' ' VAL . 2.7 mm -116.34 141.72 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 121.342 0.591 . . . . 0.0 110.844 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.765 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 24.7 t70 -80.11 116.31 20.16 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.152 178.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.745 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.2 mm? -73.57 -13.63 61.06 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.177 0.513 . . . . 0.0 112.191 -171.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.765 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -96.85 -26.25 15.16 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.849 -175.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.41 ' CB ' ' HD3' ' A' ' 58' ' ' LYS . 71.4 p -120.69 -25.68 5.44 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.887 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.48 9.18 65.12 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.421 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.42 ' O ' HD13 ' A' ' 52' ' ' ILE . 3.3 mptp? -81.88 159.66 23.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 123.157 0.583 . . . . 0.0 111.623 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.471 ' HA ' HD13 ' A' ' 52' ' ' ILE . 7.3 p -92.53 113.95 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 CA-C-O 121.943 0.878 . . . . 0.0 109.904 178.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.4 m -111.1 160.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.972 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.76 142.64 49.37 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.502 HG23 ' CG1' ' A' ' 49' ' ' VAL . 8.8 t -145.17 172.56 12.93 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.439 -177.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.42 161.02 14.82 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 121.611 0.719 . . . . 0.0 110.867 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.565 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.6 mp -94.59 142.61 13.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.488 -177.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.591 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 57.6 mm-40 -85.14 -46.28 11.26 Favored 'General case' 0 CA--C 1.492 -1.253 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -179.84 -168.01 0.1 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.313 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.61 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 37.5 t -114.07 128.6 70.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.867 -175.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 166' ' ' SER . 19.9 mt -92.6 102.12 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.1 -176.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.534 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 48.3 tttp -120.95 110.08 15.86 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.615 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -132.53 141.3 40.73 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.093 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.454 ' HD2' HG12 ' A' ' 37' ' ' VAL . 5.9 Cg_endo -50.43 140.23 35.61 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.469 2.779 . . . . 0.0 112.86 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -74.26 94.15 2.45 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.16 0.505 . . . . 0.0 110.29 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.9 p -89.01 -70.96 0.62 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.13 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -81.47 -175.06 5.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.26 0.553 . . . . 0.0 111.775 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.434 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 34.5 m170 -101.48 172.45 6.97 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.082 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' A' ' 90' ' ' THR . 11.1 mt -125.04 142.12 51.69 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.66 0.743 . . . . 0.0 111.807 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.563 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 9.9 mt -87.16 144.6 8.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 173.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 8.3 ttt180 -119.46 137.54 53.71 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.128 0.49 . . . . 0.0 109.686 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 86' ' ' SER . 52.4 m-85 -115.35 126.71 54.76 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.603 -178.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.438 ' O ' ' N ' ' A' ' 152' ' ' LYS . 57.6 tt0 -111.66 125.24 53.75 Favored 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.73 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.4 mm? -90.49 158.44 17.03 Favored 'General case' 0 C--N 1.277 -2.564 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.605 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.765 ' HG2' HD11 ' A' ' 149' ' ' LEU . 0.3 OUTLIER -60.4 -18.12 48.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.271 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -90.76 -12.47 36.41 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.794 0.807 . . . . 0.0 109.556 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.41 16.69 39.22 Favored Glycine 0 N--CA 1.432 -1.59 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.88 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.582 ' O ' HD23 ' A' ' 81' ' ' LEU . 2.9 mtt180 -86.13 137.11 32.91 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 177.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 6.3 p -139.81 136.66 34.27 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 119.046 -1.062 . . . . 0.0 112.565 176.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -132.77 150.75 52.12 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.261 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.48 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 73.1 mt-10 -126.95 149.14 49.98 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.478 -176.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 0.9 OUTLIER -146.66 161.35 40.75 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.925 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.749 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -70.89 15.16 0.11 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.451 0.7 . . . . 0.0 112.66 -176.481 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.01 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.7 OUTLIER 72.03 -34.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 C-N-CA 125.253 1.421 . . . . 0.0 112.93 177.325 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.469 ' OD1' ' HB ' ' A' ' 90' ' ' THR . 6.1 p-10 -84.42 -5.52 59.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.13 0.491 . . . . 0.0 110.238 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 57.7 t-80 -84.45 126.49 69.05 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.799 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 93' ' ' HIS . 23.0 Cg_exo -65.9 124.14 12.28 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.842 2.362 . . . . 0.0 112.942 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 21.8 t -97.85 147.19 6.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.645 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.506 ' HB2' ' N ' ' A' ' 184' ' ' HIS . 9.5 tp -101.26 107.38 18.74 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.984 0.421 . . . . 0.0 111.102 -177.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.601 HG21 ' OD1' ' A' ' 115' ' ' ASP . 1.6 p -113.29 147.78 16.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.549 0.69 . . . . 0.0 111.87 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -105.2 93.12 4.51 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.046 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.635 ' CG ' HD11 ' A' ' 104' ' ' ILE . 8.1 pt-20 -137.68 159.52 41.75 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 93.0 m-20 63.27 21.43 12.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.327 0.584 . . . . 0.0 109.753 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 65.45 16.23 62.63 Favored Glycine 0 N--CA 1.436 -1.367 0 CA-C-N 115.242 -0.89 . . . . 0.0 113.326 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -135.93 172.91 12.33 Favored 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 117.859 0.829 . . . . 0.0 109.844 179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -100.55 120.45 40.04 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.635 HD11 ' CG ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -123.16 148.12 27.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.209 -179.68 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 23.7 mt-10 -104.99 110.52 22.96 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.414 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.514 ' HE3' HG11 ' A' ' 97' ' ' VAL . 77.7 mttt -117.76 134.74 54.6 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.594 ' O ' HG23 ' A' ' 111' ' ' VAL . 4.4 mpt_? -60.73 164.13 4.96 Favored 'General case' 0 C--O 1.215 -0.725 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.01 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -62.04 -41.32 97.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 118.955 -1.098 . . . . 0.0 109.539 -178.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.461 ' HB3' ' HB ' ' A' ' 91' ' ' VAL . 3.1 p90 -73.32 -2.63 22.83 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.691 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.469 ' HB3' ' N ' ' A' ' 107' ' ' ARG . 49.3 tp10 -109.68 -15.28 14.19 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.565 0.697 . . . . 0.0 109.988 -178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 107' ' ' ARG . 79.3 t -82.46 148.76 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.648 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 30.7 mttt -125.65 165.63 18.21 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.035 0.445 . . . . 0.0 111.129 -176.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -64.83 141.19 58.86 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.928 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.3 4.1 77.85 Favored Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.988 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.648 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -77.55 168.3 20.21 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.406 ' HE3' ' HG3' ' A' ' 150' ' ' GLU . 32.0 mttp -121.41 167.98 12.19 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 121.363 0.601 . . . . 0.0 111.149 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.58 159.96 39.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.993 170.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.48 133.11 35.78 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.7 OUTLIER -102.04 157.7 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.369 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.525 ' HB3' HD22 ' A' ' 180' ' ' ASN . 43.9 t -72.55 7.88 1.67 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.893 0.378 . . . . 0.0 110.953 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 145' ' ' HIS . 26.4 mt-10 65.68 -27.97 0.11 Allowed 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.525 1.13 . . . . 0.0 113.861 178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 120' ' ' SER . 34.1 tp -126.92 126.65 43.6 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -172.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -94.15 115.87 28.21 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.959 175.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.733 ' HG ' ' HB2' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -55.4 -29.37 58.41 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 121.621 0.724 . . . . 0.0 112.013 178.017 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.519 ' H ' HD13 ' A' ' 124' ' ' LEU . 22.8 t -39.51 148.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 CA-C-N 113.114 -1.857 . . . . 0.0 110.845 172.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -115.28 135.55 54.04 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 122.162 -0.337 . . . . 0.0 110.87 -175.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -55.53 -62.94 1.35 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.171 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.9 t -94.01 61.99 3.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.409 0.623 . . . . 0.0 109.785 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.9 p -84.43 102.95 13.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.199 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.0 p -94.21 152.95 18.33 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.231 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.8 m 62.55 84.22 0.14 Allowed 'General case' 0 C--O 1.237 0.418 0 O-C-N 123.85 0.719 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -66.82 129.8 41.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.21 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 134' ' ' ASN . 12.4 t70 -147.37 -155.47 0.63 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.037 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.468 ' H ' ' CG ' ' A' ' 133' ' ' ASP . 43.8 t30 -65.9 -49.88 56.06 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 134' ' ' ASN . 2.8 Cg_endo -82.56 -12.09 10.24 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.886 2.39 . . . . 0.0 113.907 -175.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -145.8 105.25 3.95 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -127.65 -46.02 1.45 Allowed 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.418 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.8 mp0 -79.13 125.86 29.98 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.503 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -82.47 171.8 13.73 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 45.7 tp 68.36 -79.81 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.498 0.498 . . . . 0.0 110.88 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 53.27 56.93 16.93 Favored Glycine 0 C--N 1.318 -0.417 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.895 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.1 m -65.76 117.69 44.16 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-O 120.615 0.245 . . . . 0.0 110.611 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -56.1 -60.63 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.374 2.716 . . . . 0.0 112.879 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 61.29 80.0 0.23 Allowed 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.459 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.607 ' O ' ' HG2' ' A' ' 147' ' ' GLN . 1.6 p80 -104.72 174.03 6.05 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.304 -176.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.4 t70 67.6 23.99 8.67 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.026 0.917 . . . . 0.0 109.946 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.607 ' HG2' ' O ' ' A' ' 145' ' ' HIS . 7.8 pt20 -156.91 137.6 13.23 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.362 -177.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 147' ' ' GLN . 18.5 mt -111.49 159.83 17.71 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-O 121.227 0.537 . . . . 0.0 110.257 177.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.765 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -111.15 135.83 51.1 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.822 -172.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.412 ' H ' HD13 ' A' ' 149' ' ' LEU . 23.9 mt-10 -90.52 147.41 23.39 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 122.448 1.118 . . . . 0.0 112.557 175.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.469 HG21 ' CG1' ' A' ' 154' ' ' ILE . 74.9 mt -79.01 110.03 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.648 0 CA-C-N 113.355 -1.748 . . . . 0.0 110.607 176.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 80' ' ' GLU . 29.7 mtmt -63.48 -46.69 85.02 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.748 175.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -150.6 135.69 17.68 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 76.5 mt -118.92 130.72 73.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 113.798 -1.546 . . . . 0.0 110.981 176.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.608 ' HD3' HG13 ' A' ' 157' ' ' VAL . 3.3 ptpp? -134.23 163.51 29.46 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.57 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.563 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 8.8 m-85 -101.34 120.36 40.14 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.844 175.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.608 HG13 ' HD3' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -131.56 174.45 13.12 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.603 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.983 -177.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -104.65 163.85 12.19 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.345 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.06 126.31 29.41 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.859 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -71.11 -40.55 71.39 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.372 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.19 176.33 6.27 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -95.59 -2.29 48.64 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.405 0.621 . . . . 0.0 110.12 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -136.84 154.91 50.39 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.45 174.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.443 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 0.9 OUTLIER -118.32 151.46 20.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.647 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.742 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 9.8 m-85 -134.67 164.42 27.57 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.19 -170.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.703 ' OG ' ' HA ' ' A' ' 1' ' ' CYS . 74.5 m -158.55 -18.03 0.07 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.275 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.459 ' HG ' ' CD2' ' A' ' 24' ' ' LEU . 2.1 tm? 60.04 106.25 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.917 0.865 . . . . 0.0 111.462 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -90.33 125.26 35.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.856 0.836 . . . . 0.0 112.291 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.591 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -140.98 -130.06 0.1 Allowed 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.132 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.495 ' CB ' HG21 ' A' ' 62' ' ' THR . 81.0 tttt -61.53 128.48 36.52 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt 62.28 -12.03 0.07 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.426 ' H ' ' C ' ' A' ' 170' ' ' LYS . 22.4 m-85 68.29 133.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.954 0.902 . . . . 0.0 111.152 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 33.2 m170 66.63 -4.35 0.76 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -89.54 100.09 12.96 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.717 HG21 HD11 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -152.88 165.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-O 121.401 0.619 . . . . 0.0 112.322 -175.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.601 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.8 mt -105.74 117.43 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.059 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.535 HG23 HG13 ' A' ' 175' ' ' VAL . 44.7 pt -122.84 172.58 9.93 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.483 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.811 -176.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 7.4 t-20 48.99 -131.48 1.76 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.683 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -90.67 57.82 3.71 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.155 0.979 . . . . 0.0 109.502 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.742 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 6.2 m-20 68.03 48.83 0.93 Allowed 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.071 -1.877 . . . . 0.0 113.686 176.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.1 mt -90.03 113.91 26.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.932 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 64.1 t -86.67 126.61 40.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.156 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.8 t -126.49 150.42 48.74 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.115 177.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.506 ' N ' ' HB2' ' A' ' 96' ' ' LEU . 59.5 t60 60.96 140.35 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -176.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 . . . . . 0 C--O 1.257 1.477 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.895 178.176 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 89' ' ' THR . 72.2 m . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.203 0.525 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.512 ' CE1' HD13 ' A' ' 177' ' ' ILE . 2.8 m-85 -86.18 160.34 51.99 Favored Pre-proline 0 C--N 1.304 -1.385 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.19 -177.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.576 ' HD3' HD13 ' A' ' 76' ' ' LEU . 18.3 Cg_endo -59.48 -77.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.299 1.999 . . . . 0.0 109.997 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.419 ' H ' ' HG2' ' A' ' 3' ' ' PRO . . . 179.73 -28.6 0.05 OUTLIER Glycine 0 N--CA 1.414 -2.78 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 176.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -67.18 -7.53 24.35 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.283 0.563 . . . . 0.0 111.584 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 23.9 m -67.7 130.22 42.32 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 19.3 mtm180 -84.55 133.88 34.43 Favored 'General case' 0 C--O 1.183 -2.442 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.64 HD11 HG21 ' A' ' 175' ' ' VAL . 10.1 tt -121.45 130.55 74.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 C-N-CA 122.736 0.415 . . . . 0.0 110.098 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.57 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -87.08 123.94 32.7 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 121.424 0.63 . . . . 0.0 109.597 178.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.2 m -135.41 -179.31 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.595 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . 29.2 tt0 -129.95 122.32 28.31 Favored 'General case' 0 CA--C 1.489 -1.386 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.883 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.594 HG12 HG13 ' A' ' 47' ' ' ILE . 18.2 mt -121.83 122.68 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.009 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.553 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.0 t0 55.66 37.39 28.81 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.764 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.39 16.08 78.89 Favored Glycine 0 C--N 1.309 -0.945 0 CA-C-N 114.719 -1.128 . . . . 0.0 113.71 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.5 t -121.8 119.51 28.98 Favored Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.49 ' O ' HD13 ' A' ' 124' ' ' LEU . 36.2 Cg_endo -71.29 128.0 14.09 Favored 'Trans proline' 0 N--CA 1.431 -2.172 0 C-N-CA 122.111 1.874 . . . . 0.0 110.324 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -129.91 141.55 50.78 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -109.11 100.76 9.88 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -122.16 -173.16 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.181 -2.51 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.105 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.731 ' OG1' ' HG2' ' A' ' 22' ' ' ARG . 9.7 p -96.1 170.64 9.13 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.66 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.3 mm? -67.59 -27.11 66.64 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.445 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.731 ' HG2' ' OG1' ' A' ' 20' ' ' THR . 6.6 ptm180 -84.06 -22.77 31.12 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' HB2' ' H ' ' A' ' 20' ' ' THR . 10.2 mm-40 -85.32 -42.27 14.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.819 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.504 ' HA ' HD12 ' A' ' 19' ' ' ILE . 27.5 tp -58.26 -44.21 88.28 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.967 0.889 . . . . 0.0 109.884 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.686 ' CZ ' ' HB3' ' A' ' 165' ' ' PHE . 4.4 m-30 -55.35 -29.37 58.24 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 113.553 -1.658 . . . . 0.0 113.486 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 10.7 mm-40 -79.06 -11.75 60.0 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.02 -175.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.29 6.7 11.23 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.349 0.595 . . . . 0.0 109.528 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 97.6 m-85 -118.68 164.96 14.57 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.885 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.595 ' HG3' ' HD3' ' A' ' 44' ' ' LYS . 30.2 mt-10 -137.53 -172.86 3.33 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.575 175.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 2.5 t70 61.75 83.66 0.15 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.479 0.657 . . . . 0.0 111.082 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -99.0 122.42 42.24 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.536 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -113.59 150.57 32.88 Favored 'General case' 0 N--CA 1.409 -2.516 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.342 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.505 ' OH ' ' HA ' ' A' ' 36' ' ' MET . 28.1 t80 -106.87 129.62 54.68 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.316 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.456 ' HG3' ' ND2' ' A' ' 35' ' ' ASN . 7.6 tp10 -167.46 142.27 3.83 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.696 -177.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.456 ' ND2' ' HG3' ' A' ' 34' ' ' GLU . 51.9 m-80 58.29 23.17 10.12 Favored 'General case' 0 CA--C 1.497 -1.065 0 O-C-N 123.478 0.486 . . . . 0.0 111.457 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.505 ' HA ' ' OH ' ' A' ' 33' ' ' TYR . 43.8 mtm 72.24 18.66 4.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.814 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.527 HG12 ' HD2' ' A' ' 71' ' ' PRO . 4.3 m -129.37 179.92 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 176.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.433 ' HB2' ' HB3' ' A' ' 69' ' ' LYS . 81.1 m-85 -118.36 142.02 47.95 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.31 0.576 . . . . 0.0 110.278 -178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.36 123.77 60.66 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.928 -177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.622 ' HB3' ' HB ' ' A' ' 67' ' ' VAL . 40.9 ttm180 -115.06 126.55 54.83 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -134.2 146.73 50.42 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.98 -174.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 54.5 tptt 83.2 112.62 0.03 OUTLIER Pre-proline 0 C--N 1.318 -0.799 0 O-C-N 124.902 1.376 . . . . 0.0 110.868 -177.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.602 ' HB2' HD13 ' A' ' 47' ' ' ILE . 59.4 Cg_endo -78.79 152.26 25.22 Favored 'Trans proline' 0 N--CA 1.426 -2.482 0 C-N-CA 121.877 1.718 . . . . 0.0 111.4 177.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.595 ' HD3' ' HG3' ' A' ' 29' ' ' GLU . 36.2 mtmt -80.87 -6.23 58.36 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.796 -177.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -147.09 -165.77 2.33 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.579 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 5.2 tp10 -86.21 100.07 11.99 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 175.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.602 HD13 ' HB2' ' A' ' 43' ' ' PRO . 1.3 mp -115.47 117.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.433 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 34.8 mmtp -119.91 166.66 13.02 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.689 174.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 175' ' ' VAL . 13.7 p -120.42 127.07 75.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-O 121.111 0.481 . . . . 0.0 112.186 -174.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.425 ' CD1' HD12 ' A' ' 9' ' ' LEU . 6.5 m-85 -80.56 123.14 27.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.65 178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.0 p -133.27 176.92 8.09 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.271 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.532 HG12 HD11 ' A' ' 176' ' ' ILE . 2.4 mm -122.96 140.26 47.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.248 0.547 . . . . 0.0 110.024 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -78.17 119.34 21.42 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.787 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -72.01 -14.0 61.77 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.106 0.479 . . . . 0.0 111.902 -171.591 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -99.41 -28.35 13.31 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.914 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.486 ' OG1' ' HD3' ' A' ' 58' ' ' LYS . 82.4 p -117.2 -26.24 6.84 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.728 -175.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.82 12.7 68.31 Favored Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.332 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.486 ' HD3' ' OG1' ' A' ' 56' ' ' THR . 17.1 mtpp -85.97 158.01 19.99 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.5 t -86.64 109.33 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.368 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.3 m -112.58 157.93 13.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.085 178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.7 tp -122.29 135.77 54.79 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -137.83 172.88 12.28 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.669 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.08 161.03 16.0 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.224 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.554 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.9 mp -96.34 144.62 10.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.304 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.478 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 48.5 mm-40 -91.07 -41.5 11.02 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -179.96 178.63 0.59 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.896 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.622 ' HB ' ' HB3' ' A' ' 40' ' ' ARG . 9.4 t -109.9 129.23 65.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.699 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.5 mt -97.19 102.3 13.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.826 -174.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 38' ' ' TYR . 45.5 tttp -116.87 107.73 14.97 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.84 137.24 30.47 Favored Pre-proline 0 C--N 1.31 -1.141 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.154 -176.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.527 ' HD2' HG12 ' A' ' 37' ' ' VAL . 80.9 Cg_exo -47.89 124.14 9.53 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 123.424 2.749 . . . . 0.0 113.116 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -82.46 80.01 8.74 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.948 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.6 m -86.91 -24.68 24.74 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.336 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -101.91 -179.7 4.08 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.042 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 157' ' ' VAL . 59.5 m170 -111.37 172.31 6.96 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.426 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.591 ' CD2' ' HA ' ' A' ' 90' ' ' THR . 22.4 mt -123.78 146.71 48.13 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.856 0.836 . . . . 0.0 111.972 -173.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.482 HD12 ' C ' ' A' ' 108' ' ' ALA . 19.9 mt -88.77 143.05 12.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.195 173.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 37.2 ttt-85 -120.76 138.96 53.73 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-O 121.331 0.586 . . . . 0.0 109.426 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.623 ' O ' ' HA ' ' A' ' 86' ' ' SER . 54.0 m-85 -116.05 126.44 53.78 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.038 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 152' ' ' LYS . 31.3 tt0 -109.2 122.68 47.83 Favored 'General case' 0 CA--C 1.475 -1.93 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.751 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -88.02 154.07 20.78 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.643 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.979 ' HG2' HD11 ' A' ' 149' ' ' LEU . 5.2 pt-20 -57.21 -22.43 40.72 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.038 0.535 . . . . 0.0 111.943 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.28 -11.09 55.57 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.005 0.907 . . . . 0.0 109.111 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.28 14.93 46.29 Favored Glycine 0 N--CA 1.434 -1.451 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.918 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.554 ' O ' HD23 ' A' ' 81' ' ' LEU . 1.5 mtt180 -85.63 139.21 31.59 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 30.5 p -140.02 143.51 36.46 Favored 'General case' 0 C--N 1.285 -2.221 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.11 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -139.49 155.11 47.76 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.373 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 77' ' ' ILE . 23.7 mt-10 -128.45 151.91 48.84 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.928 -176.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 1.0 OUTLIER -148.33 160.54 42.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.867 178.137 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.591 ' HA ' ' CD2' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -71.55 13.81 0.23 Allowed 'General case' 0 C--N 1.353 0.738 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -175.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.077 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 0.8 OUTLIER 68.14 -39.32 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 C-N-CA 124.681 1.192 . . . . 0.0 113.691 176.11 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -79.68 2.47 22.52 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.803 0.335 . . . . 0.0 111.317 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 50.4 m170 -115.13 143.47 30.29 Favored Pre-proline 0 C--N 1.313 -1.016 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.885 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 15.4 Cg_exo -69.05 140.14 44.53 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.561 2.841 . . . . 0.0 115.25 -175.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 20.6 t -112.15 149.55 14.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 125.285 1.434 . . . . 0.0 107.211 175.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.8 tp -107.59 111.66 24.02 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.485 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.693 HG21 ' OD1' ' A' ' 115' ' ' ASP . 1.8 p -111.47 150.18 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.424 0.63 . . . . 0.0 112.167 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.641 ' CD2' HD12 ' A' ' 148' ' ' LEU . 71.7 t80 -103.31 93.37 4.94 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.256 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -135.94 154.94 50.96 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 62.26 22.98 13.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.086 0.469 . . . . 0.0 110.394 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 66.84 13.96 62.31 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.33 -0.85 . . . . 0.0 113.058 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -130.51 171.34 13.12 Favored 'General case' 0 N--CA 1.399 -2.987 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -104.35 121.13 42.73 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.644 HG13 HG13 ' A' ' 97' ' ' VAL . 28.7 pt -121.61 142.42 37.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.995 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.548 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 0.3 OUTLIER -106.16 111.55 24.21 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.008 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HG3' HG22 ' A' ' 111' ' ' VAL . 12.6 ptpt -125.24 144.54 50.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.915 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.608 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 64.9 mtt180 -64.85 160.67 19.87 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.077 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -59.95 -41.54 92.08 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.413 -176.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.459 ' HB3' ' CG2' ' A' ' 91' ' ' VAL . 1.8 p90 -74.29 1.73 10.85 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.824 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -112.9 -13.91 13.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.827 0.822 . . . . 0.0 109.701 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 107' ' ' ARG . 98.9 t -76.79 150.0 6.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 175.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.714 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -123.89 166.16 16.14 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 120.606 0.241 . . . . 0.0 110.824 -177.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -70.61 141.94 51.7 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.17 4.7 77.5 Favored Glycine 0 C--N 1.306 -1.11 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.638 -175.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.714 ' HB2' ' O ' ' A' ' 112' ' ' LYS . 1.7 t0 -78.5 166.56 22.45 Favored 'General case' 0 C--O 1.212 -0.905 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.433 ' CG ' ' HG3' ' A' ' 150' ' ' GLU . 35.1 mttp -120.01 168.68 10.91 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.79 0.805 . . . . 0.0 111.459 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.62 160.35 37.4 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 169.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 182' ' ' VAL . 1.1 tt -90.31 122.18 32.98 Favored 'General case' 0 N--CA 1.395 -3.189 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.226 177.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.0 OUTLIER -104.82 128.76 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 173.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.8 t -61.43 -22.54 65.12 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.544 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 145' ' ' HIS . 6.2 mm-40 46.9 13.26 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 125.578 1.551 . . . . 0.0 113.963 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.7 tt -113.15 127.07 56.08 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -114.44 -168.88 1.43 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.312 0.577 . . . . 0.0 112.324 -175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.57 ' CD2' HD21 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -113.85 17.71 17.83 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.8 t 73.34 80.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.374 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.433 ' HG2' ' N ' ' A' ' 127' ' ' GLN . 41.7 tt0 -150.81 165.95 31.99 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.319 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.433 ' N ' ' HG2' ' A' ' 126' ' ' GLU . 83.8 mm-40 -87.23 168.23 13.4 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.594 0.235 . . . . 0.0 110.471 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.1 p -66.34 -43.52 85.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.842 0.353 . . . . 0.0 111.708 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.8 t -96.99 115.4 27.37 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 55.5 p -147.89 157.82 43.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.812 0.339 . . . . 0.0 111.168 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.6 p -107.46 -53.1 2.67 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 176.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -166.09 151.52 8.62 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.523 177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -141.33 175.45 9.64 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.659 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 12.1 t-20 -179.98 -48.87 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 123.456 0.473 . . . . 0.0 111.466 -177.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 134' ' ' ASN . 2.4 Cg_endo -46.02 151.91 1.35 Allowed 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 123.909 3.073 . . . . 0.0 113.148 177.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -122.28 179.47 4.55 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.019 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 67.7 91.48 0.09 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 123.88 0.737 . . . . 0.0 112.086 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -135.39 -78.79 0.44 Allowed 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.896 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -157.53 -179.73 8.45 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 25.6 tp -76.13 147.25 38.68 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.93 54.07 0.56 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.345 -0.931 . . . . 0.0 111.429 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.5 p -63.88 118.54 46.44 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.724 0.297 . . . . 0.0 110.69 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -79.1 158.21 26.77 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.156 1.904 . . . . 0.0 112.725 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -167.2 19.55 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.886 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.631 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 8.7 m170 -85.8 124.76 32.66 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -137.38 98.54 3.74 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.373 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.454 ' C ' HD23 ' A' ' 148' ' ' LEU . 8.2 pt20 -164.69 139.24 5.32 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.464 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.641 HD12 ' CD2' ' A' ' 98' ' ' TYR . 13.8 mt -108.73 148.36 30.6 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-O 121.709 0.766 . . . . 0.0 111.485 178.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.979 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -111.36 135.97 51.15 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 114.514 -1.221 . . . . 0.0 113.07 -172.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.433 ' HG3' ' CG ' ' A' ' 116' ' ' LYS . 11.3 mt-10 -91.56 147.33 23.09 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 114.691 -1.141 . . . . 0.0 112.497 175.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.522 HD12 ' HB3' ' A' ' 115' ' ' ASP . 75.4 mt -78.29 106.93 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.594 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.844 176.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.652 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 34.4 mmtm -70.27 -39.58 74.87 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.856 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -150.94 132.46 14.74 Favored 'General case' 0 CA--C 1.482 -1.672 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 71.8 mt -111.76 143.98 20.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 113.658 -1.61 . . . . 0.0 110.791 176.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.413 ' CG ' ' HB3' ' A' ' 78' ' ' ARG . 19.4 ptpt -146.77 159.83 43.01 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.398 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -100.26 114.9 28.71 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 0.3 OUTLIER -126.98 175.5 8.84 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.751 -179.073 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -99.64 154.33 18.36 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.81 -0.556 . . . . 0.0 111.443 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 76' ' ' LEU . . . -56.56 3.11 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 66.78 -54.41 0.44 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -104.81 -175.1 2.7 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -177.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -99.67 9.57 42.88 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.181 0.515 . . . . 0.0 110.021 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -141.19 155.37 46.07 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.989 176.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 3' ' ' PRO . 1.4 m -124.85 154.15 32.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 177.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.686 ' HB3' ' CZ ' ' A' ' 25' ' ' TYR . 8.3 m-85 -131.73 163.04 29.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.1 -172.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -159.09 -16.11 0.07 Allowed 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.829 176.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.424 ' HG ' HD21 ' A' ' 24' ' ' LEU . 2.8 tm? 62.64 112.12 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.333 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -87.3 114.57 24.03 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.738 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.478 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -126.14 -156.16 0.72 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 170' ' ' LYS . 35.0 mmtm -63.11 138.9 58.7 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 92.0 mttt 69.64 -73.88 0.09 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.769 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -140.12 -158.07 0.82 Allowed 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -97.96 29.38 3.47 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -63.38 109.8 1.72 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.178 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.64 HG21 HD11 ' A' ' 8' ' ' ILE . 5.2 p -149.02 166.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 121.557 0.694 . . . . 0.0 111.906 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.554 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 81.0 mt -97.57 114.08 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.067 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.136 178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.551 HG23 HG13 ' A' ' 175' ' ' VAL . 45.0 pt -118.89 174.85 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 CA-C-O 120.978 0.418 . . . . 0.0 111.649 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 7' ' ' ARG . 2.1 t-20 44.66 -123.18 0.95 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.13 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -99.57 64.92 1.33 Allowed 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.822 0.82 . . . . 0.0 108.928 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.701 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 7.8 m120 68.65 38.92 2.14 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 113.537 -1.665 . . . . 0.0 114.339 176.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.404 ' O ' HG12 ' A' ' 177' ' ' ILE . 99.1 mt -88.31 113.52 25.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 118' ' ' LEU . 2.5 m -83.68 158.2 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 2.4 t -162.5 158.4 23.58 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.997 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -69.39 -26.28 64.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.273 0.559 . . . . 0.0 109.874 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? . . . . . 0 C--O 1.257 1.464 0 CA-C-O 116.493 -1.717 . . . . 0.0 109.655 179.586 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.703 ' O ' ' HA ' ' A' ' 89' ' ' THR . 63.2 m . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.927 0.394 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.501 ' HB3' ' OG1' ' A' ' 6' ' ' THR . 30.9 m-85 -114.71 145.81 34.7 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.504 ' HA ' HG12 ' A' ' 164' ' ' VAL . 14.9 Cg_endo -56.42 -27.46 68.17 Favored 'Trans proline' 0 N--CA 1.48 0.706 0 C-N-CA 123.418 2.746 . . . . 0.0 112.771 -177.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 20' ' ' THR . . . 125.21 -39.38 2.09 Favored Glycine 0 N--CA 1.417 -2.626 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -69.6 -11.14 60.6 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.697 0.76 . . . . 0.0 111.176 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 2' ' ' PHE . 55.2 m -60.72 131.12 49.68 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.687 177.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.576 ' HA ' ' HA ' ' A' ' 20' ' ' THR . 21.0 mmt180 -86.26 132.38 34.0 Favored 'General case' 0 C--O 1.185 -2.3 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.888 HD11 HG21 ' A' ' 175' ' ' VAL . 11.6 tt -119.64 130.57 73.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 CA-C-O 120.862 0.363 . . . . 0.0 110.111 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.82 HD21 HD11 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -88.46 125.35 34.7 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-O 121.452 0.644 . . . . 0.0 109.959 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 28.6 m -135.15 177.8 6.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.504 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -126.89 119.67 27.33 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.23 0.538 . . . . 0.0 109.875 177.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.61 HG12 HG13 ' A' ' 47' ' ' ILE . 12.5 mt -118.43 120.18 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.701 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.788 -178.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 54.69 37.93 29.14 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.15 -1.387 . . . . 0.0 109.824 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.83 18.26 79.52 Favored Glycine 0 C--N 1.3 -1.47 0 CA-C-N 114.886 -1.052 . . . . 0.0 113.609 -177.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.452 HG11 HD22 ' A' ' 134' ' ' ASN . 38.2 t -124.04 119.22 26.62 Favored Pre-proline 0 N--CA 1.439 -1.014 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 10' ' ' VAL . 48.0 Cg_endo -73.31 122.05 7.67 Favored 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 122.534 2.156 . . . . 0.0 111.468 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -124.41 141.74 51.84 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.711 -177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 127' ' ' GLN . 40.4 ttmt -107.94 101.28 10.56 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.025 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.486 HD12 ' HA ' ' A' ' 24' ' ' LEU . 3.0 pt -123.63 -175.48 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.681 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.752 ' HG1' ' HG2' ' A' ' 22' ' ' ARG . 9.6 p -90.28 173.54 8.08 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.727 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.617 ' HB3' ' HB2' ' A' ' 165' ' ' PHE . 4.2 mm? -69.24 -26.91 65.02 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.395 177.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.752 ' HG2' ' HG1' ' A' ' 20' ' ' THR . 10.7 ptm180 -84.8 -24.91 28.5 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' HB2' ' H ' ' A' ' 20' ' ' THR . 39.2 mt-10 -82.98 -39.4 21.39 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.977 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.512 HD23 HD13 ' A' ' 8' ' ' ILE . 16.2 tp -57.82 -42.18 83.76 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.089 0.947 . . . . 0.0 108.7 176.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.4 ' CD1' HG11 ' A' ' 67' ' ' VAL . 7.4 t80 -53.71 -31.23 47.29 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.216 -1.811 . . . . 0.0 112.594 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 28.9 mt-10 -76.0 -17.82 59.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -78.89 2.29 20.62 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.732 0.777 . . . . 0.0 109.429 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.476 ' C ' ' HD3' ' A' ' 40' ' ' ARG . 96.0 m-85 -117.91 162.24 18.46 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.602 -178.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.7 -173.84 3.99 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.175 176.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 t70 63.47 81.36 0.21 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.248 0.547 . . . . 0.0 110.159 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -106.42 134.18 49.96 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-O 122.088 0.946 . . . . 0.0 111.465 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.451 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 12.2 ptt180 -122.54 154.44 37.9 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.557 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -105.57 124.94 50.38 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -160.89 137.66 8.77 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.476 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 61.7 23.12 13.5 Favored 'General case' 0 CA--C 1.498 -1.032 0 O-C-N 123.579 0.55 . . . . 0.0 110.918 177.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 35.1 mtt 75.6 13.82 2.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.064 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.495 HG12 ' HD2' ' A' ' 71' ' ' PRO . 5.1 m -129.64 -179.71 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -115.55 140.46 49.14 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.127 0.489 . . . . 0.0 109.823 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HB ' ' HG2' ' A' ' 32' ' ' ARG . 2.2 t -129.49 123.29 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.093 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.476 ' HD3' ' C ' ' A' ' 28' ' ' PHE . 16.7 ttm180 -112.71 126.75 55.74 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -131.65 146.08 52.0 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.654 -174.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 41' ' ' LYS . 27.5 tptp 80.68 113.08 0.03 OUTLIER Pre-proline 0 C--O 1.237 0.438 0 O-C-N 124.531 1.145 . . . . 0.0 111.396 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.556 ' HB2' HD13 ' A' ' 47' ' ' ILE . 56.9 Cg_endo -78.02 155.94 30.15 Favored 'Trans proline' 0 N--CA 1.435 -1.918 0 C-N-CA 122.208 1.939 . . . . 0.0 111.974 178.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -86.97 -3.46 59.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.349 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -147.3 -164.8 2.09 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 12' ' ' ILE . 6.0 tp10 -84.5 98.25 10.01 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 175.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.61 HG13 HG12 ' A' ' 12' ' ' ILE . 1.5 mp -117.34 116.02 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.835 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -116.43 167.52 10.97 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.356 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 61' ' ' LEU . 13.2 p -116.05 121.53 67.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 121.714 0.769 . . . . 0.0 112.097 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.526 ' CE1' HG11 ' A' ' 59' ' ' VAL . 65.8 t80 -76.1 110.27 10.44 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.643 177.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -134.22 176.52 8.52 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.738 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.547 HG12 HD11 ' A' ' 176' ' ' ILE . 4.3 mm -121.18 144.17 31.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.267 0.556 . . . . 0.0 110.922 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.657 ' OD2' ' HG3' ' A' ' 55' ' ' GLU . 19.4 t70 -81.52 120.98 25.73 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.298 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.732 ' H ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -74.91 -12.24 60.31 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -170.488 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.657 ' HG3' ' OD2' ' A' ' 53' ' ' ASP . 2.7 pt-20 -104.33 -27.12 12.17 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.2 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.522 ' OG1' ' HD2' ' A' ' 58' ' ' LYS . 72.2 p -115.18 -24.95 8.26 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.578 -176.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.69 70.53 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.045 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.522 ' HD2' ' OG1' ' A' ' 56' ' ' THR . 40.2 mttt -85.47 163.74 18.27 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.526 HG11 ' CE1' ' A' ' 50' ' ' TYR . 90.4 t -88.62 111.43 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.162 177.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.9 146.71 14.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.299 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 49' ' ' VAL . 14.1 tp -120.12 138.59 53.48 Favored 'General case' 0 N--CA 1.406 -2.662 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.437 HG21 ' HB3' ' A' ' 170' ' ' LYS . 10.2 t -150.54 171.35 17.22 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 120.753 0.311 . . . . 0.0 110.868 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -80.45 161.12 25.06 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-O 121.574 0.702 . . . . 0.0 111.169 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.542 ' N ' HD12 ' A' ' 64' ' ' ILE . 2.2 mp -101.06 135.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.887 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.516 ' H ' ' HA ' ' A' ' 169' ' ' ALA . 17.3 mt-10 -81.1 -39.62 25.37 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 178.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 p30 179.65 175.49 0.74 Allowed 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.458 -175.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.48 ' HA ' HD22 ' A' ' 167' ' ' LEU . 6.0 t -105.8 131.71 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.867 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.635 ' O ' ' HA ' ' A' ' 165' ' ' PHE . 57.6 mt -91.53 105.8 16.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.267 -178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.449 ' O ' ' HB ' ' A' ' 37' ' ' VAL . 87.1 tttt -119.87 108.16 14.02 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.25 138.62 33.25 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.343 -175.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HD2' HG12 ' A' ' 37' ' ' VAL . 75.1 Cg_exo -48.54 134.09 26.51 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 123.274 2.649 . . . . 0.0 112.608 177.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.73 95.6 3.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.391 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 34.7 p -92.76 -54.33 3.8 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.322 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.71 -179.92 6.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.918 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -100.9 170.71 8.12 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.696 HD23 ' HA ' ' A' ' 90' ' ' THR . 17.1 mt -115.23 131.35 56.96 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.504 0.669 . . . . 0.0 112.062 -175.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.575 HD11 ' CZ ' ' A' ' 156' ' ' TYR . 19.5 mt -82.82 141.84 14.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 171.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.603 ' O ' ' HA ' ' A' ' 154' ' ' ILE . 24.5 ttt-85 -117.11 136.93 52.63 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-O 121.17 0.509 . . . . 0.0 109.769 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.582 ' CD1' HD13 ' A' ' 151' ' ' ILE . 56.1 m-85 -116.01 127.53 54.99 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.7 -178.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 152' ' ' LYS . 43.7 tt0 -111.97 128.27 56.12 Favored 'General case' 0 CA--C 1.472 -2.051 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.754 HD12 ' HB3' ' A' ' 149' ' ' LEU . 1.8 mm? -91.09 157.65 17.11 Favored 'General case' 0 C--N 1.269 -2.915 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.576 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.755 ' HG2' HD11 ' A' ' 149' ' ' LEU . 2.3 pt-20 -63.88 -14.5 53.87 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.569 0.7 . . . . 0.0 111.07 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -92.81 -9.45 40.39 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.264 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.14 14.59 54.14 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.217 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.554 ' O ' HD23 ' A' ' 81' ' ' LEU . 3.0 mtt180 -86.34 141.8 28.95 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 79' ' ' PHE . 26.1 p -141.69 146.52 36.19 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.274 -0.97 . . . . 0.0 112.488 175.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -141.58 150.21 41.76 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.635 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 78' ' ' ARG . 29.3 mt-10 -121.85 145.83 47.69 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.351 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.703 ' HA ' ' O ' ' A' ' 1' ' ' CYS . 1.6 p -144.12 157.22 44.44 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.731 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.696 ' HA ' HD23 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -75.46 9.26 2.26 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -175.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.035 ' HA ' ' HB3' ' A' ' 108' ' ' ALA . 1.6 t 76.17 -42.62 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 O-C-N 123.503 0.502 . . . . 0.0 111.274 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.37 -20.53 65.6 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 123.764 0.826 . . . . 0.0 110.888 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.505 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 0.4 OUTLIER -103.31 129.56 25.27 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.786 -176.416 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.611 ' HA ' ' HA ' ' A' ' 107' ' ' ARG . 25.3 Cg_exo -65.18 142.82 75.38 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.623 2.882 . . . . 0.0 114.486 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 105' ' ' GLU . 17.4 t -105.34 146.89 11.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.169 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.452 ' CD1' ' HG3' ' A' ' 105' ' ' GLU . 32.4 tp -98.47 106.99 19.35 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.074 -0.251 . . . . 0.0 110.526 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.596 HG13 HG13 ' A' ' 104' ' ' ILE . 1.7 p -108.74 145.8 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 121.475 0.655 . . . . 0.0 111.55 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.548 ' CD2' HD12 ' A' ' 148' ' ' LEU . 86.3 t80 -104.0 91.74 4.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.209 178.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.523 ' CG ' HD11 ' A' ' 104' ' ' ILE . 9.1 pt-20 -138.87 155.94 47.7 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 32.4 m-80 65.98 22.61 11.24 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.355 0.597 . . . . 0.0 110.02 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.72 13.96 64.38 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.118 -0.946 . . . . 0.0 112.931 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -136.23 171.28 14.7 Favored 'General case' 0 N--CA 1.401 -2.925 0 CA-C-O 121.258 0.551 . . . . 0.0 110.24 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -101.92 121.28 41.82 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.084 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.596 HG13 HG13 ' A' ' 97' ' ' VAL . 16.1 pt -127.61 145.11 35.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.926 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 8.4 mp0 -106.46 115.13 29.68 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.079 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.618 ' HG3' HG22 ' A' ' 111' ' ' VAL . 12.7 ptpt -128.31 141.71 51.35 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.894 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.719 ' HB3' ' O ' ' A' ' 91' ' ' VAL . 99.8 mtt180 -61.47 165.73 4.58 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 119.404 -0.331 . . . . 0.0 110.635 -176.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 1.035 ' HB3' ' HA ' ' A' ' 91' ' ' VAL . . . -62.67 -40.27 96.55 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.47 -173.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.525 ' HB3' HG13 ' A' ' 91' ' ' VAL . 5.8 p90 -72.71 -7.53 50.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.868 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -102.75 -17.01 15.8 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.716 0.769 . . . . 0.0 109.175 -177.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.618 HG22 ' HG3' ' A' ' 106' ' ' LYS . 69.4 t -77.42 150.41 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.569 ' HE3' ' H ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -124.27 163.69 21.12 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.106 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.82 142.95 56.0 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.57 4.54 76.31 Favored Glycine 0 C--N 1.305 -1.165 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.584 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.962 ' HB3' HD12 ' A' ' 151' ' ' ILE . 18.4 t70 -71.95 164.4 26.16 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.467 ' HE2' ' O ' ' A' ' 148' ' ' LEU . 24.2 mttt -122.55 154.67 37.6 Favored 'General case' 0 CA--C 1.486 -1.501 0 CA-C-O 121.568 0.699 . . . . 0.0 110.753 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.25 159.65 34.75 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.93 129.58 35.59 Favored 'General case' 0 N--CA 1.399 -3.014 0 C-N-CA 119.394 -0.923 . . . . 0.0 108.679 177.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 180' ' ' ASN . 0.2 OUTLIER -113.42 132.89 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.153 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 173.34 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.7 t -63.29 -17.54 62.62 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.956 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 145' ' ' HIS . 36.1 mm-40 47.48 8.77 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 125.599 1.56 . . . . 0.0 115.064 -178.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.402 ' HB3' ' OH ' ' A' ' 50' ' ' TYR . 29.3 tp -91.35 127.03 36.63 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 120.839 0.352 . . . . 0.0 110.983 -177.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.443 ' HB2' ' HG2' ' A' ' 143' ' ' PRO . 40.6 mt-10 -88.6 160.23 17.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.663 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.82 HD11 HD21 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -144.99 -58.85 0.35 Allowed 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.538 0.685 . . . . 0.0 110.134 -178.292 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 126' ' ' GLU . 7.7 p -162.44 -177.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.496 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.653 ' H ' HG22 ' A' ' 125' ' ' VAL . 9.6 tp10 -81.93 -98.38 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.827 -177.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 18' ' ' LYS . 21.8 tm0? 179.76 -38.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -178.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.3 p -59.78 -81.79 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.934 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.8 t 56.16 83.97 0.09 Allowed 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.502 0.501 . . . . 0.0 109.761 -176.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.0 m -47.27 -45.41 23.93 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.584 -177.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.6 t -112.06 129.52 56.18 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -82.81 91.32 7.04 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -128.17 -3.84 5.63 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.305 0.574 . . . . 0.0 111.098 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.476 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 17.2 m120 46.6 60.33 14.81 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.907 -178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 134' ' ' ASN . 25.5 Cg_exo -62.89 -74.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.81 2.34 . . . . 0.0 113.12 -179.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt 63.08 -89.39 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.509 -177.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 66.0 t30 53.33 39.72 30.23 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.412 0.625 . . . . 0.0 111.532 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -146.78 131.08 17.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.132 0.492 . . . . 0.0 111.526 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -133.49 174.24 10.63 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.582 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' A' ' 142' ' ' SER . 32.9 tp 72.88 -42.22 0.53 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.046 0.938 . . . . 0.0 112.988 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.47 41.51 0.18 Allowed Glycine 0 CA--C 1.506 -0.476 0 O-C-N 123.537 0.523 . . . . 0.0 113.157 178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 140' ' ' LEU . 44.0 t -82.83 118.74 72.76 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.443 ' HG2' ' HB2' ' A' ' 123' ' ' GLU . 7.9 Cg_exo -71.95 165.44 32.56 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.313 2.009 . . . . 0.0 111.385 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -112.15 -68.15 0.95 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.067 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 10.1 m-70 66.95 166.97 0.23 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 178.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 179.43 85.5 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.853 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.463 ' C ' HD23 ' A' ' 148' ' ' LEU . 26.4 pt20 -164.99 138.08 4.64 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.165 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.548 HD12 ' CD2' ' A' ' 98' ' ' TYR . 12.4 mt -109.61 152.75 25.14 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-O 121.215 0.531 . . . . 0.0 110.242 176.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.755 HD11 ' HG2' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -113.68 136.74 52.51 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.045 -0.98 . . . . 0.0 112.946 -173.312 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.434 ' HG3' ' HE3' ' A' ' 116' ' ' LYS . 28.4 mt-10 -90.22 147.2 23.7 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 114.655 -1.157 . . . . 0.0 113.126 176.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.962 HD12 ' HB3' ' A' ' 115' ' ' ASP . 81.3 mt -79.46 112.64 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 CA-C-N 113.37 -1.741 . . . . 0.0 110.012 175.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.62 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 4.9 mmpt? -76.89 -39.81 49.63 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.642 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -148.26 131.55 16.52 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -175.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.603 ' HA ' ' O ' ' A' ' 78' ' ' ARG . 86.7 mt -114.26 148.32 17.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-N 113.316 -1.765 . . . . 0.0 110.754 174.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -154.33 162.03 41.41 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.708 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.575 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 15.8 m-85 -101.72 116.9 33.75 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.39 133.16 64.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.371 -177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.436 ' HG2' ' N ' ' A' ' 159' ' ' ALA . 60.3 ttt180 -68.85 161.24 29.02 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.167 0.508 . . . . 0.0 111.726 -176.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.436 ' N ' ' HG2' ' A' ' 158' ' ' ARG . . . -70.4 120.08 15.53 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.14 178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -62.77 -32.76 73.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.833 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -110.9 -173.9 2.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.484 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -100.51 0.03 38.76 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 120.858 0.361 . . . . 0.0 111.413 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -138.98 159.42 42.19 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 3' ' ' PRO . 6.3 m -132.39 161.41 41.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.921 177.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.635 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 76.2 m-85 -134.56 173.0 12.14 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 -175.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.565 ' HB2' HD12 ' A' ' 68' ' ' ILE . 69.8 m -158.76 -24.68 0.08 Allowed 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.512 ' HG ' HD21 ' A' ' 24' ' ' LEU . 1.4 tm? 68.5 111.01 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.253 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -92.65 115.71 28.35 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.99 -177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.516 ' HA ' ' H ' ' A' ' 65' ' ' GLU . . . -127.38 -146.57 0.33 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.437 ' HB3' HG21 ' A' ' 62' ' ' THR . 23.4 tptm -61.49 134.4 56.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.761 0.315 . . . . 0.0 110.309 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 170' ' ' LYS . 92.4 mttt 72.16 -84.09 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.519 -175.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -151.85 -165.58 2.27 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.902 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -74.49 45.29 0.23 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.878 179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.407 ' OD1' HD11 ' A' ' 54' ' ' LEU . 10.0 t30 -83.85 104.05 13.62 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.888 HG21 HD11 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -141.21 167.15 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.34 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.58 ' CG2' ' HA ' ' A' ' 180' ' ' ASN . 96.0 mt -105.7 117.53 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 CA-C-N 113.934 -1.484 . . . . 0.0 109.73 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.518 HG23 HG13 ' A' ' 175' ' ' VAL . 44.7 pt -122.27 170.09 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.448 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 48.59 -132.94 1.48 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 124.036 0.934 . . . . 0.0 110.318 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.95 53.87 2.56 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.35 0.595 . . . . 0.0 110.233 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.754 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 14.7 m120 69.88 44.4 0.83 Allowed 'General case' 0 CA--C 1.5 -0.967 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.887 176.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 91.7 mt -87.38 116.83 30.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.475 HG22 HG12 ' A' ' 176' ' ' ILE . 59.1 t -94.05 130.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.478 -175.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.522 ' OG1' ' HA ' ' A' ' 95' ' ' VAL . 15.1 t -135.55 159.99 39.89 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.532 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -152.27 145.84 24.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 . . . . . 0 C--O 1.26 1.616 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.762 179.5 . . . . . . . . 0 0 . 1 stop_ save_